PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ferrari, F; Jung, YL; Kharchenko, PV; Plachetka, A; Alekseyenko, AA; Kuroda, MI; Park, PJ				Ferrari, F.; Jung, Y. L.; Kharchenko, P. V.; Plachetka, A.; Alekseyenko, A. A.; Kuroda, M. I.; Park, P. J.			Comment on "Drosophila Dosage Compensation Involves Enhanced Pol II Recruitment to Male X-Linked Promoters"	SCIENCE			English	Editorial Material									[Ferrari, F.; Jung, Y. L.; Kharchenko, P. V.; Park, P. J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Jung, Y. L.; Plachetka, A.; Alekseyenko, A. A.; Kuroda, M. I.; Park, P. J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Kharchenko, P. V.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Plachetka, A.; Alekseyenko, A. A.; Kuroda, M. I.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Kuroda, MI (corresponding author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.	mkuroda@genetics.med.harvard.edu; peter_park@harvard.edu	Straub, Tobias/B-2023-2009; Ferrari, Francesco/H-5007-2012	Straub, Tobias/0000-0002-0547-0453; Ferrari, Francesco/0000-0002-9811-3753; Becker, Peter/0000-0001-7186-0372	NIGMS NIH HHS [R01 GM045744, GM45744, R37 GM045744] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali R., 2012, PIPLINE CHIP SEQ DAT; Conrad T, 2012, SCIENCE, V337, P742, DOI 10.1126/science.1221428; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421	8	17	17	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130								10.1126/science.1231815	http://dx.doi.org/10.1126/science.1231815			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599463	Green Accepted			2022-12-28	WOS:000317657500023
J	Straub, T; Becker, PB				Straub, Tobias; Becker, Peter B.			Comment on "Drosophila Dosage Compensation Involves Enhanced Pol II Recruitment to Male X-Linked Promoters"	SCIENCE			English	Editorial Material									[Straub, Tobias] Univ Munich, Bioinformat Unit, Adolf Butenandt Inst, D-80336 Munich, Germany; [Straub, Tobias; Becker, Peter B.] Univ Munich, Ctr Integrated Prot Sci, D-80336 Munich, Germany; [Becker, Peter B.] Univ Munich, Mol Biol Unit, Adolf Butenandt Inst, D-80336 Munich, Germany	University of Munich; University of Munich; University of Munich	Straub, T (corresponding author), Univ Munich, Bioinformat Unit, Adolf Butenandt Inst, D-80336 Munich, Germany.	tobias.straub@lmu.de; peter.becker@med.uni-muenchen.de	Straub, Tobias/B-2023-2009; Ferrari, Francesco/H-5007-2012	Straub, Tobias/0000-0002-0547-0453; Ferrari, Francesco/0000-0002-9811-3753; Becker, Peter/0000-0001-7186-0372	NIGMS NIH HHS [R01 GM045744, GM45744, R37 GM045744] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Conrad T, 2012, SCIENCE, V337, P742, DOI 10.1126/science.1221428; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Straub T, 2011, CURR OPIN GENET DEV, V21, P147, DOI 10.1016/j.gde.2011.01.012	3	17	17	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130								10.1126/science.1231895	http://dx.doi.org/10.1126/science.1231895			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599463				2022-12-28	WOS:000317657500024
J	Lucchitta, I				Lucchitta, Ivo			Comment on "Apatite He-4/He-3 and (U-Th)/He Evidence for an Ancient Grand Canyon"	SCIENCE			English	Editorial Material							DRAINAGE		[Lucchitta, Ivo] US Geol Survey, Flagstaff, AZ 86001 USA; [Lucchitta, Ivo] Museum Northern Arizona, Flagstaff, AZ 86001 USA	United States Department of the Interior; United States Geological Survey	Lucchitta, I (corresponding author), US Geol Survey, Flagstaff, AZ 86001 USA.	ilucchitta@gmail.com						ELSTON DP, 1991, J GEOPHYS RES-SOLID, V96, P12389, DOI 10.1029/90JB01978; Faulds J.E., 2001, COLORADO RIVER ORIGI, P81; Flowers RM, 2012, SCIENCE, V338, P1616, DOI [10.1126/science.51229390, 10.1126/science.1229390]; LONGWELL CR, 1936, GEOL SOC AM BULL, V47, P1393, DOI DOI 10.1130/GSAB-47-1393; Lopez Pearce J. C., 2011, 20111210 US GEOL SUR, P180; LUCCHITTA I, 1987, MOUTH GRAND CANYON E, P365; LUCCHITTA I, 1989, GEOLOGIC EVOLUTION A, V17, P701; Lucchitta I., 1966, THESIS PENNSYLVANIA; Young RA, 2008, GEOL SOC AM SPEC PAP, V439, P319, DOI 10.1130/2008.2439(14)	9	17	16	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129								10.1126/science.1234567	http://dx.doi.org/10.1126/science.1234567			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23589897				2022-12-28	WOS:000317341400033
J	Martinez, JB; Ramos, SG				Martinez, Jose Baddini; Ramos, Simone Gusmao			Dendriform pulmonary ossification	LANCET			English	Editorial Material									[Martinez, Jose Baddini] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Internal Med, Div Pulm, Sao Paulo, Brazil; [Ramos, Simone Gusmao] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Martinez, JB (corresponding author), Med Sch Ribeirao Preto, Dept Internal Med, Ave Bandeirantes 3900, BR-14048900 Sao Paulo, Brazil.	baddini@fmrp.usp.br	Baddini-Martinez, Jose/E-3098-2012	Baddini-Martinez, Jose/0000-0001-8160-5084; Ramos, Simone/0000-0002-1981-5248					0	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2013	382	9904					E22	E22		10.1016/S0140-6736(13)60097-5	http://dx.doi.org/10.1016/S0140-6736(13)60097-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247NE	23582722	Bronze			2022-12-28	WOS:000326623900002
J	Rosenau, AM				Rosenau, Alex M.			Guidelines for Opioid Prescription: The Devil Is in the Details	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Lehigh Valley Hlth Network, Allentown, PA 18103 USA	Lehigh Valley Health Network	Rosenau, AM (corresponding author), Lehigh Valley Hlth Network, JDMCC 214,I-78 & Cedar Crest Blvd, Allentown, PA 18103 USA.	alex.rosenau@gmail.com						American College of Emergency Physicians, 2013, POL COMP EL PRESCR M; American College of Emergency Physicians, 2013, POL COMP OPT TREATM; American College of Emergency Physicians, 2013, POL COMP EM PHYS RIG; Benard A, 2013, AM MED ASS STAT LEG; Cantrill SV, 2012, ANN EMERG MED, V60, P499, DOI 10.1016/j.annemergmed.2012.06.013; Chu J, 2013, NEW YORK CITY EMERGE; Governale L., 2010, JOINT M AN LIF SUPP; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Warner Margaret, 2011, NCHS Data Brief, P1	9	6	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					843	+		10.7326/0003-4819-158-11-201306040-00632	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00632			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164AA	23567867				2022-12-28	WOS:000320379800009
J	Bernien, H; Hensen, B; Pfaff, W; Koolstra, G; Blok, MS; Robledo, L; Taminiau, TH; Markham, M; Twitchen, DJ; Childress, L; Hanson, R				Bernien, H.; Hensen, B.; Pfaff, W.; Koolstra, G.; Blok, M. S.; Robledo, L.; Taminiau, T. H.; Markham, M.; Twitchen, D. J.; Childress, L.; Hanson, R.			Heralded entanglement between solid-state qubits separated by three metres	NATURE			English	Article							QUANTUM-DOT SPIN; PHOTON	Quantum entanglement between spatially separated objects is one of the most intriguing phenomena in physics. The outcomes of independent measurements on entangled objects show correlations that cannot be explained by classical physics. As well as being of fundamental interest, entanglement is a unique resource for quantum information processing and communication. Entangled quantum bits (qubits) can be used to share private information or implement quantum logical gates(1,2). Such capabilities are particularly useful when the entangled qubits are spatially separated(3-5), providing the opportunity to create highly connected quantum networks(6) or extend quantum cryptography to long distances(7,8). Here we report entanglement of two electron spin qubits in diamond with a spatial separation of three metres. We establish this entanglement using a robust protocol based on creation of spin-photon entanglement at each location and a subsequent joint measurement of the photons. Detection of the photons heralds the projection of the spin qubits onto an entangled state. We verify the resulting non-local quantum correlations by performing single-shot readout(9) on the qubits in different bases. The long-distance entanglement reported here can be combined with recently achieved initialization, readout and entanglement operations(9-13) on local long-lived nuclear spin registers, paving the way for deterministic long-distance teleportation, quantum repeaters and extended quantum networks.	[Bernien, H.; Hensen, B.; Pfaff, W.; Koolstra, G.; Blok, M. S.; Robledo, L.; Taminiau, T. H.; Hanson, R.] Delft Univ Technol, Kavli Inst Nanosci Delft, NL-2600 GA Delft, Netherlands; [Markham, M.; Twitchen, D. J.] Element Six Ltd, Ascot SL5 8BP, Berks, England; [Childress, L.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada	Delft University of Technology; Element Six; McGill University	Hanson, R (corresponding author), Delft Univ Technol, Kavli Inst Nanosci Delft, POB 5046, NL-2600 GA Delft, Netherlands.	r.hanson@tudelft.nl	Bernien, Hannes/AAM-5598-2020; Blok, Machiel/GNP-0018-2022; Hanson, Ronald/B-9555-2008; Childress, Lilian/H-1359-2012; Bernien, Hannes/E-6197-2012; Robledo, Lucio M/F-3120-2011; Pfaff, Wolfgang/G-9152-2012; Taminiau, Tim Hugo H/A-8094-2008; Blok, Machiel/J-6707-2012	Bernien, Hannes/0000-0002-1950-7368; Blok, Machiel/0000-0001-9736-4158; Childress, Lilian/0000-0002-0507-6392; Taminiau, Tim Hugo H/0000-0002-2355-727X; Markham, Matthew/0000-0001-8898-5884; Koolstra, Gerwin/0000-0002-6574-5789	Dutch Organization for Fundamental Research on Matter (FOM); Netherlands Organization for Scientific Research (NWO); DARPA QuASAR; EU SOLID programme; EU DIAMANT programme; EU S3NANO programme; European Research Council	Dutch Organization for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); DARPA QuASAR; EU SOLID programme; EU DIAMANT programme; EU S3NANO programme; European Research Council(European Research Council (ERC)European Commission)	We thank F. Jelezko, P. Kok, M. Lukin, J. Morton, E. Togan and L. Vandersypen for discussions and comments, and R. N. Schouten and M. J. Tiggelman for technical assistance. We acknowledge support from the Dutch Organization for Fundamental Research on Matter (FOM), the Netherlands Organization for Scientific Research (NWO), the DARPA QuASAR programme, the EU SOLID, DIAMANT and S3NANO programmes and the European Research Council through a Starting Grant.	Aharonovich I, 2011, NAT PHOTONICS, V5, P397, DOI [10.1038/NPHOTON.2011.54, 10.1038/nphoton.2011.54]; Barrett SD, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.060310; Bassett LC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.266403; Bernien H, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.043604; Childress L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.070504; De Greve K, 2012, NATURE, V491, P421, DOI 10.1038/nature11577; de Lange G, 2010, SCIENCE, V330, P60, DOI 10.1126/science.1192739; Dolde F, 2013, NAT PHYS, V9, P139, DOI 10.1038/nphys2545; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Flagg EB, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.137401; Fu KMC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.256404; Hofmann J, 2012, SCIENCE, V337, P72, DOI 10.1126/science.1221856; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Neumann P, 2008, SCIENCE, V320, P1326, DOI 10.1126/science.1157233; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Patel RB, 2010, NAT PHOTONICS, V4, P632, DOI [10.1038/NPHOTON.2010.161, 10.1038/nphoton.2010.161]; Pfaff W, 2013, NAT PHYS, V9, P29, DOI [10.1038/nphys2444, 10.1038/NPHYS2444]; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Robledo L, 2011, NATURE, V477, P574, DOI 10.1038/nature10401; Robledo L, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177403; Sipahigil A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.143601; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; van der Sar T, 2012, NATURE, V484, P82, DOI 10.1038/nature10900	31	652	664	9	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					86	90		10.1038/nature12016	http://dx.doi.org/10.1038/nature12016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23615617	Green Submitted			2022-12-28	WOS:000318221500038
J	Gill, CJ; Young, M; Schroder, K; Carvajal-Velez, L; McNabb, M; Aboubaker, S; Qazi, S; Bhutta, ZA				Gill, Christopher J.; Young, Mark; Schroder, Kate; Carvajal-Velez, Liliana; McNabb, Marion; Aboubaker, Samira; Qazi, Shamim; Bhutta, Zulfiqar A.			Bottlenecks, barriers, and solutions: results from multicountry consultations focused on reduction of childhood pneumonia and diarrhoea deaths	LANCET			English	Article							INTEGRATED MANAGEMENT; ZINC SUPPLEMENTATION; MORTALITY; HEALTH; MORBIDITY; DISEASE; PREVENTION; COUNTRIES; COUNTDOWN; NEWBORN	Millions of children still die unnecessarily from pneumonia and diarrhoea, mainly in resource-poor settings. A series of collaborative consultations and workshops involving several hundred academic, public health, governmental and private sector stakeholders were convened to identify the key barriers to progress and to issue recommendations. Bottlenecks impairing access to commodities included antiquated supply management systems, insufficient funding for drugs, inadequate knowledge about interventions by clients and providers, health worker shortages, poor support for training or retention of health workers, and a failure to convert national policies into action plans. Key programmatic barriers included an absence of effective programme coordination between and within partner organisations, scarce financial resources, inadequate training and support for health workers, sporadic availability of key commodities, and suboptimal programme management. However, these problems are solvable. Advocacy could help to mobilise needed resources, raise awareness, and prioritise childhood pneumonia and diarrhoea deaths in the coming decade.	[Gill, Christopher J.; McNabb, Marion] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA; [Young, Mark; Carvajal-Velez, Liliana] UNICEF, New York, NY USA; [Schroder, Kate] Clinton Hlth Access Initiat, Boston, MA USA; [Aboubaker, Samira; Qazi, Shamim] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Bhutta, Zulfiqar A.] Aga Khan Univ, Karachi, Pakistan	Boston University; UNICEF; World Health Organization; Aga Khan University	Gill, CJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Int Hlth, Ctr Global Hlth & Dev, 801 Massachusetts Ave, Boston, MA 02118 USA.	cgill@bu.edu		gill, christopher/0000-0003-3353-0617	Bill & Melinda Gates Foundation; Bloomberg School of Public Health Johns Hopkins University; Boston University School of Public Health; Program for Global Pediatric Research, Hospital for Sick Children, Toronto; WHO; UNICEF	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Bloomberg School of Public Health Johns Hopkins University; Boston University School of Public Health; Program for Global Pediatric Research, Hospital for Sick Children, Toronto; WHO(World Health Organization); UNICEF	The work summarised in this Series was supported by an unrestricted grant from the Bill & Melinda Gates Foundation to the Aga Khan University and through it to collaborating universities and institutions (Bloomberg School of Public Health Johns Hopkins University; Boston University School of Public Health; and Program for Global Pediatric Research, Hospital for Sick Children, Toronto). Additional support was provided by internal resources from WHO and UNICEF. The funding agency had no influence or control over the content and process for the development of this Series. We thank the following individuals for their work on these projects: Shams El Arifeen, Narendra Arora, Godfrey Biemba, William Brieger, Cathleen Cisse, Thomas Cherian, Alejandro Cravioto, Jai Das, Teshome Desta, Stalin Ewoigbokhan, Olivier Fontaine, Tracy Goodman, Duc Ha, Phanuel Habimana, Corrie Haley, Davidson Hamer, Cheryl Hendrickson, Rose Kamenwa, Rajesh Kumar, William Macharia, Carsten Mantel, Holly Newby, Ashok Patwari, Neena Raina, Affan Shaikh, Kira Skolos, Tazeen Tahsina, Samantha Xia, and Danzhen You. The opinions expressed in this paper are those of the authors, and do not necessarily represent those of their parent organisations.	[Anonymous], 2010, MILL DEV GOALS REP; [Anonymous], 2012, UNICEF PROGR REPORT; [Anonymous], 2011, UN INT GROUP CHILD M; [Anonymous], 2012, COMM REP; Bari A, 2011, LANCET, V378, P1796, DOI 10.1016/S0140-6736(11)61140-9; Bhutta ZA, 2013, LANCET, V381, P2207, DOI 10.1016/S0140-6736(12)61999-0; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI69, DOI 10.1093/heapol/czi053; Bryce J, 2004, AM J PUBLIC HEALTH, V94, P406, DOI 10.2105/AJPH.94.3.406; Butler JC, 1999, AM J MED, V107, P69, DOI 10.1016/S0002-9343(99)00105-9; Carrera C, 2012, LANCET, V380, P1341, DOI 10.1016/S0140-6736(12)61378-6; Chopra M, 2012, ARCH DIS CHILD, V97, P350, DOI 10.1136/archdischild-2011-301191; Clinton Health Access Initiative, 2011, PRIV SECT MARK DIARR; Goveia MG, 2011, ANN NY ACAD SCI, V1222, P14, DOI 10.1111/j.1749-6632.2011.05970.x; Haffejee I E, 1995, Glob Child Health New Rev, V3, P18; Hecht R, 2010, LANCET, V376, P1254, DOI 10.1016/S0140-6736(10)61255-X; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, GLOB REP 2012; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Marshall GS, 2009, PEDIATR INFECT DIS J, V28, P355, DOI 10.1097/INF.0b013e318199494a; Mazumder S, 2010, B WORLD HEALTH ORGAN, V88, P754, DOI 10.2471/BLT.10.075986; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; National Population Commission and ICF, 2009, NIG DEM HLTH SURV 20; ONI GA, 1991, J DIARRHOEAL DIS RES, V9, P250; Poland GA, 2001, INFECT DIS CLIN N AM, V15, P97, DOI 10.1016/S0891-5520(05)70270-1; Soucat A, 2002, MARGINAL BUDGETTING; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; The UN Inter-agency Group for Child Mortality Estimation, 2012, LEV TRENDS CHILD MOR; UNICEF, 2006, MAN SICK CHILDR COMM; UNICEF, 2012, PNEUM DIARRH; UNICEF WHO, 2004, WHO UNICEF JOINT STA; UNICEF/WHO, 2009, DIARRH WHY CHILDR AR; UNICEF WHO, 2004, JOINT STAT CLIN MAN; UNICEF WHO, 2012, WHO UNICEF JOINT STA; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walker CLF, 2010, INT J EPIDEMIOL, V39, P63, DOI 10.1093/ije/dyq023; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Ward RL, 2009, CLIN INFECT DIS, V48, P222, DOI 10.1086/595702; WHO/UNICEF, 2009, GLOB ACT PLAN PREV G; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S23	44	55	55	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2013	381	9876					1487	1498		10.1016/S0140-6736(13)60314-1	http://dx.doi.org/10.1016/S0140-6736(13)60314-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139TK	23582720				2022-12-28	WOS:000318607300038
J	Curtis, AB; Worley, SJ; Adamson, PB; Chung, ES; Niazi, I; Sherfesee, L; Shinn, T; Sutton, MS				Curtis, Anne B.; Worley, Seth J.; Adamson, Philip B.; Chung, Eugene S.; Niazi, Imran; Sherfesee, Lou; Shinn, Timothy; Sutton, Martin St John		Biventricular Versus Right Ventric	Biventricular Pacing for Atrioventricular Block and Systolic Dysfunction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; SINUS-NODE DYSFUNCTION; ATRIAL-FIBRILLATION; VENTRICULAR-FUNCTION; DUAL-CHAMBER; OUTFLOW; DEFIBRILLATOR; ABLATION; DESIGN; TRIAL	BACKGROUND Right ventricular pacing restores an adequate heart rate in patients with atrioventricular block, but high percentages of right ventricular apical pacing may promote left ventricular systolic dysfunction. We evaluated whether biventricular pacing might reduce mortality, morbidity, and adverse left ventricular remodeling in such patients. METHODS We enrolled patients who had indications for pacing with atrioventricular block; New York Heart Association (NYHA) class I, II, or III heart failure; and a left ventricular ejection fraction of 50% or less. Patients received a cardiac-resynchronization pacemaker or implantable cardioverter-defibrillator (ICD) (the latter if the patient had an indication for defibrillation therapy) and were randomly assigned to standard right ventricular pacing or biventricular pacing. The primary outcome was the time to death from any cause, an urgent care visit for heart failure that required intravenous therapy, or a 15% or more increase in the left ventricular end-systolic volume index. RESULTS Of 918 patients enrolled, 691 underwent randomization and were followed for an average of 37 months. The primary outcome occurred in 190 of 342 patients (55.6%) in the right-ventricular-pacing group, as compared with 160 of 349 (45.8%) in the biventricular-pacing group. Patients randomly assigned to biventricular pacing had a significantly lower incidence of the primary outcome over time than did those assigned to right ventricular pacing (hazard ratio, 0.74; 95% credible interval, 0.60 to 0.90); results were similar in the pacemaker and ICD groups. Left ventricular lead-related complications occurred in 6.4% of patients. CONCLUSIONS Biventricular pacing was superior to conventional right ventricular pacing in patients with atrioventricular block and left ventricular systolic dysfunction with NYHA class I, II, or III heart failure. (Funded by Medtronic; BLOCK HF ClinicalTrials. gov number, NCT00267098.)	[Curtis, Anne B.] SUNY Buffalo, Buffalo, NY 14203 USA; [Worley, Seth J.] Lancaster Gen Hosp, Lancaster, PA USA; [Adamson, Philip B.] Oklahoma Fdn Cardiovasc Res, Oklahoma City, OK USA; [Chung, Eugene S.] Christ Hosp, Heart & Vasc Ctr, Cincinnati, OH 45219 USA; [Niazi, Imran] St Lukes Med Ctr, Milwaukee, WI USA; [Sherfesee, Lou] Medtronic, Minneapolis, MN USA; [Shinn, Timothy] St Joseph Mercy, Ann Arbor, MI USA; [Sutton, Martin St John] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Christ Hospital - Ohio; Medtronic; Saint Joseph Mercy Health System (SJMHS); University of Pennsylvania	Curtis, AB (corresponding author), SUNY Buffalo, Dept Med, Buffalo Gen Med Ctr, 100 High St,D2-76, Buffalo, NY 14203 USA.	abcurtis@buffalo.edu			Biosense Webster; St. Jude Medical; Sanofi-Aventis; Pfizer; Bristol-Myers Squibb; Medtronic; Spectranetics; Pressure Products Medical Supplies; Janssen Pharmaceuticals; Boehringer Ingelheim; CardioMEMS; Gambro; Boston Scientific; Osprey Medical; Biotronik; BioContro Medical	Biosense Webster; St. Jude Medical(St. Jude Medical); Sanofi-Aventis(Sanofi-Aventis); Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); Medtronic(Medtronic); Spectranetics; Pressure Products Medical Supplies; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Boehringer Ingelheim(Boehringer Ingelheim); CardioMEMS; Gambro; Boston Scientific(Boston Scientific); Osprey Medical; Biotronik; BioContro Medical	Dr. Curtis reports receiving fees for serving on the advisory boards of Biosense Webster, St. Jude Medical, Sanofi-Aventis, Pfizer, and Bristol-Myers Squibb; receiving consulting fees from Medtronic; receiving lecture fees from Sanofi-Aventis, St. Jude Medical, and Medtronic; and receiving payment for the development of educational presentations from Horizon CME, WebMD Health Services, and the North American Center for Continuing Medical Education. Dr. Worley reports receiving consulting fees from Medtronic, St. Jude Medical, Pressure Products Medical Supplies, and Spectranetics; receiving grant support from Medtronic; receiving lecture fees from Sanofi-Aventis, St. Jude Medical, Medtronic, Janssen Pharmaceuticals, and Boehringer Ingelheim; holding patents through and receiving royalties from Pressure Products Medical Supplies and Oscor regarding implantable devices; and receiving payment for the development of educational presentations from Medtronic, Pressure Products Medical Supplies, and Spectranetics. Dr. Adamson reports receiving consulting fees from Medtronic, St. Jude Medical, and CardioMEMS and lecture fees from St. Jude Medical. Dr. Chung reports receiving consulting fees from Boston Scientific, Medtronic, and CardioMEMS, payment for the development of educational presentations from Boston Scientific, and grant support through his institution from Gambro, Medtronic, and Boston Scientific. Dr. Niazi reports receiving consulting fees from Osprey Medical, St. Jude Medical, and Medtronic; holding stock in Medtronic; receiving grant support through his institution from Medtronic, Biotronik, Boston Scientific, Sanofi-Aventis, Janssen Pharmaceuticals, and Bristol-Myers Squibb; receiving lecture fees from Sanofi-Aventis and Janssen Pharmaceuticals; and holding a patent regarding a guide catheter for coronary-sinus cannulation and a pending patent regarding pacing in implantable cardioverter-defibrillators. Dr. Sherfesee reports being an employee of and holding stock and stock options in Medtronic. Dr. Shinn reports receiving consulting fees from Medtronic and Spectranetics and grant support through his institution from Medtronic, Boston Scientific, Biotronik, St. Jude Medical, Sanofi-Aventis, and Forest Pharmaceuticals. Dr. St. John Sutton reports receiving consulting fees from Medtronic and BioContro Medical. No other potential conflict of interest relevant to this article was reported.	Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bourke JP, 2002, EUROPACE, V4, P219, DOI 10.1053/eupc.2002.0238; Curtis AB, 2007, J CARDIOVASC ELECTR, V18, P965, DOI 10.1111/j.1540-8167.2007.00907.x; Deshmukh PM, 2004, PACE, V27, P862, DOI 10.1111/j.1540-8159.2004.00548.x; Kaye G, 2009, PACE, V32, P426, DOI 10.1111/j.1540-8159.2009.02301.x; Lamas GA, 2002, NEW ENGL J MED, V346, P1854, DOI 10.1056/NEJMoa013040; Mera F, 1999, PACE, V22, P1234, DOI 10.1111/j.1540-8159.1999.tb00606.x; Stambler BS, 2003, J CARDIOVASC ELECTR, V14, P1180, DOI 10.1046/j.1540-8167.2003.03216.x; Sweeney MO, 2003, CIRCULATION, V107, P2932, DOI 10.1161/01.CIR.0000072769.17295.B1; Tse HF, 2002, J AM COLL CARDIOL, V40, P1451, DOI 10.1016/S0735-1097(02)02169-1; Victor F, 1999, J AM COLL CARDIOL, V33, P311, DOI 10.1016/S0735-1097(98)00589-0; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115; Yu CM, 2009, NEW ENGL J MED, V361, P2123, DOI 10.1056/NEJMoa0907555	14	433	456	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1585	1593		10.1056/NEJMoa1210356	http://dx.doi.org/10.1056/NEJMoa1210356			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130YK	23614585	Bronze			2022-12-28	WOS:000317956300007
J	Song, CX; Szulwach, KE; Dai, Q; Fu, Y; Mao, SQ; Lin, L; Street, C; Li, YJ; Poidevin, M; Wu, H; Gao, J; Liu, P; Li, L; Xu, GL; Jin, P; He, C				Song, Chun-Xiao; Szulwach, Keith E.; Dai, Qing; Fu, Ye; Mao, Shi-Qing; Lin, Li; Street, Craig; Li, Yujing; Poidevin, Mickael; Wu, Hao; Gao, Juan; Liu, Peng; Li, Lin; Xu, Guo-Liang; Jin, Peng; He, Chuan			Genome-wide Profiling of 5-Formylcytosine Reveals Its Roles in Epigenetic Priming	CELL			English	Article							EMBRYONIC STEM-CELLS; THYMINE DNA GLYCOSYLASE; BASE-RESOLUTION; MAMMALIAN DNA; TET PROTEINS; SELF-RENEWAL; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; DEMETHYLATION; METHYLATION	TET proteins oxidize 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC). 5fC and 5caC are excised by mammalian DNA glycosylase TDG, implicating 5mC oxidation in DNA demethylation. Here, we show that the genomic locations of 5fC can be determined by coupling chemical reduction with biotin tagging. Genome-wide mapping of 5fC in mouse embryonic stem cells (mESCs) reveals that 5fC preferentially occurs at poised enhancers among other gene regulatory elements. Application to Tdg null mESCs further suggests that 5fC production coordinates with p300 in remodeling epigenetic states of enhancers. This process, which is not influenced by 5hmC, appears to be associated with further oxidation of 5hmC and commitment to demethylation through 5fC. Finally, we resolved 5fC at base resolution by hydroxylamine-based protection from bisulfite-mediated deamination, thereby confirming sites of 5fC accumulation. Our results reveal roles of active 5mC/5hmC oxidation and TDG-mediated demethylation in epigenetic tuning at regulatory elements.	[Song, Chun-Xiao; Dai, Qing; Fu, Ye; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Song, Chun-Xiao; Dai, Qing; Fu, Ye; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Szulwach, Keith E.; Lin, Li; Street, Craig; Li, Yujing; Poidevin, Mickael; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Wu, Hao] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Mao, Shi-Qing; Gao, Juan; Liu, Peng; Li, Lin; Xu, Guo-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Grp DNA Metab,State Key Lab Mol Biol, Shanghai 200031, Peoples R China	University of Chicago; University of Chicago; Emory University; Emory University; Rollins School Public Health; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jin, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	jin@emory.edu; chuanhe@uchicago.edu	Mao, Shiqing/AAV-1168-2020; Dai, Qing/ABD-8444-2021; Li, Yujing/AAJ-1411-2020; gao, juan/GXV-1381-2022; Wu, Hao/H-3899-2017; Li, yujing/GQA-4109-2022	Mao, Shiqing/0000-0001-9902-0199; Li, Yujing/0000-0002-4363-2484; Wu, Hao/0000-0003-1269-7354; Song, Chun-Xiao/0000-0002-7781-6521; Fu, Ye/0000-0002-3807-9717; Liu, Peng/0000-0002-6469-6460; Fu, Ye/0000-0003-4434-6014	National Institutes of Health [HG006827, NS079625/NS051630/HD073162/AG025688]; Ministry of Science and Technology of China [2011CB946102, 2012CB966903]; Emory Genetics Discovery Fund; Simons Foundation Autism Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD073162] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG006699, R01HG006827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Emory Genetics Discovery Fund; Simons Foundation Autism Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (HG006827 to C.H. and NS079625/NS051630/HD073162/AG025688 to P.J.), grants from the Ministry of Science and Technology of China (2011CB946102 and 2012CB966903 to G.X.), the Emory Genetics Discovery Fund (P.J.), and the Simons Foundation Autism Research Initiative (P.J.). We thank Drs. Bing Ren and Gary Hon for sharing single-base maps of 5mC+5hmC and 5hmC. We thank S.F. Reichard for editing the manuscript. A patent application has been filed for the technology disclosed in this publication.	Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jin SG, 2011, NUCLEIC ACIDS RES, V39, P5015, DOI 10.1093/nar/gkr120; Khare T, 2012, NAT STRUCT MOL BIOL, V19, P1037, DOI 10.1038/nsmb.2372; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Matarese F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.95; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raiber EA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r69; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Statham AL, 2012, GENOME RES, V22, P1120, DOI 10.1101/gr.132076.111; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Wilder PJ, 1997, DEV BIOL, V192, P614, DOI 10.1006/dbio.1997.8777; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	50	405	421	3	154	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					678	691		10.1016/j.cell.2013.04.001	http://dx.doi.org/10.1016/j.cell.2013.04.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23602153	Green Accepted, Bronze			2022-12-28	WOS:000318063500019
J	Algra, AM				Algra, Annemijn M.			Towards a global brief on aspirin	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Algra, AM (corresponding author), The Lancet, London NW1 7BY, England.	annechien.algra@ndcn.ox.ac.uk						Chan AT, 2012, LANCET, V379, P1569, DOI 10.1016/S0140-6736(11)61654-1; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; George Mary G, 2012, MMWR Suppl, V61, P11; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Vandvik PO, 2012, CHEST, V141, P1129, DOI 10.1378/chest.11-2306; WHO, 2013, GLOB BRIEF HYP; World Heart Federation, 2012, 25 BY 2025 A GAME CH	7	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1344	1345		10.1016/S0140-6736(13)60772-2	http://dx.doi.org/10.1016/S0140-6736(13)60772-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130EF	23601936				2022-12-28	WOS:000317894800011
J	Walker, CLF; Rudan, I; Liu, L; Nair, H; Theodoratou, E; Bhutta, ZA; O'Brien, KL; Campbell, H; Black, RE				Walker, Christa L. Fischer; Rudan, Igor; Liu, Li; Nair, Harish; Theodoratou, Evropi; Bhutta, Zulfiqar A.; O'Brien, Katherine L.; Campbell, Harry; Black, Robert E.			Childhood Pneumonia and Diarrhoea 1 Global burden of childhood pneumonia and diarrhoea	LANCET			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; RESPIRATORY-TRACT INFECTION; COMMUNITY CASE-MANAGEMENT; RISK-FACTORS; YOUNG-CHILDREN; STREPTOCOCCUS-PNEUMONIAE; PERSISTENT DIARRHEA; SYSTEMATIC ANALYSIS; PRESCHOOL-CHILDREN; RURAL BANGLADESH	Diarrhoea and pneumonia are the leading infectious causes of childhood morbidity and mortality. We comprehensively reviewed the epidemiology of childhood diarrhoea and pneumonia in 2010-11 to inform the planning of integrated control programmes for both illnesses. We estimated that, in 2010, there were 1.731 billion episodes of diarrhoea (36 million of which progressed to severe episodes) and 120 million episodes of pneumonia (14 million of which progressed to severe episodes) in children younger than 5 years. We estimated that, in 2011, 700 000 episodes of diarrhoea and 1.3 million of pneumonia led to death. A high proportion of deaths occurs in the first 2 years of life in both diseases-72% for diarrhoea and 81% for pneumonia. The epidemiology of childhood diarrhoea and that of pneumonia overlap, which might be partly because of shared risk factors, such as undernutrition, suboptimum breastfeeding, and zinc deficiency. Rotavirus is the most common cause of vaccine-preventable severe diarrhoea (associated with 28% of cases), and Streptococcus pneumoniae (18.3%) of vaccine-preventable severe pneumonia. Morbidity and mortality from childhood pneumonia and diarrhoea are falling, but action is needed globally and at country level to accelerate the reduction.	[Walker, Christa L. Fischer; Liu, Li; O'Brien, Katherine L.; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Rudan, Igor; Nair, Harish; Theodoratou, Evropi; Campbell, Harry] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Rudan, Igor; Nair, Harish; Theodoratou, Evropi; Campbell, Harry] Univ Edinburgh, Sch Med, Global Hlth Acad, Edinburgh, Midlothian, Scotland; [Nair, Harish] Publ Hlth Fdn India, New Delhi, India; [Bhutta, Zulfiqar A.] Aga Khan Univ, Karachi, Pakistan	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Edinburgh; University of Edinburgh; Public Health Foundation of India; Aga Khan University	Black, RE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	rblack@jhsph.edu	Rudan, Igor/I-1467-2012; Campbell, Harry/E-2959-2010; liu, li/HGC-0900-2022; Theodoratou, Evropi/C-3430-2014; Nair, Harish/E-7431-2010	Rudan, Igor/0000-0001-6993-6884; Campbell, Harry/0000-0002-6169-6262; Theodoratou, Evropi/0000-0001-5887-9132; Nair, Harish/0000-0002-9432-9100; Black, Robert/0000-0001-9926-7984; O'Brien, Katherine/0000-0002-0164-4030	Bill & Melinda Gates Foundation [51285, OPPGH5308]; Child Health Epidemiology Reference Group of WHO and UNICEF	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Child Health Epidemiology Reference Group of WHO and UNICEF	Funding was provided by grants from the Bill & Melinda Gates Foundation for the Global Action Plan for Pneumonia and Diarrhoea to the Aga Khan University and the Child Health Epidemiology Reference Group of WHO and UNICEF. Additional support was provided via grants from the Bill & Melinda Gates Foundation (51285 and OPPGH5308). We thank Jamie Perin (Johns Hopkins Bloomberg School of Public Health) for additional analyses and contributions to the 2011 mortality estimates, and Hope Johnson (GAVI Alliance) and Maria Deloria Knoll (Johns Hopkins Bloomberg School of Public Health) for help with revision and updating of the meta-analysis of vaccine trials needed to estimate the burden of S pneumoniae and H influenzae.	Abu-Elyazeed R, 1999, J INFECT DIS, V179, P382, DOI 10.1086/314593; BAQUI AH, 1993, AM J EPIDEMIOL, V137, P355, DOI 10.1093/oxfordjournals.aje.a116682; BARKER DJP, 1991, BRIT MED J, V303, P671, DOI 10.1136/bmj.303.6804.671; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; BHAN MK, 1989, B WORLD HEALTH ORGAN, V67, P281; Bhutta ZA, 2013, LANCET; BLACK RE, 1989, AM J EPIDEMIOL, V129, P785, DOI 10.1093/oxfordjournals.aje.a115193; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Broor S, 2001, Indian Pediatr, V38, P1361; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; CERQUEIRO MC, 1990, REV INFECT DIS, V12, pS1021; Checkley W, 2000, LANCET, V355, P442, DOI 10.1016/S0140-6736(00)82010-3; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Chowdhury EK, 2008, LANCET, V372, P822, DOI 10.1016/S0140-6736(08)61166-6; Clara W, 2012, B WORLD HEALTH ORGAN, V90, P756, DOI 10.2471/BLT.11.098202; Cravioto A, FINAL REPORT INDEPEN; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; CRUZ JR, 1994, PEDIATR INFECT DIS J, V13, P216, DOI 10.1097/00006454-199403000-00010; de Melo MCN, 2008, BRAZ J INFECT DIS, V12, P89, DOI 10.1590/S1413-86702008000100019; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Duke T, 2003, LANCET, V361, P763, DOI 10.1016/S0140-6736(03)12661-X; Duke T, 2002, LANCET, V359, P474, DOI 10.1016/S0140-6736(02)07677-8; Edmond K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031239; Enarson Penny M, 2010, Expert Rev Respir Med, V4, P211, DOI 10.1586/ers.10.14; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Fatmi Zafar, 2002, International Journal of Infectious Diseases, V6, P294, DOI 10.1016/S1201-9712(02)90164-5; Feachem R G, 1982, Trop Dis Bull, V79, P1; FEACHEM RG, 1983, B WORLD HEALTH ORGAN, V61, P641; Feng Xing Lin, 2012, J Glob Health, V2, P010405, DOI 10.7189/jogh.02.010405; Fischer Walker CL, J GLOB HLTH IN PRESS; Fischer Walker CL, 2012, BMC PUBLIC HEALTH, V12, P220, DOI DOI 10.1186/1471-2458-12-220; Fishman SM, 2004, COMP QUANTIFICATION, P39; Fonseca W, 1996, B WORLD HEALTH ORGAN, V74, P199; Genser B, 2006, EPIDEMIOLOGY, V17, P658, DOI 10.1097/01.ede.0000239728.75215.86; GLASS RI, 1982, AM J EPIDEMIOL, V116, P959, DOI 10.1093/oxfordjournals.aje.a113498; Glass Roger I., 1992, P129; Glass RI, 2012, JAMA-J AM MED ASSOC, V308, P141, DOI 10.1001/jama.2012.7357; Graham SM, 2007, ANN TROP PAEDIATR, V27, P243, DOI 10.1179/146532807X245625; Graham SM, 2005, INT J TUBERC LUNG D, V9, P592; Gupta DN, 2007, PEDIATR INFECT DIS J, V26, P306, DOI 10.1097/01.inf.0000258692.65485.d9; Haque R, 2003, AM J TROP MED HYG, V69, P398, DOI 10.4269/ajtmh.2003.69.398; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Hartley DM, 2006, PLOS MED, V3, P63, DOI 10.1371/journal.pmed.0030007; Hershey Christine L, 2011, Confl Health, V5, P24, DOI 10.1186/1752-1505-5-24; Holmgren J, 2012, LANCET INFECT DIS, V12, P818, DOI 10.1016/S1473-3099(12)70204-9; Ibrahim MM, 1998, ANN TROP PAEDIATR, V18, P145, DOI 10.1080/02724936.1998.11747941; Jawad Issrah, 2012, J Glob Health, V2, P010404, DOI 10.7189/jogh.02.010404; Johnston IDA, 1998, NEW ENGL J MED, V338, P581, DOI 10.1056/NEJM199802263380904; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1031; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Madhi SA, 2000, CLIN INFECT DIS, V31, P170, DOI 10.1086/313925; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Mahmud MA, 2001, J HEALTH POPUL NUTR, V19, P313; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; Mitra AK, 1997, J NUTR, V127, P1451, DOI 10.1093/jn/127.8.1451; Mohammed Ali, 2001, Ethiopian Journal of Health Development, V15, P165; Morris JG, 2003, CLIN INFECT DIS, V37, P272, DOI 10.1086/375600; MOY RJD, 1991, J TROP PEDIATRICS, V37, P293, DOI 10.1093/tropej/37.6.293; Mulholland EK, 1999, PEDIATR INFECT DIS J, V18, pS35, DOI 10.1097/00006454-199910001-00007; Naficy AB, 2000, J INFECT DIS, V182, P685, DOI 10.1086/315763; Nair H, 2013, LANCET; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; ONI GA, 1991, J DIARRHOEAL DIS RES, V9, P250; Pathela P, 2006, ACTA PAEDIATR, V95, P430, DOI 10.1080/08035250500444875; Paynter S, 2010, LANCET, V376, P1804, DOI 10.1016/S0140-6736(10)62141-1; Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602; RAHMATHULLAH L, 1991, AM J CLIN NUTR, V54, P568, DOI 10.1093/ajcn/54.3.568; RAMAKRISHNAN U, 1995, AM J CLIN NUTR, V61, P1295, DOI 10.1093/ajcn/61.6.1295; Rao MR, 2003, J CLIN MICROBIOL, V41, P4862, DOI 10.1128/JCM.41.10.4862-4864.2003; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, J GLOB HLTH IN PRESS; Rudan I, 2008, LANCET, V372, P781, DOI 10.1016/S0140-6736(08)61167-8; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Rudan I, 2007, LANCET INFECT DIS, V7, P56, DOI 10.1016/S1473-3099(06)70687-9; Rudan Igor, 2012, J Glob Health, V2, P010304, DOI 10.7189/jogh.02.010304; SANTOSHAM M, 1995, J DIARRHOEAL DIS RES, V13, P18; Schmidt WP, 2009, INT J EPIDEMIOL, V38, P766, DOI 10.1093/ije/dyp159; Shaheen SO, 1998, THORAX, V53, P549, DOI 10.1136/thx.53.7.549; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Soofi S, 2012, LANCET, V379, P729, DOI 10.1016/S0140-6736(11)61714-5; Spiegel P, 2002, LANCET, V360, P1927, DOI 10.1016/S0140-6736(02)11915-5; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Strina A, 2005, T ROY SOC TROP MED H, V99, P407, DOI 10.1016/j.trstmh.2004.07.007; Torti Jacqueline, 2012, J Glob Health, V2, P020304, DOI 10.7189/jogh.02.020304; Udompornwattana Songkiat, 2012, Journal of the Medical Association of Thailand, V95, P403; UN Inter-agency Group for Child Mortality Estimation, 2012, LEV TRENDS CHILD MOR; UNICEF, 2012, BUILD FUT WOM CHILDR; van der Hoek W, 2002, J HEALTH POPUL NUTR, V20, P77; Walker CLF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047908; Walker CLF, 2012, J HEALTH POPUL NUTR, V30, P257; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Waters Donald, 2011, J Glob Health, V1, P154; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; WHO, 2009, PROT HLTH CLIMATE CH; WHO UNICEF, 2008, IMCI CHART BOOKL STA; WHO/UNICEF, 2009, DIARRH WHY CHILDR AR; Wilcox CM, 2000, WORLD J GASTROENTERO, V6, P177; World Health Organization, INT MAN CHILDH ILLN; World Health Organization, IMM SURV ASS MON; YANG CR, 1990, J DIARRHOEAL DIS RES, V8, P155; Young M, 2012, AM J TROP MED HYG, V87, P6, DOI 10.4269/ajtmh.2012.12-0221; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X; Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769	110	1349	1421	6	171	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1405	1416		10.1016/S0140-6736(13)60222-6	http://dx.doi.org/10.1016/S0140-6736(13)60222-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130EF	23582727	Green Published, Bronze			2022-12-28	WOS:000317894800038
J	Congreve, DN; Lee, JY; Thompson, NJ; Hontz, E; Yost, SR; Reusswig, PD; Bahlke, ME; Reineke, S; Van Voorhis, T; Baldo, MA				Congreve, Daniel N.; Lee, Jiye; Thompson, Nicholas J.; Hontz, Eric; Yost, Shane R.; Reusswig, Philip D.; Bahlke, Matthias E.; Reineke, Sebastian; Van Voorhis, Troy; Baldo, Marc A.			External Quantum Efficiency Above 100% in a Singlet-Exciton-Fission-Based Organic Photovoltaic Cell	SCIENCE			English	Article							ELECTRONIC-STRUCTURE; ENERGY; ANNIHILATION; DYNAMICS	Singlet exciton fission transforms a molecular singlet excited state into two triplet states, each with half the energy of the original singlet. In solar cells, it could potentially double the photocurrent from high-energy photons. We demonstrate organic solar cells that exploit singlet exciton fission in pentacene to generate more than one electron per incident photon in a portion of the visible spectrum. Using a fullerene acceptor, a poly(3-hexylthiophene) exciton confinement layer, and a conventional optical trapping scheme, we show a peak external quantum efficiency of (109 +/- 1)% at wavelength lambda = 670 nanometers for a 15-nanometer-thick pentacene film. The corresponding internal quantum efficiency is (160 +/- 10)%. Analysis of the magnetic field effect on photocurrent suggests that the triplet yield approaches 200% for pentacene films thicker than 5 nanometers.	[Congreve, Daniel N.; Lee, Jiye; Thompson, Nicholas J.; Hontz, Eric; Yost, Shane R.; Reusswig, Philip D.; Bahlke, Matthias E.; Reineke, Sebastian; Van Voorhis, Troy; Baldo, Marc A.] MIT, Energy Frontier Res Ctr Exciton, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Baldo, MA (corresponding author), MIT, Energy Frontier Res Ctr Exciton, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	baldo@mit.edu	Reineke, Sebastian/G-9894-2014; Reineke, Sebastian/AAE-2691-2020	Reineke, Sebastian/0000-0002-4112-6991; Reineke, Sebastian/0000-0002-4112-6991; /0000-0002-2914-3561; Yost, Shane/0000-0001-5010-1051	Center for Excitonics, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001088]; NSF [1122374]; Direct For Mathematical & Physical Scien [0963009] Funding Source: National Science Foundation	Center for Excitonics, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported as part of the Center for Excitonics, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award no. DE-SC0001088 (MIT). D.N.C. was partially supported by the NSF Graduate Research Fellowship under grant 1122374. MIT has filed a provisional application for patent based on this technology that names D.N.C., N.J.T., and M. A. B. as inventors.	BOUCHRIHA H, 1978, J PHYS-PARIS, V39, P257, DOI 10.1051/jphys:01978003903025700; Chan WL, 2011, SCIENCE, V334, P1541, DOI 10.1126/science.1213986; DEXTER DL, 1979, J LUMIN, V18-9, P779, DOI 10.1016/0022-2313(79)90235-7; Ehrler B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2012; Ehrler B, 2012, NANO LETT, V12, P1053, DOI 10.1021/nl204297u; Green MA, 2009, PROG PHOTOVOLTAICS, V17, P183, DOI 10.1002/pip.892; Guan ZL, 2010, ORG ELECTRON, V11, P1779, DOI 10.1016/j.orgel.2010.07.023; Hwang J, 2009, MAT SCI ENG R, V64, P1, DOI 10.1016/j.mser.2008.12.001; Jadhav PJ, 2012, ADV MATER, V24, P6169, DOI 10.1002/adma.201202397; Jadhav PJ, 2011, NANO LETT, V11, P1495, DOI 10.1021/nl104202j; Johnson JC, 2009, J PHYS CHEM C, V113, P6871, DOI 10.1021/jp901419s; JOHNSON RC, 1970, PHYS REV B-SOLID ST, V1, P896, DOI 10.1103/PhysRevB.1.896; JUNDT C, 1995, CHEM PHYS LETT, V241, P84, DOI 10.1016/0009-2614(95)00603-2; Kahn A, 2003, J POLYM SCI POL PHYS, V41, P2529, DOI 10.1002/polb.10642; Lee J, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3182787; Marciniak H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.176402; Monestier F, 2007, J APPL PHYS, V102, DOI 10.1063/1.2767619; Peumans P, 2003, J APPL PHYS, V93, P3693, DOI 10.1063/1.1534621; Reusswig PD, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4752445; Rim SB, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789677; SATO N, 1992, CHEM PHYS, V162, P433, DOI 10.1016/0301-0104(92)85020-U; Semonin OE, 2011, SCIENCE, V334, P1530, DOI 10.1126/science.1209845; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Smith MB, 2010, CHEM REV, V110, P6891, DOI 10.1021/cr1002613; SUNA A, 1970, PHYS REV B-SOLID ST, V1, P1716, DOI 10.1103/PhysRevB.1.1716; Thorsmolle VK, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017401; Tvingstedt K, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789393; Wilson MWB, 2011, J AM CHEM SOC, V133, P11830, DOI 10.1021/ja201688h; XU B, 1994, ADV MATER, V6, P325, DOI 10.1002/adma.19940060417; Yoo S, 2004, APPL PHYS LETT, V85, P5427, DOI 10.1063/1.1829777	30	677	694	18	792	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					334	337		10.1126/science.1232994	http://dx.doi.org/10.1126/science.1232994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599489				2022-12-28	WOS:000317657500050
J	Gao, M; Lu, C; Jean-Ruel, H; Liu, LC; Marx, A; Onda, K; Koshihara, S; Nakano, Y; Shao, XF; Hiramatsu, T; Saito, G; Yamochi, H; Cooney, RR; Moriena, G; Sciaini, G; Miller, RJD				Gao, Meng; Lu, Cheng; Jean-Ruel, Hubert; Liu, Lai Chung; Marx, Alexander; Onda, Ken; Koshihara, Shin-ya; Nakano, Yoshiaki; Shao, Xiangfeng; Hiramatsu, Takaaki; Saito, Gunzi; Yamochi, Hideki; Cooney, Ryan R.; Moriena, Gustavo; Sciaini, German; Miller, R. J. Dwayne			Mapping molecular motions leading to charge delocalization with ultrabright electrons	NATURE			English	Article							STRUCTURAL DYNAMICS; PHASE-TRANSITION; DIFFRACTION; (EDO-TTF)(2)PF6; TIME; RESOLUTION	Ultrafast processes can now be studied with the combined atomic spatial resolution of diffraction methods and the temporal resolution of femtosecond optical spectroscopy by using femtosecond pulses of electrons(1-14) or hard X-rays(15-19) as structural probes. However, it is challenging to apply these methods to organic materials, which have weak scattering centres, thermal lability, and poor heat conduction. These characteristics mean that the source needs to be extremely bright to enable us to obtain high-quality diffraction data before cumulative heating effects from the laser excitation either degrade the sample or mask the structural dynamics(20). Here we show that a recently developed, ultrabright femtosecond electron source(7-9) makes it possible to monitor the molecular motions in the organic salt (EDO-TTF)(2)PF6 as it undergoes its photo-induced insulator-to-metal phase transition(21-24). After the ultrafast laser excitation, we record time-delayed diffraction patterns that allow us to identify hundreds of Bragg reflections with which to map the structural evolution of the system. The data and supporting model calculations indicate the formation of a transient intermediate structure in the early stage of charge delocalization (less than five picoseconds), and reveal that the molecular motions driving its formation are distinct from those that, assisted by thermal relaxation, convert the system into a metallic state on the hundred-picosecond timescale. These findings establish the potential of ultrabright femtosecond electron sources(7-14) for probing the primary processes governing structural dynamics with atomic resolution in labile systems relevant to chemistry and biology.	[Gao, Meng; Lu, Cheng; Jean-Ruel, Hubert; Liu, Lai Chung; Cooney, Ryan R.; Moriena, Gustavo; Sciaini, German; Miller, R. J. Dwayne] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Gao, Meng; Lu, Cheng; Jean-Ruel, Hubert; Liu, Lai Chung; Cooney, Ryan R.; Moriena, Gustavo; Sciaini, German; Miller, R. J. Dwayne] Univ Toronto, Dept Phys, Toronto, ON M5S 3H6, Canada; [Gao, Meng; Jean-Ruel, Hubert; Liu, Lai Chung; Marx, Alexander; Cooney, Ryan R.; Moriena, Gustavo; Sciaini, German; Miller, R. J. Dwayne] Univ Hamburg, Hamburg Ctr Ultrafast Imaging, Dept Phys, Max Planck Res Dept Struct Dynam, D-22761 Hamburg, Germany; [Onda, Ken] Tokyo Inst Technol, Interact Res Ctr Sci, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Onda, Ken] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Koshihara, Shin-ya] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan; [Koshihara, Shin-ya] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1028666, Japan; [Nakano, Yoshiaki; Shao, Xiangfeng; Yamochi, Hideki] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Sakyo Ku, Kyoto 6068501, Japan; [Hiramatsu, Takaaki; Saito, Gunzi] Meijo Univ, Fac Agr, Tempaku Ku, Nagoya, Aichi 4688502, Japan	University of Toronto; University of Toronto; Max Planck Society; University of Hamburg; Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Kyoto University; Meijo University	Miller, RJD (corresponding author), Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada.	dwayne.miller@mpsd.cfel.de	Shao, Xiangfeng/N-3461-2015; Koshihara, Shinya/ABA-1213-2021; Onda, Ken/H-3389-2014; Koshihara, Shinya/B-5095-2015	Shao, Xiangfeng/0000-0002-8710-4122; Onda, Ken/0000-0003-1724-2009; Koshihara, Shinya/0000-0002-7119-2017; Moriena, Gustavo/0000-0001-9249-1764; Liu, Lai Chung/0000-0002-7775-5933; Sciaini, German/0000-0002-2120-3996; Nakano, Yoshiaki/0000-0003-3616-7286	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Ministry of Education, Culture, Sports, Science and Technology in Japan [20110006]; Japan Society for the Promotion of Science [18GS0208]; Grants-in-Aid for Scientific Research [20110006] Funding Source: KAKEN	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge the contributions of J. Stampe, M. de Jong, M. Harb and S. G. Kruglik in developing the radio-frequency cavity system and of E. Pelletier in developing the laser system. We also thank K. Iwano and M. Hoshino and K. Yonemitsu for discussions. Funding for this project was provided by the Natural Sciences and Engineering Research Council of Canada and the Canada Foundation for Innovation. This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas (grant number 20110006) and the Global Centre of Excellence (G-COE) programme for Chemistry from The Ministry of Education, Culture, Sports, Science and Technology in Japan and by Creative Scientific Research (grant number 18GS0208) from The Japan Society for the Promotion of Science.	Baum P, 2006, P NATL ACAD SCI USA, V103, P16105, DOI 10.1073/pnas.0607451103; Beaud P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.174801; Chatelain RP, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4747155; Chergui M, 2009, CHEMPHYSCHEM, V10, P28, DOI 10.1002/cphc.200800667; Chollet M, 2005, SCIENCE, V307, P86, DOI 10.1126/science.1105067; Coppens P, 2005, ACTA CRYSTALLOGR A, V61, P162, DOI 10.1107/S0108767304029551; Eichberger M, 2010, NATURE, V468, P799, DOI 10.1038/nature09539; Filatov M, 2011, PHYS CHEM CHEM PHYS, V13, P12328, DOI 10.1039/c0cp02450c; Fritz DM, 2007, SCIENCE, V315, P633, DOI 10.1126/science.1135009; Fukazawa N, 2012, J PHYS CHEM C, V116, P5892, DOI 10.1021/jp210708q; Gao M, 2012, OPT EXPRESS, V20, P12048, DOI 10.1364/OE.20.012048; Harb M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.094301; Hastings JB, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2372697; Iwano K, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075120; JEROME D, 1991, SCIENCE, V252, P1509, DOI 10.1126/science.252.5012.1509; Kassier GH, 2012, APPL PHYS B-LASERS O, V109, P249, DOI 10.1007/s00340-012-5207-2; Muro'oka Y, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3602314; Musumeci P, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3478005; Onda K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.067403; Ota A, 2002, J MATER CHEM, V12, P2600, DOI 10.1039/b206293c; Poulin PR, 2006, SCIENCE, V313, P1756, DOI 10.1126/science.1127826; Raman RK, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.077401; Rousse A, 2001, NATURE, V410, P65, DOI 10.1038/35065045; Sciaini G, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/9/096101; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Sokolowski-Tinten K, 2003, NATURE, V422, P287, DOI 10.1038/nature01490; Tokita S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.215004; van Oudheusden T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.264801; Yonemitsu K, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075105; Zamponi F, 2012, P NATL ACAD SCI USA, V109, P5207, DOI 10.1073/pnas.1108206109	30	198	200	4	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					343	346		10.1038/nature12044	http://dx.doi.org/10.1038/nature12044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23598343				2022-12-28	WOS:000317599200033
J	Hunt, DP; Muse, VV; Pitman, MB				Hunt, Daniel P.; Muse, Victorine V.; Pitman, Martha B.			Case 12-2013: An 18-Year-Old Woman with Pulmonary Infiltrates and Respiratory Failure Herpes simplex virus type 1 pneumonia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPSTEIN-BARR-VIRUS; INFECTIOUS-MONONUCLEOSIS; TULAREMIA; MARIJUANA		[Hunt, Daniel P.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Muse, Victorine V.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Pitman, Martha B.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hunt, Daniel P.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Muse, Victorine V.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Pitman, Martha B.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Hunt, DP (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Hunt, Dan/AAL-3807-2021					Cunnington D, 2000, CHEST, V117, P1511, DOI 10.1378/chest.117.5.1511; EVANS ME, 1985, MEDICINE, V64, P251, DOI 10.1097/00005792-198507000-00006; Faul JL, 1999, CHEST, V116, P222, DOI 10.1378/chest.116.1.222; GRAHAM BS, 1983, MEDICINE, V62, P384, DOI 10.1097/00005792-198311000-00004; HAMADEH R, 1988, CHEST, V94, P432, DOI 10.1378/chest.94.2.432; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Luyt CE, 2007, AM J RESP CRIT CARE, V175, P935, DOI 10.1164/rccm.200609-1322OC; Mandell GL, 2010, MANDELL DOUGLAS BENN; MARTINEZ E, 1994, EUR RESPIR J, V7, P1185; Matyas BI, 2007, ANN NY ACAD SCI, V1105, P351, DOI 10.1196/annals.1409.013; MCMILLAN JA, 1993, PEDIATR INFECT DIS J, V12, P280, DOI 10.1097/00006454-199304000-00004; Miron D, 2002, ISRAEL MED ASSOC J, V4, P733; Miyazato A, 2001, INTERNAL MED, V40, P836, DOI 10.2169/internalmedicine.40.836; Reyes CV, 2009, HEART LUNG, V38, P526, DOI 10.1016/j.hrtlng.2009.05.002; Sauvaget E, 2010, PEDIATR PULM, V45, P1246, DOI 10.1002/ppul.21314; Sriskandan S, 1996, CLIN INFECT DIS, V22, P578, DOI 10.1093/clinids/22.3.578; Thomas LD, 2010, INFECT DIS CLIN N AM, V24, P43, DOI 10.1016/j.idc.2009.10.012	17	10	10	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1537	1545		10.1056/NEJMcpc1209608	http://dx.doi.org/10.1056/NEJMcpc1209608			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126HC	23594007				2022-12-28	WOS:000317603300013
J	Mandyam, MC; Soliman, EZ; Heckbert, SR; Vittinghoff, E; Marcus, GM				Mandyam, Mala C.; Soliman, Elsayed Z.; Heckbert, Susan R.; Vittinghoff, Eric; Marcus, Gregory M.			Long-term Outcomes of Left Anterior Fascicular Block in the Absence of Overt Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							FIBROSIS		[Mandyam, Mala C.; Marcus, Gregory M.] Univ Calif San Francisco, Div Cardiol, Electrophysiol Sect, San Francisco, CA 94143 USA; [Vittinghoff, Eric] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Epidemiol Cardiol Res Ctr, Winston Salem, NC USA; [Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Wake Forest University; University of Washington; University of Washington Seattle	Mandyam, MC (corresponding author), Univ Calif San Francisco, Div Cardiol, Electrophysiol Sect, San Francisco, CA 94143 USA.	marcusg@medicine.ucsf.edu	Marcus, Gregory/AAN-8584-2021; Soliman, Elsayed Z/AAD-7135-2020	Marcus, Gregory/0000-0001-5197-7696; Soliman, Elsayed Z/0000-0001-5632-8150	NCRR NIH HHS [TL1 RR024129] Funding Source: Medline; NHLBI NIH HHS [N01HC85080, U01 HL080295, R01 HL068986, HL068986, N01HC85086, N01HC85081, N01 HC55222, N01 HC085079, N01HC55222, R01 HL080295, HHSN268201200036C, N01HC85239, N01 HC085083, HL080295, N01HC85083, N01HC85082, N01HC85079] Funding Source: Medline; NIA NIH HHS [R01 AG023629, R56 AG023629, AG023629] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085083, N01HC055222, N01HC085086, N01HC085079, N01HC085082, N01HC085081, N01HC085080] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024129] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085083, U01HL080295, R01HL080295, R01HL068986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG023629, R01AG023629] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		DAVIES M, 1969, BRIT HEART J, V31, P219; DEMOULIN JC, 1975, AM J CARDIOL, V36, P751, DOI 10.1016/0002-9149(75)90456-7; Elizari MV, 2007, CIRCULATION, V115, P1154, DOI 10.1161/CIRCULATIONAHA.106.637389; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Marcus GM, 2007, HEART RHYTHM, V4, P138, DOI 10.1016/j.hrthm.2006.10.017; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A	6	16	16	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1587	1588		10.1001/jama.2013.2729	http://dx.doi.org/10.1001/jama.2013.2729			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126FY	23592102	Green Accepted, Bronze			2022-12-28	WOS:000317599500017
J	Hempel, S				Hempel, Sandra			John Snow Obituary	LANCET			English	Biographical-Item												palewell@globalnet.co.uk							0	11	12	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 13	2013	381	9874					1269	1270		10.1016/S0140-6736(13)60830-2	http://dx.doi.org/10.1016/S0140-6736(13)60830-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122XD	23589914				2022-12-28	WOS:000317351000017
J	Omer, SB; Orenstein, WA; Koplan, JP				Omer, Saad B.; Orenstein, Walter A.; Koplan, Jeffrey P.			Go Big and Go Fast - Vaccine Refusal and Disease Eradication	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Omer, Saad B.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Omer, Saad B.; Orenstein, Walter A.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Koplan, Jeffrey P.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [Omer, Saad B.] Ctr Hlth Res Southeast, Atlanta, GA USA	Emory University; Rollins School Public Health; Emory University; Emory University	Omer, SB (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.							[Anonymous], 2013, MMWR MORB MORTAL WKL, V61; Chen RT, 1998, PEDIATR ANN, V27, P445, DOI 10.3928/0090-4481-19980701-11; Cochi SL, 2011, J INFECT DIS, V204, pS4, DOI 10.1093/infdis/jir100; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; Yahya M, 2006, IDS WORKING PAPERS, V261	5	28	28	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1374	1376		10.1056/NEJMp1300765	http://dx.doi.org/10.1056/NEJMp1300765			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122QT	23574116				2022-12-28	WOS:000317333600003
J	Tsuneyoshi, N; Dunn, NR				Tsuneyoshi, Norihiro; Dunn, N. Ray			Guards at the Gate to Embryonic Stem Cell Differentiation	CELL			English	Editorial Material							SELF-RENEWAL; GENE; TARGET; ESRRB	A core network of genes maintaining pluripotency has been at least partially defined. How the genetic switch is flipped to differentiation is the subject of a new study that reveals some unexpected players.	[Tsuneyoshi, Norihiro; Dunn, N. Ray] ASTAR, Inst Med Biol, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Dunn, NR (corresponding author), ASTAR, Inst Med Biol, 8A Biomed Grove,06-06 Immunos, Singapore 138648, Singapore.	ray.dunn@imb.a-star.edu.sg	Dunn, Norris Ray/W-5124-2019	Dunn, Norris Ray/0000-0002-6259-2975				Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Hong SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015793; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	10	4	4	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					281	283		10.1016/j.cell.2013.03.037	http://dx.doi.org/10.1016/j.cell.2013.03.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582317	Bronze			2022-12-28	WOS:000317349700006
J	Adams, SG; Peters, JI				Adams, Sandra G.; Peters, Jay I.			Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Adams, Sandra G.] Univ Texas San Antonio, Hlth Sci Ctr, San Antonio, TX 78249 USA; South Texas Vet Hlth Care Syst, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Adams, SG (corresponding author), Univ Texas San Antonio, Hlth Sci Ctr, San Antonio, TX 78249 USA.			Miravitlles, Marc/0000-0002-9850-9520				Niewoehner DE, 2007, CHEST, V131, P20, DOI 10.1378/chest.06-1316; SAINT S, 1995, JAMA-J AM MED ASSOC, V273, P957, DOI 10.1001/jama.273.12.957	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6							JC3	10.7326/0003-4819-158-6-201303190-02003	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23552686				2022-12-28	WOS:000316565100002
J	Kikwete, J; Jenkins, K; Whitbread, J				Kikwete, Jakaya; Jenkins, Kevin; Whitbread, Jasmine			Playing our part to save children's lives	LANCET			English	Editorial Material									[Kikwete, Jakaya] Presidents Off, Dar Es Salaam, Tanzania; [Jenkins, Kevin] World Vis Int, Uxbridge UB11 1FG, Middx, England; [Whitbread, Jasmine] Save Children Int, London, England	Save the Children	Jenkins, K (corresponding author), World Vis Int, Stockley Pk, Uxbridge UB11 1FG, Middx, England.	kevin_jenkins@wvi.org						[Anonymous], LEV TRENDS CHILD MOR; [Anonymous], 2012, UNICEF PROGR REPORT; Bhutta ZA, 2013, LANCET; Chopra M, 2013, LANCET; Fischer Walker CL, 2013, LANCET; Gill CJ, 2013, LANCET; Jonathan GE, 2013, LANCET, V381, P350, DOI 10.1016/S0140-6736(13)60111-7; WHO UNICEF(World Health Organization United Nations International Children's Emergency Fund), 2013, INT GLOB ACT PLAN PR; World Health Organization/United Nations Children's Fund, 2012, COUNTD 2015 BUILD FU	9	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 25	2013	381	9880					1798	1799		10.1016/S0140-6736(13)60719-9	http://dx.doi.org/10.1016/S0140-6736(13)60719-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151EO	23582724				2022-12-28	WOS:000319443700008
J	Worrell, BT; Malik, JA; Fokin, VV				Worrell, B. T.; Malik, J. A.; Fokin, V. V.			Direct Evidence of a Dinuclear Copper Intermediate in Cu(I)-Catalyzed Azide-Alkyne Cycloadditions	SCIENCE			English	Article							N-HETEROCYCLIC CARBENE; METAL-COMPLEXES; ORGANIC AZIDES; CU; REACTIVITY; MECHANISM	Copper(I)-catalyzed azide-alkyne cycloaddition has become a commonly employed method for the synthesis of complex molecular architectures under challenging conditions. Despite the widespread use of copper-catalyzed cycloaddition reactions, the mechanism of these processes has remained difficult to establish due to the involvement of multiple equilibria between several reactive intermediates. Real-time monitoring of a representative cycloaddition process via heat-flow reaction calorimetry revealed that monomeric copper acetylide complexes are not reactive toward organic azides unless an exogenous copper catalyst is added. Furthermore, crossover experiments with an isotopically enriched exogenous copper source illustrated the stepwise nature of the carbon-nitrogen bond-forming events and the equivalence of the two copper atoms within the cycloaddition steps.	[Worrell, B. T.; Malik, J. A.; Fokin, V. V.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Fokin, VV (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	fokin@scripps.edu		Malik, Jamal A./0000-0003-3726-5902; Worrell, Brady/0000-0001-7472-2063	NSF [CHE-0848982]; NIH National Institute of General Medical Sciences [GM-087620]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087620] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NSF (CHE-0848982) and the NIH National Institute of General Medical Sciences (GM-087620). We thank B. Webb for assistance with mass spectrometry analyses, S. W. Kwok (Harvard University) for support with reaction calorimetry, and J. Hein (University of California, Merced) for helpful scientific discussions.	Ahlquist M, 2007, ORGANOMETALLICS, V26, P4389, DOI 10.1021/om700669v; Blackmond DG, 2005, ANGEW CHEM INT EDIT, V44, P4302, DOI 10.1002/anie.200462544; Boehme C, 1998, ORGANOMETALLICS, V17, P5801, DOI 10.1021/om980394r; Comas-Vives A, 2011, EUR J INORG CHEM, P5025, DOI 10.1002/ejic.201100721; Crumbliss AL., 1979, INORG SYNTH, V19, P90, DOI DOI 10.1002/9780470132500.CH18; Dias HVR, 2009, J AM CHEM SOC, V131, P11249, DOI 10.1021/ja904232v; Hathaway B.J., 1987, COMPREHENSIVE COORDI, P533; Haynes WM, 2012, CRC HDB CHEM PHYS, P93; Hein JE, 2010, CHEM SOC REV, V39, P1302, DOI 10.1039/b904091a; Hein JE, 2009, ANGEW CHEM INT EDIT, V48, P8018, DOI 10.1002/anie.200903558; Himo F, 2005, J AM CHEM SOC, V127, P210, DOI 10.1021/ja0471525; Kuang GC, 2011, J AM CHEM SOC, V133, P13984, DOI 10.1021/ja203733q; Kuijpers BHM, 2005, SYNLETT, P3059, DOI 10.1055/s-2005-921919; Ley SV, 2003, ANGEW CHEM INT EDIT, V42, P5400, DOI 10.1002/anie.200300594; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; MOEN A, 1995, J CHEM SOC FARADAY T, V91, P3529, DOI 10.1039/ft9959103529; Monnier F, 2009, ANGEW CHEM INT EDIT, V48, P6954, DOI 10.1002/anie.200804497; Mykhalichko B. M., 2000, RUSS CHEM REV, V69, P957, DOI DOI 10.1070/RC2000V069N11ABEH000609; NIGH WG, 1973, OXIDATION ORGANIC B, P1; Nolte C, 2007, ANGEW CHEM INT EDIT, V46, P2101, DOI 10.1002/anie.200604444; Partyka DV, 2009, ORGANOMETALLICS, V28, P6171, DOI 10.1021/om9005774; Rodionov VO, 2007, J AM CHEM SOC, V129, P12705, DOI 10.1021/ja072679d; Rodionov VO, 2005, ANGEW CHEM INT EDIT, V44, P2210, DOI 10.1002/anie.200461496; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sanderson MD, 2006, J AM CHEM SOC, V128, P16514, DOI 10.1021/ja067475w; Schindler S, 2000, EUR J INORG CHEM, P2311; Straub BF, 2007, CHEM COMMUN, P3868, DOI 10.1039/b706926j; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Zhou YH, 2010, ANGEW CHEM INT EDIT, V49, P2607, DOI 10.1002/anie.200907016	29	553	561	33	529	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					457	460		10.1126/science.1229506	http://dx.doi.org/10.1126/science.1229506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23558174	Green Accepted			2022-12-28	WOS:000318016700036
J	Crochet, JR; Bastian, LA; Chireau, MV				Crochet, John R.; Bastian, Lori A.; Chireau, Monique V.			Does This Woman Have an Ectopic Pregnancy? The Rational Clinical Examination Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN CHORIONIC-GONADOTROPIN; SERUM PROGESTERONE MEASUREMENT; UNKNOWN LOCATION; TRANSVAGINAL SONOGRAPHY; EMERGENCY-DEPARTMENT; EXPECTANT MANAGEMENT; PHYSICAL-EXAMINATION; DIAGNOSTIC-ACCURACY; SPONTANEOUS RESOLUTION; PREDICTION MODEL	Importance The rapid identification and accurate diagnosis of women who may have an ectopic pregnancy is critically important for reducing the maternal morbidity and mortality associated with this condition. Objective To systematically review the accuracy and precision of the patient history, clinical examination, readily available laboratory values, and sonography in the diagnosis of ectopic pregnancy in women with abdominal pain or vaginal bleeding during early pregnancy. Data Sources We conducted MEDLINE and EMBASE searches for English-language articles from 1965 to December 2012 reporting on the diagnosis of ectopic pregnancy. Study Selection The analysis included prospective studies of 100 or more pregnant women with abdominal pain or vaginal bleeding that evaluated patient history, physical examination, laboratory values, and sonography compared with a reference standard of either (1) direct surgical visualization of ectopic pregnancy or (2) clinical follow-up for all pregnancies to prove that ectopic pregnancy was not missed. Of 10 890 articles identified by the search, 14 studies with 12 101 patients met the inclusion criteria. Data Extraction and Synthesis Two authors (J.R.C. and M. V. C.) independently extracted data and assessed the quality of each study. A third author (L. A. B.) resolved any discrepancies. Results All components of the patient history had a positive likelihood ratio (LR+) less than 1.5. The presence of an adnexal mass in the absence of an intrauterine pregnancy on transvaginal sonography (LR+ 111; 95% CI, 12-1028; n=6885), and the physical examination findings of cervical motion tenderness (LR+ 4.9; 95% CI, 1.7-14; n=1435), an adnexal mass (LR+ 2.4; 95% CI, 1.6-3.7; n=1378), and adnexal tenderness (LR+ 1.9; 95% CI, 1.0-3.5; n=1435) all increase the likelihood of ectopic pregnancy. A lack of adnexal abnormalities on transvaginal sonography (negative LR [LR-] 0.12; 95% CI, 0.03-0.55; n=6885) decreases the likelihood of ectopic pregnancy. Existing studies do not establish a single serum human chorionic gonadotropin (hCG) level that is diagnostic of ectopic pregnancy. Conclusions and Relevance Transvaginal sonography is the single best diagnostic modality for evaluating women with suspected ectopic pregnancy. The presence of abdominal pain or vaginal bleeding during early pregnancy should prompt a transvaginal sonogram and quantitative serum hCG testing. JAMA. 2013;309(16):1722-1729 www.jama.com	[Crochet, John R.] Ctr Reprod Med, Webster, TX USA; [Crochet, John R.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol & Fertil, Durham, NC 27710 USA; [Crochet, John R.; Chireau, Monique V.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; [Bastian, Lori A.] Univ Connecticut, Ctr Hlth, Dept Internal Med, Farmington, CT USA; [Bastian, Lori A.] Vet Affairs Connecticut Healthcare Syst, Newington, CT USA; [Chireau, Monique V.] Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA	Duke University; Duke University; University of Connecticut; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Chireau, MV (corresponding author), Duke Univ, Med Ctr, Box 3084, Durham, NC 27710 USA.	monique.chireau@duke.edu						ANKUM WM, 1993, HUM REPROD, V8, P1307, DOI 10.1093/oxfordjournals.humrep.a138247; Backman T, 2004, AM J OBSTET GYNECOL, V190, P50, DOI 10.1016/j.ajog.2003.07.021; Banerjee S, 1999, ULTRASOUND OBST GYN, V14, P231, DOI 10.1046/j.1469-0705.1999.14040231.x; Banerjee S, 2001, BRIT J OBSTET GYNAEC, V108, P158, DOI 10.1111/j.1471-0528.2001.00031.x; Barnhart K, 2004, OBSTET GYNECOL, V104, P975, DOI 10.1097/01.AOG.0000142712.80407.fd; BARNHART K, 1994, OBSTET GYNECOL, V84, P1010; Barnhart KT, 2004, OBSTET GYNECOL, V104, P50, DOI 10.1097/01.AOG.0000128174.48843.12; Barnhart K, 2011, FERTIL STERIL, V95, P857, DOI 10.1016/j.fertnstert.2010.09.006; Barnhart KT, 2009, NEW ENGL J MED, V361, P379, DOI 10.1056/NEJMcp0810384; Bastian LA, 1997, JAMA-J AM MED ASSOC, V278, P586, DOI 10.1001/jama.278.7.586; Bouyer J, 2002, HUM REPROD, V17, P3224, DOI 10.1093/humrep/17.12.3224; BRENNAN DF, 1995, ACAD EMERG MED, V2, P1081, DOI 10.1111/j.1553-2712.1995.tb03154.x; BROWN DL, 1994, J ULTRAS MED, V13, P259, DOI 10.7863/jum.1994.13.4.259; Buckley RG, 1998, ACAD EMERG MED, V5, P951, DOI 10.1111/j.1553-2712.1998.tb02770.x; Buckley RG, 2000, ANN EMERG MED, V36, P95, DOI 10.1067/mem.2000.108653; Buckley RG, 1999, ANN EMERG MED, V34, P589, DOI 10.1016/S0196-0644(99)70160-5; Cartwright J, 2009, REPRODUCTION, V138, P9, DOI 10.1530/REP-09-0060; CARTWRIGHT PS, 1991, OBSTET GYN CLIN N AM, V18, P19; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P46; CHAMBERS SE, 1990, BRIT J RADIOL, V63, P246, DOI 10.1259/0007-1285-63-748-246; Chang Jeani, 2003, MMWR Surveill Summ, V52, P1; Condous G, 2006, HUM REPROD, V21, P2706, DOI 10.1093/humrep/del223; Condous G, 2005, ULTRASOUND OBST GYN, V26, P770, DOI 10.1002/uog.2636; Condous G, 2005, HUM REPROD, V20, P1404, DOI 10.1093/humrep/deh770; Condous G, 2004, INT J GYNECOL OBSTET, V86, P351, DOI 10.1016/j.ijgo.2004.04.004; Creanga AA, 2011, OBSTET GYNECOL, V117, P837, DOI 10.1097/AOG.0b013e3182113c10; Crochet JR, 2012, J REPROD MED, V57, P171; Dart R, 2002, AM J EMERG MED, V20, P575, DOI 10.1053/ajem.2002.35460; Dart RG, 1999, ANN EMERG MED, V33, P283, DOI 10.1016/S0196-0644(99)70364-1; Day A, 2009, ULTRASOUND OBST GYN, V33, P704, DOI 10.1002/uog.6380; Della-Giustina D, 2003, EMERG MED CLIN N AM, V21, P565, DOI 10.1016/S0733-8627(03)00036-1; Doubilet PM, 2011, J ULTRAS MED, V30, P1637, DOI 10.7863/jum.2011.30.12.1637; Durham B, 1997, ANN EMERG MED, V29, P338, DOI 10.1016/S0196-0644(97)70345-7; El Bishry G, 2008, J OBSTET GYNAECOL, V28, P413, DOI 10.1080/01443610802149806; Fernandez H, 2004, HUM REPROD UPDATE, V10, P503, DOI 10.1093/humupd/dmh043; Florio P, 2007, J CLIN ENDOCR METAB, V92, P1748, DOI 10.1210/jc.2006-2188; Furlong LA, 2002, J REPROD MED, V47, P881; Goldner T E, 1993, MMWR CDC Surveill Summ, V42, P73; HAHLIN M, 1995, HUM REPROD, V10, P1223, DOI 10.1093/oxfordjournals.humrep.a136123; Hoover KW, 2010, OBSTET GYNECOL, V115, P495, DOI 10.1097/AOG.0b013e3181d0c328; Huchon C, 2012, ACAD EMERG MED, V19, P24, DOI 10.1111/j.1553-2712.2011.01238.x; Jaspan D, 2010, FERTIL STERIL, V94, P1122, DOI 10.1016/j.fertnstert.2009.10.032; Kaplan BC, 1996, ANN EMERG MED, V28, P10, DOI 10.1016/S0196-0644(96)70131-2; Kirk E, 2007, HUM REPROD, V22, P2824, DOI 10.1093/humrep/dem283; Kirk E, 2009, BEST PRACT RES CL OB, V23, P501, DOI 10.1016/j.bpobgyn.2008.12.010; KORHONEN J, 1994, FERTIL STERIL, V61, P632; Lozeau AM, 2005, AM FAM PHYSICIAN, V72, P1707; Mateer JR, 1996, ANN EMERG MED, V27, P283, DOI 10.1016/S0196-0644(96)70260-3; McRae A, 2009, CAN J EMERG MED, V11, P355; Mehta TS, 1997, RADIOLOGY, V205, P569, DOI 10.1148/radiology.205.2.9356647; Mol BWJ, 1998, HUM REPROD, V13, P3220, DOI 10.1093/humrep/13.11.3220; Mol BWJ, 1999, FERTIL STERIL, V71, P155, DOI 10.1016/S0015-0282(98)00396-3; Moore C, 2007, ACAD EMERG MED, V14, P755, DOI 10.1197/j.aem.2007.04.010; NORMAN RJ, 1988, OBSTET GYNECOL, V71, P315; Ramakrishnan K, 2006, J FAM PRACTICE, V55, P388; Rojansky N, 1996, J ASSIST REPROD GEN, V13, P594, DOI 10.1007/BF02066615; Seeber BE, 2006, OBSTET GYNECOL, V107, P399, DOI 10.1097/01.AOG.0000198632.15229.be; Shalev E, 1998, FERTIL STERIL, V69, P62, DOI 10.1016/S0015-0282(97)00425-1; Shaw JLV, 2010, HUM REPROD UPDATE, V16, P432, DOI 10.1093/humupd/dmp057; Silva C, 2006, OBSTET GYNECOL, V107, P605, DOI 10.1097/01.AOG.0000198635.25135.e7; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Simel DL, 2009, RATIONAL CLIN EXAMIN; Stein JC, 2010, ANN EMERG MED, V56, P674, DOI 10.1016/j.annemergmed.2010.06.563; STOVALL TG, 1990, ANN EMERG MED, V19, P1098, DOI 10.1016/S0196-0644(05)81511-2; STOVALL TG, 1992, HUM REPROD, V7, P723, DOI 10.1093/oxfordjournals.humrep.a137725; TIMORTRITSCH IE, 1989, AM J OBSTET GYNECOL, V161, P157, DOI 10.1016/0002-9378(89)90255-X; Trabert B, 2011, AM J PREV MED, V40, P556, DOI 10.1016/j.amepre.2010.12.026; VALENZANO M, 1991, GYNECOL OBSTET INVES, V31, P8, DOI 10.1159/000293092; Van den Eeden SK, 2005, OBSTET GYNECOL, V105, P1052, DOI 10.1097/01.AOG.0000158860.26939.2d; Wang R, 2011, ANN EMERG MED, V58, P12, DOI 10.1016/j.annemergmed.2010.12.023; Wong TW, 1998, J ACCID EMERG MED, V15, P155; Zane Suzanne B, 2002, Matern Child Health J, V6, P227, DOI 10.1023/A:1021106032198	72	42	42	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1722	1729		10.1001/jama.2013.3914	http://dx.doi.org/10.1001/jama.2013.3914			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130IG	23613077				2022-12-28	WOS:000317906700029
J	Donovan, MS				Donovan, M. Suzanne			Generating Improvement Through Research and Development in Education Systems	SCIENCE			English	Review							SCHOOL; INTERVENTIONS; BEHAVIORS; SCIENCE	To effectively address problems in education, research must be shaped around a problem of practice. Reorienting research and development in this way must overcome three obstacles. First, the incentive system for university researchers must be changed to reward research on problems of practice. Second, the contexts must be created that will allow the complexity of problems of practice to be understood and addressed by interdisciplinary teams of researchers, practitioners, and education designers. And third, meaningful experimentation must become acceptable in school systems in order to develop a better understanding of how to effectively stimulate and support the desired changes.	Strateg Educ Res Partnership Inst, Washington, DC 20005 USA		Donovan, MS (corresponding author), Strateg Educ Res Partnership Inst, Washington, DC 20005 USA.	sdonovan@serpinstitute.org						[Anonymous], 2012, OBSERVATIONS MADE SE; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bryk AS, 2011, FRONTIERS IN SOCIOLOGY OF EDUCATION, P127, DOI 10.1007/978-94-007-1576-9_7; Coburn C. E., 2003, EDUC RESEARCHER, V32, P3, DOI [10.3102/, DOI 10.3102/0013189X032006003]; Cutler D. M., AM EC ASS 10 YEARS E; Dweck C. S, 1999, SELF THEORIES THEIR; Eccles MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-1; Eccles MP, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-99; Ernst MM, 2010, J PEDIATR PSYCHOL, V35, P14, DOI 10.1093/jpepsy/jsp013; Feinstein S., 2008, L PASTEUR FATHER MIC; Fryer RG, 2011, Q J ECON, V126, P1755, DOI 10.1093/qje/qjr045; Gawande A, 2011, CHECKLIST MANIFESTO; GOTTLIEB NH, 1986, SOC SCI MED, V22, P915, DOI 10.1016/0277-9536(86)90164-4; Holsinger VH, 1997, REV SCI TECH OIE, V16, P441, DOI 10.20506/rst.16.2.1037; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jain M, 2006, QUAL SAF HEALTH CARE, V15, P235, DOI 10.1136/qshc.2005.016576; Kennedy M., 2005, INSIDE TEACHING CLAS; Lewis M. J., 2000, CONTINUOUS THERMAL P; McLaughlin M. W., 2001, J EDUC CHANG, V2, P301, DOI [10.1023/a:1014616908334, DOI 10.1023/A:1014616908334, 10.1023/A:1014616908334]; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; National Research Council, 2003, STRATEGIC ED RES PAR; Penuel W, 2009, TEACH COLL REC, V111, P124; Penuel WR, 2012, J RES SCI TEACH, V49, P281, DOI 10.1002/tea.21001; Pfeffer J., 2000, KNOWING DOING GAP SM; Schoenfeld AH, 2011, ZDM-MATH EDUC, V43, P457, DOI 10.1007/s11858-011-0307-8; Steele C. M., 2003, AM PSYCHOL, V24, P645; Stein MK, 2008, AM J EDUC, V114, P583, DOI 10.1086/589315; Stokes D. E., 1997, PASTEURS QUADRANT BA; Stringfield S, 1998, EDUC URBAN SOC, V30, P269, DOI 10.1177/0013124598030003001; TERRY DJ, 1995, BRIT J SOC PSYCHOL, V34, P199, DOI 10.1111/j.2044-8309.1995.tb01058.x; Walker AE, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-22; Yeager DS, 2011, REV EDUC RES, V81, P267, DOI 10.3102/0034654311405999	32	34	34	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					317	319		10.1126/science.1236180	http://dx.doi.org/10.1126/science.1236180			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126XZ	23599484				2022-12-28	WOS:000317657500045
J	Jaffe, R; Ding, Y; Niggemann, J; Vahatalo, AV; Stubbins, A; Spencer, RGM; Campbell, J; Dittmar, T				Jaffe, Rudolf; Ding, Yan; Niggemann, Jutta; Vahatalo, Anssi V.; Stubbins, Aron; Spencer, Robert G. M.; Campbell, John; Dittmar, Thorsten			Global Charcoal Mobilization from Soils via Dissolution and Riverine Transport to the Oceans	SCIENCE			English	Article							DISSOLVED BLACK CARBON; ORGANIC-MATTER	Global biomass burning generates 40 million to 250 million tons of charcoal every year, part of which is preserved for millennia in soils and sediments. We have quantified dissolution products of charcoal in a wide range of rivers worldwide and show that globally, a major portion of the annual charcoal production is lost from soils via dissolution and subsequent transport to the ocean. The global flux of soluble charcoal accounts to 26.5 +/- 1.8 million tons per year, which is similar to 10% of the global riverine flux of dissolved organic carbon (DOC). We suggest that the mobilization of charcoal and DOC out of soils is mechanistically coupled. This study closes a major gap in the global charcoal budget and provides critical information in the context of geoengineering.	[Jaffe, Rudolf; Ding, Yan] Florida Int Univ, SERC, Miami, FL 33199 USA; [Jaffe, Rudolf; Ding, Yan] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Niggemann, Jutta; Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Max Planck Res Grp Marine Geochem, D-29129 Oldenburg, Germany; [Vahatalo, Anssi V.] Univ Helsinki, Dept Environm Sci, FIN-00014 Helsinki, Finland; [Vahatalo, Anssi V.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40500, Finland; [Stubbins, Aron] Skidaway Inst Oceanog, Savannah, GA 31411 USA; [Spencer, Robert G. M.] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Campbell, John] US Forest Serv, USDA, No Res Stn, Durham, NH 03824 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University; Carl von Ossietzky Universitat Oldenburg; Max Planck Society; University of Helsinki; University of Jyvaskyla; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography; Woods Hole Research Center; United States Department of Agriculture (USDA); United States Forest Service	Jaffe, R (corresponding author), Florida Int Univ, SERC, Miami, FL 33199 USA.	jaffer@fiu.edu; tdittmar@mpi-bremen.de	Dittmar, Thorsten/L-7796-2013; Stubbins, Aron/M-8801-2014	Dittmar, Thorsten/0000-0002-3462-0107; Stubbins, Aron/0000-0002-3994-1946; Vahatalo, Anssi/0000-0003-3434-5915; Campbell, John/0000-0002-6752-3493; Campbell, John/0000-0003-4956-1696	NSF [DBI-0620409, ETBC-0851101, DEB-1145932, ANT-1203885, OPP-1107774, DEB-1146161]; SERC Barley Chair; FIU-University Graduate School; Academy of Finland; Hanse Institute for Advanced Studies (HWK, Delmenhorst, Germany); Direct For Biological Sciences [1146161] Funding Source: National Science Foundation; Division Of Environmental Biology [1237517] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); SERC Barley Chair; FIU-University Graduate School; Academy of Finland(Academy of Finland); Hanse Institute for Advanced Studies (HWK, Delmenhorst, Germany); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	R.J. and Y.D. thank the NSF [grant DBI-0620409; Florida Coast Everglades-LTER program], the SERC Barley Chair, and the FIU-University Graduate School for financial support. The Academy of Finland funded A.V.V. and the collection of samples from large rivers. R.G.M.S. was supported by NSF grants (ETBC-0851101, DEB-1145932, ANT-1203885, and OPP-1107774). A.S. was supported by the NSF (DEB-1146161) and a Fellowship from the Hanse Institute for Advanced Studies (HWK, Delmenhorst, Germany). R. Max Holmes, James W. McClelland, and the rest of the Arctic Great Rivers Observatory (www.arcticgreatrivers.org) team are thanked for providing Arctic river samples (NSF OPP-0732522, OPP-0732821, and OPP-1107774). We thank Y. Yamashita, J. Jones (Bonanza Creek-LTER), W. Dodds (Konza Prairie-LTER), C. Craft (Georgia Coastal Ecosystems-LTER), N. Jaffe, C. Nunes, K. Cawley, P. Wolski, R. Price, C. Rezende, E. M. Paolucci, E. Musibono, A. Shantz, Y. Gelinas, S. R. Khan, Q. Huang, W. Schneider, E. Petrescu and H. E. Reader for providing samples and for field support and M. Friebe and I. Ulber for analytical support. This is SERC Contribution 593. Original data will be available at http://fcelter.fiu.edu/data/public_data_access/RJaffe_Global_DissolvedBlack_Corg.xls.	Abiven S, 2011, SOIL BIOL BIOCHEM, V43, P1615, DOI 10.1016/j.soilbio.2011.03.027; Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; Bird MI, 1999, GLOBAL BIOGEOCHEM CY, V13, P923, DOI 10.1029/1999GB900067; Cusack DF, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004109; Czimczik CI, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001956; Czimczik CI, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002798; Ding Y, 2013, CHEMOSPHERE, V90, P2557, DOI 10.1016/j.chemosphere.2012.10.098; Dittmar T, 2008, ORG GEOCHEM, V39, P396, DOI 10.1016/j.orggeochem.2008.01.015; Dittmar T, 2006, MAR CHEM, V102, P208, DOI 10.1016/j.marchem.2006.04.003; Dittmar T, 2012, NAT GEOSCI, V5, P618, DOI [10.1038/ngeo1541, 10.1038/NGEO1541]; Dittmar T, 2012, LIMNOL OCEANOGR, V57, P1171, DOI 10.4319/lo.2012.57.4.1171; Dittmar T, 2009, NAT GEOSCI, V2, P175, DOI 10.1038/NGEO440; Glaser B, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002019; Goldberg E.D., 1985, BLACK CARBON ENV PRO; Hammes K, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002914; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Hockaday WC, 2007, GEOCHIM COSMOCHIM AC, V71, P3432, DOI 10.1016/j.gca.2007.02.023; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; Levine J. S., 1996, BIOMASS BURNING GLOB; Mannino A, 2004, LIMNOL OCEANOGR, V49, P735, DOI 10.4319/lo.2004.49.3.0735; Masiello CA, 1998, SCIENCE, V280, P1911, DOI 10.1126/science.280.5371.1911; Masiello CA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015050; Masiello CA, 2004, MAR CHEM, V92, P201, DOI 10.1016/j.marchem.2004.06.043; Mitra S, 2002, ENVIRON SCI TECHNOL, V36, P2296, DOI 10.1021/es015834b; Nguyen BT, 2010, ENVIRON SCI TECHNOL, V44, P3324, DOI 10.1021/es903016y; Ohlson M, 2009, NAT GEOSCI, V2, P692, DOI 10.1038/NGEO617; Schmidt MWI, 2004, NATURE, V427, P305, DOI 10.1038/427305a; Schneider MPW, 2010, ORG GEOCHEM, V41, P1082, DOI 10.1016/j.orggeochem.2010.07.001; Singh N, 2012, BIOGEOSCIENCES, V9, P2847, DOI 10.5194/bg-9-2847-2012; Skjemstad JO, 2002, SOIL SCI SOC AM J, V66, P1249, DOI 10.2136/sssaj2002.1249	30	328	341	37	489	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					345	347		10.1126/science.1231476	http://dx.doi.org/10.1126/science.1231476			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599492				2022-12-28	WOS:000317657500053
J	Zou, Y; Chiu, H; Zinovyeva, A; Ambros, V; Chuang, CF; Chang, C				Zou, Yan; Chiu, Hui; Zinovyeva, Anna; Ambros, Victor; Chuang, Chiou-Fen; Chang, Chieh			Developmental Decline in Neuronal Regeneration by the Progressive Change of Two Intrinsic Timers	SCIENCE			English	Article							ELEGANS; MICRORNA; ENCODES; PATHWAY; PROTEIN; LIN-14; RNA	Like mammalian neurons, Caenorhabditis elegans neurons lose axon regeneration ability as they age, but it is not known why. Here, we report that let-7 contributes to a developmental decline in anterior ventral microtubule (AVM) axon regeneration. In older AVM axons, let-7 inhibits regeneration by down-regulating LIN-41, an important AVM axon regeneration-promoting factor. Whereas let-7 inhibits lin-41 expression in older neurons through the lin-41 3' untranslated region, lin-41 inhibits let-7 expression in younger neurons through Argonaute ALG-1. This reciprocal inhibition ensures that axon regeneration is inhibited only in older neurons. These findings show that a let-7-lin-41 regulatory circuit, which was previously shown to control timing of events in mitotic stem cell lineages, is reutilized in postmitotic neurons to control postdifferentiation events.	[Zou, Yan; Chiu, Hui; Chuang, Chiou-Fen; Chang, Chieh] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; [Zinovyeva, Anna; Ambros, Victor] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Zinovyeva, Anna; Ambros, Victor] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Chang, Chieh] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 1B1, Canada	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; McGill University	Chuang, CF (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA.	chiou-fen.chuang@cchmc.org; chieh.chang@cchmc.org	Zou, Yan/AAR-2564-2020	Zou, Yan/0000-0002-4743-4995; Chiu, Hui (Vivian)/0000-0002-1820-8411; Chuang, Chiou-Fen/0000-0001-7469-076X	Whitehall Foundation; March of Dimes Foundation; Canada Foundation for Innovation; Alfred P. Sloan Research Fellowships; NIH [R01 GM098026, R01 GM034028-25]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034028, R01GM098026] Funding Source: NIH RePORTER	Whitehall Foundation; March of Dimes Foundation(March of Dimes); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alfred P. Sloan Research Fellowships; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the C. elegans Genetic Center for C. elegans strains; the WormBase for readily accessible information; F. Ciamacco, B. Bayne, and C. Carrelli for technical assistance; A. Fire for C. elegans vectors; and V. Cleghon for critical reading of the manuscript. This work was funded by grants from the Whitehall Foundation (C.C. and C.-F.C.), the March of Dimes Foundation (C.C.), the Canada Foundation for Innovation (C.C.), by Alfred P. Sloan Research Fellowships to C.-F.C., by NIH grant R01 GM098026 to C.-F.C., and by NIH grant R01 GM034028-25 to V.A.	Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chiu H, 2011, CELL ADHES MIGR, V5, P387, DOI 10.4161/cam.5.5.17985; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Gabel CV, 2008, DEVELOPMENT, V135, P3623, DOI 10.1242/dev.030817; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hsieh YW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002864; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; ROUGVIE AE, 1995, DEVELOPMENT, V121, P2491; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu Z, 2007, P NATL ACAD SCI USA, V104, P15132, DOI 10.1073/pnas.0707001104; Zou Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002437	19	104	109	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					372	376		10.1126/science.1231321	http://dx.doi.org/10.1126/science.1231321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599497	Green Accepted			2022-12-28	WOS:000317657500061
J	Bohmer, RMJ				Bohmer, Richard M. J.			Leading Clinicians and Clinicians Leading	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DOCTORS		[Bohmer, Richard M. J.] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Bohmer, Richard M. J.] Kings Fund, London, England	Harvard University	Bohmer, RMJ (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.		Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285				Beckman HB, 2011, ANN INTERN MED, V154, P430, DOI 10.7326/0003-4819-154-6-201103150-00010; Curry LA, 2011, ANN INTERN MED, V154, P384, DOI 10.7326/0003-4819-154-6-201103150-00003; Gilbert A, 2012, BMJ QUAL SAF, V21, P234, DOI 10.1136/bmjqs-2011-000611; Lee TH, 2010, HARVARD BUS REV, V88, P50; UnitedHealth Center for Health Reform and Modernization, 2012, 8 UNITEDHEALTH CTR H	5	48	48	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1468	1470		10.1056/NEJMp1301814	http://dx.doi.org/10.1056/NEJMp1301814			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126HC	23594000				2022-12-28	WOS:000317603300002
J	Chang, WC; Dey, M; Liu, PH; Mansoorabadi, SO; Moon, SJ; Zhao, ZBK; Drennan, CL; Liu, HW				Chang, Wei-chen; Dey, Mishtu; Liu, Pinghua; Mansoorabadi, Steven O.; Moon, Sung-Ju; Zhao, Zongbao K.; Drennan, Catherine L.; Liu, Hung-wen			Mechanistic studies of an unprecedented enzyme-catalysed 1,2-phosphono-migration reaction	NATURE			English	Article							(S)-2-HYDROXYPROPYLPHOSPHONIC ACID EPOXIDASE; ANTIBIOTIC FOSFOMYCIN BIOSYNTHESIS; MONONUCLEAR IRON ENZYME; ESCHERICHIA-COLI; IDENTIFICATION; ACTIVATION; RESISTANT; INSIGHT; OXYGEN; SITE	(S)-2-hydroxypropylphosphonate ((S)-2-HPP) epoxidase (HppE) is a mononuclear non-haem-iron-dependent enzyme(1-3) responsible for the final step in the biosynthesis of the clinically useful antibiotic fosfomycin(4). Enzymes of this class typically catalyse oxygenation reactions that proceed via the formation of substrate radical intermediates. By contrast, HppE catalyses an unusual dehydrogenation reaction while converting the secondary alcohol of (S)-2-HPP to the epoxide ring of fosfomycin(1,5). Here we show that HppE also catalyses a biologically unprecedented 1,2-phosphono migration with the alternative substrate (R)-1-HPP. This transformation probably involves an intermediary carbocation, based on observations with additional substrate analogues, such as (1R)-1-hydroxyl-2-aminopropylphosphonate, and model reactions for both radical- and carbocation-mediated migration. The ability of HppE to catalyse distinct reactions depending on the regio- and stereochemical properties of the substrate is given a structural basis using X-ray crystallography. These results provide compelling evidence for the formation of a substrate-derived cation intermediate in the catalytic cycle of a mononuclear non-haem-iron-dependent enzyme. The underlying chemistry of this unusual phosphono migration may represent a new paradigm for the in vivo construction of phosphonate-containing natural products that can be exploited for the preparation of new phosphonate derivatives.	[Chang, Wei-chen; Liu, Pinghua; Mansoorabadi, Steven O.; Moon, Sung-Ju; Zhao, Zongbao K.; Liu, Hung-wen] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA; [Chang, Wei-chen; Liu, Pinghua; Mansoorabadi, Steven O.; Moon, Sung-Ju; Zhao, Zongbao K.; Liu, Hung-wen] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Dey, Mishtu; Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Dey, Mishtu; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Dey, Mishtu; Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 02139 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Liu, HW (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA.	h.w.liu@mail.utexas.edu	Mansoorabadi, Steven/I-3688-2017; Zhao, Zongbao K/F-5518-2011	Mansoorabadi, Steven/0000-0002-6369-3815; Zhao, Zongbao K/0000-0003-0654-1193; CHANG, WEI-CHEN/0000-0002-2341-9846	National Institutes of Health [GM040541]; Welch Foundation [F-1511]; Advanced Light Source, a Department of Energy (DOE) national user facility [DE-AC02-05CH11231]; DOE; National Institutes of Health/National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Advanced Light Source, a Department of Energy (DOE) national user facility; DOE(United States Department of Energy (DOE)); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Johnson and S. Sorey for assistance with the NMR experiment setup. This work is supported in part by grants from The National Institutes of Health (GM040541 to H.-w.L.) and the Welch Foundation (F-1511). C. L. D. is a Howard Hughes Medical Institute Investigator. Crystallographic data collection were conducted at the Advanced Light Source, a Department of Energy (DOE) national user facility (Contract DE-AC02-05CH11231), at beamline 8.2.2 operated by the Berkeley Center for Structural Biology, which is supported in part by DOE and National Institutes of Health/National Institute of General Medical Sciences.	BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; Cassone M, 2004, MICROB DRUG RESIST, V10, P43, DOI 10.1089/107662904323047790; CHURI RH, 1966, J AM CHEM SOC, V88, P1824, DOI 10.1021/ja00960a049; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Girotra N. N., 1969, TETRAHEDRON LETT, V10, P4647; Hammerschmidt F., 1990, LIEBIGS ANN CHEM, P1055; HIDAKA T, 1995, MOL GEN GENET, V249, P274, DOI 10.1007/BF00290527; Higgins LJ, 2005, NATURE, V437, P838, DOI 10.1038/nature03924; Huang H., 2012, J AM CHEM SOC, V134, P13946; Kappock TJ, 1996, CHEM REV, V96, P2659, DOI 10.1021/cr9402034; Ko KS, 2007, DIAGN MICR INFEC DIS, V58, P111, DOI [10.1016/j.diaginicrobio.2006.11.015, 10.1016/j.diagmicrobio.2006.11.015]; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Lesburg CA, 1998, CURR OPIN STRUC BIOL, V8, P695, DOI 10.1016/S0959-440X(98)80088-2; Liu PH, 2001, J AM CHEM SOC, V123, P4619, DOI 10.1021/ja004153y; Liu PH, 2003, BIOCHEMISTRY-US, V42, P11577, DOI 10.1021/bi030140w; Liu SJ, 2002, BIOCHEMISTRY-US, V41, P10270, DOI 10.1021/bi026024v; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; Mirica LM, 2008, J AM CHEM SOC, V130, P8122, DOI 10.1021/ja800265s; Nakazawa Hiroaki, 2003, Journal of Infection and Chemotherapy, V9, P304, DOI 10.1007/s10156-003-0266-2; SEIDEL HM, 1988, NATURE, V335, P457, DOI 10.1038/335457a0; Stengel D, 2005, J CHEMOTHERAPY, V17, P527, DOI 10.1179/joc.2005.17.5.527; van der Donk WA, 2010, CURR OPIN STRUC BIOL, V20, P673, DOI 10.1016/j.sbi.2010.08.005; Woodyer RD, 2007, CHEM COMMUN, P359, DOI 10.1039/b614678c; YAMASHITA M, 1987, SYNTHESIS-STUTTGART, P62; Yan F, 2005, ARCH BIOCHEM BIOPHYS, V442, P82, DOI 10.1016/j.abb.2005.07.024; Yan F, 2007, BIOCHEMISTRY-US, V46, P12628, DOI 10.1021/bi701370e; Yan F, 2006, BIOCHEMISTRY-US, V45, P11473, DOI 10.1021/bi060839c; Yun D, 2011, J AM CHEM SOC, V133, P11262, DOI 10.1021/ja2025728; Zhao ZB, 2002, ANGEW CHEM INT EDIT, V41, P4529, DOI 10.1002/1521-3773(20021202)41:23<4529::AID-ANIE4529>3.0.CO;2-2	29	46	48	1	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2013	496	7443					114	118		10.1038/nature11998	http://dx.doi.org/10.1038/nature11998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23552950	Green Accepted, Green Submitted			2022-12-28	WOS:000316993400036
J	Goldstein, AO; Barnhouse, KK; Viera, AJ; Tulsky, JA; Richman, BD				Goldstein, Adam O.; Barnhouse, Kathleen K.; Viera, Anthony J.; Tulsky, James A.; Richman, Barak D.			Assessing Competency for Concealed-Weapons Permits - The Physician's Role	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goldstein, Adam O.; Barnhouse, Kathleen K.; Viera, Anthony J.] Univ N Carolina, Sch Med, Dept Family Med, Chapel Hill, NC 27515 USA; [Tulsky, James A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Richman, Barak D.] Duke Univ, Sch Law, Durham, NC 27706 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Duke University	Goldstein, AO (corresponding author), Univ N Carolina, Sch Med, Dept Family Med, Chapel Hill, NC 27515 USA.							Florida Department of Agricultural and Consumer Services Division of Licensing, NEW FLOR CONC WEAP L; Michigan State Police Criminal Justice Information Center, 2009, CONC PIST LIC ANN RE; Teeple K, 2013, J EMERG MED; Webster D, 2012, CASE GUN POLICY REFO	4	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2251	2253		10.1056/NEJMp1302795	http://dx.doi.org/10.1056/NEJMp1302795			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YN	23593979	Bronze, Green Published			2022-12-28	WOS:000320230500016
J	Xiong, XL; Coombs, PJ; Martin, SR; Liu, JF; Xiao, HX; McCauley, JW; Locher, K; Walker, PA; Collins, PJ; Kawaoka, Y; Skehel, JJ; Gamblin, SJ				Xiong, Xiaoli; Coombs, Peter J.; Martin, Stephen R.; Liu, Junfeng; Xiao, Haixia; McCauley, John W.; Locher, Kathrin; Walker, Philip A.; Collins, Patrick J.; Kawaoka, Yoshihiro; Skehel, John J.; Gamblin, Steven J.			Receptor binding by a ferret-transmissible H5 avian influenza virus	NATURE			English	Article							A VIRUS; HEMAGGLUTININ; SPECIFICITY; EVOLUTION; SELECTION; VARIANTS; MAMMALS; FUSION; CELL; H2	Cell-surface-receptor binding by influenza viruses is a key determinant of their transmissibility, both from avian and animal species to humans as well as from human to human. Highly pathogenic avian H5N1 viruses that are a threat to public health have been observed to acquire affinity for human receptors, and transmissible-mutant-selection experiments have identified a virus that is transmissible in ferrets(1-3), the generally accepted experimental model for influenza in humans. Here, our quantitative biophysical measurements of the receptor-binding properties of haemagglutinin (HA) from the transmissible mutant indicate a small increase in affinity for human receptor and a marked decrease in affinity for avian receptor. From analysis of virus and HA binding data we have derived an algorithm that predicts virus avidity from the affinity of individual HA-receptor interactions. It reveals that the transmissible-mutant virus has a 200-fold preference for binding human over avian receptors. The crystal structure of the transmissible-mutant HA in complex with receptor analogues shows that it has acquired the ability to bind human receptor in the same folded-back conformation as seen for HA from the 1918, 1957 (ref. 4), 1968 (ref. 5) and 2009 (ref. 6) pandemic viruses. This binding mode is substantially different from that by which non-transmissible wild-type H5 virus HA binds human receptor. The structure of the complex also explains how the change in preference from avian to human receptors arises from the Gln226Leu substitution, which facilitates binding to human receptor but restricts binding to avian receptor. Both features probably contribute to the acquisition of transmissibility by this mutant virus.	[Xiong, Xiaoli; Coombs, Peter J.; Martin, Stephen R.; Xiao, Haixia; McCauley, John W.; Walker, Philip A.; Collins, Patrick J.; Skehel, John J.; Gamblin, Steven J.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Liu, Junfeng] China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing 100193, Peoples R China; [Locher, Kathrin] Novartis Inst BioMed Res, CH-4057 Basel, Switzerland; [Kawaoka, Yoshihiro] Univ Wisconsin Madison, Dept Pathobiol Sci, Madison, WI 53711 USA	MRC National Institute for Medical Research; China Agricultural University; Ministry of Agriculture & Rural Affairs; Novartis; University of Wisconsin System; University of Wisconsin Madison	Gamblin, SJ (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	skeheljj@nimr.mrc.ac.uk; sgambli@nimr.mrc.ac.uk	Xiao, Haixia/AAZ-3374-2020	Xiao, Haixia/0000-0003-0032-5430; Gamblin, Steve/0000-0001-5331-639X; Coombs, Peter/0000-0002-3711-5480; liu, junfeng/0000-0001-5825-5397; Xiong, Xiaoli/0000-0002-4632-9122	BBSRC [BB/E010806]; Medical Research Council [U117584222, U117512723, U117570592]; Medical Research Council [MC_U117512723, MC_U117584222] Funding Source: researchfish; MRC [MC_U117584222, MC_U117512723] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to staff at the Diamond Light Source Synchrotron for assistance and beamline access under proposal 7707, E. Christodoulou and S. Vachieri for discussions on protein expression, the staff of the NIMR Large Scale Laboratory, L Haire for assistance with crystallization experiments and S. Smerdon and P. Rosenthal for discussions. H. X. was supported by BBSRC (award number BB/E010806). This work was funded by the Medical Research Council through programmes U117584222, U117512723 and U117570592.	Arinaminpathy N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015674; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Gambaryan AS, 2012, J VIROL, V86, P4370, DOI 10.1128/JVI.06959-11; Gambaryan AS, 1997, VIROLOGY, V232, P345, DOI 10.1006/viro.1997.8572; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; RUIGROK RWH, 1986, VIROLOGY, V155, P484, DOI 10.1016/0042-6822(86)90210-2; SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Steinhauer DA, 1996, P NATL ACAD SCI USA, V93, P12873, DOI 10.1073/pnas.93.23.12873; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Xu R, 2012, J VIROL, V86, P982, DOI 10.1128/JVI.06322-11; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	30	156	168	0	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					392	+		10.1038/nature12144	http://dx.doi.org/10.1038/nature12144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23615615	Bronze			2022-12-28	WOS:000318952000043
J	Feinstein, NW; Allen, S; Jenkins, E				Feinstein, Noah Weeth; Allen, Sue; Jenkins, Edgar			Outside the Pipeline: Reimagining Science Education for Nonscientists	SCIENCE			English	Review							LITERACY; STUDENTS; LEARN	Educational policy increasingly emphasizes knowledge and skills for the preprofessional "science pipeline" rather than helping students use science in daily life. We synthesize research on public engagement with science to develop a research-based plan for cultivating competent outsiders: nonscientists who can access and make sense of science relevant to their lives. Schools should help students access and interpret the science they need in response to specific practical problems, judge the credibility of scientific claims based on both evidence and institutional cues, and cultivate deep amateur involvement in science.	[Feinstein, Noah Weeth] Univ Wisconsin Madison, Dept Curriculum & Instruct, Madison, WI 53706 USA; [Feinstein, Noah Weeth] Univ Wisconsin Madison, Dept Community & Environm Sociol, Madison, WI 53706 USA; [Allen, Sue] Allen & Associates, Newcastle, ME 04553 USA; [Jenkins, Edgar] Univ Leeds, Ctr Studies Sci & Math Educ, Leeds LS2 9JT, W Yorkshire, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Leeds	Feinstein, NW (corresponding author), Univ Wisconsin Madison, Dept Curriculum & Instruct, 225 North Mills St, Madison, WI 53706 USA.	nfeinstein@wisc.edu						Bennett J, 2007, SCI EDUC, V91, P347, DOI 10.1002/sce.20186; Bonney R, 2009, PUBLIC PARTICIPATION; Bransford JD., 2000, PEOPLE LEARN; Bubela T, 2009, NAT BIOTECHNOL, V27, P514, DOI 10.1038/nbt0609-514; Davey A., 1993, INARTICULATE SCI; DeBoer G, 1991, HIST IDEAS SCI ED; Falk JH, 2007, PUBLIC UNDERST SCI, V16, P455, DOI 10.1177/0963662506064240; Feinstein N. W., 2012, PUBLIC UNDERST SCI, V2012; Feinstein N, 2011, SCI EDUC, V95, P168, DOI 10.1002/sce.20414; Fernandes R, 1999, POLICY SCI, V32, P225, DOI 10.1023/A:1004668303848; GALISON P, 1997, IMAGE LOGIC; Goldstone RL, 2012, EDUC PSYCHOL-US, V47, P149, DOI 10.1080/00461520.2012.695710; Hmelo-Silver CE, 2004, EDUC PSYCHOL REV, V16, P235, DOI 10.1023/B:EDPR.0000034022.16470.f3; Irwin B., 1996, MISUNDERSTANDING SCI; Kahnemann Daniel, 2011, THINKING FAST SLOW; Krajcik JS, 2010, SCIENCE, V328, P456, DOI 10.1126/science.1182593; Lee O., 2010, DIVERSITY EQUITY SCI; Leiserowitz A, 2012, GLOBAL WARMINGS 6 AM; Miller J.D., 2009, CURATOR, V53, P191, DOI [10.1111/j.2151-6952.2010.00019.x, DOI 10.1111/J.2151-6952.2010.00019.X]; Miller S, 2001, PUBLIC UNDERST SCI, V10, P115, DOI 10.1088/0963-6625/10/1/308; National Research Council, 2007, LEARN SCI INF ENV; National Research Council, 2012, FRAM SCI ED; National Science Board, 2012, SCI ENG IND 2012; Norris SP, 2003, SCI EDUC, V87, P224, DOI 10.1002/sce.10066; Osborne J, 2003, INT J SCI EDUC, V25, P1049, DOI 10.1080/0950069032000032199; Osborne J, 2010, SCIENCE, V328, P463, DOI 10.1126/science.1183944; Roth W.-M., 2004, RETHINKING SCI LITER; Ryder J., 2001, STUDIES SCI ED, V36, P1, DOI [10.1080/03057260108560166, DOI 10.1080/03057260108560166]; Sadler TD, 2009, J RES SCI TEACH, V46, P909, DOI 10.1002/tea.20327; Schwartz DL., 2005, TRANSFER LEARNING MO, P1; Semken S., 2006, SCI ED, V92, P1042; The National Academies, 2007, RIS GATH STORM; Vedder-Weiss D, 2012, J RES SCI TEACH, V49, P1057, DOI 10.1002/tea.21049; Wirkala C, 2011, AM EDUC RES J, V48, P1157, DOI 10.3102/0002831211419491; Wynne B., 1992, PUBLIC UNDERST SCI, V1, P281, DOI [10.1088/0963-6625/1/3/004, DOI 10.1088/0963-6625/1/3/004]	35	83	85	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					314	317		10.1126/science.1230855	http://dx.doi.org/10.1126/science.1230855			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126XZ	23599483				2022-12-28	WOS:000317657500044
J	Neubauer, P; Jensen, OP; Hutchings, JA; Baum, JK				Neubauer, Philipp; Jensen, Olaf P.; Hutchings, Jeffrey A.; Baum, Julia K.			Resilience and Recovery of Overexploited Marine Populations	SCIENCE			English	Article							FISHERIES-INDUCED EVOLUTION; FISH STOCKS; FORAGE FISH; CONSEQUENCES; DYNAMICS; IMPACTS; PLANS	Recovery of overexploited marine populations has been slow, and most remain below target biomass levels. A key question is whether this is due to insufficient reductions in harvest rates or the erosion of population resilience. Using a global meta-analysis of overfished stocks, we find that resilience of those stocks subjected to moderate levels of overfishing is enhanced, not compromised, offering the possibility of swift recovery. However, prolonged intense overexploitation, especially for collapsed stocks, not only delays rebuilding but also substantially increases the uncertainty in recovery times, despite predictable influences of fishing and life history. Timely and decisive reductions in harvest rates could mitigate this uncertainty. Instead, current harvest and low biomass levels render recovery improbable for the majority of the world's depleted stocks.	[Neubauer, Philipp; Jensen, Olaf P.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Hutchings, Jeffrey A.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada; [Hutchings, Jeffrey A.] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Baum, Julia K.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada	Rutgers State University New Brunswick; Dalhousie University; University of Oslo; University of Victoria	Neubauer, P (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA.	neubauer.phil@gmail.com	Hutchings, Jeffrey/ABA-1098-2020	Neubauer, Philipp/0000-0002-4150-848X; Baum, Julia/0000-0002-9827-1612; Hutchings, Jeffrey/0000-0003-1572-5429	NFS/National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO) [1041678]; Natural Sciences and Engineering Research Council; Sloan Fellowship	NFS/National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sloan Fellowship(Alfred P. Sloan Foundation)	We acknowledge financial support from NFS/National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO) grant 1041678, Natural Sciences and Engineering Research Council Discovery Grants to J.A.H. and J.K.B., and a Sloan Fellowship to J.K.B. We thank R. Hilborn, T. Branch, and the Jensen Laboratory group for insightful comments. Comments by three anonymous reviewers substantially improved the manuscript. Source data are available at http://ramlegacy.marinebiodiversity.ca.	[Anonymous], 2012, 2012 ATL BLUEF TUN S; Caddy JF, 2004, REV FISH BIOL FISHER, V14, P43, DOI 10.1007/s11160-004-3770-2; Choi JS, 2004, CAN J FISH AQUAT SCI, V61, P505, DOI 10.1139/F04-079; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Enberg K, 2009, EVOL APPL, V2, P394, DOI 10.1111/j.1752-4571.2009.00077.x; European Commission, 2011, EUR CFP REF MAX SUST; Grafton RQ, 2007, SCIENCE, V318, P1601, DOI 10.1126/science.1146017; Hilborn Ray, 2009, Open Fish Science Journal, V2, P32; Holt CA, 2009, FISH RES, V100, P57, DOI 10.1016/j.fishres.2009.03.002; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Jiao Y, 2009, REV FISH BIOL FISHER, V19, P177, DOI 10.1007/s11160-008-9096-8; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Keith DM, 2012, CAN J FISH AQUAT SCI, V69, P1150, DOI 10.1139/F2012-055; Kuparinen A, 2012, P ROY SOC B-BIOL SCI, V279, P2571, DOI 10.1098/rspb.2012.0120; Murawski SA, 2010, ICES J MAR SCI, V67, P1830, DOI 10.1093/icesjms/fsq125; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; Safina C, 2005, SCIENCE, V309, P707, DOI 10.1126/science.1113725; Sharpe DMT, 2009, EVOL APPL, V2, P260, DOI 10.1111/j.1752-4571.2009.00080.x; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Swain DP, 2012, CAN J FISH AQUAT SCI, V69, P997, DOI 10.1139/F2012-045; United Nations, 2002, REP WORLD SUMM SUST; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Walters CJ, 2008, CAN J FISH AQUAT SCI, V65, P2536, DOI 10.1139/F08-170; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Ye YM, 2013, FISH FISH, V14, P174, DOI 10.1111/j.1467-2979.2012.00460.x	28	169	173	11	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					347	349		10.1126/science.1230441	http://dx.doi.org/10.1126/science.1230441			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599493				2022-12-28	WOS:000317657500054
J	Tanner, M				Tanner, Michael			Metformin reduced CV events compared with glipizide in patients with type 2 diabetes and CAD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									NYU, Sch Med, New York, NY USA	New York University	Tanner, M (corresponding author), NYU, Sch Med, New York, NY USA.			Tanner, Michael/0000-0002-3012-8641				Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8							JC4	10.7326/0003-4819-158-8-201304160-02004	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588769				2022-12-28	WOS:000318062100007
J	Kim, TI; McCall, JG; Jung, YH; Huang, X; Siuda, ER; Li, YH; Song, JZ; Song, YM; Pao, HA; Kim, RH; Lu, CF; Lee, SD; Song, IS; Shin, G; Al-Hasani, R; Kim, S; Tan, MP; Huang, YG; Omenetto, FG; Rogers, JA; Bruchas, MR				Kim, Tae-il; McCall, Jordan G.; Jung, Yei Hwan; Huang, Xian; Siuda, Edward R.; Li, Yuhang; Song, Jizhou; Song, Young Min; Pao, Hsuan An; Kim, Rak-Hwan; Lu, Chaofeng; Lee, Sung Dan; Song, Il-Sun; Shin, Gunchul; Al-Hasani, Ream; Kim, Stanley; Tan, Meng Peun; Huang, Yonggang; Omenetto, Fiorenzo G.; Rogers, John A.; Bruchas, Michael R.			Injectable, Cellular-Scale Optoelectronics with Applications for Wireless Optogenetics	SCIENCE			English	Article							IN-VIVO CONTROL; DOPAMINERGIC-NEURONS; TRANSISTORS; MODULATION; CIRCUITS; ARRAYS; REWARD; MODEL; FILMS	Successful integration of advanced semiconductor devices with biological systems will accelerate basic scientific discoveries and their translation into clinical technologies. In neuroscience generally, and in optogenetics in particular, the ability to insert light sources, detectors, sensors, and other components into precise locations of the deep brain yields versatile and important capabilities. Here, we introduce an injectable class of cellular-scale optoelectronics that offers such features, with examples of unmatched operational modes in optogenetics, including completely wireless and programmed complex behavioral control over freely moving animals. The ability of these ultrathin, mechanically compliant, biocompatible devices to afford minimally invasive operation in the soft tissues of the mammalian brain foreshadow applications in other organ systems, with potential for broad utility in biomedical science and engineering.	[Kim, Tae-il; Jung, Yei Hwan; Huang, Xian; Song, Young Min; Pao, Hsuan An; Kim, Rak-Hwan; Shin, Gunchul; Kim, Stanley; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Kim, Tae-il] Sungkyunkwan Univ SKKU, Sch Chem Engn, Suwon 440746, South Korea; [McCall, Jordan G.; Siuda, Edward R.; Al-Hasani, Ream; Bruchas, Michael R.] Washington Univ, Sch Med, Basic Res Div, Dept Anesthesiol, St Louis, MO 63110 USA; [McCall, Jordan G.; Siuda, Edward R.; Al-Hasani, Ream; Bruchas, Michael R.] Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63110 USA; [McCall, Jordan G.; Siuda, Edward R.; Al-Hasani, Ream; Bruchas, Michael R.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [McCall, Jordan G.; Siuda, Edward R.; Bruchas, Michael R.] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA; [Li, Yuhang] Northwestern Univ, Dept Civil & Environm Engn, Dept Mech Engn, Evanston, IL 60208 USA; [Li, Yuhang] Northwestern Univ, Inst Publ Hlth & Med, Evanston, IL 60208 USA; [Song, Jizhou] Univ Miami, Dept Mech & Aerosp Engn, Coral Gables, FL 33146 USA; [Lu, Chaofeng] Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310027, Zhejiang, Peoples R China; [Lu, Chaofeng] Zhejiang Univ, Dept Civil Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Lee, Sung Dan; Tan, Meng Peun; Rogers, John A.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61802 USA; [Song, Il-Sun; Rogers, John A.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61802 USA; [Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Medford, MA 02115 USA; [Omenetto, Fiorenzo G.] Tufts Univ, Dept Phys, Medford, MA 02115 USA; [Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61802 USA	University of Illinois System; University of Illinois Urbana-Champaign; Sungkyunkwan University (SKKU); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Northwestern University; Northwestern University; University of Miami; Zhejiang University; Zhejiang University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Tufts University; Tufts University; University of Illinois System; University of Illinois Urbana-Champaign	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, Frederick Seitz Mat Res Lab, 1304 W Green St, Urbana, IL 61801 USA.	jrogers@uiuc.edu; bruchasm@wustl.edu	McCall, Jordan/O-4795-2016; Rogers, John/L-2798-2016; Bruchas, Michael/G-7616-2012; Song, Young Min/B-2215-2010; Kim, Tae-il/C-4769-2015; huang, yonggang/O-6236-2019; Li, Yuhang/N-6104-2019; Kim, Rak-Hwan/A-6155-2012; Huang, Yonggang/B-6998-2009; Al-Hasani, Ream/GPX-3398-2022; Song, Jizhou/B-1935-2008; Huang, Xian/H-1820-2013	McCall, Jordan/0000-0001-8295-0664; Song, Young Min/0000-0002-4473-6883; Kim, Tae-il/0000-0002-6667-5356; Song, Jizhou/0000-0003-2821-9429; Huang, Xian/0000-0002-8788-9185	NIH; National Institute of Neurological Disorders and Stroke, NIH [R01NS081707]; National Institute on Drug Abuse, NIH [R00DA025182]; McDonnell Center for Systems Neuroscience; National Security Science and Engineering Faculty Fellowship of Energy; Division of Materials Sciences, U.S. Department of Energy [DE-FG02-07ER46471]; Materials Research Laboratory; Center for Microanalysis of Materials [DE-FG02-07ER46453]; Division of Biology and Biomedical Sciences, Washington University in St. Louis (WUSTL); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA025182] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Drug Abuse, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); McDonnell Center for Systems Neuroscience; National Security Science and Engineering Faculty Fellowship of Energy; Division of Materials Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); Materials Research Laboratory; Center for Microanalysis of Materials; Division of Biology and Biomedical Sciences, Washington University in St. Louis (WUSTL); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by the NIH Common Fund; National Institute of Neurological Disorders and Stroke, NIH, R01NS081707 (M.R.B., J.A.R.); National Institute on Drug Abuse, NIH, R00DA025182 (M.R.B.); McDonnell Center for Systems Neuroscience (M.R.B.); National Security Science and Engineering Faculty Fellowship of Energy (J.A.R.); Division of Materials Sciences, U. S. Department of Energy, under award no. DE-FG02-07ER46471 (J.A.R.), and the Materials Research Laboratory and Center for Microanalysis of Materials (DE-FG02-07ER46453) (J.A.R.); and the Division of Biology and Biomedical Sciences, Washington University in St. Louis (WUSTL) (J.G.M.). We thank H. Tao (Tufts University) and S. Hwang (University of Illinois at Urbana-Champaign) for their help in preparation of silk solution and valuable discussions; the Bruchas laboratory and the laboratories of R. W. Gereau IV (WUSTL) and G. D. Stuber (University of North Carolina at Chapel Hill) for helpful discussions; K. Deisseroth (Stanford University) for the channelrhodopsin-2 (H134) and OPTO-beta 2 constructs; G. D. Stuber for the TH-IRES-Cre mice; the WUSTL Bakewell Neuroimaging Laboratory Core; and the WUSTL Hope Center Viral Vector Core.	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Cao H, 2013, IEEE T BIO-MED ENG, V60, P225, DOI 10.1109/TBME.2012.2217395; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Coque L, 2011, NEUROPSYCHOPHARMACOL, V36, P1478, DOI 10.1038/npp.2011.33; Elwassif MM, 2006, J NEURAL ENG, V3, P306, DOI 10.1088/1741-2560/3/4/008; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Kim KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033612; Kim TI, 2012, SMALL, V8, P1643, DOI 10.1002/smll.201200382; Kim YT, 2012, MRS BULL, V37, P573, DOI 10.1557/mrs.2012.99; Kozai TDY, 2009, J NEUROSCI METH, V184, P199, DOI 10.1016/j.jneumeth.2009.08.002; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/NMAT2834, 10.1038/nmat2834]; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; McGranahan TM, 2011, J NEUROSCI, V31, P10891, DOI 10.1523/JNEUROSCI.0937-11.2011; Ordonez J, 2012, MRS BULL, V37, P590, DOI 10.1557/mrs.2012.117; Qing Q, 2010, P NATL ACAD SCI USA, V107, P1882, DOI 10.1073/pnas.0914737107; Sekitani T, 2012, MRS BULL, V37, P236, DOI 10.1557/mrs.2012.42; Sekitani T, 2009, SCIENCE, V326, P1516, DOI 10.1126/science.1179963; Stark E, 2012, J NEUROPHYSIOL, V108, P349, DOI 10.1152/jn.00153.2012; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Takeuchi S, 2004, J MICROMECH MICROENG, V14, P104, DOI 10.1088/0960-1317/14/1/014; Tian BZ, 2012, NAT MATER, V11, P986, DOI [10.1038/NMAT3404, 10.1038/nmat3404]; Tian BZ, 2010, SCIENCE, V329, P830, DOI 10.1126/science.1192033; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Viventi J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000738; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zorzos AN, 2012, OPT LETT, V37, P4841, DOI 10.1364/OL.37.004841	32	792	822	34	682	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					211	216		10.1126/science.1232437	http://dx.doi.org/10.1126/science.1232437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580530	Green Accepted, Green Submitted			2022-12-28	WOS:000317341400059
J	Wilson, EB; Yamada, DH; Elsaesser, H; Herskovitz, J; Deng, JN; Cheng, GH; Aronow, BJ; Karp, CL; Brooks, DG				Wilson, Elizabeth B.; Yamada, Douglas H.; Elsaesser, Heidi; Herskovitz, Jonathan; Deng, Jane; Cheng, Genhong; Aronow, Bruce J.; Karp, Christopher L.; Brooks, David G.			Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection	SCIENCE			English	Article							CHRONIC HEPATITIS-C; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; CHRONIC VIRAL-INFECTION; T-CELLS; INTERLEUKIN-10 RECEPTOR; EXPRESSION; IL-10; GAMMA; PROGRESSION	Type I interferons (IFN-I) are critical for antiviral immunity; however, chronic IFN-I signaling is associated with hyperimmune activation and disease progression in persistent infections. We demonstrated in mice that blockade of IFN-I signaling diminished chronic immune activation and immune suppression, restored lymphoid tissue architecture, and increased immune parameters associated with control of virus replication, ultimately facilitating clearance of the persistent infection. The accelerated control of persistent infection induced by blocking IFN-I signaling required CD4 T cells and was associated with enhanced IFN-gamma production. Thus, we demonstrated that interfering with chronic IFN-I signaling during persistent infection redirects the immune environment to enable control of infection.	[Wilson, Elizabeth B.; Yamada, Douglas H.; Elsaesser, Heidi; Herskovitz, Jonathan; Cheng, Genhong; Brooks, David G.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Wilson, Elizabeth B.; Yamada, Douglas H.; Elsaesser, Heidi; Herskovitz, Jonathan; Cheng, Genhong; Brooks, David G.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Deng, Jane] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp Res Fdn, Div Biomed Informat, Cincinnati, OH 45267 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45267 USA; [Aronow, Bruce J.; Karp, Christopher L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA; [Karp, Christopher L.] Cincinnati Childrens Hosp Res Fdn, Div Mol Immunol, Cincinnati, OH 45267 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Brooks, DG (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	dbrooks@microbio.ucla.edu		Karp, Christopher/0000-0002-0832-2659; Brooks, David/0000-0001-7763-8764	NIH [AI085043, AI082975, AI060567, HL108949]; Institutional Clinical and Translational Science Award [NIH/NCATS 8UL1TR000077-04]; UCLA Center for AIDS Research [P30 AI028697]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697, R01AI085043, R01AI056154, U01AI082975, R01AI047868, T32AI060567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063020] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Clinical and Translational Science Award; UCLA Center for AIDS Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank S. Bensinger for insightful discussion and critical review of the manuscript, all the members of the Brooks laboratory for discussions and technical assistance, and the UCLA Translational Pathology Core Facility for expert histological tissue processing and analysis. The data presented in the manuscript are tabulated in the main paper and in the supplementary materials. D.G.B. and E.B.W. are named inventors on a provisional patent assigned to The Regents of the University of California relating in part to methods of treating chronic viral infections by administering agents that inhibit IFN. The microarray data set from this study is available at www.ncbi.nlm.nih.gov/geo/ (accession no. GSE44322). Our work was supported by the NIH (grants AI085043 and AI082975 to D.G.B., AI060567 to E.B.W., and HL108949 to J.D.), an Institutional Clinical and Translational Science Award (NIH/NCATS 8UL1TR000077-04 to B.J.A.), and the UCLA Center for AIDS Research (P30 AI028697).	AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bolen CR, 2013, J INTERF CYTOK RES, V33, P15, DOI 10.1089/jir.2012.0037; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; CLERICI M, 1994, J CLIN INVEST, V93, P768, DOI 10.1172/JCI117031; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Flynn JK, 2011, J VIRAL HEPATITIS, V18, P549, DOI 10.1111/j.1365-2893.2010.01335.x; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Landay AL, 1996, J INFECT DIS, V173, P1085, DOI 10.1093/infdis/173.5.1085; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Muller S, 2002, J VIROL, V76, P2375, DOI 10.1128/JVI.76.5.2375-2383.2002; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; Rigopoulou EI, 2005, CLIN IMMUNOL, V117, P57, DOI 10.1016/j.clim.2005.06.003; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; TISHON A, 1993, VIROLOGY, V195, P397, DOI 10.1006/viro.1993.1389; TISHON A, 1995, VIROLOGY, V212, P244, DOI 10.1006/viro.1995.1477; VonHerrath MG, 1997, VIROLOGY, V229, P349, DOI 10.1006/viro.1997.8442; Wilson EB, 2012, CELL HOST MICROBE, V11, P481, DOI 10.1016/j.chom.2012.03.009; Wilson EB, 2010, IMMUNOL RES, V48, P3, DOI 10.1007/s12026-010-8162-1	28	495	507	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129					202	207		10.1126/science.1235208	http://dx.doi.org/10.1126/science.1235208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580528	Green Accepted			2022-12-28	WOS:000317341400057
J	Mejdahl, MK; Andersen, KG; Gartner, R; Kroman, N; Kehlet, H				Mejdahl, Mathias Kvist; Andersen, Kenneth Geving; Gartner, Rune; Kroman, Niels; Kehlet, Henrik			Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTOPERATIVE PAIN; IMMPACT RECOMMENDATIONS; FUNCTIONAL IMPAIRMENT; COOPERATIVE GROUP; CLINICAL-TRIALS; RISK-FACTORS; HEALTH; DBCG; AGE; RADIOTHERAPY	Objective To examine the development of persistent pain after treatment for breast cancer and to examine risk factors associated with continuing pain. Design Repeated cross sectional study in a previously examined nationwide cohort. All eligible women who underwent surgery for primary breast cancer in Denmark in 2005 and 2006 and were examined in 2008 were surveyed again with the same questionnaire. Setting Surgical centres in Denmark. Main outcome measures Prevalence, location, and severity of persistent pain after treatment for breast cancer in well defined treatment groups and changes in pain reporting and sensory disturbances from 2008 to 2012. Participants In 2012, 2828 women were eligible in our database, and 108 were excluded. Exclusion criteria were death; new, recurrent, or other cancer; reconstructive breast surgery; and emigration. Results 2411 (89%) women returned the questionnaire. Prevalence of persistent pain after treatment for breast cancer ranged from 22% to 53% depending on treatment. In 2012, 903 (37%) women reported such pain, a fall from 45% in 2008. Of these, 378 (16%) reported pain of >= 4 on a numerical rating scale (scale 0-10), a fall from 19%. Among women reporting pain in 2008, 36% no longer reported it in 2012. In contrast, 15% of the women who did not report pain in 2008 reported it in 2012. Risk factors for having pain were axillary lymph node dissection rather than sentinel lymph node biopsy (odds ratio 2.04, 95% confidence interval 1.60 to 2.61; P<0.001) and age <= 49 (1.78, 1.25 to 2.54; P<0.001). No particular method of treatment or age was associated with an increase in pain from 2008 to 2012. Conclusions Persistent pain after treatment for breast cancer remains an important problem five to seven years later. The problem is not static as it can either progress or regress with time.	[Mejdahl, Mathias Kvist; Andersen, Kenneth Geving; Kehlet, Henrik] Univ Copenhagen, Rigshosp, Sect Surg Pathophysiol, DK-2100 Copenhagen, Denmark; [Gartner, Rune; Kroman, Niels] Univ Copenhagen, Rigshosp, Dept Breast Surg, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Mejdahl, MK (corresponding author), Univ Copenhagen, Rigshosp, Sect Surg Pathophysiol, 7621,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	mathias.kvist.mejdahl@rh.regionh.dk; kenneth.geving.andersen@rh.regionh.dk	Andersen, Kenneth Geving/G-9486-2011; Andersen, Kenneth G/D-4965-2013	Andersen, Kenneth G/0000-0001-8371-2326; Kehlet, Henrik/0000-0002-2209-1711; Mejdahl, Mathias Kvist/0000-0002-4286-1533	Danish Cancer Society; Innovative Medicines Initiative from the European Union [115007]; EFPIA	Danish Cancer Society(Danish Cancer Society); Innovative Medicines Initiative from the European Union; EFPIA	This study was partially funded by a grant from the Danish Cancer Society and the research leading to these results is part of the Europain Collaboration, which has received support from the Innovative Medicines Initiative Joint Undertaking, under grant agreement no 115007, which receives financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.	Aasvang E K, 2006, Hernia, V10, P316, DOI 10.1007/s10029-006-0098-y; Andersen KG, 2012, ACTA ONCOL, V51, P1036, DOI 10.3109/0284186X.2012.692884; Andersen KG, 2011, J PAIN, V12, P725, DOI 10.1016/j.jpain.2010.12.005; Bajrovic A, 2004, RADIOTHER ONCOL, V71, P297, DOI 10.1016/j.radonc.2004.03.005; Bender R, 2007, STAT MED, V26, P5586, DOI 10.1002/sim.3061; Bergh I, 2000, AGING CLIN EXP RES, V12, P380, DOI 10.1007/BF03339864; Blichert-Toft M, 2008, ACTA ONCOL, V47, P497, DOI 10.1080/02841860802068615; Blyth FM, 2004, PAIN, V111, P51, DOI 10.1016/j.pain.2004.05.020; Blyth FM, 2003, MED J AUSTRALIA, V179, P84, DOI 10.5694/j.1326-5377.2003.tb05441.x; Cronin-Fenton DP, 2007, BRIT J CANCER, V96, P1462, DOI 10.1038/sj.bjc.6603717; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Deimling GT, 2005, CANCER NURS, V28, P415, DOI 10.1097/00002820-200511000-00002; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Gagliese L, 2003, PAIN, V103, P11, DOI 10.1016/S0304-3959(02)00327-5; Gartner R, 2010, BREAST, V19, P506, DOI 10.1016/j.breast.2010.05.015; Gartner R, 2009, JAMA-J AM MED ASSOC, V302, P1985, DOI 10.1001/jama.2009.1568; Gerbershagen HJ, 2011, BRIT J ANAESTH, V107, P619, DOI 10.1093/bja/aer195; Gibson SJ, 2001, CLIN GERIATR MED, V17, P433, DOI 10.1016/S0749-0690(05)70079-3; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Grant AM, 2004, BRIT J SURG, V91, P1570, DOI 10.1002/bjs.4799; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Johansson S, 2000, INT J RADIAT ONCOL, V48, P745, DOI 10.1016/S0360-3016(00)00674-X; Jung BF, 2003, PAIN, V104, P1, DOI 10.1016/S0304-3959(03)00241-0; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kroman N, 2000, BRIT MED J, V320, P474, DOI 10.1136/bmj.320.7233.474; Lundeberg T, 2001, J REHABIL MED, V33, P279; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Macdonald L, 2005, BRIT J CANCER, V92, P225, DOI 10.1038/sj.bjc.6602304; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; Mouridsen HT, 2008, ACTA ONCOL, V47, P525, DOI 10.1080/02841860802027009; Peuckmann V, 2009, EUR J PAIN, V13, P478, DOI 10.1016/j.ejpain.2008.05.015; Smith BH, 1999, FAM PRACT, V16, P475, DOI 10.1093/fampra/16.5.475; Smith WCS, 1999, PAIN, V83, P91, DOI 10.1016/S0304-3959(99)00076-7; Tryggvadottir L, 2010, ACTA ONCOL, V49, P624, DOI 10.3109/02841860903575323	37	145	151	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2013	346								f1865	10.1136/bmj.f1865	http://dx.doi.org/10.1136/bmj.f1865			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125ZP	23580693	hybrid			2022-12-28	WOS:000317581200001
J	Whyte, WA; Orlando, DA; Hnisz, D; Abraham, BJ; Lin, CY; Kagey, MH; Rahl, PB; Lee, TI; Young, RA				Whyte, Warren A.; Orlando, David A.; Hnisz, Denes; Abraham, Brian J.; Lin, Charles Y.; Kagey, Michael H.; Rahl, Peter B.; Lee, Tong Ihn; Young, Richard A.			Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes	CELL			English	Article							RNAI SCREEN; COACTIVATOR COMPLEX; EXPRESSION; CIRCUITRY; NETWORK; PLURIPOTENCY; BINDING; IDENTIFICATION; LYMPHOPOIESIS; TROPHECTODERM	Master transcription factors Oct4, Sox2, and Nanog bind enhancer elements and recruit Mediator to activate much of the gene expression program of pluripotent embryonic stem cells (ESCs). We report here that the ESC master transcription factors form unusual enhancer domains at most genes that control the pluripotent state. These domains, which we call super-enhancers, consist of clusters of enhancers that are densely occupied by the master regulators and Mediator. Super-enhancers differ from typical enhancers in size, transcription factor density and content, ability to activate transcription, and sensitivity to perturbation. Reduced levels of Oct4 or Mediator cause preferential loss of expression of super-enhancer-associated genes relative to other genes, suggesting how changes in gene expression programs might be accomplished during development. In other more differentiated cells, super-enhancers containing cell-type-specific master transcription factors are also found at genes that define cell identity. Super-enhancers thus play key roles in the control of mammalian cell identity.	[Whyte, Warren A.; Orlando, David A.; Hnisz, Denes; Abraham, Brian J.; Lin, Charles Y.; Kagey, Michael H.; Rahl, Peter B.; Lee, Tong Ihn; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lin, Charles Y.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	; Abraham, Brian/C-2230-2019	/0000-0001-8855-8647; Abraham, Brian/0000-0001-8085-3027; Hnisz, Denes/0000-0002-6256-1693	National Institutes of Health [HG002668, CA146445]; NATIONAL CANCER INSTITUTE [R01CA146445, P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Tom Volkert, Jennifer Love, Sumeet Gupta, and Jeong-Ah Kwon at the Whitehead Genome Technologies Core for Solexa sequencing; Lee M. Lawton, Jessica Reddy, Ana D'Alessio, and Jasmine M. De Cock for experimental assistance; and Alla A. Sigova, Alan C. Mullen, Roshan M. Kumar, and members of the Young lab for helpful discussion. This work was supported by the National Institutes of Health grants HG002668 (R.A.Y.) and CA146445 (R.A.Y. and T.I.L.). R.A.Y. is a founder and D.A.O. and P.B.R. have become employees of Syros Pharmaceuticals.	Abujarour R, 2010, STEM CELLS, V28, P1487, DOI 10.1002/stem.472; Alinikula J, 2010, EUR J IMMUNOL, V40, P2599, DOI 10.1002/eji.200940002; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; GRIGGS DW, 1991, P NATL ACAD SCI USA, V88, P8597, DOI 10.1073/pnas.88.19.8597; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mansson R, 2012, P NATL ACAD SCI USA, V109, P21028, DOI 10.1073/pnas.1211427109; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; MICHAELSON JS, 1995, NUCLEIC ACIDS RES, V23, P975, DOI 10.1093/nar/23.6.975; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Risley MD, 2010, DEV BIOL, V342, P146, DOI 10.1016/j.ydbio.2010.03.019; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wlodarski P, 2007, J BIOL CHEM, V282, P6316, DOI 10.1074/jbc.M607526200; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xue HH, 2012, ANN NY ACAD SCI, V1247, P16, DOI 10.1111/j.1749-6632.2011.06302.x; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	75	2210	2259	9	304	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					307	319		10.1016/j.cell.2013.03.035	http://dx.doi.org/10.1016/j.cell.2013.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582322	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000317349700011
J	Houchens, N; Dhaliwal, G; Askari, F; Kim, B; Saint, S				Houchens, Nathan; Dhaliwal, Gurpreet; Askari, Frederick; Kim, Benjamin; Saint, Sanjay			The Essential Element	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; FULMINANT HEPATIC-FAILURE; ACUTE LIVER-FAILURE; WILSONS-DISEASE; HEMOLYTIC-ANEMIA; DIAGNOSIS; UPDATE		[Houchens, Nathan; Askari, Frederick; Saint, Sanjay] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Saint, Sanjay] Hlth Serv Res & Dev Ctr Excellence, Dept Vet Affairs VA, Ann Arbor, MI USA; [Dhaliwal, Gurpreet; Kim, Benjamin] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Dhaliwal, Gurpreet] San Francisco VA Med Ctr, San Francisco, CA USA	University of Michigan System; University of Michigan; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Houchens, N (corresponding author), Univ Michigan Hlth Syst, 3119 Taubman Ctr,1500 E Med Ctr Dr,SPC 5376, Ann Arbor, MI 48109 USA.	nathanho@umich.edu	Saint, Sanjay/AAF-5126-2019		Doximity	Doximity	Dr. Saint reports receiving payment for board membership from and holding stock in Doximity. No other potential conflict of interest relevant to this article was reported.	Bain BJ, 2005, NEW ENGL J MED, V353, P498, DOI 10.1056/NEJMra043442; Das SK, 2006, NAT CLIN PRACT NEURO, V2, P482, DOI 10.1038/ncpneuro0291; DEISS A, 1970, ANN INTERN MED, V73, P413, DOI 10.7326/0003-4819-73-3-413; Dhawan A, 2005, LIVER TRANSPLANT, V11, P441, DOI 10.1002/lt.20352; Garratty G, 2005, SEMIN HEMATOL, V42, P156, DOI 10.1053/j.seminhematol.2005.04.005; GOLDMAN M, 1991, CAN MED ASSOC J, V145, P971; HOSHINO T, 1995, CLIN CHIM ACTA, V238, P91, DOI 10.1016/0009-8981(95)06073-M; Kitazawa J, 2004, PEDIATR INT, V46, P726, DOI 10.1111/j.1442-200x.2004.01993.x; Korman JD, 2008, HEPATOLOGY, V48, P1167, DOI 10.1002/hep.22446; Lee Je-Jung, 1998, Journal of Korean Medical Science, V13, P548; Merle U, 2007, GUT, V56, P115, DOI 10.1136/gut.2005.087262; Oosthuizen NM, 2011, CLIN CHEM, V57, P382, DOI 10.1373/clinchem.2010.152447; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Roberts EA, 2003, HEPATOLOGY, V37, P1475, DOI 10.1053/jhep.2003.50252; Sakka V, 2006, EUR J INTERN MED, V17, P394, DOI 10.1016/j.ejim.2006.04.004	15	1	1	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1345	1351		10.1056/NEJMcps1203173	http://dx.doi.org/10.1056/NEJMcps1203173			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117YT	23550673				2022-12-28	WOS:000316989900013
J	Jain, SH				Jain, Sachin H.			The Racist Patient	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Jain, Sachin H.] Boston Vet Affairs Med Ctr, West Roxbury, MA USA		Jain, SH (corresponding author), 65 East India Row,Apartment 33B, Boston, MA 02110 USA.	shjain@gmail.com							0	23	22	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8					632	632		10.7326/0003-4819-158-8-201304160-00010	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-00010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588752				2022-12-28	WOS:000318062100021
J	de Vet, HCW; Mokkink, LB; Terwee, CB; Hoekstra, OS; Knol, DL				de Vet, Henrica C. W.; Mokkink, Lidwine B.; Terwee, Caroline B.; Hoekstra, Otto S.; Knol, Dirk L.			Clinicians are right not to like Cohen's kappa	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIGH AGREEMENT; RELIABILITY; COEFFICIENT; PARADOXES	Clinicians are interested in observer variation in terms of the probability of other raters (interobserver) or themselves (intraobserver) obtaining the same answer. Cohen's. is commonly used in the medical literature to express such agreement in categorical outcomes. The value of Cohen's kappa, however, is not sufficiently informative because it is a relative measure, while the clinician's question of observer variation calls for an absolute measure. Using an example in which the observed agreement and. lead to different conclusions, we illustrate that percentage agreement is an absolute measure (a measure of agreement) and that kappa is a relative measure (a measure of reliability). For the data to be useful for clinicians, measures of agreement should be used. The proportion of specific agreement, expressing the agreement separately for the positive and the negative ratings, is the most appropriate measure for conveying the relevant information in a 2x2 table and is most informative for clinicians.	[de Vet, Henrica C. W.; Mokkink, Lidwine B.; Terwee, Caroline B.; Knol, Dirk L.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Hoekstra, Otto S.] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	de Vet, HCW (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands.	hcw.devet@vumc.nl		Mokkink, Lidwine/0000-0001-6489-2827; Hoekstra, Otto S/0000-0003-0767-2734; Terwee, Caroline/0000-0003-4570-2826; de Vet, Henrica/0000-0002-5454-2804				Altman D.G., 1991, PRACTICAL STAT MED R, DOI [DOI 10.1002/SIM.4780101015, 10.1002/sim.4780101015]; Bruynesteyn K, 2002, J RHEUMATOL, V29, P2306; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Robinson PJA, 1997, BRIT J RADIOL, V70, P1085, DOI 10.1259/bjr.70.839.9536897; Sackett D, 1991, CLIN EPIDEMIOLOGY BA, P25	12	166	167	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 12	2013	346								f2125	10.1136/bmj.f2125	http://dx.doi.org/10.1136/bmj.f2125			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126AB	23585065	Bronze			2022-12-28	WOS:000317582400002
J	Geibel, S; Procko, E; Hultgren, SJ; Baker, D; Waksman, G				Geibel, Sebastian; Procko, Erik; Hultgren, Scott J.; Baker, David; Waksman, Gabriel			Structural and energetic basis of folded-protein transport by the FimD usher	NATURE			English	Article							BACTERIAL OUTER-MEMBRANE; CRYSTAL-STRUCTURE; PILUS; CRYSTALLOGRAPHY; REFINEMENT	Type 1 pili, produced by uropathogenic Escherichia coli, are multi-subunit fibres crucial in recognition of and adhesion to host tissues(1). During pilus biogenesis, subunits are recruited to an outer membrane assembly platform, the FimD usher, which catalyses their polymerization and mediates pilus secretion(2). The recent determination of the crystal structure of an initiation complex provided insight into the initiation step of pilus biogenesis resulting in pore activation, but very little is known about the elongation steps that follow(3). Here, to address this question, we determine the structure of an elongation complex in which the tip complex assembly composed of FimC, FimF, FimG and FimH passes through FimD. This structure demonstrates the conformational changes required to prevent backsliding of the nascent pilus through the FimD pore and also reveals unexpected properties of the usher pore. We show that the circular binding interface between the pore lumen and the folded substrate participates in transport by defining a low-energy pathway along which the nascent pilus polymer is guided during secretion.	[Geibel, Sebastian; Waksman, Gabriel] UCL, Inst Struct & Mol Biol, London WC1E 7HX, England; [Geibel, Sebastian; Waksman, Gabriel] Univ London Birkbeck Coll, London WC1E 7HX, England; [Procko, Erik; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Procko, Erik; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Hultgren, Scott J.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63011 USA; [Hultgren, Scott J.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63011 USA	University of London; Birkbeck University London; University College London; University of London; Birkbeck University London; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL); Washington University (WUSTL)	Waksman, G (corresponding author), UCL, Inst Struct & Mol Biol, Malet St, London WC1E 7HX, England.	dabaker@u.washington.edu; g.waksman@ucl.ac.uk	Geibel, Sebastian/B-5607-2015; Baker, David/K-8941-2012	Geibel, Sebastian/0000-0003-0068-680X; Baker, David/0000-0001-7896-6217; Procko, Erik/0000-0002-0028-490X	Medical Research Council [85602]; National Institute of General Medical Studies at the US National Institutes of Health (NIH) [P41 GM103533]; National Institute of Allergy and Infectious Disease at the NIH [AI029549]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029549, R01AI029549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; MRC [G0800002, MR/K018434/1] Funding Source: UKRI; Medical Research Council [MR/K018434/1, G0800002] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of General Medical Studies at the US National Institutes of Health (NIH); National Institute of Allergy and Infectious Disease at the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Medical Research Council grant 85602 to G. W. D. B. and E. P. are supported by grant P41 GM103533 from the National Institute of General Medical Studies at the US National Institutes of Health (NIH). S.J.H. was supported by grant AI029549 from the National Institute of Allergy and Infectious Disease at the NIH. We thank the staff of beamline ID23-1 at the European Synchrotron Radiation Facility, the staff of beamline IO2 at the Diamond Light source and A. Cole for technical assistance during data collection.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Huang YH, 2009, P NATL ACAD SCI USA, V106, P7403, DOI 10.1073/pnas.0902789106; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; O'Donovan DJ, 2012, ACTA CRYSTALLOGR D, V68, P261, DOI 10.1107/S0907444912001163; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	26	72	72	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					243	+		10.1038/nature12007	http://dx.doi.org/10.1038/nature12007			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23579681	Green Accepted			2022-12-28	WOS:000317346300046
J	Kaufman, MT; Churchland, AK				Kaufman, Matthew T.; Churchland, Anne K.			COGNITIVE NEUROSCIENCE Sensory noise drives bad decisions	NATURE			English	Editorial Material							INTEGRATION; RATS		[Kaufman, Matthew T.; Churchland, Anne K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Kaufman, MT (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	churchland@cshl.edu	Kaufman, Matthew T/B-6273-2014; Kaufman, Matthew/AAK-2860-2020	Kaufman, Matthew T/0000-0002-8072-023X; Kaufman, Matthew/0000-0002-8072-023X				Adams GK, 2012, CURR OPIN NEUROBIOL, V22, P982, DOI 10.1016/j.conb.2012.07.009; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kimchi EY, 2009, J NEUROSCI, V29, P3148, DOI 10.1523/JNEUROSCI.5206-08.2009; Krajbich I, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00193; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Wong KF, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.006.2007	11	7	7	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					172	173		10.1038/496172a	http://dx.doi.org/10.1038/496172a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	122VM	23579673				2022-12-28	WOS:000317346300027
J	Lee, YS; Morinaga, H; Kim, JJ; Lagakos, W; Taylor, S; Keshwani, M; Perkins, G; Dong, H; Kayali, AG; Sweet, IR; Olefsky, J				Lee, Yun Sok; Morinaga, Hidetaka; Kim, Jane J.; Lagakos, William; Taylor, Susan; Keshwani, Malik; Perkins, Guy; Dong, Hui; Kayali, Ayse G.; Sweet, Ian R.; Olefsky, Jerrold			The Fractalkine/CX3CR1 System Regulates beta Cell Function and Insulin Secretion	CELL			English	Article							NECROSIS-FACTOR-ALPHA; PANCREATIC-ISLETS; CHEMOKINE FRACTALKINE; GENE-EXPRESSION; IN-VITRO; MICE; INFLAMMATION; RESISTANCE; ADHESION; GLUCOSE	Here, we demonstrate that the fractalkine (FKN)/CX3CR1 system represents a regulatory mechanism for pancreatic islet beta cell function and insulin secretion. CX3CR1 knockout (KO) mice exhibited a marked defect in glucose and GLP1-stimulated insulin secretion, and this defect was also observed in vitro in isolated islets from CX3CR1 KO mice. In vivo administration of FKN improved glucose tolerance with an increase in insulin secretion. In vitro treatment of islets with FKN increased intracellular Ca2+ and potentiated insulin secretion in both mouse and human islets. The KO islets exhibited reduced expression of a set of genes necessary for the fully functional, differentiated b cell state, whereas treatment of wild-type (WT) islets with FKN led to increased expression of these genes. Lastly, expression of FKN in islets was decreased by aging and high-fat diet/obesity, suggesting that decreased FKN/CX3CR1 signaling could be a mechanism underlying b cell dysfunction in type 2 diabetes.	[Lee, Yun Sok; Morinaga, Hidetaka; Lagakos, William; Olefsky, Jerrold] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Kim, Jane J.; Kayali, Ayse G.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Taylor, Susan; Keshwani, Malik] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Perkins, Guy] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Dong, Hui] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA; [Sweet, Ian R.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Washington; University of Washington Seattle	Olefsky, J (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	Lee, Yun Sok/ABC-9195-2021; Lee, Yun Sok/B-3265-2015	Lee, Yun Sok/0000-0001-7967-4734; Lee, Yun Sok/0000-0001-7967-4734; Kim, Jane/0000-0002-0228-0128; Perkins, Guy/0000-0002-1834-6646	National Institutes of Health (NIH) [DK-033651, DK-074868, T32-DK-007494, DK-063491]; Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research [U54-HD-012303-25]; American Diabetes Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, R37DK033651, P30DK063491, P30DK017047, R01DK101395, T32DK007494, P01DK074868] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research; American Diabetes Association(American Diabetes Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) grants DK-033651, DK-074868, T32-DK-007494, and DK-063491 and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH through cooperative agreement of U54-HD-012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research. Y.S.L. was supported by a Mentor-Based Postdoctoral Fellowship Award from American Diabetes Association. Islet perifusions were carried out by the Diabetes and Endocrine Research Center Islet Core located at the University of Washington (P30 DK017047). We thank Dr. Ulupi Jhala (University of California, San Diego) for providing Min6 cells with permission from Dr. Miyazaki Jun-Ichi (Osaka University). H.D. is a cofounder of AddexBio.	Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795; Boehme SA, 2000, J IMMUNOL, V165, P397, DOI 10.4049/jimmunol.165.1.397; Calabrese A, 2003, DIABETES, V52, P417, DOI 10.2337/diabetes.52.2.417; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chandrasekar B, 2003, BIOCHEM J, V373, P547, DOI 10.1042/BJ20030207; Cho IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034860; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Eberhard D, 2010, TRENDS ENDOCRIN MET, V21, P457, DOI 10.1016/j.tem.2010.03.003; Favre D, 2011, DIABETOLOGIA, V54, P2337, DOI 10.1007/s00125-011-2165-x; Fong AM, 2002, J BIOL CHEM, V277, P19418, DOI 10.1074/jbc.M201396200; Garton KJ, 2001, J BIOL CHEM, V276, P37993; GIORDANO E, 1993, AM J PHYSIOL, V265, pC358, DOI 10.1152/ajpcell.1993.265.2.C358; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hussain MA, 2000, DIABETES, V49, P1681, DOI 10.2337/diabetes.49.10.1681; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kayali AG, 2007, DIABETES, V56, P703, DOI 10.2337/db06-1545; Kutlu B, 2009, PHYSIOL GENOMICS, V39, P72, DOI 10.1152/physiolgenomics.00063.2009; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Lee YS, 2010, J BIOL CHEM, V285, P22174, DOI 10.1074/jbc.M109.085464; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Lucas AD, 2001, AM J PATHOL, V158, P855, DOI 10.1016/S0002-9440(10)64034-5; MACLEAN N, 1955, Diabetes, V4, P367; Morris DL, 2012, OBESITY, V20, P1189, DOI 10.1038/oby.2012.7; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Shah R, 2011, DIABETES, V60, P1512, DOI 10.2337/db10-0956; Sirois-Gagnon D, 2011, OBESITY, V19, P222, DOI 10.1038/oby.2010.125; Speier S, 2007, DIABETES, V56, P1078, DOI 10.2337/db06-0232; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Zhou YP, 2003, J BIOL CHEM, V278, P51316, DOI 10.1074/jbc.M307972200	42	99	99	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					413	425		10.1016/j.cell.2013.03.001	http://dx.doi.org/10.1016/j.cell.2013.03.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582329	Green Accepted, Bronze			2022-12-28	WOS:000317349700019
J	Hennecke, U				Hennecke, Ulrich			Revealing the Positive Side of Fluorine	SCIENCE			English	Editorial Material							FLUORONIUM IONS		WWU Munster, Inst Organ Chem, D-48149 Munster, Germany	University of Munster	Hennecke, U (corresponding author), WWU Munster, Inst Organ Chem, Corrensstr 40, D-48149 Munster, Germany.	ulrich.hennecke@uni-muenster.de	Hennecke, Ulrich/A-7723-2010	Hennecke, Ulrich/0000-0002-4904-6793				Berger R, 2011, CHEM SOC REV, V40, P3496, DOI 10.1039/c0cs00221f; Kirsch P., 2013, MODERN FLUOROORGANIC; MOOTZ D, 1988, ANGEW CHEM INT EDIT, V27, P391, DOI 10.1002/anie.198803911; NGUYEN V, 1992, J AM CHEM SOC, V114, P7127, DOI 10.1021/ja00044a026; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Panisch R, 2006, J AM CHEM SOC, V128, P9676, DOI 10.1021/ja061800y; Struble MD, 2013, SCIENCE, V340, P57, DOI 10.1126/science.1231247; Uneyama K., 2006, ORGANOFLUORINE CHEM	8	10	10	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					41	42		10.1126/science.1236150	http://dx.doi.org/10.1126/science.1236150			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559241				2022-12-28	WOS:000317061100037
J	Sydnes, LK				Sydnes, Leiv K.			Update the Chemical Weapons Convention	NATURE			English	Editorial Material									Univ Bergen, Dept Chem, NO-5007 Bergen, Norway	University of Bergen	Sydnes, LK (corresponding author), Univ Bergen, Dept Chem, NO-5007 Bergen, Norway.	leiv.sydnes@kj.uib.no						Dando M, 2009, NATURE, V460, P950, DOI 10.1038/460950a; Mogl S., 2012, TECHN WORKSH INC CHE	2	5	5	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2013	496	7443					25	26		10.1038/496025a	http://dx.doi.org/10.1038/496025a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117ZZ	23552927	Bronze			2022-12-28	WOS:000316993400009
J	Dunn, A				Dunn, Andrew			A restrictive transfusion strategy reduced 45-day mortality in patients with acute upper GI bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Dunn, A (corresponding author), Mt Sinai Sch Med, New York, NY 10029 USA.							Carson JL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub3; Jairath V, 2011, TRANSFUSION, V51, P1940, DOI 10.1111/j.1537-2995.2011.03119.x; STERN SA, 1993, ANN EMERG MED, V22, P155, DOI 10.1016/S0196-0644(05)80195-7	3	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6							JC6	10.7326/0003-4819-158-6-201303190-02006	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23552808				2022-12-28	WOS:000316565100005
J	Qaseem, A; Barry, MJ; Denberg, TD; Owens, DK; Shekelle, P				Qaseem, Amir; Barry, Michael J.; Denberg, Thomas D.; Owens, Douglas K.; Shekelle, Paul		Amer Coll Phys	Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED PROSTATE; MORTALITY; STATISTICS; TIME	Description: Prostate cancer is an important health problem in men. It rarely causes death in men younger than 50 years; most deaths associated with it occur in men older than 75 years. The benefits of screening with the prostate-specific antigen (PSA) test are outweighed by the harms for most men. Prostate cancer never becomes clinically significant in a patient's lifetime in a considerable proportion of men with prostate cancer detected with the PSA test. They will receive no benefit and are subject to substantial harms from the treatment of prostate cancer. The American College of Physicians (ACP) developed this guidance statement for clinicians by assessing current prostate cancer screening guidelines developed by other organizations. ACP believes that it is more valuable to provide clinicians with a rigorous review of available guidelines rather than develop a new guideline on the same topic when several guidelines are available on a topic or when existing guidelines conflict. The purpose of this guidance statement is to critically review available guidelines to help guide internists and other clinicians in making decisions about screening for prostate cancer. The target patient population for this guidance statement is all adult men. Methods: This guidance statement is derived from an appraisal of available guidelines on screening for prostate cancer. Authors searched the National Guideline Clearinghouse to identify prostate cancer screening guidelines in the United States and selected 4 developed by the American College of Preventive Medicine, American Cancer Society, American Urological Association, and U. S. Preventive Services Task Force. The AGREE II (Appraisal of Guidelines, Research and Evaluation in Europe) instrument was used to evaluate the guidelines. Guidance Statement 1: ACP recommends that clinicians inform men between the age of 50 and 69 years about the limited potential benefits and substantial harms of screening for prostate cancer. ACP recommends that clinicians base the decision to screen for prostate cancer using the prostate-specific antigen test on the risk for prostate cancer, a discussion of the benefits and harms of screening, the patient's general health and life expectancy, and patient preferences. ACP recommends that clinicians should not screen for prostate cancer using the prostate-specific antigen test in patients who do not express a clear preference for screening. Guidance Statement 2: ACP recommends that clinicians should not screen for prostate cancer using the prostate-specific antigen test in average-risk men under the age of 50 years, men over the age of 69 years, or men with a life expectancy of less than 10 to 15 years.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; West Los Angeles Vet Affairs Med Ctr, Los Angeles, CA USA; Harvard Vanguard Med Associates, Auburndale, MA USA	American College of Physicians; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Harvard University; Massachusetts General Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); West Los Angeles VA Medical Center; Harvard Vanguard Medical Associates	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			ACP	ACP	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Federman D G, 1999, Eff Clin Pract, V2, P152; Greene KL, 2009, J UROLOGY, V182, P2232, DOI 10.1016/j.juro.2009.07.093; Gulati R, 2013, ANN INTERN MED, V158, P145, DOI 10.7326/0003-4819-158-3-201302050-00003; Hoffman RM, 2009, ARCH INTERN MED, V169, P1611, DOI 10.1001/archinternmed.2009.262; Howlader N, 2011, SEER CANC STAT REV 1; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lamplugh M, 2006, ANN ROY COLL SURG, V88, P284, DOI 10.1308/003588406X98685; Lim LS, 2008, AM J PREV MED, V34, P164, DOI 10.1016/j.amepre.2007.10.003; Merrill RM, 1997, CANCER EPIDEM BIOMAR, V6, P763; National Cancer Institute, SEER STAT FACT SHEET; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Ries LAG, SEER CANC STAT REV 1; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; Welch HG, 2009, J NATL CANCER I, V101, P1325, DOI 10.1093/jnci/djp278; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066	25	206	212	0	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10					761	+		10.7326/0003-4819-158-10-201305210-00633	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-00633			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23567643				2022-12-28	WOS:000319666200018
J	Uyeki, TM; Cox, NJ				Uyeki, Timothy M.; Cox, Nancy J.			Global Concerns Regarding Novel Influenza A (H7N9) Virus Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSMISSION; FERRETS		[Uyeki, Timothy M.; Cox, Nancy J.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Uyeki, TM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.				Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jernigan DB, 2011, CLIN INFECT DIS, V52, pS36, DOI 10.1093/cid/ciq020; Lurie N, 2013, NEW ENGL J MED, V368, P1251, DOI 10.1056/NEJMsb1209510; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101	5	169	187	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1862	1864		10.1056/NEJMp1304661	http://dx.doi.org/10.1056/NEJMp1304661			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143VK	23577629	Green Accepted			2022-12-28	WOS:000318896200004
J	Kamat, SS; Williams, HJ; Dangott, LJ; Chakrabarti, M; Raushel, FM				Kamat, Siddhesh S.; Williams, Howard J.; Dangott, Lawrence J.; Chakrabarti, Mrinmoy; Raushel, Frank M.			The catalytic mechanism for aerobic formation of methane by bacteria	NATURE			English	Article							CARBON-PHOSPHORUS LYASE; STRUCTURAL BASIS; RADICAL SAM; GLYCYL; DEGRADATION; PHOSPHATE; ENZYME; ACID	Methane is a potent greenhouse gas that is produced in significant quantities by aerobic marine organisms(1). These bacteria apparently catalyse the formation of methane through the cleavage of the highly unreactive carbon-phosphorus bond inmethylphosphonate(MPn), but the biological or terrestrial source of this compound is unclear(2). However, the ocean-dwelling bacterium Nitrosopumilus maritimus catalyses the biosynthesis of MPn from 2-hydroxyethyl phosphonate(3) and the bacterial C-P lyase complex is known to convert MPn to methane(4-7). In addition to MPn, the bacterial C-P lyase complex catalyses C-P bond cleavage of many alkyl phosphonates when the environmental concentration of phosphate is low(4-7). PhnJ from the C-P lyase complex catalyses an unprecedented C-P bond cleavage reaction of ribose-1-phosphonate-5-phosphate to methane and ribose-1,2-cyclic-phosphate-5-phosphate. This reaction requires a redox-active [4Fe-4S]-cluster and S-adenosyl-L-methionine, which is reductively cleaved to L-methionine and 5'-deoxyadenosine(8). Here we show that PhnJ is a novel radical S-adenosyl-L-methionine enzyme that catalyses C-P bond cleavage through the initial formation of a 5'-deoxyadenosyl radical and two protein-based radicals localized at Gly 32 and Cys 272. During this transformation, the pro-R hydrogen from Gly 32 is transferred to the 5'-deoxyadenosyl radical to form 5'-deoxyadenosine and the pro-S hydrogen is transferred to the radical intermediate that ultimately generates methane. A comprehensive reaction mechanism is proposed for cleavage of the C-P bond by the C-P lyase complex that uses a covalent thiophosphate intermediate for methane and phosphate formation.	[Kamat, Siddhesh S.; Williams, Howard J.; Chakrabarti, Mrinmoy; Raushel, Frank M.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Dangott, Lawrence J.] Texas A&M Univ, Dept Biochem & Biophys, Prot Chem Lab, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Raushel, FM (corresponding author), Texas A&M Univ, Dept Chem, POB 30012, College Stn, TX 77843 USA.	raushel@tamu.edu	Raushel, Frank/B-7125-2015	Raushel, Frank/0000-0002-5918-3089; Kamat, Siddhesh/0000-0001-6132-7574	Robert A. Welch Foundation [A-840]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084266] Funding Source: NIH RePORTER	Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Barondeau for use of the anaerobic chamber, R. Stipanovic for use of the gas chromatography mass spectrometer, A. Mehta and T. Begley for use of the liquid chromatography mass spectrometer, and C. Hilty for use of the <SUP>31</SUP>P-NMR spectrometer. We thank P. A. Lindahl for help with the EPR measurements (GM084266). This work was supported by the Robert A. Welch Foundation (A-840).	Becker A, 1999, NAT STRUCT BIOL, V6, P969; Booker Squire J, 2010, F1000 Biol Rep, V2, P52, DOI 10.3410/B2-52; Cicchillo RM, 2005, J AM CHEM SOC, V127, P7310, DOI 10.1021/ja051369x; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P11770, DOI 10.1021/bi0488505; Eklund H, 1999, STRUCT FOLD DES, V7, pR257, DOI 10.1016/S0969-2126(00)80019-2; FREY M, 1994, J BIOL CHEM, V269, P12432; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; FROST JW, 1987, J AM CHEM SOC, V109, P2166, DOI 10.1021/ja00241a039; Ghanem E, 2007, BIOCHEMISTRY-US, V46, P9032, DOI 10.1021/bi700561k; Kamat SS, 2011, NATURE, V480, P570, DOI 10.1038/nature10622; Karl DM, 2008, NAT GEOSCI, V1, P473, DOI 10.1038/ngeo234; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; McGlynn SE, 2010, J BACTERIOL, V192, P595, DOI 10.1128/JB.01125-09; Metcalf WW, 2012, SCIENCE, V337, P1104, DOI 10.1126/science.1219875; METCALF WW, 1993, J BACTERIOL, V175, P3430, DOI 10.1128/jb.175.11.3430-3442.1993; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; WACKETT LP, 1987, J BACTERIOL, V169, P710, DOI 10.1128/jb.169.2.710-717.1987; WACKETT LP, 1987, J BACTERIOL, V169, P1753, DOI 10.1128/jb.169.4.1753-1756.1987; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138	22	65	66	8	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					132	136		10.1038/nature12061	http://dx.doi.org/10.1038/nature12061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23615610				2022-12-28	WOS:000318221500048
J	Chan, M; Lake, A				Chan, Margaret; Lake, Anthony			Integrated action for the prevention and control of pneumonia and diarrhoea	LANCET			English	Editorial Material									[Chan, Margaret] WHO, CH-1211 Geneva, Switzerland; [Lake, Anthony] UNICEF, New York, NY 10017 USA	World Health Organization; UNICEF	Lake, A (corresponding author), UNICEF, New York, NY 10017 USA.	alake@unicef.org						Bhutta ZA, 2013, LANCET; Chopra M, 2013, LANCET; Fischer Walker CL, 2013, LANCET; Gill CJ, 2013, LANCET; WHO UNICEF, 2009, B WORLD HEALTH ORGAN, V86, P1; WHO UNICEF(World Health Organization United Nations International Children's Emergency Fund), 2013, INT GLOB ACT PLAN PR; World Health Organization, 2009, DIARRH WHY CHILDR AR	7	10	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 27	2013	381	9876					1436	1437		10.1016/S0140-6736(13)60692-3	http://dx.doi.org/10.1016/S0140-6736(13)60692-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139TK	23582728				2022-12-28	WOS:000318607300010
J	Dasgupta, PS; Ehrlich, PR				Dasgupta, Partha S.; Ehrlich, Paul R.			Pervasive Externalities at the Population, Consumption, and Environment Nexus	SCIENCE			English	Article							FERTILITY	Growing concerns that contemporary patterns of economic development are unsustainable have given rise to an extensive empirical literature on population growth, consumption increases, and our growing use of nature's products and services. However, far less has been done to reach a theoretical understanding of the socio-ecological processes at work at the population-consumption-environment nexus. In this Research Article, we highlight the ubiquity of externalities ( which are the unaccounted for consequences for others, including future people) of decisions made by each of us on reproduction, consumption, and the use of our natural environment. Externalities, of which the "tragedy of the commons" remains the most widely discussed illustration, are a cause of inefficiency in the allocation of resources across space, time, and contingencies; in many situations, externalities accentuate inequity as well. Here, we identify and classify externalities in consumption and reproductive decisions and use of the natural environment so as to construct a unified theoretical framework for the study of data drawn from the nexus. We show that externalities at the nexus are not self-correcting in the marketplace. We also show that fundamental nonlinearities, built into several categories of externalities, amplify the socio-ecological processes operating at the nexus. Eliminating the externalities would, therefore, require urgent collective action at both local and global levels.	[Dasgupta, Partha S.] Univ Cambridge, Fac Econ, Cambridge CB3 9DD, England; [Dasgupta, Partha S.] Univ Manchester, Sustainable Consumpt Inst, Manchester M13 9PL, Lancs, England; [Ehrlich, Paul R.] Stanford Univ, Dept Biol, Ctr Conservat Biol, Stanford, CA 94305 USA	University of Cambridge; University of Manchester; Stanford University	Dasgupta, PS (corresponding author), Univ Cambridge, Fac Econ, Cambridge CB3 9DD, England.	partha.dasgupta@econ.cam.ac.uk; pre@stanford.edu			Mertz Gilmore Foundation; Winslow Foundation	Mertz Gilmore Foundation; Winslow Foundation	We thank K. Arrow, M. Campbell, G. Daily, A. Dasgupta, N. Diamond-Smith, A. Ehrlich, L. Goulder, D. Karp, D. Kennedy, M. Potts, A. Ulph, and, most especially, the editors and three anonymous referees for their comments. P. R. E. thanks the Mertz Gilmore Foundation, the Winslow Foundation, and P. Bing and H. Bing for their support.	Aggarwal R, 2001, ENVIRON DEV ECON, V6, P209, DOI 10.1017/S1355770X01000122; ARROW K. J., 1971, GEN COMPETITIVE ANAL; Arrow KJ, 2012, ENVIRON DEV ECON, V17, P317, DOI 10.1017/S1355770X12000137; Arrow KJ, 2009, ECON J, V119, pF497, DOI 10.1111/j.1468-0297.2009.02318.x; Ash N., 2005, ECOSYSTEMS WELL BEIN; Banerjee A., 2011, POOR EC; Barrett CB, 2011, P NATL ACAD SCI USA, V108, P13907, DOI 10.1073/pnas.1011521108; Blume L.E., 2011, HDB SOCIAL EC, V1, P853, DOI DOI 10.1016/B978-0-444-53707-2.00001-3; Bongaarts J, 1996, POPUL DEV REV, V22, P639, DOI 10.2307/2137804; Boserup Ester, 1981, POPULATION TECHNOLOG; Bourdieu P., 2004, SCI SCI REFLEXIVITY; Butzer KW, 2012, P NATL ACAD SCI USA, V109, P3628, DOI 10.1073/pnas.1114772109; CALDWELL JC, 1987, POPUL DEV REV, V13, P409, DOI 10.2307/1973133; Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x; Dasgupta P, 2002, NEW HOR ENV ECO, P118; Dasgupta P, 2000, EUR ECON REV, V44, P619, DOI 10.1016/S0014-2921(00)00039-8; Dasgupta P., 1993, INQUIRY WELL BEING D; Donati P., 2011, RELATIONAL SOCIOLOGY; Douglas Mary, 1996, WORLD GOODS ANTHR CO; Ehrlich PR, 2007, CONSERV BIOL, V21, P1145, DOI 10.1111/j.1523-1739.2007.00779.x; Ehrlich PR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2845; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Gadgil M., 1992, THIS FISSURED LAND; HAJNAL J, 1982, POPUL DEV REV, V8, P449, DOI 10.2307/1972376; Illife J., 2011, AFRICANS HIST CONTIN; Jensen R, 2009, Q J ECON, V124, P1057, DOI 10.1162/qjec.2009.124.3.1057; Jodha N. S., 2001, LIVING EDGE SUSTAINI; Kuhn P, 2011, AM ECON REV, V101, P2226, DOI 10.1257/aer.101.5.2226; Layard R., 2005, PROSPECT, V108; Lopez R, 1998, WORLD BANK ECON REV, V12, P105, DOI 10.1093/wber/12.1.105; Lutz W, 2011, SCIENCE, V333, P587, DOI 10.1126/science.1206964; Magrath W., 1989, WASTING ASSETS NATUR; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Ostrom E., 1990, GOVERNING COMMONS EV; Population Reference Bureau, 2012, 2012 WORLD POP DAT S; Rees W. E., 2001, ENCY BIODIVERSITY, V2, DOI DOI 10.1016/BO-12-226865-2/00080-8; Ridley M., 2010, RATIONAL OPTIMIST PR; Samuelson L, 2006, REPEATED GAMES REPUT; Schellnhuber H.J., 2004, GLOBAL CHANGE EARTH; Schor J., 1998, OVERSPENT AM UPSCALI; Speidel JJ, 2009, PHILOS T R SOC B, V364, P3049, DOI 10.1098/rstb.2009.0162; STARRETT DA, 1972, J ECON THEORY, V4, P180, DOI 10.1016/0022-0531(72)90148-2; Sunstein CR, 2001, J POLIT PHILOS, V9, P129, DOI 10.1111/1467-9760.00121; The Royal Society, 2012, PEOPL PLAN; Turner BL, 1996, P NATL ACAD SCI USA, V93, P14984, DOI 10.1073/pnas.93.25.14984; United Nations Development Programme, 2010, HUM DEV REP; Veblen T.B., 1925, THEORY LEISURE CLASS; VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258; World Bank, 2010, WORLD DEV REP DEV CL	49	57	59	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					324	328		10.1126/science.1224664	http://dx.doi.org/10.1126/science.1224664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126XZ	23599486				2022-12-28	WOS:000317657500047
J	Rodriguez-Fortuno, FJ; Marino, G; Ginzburg, P; O'Connor, D; Martinez, A; Wurtz, GA; Zayats, AV				Rodriguez-Fortuno, Francisco J.; Marino, Giuseppe; Ginzburg, Pavel; O'Connor, Daniel; Martinez, Alejandro; Wurtz, Gregory A.; Zayats, Anatoly V.			Near-Field Interference for the Unidirectional Excitation of Electromagnetic Guided Modes	SCIENCE			English	Article							BROAD-BAND; PROPAGATION; RADIATION; ANTENNAS; PHASE	Wave interference is a fundamental manifestation of the superposition principle with numerous applications. Although in conventional optics, interference occurs between waves undergoing different phase advances during propagation, we show that the vectorial structure of the near field of an emitter is essential for controlling its radiation as it interferes with itself on interaction with a mediating object. We demonstrate that the near-field interference of a circularly polarized dipole results in the unidirectional excitation of guided electromagnetic modes in the near field, with no preferred far-field radiation direction. By mimicking the dipole with a single illuminated slit in a gold film, we measured unidirectional surface-plasmon excitation in a spatially symmetric structure. The surface wave direction is switchable with the polarization.	[Rodriguez-Fortuno, Francisco J.; Marino, Giuseppe; Ginzburg, Pavel; O'Connor, Daniel; Wurtz, Gregory A.; Zayats, Anatoly V.] Kings Coll London, Dept Phys, London WC2R 2LS, England; [Rodriguez-Fortuno, Francisco J.; Martinez, Alejandro] Univ Politecn Valencia, Nanophoton Technol Ctr, Valencia 46022, Spain	University of London; King's College London; Universitat Politecnica de Valencia	Zayats, AV (corresponding author), Kings Coll London, Dept Phys, London WC2R 2LS, England.	frarodfo@ntc.upv.es; a.zayats@kcl.ac.uk	Marino, Giuseppe/P-6707-2018; O'Connor, Daniel/J-2226-2014; Rodríguez-Fortuño, Francisco José/N-1663-2013; Martínez, Alejandro/D-8616-2014; Ginzburg, Pavel/N-9887-2015	Marino, Giuseppe/0000-0001-8979-051X; O'Connor, Daniel/0000-0002-3999-3797; Rodríguez-Fortuño, Francisco José/0000-0002-4555-1186; Martínez, Alejandro/0000-0001-5448-0140; Ginzburg, Pavel/0000-0002-9717-3682	Engineering and Physical Sciences Research Council [EP/H000917/2]; FPI of Generalitat Valenciana; Spanish government [CSD2008-00066, TEC2011-28664-C02-02]; Royal Society; EPSRC [EP/K007793/1, EP/H000917/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K007793/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); FPI of Generalitat Valenciana; Spanish government(Spanish GovernmentEuropean Commission); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work has been supported in part by the Engineering and Physical Sciences Research Council (grant EP/H000917/2). F.J.R.-F. acknowledges support from grant FPI of Generalitat Valenciana. A. M. acknowledges financial support from the Spanish government (contracts Consolider EMET CSD2008-00066 and TEC2011-28664-C02-02). P. G. acknowledges the Royal Society for a Newton International Fellowship.	Aeschlimann M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033030; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Bonod N, 2007, OPT EXPRESS, V15, P11427, DOI 10.1364/OE.15.011427; Bouillard JS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00829; Curto AG, 2010, SCIENCE, V329, P930, DOI 10.1126/science.1191922; Eleftheriades GV, 2008, IEEE MICROW WIREL CO, V18, P236, DOI 10.1109/LMWC.2008.918871; HANSEN WN, 1968, J OPT SOC AM, V58, P380, DOI 10.1364/JOSA.58.000380; Helseth LE, 2008, OPT COMMUN, V281, P1981, DOI 10.1016/j.optcom.2007.12.018; Kim H, 2009, PLASMONICS, V4, P153, DOI 10.1007/s11468-009-9086-2; Laroche M, 2005, OPT LETT, V30, P2623, DOI 10.1364/OL.30.002623; Lee JY, 2009, NATURE, V460, P498, DOI 10.1038/nature08173; Li XW, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3602322; Liu YM, 2012, NANO LETT, V12, P4853, DOI 10.1021/nl302339z; Merlin R, 2007, SCIENCE, V317, P927, DOI 10.1126/science.1143884; Ni XJ, 2012, SCIENCE, V335, P427, DOI 10.1126/science.1214686; Novotny L., 2011, PRINCIPLES NANOOPTIC; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Radko IP, 2009, OPT EXPRESS, V17, P7228, DOI 10.1364/OE.17.007228; Roelkens G, 2010, J NANOSCI NANOTECHNO, V10, P1551, DOI 10.1166/jnn.2010.2031; Rotenberg N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.127402; Ruan ZC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.013901; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; Stockman MI, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067402; Sukharev M, 2006, NANO LETT, V6, P715, DOI 10.1021/nl0524896; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713	25	473	482	18	397	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					328	330		10.1126/science.1233739	http://dx.doi.org/10.1126/science.1233739			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599487				2022-12-28	WOS:000317657500048
J	Cao, Y; Pan, YP; Huang, H; Jin, XS; Levin, EJ; Kloss, B; Zhou, M				Cao, Yu; Pan, Yaping; Huang, Hua; Jin, Xiangshu; Levin, Elena J.; Kloss, Brian; Zhou, Ming			Gating of the TrkH ion channel by its associated RCK protein TrkA	NATURE			English	Article							MEMBRANE REGION M-2C2; K+-UPTAKE SYSTEM; ESCHERICHIA-COLI; KTRAB SYSTEM; MECHANISM; TRANSPORT; DOMAINS; BINDING; RING; FLUX	TrkH belongs to a superfamily of K+ transport proteins required for growth of bacteria in low external K+ concentrations. The crystal structure of TrkH from Vibrio parahaemolyticus showed that TrkH resembles a K+ channel and may have a gating mechanism substantially different from K+ channels. TrkH assembles with TrkA, a cytosolic protein comprising two RCK (regulate the conductance of K+) domains, which are found in certain K+ channels and control their gating. However, fundamental questions on whether TrkH is an ion channel and how it is regulated by TrkA remain unresolved. Here we show single-channel activity of TrkH that is upregulated by ATP via TrkA. We report two structures of the tetrameric TrkA ring, one in complex with TrkH and one in isolation, in which the ring assumes two markedly different conformations. These results suggest a mechanism for how ATP increases TrkH activity by inducing conformational changes in TrkA.	[Cao, Yu; Pan, Yaping; Huang, Hua; Levin, Elena J.; Zhou, Ming] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Pan, Yaping; Huang, Hua; Levin, Elena J.; Zhou, Ming] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Jin, Xiangshu] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Kloss, Brian] New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, New York, NY 10027 USA	Columbia University; Baylor College of Medicine; National Institute of Biological Sciences, Beijing	Zhou, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	mzhou@bcm.edu	Cao, Yu/GNP-6653-2022	Cao, Yu/0000-0003-1409-2068; Jin, Xiangshu/0000-0002-6551-8850; Kloss, Brian/0000-0003-0130-8739	US National Institutes of Health [DK088057, GM098878, HL086392]; PSI: Biology grant [5808, U54GM095315]; American Heart Association [12EIA8850017, 0826067D]; Irma T. Hirschl Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM095315, U54GM075026, R01GM098878] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PSI: Biology grant; American Heart Association(American Heart Association); Irma T. Hirschl Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Diffraction data for this study were measured at beamlines X4A, X4C, X25 and X29 of the National Synchrotron Light Source, ID-17 and ID-24 at the Advanced Photon Source, 5.0.2 and 8.2.2 at the Advanced Light Source, and A1 and F1 at the Cornell High Energy Synchrotron Source. M.Z. thanks E. Bakker, I. Booth, R. Kramer and C. Slayman for discussions and insights, and K. R. Rajashankar for help with X-ray crystallography. This work was supported by the US National Institutes of Health (DK088057, GM098878 and HL086392 to M.Z., and a subcontract (sub 5808 to M.Z.) from the PSI: Biology grant U54GM095315 to W. Hendrickson), the American Heart Association (12EIA8850017 to M.Z. and 0826067D to Y.P.), and the Irma T. Hirschl Trust Award to M.Z. M.Z. was a Pew Scholar in Biomedical Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; BAKKER EP, 1983, BIOCHIM BIOPHYS ACTA, V730, P379, DOI 10.1016/0005-2736(83)90355-3; BOSSEMEYER D, 1989, J BIOL CHEM, V264, P16403; BUEHNER M, 1973, P NATL ACAD SCI USA, V70, P3052, DOI 10.1073/pnas.70.11.3052; Cao Y, 2011, NATURE, V471, P336, DOI 10.1038/nature09731; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corratge-Faillie C, 2010, CELL MOL LIFE SCI, V67, P2511, DOI 10.1007/s00018-010-0317-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELLE H, 1980, BIOCHEMISTRY-US, V19, P3585, DOI 10.1021/bi00556a026; Hanelt I, 2010, J BIOL CHEM, V285, P28210, DOI 10.1074/jbc.M110.139311; Hanelt I, 2010, J BIOL CHEM, V285, P10318, DOI 10.1074/jbc.M109.089870; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Kong CG, 2012, ELIFE, V1, DOI 10.7554/eLife.00184; Kuo MMC, 2007, J BIOL CHEM, V282, P24294, DOI 10.1074/jbc.M703618200; LONG WS, 1978, J BACTERIOL, V133, P995, DOI 10.1128/JB.133.2.995-1007.1978; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; RHOADS DB, 1977, J BIOL CHEM, V252, P1394; Roosild TP, 2010, P NATL ACAD SCI USA, V107, P19784, DOI 10.1073/pnas.1012716107; Roosild TP, 2009, STRUCTURE, V17, P893, DOI 10.1016/j.str.2009.03.018; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; STEWART LMD, 1985, J GEN MICROBIOL, V131, P77; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414	33	66	68	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					317	+		10.1038/nature12056	http://dx.doi.org/10.1038/nature12056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23598339	Green Accepted			2022-12-28	WOS:000317599200028
J	Pla, JJ; Tan, KY; Dehollain, JP; Lim, WH; Morton, JJL; Zwanenburg, FA; Jamieson, DN; Dzurak, AS; Morello, A				Pla, Jarryd J.; Tan, Kuan Y.; Dehollain, Juan P.; Lim, Wee H.; Morton, John J. L.; Zwanenburg, Floris A.; Jamieson, David N.; Dzurak, Andrew S.; Morello, Andrea			High-fidelity readout and control of a nuclear spin qubit in silicon	NATURE			English	Article							SINGLE-SHOT READOUT; ELECTRON-SPIN; QUANTUM; MEMORY; STORAGE	Detection of nuclear spin precession is critical for a wide range of scientific techniques that have applications in diverse fields including analytical chemistry, materials science, medicine and biology. Fundamentally, it is possible because of the extreme isolation of nuclear spins from their environment. This isolation also makes single nuclear spins desirable for quantum-information processing, as shown by pioneering studies on nitrogen-vacancy centres in diamond(1-4). The nuclear spin of a P-31 donor in silicon is very promising as a quantum bit(5): bulk measurements indicate that it has excellent coherence times(6,7) and silicon is the dominant material in the microelectronics industry. Here we demonstrate electrical detection and coherent manipulation of a single P-31 nuclear spin qubit with sufficiently high fidelities for fault-tolerant quantum computing(8). By integrating single-shot readout of the electron spin(9) with on-chip electron spin resonance(10), we demonstrate quantum non-demolition(11) and electrical single-shot readout of the nuclear spin with a readout fidelity higher than 99.8 per cent-the highest so far reported for any solid-state qubit. The single nuclear spin is then operated as a qubit by applying coherent radio-frequency pulses. For an ionized P-31 donor, we find a nuclear spin coherence time of 60 milliseconds and a one-qubit gate control fidelity exceeding 98 per cent. These results demonstrate that the dominant technology of modern electronics can be adapted to host a complete electrical measurement and control platform for nuclear-spin-based quantum-information processing.	[Pla, Jarryd J.; Tan, Kuan Y.; Dehollain, Juan P.; Lim, Wee H.; Zwanenburg, Floris A.; Dzurak, Andrew S.; Morello, Andrea] Univ New S Wales, Sch Elect Engn & Telecommun, Ctr Quantum Computat & Commun Technol, Sydney, NSW 2052, Australia; [Morton, John J. L.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Jamieson, David N.] Univ Melbourne, Sch Phys, Ctr Quantum Computat & Commun Technol, Melbourne, Vic 3010, Australia	University of New South Wales Sydney; University of London; University College London; University of Melbourne	Morello, A (corresponding author), Univ New S Wales, Sch Elect Engn & Telecommun, Ctr Quantum Computat & Commun Technol, Sydney, NSW 2052, Australia.	a.morello@unsw.edu.au	Morton, John/I-3515-2013; Dzurak, Andrew S/C-5973-2009; Jamieson, David N/G-3753-2010; Pla, Jarryd J/J-4987-2015; Tan, Kuan Yen/G-4475-2010; Morello, Andrea/B-6475-2008; Zwanenburg, Floris A/K-2183-2013; Dehollain, Juan Pablo/G-9915-2012	Dzurak, Andrew S/0000-0003-1389-5096; Pla, Jarryd J/0000-0002-7152-3453; Tan, Kuan Yen/0000-0001-5168-4914; Morello, Andrea/0000-0001-7445-699X; Dehollain, Juan Pablo/0000-0002-0425-4345; Zwanenburg, Floris/0000-0003-1713-7866; Jamieson, David/0000-0001-7733-6715	Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology [CE11E0096]; US Army Research Office [W911NF-13-1-0024]; Australian National Fabrication Facility; EPSRC [EP/I035536/2, EP/H025952/1, EP/H025952/2, EP/I035536/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I035536/1, EP/H025952/2, EP/H025952/1, EP/I035536/2] Funding Source: researchfish	Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology(Australian Research Council); US Army Research Office; Australian National Fabrication Facility; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank R. P. Starrett, D. Barber, C. Y. Yang and R. Szymanski for technical assistance and A. Laucht, R. Kalra and J. Muhonen for discussions. This research was funded by the Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology (project number CE11E0096) and the US Army Research Office (W911NF-13-1-0024). We acknowledge support from the Australian National Fabrication Facility.	Angus SJ, 2007, NANO LETT, V7, P2051, DOI 10.1021/nl070949k; Becker P, 2010, PHYS STATUS SOLIDI A, V207, P49, DOI 10.1002/pssa.200925148; Braginsky VB, 1996, REV MOD PHYS, V68, P1, DOI 10.1103/RevModPhys.68.1; Brown KR, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.030303; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Dehollain JP, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/1/015202; Dreher L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.027602; FEHER G, 1959, PHYS REV, V114, P1219, DOI 10.1103/PhysRev.114.1219; Hanson R, 2008, NATURE, V453, P1043, DOI 10.1038/nature07129; Jamieson DN, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1925320; Jelezko F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.130501; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; McCamey DR, 2010, SCIENCE, V330, P1652, DOI 10.1126/science.1197931; Mehring M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.153001; Morello A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.081307; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Morton JJL, 2008, NATURE, V455, P1085, DOI 10.1038/nature07295; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Pfaff W, 2013, NAT PHYS, V9, P29, DOI [10.1038/nphys2444, 10.1038/NPHYS2444]; PINES D, 1957, PHYS REV, V106, P489, DOI 10.1103/PhysRev.106.489; Pla JJ, 2012, NATURE, V489, P541, DOI 10.1038/nature11449; Simmons S, 2011, NATURE, V470, P69, DOI 10.1038/nature09696; Steger M, 2012, SCIENCE, V336, P1280, DOI 10.1126/science.1217635; Steger M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3577614; Vincent R, 2012, NATURE, V488, P357, DOI 10.1038/nature11341; Witzel WM, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035452	30	374	379	7	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					334	338		10.1038/nature12011	http://dx.doi.org/10.1038/nature12011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23598342	Green Submitted			2022-12-28	WOS:000317599200031
J	Kapur, N				Kapur, Narinder			The NHS could learn much from Gandhi's teaching	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, London WC1E 7HJ, England	University of London; University College London	Kapur, N (corresponding author), UCL, London WC1E 7HJ, England.	n.kapur@ucl.ac.uk						English T., 2013, TIMES; Francis R., 2013, REPORT MID STAFFORDS; Gandhi Mohandas K., 2000, GANDHIS HLTH GUIDE; Gardner H., 1993, CREATING MINDS; Goldstein N.J., 2007, YES 50 SECRETS SCI P; Kapur N, 2010, TIMELESS INSPIRATOR, P228; Kapur N, 2013, HLTH SERVICE J; Keating E., 2005, LANGUAGE CULTURE ENC; Mitterer H, 2009, J EXP PSYCHOL LEARN, V35, P1557, DOI 10.1037/a0017019; Owen D, 2009, BRAIN, V132, P1396, DOI 10.1093/brain/awp008; Robertson IH, 2013, PSYCHOLOGIST, V26, P186; Smyth C, 2013, TIMES; Socialist Health Association, GRIFF REP NHS OCT 19	13	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2013	346								f2411	10.1136/bmj.f2411	http://dx.doi.org/10.1136/bmj.f2411			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AT	23596222				2022-12-28	WOS:000317963400007
J	Moll, S				Moll, Stephan			Apixaban reduced recurrence and did not increase major bleeding in previously treated VTE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ N Carolina, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Moll, S (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.							Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8							JC2	10.7326/0003-4819-158-8-201304160-02002	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588767				2022-12-28	WOS:000318062100005
J	Spence, D				Spence, Des			FROM THE FRONTLINE Thatcher's legacy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], 2011, STAT B; [Anonymous], 2010, BBC NEWS; Institute of Education National Centre for Social Research, 2012, INT TRANSM WORKL EV; McInnes R, 2012, 13 COMM LIB; NatCen Social Research, 2012, BRIT SOC ATT	5	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2013	346								f2382	10.1136/bmj.f2382	http://dx.doi.org/10.1136/bmj.f2382			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AI	23587566				2022-12-28	WOS:000317962200007
J	Srinivasan, S				Srinivasan, Sandhya			Has Tamil Nadu turned the tide on the transplant trade?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sandhya_srinivasan@vsnl.com						Abraham G, 2012, TRANSPLANTATION, V93, P757, DOI 10.1097/TP.0b013e3182469b91; Abraham G, 2010, KIDNEY INT, V77, P378, DOI 10.1038/ki.2009.494; [Anonymous], FRONTLINE; Dorairaj S, 2009, FRONTLINE, P26; Government of Tamil Nadu, CAD TRANSPL PROGR OR; Horvat LD, 2009, KIDNEY INT, V75, P1088, DOI 10.1038/ki.2009.20; MOHAN Foundation, 2013, INDIAN TRANSPLAN FEB, P37; Nagral Sanjay, 2009, Indian J Med Ethics, V6, P155; Tamil Nadu Cadaver Transplant Program, DEC DON TRANSPL DAT; Tamil Nadu Cadaver Transplant Program, WAITL STAT KIDN; World Health Organization, 2013, GLOB STAT REP ROAD S; World Health Organization, GLOB HLTH OBS DAT RE	12	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 12	2013	346								f2155	10.1136/bmj.f2155	http://dx.doi.org/10.1136/bmj.f2155			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126AB	23585066				2022-12-28	WOS:000317582400003
J	Nussinov, R; Tsai, CJ				Nussinov, Ruth; Tsai, Chung-Jung			Allostery in Disease and in Drug Discovery	CELL			English	Review							PROTEIN-KINASE; BINDING CASCADES; MAP KINASE; BCR-ABL; INHIBITORS; ACTIVATION; RECEPTOR; LANDSCAPES; DYNAMICS; SITES	Allostery is largely associated with conformational and functional transitions in individual proteins. This concept can be extended to consider the impact of conformational perturbations on cellular function and disease states. Here, we clarify the concept of allostery and how it controls physiological activities. We focus on the challenging questions of how allostery can both cause disease and contribute to development of new therapeutics. We aim to increase the awareness of the linkage between disease symptoms on the cellular level and specific aberrant allosteric actions on the molecular level and to emphasize the potential of allosteric drugs in innovative therapies.	[Nussinov, Ruth; Tsai, Chung-Jung] NCI, Ctr Canc Res, Nanobiol Program, Frederick Natl Lab Canc Res,SAIC Frederick Inc, Frederick, MD 21702 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Inst Mol Med, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tel Aviv University; Sackler Faculty of Medicine	Nussinov, R (corresponding author), NCI, Ctr Canc Res, Nanobiol Program, Frederick Natl Lab Canc Res,SAIC Frederick Inc, Frederick, MD 21702 USA.	nussinor@helix.nih.gov		Nussinov, Ruth/0000-0002-8115-6415	NCI, NIH [HHSN261200800001E]; Intramural Research Program of the NIH, NCI, CCR; NATIONAL CANCER INSTITUTE [ZIABC010440, ZIABC010441] Funding Source: NIH RePORTER	NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, NCI, CCR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with Federal funds from the NCI, NIH, under contract number HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of DHHS, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported in part by the Intramural Research Program of the NIH, NCI, CCR.	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Autret A, 2007, J VIROL, V81, P7504, DOI 10.1128/JVI.02690-06; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Fenwick RB, 2011, EUR BIOPHYS J BIOPHY, V40, P1339, DOI 10.1007/s00249-011-0754-8; Capra JA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000585; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chi CN, 2011, J BIOL CHEM, V286, P3597, DOI 10.1074/jbc.M110.190264; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Deng XM, 2010, J MED CHEM, V53, P6934, DOI 10.1021/jm100555f; Deng XM, 2009, BLOOD, V113, P422, DOI 10.1182/blood-2008-06-165134; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Di Marco S, 2005, J BIOL CHEM, V280, P29765, DOI 10.1074/jbc.M505423200; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Endres NF, 2011, CURR OPIN STRUC BIOL, V21, P777, DOI 10.1016/j.sbi.2011.07.007; Ferrai C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000270; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Fuxreiter M, 2012, MOL BIOSYST, V8, P168, DOI 10.1039/c1mb05234a; Gao JJ, 2012, CHEM BIOL DRUG DES, V79, P209, DOI 10.1111/j.1747-0285.2011.01261.x; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Grant BD, 1996, BIOCHEMISTRY-US, V35, P2022, DOI 10.1021/bi952144+; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Gupta M, 2012, BLOOD, V119, P476, DOI 10.1182/blood-2011-04-346601; Hassan AQ, 2010, CELL CYCLE, V9, P3710, DOI 10.4161/cc.9.18.13232; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joseph RE, 2010, J MOL BIOL, V403, P231, DOI 10.1016/j.jmb.2010.08.035; Kar G, 2010, CURR OPIN PHARMACOL, V10, P715, DOI 10.1016/j.coph.2010.09.002; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kenakin TP, 2009, TRENDS PHARMACOL SCI, V30, P460, DOI 10.1016/j.tips.2009.06.007; Kim C, 2006, EUR J CELL BIOL, V85, P651, DOI 10.1016/j.ejcb.2006.02.004; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kumar S, 2000, PROTEIN SCI, V9, P10; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lechtenberg BC, 2012, BIOL CHEM, V393, P889, DOI 10.1515/hsz-2012-0178; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Leitner DM, 2008, ANNU REV PHYS CHEM, V59, P233, DOI 10.1146/annurev.physchem.59.032607.093606; Liggett SB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002331; Liu ZX, 2009, PROTEINS, V77, P823, DOI 10.1002/prot.22498; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Maksay G, 2011, PROG BIOPHYS MOL BIO, V106, P463, DOI 10.1016/j.pbiomolbio.2011.01.001; Marti MA, 2009, J PHYS CHEM B, V113, P2135, DOI 10.1021/jp808055e; Martin-Montalvo A, 2011, ONCOGENE, V30, P505, DOI 10.1038/onc.2010.492; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Mazzoletti M, 2011, CANCER RES, V71, P4573, DOI 10.1158/0008-5472.CAN-10-4322; Medves S, 2012, J CELL MOL MED, V16, P237, DOI 10.1111/j.1582-4934.2011.01415.x; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nachtergaele S, 2012, NAT CHEM BIOL, V8, P211, DOI 10.1038/nchembio.765; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nussinov R., 2013, ANNU REV BIOPHYS; Nussinov R, 2012, TRENDS BIOCHEM SCI, V37, P447, DOI 10.1016/j.tibs.2012.07.001; Nussinov R, 2012, BRIT J PHARMACOL, V165, P2110, DOI 10.1111/j.1476-5381.2011.01793.x; Nussinov R, 2011, TRENDS PHARMACOL SCI, V32, P686, DOI 10.1016/j.tips.2011.08.004; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pan YP, 2010, TRENDS GENET, V26, P75, DOI 10.1016/j.tig.2009.12.003; Paulsen RB, 2010, P NATL ACAD SCI USA, V107, P7263, DOI 10.1073/pnas.0911896107; Pfaff SJ, 2010, J BIOL CHEM, V285, P15256, DOI 10.1074/jbc.M110.108118; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; Sadowsky JD, 2011, P NATL ACAD SCI USA, V108, P6056, DOI 10.1073/pnas.1102376108; Schelshorn D, 2012, MOL PHARMACOL, V81, P309, DOI 10.1124/mol.111.074757; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Shan Q, 2012, BRIT J PHARMACOL, V165, P2113, DOI 10.1111/j.1476-5381.2011.01701.x; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Shopland LS, 2003, J CELL BIOL, V162, P981, DOI 10.1083/jcb.200303131; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Sinha N, 2001, P NATL ACAD SCI USA, V98, P3139, DOI 10.1073/pnas.051399098; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109; Whitley MJ, 2009, CURR PROTEIN PEPT SC, V10, P116, DOI 10.2174/138920309787847563; Wood MR, 2011, BIOCHEMISTRY-US, V50, P2403, DOI 10.1021/bi200129s; Wrabl JO, 2011, BIOPHYS CHEM, V159, P129, DOI 10.1016/j.bpc.2011.05.020; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhuravlev PI, 2010, Q REV BIOPHYS, V43, P295, DOI 10.1017/S0033583510000119; Zocchi G, 2009, ANNU REV BIOPHYS, V38, P75, DOI 10.1146/annurev.biophys.050708.133637	96	449	451	1	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					293	305		10.1016/j.cell.2013.03.034	http://dx.doi.org/10.1016/j.cell.2013.03.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582321	Bronze			2022-12-28	WOS:000317349700010
J	Wu, H				Wu, Hao			Higher-Order Assemblies in a New Paradigm of Signal Transduction	CELL			English	Article							CRYSTAL-STRUCTURE; RECEPTOR; COMPLEX; ACTIVATION; APOPTOSIS; MECHANISM; REVEALS; KINASE; TRAF6; FORMS	Recent studies have revealed that multiple intracellular signaling proteins may assemble into structured, yet sometimes infinite, higher-order signaling machines for transmission of receptor activation information to cellular responses. These studies advance our understanding of cell signaling and implicate new molecular mechanisms in proximity-driven enzyme activation, threshold behavior, signal amplification, reduction of biological noise, and temporal and spatial control of signal transduction.	[Wu, Hao] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Wu, Hao] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Wu, H (corresponding author), Childrens Hosp, Program Cellular & Mol Med, 300 Longwood Ave, Boston, MA 02115 USA.	hao.wu@childrens.harvard.edu			National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045937, R01AI076927, R01AI079260, R01AI089882, R01AI050872, R37AI050872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	I apologize for incomplete citations due to space limitation and thank my colleagues and lab members for many insightful discussions, in particular Kai Wucherpfennig, Hong Qian, Qi Qiao, Qian Yin, and Neer Asherie. This work is supported by the National Institutes of Health.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Endres NF, 2011, CURR OPIN STRUC BIOL, V21, P777, DOI 10.1016/j.sbi.2011.07.007; FLORESRIVEROS JR, 1989, J BIOL CHEM, V264, P21557; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Granier S, 2012, NAT CHEM BIOL, V8, P670, DOI 10.1038/nchembio.1025; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kleiman LB, 2011, MOL CELL, V43, P723, DOI 10.1016/j.molcel.2011.07.014; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lohse MJ, 2008, BRIT J PHARMACOL, V153, pS125, DOI 10.1038/sj.bjp.0707656; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Qian H, 2012, ANNU REV BIOPHYS, V41, P179, DOI 10.1146/annurev-biophys-050511-102240; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang PJ, 2007, P NATL ACAD SCI USA, V104, P3777, DOI 10.1073/pnas.0610106104	24	230	232	1	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					287	292		10.1016/j.cell.2013.03.013	http://dx.doi.org/10.1016/j.cell.2013.03.013			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582320	Green Accepted, Bronze			2022-12-28	WOS:000317349700009
J	Ginsburg, GS				Ginsburg, Geoffrey S.			Realizing the Opportunities of Genomics in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Duke Univ, Inst Genome Sci & Policy, Ctr Personalized Med, Durham, NC 27708 USA	Duke University	Ginsburg, GS (corresponding author), Duke Univ, Inst Genome Sci & Policy, Ctr Personalized Med, 101 Sci Dr, Durham, NC 27708 USA.	geoffrey.ginsburg@duke.edu						Bianchi DW, 2012, NAT MED, V18, P1041, DOI 10.1038/nm.2829; Damman CJ, 2012, AM J GASTROENTEROL, V107, P1452, DOI 10.1038/ajg.2012.93; Food and Drug Administration, TABL PHARM BIOM DRUG; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; National Human Genome Research Institute, STRAT PLAN CHART COU	6	24	24	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1463	1464		10.1001/jama.2013.1465	http://dx.doi.org/10.1001/jama.2013.1465			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571581				2022-12-28	WOS:000317271700020
J	Loman, NJ; Constantinidou, C; Christner, M; Rohde, H; Chan, JZM; Quick, J; Weir, JC; Quince, C; Smith, GP; Betley, JR; Aepfelbacher, M; Pallen, MJ				Loman, Nicholas J.; Constantinidou, Chrystala; Christner, Martin; Rohde, Holger; Chan, Jacqueline Z. -M.; Quick, Joshua; Weir, Jacqueline C.; Quince, Christopher; Smith, Geoffrey P.; Betley, Jason R.; Aepfelbacher, Martin; Pallen, Mark J.			A Culture-Independent Sequence-Based Metagenomics Approach to the Investigation of an Outbreak of Shiga-Toxigenic Escherichia coli O104:H4	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Importance Identification of the bacterium responsible for an outbreak can aid in disease management. However, traditional culture-based diagnosis can be difficult, particularly if no specific diagnostic test is available for an outbreak strain. Objective To explore the potential of metagenomics, which is the direct sequencing of DNA extracted from microbiologically complex samples, as an open-ended clinical discovery platform capable of identifying and characterizing bacterial strains from an outbreak without laboratory culture. Design, Setting, and Patients In a retrospective investigation, 45 samples were selected from fecal specimens obtained from patients with diarrhea during the 2011 outbreak of Shiga-toxigenic Escherichia coli (STEC) O104:H4 in Germany. Samples were subjected to high-throughput sequencing (August-September 2012), followed by a 3-phase analysis (November 2012-February 2013). In phase 1, a de novo assembly approach was developed to obtain a draft genome of the outbreak strain. In phase 2, the depth of coverage of the outbreak strain genome was determined in each sample. In phase 3, sequences from each sample were compared with sequences from known bacteria to identify pathogens other than the outbreak strain. Main Outcomes and Measures The recovery of genome sequence data for the purposes of identification and characterization of the outbreak strain and other pathogens from fecal samples. Results During phase 1, a draft genome of the STEC outbreak strain was obtained. During phase 2, the outbreak strain genome was recovered from 10 samples at greater than 10-fold coverage and from 26 samples at greater than 1-fold coverage. Sequences from the Shiga-toxin genes were detected in 27 of 40 STEC-positive samples (67%). In phase 3, sequences from Clostridium difficile, Campylobacter jejuni, Campylobacter concisus, and Salmonella enterica were recovered. Conclusions and Relevance These results suggest the potential of metagenomics as a culture-independent approach for the identification of bacterial pathogens during an outbreak of diarrheal disease. Challenges include improving diagnostic sensitivity, speeding up and simplifying workflows, and reducing costs. JAMA. 2013;309(14):1502-1510 www.jama.com	[Loman, Nicholas J.; Quick, Joshua] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Constantinidou, Chrystala; Chan, Jacqueline Z. -M.; Pallen, Mark J.] Univ Warwick, Div Microbiol & Infect, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Christner, Martin; Rohde, Holger; Aepfelbacher, Martin] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Quince, Christopher] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland; [Weir, Jacqueline C.; Smith, Geoffrey P.; Betley, Jason R.] Illumina Inc, Chesterford Res Pk, Essex, England	University of Birmingham; University of Warwick; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Glasgow; Illumina	Pallen, MJ (corresponding author), Univ Warwick, Div Microbiol & Infect, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	m.pallen@warwick.ac.uk	Loman, Nicholas/Z-1573-2019	Loman, Nicholas/0000-0002-9843-8988; Pallen, Mark/0000-0003-1807-3657; Rohde, Holger/0000-0001-8587-4433; Quince, Christopher/0000-0003-1884-8440	Novartis; Gilead; Germany by the Medical Faculty of the University Medical Center Hamburg-Eppendorf; UK's Biotechnology and Biological Sciences Research Council; UK's National Institute for Health Research; MRC Special Training Fellowship in Biomedical Informatics; Illumina Inc.; Biotechnology and Biological Sciences Research Council [BB/E011179/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H003851/1] Funding Source: researchfish; Medical Research Council [MR/J014370/1, G0901717] Funding Source: researchfish; BBSRC [BB/E011179/1] Funding Source: UKRI; EPSRC [EP/H003851/1] Funding Source: UKRI; MRC [G0901717, MR/J014370/1] Funding Source: UKRI	Novartis(Novartis); Gilead(Gilead Sciences); Germany by the Medical Faculty of the University Medical Center Hamburg-Eppendorf; UK's Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK's National Institute for Health Research; MRC Special Training Fellowship in Biomedical Informatics(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Illumina Inc.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Rohde reported receiving speakers fees from Novartis and Gilead; and receiving travel reimbursement from Novartis and Merck Sharp Dohme. Ms Weir and Drs Smith and Betley are employees of and own stock in Illumina Inc, which manufactures the MiSeq and HiSeq 2500 instruments. No other authors reported disclosures.; This work was supported in Germany by the Medical Faculty of the University Medical Center Hamburg-Eppendorf. Work in Birmingham, England, was supported by a grant from the UK's Biotechnology and Biological Sciences Research Council supporting the xBASE project, by a grant from the UK's National Institute for Health Research awarded to the Surgical Reconstruction and Microbiology Research Centre (MRC), and by an MRC Special Training Fellowship in Biomedical Informatics to Dr Loman. The HiSeq2500 sequencing was supported by Illumina Inc.	Ahmed SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048228; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Chan JZM, 2012, NAT BIOTECHNOL, V30, P1068, DOI 10.1038/nbt.2410; de Boer RF, 2010, J CLIN MICROBIOL, V48, P4140, DOI 10.1128/JCM.01124-10; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Garcia LS, 2010, CLINICAL MICROBIOLOG; Kaakoush NO, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00004; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Nitschke M, 2012, JAMA-J AM MED ASSOC, V307, P1046, DOI 10.1001/jama.2012.264; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Rogers GB, 2010, TRENDS MICROBIOL, V18, P357, DOI 10.1016/j.tim.2010.04.005; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Snyder LAS, 2009, MICROB ECOL, V57, P1, DOI 10.1007/s00248-008-9465-9; Vonberg RP, 2013, CLIN INFECT DIS, V56, P1132, DOI 10.1093/cid/cis1218; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4	18	203	214	2	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1502	1510		10.1001/jama.2013.3231	http://dx.doi.org/10.1001/jama.2013.3231			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571589	Bronze			2022-12-28	WOS:000317271700028
J	Pandey, A				Pandey, Abhishek			Preparing for the 21st-Century Patient	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Sch Med, Washington, DC 20007 USA	Georgetown University	Pandey, A (corresponding author), Georgetown Univ, Sch Med, Washington, DC 20007 USA.	ap458@georgetown.edu						Marshall E, 2011, SCIENCE, V331, P526, DOI 10.1126/science.331.6017.526	1	6	6	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1471	1472		10.1001/jama.2012.116971	http://dx.doi.org/10.1001/jama.2012.116971			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571585				2022-12-28	WOS:000317271700024
J	Das, P				Das, Pamela			Duncan Selbie: the new face of public health in England	LANCET			English	Biographical-Item																			0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 6	2013	381	9873					1175	1175		10.1016/S0140-6736(13)60787-4	http://dx.doi.org/10.1016/S0140-6736(13)60787-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WU	23561989	Bronze			2022-12-28	WOS:000317350100013
J	Stefani, A; Rossi, G; Pecchi, A; Bertolini, F; Falasca, A; Aramini, B; Morandi, U				Stefani, Alessandro; Rossi, Giulio; Pecchi, Annarita; Bertolini, Federica; Falasca, Angelo; Aramini, Beatrice; Morandi, Uliano			An unusual case of cystic interstitial lung disease	LANCET			English	Editorial Material							BENIGN METASTATIC MENINGIOMA		[Stefani, Alessandro; Aramini, Beatrice; Morandi, Uliano] Modena Univ Hosp, Div Thorac Surg, Modena, Italy; [Pecchi, Annarita] Modena Univ Hosp, Dept Radiol, Modena, Italy; [Bertolini, Federica] Modena Univ Hosp, Div Oncol, Modena, Italy; [Rossi, Giulio] Azienda Arcispedale S Maria Nuova IRCCS, Operat Unit Pathol, Reggio Emilia, Italy; [Falasca, Angelo] Nuovo Osped Civile S Agostino Estense, Div Neurosurg, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; IRCCS Arcispedale S. Maria Nuova	Stefani, A (corresponding author), Univ Modena Policlin, Via Pozzo 71, I-41100 Modena, Italy.	alessandro.stefani@unimore.it	Pecchi, Annarita/M-2559-2016; Aramini, Beatrice/P-5193-2019; Aramini, Beatrice/K-2754-2018; Rossi, Antonio/K-7054-2016; Stefani, Alessandro/I-8199-2014; Bertolini, Federica/AAC-5253-2022; Rossi, Giulio/K-6217-2016; Morandi, Uliano/C-9451-2017	Pecchi, Annarita/0000-0001-8142-3256; Aramini, Beatrice/0000-0002-5326-710X; Rossi, Antonio/0000-0003-3295-0345; Stefani, Alessandro/0000-0003-4547-6232; Rossi, Giulio/0000-0001-8855-1218; Morandi, Uliano/0000-0002-4039-7626; Bertolini, Federica/0000-0002-8112-2936				Asioli S, 2007, VIRCHOWS ARCH, V450, P591, DOI 10.1007/s00428-007-0392-9; Cerda-Nicolas M, 2003, J NEUROSURG, V98, P194, DOI 10.3171/jns.2003.98.1.0194; Fulkerson DH, 2008, CLIN NEUROL NEUROSUR, V110, P416, DOI 10.1016/j.clineuro.2007.12.025; Rubin Adalberto Sperb, 2005, J. bras. pneumol., V31, P177, DOI 10.1590/S1806-37132005000200015; STOLLER JK, 1987, CLEV CLIN J MED, V54, P521, DOI 10.3949/ccjm.54.6.521	5	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2013	381	9873					1246	1246		10.1016/S0140-6736(13)60179-8	http://dx.doi.org/10.1016/S0140-6736(13)60179-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WU	23562001				2022-12-28	WOS:000317350100035
J	Bernstein, A				Bernstein, Alan			Link the world's best investigators	NATURE			English	Editorial Material									Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	Canadian Institute for Advanced Research (CIFAR)	Bernstein, A (corresponding author), Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada.	abernstein@cifar.ca						Acemoglu D., 2012, WHY NATIONS FAIL; Barouch D. H., 2010, NATURE PRECEDINGS; Evans R. G., 1994, WHY ARE SOME PEOPLE; Hertzman C, 2012, P NATL ACAD SCI USA, V109, P17160, DOI 10.1073/pnas.1202203109	4	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2013	496	7443					27	27		10.1038/496027a	http://dx.doi.org/10.1038/496027a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117ZZ	23552928	Bronze			2022-12-28	WOS:000316993400010
J	Patel, K				Patel, Kinesh			How to encourage compassion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk							0	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2013	346								f2049	10.1136/bmj.f2049	http://dx.doi.org/10.1136/bmj.f2049			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122SG	23553880				2022-12-28	WOS:000317337800015
J	Bolze, A; Mahlaoui, N; Byun, M; Turner, B; Trede, N; Ellis, SR; Abhyankar, A; Itan, Y; Patin, E; Brebner, S; Sackstein, P; Puel, A; Picard, C; Abel, L; Quintana-Murci, L; Faust, SN; Williams, AP; Baretto, R; Duddridge, M; Kini, U; Pollard, AJ; Gaud, C; Frange, P; Orbach, D; Emile, LF; Stephan, JL; Sorensen, R; Plebani, A; Hammarstrom, L; Mary, E; Selleri, L; Casanova, JL				Bolze, Alexandre; Mahlaoui, Nizar; Byun, Minji; Turner, Bridget; Trede, Nikolaus; Ellis, Steven R.; Abhyankar, Avinash; Itan, Yuval; Patin, Etienne; Brebner, Samuel; Sackstein, Paul; Puel, Anne; Picard, Capucine; Abel, Laurent; Quintana-Murci, Lluis; Faust, Saul N.; Williams, Anthony P.; Baretto, Richard; Duddridge, Michael; Kini, Usha; Pollard, Andrew J.; Gaud, Catherine; Frange, Pierre; Orbach, Daniel; Emile, Lean-Francois; Stephan, Jean-Louis; Sorensen, Ricardo; Plebani, Alessandro; Hammarstrom, Lennart; Conley, Mary Ellen; Selleri, Licia; Casanova, Jean-Laurent			Ribosomal Protein SA Haploinsufficiency in Humans with Isolated Congenital Asplenia	SCIENCE			English	Article							DIAMOND-BLACKFAN ANEMIA; MUTATIONS; DISCOVERY; SPLEEN	Isolated congenital asplenia (ICA) is characterized by the absence of a spleen at birth in individuals with no other developmental defects. The patients are prone to life-threatening bacterial infections. The unbiased analysis of exomes revealed heterozygous mutations in RPSA in 18 patients from eight kindreds, corresponding to more than half the patients and over one-third of the kindreds studied. The clinical penetrance in these kindreds is complete. Expression studies indicated that the mutations carried by the patients-a nonsense mutation, a frameshift duplication, and five different missense mutations-cause autosomal dominant ICA by haploinsufficiency. RPSA encodes ribosomal protein SA, a component of the small subunit of the ribosome. This discovery establishes an essential rote for RPSA in human spleen development.	[Bolze, Alexandre; Byun, Minji; Abhyankar, Avinash; Itan, Yuval; Brebner, Samuel; Sackstein, Paul; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Bolze, Alexandre; Puel, Anne; Picard, Capucine; Abel, Laurent; Casanova, Jean-Laurent] Univ Paris 05, Imagine Inst, Sorbonne Paris Cite, F-75006 Paris, France; [Mahlaoui, Nizar] Hop Necker Enfants Malad, French Natl Reference Ctr Primary Immune Deficien, Pediat Hematol Immunol & Rheumatol Unit, F-75015 Paris, France; [Turner, Bridget; Trede, Nikolaus] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Ellis, Steven R.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Patin, Etienne; Quintana-Murci, Lluis] Inst Pasteur, Dept Genomes & Genet, Unit Human Evolutionary Genet, CNRS,URA3012, F-75015 Paris, France; [Puel, Anne; Picard, Capucine; Abel, Laurent; Casanova, Jean-Laurent] INSERM, Lab Human Genet Infect Dis, U980, Necker Branch, F-75015 Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Study Ctr Primary Immunodeficiency, F-75015 Paris, France; [Faust, Saul N.] Univ Hosp Southampton NHS Fdn Trust, NIHR Wellcome Trust Clin Res Facil, Southampton S016 6YD, Hants, England; [Faust, Saul N.; Williams, Anthony P.] Univ Southampton, Fac Med, Southampton S016 6YD, Hants, England; [Faust, Saul N.; Williams, Anthony P.] Univ Southampton, Inst Life Sci, Southampton S016 6YD, Hants, England; [Williams, Anthony P.] Univ Hosp Southampton NHS Fdn Trust, Southampton S016 6YD, Hants, England; [Baretto, Richard; Duddridge, Michael] Univ Hosp Leicester NHS Trust, Dept Immunol, Leicester LE1 5WW, Leics, England; [Kini, Usha] Oxford Univ Hosp NHS Trust, Dept Clin Genet, Oxford OX3 7LE, England; [Pollard, Andrew J.] Univ Oxford, Dept Pediat, Oxford OX3 9DU, England; [Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford OX3 9DU, England; [Gaud, Catherine] CHU Reun Site Nord, Dept Clin Immunol, F-97405 St Denis, Reunion, France; [Frange, Pierre; Casanova, Jean-Laurent] Hop Necker Enfants Malad, AP HP, Pediat Immunol Hematol Unit, F-75015 Paris, France; [Frange, Pierre] Univ Paris 05, EA 3620, Sorbonne Paris Cite, F-75015 Paris, France; [Orbach, Daniel] Inst Curie, Dept Pediat, F-75005 Paris, France; [Emile, Lean-Francois] Univ Versailles SOY, EA 4340, F-92104 Boulogne, France; [Emile, Lean-Francois] Hop Ambroise Pare, AP HP, F-92104 Boulogne, France; [Stephan, Jean-Louis] CHU Nord, Dept Pediat, F-42055 St Etienne, France; [Sorensen, Ricardo] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, Jeffrey Modell Diagnost Ctr Primary Immunodeficie, New Orleans, LA 70118 USA; [Sorensen, Ricardo] Childrens Hosp, New Orleans, LA 70118 USA; [Plebani, Alessandro] Univ Brescia, Spedali Civili Brescia, Dept Pediat, I-25123 Brescia, Italy; [Plebani, Alessandro] Univ Brescia, Spedali Civili Brescia, Inst Mol Med A Nocivelti, I-25123 Brescia, Italy; [Hammarstrom, Lennart] Karolinska Univ Hosp Huddnge, Dept Lab Med, Div Clin Immunol, Karolinska Inst, SE-14186 Stockholm, Sweden; [Conley, Mary Ellen] Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN 38101 USA; [Selleri, Licia] Cornell Univ, Dept Cell & Dev Biol, Weill Med Coll, New York, NY 10065 USA	Rockefeller University; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Louisville; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University Hospitals of Leicester NHS Trust; University of Leicester; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; CHU Reunion; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; CHU de St Etienne; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; Hospital Spedali Civili Brescia; University of Brescia; Hospital Spedali Civili Brescia; University of Brescia; Karolinska Institutet; University of Tennessee System; University of Tennessee Health Science Center; Cornell University	Bolze, A (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA.	albo719@rockefeller.edu	Picard, Capucine/H-3914-2017; Frange, Pierre/O-6311-2017; MAHLAOUI, Nizar/AAH-6103-2020; Abel, Laurent/H-8888-2017; Puel, Anne/H-7305-2017; Mahlaoui, Nizar/J-7928-2017; Quintana-Murci, Lluis/AAB-7468-2022; Casanova, Jean-Laurent/I-3418-2017; Faust, Saul/J-9779-2014	Picard, Capucine/0000-0001-8788-5056; MAHLAOUI, Nizar/0000-0002-0030-8094; Abel, Laurent/0000-0001-7016-6493; Puel, Anne/0000-0003-2603-0323; Mahlaoui, Nizar/0000-0002-0030-8094; Faust, Saul/0000-0003-3410-7642; Casanova, Jean-Laurent/0000-0002-7782-4169; Byun, Minji/0000-0002-2830-4079; Quintana-Murci, Lluis/0000-0003-2429-6320; Patin, Etienne/0000-0002-9911-4459; Bolze, Alexandre/0000-0001-7399-2766	March of Dimes [1-FY12-440]; St. Cites Foundation; National Center for Research Resources and the National Center for Advancing Sciences (NCATS) [8UL1TR000043]; NIH [R01HD061403]; Rockefeller University; Institut National de la Saute et de la Recherche Medicate; Fondazione C. Golgi of Brescia; Paris Descartes University;  [SRP018839]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061403] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); St. Cites Foundation; National Center for Research Resources and the National Center for Advancing Sciences (NCATS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; Institut National de la Saute et de la Recherche Medicate; Fondazione C. Golgi of Brescia; Paris Descartes University; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the patients and their families. We thank A. Belkadi, M. Bensifi, M. Chrabieh, T. Kochetkov, and N. Wang for technical help and I. Ionita-Laza, V. Lougaris, and all members of the laboratory for fruitful. discussions. This work was supported in part by the March of Dimes (no. 1-FY12-440), St. Cites Foundation, National Center for Research Resources and the National Center for Advancing Sciences (NCATS) grant no. 8UL1TR000043, and grant no R01HD061403 from the NIH, Rockefeller University, Institut National de la Saute et de la Recherche Medicate, Fondazione C. Golgi of Brescia, and Paris Descartes University. The raw sequence data are available on the Sequence Read Archive (SRA) database: Bioproject SRP018839.	Almoznino-Sarafian D, 2007, ACTA HAEMATOL-BASEL, V118, P226, DOI 10.1159/000112308; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Balasubramanian S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r2; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Brendolan A, 2007, BIOESSAYS, V29, P166, DOI 10.1002/bies.20528; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Eilertson KE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002806; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Imashuku S, 2012, INT J HEMATOL, V95, P702, DOI 10.1007/s12185-012-1082-1; Koss M, 2012, DEV CELL, V22, P913, DOI 10.1016/j.devcel.2012.02.009; Lipton JM, 2010, CURR OPIN PEDIATR, V22, P12, DOI 10.1097/MOP.0b013e328334573b; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Mahlaoui N., 2011, J PEDIAT, V142, pe1; MYERSON RM, 1956, NEW ENGL J MED, V254, P1131, DOI 10.1056/NEJM195606142542406; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; O'Donohue MF, 2010, J CELL BIOL, V190, P853, DOI 10.1083/jcb.201005117; Scheiman J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.19; Uchida Y, 2012, J INFECT CHEMOTHER, V18, P576, DOI 10.1007/s10156-011-0341-z; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359	22	129	134	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					976	978		10.1126/science.1234864	http://dx.doi.org/10.1126/science.1234864			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23579497	Green Accepted, Green Submitted			2022-12-28	WOS:000319344100046
J	Bhatt, S; Gething, PW; Brady, OJ; Messina, JP; Farlow, AW; Moyes, CL; Drake, JM; Brownstein, JS; Hoen, AG; Sankoh, O; Myers, MF; George, DB; Jaenisch, T; Wint, GRW; Simmons, CP; Scott, TW; Farrar, JJ; Hay, SI				Bhatt, Samir; Gething, Peter W.; Brady, Oliver J.; Messina, Jane P.; Farlow, Andrew W.; Moyes, Catherine L.; Drake, John M.; Brownstein, John S.; Hoen, Anne G.; Sankoh, Osman; Myers, Monica F.; George, Dylan B.; Jaenisch, Thomas; Wint, G. R. William; Simmons, Cameron P.; Scott, Thomas W.; Farrar, Jeremy J.; Hay, Simon I.			The global distribution and burden of dengue	NATURE			English	Article							PLASMODIUM-FALCIPARUM; YELLOW-FEVER; DISEASE; TRANSMISSION; ENDEMICITY; VACCINE; VECTOR; VIRUS	Dengue is a systemic viral infection transmitted between humans by Aedes mosquitoes(1). For some patients, dengue is a life-threatening illness(2). There are currently no licensed vaccines or specific therapeutics, and substantial vector control efforts have not stopped its rapid emergence and global spread(3). The contemporary worldwide distribution of the risk of dengue virus infection(4) and its public health burden are poorly known(2,5). Here we undertake an exhaustive assembly of known records of dengue occurrence worldwide, and use a formal modelling framework to map the global distribution of dengue risk. We then pair the resulting risk map with detailed longitudinal information from dengue cohort studies and population surfaces to infer the public health burden of dengue in 2010. We predict dengue to be ubiquitous throughout the tropics, with local spatial variations in risk influenced strongly by rainfall, temperature and the degree of urbanization. Using cartographic approaches, we estimate there to be 390 million (95% credible interval 284-528) dengue infections per year, of which 96 million (67-136) manifest apparently (any level of disease severity). This infection total is more than three times the dengue burden estimate of the World Health Organization(2). Stratification of our estimates by country allows comparison with national dengue reporting, after taking into account the probability of an apparent infection being formally reported. The most notable differences are discussed. These new risk maps and infection estimates provide novel insights into the global, regional and national public health burden imposed by dengue. We anticipate that they will provide a starting point for a wider discussion about the global impact of this disease and will help to guide improvements in disease control strategies using vaccine, drug and vector control methods, and in their economic evaluation.	[Bhatt, Samir; Gething, Peter W.; Brady, Oliver J.; Messina, Jane P.; Farlow, Andrew W.; Moyes, Catherine L.; Drake, John M.; Myers, Monica F.; Wint, G. R. William; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Brady, Oliver J.] Oxitec Ltd, Abingdon OX14 4RX, Oxon, England; [Drake, John M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Brownstein, John S.] Harvard Univ, Sch Med, Dept Phys, Boston, MA 02115 USA; [Brownstein, John S.] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Hoen, Anne G.] Dartmouth Coll, Geisel Sch Med, Dept Community & Family Med, Hanover, NH 03755 USA; [Sankoh, Osman] INDEPTH Network Secretariat, East Legon, Accra, Ghana; [Sankoh, Osman] Univ Witwatersrand, Sch Publ Hlth, ZA-2000 Johannesburg, South Africa; [Sankoh, Osman] Heidelberg Univ, Inst Publ Hlth, D-69120 Heidelberg, Germany; [George, Dylan B.; Scott, Thomas W.; Hay, Simon I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Jaenisch, Thomas] Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, INF 324, D-69120 Heidelberg, Germany; [Wint, G. R. William] Univ Oxford, Dept Zool, ERGO, Oxford OX1 3PS, England; [Simmons, Cameron P.; Farrar, Jeremy J.] Oxford Univ Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Simmons, Cameron P.; Farrar, Jeremy J.] Univ Oxford, Churchill Hosp, Ctr Trop Med, Oxford OX3 7LJ, England; [Scott, Thomas W.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Farrar, Jeremy J.] Natl Univ Singapore, Dept Med, Singapore 119228, Singapore	University of Oxford; University System of Georgia; University of Georgia; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Dartmouth College; INDEPTH Network; University of Witwatersrand; Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Ruprecht Karls University Heidelberg; University of Oxford; University of Oxford; University of California System; University of California Davis; National University of Singapore	Hay, SI (corresponding author), Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Tinbergen Bldg,South Parks Rd, Oxford OX1 3PS, England.	simon.hay@zoo.ox.ac.uk	Bhatt, Samir/ABE-7938-2020; Hay, Simon Iain/F-8967-2015; Sankoh, Osman/ABB-3755-2020; Simmons, Cameron P/ABA-3896-2021; Farrar, Jeremy J./HGA-7610-2022; Gething, Peter/ABD-2110-2020; Gething, Peter/GQR-1884-2022; Jaenisch, Thomas/H-3473-2017; Brady, Oliver/P-9421-2019	Hay, Simon Iain/0000-0002-0611-7272; Sankoh, Osman/0000-0003-4405-9808; Simmons, Cameron P/0000-0002-9039-7392; Gething, Peter/0000-0001-6759-5449; Brady, Oliver/0000-0002-3235-2129; Moyes, Catherine/0000-0002-8028-4079; Wint, William/0000-0003-0916-0847; Drake, John/0000-0003-4646-1235; Bhatt, Samir/0000-0002-0891-4611; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust [095066, 084368]; BBSRC Industrial CASE studentship; International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS) [21803]; EU [2011-261504 EDENEXT]; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Biotechnology and Biological Sciences Research Council [1090403] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091980, R01AI069341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083224] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC Industrial CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS); EU(European Commission); RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.I.H. is funded by a Senior Research Fellowship from the Wellcome Trust (095066) which also supports S. B. and P. W. G. C. P. S. is also funded by a Senior Research Fellowship from the Wellcome Trust (084368). O.J.B. is funded by a BBSRC Industrial CASE studentship. J.P.M., A. W. F., T.J., G. R. W. W., C. P. S., T. W. S. and S. I. H. received funding from, and with S. B., P. W. G., O.J.B. and J.J.F. acknowledge the contribution of, the International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS, 21803, http://www.idams.eu). This work was funded in part by EU grant 2011-261504 EDENEXT and the paper is catalogued by the EDENEXT Steering Committee as EDENEXT. S. I. H. and T. W. S. also acknowledge funding support from the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health.	Anders KL, 2012, LANCET INFECT DIS, V12, P977, DOI 10.1016/S1473-3099(12)70246-3; [Anonymous], 2009, WHOHTMNTDDEN20091; Bambrick H., 2009, TROPIKA; BEATTY ME, 2009, AM J TROP MED HYG S, V81, P231; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Chakravarti A, 2012, T ROY SOC TROP MED H, V106, P273, DOI 10.1016/j.trstmh.2011.12.007; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2012, LANCET, V380, P1535, DOI 10.1016/S0140-6736(12)61510-4; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042; Kakkar M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8574; MONATH TP, 1994, SEMIN VIROL, V5, P133, DOI 10.1006/smvy.1994.1014; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Rodhain F, 1996, B SOC PATHOL EXOT, V89, P87; Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; TDR/World Health Organization, 2006, TDRSWG08 WHO; World Health Organization, 2012, INT TRAV HLTH SIT 1	30	5350	5606	46	1281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					504	507		10.1038/nature12060	http://dx.doi.org/10.1038/nature12060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23563266	Green Accepted, Green Submitted			2022-12-28	WOS:000317984400041
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA MMR, measles, and the South Wales Evening Post	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2013, S WALES EVENING 0409; BBC News, 2013, BBC NEWS; Demicheli V, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub3; Faasse K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5613; Godlee, 2011, BRIT MED J, V342, pd22, DOI [10.1136/bmj.d22, DOI 10.1136/BMJ.D22]; Goodyear-Smith F, 2002, CONTRACEPTION, V66, P163, DOI 10.1016/S0010-7824(02)00341-4; Hitchens Peter, 2013, DAILY MAIL; *HLTH PROT AG, CONF CAS MEASL REG A; Hookham M, 2013, SUNDAY TIMES, P1; Leveson Lord, 2012, INQUIRY CULTURE PRAC, VII; Mason B W, 2000, Commun Dis Public Health, V3, P67; Mason BW, 2000, J EPIDEMIOL COMMUN H, V54, P473, DOI 10.1136/jech.54.6.473; Payne C, 1998, LANCET, V351, P907, DOI 10.1016/S0140-6736(05)70319-6; Public Health Wales, 2013, VACC PLEA CONT MEASL; Szarewski A, 1999, HUM REPROD UPDATE, V5, P627, DOI 10.1093/humupd/5.6.627; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wakefield W, 2013, INDEPENDENT; Wise J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2545	18	1	1	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2013	346								f2598	10.1136/bmj.f2598	http://dx.doi.org/10.1136/bmj.f2598			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134PK	23610382				2022-12-28	WOS:000318224700007
J	Andreae, MO; Ramanathan, V				Andreae, Meinrat O.; Ramanathan, V.			Climate's Dark Forcings	SCIENCE			English	Editorial Material							BLACK CARBON; BROWN CARBON; ABSORPTION		[Andreae, Meinrat O.] Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany; [Andreae, Meinrat O.; Ramanathan, V.] Univ Calif San Diego, Inst Oceanog Sci, La Jolla, CA 92093 USA; [Ramanathan, V.] TERI Univ, New Delhi 110070, India	Max Planck Society; University of California System; University of California San Diego; TERI University	Andreae, MO (corresponding author), Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany.	m.andreae@mpic.de	Andreae, Meinrat O./B-1068-2008	Andreae, Meinrat O./0000-0003-1968-7925				Allen RJ, 2012, NATURE, V485, P350, DOI 10.1038/nature11097; Andreae MO, 2006, ATMOS CHEM PHYS, V6, P3131, DOI 10.5194/acp-6-3131-2006; [Anonymous], 2011, INTEGRATED ASSESSMEN; Bahadur R, 2012, P NATL ACAD SCI USA, V109, P17366, DOI 10.1073/pnas.1205910109; Bahadur R, 2011, ATMOS ENVIRON, V45, P1162, DOI 10.1016/j.atmosenv.2010.10.054; Bond TC, 2013, J GEOPHYS RES-ATMOS, V118, P5380, DOI 10.1002/jgrd.50171; Chung CE, 2012, P NATL ACAD SCI USA, V109, P11624, DOI 10.1073/pnas.1203707109; Jacobson MZ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013795; Kirchstetter TW, 2012, ATMOS CHEM PHYS, V12, P6067, DOI 10.5194/acp-12-6067-2012; Lau WKM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043255; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Manoj MG, 2011, CLIM DYNAM, V37, P2181, DOI 10.1007/s00382-010-0971-3; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Rosenfeld D, 2008, SCIENCE, V321, P1309, DOI 10.1126/science.1160606; Xu BQ, 2009, P NATL ACAD SCI USA, V106, P22114, DOI [10.1073/pnas.0910444106, 10.1073/pnas.pnas.0910444106]	15	95	98	2	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					280	281		10.1126/science.1235731	http://dx.doi.org/10.1126/science.1235731			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599469				2022-12-28	WOS:000317657500030
J	Tanis, W; Habets, J				Tanis, Wilco; Habets, Jesse			The Silence of the Leaflets	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tanis, Wilco; Habets, Jesse] Univ Med Ctr Utrecht, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Tanis, W (corresponding author), Univ Med Ctr Utrecht, Utrecht, Netherlands.	w.tanis-2@umcutrecht.nl							0	1	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					E21	E21		10.1056/NEJMicm1209719	http://dx.doi.org/10.1056/NEJMicm1209719			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126HC	23594024				2022-12-28	WOS:000317603300012
J	Teo, K; Lear, S; Islam, S; Mony, P; Dehghan, M; Li, W; Rosengren, A; Lopez-Jaramillo, P; Diaz, R; Oliveira, G; Miskan, M; Rangarajan, S; Iqbal, R; Ilow, R; Puone, T; Bahonar, A; Gulec, S; Darwish, EA; Lanas, F; Vijaykumar, K; Rahman, O; Chifamba, J; Hou, Y; Li, N; Yusuf, S				Teo, Koon; Lear, Scott; Islam, Shofiqul; Mony, Prem; Dehghan, Mahshid; Li, Wei; Rosengren, Annika; Lopez-Jaramillo, Patricio; Diaz, Rafael; Oliveira, Gustavo; Miskan, Maizatullifah; Rangarajan, Sumathy; Iqbal, Romaina; Ilow, Rafal; Puone, Thandi; Bahonar, Ahmad; Gulec, Sadi; Darwish, Ebtihal A.; Lanas, Fernando; Vijaykumar, Krishnapillai; Rahman, Omar; Chifamba, Jephat; Hou, Yan; Li, Ning; Yusuf, Salim		PURE Investigators	Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries The Prospective Urban Rural Epidemiology (PURE) Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOOD FREQUENCY QUESTIONNAIRES; MYOCARDIAL-INFARCTION; RISK-FACTORS; SECONDARY PREVENTION; DRUG THERAPIES; TOBACCO USE; INTERHEART; DIET; COMMUNITY; EXERCISE	Importance Little is known about adoption of healthy lifestyle behaviors among individuals with a coronary heart disease (CHD) or stroke event in communities across a range of countries worldwide. Objective To examine the prevalence of avoidance or cessation of smoking, eating a healthy diet, and undertaking regular physical activities by individuals with a CHD or stroke event. Design, Setting, and Participants Prospective Urban Rural Epidemiology (PURE) was a large, prospective cohort study that used an epidemiological survey of 153 996 adults, aged 35 to 70 years, from 628 urban and rural communities in 3 high-income countries (HIC), 7 upper-middle-income countries (UMIC), 3 lower-middle-income countries (LMIC), and 4 low-income countries (LIC), who were enrolled between January 2003 and December 2009. Main Outcome Measures Smoking status (current, former, never), level of exercise (low, <600 metabolic equivalent task [MET]-min/wk; moderate, 600-3000 MET-min/wk; high, >3000 MET-min/wk), and diet (classified by the Food Frequency Questionnaire and defined using the Alternative Healthy Eating Index). Results Among 7519 individuals with self-reported CHD (past event: median, 5.0 [interquartile range {IQR}, 2.0-10.0] years ago) or stroke (past event: median, 4.0 [IQR, 2.0-8.0] years ago), 18.5% (95% CI, 17.6%-19.4%) continued to smoke; only 35.1% (95% CI, 29.6%-41.0%) undertook high levels of work-or leisure-related physical activity, and 39.0% (95% CI, 30.0%-48.7%) had healthy diets; 14.3% (95% CI, 11.7%-17.3%) did not undertake any of the 3 healthy lifestyle behaviors and 4.3% (95% CI, 3.1%-5.8%) had all 3. Overall, 52.5% (95% CI, 50.7%-54.3%) quit smoking (by income country classification: 74.9% [95% CI, 71.1%-78.6%] in HIC; 56.5% [95% CI, 53.4%-58.6%] in UMIC; 42.6% [95% CI, 39.6%-45.6%] in LMIC; and 38.1% [95% CI, 33.1%-43.2%] in LIC). Levels of physical activity increased with increasing country income but this trend was not statistically significant. The lowest prevalence of eating healthy diets was in LIC (25.8%; 95% CI, 13.0%-44.8%) compared with LMIC (43.2%; 95% CI, 30.0%-57.4%), UMIC (45.1%, 95% CI, 30.9%-60.1%), and HIC (43.4%, 95% CI, 21.0%-68.7%). Conclusion and Relevance Among a sample of patients with a CHD or stroke event from countries with varying income levels, the prevalence of healthy lifestyle behaviors was low, with even lower levels in poorer countries. JAMA. 2013;309(15):1613-1621 www.jama.com	[Teo, Koon; Islam, Shofiqul; Dehghan, Mahshid; Rangarajan, Sumathy; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON, Canada; [Lear, Scott] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Vancouver, BC, Canada; [Lear, Scott] Providence Hlth Care, Vancouver, BC, Canada; [Mony, Prem] St Johns Med Coll & Res Inst, Bangalore, Karnataka, India; [Li, Wei] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Cardiovasc Inst, Beijing 100730, Peoples R China; [Li, Wei] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Lopez-Jaramillo, Patricio] Fdn Oftalmol Sandander, Santander, Colombia; [Diaz, Rafael] Latinoamer ECLA, Estudios Clin, Rosario, Santa Fe, Argentina; [Oliveira, Gustavo] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Miskan, Maizatullifah] Univ Teknol MARA, Fac Med, Sungai Boloh, Malaysia; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci & Med, Karachi, Pakistan; [Ilow, Rafal] Wroclaw Med Univ, Dept Food Sci & Dietet, Wroclaw, Poland; [Puone, Thandi] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Bahonar, Ahmad] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Gulec, Sadi] Ankara Univ, Dept Cardiol, TR-06100 Ankara, Turkey; [Darwish, Ebtihal A.] Dubai Med Coll, Dept Family Med, Dubai, U Arab Emirates; [Lanas, Fernando] Univ La Frontera, Temuco, Chile; [Vijaykumar, Krishnapillai] Hlth Act People, Trivandrum, Kerala, India; [Rahman, Omar] Independent Univ Bangladesh, Dhaka, Bangladesh; [Chifamba, Jephat] Univ Zimbabwe, Dept Physiol, Coll Hlth Sci, Harare, Zimbabwe; [Hou, Yan] Beilingbridge Community Hlth Serv Ctr, Taiyuan, Shanxi Province, Peoples R China; [Li, Ning] Qingshanhu Community Hlth Serv Stn, Nanchang, Jiangxi, Peoples R China	McMaster University; Population Health Research Institute; Simon Fraser University; St. John's National Academy of Health Sciences; St. John's Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; University of Gothenburg; Instituto Dante Pazzanese de Cardiologia; Aga Khan University; Wroclaw Medical University; University of the Western Cape; Isfahan University Medical Science; Ankara University; Universidad de La Frontera; Independent University Bangladesh (IUB); University of Zimbabwe	Teo, K (corresponding author), Hamilton Gen Hosp, Populat Hlth Res Inst, DBCVSRI, Room C2-106,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	koon.teo@phri.ca	Igumbor, Ehimario U/B-2652-2012; Ramli, Anis Safura/K-3322-2014; Bahonar, Ahmad/Q-7698-2019; Kelishadi, Roya/E-6154-2012; Ramli, Anis Safura/U-3548-2018; Mony, Prem K./GRF-4752-2022; Nawawi, Hapizah Mohd/J-8873-2019; Rahman, Omar/E-1329-2019; Chifamba, Jephat/AHE-4535-2022; Lanas, Fernando/AAE-8842-2022; Nor-Ashikin, Mohamed Noor Khan/P-2055-2015; Nawawi, Hapizah/N-7446-2019; Gomez-Arbelaez, Diego/K-1883-2013; Rozanska, Dorota/S-5239-2018; Corsi, Daniel J/S-4689-2018	Igumbor, Ehimario U/0000-0002-6313-6031; Ramli, Anis Safura/0000-0002-9517-1413; Kelishadi, Roya/0000-0001-7455-1495; Ramli, Anis Safura/0000-0002-9517-1413; Mony, Prem K./0000-0002-1399-0520; Nawawi, Hapizah Mohd/0000-0003-4462-8484; Rahman, Omar/0000-0002-0606-2507; Chifamba, Jephat/0000-0001-8166-1182; Nor-Ashikin, Mohamed Noor Khan/0000-0002-1325-9236; Nawawi, Hapizah/0000-0003-4462-8484; Iqbal, Romaina/0000-0002-5364-4366; Zatonska, Katarzyna/0000-0002-3772-5588; Jerling, Johann/0000-0003-2600-3536; Teo, Koon/0000-0002-3731-0956; Lanas, Fernando/0000-0003-3595-9759; Dehghan, Mahshid/0000-0003-2149-847X; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Gulec, Sadi/0000-0002-2685-2522; Gomez-Arbelaez, Diego/0000-0001-6150-0066; Rosengren, Annika/0000-0002-5409-6605; Yusuf, Salim/0000-0003-4776-5601; Szuba, Andrzej/0000-0002-7555-6201; Wolyniec, Maria/0000-0003-2054-1691; Rozanska, Dorota/0000-0002-0561-2749; Regulska-Ilow, Bozena/0000-0002-5941-1715; Corsi, Daniel J/0000-0001-7063-3354	Population Health Research Institute (Hamilton, Ontario, Canada); Boehringer; Merck; Polish Minstry of Science and Higher Education; Population Health Research Institute; sanofi-aventis; AstraZeneca; Novartis; Pfizer; Bayer; Boehringer Ingelheim; Abdi Ibrahim (Turkey); Universidad de La Frontera; Mary W. Burke endowed chair of the Heart and Stroke Foundation of Ontario; National Heart and Medical Research Council of Australia; National Heart Foundation of Australia; Sydney Medical Foundation; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; AstraZeneca in Sweden; AstraZeneca in Canada; sanofi-aventis in France; sanofi-aventis in Canada; Boehringer Ingelheim in Germany; Boehringer Ingelheim in Canada; Servier; King Pharma; GlaxoSmithKline; Independent University, Bangladesh; Mitra and Associates; Unilever Health Institute, Brazil; Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network; National Center for Cardiovascular Diseases; Colciencias [6566-04-18062]; Indian Council of Medical Research; Ministry of Science, Technology, and Innovation of Malaysia [07-05-IFN-MEB010]; Universiti Teknologi MARA; Universiti Kebangsaan Malaysia [UKM-Hejim-Komuniti-15-2010]; Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]; Wroclaw Medical University; North-West University, SANPAD (South Africa and Netherlands Programme for Alternative Development); National Research Foundation; Medical Research Council of South Africa; South Africa Sugar Association; Faculty of Community and Health Sciences (University of Western Cape); Swedish Council for Working Life and Social Research; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Swedish Heart and Lung Foundation; Swedish Research Council; Swedish State under LakarUtbildningsAvtalet; Vastra Gotaland Region; Metabolic Syndrome Society; Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences; Dubai Health Authority	Population Health Research Institute (Hamilton, Ontario, Canada); Boehringer(Boehringer Ingelheim); Merck(Merck & Company); Polish Minstry of Science and Higher Education; Population Health Research Institute; sanofi-aventis(Sanofi-Aventis); AstraZeneca(AstraZeneca); Novartis(Novartis); Pfizer(Pfizer); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Abdi Ibrahim (Turkey); Universidad de La Frontera; Mary W. Burke endowed chair of the Heart and Stroke Foundation of Ontario; National Heart and Medical Research Council of Australia; National Heart Foundation of Australia(National Heart Foundation of Australia); Sydney Medical Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); AstraZeneca in Sweden(AstraZeneca); AstraZeneca in Canada(AstraZeneca); sanofi-aventis in France; sanofi-aventis in Canada; Boehringer Ingelheim in Germany(Boehringer Ingelheim); Boehringer Ingelheim in Canada(Boehringer Ingelheim); Servier(Servier); King Pharma; GlaxoSmithKline(GlaxoSmithKline); Independent University, Bangladesh; Mitra and Associates; Unilever Health Institute, Brazil(Unilever); Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network; National Center for Cardiovascular Diseases; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Ministry of Science, Technology, and Innovation of Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Teknologi MARA; Universiti Kebangsaan Malaysia; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Wroclaw Medical University; North-West University, SANPAD (South Africa and Netherlands Programme for Alternative Development); National Research Foundation; Medical Research Council of South Africa(South African Medical Research Council); South Africa Sugar Association; Faculty of Community and Health Sciences (University of Western Cape); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish State under LakarUtbildningsAvtalet; Vastra Gotaland Region; Metabolic Syndrome Society; Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences; Dubai Health Authority	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Lear reported that the Population Health Research Institute (Hamilton, Ontario, Canada) provided funding support for travel to meetings for the Prospective Urban Rural Epidemiology (PURE) study. Dr Lopez-Jaramillo reported receiving speakers fees from Boehringer and Merck. Dr Ilow reported receiving research funding from the Polish Minstry of Science and Higher Education and the Population Health Research Institute. Dr Bahonar reported receiving institutional funding from the Population Health Research Institute for the costs of the study. Dr Gulec reported serving on the board of Pfizer, Novartis, AstraZeneca, and Boehringer Ingelheim; receiving speakers fees from sanofi-aventis, AstraZeneca, Novartis, Pfizer, Bayer, and Boehringer Ingelheim; receiving payment for the development of educational presentations from Abdi Ibrahim (Turkey); and receiving travel reimbursement from Boehringer Ingelheim and sanofi-aventis. Dr Lanas reported receiving a grant from the Universidad de La Frontera; and receiving travel reimbursement from the Population Health Research Institute. No other author reported disclosures.; Dr Yusuf is supported by the Mary W. Burke endowed chair of the Heart and Stroke Foundation of Ontario. Dr Chow is supported by a fellowship co-funded by the National Heart and Medical Research Council of Australia, the National Heart Foundation of Australia, and the Sydney Medical Foundation. The PURE study is funded by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Ontario, and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca in Sweden and Canada, Novartis, sanofi-aventis in France and Canada, Boehringer Ingelheim in Germany and Canada, Servier, King Pharma, and GlaxoSmithKline), and additionally by contributions from various national or local organizations in the following countries: Bangladesh: Independent University, Bangladesh, Mitra and Associates. Brazil: Unilever Health Institute, Brazil. Canada: Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network. Chile: Universidad de la Frontera. China: National Center for Cardiovascular Diseases. Colombia: Colciencias grant 6566-04-18062. India: Indian Council of Medical Research. Malaysia: Ministry of Science, Technology, and Innovation of Malaysia grant 07-05-IFN-MEB010, Universiti Teknologi MARA, and Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010). Poland: Polish Ministry of Science and Higher Education grant Nr 290/W-PURE/2008/0, and Wroclaw Medical University. South Africa: North-West University, SANPAD (South Africa and Netherlands Programme for Alternative Development), National Research Foundation, Medical Research Council of South Africa, South Africa Sugar Association, and Faculty of Community and Health Sciences (University of Western Cape). Sweden: Swedish Council for Working Life and Social Research, Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Swedish Heart and Lung Foundation, Swedish Research Council, grant from the Swedish State under LakarUtbildningsAvtalet agreement, and grant from the Vastra Gotaland Region. Turkey: Metabolic Syndrome Society, AstraZeneca, and sanofi-aventis. United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, and Dubai Health Authority.	Bharathi AV, 2008, ASIA PAC J CLIN NUTR, V17, P178; Chow CK, 2010, CIRCULATION, V121, P750, DOI 10.1161/CIRCULATIONAHA.109.891523; Dehghan M, 2012, J HUM NUTR DIET, V25, P225, DOI 10.1111/j.1365-277X.2012.01240.x; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-18; Dehghan M, 2012, CIRCULATION, V126, P2705, DOI 10.1161/CIRCULATIONAHA.112.103234; Dehghan M, 2012, J NUTR EDUC BEHAV, V44, P609, DOI 10.1016/j.jneb.2010.10.001; IPAQ-International Physical Activity Questionnaire, GUID DAT PROC AN INT; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; Kelemen LE, 2003, J AM DIET ASSOC, V103, P1178, DOI 10.1016/S0002-8223(03)00985-4; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; Kumra V, 2000, CLIN CHEST MED, V21, P1, DOI 10.1016/S0272-5231(05)70004-6; MacQueen KM, 2001, AM J PUBLIC HEALTH, V91, P1929, DOI 10.2105/AJPH.91.12.1929; McCullough ML, 2006, PUBLIC HEALTH NUTR, V9, P152, DOI 10.1079/PHN2005938; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Merchant AT, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-37; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; World Bank, DO WE CLASS COUNTR; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	24	186	196	1	74	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1613	1621		10.1001/jama.2013.3519	http://dx.doi.org/10.1001/jama.2013.3519			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126FY	23592106	Green Accepted, Bronze			2022-12-28	WOS:000317599500025
J	Reginster, JY; Pelousse, F				Reginster, Jean-Yves; Pelousse, Franz			Supplementation with vitamin D did not reduce cartilage volume loss or pain in knee osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Reginster, Jean-Yves; Pelousse, Franz] Univ Liege, Liege, Belgium	University of Liege	Reginster, JY (corresponding author), Univ Liege, Liege, Belgium.			LaValley, Michael/0000-0002-8488-5170				Bruyere O, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-165; Tat SK, 2010, BEST PRACT RES CL RH, V24, P51, DOI 10.1016/j.berh.2009.08.004	2	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8							JC9	10.7326/0003-4819-158-8-201304160-02009	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588774				2022-12-28	WOS:000318062100012
J	Flowers, RM; Farley, KA				Flowers, R. M.; Farley, K. A.			Response to Comments on "Apatite He-4/He-3 and (U-Th)/He Evidence for an Ancient Grand Canyon"	SCIENCE			English	Editorial Material							COLORADO PLATEAU		[Flowers, R. M.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Farley, K. A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	University of Colorado System; University of Colorado Boulder; California Institute of Technology	Flowers, RM (corresponding author), Univ Colorado, Dept Geol Sci, 2200 Colorado Ave,UCB 399, Boulder, CO 80309 USA.	rebecca.flowers@colorado.edu	Farley, Kenneth/AAE-7735-2020	Farley, Kenneth/0000-0002-7846-7546				ELSTON DP, 1991, J GEOPHYS RES-SOLID, V96, P12389, DOI 10.1029/90JB01978; Farley KA, 2012, EARTH PLANET SC LETT, V359, P131, DOI 10.1016/j.epsl.2012.10.010; Flowers RM, 2008, GEOL SOC AM BULL, V120, P571, DOI 10.1130/B26231.1; Flowers RM, 2012, SCIENCE, V338, P1616, DOI [10.1126/science.51229390, 10.1126/science.1229390]; Flowers RM, 2009, GEOCHIM COSMOCHIM AC, V73, P2347, DOI 10.1016/j.gca.2009.01.015; Kelley S. A, 2001, COLORADO RIVER ORIGI, P37; Lee J. P., 2011, 20111210 USGS; LEE JP, 2007, THESIS U KANSAS LAWR; Lucchitta I, 1984, LANDSCAPES ARIZONA T, P269; Lucchitta I, 2013, SCIENCE, V340, DOI 10.1126/science.1234567; Polyak V, 2008, SCIENCE, V319, P1377, DOI 10.1126/science.1151248; Wernicke B, 2011, GEOL SOC AM BULL, V123, P1288, DOI 10.1130/B30274.1; Young R. A., 1989, GEOLOGY GRAND CANYON, P166; YOUNG RA, 1979, TECTONOPHYSICS, V61, P25, DOI 10.1016/0040-1951(79)90290-7; YOUNG RA, 2001, COLORADO RIVER ORIGI, P7; Young RA, 2008, GEOL SOC AM SPEC PAP, V439, P319, DOI 10.1130/2008.2439(14)	16	18	18	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129								10.1126/science.1234203	http://dx.doi.org/10.1126/science.1234203			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580513				2022-12-28	WOS:000317341400035
J	Schmid, P; Churchill, SE; Nalla, S; Weissen, E; Carlson, KJ; de Ruiter, DJ; Berger, LR				Schmid, Peter; Churchill, Steven E.; Nalla, Shahed; Weissen, Eveline; Carlson, Kristian J.; de Ruiter, Darryl J.; Berger, Lee R.			Mosaic Morphology in the Thorax of Australopithecus sediba	SCIENCE			English	Article							ARDIPITHECUS-RAMIDUS; COSTAL SKELETON; AL 288-1; EVOLUTION; HOMO; LOCOMOTION; POSTURE; WALKING; PELVIS; RIB	The shape of the thorax of early hominins has been a point of contention for more than 30 years. Owing to the generally fragmentary nature of fossil hominin ribs, few specimens have been recovered that have rib remains complete enough to allow accurate reassembly of thoracic shape, thus leaving open the question of when the cylindrical-shaped chest of humans and their immediate ancestors evolved. The ribs of Australopithecus sediba exhibit a mediolaterally narrow, ape-like upper thoracic shape, which is unlike the broad upper thorax of Homo that has been related to the locomotor pattern of endurance walking and running. The lower thorax, however, appears less laterally flared than that of apes and more closely approximates the morphology found in humans.	[Schmid, Peter; Weissen, Eveline] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [Schmid, Peter; Churchill, Steven E.; Nalla, Shahed; Carlson, Kristian J.; de Ruiter, Darryl J.; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Churchill, Steven E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Nalla, Shahed] Univ Johannesburg, Fac Hlth Sci, Dept Human Anat & Phys, Johannesburg, South Africa; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [de Ruiter, Darryl J.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA	University of Zurich; University of Witwatersrand; Duke University; University of Johannesburg; Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station	Schmid, P (corresponding author), Univ Zurich, Anthropol Inst & Museum, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	smidi@aim.uzh.ch	Churchill, Steven/AAA-9386-2022; Nalla, Shahed/U-2213-2017; Berger, Lee Rogers/AAC-3484-2020	Nalla, Shahed/0000-0002-0957-1067; Berger, Lee Rogers/0000-0002-0367-7629; de Ruiter, Darryl/0000-0003-1183-0352	South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation; Institute for Human Evolution; University of the Witwatersrand; University of the Witwatersrand's Vice Chancellor's Discretionary Fund; National Geographic Society; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; A. H. Schultz Foundation; Duke University; Texas AM University; Oppenheimer and Ackerman families; University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences; Bernard Price Institute for Palaeontology	South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation(National Research Foundation - South Africa); Institute for Human Evolution; University of the Witwatersrand; University of the Witwatersrand's Vice Chancellor's Discretionary Fund; National Geographic Society(National Geographic Society); Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; A. H. Schultz Foundation; Duke University; Texas AM University; Oppenheimer and Ackerman families; University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences; Bernard Price Institute for Palaeontology	We thank the South African Heritage Resource agency for permits to work at the Malapa site; the Nash family for granting access to the Malapa site and continued support of research on their reserve; the South African Department of Science and Technology and the African Origins Platform (AOP), the South African National Research Foundation, the Institute for Human Evolution, University of the Witwatersrand, the University of the Witwatersrand's Vice Chancellor's Discretionary Fund, the National Geographic Society, the Palaeontological Scientific Trust, the Andrew W. Mellon Foundation, the Ford Foundation, the U.S. Diplomatic Mission to South Africa, the French Embassy of South Africa, the A. H. Schultz Foundation, Duke University, Ray A. Rothrock '77 Fellowship and IRTAG of Texas A&M University, and the Oppenheimer and Ackerman families and Sir Richard Branson for funding; the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities; the Gauteng Government, Gauteng Department of Agriculture, Conservation and Environment and the Cradle of Humankind Management Authority; and our respective universities for ongoing support. We thank the Virtual Image Processing Lab and the Microfocus X-ray CT facility of the Palaeosciences Centre at Wits, and for funding these facilities, we thank the University of the Witwatersrand Office of Research and the NRF Strategic Research Infrastructure Grant and AOP funding programs. For access to comparative specimens, we thank E. Mbua, P. Kiura, V. Iminjili, and the National Museums of Kenya; B. Billings, B. Zipfel, and the School of Anatomical Sciences at the University of the Witwatersrand; S. Potze and L. C. Kgasi at the Ditsong Museum; and M. Ponce de Le~n and C. Zollikofer at the Anthropological Institute and Museum. For technical and material support, we thank Duke University and the University of Zurich 2009 and 2010 Field Schools. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Other individuals who have given notable support to this project include B. de Klerk, W. Lawrence, C. Steininger, B. Kuhn, L. Pollarolo, B. Zipfel, J. Kretzen, D. Conforti, J. McCaffery, C. Dlamini, H. Visser, R. McCrae-Samuel, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, and M. Peltier. J. Smilg facilitated computed tomography scanning of the specimens. The Au. sediba specimens are archived at the Evolutionary Studies Institute at the University of the Witwatersrand. All data used in this study are available upon request, including access to the original specimens, by bona fide scientists.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Cachel S., 1996, ASPECTS AFRICAN ARCH, P3; Chan LK, 2007, FOLIA PRIMATOL, V78, P19, DOI 10.1159/000095683; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; DeSilva JM, 2013, SCIENCE, V340, DOI 10.1126/science.1232999; Franciscus RG, 2002, J HUM EVOL, V42, P303, DOI 10.1006/jhev.2001.0528; GEHR P, 1981, RESP PHYSIOL, V44, P61, DOI 10.1016/0034-5687(81)90077-3; Gomez-Olivencia A, 2010, J HUM EVOL, V59, P620, DOI 10.1016/j.jhevol.2010.07.023; Gomez-Olivencia A, 2009, J HUM EVOL, V57, P75, DOI 10.1016/j.jhevol.2009.02.009; Haeusler M, 2011, J HUM EVOL, V61, P575, DOI 10.1016/j.jhevol.2011.07.004; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; HILL W. C. OSMAN, 1939, AMER JOUR PHYS ANTHROPOL, V24, P449, DOI 10.1002/ajpa.1330240324; HUNT KD, 1991, AM J PHYS ANTHROPOL, V86, P521, DOI 10.1002/ajpa.1330860408; Jellema Lyman M., 1993, P294; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P403, DOI 10.1002/ajpa.1330570403; Kagaya M, 2008, PRIMATES, V49, P89, DOI 10.1007/s10329-007-0064-z; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Kramer Patricia Ann, 2009, Paleoanthropology, V2009, P238; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; OHMAN JC, 1986, AM J PHYS ANTHROPOL, V70, P209, DOI 10.1002/ajpa.1330700208; Pontzer H, 2010, J HUM EVOL, V58, P492, DOI 10.1016/j.jhevol.2010.03.006; Preuschoft H, 2004, J ANAT, V204, P363, DOI 10.1111/j.0021-8782.2004.00303.x; Robinson J.T., 1972, EARLY HOMINID POSTUR; Ruff Christopher B., 1993, P234; Schmid P, 2004, FROM BIPED TO STRIDER, P49; SCHMID P, 1983, FOLIA PRIMATOL, V40, P283, DOI 10.1159/000156111; Schmid P., 1991, CAHIERS PALEOANTHROP, P225; Schultz A. H., 1961, pUnpaginated; SHAPIRO LJ, 1988, AM J PHYS ANTHROPOL, V77, P201, DOI 10.1002/ajpa.1330770208; Shaw CN, 2011, AM J PHYS ANTHROPOL, V144, P22, DOI 10.1002/ajpa.21363; WARD CV, 1993, AM J PHYS ANTHROPOL, V92, P291, DOI 10.1002/ajpa.1330920306; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; Williams SA, 2013, SCIENCE, V340, DOI 10.1126/science.1232996; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	40	50	50	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129							1234598	10.1126/science.1234598	http://dx.doi.org/10.1126/science.1234598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580537				2022-12-28	WOS:000317341400006
J	Savir, Y; Tlusty, T				Savir, Yonatan; Tlusty, Tsvi			The Ribosome as an Optimal Decoder: A Lesson in Molecular Recognition	CELL			English	Article							TRANSFER-RNA SELECTION; AMINOACYL-TRANSFER-RNA; INDUCED FIT; CONFORMATIONAL-CHANGES; ENERGY LANDSCAPES; GTPASE ACTIVATION; PROTEIN-SYNTHESIS; EF-TU; FIDELITY; TRANSLATION	The ribosome is a complex molecular machine that, in order to synthesize proteins, has to decode mRNAs by pairing their codons with matching tRNAs. Decoding is a major determinant of fitness and requires accurate and fast selection of correct tRNAs among many similar competitors. However, it is unclear whether the modern ribosome, and in particular its large conformational changes during decoding, are the outcome of adaptation to its task as a decoder or the result of other constraints. Here, we derive the energy landscape that provides optimal discrimination between competing substrates and thereby optimal tRNA decoding. We show that the measured landscape of the prokaryotic ribosome is sculpted in this way. This model suggests that conformational changes of the ribosome and tRNA during decoding are means to obtain an optimal decoder. Our analysis puts forward a generic mechanism that may be utilized broadly by molecular recognition systems.	[Savir, Yonatan] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Tlusty, Tsvi] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA	Harvard University; Harvard Medical School; Institute for Advanced Study - USA	Tlusty, T (corresponding author), Inst Adv Study, Simons Ctr Syst Biol, Olden Lane, Princeton, NJ 08540 USA.	tlusty@ias.edu	Tlusty, Tsvi/A-9880-2008	Tlusty, Tsvi/0000-0002-9662-3725	Human Frontier Science Program fellowship	Human Frontier Science Program fellowship(Human Frontier Science Program)	We thank Marina Rodnina, Ada Yonath, Mans Ehrenberg, Jacques Ninio, Elisha Moses, Uri Alon, Rami Pugatch, Adam Lampert, Tamar Friedlander, Michel Springer, Tzachi Pilpel, Ron Milo, and Jean-Pierre Eckmann for valuable discussions. Y.S. is supported by the Human Frontier Science Program fellowship. T.T. thanks the Simons Foundation and Helen and Martin Chooljian for their generous support. T.T. is the Helen and Martin Chooljian Founders Circle Member in the Simons Center for Systems Biology of the Institute for Advanced Study, Princeton.	Bashan A, 2008, TRENDS MICROBIOL, V16, P326, DOI 10.1016/j.tim.2008.05.001; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; BOUADLOUN F, 1983, EMBO J, V2, P1351, DOI 10.1002/j.1460-2075.1983.tb01591.x; De Vlaminck I, 2012, MOL CELL, V46, P616, DOI 10.1016/j.molcel.2012.03.029; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; EHRENBERG M, 1984, Q REV BIOPHYS, V17, P45, DOI 10.1017/S0033583500005254; Ferreiro DU, 2011, P NATL ACAD SCI USA, V108, P3499, DOI 10.1073/pnas.1018980108; Fersht A., 1985, ENZYME STRUCTURE MEC; Fersht A., 1999, STRUCTURE MECH PROTE; Frank J, 2005, FEBS LETT, V579, P959, DOI 10.1016/j.febslet.2004.10.105; Gromadski KB, 2006, MOL CELL, V21, P369, DOI 10.1016/j.molcel.2005.12.018; Gromadski KB, 2004, NAT STRUCT MOL BIOL, V11, P316, DOI 10.1038/nsmb742; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Helstrom CW, 1995, ELEMENTS SIGNAL DETE; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Johansson M, 2008, CURR OPIN MICROBIOL, V11, P141, DOI 10.1016/j.mib.2008.02.015; Johansson M, 2011, RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS, P225; Johansson M, 2012, P NATL ACAD SCI USA, V109, P131, DOI 10.1073/pnas.1116480109; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Lee TH, 2007, P NATL ACAD SCI USA, V104, P13661, DOI 10.1073/pnas.0705988104; Marshall RA, 2008, ANNU REV BIOCHEM, V77, P177, DOI 10.1146/annurev.biochem.77.070606.101431; MIKKOLA R, 1988, FEMS MICROBIOL LETT, V56, P265, DOI 10.1016/0378-1097(88)90071-7; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Ninio J, 2006, BIOCHIMIE, V88, P963, DOI 10.1016/j.biochi.2006.06.002; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Post CB, 1995, BIOCHEMISTRY-US, V34, P15881, DOI 10.1021/bi00049a001; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Savir Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000468; Savir Y, 2010, MOL CELL, V40, P388, DOI 10.1016/j.molcel.2010.10.020; Savir Y, 2009, 2009 43RD ANNUAL CONFERENCE ON INFORMATION SCIENCES AND SYSTEMS, VOLS 1 AND 2, P835, DOI 10.1109/CISS.2009.5054833; Savir Y, 2008, IEEE J-STSP, V2, P390, DOI 10.1109/JSTSP.2008.923859; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Schug A, 2010, CURR OPIN PHARMACOL, V10, P709, DOI 10.1016/j.coph.2010.09.012; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Whitford PC, 2011, RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS, P303; Whitford PC, 2011, P NATL ACAD SCI USA, V108, P18943, DOI 10.1073/pnas.1108363108; Whitford PC, 2010, J AM CHEM SOC, V132, P13170, DOI 10.1021/ja1061399; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yarus M, 2003, RNA, V9, P384, DOI 10.1261/rna.2184703; Zaher HS, 2010, MOL CELL, V39, P110, DOI 10.1016/j.molcel.2010.06.009; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036	50	34	34	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					471	479		10.1016/j.cell.2013.03.032	http://dx.doi.org/10.1016/j.cell.2013.03.032			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582332	Bronze			2022-12-28	WOS:000317349700024
J	Korf, BR; Rehm, HL				Korf, Bruce R.; Rehm, Heidi L.			New Approaches to Molecular Diagnosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHROMOSOMAL MICROARRAY; GENE; MEDICINE; EXOME; IDENTIFICATION; STRATEGIES; HEALTH	Advances in understanding the molecular basis of rare and common disorders, as well as in the technology of DNA analysis, are rapidly changing the landscape of molecular genetic and genomic testing. High-resolution molecular cytogenetic analysis can now detect deletions or duplications of DNA of a few hundred thousand nucleotides, well below the resolution of the light microscope. Diagnostic testing for "single-gene" disorders can be done by targeted analysis for specific mutations, by sequencing a specific gene to scan for mutations, or by analyzing multiple genes in which mutation may lead to a similar phenotype. The advent of massively parallel next-generation sequencing facilitates the analysis of multiple genes and now is being used to sequence the coding regions of the genome (the exome) for clinical testing. Exome sequencing requires bioinformatic analysis of the thousands of variants that are identified to find one that is contributing to the pathology; there is also a possibility of incidental identification of other medically significant variants, which may complicate genetic counseling. DNA testing can also be used to identify variants that influence drug metabolism or interaction of a drug with its cellular target, allowing customization of choice of drug and dosage. Exome and genome sequencing are being applied to identify specific gene changes in cancer cells to guide therapy, to identify inherited cancer risk, and to estimate prognosis. Genomic testing may be used to identify risk factors for common disorders, although the clinical utility of such testing is unclear. Genetic and genomic tests may raise new ethical, legal, and social issues, some of which may be addressed by existing genetic nondiscrimination legislation, but which also must be addressed in the course of genetic counseling. The purpose of this article is to assist physicians in recognizing where new approaches to genetic and genomic testing may be applied clinically and in being aware of the principles of interpretation of test results. JAMA. 2013;309(14):1511-1521 www.jama.com	[Korf, Bruce R.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Rehm, Heidi L.] Partners Healthcare Ctr Personalized Genet Med, Mol Med Lab, Cambridge, MA USA	University of Alabama System; University of Alabama Birmingham; Partners Healthcare System	Korf, BR (corresponding author), Univ Alabama Birmingham, Dept Genet, 1720 2nd Ave S,Kaul 230, Birmingham, AL 35294 USA.	bkorf@uab.edu	Korf, Bruce R/H-4882-2012	Rehm, Heidi L./0000-0002-6025-0015	National Institutes of Health; US Department of Defense; GeneInsight software development from Illumina; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC007183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); GeneInsight software development from Illumina; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Korf reported serving on the board for the Neurofibromatosis Therapeutic Acceleration Project, receiving grants from the National Institutes of Health and US Department of Defense, receiving payment for lectures to academic groups, receiving royalties from John Wiley and Elsevier, and receiving funds for travel for multiple academic meetings. Dr Rehm reported being employed by a fee-for-service nonprofit molecular diagnostic laboratory; having served on advisory boards for Knome, Complete Genomics, GenomeQuest, and Omicia; having consulted for Generation Health; having received honoraria for lectures to academic groups; having owned stock or stock options for Generation Health; and having received travel support for multiple academic meetings; she also reported that her institution has received support for GeneInsight software development from Illumina.	Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Angeli SI, 2011, OTOL NEUROTOL, V32, P1437, DOI 10.1097/MAO.0b013e31823387f9; [Anonymous], 1999, Genet Med, V1, P237; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P74, DOI 10.1001/jama.2008.901; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Bick D, 2011, CURR OPIN PEDIATR, V23, P594, DOI 10.1097/MOP.0b013e32834b20ec; Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893; Boone PM, 2013, GENET MED, V15, P45, DOI 10.1038/gim.2012.95; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; Burke W, 2009, CURR PROTOC HUM GENE, V60, P1; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen WT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023087; Cook-Deegan R, 2012, EUR J HUM GENET; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Eriksson N, 2012, PHARMACOGENOMICS, V13, P429, DOI [10.2217/pgs.11.184, 10.2217/PGS.11.184]; Evans JP, 2009, GENET MED, V11, P568, DOI 10.1097/GIM.0b013e3181afbaed; Feero WG, 2010, NEW ENGL J MED, V362, P2001, DOI 10.1056/NEJMra0907175; Feldman EA, 2012, J GEN INTERN MED, V27, P743, DOI 10.1007/s11606-012-1988-6; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Giacomini KM, 2012, SCI TRANSL MED, V4; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Hanson EH, 2001, AM J EPIDEMIOL, V154, P193, DOI 10.1093/aje/154.3.193; Klee EW, 2011, EXPERT REV MOL DIAGN, V11, P703, DOI [10.1586/erm.11.58, 10.1586/ERM.11.58]; Kohane IS, 2012, GENET MED, V14, P399, DOI 10.1038/gim.2011.68; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; McBride CM, 2010, AM J PREV MED, V38, P556, DOI 10.1016/j.amepre.2010.01.027; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Miller DT, 2012, CURR PROTOC HUM GENE, P1; National Center for Biotechnology Information, GEN TEST REG; Ned RM, 2010, PLOS CURR, V2; Ng PC, 2009, NATURE, V461, P724, DOI 10.1038/461724a; PharmGKB, CLIN ANN LEV EV; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Ross LF, 2013, GENET MED, V15, P321, DOI [10.1038/gim.2012.176, 10.1038/gim.2013.39]; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Rubinstein WS, 2013, NUCLEIC ACIDS RES, V41, pD925, DOI 10.1093/nar/gks1173; Scott SA, 2011, GENET MED, V13, P987, DOI 10.1097/GIM.0b013e318238b38c; Shendure J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-408; Teutsch SM, 2009, GENET MED, V11, P3, DOI 10.1097/GIM.0b013e318184137c; Vadakara J, 2012, PHARMACOGEN PERS MED, V5, P113, DOI 10.2147/PGPM.S24258; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158	49	87	90	1	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1511	1521		10.1001/jama.2013.3239	http://dx.doi.org/10.1001/jama.2013.3239			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571590				2022-12-28	WOS:000317271700029
J	Raaschou, P; Simard, JF; Holmqvist, M; Askling, J				Raaschou, Pauline; Simard, Julia F.; Holmqvist, Marie; Askling, Johan		ARTIS Study Grp	Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TNF-ALPHA; CANCER INCIDENCE; SKIN-CANCER; METAANALYSIS; RECIPIENTS; REGISTER	Objectives To investigate the potential association between tumour necrosis factor (TNF) inhibitor treatment and malignant melanomas in rheumatoid arthritis, melanoma risks in rheumatoid arthritis patients not treated with biological drugs, and risk of all site cancer with TNF inhibitors as used in rheumatoid arthritis. Design Population based cohort study. Setting Prospectively recorded data from national clinical, health, and demographic registers in Sweden 2001-10. Patients with rheumatoid arthritis treated (n=10 878) or not (n=42 198) with TNF inhibitors and matched general population comparators (n=162 743). Main outcome measures The primary outcome was first invasive melanoma in people without any history of invasive cancer of any type. Hazard ratios were estimated using Cox regression, comparing non-biological drug treated rheumatoid arthritis patients with the general population comparator and TNF inhibitor treated rheumatoid arthritis patients with those not treated with biological drugs. Secondary outcomes included in situ melanomas, second primary melanomas, and all site cancer. Results 113 first invasive melanomas occurred in rheumatoid arthritis patients not treated with biological drugs, and 393 occurred in the general population comparator cohort. Rheumatoid arthritis patients not treated with biological drugs were not at significantly increased risk of melanoma compared with the general population (hazard ratio 1.2, 95% confidence interval 0.9 to 1.5). 38 first invasive melanomas occurred in rheumatoid arthritis patients treated with TNF inhibitors; these patients had an increased risk of melanoma compared with rheumatoid arthritis patients not treated with biological drugs (hazard ratio 1.5, 1.0 to 2.2; 20 additional cases per 100 000 person years). The risk of a second primary melanoma was non-significantly increased (hazard ratio 3.2, 0.8 to 13.1; n=3 v 10) in rheumatoid arthritis patients treated with TNF inhibitors compared with those not treated with biological drugs. Conclusion Overall, patients with rheumatoid arthritis who have not been treated with biological drugs are not at increased risk of invasive melanoma compared with the general population. Rheumatoid arthritis patients selected for TNF inhibitor treatment are not at increased overall risk for cancer but have a 50% increased relative risk of invasive melanoma. Given the small increase in absolute risk, these finding may not markedly shift the overall risk-benefit balance of TNF inhibitors as used in clinical practice but might do so in patients at high risk of melanoma for other reasons.	[Raaschou, Pauline; Simard, Julia F.; Holmqvist, Marie; Askling, Johan] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden; [Raaschou, Pauline] Karolinska Inst, Dept Med Solna, Clin Pharmacol Unit, SE-17176 Stockholm, Sweden; [Askling, Johan] Karolinska Inst, Dept Med Solna, Rheumatol Unit, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Raaschou, P (corresponding author), Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, SE-17176 Stockholm, Sweden.	pauline.raaschou@karolinska.se		Simard, Julia/0000-0001-5735-9856; Holmqvist, Marie/0000-0001-8996-5260; Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863; Klareskog, Lars/0000-0001-9601-6186	Swedish Cancer Society; Swedish Research Council; Stockholm County Council; Swedish Foundation for Strategic Research; Merck; BMS; Pfizer; Abbott Laboratories; SOBI; UCB; Roche; Astra-Zeneca	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Merck(Merck & Company); BMS(Bristol-Myers Squibb); Pfizer(Pfizer); Abbott Laboratories(Abbott Laboratories); SOBI; UCB(UCB Pharma SA); Roche(Roche Holding); Astra-Zeneca(AstraZeneca)	This study was supported by public grants from the Swedish Cancer Society, the Swedish Research Council, Stockholm County Council, and the Swedish Foundation for Strategic Research. The ARTIS Study Group conducts scientific analyses using data from the Swedish biologics register ARTIS run by the Swedish Society for Rheumatology. For the maintenance of this register, the Swedish Society for Rheumatology has received funding, independent of the conduct of these scientific analyses, from Merck, BMS, Pfizer, Abbott Laboratories, SOBI, UCB, and Roche. These entities had no influence on the data collection, statistical analyses, manuscript preparation, or decision to submit. They were allowed to comment on the findings before submission, although all final decisions resided with the investigators.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: JA has received research grants from Pfizer and Astra-Zeneca as part of a public-private research consortium (COMBINE, www.combinesweden.se) and speakers' honorariums from Merck; no other relationships or activities that could appear to have influenced the submitted work.	Alaibac M, 2003, J AM ACAD DERMATOL, V49, P1020, DOI 10.1016/S0190-9622(03)02482-4; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Askling J, 2006, ANN RHEUM DIS, V65, P707, DOI 10.1136/ard.2005.045872; Askling J., 2009, ANNUAL EUROPEAN CONG; Askling J, 2011, PHARMACOEPIDEM DR S, V20, P119, DOI 10.1002/pds.2046; Askling J, 2009, ARTHRITIS RHEUM-US, V60, P3180, DOI 10.1002/art.24941; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Bongartz T, 2009, ANN RHEUM DIS, V68, P1177, DOI 10.1136/ard.2008.094904; Buchbinder R, 2008, ARTHRIT RHEUM-ARTHR, V59, P794, DOI 10.1002/art.23716; Chakravarty EF, 2008, EXPERT OPIN DRUG SAF, V7, P539, DOI 10.1517/14740338.7.5.539 ; Collett D, 2010, AM J TRANSPLANT, V10, P1889, DOI 10.1111/j.1600-6143.2010.03181.x; Deroose JP, 2011, CURR OPIN ONCOL, V23, P183, DOI 10.1097/CCO.0b013e3283424dbc; Dixon WG, 2010, ARTHRIT CARE RES, V62, P755, DOI 10.1002/acr.20129; Dreyer L, 2013, ANN RHEUM DIS, V72, P79, DOI 10.1136/annrheumdis-2012-201969; Fulchiero GJ, 2007, J AM ACAD DERMATOL, V56, pS65, DOI 10.1016/j.jaad.2006.12.024; GRIDLEY G, 1993, JNCI-J NATL CANCER I, V85, P307, DOI 10.1093/jnci/85.4.307; Gruenhagen Dirk J., 2009, V179, P257; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Haynes K, 2013, ARTHRITIS RHEUM-US, V65, P48, DOI 10.1002/art.37740; Hofmann MA, 2011, J CANCER RES CLIN, V137, P455, DOI 10.1007/s00432-010-0900-1; Jack A, 2006, SURG ONCOL, V15, P13, DOI 10.1016/j.suronc.2006.05.003; Kasiske BL, 2004, AM J TRANSPLANT, V4, P905, DOI 10.1111/j.1600-6143.2004.00450.x; Katoulis AC, 2010, DERMATOLOGY, V221, P9, DOI 10.1159/000300136; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; Leombruno JP, 2009, ANN RHEUM DIS, V68, P1136, DOI 10.1136/ard.2008.091025; Lizee G, 2006, CLIN CANCER RES, V12, p2359S, DOI 10.1158/1078-0432.CCR-05-2537; Lopez-Olivo MA, 2012, JAMA-J AM MED ASSOC, V308, P898, DOI 10.1001/2012.jama.10857; Manganoni Ausilia Maria, 2011, Dermatol Online J, V17, P12; Mellemkjaer L, 1996, EUR J CANCER, V32A, P1753, DOI 10.1016/0959-8049(96)00210-9; Moloney FJ, 2006, BRIT J DERMATOL, V154, P498, DOI 10.1111/j.1365-2133.2005.07021.x; Mukherji Bijay, 1995, Current Opinion in Oncology, V7, P175, DOI 10.1097/00001622-199503000-00014; Neovius M, 2011, ANN RHEUM DIS, V70, P516, DOI 10.1136/ard.2010.130914; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Oble Darryl A, 2009, Cancer Immun, V9, P3; Perkins S, 2012, CLIN RHEUMATOL, V31, P1001, DOI 10.1007/s10067-011-1908-x; Setoguchi S, 2006, ARTHRITIS RHEUM-US, V54, P2757, DOI 10.1002/art.22056; Socialstyrelsen, CANCER INCIDENCE IN; Thomas E, 2000, INT J CANCER, V88, P497, DOI 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.3.CO;2-A; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P2886, DOI 10.1002/art.22864; World Health Organization, 1955, INTERNATIONAL CLASSI; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465	45	122	126	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2013	346								f1939	10.1136/bmj.f1939	http://dx.doi.org/10.1136/bmj.f1939			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125YO	23568792	hybrid			2022-12-28	WOS:000317578300001
J	Charbonneau, P; Smolarkiewicz, PK				Charbonneau, Paul; Smolarkiewicz, Piotr K.			Modeling the Solar Dynamo	SCIENCE			English	Editorial Material							MAGNETIC WREATHS; CONVECTION; CYCLES; SIMULATION; FIELDS		[Charbonneau, Paul] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Smolarkiewicz, Piotr K.] European Ctr Medium Range Weather Forecasts, Reading RG2 9AX, Berks, England	Universite de Montreal; European Centre for Medium-Range Weather Forecasts (ECMWF)	Charbonneau, P (corresponding author), Univ Montreal, Dept Phys, CP 6128, Montreal, PQ H3C 3J7, Canada.	paulchar@astro.umontreal.ca; smolar@ecmwf.int	SMOLARKIEWICZ, PIOTR/ABG-3591-2020	SMOLARKIEWICZ, PIOTR/0000-0001-7077-3285				Brown BP, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/69; Brown BP, 2010, ASTROPHYS J, V711, P424, DOI 10.1088/0004-637X/711/1/424; Brun AS, 2004, ASTROPHYS J, V614, P1073, DOI 10.1086/423835; Cattaneo F, 1999, ASTROPHYS J, V515, pL39, DOI 10.1086/311962; Fan YH, 2009, LIVING REV SOL PHYS, V6, DOI 10.12942/lrsp-2009-4; Ghizaru M, 2010, ASTROPHYS J LETT, V715, pL133, DOI 10.1088/2041-8205/715/2/L133; Kapyla P. J., 2010, ASTRON ASTROPHYS, V548, pA88; Nelson N J, 2011, MON NOT R ASTRON SOC, V739; Nelson NJ, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/73; Prusa JM, 2008, COMPUT FLUIDS, V37, P1193, DOI 10.1016/j.compfluid.2007.12.001; Racine E, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/46; Schrijver C. J., 2010, HELIOPHYSICS, VI; Schrijver C. J., 2010, HELIOPHYSICS, VIII; Smolarkiewicz PK, 2013, J COMPUT PHYS, V236, P608, DOI 10.1016/j.jcp.2012.11.008	14	13	13	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					42	43		10.1126/science.1235954	http://dx.doi.org/10.1126/science.1235954			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559242				2022-12-28	WOS:000317061100038
J	Itoh, Y; Brocker, MJ; Sekine, S; Hammond, G; Suetsugu, S; Soll, D; Yokoyama, S				Itoh, Yuzuru; Broecker, Markus J.; Sekine, Shun-ichi; Hammond, Gifty; Suetsugu, Shiro; Soell, Dieter; Yokoyama, Shigeyuki			Decameric SelA.tRNA(Sec) Ring Structure Reveals Mechanism of Bacterial Selenocysteine Formation	SCIENCE			English	Article							TRANSFER-RNA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; IDENTIFICATION; COMPLEX; KINASE	The 21st amino acid, selenocysteine (Sec), is synthesized on its cognate transfer RNA (tRNA(Sec)). In bacteria, SelA synthesizes Sec from Ser-tRNA(Sec), whereas in archaea and eukaryotes SepSecS forms Sec from phosphoserine (Sep) acylated to tRNA(Sec). We determined the crystal structures of Aquifex aeolicus SelA complexes, which revealed a ring-shaped homodecamer that binds 10 tRNA(Sec) molecules, each interacting with four SelA subunits. The SelA N-terminal domain binds the tRNA(Sec)-specific D-arm structure, thereby discriminating Ser-tRNA(Sec) from Ser-tRNA(Ser). A large cleft is created between two subunits and accommodates the 3'-terminal region of Ser-tRNA(Sec). The SelA structures together with in vivo and in vitro enzyme assays show decamerization to be essential for SelA function. SelA catalyzes pyridoxal 5'-phosphate-dependent Sec formation involving Arg residues nonhomologous to those in SepSecS. Different protein architecture and substrate coordination of the bacterial enzyme provide structural evidence for independent evolution of the two Sec synthesis systems present in nature.	[Itoh, Yuzuru; Sekine, Shun-ichi; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Itoh, Yuzuru; Sekine, Shun-ichi; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Itoh, Yuzuru; Sekine, Shun-ichi; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Itoh, Yuzuru; Suetsugu, Shiro] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Membrane & Cytoskeleton Dynam, Bunkyo Ku, Tokyo 1130032, Japan; [Broecker, Markus J.; Hammond, Gifty; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA	RIKEN; University of Tokyo; University of Tokyo; University of Tokyo; Yale University; Yale University	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	dieter.soll@yale.edu; yokoyama@riken.jp	Suetsugu, Shiro/ABB-6033-2020; Suetsugu, Shiro/B-3300-2010; Yokoyama, Shigeyuki/N-6911-2015; Itoh, Yuzuru/M-1454-2017; Sekine, Shun-ichi/N-5450-2015; Suetsugu, Shiro/AAF-4427-2019	Suetsugu, Shiro/0000-0002-4612-0628; Yokoyama, Shigeyuki/0000-0003-3133-7338; Sekine, Shun-ichi/0000-0001-8174-8704; Suetsugu, Shiro/0000-0002-4612-0628; Itoh, Yuzuru/0000-0001-7802-5572	Japan Society for the Promotion of Science (JSPS); Alexander von Humboldt Foundation (Bonn, Germany); JSPS; Ministry of Education, Culture, Sports, Science and Technology; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-98ER20311]; National Institute of General Medical Sciences [GM22854]; Defense Advanced Research Projects Agency [N66001-12-C-4020, N66001-12-C-4211]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854, R37GM022854] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alexander von Humboldt Foundation (Bonn, Germany)(Alexander von Humboldt Foundation); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Y.I. was supported by research fellowships from the Japan Society for the Promotion of Science (JSPS). M.J.B. holds a Feodor Lynen Postdoctoral Fellowship of the Alexander von Humboldt Foundation (Bonn, Germany). We thank the staff members of SPring-8 BL41XU and the Photon Factory beam lines for assistance with our data collection, A. Ishii and T. Nakayama for assistance in the manuscript preparation, and M. Simonovic (University of Illinois, Chicago) for critical discussions. We are grateful to the National BioResource Project in Japan for providing the ASKA E. coli K12 ORF library. This work was supported in part by JSPS Grants-in-Aid for Scientific Research (A) to S.Y. and (C) to S. S. and the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology (to S.Y.). D. S. acknowledges support from the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy (DE-FG02-98ER20311) for funding the genetic experiments; the National Institute of General Medical Sciences (GM22854); and Defense Advanced Research Projects Agency (contracts N66001-12-C-4020 and N66001-12-C-4211). The plasmids for protein expression and tRNA transcription are available from S.Y. under a material transfer agreement with RIKEN. The atomic coordinates and structure factors have been deposited in the Protein Data Bank (PDB IDs 3W1H, 3W1I, 3W1J, and 3W1K).	BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; BOCK A, 2005, AMINOACYL TRNA SYNTH, P320; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Chiba S, 2010, MOL CELL, V39, P410, DOI 10.1016/j.molcel.2010.07.018; CONE JE, 1976, P NATL ACAD SCI USA, V73, P2659, DOI 10.1073/pnas.73.8.2659; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; ENGELHARDT H, 1992, MOL MICROBIOL, V6, P3461, DOI 10.1111/j.1365-2958.1992.tb01781.x; Fischer N, 2007, BIOL CHEM, V388, P1061, DOI 10.1515/BC.2007.108; Itoh Y, 2009, NUCLEIC ACIDS RES, V37, P6259, DOI 10.1093/nar/gkp648; Palioura S, 2009, SCIENCE, V325, P321, DOI 10.1126/science.1173755; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; SCHON A, 1989, NUCLEIC ACIDS RES, V17, P7159, DOI 10.1093/nar/17.18.7159; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104	14	40	44	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					75	78		10.1126/science.1229521	http://dx.doi.org/10.1126/science.1229521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559248	Green Accepted			2022-12-28	WOS:000317061100048
J	Schlechte, JA				Schlechte, Janet A.			Update in Endocrinology: Evidence Published in 2012	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Schlechte, Janet A.] Univ Iowa, Iowa City, IA 52242 USA	University of Iowa	Schlechte, JA (corresponding author), Univ Iowa, 200 Hawkins Dr,E401-1 GH, Iowa City, IA 52242 USA.	janet-schlechte@uiowa.edu		Schlechte, Janet/0000-0002-4089-0445				Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Boonen S, 2012, NEW ENGL J MED, V367, P1714, DOI 10.1056/NEJMoa1204061; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Gourlay ML, 2012, NEW ENGL J MED, V366, P225, DOI 10.1056/NEJMoa1107142; Mallick U, 2012, NEW ENGL J MED, V366, P1674, DOI 10.1056/NEJMoa1109589; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schlumberger M, 2012, NEW ENGL J MED, V366, P1663, DOI 10.1056/NEJMoa1108586; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	10	2	2	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					821	824		10.7326/0003-4819-158-11-201306040-00106	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00106			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164AA	23580066				2022-12-28	WOS:000320379800020
J	Kim, YJ; Hofmann, KP; Ernst, OP; Scheerer, P; Choe, HW; Sommer, ME				Kim, Yong Ju; Hofmann, Klaus Peter; Ernst, Oliver P.; Scheerer, Patrick; Choe, Hui-Woog; Sommer, Martha E.			Crystal structure of pre-activated arrestin p44	NATURE			English	Article							SPLICE VARIANT; RHODOPSIN INTERACTIONS; VISUAL ARRESTIN; 48-KDA PROTEIN; BETA-ARRESTIN; BINDING; DYNAMICS; MECHANISM; MODEL	Arrestins interact with G-protein-coupled receptors (GPCRs) to block interaction with G proteins(1,2) and initiate G-protein-independent signalling(3). Arrestins have a bi-lobed structure that is stabilized by a long carboxy-terminal tail (C-tail), and displacement of the C-tail by receptor-attached phosphates activates arrestins for binding active GPCRs(4). Structures of the inactive state of arrestin are available(5,6), but it is not known how C-tail displacement activates arrestin for receptor coupling. Here we present a 3.0 angstrom crystal structure of the bovine arrestin-1 splice variant p44, in which the activation step is mimicked by C-tail truncation. The structure of this pre-activated arrestin is profoundly different from the basal state and gives insight into the activation mechanism. p44 displays breakage of the central polar core and other interlobe hydrogen-bond networks, leading to a 216 rotation of the two lobes as compared to basal arrestin-1. Rearrangements in key receptor-binding loops in the central crest region include the finger loop(7-9), loop 139 (refs 8, 10, 11) and the sequence Asp 296-Asn 305 (or gate loop), here identified as controlling the polar core. We verified the role of these conformational alterations in arrestin activation and receptor binding by site-directed fluorescence spectroscopy. The data indicate a mechanism for arrestin activation in which C-tail displacement releases critical central-crest loops from restricted to extended receptor-interacting conformations. In parallel, increased flexibility between the two lobes facilitates a proper fitting of arrestin to the active receptor surface. Our results provide a snapshot of an arrestin ready to bind the active receptor, and give an insight into the role of naturally occurring truncated arrestins in the visual system.	[Kim, Yong Ju; Hofmann, Klaus Peter; Choe, Hui-Woog; Sommer, Martha E.] Charite, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany; [Ernst, Oliver P.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Ernst, Oliver P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Scheerer, Patrick] Charite, AG Prot Xray Crystallog, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Choe, Hui-Woog] Chonbuk Natl Univ, Coll Nat Sci, Dept Chem, Chonju 561756, South Korea	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; University of Toronto; University of Toronto; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jeonbuk National University	Sommer, ME (corresponding author), Charite, Inst Med Phys & Biophys CC2, Charitepl 1, D-10117 Berlin, Germany.	patrick.scheerer@charite.de; hwchoe@chonbuk.ac.kr; martha.sommer@charite.de		Sommer, Martha E./0000-0003-0493-8584; Scheerer, Patrick/0000-0001-5028-2075	Deutsche Forschungsgemeinschaft [SFB449, SFB740, SFB1078-B6, SO1037/1-2]; DFG Cluster of Excellence 'Unifying Concepts in Catalysis' [D3/E3-1]; European Research Council [ERC-2009/249910-TUDOR]; Canada Excellence Research Chair program; Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2012R1A1A2044752]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG Cluster of Excellence 'Unifying Concepts in Catalysis'(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Canada Excellence Research Chair program; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank J. H. Park for help at the early stage of the project and B. Bauer, J. Engelmann, C. Koch and H. Seibel for technical assistance. We are grateful to U. Muller, M. Weiss and the scientific staff of the BESSY-MX/Helmholtz Zentrum Berlin fur Materialien und Energie at beamlines BL 14.1, BL 14.2 and BL 14.3 operated by the Joint Berlin MX-Laboratory at the BESSY II electron storage ring (Berlin-Adlershof, Germany) and the scientific staff of the European Synchrotron Radiation Facility (ESRF, Grenoble) at beamlines ID14-1, ID 23-1, ID 23-2, ID 29S, ID 29 and ID 14-4 for continuous support. The data presented here were recorded at beamline ID 14-4 (ESRF, Grenoble). This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB449 to O.P.E., SFB740 to K. P. H. and O.P.E., SFB1078-B6 to P. S., SO1037/1-2 to M. E. S.), DFG Cluster of Excellence 'Unifying Concepts in Catalysis' (Research Field D3/E3-1 to P. S.), European Research Council (Advanced Investigator Grant (ERC-2009/249910-TUDOR to K. P. H.)), the Canada Excellence Research Chair program (to O.P.E.) and the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012R1A1A2044752 to H.-W.C.). O.P.E. holds The Anne and Max Tanenbaum Chair in Neuroscience at the University of Toronto.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AZARIAN SM, 1995, J BIOL CHEM, V270, P24375, DOI 10.1074/jbc.270.41.24375; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feuerstein SE, 2009, BIOCHEMISTRY-US, V48, P10733, DOI 10.1021/bi900544p; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Granzin J, 2012, J MOL BIOL, V416, P611, DOI 10.1016/j.jmb.2012.01.028; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Mansoor SE, 2010, BIOCHEMISTRY-US, V49, P9722, DOI 10.1021/bi100907m; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Schroder K, 2002, J BIOL CHEM, V277, P43987, DOI 10.1074/jbc.M206211200; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; SMITH WC, 1994, J BIOL CHEM, V269, P15407; Sommer ME, 2007, J BIOL CHEM, V282, P25560, DOI 10.1074/jbc.M702155200; Sommer ME, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2000; Sommer ME, 2011, J BIOL CHEM, V286, P7359, DOI 10.1074/jbc.M110.204941; Sommer ME, 2006, J BIOL CHEM, V281, P9407, DOI 10.1074/jbc.M510037200; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vishnivetskiy S. A., 2013, J BIOL CHEM; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	47	106	109	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					142	+		10.1038/nature12133	http://dx.doi.org/10.1038/nature12133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23604253				2022-12-28	WOS:000318221500050
J	Howe, K; Clark, MD; Torroja, CF; Torrance, J; Berthelot, C; Muffato, M; Collins, JE; Humphray, S; McLaren, K; Matthews, L; McLaren, S; Sealy, I; Caccamo, M; Churcher, C; Scott, C; Barrett, JC; Koch, R; Rauch, GJ; White, S; Chow, W; Kilian, B; Quintais, LT; Guerra-Assuncao, JA; Zhou, Y; Gu, Y; Yen, J; Vogel, JH; Eyre, T; Redmond, S; Banerjee, R; Chi, JX; Fu, BY; Langley, E; Maguire, SF; Laird, GK; Lloyd, D; Kenyon, E; Donaldson, S; Sehra, H; Almeida-King, J; Loveland, J; Trevanion, S; Jones, M; Quail, M; Willey, D; Hunt, A; Burton, J; Sims, S; McLay, K; Plumb, B; Davis, J; Clee, C; Oliver, K; Clark, R; Riddle, C; Eliott, D; Threadgold, G; Harden, G; Ware, D; Mortimer, B; Kerry, G; Heath, P; Phillimore, B; Tracey, A; Corby, N; Dunn, M; Johnson, C; Wood, J; Clark, S; Pelan, S; Griffiths, G; Smith, M; Glithero, R; Howden, P; Barker, N; Stevens, C; Harley, J; Holt, K; Panagiotidis, G; Lovell, J; Beasley, H; Henderson, C; Gordon, D; Auger, K; Wright, D; Collins, J; Raisen, C; Dyer, L; Leung, K; Robertson, L; Ambridge, K; Leongamornlert, D; McGuire, S; Gilderthorp, R; Griffiths, C; Manthravadi, D; Nichol, S; Barker, G; Whitehead, S; Kay, M; Brown, J; Murnane, C; Gray, E; Humphries, M; Sycamore, N; Barker, D; Saunders, D; Wallis, J; Babbage, A; Hammond, S; Mashreghi-Mohammadi, M; Barr, L; Martin, S; Wray, P; Ellington, A; Matthews, N; Ellwood, M; Woodmansey, R; Clark, G; Cooper, J; Tromans, A; Grafham, D; Skuce, C; Pandian, R; Andrews, R; Harrison, E; Kimberley, A; Garnett, J; Fosker, N; Hall, R; Garner, P; Kelly, D; Bird, C; Palmer, S; Gehring, I; Berger, A; Dooley, CM; Ersan-Urun, Z; Eser, C; Geiger, H; Geisler, M; Karotki, L; Kirn, A; Konantz, J; Konantz, M; Oberlander, M; Rudolph-Geiger, S; Teucke, M; Osoegawa, K; Zhu, BL; Rapp, A; Widaa, S; Langford, C; Yang, FT; Carter, NP; Harrow, J; Ning, ZM; Herrero, J; Searle, SMJ; Enright, A; Geisler, R; Plasterk, RHA; Lee, C; Westerfield, M; de Jong, PJ; Zon, LI; Postlethwait, JH; Nusslein-Volhard, C; Hubbard, TJP; Roest Crollius, H; Rogers, J; Stemple, DL				Howe, Kerstin; Clark, Matthew D.; Torroja, Carlos F.; Torrance, James; Berthelot, Camille; Muffato, Matthieu; Collins, John E.; Humphray, Sean; McLaren, Karen; Matthews, Lucy; McLaren, Stuart; Sealy, Ian; Caccamo, Mario; Churcher, Carol; Scott, Carol; Barrett, Jeffrey C.; Koch, Romke; Rauch, Gerd-Joerg; White, Simon; Chow, William; Kilian, Britt; Quintais, Leonor T.; Guerra-Assuncao, Jose A.; Zhou, Yi; Gu, Yong; Yen, Jennifer; Vogel, Jan-Hinnerk; Eyre, Tina; Redmond, Seth; Banerjee, Ruby; Chi, Jianxiang; Fu, Beiyuan; Langley, Elizabeth; Maguire, Sean F.; Laird, Gavin K.; Lloyd, David; Kenyon, Emma; Donaldson, Sarah; Sehra, Harminder; Almeida-King, Jeff; Loveland, Jane; Trevanion, Stephen; Jones, Matt; Quail, Mike; Willey, Dave; Hunt, Adrienne; Burton, John; Sims, Sarah; McLay, Kirsten; Plumb, Bob; Davis, Joy; Clee, Chris; Oliver, Karen; Clark, Richard; Riddle, Clare; Eliott, David; Threadgold, Glen; Harden, Glenn; Ware, Darren; Mortimer, Beverly; Kerry, Giselle; Heath, Paul; Phillimore, Benjamin; Tracey, Alan; Corby, Nicole; Dunn, Matthew; Johnson, Christopher; Wood, Jonathan; Clark, Susan; Pelan, Sarah; Griffiths, Guy; Smith, Michelle; Glithero, Rebecca; Howden, Philip; Barker, Nicholas; Stevens, Christopher; Harley, Joanna; Holt, Karen; Panagiotidis, Georgios; Lovell, Jamieson; Beasley, Helen; Henderson, Carl; Gordon, Daria; Auger, Katherine; Wright, Deborah; Collins, Joanna; Raisen, Claire; Dyer, Lauren; Leung, Kenric; Robertson, Lauren; Ambridge, Kirsty; Leongamornlert, Daniel; McGuire, Sarah; Gilderthorp, Ruth; Griffiths, Coline; Manthravadi, Deepa; Nichol, Sarah; Barker, Gary; Whitehead, Siobhan; Kay, Michael; Brown, Jacqueline; Murnane, Clare; Gray, Emma; Humphries, Matthew; Sycamore, Neil; Barker, Darren; Saunders, David; Wallis, Justene; Babbage, Anne; Hammond, Sian; Mashreghi-Mohammadi, Maryam; Barr, Lucy; Martin, Sancha; Wray, Paul; Ellington, Andrew; Matthews, Nicholas; Ellwood, Matthew; Woodmansey, Rebecca; Clark, Graham; Cooper, James; Tromans, Anthony; Grafham, Darren; Skuce, Carl; Pandian, Richard; Andrews, Robert; Harrison, Elliot; Kimberley, Andrew; Garnett, Jane; Fosker, Nigel; Hall, Rebekah; Garner, Patrick; Kelly, Daniel; Bird, Christine; Palmer, Sophie; Gehring, Ines; Berger, Andrea; Dooley, Christopher M.; Ersan-Ueruen, Zuebeyde; Eser, Cigdem; Geiger, Horst; Geisler, Maria; Karotki, Lena; Kirn, Anette; Konantz, Judith; Konantz, Martina; Oberlaender, Martina; Rudolph-Geiger, Silke; Teucke, Mathias; Osoegawa, Kazutoyo; Zhu, Baoli; Rapp, Amanda; Widaa, Sara; Langford, Cordelia; Yang, Fengtang; Carter, Nigel P.; Harrow, Jennifer; Ning, Zemin; Herrero, Javier; Searle, Steve M. J.; Enright, Anton; Geisler, Robert; Plasterk, Ronald H. A.; Lee, Charles; Westerfield, Monte; de Jong, Pieter J.; Zon, Leonard I.; Postlethwait, John H.; Nuesslein-Volhard, Christiane; Hubbard, Tim J. P.; Roest Crollius, Hugues; Rogers, Jane; Stemple, Derek L.			The zebrafish reference genome sequence and its relationship to the human genome	NATURE			English	Article							DANIO-RERIO; DUPLICATION; EVOLUTION; FISH; GENE; MUTATIONS; VERTEBRATES; REVEALS; MAP	Zebrafish have become a popular organism for the study of vertebrate gene function(1,2). The virtually transparent embryos of this species, and the ability to accelerate genetic studies by gene knockdown or overexpression, have led to the widespread use of zebrafish in the detailed investigation of vertebrate gene function and increasingly, the study of human genetic disease(3-5). However, for effective modelling of human genetic disease it is important to understand the extent to which zebrafish genes and gene structures are related to orthologous human genes. To examine this, we generated a high-quality sequence assembly of the zebrafish genome, made up of an overlapping set of completely sequenced large-insert clones that were ordered and oriented using a high-resolution high-density meiotic map. Detailed automatic and manual annotation provides evidence of more than 26,000 protein-coding genes(6), the largest gene set of any vertebrate so far sequenced. Comparison to the human reference genome shows that approximately 70% of human genes have at least one obvious zebrafish orthologue. In addition, the high quality of this genome assembly provides a clearer understanding of key genomic features such as a unique repeat content, a scarcity of pseudogenes, an enrichment of zebrafish-specific genes on chromosome 4 and chromosomal regions that influence sex determination.	[Howe, Kerstin; Clark, Matthew D.; Torroja, Carlos F.; Torrance, James; Collins, John E.; Humphray, Sean; McLaren, Karen; Matthews, Lucy; McLaren, Stuart; Sealy, Ian; Churcher, Carol; Scott, Carol; Barrett, Jeffrey C.; White, Simon; Chow, William; Kilian, Britt; Gu, Yong; Yen, Jennifer; Vogel, Jan-Hinnerk; Eyre, Tina; Redmond, Seth; Banerjee, Ruby; Chi, Jianxiang; Fu, Beiyuan; Langley, Elizabeth; Maguire, Sean F.; Laird, Gavin K.; Lloyd, David; Kenyon, Emma; Donaldson, Sarah; Sehra, Harminder; Almeida-King, Jeff; Loveland, Jane; Trevanion, Stephen; Jones, Matt; Quail, Mike; Willey, Dave; Hunt, Adrienne; Burton, John; Sims, Sarah; McLay, Kirsten; Plumb, Bob; Davis, Joy; Clee, Chris; Oliver, Karen; Clark, Richard; Riddle, Clare; Eliott, David; Threadgold, Glen; Harden, Glenn; Ware, Darren; Mortimer, Beverly; Kerry, Giselle; Heath, Paul; Phillimore, Benjamin; Tracey, Alan; Corby, Nicole; Dunn, Matthew; Johnson, Christopher; Wood, Jonathan; Clark, Susan; Pelan, Sarah; Griffiths, Guy; Smith, Michelle; Glithero, Rebecca; Howden, Philip; Barker, Nicholas; Stevens, Christopher; Harley, Joanna; Holt, Karen; Panagiotidis, Georgios; Lovell, Jamieson; Beasley, Helen; Henderson, Carl; Gordon, Daria; Auger, Katherine; Wright, Deborah; Collins, Joanna; Raisen, Claire; Dyer, Lauren; Leung, Kenric; Robertson, Lauren; Ambridge, Kirsty; Leongamornlert, Daniel; McGuire, Sarah; Gilderthorp, Ruth; Griffiths, Coline; Manthravadi, Deepa; Nichol, Sarah; Barker, Gary; Whitehead, Siobhan; Kay, Michael; Brown, Jacqueline; Murnane, Clare; Gray, Emma; Humphries, Matthew; Sycamore, Neil; Barker, Darren; Saunders, David; Wallis, Justene; Babbage, Anne; Hammond, Sian; Mashreghi-Mohammadi, Maryam; Barr, Lucy; Martin, Sancha; Wray, Paul; Ellington, Andrew; Matthews, Nicholas; Ellwood, Matthew; Woodmansey, Rebecca; Clark, Graham; Cooper, James; Tromans, Anthony; Grafham, Darren; Skuce, Carl; Pandian, Richard; Andrews, Robert; Harrison, Elliot; Kimberley, Andrew; Garnett, Jane; Fosker, Nigel; Hall, Rebekah; Garner, Patrick; Kelly, Daniel; Bird, Christine; Palmer, Sophie; Berger, Andrea; Dooley, Christopher M.; Widaa, Sara; Langford, Cordelia; Yang, Fengtang; Carter, Nigel P.; Harrow, Jennifer; Ning, Zemin; Searle, Steve M. J.; Hubbard, Tim J. P.; Rogers, Jane; Stemple, Derek L.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Clark, Matthew D.; Caccamo, Mario; Rogers, Jane] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Torroja, Carlos F.] Ctr Nacl Invest Cardiovasc, Bioinformat Unit, Madrid 28029, Spain; [Berthelot, Camille; Roest Crollius, Hugues] ENS, Inst Biol, IBENS, F-75005 Paris, France; [Berthelot, Camille; Roest Crollius, Hugues] INSERM, U1024, F-75005 Paris, France; [Berthelot, Camille; Roest Crollius, Hugues] CNRS, UMR 8197, F-75005 Paris, France; [Muffato, Matthieu; Quintais, Leonor T.; Guerra-Assuncao, Jose A.; Herrero, Javier; Enright, Anton] EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; [Humphray, Sean] Illumina Cambridge, Saffron Walden CB10 1XL, Essex, England; [Koch, Romke; Plasterk, Ronald H. A.] Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; [Rauch, Gerd-Joerg; Gehring, Ines; Berger, Andrea; Dooley, Christopher M.; Ersan-Ueruen, Zuebeyde; Eser, Cigdem; Geiger, Horst; Geisler, Maria; Karotki, Lena; Kirn, Anette; Konantz, Judith; Konantz, Martina; Oberlaender, Martina; Rudolph-Geiger, Silke; Teucke, Mathias; Geisler, Robert; Nuesslein-Volhard, Christiane] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Zhou, Yi; Zon, Leonard I.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Zhou, Yi; Zon, Leonard I.] Childrens Hosp, Div Hematol & Oncol, Boston, MA 02115 USA; [Zhou, Yi; Zon, Leonard I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Osoegawa, Kazutoyo; Zhu, Baoli; de Jong, Pieter J.] Childrens Hosp Oakland, Oakland, CA 94609 USA; [Rapp, Amanda; Westerfield, Monte; Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Geisler, Robert] KIT, ITG, D-76344 Eggenstein Leopoldshafen, Germany; [Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lee, Charles] Harvard Univ, Sch Med, Boston, MA 02115 USA	Wellcome Trust Sanger Institute; The Genome Analysis Centre (TGAC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); European Molecular Biology Laboratory (EMBL); Illumina; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Max Planck Society; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Oregon; Helmholtz Association; Karlsruhe Institute of Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Stemple, DL (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	ds4@sanger.ac.uk	Enright, Anton/F-3094-2011; Hubbard, Tim J.P./AAT-4571-2020; Vogel, Jan-Hinnerk/C-4582-2013; Berthelot, Camille/K-5570-2017; Ning, Zemin/D-2411-2013; Yang, Fan/GYU-4249-2022; Torroja, Carlos/N-6022-2014; Herrero, Javier/H-6971-2019; Hubbard, Tim J/C-2567-2008; Geisler, Robert/K-6201-2013; Guerra-Assuncao, Jose Afonso/F-3887-2011	Enright, Anton/0000-0002-6090-3100; Hubbard, Tim J.P./0000-0002-1767-9318; Berthelot, Camille/0000-0001-5054-2690; Torroja, Carlos/0000-0001-8914-3400; Herrero, Javier/0000-0001-7313-717X; Hubbard, Tim J/0000-0002-1767-9318; Geisler, Robert/0000-0002-3909-8311; Kilian, Britt/0000-0003-1493-2768; Barrett, Jeffrey/0000-0002-1152-370X; Hunt, Adrienne/0000-0002-1227-0310; Chow, William/0000-0002-9056-201X; Yang, Fengtang/0000-0002-3573-2354; Howe, Kerstin/0000-0003-2237-513X; Trevanion, Stephen/0000-0002-4862-3333; Donaldson, Sarah/0000-0002-2576-3173; Stemple, Derek/0000-0002-8296-9928; ROEST CROLLIUS, Hugues/0000-0002-8209-173X; Harrow, Jennifer/0000-0003-0338-3070; Loveland, Jane/0000-0002-7669-2934; Torrance, James/0000-0002-6117-8190; Martin, Sancha/0000-0001-6213-5259; Fosker, Christine/0000-0002-3799-9474; Guerra-Assuncao, Jose Afonso/0000-0001-6593-403X; redmond, seth/0000-0003-2653-760X; Konantz, Martina/0000-0002-4319-3119; Leongamornlert, Daniel/0000-0002-3486-3168; Almeida-King, Jeff/0000-0002-3716-4880; Ning, Zemin/0000-0003-4359-776X; White, Simon/0000-0001-6375-2363; Kerry, Giselle/0000-0002-2380-6707; Kay, Mike/0000-0002-3282-0834; Cooper, James/0000-0002-4932-1740; Muffato, Matthieu/0000-0002-7860-3560; Clark, Matthew/0000-0002-8049-5423	National Institutes of Health (NIH) [R01 GM085318, P01 HD22486, R01 OD011116, R01 RR020833, 1 R01 DK55377-01A1]; European Commission [LSHG-CT-2003-503496, HEALTH-F4-2010-242048]; German Human Genome Project (DHGP) [01 KW 9627, 01 KW 9919]; Wellcome Trust [098051]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR010715, R01RR020833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085318] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011116] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish; BBSRC [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); German Human Genome Project (DHGP); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We wish to thank R. Durbin, E. Birney, A. Scally, C. P. Ponting, E. Busch-Nentwich and R. Kettleborough for helpful discussions, as well as F. L. Marlow and P. Aanstad for critical reading and helpful comments on manuscripts. We thank the zebrafish information network (ZFIN) for funding part of the manual annotation of the zebrafish genome and the ZFIN staff for support with gene nomenclature and other genome issues. We also thank the Genome Reference Consortium for the maintenance and improvement of the zebrafish genome assembly. We are indebted to the Ensembl team for providing a browser and database that greatly facilitated the use and the analyses of the zebrafish genome. We thank A. Pirani at Affymetrix for genotyping advice support, and the Zebrafish International Resource Center (ZIRC) for distributing the SAT strain. J.H.P. was supported by the National Institutes of Health (NIH) grant R01 GM085318 (to J.H.P.), NIH grant P01 HD22486 (to J.H.P.) and R01 OD011116 (later changed to R01 RR020833) (to J.H.P.). We would like to acknowledge the support of the European Commission's Sixth Framework Programme (contract no. LSHG-CT-2003-503496, ZF-MODELS) and Seventh Framework Programme (grant no. HEALTH-F4-2010-242048, ZF-HEALTH). R. G. was supported by the German Human Genome Project (DHGP Grant 01 KW 9627 and 01 KW 9919). C. N.-V., G.-J.R. and R. G. were supported by the NIH (NIH grant 1 R01 DK55377-01A1). The Zebrafish Genome Project at the Wellcome Trust Sanger Institute was funded by Wellcome Trust grant number 098051.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amores A, 2004, GENOME RES, V14, P1, DOI 10.1101/gr.1717804; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Anderson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040701; Bradley KM, 2011, G3-GENES GENOM GENET, V1, P3, DOI 10.1534/g3.111.000190; Collins JE, 2012, GENOME RES, V22, P2067, DOI 10.1101/gr.137901.112; Driever W, 1996, DEVELOPMENT, V123, P37; Freeman JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-195; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Haffter P, 1996, DEVELOPMENT, V123, P1; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kettleborough R. N. W., NATURE IN PRESS; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; Rodriguez-Mari A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001357; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; Sola L, 2001, GENETICA, V111, P397, DOI 10.1023/A:1013776323077; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; TALBOT WS, 1995, NATURE, V378, P150, DOI 10.1038/378150a0; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Varshney GK, 2013, GENOME RES, V23, P727, DOI 10.1101/gr.151464.112; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560	30	2494	3870	73	738	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					498	503		10.1038/nature12111	http://dx.doi.org/10.1038/nature12111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23594743	Green Accepted, hybrid			2022-12-28	WOS:000317984400040
J	Lo, S				Lo, Selina			Suzanne Crowe: a dame for all reasons	LANCET			English	Biographical-Item																		CROWE S, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1353	1353		10.1016/S0140-6736(13)60873-9	http://dx.doi.org/10.1016/S0140-6736(13)60873-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130EF	23601939	Bronze			2022-12-28	WOS:000317894800017
J	de Jong, T; Linn, MC; Zacharia, ZC				de Jong, Ton; Linn, Marcia C.; Zacharia, Zacharias C.			Physical and Virtual Laboratories in Science and Engineering Education	SCIENCE			English	Review							COMPUTER-SIMULATIONS; STUDENTS; REPRESENTATIONS; MANIPULATIVES; ENHANCE; SCHOOL; INSTRUCTION; CONTEXT; OBJECTS; HANDS	The world needs young people who are skillful in and enthusiastic about science and who view science as their future career field. Ensuring that we will have such young people requires initiatives that engage students in interesting and motivating science experiences. Today, students can investigate scientific phenomena using the tools, data collection techniques, models, and theories of science in physical laboratories that support interactions with the material world or in virtual laboratories that take advantage of simulations. Here, we review a selection of the literature to contrast the value of physical and virtual investigations and to offer recommendations for combining the two to strengthen science learning.	[de Jong, Ton] Univ Twente, Fac Behav Sci, Dept Instruct Technol, NL-7500 AE Enschede, Netherlands; [Linn, Marcia C.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Zacharia, Zacharias C.] Univ Cyprus, Dept Educ Sci, CY-1678 Nicosia, Cyprus	University of Twente; University of California System; University of California Berkeley; University of Cyprus	de Jong, T (corresponding author), Univ Twente, Fac Behav Sci, Dept Instruct Technol, NL-7500 AE Enschede, Netherlands.	a.j.m.dejong@utwente.nl		Zacharia, Zacharias/0000-0002-6381-0962	European Union [317601]; NSF [DRL-1119670, DRL-0918743, DRL-0733299]	European Union(European Commission); NSF(National Science Foundation (NSF))	The contribution by T.d.J. and Z.C.Z. was partially funded by the European Union in the context of the Go-Lab project (grant agreement no. 317601) under the Information and Communication Technologies (ICT) theme of the 7th Framework Programme for R&D (FP7). This document does not represent the opinion of the European Union, and the European Union is not responsible for any use that might be made of its content. M.C.L.'s contribution is based on work supported, in part, by the NSF under grants DRL-1119670: Continuous Learning and Automated Scoring in Science (CLASS); DRL-0918743: Visualizing to Integrate Science Understanding for All Learners (VISUAL); and DRL-0733299: Logging Opportunities in Online Programs for Science (LOOPS). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the NSF.	Alfieri L, 2011, J EDUC PSYCHOL, V103, P1, DOI 10.1037/a0021017; [Anonymous], 2006, AM LAB REP INV HIGH; Barbas A., 2007, 8 INT C COMP BAS LEA, P523; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Chini JJ, 2012, PHYS REV SPEC TOP-PH, V8, DOI 10.1103/PhysRevSTPER.8.010113; de Jong T, 2010, BRIT J EDUC TECHNOL, V41, P909, DOI 10.1111/j.1467-8535.2010.01121.x; Deslauriers L, 2011, PHYS REV SPEC TOP-PH, V7, DOI 10.1103/PhysRevSTPER.7.010101; Finkelstein ND, 2005, PHYS REV SPEC TOP-PH, V1, DOI 10.1103/PhysRevSTPER.1.010101; Ford D.N., 2000, SIMULATION GAMING, V31, P309, DOI [10.1177/104687810003100301, DOI 10.1177/104687810003100301]; Gillet D., 2013, IEEE EDUCON BERL 13; Huppert J, 2002, INT J SCI EDUC, V24, P803, DOI 10.1080/09500690110049150; Jaakkola T., 2010, USE EXTERNAL REPRESE, P133; Jaakkola T, 2011, J RES SCI TEACH, V48, P71, DOI 10.1002/tea.20386; Klahr D, 2007, J RES SCI TEACH, V44, P183, DOI 10.1002/tea.20152; Kolloffel B., J ENG ED; Linn MC, 2006, SCIENCE, V313, P1049, DOI 10.1126/science.1131408; Martinez-Jimenez P, 2003, J CHEM EDUC, V80, P346; McElhaney KW, 2011, J RES SCI TEACH, V48, P745, DOI 10.1002/tea.20423; Borrero AM, 2012, J SCI EDUC TECHNOL, V21, P540, DOI 10.1007/s10956-011-9345-9; Minner DD, 2010, J RES SCI TEACH, V47, P474, DOI 10.1002/tea.20347; National Science Teaching Association, 2007, NSTA POS STAT INT RO; Olympiou G, 2013, INSTR SCI, V41, P575, DOI 10.1007/s11251-012-9245-2; Olympiou G, 2012, SCI EDUC, V96, P21, DOI 10.1002/sce.20463; Pyatt K, 2012, J SCI EDUC TECHNOL, V21, P133, DOI 10.1007/s10956-011-9291-6; Renken MD, 2013, LEARN INSTR, V23, P10, DOI 10.1016/j.learninstruc.2012.08.006; Rocard M., 2007, SCI ED NOW RENEWED P; Toth EE, 2009, INNOV HIGH EDUC, V33, P333, DOI 10.1007/s10755-008-9087-7; Triona LM, 2003, COGNITION INSTRUCT, V21, P149, DOI 10.1207/S1532690XCI2102_02; Trundle KC, 2010, COMPUT EDUC, V54, P1078, DOI 10.1016/j.compedu.2009.10.012; van der Meij J, 2006, LEARN INSTR, V16, P199, DOI 10.1016/j.learninstruc.2006.03.007; Wiesner TF, 2004, J ENG EDUC, V93, P195, DOI 10.1002/j.2168-9830.2004.tb00806.x; Windschitl M, 1998, J RES SCI TEACH, V35, P145, DOI 10.1002/(SICI)1098-2736(199802)35:2<145::AID-TEA5>3.0.CO;2-S; Zacharia ZC, 2008, J RES SCI TEACH, V45, P1021, DOI 10.1002/tea.20260; Zacharia ZC, 2008, AM J PHYS, V76, P425, DOI 10.1119/1.2885059; Zacharia ZC, 2012, EARLY CHILD RES Q, V27, P447, DOI 10.1016/j.ecresq.2012.02.004; Zhang ZH, 2011, J RES SCI TEACH, V48, P1177, DOI 10.1002/tea.20443	36	425	433	26	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					305	308		10.1126/science.1230579	http://dx.doi.org/10.1126/science.1230579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126XZ	23599479				2022-12-28	WOS:000317657500040
J	Masiello, CA; Louchouarn, P				Masiello, C. A.; Louchouarn, P.			Fire in the Ocean	SCIENCE			English	Editorial Material							ORGANIC-CARBON; RECALCITRANCE; CHARCOAL		[Masiello, C. A.] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; [Louchouarn, P.] Texas A&M Univ, Dept Marine Sci, Galveston, TX 77553 USA; [Louchouarn, P.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77853 USA	Rice University; Texas A&M University System; Texas A&M University System; Texas A&M University College Station	Masiello, CA (corresponding author), Rice Univ, Dept Earth Sci, 6100 Main St,MS 126, Houston, TX 77005 USA.	masiello@rice.edu	Masiello, Caroline/A-2653-2011	Masiello, Caroline/0000-0003-2102-6229	Directorate For Geosciences [0911685] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Bianchi TS, 2011, P NATL ACAD SCI USA, V108, P19473, DOI 10.1073/pnas.1017982108; Harvey OR, 2012, ENVIRON SCI TECHNOL, V46, P10641, DOI 10.1021/es302971d; Harvey OR, 2012, ENVIRON SCI TECHNOL, V46, P1415, DOI 10.1021/es2040398; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; Hockaday WC, 2007, GEOCHIM COSMOCHIM AC, V71, P3432, DOI 10.1016/j.gca.2007.02.023; Hunsinger G. B., 2008, J GEOPHYS RES, V113, P14; Jaffe R, 2013, SCIENCE, V340, P345, DOI 10.1126/science.1231476; Masiello CA, 2004, MAR CHEM, V92, P201, DOI 10.1016/j.marchem.2004.06.043; McBeath AV, 2013, ORG GEOCHEM, V55, P38, DOI 10.1016/j.orggeochem.2012.11.006; Norwood MJ, 2013, ORG GEOCHEM, V56, P111, DOI 10.1016/j.orggeochem.2012.12.008; Sohi SP, 2012, SCIENCE, V338, P1034, DOI 10.1126/science.1225987; Spencer RGM, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000968; Stubbins A, 2012, BIOGEOSCIENCES, V9, P1661, DOI 10.5194/bg-9-1661-2012; Zimmerman AR, 2010, ENVIRON SCI TECHNOL, V44, P1295, DOI 10.1021/es903140c; Ziolkowski LA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043963	15	26	27	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					287	288		10.1126/science.1237688	http://dx.doi.org/10.1126/science.1237688			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599474				2022-12-28	WOS:000317657500035
J	Sartain, K				Sartain, Kate			An outstanding example of hospital care for patients with dementia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												katesartain@btinternet.com			Department of Health [RP-PG-0407-10147] Funding Source: Medline; National Institute for Health Research [RP-PG-0407-10147] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))			0	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2013	346								f2513	10.1136/bmj.f2513	http://dx.doi.org/10.1136/bmj.f2513			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131BG	23604085				2022-12-28	WOS:000317965000011
J	Sharp, PM; Rayner, JC; Hahn, BH				Sharp, Paul M.; Rayner, Julian C.; Hahn, Beatrice H.			Great Apes and Zoonoses	SCIENCE			English	Editorial Material							HUMAN MALARIA PARASITE; PLASMODIUM-FALCIPARUM; ORIGIN; RESERVOIRS; VIVAX		[Sharp, Paul M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Rayner, Julian C.] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge CB10 1SA, England; [Hahn, Beatrice H.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Hahn, Beatrice H.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Edinburgh; Wellcome Trust Sanger Institute; University of Pennsylvania; University of Pennsylvania	Sharp, PM (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	bhahn@upenn.edu	Sharp, Paul M/F-5783-2010; Sharp, Paul M/GPX-1497-2022; Sharp, Paul/Y-3787-2019	Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Rayner, Julian/0000-0002-9835-1014; Hahn, Beatrice/0000-0002-9400-9887	NIAID NIH HHS [R01 AI091595] Funding Source: Medline; Wellcome Trust [095831] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091595] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ayouba A, 2012, INT J PARASITOL, V42, P709, DOI 10.1016/j.ijpara.2012.05.004; Carter R, 2003, TRENDS PARASITOL, V19, P214, DOI 10.1016/S1471-4922(03)00070-9; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; Duval L, 2010, P NATL ACAD SCI USA, V107, P10561, DOI 10.1073/pnas.1005435107; Escalante AA, 2005, P NATL ACAD SCI USA, V102, P1980, DOI 10.1073/pnas.0409652102; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Kantele A, 2011, CLIN INFECT DIS, V52, P1356, DOI 10.1093/cid/cir180; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; Pepin Jacques, 2011, ORIGINS AIDS; Rayner JC, 2011, TRENDS PARASITOL, V27, P222, DOI 10.1016/j.pt.2011.01.006; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Tanabe K, 2010, CURR BIOL, V20, P1283, DOI 10.1016/j.cub.2010.05.053	16	25	26	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					284	286		10.1126/science.1236958	http://dx.doi.org/10.1126/science.1236958			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599472	Green Accepted			2022-12-28	WOS:000317657500033
J	Jiang, C; Srinivasan, SG				Jiang, Chao; Srinivasan, Srivilliputhur G.			Unexpected strain-stiffening in crystalline solids	NATURE			English	Article							INSTABILITIES; PLASTICITY; STRENGTH; ALUMINUM; SCIENCE; CARBON	Strain-stiffening-an increase in material stiffness at large strains-is a vital mechanism by which many soft biological materials thwart excessive deformation to protect tissue integrity(1-3). Understanding the fundamental science of strain-stiffening and incorporating this concept into the design of metals and ceramics for advanced applications is an attractive prospect. Using cementite (Fe3C) and aluminium borocarbide (Al3BC3) as prototypes, here we show via quantum-mechanical calculations that strain-stiffening also occurs, surprisingly, in simple inorganic crystalline solids and confers exceptionally high strengths to these two solids, which have anomalously low resistance to deformation near equilibrium. For Fe3C and Al3BC3, their ideal shear strength to shear modulus ratios attain remarkably high values of 1.14 and 1.34 along the (010)[ 001] and (0001) [01 (1) over bar0] slip systems, respectively. These values are more than seven times larger than the original Frenkel value of 1/2 pi (refs 4, 5) and are the highest yet reported for crystalline solids. The extraordinary stiffening of Fe3C arises from the strain-induced reversible 'cross-linking' between weakly coupled edge- and corner-sharing Fe6C slabs. This new bond formation creates a strong, three-dimensional covalent bond network that resists large shear deformation. Unlike Fe3C, no new bond forms in Al3BC3 but stiffening still occurs because strong repulsion between Al and B in a compressed Al-B bond unsettles the existing covalent bond network. These discoveries challenge the conventional wisdom that large shear modulus is a reliable predictor of hardness and strength of materials(4-7), and provide new lessons for materials selection and design.	[Jiang, Chao] Los Alamos Natl Lab, Struct Property Relat Grp MST 8, Los Alamos, NM 87545 USA; [Srinivasan, Srivilliputhur G.] Univ N Texas, Dept Mat Sci & Engn, Denton, TX 76203 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of North Texas System; University of North Texas Denton	Jiang, C (corresponding author), Univ Wisconsin, Dept Mat Sci & Engn, 1509 Univ Ave, Madison, WI 53706 USA.	chaopsu@gmail.com; srinivasan.srivilliputhur@unt.edu	Jiang, Chao/D-1957-2017	Jiang, Chao/0000-0003-0610-6327; Srivilliputhur, Srinivasan/0000-0002-6477-9821	Los Alamos National Laboratory (LANL); National Science Foundation [0846444]	Los Alamos National Laboratory (LANL)(United States Department of Energy (DOE)Los Alamos National Laboratory); National Science Foundation(National Science Foundation (NSF))	C.J. acknowledges the support of a Director's Fellowship at Los Alamos National Laboratory (LANL), where a systematic study of cementite was conceived and initiated. S.G.S. acknowledges support from the National Science Foundation (grant number 0846444). We also thank J. Wills, M. I. Baskes, A. Caro, A. Misra, S. Maloy, A. Srivastava, V. Vitek and S. Ranganathan for their discussions.	Alkorta J, 2012, J MATER RES, V27, P45, DOI 10.1557/jmr.2011.284; Chacham H, 2000, PHYS REV LETT, V85, P4904, DOI 10.1103/PhysRevLett.85.4904; Dubrovinsky LS, 2001, NATURE, V410, P653, DOI 10.1038/35070650; Fang CM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.055503; Frenkel J, 1926, Z PHYS, V37, P572, DOI 10.1007/BF01397292; Grimvall G, 2012, REV MOD PHYS, V84, P945, DOI 10.1103/RevModPhys.84.945; Jhi SH, 1999, NATURE, V399, P132, DOI 10.1038/20148; Jhi SH, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.075503; Jiang C, 2008, J APPL PHYS, V103, DOI 10.1063/1.2884529; Kaner RB, 2005, SCIENCE, V308, P1268, DOI 10.1126/science.1109830; Kelly A., 1973, STRONG SOLIDS; Krenn CR, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.134111; Lee SH, 2010, J EUR CERAM SOC, V30, P1015, DOI 10.1016/j.jeurceramsoc.2009.09.027; Legut D, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214118; Meyers M., 2008, MECH BEHAV MAT; Minor AM, 2006, NAT MATER, V5, P697, DOI 10.1038/NMAT1714; Nikolussi M, 2008, SCRIPTA MATER, V59, P814, DOI 10.1016/j.scriptamat.2008.06.015; Ogata S, 2002, SCIENCE, V298, P807, DOI 10.1126/science.1076652; Roundy D, 1999, PHYS REV LETT, V82, P2713, DOI 10.1103/PhysRevLett.82.2713; Shadwick RE, 1999, J EXP BIOL, V202, P3305; Sob M, 1997, MAT SCI ENG A-STRUCT, V234, P1075, DOI 10.1016/S0921-5093(97)00329-8; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Telling RH, 2000, PHYS REV LETT, V84, P5160, DOI 10.1103/PhysRevLett.84.5160; Teter DM, 1998, MRS BULL, V23, P22, DOI 10.1557/S0883769400031420; Teter DM, 1996, SCIENCE, V271, P53, DOI 10.1126/science.271.5245.53; Umemoto M, 2001, SCRIPTA MATER, V45, P391, DOI 10.1016/S1359-6462(01)01016-8; Wang H, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.224102; Wang JY, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2220549; WOOD BJ, 1993, EARTH PLANET SC LETT, V117, P593, DOI 10.1016/0012-821X(93)90105-I; Zhao H.E., 2010, PHYS REV LETT, V104	30	54	57	3	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					339	342		10.1038/nature12008	http://dx.doi.org/10.1038/nature12008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23575634				2022-12-28	WOS:000317599200032
J	Wheeler, Q; Assis, L; Rieppel, O				Wheeler, Quentin; Assis, Leandro; Rieppel, Olivier			Heed the father of cladistics	NATURE			English	Editorial Material									[Wheeler, Quentin] Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA; [Wheeler, Quentin] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Assis, Leandro] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Rieppel, Olivier] Field Museum Nat Hist, Chicago, IL 60605 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Universidade Federal de Minas Gerais; Field Museum of Natural History (Chicago)	Wheeler, Q (corresponding author), Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA.	quentin.wheeler@asu.edu	Assis, Leandro/G-1205-2012					Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; Hull D. L., 1988, SCI PROCESS; Nelson G, 2004, SYST ASSOC SPEC VOL, P127; Nelson G., 1981, SYSTEMATICS BIOGEORA; Rieppel O. C., 1988, FUNDAMENTALS COMP BI; Schmitt M, 2013, FROM TAXONOMY TO PHYLOGENETICS-LIFE AND WORK OF WILLI HENNIG, P1, DOI 10.1163/9789004219298; Schuh R. T., 2009, BIOL SYSTEMATICS; Wheeler QD, 2012, SYST BIODIVERS, V10, P1, DOI 10.1080/14772000.2012.665095; Wheeler WC., 2012, SYSTEMATICS	10	17	17	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					295	296		10.1038/496295a	http://dx.doi.org/10.1038/496295a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126FV	23598324	Bronze			2022-12-28	WOS:000317599200013
J	Yach, D				Yach, Derek			Can we leave industry to lead efforts to improve population health? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDREN		Vital Inst, New York, NY 10036 USA		Yach, D (corresponding author), Vital Inst, 1515 Broadway, New York, NY 10036 USA.	dyach@thevitalitygroup.com						American Beverage Alliance, 2010, ALL SCH BEV GUID FIN; An RP, 2013, AM J HEALTH BEHAV, V37, P56, DOI 10.5993/AJHB.37.1.6; Floud R., 2011, CHANGING BODY HLTH N; Hudson Institute Obesity Solutions Initiative, 2013, LOW CAL FOODS ITS JU; International Food and Beverage Alliance, OUR COMM; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Pan LP, 2012, JAMA-J AM MED ASSOC, V308, P2563, DOI 10.1001/jama.2012.108099; Slining MM, 2013, AM J PREV MED, V44, P174, DOI 10.1016/j.amepre.2012.09.064; Sunstein Cass R, 2008, NUDGE IMPROVING DECI; Wansink B, 2012, PEDIATR OBES, V7, P121, DOI 10.1111/j.2047-6310.2011.00003.x; Wansink B, 2012, MARKET SCI, V31, P54, DOI 10.1287/mksc.1110.0699b	13	7	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2013	346								f2279	10.1136/bmj.f2279	http://dx.doi.org/10.1136/bmj.f2279			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AT	23596215				2022-12-28	WOS:000317963400004
J	Watanabe, S; Radman-Livaja, M; Rando, OJ; Peterson, CL				Watanabe, Shinya; Radman-Livaja, Marta; Rando, Oliver J.; Peterson, Craig L.			A Histone Acetylation Switch Regulates H2A.Z Deposition by the SWR-C Remodeling Enzyme	SCIENCE			English	Article							H3K56 ACETYLATION; GENOME INTEGRITY; VARIANT; EXCHANGE; NUCLEOSOMES; ACTIVATION; PROMOTERS; TURNOVER; DYNAMICS; COMPLEX	The histone variant H2A.Z plays key roles in gene expression, DNA repair, and centromere function. H2A.Z deposition is controlled by SWR-C chromatin remodeling enzymes that catalyze the nucleosomal exchange of canonical H2A with H2A.Z. Here we report that acetylation of histone H3 on lysine 56 (H3-K56Ac) alters the substrate specificity of SWR-C, leading to promiscuous dimer exchange in which either H2A.Z or H2A can be exchanged from nucleosomes. This result was confirmed in vivo, where genome-wide analysis demonstrated widespread decreases in H2A.Z levels in yeast mutants with hyperacetylated H3K56. Our work also suggests that a conserved SWR-C subunit may function as a "lock" that prevents removal of H2A.Z from nucleosomes. Our study identifies a histone modification that regulates a chromatin remodeling reaction and provides insights into how histone variants and nucleosome turnover can be controlled by chromatin regulators.	[Watanabe, Shinya; Peterson, Craig L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Radman-Livaja, Marta; Rando, Oliver J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Peterson, CL (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	craig.peterson@umassmed.edu		Radman-Livaja, Marta/0000-0003-4987-0608	NIH [RO1 GM49650, R01 GM079205]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049650, R01GM079205, R01GM049650] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. D. Kaufman (University of Massachusetts Medical School) for the gift of purified Rtt109/Vps75. We apologize to colleagues whose work we could not cite due to space constraints. This work was supported by grants from the NIH to C.L.P. (RO1 GM49650) and to O.J.R. (R01 GM079205). Chip-Seq data sets have been assigned the Gene Expression Omnibus accession no. GSE43935.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cai Y, 2005, J BIOL CHEM, V280, P13665, DOI 10.1074/jbc.M500001200; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Lo KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019778; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Pollard KJ, 1998, BIOESSAYS, V20, P771, DOI 10.1002/(SICI)1521-1878(199809)20:9<771::AID-BIES10>3.0.CO;2-V; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Watanabe S, 2010, BBA-GENE REGUL MECH, V1799, P480, DOI 10.1016/j.bbagrm.2010.01.009; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	23	146	146	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129					195	199		10.1126/science.1229758	http://dx.doi.org/10.1126/science.1229758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580526	Green Accepted			2022-12-28	WOS:000317341400055
J	Loven, J; Hoke, HA; Lin, CY; Lau, A; Orlando, DA; Vakoc, CR; Bradner, JE; Lee, TI; Young, RA				Loven, Jakob; Hoke, Heather A.; Lin, Charles Y.; Lau, Ashley; Orlando, David A.; Vakoc, Christopher R.; Bradner, James E.; Lee, Tong Ihn; Young, Richard A.			Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers	CELL			English	Article							RNA-POLYMERASE-II; BROMODOMAIN PROTEIN BRD4; MULTIPLE-MYELOMA; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; C-MYC; THERAPEUTIC TARGET; CANCER EPIGENETICS; BET BROMODOMAINS; MEDIATOR COMPLEX	Chromatin regulators have become attractive targets for cancer therapy, but it is unclear why inhibition of these ubiquitous regulators should have gene-specific effects in tumor cells. Here, we investigate how inhibition of the widely expressed transcriptional coactivator BRD4 leads to selective inhibition of the MYC oncogene in multiple myeloma (MM). BRD4 and Mediator were found to co-occupy thousands of enhancers associated with active genes. They also co-occupied a small set of exceptionally large super-enhancers associated with genes that feature prominently in MM biology, including the MYC oncogene. Treatment of MM tumor cells with the BET-bromodomain inhibitor JQ1 led to preferential loss of BRD4 at super-enhancers and consequent transcription elongation defects that preferentially impacted genes with super-enhancers, including MYC. Super-enhancers were found at key oncogenic drivers in many other tumor cells. These observations have implications for the discovery of cancer therapeutics directed at components of super-enhancers in diverse tumor types.	[Loven, Jakob; Hoke, Heather A.; Lin, Charles Y.; Lau, Ashley; Orlando, David A.; Lee, Tong Ihn; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hoke, Heather A.; Lau, Ashley; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lin, Charles Y.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Vakoc, Christopher R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Lin, Charles Y.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Cold Spring Harbor Laboratory; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Vakoc, Christopher/0000-0002-1158-7180	Swedish Research Council [VR-B0086301]; Damon-Runyon Cancer Research Foundation; Burroughs-Welcome CAMS award; NCI Cancer Center Support Grant Development Fund [CA45508]; National Institutes of Health [HG002668, CA146445]; NATIONAL CANCER INSTITUTE [R01CA146445, P30CA045508, R01CA174793, P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Damon-Runyon Cancer Research Foundation; Burroughs-Welcome CAMS award; NCI Cancer Center Support Grant Development Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Zi Peng Fan for bioinformatics support; Michael R. McKeown for help with cell viability assays; Jun Qi for providing JQ1; Tom Volkert, Jennifer Love, Sumeet Gupta, and Jeong-Ah Kwon at the Whitehead Genome Technologies Core for Solexa sequencing; and members of the Young, Bradner, and Vakoc labs for helpful discussion. This work was supported by a Swedish Research Council Postdoctoral Fellowship VR-B0086301 (J.L.), the Damon-Runyon Cancer Research Foundation (J.E.B.), a Burroughs-Welcome CAMS award and NCI Cancer Center Support Grant Development Fund CA45508 (C.R.V.), and National Institutes of Health grants HG002668 (R.A.Y.) and CA146445 (R.A.Y., T. I. L.). R.A.Y. and J.E.B. are founders, J.L. and D.A.O. have become employees, and C.R.V. is a scientific advisor of Syros Pharmaceuticals.	Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bergsagel PL, 2005, BLOOD, V106, P296, DOI 10.1182/blood-2005-01-0034; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Chng WJ, 2011, LEUKEMIA, V25, P1026, DOI 10.1038/leu.2011.53; Claudio JO, 2002, BLOOD, V100, P2175, DOI 10.1182/blood-2002-01-0008; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dib Amel, 2008, J Natl Cancer Inst Monogr, P25, DOI 10.1093/jncimonographs/lgn011; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Elsasser SJ, 2011, SCIENCE, V331, P1145, DOI 10.1126/science.1203280; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Geutjes EJ, 2012, ONCOGENE, V31, P3827, DOI 10.1038/onc.2011.552; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; GRIGGS DW, 1991, P NATL ACAD SCI USA, V88, P8597, DOI 10.1073/pnas.88.19.8597; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Holien T, 2012, BLOOD, V120, P2450, DOI 10.1182/blood-2011-08-371567; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Maldonado V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-152; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Pedersen N, 2003, CANCER RES, V63, P1943; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Wu SY, 2003, MOL CELL BIOL, V23, P6229, DOI 10.1128/MCB.23.17.6229-6242.2003; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zhang WS, 2012, J BIOL CHEM, V287, P43137, DOI 10.1074/jbc.M112.413047; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	74	1742	1814	9	278	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					320	334		10.1016/j.cell.2013.03.036	http://dx.doi.org/10.1016/j.cell.2013.03.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582323	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000317349700012
J	Rechtsman, MC; Zeuner, JM; Plotnik, Y; Lumer, Y; Podolsky, D; Dreisow, F; Nolte, S; Segev, M; Szameit, A				Rechtsman, Mikael C.; Zeuner, Julia M.; Plotnik, Yonatan; Lumer, Yaakov; Podolsky, Daniel; Dreisow, Felix; Nolte, Stefan; Segev, Mordechai; Szameit, Alexander			Photonic Floquet topological insulators	NATURE			English	Article							STATES; PHASE	Topological insulators are a new phase of matter(1), with the striking property that conduction of electrons occurs only on their surfaces(1-3). In two dimensions, electrons on the surface of a topological insulator are not scattered despite defects and disorder, providing robustness akin to that of superconductors. Topological insulators are predicted to have wide-ranging applications in fault-tolerant quantum computing and spintronics. Substantial effort has been directed towards realizing topological insulators for electromagnetic waves(4-13). One-dimensional systems with topological edge states have been demonstrated, but these states are zero-dimensional and therefore exhibit no transport properties(11,12,14). Topological protection of microwaves has been observed using a mechanism similar to the quantum Hall effect(15), by placing a gyromagnetic photonic crystal in an external magnetic field(5). But because magnetic effects are very weak at optical frequencies, realizing photonic topological insulators with scatter-free edge states requires a fundamentally different mechanism-one that is free of magnetic fields. A number of proposals for photonic topological transport have been put forward recently(6-10). One suggested temporal modulation of a photonic crystal, thus breaking time-reversal symmetry and inducing one-way edge states(10). This is in the spirit of the proposed Floquet topological insulators(16-19), in which temporal variations in solid-state systems induce topological edge states. Here we propose and experimentally demonstrate a photonic topological insulator free of external fields and with scatter-free edge transport-a photonic lattice exhibiting topologically protected transport of visible light on the lattice edges. Our system is composed of an array of evanescently coupled helical waveguides(20) arranged in a graphene-like honeycomblattice(21-26). Paraxial diffraction of light is described by a Schrodinger equation where the propagation coordinate (z) acts as 'time'(27). Thus the helicity of the waveguides breaks z-reversal symmetry as proposed for Floquet topological insulators. This structure results in one-way edge states that are topologically protected from scattering.	[Rechtsman, Mikael C.; Plotnik, Yonatan; Lumer, Yaakov; Podolsky, Daniel; Segev, Mordechai] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Rechtsman, Mikael C.; Plotnik, Yonatan; Lumer, Yaakov; Podolsky, Daniel; Segev, Mordechai] Technion Israel Inst Technol, Inst Solid State, IL-32000 Haifa, Israel; [Zeuner, Julia M.; Dreisow, Felix; Nolte, Stefan; Szameit, Alexander] Univ Jena, Abbe Ctr Photon, Inst Appl Phys, D-07743 Jena, Germany	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Friedrich Schiller University of Jena	Rechtsman, MC (corresponding author), Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel.	mcrworld@gmail.com; yonatanplotnik@gmail.com	Rechtsman, Mikael C./L-8926-2013; Szameit, Alexander/AGK-5446-2022; Nolte, Stefan/B-1323-2009; Podolsky, Daniel/D-5576-2013	Rechtsman, Mikael C./0000-0002-6909-8355; Szameit, Alexander/0000-0003-0071-6941; Nolte, Stefan/0000-0002-2919-2662; Podolsky, Daniel/0000-0001-6428-2957	Azrieli Foundation; Israel Science Foundation; USA-Israel Binational Science Foundation; European Research Council; German Ministry of Education and Research (Center for Innovation Competence program) [03Z1HN31]; Thuringian Ministry for Education, Science and Culture (Research group Spacetime) [11027-514]	Azrieli Foundation; Israel Science Foundation(Israel Science Foundation); USA-Israel Binational Science Foundation(US-Israel Binational Science Foundation); European Research Council(European Research Council (ERC)European Commission); German Ministry of Education and Research (Center for Innovation Competence program); Thuringian Ministry for Education, Science and Culture (Research group Spacetime)	M.C.R. is grateful to the Azrieli Foundation for the Azrieli fellowship while at the Technion. M. S. acknowledges the support of the Israel Science Foundation, the USA-Israel Binational Science Foundation, and an Advanced Grant from the European Research Council. A. S. thanks the German Ministry of Education and Research (Center for Innovation Competence program, grant 03Z1HN31) and the Thuringian Ministry for Education, Science and Culture (Research group Spacetime, grant 11027-514) for support. The authors thank S. Raghu and T. Pereg-Barnea for discussions.	Ablowitz MJ, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.053830; Bahat-Treidel O, 2008, OPT LETT, V33, P2251, DOI 10.1364/OL.33.002251; Crespi A, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/013012; Fang KJ, 2012, NAT PHOTONICS, V6, P782, DOI [10.1038/NPHOTON.2012.236, 10.1038/nphoton.2012.236]; Fefferman CL, 2012, J AM MATH SOC, V25, P1169, DOI 10.1090/S0894-0347-2012-00745-0; Gu ZH, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.216601; Hafezi M, 2011, NAT PHYS, V7, P907, DOI [10.1038/NPHYS2063, 10.1038/nphys2063]; Haldane FDM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013904; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Kawano K, 2001, INTRO OPTICAL WAVEGU; Khanikaev AB, 2013, NAT MATER, V12, P233, DOI [10.1038/nmat3520, 10.1038/NMAT3520]; Kitagawa T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1872; Kitagawa T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.235114; Koch J, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.043811; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Kraus YE, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.106402; Lederer F, 2008, PHYS REP, V463, P1, DOI 10.1016/j.physrep.2008.04.004; Lindner NH, 2011, NAT PHYS, V7, P490, DOI 10.1038/NPHYS1926; Lu L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.243901; Malkova N, 2009, OPT LETT, V34, P1633, DOI 10.1364/OL.34.001633; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Oka T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.081406; Peleg O, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.103901; Rechtsman MC, 2013, NAT PHOTONICS, V7, P153, DOI [10.1038/NPHOTON.2012.302, 10.1038/nphoton.2012.302]; Szameit A, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/16/163001; Umucalilar RO, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.043804; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; ZAK J, 1989, PHYS REV LETT, V62, P2747, DOI 10.1103/PhysRevLett.62.2747	30	1992	2014	58	986	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					196	200		10.1038/nature12066	http://dx.doi.org/10.1038/nature12066			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23579677	Green Submitted			2022-12-28	WOS:000317346300036
J	He, FJ; Li, JF; MacGregor, GA				He, Feng J.; Li, Jiafu; MacGregor, Graham A.			Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MODERATE SODIUM RESTRICTION; DIETARY-SODIUM; DOUBLE-BLIND; CARDIOVASCULAR-DISEASE; POTASSIUM SUPPLEMENTATION; MILD HYPERTENSION; URINARY SODIUM; HEALTH-CARE; EXCRETION; COSTS	Objective To determine the effects of longer term modest salt reduction on blood pressure, hormones, and lipids. Design Systematic review and meta-analysis. Data sources Medline, Embase, Cochrane Hypertension Group Specialised Register, Cochrane Central Register of Controlled Trials, and reference list of relevant articles. Inclusion criteria Randomised trials with a modest reduction in salt intake and duration of at least four weeks. Data extraction and analysis Data were extracted independently by two reviewers. Random effects meta-analyses, subgroup analyses, and meta-regression were performed. Results Thirty four trials (3230 participants) were included. Meta-analysis showed that the mean change in urinary sodium (reduced salt v usual salt) was -75 mmol/24 h (equivalent to a reduction of 4.4 g/day salt), and with this reduction in salt intake, the mean change in blood pressure was -4.18 mm Hg (95% confidence interval -5.18 to -3.18, I-2=75%) for systolic blood pressure and -2.06 mm Hg (-2.67 to -1.45, I-2=68%) for diastolic blood pressure. Meta-regression showed that age, ethnic group, blood pressure status (hypertensive or normotensive), and the change in 24 hour urinary sodium were all significantly associated with the fall in systolic blood pressure, explaining 68% of the variance between studies. A 100 mmol reduction in 24 hour urinary sodium (6 g/day salt) was associated with a fall in systolic blood pressure of 5.8 mm Hg (2.5 to 9.2, P=0.001) after adjustment for age, ethnic group, and blood pressure status. For diastolic blood pressure, age, ethnic group, blood pressure status, and the change in 24 hour urinary sodium explained 41% of the variance between studies. Meta-analysis by subgroup showed that in people with hypertension the mean effect was -5.39 mm Hg (-6.62 to -4.15, I-2=61%) for systolic blood pressure and -2.82 mm Hg (-3.54 to -2.11, I-2=52%) for diastolic blood pressure. In normotensive people, the figures were -2.42 mm Hg (-3.56 to -1.29, I-2=66%) and -1.00 mm Hg (-1.85 to -0.15, I-2=66%), respectively. Further subgroup analysis showed that the decrease in systolic blood pressure was significant in both white and black people and in men and women. Meta-analysis of data on hormones and lipids showed that the mean change was 0.26 ng/mL/h (0.17 to 0.36, I-2=70%) for plasma renin activity, 73.20 pmol/L (44.92 to 101.48, I-2=62%) for aldosterone, 187 pmol/L (39 to 336, I-2=5%) for noradrenaline (norepinephrine), 37 pmol/L (-1 to 74, I-2=12%) for adrenaline (epinephrine), 0.05 mmol/L (-0.02 to 0.11, I-2=0%) for total cholesterol, 0.05 mmol/L (-0.01 to 0.12, I-2=0%) for low density lipoprotein cholesterol, -0.02 mmol/L (-0.06 to 0.01, I-2=16%) for high density lipoprotein cholesterol, and 0.04 mmol/L (-0.02 to 0.09, I-2=0%) for triglycerides. Conclusions A modest reduction in salt intake for four or more weeks causes significant and, from a population viewpoint, important falls in blood pressure in both hypertensive and normotensive individuals, irrespective of sex and ethnic group. Salt reduction is associated with a small physiological increase in plasma renin activity, aldosterone, and noradrenaline and no significant change in lipid concentrations. These results support a reduction in population salt intake, which will lower population blood pressure and thereby reduce cardiovascular disease. The observed significant association between the reduction in 24 hour urinary sodium and the fall in systolic blood pressure, indicates that larger reductions in salt intake will lead to larger falls in systolic blood pressure. The current recommendations to reduce salt intake from 9-12 to 5-6 g/day will have a major effect on blood pressure, but a further reduction to 3 g/day will have a greater effect and should become the long term target for population salt intake.	[He, Feng J.; MacGregor, Graham A.] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Li, Jiafu] LuZhou Med Coll, Dept Cardiol, Affiliated Hosp, Luzhou, Sichuan, Peoples R China	University of London; Queen Mary University London; Southwest Medical University	He, FJ (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London EC1M 6BQ, England.	f.he@qmul.ac.uk	He, Feng/HHS-6457-2022	He, Feng/0000-0002-1996-0744				[Anonymous], 1989, CLIN EXP HYPERTENS A, V11, P1011; [Anonymous], 2003, DIET NUTR PREV CHRON; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; BECKMANN SL, 1995, AM J HYPERTENS, V8, P704, DOI 10.1016/0895-7061(95)00122-6; BENETOS A, 1992, J HYPERTENS, V10, P355, DOI 10.1097/00004872-199204000-00006; Berlin JA, 2002, STAT MED, V21, P371, DOI 10.1002/sim.1023; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Bray GA, 2004, AM J CARDIOL, V94, P222, DOI 10.1016/j.amjcard.2004.03.070; CAPPUCCIO FP, 1991, J HYPERTENS, V9, P465, DOI 10.1097/00004872-199105000-00011; Cappuccio FP, 1997, LANCET, V350, P850, DOI 10.1016/S0140-6736(97)02264-2; CHALMERS J, 1986, J HYPERTENS, V4, pS629; CHALMERS JP, 1989, LANCET, V1, P399; COBIAC L, 1992, J HYPERTENS, V10, P87, DOI 10.1097/00004872-199201000-00014; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; DENTON D, 1995, NAT MED, V1, P1009, DOI 10.1038/nm1095-1009; Department of Health, 2011, ASS DIET SOD LEV AD; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; ERWTEMAN TM, 1984, BMJ-BRIT MED J, V289, P406, DOI 10.1136/bmj.289.6442.406; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; FORTE JG, 1989, J HUM HYPERTENS, V3, P179; FOTHERBY MD, 1993, J HYPERTENS, V11, P657, DOI 10.1097/00004872-199306000-00010; Gates PE, 2004, HYPERTENSION, V44, P35, DOI 10.1161/01.HYP.0000132767.74476.64; Graudal NA, 2012, AM J HYPERTENS, V25, P1, DOI 10.1038/ajh.2011.210; Graudal NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub3; GROBBEE DE, 1987, J HYPERTENS, V5, P115, DOI 10.1097/00004872-198702000-00016; Harsha DW, 2004, HYPERTENSION, V43, P393, DOI 10.1161/01.HYP.0000113046.83819.a2; He FJ, 2006, HYPERTENSION, V48, P861, DOI 10.1161/01.HYP.0000245672.27270.4a; He FJ, 2012, NAT REV NEPHROL, V8, P134, DOI 10.1038/nrneph.2011.220; He FJ, 2011, KIDNEY INT, V80, P696, DOI 10.1038/ki.2011.246; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; He FJ, 2009, HYPERTENSION, V54, P482, DOI 10.1161/HYPERTENSIONAHA.109.133223; He FJ, 1998, HYPERTENSION, V32, P820, DOI 10.1161/01.HYP.32.5.820; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Institute of Medicine, 2010, STRAT RED SOD INT US; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; MACGREGOR GA, 1982, LANCET, V1, P351, DOI 10.1016/S0140-6736(82)91389-7; MACGREGOR GA, 1989, LANCET, V2, P1244, DOI 10.1016/S0140-6736(89)91852-7; MASCIOLI S, 1991, HYPERTENSION, V17, pI21, DOI 10.1161/01.HYP.17.1_Suppl.I21; Meland E, 1997, SCAND J CLIN LAB INV, V57, P501, DOI 10.3109/00365519709084600; Melander O, 2007, J HYPERTENS, V25, P619, DOI 10.1097/HJH.0b013e328013cd50; MORGAN TO, 1981, MED J AUSTRALIA, V2, P396, DOI 10.5694/j.1326-5377.1981.tb101026.x; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; NESTEL PJ, 1993, J HYPERTENS, V11, P1387, DOI 10.1097/00004872-199312000-00011; NICE. National Institute for Health and Clinical Excellence (NICE), 2010, GUID PREV CARD DIS P; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Ofcom Office of Communications, IMP ASS; Palar K, 2009, AM J HEALTH PROMOT, V24, P49, DOI 10.4278/ajhp.080826-QUAN-164; PARIJS J, 1973, AM HEART J, V85, P22, DOI 10.1016/0002-8703(73)90522-X; Paterna S, 2008, CLIN SCI, V114, P221, DOI 10.1042/CS20070193; POULTER NR, 1990, BMJ-BRIT MED J, V300, P967, DOI 10.1136/bmj.300.6730.967; PUSKA P, 1983, LANCET, V1, P1; RICHARDS AM, 1984, LANCET, V1, P757, DOI 10.1016/S0140-6736(84)91276-5; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; RUPPERT M, 1993, J HYPERTENS, V11, P743, DOI 10.1097/00004872-199307000-00010; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Schorr U, 1996, J HYPERTENS, V14, P131; Scientific Advisory Committee on Nutrition, 2003, SALT HLTH; Selmer RM, 2000, J EPIDEMIOL COMMUN H, V54, P697, DOI 10.1136/jech.54.9.697; SILMAN AJ, 1983, LANCET, V1, P1179; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Strazzullo Pasquale, 2009, BMJ, V339, pb4567, DOI 10.1136/bmj.b4567; Swift PA, 2005, HYPERTENSION, V46, P308, DOI 10.1161/01.HYP.0000172662.12480.7f; Taylor RS, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003331.pub4; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; WATT GCM, 1983, BMJ-BRIT MED J, V286, P432, DOI 10.1136/bmj.286.6363.432; WATT GCM, 1985, BMJ-BRIT MED J, V291, P1525, DOI 10.1136/bmj.291.6508.1525; WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657	77	436	444	7	159	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2013	346								f1325	10.1136/bmj.f1325	http://dx.doi.org/10.1136/bmj.f1325			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122SI	23558162	hybrid			2022-12-28	WOS:000317338000001
J	Poggio, T				Poggio, Tomaso			Donald Arthur Glaser (1926-2013) OBITUARY	NATURE			English	Biographical-Item									[Poggio, Tomaso] MIT, Dept Brain & Cognit Sci, McGovern Inst, Cambridge, MA 02139 USA; [Poggio, Tomaso] MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Poggio, T (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst, E25-618, Cambridge, MA 02139 USA.	tp@csail.mit.edu							0	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2013	496	7443					32	32		10.1038/496032a	http://dx.doi.org/10.1038/496032a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23552936	Bronze			2022-12-28	WOS:000316993400015
J	Hegarty, K; O'Doherty, L; Taft, A; Chondros, P; Brown, S; Valpied, J; Astbury, J; Taket, A; Gold, L; Feder, G; Gunn, J				Hegarty, Kelsey; O'Doherty, Lorna; Taft, Angela; Chondros, Patty; Brown, Stephanie; Valpied, Jodie; Astbury, Jill; Taket, Ann; Gold, Lisa; Feder, Gene; Gunn, Jane			Screening and counselling in the primary care setting for women who have experienced intimate partner violence (WEAVE): a cluster randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; GENERAL-PRACTICE; HEALTH; ABUSE; DEPRESSION; INTERVENTION; READINESS; VICTIMS; PROGRAM; SUPPORT	Background Evidence for a benefit of interventions to help women who screen positive for intimate partner violence (IPV) in health-care settings is limited. We assessed whether brief counselling from family doctors trained to respond to women identified through IPV screening would increase women's quality of life, safety planning and behaviour, and mental health. Methods In this cluster randomised controlled trial, we enrolled family doctors from clinics in Victoria, Australia, and their female patients (aged 16-50 years) who screened positive for fear of a partner in past 12 months in a health and lifestyle survey. The study intervention consisted of the following: training of doctors, notification to doctors of women screening positive for fear of a partner, and invitation to women for one-to-six sessions of counselling for relationship and emotional issues. We used a computer-generated randomisation sequence to allocate doctors to control (standard care) or intervention, stratified by location of each doctor's practice (urban vs rural), with random permuted block sizes of two and four within each stratum. Data were collected by postal survey at baseline and at 6 months and 12 months post-invitation (2008-11). Researchers were masked to treatment allocation, but women and doctors enrolled into the trial were not. Primary outcomes were quality of life (WHO Quality of Life-BREF), safety planning and behaviour, mental health (SF-12) at 12 months. Secondary outcomes included depression and anxiety (Hospital Anxiety and Depression Scale; cut-off >= 8); women's report of an inquiry from their doctor about the safety of them and their children; and comfort to discuss fear with their doctor (five-point Likert scale). Analyses were by intention to treat, accounting for missing data, and estimates reported were adjusted for doctor location and outcome scores at baseline. This trial is registered with the Australian New Zealand Clinical Trial Registry, number ACTRN12608000032358. Findings We randomly allocated 52 doctors (and 272 women who were eligible for inclusion and returned their baseline survey) to either intervention (25 doctors, 137 women) or control (27 doctors, 135 women). 96 (70%) of 137 women in the intervention group (seeing 23 doctors) and 100 (74%) of 135 women in the control group (seeing 26 doctors) completed 12 month follow-up. We detected no difference in quality of life, safety planning and behaviour, or mental health SF-12 at 12 months. For secondary outcomes, we detected no between-group difference in anxiety at 12 months or comfort to discuss fear at 6 months, but depressiveness caseness at 12 months was improved in the intervention group compared with the control group (odds ratio 0.3, 0.1-0.7; p=0.005), as was doctor enquiry at 6 months about women's safety (5.1, 1.9-14.0; p=0.002) and children's safety (5.5, 1.6-19.0; p=0.008). We recorded no adverse events. Interpretation Our findings can inform further research on brief counselling for women disclosing intimate partner violence in primary care settings, but do not lend support to the use of postal screening in the identification of those patients. However, we suggest that family doctors should be trained to ask about the safety of women and children, and to provide supportive counselling for women experiencing abuse, because our findings suggest that, although we detected no improvement in quality of life, counselling can reduce depressive symptoms.	[Hegarty, Kelsey; O'Doherty, Lorna; Chondros, Patty; Valpied, Jodie; Gunn, Jane] Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, Carlton, Vic 3053, Australia; [Taft, Angela] La Trobe Univ, Mother & Child Hlth Res Ctr, Bundoora, Vic 3086, Australia; [Brown, Stephanie] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Astbury, Jill] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [Taket, Ann] Deakin Univ, Sch Hlth & Social Dev, Geelong, Vic 3217, Australia; [Gold, Lisa] Deakin Univ, Deakin Hlth Econ, Geelong, Vic 3217, Australia; [Feder, Gene] Univ Bristol, Sch Social & Community Med, Bristol BS8 1TH, Avon, England	University of Melbourne; La Trobe University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Monash University; Deakin University; Deakin University; University of Bristol	Hegarty, K (corresponding author), Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, 200 Berkeley St, Carlton, Vic 3053, Australia.	k.hegarty@unimelb.edu.au	Chondros, Patty/AAT-6426-2020; Brown, Stephanie/AAE-1662-2019; Taket, Ann R/G-1381-2010; Valpied, Jodie/C-2544-2014	Taket, Ann R/0000-0002-0971-5884; O'Doherty, Lorna Jane/0000-0003-0816-9321; Brown, Stephanie/0000-0001-9812-0067; Taft, Angela/0000-0002-6350-843X; Chondros, Patty/0000-0003-0393-8734; Feder, Gene/0000-0002-7890-3926; Gold, Lisa/0000-0002-2733-900X; Hegarty, Kelsey/0000-0002-7532-5147; Gunn, Jane/0000-0001-8836-7525	Australian National Health and Medical Research Council; National Institute for Health Research [RP-PG-0108-10084] Funding Source: researchfish	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research(National Institute for Health Research (NIHR))	Australian National Health and Medical Research Council.	Australian Institute of Health and Welfare (AIHW), 2011, MEDICAL LABOUR FORCE; Britt H, 2009, GENERAL PRACTICE ACT; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Chang JC, 2010, J WOMENS HEALTH, V19, P251, DOI 10.1089/jwh.2009.1568; Cluss PA, 2006, WOMEN HEALTH ISS, V16, P262, DOI 10.1016/j.whi.2006.06.006; Feder G, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13160; Feder G, 2011, LANCET, V378, P1788, DOI 10.1016/S0140-6736(11)61179-3; Feder GS, 2006, ARCH INTERN MED, V166, P22, DOI 10.1001/archinte.166.1.22; Goodyear-Smith F, 2009, ANN FAM MED, V7, P239, DOI 10.1370/afm.962; Grouin JM, 2004, STAT MED, V23, P701; Gunn J, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-88; Hegarty K, 2004, BRIT MED J, V328, P621, DOI 10.1136/bmj.328.7440.621; Hegarty K, 2012, AUST J PRIMARY HEALT, DOI org/2010.1071/PY11101; Hegarty K., 2008, BMJ-BRIT MED J, V337, P346; Hegarty Kelsey, 2005, Violence Vict, V20, P529, DOI 10.1891/088667005780927548; Hegarty KL, 2013, J INTERPERS VIOLENCE, V28, P273, DOI 10.1177/0886260512454722; Hegarty KL, 2008, J FAM STUD, V14, P376, DOI 10.5172/jfs.327.14.2-3.376; Hegarty KL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-2; Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; Klevens J, 2012, JAMA-J AM MED ASSOC, V308, P681, DOI 10.1001/jama.2012.6434; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; McFarlane J, 1998, J Obstet Gynecol Neonatal Nurs, V27, P64, DOI 10.1111/j.1552-6909.1998.tb02592.x; McFarlane JM, 2006, NURS RES, V55, P52, DOI 10.1097/00006199-200601000-00007; National Research Council Institute of Medicine, 2011, CLINICAL PREVENTIVE; Nelson HD, 2012, ANN INTERN MED, V157, P104, DOI 10.7326/0003-4819-157-2-201207170-00466; Potiriadis M, 2008, MED J AUSTRALIA, V189, P215, DOI 10.5694/j.1326-5377.2008.tb01986.x; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Spangaro J, 2009, TRAUMA VIOLENCE ABUS, V10, P55, DOI 10.1177/1524838008327261; STATA, 2014, STAT STAT SOFTW REL; Stayton CD, 2005, TRAUMA VIOLENCE ABUS, V6, P271, DOI 10.1177/1524838005277439; Sullivan CM, 1999, J CONSULT CLIN PSYCH, V67, P43, DOI 10.1037/0022-006X.67.1.43; Taft AJ, 2010, JAMA-J AM MED ASSOC, V304, P577, DOI 10.1001/jama.2010.1093; Tiwari A, 2005, BJOG-INT J OBSTET GY, V112, P1249, DOI 10.1111/j.1471-0528.2005.00709.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wathen CN, 2012, JAMA-J AM MED ASSOC, V308, P712, DOI 10.1001/jama.2012.9913; WHO, 2005, WHO MULTI COUNTRY ST; Williamson MK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-42; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zink T, 2004, ANN FAM MED, V2, P231, DOI 10.1370/afm.74	39	151	156	1	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 20	2013	382	9888					249	258		10.1016/S0140-6736(13)60052-5	http://dx.doi.org/10.1016/S0140-6736(13)60052-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193FL	23598181				2022-12-28	WOS:000322543700034
J	Jewkes, R				Jewkes, Rachel			Intimate partner violence: the end of routine screening	LANCET			English	Editorial Material							RANDOMIZED-CONTROLLED-TRIAL; HEALTH-CARE SETTINGS; TASK-FORCE; WOMEN; RECOMMENDATION		MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa		Jewkes, R (corresponding author), MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa.	rjewkes@mrc.ac.za		Jewkes, Rachel/0000-0002-4330-6267				Feder G, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13160; Hegarty K, 2013, LANCET, V382, P249, DOI 10.1016/S0140-6736(13)60052-5; Institute for Health Metrics and Evaluation, GBD 2010 LEADING CAU; Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; Klevens J, 2012, JAMA-J AM MED ASSOC, V308, P681, DOI 10.1001/jama.2012.6434; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; Nelson HD, 2012, ANN INTERN MED, V156, P796, DOI 10.7326/0003-4819-156-11-201206050-00447; Tiwari A, 2005, BJOG-INT J OBSTET GY, V112, P1249, DOI 10.1111/j.1471-0528.2005.00709.x; Wathen CN, 2003, CAN MED ASSOC J, V169, P582	9	23	25	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 20	2013	382	9888					190	191		10.1016/S0140-6736(13)60584-X	http://dx.doi.org/10.1016/S0140-6736(13)60584-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193FL	23598182				2022-12-28	WOS:000322543700009
J	Soofi, S; Cousens, S; Iqbal, SP; Akhund, T; Khan, J; Ahmed, I; Zaidi, AKM; Bhutta, ZA				Soofi, Sajid; Cousens, Simon; Iqbal, Saleem P.; Akhund, Tauseef; Khan, Javed; Ahmed, Imran; Zaidi, Anita K. M.; Bhutta, Zulfiqar A.			Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomised trial	LANCET			English	Article								Background Powders containing iron and other micronutrients are recommended as a strategy to prevent nutritional anaemia and other micronutrient deficiencies in children. We assessed the effects of provision of two micronutrient powder formulations, with or without zinc, to children in Pakistan. Methods We did a cluster randomised trial in urban and rural sites in Sindh, Pakistan. A baseline survey identified 256 clusters, which were randomly assigned (within urban and rural strata, by computer-generated random numbers) to one of three groups: non-supplemented control (group A), micronutrient powder without zinc (group B), or micronutrient powder with 10 mg zinc (group C). Children in the clusters aged 6 months were eligible for inclusion in the study. Powders were to be given daily between 6 and 18 months of age; follow-up was to age 2 years. Micronutrient powder sachets for groups B and C were identical except for colour; investigators and field and supervisory staff were masked to composition of the micronutrient powders until trial completion. Parents knew whether their child was receiving supplementation, but did not know whether the powder contained zinc. Primary outcomes were growth, episodes of diarrhoea, acute lower respiratory tract infection, fever, and incidence of admission to hospital. This trial is registered with ClinicalTrials.gov, number NCT00705445. Results The trial was done between Nov 1, 2008, and Dec 31, 2011. 947 children were enrolled in group A clusters, 910 in group B clusters, and 889 in group C clusters. Micronutrient powder administration was associated with lower risk of iron-deficiency anaemia at 18 months compared with the control group (odds ratio [OR] for micronutrient powder without zinc=0.20, 95% CI 0.11-0.36; OR for micronutrient powder with zinc=0.25, 95% CI 0.14-0.44). Compared with the control group, children in the group receiving micronutrient powder without zinc gained an extra 0.31 cm (95% CI 0.03-0.59) between 6 and 18 months of age and children receiving micronutrient powder with zinc an extra 0.56 cm (0.29-0.84). We recorded strong evidence of an increased proportion of days with diarrhoea (p=0.001) and increased incidence of bloody diarrhoea (p=0.003) between 6 and 18 months in the two micronutrient powder groups, and reported chest indrawing (p=0.03). Incidence of febrile episodes or admission to hospital for diarrhoea, respiratory problems, or febrile episodes did not differ between the three groups. Interpretation Use of micronutrient powders reduces iron-deficiency anaemia in young children. However, the excess burden of diarrhoea and respiratory morbidities associated with micronutrient powder use and the very small effect on growth recorded suggest that a careful assessment of risks and benefits must be done in populations with malnourished children and high diarrhoea burdens.	[Soofi, Sajid; Iqbal, Saleem P.; Akhund, Tauseef; Khan, Javed; Ahmed, Imran; Zaidi, Anita K. M.; Bhutta, Zulfiqar A.] Aga Khan Univ, Div Women & Child Hlth, Dept Paediat & Child Hlth, Karachi 74800, Pakistan; [Cousens, Simon; Bhutta, Zulfiqar A.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Aga Khan University; University of London; London School of Hygiene & Tropical Medicine	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu	Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Bill & Melinda Gates Foundation.		0	236	238	0	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 6	2013	382	9886					29	40		10.1016/S0140-6736(13)60437-7	http://dx.doi.org/10.1016/S0140-6736(13)60437-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177AD	23602230				2022-12-28	WOS:000321347000026
J	Chung, K; Wallace, J; Kim, SY; Kalyanasundaram, S; Andalman, AS; Davidson, TJ; Mirzabekov, JJ; Zalocusky, KA; Mattis, J; Denisin, AK; Pak, S; Bernstein, H; Ramakrishnan, C; Grosenick, L; Gradinaru, V; Deisseroth, K				Chung, Kwanghun; Wallace, Jenelle; Kim, Sung-Yon; Kalyanasundaram, Sandhiya; Andalman, Aaron S.; Davidson, Thomas J.; Mirzabekov, Julie J.; Zalocusky, Kelly A.; Mattis, Joanna; Denisin, Aleksandra K.; Pak, Sally; Bernstein, Hannah; Ramakrishnan, Charu; Grosenick, Logan; Gradinaru, Viviana; Deisseroth, Karl			Structural and molecular interrogation of intact biological systems	NATURE			English	Article							MOUSE-BRAIN; FLUORESCENT PROTEINS; NERVOUS-SYSTEM; SELF-AVOIDANCE; TOMOGRAPHY; MICROSCOPY; LOCALIZATION; ORGANIZATION; ARCHITECTURE; CONNECTOME	Obtaining high-resolution information from a complex system, while maintaining the global perspective needed to understand system function, represents a key challenge in biology. Here we address this challenge with a method (termed CLARITY) for the transformation of intact tissue into a nanoporous hydrogel-hybridized form (crosslinked to a three-dimensional network of hydrophilic polymers) that is fully assembled but optically transparent and macromolecule-permeable. Using mouse brains, we show intact-tissue imaging of long-range projections, local circuit wiring, cellular relationships, subcellular structures, protein complexes, nucleic acids and neurotransmitters. CLARITY also enables intact-tissue in situ hybridization, immunohistochemistry with multiple rounds of staining and de-staining in non-sectioned tissue, and antibody labelling throughout the intact adult mouse brain. Finally, we show that CLARITY enables fine structural analysis of clinical samples, including non-sectioned human tissue from a neuropsychiatric-disease setting, establishing a path for the transmutation of human tissue into a stable, intact and accessible form suitable for probing structural and molecular underpinnings of physiological function and disease.	[Chung, Kwanghun; Wallace, Jenelle; Kim, Sung-Yon; Andalman, Aaron S.; Davidson, Thomas J.; Mirzabekov, Julie J.; Zalocusky, Kelly A.; Mattis, Joanna; Denisin, Aleksandra K.; Pak, Sally; Bernstein, Hannah; Ramakrishnan, Charu; Grosenick, Logan; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Chung, Kwanghun; Kalyanasundaram, Sandhiya; Andalman, Aaron S.; Davidson, Thomas J.; Zalocusky, Kelly A.; Gradinaru, Viviana; Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Chung, Kwanghun/H-7714-2014; Andalman, Aaron S/C-7694-2011; Denisin, Aleksandra/N-4715-2018; Kim, Sung-Yon/AAO-8405-2020	Chung, Kwanghun/0000-0002-8167-3340; Denisin, Aleksandra/0000-0002-4262-9371; Kim, Sung-Yon/0000-0003-0791-7308; Bernstein, Hannah/0000-0002-6512-1378; Wallace, Jenelle/0000-0002-9565-2751; Mattis, Joanna/0000-0003-0341-1270; Ramakrishnan, Charu/0000-0002-3474-6332	National Institutes of Health (NIH) from NIMH [TR01]; NSF; Simons Foundation; Stanford University; NIDA; DARPA REPAIR program; Wiegers Foundation; Snyder Foundation; Reeves Foundation; Gatsby Foundation; Yu Foundation; Burroughs Wellcome Fund Career Award at the Scientific Interface; Samsung Scholarship; Helen Hay Whitney Foundation; NSF Graduate Research Fellowship; NIH MSTP; Deisseroth laboratory; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA035377, R01DA020794] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000616] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from NIMH; NSF(National Science Foundation (NSF)); Simons Foundation; Stanford University(Stanford University); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA REPAIR program; Wiegers Foundation; Snyder Foundation; Reeves Foundation; Gatsby Foundation; Yu Foundation; Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); Samsung Scholarship(Samsung); Helen Hay Whitney Foundation; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deisseroth laboratory; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by a National Institutes of Health (NIH) Director's Transformative Research Award (TR01) to K. D. from NIMH, as well as by NSF, the Simons Foundation, and the President and Provost of Stanford University. K. D. is also funded by NIDA, the DARPA REPAIR program, and the Wiegers, Snyder, Reeves, Gatsby, and Yu Foundations. K. C. is supported by the Burroughs Wellcome Fund Career Award at the Scientific Interface. S.-Y.K. is supported by a Samsung Scholarship, A. S. A. by the Helen Hay Whitney Foundation, K.A.Z. and A. K. D. by an NSF Graduate Research Fellowship and J.M. by the NIH MSTP. We acknowledge H. Vogel, L. Luo, L. Schwarz, M. Monje, S. Hestrin and D. Castaneda for advice, and the Autism Tissue Program for providing human brain tissue, as well as J. J. Perrino, J. Mulholland and the Cell Sciences Imaging Facility at Stanford for electron microscopy imaging and advice. We would also like to thank the entire Deisseroth laboratory for discussions and support. CLARITY resources and protocols are freely supported online (http://CLARITYresourcecenter.org).	Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Botcherby EJ, 2012, P NATL ACAD SCI USA, V109, P2919, DOI 10.1073/pnas.1111662109; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; Cheng CM, 1998, J NEUROSCI, V18, P5673; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; CONDE F, 1994, J COMP NEUROL, V341, P95, DOI 10.1002/cne.903410109; DeFelipe J, 2010, SCIENCE, V330, P1198, DOI 10.1126/science.1193378; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Drobizhev M, 2011, NAT METHODS, V8, P393, DOI [10.1038/NMETH.1596, 10.1038/nmeth.1596]; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GOLDENTHAL KL, 1985, J HISTOCHEM CYTOCHEM, V33, P813, DOI 10.1177/33.8.3894499; GROSSFELD RM, 1971, J NEUROCHEM, V18, P2265, DOI 10.1111/j.1471-4159.1971.tb00183.x; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Kasthuri N, 2007, NAT METHODS, V4, P307, DOI 10.1038/nmeth0407-307; KOLODZIEJCZYK E, 1986, J HISTOCHEM CYTOCHEM, V34, P1725, DOI 10.1177/34.12.3023476; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Macdonald R, 1999, METH MOL B, V127, P77, DOI 10.1385/1-59259-678-9:77; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Porrero C, 2010, BRAIN RES, V1345, P59, DOI 10.1016/j.brainres.2010.05.061; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/nmeth.1854, 10.1038/NMETH.1854]; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; TRAMU G, 1978, J HISTOCHEM CYTOCHEM, V26, P322, DOI 10.1177/26.4.207771; Wahlby C, 2002, CYTOMETRY, V47, P32, DOI 10.1002/cyto.10026; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	46	1271	1374	35	765	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					332	+		10.1038/nature12107	http://dx.doi.org/10.1038/nature12107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23575631	Green Accepted			2022-12-28	WOS:000318952000030
J	Sampson, TR; Saroj, SD; Llewellyn, AC; Tzeng, YL; Weiss, DS				Sampson, Timothy R.; Saroj, Sunil D.; Llewellyn, Anna C.; Tzeng, Yih-Ling; Weiss, David S.			A CRISPR/Cas system mediates bacterial innate immune evasion and virulence	NATURE			English	Article							FRANCISELLA-TULARENSIS; CAS SYSTEMS; SMALL RNAS; DNA; DEFENSE; BACTERIOPHAGE; IDENTIFICATION; LIPOPROTEINS; RECOGNITION; EVOLUTION	CRISPR/Cas (clustered regularly interspaced palindromic repeats/CRISPR-associated) systems are a bacterial defence against invading foreign nucleic acids derived from bacteriophages or exogenous plasmids(1-4). These systems use an array of small CRISPR RNAs (crRNAs) consisting of repetitive sequences flanking unique spacers to recognize their targets, and conserved Cas proteins to mediate target degradation(5-8). Recent studies have suggested that these systems may have broader functions in bacterial physiology, and it is unknown if they regulate expression of endogenous genes(9,10). Here we demonstrate that the Cas protein Cas9 of Francisella novicida uses a unique, small, CRISPR/Cas-associated RNA (scaRNA) to repress an endogenous transcript encoding a bacterial lipoprotein. As bacterial lipoproteins trigger a proinflammatory innate immune response aimed at combating pathogens(11,12), CRISPR/Cas-mediated repression of bacterial lipoprotein expression is critical for F. novicida to dampen this host response and promote virulence. Because Cas9 proteins are highly enriched in pathogenic and commensal bacteria, our work indicates that CRISPR/Cas-mediated gene regulation may broadly contribute to the regulation of endogenous bacterial genes, particularly during the interaction of such bacteria with eukaryotic hosts.	[Sampson, Timothy R.; Llewellyn, Anna C.] Emory Univ, Dept Microbiol & Immunol, Microbiol & Mol Genet Program, Atlanta, GA 30329 USA; [Sampson, Timothy R.; Llewellyn, Anna C.; Weiss, David S.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Sampson, Timothy R.; Llewellyn, Anna C.; Weiss, David S.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Saroj, Sunil D.; Tzeng, Yih-Ling; Weiss, David S.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30329 USA	Emory University; Emory University; Emory University; Emory University	Weiss, DS (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.	david.weiss@emory.edu	Saroj, Sunil/R-8113-2019; Sampson, Tim/B-9061-2013	Sampson, Timothy/0000-0002-2486-8766; Saroj, Sunil D/0000-0002-8071-2731; Llewellyn, Anna/0000-0001-6712-7477	National Institutes of Health (NIH) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense [U54-AI057157]; NSF Graduate Research Fellowship; ARCS Foundation;  [R56-AI87673];  [R56-AI061031]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI061031, R56AI087673, U54AI057157] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); ARCS Foundation; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank R. Ahmed, G. Conn, C. Dunham, C. Moran, B. Napier, D. S. Stephens and the Stephens laboratory, and M. Swanson for discussions and critical reading of this manuscript. The project described was supported by National Institutes of Health (NIH) grant U54-AI057157 from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense and R56-AI87673 to D. S. W., and R56-AI061031 to Y.-L.T. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. T. R. S. was supported by the NSF Graduate Research Fellowship, as well as the ARCS Foundation. T. R. S. and D. S. W. have filed a related provisional patent.	Abplanalp AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007920; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bayer TS, 2005, RNA, V11, P1848, DOI 10.1261/rna.2167605; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Bryksin AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013244; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Gallagher LA, 2008, J BACTERIOL, V190, P7830, DOI 10.1128/JB.01188-08; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; JANIK A, 1976, J CLIN MICROBIOL, V4, P71; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones CL, 2012, CELL MICROBIOL, V14, P1531, DOI 10.1111/j.1462-5822.2012.01816.x; Jones CL, 2012, MICROBIOL MOL BIOL R, V76, P383, DOI 10.1128/MMBR.05027-11; Kumar P, 2011, MOL MICROBIOL, V79, P1557, DOI 10.1111/j.1365-2958.2011.07546.x; Llewellyn AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024201; Louwen R, 2013, EUR J CLIN MICROBIOL, V32, P207, DOI 10.1007/s10096-012-1733-4; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MENARD R, 1993, J BACTERIOL, V175, P5899; Postic G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041999; Postic G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-625; Schaible UE, 2002, METHOD MICROBIOL, V31, P343, DOI 10.1016/S0580-9517(02)31020-1; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08	32	280	340	12	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					254	+		10.1038/nature12048	http://dx.doi.org/10.1038/nature12048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23584588	Green Accepted			2022-12-28	WOS:000318558200039
J	Collier, F; Smith, RC; Morton, CA				Collier, Fiona; Smith, Robert C.; Morton, Colin A.			Diagnosis and management of hidradenitis suppurativa	BMJ-BRITISH MEDICAL JOURNAL			English	Review							THERAPY; ISOTRETINOIN; CLINDAMYCIN; INNATE		[Collier, Fiona] Stirling Community Hosp, Dept Dermatol, Stirling, Scotland; [Smith, Robert C.] Forth Valley Royal Hosp, Dept Surg, Larbert, England; [Morton, Colin A.] Forth Valley Royal Hosp, Dept Dermatol, Larbert, England		Collier, F (corresponding author), Alva Med Practice, Alva FK12 5BD, England.	fiona.collier@nhs.net			Forth Valley Research and Development Committee	Forth Valley Research and Development Committee	Study funding was received from Forth Valley Research and Development Committee.	Alikhan A, 2009, J AM ACAD DERMATOL, V60, P539, DOI 10.1016/j.jaad.2008.11.911; Blok JL, 2013, BRIT J DERMATOL, V168, P243, DOI 10.1111/bjd.12104; Boer J, 2011, BRIT J DERMATOL, V164, P170, DOI 10.1111/j.1365-2133.2010.10071.x; Boer J, 1999, J AM ACAD DERMATOL, V40, P73, DOI 10.1016/S0190-9622(99)70530-X; Brocard A, 2007, DERMATOLOGY, V214, P325, DOI 10.1159/000100883; CHURCH JM, 1993, INT J COLORECTAL DIS, V8, P117, DOI 10.1007/BF00341181; CLEMMENSEN OJ, 1983, INT J DERMATOL, V22, P325, DOI 10.1111/j.1365-4362.1983.tb02150.x; de Vries E, 2012, CLIN EXP IMMUNOL, V167, P108, DOI 10.1111/j.1365-2249.2011.04461.x; Dreno B, 2012, ARCH DERMATOL, V148, P182, DOI 10.1001/archdermatol.2011.315; FITZSIMMONS JS, 1985, J MED GENET, V22, P367, DOI 10.1136/jmg.22.5.367; Fogo A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5343; Gener G, 2009, DERMATOLOGY, V219, P148, DOI 10.1159/000228334; Giamarellos-Bourboulis EJ, 2007, BRIT J DERMATOL, V156, P51, DOI 10.1111/j.1365-2133.2006.07556.x; HARRISON BJ, 1985, BRIT J SURG, V72, P1002, DOI 10.1002/bjs.1800721223; Hazen PG, 2010, DERMATOL SURG, V36, P208, DOI 10.1111/j.1524-4725.2009.01427.x; Hurley H., 1989, DERMATOLOGIC SURG PR, V729, P39; Jemec GBE, 1998, J AM ACAD DERMATOL, V39, P971, DOI 10.1016/S0190-9622(98)70272-5; Jemec GBE, 1996, DERMATOLOGY, V193, P203, DOI 10.1159/000246246; Kraft JN, 2007, J CUTAN MED SURG, V11, P125, DOI 10.2310/7750.2007.00019; Lavogiez C, 2010, DERMATOLOGY, V220, P147, DOI 10.1159/000269836; Matusiak L, 2010, ACTA DERM-VENEREOL, V90, P264, DOI 10.2340/00015555-0866; Menderes A, 2010, INT J MED SCI, V7, P240; Mendonca CO, 2006, BRIT J DERMATOL, V154, P977, DOI 10.1111/j.1365-2133.2006.07155.x; Naldi L., 2006, HIDRADENITIS SUPPURA, P58, DOI 10.1007/978-3-540-33101-8_8; Revuz J, 2009, J EUR ACAD DERMATOL, V23, P985, DOI 10.1111/j.1468-3083.2009.03356.x; Revuz JE, 2008, J AM ACAD DERMATOL, V59, P596, DOI 10.1016/j.jaad.2008.06.020; Sabat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031810; Sartorius K, 2009, BRIT J DERMATOL, V161, P831, DOI 10.1111/j.1365-2133.2009.09198.x; Slade DEM, 2003, BRIT J PLAST SURG, V56, P451, DOI 10.1016/S0007-1226(03)00177-2; Soria A, 2009, DERMATOLOGY, V218, P134, DOI 10.1159/000182261; STELLON AJ, 1989, BRIT MED J, V298, P28, DOI 10.1136/bmj.298.6665.28; SUGIMOTO Y, 1995, J INVEST DERMATOL, V104, P775, DOI 10.1111/1523-1747.ep12606985; Tierney E, 2009, DERMATOL SURG, V35, P1188, DOI 10.1111/j.1524-4725.2009.01214.x; van der Zee HH, 2010, J AM ACAD DERMATOL, V63, P475, DOI 10.1016/j.jaad.2009.12.018; van der Zee HH, 2009, DERMATOLOGY, V219, P143, DOI 10.1159/000228337; Verdolini R, 2012, J EUR ACAD DERMATOL; von der Werth JM, 2000, J EUR ACAD DERMATOL, V14, P389, DOI 10.1046/j.1468-3083.2000.00087.x; WATSON JD, 1985, BRIT J PLAST SURG, V38, P567, DOI 10.1016/0007-1226(85)90022-0; Wolkenstein P, 2007, J AM ACAD DERMATOL, V56, P621, DOI 10.1016/j.jaad.2006.08.061; Yazdanyar S, 2011, DERMATOLOGY, V222, P342, DOI 10.1159/000329023; YU CCW, 1990, BRIT J DERMATOL, V122, P763	41	31	33	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2013	346								f2121	10.1136/bmj.f2121	http://dx.doi.org/10.1136/bmj.f2121			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134PL	23613539				2022-12-28	WOS:000318224800002
J	Berry, B				Berry, Barnett			Teacherpreneurs: A Bold Brand of Teacher Leadership for 21st-Century Teaching and Learning	SCIENCE			English	Article								Challenges facing our public schools demand a bold brand of teacher leadership. Teacherpreneurs, effective teachers who teach students regularly but also incubate and execute the kinds of policies and pedagogies students deserve, represent a new culture of training and ingenuity. Teachers who lead outside the classroom but do not lose their connection to students are best positioned to develop and disseminate best policies and practices for 21st-century teaching and learning.	Ctr Teaching Qual, Carrboro, NC 27510 USA		Berry, B (corresponding author), Ctr Teaching Qual, 605 West Main St, Carrboro, NC 27510 USA.	bberry@teachingquality.org						Berry B., 2013, TEACHERPRENEURS INNO; Branson R., 2012, WHAT IS YOUR DEFINIT; Bushaw B., 2012, KAPPAN; Cavaenaugh S., 2013, ED WEEK, V32, P7; Clotfelter C. T., 2007, WORKING PAPER SERIES, V13617; Coleman J., 1966, EQUALITY ED OPPORTUN; Darling-Hammond L., 2005, PREPARING TEACHERS C; Elmore R. F., 1996, HARV ED REV, V66; FERGUSON RF, 1991, HARVARD J LEGIS, V28, P465; Jackson C. K., 2009, TEACHING STUDENTS TE; Markow D., 2010, METLIFE SURVEY AM TE; MetLife Corportation, 2013, METL SURV AM TEACH C; National Research Council, 2000, PEOPLE LEARN BRAIN M; OECD, LESS PISA US STRONG; Rosenholtz S., 1991, TEACHERS WORKPLACE S; Strauss R., 1986, ECON EDUC REV, V5, P41, DOI DOI 10.1016/0272-7757(86)90161-5; Zell J. E., 2002, ART CHANGING BRAIN E	17	3	3	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					309	310		10.1126/science.1230580	http://dx.doi.org/10.1126/science.1230580			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126XZ	23599480				2022-12-28	WOS:000317657500041
J	Ferrini-Mundy, J				Ferrini-Mundy, Joan			Driven by Diversity	SCIENCE			English	Editorial Material									Natl Sci Fdn, Arlington, VA 22230 USA	National Science Foundation (NSF)	Ferrini-Mundy, J (corresponding author), Natl Sci Fdn, 4201 Wilson Blvd, Arlington, VA 22230 USA.	jferrini@nsf.gov						Bayer, 2012, STEM ED SCI LIT INN; Biomedical Research Workforce, 2012, WORK GROUP REP; Bush, 1945, SCI THE ENDLESS FRON, DOI DOI 10.1016/j.techsoc.2019.03.007; Carnevale A.P., 2011, STEM SCI TECHNOLOGY; Council of Graduate Schools and Educational Testing Service, 2012, PATHW GRAD SCH CAR; Duschl R. A., 2007, TAKING SCI SCH LEARN, DOI DOI 10.17226/11625; Hazari Z, 2010, J RES SCI TEACH, V47, P978, DOI 10.1002/tea.20363; Loes C., EFFECTS DIVERSITY EX; Nagda BA, 1998, REV HIGH EDUC, V22, P55; National Academy of Sciences National Academy of Engineering Institute of Medicine, 2011, EXP UND MIN PART AM; National Science Board, 2012, SCI ENG IND 2012; Olson S., 2012, ENG EXC PROD ON MILL; Page SE, 2007, DIFFERENCE POWER DIV; Subotnik R. F., 2011, NRC WORKSH SUCC STEM; U.S. Department of Education, CIV RIGHTS DAT COLL	15	31	31	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					278	278		10.1126/science.1235521	http://dx.doi.org/10.1126/science.1235521			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126XZ	23599467				2022-12-28	WOS:000317657500028
J	Rosell, R				Rosell, Rafael			Mediating Resistance in Oncogene-Driven Cancers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TGF-BETA RECEPTOR; LUNG-CANCER		[Rosell, Rafael] Catalan Inst Oncol, Badalona, Spain; [Rosell, Rafael] Dexeus Univ Inst, Pangaea Biotech, Breakthrough Canc Res Unit, Barcelona, Spain	Catalan Institute of Oncology	Rosell, R (corresponding author), Catalan Inst Oncol, Badalona, Spain.							Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Kim YW, 2012, BIOCHEM J, V445, P403, DOI 10.1042/BJ20111923; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Yang X, 2012, P NATL ACAD SCI USA, V109, pE2813, DOI 10.1073/pnas.1204311109	5	14	14	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1551	1552		10.1056/NEJMcibr1214549	http://dx.doi.org/10.1056/NEJMcibr1214549			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126HC	23594009				2022-12-28	WOS:000317603300016
J	Wilmshurst, P				Wilmshurst, Peter			No doctor should be untouchable	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hosp North Staffordshire, Stoke On Trent ST4 6QG, Staffs, England		Wilmshurst, P (corresponding author), Univ Hosp North Staffordshire, Stoke On Trent ST4 6QG, Staffs, England.	peter.wilmshurst@tiscali.co.uk						Wilmshurst P., 2006, CARDIOLOGY NEWS  OCT, V10, P13; Wilmshurst Peter, 2007, Med Leg J, V75, P3	2	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2013	346								f2338	10.1136/bmj.f2338	http://dx.doi.org/10.1136/bmj.f2338			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AZ	23599300				2022-12-28	WOS:000317964200014
J	Clase, CM; Zimmerman, DL; Thomson, BKA				Clase, Catherine M.; Zimmerman, Deborah L.; Thomson, Benjamin K. A.			Adding renal dysfunction to CHADS(2) did not improve prediction of stroke or systemic embolism in AF	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Clase, Catherine M.] McMaster Univ, Hamilton, ON, Canada; [Zimmerman, Deborah L.] Univ Ottawa, Ottawa, ON, Canada; [Thomson, Benjamin K. A.] Western Univ, London, ON, Canada	McMaster University; University of Ottawa; Western University (University of Western Ontario)	Clase, CM (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Thomson, Benjamin/ABG-6911-2021					Limdi NA, 2009, J AM SOC NEPHROL, V20, P912, DOI 10.1681/ASN.2008070802; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8							JC13	10.7326/0003-4819-158-8-201304160-02013	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588766				2022-12-28	WOS:000318062100004
J	Pickhardt, PJ; Pooler, BD; Lauder, T; del Rio, AM; Bruce, RJ; Binkley, N				Pickhardt, Perry J.; Pooler, B. Dustin; Lauder, Travis; del Rio, Alejandro Munoz; Bruce, Richard J.; Binkley, Neil			Opportunistic Screening for Osteoporosis Using Abdominal Computed Tomography Scans Obtained for Other Indications	ANNALS OF INTERNAL MEDICINE			English	Article							BONE-MINERAL DENSITY; OFFICIAL POSITIONS; CLINICAL-DENSITOMETRY; INTERNATIONAL-SOCIETY; POSTMENOPAUSAL WOMEN; OLDER WOMEN; FRACTURE; MEN; INTERVAL; CARE	Background: Osteoporosis is a prevalent but underdiagnosed condition. Objective: To evaluate computed tomography (CT)-derived bone mineral density (BMD) assessment compared with dual-energy x-ray absorptiometry (DXA) measures for identifying osteoporosis by using CT scans performed for other clinical indications. Design: Cross-sectional study. Setting: Single academic health center. Patients: 1867 adults undergoing CT and DXA (n = 2067 pairs) within a 6-month period over 10 years. Measurements: CT-attenuation values (in Hounsfield units [HU]) of trabecular bone between the T12 and L5 vertebral levels, with an emphasis on L1 measures (study test); DXA BMD measures (reference standard). Sagittal CT images assessed for moderate-to-severe vertebral fractures. Results: CT-attenuation values were significantly lower at all vertebral levels for patients with DXA-defined osteoporosis (P < 0.001). An L1 CT-attenuation threshold of 160 HU or less was 90% sensitive and a threshold of 110 HU was more than 90% specific for distinguishing osteoporosis from osteopenia and normal BMD. Positive predictive values for osteoporosis were 68% or greater at L1 CT-attenuation thresholds less than 100 HU; negative predictive values were 99% at thresholds greater than 200 HU. Among 119 patients with at least 1 moderate-to-severe vertebral fracture, 62 (52.1%) had nonosteoporotic T-scores (DXA false-negative results), and most (97%) had L1 or mean T12 to L5 vertebral attenuation of 145 HU or less. Similar performance was seen at all vertebral levels. Intravenous contrast did not affect CT performance. Limitation: The potential benefits and costs of using the various CT-attenuation thresholds identified were not formally assessed. Conclusion: Abdominal CT images obtained for other reasons that include the lumbar spine can be used to identify patients with osteoporosis or normal BMD without additional radiation exposure or cost.	[Pickhardt, Perry J.; Pooler, B. Dustin; Lauder, Travis; del Rio, Alejandro Munoz; Bruce, Richard J.; Binkley, Neil] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Pickhardt, PJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, E3-311 Clin Sci Ctr,600 Highland Ave, Madison, WI 53792 USA.	ppickhardt2@uwhealth.org			National Institutes of Health [1R01CA144835-01, 1R01CA169331-01]; NATIONAL CANCER INSTITUTE [R01CA169331, R01CA144835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Institutes of Health (grants 1R01CA144835-01 and 1R01CA169331-01).	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Altman DG, 2000, STAT CONFIDENCE CONF, P109; [Anonymous], 2010, CLIN GUID PREV TREAT; Baim S, 2008, J CLIN DENSITOM, V11, P75, DOI 10.1016/j.jocd.2007.12.007; Bessette L, 2008, OSTEOPOROSIS INT, V19, P79, DOI 10.1007/s00198-007-0426-9; CONRY CM, 1993, J FAM PRACTICE, V37, P356; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ebeling PR, 2008, NEW ENGL J MED, V358, P1474, DOI 10.1056/NEJMcp0707217; Engelke K, 2008, J CLIN DENSITOM, V11, P123, DOI 10.1016/j.jocd.2007.12.010; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Gourlay ML, 2012, NEW ENGL J MED, V366, P225, DOI 10.1056/NEJMoa1107142; Hans DB, 2011, J CLIN DENSITOM, V14, P171, DOI 10.1016/j.jocd.2011.05.007; IMV, 2011, IMV 2011 CT MARK OUT; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2010, OSTEOPOROSIS INT, V21, P407, DOI 10.1007/s00198-010-1253-y; King AB, 2011, HEALTH AFFAIR, V30, P2362, DOI 10.1377/hlthaff.2011.0233; Leslie WD, 2012, OSTEOPOROSIS INT, V23, P1623, DOI 10.1007/s00198-011-1630-1; Lewiecki EM, 2008, BONE, V43, P1115, DOI 10.1016/j.bone.2008.08.106; Lumley T., 2004, R NEWS; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Metge CJ, 2008, CAN FAM PHYSICIAN, V54, P1270; Nayak S, 2011, ANN INTERN MED, V155, P751, DOI 10.7326/0003-4819-155-11-201112060-00007; Pickhardt PJ, 2011, J BONE MINER RES, V26, P2194, DOI 10.1002/jbmr.428; R Development Core Team, 2012, R LANG ENV STAT COMP; Raisz LG, 2005, NEW ENGL J MED, V353, P164, DOI 10.1056/NEJMcp042092; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Siris ES, 2006, OSTEOPOROSIS INT, V17, P565, DOI 10.1007/s00198-005-0027-4; YU W, 1995, CALCIFIED TISSUE INT, V57, P169, DOI 10.1007/BF00310253	28	404	419	6	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8					588	+		10.7326/0003-4819-158-8-201304160-00003	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588747	Green Accepted			2022-12-28	WOS:000318062100015
J	Nandhagopal, R				Nandhagopal, Ramachandiran			PICTURE QUIZ Visual impairment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK STRATIFICATION; ATRIAL-FIBRILLATION; PREDICTING STROKE; THROMBOEMBOLISM; WARFARIN		Coll Med & Hlth Sci, Dept Med, Muscat 123, Oman		Nandhagopal, R (corresponding author), Coll Med & Hlth Sci, Dept Med, Muscat 123, Oman.	rnandagopal@yahoo.com		Ramachandiran, Nandhagopal/0000-0002-2379-0055				Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cornblath WT, 2010, SEMIN NEUROL, V30, P44, DOI 10.1055/s-0029-1244997; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Yamamoto Y, 1999, ARCH NEUROL-CHICAGO, V56, P824, DOI 10.1001/archneur.56.7.824	8	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 10	2013	346								f2163	10.1136/bmj.f2163	http://dx.doi.org/10.1136/bmj.f2163			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125ZK	23575567				2022-12-28	WOS:000317580600009
J	Dekkers, MPJ; Barde, YA				Dekkers, Martijn P. J.; Barde, Yves-Alain			Programmed Cell Death in Neuronal Development	SCIENCE			English	Editorial Material							NERVE GROWTH-FACTOR; RAT		[Dekkers, Martijn P. J.; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Dekkers, MPJ (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	yves.barde@unibas.ch		Barde, Yves/0000-0002-7627-461X; Dekkers, Martijn/0000-0002-1627-2882				Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Gartner A., 2008, WORMBOOK; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hatzold J, 2008, PLOS BIOL, V6, P771, DOI 10.1371/journal.pbio.0060084; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; MILLER MW, 1995, J COMP NEUROL, V355, P6, DOI 10.1002/cne.903550104; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Purves D., 1984, PRINCIPLES NEURAL DE, P131; Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010; Sahara S, 2012, J NEUROSCI, V32, P4755, DOI 10.1523/JNEUROSCI.6412-11.2012; Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523; SULSTON J, 1988, NEMATODE CAENORHABDI, P123	14	35	36	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2013	340	6128					39	41		10.1126/science.1236152	http://dx.doi.org/10.1126/science.1236152			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559240				2022-12-28	WOS:000317061100036
J	Zhang, SJ; Ye, J; Miao, CL; Tsao, A; Cerniauskas, I; Ledergerber, D; Moser, MB; Moser, EI				Zhang, Sheng-Jia; Ye, Jing; Miao, Chenglin; Tsao, Albert; Cerniauskas, Ignas; Ledergerber, Debora; Moser, May-Britt; Moser, Edvard I.			Optogenetic Dissection of Entorhinal-Hippocampal Functional Connectivity	SCIENCE			English	Article							GRID CELLS; SPATIAL REPRESENTATION; PATH-INTEGRATION; PLACE FIELDS; NEURONAL POPULATIONS; GABAERGIC NEURONS; CORTICAL-NEURONS; CORTEX; MAP; ACTIVATION	We used a combined optogenetic-electrophysiological strategy to determine the functional identity of entorhinal cells with output to the place-cell population in the hippocampus. Channelrhodopsin-2 (ChR2) was expressed selectively in the hippocampus-targeting subset of entorhinal projection neurons by infusing retrogradely transportable ChR2-coding recombinant adeno-associated virus in the hippocampus. Virally transduced ChR2-expressing cells were identified in medial entorhinal cortex as cells that fired at fixed minimal latencies in response to local flashes of light. A large number of responsive cells were grid cells, but short-latency firing was also induced in border cells and head-direction cells, as well as cells with irregular or nonspatial firing correlates, which suggests that place fields may be generated by convergence of signals from a broad spectrum of entorhinal functional cell types.	[Zhang, Sheng-Jia] Norwegian Univ Sci & Technol, Norwegian Brain Ctr, Kavli Inst Syst Neurosci, N-7491 Trondheim, Norway; Norwegian Univ Sci & Technol, Norwegian Brain Ctr, Ctr Neural Computat, N-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Zhang, SJ (corresponding author), Norwegian Univ Sci & Technol, Norwegian Brain Ctr, Kavli Inst Syst Neurosci, Olav Kyrres Gate 9, N-7491 Trondheim, Norway.	sheng-jia.zhang@ntnu.no; edvard.moser@ntnu.no	Ye, Jing/M-3366-2017	Ye, Jing/0000-0002-6364-4124	European Research Council (CIRCUIT) [232608]; Louis-Jeantet Prize for Medicine; Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway	European Research Council (CIRCUIT); Louis-Jeantet Prize for Medicine; Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway	The work was supported by an Advanced Investigator Grant from the European Research Council (CIRCUIT grant agreement no. 232608), the Louis-Jeantet Prize for Medicine, the Kavli Foundation, and the Centre of Excellence scheme of the Research Council of Norway. We thank M. P. Witter for discussion; A. M. Amundsgard, A. Buroy, K. Haugen, K. Jenssen, E. Krakvik, R. Skjerpeng, H. Waade, J. Wu, and Q. Zhang for technical assistance; K. Deisseroth for providing ChR2-H134R and eNpHR3.0 plasmids; and E. Boyden for providing Arch plasmid. S.-J.Z., J.Y., M.-B.M., and E. I. M. planned and designed the study; S.-J.Z. designed and performed all molecular biology, modified and made all viruses, and performed all surgeries; J.Y., C. M., I. C., S.-J.Z., and D. L. performed experimental recordings; J.Y. performed analyses and made figures; A. T., C. M., and J.Y. designed the laser system; A. T. made stimulation and shuffle programs; M.-B.M. and E. I. M. supervised experiments and analyses; and E. I. M. wrote the paper with input from all authors. The molecular biology sections were written by S.-J.Z, with some support from E. I. M. All authors discussed analyses and results.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Barry C, 2006, REV NEUROSCIENCE, V17, P71; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; FOX SE, 1981, EXP BRAIN RES, V41, P399; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; GERMROTH P, 1989, BRAIN RES, V494, P187, DOI 10.1016/0006-8993(89)90162-5; Gothard KM, 1996, J NEUROSCI, V16, P8027; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kaspar BK, 2002, MOL THER, V5, P50, DOI 10.1006/mthe.2001.0520; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; Monaco JD, 2011, J NEUROSCI, V31, P9414, DOI 10.1523/JNEUROSCI.1433-11.2011; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Muller R. U., 1991, BRAIN SPACE, P296; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Rivard B, 2004, J GEN PHYSIOL, V124, P9, DOI 10.1085/jgp.200409015; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2010, J NEUROPHYSIOL, V103, P3167, DOI 10.1152/jn.00932.2009; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Skaggs WE, 1993, ADV NEURAL INFORM PR, V5, P1030, DOI DOI 10.1109/PROC.1977.10559; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Terrazas A, 2005, J NEUROSCI, V25, P8085, DOI 10.1523/JNEUROSCI.0693-05.2005; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; WITTER MP, 1988, NEUROSCIENCE, V24, P519, DOI 10.1016/0306-4522(88)90347-8; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	61	159	164	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2013	340	6128					44	U17	1232627	10.1126/science.1232627	http://dx.doi.org/10.1126/science.1232627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151YZ	23559255				2022-12-28	WOS:000319497600001
J	O'Connor, E; Gaynes, BN; Burda, BU; Soh, C; Whitlock, EP				O'Connor, Elizabeth; Gaynes, Bradley N.; Burda, Brittany U.; Soh, Clara; Whitlock, Evelyn P.			Screening for and Treatment of Suicide Risk Relevant to Primary Care: A Systematic Review for the U.S. Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; DELIBERATE SELF-HARM; DIALECTICAL BEHAVIOR-THERAPY; BORDERLINE PERSONALITY-DISORDER; PROBLEM-SOLVING THERAPY; TERM LITHIUM TREATMENT; FOLLOW-UP; COGNITIVE THERAPY; PARTIAL HOSPITALIZATION; POSTCARD INTERVENTION	Background: In 2009, suicide accounted for 36 897 deaths in the United States. Purpose: To review the accuracy of screening instruments and the efficacy and safety of screening for and treatment of suicide risk in populations and settings relevant to primary care. Data Sources: Citations from MEDLINE, PsycINFO, the Cochrane Central Register of Controlled Trials, and CINAHL (2002 to 17 July 2012); gray literature; and a surveillance search of MEDLINE for additional screening trials (July to December 2012). Study Selection: Fair-or good-quality English-language studies that assessed the accuracy of screening instruments in primary care or similar populations and trials of suicide prevention interventions in primary or mental health care settings. Data Extraction: One investigator abstracted data; a second checked the abstraction. Two investigators rated study quality. Data Synthesis: Evidence was insufficient to determine the benefits of screening in primary care populations; very limited evidence identified no serious harms. Minimal evidence suggested that screening tools can identify some adults at increased risk for suicide in primary care, but accuracy was lower in studies of older adults. Minimal evidence limited to high-risk populations suggested poor performance of screening instruments in adolescents. Trial evidence showed that psychotherapy reduced suicide attempts in high-risk adults but not adolescents. Most trials were insufficiently powered to detect effects on deaths. Limitation: Treatment evidence was derived from high-risk rather than screening-detected populations. Evidence relevant to adolescents, older adults, and racial or ethnic minorities was limited. Conclusion: Primary care-feasible screening tools might help to identify some adults at increased risk for suicide but have limited ability to detect suicide risk in adolescents. Psychotherapy may reduce suicide attempts in some high-risk adults, but effective interventions for high-risk adolescents are not yet proven.	Kaiser Permanente Northwest, Portland, OR USA; Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; Pharmaceut Res & Manufacturers Amer, Washington, DC 20004 USA	Kaiser Permanente; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	O'Connor, E (corresponding author), Kaiser Permanente NW, Ctr Hlth Res, 3800 North Interstate Ave, Portland, OR 97227 USA.	elizabeth.oconnor@kpchr.org		Gaynes, Bradley/0000-0002-8283-5030	Oregon Evidence-based Practice Center [HHS-290-2007-10057-I]	Oregon Evidence-based Practice Center	Grant Support: By the Oregon Evidence-based Practice Center under contract to AHRQ, Rockville, Maryland (contract HHS-290-2007-10057-I).	Alexopoulos GS, 2009, AM J PSYCHIAT, V166, P882, DOI 10.1176/appi.ajp.2009.08121779; ALLARD R, 1992, SUICIDE LIFE-THREAT, V22, P303; Almeida OP, 2012, ANN FAM MED, V10, P347, DOI 10.1370/afm.1368; Angst F, 2002, J AFFECT DISORDERS, V68, P167, DOI 10.1016/S0165-0327(01)00377-9; [Anonymous], 2003, Am J Psychiatry, V160, P1; [Anonymous], 2012, COCHRANE HDB SYSTEMA; Arensman E, 2004, PSYCHOL MED, V34, P1143, DOI 10.1017/S0033291704002752; Baldessarini RJ, 2006, BIPOLAR DISORD, V8, P625, DOI 10.1111/j.1399-5618.2006.00344.x; Bannan N, 2010, COUNS PSYCHOTHER RES, V10, P201, DOI 10.1080/14733140903337292; Bao YH, 2011, ARCH GEN PSYCHIAT, V68, P627, DOI 10.1001/archgenpsychiatry.2011.55; Barnes AJ, 2011, EVID-BASED MENT HEAL, V14, P8, DOI 10.1136/ebmh.14.1.8; Bateman A, 1999, AM J PSYCHIAT, V156, P1563, DOI 10.1176/ajp.156.10.1563; Bateman A, 2001, AM J PSYCHIAT, V158, P36, DOI 10.1176/appi.ajp.158.1.36; Beautrais AL, 2010, BRIT J PSYCHIAT, V197, P55, DOI 10.1192/bjp.bp.109.075754; Bennewith O, 2002, BRIT MED J, V324, P1254, DOI 10.1136/bmj.324.7348.1254; Bogner HR, 2007, DIABETES CARE, V30, P3005, DOI 10.2337/dc07-0974; Bolton JM, 2010, AM J PUBLIC HEALTH, V100, P2473, DOI 10.2105/AJPH.2010.192252; Borenstein M., 2009, INTRO METAANALYSIS; Borges G, 2006, PSYCHOL MED, V36, P1747, DOI 10.1017/S0033291706008786; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; Bruce ML, 2004, JAMA-J AM MED ASSOC, V291, P1081, DOI 10.1001/jama.291.9.1081; Byers AL, 2009, AM J GERIAT PSYCHIAT, V17, pA86; Carter GL, 2005, BMJ-BRIT MED J, V331, P805, DOI 10.1136/bmj.38579.455266.E0; Carter GL, 2007, BRIT J PSYCHIAT, V191, P548, DOI 10.1192/bjp.bp.107.038406; Carter GL, 2010, AUST NZ J PSYCHIAT, V44, P162, DOI 10.3109/00048670903393621; CDC, 2021, CTR DIS CONTROL PREV; Cedereke M, 2002, EUR PSYCHIAT, V17, P82, DOI 10.1016/S0924-9338(02)00632-6; Centers for Disease Control and Prevention, 2012, YEARS POT LIF LOST Y; Chanen AM, 2008, BRIT J PSYCHIAT, V193, P477, DOI 10.1192/bjp.bp.107.048934; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; Clarke T., 2002, J MENT HEALTH, V11, P167, DOI DOI 10.1080/09638230020023561-1; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Comtois KA, 2011, DEPRESS ANXIETY, V28, P963, DOI 10.1002/da.20895; Coyne JC, 2004, JAMA-J AM MED ASSOC, V291, P2814, DOI 10.1001/jama.291.23.2814-a; Crawford MJ, 2010, PSYCHOL MED, V40, P1821, DOI 10.1017/S0033291709991899; Crawford MJ, 2011, BRIT J PSYCHIAT, V198, P379, DOI 10.1192/bjp.bp.110.083592; Currier GW, 2010, ACAD EMERG MED, V17, P36, DOI 10.1111/j.1553-2712.2009.00619.x; Davidson K, 2004, PSYCHOL MED, V34, P855, DOI 10.1017/S0033291703001855; Diamond GS, 2010, J AM ACAD CHILD PSY, V49, P122, DOI 10.1016/j.jaac.2009.11.002; Donaldson D, 2005, J AM ACAD CHILD PSY, V44, P113, DOI 10.1097/00004583-200502000-00003; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Eggert Leona L, 2002, J Child Adolesc Psychiatr Nurs, V15, P48, DOI 10.1111/j.1744-6171.2002.tb00326.x; EKEBERG O, 1991, ACTA PSYCHIAT SCAND, V83, P432, DOI 10.1111/j.1600-0447.1991.tb05570.x; Esposito-Smythers C, 2012, COGN BEHAV PRACT, V19, P245; Esposito-Smythers C, 2011, J CONSULT CLIN PSYCH, V79, P728, DOI 10.1037/a0026074; Evans K, 1999, PSYCHOL MED, V29, P19, DOI 10.1017/S003329179800765X; Fitzpatrick KK, 2005, BEHAV THER, V36, P323, DOI 10.1016/S0005-7894(05)80114-5; Freedenthal S, 2008, ARCH SUICIDE RES, V12, P277, DOI 10.1080/13811110802324698; Gallo JJ, 2007, ANN INTERN MED, V146, P689, DOI 10.7326/0003-4819-146-10-200705150-00002; Garssen J, 2011, SUICIDE LIFE-THREAT, V41, P585, DOI 10.1111/j.1943-278X.2011.00050.x; Gaynes BN, 2004, ANN INTERN MED, V140, P822, DOI 10.7326/0003-4819-140-10-200405180-00015; Ghahramanlou-Holloway M, 2012, PSYCHOL MED, V42, P1185, DOI 10.1017/S0033291711002169; Goldney RD, 2002, SUICIDE LIFE-THREAT, V32, P454, DOI 10.1521/suli.32.4.454.22337; Gould MS, 2005, JAMA-J AM MED ASSOC, V293, P1635, DOI 10.1001/jama.293.13.1635; Grandjean EM, 2009, CNS DRUGS, V23, P397, DOI 10.2165/00023210-200923050-00004; Greenfield B, 2002, PSYCHIATR SERV, V53, P1574, DOI 10.1176/appi.ps.53.12.1574; Guthrie E, 2003, AUST NZ J PSYCHIAT, V37, P532, DOI 10.1046/j.1440-1614.2003.01197.x; Guthrie E, 2001, BRIT MED J, V323, P135, DOI 10.1136/bmj.323.7305.135; Hamza CA, 2012, CLIN PSYCHOL REV, V32, P482, DOI 10.1016/j.cpr.2012.05.003; Harned MS, 2010, J TRAUMA STRESS, V23, P421, DOI 10.1002/jts.20553; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hassanian-Moghaddam H, 2011, BRIT J PSYCHIAT, V198, P309, DOI 10.1192/bjp.bp.109.067199; Hatcher S, 2011, BRIT J PSYCHIAT, V199, P310, DOI 10.1192/bjp.bp.110.090126; HAWTON K, 1987, PSYCHOL MED, V17, P751, DOI 10.1017/S0033291700025988; Hawton K, 2000, COCHRANE DATABASE SY; Hazell PL, 2009, J AM ACAD CHILD PSY, V48, P662, DOI [10.1097/CHI.0b013e3181aOacec, 10.1097/CHI.0b013e3181a0acec]; Heisel MJ, 2010, J AM BOARD FAM MED, V23, P260, DOI 10.3122/jabfm.2010.02.080163; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holi MM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-97; Hooven C, 2012, FAM COMMUNITY HEALTH, V35, P225, DOI 10.1097/FCH.0b013e318250bcf9; Hysinger EB, 2011, PEDIATRICS, V128, P447, DOI 10.1542/peds.2010-3262; Isometsa ET, 1998, BRIT J PSYCHIAT, V173, P531, DOI 10.1192/bjp.173.6.531; King CA, 2009, J CONSULT CLIN PSYCH, V77, P880, DOI 10.1037/a0016552; Kovac SH, 2002, SUICIDE LIFE-THREAT, V32, P428, DOI 10.1521/suli.32.4.428.22335; Lauterbach E, 2008, ACTA PSYCHIAT SCAND, V118, P469, DOI 10.1111/j.1600-0447.2008.01266.x; Li ZY, 2011, SOC SCI MED, V72, P608, DOI 10.1016/j.socscimed.2010.11.008; Linehan MM, 2006, ARCH GEN PSYCHIAT, V63, P757, DOI 10.1001/archpsyc.63.7.757; LINEHAN MM, 1991, ARCH GEN PSYCHIAT, V48, P1060; Luoma JB, 2002, AM J PSYCHIAT, V159, P909, DOI 10.1176/appi.ajp.159.6.909; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Marasinghe RB, 2012, J TELEMED TELECARE, V18, P151, DOI [10.1258/jtt.2012.SfT107, 10.1258/jtt.2012.SFT107]; McCarty CA, 2011, ACAD PEDIATR, V11, P422, DOI 10.1016/j.acap.2011.01.004; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; McNeill YL, 2002, FAM PRACT, V19, P461, DOI 10.1093/fampra/19.5.461; Motto JA, 2001, PSYCHIATR SERV, V52, P828, DOI 10.1176/appi.ps.52.6.828; National Institute for Health and Clinical Excellence, 2011, SELF HARM NICE GUID; NIELSEN B, 1990, ACTA PSYCHIAT SCAND, V81, P250, DOI 10.1111/j.1600-0447.1990.tb06490.x; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; NORDSTROM P, 1995, ACTA PSYCHIAT SCAND, V92, P345, DOI 10.1111/j.1600-0447.1995.tb09595.x; O'Connor EA, 2012, SCREENING SUICIDE RI; O'Connor EA, 2009, ANN INTERN MED, V151, P793, DOI 10.7326/0003-4819-151-11-200912010-00007; O'Neil ME, 2012, SUICIDE PREVENTION I; Olfson M, 1996, J GEN INTERN MED, V11, P447, DOI 10.1007/BF02599038; Ougrin D, 2011, EVID-BASED MENT HEAL, V14, P84, DOI 10.1136/ebmh.14.3.84; Pena JB, 2006, SUICIDE LIFE-THREAT, V36, P614, DOI 10.1521/suli.2006.36.6.614; Perlis RH, 2011, AM J PSYCHIAT, V168, P1009, DOI 10.1176/appi.ajp.2011.11081250; Randell BP, 2001, SUICIDE LIFE-THREAT, V31, P41, DOI 10.1521/suli.31.1.41.21308; Reynolds SK, 2006, SUICIDE LIFE-THREAT, V36, P19, DOI 10.1521/suli.2006.36.1.19; Robinson J, 2012, EARLY INTERV PSYCHIA, V6, P145, DOI 10.1111/j.1751-7893.2011.00334.x; Robinson J, 2011, CRISIS, V32, P254, DOI 10.1027/0227-5910/a000087; Robinson J, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-59; Rudd MD, 1996, J CONSULT CLIN PSYCH, V64, P179, DOI 10.1037/0022-006X.64.1.179; Samaraweera S, 2007, EUR J PSYCHIAT, V21, P175, DOI 10.4321/s0213-61632007000300001; Seguin M, 2011, J PSYCHIATR RES, V45, P863, DOI 10.1016/j.jpsychires.2011.05.005; Slee N, 2008, CLIN PSYCHOL PSYCHOT, V15, P205, DOI 10.1002/cpp.577; Slee N, 2008, BRIT J PSYCHIAT, V192, P202, DOI 10.1192/bjp.bp.107.037564; Steele MM, 2007, CAN J PSYCHIAT, V52, p21S; Steele MM, 2007, CAN J PSYCHIAT, V52, p35S; Szanto K, 2007, ARCH GEN PSYCHIAT, V64, P914, DOI 10.1001/archpsyc.64.8.914; Tang TC, 2009, PSYCHIAT CLIN NEUROS, V63, P463, DOI 10.1111/j.1440-1819.2009.01991.x; Tepper M, 2005, JAMA-J AM MED ASSOC, V294, P2847, DOI 10.1001/jama.294.22.2847-b; Thombs Brett D, 2008, Diabetes Care, V31, pe55, DOI 10.2337/dc08-0446; Thompson EA, 1999, J AM ACAD CHILD PSY, V38, P1506, DOI 10.1097/00004583-199912000-00011; Thompson EA, 2001, AM J PUBLIC HEALTH, V91, P742, DOI 10.2105/AJPH.91.5.742; Tidemalm D, 2011, PSYCHOL MED, V41, P2527, DOI 10.1017/S0033291711000833; Tyrer P, 2004, J PERS DISORD, V18, P102, DOI 10.1521/pedi.18.1.102.32770; Tyrer P, 2003, INT J SOC PSYCHIATR, V49, P58, DOI 10.1177/0020764003049001148; Tyrer P, 2003, PSYCHOL MED, V33, P969, DOI 10.1017/S0033291703008171; Vaiva G, 2006, BRIT MED J, V332, P1241, DOI 10.1136/bmj.332.7552.1241; van den Bosch LMC, 2005, BEHAV RES THER, V43, P1231, DOI 10.1016/j.brat.2004.09.008; VANHEERINGEN C, 1995, PSYCHOL MED, V25, P963, DOI 10.1017/S0033291700037454; Verheul R, 2003, BRIT J PSYCHIAT, V182, P135, DOI 10.1192/bjp.182.2.135; WELU TC, 1977, SUICIDE LIFE-THREAT, V7, P17; Werneke U, 2012, ACTA PSYCHIAT SCAND, V126, P186, DOI 10.1111/j.1600-0447.2012.01847.x; Wexler LM, 2012, AM J PUBLIC HEALTH, V102, P800, DOI 10.2105/AJPH.2011.300432; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Williamson MK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-42; Wood A, 2001, J AM ACAD CHILD PSY, V40, P1246, DOI 10.1097/00004583-200111000-00003; Wortzel HS, 2010, SUICIDE LIFE-THREAT, V40, P500, DOI 10.1521/suli.2010.40.5.500	130	114	114	0	43	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10					741	+		10.7326/0003-4819-158-10-201305210-00642	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-00642			27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	154HY	23609101				2022-12-28	WOS:000319666200017
J	Rock, JM; Lim, D; Stach, L; Ogrodowicz, RW; Keck, JM; Jones, MH; Wong, CCL; Yates, JR; Winey, M; Smerdon, SJ; Yaffe, MB; Amon, A				Rock, Jeremy M.; Lim, Daniel; Stach, Lasse; Ogrodowicz, Roksana W.; Keck, Jamie M.; Jones, Michele H.; Wong, Catherine C. L.; Yates, John R., III; Winey, Mark; Smerdon, Stephen J.; Yaffe, Michael B.; Amon, Angelika			Activation of the Yeast Hippo Pathway by Phosphorylation-Dependent Assembly of Signaling Complexes	SCIENCE			English	Article							MITOTIC EXIT; SCAFFOLD PROTEINS; FHA DOMAIN; KINASE; INFORMATION; PHOSPHATASE; CENTROSOME; MITOSIS; TEM1	Scaffold-assisted signaling cascades guide cellular decision-making. In budding yeast, one such signal transduction pathway called the mitotic exit network (MEN) governs the transition from mitosis to the G(1) phase of the cell cycle. The MEN is conserved and in metazoans is known as the Hippo tumor-suppressor pathway. We found that signaling through the MEN kinase cascade was mediated by an unusual two-step process. The MEN kinase Cdc15 first phosphorylated the scaffold Nud1. This created a phospho-docking site on Nud1, to which the effector kinase complex Dbf2-Mob1 bound through a phosphoserine-threonine binding domain, in order to be activated by Cdc15. This mechanism of pathway activation has implications for signal transmission through other kinase cascades and might represent a general principle in scaffold-assisted signaling.	[Rock, Jeremy M.; Lim, Daniel; Yaffe, Michael B.; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Rock, Jeremy M.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Stach, Lasse; Ogrodowicz, Roksana W.; Smerdon, Stephen J.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Keck, Jamie M.; Jones, Michele H.; Winey, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, UCB 347, Boulder, CO 80309 USA; [Wong, Catherine C. L.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); MRC National Institute for Medical Research; University of Colorado System; University of Colorado Boulder; Scripps Research Institute	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu		Ogrodowicz, Roksana/0000-0002-3176-7744; Smerdon, Stephen/0000-0001-5688-8465; Amon, Angelika/0000-0001-9837-0314; Wong, Catherine CL/0000-0001-7270-980X; Rock, Jeremy/0000-0002-9310-951X	NIH [GM056800, CA112967, ES015339, P41 RR011823, GM51312, F32 GM086038]; MRC UK [U117584228]; MRC; NSF; NATIONAL CANCER INSTITUTE [U54CA112967, P30CA014051] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051312, F32GM086038, P41GM103533, R01GM056800, R29GM056800] Funding Source: NIH RePORTER; MRC [MC_U117584228] Funding Source: UKRI; Medical Research Council [MC_U117584228] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank I. Cheeseman, F. Solomon, and the Amon lab for comments and E. Schiebel for reagents. Coordinates and structure factors for the hMob1-phosphopeptide complex have been deposited with the Protein Data Bank (PDBID: 4JIZ). Supported by the NIH (GM056800 to A. A.; CA112967 and ES015339 to M.B.Y; P41 RR011823 to J.R.Y. III and T. N. Davis, principal investigator; and GM51312 to M. W.); MRC UK (U117584228) to S.J.S; MRC centenary fellowship to L. S.; NIH F32 GM086038 to J.M.K.; and NSF Predoctoral Fellowship to J.M.R. A. A. is an investigator of the Howard Hughes Medical Institute.	Caydasi AK, 2012, EXP CELL RES, V318, P1421, DOI 10.1016/j.yexcr.2012.03.031; Ding Z, 2007, BIOCHEMISTRY-US, V46, P2684, DOI 10.1021/bi061763n; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Geymonat M, 2009, J CELL BIOL, V187, P497, DOI 10.1083/jcb.200905114; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Gruneberg U, 2000, EMBO J, V19, P6475, DOI 10.1093/emboj/19.23.6475; Hergovich A, 2012, SEMIN CELL DEV BIOL, V23, P794, DOI 10.1016/j.semcdb.2012.04.001; Keck JM, 2011, SCIENCE, V332, P1557, DOI 10.1126/science.1205193; Konig C, 2010, J CELL BIOL, V188, P351, DOI 10.1083/jcb.200911128; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Maekawa H, 2007, J CELL BIOL, V179, P423, DOI 10.1083/jcb.200705197; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Mrkobrada S, 2006, J MOL BIOL, V362, P430, DOI 10.1016/j.jmb.2006.07.007; Park CJ, 2008, EUKARYOT CELL, V7, P444, DOI 10.1128/EC.00283-07; Rock JM, 2011, GENE DEV, V25, P1943, DOI 10.1101/gad.17257711; Shou WY, 2001, MOL CELL, V8, P45, DOI 10.1016/S1097-2765(01)00291-X; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Valerio-Santiago M, 2011, J CELL BIOL, V192, P599, DOI 10.1083/jcb.201007044	19	76	78	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					871	875		10.1126/science.1235822	http://dx.doi.org/10.1126/science.1235822			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23579499	Green Published, Green Accepted			2022-12-28	WOS:000318997400046
J	Conti, RM; Bach, PB				Conti, Rena M.; Bach, Peter B.			Cost Consequences of the 340B Drug Discount Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Conti, Rena M.] Univ Chicago, Dept Pediat, Hematol Oncol Sect, Chicago, IL 60637 USA; [Bach, Peter B.] Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, New York, NY 10021 USA	University of Chicago; Memorial Sloan Kettering Cancer Center	Conti, RM (corresponding author), Univ Chicago, Dept Pediat, Hematol Oncol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	rconti@uchicago.edu			NATIONAL CANCER INSTITUTE [P30CA008748, K07CA138906] Funding Source: NIH RePORTER; NCI NIH HHS [K07 CA138906, P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander A, 2013, CHARLOTTE OBSERVER; *C BUDG OFF, 1996, MED REB PRESCR DRUGS; Centers BJ, 2013, 340B U C MARCH 11 BA; Cuellar AE, 2006, J HEALTH ECON, V25, P1, DOI 10.1016/j.jhealeco.2005.04.009; Fitch K, 2011, MILLIMAN INC SITE SE; Jacobson M, 2010, HEALTH AFFAIR, V29, P1391, DOI 10.1377/hlthaff.2009.0563; Pollack A, NY TIMES; TAYLOR M, 2010, HOSP HEALTH NETWORK, V84, P12; United States Government Accountability Office, 2011, GAO11836	9	41	42	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2013	309	19					1995	1996		10.1001/jama.2013.4156	http://dx.doi.org/10.1001/jama.2013.4156			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143GQ	23609758	Green Accepted			2022-12-28	WOS:000318855500018
J	Miroshnichenko, AE; Kivshar, YS				Miroshnichenko, Andrey E.; Kivshar, Yuri S.			Polarization Traffic Control for Surface Plasmons	SCIENCE			English	Editorial Material							INTERFERENCE; SCATTERING; EXCITATION		[Miroshnichenko, Andrey E.; Kivshar, Yuri S.] Australian Natl Univ, Nonlinear Phys Ctr, Canberra, ACT 0200, Australia	Australian National University	Miroshnichenko, AE (corresponding author), Australian Natl Univ, Nonlinear Phys Ctr, GPO Box 4, Canberra, ACT 0200, Australia.	aem124@physics.anu.edu.au; ysk124@physics.anu.edu.au	Kivshar, Yuri/AAJ-1901-2020; Kivshar, Yuri/ABA-7970-2020; Miroshnichenko, Andrey E./E-4285-2013	Kivshar, Yuri/0000-0002-3410-812X; Miroshnichenko, Andrey E./0000-0001-9607-6621				Hecht B, 1996, PHYS REV LETT, V77, P1889, DOI 10.1103/PhysRevLett.77.1889; Li L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.126804; Li L, 2011, NANO LETT, V11, P4357, DOI 10.1021/nl2024855; Lin J, 2013, SCIENCE, V340, P331, DOI 10.1126/science.1233746; Lin J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.093904; Liu W, 2012, ACS NANO, V6, P5489, DOI 10.1021/nn301398a; Lopez-Tejeira F, 2007, NAT PHYS, V3, P324, DOI 10.1038/nphys584; Minovich A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.116802; Rodriguez-Fortuno FJ, 2013, SCIENCE, V340, P328, DOI 10.1126/science.1233739; Rotenberg N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.127402; Yin LL, 2005, NANO LETT, V5, P1399, DOI 10.1021/nl050723m; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zheludev NI, 2012, NAT MATER, V11, P917, DOI [10.1038/NMAT3431, 10.1038/nmat3431]	13	52	55	2	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					283	284		10.1126/science.1236154	http://dx.doi.org/10.1126/science.1236154			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599471				2022-12-28	WOS:000317657500032
J	Hahn, BH				Hahn, Bevra Hannahs			Belimumab for Systemic Lupus Erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-LYMPHOCYTE STIMULATOR; DISEASE-ACTIVITY; ASSOCIATION; GENES	This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major clinical studies, the clinical use of this therapy, and potential adverse effects are reviewed. Relevant formal guidelines, if they exist, are presented. The article ends with the author's clinical recommendations. A 20-year-old woman was evaluated by her rheumatologist because she was disabled by flares of systemic lupus erythematosus (SLE). A diagnosis of SLE had been made 2 years earlier, on the basis of a photosensitive malar rash, oral ulcers, polyarthritis, pericarditis, and positive assays for antinuclear antibodies (ANA) and anti-double-stranded DNA (dsDNA) antibodies. Treatment with analgesics and hydroxychloroquine for 6 months was not beneficial; prednisone at a dose of 40 mg daily resulted in some improvement, but the patient gained 6.8 kg (15 lb) and required two hospitalizations for infections. SLE flares occurred when the prednisone dose was less than 30 mg daily. Trials of methotrexate, mycophenolate mofetil, and azathioprine either had unacceptable side effects or failed to control flares or permit prednisone tapering. On examination, she had cushingoid features with 20 swollen, tender joints and 3 oral ulcers. The ANA titer was positive, at 1:320. An assay for anti-dsDNA antibodies was negative, and the serum complement level was normal. The rheumatologist recommended a trial of belimumab.	[Hahn, Bevra Hannahs] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hahn, BH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Rheumatol, 1000 Vet Ave, Los Angeles, CA 90095 USA.	bhahn@mednet.ucla.edu			UCB; Abbott Laboratories; Eli Lilly; Aspreva Pharmaceuticals; Teva Pharmaceuticals; Anthera Pharmaceuticals	UCB(UCB Pharma SA); Abbott Laboratories(Abbott Laboratories); Eli Lilly(Eli Lilly); Aspreva Pharmaceuticals; Teva Pharmaceuticals(Teva Pharmaceutical Industries); Anthera Pharmaceuticals	Dr. Hahn reports receiving consulting fees through her institution from UCB, Abbott Laboratories, and Eli Lilly; grant support through her institution from Aspreva Pharmaceuticals and Teva Pharmaceuticals; and fees for serving on a data and safety monitoring board from Anthera Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Chatham WW, 2012, J RHEUMATOL, V39, P1632, DOI 10.3899/jrheum.111587; Costenbader KH, 2012, AUTOIMMUN REV, V11, P604, DOI 10.1016/j.autrev.2011.10.022; Davidson A, 2010, CURR OPIN IMMUNOL, V22, P732, DOI 10.1016/j.coi.2010.09.010; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Dorner T, 2011, J IMMUNOL METHODS, V363, P187, DOI 10.1016/j.jim.2010.06.009; Dooley MA, 2013, LUPUS, V22, P63, DOI 10.1177/0961203312465781; Fessler BJ, 2005, ARTHRITIS RHEUM, V52, P1473, DOI 10.1002/art.21039; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Furie RA, 2009, ARTHRIT RHEUM-ARTHR, V61, P1143, DOI 10.1002/art.24698; GlaxoSmithKline, 2012, ASS BENL BEL HYP INF; Green NM, 2011, SEMIN IMMUNOL, V23, P106, DOI 10.1016/j.smim.2011.01.016; Hahn BH., 2013, DUBOISLUPUS ERYTHEMA, V8th ed, P25; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Isenberg DA, 2000, LUPUS, V9, P651, DOI 10.1191/096120300672904669; Jacobi AM, 2010, ARTHRITIS RHEUM-US, V62, P201, DOI 10.1002/art.27189; Jacobi AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005776; James JA, 2006, CURR OPIN RHEUMATOL, V18, P462, DOI 10.1097/01.bor.0000240355.37927.94; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Manzi S, 2012, ANN RHEUM DIS, V71, P1833, DOI 10.1136/annrheumdis-2011-200831; Merrill JT, 2012, ARTHRITIS RHEUM-US, V64, P3364, DOI 10.1002/art.34564; MicroMedEx, 2012, BEL; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Nikpour M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1152, DOI 10.1002/art.24741; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Petri M, 2008, ARTHRITIS RHEUM, V58, P2453, DOI 10.1002/art.23678; Pons-Estel GJ, 2010, SEMIN ARTHRITIS RHEU, V39, P257, DOI 10.1016/j.semarthrit.2008.10.007; Rose BD, 2012, END STAGE RENAL DIS; Sestak AL, 2011, ANN RHEUM DIS, V70, pI37, DOI 10.1136/ard.2010.138057; Singh RP, 2012, AUTOIMMUN REV, V11, P664, DOI 10.1016/j.autrev.2011.11.017; Slawsky KA, 2011, ARTHRIT CARE RES, V63, P1224, DOI 10.1002/acr.20502; Touma Z., 2013, DUBOIS LUPUS ERYTHEM, P563; van Vollenhoven RF, 2012, ANN RHEUM DIS, V71, P1343, DOI 10.1136/annrheumdis-2011-200937; Wallace DJ, 2013, LUPUS, V22, P144, DOI 10.1177/0961203312469259; Yelin E, 2012, ARTHRIT CARE RES, V64, P169, DOI 10.1002/acr.20669	37	94	100	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1528	1535		10.1056/NEJMct1207259	http://dx.doi.org/10.1056/NEJMct1207259			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126HC	23594005				2022-12-28	WOS:000317603300010
J	Shimozono, S; Iimura, T; Kitaguchi, T; Higashijima, S; Miyawaki, A				Shimozono, Satoshi; Iimura, Tadahiro; Kitaguchi, Tetsuya; Higashijima, Shin-ichi; Miyawaki, Atsushi			Visualization of an endogenous retinoic acid gradient across embryonic development	NATURE			English	Article							BINDING PROTEINS; HINDBRAIN DEVELOPMENT; MORPHOGEN GRADIENT; GENE-EXPRESSION; DISTINCT ROLES; ZEBRAFISH; BOUNDARY; FGF8; PATTERN; DIFFERENTIATION	In vertebrate development, the body plan is determined by primordial morphogen gradients that suffuse the embryo. Retinoic acid (RA) is an important morphogen involved in patterning the anterior-posterior axis of structures, including the hindbrain(1-6) and paraxial mesoderm(7,8). RA diffuses over long distances, and its activity is spatially restricted by synthesizing and degrading enzymes(9). However, gradients of endogenous morphogens in live embryos have not been directly observed; indeed, their existence, distribution and requirement for correct patterning remain controversial(10). Here we report a family of genetically encoded indicators for RA that we have termed GEPRAs (genetically encoded probes for RA). Using the principle of fluorescence resonance energy transfer we engineered the ligand-binding domains of RA receptors to incorporate cyan-emitting and yellow-emitting fluorescent proteins as fluorescence resonance energy transfer donor and acceptor, respectively, for the reliable detection of ambient free RA. We created three GEPRAs with different affinities for RA, enabling the quantitative measurement of physiological RA concentrations. Live imaging of zebrafish embryos at the gastrula and somitogenesis stages revealed a linear concentration gradient of endogenous RA in a two-tailed source-sink arrangement across the embryo. Modelling of the observed linear RA gradient suggests that the rate of RA diffusion exceeds the spatiotemporal dynamics of embryogenesis, resulting in stability to perturbation. Furthermore, we used GEPRAs in combination with genetic and pharmacological perturbations to resolve competing hypotheses on the structure of the RA gradient during hindbrain formation and somitogenesis. Live imaging of endogenous concentration gradients across embryonic development will allow the precise assignment of molecular mechanisms to developmental dynamics and will accelerate the application of approaches based on morphogen gradients to tissue engineering and regenerative medicine.	[Shimozono, Satoshi; Iimura, Tadahiro; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama 3510198, Japan; [Kitaguchi, Tetsuya; Miyawaki, Atsushi] JST, ERATO, Life Funct & Dynam, Wako, Saitama 3510198, Japan; [Higashijima, Shin-ichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan	RIKEN; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB)	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsushi@brain.riken.jp	KITAGUCHI, TETSUYA/AAR-1895-2021; Iimura, Tadahiro/P-3550-2018; Kitaguchi, Tetsuya/F-5260-2017; Miyawaki, Atsushi/K-3569-2014	KITAGUCHI, TETSUYA/0000-0001-6701-1933; Iimura, Tadahiro/0000-0002-1431-0689; Kitaguchi, Tetsuya/0000-0001-6701-1933; Miyawaki, Atsushi/0000-0002-2329-3235; Higashijima, Shin-ichi/0000-0001-6350-4992	Japan Ministry of Education, Culture, Sports, Science and Technology; Human Frontier Science Program	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program)	The authors thank Y. Wada, R. Aoki, M. Sugiyama, F. Picazo and members of the Brain Science Institute Research Resource Center for technical assistance; C. Yokoyama and A. Terashima for critical reading of the manuscript; the FANTOM Consortium for the cDNA clones; and the Zebrafish International Resource Center for the transgenic zebrafish. This work was partly supported by grants from Japan Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research on Priority Areas 'Fluorescence Live Imaging' and 'Cell Innovation' and the Human Frontier Science Program.	Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Begemann G, 2004, DEV BIOL, V271, P119, DOI 10.1016/j.ydbio.2004.03.033; Brand M, 1996, DEVELOPMENT, V123, P179; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; Diez del Corral R, 2003, NEURON, V40, P65; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; EICHELE G, 1987, J CELL BIOL, V105, P1917, DOI 10.1083/jcb.105.4.1917; Emoto Y, 2005, DEV BIOL, V278, P415, DOI 10.1016/j.ydbio.2004.11.023; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Gustafson AL, 1996, MECH DEVELOP, V58, P27, DOI 10.1016/S0925-4773(96)00554-0; Hamade A, 2006, DEV BIOL, V289, P127, DOI 10.1016/j.ydbio.2005.10.019; Haugland R.P., 1999, FLUORESCENT LUMINESC, P40; Hernandez RE, 2007, DEVELOPMENT, V134, P177, DOI 10.1242/dev.02706; Kudoh T, 2002, DEVELOPMENT, V129, P4335; Maves L, 2005, DEV BIOL, V285, P593, DOI 10.1016/j.ydbio.2005.07.015; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Muller P, 2012, SCIENCE, V336, P721, DOI 10.1126/science.1221920; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; NORRIS AW, 1994, BBA-PROTEIN STRUCT M, V1209, P10, DOI 10.1016/0167-4838(94)90130-9; Perz-Edwards A, 2001, DEV BIOL, V229, P89, DOI 10.1006/dbio.2000.9979; Reifers F, 1998, DEVELOPMENT, V125, P2381; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Sawada A, 2001, DEVELOPMENT, V128, P4873; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Sirbu IO, 2005, DEVELOPMENT, V132, P2611, DOI 10.1242/dev.01845; Stern CD, 1998, CELL, V94, P143, DOI 10.1016/S0092-8674(00)81412-9; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; White RJ, 2008, DEV DYNAM, V237, P2775, DOI 10.1002/dvdy.21695; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; Zhang ZP, 2000, ARCH BIOCHEM BIOPHYS, V380, P339, DOI 10.1006/abbi.2000.1932	37	140	144	0	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					363	+		10.1038/nature12037	http://dx.doi.org/10.1038/nature12037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23563268				2022-12-28	WOS:000317599200038
J	Bhaumik, S				Bhaumik, Soumyadeep			India's rejection of Novartis's patent is but a small step in the right direction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												soumyadeepbhaumik@rediffmail.com		Bhaumik, Soumyadeep/0000-0001-9579-4453				Ardal C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001827; Arie S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2099; D'Silva J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1605; Hitchings AW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7941; Jain A., 2013, BRIT MED J, V346, pf2218; Kumar Raman, 2012, J Family Med Prim Care, V1, P10, DOI 10.4103/2249-4863.94442; Mudur G., 2012, BMJ-BRIT MED J, V344; Planning Commission, FAST SUST MOR INCL G; World Health Organization (WHO), 2012, WORLD HLTH STAT 2012	9	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2013	346								f2412	10.1136/bmj.f2412	http://dx.doi.org/10.1136/bmj.f2412			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AT	23596223				2022-12-28	WOS:000317963400015
J	Oh, S				Oh, Seongshik			The Complete Quantum Hall Trio	SCIENCE			English	Editorial Material							TOPOLOGICAL INSULATORS		[Oh, Seongshik] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Oh, Seongshik] Rutgers State Univ, Inst Adv Mat Devices & Nanotechnol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Oh, S (corresponding author), Rutgers State Univ, Dept Phys & Astron, POB 849, Piscataway, NJ 08854 USA.	ohsean@physics.rutgers.edu						Bansal N, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.116804; Chang CZ, 2013, SCIENCE, V340, P167, DOI 10.1126/science.1234414; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Hall E. H., 1881, PHILOS MAG, V12, P157, DOI DOI 10.1080/14786448108627086; Hall E.H., 1879, AM J MATH, V2, P287, DOI DOI 10.2307/2369245; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; LIU CX, 2008, PHYS REV LETT, V101; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Yu R, 2010, SCIENCE, V329, P61, DOI 10.1126/science.1187485; Zhang JS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1588	11	32	35	5	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129					153	154		10.1126/science.1237215	http://dx.doi.org/10.1126/science.1237215			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580518				2022-12-28	WOS:000317341400042
J	Akiyama, BM; Stone, MD				Akiyama, Benjamin M.; Stone, Michael D.			STRUCTURAL BIOLOGY A solution to the telomerase puzzle	NATURE			English	Editorial Material									[Akiyama, Benjamin M.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Akiyama, Benjamin M.; Stone, Michael D.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [Stone, Michael D.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Akiyama, BM (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	mds@ucsc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646, R01GM095850] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM095850, T32 GM008646] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Mason M, 2011, CURR OPIN STRUC BIOL, V21, P92, DOI 10.1016/j.sbi.2010.11.005; Min BS, 2009, MOL CELL, V36, P609, DOI 10.1016/j.molcel.2009.09.041; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Sauerwald A, 2013, NAT STRUCT MOL BIOL, V20, P454, DOI 10.1038/nsmb.2530; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005	9	3	4	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					177	178		10.1038/nature12090	http://dx.doi.org/10.1038/nature12090			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23552897				2022-12-28	WOS:000317346300031
J	Naik, SH; Perie, L; Swart, E; Gerlach, C; van Rooij, N; de Boer, RJ; Schumacher, TN				Naik, Shalin H.; Perie, Leila; Swart, Erwin; Gerlach, Carmen; van Rooij, Nienke; de Boer, Rob J.; Schumacher, Ton N.			Diverse and heritable lineage imprinting of early haematopoietic progenitors	NATURE			English	Article							DENDRITIC-CELL-DEVELOPMENT; STEM-CELLS; IN-VIVO; T-CELLS; COMMITMENT; SUBTYPES; PROMISCUITY; COMPARTMENT; SUBSETS; SYSTEM	Haematopoietic stem cells (HSCs) and their subsequent progenitors produce blood cells, but the precise nature and kinetics of this production is a contentious issue. In one model, lymphoid and myeloid production branch after the lymphoid-primed multipotent progenitor (LMPP)(1), with both branches subsequently producing dendritic cells(2). However, this model is based mainly on in vitro clonal assays and population-based tracking in vivo, which could miss in vivo single-cell complexity(3-7). Here we avoid these issues by using a new quantitative version of 'cellular barcoding'(8-10) to trace the in vivo fate of hundreds of LMPPs and HSCs at the single-cell level. These data demonstrate that LMPPs are highly heterogeneous in the cell types that they produce, separating into combinations of lymphoid-, myeloid-and dendritic-cell-biased producers. Conversely, although we observe a known lineage bias of some HSCs11-14, most cellular output is derived from a small number of HSCs that each generates all cell types. Crucially, in vivo analysis of the output of sibling cells derived from single LMPPs shows that they often share a similar fate, suggesting that the fate of these progenitors was imprinted. Furthermore, as this imprinting is also observed for dendritic-cell-biased LMPPs, dendritic cells may be considered a distinct lineage on the basis of separate ancestry. These data suggest a 'graded commitment' model of haematopoiesis, in which heritable and diverse lineage imprinting occurs earlier than previously thought.	[Naik, Shalin H.; Perie, Leila; Swart, Erwin; Gerlach, Carmen; van Rooij, Nienke; Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Perie, Leila; de Boer, Rob J.] Univ Utrecht, NL-3584 CH Utrecht, Netherlands	Netherlands Cancer Institute; Utrecht University	Naik, SH (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	naik.s@wehi.edu.au; t.schumacher@nki.nl	Naik, Shalin/AFD-5605-2022; de Boer, Rob/B-6050-2011; Schumacher, Ton/Y-2432-2019	de Boer, Rob/0000-0002-2130-691X; Schumacher, Ton/0000-0003-0517-8804; Perie, Leila/0000-0003-0798-4498; Naik, Shalin/0000-0003-0299-3301; Gerlach, Carmen/0000-0001-7889-2393	ERC grant LIFE-HIS-T and HFSP [RGP0060/2012]; National Health and Medical Research Council Australia; Marie Curie Incoming International FP6 Fellowship; Leukemia and Lymphoma Society; Marie Curie Intra European FP7 Fellowship; Bettencourt Schueller Fondation	ERC grant LIFE-HIS-T and HFSP; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Marie Curie Incoming International FP6 Fellowship; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Marie Curie Intra European FP7 Fellowship; Bettencourt Schueller Fondation	We thank G. Filion, U. Braunschweig, L. Pagie, M. Hauptmann, P. Lio, R. van der Wath and the NKI Genomics Facility for computational assistance; J. van Heijst, J. Rohr and J. Urbanus for useful discussions; http://www.josharris.com for illustrations in Fig. 1a and Supplementary Fig. 1; NKI cytometry and animal facilities; D. Leone, Z. Ping and M. Lodder for technical assistance; and P. Hodgkin, K. Duffy and J. Coquet for critical reading of the manuscript. This work was supported by ERC grant LIFE-HIS-T and HFSP grant RGP0060/2012, S.H.N. was supported by the National Health and Medical Research Council Australia, Marie Curie Incoming International FP6 Fellowship, and the Leukemia and Lymphoma Society; and L. P. was supported by a Marie Curie Intra European FP7 Fellowship and the Bettencourt Schueller Fondation.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2005, ANN NY ACAD SCI, V1044, P125, DOI 10.1196/annals.1349.016; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Ceredig R, 2009, NAT REV IMMUNOL, V9, P293, DOI 10.1038/nri2525; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Gerrits A, 2010, BLOOD, V115, P2610, DOI 10.1182/blood-2009-06-229757; Goncalves MAFV, 2008, MOL THER, V16, P741, DOI 10.1038/mt.2008.16; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LEMISCHKA IR, 1992, CURR TOP MICROBIOL, V177, P59; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Muller-Sieburg CE, 2006, CELL CYCLE, V5, P394, DOI 10.4161/cc.5.4.2487; Naik SH, 2008, IMMUNOL CELL BIOL, V86, P439, DOI 10.1038/icb.2008.28; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2009, CELL BIO RES PROG, P79; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Reeves JP, 2001, CURR PROTOC IMMUNOL, V10, P1; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Schumacher TNM, 2010, NAT REV IMMUNOL, V10, P621, DOI 10.1038/nri2822; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; van Heijst JWJ, 2009, SCIENCE, V325, P1265, DOI 10.1126/science.1175455; Welner RS, 2008, NAT REV IMMUNOL, V8, P95, DOI 10.1038/nri2234	30	267	270	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					229	+		10.1038/nature12013	http://dx.doi.org/10.1038/nature12013			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23552896				2022-12-28	WOS:000317346300043
J	Ryan, DP; Friedmann, AM; Schmitz, MD; Ryan, RJH				Ryan, Daniel P.; Friedmann, Alison M.; Schmitz, Matthew D.; Ryan, Russell J. H.			Case 11-2013: A 4-Year-Old Boy with Fever and Abdominal Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDREN; APPENDECTOMY; LYMPHOMA; ABSCESS; RISK		[Ryan, Daniel P.] Massachusetts Gen Hosp, Dept Pediat Surg, Boston, MA 02114 USA; [Friedmann, Alison M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Schmitz, Matthew D.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Ryan, Russell J. H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ryan, Daniel P.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Friedmann, Alison M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Schmitz, Matthew D.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Ryan, Russell J. H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Ryan, DP (corresponding author), Massachusetts Gen Hosp, Dept Pediat Surg, Boston, MA 02114 USA.			Ryan, Russell/0000-0001-8174-3962				Andersson RE, 2007, ANN SURG, V246, P741, DOI 10.1097/SLA.0b013e31811f3f9f; [Anonymous], 2008, WHO CLASSIFICATION T, V4th ed; Bellan C, 2005, BLOOD, V106, P1031, DOI 10.1182/blood-2005-01-0168; Bhardwaj Neil, 2010, Afr J Paediatr Surg, V7, P214, DOI 10.4103/0189-6725.70433; Bickell NA, 2006, J AM COLL SURGEONS, V202, P401, DOI 10.1016/j.jamcollsurg.2005.11.016; Blakely ML, 2011, ARCH SURG-CHICAGO, V146, P660, DOI 10.1001/archsurg.2011.6; BURKITT D, 1967, CANCER, V20, P756, DOI 10.1002/1097-0142(1967)20:5<756::AID-CNCR2820200530>3.0.CO;2-P; Caron G, 2009, J IMMUNOL, V182, P7595, DOI 10.4049/jimmunol.0804272; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Goh BKP, 2005, J PEDIATR SURG, V40, P1134, DOI 10.1016/j.jpedsurg.2005.03.046; Patte C, 2007, BLOOD, V109, P2773, DOI 10.1182/blood-2006-07-036673; Perkins SL, 2007, PEDIAT ONCOLOGY, P101; Simillis C, 2010, SURGERY, V147, P818, DOI 10.1016/j.surg.2009.11.013; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Wang SM, 2010, J FORMOS MED ASSOC, V109, P476, DOI 10.1016/S0929-6646(10)60080-0; Wossmann W, 2003, ANN HEMATOL, V82, P160, DOI 10.1007/s00277-003-0608-2	16	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1435	1444		10.1056/NEJMcpc1209304	http://dx.doi.org/10.1056/NEJMcpc1209304			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122QT	23574123				2022-12-28	WOS:000317333600013
J	Crotti, L; Tester, DJ; White, WM; Bartos, DC; Insolia, R; Besana, A; Kunic, JD; Will, ML; Velasco, EJ; Bair, JJ; Ghidoni, A; Cetin, I; Van Dyke, DL; Wick, MJ; Brost, B; Delisle, BP; Facchinetti, F; George, AL; Schwartz, PJ; Ackerman, MJ				Crotti, Lia; Tester, David J.; White, Wendy M.; Bartos, Daniel C.; Insolia, Roberto; Besana, Alessandra; Kunic, Jennifer D.; Will, Melissa L.; Velasco, Ellyn J.; Bair, Jennifer J.; Ghidoni, Alice; Cetin, Irene; Van Dyke, Daniel L.; Wick, Myra J.; Brost, Brian; Delisle, Brian P.; Facchinetti, Fabio; George, Alfred L., Jr.; Schwartz, Peter J.; Ackerman, Michael J.			Long QT Syndrome-Associated Mutations in Intrauterine Fetal Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIAC SODIUM-CHANNEL; GENE; SCN5A; STILLBIRTHS; HERG; PROGESTERONE; POLYMORPHISM; DYSFUNCTION; BRUGADA; R1193Q	Importance Intrauterine fetal death or stillbirth occurs in approximately 1 out of every 160 pregnancies and accounts for 50% of all perinatal deaths. Postmortem evaluation fails to elucidate an underlying cause in many cases. Long QT syndrome (LQTS) may contribute to this problem. Objective To determine the spectrum and prevalence of mutations in the 3 most common LQTS susceptible genes (KCNQ1, KCNH2, and SCN5A) for a cohort of unexplained cases. Design, Setting, and Patients In this case series, retrospective postmortem genetic testing was conducted on a convenience sample of 91 unexplained intrauterine fetal deaths (mean [SD] estimated gestational age at fetal death, 26.3 [8.7] weeks) that were collected from 2006-2012 by the Mayo Clinic, Rochester, Minnesota, or the Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. More than 1300 ostensibly healthy individuals served as controls. In addition, publicly available exome databases were assessed for the general population frequency of identified genetic variants. Main Outcomes and Measures Comprehensive mutational analyses of KCNQ1 (K(V)7.1, LQTS type 1), KCNH2 (HERG/K(V)11.1, LQTS type 2), and SCN5A (Na(V)1.5, LQTS type 3) were performed using denaturing high-performance liquid chromatography and direct DNA sequencing on genomic DNA extracted from decedent tissue. Functional analyses of novel mutations were performed using heterologous expression and patch-clamp recording. Results The 3 putative LQTS susceptibility missense mutations (KCNQ1, p.A283T; KCNQ1, p.R397W; and KCNH2[1b], p.R25W), with a heterozygous frequency of less than 0.05% in more than 10 000 publicly available exomes and absent in more than 1000 ethnically similar control patients, were discovered in 3 intrauterine fetal deaths (3.3% [95% CI, 0.68%-9.3%]). Both K(V)7.1-A283T (16-week male) and K(V)7.1-R397W (16-week female) mutations were associated with marked K(V)7.1 loss-of-function consistent with in utero LQTS type 1, whereas the HERG1b-R25W mutation (33.2-week male) exhibited a loss of function consistent with in utero LQTS type 2. In addition, 5 intrauterine fetal deaths hosted SCN5A rare nonsynonymous genetic variants (p.T220I, p.R1193Q, involving 2 cases, and p.P2006A, involving 2 cases) that conferred in vitro electrophysiological characteristics consistent with potentially pro-arrhythmic phenotypes. Conclusions and Relevance In this molecular genetic evaluation of 91 cases of intrauterine fetal death, missense mutations associated with LQTS susceptibility were discovered in 3 cases (3.3%) and overall, genetic variants leading to dysfunctional LQTS-associated ion channels in vitro were discovered in 8 cases (8.8%). These preliminary findings may provide insights into mechanisms of some cases of stillbirth. JAMA. 2013;309(14):1473-1482 www.jama.com	[Crotti, Lia; Insolia, Roberto; Ghidoni, Alice; Schwartz, Peter J.] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Crotti, Lia; Insolia, Roberto; Ghidoni, Alice; Schwartz, Peter J.] Fdn IRRCCS Policlin S Matteo, Mol Cardiol Lab, Pavia, Italy; [Crotti, Lia] Helmholtz Ctr, Inst Human Genet, Munich, Germany; [Tester, David J.; Will, Melissa L.; Ackerman, Michael J.] Mayo Clin, Windland Smith Rice Sudden Death Genom Lab, Dept Med Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Tester, David J.; Will, Melissa L.; Ackerman, Michael J.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [White, Wendy M.; Wick, Myra J.; Brost, Brian] Mayo Clin, Div Maternal Fetal Med, Rochester, MN 55905 USA; [Ackerman, Michael J.] Mayo Clin, Dept Pediat, Div Pediat Cardiol, Rochester, MN 55905 USA; [Bair, Jennifer J.; Van Dyke, Daniel L.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Bartos, Daniel C.; Velasco, Ellyn J.; Delisle, Brian P.] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Besana, Alessandra] IRCCS Insituto Auxol Italiano, Lab Cardiovasc Genet, Milan, Italy; [Kunic, Jennifer D.; George, Alfred L., Jr.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [George, Alfred L., Jr.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [George, Alfred L., Jr.] Vanderbilt Univ, Inst Integrat Genom, Nashville, TN USA; [Cetin, Irene] Univ Milan, Dept Clin Sci Luigi Sacco, I-20122 Milan, Italy; [Facchinetti, Fabio] Univ Modena & Reggio Emilia, Dept Obstet & Gynaecol, Modena, Italy; [Schwartz, Peter J.] Univ Cape Town, Cardiovasc Genet Lab, Hatter Inst Cardiovasc Res, Dept Med, ZA-7700 Rondebosch, South Africa; [Schwartz, Peter J.] Univ Stellenbosch, Dept Med, ZA-7600 Stellenbosch, South Africa; [Schwartz, Peter J.] King Saud Univ, Coll Med, Dept Family & Community Med, Riyadh 11461, Saudi Arabia	University of Pavia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Kentucky; IRCCS Istituto Auxologico Italiano; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Milan; Luigi Sacco Hospital; Universita di Modena e Reggio Emilia; University of Cape Town; Stellenbosch University; King Saud University	Ackerman, MJ (corresponding author), Mayo Clin, Long QT Syndrome Clin, Guggenheim 501,200 1st St SW, Rochester, MN 55905 USA.	ackerman.michael@mayo.edu	Schwartz, Peter J/J-4267-2016; cetin, irene/K-6112-2016; Facchinetti, Fabio/K-9929-2014; Crotti, Lia/AAB-3914-2019; Ghidoni, Alice/AAA-7556-2020	Schwartz, Peter J/0000-0003-0367-1048; cetin, irene/0000-0002-9217-3034; Facchinetti, Fabio/0000-0003-4694-9564; Ghidoni, Alice/0000-0003-3435-9823; Brost, Brian/0000-0002-4903-4186; Delisle, Brian/0000-0002-2146-327X; crotti, lia/0000-0001-8739-6527	Italian Ministry of Health [GR-2010-2305717]; American Heart Association; National Institutes of Health (NIH) [HD042569, HL087039, HL083374]; Italian Ministero dell'Istruzione, dell'Universita e della Ricerca; European Community; T. Denny Sanford Endowed Collaborative Research Fund; National Heart, Lung, and Blood Institute; Institut Biochimique SA (IBSA) in Switzerland; Ferring SA in Switzerland; NIH; Allergan Inc; Gilead Sciences; Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy; Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program; Sheikh Zayed Saif Mohammed Al Nahyan Fund in Pediatric Cardiology Research; Dr Scholl Foundation; Hannah M. Wernke Memorial Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042569] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087039, R01HL083374] Funding Source: NIH RePORTER	Italian Ministry of Health(Ministry of Health, Italy); American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); European Community(European Commission); T. Denny Sanford Endowed Collaborative Research Fund; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Institut Biochimique SA (IBSA) in Switzerland; Ferring SA in Switzerland(Ferring Pharmaceuticals); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergan Inc(AbbVieAllergan); Gilead Sciences(Gilead Sciences); Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy; Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program; Sheikh Zayed Saif Mohammed Al Nahyan Fund in Pediatric Cardiology Research; Dr Scholl Foundation; Hannah M. Wernke Memorial Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Crotti reported receiving an institutional grant from the Italian Ministry of Health. Mr Tester reported receiving royalties personally and to his institution from Transgenomic. Mr Bartos reported receiving a predoctoral grant from the American Heart Association. Dr Insolia reported receiving a grant to his institution from the Italian Ministry of Health, Ms Kunic reported receiving grant to her institution from the National Institutes of Health (NIH). Dr Ghidoni reported receiving a grant to her institution from the Italian Ministry of Health. Dr Cetin reported receiving a grant to her institution from the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca and has grants to her institution pending from the European Community, Italian Ministry of Health, and Italian Ministero dell'Istruzione, dell'Universita e della Ricerca. Dr Van Dyke reported that he has grants to his institution pending from the National Institutes of Health and receives institutional support from the College of American Pathologists for which he serves as a consultant to the College of American Pathologists Cytogenices Resource Center. Dr Wick reported a pending grant to his institution from the T. Denny Sanford Endowed Collaborative Research Fund. Dr Delisle reported a grant to his insitution from the National Heart, Lung, and Blood Institute. Dr Facchinetti reported receiving consultancy fees from Institut Biochimique SA (IBSA) and lecture fees from Ferring SA, both in Switzerland, and travel expenses from Lo.Li. Pharma, Italy. Dr George reported receiving a grant to his institution from the NIH, has pending grants to his institution from Allergan Inc and Gilead Sciences, and receives royalties from Gilead Sciences Inc and Merck Inc. Dr Ackerman reported receiving royalties personally and to his institution from Transgenomic and received a grant from the NIH. Intellectual property derived from Dr Ackerman's research program resulted in license agreements in 2004 between Mayo Clinic Health Solutions (formerly Mayo Medical Ventures) and PGxHealth (formerly Genaissance Pharmaceuticals and now recently acquired by Transgenomic). However, Transgenomic did not contribute directly to this study in any manner. No other financial disclosures were reported.; Dr Spazzolini's work is supported by Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy. This research is supported by the Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program (Dr Ackerman), the Sheikh Zayed Saif Mohammed Al Nahyan Fund in Pediatric Cardiology Research (Dr Ackerman), the Dr Scholl Foundation (Dr Ackerman), the Hannah M. Wernke Memorial Foundation (Dr Ackerman), the National Institutes of Health (grants HD042569 to MJA, HL087039 to BPD, and HL083374 to Dr George), and the Italian Ministry of Health (GR-2010-2305717 to Dr Crotti).	Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264; AISIEN AO, 1994, INT J GYNECOL OBSTET, V47, P27, DOI 10.1016/0020-7292(94)90457-X; [Anonymous], EX VAR SERV SEATTL G; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Arnestad M, 2007, CIRCULATION, V115, P361, DOI 10.1161/CIRCULATIONAHA.106.658021; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Bhuiyan ZA, 2008, HEART RHYTHM, V5, P553, DOI 10.1016/j.hrthm.2008.01.020; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Chia EL, 2005, PRENATAL DIAG, V25, P546, DOI 10.1002/pd.1184; Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Hwang HW, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027995; Ishikawa S, 2013, FETAL DIAGN THER, V33, P1, DOI 10.1159/000339150; Kahler C, 2002, PRENATAL DIAG, V22, P408, DOI 10.1002/pd.322; Kapa S, 2009, CIRCULATION, V120, P1752, DOI 10.1161/CIRCULATIONAHA.109.863076; Larsen AP, 2008, PFLUG ARCH EUR J PHY, V456, P1137, DOI 10.1007/s00424-008-0476-7; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; MacDorman Marian F, 2012, Natl Vital Stat Rep, V60, P1; Miller TE, 2004, CIRCULATION, V109, P3029, DOI 10.1161/01.CIR.0000130666.81539.9E; Murphy LL, 2012, HEART RHYTHM, V9, P590, DOI 10.1016/j.hrthm.2011.11.006; Nof E, 2010, CIRC-CARDIOVASC GENE, V3, P199, DOI 10.1161/CIRCGENETICS.109.898569; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; Schwartz PJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P868, DOI 10.1161/CIRCEP.111.962019; Schwartz PJ, 2009, CIRCULATION, V120, P1761, DOI 10.1161/CIRCULATIONAHA.109.863209; Schwartz PJ, 2001, CIRCULATION, V103, P89; Schwartz PJ, 2004, CIRCULATION, V109, P2930, DOI 10.1161/01.CIR.0000133180.77213.43; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Tan BH, 2005, HEART RHYTHM, V2, P741, DOI 10.1016/j.hrthm.2005.04.021; Tester DJ, 2008, HEART RHYTHM, V5, P1282, DOI 10.1016/j.hrthm.2008.07.002; Tester DJ, 2012, MAYO CLIN PROC, V87, P524, DOI 10.1016/j.mayocp.2012.02.017; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; The R Fouridation for Statistical Computing, R PROJ STAT COMP; Van Norstrand DW, 2009, HEART RHYTHM, V6, P272, DOI 10.1016/j.hrthm.2008.07.028; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; WALSH S, 1995, MED HYPOTHESES, V45, P73, DOI 10.1016/0306-9877(95)90206-6; Wang DW, 2007, CIRCULATION, V115, P368, DOI 10.1161/CIRCULATIONAHA.106.646513; Wang Q, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013300; Wu ZY, 2011, J BIOL CHEM, V286, P22186, DOI 10.1074/jbc.M110.198853	40	106	111	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1473	1482		10.1001/jama.2013.3219	http://dx.doi.org/10.1001/jama.2013.3219			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571586	Green Accepted			2022-12-28	WOS:000317271700025
J	Tuckson, RV; Newcomer, L; De Sa, JM				Tuckson, Reed V.; Newcomer, Lee; De Sa, Jeanne M.			Accessing Genomic Medicine Affordability, Diffusion, and Disparities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Tuckson, Reed V.] UnitedHlth Grp, Minnetonka, MN 55343 USA; [Newcomer, Lee] UnitedHealthcare, Minnetonka, MN USA; [De Sa, Jeanne M.] UnitedHlth Ctr Hlth Reform & Modernizat, Washington, DC USA		Tuckson, RV (corresponding author), UnitedHlth Grp, 9900 Bren Rd E,MN008-T902, Minnetonka, MN 55343 USA.	reed.v.tuckson@uhg.com						Congressional Budget Office, 2008, TECHN CHANG GROWTH H; *DEP HLTH HUM SERV, 2008, US SYST OV GEN TEST; Express Scripts, 2011, 2011 DRUG TREND REP; FederalReserve BankofStLouis, 2022, CAS SHILL US NAT HOM; Khoury MJ, 2012, AM J PREV MED, V42, P639, DOI 10.1016/j.amepre.2012.02.012; Smith M, 2012, BEST CARE LOWER COST; UnitedHealth, 2010, US DIAB CHALL OPP DE	7	22	22	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1469	1470		10.1001/jama.2013.1468	http://dx.doi.org/10.1001/jama.2013.1468			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571584				2022-12-28	WOS:000317271700023
J	Ostroumov, EE; Mulvaney, RM; Cogdell, RJ; Scholes, GD				Ostroumov, Evgeny E.; Mulvaney, Rachel M.; Cogdell, Richard J.; Scholes, Gregory D.			Broadband 2D Electronic Spectroscopy Reveals a Carotenoid Dark State in Purple Bacteria	SCIENCE			English	Article							BACTERIOCHLOROPHYLL ENERGY-TRANSFER; BETA-CAROTENE; RHODOBACTER-SPHAEROIDES; ULTRAFAST DYNAMICS; TARGET ANALYSIS; EXCITED-STATES; LH2 COMPLEXES; PHOTOSYNTHESIS; SPECTRA; SPHEROIDENE	Although the energy transfer processes in natural light-harvesting systems have been intensively studied for the past 60 years, certain details of the underlying mechanisms remain controversial. We performed broadband two-dimensional (2D) electronic spectroscopy measurements on light-harvesting proteins from purple bacteria and isolated carotenoids in order to characterize in more detail the excited-state manifold of carotenoids, which channel energy to bacteriochlorophyll molecules. The data revealed a well-resolved signal consistent with a previously postulated carotenoid dark state, the presence of which was confirmed by global kinetic analysis. The results point to this state's role in mediating energy flow from carotenoid to bacteriochlorophyll.	[Ostroumov, Evgeny E.; Scholes, Gregory D.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Mulvaney, Rachel M.; Cogdell, Richard J.] Univ Glasgow, Inst Biomed & Life Sci, Glasgow Biomed Res Ctr, Glasgow G12 8TA, Lanark, Scotland	University of Toronto; University of Glasgow	Scholes, GD (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.	greg.scholes@utoronto.ca			Natural Sciences and Engineering Research Council of Canada; U.S. Defense Advanced Research Projects Agency (QuBE); U.S. Air Force Office of Scientific Research [FA9550-10-1-0260]; Biotechnology and Biological Sciences Research Council; U.S. Department of Energy Office of Basic Energy Sciences, Photosynthetic Antenna Research Center (PARC) Energy Frontier Research Center [DE-SC0001035]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); U.S. Defense Advanced Research Projects Agency (QuBE); U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. Department of Energy Office of Basic Energy Sciences, Photosynthetic Antenna Research Center (PARC) Energy Frontier Research Center(United States Department of Energy (DOE))	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the U.S. Defense Advanced Research Projects Agency (QuBE), and the U.S. Air Force Office of Scientific Research (grant FA9550-10-1-0260) to G. D. S.; a research scholarship from the Biotechnology and Biological Sciences Research Council to R. M. M.; and the U.S. Department of Energy Office of Basic Energy Sciences, as part of the Photosynthetic Antenna Research Center (PARC) Energy Frontier Research Center, grant DE-SC0001035 to R.J.C., which allowed R. M. M. and R.J.C. to be involved in both the preparation of the biological material and the initial measurements. We thank D. B. Turner for assistance with 2DES setup and J. M. Anna for helpful discussions.	Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429; Christensson N, 2010, J PHYS CHEM LETT, V1, P3366, DOI 10.1021/jz101409r; Chumanov G, 2000, PHOTOCHEM PHOTOBIOL, V71, P589, DOI 10.1562/0031-8655(2000)071<0589:RRASER>2.0.CO;2; Cong H, 2008, J PHYS CHEM B, V112, P10689, DOI 10.1021/jp711946w; Frank HA, 1997, J PHYS CHEM A, V101, P149, DOI 10.1021/jp962373l; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; GELDOF PA, 1971, CHEM PHYS LETT, V10, P549, DOI 10.1016/0009-2614(71)87035-5; Herzberg G, 1933, Z PHYS CHEM B-CHEM E, V21, P410; Hiller R., 2004, PHOTOCHEMISTRY CAROT, V8, P81; Holzwarth AR, 1996, BIOPHYSICAL TECHNIQU, P75, DOI DOI 10.1007/0-306-47960-5_; Jonas DM, 2003, ANNU REV PHYS CHEM, V54, P425, DOI 10.1146/annurev.physchem.54.011002.103907; Kleinschmidt M, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3062842; Kosumi D, 2006, CHEM PHYS LETT, V425, P66, DOI 10.1016/j.cplett.2006.05.023; Kosumi D, 2011, ANGEW CHEM INT EDIT, V50, P1097, DOI 10.1002/anie.201003771; Kosumi D, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201000684; Krueger BP, 1998, J PHYS CHEM B, V102, P2284, DOI 10.1021/jp973062t; Krueger BP, 1998, J PHYS CHEM B, V102, P5378, DOI 10.1021/jp9811171; Macpherson AN, 2001, BIOPHYS J, V80, P923, DOI 10.1016/S0006-3495(01)76071-7; Maiuri M, 2012, PHYS CHEM CHEM PHYS, V14, P6312, DOI 10.1039/c2cp23585d; Mameloot M., 1992, METHOD ENZYMOL, V210, P314; MCCLURE DS, 1954, J CHEM PHYS, V22, P1668, DOI 10.1063/1.1739870; Niedzwiedzki D, 2007, J PHYS CHEM B, V111, P5984, DOI 10.1021/jp070500f; Ostroumov E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108302; Polivka T, 2004, CHEM REV, V104, P2021, DOI 10.1021/cr020674n; Polivka T, 2010, ACCOUNTS CHEM RES, V43, P1125, DOI 10.1021/ar100030m; Polli D, 2006, BIOPHYS J, V90, P2486, DOI 10.1529/biophysj.105.069286; Ritz T, 2000, PHOTOSYNTH RES, V66, P125, DOI 10.1023/A:1010750332320; Robert B, 2009, PHOTOSYNTH RES, V101, P147, DOI 10.1007/s11120-009-9440-4; TAVAN P, 1987, PHYS REV B, V36, P4337, DOI 10.1103/PhysRevB.36.4337; Telfer Alison, 2008, V4, P265, DOI 10.1007/978-3-7643-7499-0_14; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; Walla PJ, 2000, P NATL ACAD SCI USA, V97, P10808, DOI 10.1073/pnas.190230097; Wohlleben W, 2004, J PHYS CHEM B, V108, P3320, DOI 10.1021/jp036145k; Wohlleben W, 2003, BIOPHYS J, V85, P442, DOI 10.1016/S0006-3495(03)74489-0; Yoshizawa M, 2006, LASER PHYS, V16, P325, DOI 10.1134/S1054660X06020204; Zhang JP, 2000, CHEM PHYS LETT, V331, P154, DOI 10.1016/S0009-2614(00)01165-9	36	123	124	0	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					52	56		10.1126/science.1230106	http://dx.doi.org/10.1126/science.1230106			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559244	Green Published			2022-12-28	WOS:000317061100041
J	Sherkow, JS; Greely, HT				Sherkow, Jacob S.; Greely, Henry T.			What If Extinction Is Not Forever?	SCIENCE			English	Editorial Material									[Sherkow, Jacob S.] Stanford Law Sch, Ctr Law & Biosci, Stanford, CA 94305 USA; [Greely, Henry T.] Stanford Univ, Stanford, CA 94305 USA	Stanford University; Stanford University	Greely, HT (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	hgreely@stanford.edu		Sherkow, Jacob/0000-0002-9724-9261				[Anonymous], 1933, LAST TASMANIAN TIGER; Chavatte-Palmer P, 2012, PLACENTA, V33, pS99, DOI 10.1016/j.placenta.2011.09.012; Folch J, 2009, THERIOGENOLOGY, V71, P1026, DOI 10.1016/j.theriogenology.2008.11.005; IUCN, 1994, IUCN RED LIST CAT CR; RIDLEY M, 2013, WALL STREET J   0330, pC4; Rohrbaugh Mark L, 1997, AIPLA QJ, V25, P371; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/NMETH.1971, 10.1038/nmeth.1971]; Zimmer Carl, 2013, NATL GEOGR; Zimov SA, 2005, SCIENCE, V308, P796, DOI 10.1126/science.1113442	9	92	96	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					32	33		10.1126/science.1236965	http://dx.doi.org/10.1126/science.1236965			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	118XS	23559235	Green Submitted, Green Published			2022-12-28	WOS:000317061100031
J	Li, TQ; Patz, A; Mouchliadis, L; Yan, JQ; Lograsso, TA; Perakis, IE; Wang, JG				Li, Tianqi; Patz, Aaron; Mouchliadis, Leonidas; Yan, Jiaqiang; Lograsso, Thomas A.; Perakis, Ilias E.; Wang, Jigang			Femtosecond switching of magnetism via strongly correlated spin-charge quantum excitations	NATURE			English	Article							TRANSITION-METAL OXIDES; PHASE-SEPARATION; DENSITY-WAVE; ULTRAFAST; MANGANITE; PULSES; STATE; ORDER	The technological demand to push the gigahertz (10(9) hertz) switching speed limit of today's magnetic memory and logic devices into the terahertz (10(12) hertz) regime underlies the entire field of spin-electronics and integrated multi-functional devices. This challenge is met by all-optical magnetic switching based on coherent spin manipulation(1). By analogy to femtosecond chemistry and photosynthetic dynamics(2)-in which photoproducts of chemical and biochemical reactions can be influenced by creating suitable superpositions of molecular states-femtosecond-laser-excited coherence between electronic states can switch magnetic order by 'suddenly' breaking the delicate balance between competing phases of correlated materials: for example, manganites exhibiting colossal magneto-resistance suitable for applications(3,4). Here we show femtosecond (10(-15) seconds) photo-induced switching from anti-ferromagnetic to ferromagnetic ordering in Pr0.7Ca0.3MnO3, by observing the establishment (within about 120 femtoseconds) of a huge temperature-dependent magnetization with photo-excitation threshold behaviour absent in the optical reflectivity. The development of ferromagnetic correlations during the femtosecond laser pulse reveals an initial quantum coherent regime of magnetism, distinguished from the picosecond (10(-12) seconds) lattice-heating regime characterized by phase separation without threshold behaviour(5,6). Our simulations reproduce the nonlinear femtosecond spin generation and underpin fast quantum spin-flip fluctuations correlated with coherent superpositions of electronic states to initiate local ferromagnetic correlations. These results merge two fields, femtosecond magnetism in metals and band insulators(1,7-9), and non-equilibrium phase transitions of strongly correlated electrons(10-17), in which local interactions exceeding the kinetic energy produce a complex balance of competing orders.	[Li, Tianqi; Patz, Aaron; Wang, Jigang] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Li, Tianqi; Patz, Aaron; Yan, Jiaqiang; Lograsso, Thomas A.; Wang, Jigang] US DOE, Ames Lab, Ames, IA 50011 USA; [Mouchliadis, Leonidas; Perakis, Ilias E.] Univ Crete, Dept Phys, Iraklion 71003, Crete, Greece; [Mouchliadis, Leonidas; Perakis, Ilias E.] Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion 71110, Crete, Greece	Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; University of Crete; Foundation for Research & Technology - Hellas (FORTH)	Wang, JG (corresponding author), Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA.	ilias@physics.uoc.gr; jgwang@iastate.edu	Lograsso, Thomas A/B-9064-2014; Mouchliadis, Leonidas/AAG-8074-2019; Perakis, Ilias/ABC-5659-2020; Li, Tianqi/C-5142-2014; Perakis, Ilias/G-9186-2011	Li, Tianqi/0000-0002-5238-8540; Yan, Jiaqiang/0000-0001-6625-4706	National Science Foundation [DMR-1055352]; US Department of Energy-Basic Energy Sciences [DE-AC02-7CH11358]; Project BIOSOLENUTI [FP7-REGPOT-2008-1, 229927]; EU Social Fund; National resources through the THALES program NANOPHOS	National Science Foundation(National Science Foundation (NSF)); US Department of Energy-Basic Energy Sciences(United States Department of Energy (DOE)); Project BIOSOLENUTI; EU Social Fund; National resources through the THALES program NANOPHOS(Thales Group)	This work was supported by the National Science Foundation (contract no. DMR-1055352). Material synthesis at the Ames Laboratory was supported by the US Department of Energy-Basic Energy Sciences (contract no. DE-AC02-7CH11358). L. M. acknowledges FP7-REGPOT-2008-1, Project BIOSOLENUTI no. 229927 for financial support. L. M. and I. E. P. were partially supported by the EU Social Fund and National resources through the THALES program NANOPHOS.	Axt VM, 1998, REV MOD PHYS, V70, P145, DOI 10.1103/RevModPhys.70.145; Bigot JY, 2009, NAT PHYS, V5, P515, DOI 10.1038/NPHYS1285; Boeglin C, 2010, NATURE, V465, P458, DOI 10.1038/nature09070; Brumer P, 2011, PHYS TODAY, V64, P11, DOI 10.1063/PT.3.1345; Cepas O, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.035218; Dagotto E, 2001, PHYS REP, V344, P1, DOI 10.1016/S0370-1573(00)00121-6; Ehrke H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.217401; Fausti D, 2011, SCIENCE, V331, P189, DOI 10.1126/science.1197294; Fiebig M, 2000, APPL PHYS B-LASERS O, V71, P211, DOI 10.1007/s003400000338; Gedik N, 2007, SCIENCE, V316, P425, DOI 10.1126/science.1138834; Ichikawa H, 2011, NAT MATER, V10, P101, DOI 10.1038/nmat2929; Kagan MY, 1999, EUR PHYS J B, V12, P217, DOI 10.1007/s100510050998; Kapetanakis MD, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3634031; Kapetanakis MD, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.047404; Karadimitriou ME, 2011, J PHYS CHEM B, V115, P5634, DOI 10.1021/jp1118794; Kim KW, 2012, NAT MATER, V11, P497, DOI [10.1038/nmat3294, 10.1038/NMAT3294]; Kimel AV, 2005, NATURE, V435, P655, DOI [10.1038/nature03564, 10.1038/nature03S64]; Kirilyuk A, 2010, REV MOD PHYS, V82, P2731, DOI 10.1103/RevModPhys.82.2731; Liu MK, 2012, NATURE, V487, P345, DOI 10.1038/nature11231; MATSUBARA M, 2007, PHYS REV LETT, V99, DOI DOI 10.1103/PHYSREVLETT.99.207401; McGill SA, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.075117; Mertelj T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.113103; Miyasaka K, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.012401; Rini M, 2007, NATURE, V449, P72, DOI 10.1038/nature06119; Schmitt F, 2008, SCIENCE, V321, P1649, DOI 10.1126/science.1160778; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Wang J, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3058765; WANG J, 2007, PHYS REV LETT, V98, DOI DOI 10.1103/PHYSREVLETT.98.217401; Yamaguchi S, 1998, PHYS REV B, V58, P6862, DOI 10.1103/PhysRevB.58.6862; Zhang GP, 2009, NAT PHYS, V5, P499, DOI 10.1038/NPHYS1315	30	133	136	7	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2013	496	7443					69	73		10.1038/nature11934	http://dx.doi.org/10.1038/nature11934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23552945				2022-12-28	WOS:000316993400026
J	Burden, ACF				Burden, A. C. Felix			Review: Continuous glucose monitoring reduces HbA(1c) more than self-monitoring in type 1 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Heart Birmingham Teaching Primary Care Trust, Birmingham, W Midlands, England		Burden, ACF (corresponding author), Heart Birmingham Teaching Primary Care Trust, Birmingham, W Midlands, England.		Burden, Felix/AAE-9711-2020	Burden, Andrew/0000-0001-8764-376X	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.		0	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6							JC9	10.7326/0003-4819-158-6-201303190-02009	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23552900				2022-12-28	WOS:000316565100008
J	Harrington, RA				Harrington, Robert A.			PCI using drug-eluting stents had higher mortality than CABG in diabetes and multivessel CAD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							THORACIC SURGEONS; AMERICAN-COLLEGE; ASSOCIATION; CARDIOLOGY		Stanford Univ, Stanford, CA 94305 USA	Stanford University	Harrington, RA (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Patel MR, 2012, J THORAC CARDIOV SUR, V143, P780, DOI 10.1016/j.jtcvs.2012.01.061; Qaseem A, 2012, ANN INTERN MED, V157, P735, DOI 10.7326/0003-4819-157-10-201211200-00011	3	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6							JC8	10.7326/0003-4819-158-6-201303190-02008	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23552875				2022-12-28	WOS:000316565100007
J	Mersch, DP; Crespi, A; Keller, L				Mersch, Danielle P.; Crespi, Alessandro; Keller, Laurent			Tracking Individuals Shows Spatial Fidelity Is a Key Regulator of Ant Social Organization	SCIENCE			English	Article							DIVISION-OF-LABOR; TEMPORAL POLYETHISM	Ants live in organized societies with a marked division of labor among workers, but little is known about how this division of labor is generated. We used a tracking system to continuously monitor individually tagged workers in six colonies of the ant Camponotus fellah over 41 days. Network analyses of more than 9 million interactions revealed three distinct groups that differ in behavioral repertoires. Each group represents a functional behavioral unit with workers moving from one group to the next as they age. The rate of interactions was much higher within groups than between groups. The precise information on spatial and temporal distribution of all individuals allowed us to calculate the expected rates of within- and between-group interactions. These values suggest that the network of interaction within colonies is primarily mediated by age-induced changes in the spatial location of workers.	[Mersch, Danielle P.; Keller, Laurent] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Crespi, Alessandro] Ecole Polytech Fed Lausanne, Biorobot Lab, CH-1015 Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Mersch, DP (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	danielle.mersch@unil.ch; laurent.keller@unil.ch	keller, laurent/AAI-7175-2020; Crespi, Alessandro/M-6777-2014	Crespi, Alessandro/0000-0001-9863-5220; keller, laurent/0000-0002-5046-9953	advanced European Research Council grant; Swiss National Science Foundation; Societe Academique Vaudoise; Fondation Erna Hamburger	advanced European Research Council grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Societe Academique Vaudoise; Fondation Erna Hamburger	This work was funded by an advanced European Research Council grant, several grants from the Swiss National Science Foundation, the Societe Academique Vaudoise, and the Fondation Erna Hamburger. We declare no conflicts of interest. We thank M. Fiala for advice on the use of the ARTag library; A. Hefetz for collecting queens; B. Hollis for help with the information spread analysis; R. James for discussions on network analysis; the Swiss Institute of Bioinformatics for data storage; and M. Chapuisat, B. Hollis, T. Kawecki, E. Lucas, N. Stroeymeyt, T. Richardson, and three anonymous reviewers for comments on the manuscript. Electronic schematics and software are available upon request. Data (social networks, behavior, spatial structure, observed and expected interaction frequencies, and information spread) that pertain to the experiments and analyses reported in this paper can be accessed at DOI: 10.5061/dryad.8d8h7.	Blonder B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020298; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Camazine S., 2003, SELF ORG BIOL SYSTEM; Fiala M., 2005, HAVE 2005 IEEE INT W; Holldobler B., 1990, pi; Jandt JM, 2009, ANIM BEHAV, V77, P641, DOI 10.1016/j.anbehav.2008.11.019; Johnson BR, 2008, BEHAV ECOL SOCIOBIOL, V62, P777, DOI 10.1007/s00265-007-0503-2; Lenoir A, 1979, B BIOL FR BELG, V2-3, P80; Lusseau D, 2006, J ANIM ECOL, V75, P14, DOI 10.1111/j.1365-2656.2005.01013.x; Mourier J, 2012, ANIM BEHAV, V83, P389, DOI 10.1016/j.anbehav.2011.11.008; Robinson EJH, 2009, P ROY SOC B-BIOL SCI, V276, P4373, DOI 10.1098/rspb.2009.1244; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Seid MA, 2006, BEHAV ECOL SOCIOBIOL, V60, P631, DOI 10.1007/s00265-006-0207-z; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Vonshak Merav, 2010, Israel Journal of Entomology, V39, P165	18	244	247	8	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1090	1093		10.1126/science.1234316	http://dx.doi.org/10.1126/science.1234316			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23599264	Green Published			2022-12-28	WOS:000319664500043
J	Hemenway, D; Miller, M				Hemenway, David; Miller, Matthew			Public Health Approach to the Prevention of Gun Violence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hemenway, David; Miller, Matthew] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hemenway, D (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							[Anonymous], 1998, INT STUD FIR REG; *CDCP, PUBL HLTH APPR VIOL; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P369; Hahn Robert A, 2003, MMWR Recomm Rep, V52, P11; Hemenway D., 2012, INJ PREV; Hemenway D., 2009, WE WERE SLEEPING SUC, P12; Hemenway D, 2006, PRIVATE GUNS PUBLIC; Hemenway D, 2009, AM J PREV MED, V37, P68, DOI 10.1016/j.amepre.2009.03.005; Kennedy D.M., 2011, DONT SHOOT ONE MAN S; National Highway Traffic Safety Administration, 2012, 2010 MOT VEH CRASH O; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf; Sorenson SB, 2003, INJ PREV, V9, P147, DOI 10.1136/ip.9.2.147; Webster DW, 2006, INJURY PREV, V12, P225, DOI 10.1136/ip.2006.012120; Whitehill JM, 2013, J URBAN HLTH; Williams AF, 2010, J SAFETY RES, V41, P77, DOI 10.1016/j.jsr.2010.03.002; WINSTEN JA, 1994, AM J PREV MED, V10, P11, DOI 10.1016/S0749-3797(18)30544-0	16	66	66	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					2033	2035		10.1056/NEJMsb1302631	http://dx.doi.org/10.1056/NEJMsb1302631			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148TJ	23581254				2022-12-28	WOS:000319270200008
J	Jangi, S				Jangi, Sushrut			Under the Medical Tent at the Boston Marathon	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Jangi, S (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.								0	10	10	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1953	1955		10.1056/NEJMp1305299	http://dx.doi.org/10.1056/NEJMp1305299			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194KD	23611490				2022-12-28	WOS:000322630700002
J	Russell, AB; LeRoux, M; Hathazi, K; Agnello, DM; Ishikawa, T; Wiggins, PA; Wai, SN; Mougous, JD				Russell, Alistair B.; LeRoux, Michele; Hathazi, Krisztina; Agnello, Danielle M.; Ishikawa, Takahiko; Wiggins, Paul A.; Wai, Sun Nyunt; Mougous, Joseph D.			Diverse type VI secretion phospholipases are functionally plastic antibacterial effectors	NATURE			English	Article							COMPLETE GENOME SEQUENCE; PSEUDOMONAS-AERUGINOSA; MEMBRANE-LIPIDS; VIRULENCE; EXPRESSION; PROTEIN; SYSTEM; IDENTIFICATION; PREDICTION; SURVIVAL	Membranes allow the compartmentalization of biochemical processes and are therefore fundamental to life. The conservation of the cellular membrane, combined with its accessibility to secreted proteins, has made it a common target of factors mediating antagonistic interactions between diverse organisms. Here we report the discovery of a diverse superfamily of bacterial phospholipase enzymes. Within this superfamily, we defined enzymes with phospholipase A(1) and A(2) activity, which are common in host-cell-targeting bacterial toxins and the venoms of certain insects and reptiles(1,2). However, we find that the fundamental role of the superfamily is to mediate antagonistic bacterial interactions as effectors of the type VI secretion system (T6SS) translocation apparatus; accordingly, we name these proteins type VI lipase effectors. Our analyses indicate that PldA of Pseudomonas aeruginosa, a eukaryotic-like phospholipase D-3, is a member of the type VI lipase effector superfamily and the founding substrate of the haemolysin co-regulated protein secretion island II T6SS (H2-T6SS). Although previous studies have specifically implicated PldA and the H2-T6SS in pathogenesis(3-5), we uncovered a specific role for the effector and its secretory machinery in intra-and interspecies bacterial interactions. Furthermore, we find that this effector achieves its antibacterial activity by degrading phosphatidylethanolamine, the major component of bacterial membranes. The surprising finding that virulence-associated phospholipases can serve as specific antibacterial effectors suggests that interbacterial interactions are a relevant factor driving the continuing evolution of pathogenesis.	[Russell, Alistair B.; LeRoux, Michele; Agnello, Danielle M.; Mougous, Joseph D.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [LeRoux, Michele; Mougous, Joseph D.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Hathazi, Krisztina; Ishikawa, Takahiko; Wai, Sun Nyunt] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; [Hathazi, Krisztina; Ishikawa, Takahiko; Wai, Sun Nyunt] Umea Univ, Lab Mol Infect Med Sweden MIMS, SE-90187 Umea, Sweden; [Wiggins, Paul A.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Wiggins, Paul A.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Umea University; Umea University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mougous, JD (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	mougous@u.washington.edu		Russell, Alistair/0000-0002-5342-2309; Wiggins, Paul/0000-0002-8316-4339; Wai, Sun Nyunt/0000-0003-4793-4671; LeRoux, Michele/0000-0003-2075-4208	National Institutes of Health (NIH) [AI080609, AI057141, AI105268, GM07270]; Cystic Fibrosis Foundation [CFR565-CR07]; National Science Foundation [PHY-084845, MCB-1151043, DGE-0718124]; Swedish Research Council [2010-3073, 2007-8673 UCMR Linnaeus, 2006-7431 MIMS]; Faculty of Medicine, Umea University; University of Washington Royalty Research Fund; Sloan Foundation; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105268, R01AI080609, U54AI057141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Science Foundation(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Faculty of Medicine, Umea University; University of Washington Royalty Research Fund(University of Washington); Sloan Foundation(Alfred P. Sloan Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Kulasekara, B. E. Uhlin and members of the Mougous and Wai laboratories for discussions, J. Woodward for sharing chemistry expertise, the Manoil laboratory for sharing B. thailandensis transposon mutants, and the Parsek laboratory and K. Korotkov for sharing reagents. This work was supported by grants from the National Institutes of Health (NIH) (AI080609, AI057141 and AI105268), Cystic Fibrosis Foundation (CFR565-CR07), the National Science Foundation (PHY-084845 and MCB-1151043), the Swedish Research Council (2010-3073, 2007-8673 UCMR Linnaeus and 2006-7431 MIMS), and the Faculty of Medicine, Umea University. A. B. R. was supported by a Graduate Research Fellowship from the National Science Foundation (DGE-0718124), M. L. was supported by the NIH Cellular and Molecular Training Grant (GM07270), P. A. W. received support from the University of Washington Royalty Research Fund and the Sloan Foundation, and J. D. M. holds an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Aloulou A, 2012, METHODS MOL BIOL, V861, P63, DOI 10.1007/978-1-61779-600-5_4; Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Barret M, 2011, MICROBIOL-SGM, V157, P1726, DOI 10.1099/mic.0.048645-0; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Chandler JR, 2009, J BACTERIOL, V191, P5901, DOI 10.1128/JB.00591-09; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hsu FS, 2009, MOL MICROBIOL, V72, P1111, DOI 10.1111/j.1365-2958.2009.06701.x; Imperi F, 2009, PROTEOMICS, V9, P1901, DOI 10.1002/pmic.200800618; Ishikawa T, 2012, INFECT IMMUN, V80, P575, DOI 10.1128/IAI.05510-11; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim HS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-174; Korotkov K. V., 2013, J STRUCT BIOL; LeRoux M, 2012, P NATL ACAD SCI USA, V109, P19804, DOI 10.1073/pnas.1213963109; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Mougous JD, 2004, NAT STRUCT MOL BIOL, V11, P721, DOI 10.1038/nsmb802; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sana TG, 2012, J BIOL CHEM, V287, P27095, DOI 10.1074/jbc.M112.376368; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schmiel DH, 1999, MICROBES INFECT, V1, P1103, DOI 10.1016/S1286-4579(99)00205-1; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Termine E, 2009, INT MICROBIOL, V12, P7, DOI 10.2436/20.1501.01.76; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Valeru SP, 2009, INFECT IMMUN, V77, P935, DOI 10.1128/IAI.00929-08; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; VONTIGERSTROM RG, 1989, CAN J MICROBIOL, V35, P511, DOI 10.1139/m89-079; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wilderman PJ, 2001, MOL MICROBIOL, V39, P291, DOI 10.1046/j.1365-2958.2001.02282.x; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998	48	243	249	4	142	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					508	+		10.1038/nature12074	http://dx.doi.org/10.1038/nature12074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23552891	Green Accepted			2022-12-28	WOS:000317984400042
J	Groves, T				Groves, Trish			Research Paper of the Year award 2013	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER					tgroves@bmj.com	Groves, Trish/A-9119-2009	Groves, Trish/0000-0001-7915-6419				Butler CC, 2012, BMJ-BRIT MED J, V344, DOI [10.1136/bmj.d8173, 10.1136/bmj.e682]; Krogsboll LT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7191; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Simmons RK, 2012, LANCET, V380, P1741, DOI 10.1016/S0140-6736(12)61422-6; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2013	346								f2512	10.1136/bmj.f2512	http://dx.doi.org/10.1136/bmj.f2512			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134PM	23616033				2022-12-28	WOS:000318224900012
J	Stephens, R; Richey, M				Stephens, Rick; Richey, Mike			A Business View on U.S. Education	SCIENCE			English	Article							CHALLENGES	Business leaders depend on an education system capable of providing a workforce able to compete in a global marketplace. As a partner in education reform, the business community advocates for an increased focus on helping schools connect students more effectively to the world of work through hands-on problem-solving activities and practical experiences.	[Stephens, Rick; Richey, Mike] Boeing Co, 100 North Riverside, Chicago, IL 60606 USA	Boeing		rickstephens@me.com		Richey, Michael/0000-0001-8293-5720				[Anonymous], 2012, NY TIMES; National Commission on Excellence in Education, 1983, NAT RISK IMP ED REF; Pellegrino JW, 2013, SCIENCE, V340, P320, DOI 10.1126/science.1232065; Stage EK, 2013, SCIENCE, V340, P276, DOI 10.1126/science.1234011	4	1	1	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					313	314		10.1126/science.1230728	http://dx.doi.org/10.1126/science.1230728			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599482				2022-12-28	WOS:000317657500043
J	Auerbach, DI; Staiger, DO; Muench, U; Buerhaus, PI				Auerbach, David I.; Staiger, Douglas O.; Muench, Ulrike; Buerhaus, Peter I.			The Nursing Workforce in an Era of Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Auerbach, David I.] RAND, Boston, MA USA; [Staiger, Douglas O.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Staiger, Douglas O.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Muench, Ulrike; Buerhaus, Peter I.] Vanderbilt Univ, Sch Nursing, Nashville, TN 37240 USA; [Muench, Ulrike; Buerhaus, Peter I.] Vanderbilt Univ, Ctr Interdisciplinary Hlth Workforce Studies, Nashville, TN USA; [Buerhaus, Peter I.] Vanderbilt Univ, Inst Med & Publ Hlth, Nashville, TN USA	RAND Corporation; Dartmouth College; National Bureau of Economic Research; Vanderbilt University; Vanderbilt University; Vanderbilt University	Auerbach, DI (corresponding author), RAND, Boston, MA USA.							American Association of Colleges of Nursing, AACN RELEASES PRELIM; Auerbach DI, 2011, HEALTH AFFAIR, V30, P2286, DOI 10.1377/hlthaff.2011.0588; Buerhaus Peter I, 2013, Nurs Econ, V31, P13; Pryor J. H., 2010, THE AMERICAN FRESHMA; Staiger DO, 2012, NEW ENGL J MED, V366, P1463, DOI 10.1056/NEJMp1200641	5	56	56	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1470	1472		10.1056/NEJMp1301694	http://dx.doi.org/10.1056/NEJMp1301694			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126HC	23594001				2022-12-28	WOS:000317603300003
J	McKnight, R; Geddes, J				McKnight, Rebecca; Geddes, John			Cognitive-behavioral therapy improved response and remission at 6 and 12 months in treatment-resistant depression	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[McKnight, Rebecca; Geddes, John] Univ Oxford, Oxford, England	University of Oxford	McKnight, R (corresponding author), Univ Oxford, Oxford, England.		Geddes, John/B-8240-2011	Geddes, John/0000-0002-5281-5960	National Institute for Health Research [NF-SI-0611-10150] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28	1	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8							JC7	10.7326/0003-4819-158-8-201304160-02007	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588772				2022-12-28	WOS:000318062100010
J	Taubes, G				Taubes, Gary			The science of obesity: what do we really know about what makes us fat? An essay by Gary Taubes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LOW-CARBOHYDRATE; WEIGHT-LOSS; DIETS		Nutr Sci Initiat, San Diego, CA 92121 USA		Taubes, G (corresponding author), Nutr Sci Initiat, San Diego, CA 92121 USA.	gataubes@gmail.com						Atwater WO, 1899, BULLETIN, V69; Bauer J, 1941, ARCH INTERN MED, V67, P968, DOI 10.1001/archinte.1941.00200050076006; BERSON SA, 1965, DIABETES, V14, P549, DOI 10.2337/diab.14.9.549; Falta W, 1940, OBESITY LEANNESS; Falta W., 1923, ENDOCRINE DIS INCLUD; Feynman R.P., 1967, CHARACTER PHYS LAW; Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Grafe E., 1933, METABOLIC DIS THEIR; Newburgh LH, 1930, J CLIN INVEST, V8, P197, DOI 10.1172/JCI100260; Newburgh LH, 1930, ANN INTERN MED, V3, P815, DOI 10.7326/0003-4819-3-8-815; PASSMORE R, 1963, BRIT J NUTR, V17, P331, DOI 10.1079/BJN19630036; RONY HR, 1940, OBESITY LEANNESS; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; University of Michigan Faculty History Project, PROFESSOR MED AUGMEN; VANGAAL LF, 1998, HDB OBESITY, P875; Von Noorden C, 1907, METABOLISM PRACTICAL, V3, P693; Wilder RM, 1938, ARCH INTERN MED, V61, P297, DOI 10.1001/archinte.1938.00180080139009; WILLIAMS RH, 1948, ANN INTERN MED, V29, P510, DOI 10.7326/0003-4819-29-3-510	20	51	51	1	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2013	346								f1050	10.1136/bmj.f1050	http://dx.doi.org/10.1136/bmj.f1050			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AO	23596125				2022-12-28	WOS:000317962900001
J	Liebensteiner, MG; Pinkse, MWH; Schaap, PJ; Stams, AJM; Lomans, BP				Liebensteiner, Martin G.; Pinkse, Martijn W. H.; Schaap, Peter J.; Stams, Alfons J. M.; Lomans, Bart P.			Archaeal (Per)Chlorate Reduction at High Temperature: An Interplay of Biotic and Abiotic Reactions	SCIENCE			English	Article							ARCHAEOGLOBUS-FULGIDUS; PERCHLORATE	Perchlorate and chlorate anions [(per) chlorate] exist in the environment from natural and anthropogenic sources, where they can serve as electron acceptors for bacteria. We performed growth experiments combined with genomic and proteomic analyses of the hyperthermophile Archaeoglobus fulgidus that show (per) chlorate reduction also extends into the archaeal domain of life. The (per) chlorate reduction pathway in A. fulgidus relies on molybdo-enzymes that have similarity with bacterial enzymes; however, chlorite is not enzymatically split into chloride and oxygen. Evidence suggests that it is eliminated by an interplay of abiotic and biotic redox reactions involving sulfur compounds. Biological (per) chlorate reduction by ancient archaea at high temperature may have prevented accumulation of perchlorate in early terrestrial environments and consequently given rise to oxidizing conditions on Earth before the rise of oxygenic photosynthesis.	[Liebensteiner, Martin G.; Stams, Alfons J. M.] Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [Pinkse, Martijn W. H.] Delft Univ Technol, Dept Biotechnol, Analyt Biotechnol Sect, NL-2628 BC Delft, Netherlands; [Pinkse, Martijn W. H.] Netherlands Prote Ctr, NL-2628 BC Delft, Netherlands; [Schaap, Peter J.] Wageningen Univ, Lab Syst & Synthet Biol, NL-6703 HB Wageningen, Netherlands; [Stams, Alfons J. M.] Univ Minho, Ctr Biol Engn, P-4710057 Braga, Portugal; [Lomans, Bart P.] Shell Global Solut Int BV, NL-2288 GS Rijswijk, Netherlands	Wageningen University & Research; Delft University of Technology; Wageningen University & Research; Universidade do Minho; Royal Dutch Shell	Stams, AJM (corresponding author), Wageningen Univ, Microbiol Lab, Dreijenpl 10, NL-6703 HB Wageningen, Netherlands.	Fons.Stams@wur.nl	Stams, Alfons/C-8167-2014	Stams, Alfons/0000-0001-7840-6500; Schaap, Peter/0000-0002-4346-6084	Shell Global Solutions International BV; Technology Foundation STW [08053]; Chemical Sciences division CW of the Netherlands Science Foundation (NWO) [700.55.343]	Shell Global Solutions International BV; Technology Foundation STW(Technologiestichting STW); Chemical Sciences division CW of the Netherlands Science Foundation (NWO)	We thank D. Frigo and M. Golombok for critically reviewing the manuscript and Shell Global Solutions International BV for financial support. A.J.M.S. acknowledges the support of the Technology Foundation STW (project 08053) and the Chemical Sciences division CW (project 700.55.343) of the Netherlands Science Foundation (NWO). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium with the data set identifier PXD000137 and digital object identifier 10.6019/PXD000137. The experiments were conceived by M. G. L., A.J.M.S., and B. P. L. Growth experiments, enzyme activity measurements and chemical analyses were conducted by M. G. L. The proteome analysis was performed by M. W. H. P. Data processing and interpretation of the proteome analysis was done by P.J.S. and M. G. L. The manuscript was written by M. G. L. with input from all other authors.	BEEDER J, 1994, APPL ENVIRON MICROB, V60, P1227, DOI 10.1128/AEM.60.4.1227-1231.1994; Bender KS, 2005, J BACTERIOL, V187, P5090, DOI 10.1128/JB.187.15.5090-5096.2005; Castresana J, 1999, J MOL EVOL, V49, P453, DOI 10.1007/PL00006568; Coates JD, 1999, APPL ENVIRON MICROB, V65, P5234; Coates JD, 2004, NAT REV MICROBIOL, V2, P569, DOI 10.1038/nrmicro926; Coulthurst SJ, 2012, BIOCHEMISTRY-US, V51, P1678, DOI 10.1021/bi201852d; Dasgupta PK, 2005, ENVIRON SCI TECHNOL, V39, P1569, DOI 10.1021/es048612x; Dridge EJ, 2006, BIOCHEM SOC T, V34, P118, DOI 10.1042/BST0340118; Fardeau ML, 2009, GEOMICROBIOL J, V26, P119, DOI 10.1080/01490450802674970; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Kengen SWM, 1999, J BACTERIOL, V181, P6706, DOI 10.1128/JB.181.21.6706-6711.1999; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Kounaves SP, 2010, ENVIRON SCI TECHNOL, V44, P2360, DOI 10.1021/es9033606; Kurakin A, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-4; Mao SC, 2009, J PHYS CHEM A, V113, P1231, DOI 10.1021/jp807802v; ORBAN M, 1982, J PHYS CHEM-US, V86, P431, DOI 10.1021/j100393a001; Parker DR, 2009, ENVIRON CHEM, V6, P10, DOI 10.1071/EN09001; Plummer LN, 2006, ENVIRON SCI TECHNOL, V40, P1757, DOI 10.1021/es051739h; Rikken GB, 1996, APPL MICROBIOL BIOT, V45, P420, DOI 10.1007/s002530050707; Sperling D, 1998, FEMS MICROBIOL LETT, V162, P257, DOI 10.1111/j.1574-6968.1998.tb13007.x; STETTER KO, 1987, SCIENCE, V236, P822, DOI 10.1126/science.236.4803.822; ZELLNER G, 1989, SYST APPL MICROBIOL, V11, P151, DOI 10.1016/S0723-2020(89)80055-4	22	50	50	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					85	87		10.1126/science.1233957	http://dx.doi.org/10.1126/science.1233957			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559251				2022-12-28	WOS:000317061100051
J	Mercier, E; Boutin, A; Lauzier, F; Fergusson, DA; Simard, JF; Zarychanski, R; Moore, L; McIntyre, LA; Archambault, P; Lamontagne, F; Legare, F; Randell, E; Nadeau, L; Rousseau, F; Turgeon, AF				Mercier, Eric; Boutin, Amelie; Lauzier, Francois; Fergusson, Dean A.; Simard, Jean-Francois; Zarychanski, Ryan; Moore, Lynne; McIntyre, Lauralyn A.; Archambault, Patrick; Lamontagne, Francois; Legare, France; Randell, Edward; Nadeau, Linda; Rousseau, Francois; Turgeon, Alexis F.			Predictive value of S-100 beta protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							NEURON-SPECIFIC ENOLASE; SERUM S-100B PROTEIN; SEVERE HEAD-INJURY; OPTIMAL SEARCH STRATEGIES; S100B PROTEIN; OUTCOME PREDICTION; CEREBROSPINAL-FLUID; CARDIAC-ARREST; DAMAGE; MARKER	Objectives To determine the ability and accuracy of the S-100 beta protein in predicting prognosis after a moderate or severe traumatic brain injury. Design Systematic review and meta-analysis of randomised controlled trials and observational studies. Data sources Medline, Embase, Cochrane Central Register of Controlled Trials, BIOSIS (from their inception to April 2012), conference abstracts, bibliographies of eligible articles, and relevant narrative reviews. Study selection Two reviewers independently reviewed citations and selected eligible studies, defined as cohort studies or randomised control trials including patients with moderate or severe traumatic brain injury and evaluating the prognostic value of S-100 beta protein. Outcomes evaluated were mortality, score on the Glasgow outcome scale, or brain death. Data extraction Two independent reviewers extracted data using a standardised form and evaluated the methodological quality of included studies. Pooled results were presented with geometric means ratios and analysed with random effect models. Prespecified sensitivity analyses were performed to explain heterogeneity. Results The search strategy yielded 9228 citations. Two randomised controlled trials and 39 cohort studies were considered eligible (1862 patients). Most studies (n=23) considered Glasgow outcome score <= 3 as an unfavourable outcome. All studies reported at least one measurement of S-100 beta within 24 hours after traumatic brain injury. There was a significant positive association between S-100 beta protein concentrations and mortality (12 studies: geometric mean ratio 2.55, 95% confidence interval 2.02 to 3.21, I-2=56%) and score <= 3 (18 studies: 2.62, 2.01 to 3.42, I-2=79%). Sensitivity analysis based on sampling time, sampling type, blinding of outcome assessors, and timing of outcome assessment yielded similar results. Thresholds for serum S-100 beta protein values with 100% specificity ranged from 1.38 to 10.50 mu g/L for mortality (six studies) and from 2.16 to 14.00 mu g/L for unfavourable neurological prognosis as defined by the Glasgow outcome score. Conclusions After moderate or severe traumatic brain injury, serum S-100 beta protein concentrations are significantly associated with unfavourable prognosis in the short, mid, or long term. Optimal thresholds for discrimination remain unclear. Measuring the S-100 beta protein could be useful in evaluating the severity of traumatic brain injury and in the determination of long term prognosis in patients with moderate and severe injury.	[Mercier, Eric; Boutin, Amelie; Lauzier, Francois; Simard, Jean-Francois; Moore, Lynne; Turgeon, Alexis F.] CHU Quebec, Ctr Rech, Hop Enfant Jesus, Quebec City, PQ G1J 1Z4, Canada; [Lauzier, Francois; Turgeon, Alexis F.] Univ Laval, Dept Anesthesiol, Div Crit Care, Quebec City, PQ, Canada; [Lauzier, Francois] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Fergusson, Dean A.; McIntyre, Lauralyn A.] Ottawa Hosp Res Inst, Clin Epidemiol Unit, Ottawa, ON, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Sect Crit Care Med, Winnipeg, MB, Canada; [Moore, Lynne] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada; [McIntyre, Lauralyn A.] Univ Ottawa, Dept Med, Div Crit Care, Ottawa, ON, Canada; [Archambault, Patrick; Legare, France] Univ Laval, Dept Family & Emergency Med, Quebec City, PQ, Canada; [Lamontagne, Francois] Univ Sherbrooke, Ctr Rech Clin Etienne Le Bel CHUS, Sherbrooke, PQ J1K 2R1, Canada; [Legare, France; Rousseau, Francois] Univ Laval, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada; [Randell, Edward] Mem Univ Newfoundland, Dept Lab Med, St John, NF, Canada; [Nadeau, Linda; Rousseau, Francois] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; University of Ottawa; Ottawa Hospital Research Institute; University of Manitoba; Laval University; University of Ottawa; Laval University; University of Sherbrooke; Laval University; Memorial University Newfoundland; Laval University	Turgeon, AF (corresponding author), CHU Quebec, Ctr Rech, Hop Enfant Jesus, 1401,18E Rue,Local H-012A, Quebec City, PQ G1J 1Z4, Canada.	alexis.turgeon@fmed.ulaval.ca	Zarychanski, Ryan/AAB-6369-2022; Lauzier, Francois/B-9237-2015; McIntyre, Lauralyn/AAR-7710-2021	Lauzier, Francois/0000-0002-6530-5513; McIntyre, Lauralyn/0000-0001-7421-1407; Boutin, Amelie/0000-0003-1907-2920; Lamontagne, Francois/0000-0002-0360-3427; Fergusson, Dean/0000-0002-3389-2485; Zarychanski, Ryan/0000-0001-9455-6138; Legare, France/0000-0002-2296-6696	Fonds de la Recherche du Quebec-Sante (FRQ-S) (Traumatology Research Consortium) [23698]; Canadian Anesthesia Research Foundation (CARF); Foundation of the Association des Anesthesiologistes du Quebec (AAQ Foundation); Regroupement en Soins Critiques of the FRQ-S Respiratory Health Network; FRQ [23819]; FRQ-S; Traumatology Research Consortium of the FRQ-S; Canadian Institutes of Health Research (CIHR); CIHR	Fonds de la Recherche du Quebec-Sante (FRQ-S) (Traumatology Research Consortium); Canadian Anesthesia Research Foundation (CARF); Foundation of the Association des Anesthesiologistes du Quebec (AAQ Foundation); Regroupement en Soins Critiques of the FRQ-S Respiratory Health Network; FRQ; FRQ-S; Traumatology Research Consortium of the FRQ-S; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was funded by the Fonds de la Recherche du Quebec-Sante (FRQ-S) (Traumatology Research Consortium, grant No 23698), the Canadian Anesthesia Research Foundation (CARF), the Foundation of the Association des Anesthesiologistes du Quebec (AAQ Foundation) and the Regroupement en Soins Critiques of the FRQ-S Respiratory Health Network. EM was supported by a research training grant (MSc) from the FRQ-during the conduction of the study (No 23819). AFT, FL, and PL are recipients of a research career award from the FRQ-S. AFT and FL are supported by the Traumatology Research Consortium of the FRQ-S. LM, LAM, and DAF are recipients of new investigator awards from the Canadian Institutes of Health Research (CIHR). RZ is a recipient of an RCT mentorship award from the CIHR. Funding agencies had no role in any part of conduct of the study or preparation of the manuscript.	Ahmad O, 2012, CEREBROVASC DIS, V33, P47, DOI 10.1159/000332810; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS91; Chatfield DA, 2002, BRIT J NEUROSURG, V16, P471, DOI 10.1080/0268869021000030285; da Rocha AB, 2006, CLIN CHEM LAB MED, V44, P1234, DOI 10.1515/CCLM.2006.218; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Elting JW, 2000, J NEUROL SCI, V181, P104, DOI 10.1016/S0022-510X(00)00442-1; Friedrich JO, 2012, STAT MED, V31, P1857, DOI 10.1002/sim.4501; Ghori Kamran A, 2007, Crit Care Resusc, V9, P166; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Gonzalez-Mao MC, 2011, CLIN LAB, V57, P587; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427; Hu Dian-lei, 2004, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V16, P221; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; JENNETT B, 1975, LANCET, V1, P480; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Kuzumi E, 2000, BRIT J ANAESTH, V85, P936; Lange RT, 2010, J TRAUMA, V68, P1065, DOI 10.1097/TA.0b013e3181bb9890; Lara DR, 2001, J PSYCHIATR RES, V35, P11, DOI 10.1016/S0022-3956(01)00003-6; Lavicka P, 2007, CESK SLOV NEUROL N, V70, P521; Li Ning, 2004, Chin J Traumatol, V7, P156; Lomas JP, 2005, EMERG MED J, V22, P889, DOI 10.1136/emj.2005.031732; McKeating EG, 1998, ACT NEUR S, V71, P117; Meissner W, 1998, CRIT CARE MED S, V26, p83A; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mussack T, 2006, CLIN BIOCHEM, V39, P349, DOI 10.1016/j.clinbiochem.2005.12.007; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nash DL, 2008, NEUROCRIT CARE, V8, P301, DOI 10.1007/s12028-007-9019-x; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/neu.2004.21.1553; Pelinka LE, 2003, SHOCK, V19, P422, DOI 10.1097/01.shk.0000055345.58165.52; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Pelinka LE, 2004, INDIAN J CRIT CARE M, V8, P190; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 2004, NEUROL RES, V26, P440, DOI 10.1179/016164104225015958; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Regner A, 2001, NEUROREPORT, V12, P691, DOI 10.1097/00001756-200103260-00015; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Sawaughi S, 2005, NEUROL SURG TOKYO, V33, P1073; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Sheng JG, 1996, NEUROBIOL AGING, V17, P359, DOI 10.1016/0197-4580(96)00037-1; Shinozaki K, 2009, CRIT CARE, V13, DOI 10.1186/cc7973; Shinozaki K, 2009, RESUSCITATION, V80, P870, DOI 10.1016/j.resuscitation.2009.05.005; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Steiner J, 2011, CLIN CHEM LAB MED, V49, P409, DOI 10.1515/CCLM.2011.083; Stroick M, 2006, CURR MED CHEM, V13, P3053, DOI 10.2174/092986706778521751; TEASDALE G, 1974, LANCET, V2, P81; Teepker M, 2009, HEADACHE, V49, P245, DOI 10.1111/j.1526-4610.2008.01228.x; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Turgeon AF, 2013, CRIT CARE MED; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Ucar T, 2004, J TRAUMA, V57, P95, DOI 10.1097/01.TA.0000071352.95491.75; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Vos MJ, 2004, ANTICANCER RES, V24, P2511; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang XH, 2006, NEURAL REGEN RES, V1, P649; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Wilczynski NL, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-23; Wilczynski NL, 2005, J AM MED INFORM ASSN, V12, P481, DOI 10.1197/jamia.M1752; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Woertgen C, 2002, BRAIN INJURY, V16, P807, DOI 10.1080/02699050210128933; Yardan T, 2009, AM J EMERG MED, V27, P838, DOI 10.1016/j.ajem.2008.04.016; Yuan XS, 2008, CHIN J TRAUMATOL, V11, P54, DOI 10.1016/S1008-1275(08)60012-7; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	103	87	93	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2013	346								f1757	10.1136/bmj.f1757	http://dx.doi.org/10.1136/bmj.f1757			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122SI	23558282	hybrid			2022-12-28	WOS:000317338000004
J	Russell, JF				Russell, Jonathan F.			If a job is worth doing, it is worth doing twice	NATURE			English	Editorial Material									Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Russell, JF (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.	jonathan.russell@ucsf.edu							0	38	39	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2013	496	7443					7	7		10.1038/496007a	http://dx.doi.org/10.1038/496007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117ZZ	23552910	Bronze			2022-12-28	WOS:000316993400003
J	Sigloch, K; Mihalynuk, MG				Sigloch, Karin; Mihalynuk, Mitchell G.			Intra-oceanic subduction shaped the assembly of Cordilleran North America	NATURE			English	Article							CRETACEOUS STRATA; REFERENCE FRAMES; CENTRAL SONORA; PLATE MOTIONS; LOWER-MANTLE; OCEAN; SLAB; ACCRETION; PACIFIC; ARC	The western quarter of North America consists of accreted terranes-crustal blocks added over the past 200 million years-but the reason for this is unclear. The widely accepted explanation posits that the oceanic Farallon plate acted as a conveyor belt, sweeping terranes into the continental margin while subducting under it. Here we show that this hypothesis, which fails to explain many terrane complexities, is also inconsistent with new tomographic images of lower-mantle slabs, and with their locations relative to plate reconstructions. We offer a reinterpretation of North American palaeogeography and test it quantitatively: collision events are clearly recorded by slab geometry, and can be time calibrated and reconciled with plate reconstructions and surface geology. The seas west of Cretaceous North America must have resembled today's western Pacific, strung with island arcs. All proto-Pacific plates initially subducted into almost stationary, intra-oceanic trenches, and accumulated below as massive vertical slab walls. Above the slabs, long-lived volcanic archipelagos and subduction complexes grew. Crustal accretion occurred when North America overrode the archipelagos, causing major episodes of Cordilleran mountain building.	[Sigloch, Karin] Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany; [Mihalynuk, Mitchell G.] British Columbia Geol Survey, Victoria, BC V8W 9N3, Canada	University of Munich	Sigloch, K (corresponding author), Univ Munich, Dept Earth & Environm Sci, Theresienstr 41, D-80333 Munich, Germany.	sigloch@geophysik.uni-muenchen.de; Mitch.Mihalynuk@gov.bc.ca	Sigloch, Karin/V-2194-2017; Mihalynuk, Mitchell/AAF-7403-2021	Sigloch, Karin/0000-0002-9876-4628; Mihalynuk, Mitchell/0000-0001-7590-4715				ATWATER T, 1989, E PACIFIC OCEAN HAWA, P21, DOI DOI 10.1130/DNAG-GNA-N.21; Boyden J. A, 2011, GEOINFORMATICS CYBER, P95, DOI DOI 10.1017/CBO9780511976308.008; Bunge HP, 2000, NATURE, V405, P337, DOI 10.1038/35012586; CONEY PJ, 1980, NATURE, V288, P329, DOI 10.1038/288329a0; Decker J., 1994, GEOLOGY ALASKA GEOLO, P285, DOI DOI 10.1130/DNAG-GNA-G1.285; Dickinson WR, 2008, GEOSPHERE, V4, P329, DOI 10.1130/GES00105.1; Dickinson WR, 2001, GEOL SOC AM BULL, V113, P1142, DOI 10.1130/0016-7606(2001)113<1142:CTCAAF>2.0.CO;2; Engebretson D., 1985, GEOL SOC AM SPEC PAP, V206, P1, DOI DOI 10.1130/SPE206-P1; Enkin RJ, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001983; Ernst WG, 2011, GEOL SOC AM BULL, V123, P1667, DOI 10.1130/B30398.1; Gibert G, 2012, GEOPHYS J INT, V189, P747, DOI 10.1111/j.1365-246X.2012.05426.x; Goes S, 2011, PHYS EARTH PLANET IN, V184, P1, DOI 10.1016/j.pepi.2010.10.007; Goes S, 2008, NATURE, V451, P981, DOI 10.1038/nature06691; Gonzalez-Leon CM, 2011, GEOSPHERE, V7, P1392, DOI 10.1130/GES00679.1; Grand SP., 1997, GSA TODAY, V7, P1; Gurnis M, 2012, COMPUT GEOSCI-UK, V38, P35, DOI 10.1016/j.cageo.2011.04.014; Johnston ST, 2001, EARTH PLANET SC LETT, V193, P259, DOI 10.1016/S0012-821X(01)00516-7; Johnston ST, 1996, GEOLOGY, V24, P997, DOI 10.1130/0091-7613(1996)024<0997:YIYTLC>2.3.CO;2; Leier AL, 2011, GEOLOGY, V39, P399, DOI 10.1130/G31762.1; Li C., 2008, GEOCHEM GEOPHY GEOSY, V9, P5, DOI [10.1029/2007GC001806, DOI 10.1029/2007GC001806]; Liu LJ, 2008, SCIENCE, V322, P934, DOI 10.1126/science.1162921; Liu LJ, 2010, NAT GEOSCI, V3, P353, DOI 10.1038/NGEO829; LIVACCARI RF, 1981, NATURE, V289, P276, DOI 10.1038/289276a0; MASSEY NWD, 1986, GEOLOGY, V14, P602, DOI 10.1130/0091-7613(1986)14<602:MICSVI>2.0.CO;2; McDowell FW, 2001, GEOL SOC AM BULL, V113, P521, DOI 10.1130/0016-7606(2001)113<0521:DOLCET>2.0.CO;2; MIHALYNUK MG, 1994, TECTONICS, V13, P575, DOI 10.1029/93TC03492; MONGER JWH, 1982, GEOLOGY, V10, P70, DOI 10.1130/0091-7613(1982)10<70:TAATOO>2.0.CO;2; Montelli R, 2004, GEOPHYS J INT, V158, P637, DOI 10.1111/j.1365-246X.2004.02346.x; Moores EM, 1998, INT GEOL REV, V40, P40, DOI 10.1080/00206819809465197; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; MULLER RD, 1993, GEOLOGY, V21, P275, DOI 10.1130/0091-7613(1993)021<0275:RPMRTT>2.3.CO;2; O'Neill C, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000784; Pavlis GL, 2012, TECTONOPHYSICS, V532, P82, DOI 10.1016/j.tecto.2012.02.008; Poulton T. P., 2013, GEOLOGICAL ATLAS W C; Ren Y, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004154; Ribe NM, 2007, EARTH PLANET SC LETT, V254, P173, DOI 10.1016/j.epsl.2006.11.028; SAGER WW, 1988, TECTONOPHYSICS, V155, P345, DOI 10.1016/0040-1951(88)90274-0; Saha A, 2005, GEOL SOC AM BULL, V117, P1318, DOI 10.1130/B25593.1; Schmandt B, 2011, GEOLOGY, V39, P175, DOI 10.1130/G31558.1; Sdrolias M, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001090; Seton M, 2012, EARTH-SCI REV, V113, P212, DOI 10.1016/j.earscirev.2012.03.002; Shephard GE, 2012, EARTH PLANET SC LETT, V317, P204, DOI 10.1016/j.epsl.2011.11.027; Sigloch K, 2008, NAT GEOSCI, V1, P458, DOI 10.1038/ngeo231; Sigloch K, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003421; Steinberger B, 2012, SOLID EARTH, V3, P415, DOI 10.5194/se-3-415-2012; Steinberger B, 2008, NATURE, V452, P620, DOI 10.1038/nature06824; Torsvik TH, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000227; van de Zedde DMA, 2001, TECTONICS, V20, P868, DOI 10.1029/2001TC900018; van der Meer DG, 2012, NAT GEOSCI, V5, P215, DOI [10.1038/NGEO1401, 10.1038/ngeo1401]; van der Meer DG, 2010, NAT GEOSCI, V3, P36, DOI 10.1038/NGEO708; Wells R. E., 2007, GEOLOGICAL SOC AM AB, V39, P19; ZHONG SJ, 1995, SCIENCE, V267, P838, DOI 10.1126/science.267.5199.838	52	186	186	5	122	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					50	+		10.1038/nature12019	http://dx.doi.org/10.1038/nature12019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23552944	Green Submitted			2022-12-28	WOS:000316993400023
J	Bell, KJL; Hayen, A; Irwig, L; Takahashi, O; Ohde, S; Glasziou, P				Bell, Katy J. L.; Hayen, Andrew; Irwig, Les; Takahashi, Osamu; Ohde, Sachiko; Glasziou, Paul			When to remeasure cardiovascular risk in untreated people at low and intermediate risk: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To estimate the probability of becoming high risk for cardiovascular disease among people at low and intermediate risk and not being treated for high blood pressure or lipid levels. Design Observational study. Setting General communities in Japan and the United States. Participants 13 757 participants of the Tokyo health check-up study and 3855 of the Framingham studies aged 30-74 years with complete data on risk equation covariates, not receiving blood pressure or cholesterol lowering treatment, and with an estimated risk of cardiovascular disease <20% within 10 years. We stratified participants on the basis of baseline risk: <5%, 5-<10%, 10-<15%, and15-<20%. We used follow-up measurements from the Tokyo study done annually over three years (2006-10) and follow-up visits in the Framingham study done between eight (1968-75) and 19 years (1990-1995) after baseline. Main outcome measure Estimated 10 year risk of a cardiovascular event >20% using the Framingham equation. Results At baseline most participants had <5% risk (60.6% of Tokyo cohort and 45.7% of Framingham cohort) or 5-<10% risk (24.0% and 28.0%, respectively) of a cardiovascular event within 10 years. There was <10% probability of crossing the treatment threshold at 19, 8, and 3 years for baseline risk groups <5%, 5-<10%, and 10-<15%, respectively, and >10% probability of crossing the treatment threshold at one year for the 15-<20% baseline risk group. Conclusions Decisions on the frequency of remeasuring for cardiovascular risk should be made on the basis of baseline risk. Repeat risk estimation before 8-10 years is not warranted for most people initially not requiring treatment. However, remeasurement within a year seems warranted in those with an initial 15-<20% risk.	[Bell, Katy J. L.; Glasziou, Paul] Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia; [Hayen, Andrew] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; [Irwig, Les] Univ Sydney, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; [Takahashi, Osamu; Ohde, Sachiko] St Lukes Life Sci Inst, Ctr Clin Epidemiol, Tokyo, Japan; [Takahashi, Osamu] St Lukes Int Hosp, Tokyo, Japan	Bond University; University of New South Wales Sydney; University of Sydney; St. Luke's International Hospital	Bell, KJL (corresponding author), Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia.	katy.bell@sydney.edu.au	Glasziou, Paul/A-7832-2008; Bell, Katy/B-9650-2013; Ohde, Sachiko/AAC-6496-2019	Glasziou, Paul/0000-0001-7564-073X; Bell, Katy/0000-0002-0137-3218; Ohde, Sachiko/0000-0001-9137-0047; Hayen, Andrew/0000-0003-4046-8030	Australian National Health and Medical Research Council [633003, APP1013390]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study received no specific funding. The authors have received funding from the Australian National Health and Medical Research Council (Program Grant No 633003, Early Career Fellowship No. APP1013390). The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Cupples LA, 1987, FRAMINGHAM HEART STU; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Glasziou PP, 2008, ANN INTERN MED, V148, P656, DOI 10.7326/0003-4819-148-9-200805060-00005; Graham I, 2007, EUR J CARDIOV PREV R, V14, pE1, DOI 10.1097/01.hjr.0000277984.31558.c4; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Keenan K, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1492; National Heart Lung and Blood Institute, 2011, CARD RISK RED GUID A; National Vascular Disease Prevention Alliance, 2009, GUID ASS ABS CARD DI; National Vascular Disease Prevention Alliance (NVDPA), 2012, GUIDELINES MANAGEMEN; New Zealand Guideline Group, 2003, ASS MAN CARD RISK; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Scottish Intercollegiate Guidelines Network, 2007, RISK EST PREV CARD D; Takahashi O, 2012, J HUM HYPERTENS, V26, P540, DOI 10.1038/jhh.2011.72; Takahashi O, 2010, DIABETES CARE, V33, P2016, DOI 10.2337/dc10-0588; Takahashi O, 2010, HEART, V96, P448, DOI 10.1136/hrt.2009.172619; US Department of Health and Human Services National Institutes of Health National Institutes of Diabetes and Digestive and Kidney diseases, 2011, DIAGN DIAB; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; World Health Organization, 2007, PREV CARD DIS GUID A	20	15	15	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2013	346								f1895	10.1136/bmj.f1895	http://dx.doi.org/10.1136/bmj.f1895			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122SG	23553971	Green Published, hybrid			2022-12-28	WOS:000317337800001
J	Bieri, FA; Gray, DJ; Williams, GM; Raso, G; Li, YS; Yuan, LP; He, YK; Li, RS; Guo, FY; Li, SM; McManus, DP				Bieri, Franziska A.; Gray, Darren J.; Williams, Gail M.; Raso, Giovanna; Li, Yue-Sheng; Yuan, Liping; He, Yongkang; Li, Robert S.; Guo, Feng-Ying; Li, Sheng-Ming; McManus, Donald P.			Health-Education Package to Prevent Worm Infections in Chinese Schoolchildren	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEGLECTED TROPICAL DISEASES; TRANSMITTED HELMINTH INFECTIONS; ANTHELMINTIC EFFICACY; DRUG EFFICACY; SCHISTOSOMIASIS; ALBENDAZOLE; EPIDEMIOLOGY; EXPERIENCES; PREVALENCE; RESISTANCE	BACKGROUND Soil-transmitted helminths are among the most prevalent sources of human infections globally. We determined the effect of an educational package at rural schools in Linxiang City District, Hunan province, China, where these worms are prevalent. The intervention aimed to increase knowledge about soil-transmitted helminths, induce behavioral change, and reduce the rate of infection. METHODS We conducted a single-blind, unmatched, cluster-randomized intervention trial involving 1718 children, 9 to 10 years of age, in 38 schools over the course of 1 school year. Schools were randomly assigned to the health-education package, which included a cartoon video, or to a control package, which involved only the display of a health-education poster. Infection rates, knowledge about soil-transmitted helminths (as assessed with the use of a questionnaire), and hand-washing behavior were assessed before and after the intervention. Albendazole was administered in all the participants at baseline and in all the children who were found to be positive for infection with soil-transmitted helminths at the follow-up assessment at the end of the school year. RESULTS At the follow-up assessment, the mean score for the knowledge of helminths, calculated as a percentage of a total of 43 points on a questionnaire, was 90% higher in the intervention group than in the control group (63.3 vs. 33.4, P<0.001), the percentage of children who washed their hands after using the toilet was nearly twice as high in the intervention group (98.9%, vs. 54.2% in the control group; P<0.001), and the incidence of infection with soil-transmitted helminths was 50% lower in the intervention group than in the control group (4.1% vs. 8.4%, P<0.001). No adverse events were observed immediately (within 15 minutes) after albendazole treatment. CONCLUSIONS The health-education package increased students' knowledge about soil-transmitted helminths and led to a change in behavior and a reduced incidence of infection within 1 school year. (Funded by UBS Optimus Foundation, Zurich, Switzerland; Australian New Zealand Clinical Trials Registry number, ACTRN12610000048088.)	[Bieri, Franziska A.; Gray, Darren J.; Li, Yue-Sheng; McManus, Donald P.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Bieri, Franziska A.; Gray, Darren J.; Williams, Gail M.; Li, Robert S.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Raso, Giovanna] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Raso, Giovanna] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Li, Yue-Sheng; Yuan, Liping; He, Yongkang; Guo, Feng-Ying; Li, Sheng-Ming] WHO Collaborating Ctr Res & Control Schistosomias, Hunan Inst Parasit Dis, Yueyang, Peoples R China	QIMR Berghofer Medical Research Institute; University of Queensland; University of Basel; Swiss Tropical & Public Health Institute	McManus, DP (corresponding author), Queensland Inst Med Res, Mol Parasitol Lab, 300 Herston Rd, Herston, Qld 4006, Australia.	don.mcmanus@qimr.edu.au	McManus, Donald P./G-2678-2013; McManus, Don/AAC-5394-2020; Williams, Gail/S-8833-2019; LI, Yue/GRS-8071-2022	McManus, Don/0000-0001-6443-1449; Williams, Gail/0000-0002-4822-5263; Gray, Darren/0000-0003-3525-1339	UBS Optimus Foundation, Zurich, Switzerland; University of Queensland Research Scholarship; University of Queensland International Research Tuition Award; Australian Scholarships Endeavour Award; Queensland Institute of Medical Research Scholarship	UBS Optimus Foundation, Zurich, Switzerland; University of Queensland Research Scholarship(University of Queensland); University of Queensland International Research Tuition Award; Australian Scholarships Endeavour Award(Australian GovernmentDepartment of Industry, Innovation and Science); Queensland Institute of Medical Research Scholarship	Supported by UBS Optimus Foundation, Zurich, Switzerland. Ms. Bieri is supported by a University of Queensland Research Scholarship, a University of Queensland International Research Tuition Award, an Australian Scholarships Endeavour Award, and a Queensland Institute of Medical Research Scholarship; Dr. Gray is an Australian Research Council Fellow (DECRA); Dr. Yue-Sheng Li is an Australian Research Council Future Fellow; and Dr. McManus is a National Health and Medical Research Council of Australia Senior Principal Research Fellow.	Albonico M, 1996, B WORLD HEALTH ORGAN, V74, P577; Albonico M, 2004, INT J PARASITOL, V34, P1205, DOI 10.1016/j.ijpara.2004.08.001; Albonico M, 2003, ACTA TROP, V86, P233, DOI 10.1016/S0001-706X(03)00043-3; Allen T, 2012, LANCET, V379, P1097, DOI 10.1016/S0140-6736(12)60159-7; Allen T, 2011, THIRD WORLD Q, V32, P91, DOI 10.1080/01436597.2011.543816; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Beanland TJ, 2006, MEM I OSWALDO CRUZ, V101, P87, DOI 10.1590/S0074-02762006000900013; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brabin L, 2010, VACCINE, V28, P4210, DOI 10.1016/j.vaccine.2010.03.077; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Chen YD, 2008, BIOMED ENVIRON SCI, V21, P173, DOI 10.1016/S0895-3988(08)60025-2; Fenwick A, 2009, PARASITOLOGY, V136, P1719, DOI 10.1017/S0031182009990400; Glanz K., 2008, HLTH BEHAV HLTH ED T; Gray DJ, 2010, LANCET INFECT DIS, V10, P733, DOI 10.1016/S1473-3099(10)70099-2; Gray DJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000413; Gunawardena K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001341; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Horton J, 2000, PARASITOLOGY, V121, pS113, DOI 10.1017/S0031182000007290; Hotez PJ, 2009, CLIN PHARMACOL THER, V85, P659, DOI 10.1038/clpt.2009.16; Hotez P, 2008, ANN NY ACAD SCI, V1136, P38, DOI 10.1196/annals.1425.000; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hu GH, 2005, ACTA TROP, V96, P232, DOI 10.1016/j.actatropica.2005.07.016; Humphries D, 2011, AM J TROP MED HYG, V84, P792, DOI 10.4269/ajtmh.2011.11-0003; Jackson F, 2000, PARASITOLOGY, V120, pS95, DOI 10.1017/S0031182099005740; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6; Locketz L, 1976, Bull Pan Am Health Organ, V10, P219; Luginbuhl A, 2008, HDB TRANSDISCIPLINAR, P293; Mayer RE., 2014, CAMBRIDGE HDB MULTIM, P345, DOI 10.1017/CBO9781139547369.017; Molyneux D, 2012, LANCET, V379, P1098, DOI 10.1016/S0140-6736(12)60454-1; Molyneux DH, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-234; Montresor A., 1998, WORLD HLTH ORG; Montresor A., 2002, HELMINTH CONTROL SCH; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Myint-U A, 2010, HEALTH PROMOT PRACT, V11, P408, DOI 10.1177/1524839908318830; Naldi L, 2007, J INVEST DERMATOL, V127, P1871, DOI 10.1038/sj.jid.5700835; Tomono Noriaki, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P264; Torabi MR, 2000, J SCHOOL HEALTH, V70, P229, DOI 10.1111/j.1746-1561.2000.tb07422.x; Vercruysse J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000948; WHO, 2012, ACC WORK OV GLOB IMP, P13; Yuan LP, 2000, TROP MED INT HEALTH, V5, P538, DOI 10.1046/j.1365-3156.2000.00602.x; Yuan LP, 2005, ACTA TROP, V96, P248, DOI 10.1016/j.actatropica.2005.07.019	42	106	113	0	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1603	1612		10.1056/NEJMoa1204885	http://dx.doi.org/10.1056/NEJMoa1204885			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130YK	23614586				2022-12-28	WOS:000317956300009
J	Kettleborough, RNW; Busch-Nentwich, EM; Harvey, SA; Dooley, CM; de Bruijn, E; van Eeden, F; Sealy, I; White, RJ; Herd, C; Nijman, IJ; Fenyes, F; Mehroke, S; Scahill, C; Gibbons, R; Wali, N; Carruthers, S; Hall, A; Yen, J; Cuppen, E; Stemple, DL				Kettleborough, Ross N. W.; Busch-Nentwich, Elisabeth M.; Harvey, Steven A.; Dooley, Christopher M.; de Bruijn, Ewart; van Eeden, Freek; Sealy, Ian; White, Richard J.; Herd, Colin; Nijman, Isaac J.; Fenyes, Fruzsina; Mehroke, Selina; Scahill, Catherine; Gibbons, Richard; Wali, Neha; Carruthers, Samantha; Hall, Amanda; Yen, Jennifer; Cuppen, Edwin; Stemple, Derek L.			A systematic genome-wide analysis of zebrafish protein-coding gene function	NATURE			English	Article							EMBRYONIC STEM-CELLS; IDENTIFICATION; INACTIVATION; MUTAGENESIS; DISRUPTION; REPORTER; SCREEN	Since the publication of the human reference genome, the identities of specific genes associated with human diseases are being discovered at a rapid rate. A central problem is that the biological activity of these genes is often unclear. Detailed investigations in model vertebrate organisms, typically mice, have been essential for understanding the activities of many orthologues of these disease-associated genes. Although gene-targeting approaches(1-3) and phenotype analysis have led to a detailed understanding of nearly 6,000 protein-coding genes(3,4), this number falls considerably short of the more than 22,000 mouse protein-coding genes(5). Similarly, in zebrafish genetics, one-by-one gene studies using positional cloning(6), insertional mutagenesis(7-9), antisense morpholino oligonucleotides(10), targeted re-sequencing(11-13), and zinc finger and TAL endonucleases(14-17) have made substantial contributions to our understanding of the biological activity of vertebrate genes, but again the number of genes studied falls well short of the more than 26,000 zebrafish protein-coding genes(18). Importantly, for both mice and zebrafish, none of these strategies are particularly suited to the rapid generation of knockouts in thousands of genes and the assessment of their biological activity. Here we describe an active project that aims to identify and phenotype the disruptive mutations in every zebrafish protein-coding gene, using a well-annotated zebrafish reference genome sequence(18,19), high-throughput sequencing and efficient chemical mutagenesis. So far we have identified potentially disruptive mutations in more than 38% of all known zebrafish protein-coding genes. We have developed a multi-allelic phenotyping scheme to efficiently assess the effects of each allele during embryogenesis and have analysed the phenotypic consequences of over 1,000 alleles. All mutant alleles and data are available to the community and our phenotyping scheme is adaptable to phenotypic analysis beyond embryogenesis.	[Kettleborough, Ross N. W.; Busch-Nentwich, Elisabeth M.; Harvey, Steven A.; Dooley, Christopher M.; Sealy, Ian; White, Richard J.; Herd, Colin; Fenyes, Fruzsina; Mehroke, Selina; Scahill, Catherine; Gibbons, Richard; Wali, Neha; Carruthers, Samantha; Hall, Amanda; Yen, Jennifer; Stemple, Derek L.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [de Bruijn, Ewart; Nijman, Isaac J.; Cuppen, Edwin] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [de Bruijn, Ewart; Nijman, Isaac J.; Cuppen, Edwin] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [van Eeden, Freek] Univ Sheffield, Dept Biomed Sci, MRC CDBG, Sheffield S10 2TN, S Yorkshire, England	Wellcome Trust Sanger Institute; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Sheffield	Stemple, DL (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	e.cuppen@hubrecht.eu; ds4@sanger.ac.uk	Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; White, Richard/0000-0003-1842-412X; Stemple, Derek/0000-0002-8296-9928; Nijman, Isaac/0000-0002-1840-1158	Wellcome Trust [098051]; US National Institutes of Health [5R01HG004819]; EU Sixth Framework Programme (ZF-MODELS) [LSHG-CT-2003-503496]; EU Seventh Framework Programme (ZF-HEALTH); UK Medical Research Council [G0777791]; SmartMix program from the Dutch government [SSM06010]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004819, R01HG000481] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU Sixth Framework Programme (ZF-MODELS); EU Seventh Framework Programme (ZF-HEALTH); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SmartMix program from the Dutch government; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank P. Ellis, E. Markham, H. van Roekel, P. Toonen, J. van de Belt, J. Mudde and S. Widaa for technical assistance, and B. Novak, Y. Yi and E. LeProust from Agilent Technologies. We thank everyone at The Zebrafish International Resource Center and the European Zebrafish Resource Center for stocking and distributing alleles. We thank members of the Wellcome Trust Sanger Institute RSF and DNA pipelines. We also thank G. Powell, J. Collins and F. L. Marlow for critical reading of the manuscript. This work was funded through a core grant to the Sanger Institute by the Wellcome Trust (grant number 098051), the US National Institutes of Health (5R01HG004819), the EU Sixth Framework Programme (ZF-MODELS, contract number LSHG-CT-2003-503496) and the EU Seventh Framework Programme (ZF-HEALTH). F. v. E. is supported by the UK Medical Research Council (grant number G0777791) and E. C. is supported by the SmartMix program (SSM06010) from the Dutch government.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Collins JE, 2012, GENOME RES, V22, P2067, DOI 10.1101/gr.137901.112; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Driever W, 1996, DEVELOPMENT, V123, P37; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Haffter P, 1996, DEVELOPMENT, V123, P1; Howe K., NATURE IN PRESS; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kettleborough RNW, 2011, METHOD CELL BIOL, V104, P121, DOI 10.1016/B978-0-12-374814-0.00006-9; Manfroid I, 2012, DEV BIOL, V366, P268, DOI 10.1016/j.ydbio.2012.04.002; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Seiler C, 2004, DEV BIOL, V272, P328, DOI 10.1016/j.ydbio.2004.05.004; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; Sood R, 2006, METHODS, V39, P220, DOI 10.1016/j.ymeth.2006.04.012; Steffen LS, 2007, DEV BIOL, V309, P180, DOI 10.1016/j.ydbio.2007.06.015; Stemple DL, 2004, NAT REV GENET, V5, P145, DOI 10.1038/nrg1273; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	30	402	424	3	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					494	+		10.1038/nature11992	http://dx.doi.org/10.1038/nature11992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23594742	Green Accepted			2022-12-28	WOS:000317984400039
J	Oomman, N; Mehl, G; Berg, M; Silverman, R				Nandini Oomman; Mehl, Garrett; Berg, Matt; Silverman, Rachel			Modernising vital registration systems: why now?	LANCET			English	Editorial Material							COUNTS		[Mehl, Garrett] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Berg, Matt] Columbia Univ, New York, NY USA; [Silverman, Rachel] Ctr Global Dev, Washington, DC USA	World Health Organization; Columbia University		nandini.oomman@gmail.com						AbouZahr C, 2010, LANCET, V375, P619, DOI 10.1016/S0140-6736(09)60004-0; Health Metrics Network and World Health Organization, 2010, MOVE IT MDGS; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; Labrique AB, 2012, REPROD HEALTH MATTER, V20, P113, DOI 10.1016/S0968-8080(12)39631-6; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Mahgoub A., 2010, CASH DELIVERY NEW AP; Maragioglio J., 2011, KENYA USES PHONES IM; Norwegian Institute of Public Health, HARM REPR HLTH REG H; Savedoff WD, 2011, 275 CTR GLOB DEV; Sekandi AL, 2010, UGANDA MODERNIZES BI; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; UNICEF, 2012, STATE WORLDS CHILDRE; UNICEF, NIGERIA US RAPIDSMS	13	13	15	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1336	1337		10.1016/S0140-6736(13)60847-8	http://dx.doi.org/10.1016/S0140-6736(13)60847-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130EF	23602229				2022-12-28	WOS:000317894800006
J	Chen, BT; Yau, HJ; Hatch, C; Kusumoto-Yoshida, I; Cho, SL; Hopf, FW; Bonci, A				Chen, Billy T.; Yau, Hau-Jie; Hatch, Christina; Kusumoto-Yoshida, Ikue; Cho, Saemi L.; Hopf, F. Woodward; Bonci, Antonello			Rescuing cocaine-induced prefrontal cortex hypoactivity prevents compulsive cocaine seeking	NATURE			English	Article							PYRAMIDAL CELLS; DRUG SEEKING; RAT; ADDICTION; INTERNEURONS; DYSFUNCTION; EXTINCTION; CHANNELS; BEHAVIOR	Loss of control over harmful drug seeking is one of the most intractable aspects of addiction, as human substance abusers continue to pursue drugs despite incurring significant negative consequences(1). Human studies have suggested that deficits in prefrontal cortical function and consequential loss of inhibitory control(2-4) could be crucial in promoting compulsive drug use. However, it remains unknown whether chronic drug use compromises cortical activity and, equally important, whether this deficit promotes compulsive cocaine seeking. Here we use a rat model of compulsive drug seeking(5-8) in which cocaine seeking persists in a subgroup of rats despite delivery of noxious foot shocks. We show that prolonged cocaine self-administration decreases ex vivo intrinsic excitability of deep-layer pyramidal neurons in the prelimbic cortex, which was significantly more pronounced in compulsive drug-seeking animals. Furthermore, compensating for hypoactive prelimbic cortex neurons with in vivo optogenetic prelimbic cortex stimulation significantly prevented compulsive cocaine seeking, whereas optogenetic prelimbic cortex inhibition significantly increased compulsive cocaine seeking. Our results show a marked reduction in prelimbic cortex excitability in compulsive cocaine-seeking rats, and that in vivo optogenetic prelimbic cortex stimulation decreased compulsive drug-seeking behaviours. Thus, targeted stimulation of the prefrontal cortex could serve as a promising therapy for treating compulsive drug use.	[Chen, Billy T.; Yau, Hau-Jie; Hatch, Christina; Kusumoto-Yoshida, Ikue; Bonci, Antonello] NIDA, Intramural Res Program, Baltimore, MD 21224 USA; [Cho, Saemi L.; Hopf, F. Woodward] Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94608 USA; [Hopf, F. Woodward; Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94110 USA; [Bonci, Antonello] Johns Hopkins Sch Med, Solomon H Snyder Neurosci Inst, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Medicine	Chen, BT (corresponding author), NIDA, Intramural Res Program, Baltimore, MD 21224 USA.	billy.chen@nih.gov; antonello.bonci@nih.gov	Core, Vector/CAF-4832-2022	YAU, HAU-JIE/0000-0001-7454-7971	NIDA/IRP; State of California through the University of California at San Francisco; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000579] Funding Source: NIH RePORTER	NIDA/IRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); State of California through the University of California at San Francisco; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Kourrich and Y. Shaham for careful reading of the manuscript. We also thank K. Deisseroth for providingthe ChR2 and eNpHR3.0 vectors. This study was supported by funds from the NIDA/IRP and the State of California through the University of California at San Francisco.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Beck H, 2008, NAT REV NEUROSCI, V9, P357, DOI 10.1038/nrn2371; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Farovik A, 2008, J NEUROSCI, V28, P13428, DOI 10.1523/JNEUROSCI.3662-08.2008; Ghazizadeh A, 2012, J NEUROSCI, V32, P726, DOI 10.1523/JNEUROSCI.3891-11.2012; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Gregoire S, 2012, NEUROBIOL LEARN MEM, V97, P202, DOI 10.1016/j.nlm.2011.12.003; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Jonkman S, 2009, BEHAV NEUROSCI, V123, P875, DOI 10.1037/a0016330; Kasanetz F, 2012, MOL PSYCHIAT; Knackstedt LA, 2007, J PHARMACOL EXP THER, V322, P1103, DOI 10.1124/jpet.107.122861; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Martina M, 1998, J NEUROSCI, V18, P8111; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Pelloux Y, 2007, PSYCHOPHARMACOLOGY, V194, P127, DOI 10.1007/s00213-007-0805-0; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Taverna S, 2005, J NEUROSCI, V25, P9162, DOI 10.1523/JNEUROSCI.2454-05.2005; Tiffany ST, 2000, ADDICTION, V95, pS145, DOI 10.1046/j.1360-0443.95.8s2.3.x; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Yang CR, 1996, J NEUROSCI, V16, P1904; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	30	325	335	4	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					359	+		10.1038/nature12024	http://dx.doi.org/10.1038/nature12024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23552889				2022-12-28	WOS:000317599200037
J	Young, GJ; Chou, CH; Alexander, J; Lee, SYD; Raver, E				Young, Gary J.; Chou, Chia-Hung; Alexander, Jeffrey; Lee, Shoou-Yih Daniel; Raver, Eli			Provision of Community Benefits by Tax-Exempt U.S. Hospitals	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONPROFIT HOSPITALS	BACKGROUND The Patient Protection and Affordable Care Act (ACA) requires tax-exempt hospitals to conduct assessments of community needs and address identified needs. Most tax-exempt hospitals will need to meet this requirement by the end of 2013. METHODS We conducted a national study of the level and pattern of community benefits that tax-exempt hospitals provide. The study comprised more than 1800 tax-exempt hospitals, approximately two thirds of all such institutions. We used reports that hospitals filed with the Internal Revenue Service for fiscal year 2009 that provide expenditures for seven types of community benefits. We combined these reports with other data to examine whether institutional, community, and market characteristics are associated with the provision of community benefits by hospitals. RESULTS Tax-exempt hospitals spent 7.5% of their operating expenses on community benefits during fiscal year 2009. More than 85% of these expenditures were devoted to charity care and other patient care services. Of the remaining community-benefit expenditures, approximately 5% were devoted to community health improvements that hospitals undertook directly. The rest went to education in health professions, research, and contributions to community groups. The level of benefits provided varied widely among the hospitals (hospitals in the top decile devoted approximately 20% of operating expenses to community benefits; hospitals in the bottom decile devoted approximately 1%). This variation was not accounted for by indicators of community need. CONCLUSIONS In 2009, tax-exempt hospitals varied markedly in the level of community benefits provided, with most of their benefit-related expenditures allocated to patient care services. Little was spent on community health improvement.	[Young, Gary J.; Chou, Chia-Hung; Raver, Eli] Northeastern Univ, Ctr Hlth Policy & Healthcare Res, Boston, MA 02115 USA; [Young, Gary J.; Chou, Chia-Hung; Raver, Eli] Northeastern Univ, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Young, Gary J.] Northeastern Univ, DAmore McKim Sch Business, Boston, MA 02115 USA; [Chou, Chia-Hung] Univ Chicago, Chicago, IL 60637 USA; [Alexander, Jeffrey; Lee, Shoou-Yih Daniel] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	Northeastern University; Northeastern University; Northeastern University; University of Chicago; University of Michigan System; University of Michigan	Young, GJ (corresponding author), Northeastern Univ, 360 Huntington Ave,137 Richards Hall, Boston, MA 02115 USA.	ga.young@neu.edu						[Anonymous], 2009, COMM BEN REP US STAT; [Anonymous], 2007, HLTH CAR COMM BEN CO; [Anonymous], 1969, REV RUL 69 545; Bazzoli GJ, 2010, J HEALTH POLIT POLIC, V35, P999, DOI 10.1215/03616878-2010-036; Colombo John D., 2007, SAINT LOUIS U LAW J, V51; Congressional Budget Office, 2006, NONPR HOSP PROV COMM; Congressional Budget Office, 2006, NONPR HOSP VAR STAND; Folkemer D. C., 2011, HOSP COMMUNITY BENEF; Gray BH, 2009, HEALTH AFFAIR, V28, pW809, DOI 10.1377/hlthaff.28.5.w809; Health Forum, 2009, AHA GUID HLTH CAR FI; Hellinger FJ, 2009, J HEALTH POLIT POLIC, V34, P37, DOI 10.1215/03616878-2008-991; Japsen B., 2011, NY TIMES; Kane NM, 2007, ST LOUIS U L J, V51, P459; Rosenbaum S, 2011, PUBLIC HEALTH REP, V126, P283, DOI 10.1177/003335491112600220	14	121	121	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1519	1527		10.1056/NEJMsa1210239	http://dx.doi.org/10.1056/NEJMsa1210239			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126HC	23594004				2022-12-28	WOS:000317603300009
J	Odorizzi, PM; Wherry, EJ				Odorizzi, Pamela M.; Wherry, E. John			An Interferon Paradox	SCIENCE			English	Editorial Material							I INTERFERON; INFECTION; BLOCKADE		[Odorizzi, Pamela M.] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Odorizzi, PM (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, 421 Curie Blvd, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	Wherry, John/ABI-1280-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007632, R01AI105343] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI105343, T32 AI007632] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boasso A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002961; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Lee LN, 2009, J IMMUNOL, V182, P7178, DOI 10.4049/jimmunol.0802526; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208	14	48	48	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					155	156		10.1126/science.1237568	http://dx.doi.org/10.1126/science.1237568			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580520	Green Accepted			2022-12-28	WOS:000317341400044
J	Strausfeld, NJ; Hirth, F				Strausfeld, Nicholas J.; Hirth, Frank			Deep Homology of Arthropod Central Complex and Vertebrate Basal Ganglia	SCIENCE			English	Review							DOPAMINERGIC-NEURONS; DROSOPHILA-MELANOGASTER; SUBTHALAMIC NUCLEUS; MUSHROOM BODIES; BRAIN; ORGANIZATION; EVOLUTION; EXPRESSION; STRIATUM; MEMORY	The arthropod central complex and vertebrate basal ganglia derive from embryonic basal forebrain lineages that are specified by an evolutionarily conserved genetic program leading to interconnected neuropils and nuclei that populate the midline of the forebrain-midbrain boundary region. In the substructures of both the central complex and basal ganglia, network connectivity and neuronal activity mediate control mechanisms in which inhibitory (GABAergic) and modulatory (dopaminergic) circuits facilitate the regulation and release of adaptive behaviors. Both basal ganglia and central complex dysfunction result in behavioral defects including motor abnormalities, impaired memory formation, attention deficits, affective disorders, and sleep disturbances. The observed multitude of similarities suggests deep homology of arthropod central complex and vertebrate basal ganglia circuitries underlying the selection and maintenance of behavioral actions.	[Strausfeld, Nicholas J.] Univ Arizona, Dept Neurosci, Sch Mind Brain & Behav, Tucson, AZ 85721 USA; [Hirth, Frank] Kings Coll London, MRC Ctr Neurodegenerat Res, Dept Neurosci, London SE5 8AF, England	University of Arizona; University of London; King's College London	Strausfeld, NJ (corresponding author), Univ Arizona, Dept Neurosci, Sch Mind Brain & Behav, Tucson, AZ 85721 USA.	flybrain@neurobio.arizona.edu; frank.hirth@kcl.ac.uk	Hirth, Frank/B-8384-2015; Strausfeld, Nicholas James/AAF-4566-2021	Strausfeld, Nicholas James/0000-0002-1115-1774; Hirth, Frank/0000-0001-8581-9450	UK Medical Research Council [G070149]; Royal Society [Hirth2007/R2]; Parkinson's UK [G-0714]; Motor Neurone Disease Association [Hirth/Mar12/6085, Hirth/Oct07/6233]; Alzheimer Research UK [Hirth/ARUK/2012]; Fondation Thierry Latran (DrosALS); Air Force Research Laboratories [NJS/AFRL FA86511010001]; Center for Insect Science, University of Arizona, Tucson; MRC [G0701498] Funding Source: UKRI; Alzheimers Research UK [ARUK-PhD2012-18] Funding Source: researchfish; Medical Research Council [G0701498] Funding Source: researchfish; Parkinson&quot;s UK [G-0714] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Parkinson's UK(Parkinson's UK); Motor Neurone Disease Association; Alzheimer Research UK(Alzheimer's Research UK (ARUK)); Fondation Thierry Latran (DrosALS); Air Force Research Laboratories(United States Department of DefenseUS Air Force Research Laboratory); Center for Insect Science, University of Arizona, Tucson; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	Supported by grants from the UK Medical Research Council (G070149), Royal Society (Hirth2007/R2), Parkinson's UK (G-0714), Motor Neurone Disease Association (Hirth/Mar12/6085, Hirth/Oct07/6233), Alzheimer Research UK (Hirth/ARUK/2012), and Fondation Thierry Latran (DrosALS) (to F.H.); the Air Force Research Laboratories (NJS/AFRL FA86511010001) (to N.J.S.); and the Center for Insect Science, University of Arizona, Tucson (to N.J.S.). We thank G. Wolf for the image in Fig. 1D.	Abeliovich A, 2007, DEV BIOL, V304, P447, DOI 10.1016/j.ydbio.2007.01.032; Amemori KI, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00047; Blanco J, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-34; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Boyan G, 2011, ARTHROPOD STRUCT DEV, V40, P334, DOI 10.1016/j.asd.2011.02.005; Buatois LA, 2012, J PALEONTOL, V86, P7, DOI 10.1666/11-001.1; Callaerts P, 2001, J NEUROBIOL, V46, P73, DOI 10.1002/1097-4695(20010205)46:2<73::AID-NEU10>3.0.CO;2-N; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; DESBAN M, 1989, NEUROSCIENCE, V29, P551, DOI 10.1016/0306-4522(89)90130-9; EBLEN F, 1995, J NEUROSCI, V15, P5999; FLAHERTY AW, 1994, J NEUROSCI, V14, P599; Furukubo-Tokunaga K, 2012, MEMORY MECHANISMS IN HEALTH AND DISEASE: MECHANISTIC BASIS OF MEMORY, P269; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GHAFFAR H, 1984, INT J INSECT MORPHOL, V13, P357, DOI 10.1016/0020-7322(84)90011-4; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; GRONENBERG W, 1992, J COMP NEUROL, V316, P87, DOI 10.1002/cne.903160108; Guo PY, 2013, J EXP BIOL, V216, P992, DOI 10.1242/jeb.080473; Hall BK, 2003, BIOL REV, V78, P409, DOI 10.1017/S1464793102006097; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Herbert Z, 2010, J MORPHOL, V271, P1509, DOI 10.1002/jmor.10895; HIRTH F, 1995, NEURON, V15, P769, DOI 10.1016/0896-6273(95)90169-8; Hirth F., 2005, EVOLUTION NERVOUS SY, VI, P55; Hirth F, 2010, BRAIN BEHAV EVOLUT, V76, P3, DOI 10.1159/000320218; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Homberg U, 1999, J COMP NEUROL, V409, P495, DOI 10.1002/(SICI)1096-9861(19990705)409:3<495::AID-CNE12>3.0.CO;2-F; Homberg U, 2011, PHILOS T R SOC B, V366, P680, DOI 10.1098/rstb.2010.0199; Humphrey DM, 2012, HUM MOL GENET, V21, P2698, DOI 10.1093/hmg/dds096; Ito K, 1998, LEARN MEMORY, V5, P52; Ito K, 2008, ADV EXP MED BIOL, V628, P137, DOI 10.1007/978-0-387-78261-4_9; Iwano M, 2010, J COMP NEUROL, V518, P366, DOI 10.1002/cne.22224; Kahsai L, 2012, NEUROSCIENCE, V208, P11, DOI 10.1016/j.neuroscience.2012.02.007; Kahsai L, 2011, J COMP NEUROL, V519, P290, DOI 10.1002/cne.22520; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kuntz S, 2012, LEARN MEMORY, V19, P337, DOI 10.1101/lm.026369.112; Langworthy K, 1997, CELL TISSUE RES, V288, P191, DOI 10.1007/s004410050806; LEWANDOWSKI TJ, 1989, J COMP NEUROL, V288, P136, DOI 10.1002/cne.902880111; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; Ma XY, 2012, NATURE, V490, P258, DOI 10.1038/nature11495; Mallatt J, 2012, MOL PHYLOGENET EVOL, V64, P603, DOI 10.1016/j.ympev.2012.05.016; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Martin DM, 2004, DEV BIOL, V267, P93, DOI 10.1016/j.ydbio.2003.10.035; Mueller T, 2008, J COMP NEUROL, V507, P1245, DOI 10.1002/cne.21604; Muzio L, 2002, NAT NEUROSCI, V5, P737, DOI 10.1038/nn892; Northcutt RG, 2012, P NATL ACAD SCI USA, V109, P10626, DOI 10.1073/pnas.1201889109; Philips ST, 2005, EXP NEUROL, V192, P320, DOI 10.1016/j.expneurol.2004.11.008; Phillips-Portillo J, 2012, J COMP NEUROL, V520, P3088, DOI 10.1002/cne.23134; Poeck B, 2008, DEV NEUROBIOL, V68, P1046, DOI 10.1002/dneu.20643; Posnien N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002416; RAUP DM, 1969, SCIENCE, V166, P994, DOI 10.1126/science.166.3908.994; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Ritzmann RE, 2008, J COMP PHYSIOL A, V194, P341, DOI 10.1007/s00359-007-0310-2; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; Schumann G, 2011, P NATL ACAD SCI USA, V108, P7119, DOI 10.1073/pnas.1017288108; Shiflett MW, 2011, PROG NEUROBIOL, V95, P1, DOI 10.1016/j.pneurobio.2011.05.007; Simeone A, 2002, CURR OPIN GENET DEV, V12, P409, DOI 10.1016/S0959-437X(02)00318-0; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; Stephenson-Jones M, 2011, CURR BIOL, V21, P1081, DOI 10.1016/j.cub.2011.05.001; Strausfeld N.J., 2012, ARTHROPOD BRAINS EVO; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Sussel L, 1999, DEVELOPMENT, V126, P3359; Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043; Toresson H, 2001, DEVELOPMENT, V128, P4769; Tupala E, 2004, PROG NEURO-PSYCHOPH, V28, P1221, DOI 10.1016/j.pnpbp.2004.06.022; Ueno T, 2012, NAT NEUROSCI, V15, P1516, DOI 10.1038/nn.3238; Urbach R, 2008, ADV EXP MED BIOL, V628, P42, DOI 10.1007/978-0-387-78261-4_3; Vitzthum H, 1998, J COMP NEUROL, V390, P455, DOI 10.1002/(SICI)1096-9861(19980126)390:4<455::AID-CNE1>3.0.CO;2-#; White KE, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00205; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	76	214	216	2	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					157	161		10.1126/science.1231828	http://dx.doi.org/10.1126/science.1231828			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580521				2022-12-28	WOS:000317341400045
J	Reisz, RR; Huang, TD; Roberts, EM; Peng, SR; Sullivan, C; Stein, K; LeBlanc, ARH; Shieh, D; Chang, RS; Chiang, CC; Yang, CW; Zhong, SM				Reisz, Robert R.; Huang, Timothy D.; Roberts, Eric M.; Peng, ShinRung; Sullivan, Corwin; Stein, Koen; LeBlanc, Aaron R. H.; Shieh, DarBin; Chang, RongSeng; Chiang, ChengCheng; Yang, Chuanwei; Zhong, Shiming			Embryology of Early Jurassic dinosaur from China with evidence of preserved organic remains	NATURE			English	Article							SOFT-TISSUE; THEROPODS	Fossil dinosaur embryos are surprisingly rare, being almost entirely restricted to Upper Cretaceous strata that record the late stages of non-avian dinosaur evolution(1,2). Notable exceptions are the oldest known embryos from the Early Jurassic South African sauropodomorph Massospondylus(3,4) and Late Jurassic embryos of a theropod from Portugal(5). The fact that dinosaur embryos are rare and typically enclosed in eggshells limits their availability for tissue and cellular level investigations of development. Consequently, little is known about growth patterns in dinosaur embryos, even though post-hatching ontogeny has been studied in several taxa(6). Here we report the discovery of an embryonic dinosaur bone bed from the Lower Jurassic of China, the oldest such occurrence in the fossil record. The embryos are similar in geological age to those of Massospondylus and are also assignable to a sauropodomorph dinosaur, probably Lufengosaurus(7). The preservation of numerous disarticulated skeletal elements and eggshells in this monotaxic bone bed, representing different stages of incubation and therefore derived from different nests, provides opportunities for new investigations of dinosaur embryology in a clade noted for gigantism. For example, comparisons among embryonic femora of different sizes and developmental stages reveal a consistently rapid rate of growth throughout development, possibly indicating that short incubation times were characteristic of sauropodomorphs. In addition, asymmetric radial growth of the femoral shaft and rapid expansion of the fourth trochanter suggest that embryonic muscle activation played an important role in the pre-hatching ontogeny of these dinosaurs. This discovery also provides the oldest evidence of in situ preservation of complex organic remains in a terrestrial vertebrate.	[Reisz, Robert R.; LeBlanc, Aaron R. H.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Huang, Timothy D.] Natl Chung Hsing Univ, Taichung 402, Taiwan; [Roberts, Eric M.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Peng, ShinRung; Shieh, DarBin] Natl Cheng Kung Univ, Coll Med, Inst Oral Med, Tainan 701, Taiwan; [Sullivan, Corwin] Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Stein, Koen] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-53115 Bonn, Germany; [Chang, RongSeng] Natl Cent Univ, Dept Opt & Photon, Chungli 32001, Taiwan; [Chiang, ChengCheng] Natl Synchrotron Radiat Res Ctr, Hsinchu 30076, Taiwan; [Yang, Chuanwei] Lufeng Cty Dinosaur Museum, Lufeng, Yunnan, Peoples R China; [Zhong, Shiming] Chuxiong Prefectural Museum, Chuxiong 675000, Yunnan, Peoples R China	University of Toronto; University Toronto Mississauga; National Chung Hsing University; James Cook University; National Cheng Kung University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Bonn; National Central University; National Synchrotron Radiation Research Center	Reisz, RR (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	robert.reisz@utoronto.ca	Roberts, Eric/J-1836-2014; Stein, Koen HW/G-5731-2015	Roberts, Eric/0000-0002-8583-7437; Stein, Koen/0000-0003-4246-3225; Huang, Timothy/0000-0001-5381-2596; LeBlanc, Aaron/0000-0002-2497-1296; Sullivan, Corwin/0000-0002-5488-6797	NSERC Discovery and SRO Grants (Canada); University of Toronto; DFG (Germany) [FOR 533]; NSC (Taiwan) [100-2116-M-008-016]; Ministry of Education (Taiwan) under the NCKU Aim for the Top University Project; Chinese Academy of Sciences and National Natural Science Foundation of China [41150110341]	NSERC Discovery and SRO Grants (Canada); University of Toronto(University of Toronto); DFG (Germany)(German Research Foundation (DFG)); NSC (Taiwan)(Ministry of Science and Technology, Taiwan); Ministry of Education (Taiwan) under the NCKU Aim for the Top University Project; Chinese Academy of Sciences and National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)Chinese Academy of Sciences)	We thank D. Scott for specimen preparation, photography, and figure preparation; N. Campione for morphometric analysis; C. Apaldetti for the data matrix; O. Dulfer for thin sections; G. Grellet-Tinner, M. Sander, J. Steigler, P. Barrett and E. Prondvai for discussion; C. Chu and X. J. Lin for research support; S. P. Modesto and C. Brown for field assistance; J. Liu for assistance in Lufeng; and C. C. Wang, Y. F. Song, Y. C. Lee and H. S. Sheu for help with various experiments at the National Synchrotron Radiation Research Center, Taiwan. Research support was provided by NSERC Discovery and SRO Grants (Canada), University of Toronto, DFG FOR 533 (contribution 130) (Germany), NSC 100-2116-M-008-016 (Taiwan), Ministry of Education (Taiwan) under the NCKU Aim for the Top University Project, Chinese Academy of Sciences and National Natural Science Foundation of China (41150110341).	Apaldetti C., 2012, PALAEONTOLOGY; Bien M. N., 1941, B GEOLOGICAL SOC CHI, V21, P159; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Carpenter K., 1994, DINOSAUR EGGS BABIES; Carpenter K., 1999, EGGS NESTS BABY DINO; Cheng, 2000, P 3 NAT STRAT C CHIN, P208; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; de Ricqles A, 2001, CR ACAD SCI II A, V332, P647, DOI 10.1016/S1251-8050(01)01580-4; Fleming A, 2001, J ANAT, V199, P177, DOI 10.1017/S0021878201008044; Francillon-Vieillot H., 1990, SKELETAL BIOMINERALI, V1, P471, DOI [DOI 10.1029/SC005P0175, 10.1029/SC005p0175]; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Kundrat M, 2008, ACTA ZOOL-STOCKHOLM, V89, P231, DOI 10.1111/j.1463-6395.2007.00311.x; Lindgren J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019445; Muller GB, 2003, EVOL DEV, V5, P56, DOI 10.1046/j.1525-142X.2003.03009.x; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Reisz RR, 2012, P NATL ACAD SCI USA, V109, P2428, DOI 10.1073/pnas.1109385109; Reisz RR, 2010, J VERTEBR PALEONTOL, V30, P1653, DOI 10.1080/02724634.2010.521604; Reisz RR, 2005, SCIENCE, V309, P761, DOI 10.1126/science.1114942; ROGERS RR, 2007, BONEBEDS GENESIS ANA; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Sharir A, 2011, DEVELOPMENT, V138, P3247, DOI 10.1242/dev.063768; Sun A.L., 1986, P275; Weishampel DB., 2004, DINOSAURIA; Young C. C., 1941, Palaeontologia Sinica N S C, V7, P1	29	57	59	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					210	214		10.1038/nature11978	http://dx.doi.org/10.1038/nature11978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23579680	Green Accepted			2022-12-28	WOS:000317346300039
J	Chute, CG; Kohane, IS				Chute, Christopher G.; Kohane, Isaac S.			Genomic Medicine, Health Information Technology, and Patient Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chute, Christopher G.] Mayo Clin, Rochester, MN 55905 USA; [Kohane, Isaac S.] Harvard Univ, Sch Med, Boston, MA USA	Mayo Clinic; Harvard University; Harvard Medical School	Chute, CG (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	chute@mayo.edu	Chute, Christopher/AAT-8540-2021		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006379] Funding Source: NIH RePORTER; NHGRI NIH HHS [U01 HG006379] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Biesecker LG, 2012, NAT REV GENET, V13, P818, DOI 10.1038/nrg3357; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; McGinnis JM, 2010, STUD HEALTH TECHNOL, V153, P145, DOI 10.3233/978-1-60750-533-4-145; Oetting WS, 2012, HUM MUTAT, V33, P586, DOI 10.1002/humu.22018; Office of the National Coordinator, 2012, HLTH EDECISIONS HOM; Poh A., 2010, NEXT GEN SEQUENCING; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600	8	18	18	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1467	1468		10.1001/jama.2013.1414	http://dx.doi.org/10.1001/jama.2013.1414			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571583	Green Accepted			2022-12-28	WOS:000317271700022
J	Lu, XW; Wontakal, SN; Kavi, H; Kim, BJ; Guzzardo, PM; Emelyanov, AV; Xu, N; Hannon, GJ; Zavadil, J; Fyodorov, DV; Skoultchi, AI				Lu, Xingwu; Wontakal, Sandeep N.; Kavi, Harsh; Kim, Byung Ju; Guzzardo, Paloma M.; Emelyanov, Alexander V.; Xu, Na; Hannon, Gregory J.; Zavadil, Jiri; Fyodorov, Dmitry V.; Skoultchi, Arthur I.			Drosophila H1 Regulates the Genetic Activity of Heterochromatin by Recruitment of Su(var)3-9	SCIENCE			English	Article							LINKER HISTONE H1; TRANSPOSABLE ELEMENTS; MELANOGASTER; CHROMATIN; GENOME; PHOSPHORYLATION; GERMLINE; BINDING; REPEATS; RNAS	Eukaryotic genomes harbor transposable elements and other repetitive sequences that must be silenced. Small RNA interference pathways play a major role in their repression. Here, we reveal another mechanism for silencing these sequences in Drosophila. Depleting the linker histone H1 in vivo leads to strong activation of these elements. H1-mediated silencing occurs in combination with the heterochromatin-specific histone H3 lysine 9 methyltransferase Su(var)3-9. H1 physically interacts with Su(var) 3-9 and recruits it to chromatin in vitro, which promotes H3 methylation. We propose that H1 plays a key role in silencing by tethering Su(var) 3-9 to heterochromatin. The tethering function of H1 adds to its established role as a regulator of chromatin compaction and accessibility.	[Lu, Xingwu; Wontakal, Sandeep N.; Kavi, Harsh; Kim, Byung Ju; Emelyanov, Alexander V.; Xu, Na; Fyodorov, Dmitry V.; Skoultchi, Arthur I.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Guzzardo, Paloma M.; Hannon, Gregory J.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Zavadil, Jiri] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Zavadil, Jiri] NYU, Langone Med Ctr, NYU Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Zavadil, Jiri] Int Agcy Res Canc, Mechanisms Carcinogenesis Sect, F-69372 Lyon 08, France	Yeshiva University; Albert Einstein College of Medicine; Cold Spring Harbor Laboratory; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; World Health Organization; International Agency for Research on Cancer (IARC)	Fyodorov, DV (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.	dmitry.fyodorov@einstein.yu.edu; arthur.skoultchi@einstein.yu.edu	Hannon, Gregory/AAB-3568-2019; KAVI, HARSH/B-5391-2014; Zavadil, Jiri/ABG-1780-2020	Zavadil, Jiri/0000-0003-0640-5562	NIH [GM074233, GM093190, CA079057]; National Cancer Institute, NIH, Cancer Center Grant [2P30CA13330];  [5T32GM0728]; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA079057, R56CA079057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074233, R37GM062534, R01GM093190] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH, Cancer Center Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Elgin, A. Imhof, T. Kornberg, and G. Reuter for fly stocks and DNA constructs; J. Kadonaga, M. Khuong, and T. Kusch for purified recombinant GAL4-VP16 and MBP-TRR; A. Lusser for critical reading of the manuscript; and E. Vershilova for technical assistance. This work was supported by grants from the NIH to D. V. F. (GM074233) and A. I. S. (GM093190 and CA079057). A. I. S. also receives support from National Cancer Institute, NIH, Cancer Center Grant 2P30CA13330. S.N.W. was supported by 5T32GM0728. Data have been deposited in the GEO database and assigned Series accession no. GSE44148.	Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Dimitri P, 1997, GENETICA, V100, P85, DOI 10.1023/A:1018304922862; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; GRIGORYEV SA, 1990, NUCLEIC ACIDS RES, V18, P7397, DOI 10.1093/nar/18.24.7397; Hale TK, 2006, MOL CELL, V22, P693, DOI 10.1016/j.molcel.2006.04.016; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; KAMAKAKA RT, 1990, EMBO J, V9, P3997, DOI 10.1002/j.1460-2075.1990.tb07621.x; KAMINKER JS, 2002, GENOME BIOL, V0003; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Kotelnikov RN, 2009, NUCLEIC ACIDS RES, V37, P3254, DOI 10.1093/nar/gkp167; LIVAK KJ, 1990, GENETICS, V124, P303; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Lu XW, 2009, GENE DEV, V23, P452, DOI 10.1101/gad.1749309; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Trojer P, 2009, J BIOL CHEM, V284, P8395, DOI 10.1074/jbc.M807818200; Vujatovic O, 2012, NUCLEIC ACIDS RES, V40, P5402, DOI 10.1093/nar/gks224; WEINTRAUB H, 1984, CELL, V38, P17, DOI 10.1016/0092-8674(84)90522-1; Wolffe A., 1995, CHROMATIN STRUCTURE	25	69	71	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					78	81		10.1126/science.1234654	http://dx.doi.org/10.1126/science.1234654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559249	Green Accepted			2022-12-28	WOS:000317061100049
J	Gold, R; Giovannoni, G; Selmaj, K; Havrdova, E; Montalban, X; Radue, EW; Stefoski, D; Robinson, R; Riester, K; Rana, J; Elkins, J; O'Neill, G				Gold, Ralf; Giovannoni, Gavin; Selmaj, Krzysztof; Havrdova, Eva; Montalban, Xavier; Radue, Ernst-Wilhelm; Stefoski, Dusan; Robinson, Randy; Riester, Katherine; Rana, Jitesh; Elkins, Jacob; O'Neill, Gilmore		SELECT Study Investigators	Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							DISABILITY STATUS SCALE; T-CELLS; ACTIVATION	Background Daclizumab, a humanised monoclonal antibody, modulates interleukin-2 signalling by blocking the a subunit (CD25) of the interleukin-2 receptor. We assessed whether daclizumab high-yield process (HYP) would be effective when given as monotherapy for a 1 year treatment period in patients with relapsing-remitting multiple sclerosis. Methods We did a randomised, double-blind, placebo-controlled trial at 76 centres in the Czech Republic, Germany, Hungary, India, Poland, Russia, Ukraine, Turkey, and the UK between Feb 15, 2008, and May 14, 2010. Patients aged 18-55 years with relapsing-remitting multiple sclerosis were randomly assigned (1:1:1), via a central interactive voice response system, to subcutaneous injections of daclizumab HYP 150 mg or 300 mg, or placebo, every 4 weeks for 52 weeks. Patients and study personnel were masked to treatment assignment, except for the site pharmacist who prepared the study drug for injection, but had no interaction with the patient. The primary endpoint was annualised relapse rate. Analysis was by intention to treat. The trial is registered with ClinicalTrials.gov, number NCT00390221. Findings 204 patients were assigned to receive placebo, 208 to daclizumab HYP 150 mg, and 209 to daclizumab HYP 300 mg, of whom 188 (92%), 192 (92%), and 197 (94%), respectively, completed follow-up to week 52. The annualised relapse rate was lower for patients given daclizumab HYP 150 mg (0.21, 95% CI 0.16-0.29; 54% reduction, 95% CI 33-68%; p < 0.0001) or 300 mg (0.23, 0.17-0.31, 50% reduction, 28-65%; p = 0.00015) than for those given placebo (0.46, 0.37-0.57). More patients were relapse free in the daclizumab HYP 150 mg (81%) and 300 mg (80%) groups than in the placebo group (64%; p < 0.0001 in the 150 mg group and p = 0.0003 in the 300 mg group). 12 (6%) patients in the placebo group, 15 (7%) of those in the daclizumab 150 mg group, and 19 (9%) in the 300 mg group had serious adverse events excluding multiple sclerosis relapse. One patient given daclizumab HYP 150 mg who was recovering from a serious rash died because of local complication of a psoas abscess. Interpretation Subcutaneous daclizumab HYP administered every 4 weeks led to clinically important effects on multiple sclerosis disease activity during 1 year of treatment. Our findings support the potential for daclizumab HYP to off er an additional treatment option for relapsing-remitting disease.	[Gold, Ralf] Ruhr Univ Bochum, St Josef Hosp, D-44791 Bochum, Germany; [Giovannoni, Gavin] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Selmaj, Krzysztof] Med Univ Lodz, Lodz, Poland; [Havrdova, Eva] Charles Univ Prague, Prague, Czech Republic; [Montalban, Xavier] Hosp Vall dHebron Univ, Barcelona, Spain; [Radue, Ernst-Wilhelm] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Stefoski, Dusan] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Robinson, Randy] AbbVie Biotherapeut Inc, Redwood City, CA USA; [Riester, Katherine; Rana, Jitesh; Elkins, Jacob; O'Neill, Gilmore] Biogen Idec Inc, Cambridge, MA USA	Ruhr University Bochum; University of London; Queen Mary University London; Medical University Lodz; Charles University Prague; University of Basel; Rush University; AbbVie; Biogen	Gold, R (corresponding author), Ruhr Univ Bochum, St Josef Hosp, D-44791 Bochum, Germany.	ralf.gold@ruhr-uni-bochum.de	Macedo, Ana/L-9912-2018; Nehrych, Tetyana I/L-7555-2016; Pashkovskyy, Valeriy/C-1120-2017; Koziolkin, Oleksandr/AAA-5382-2019; Хабиров, Фарит/AAU-6652-2020; Havrdova, Eva Kubala/P-4892-2017; Montalban, Xavier/J-5938-2016	Macedo, Ana/0000-0002-6978-8989; Nehrych, Tetyana I/0000-0003-0170-511X; Pashkovskyy, Valeriy/0000-0001-6066-371X; Koziolkin, Oleksandr/0000-0001-9878-5798; Хабиров, Фарит/0000-0002-2572-6970; Havrdova, Eva Kubala/0000-0002-9543-4359; Montalban, Xavier/0000-0002-0098-9918; Selmaj, Krzysztof/0000-0003-1213-7218; Chan, Andrew/0000-0003-3434-7283; Wiendl, Heinz/0000-0003-4310-3432; Murray, Dianna/0000-0003-3481-825X	Biogen Idec; AbbVie Biotherapeutics Inc.	Biogen Idec(Biogen); AbbVie Biotherapeutics Inc.(AbbVie)	Biogen Idec and AbbVie Biotherapeutics Inc.	Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Castro-Borrero W, 2012, THER ADV NEUROL DISO, V5, P205, DOI 10.1177/1756285612450936; de Herve MGD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011784; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; EuroQol Group, 2011, EUROQOL A NEW FAC ME; Hao JW, 2011, ANN NEUROL, V69, P721, DOI 10.1002/ana.22339; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; KRETH HW, 1982, J NEUROIMMUNOL, V2, P177, DOI 10.1016/0165-5728(82)90008-X; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 2007, J NEUROL SCI, V256, pS14, DOI 10.1016/j.jns.2007.01.062; Martin JF, 2010, J IMMUNOL, V185, P1311, DOI 10.4049/jimmunol.0902238; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Oh U, 2009, ARCH NEUROL-CHICAGO, V66, P471, DOI 10.1001/archneurol.2009.16; Perry JSA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004140; Phillips JT, 2011, MULT SCLER J, V17, P970, DOI 10.1177/1352458511399611; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rech AJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003330; Rose JW, 2004, ANN NEUROL, V56, P864, DOI 10.1002/ana.20287; Sheridan JP, 2011, MULT SCLER J, V17, P1441, DOI 10.1177/1352458511414755; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Sormani MP, 2010, NEUROLOGY, V75, P302, DOI 10.1212/WNL.0b013e3181ea15aa; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Wynn D, 2010, LANCET NEUROL, V9, P381, DOI 10.1016/S1474-4422(10)70033-8; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014	29	213	219	0	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 22	2013	381	9884					2167	2175		10.1016/S0140-6736(12)62190-4	http://dx.doi.org/10.1016/S0140-6736(12)62190-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KH	23562009				2022-12-28	WOS:000320925600033
J	Pfeiffer, BE; Foster, DJ				Pfeiffer, Brad E.; Foster, David J.			Hippocampal place-cell sequences depict future paths to remembered goals	NATURE			English	Article							PHASE PRECESSION; MEMORY; REPLAY; NAVIGATION; CA3; INFORMATION; EXPERIENCE; STRIATUM; DYNAMICS; PREDICTS	Effective navigation requires planning extended routes to remembered goal locations. Hippocampal place cells have been proposed to have a role in navigational planning, but direct evidence has been lacking. Here we show that before goal-directed navigation in an open arena, the rat hippocampus generates brief sequences encoding spatial trajectories strongly biased to progress from the subject's current location to a known goal location. These sequences predict immediate future behaviour, even in cases in which the specific combination of start and goal locations is novel. These results indicate that hippocampal sequence events characterized previously in linearly constrained environments as 'replay' are also capable of supporting a goal-directed, trajectory-finding mechanism, which identifies important places and relevant behavioural paths, at specific times when memory retrieval is required, and in a manner that could be used to control subsequent navigational behaviour.	[Pfeiffer, Brad E.; Foster, David J.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Foster, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	david.foster@jhu.edu			Alfred P. Sloan Foundation; Brain and Behavior Research Foundation (NARSAD); National Institutes of Health [MH085823]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085823] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Brain and Behavior Research Foundation (NARSAD)(NARSAD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Alfred P. Sloan Foundation, The Brain and Behavior Research Foundation (NARSAD Young Investigator Grant) and the National Institutes of Health grant MH085823.	Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Foster DJ, 2007, HIPPOCAMPUS, V17, P1093, DOI 10.1002/hipo.20345; Foster DJ, 2012, CURR OPIN NEUROBIOL, V22, P294, DOI 10.1016/j.conb.2011.12.005; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Gerstner W, 1997, J COMPUT NEUROSCI, V4, P79, DOI 10.1023/A:1008820728122; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hok V, 2007, J NEUROSCI, V27, P472, DOI 10.1523/JNEUROSCI.2864-06.2007; Jackson J, 2007, HIPPOCAMPUS, V17, P1209, DOI 10.1002/hipo.20359; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Johnson A, 2007, CURR OPIN NEUROBIOL, V17, P692, DOI 10.1016/j.conb.2008.01.003; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Koene RA, 2003, NEURAL NETWORKS, V16, P577, DOI 10.1016/S0893-6080(03)00106-0; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULLER RU, 1989, J NEUROSCI, V9, P4101; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Olypher AV, 2002, NEUROSCIENCE, V111, P553, DOI 10.1016/S0306-4522(01)00586-3; POUCET B, 1983, ANIM BEHAV, V31, P594, DOI 10.1016/S0003-3472(83)80083-9; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Sutton R. S., 1990, NEURAL NETWORKS CONT; Tolman E.C., 1932, PURPOSIVE BEHAV ANIM; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; van der Meer MAA, 2010, NEURON, V67, P25, DOI 10.1016/j.neuron.2010.06.023; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	50	616	621	2	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					74	+		10.1038/nature12112	http://dx.doi.org/10.1038/nature12112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23594744	Green Accepted			2022-12-28	WOS:000318221500036
J	Wang, LW; Kotlyar, E; Bester, L; Feneley, MP; Omari, A; Subbiah, RN				Wang, Louis W.; Kotlyar, Eugene; Bester, Lourens; Feneley, Michael P.; Omari, Abdullah; Subbiah, Rajesh N.			Pulmonary arteriovenous malformation: an unusual cause of exertional dyspnoea	LANCET			English	Editorial Material									[Wang, Louis W.; Kotlyar, Eugene; Feneley, Michael P.; Subbiah, Rajesh N.] St Vincents Hosp, Dept Cardiol, Sydney, NSW 2010, Australia; [Bester, Lourens] St Vincents Hosp, Dept Intervent Radiol, Sydney, NSW 2010, Australia; [Omari, Abdullah] St Vincents Hosp, Dept Vasc Med, Sydney, NSW 2010, Australia; [Wang, Louis W.; Kotlyar, Eugene; Bester, Lourens; Feneley, Michael P.; Subbiah, Rajesh N.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Omari, Abdullah] Univ Technol Sydney, Fac Hlth, Sydney, NSW 2007, Australia	St Vincents Hospital Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; University of Technology Sydney	Wang, LW (corresponding author), St Vincents Hosp, Dept Cardiol, Level 4,Xavier Bldg,390 Victoria St, Sydney, NSW 2010, Australia.	louis.wang@unsw.edu.au						Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; Gossage JR, 1998, AM J RESP CRIT CARE, V158, P643, DOI 10.1164/ajrccm.158.2.9711041; Kjeldsen AD, 1999, CHEST, V116, P432, DOI 10.1378/chest.116.2.432; Zukotynski K, 2007, CHEST, V132, P18, DOI 10.1378/chest.06-2356	4	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1430	1430		10.1016/S0140-6736(12)62200-4	http://dx.doi.org/10.1016/S0140-6736(12)62200-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130EF	23601951				2022-12-28	WOS:000317894800040
J	Bennett, WM				Bennett, William M.			Torus Palatinus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Legacy Good Samaritan Hosp, Portland, OR USA		Bennett, WM (corresponding author), Legacy Good Samaritan Hosp, Portland, OR USA.	bennettw@lhs.org							0	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1434	1434		10.1056/NEJMicm1205313	http://dx.doi.org/10.1056/NEJMicm1205313			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122QT	23574122				2022-12-28	WOS:000317333600011
J	Bennartz, R; Shupe, MD; Turner, DD; Walden, VP; Steffen, K; Cox, CJ; Kulie, MS; Miller, NB; Pettersen, C				Bennartz, R.; Shupe, M. D.; Turner, D. D.; Walden, V. P.; Steffen, K.; Cox, C. J.; Kulie, M. S.; Miller, N. B.; Pettersen, C.			July 2012 Greenland melt extent enhanced by low-level liquid clouds	NATURE			English	Article							ICE-SHEET; ARCTIC SURFACE; SNOW	Melting of the world's major ice sheets can affect human and environmental conditions by contributing to sea-level rise. In July 2012, an historically rare period of extended surface melting was observed across almost the entire Greenland ice sheet(1,2), raising questions about the frequency and spatial extent of such events. Here we show that low-level clouds consisting of liquid water droplets ('liquid clouds'), via their radiative effects, played a key part in this melt event by increasing near-surface temperatures. We used a suite of surface-based observations(3), remote sensing data, and a surface energy-balance model. At the critical surface melt time, the clouds were optically thick enough and low enough to enhance the down-welling infrared flux at the surface. At the same time they were optically thin enough to allow sufficient solar radiation to penetrate through them and raise surface temperatures above the melting point. Outside this narrow range in cloud optical thickness, the radiative contribution to the surface energy budget would have been diminished, and the spatial extent of this melting event would have been smaller. We further show that these thin, low-level liquid clouds occur frequently, both over Greenland and across the Arctic, being present around 30-50 per cent of the time(3-6). Our results may help to explain the difficulties that global climate models have in simulating the Arctic surface energy budget(7-9), particularly as models tend to under-predict the formation of optically thin liquid clouds at supercooled temperatures(6)-a process potentially necessary to account fully for temperature feedbacks in a warming Arctic climate.	[Bennartz, R.] Univ Wisconsin, Madison, WI 53706 USA; [Shupe, M. D.; Steffen, K.] Univ Colorado, CIRES, Boulder, CO 80305 USA; [Shupe, M. D.; Steffen, K.] NOAA, ESRL, Boulder, CO 80305 USA; [Turner, D. D.] NOAA, Natl Severe Storms Lab, Norman, OK 73072 USA; [Walden, V. P.; Cox, C. J.] Univ Idaho, Dept Geog, Moscow, ID 83844 USA; [Steffen, K.] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Kulie, M. S.; Miller, N. B.; Pettersen, C.] Univ Wisconsin, Space Sci & Engn Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Idaho; University of Idaho; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Wisconsin System; University of Wisconsin Madison	Bennartz, R (corresponding author), Univ Wisconsin, Madison, WI 53706 USA.	bennartz@aos.wisc.edu	Pettersen, Claire/H-2687-2018; Kulie, Mark/C-3289-2011; Turner, David D/E-5180-2016; Shupe, Matthew/F-8754-2011; Steffen, Konrad/C-6027-2013; Bennartz, Ralf/F-3760-2010; Cox, Christopher/O-4276-2016	Pettersen, Claire/0000-0002-8685-6242; Kulie, Mark/0000-0003-1400-1007; Turner, David D/0000-0003-1097-897X; Shupe, Matthew/0000-0002-0973-9982; Steffen, Konrad/0000-0001-8658-1026; Cox, Christopher/0000-0003-2203-7173; Bennartz, Ralf/0000-0001-7133-9659	US National Science Foundation, Arctic Observing Network (AON) programme [ARC-0904152, 0856773, 0856559]; Directorate For Geosciences [0856559, 1304692, 1314156, 0856773] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1414314, 1303879] Funding Source: National Science Foundation	US National Science Foundation, Arctic Observing Network (AON) programme(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	ICECAPS is supported by the US National Science Foundation (grants ARC-0904152, 0856773 and 0856559) as part of the Arctic Observing Network (AON) programme. Two-metre temperature and radar measurements were provided by the NOAA Earth System Research Laboratory. Lidar and ceilometer measurements were provided by the Department of Energy Atmospheric Radiation Measurement programme. We thank the extended ICECAPS team of scientists, engineers, students and field technicians for obtaining high-quality atmosphere and cloud observations at Summit.	Bintanja R, 1996, INT J CLIMATOL, V16, P1281, DOI 10.1002/(SICI)1097-0088(199611)16:11<1281::AID-JOC83>3.0.CO;2-A; BRANDT RE, 1993, J GLACIOL, V39, P99, DOI 10.3189/S0022143000015756; Brandt RE, 1997, J GLACIOL, V43, P339, DOI 10.3189/S0022143000003294; Cesana G, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053385; CLAUSEN HB, 1988, ANN GLACIOLOGY, V0010; Cox CJ, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017164; de Boer G, 2012, J CLIMATE, V25, P2676, DOI 10.1175/JCLI-D-11-00228.1; Hudson SR, 2005, J CLIMATE, V18, P1673, DOI 10.1175/JCLI3360.1; Intrieri JM, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000439; Klein SA, 2009, Q J ROY METEOR SOC, V135, P979, DOI 10.1002/qj.416; Mernild SH, 2011, J GLACIOL, V57, P621, DOI 10.3189/002214311797409712; Munneke PK, 2009, CRYOSPHERE, V3, P155; Nghiem SV, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053611; Ohmura A, 2001, J APPL METEOROL, V40, P753, DOI 10.1175/1520-0450(2001)040<0753:PBFTTB>2.0.CO;2; Ohmura A, 1998, B AM METEOROL SOC, V79, P2115, DOI 10.1175/1520-0477(1998)079<2115:BSRNBW>2.0.CO;2; Pavolonis MJ, 2003, J APPL METEOROL, V42, P827, DOI 10.1175/1520-0450(2003)042<0827:ACRFAT>2.0.CO;2; Persson POG, 2012, CLIM DYNAM, V39, P1349, DOI 10.1007/s00382-011-1196-9; Sandvik A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007351; Serreze MC, 2011, GLOBAL PLANET CHANGE, V77, P85, DOI 10.1016/j.gloplacha.2011.03.004; Shupe MD, 2011, J APPL METEOROL CLIM, V50, P626, DOI 10.1175/2010JAMC2467.1; Shupe MD, 2013, B AM METEOROL SOC, V94, P169, DOI 10.1175/BAMS-D-11-00249.1; Shupe MD, 2004, J CLIMATE, V17, P616, DOI 10.1175/1520-0442(2004)017<0616:CRFOTA>2.0.CO;2; Steffen K, 2001, J GEOPHYS RES-ATMOS, V106, P33951, DOI 10.1029/2001JD900161; Turner DD, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008530; Turner DD, 2007, B AM METEOROL SOC, V88, P177, DOI 10.1175/BAMS-88-2-177; Turner DD, 2007, IEEE T GEOSCI REMOTE, V45, P3680, DOI 10.1109/TGRS.2007.903703	26	218	222	1	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					83	86		10.1038/nature12002	http://dx.doi.org/10.1038/nature12002			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23552947				2022-12-28	WOS:000316993400029
J	Fedorov, AV; Brierley, CM; Lawrence, KT; Liu, Z; Dekens, PS; Ravelo, AC				Fedorov, A. V.; Brierley, C. M.; Lawrence, K. T.; Liu, Z.; Dekens, P. S.; Ravelo, A. C.			Patterns and mechanisms of early Pliocene warmth	NATURE			English	Article							EQUATORIAL PACIFIC THERMOCLINE; CARBON-DIOXIDE CONCENTRATION; PERMANENT EL-NINO; SURFACE TEMPERATURES; THERMAL STRUCTURE; WESTERN PACIFIC; CLIMATE-CHANGE; ICE VOLUME; ATLANTIC; CIRCULATION	About five to four million years ago, in the early Pliocene epoch, Earth had a warm, temperate climate. The gradual cooling that followed led to the establishment of modern temperature patterns, possibly in response to a decrease in atmospheric CO2 concentration, of the order of 100 parts per million, towards preindustrial values. Here we synthesize the available geochemical proxy records of sea surface temperature and show that, compared with that of today, the early Pliocene climate had substantially lower meridional and zonal temperature gradients but similar maximum ocean temperatures. Using an Earth system model, we show that none of the mechanisms currently proposed to explain Pliocene warmth can simultaneously reproduce all three crucial features. We suggest that a combination of several dynamical feedbacks underestimated in the models at present, such as those related to ocean mixing and cloud albedo, may have been responsible for these climate conditions.	[Fedorov, A. V.; Brierley, C. M.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [Brierley, C. M.] Univ London Univ Coll, Dept Geog, London WC1E 6BT, England; [Lawrence, K. T.] Lafayette Coll, Dept Geol & Environm Geosci, Easton, PA 18042 USA; [Liu, Z.] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China; [Dekens, P. S.] San Francisco State Univ, Dept Geosci, San Francisco, CA 94132 USA; [Ravelo, A. C.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA	Yale University; University of London; University College London; Lafayette College; University of Hong Kong; California State University System; San Francisco State University; University of California System; University of California Santa Cruz	Fedorov, AV (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06511 USA.	alexey.fedorov@yale.edu	Brierley, Chris M/A-8417-2009; Liu, Zhonghui/D-3163-2009	Brierley, Chris M/0000-0002-9195-6731; Liu, Zhonghui/0000-0002-2168-8305; Ravelo, Ana Christina/0000-0003-3929-677X	US National Science Foundation [OCE-0901921, OCE-0623310]; US Department of Energy Office of Science [DE-SC0007037]; David and Lucile Packard Foundation; National Science Foundation; Yale University Faculty of Arts and Sciences High Performance Computing facility	US National Science Foundation(National Science Foundation (NSF)); US Department of Energy Office of Science(United States Department of Energy (DOE)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); Yale University Faculty of Arts and Sciences High Performance Computing facility	Financial support was provided by the grants to A.V.F. and K.T.L. from the US National Science Foundation (OCE-0901921 and OCE-0623310), the US Department of Energy Office of Science (DE-SC0007037) and the David and Lucile Packard Foundation. Most of the data compiled in this study comes from samples collected by the Deep Sea Drilling Project, the Ocean Drilling Program, and the Integrated Ocean Drilling Program, supported by the National Science Foundation. This work was supported in part by the Yale University Faculty of Arts and Sciences High Performance Computing facility. A. V. F. thanks G. Philander, P. deMenocal, T. Herbert, Y. Rosenthal, A. Haywood, D. Lunt, M. Barreiro, E. Tziperman, D. Battisti, M. Cane and C. Wunsch for discussions of this topic. We are grateful to a great number of scientists who provided the data used in this study.	Anand P, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000846; Ballantyne AP, 2010, GEOLOGY, V38, P603, DOI 10.1130/G30815.1; Barreiro M, 2008, CLIM DYNAM, V31, P713, DOI 10.1007/s00382-007-0363-5; Bartoli G, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002055; Bitz CM, 2012, J CLIMATE, V25, P3053, DOI 10.1175/JCLI-D-11-00290.1; Boccaletti G, 2004, J PHYS OCEANOGR, V34, P888, DOI 10.1175/1520-0485(2004)034<0888:TTSOTU>2.0.CO;2; Brierley CM, 2009, SCIENCE, V323, P1714, DOI 10.1126/science.1167625; Brierley CM, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001809; Caballero R, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043468; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; CHANDLER M, 1994, GLOBAL PLANET CHANGE, V9, P197, DOI 10.1016/0921-8181(94)90016-7; Cleaveland LC, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001370; Collins M, 2005, CLIM DYNAM, V24, P89, DOI 10.1007/s00382-004-0478-x; Crowley TJ, 2008, NATURE, V456, P226, DOI 10.1038/nature07365; Crowley TJ, 1996, MAR MICROPALEONTOL, V27, P3, DOI 10.1016/0377-8398(95)00049-6; de Garidel-Thoron T, 2005, NATURE, V433, P294, DOI 10.1038/nature03189; Dekens PS, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001394; Dekens PS, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001931; Dekens PS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000200; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; DiNezio PN, 2009, J CLIMATE, V22, P4873, DOI 10.1175/2009JCLI2982.1; Dowsett H, 2010, STRATIGRAPHY, V7, P123; DOWSETT HJ, 1999, 99535 US GEOL SURV; Etourneau J, 2010, EARTH PLANET SC LETT, V297, P103, DOI 10.1016/j.epsl.2010.06.010; Etourneau J, 2009, GEOLOGY, V37, P871, DOI 10.1130/G25733A.1; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; Fedorov A, 2007, J PHYS OCEANOGR, V37, P896, DOI 10.1175/JPO3033.1; Fedorov AV, 2010, NATURE, V463, P1066, DOI 10.1038/nature08831; Fedorov AV, 2004, J PHYS OCEANOGR, V34, P1949, DOI 10.1175/1520-0485(2004)034<1949:TEOSOT>2.0.CO;2; Ford HL, 2012, EARTH PLANET SC LETT, V355, P152, DOI 10.1016/j.epsl.2012.08.027; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Groeneveld J., 2005, THESIS U KIEL, P9; Groeneveld J, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2006GC001564; Haug GH, 2005, NATURE, V433, P821, DOI 10.1038/nature03332; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Haug GH, 2001, GEOLOGY, V29, P207, DOI 10.1130/0091-7613(2001)029<0207:ROPUOO>2.0.CO;2; Haywood AM, 2009, GLOBAL PLANET CHANGE, V66, P208, DOI 10.1016/j.gloplacha.2008.12.014; Herbert T.D., 1998, P OCEAN DRILLING PRO, V159T, P17, DOI [10.2973/odp.proc.sr.159T.063.1998, DOI 10.2973/ODP.PROC.SR.159T.063.1998]; Herbert TD, 2010, SCIENCE, V328, P1530, DOI 10.1126/science.1185435; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Jansen E, 2000, PALEOCEANOGRAPHY, V15, P709, DOI 10.1029/1999PA000435; Jansen E., 1996, P OCEAN DRILL PROGRA, V162, P91, DOI DOI 10.2973/ODP.PROC.IR.162.104.1996; Jia GD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034792; Jochum M, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001678; Karas C, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA001949; Karas C, 2011, EARTH PLANET SC LETT, V301, P117, DOI 10.1016/j.epsl.2010.10.028; Karas C, 2009, NAT GEOSCI, V2, P433, DOI 10.1038/NGEO520; Kurschner WM, 1996, MAR MICROPALEONTOL, V27, P299, DOI 10.1016/0377-8398(95)00067-4; LaRiviere JP, 2012, NATURE, V486, P97, DOI 10.1038/nature11200; Lawrence KT, 2010, EARTH PLANET SC LETT, V300, P329, DOI 10.1016/j.epsl.2010.10.013; Lawrence KT, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P539; Lawrence KT, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001669; Li L, 2011, EARTH PLANET SC LETT, V309, P10, DOI 10.1016/j.epsl.2011.04.016; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Liu ZH, 2004, NATURE, V427, P720, DOI 10.1038/nature02338; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Lunt DJ, 2008, NATURE, V454, P1102, DOI 10.1038/nature07223; Lunt DJ, 2010, NAT GEOSCI, V3, P60, DOI 10.1038/NGEO706; Maier-Reimer E, 1990, PALEOCEANOGRAPHY, V5, P349, DOI 10.1029/PA005i003p00349; Manucharyan GE, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007295; Marlow JR, 2000, SCIENCE, V290, P2288; Martinez-Garcia A, 2010, SCIENCE, V328, P1550, DOI 10.1126/science.1184480; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; McClymont EL, 2005, QUATERNARY SCI REV, V24, P1559, DOI 10.1016/j.quascirev.2004.06.024; MCCREARY JP, 1994, J PHYS OCEANOGR, V24, P466; McKay R, 2012, P NATL ACAD SCI USA, V109, P6423, DOI 10.1073/pnas.1112248109; Medina-Elizalde M, 2008, EARTH PLANET SC LETT, V269, P584, DOI 10.1016/j.epsl.2008.03.014; Molnar P, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001574; Muller PJ, 1997, PALAEOGEOGR PALAEOCL, V135, P71, DOI 10.1016/S0031-0182(97)00018-7; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Ravelo A.C., 2006, OCEANOGRAPHY, V19, P114, DOI DOI 10.5670/0CEAN0G.2006.10; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Raymo ME, 1996, MAR MICROPALEONTOL, V27, P313, DOI 10.1016/0377-8398(95)00048-8; Regenberg M, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001019; Ruddiman WF, 2003, QUATERNARY SCI REV, V22, P1597, DOI 10.1016/S0277-3791(03)00087-8; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; SHACKLETON NJ, 1984, NATURE, V307, P620, DOI 10.1038/307620a0; Shields CA, 2012, J CLIMATE, V25, P3993, DOI 10.1175/JCLI-D-11-00260.1; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Solomon S., 2007, PHYS SCI BASIS WORKI; Sosdian S, 2009, SCIENCE, V325, P306, DOI 10.1126/science.1169938; Sriver RL, 2007, NATURE, V447, P577, DOI 10.1038/nature05785; STEPH S, 2006, P OC DRILL PROGR SCI, V0202; Steph S, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001645; Tian J, 2006, EARTH PLANET SC LETT, V252, P72, DOI 10.1016/j.epsl.2006.09.028; Tripati AK, 2009, SCIENCE, V326, P1394, DOI 10.1126/science.1178296; Tziperman E, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001652; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Williams IN, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039849; Zhang X, 2012, EARTH PLANET SC LETT, V317, P76, DOI 10.1016/j.epsl.2011.11.028	92	233	239	7	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					43	+		10.1038/nature12003	http://dx.doi.org/10.1038/nature12003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23552943	Green Submitted			2022-12-28	WOS:000316993400022
J	Zehetner, C; Bechrakis, N				Zehetner, Claus; Bechrakis, Nikolaos			Stellate Cataract	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zehetner, Claus; Bechrakis, Nikolaos] Med Univ Innsbruck, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Zehetner, C (corresponding author), Med Univ Innsbruck, A-6020 Innsbruck, Austria.	claus.zehetner@i-med.ac.at		Zehetner, Claus/0000-0003-1405-7457					0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					E18	E18		10.1056/NEJMicm1204510	http://dx.doi.org/10.1056/NEJMicm1204510			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117YT	23550686				2022-12-28	WOS:000316989900012
J	Lagu, T; Hannon, NS; Rothberg, MB; Wells, AS; Green, KL; Windom, MO; Dempsey, KR; Pekow, PS; Avrunin, JS; Chen, A; Lindenauer, PK				Lagu, Tara; Hannon, Nicholas S.; Rothberg, Michael B.; Wells, Annalee S.; Green, K. Laurie; Windom, McAllister O.; Dempsey, Katherine R.; Pekow, Penelope S.; Avrunin, Jill S.; Chen, Aaron; Lindenauer, Peter K.			Access to Subspecialty Care for Patients With Mobility Impairment A Survey	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE; BREAST-CANCER; UNITED-STATES; PREVENTIVE SERVICES; DISABILITIES; DISPARITIES; WOMEN; POPULATION; ADULTS; LIMITATIONS	Background: Adults who use wheelchairs have difficulty accessing physicians and receive less preventive care than their able-bodied counterparts. Objective: To learn about the accessibility of medical and surgical subspecialist practices for patients with mobility impairment. Design: A telephone survey was used to try to make an appointment for a fictional patient who was obese and hemiparetic, used a wheelchair, and could not self-transfer from chair to examination table. Setting: 256 endocrinology, gynecology, orthopedic surgery, rheumatology, urology, ophthalmology, otolaryngology, and psychiatry practices in 4 U.S. cities. Patients: None. Measurements: Accessibility of the practice, reasons for lack of accessibility, and planned method of transfer of the patient to an examination table. Results: Of 256 practices, 56 (22%) reported that they could not accommodate the patient, 9 (4%) reported that the building was inaccessible, 47 (18%) reported inability to transfer a patient from a wheelchair to an examination table, and 22 (9%) reported use of height-adjustable tables or a lift for transfer. Gynecology was the subspecialty with the highest rate of inaccessible practices (44%). Limitation: Small numbers of practices in 8 subspecialties in 4 cities and use of a fictional patient with obesity and hemiparesis limit generalizability. Conclusion: Many subspecialists could not accommodate a patient with mobility impairment because they could not transfer the patient to an examination table. Better awareness among providers about the requirements of the Americans with Disabilities Act and the standards of care for patients in wheelchairs is needed.	[Lagu, Tara] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Cleveland Clin, Inst Med, Cleveland, OH 44195 USA; Duke Univ, Sch Med, Durham, NC USA; Univ Massachusetts, Amherst, MA 01003 USA; Univ New England, Coll Osteopath Med, Biddeford, ME USA	Baystate Medical Center; Tufts University; Cleveland Clinic Foundation; Duke University; University of Massachusetts System; University of Massachusetts Amherst; University of New England - Maine	Lagu, T (corresponding author), Baystate Med Ctr, Ctr Qual Care Res, 280 Chestnut St,3rd Floor, Springfield, MA 01199 USA.	lagutc@gmail.com	Lagu, Tara/GPT-5173-2022	Lagu, Tara/0000-0001-6155-5796				Bisgaier J, 2011, NEW ENGL J MED, V364, P2324, DOI 10.1056/NEJMsa1013285; Brault M. W., 2008, CURRENT POPULATION R; Chan L, 1999, ARCH PHYS MED REHAB, V80, P642, DOI 10.1016/S0003-9993(99)90166-1; Diab ME, 2004, ARCH PHYS MED REHAB, V85, P749, DOI 10.1016/j.apmr.2003.06.028; Hull J., 2006, I REV BOARD MANAGEME, P210; Iezzoni LI, 2001, AM J MED QUAL, V16, P135; Iezzoni LI, 2011, HEALTH AFFAIR, V30, P1947, DOI 10.1377/hlthaff.2011.0613; Iezzoni LI, 2011, DISABIL HEALTH J, V4, P238, DOI 10.1016/j.dhjo.2011.06.001; Iezzoni LI, 2011, J WOMENS HEALTH, V20, P45, DOI 10.1089/jwh.2009.1831; Iezzoni LI, 2010, ONCOL NURS FORUM, V37, P711, DOI 10.1188/10.ONF.711-717; Iezzoni Lisa I., 2006, MORE RAMPS GUIDE IMP; Jones GC, 2008, DISABIL REHABIL, V30, P901, DOI 10.1080/09638280701800392; Kirschner KL, 2007, JAMA-J AM MED ASSOC, V297, P1121, DOI 10.1001/jama.297.10.1121; Lee JC, 2012, HEALTH SERV RES, V47, P698, DOI 10.1111/j.1475-6773.2011.01346.x; McCarthy EP, 2006, ANN INTERN MED, V145, P637, DOI 10.7326/0003-4819-145-9-200611070-00005; Mudrick NR, 2012, DISABIL HEALTH J, V5, P159, DOI 10.1016/j.dhjo.2012.02.002; Parish SL, 2006, HEALTH SOC WORK, V31, P7, DOI 10.1093/hsw/31.1.7; Reichard A, 2011, DISABIL HEALTH J, V4, P59, DOI 10.1016/j.dhjo.2010.05.003; Roetzheim RG, 2008, AM J MANAG CARE, V14, P287; Signore C, REPROD HLTH CARE WOM; Smith DL, 2008, DISABIL HEALTH J, V1, P79, DOI 10.1016/j.dhjo.2008.01.001; U.S. Department of Health and Human Services, AM DIS ACT ACC MED C; United States Access Board, PROP ACC STAND MED D	23	67	67	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6					441	U111		10.7326/0003-4819-158-6-201303190-00003	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-00003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	112AY	23552258				2022-12-28	WOS:000316565100013
J	Keller, AS; Buechler, TE; Newman, JS				Keller, A. Scott; Buechler, Tamara E.; Newman, James S.			Update in Hospital Medicine: Evidence Published in 2012	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Keller, A. Scott; Buechler, Tamara E.; Newman, James S.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Keller, AS (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	keller.scott@mayo.edu						Brotman DJ, 2012, ARCH INTERN MED, V172, P1492, DOI 10.1001/archinternmed.2012.4309; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Jneid H, 2012, CIRCULATION, V126, P875, DOI 10.1161/CIR.0b013e318256f1e0; Newby LK, 2012, J AM COLL CARDIOL, V60, P2427, DOI 10.1016/j.jacc.2012.08.969; Umpierrez GE, 2012, J CLIN ENDOCR METAB, V97, P16, DOI 10.1210/jc.2011-2098	6	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2					138	W55		10.7326/0003-4819-159-2-201307160-00103	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-00103			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23579240				2022-12-28	WOS:000322112000020
J	Lin, SJ; Foley, J; Jiang, TX; Yeh, CY; Wu, P; Foley, A; Yen, CM; Huang, YC; Cheng, HC; Chen, CF; Reeder, B; Jee, SH; Widelitz, RB; Chuong, CM				Lin, S. J.; Foley, J.; Jiang, T. X.; Yeh, C. Y.; Wu, P.; Foley, A.; Yen, C. M.; Huang, Y. C.; Cheng, H. C.; Chen, C. F.; Reeder, B.; Jee, S. H.; Widelitz, R. B.; Chuong, C. M.			Topology of Feather Melanocyte Progenitor Niche Allows Complex Pigment Patterns to Emerge	SCIENCE			English	Article							COLOR PATTERNS; AGOUTI; REGENERATION; PROTEIN; SKIN; DIFFERENTIATION; EXPRESSION; MODEL	Color patterns of bird plumage affect animal behavior and speciation. Diverse patterns are present in different species and within the individual. Here, we study the cellular and molecular basis of feather pigment pattern formation. Melanocyte progenitors are distributed as a horizontal ring in the proximal follicle, sending melanocytes vertically up into the epithelial cylinder, which gradually emerges as feathers grow. Different pigment patterns form by modulating the presence, arrangement, or differentiation of melanocytes. A layer of peripheral pulp further regulates pigmentation via patterned agouti expression. Lifetime feather cyclic regeneration resets pigment patterns for physiological needs. Thus, the evolution of stem cell niche topology allows complex pigment patterning through combinatorial co-option of simple regulatory mechanisms.	[Lin, S. J.; Jiang, T. X.; Yeh, C. Y.; Wu, P.; Widelitz, R. B.; Chuong, C. M.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Lin, S. J.; Yen, C. M.; Huang, Y. C.] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan; [Lin, S. J.; Yen, C. M.; Huang, Y. C.] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Lin, S. J.; Yen, C. M.; Jee, S. H.] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Lin, S. J.; Yen, C. M.; Jee, S. H.] Coll Med, Taipei, Taiwan; [Lin, S. J.; Chuong, C. M.] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Lin, S. J.] Natl Taiwan Univ, Genomes & Syst Biol Program, Taipei 10764, Taiwan; [Lin, S. J.] Natl Taiwan Univ, Ctr Syst Biol, Taipei 10764, Taiwan; [Foley, J.] Indiana Univ Sch Med, Dept Med Sci, Bloomington, IN USA; [Foley, J.] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Foley, A.] Foley Family Farm, Unionville, IN USA; [Cheng, H. C.] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Cheng, H. C.; Chen, C. F.; Chuong, C. M.] Natl Chung Hsing Univ, IEGG Ctr, Ctr Integrat & Evolutionary Galliformes Genom, Taichung 40227, Taiwan; [Chen, C. F.] Natl Chung Hsing Univ, Dept Anim Sci, Coll Agr & Nat Resources, Taichung 40227, Taiwan	University of Southern California; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Chuong, CM (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.	cmchuong@usc.edu		Lin, Sung-Jan/0000-0003-1325-3464; Cheng, Hsu-Chen/0000-0002-6586-6425; JEE, SHIOU-HWA/0000-0001-6737-6297; Yeh, Chao-Yuan/0000-0002-1947-1596	U.S. NIH [AR42177, AR47364, AR060306]; Taiwan National Health Research Institutes [PS9803]; Taiwan National Science Council [NSC99-2320-B-002-004-MY3, NSC101-2325-B-002-081]; National Taiwan University [101R7602D4, 100S-1580, 101S-1857, UN102-047]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060306, R01AR042177, R01AR047364] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan National Health Research Institutes; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported by U.S. NIH grants AR42177, AR47364, and AR060306 (C.M.C., R.B.W., and T.X.J.); Taiwan National Health Research Institutes grant PS9803 (S.J.L.); Taiwan National Science Council grants NSC99-2320-B-002-004-MY3 and NSC101-2325-B-002-081 (S.J.L.); National Taiwan University grant 101R7602D4 and Hospital grants 100S-1580, 101S-1857, and UN102-047 (S.J.L.). The authors thank G. S. Barsh, S. Kondo, and E. K. Nishimura for comments. We dedicate this paper to the memory of Anne Foley and Gien-Sum Lin.	Aberdam E, 1998, J BIOL CHEM, V273, P19560, DOI 10.1074/jbc.273.31.19560; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Chuong CM, 2012, PHYSIOLOGY, V27, P61, DOI 10.1152/physiol.00028.2011; Chuong CM, 2009, INT J DEV BIOL, V53, P653, DOI 10.1387/ijdb.082594cc; Darwin C., 1859, ORIGINS SPECIES MEAN; Dupin E, 2003, ONCOGENE, V22, P3016, DOI 10.1038/sj.onc.1206460; Hellstrom AR, 2010, PIGM CELL MELANOMA R, V23, P521, DOI 10.1111/j.1755-148X.2010.00700.x; Hill GE, 2006, DIGIT SIGNAL PROCESS; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Lillie F. R., 1941, Physiological Zoology Chicago, V14, P103; Lin SJ, 2013, DEV GROWTH DIFFER, V55, P139, DOI 10.1111/dgd.12024; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; Lucas A.M., 1972, AGR HDB, V362; Manceau M, 2011, SCIENCE, V331, P1062, DOI 10.1126/science.1200684; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Montalenti G, 1934, J EXP ZOOL, V69, P269, DOI 10.1002/jez.1400690205; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; Prum RO, 2002, P ROY SOC B-BIOL SCI, V269, P781, DOI 10.1098/rspb.2001.1896; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Stettenheim P, 2011, SCIENCE, V333, P939, DOI 10.1126/science.1209682; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yoshihara C, 2012, GEN COMP ENDOCR, V175, P495, DOI 10.1016/j.ygcen.2011.12.009; Yu MK, 2004, INT J DEV BIOL, V48, P181, DOI 10.1387/ijdb.15272383; Yue ZC, 2005, NATURE, V438, P1026, DOI 10.1038/nature04222; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740	28	80	81	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1442	1445		10.1126/science.1230374	http://dx.doi.org/10.1126/science.1230374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23618762	Green Accepted			2022-12-28	WOS:000320647000039
J	Deodhar, A				Deodhar, Atul			Update in Rheumatology: Evidence Published in 2012	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Deodhar, Atul] Oregon Hth & Sci Univ, Div Arthrit & Rheumat Dis OP09, Portland, OR 97239 USA		Deodhar, A (corresponding author), Oregon Hth & Sci Univ, Div Arthrit & Rheumat Dis OP09, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	deodhara@ohsu.edu						SCHJERNING OAM, 2011, CIRCULATION, V123, P226	1	1	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 18	2013	158	12					903	906		10.7326/0003-4819-158-12-201306180-00107	http://dx.doi.org/10.7326/0003-4819-158-12-201306180-00107			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167PW	23580081				2022-12-28	WOS:000320645000031
J	Frieden, TR				Frieden, Thomas R.			Government's Role in Protecting Health and Safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NEW-YORK-CITY		Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.			Frieden, Thomas/0000-0002-4759-2256				Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Chang C, 2004, AM J IND MED, V46, P188, DOI 10.1002/ajim.20030; Dumanovsky T, 2010, AM J PUBLIC HEALTH, V100, P2520, DOI 10.2105/AJPH.2010.191908; Hammond D, 2011, TOB CONTROL, V20, P327, DOI 10.1136/tc.2010.037630; Harsayani D, 2007, NANNY STATE FOOD FAS	5	42	42	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1857	1859		10.1056/NEJMp1303819	http://dx.doi.org/10.1056/NEJMp1303819			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143VK	23593978				2022-12-28	WOS:000318896200002
J	Witzburg, RA; Sondheimer, HM				Witzburg, Robert A.; Sondheimer, Henry M.			Holistic Review - Shaping the Medical Profession One Applicant at a Time	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Witzburg, Robert A.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Sondheimer, Henry M.] Assoc Amer Med Coll, Washington, DC USA	Boston University; Association of American Medical Colleges	Witzburg, RA (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.			Witzburg, Robert/0000-0001-9810-813X				Association of American Medical Colleges, HOL REV AL ADM MISS; Cooke M, 2006, NEW ENGL J MED, V355, P1339, DOI 10.1056/NEJMra055445; Julian ER, 2005, ACAD MED, V80, P910, DOI 10.1097/00001888-200510000-00010; Kirch DG, 2012, JAMA-J AM MED ASSOC, V308, P2250, DOI 10.1001/jama.2012.74126	4	90	90	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1565	1567		10.1056/NEJMp1300411	http://dx.doi.org/10.1056/NEJMp1300411			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130YK	23574032				2022-12-28	WOS:000317956300002
J	Kotecha, T; Fox, K				Kotecha, Tushar; Fox, Kevin			Investigating suspected heart failure	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NATRIURETIC PEPTIDE; EMERGENCY-DEPARTMENT; TASK-FORCE; COLLABORATION; DYSFUNCTION; GUIDELINES; DIAGNOSIS; ACCURACY; DYSPNEA; SOCIETY		[Kotecha, Tushar; Fox, Kevin] Imperial Healthcare NHS Trust, Charing Cross Hosp, London W6 8RF, England	Imperial College London	Fox, K (corresponding author), Imperial Healthcare NHS Trust, Charing Cross Hosp, London W6 8RF, England.	k.fox@imperial.ac.uk		Kotecha, Tushar/0000-0003-0059-4817				Bettencourt P, 2004, CIRCULATION, V110, P2168, DOI 10.1161/01.CIR.0000144310.04433.BE; Fox KF, 2001, EUR HEART J, V22, P228, DOI 10.1053/euhj.2000.2289; Hawkins NM, 2009, EUR J HEART FAIL, V11, P130, DOI 10.1093/eurjhf/hfn013; Januzzi JL, 2005, AM J CARDIOL, V95, P948, DOI 10.1016/j.amjcard.2004.12.032; Januzzi JL, 2006, ARCH INTERN MED, V166, P315, DOI 10.1001/archinte.166.3.315; Khunti K, 2004, EUR J HEART FAIL, V6, P571, DOI 10.1016/j.ejheart.2004.03.013; Kim HN, 2011, CIRCULATION, V123, P2015, DOI 10.1161/CIRCULATIONAHA.110.979500; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Mant J, 2009, HEALTH TECHNOL ASSES, V13, pIX, DOI 10.3310/hta13320; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Nanchen D, 2012, J CLIN ENDOCR METAB, V97, P852, DOI 10.1210/jc.2011-1978; National Institute Health and Clinical Excellence, 2010, CHRON HEART FAIL MAN; Scanlon PJ, 1999, CIRCULATION, V99, P2345, DOI 10.1161/01.CIR.99.17.2345; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; Zaphiriou A, 2005, EUR J HEART FAIL, V7, P537, DOI 10.1016/j.ejheart.2005.01.022	16	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2013	346								f2442	10.1136/bmj.f2442	http://dx.doi.org/10.1136/bmj.f2442			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134PM	23616032				2022-12-28	WOS:000318224900005
J	Roed, C; Omland, LH; Skinhoj, P; Rothman, KJ; Sorensen, HT; Obel, N				Roed, Casper; Omland, Lars Haukali; Skinhoj, Peter; Rothman, Kenneth J.; Sorensen, Henrik Toft; Obel, Niels			Educational Achievement and Economic Self-sufficiency in Adults After Childhood Bacterial Meningitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM MORTALITY; MENINGOCOCCAL DISEASE; BIRTH-WEIGHT; FOLLOW-UP; CHILDREN; OUTCOMES; AGE; RISK; DENMARK; INFANCY	Importance To our knowledge, no previous study has examined functioning in adult life among persons who had bacterial meningitis in childhood. Objective To study educational achievement and economic self-sufficiency in adults diagnosed as having bacterial meningitis in childhood. Design, Setting, and Participants Nationwide population-based cohort study using national registries of Danish-born children diagnosed as having meningococcal, pneumococcal, or Haemophilus influenzae meningitis in the period 1977-2007 (n=2784 patients). Comparison cohorts from the same population individually matched on age and sex were identified, as were siblings of all study participants. End of study period was 2010. Main Outcomes and Measures Cumulative incidences of completed vocational education, high school education, higher education, time to first full year of economic self-sufficiency, and receipt of disability pension and differences in these outcomes at age 35 years among meningitis patients, comparison cohorts, and siblings. Results By age 35 years, among persons who had a history of childhood meningococcal (n=1338), pneumococcal (n=455), and H influenzae (n=991) meningitis, an estimated 11.0% (41.5% vs 52.5%; 95% CI, 7.3%-14.7%), 10.2% (42.6% vs 52.8%; 95% CI, 3.8%-16.6%), and 5.5% (47.7% vs 53.2%; 95% CI, 1.9%-9.1%) fewer persons, respectively, had completed high school and 7.9% (29.3% vs 37.2%; 95% CI, 1.6%-14.2%), 8.9% (28.1% vs 37.0%; 95% CI, 0.6%-17.2%), and 6.5% (33.5% vs 40.0%; 95% CI, 1.4%-11.6%) fewer had attained a higher education compared with individuals from the comparison cohort. Siblings of meningococcal meningitis patients also had lower educational achievements, while educational achievements of siblings of pneumococcal and H influenzae meningitis patients did not differ substantially from those in the general population. At end of follow-up, 3.8% (90.3% vs 94.1%; 95% CI, 1.1%-6.5%), 10.6% (84.0% vs 94.6%; 95% CI, 5.1%-16.1%), and 4.3% (90.6% vs 94.9%; 95% CI, 2.0%-6.6%) fewer meningococcal, pneumococcal, and H influenzae meningitis patients were economically self-sufficient and 1.5% (3.7% vs 2.3%; 95% CI, -0.2% to 3.2%), 8.7% (10.0% vs 1.3%; 95% CI, 5.0%-12.4%), and 3.7% (6.2% vs 2.5%; 95% CI, 1.6%-5.8%) more received disability pension compared with individuals from the comparison cohort. Conclusions and Relevance In a Danish population, bacterial meningitis in childhood was associated with lower educational achievement and economic self-sufficiency in adult life. This association may apply particularly to pneumococcal and H influenzae meningitis, whereas for meningococcal meningitis the lower educational achievement may be family-related. JAMA. 2013;309(16):1714-1721 www.jama.com	[Roed, Casper; Omland, Lars Haukali; Skinhoj, Peter; Obel, Niels] Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Rothman, Kenneth J.] RTI Hlth Solut, Res Triangle Inst, Res Triangle Pk, NC USA; [Rothman, Kenneth J.; Sorensen, Henrik Toft] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark	University of Copenhagen; Research Triangle Institute; Boston University; Aarhus University	Roed, C (corresponding author), Copenhagen Univ Hosp, Dept Infect Dis, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	casper.roed@rh.regionh.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Omland, Lars Haukali/0000-0002-5338-8948; Obel, Niels/0000-0002-5031-0045; Roed, Casper/0000-0001-8987-5230; Rothman, Kenneth/0000-0003-2398-1705	Faculty of Health Sciences, Copenhagen University; NOVO Nordisk Foundation	Faculty of Health Sciences, Copenhagen University; NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The work was supported by the Faculty of Health Sciences, Copenhagen University, and the NOVO Nordisk Foundation.	Agerbo E, 2002, BMJ-BRIT MED J, V325, P74, DOI 10.1136/bmj.325.7355.74; Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; Bedford H, 2001, BRIT MED J, V323, P533, DOI 10.1136/bmj.323.7312.533; Carter JA, 2003, BRAIN RES REV, V43, P57, DOI 10.1016/S0165-0173(03)00192-9; Christiansen AH, 1993, PURULENT MENINGITIS; Christiansen AH, 1989, HAEMOPHILUS INFLUENZ; Christie D, 2011, EUR J PEDIATR, V170, P997, DOI 10.1007/s00431-010-1390-5; de Louvois J, 2007, ARCH DIS CHILD, V92, P959, DOI 10.1136/adc.2006.105916; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; Gianinazzi C, 2003, ACTA NEUROPATHOL, V105, P499, DOI 10.1007/s00401-003-0672-7; Grimwood K, 2000, ARCH DIS CHILD, V83, P111, DOI 10.1136/adc.83.2.111; GRIMWOOD K, 1995, PEDIATRICS, V95, P646; Hansen ABE, 2007, J INFECT DIS, V195, P230, DOI 10.1086/510246; Heyderman RS, 2004, ARCH DIS CHILD, V89, P1064, DOI 10.1136/adc.2003.036004; Howitz MF, 2008, EPIDEMIOL INFECT, V136, P1088, DOI 10.1017/S0950268807009466; Howitz M, 2008, SCAND J INFECT DIS, V40, P881, DOI 10.1080/00365540802325914; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lee CC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000374; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mathiasen R, 2010, PEDIATRICS, V126, pE1553, DOI 10.1542/peds.2009-0829; Olowokure B, 2006, J INFECTION, V52, P61, DOI 10.1016/j.jinf.2005.01.013; Pedersen CB, 2006, DAN MED BULL, V53, P441; Roed C, 2011, PEDIATR INFECT DIS J, V30, pE147, DOI 10.1097/INF.0b013e3182191a63; Roed C, 2010, AM J EPIDEMIOL, V172, P309, DOI 10.1093/aje/kwq126; Roed C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009662; Sorensen H T, 1995, Int J Risk Saf Med, V7, P179, DOI 10.3233/JRS-1995-7303; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401; Sorensen HT, 2004, INT J EPIDEMIOL, V33, P816, DOI 10.1093/ije/dyh169; StatisticsDenmark, EMPL CLASS MOD; Valentiner-Branth P, CONJUGATED PNEUMOCOC; Viner RM, 2012, LANCET NEUROL, V11, P774, DOI 10.1016/S1474-4422(12)70180-1; Wang WL, 2008, J PEDIATR-US, V153, P333, DOI 10.1016/j.jpeds.2008.04.017; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4	35	31	32	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1714	1721		10.1001/jama.2013.3792	http://dx.doi.org/10.1001/jama.2013.3792			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130IG	23613076				2022-12-28	WOS:000317906700028
J	Kremer, M; Brannen, C; Glennerster, R				Kremer, Michael; Brannen, Conner; Glennerster, Rachel			The Challenge of Education and Learning in the Developing World	SCIENCE			English	Review							RANDOMIZED EVALUATION; PROGRAMS EVIDENCE; INCENTIVES; TEACHER; VOUCHERS; IMPACT	Across many different contexts, randomized evaluations find that school participation is sensitive to costs: Reducing out-of-pocket costs, merit scholarships, and conditional cash transfers all increase schooling. Addressing child health and providing information on how earnings rise with education can increase schooling even more cost-effectively. However, among those in school, test scores are remarkably low and unresponsive to more-of-the-same inputs, such as hiring additional teachers, buying more textbooks, or providing flexible grants. In contrast, pedagogical reforms that match teaching to students' learning levels are highly cost effective at increasing learning, as are reforms that improve accountability and incentives, such as local hiring of teachers on short-term contracts. Technology could potentially improve pedagogy and accountability. Improving pre- and postprimary education are major future challenges.	[Kremer, Michael; Brannen, Conner] Harvard Univ, Cambridge, MA 02138 USA; [Glennerster, Rachel] MIT, Abdul Latif Jameel Poverty Act Lab, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Glennerster, R (corresponding author), MIT, Abdul Latif Jameel Poverty Act Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rglenner@mit.edu						Andrabi T., 2007, LEARNING ED ACHIEVEM; Angrist J, 2002, AM ECON REV, V92, P1535, DOI 10.1257/000282802762024629; Baird S., 2010, WORLD BANK POLICY RE, V5259; Baird S, 2012, WORMS WORK LONG RUN; Banerjee AV, 2007, Q J ECON, V122, P1235, DOI 10.1162/qjec.122.3.1235; Banerjee AV, 2010, AM ECON J-ECON POLIC, V2, P1, DOI 10.1257/pol.2.1.1; Barrera-Osorio F., 2009, USE MISUSE COMPUTERS, V1; Barros P. P., 2011, HDB HLTH EC, V2; Bleakley H, 2007, Q J ECON, V122, P73, DOI 10.1162/qjec.121.1.73; Bold T., 2012, INTERVENTIONS I EXPT; Burde D., 2012, 18039 NBER; Chaudhury N, 2006, J ECON PERSPECT, V20, P91, DOI 10.1257/089533006776526058; Cristia J., 2012, 6401 IZA FORSCH ZUK; Duflo E., 2012, ED HIV EARLY FERTILI; Duflo E., 2012, 14475 NBER; Duflo E, 2012, AM ECON REV, V102, P1241, DOI 10.1257/aer.102.4.1241; Duflo E, 2011, AM ECON REV, V101, P1739, DOI 10.1257/aer.101.5.1739; Evans D., 2011, SCH BASED MANAGEMENT; Fiszbein A, 2009, CONDITIONAL CASH TRA; Glewwe P, 2004, J DEV ECON, V74, P251, DOI 10.1016/j.jdeveco.2003.12.010; Glewwe P., ED POLICY D IN PRESS; Glewwe P, 2010, AM ECON J-APPL ECON, V2, P205, DOI 10.1257/app.2.3.205; Glewwe P, 2009, AM ECON J-APPL ECON, V1, P112, DOI 10.1257/app.1.1.112; Jensen R, 2010, Q J ECON, V125, P515, DOI 10.1162/qjec.2010.125.2.515; Kremer M, 2009, ANNU REV ECON, V1, P513, DOI 10.1146/annurev.economics.050708.143323; Kremer M, 2009, REV ECON STAT, V91, P437, DOI 10.1162/rest.91.3.437; Krueger AB, 2001, ECON J, V111, P1, DOI 10.1111/1468-0297.00586; Kumler T., 2012, 17185 NBER; Linden L., 2009, 18183 NBER; Miguel E, 2004, ECONOMETRICA, V72, P159, DOI 10.1111/j.1468-0262.2004.00481.x; Muralidharan K, 2010, ECON J, V120, pF187, DOI 10.1111/j.1468-0297.2010.02373.x; Nguyen T., 2008, INFORM ROLE MODELS P; Oster E, 2011, AM ECON J-APPL ECON, V3, P91, DOI 10.1257/app.3.1.91; Pradhan M., 2011, 5795 WORLD BANK; Pratham E., 2011, ANN STATUS ED REPORT; Rouse CE, 1998, Q J ECON, V113, P553, DOI 10.1162/003355398555685; Schultz TP, 2004, J DEV ECON, V74, P199, DOI 10.1016/j.jdeveco.2003.12.009; Sundararaman V., 2009, 15323 NBER	39	144	146	3	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					297	300		10.1126/science.1235350	http://dx.doi.org/10.1126/science.1235350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126XZ	23599477				2022-12-28	WOS:000317657500038
J	Craig, OE; Saul, H; Lucquin, A; Nishida, Y; Tache, K; Clarke, L; Thompson, A; Altoft, DT; Uchiyama, J; Ajimoto, M; Gibbs, K; Isaksson, S; Heron, CP; Jordan, P				Craig, O. E.; Saul, H.; Lucquin, A.; Nishida, Y.; Tache, K.; Clarke, L.; Thompson, A.; Altoft, D. T.; Uchiyama, J.; Ajimoto, M.; Gibbs, K.; Isaksson, S.; Heron, C. P.; Jordan, P.			Earliest evidence for the use of pottery	NATURE			English	Article							ARCHAEOLOGICAL CERAMIC VESSELS; JAPANESE ISLANDS; EAST-ASIA; PRODUCTS; EUROPE; TECHNOLOGY; RESIDUES; LIPIDS; ACIDS	Pottery was a hunter-gatherer innovation that first emerged in East Asia between 20,000 and 12,000 calibrated years before present(1,2) (cal BP), towards the end of the Late Pleistocene epoch, a period of time when humans were adjusting to changing climates and new environments. Ceramic container technologies were one of a range of late glacial adaptations that were pivotal to structuring subsequent cultural trajectories in different regions of the world, but the reasons for their emergence and widespread uptake are poorly understood. The first ceramic containers must have provided prehistoric hunter-gatherers with attractive new strategies for processing and consuming foodstuffs, but virtually nothing is known of how early pots were used. Here we report the chemical analysis of food residues associated with Late Pleistocene pottery, focusing on one of the best-studied prehistoric ceramic sequences in the world, the Japanese Jomon. We demonstrate that lipids can be recovered reliably from charred surface deposits adhering to pottery dating from about 15,000 to 11,800 cal BP (the Incipient Jomon period), the oldest pottery so far investigated, and that in most cases these organic compounds are unequivocally derived from processing freshwater and marine organisms. Stable isotope data support the lipid evidence and suggest that most of the 101 charred deposits analysed, from across the major islands of Japan, were derived from high-trophic-level aquatic food. Productive aquatic ecotones were heavily exploited by late glacial foragers(3), perhaps providing an initial impetus for investment in ceramic container technology, and paving the way for further intensification of pottery use by hunter-gatherers in the early Holocene epoch. Now that we have shown that it is possible to analyse organic residues from some of the world's earliest ceramic vessels, the subsequent development of this critical technology can be clarified through further widespread testing of hunter-gatherer pottery from later periods.	[Craig, O. E.; Saul, H.; Lucquin, A.; Tache, K.; Altoft, D. T.] Univ York, Dept Archaeol, BioArCh, York YO10 5DD, N Yorkshire, England; [Saul, H.; Nishida, Y.] Niigata Prefectural Museum Hist, Nagaoka, Niigata 9402035, Japan; [Clarke, L.; Heron, C. P.] Univ Bradford, Bradford BD7 1DP, W Yorkshire, England; [Clarke, L.] Manchester Metropolitan Univ, Sch Sci & Environm Sci, Div Chem & Environm Sci, Manchester M1 5GD, Lancs, England; [Thompson, A.] Univ Liverpool, Sch Environm Sci, Liverpool L69 3GP, Merseyside, England; [Uchiyama, J.] Res Inst Humanity & Nat, Kita Ku, Kyoto 6038047, Japan; [Ajimoto, M.] Wakasa Hist & Folklore Museum, Obama, Fukui 9170241, Japan; [Gibbs, K.] Univ Aberdeen, Dept Archaeol, Aberdeen AB24 3UF, Scotland; [Isaksson, S.] Stockholm Univ, Ctr Study Cultural Evolut, SE-10691 Stockholm, Sweden; [Isaksson, S.] Stockholm Univ, Dept Archaeol & Class Studies, Archaeol Res Lab, SE-10691 Stockholm, Sweden; [Jordan, P.] Univ Groningen, Arctic Ctr, NL-9700 AS Groningen, Netherlands	University of York - UK; University of Bradford; Manchester Metropolitan University; University of Liverpool; Research Institute for Humanity & Nature (RIHN); University of Aberdeen; Stockholm University; Stockholm University; University of Groningen	Craig, OE (corresponding author), Univ York, Dept Archaeol, BioArCh, York YO10 5DD, N Yorkshire, England.	oliver.craig@york.ac.uk	Clarke, Leon/R-5307-2016; Jordan, Peter/HDO-4721-2022; Lucquin, Alexandre/K-9045-2017	Clarke, Leon/0000-0002-2278-4139; Jordan, Peter/0000-0002-2837-3920; Saul, Hayley/0000-0001-9764-7115; Tache, Karine/0000-0003-0460-498X; Heron, Carl/0000-0002-5206-7464; Lucquin, Alexandre/0000-0003-4892-6323	Leverhulme trust [F/00 152/AM]; Japanese Society for the Promotion of Science [PE 11560]	Leverhulme trust(Leverhulme Trust); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank the Leverhulme trust (F/00 152/AM) and the Japanese Society for the Promotion of Science (PE 11560) for their support. We are grateful to K. Adachi, K. Higashi, Y. Kasai, H. Kato, K. Nagahama, H. Oguma, T. Tsuchiya, T. Watanabe and T. Yamahara for providing access to samples.	Bailey GN, 2008, QUATERNARY SCI REV, V27, P2153, DOI 10.1016/j.quascirev.2008.08.012; Craig OE, 2007, ARCHAEOMETRY, V49, P135, DOI 10.1111/j.1475-4754.2007.00292.x; Craig OE, 2005, ANTIQUITY, V79, P882, DOI 10.1017/S0003598X00115017; Craig OE, 2004, J ANAL APPL PYROL, V71, P613, DOI 10.1016/j.jaap.2003.09.001; Craig OE, 2012, RAPID COMMUN MASS SP, V26, P2359, DOI 10.1002/rcm.6349; Craig OE, 2011, P NATL ACAD SCI USA, V108, P17910, DOI 10.1073/pnas.1107202108; Evershed RP, 2008, ARCHAEOMETRY, V50, P101, DOI 10.1111/j.1475-4754.2007.00368.x; Evershed RP, 2008, ARCHAEOMETRY, V50, P895, DOI 10.1111/j.1475-4754.2008.00446.x; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Faure H, 2002, GLOBAL PLANET CHANGE, V33, P47, DOI 10.1016/S0921-8181(02)00060-7; Hamilton R.J., 1992, LIPID ANAL PRACTICAL, P53; Hansel FA, 2004, TETRAHEDRON LETT, V45, P2999, DOI 10.1016/j.tetlet.2004.01.111; Hayden B, 1995, EMERGENCE POTTERY TE, P257; IKAWASMITH F, 1976, CURR ANTHROPOL, V17, P513, DOI 10.1086/201773; Isaksson S., 2009, CURR SWED ARCHAEOL, V17, P131; Jordan P., 2009, CERAMICS FARMING DIS; Jordan P., 2009, CERAMICS FARMING DIS, P33; Kaner S., 2009, CERAMICS FARMING DIS, P93; Keally C. T., 2003, REV ARCHAEOLOGY, V24, P3; Keally CT, 2004, RADIOCARBON, V46, P345, DOI 10.1017/S0033822200039643; Kudo Y, 2012, QUATERN INT, V248, P22, DOI 10.1016/j.quaint.2011.02.016; Morton JD, 2004, J ARCHAEOL SCI, V31, P503, DOI 10.1016/j.jas.2003.10.001; Nakamura T, 2001, RADIOCARBON, V43, P1129; Ono A, 2002, RADIOCARBON, V44, P477, DOI 10.1017/S0033822200031854; Regert M, 2011, MASS SPECTROM REV, V30, P177, DOI 10.1002/mas.20271; Regert M, 1998, P ROY SOC B-BIOL SCI, V265, P2027, DOI 10.1098/rspb.1998.0536; Rice PM, 1999, J ARCHAEOL METHOD TH, V6, P1, DOI 10.1023/A:1022924709609; Tanabe S, 2010, QUATERNARY SCI REV, V29, P3956, DOI 10.1016/j.quascirev.2010.09.018; Taniguchi Y., 2002, IBOU, V20, P2; Wu XH, 2012, SCIENCE, V336, P1696, DOI 10.1126/science.1218643	30	172	178	5	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 18	2013	496	7445					351	354		10.1038/nature12109	http://dx.doi.org/10.1038/nature12109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	126FV	23575637				2022-12-28	WOS:000317599200035
J	Paneth, N; Fine, P				Paneth, Nigel; Fine, Paul			The art of medicine The singular science of John Snow	LANCET			English	Editorial Material									[Paneth, Nigel] Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Paneth, Nigel] Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, E Lansing, MI 48824 USA; [Fine, Paul] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Michigan State University College of Human Medicine; University of London; London School of Hygiene & Tropical Medicine	Paneth, N (corresponding author), Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.	paneth@epi.msu.edu						[Anonymous], 1855, LANCET, V1, P634; Snow J, 1853, ON CONTINUOUS MOLECU; Snow J, 1838, LANCET, V1, P264; Snow J, 1847, ON THE INHALATION OF; Snow J., 1849, MODE COMMUNICATION C; Vinten-Johansen P, 2003, CHOLERA CHLOROFORM A	6	5	5	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 13	2013	381	9874					1267	1268		10.1016/S0140-6736(13)60829-6	http://dx.doi.org/10.1016/S0140-6736(13)60829-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122XD	23589913				2022-12-28	WOS:000317351000016
J	Berger, LR				Berger, Lee R.			The Mosaic Nature of Australopithecus sediba INTRODUCTION	SCIENCE			English	Editorial Material									Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa	University of Witwatersrand	Berger, LR (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Private Bag 3, ZA-2050 Johannesburg, South Africa.	profleeberger@yahoo.com	Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629					0	15	16	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129					163	163		10.1126/science.340.6129.163	http://dx.doi.org/10.1126/science.340.6129.163			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580522	Bronze			2022-12-28	WOS:000317341400046
J	Arias-Palomo, E; O'Shea, VL; Hood, IV; Berger, JM				Arias-Palomo, Ernesto; O'Shea, Valerie L.; Hood, Iris V.; Berger, James M.			The Bacterial DnaC Helicase Loader Is a DnaB Ring Breaker	CELL			English	Article							ESCHERICHIA-COLI DNAB; PROTEIN-PROTEIN INTERACTIONS; SLIDING CLAMP INTERACTIONS; N-TERMINAL DOMAIN; REPLICATIVE HELICASE; CRYSTAL-STRUCTURE; FUNCTIONAL INTERACTION; HEXAMERIC HELICASE; POLYMERASE CLAMP; QUANTITATIVE-ANALYSIS	Dedicated AAA+ ATPases deposit hexameric ring-shaped helicases onto DNA to promote replication in cellular organisms. To understand how loading occurs, we used electron microscopy and small angle X-ray scattering (SAXS) to determine the ATP-bound structure of the intact E. coli DnaB, DnaC helicase/loader complex. The 480 kDa dodecamer forms a three-tiered assembly, in which DnaC adopts a spiral configuration that remodels N-terminal scaffolding and C-terminal motor regions of DnaB to produce a clear break in the helicase ring. Surprisingly, DnaC's AAA+ fold is dispensable for ring remodeling because the DnaC isolated helicase-binding domain can both load DnaB onto DNA and increase the efficiency by which the helicase acts on substrates in vitro. Our data demonstrate that DnaC opens DnaB by a mechanism akin to that of polymerase clamp loaders and indicate that bacterial replicative helicases, like their eukaryotic counterparts, possess autoregulatory elements that influence how hexameric motor domains are loaded onto and unwind DNA.	[Arias-Palomo, Ernesto; O'Shea, Valerie L.; Hood, Iris V.; Berger, James M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, 229 Stanley Hall, Berkeley, CA 94720 USA.	jmberger@berkeley.edu	Arias Palomo, Ernesto/L-1853-2017; Bustelo, Xose R./A-9526-2010; Garcia, Pedro/L-2808-2017	Bustelo, Xose R./0000-0001-9398-6072; Arias-Palomo, Ernesto/0000-0002-2706-7411; Garcia, Pedro/0000-0001-6717-8717	NIH NRSA postdoctoral fellowship [F32GM090803]; Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I+D+i from the Spanish Ministry of Education; Department of Energy Office of Science Graduate Fellowship; NIGMS [RO1-GM071747]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404, T32GM007232, F32GM090803, R01GM071747] Funding Source: NIH RePORTER	NIH NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I+D+i from the Spanish Ministry of Education; Department of Energy Office of Science Graduate Fellowship(United States Department of Energy (DOE)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to Eva Nogales and her research group, to the staff at beamlines 8.3.1 and 12.3.1 of the Advanced Light Source for help with data collection and analysis, and to the J.M.B. laboratory members for helpful discussions and aid in preparing the manuscript. This work was supported by an NIH NRSA postdoctoral fellowship (F32GM090803) to V.L.O., a postdoctoral fellowship from the Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I+D+i 2008-2011 from the Spanish Ministry of Education to E.A.-P., a Department of Energy Office of Science Graduate Fellowship to I.V.H., and by the NIGMS (RO1-GM071747) to J.M.	Ason B, 2000, J BIOL CHEM, V275, P3006, DOI 10.1074/jbc.275.4.3006; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Barcena M, 2001, EMBO J, V20, P1462, DOI 10.1093/emboj/20.6.1462; BISWAS EE, 1986, BIOCHEMISTRY-US, V25, P7368, DOI 10.1021/bi00371a019; Biswas SB, 2004, BIOCHEM J, V379, P553, DOI 10.1042/BJ20031255; Biswas T, 2008, FEBS J, V275, P3064, DOI 10.1111/j.1742-4658.2008.06460.x; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Chang P, 2000, J BIOL CHEM, V275, P26187, DOI 10.1074/jbc.M001800200; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Davey MJ, 2003, CURR BIOL, V13, pR594, DOI 10.1016/S0960-9822(03)00523-2; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; Galletto R, 2004, BIOCHEMISTRY-US, V43, P10988, DOI 10.1021/bi049377y; Galletto R, 2003, J MOL BIOL, V329, P441, DOI 10.1016/S0022-2836(03)00435-2; Goedken ER, 2005, NAT STRUCT MOL BIOL, V12, P183, DOI 10.1038/nsmb889; Hingorani MM, 1999, EMBO J, V18, P5131, DOI 10.1093/emboj/18.18.5131; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; JARVIS TC, 1989, J BIOL CHEM, V264, P12717; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Kaguni JM, 2011, CURR OPIN CHEM BIOL, V15, P606, DOI 10.1016/j.cbpa.2011.07.016; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 1999, J BIOL CHEM, V274, P6889, DOI 10.1074/jbc.274.11.6889; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kelch BA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-34; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; KOBORI JA, 1982, J BIOL CHEM, V257, P13770; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KOONIN EV, 1992, NUCLEIC ACIDS RES, V20, P1997, DOI 10.1093/nar/20.8.1997; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Latham GJ, 1997, J BIOL CHEM, V272, P31677, DOI 10.1074/jbc.272.50.31677; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Lo YH, 2009, NUCLEIC ACIDS RES, V37, P804, DOI 10.1093/nar/gkn999; Ludlam AV, 2001, J BIOL CHEM, V276, P27345, DOI 10.1074/jbc.M101940200; Lyubimov AY, 2012, P NATL ACAD SCI USA, V109, P11999, DOI 10.1073/pnas.1209406109; MacNeill SA, 2011, BIOCHEM SOC T, V39, P163, DOI 10.1042/BST0390163; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; McGlynn P, 2011, BIOCHEM SOC T, V39, P606, DOI 10.1042/BST0390606; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Nielsen O, 2008, EMBO REP, V9, P151, DOI 10.1038/sj.embor.2008.2; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietroni P, 1997, J BIOL CHEM, V272, P31666, DOI 10.1074/jbc.272.50.31666; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; San Martin C, 1998, STRUCTURE, V6, P501; SANMARTIN MC, 1995, J STRUCT BIOL, V114, P167, DOI 10.1006/jsbi.1995.1016; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Schaeffer PM, 2005, IUBMB LIFE, V57, P5, DOI 10.1080/15216540500058956; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; Seybert A, 2006, EMBO J, V25, P2209, DOI 10.1038/sj.emboj.7601093; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Soultanas P, 2002, NUCLEIC ACIDS RES, V30, P966, DOI 10.1093/nar/30.4.966; Soultanas P, 2012, MOL MICROBIOL, V84, P6, DOI 10.1111/j.1365-2958.2012.08012.x; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TOUGU K, 1994, J BIOL CHEM, V269, P4675; Tsai KL, 2009, J MOL BIOL, V393, P1056, DOI 10.1016/j.jmb.2009.09.002; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; WAHLE E, 1989, J BIOL CHEM, V264, P2469; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921; Yang SX, 2002, J MOL BIOL, V321, P839, DOI 10.1016/S0022-2836(02)00711-8; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103	78	61	61	3	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					438	448		10.1016/j.cell.2013.03.006	http://dx.doi.org/10.1016/j.cell.2013.03.006			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23562643	Green Accepted, Bronze			2022-12-28	WOS:000317349700021
J	Harvey, JJ; Duddy, MJ				Harvey, John Julian; Duddy, Martin J.			CASE REPORT A painful swelling in the groin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VASCULAR CLOSURE DEVICES; CARDIAC-CATHETERIZATION; PSEUDOANEURYSMS; RISK		[Harvey, John Julian; Duddy, Martin J.] Queen Elizabeth Hosp Birmingham, Dept Diagnost & Intervent Radiol, Birmingham B15 2WB, W Midlands, England; [Harvey, John Julian] Queen Elizabeth Hosp Birmingham, Royal Ctr Def Med, Birmingham B15 2WB, W Midlands, England	University of Birmingham; Royal Centre for Defence Medicine; University of Birmingham	Harvey, JJ (corresponding author), Queen Elizabeth Hosp Birmingham, Dept Diagnost & Intervent Radiol, Birmingham B15 2WB, W Midlands, England.	julesharvey@gmail.com		Harvey, John Julian/0000-0001-5866-5847				Arora N, 2007, AM HEART J, V153, P606, DOI 10.1016/j.ahj.2006.12.014; Ates M, 2006, J VASC SURG, V43, P520, DOI 10.1016/j.jvs.2005.11.009; Biancari F, 2010, AM HEART J, V159, P518, DOI 10.1016/j.ahj.2009.12.027; Cornwett JL., RUTHERFORDS VASCULAR; Mlekusch W, 2006, RADIOLOGY, V240, P597, DOI 10.1148/radiol.2402050907; Tsetis D, 2010, CARDIOVASC INTER RAD, V33, P457, DOI 10.1007/s00270-010-9820-3; Webber GW, 2007, CIRCULATION, V115, P2666, DOI 10.1161/CIRCULATIONAHA.106.681973	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2013	346								f2185	10.1136/bmj.f2185	http://dx.doi.org/10.1136/bmj.f2185			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125ZP	23580694				2022-12-28	WOS:000317581200002
J	Tingley, MP; Huybers, P				Tingley, Martin P.; Huybers, Peter			Recent temperature extremes at high northern latitudes unprecedented in the past 600 years	NATURE			English	Article							NH MEAN TEMPERATURE; RECONSTRUCTING CLIMATE ANOMALIES; TREE-RING WIDTH; BAYESIAN ALGORITHM; DENSITY DATA; ICE; VARIABILITY; HEMISPHERE; SUMMER; TRENDS	Recently observed extreme temperatures at high northern latitudes(1-7) are rare by definition, making the longer time span afforded by climate proxies important for assessing how the frequency of such extremes may be changing. Previous reconstructions of past temperature variability have demonstrated that recent warmth is anomalous relative to preceding centuries(2,8,9) or millennia(10), but extreme events can be more thoroughly evaluated using a spatially resolved approach that provides an ensemble of possible temperature histories(11,12). Here, using a hierarchical Bayesian analysis(13,14) of instrumental, tree-ring, ice-core and lake-sediment records, we show that the magnitude and frequency of recent warm temperature extremes at high northern latitudes are unprecedented in the past 600 years. The summers of 2005, 2007, 2010 and 2011 were warmer than those of all prior years back to 1400 (probability P > 0.95), in terms of the spatial average. The summer of 2010 was the warmest in the previous 600 years in western Russia (P > 0.99) and probably the warmest in western Greenland and the Canadian Arctic as well (P > 0.90). These and other recent extremes greatly exceed those expected from a stationary climate, but can be understood as resulting from constant space-time variability about an increased mean temperature.	[Tingley, Martin P.; Huybers, Peter] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Tingley, MP (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	tingley@fas.harvard.edu		Huybers, Peter/0000-0002-3734-8145	FAS Science Division Research Computing Group at Harvard University; NSF [ATM-0902374]; Directorate For Geosciences [0902374] Funding Source: National Science Foundation	FAS Science Division Research Computing Group at Harvard University; NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Data analysis was performed on the Odyssey cluster supported by the FAS Science Division Research Computing Group at Harvard University. Funding for this work was provided in part by NSF grant ATM-0902374. We thank E. Butler, P. Craigmile, N. Cressie, M. Haran, B. Li, E. Mannshardt, K. McKinnon, D. Nychka, B. Rajaratnam, A. Rhines, D. Schrag and A. Stine for comments and discussions.	[Anonymous], AM METEOROL SOC; Barriopedro D, 2011, SCIENCE, V332, P220, DOI 10.1126/science.1201224; Berliner LM, 2000, J CLIMATE, V13, P3953, DOI 10.1175/1520-0442(2001)013<3953:LLPOPS>2.0.CO;2; Briffa KR, 2002, HOLOCENE, V12, P759, DOI 10.1191/0959683602hl588rp; Briffa KR, 1998, NATURE, V391, P678, DOI 10.1038/35596; Brohan P, 2006, J GEOPHYS RES, V2, P99; Christiansen B, 2012, CLIM PAST, V8, P765, DOI 10.5194/cp-8-765-2012; Christiansen B, 2012, J CLIMATE, V25, P3447, DOI 10.1175/JCLI-D-11-00162.1; Christiansen B, 2011, J CLIMATE, V24, P6013, DOI 10.1175/2011JCLI4145.1; Christiansen B, 2011, J CLIMATE, V24, P674, DOI 10.1175/2010JCLI3646.1; Christiansen B, 2010, J CLIMATE, V23, P4306, DOI 10.1175/2010JCLI3014.1; Craigmile PF, 2004, ENVIRONMETRICS, V15, P313, DOI 10.1002/env.642; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; Dole R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046582; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Fisher DA, 1998, SCIENCE, V279, P692, DOI 10.1126/science.279.5351.692; FISHER DA, 1979, QUATERNARY RES, V11, P299, DOI 10.1016/0033-5894(79)90077-2; Fisher D, 2008, HOLOCENE, V18, P667, DOI 10.1177/0959683608092236; Gao RS, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009358; Gelman A., 2003, BAYESIAN DATA ANAL; Genton MG, 2007, ENVIRONMETRICS, V18, P681, DOI 10.1002/env.854; Hamill TM, 2001, MON WEATHER REV, V129, P550, DOI 10.1175/1520-0493(2001)129<0550:IORHFV>2.0.CO;2; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Haslett J, 2006, J R STAT SOC A STAT, V169, P395, DOI 10.1111/j.1467-985X.2006.00429.x; Isaksson E, 2005, GEOGR ANN A, V87A, P203, DOI 10.1111/j.0435-3676.2005.00253.x; Isaksson E., 2011, DATA CONTRIBUTION SE, V2011-068; Kaufman DS, 2009, SCIENCE, V325, P1236, DOI 10.1126/science.1173983; Kinnard C, 2011, NATURE, V479, P509, DOI 10.1038/nature10581; Krivobokova T, 2010, J AM STAT ASSOC, V105, P852, DOI 10.1198/jasa.2010.tm09165; Lee TCK, 2008, CLIM DYNAM, V31, P263, DOI 10.1007/s00382-007-0351-9; Li B, 2007, TELLUS A, V59, P591, DOI [10.1111/j.1600-0870.2007.00270.x, 10.1111/J.1600-0870.2007.00270.x]; Li B, 2010, J AM STAT ASSOC, V105, P883, DOI 10.1198/jasa.2010.ap09379; Loso MG, 2009, J PALEOLIMNOL, V41, P117, DOI 10.1007/s10933-008-9264-9; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; McShane BB, 2011, ANN APPL STAT, V5, P5, DOI 10.1214/10-AOAS398; National Research Council, 2006, SURF TEM REC LAST 20; Otto FEL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050422; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; Rahmstorf S, 2011, P NATL ACAD SCI USA, V108, P17905, DOI 10.1073/pnas.1101766108; Rhines A, 2013, P NATL ACAD SCI USA, V110, pE546, DOI 10.1073/pnas.1218748110; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Schneider T, 2001, J CLIMATE, V14, P853, DOI 10.1175/1520-0442(2001)014<0853:AOICDE>2.0.CO;2; Smerdon JE, 2010, J CLIMATE, V23, P4856, DOI 10.1175/2010JCLI3328.1; Tedesco M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014005; Tingley MP, 2012, J CLIMATE, V25, P3441, DOI 10.1175/JCLI-D-11-00005.1; Tingley MP, 2012, QUATERNARY SCI REV, V35, P1, DOI 10.1016/j.quascirev.2012.01.012; Tingley MP, 2012, J CLIMATE, V25, P777, DOI 10.1175/JCLI-D-11-00008.1; Tingley MP, 2010, J CLIMATE, V23, P2782, DOI 10.1175/2009JCLI3016.1; Tingley MP, 2010, J CLIMATE, V23, P2759, DOI 10.1175/2009JCLI3015.1; van As D, 2012, CRYOSPHERE, V6, P199, DOI 10.5194/tc-6-199-2012; Werner JP, 2013, J CLIMATE, V26, P851, DOI 10.1175/JCLI-D-12-00016.1	53	124	126	4	215	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					201	+		10.1038/nature11969	http://dx.doi.org/10.1038/nature11969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23579678				2022-12-28	WOS:000317346300037
J	Shipman, KE; Holt, AD; Gama, R				Shipman, Kate Elizabeth; Holt, Ashley David; Gama, Rousseau			Interpreting an isolated raised serum alkaline phosphatase level in an asymptomatic patient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VITAMIN-D DEFICIENCY; DISEASE; DIAGNOSIS; TESTS; BONE		[Shipman, Kate Elizabeth; Holt, Ashley David; Gama, Rousseau] New Cross Hosp, Wolverhampton WV10 0QP, W Midlands, England	New Cross Hospital	Shipman, KE (corresponding author), New Cross Hosp, Wolverhampton WV10 0QP, W Midlands, England.	kate.shipman@doctors.net.uk	Shipman, Kate/H-7638-2019	Shipman, Kate/0000-0002-6043-3532; Gama, Rousseau/0000-0001-7483-9253				Aragon G, 2010, CLEV CLIN J MED, V77, P195, DOI 10.3949/ccjm.77a.09064; Collier J, 2002, CLIN MED, V2, P406, DOI 10.7861/clinmedicine.2-5-406; Green RM, 2002, GASTROENTEROLOGY, V123, P1367, DOI 10.1053/gast.2002.36061; Josse RG, 2007, CLIN INVEST MED, V30, pE210; Kotowicz KK, 2004, AUST FARM PHYS, V33, P127; LIEBERMAN D, 1990, J CLIN GASTROENTEROL, V12, P475, DOI 10.1097/00004836-199008000-00012; Lott J. A., 1986, CLIN ENZYMOLOGY CASE; McTaggart MP, 2012, ANN CLIN BIOCHEM, V49, P405, DOI 10.1258/acb.2011.011224; Mikhail N, 2011, SOUTH MED J, V104, P29, DOI 10.1097/SMJ.0b013e3181fcd772; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Ricos C, 2007, ANN CLIN BIOCHEM, V44, P343, DOI 10.1258/000456307780945633; RUBENSTEIN LV, 1986, J GEN INTERN MED, V1, P38, DOI 10.1007/BF02596324; SCHIELE F, 1983, CLIN CHEM, V29, P634; Smellie WSA, 2006, J CLIN PATHOL, V59, P1229, DOI 10.1136/jcp.2006.037754; Sorbi D, 2000, AM J GASTROENTEROL, V95, P3206; Young DS, 2000, EFFECTS DRUGS CLIN L, Vone	16	13	13	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2013	346								f976	10.1136/bmj.f976	http://dx.doi.org/10.1136/bmj.f976			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122SG	23553977				2022-12-28	WOS:000317337800013
J	Lawoyin, TO; Lawoyin, OO				Lawoyin, Taiwo O.; Lawoyin, Olusheyi O.			Translation of research into reality in sub-Saharan Africa	LANCET			English	Editorial Material							NEONATAL-MORTALITY; CARE; METAANALYSIS; PREGNANCY		[Lawoyin, Taiwo O.] Frontline Res & Training Reprod & Family Hlth, Columbia, MD 21045 USA; [Lawoyin, Olusheyi O.] Emory Univ, Goizueta Business Sch, Atlanta, GA 30322 USA	Emory University	Lawoyin, TO (corresponding author), Frontline Res & Training Reprod & Family Hlth, POB 133, Columbia, MD 21045 USA.	toolawoyin@yahoo.com						Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Darmstadt GL, 2003, B WORLD HEALTH ORGAN, V81, P224; Eisele TP, 2012, LANCET INFECT DIS, V12, P942, DOI 10.1016/S1473-3099(12)70222-0; Kirkwood BR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-58; Kirkwood BR, 2013, LANCET, P60095, DOI 10.1016/S0140-6736(13)60095-1; Lawoyin T O, 2010, West Afr J Med, V29, P19; Rose-Wood A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-319; Tura G, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-18; WHO/UNICEF, 2009, HOM VIS NEWB CHILD S	10	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 22	2013	381	9884					2146	2147		10.1016/S0140-6736(13)60601-7	http://dx.doi.org/10.1016/S0140-6736(13)60601-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KH	23578529				2022-12-28	WOS:000320925600010
J	Kono, N; Ohto, U; Hiramatsu, T; Urabe, M; Uchida, Y; Satow, Y; Arai, H				Kono, Nozomu; Ohto, Umeharu; Hiramatsu, Tatsufumi; Urabe, Michiko; Uchida, Yasunori; Satow, Yoshinori; Arai, Hiroyuki			Impaired alpha-TTP-PIPs Interaction Underlies Familial Vitamin E Deficiency	SCIENCE			English	Article							RETINALDEHYDE-BINDING PROTEIN; MOLECULAR-MECHANISMS; LIPID TRANSPORT; TOCOPHEROL; ATAXIA; SECRETION	alpha-Tocopherol (vitamin E) transfer protein (alpha-7P) regulates the secretion of a-tocopherol from liver cells. Missense mutations of some arginine residues at the surface of alpha-TIP cause severe vitamin E deficiency in humans, but the role of these residues is unclear. Here, we found that wild-type a-UP bound phosphatidylinositol phosphates (PIPs), whereas the arginine mutants did not. In addition, PIPs in the target membrane promoted the intermembrane transfer of alpha-tocopherot by alpha-UP. The crystal structure of the alpha-UP PIPs complex revealed that the disease-related arginine residues interacted with phosphate groups of the PIPs and that the PIPs binding caused the lid of the alpha-tocopherol binding pocket to open. Thus, PIPs have a rote in promoting the release of a ligand from a lipid-transfer protein.	[Kono, Nozomu; Ohto, Umeharu; Hiramatsu, Tatsufumi; Urabe, Michiko; Uchida, Yasunori; Satow, Yoshinori; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kono, Nozomu; Arai, Hiroyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Arai, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	harai@mol.f.u-tokyo.ac.jp	KONO, nozomu/AAM-3178-2020		Core Research for Evolutional Science and Technology; Japan Science and Technology Agency (CREST, JST); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japanese Ministry of Education, Culture, Sports, Science, and Technology [20370045]; Japanese Ministry of Health, Labor, and Welfare	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (CREST, JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	We thank P. T. Hawkins for providing PI(3,4)P<INF>2</INF>-derivatized beads; K. Yamamoto for providing Ricinus communis agglutinin 120; the beamline staffs at Photon Factory for their assistance with data collection; and J. Raymond for English proofreading. This work was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (CREST, JST) (to H.A.); the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (to H.A.), Grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (20370045 to H.A.); and the Japanese Ministry of Health, Labor, and Welfare (to H.A.). The coordinate and structure factor data of alpha-TTP-PI(3,4)P<INF>2</INF> and alpha-TTP-PI(4,5)P<INF>2</INF> complexes have been deposited to the Protein Data Bank under the accession codes 3W67 and 3W68, respectively.	Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; Arita M, 1997, P NATL ACAD SCI USA, V94, P12437, DOI 10.1073/pnas.94.23.12437; Cavalier L, 1998, AM J HUM GENET, V62, P301, DOI 10.1086/301699; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Di Donato I, 2010, NEUROL SCI, V31, P511, DOI 10.1007/s10072-010-0261-1; He XQ, 2009, P NATL ACAD SCI USA, V106, P18545, DOI 10.1073/pnas.0907454106; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Huynh H, 2003, J IMMUNOL, V171, P6661, DOI 10.4049/jimmunol.171.12.6661; Katoh Y, 2009, J BIOL CHEM, V284, P27646, DOI 10.1074/jbc.M109.034884; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Meier R, 2003, J MOL BIOL, V331, P725, DOI 10.1016/S0022-2836(03)00724-1; Merkulova M, 2005, FEBS J, V272, P5595, DOI 10.1111/j.1742-4658.2005.04955.x; Min KC, 2003, P NATL ACAD SCI USA, V100, P14713, DOI 10.1073/pnas.2136684100; Nile AH, 2010, CLIN LIPIDOL, V5, P867, DOI 10.2217/CLP.10.67; Saari JC, 2009, MOL VIS, V15, P844; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Suh BC, 1996, EUR J PHARMACOL, V314, P235, DOI 10.1016/S0014-2999(96)00555-9; Takada T, 2010, MOL NUTR FOOD RES, V54, P616, DOI 10.1002/mnfr.200900481; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; VOELKER DR, 1990, EXPERIENTIA, V46, P569, DOI 10.1007/BF01939695	22	89	93	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1106	1110		10.1126/science.1233508	http://dx.doi.org/10.1126/science.1233508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23599266				2022-12-28	WOS:000319664500047
J	Mahmoud, AI; Kocabas, F; Muralidhar, SA; Kimura, W; Koura, AS; Thet, S; Porrello, ER; Sadek, HA				Mahmoud, Ahmed I.; Kocabas, Fatih; Muralidhar, Shalini A.; Kimura, Wataru; Koura, Ahmed S.; Thet, Suwannee; Porrello, Enzo R.; Sadek, Hesham A.			Meis1 regulates postnatal cardiomyocyte cell cycle arrest	NATURE			English	Article							ZEBRAFISH HEART REGENERATION; HEMATOPOIETIC STEM-CELLS; CARDIAC MYOCYTES; PROLIFERATION; INJURY; PHENOTYPE; PROTEINS; RENEWAL; HUMANS; GROWTH	The neonatal mammalian heart is capable of substantial regeneration following injury through cardiomyocyte proliferation(1,2). However, this regenerative capacity is lost by postnatal day 7 and the mechanisms of cardiomyocyte cell cycle arrest remain unclear. The homeodomain transcription factor Meis1 is required for normal cardiac development but its role in cardiomyocytes is unknown(3,4). Here we identify Meis1 as a critical regulator of the cardiomyocyte cell cycle. Meis1 deletion in mouse cardiomyocytes was sufficient for extension of the postnatal proliferative window of cardiomyocytes, and for re-activation of cardiomyocyte mitosis in the adult heart with no deleterious effect on cardiac function. In contrast, overexpression of Meis1 in cardiomyocytes decreased neonatal myocyte proliferation and inhibited neonatal heart regeneration. Finally, we show that Meis1 is required for transcriptional activation of the synergistic CDK inhibitors p15, p16 and p21. These results identify Meis1 as a critical transcriptional regulator of cardiomyocyte proliferation and a potential therapeutic target for heart regeneration.	[Mahmoud, Ahmed I.; Kocabas, Fatih; Muralidhar, Shalini A.; Kimura, Wataru; Thet, Suwannee; Sadek, Hesham A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Koura, Ahmed S.] Ain Shams Univ, Sch Med, Cairo 1156, Egypt; [Porrello, Enzo R.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia	University of Texas System; University of Texas Southwestern Medical Center Dallas; Egyptian Knowledge Bank (EKB); Ain Shams University; University of Queensland	Sadek, HA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA.	hesham.sadek@utsouthwestern.edu	Kocabas, Fatih/AAM-6391-2021; Kocabas, Fatih/B-2975-2012	Kocabas, Fatih/0000-0001-8096-6056; Kocabas, Fatih/0000-0001-8096-6056; Mahmoud, Ahmed/0000-0003-1528-7393; Kocabas, Fatih/0000-0002-2854-9180; Kimura, Wataru/0000-0001-6548-6353; Porrello, Enzo/0000-0001-6105-7463	American Heart Association; Gilead Research Scholars Program in Cardiovascular Disease; Foundation for Heart Failure Research, NY; National Institutes of Health [1R01HL115275-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115275] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Gilead Research Scholars Program in Cardiovascular Disease; Foundation for Heart Failure Research, NY; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Shelton for help with histology, J. Cabrera for help with figures, N. Copeland and N. Jenkins for providing the Meis1 KO mice, S. Das for statistics consultation, K. Luby-Phelps for help with microscopy, A. Bugde for confocal assistance, D. Farrar for discussions, H. Nguyen for help with echocardiography, as well as K. Sheth, A. Mercadel and Z. Sadek for technical assistance. This work is supported by grants from the American Heart Association (Grant in Aid) (H. A. S.), the Gilead Research Scholars Program in Cardiovascular Disease (H. A. S.), the Foundation for Heart Failure Research, NY, and the National Institutes of Health (1R01HL115275-01) (H.A.S.).	Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Gude N, 2006, CIRC RES, V99, P381, DOI 10.1161/01.RES.0000236754.21499.1c; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Imamura T, 2002, BRIT J HAEMATOL, V119, P119, DOI 10.1046/j.1365-2141.2002.03803.x; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; MacLellan WR, 2005, MOL CELL BIOL, V25, P2486, DOI 10.1128/MCB.25.6.2486-2497.2005; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Poolman RA, 1998, INT J CARDIOL, V67, P133, DOI 10.1016/S0167-5273(98)00320-9; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035	28	343	353	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					249	253		10.1038/nature12054	http://dx.doi.org/10.1038/nature12054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23594737	Green Accepted			2022-12-28	WOS:000318558200038
J	Liao, HX; Lynch, R; Zhou, TQ; Gao, F; Alam, SM; Boyd, SD; Fire, AZ; Roskin, KM; Schramm, CA; Zhang, ZH; Zhu, J; Shapiro, L; Mullikin, JC; Gnanakaran, S; Hraber, P; Wiehe, K; Kelsoe, G; Yang, G; Xia, SM; Montefiori, DC; Parks, R; Lloyd, KE; Scearce, RM; Soderberg, KA; Cohen, M; Kamanga, G; Louder, MK; Tran, LM; Chen, Y; Cai, FP; Chen, SR; Moquin, S; Du, XL; Joyce, MG; Srivatsan, S; Zhang, BS; Zheng, AQ; Shaw, GM; Hahn, BH; Kepler, TB; Korber, BTM; Kwong, PD; Mascola, JR; Haynes, BF				Liao, Hua-Xin; Lynch, Rebecca; Zhou, Tongqing; Gao, Feng; Alam, S. Munir; Boyd, Scott D.; Fire, Andrew Z.; Roskin, Krishna M.; Schramm, Chaim A.; Zhang, Zhenhai; Zhu, Jiang; Shapiro, Lawrence; Mullikin, James C.; Gnanakaran, S.; Hraber, Peter; Wiehe, Kevin; Kelsoe, Garnett; Yang, Guang; Xia, Shi-Mao; Montefiori, David C.; Parks, Robert; Lloyd, Krissey E.; Scearce, Richard M.; Soderberg, Kelly A.; Cohen, Myron; Kamanga, Gift; Louder, Mark K.; Tran, Lillian M.; Chen, Yue; Cai, Fangping; Chen, Sheri; Moquin, Stephanie; Du, Xiulian; Joyce, M. Gordon; Srivatsan, Sanjay; Zhang, Baoshan; Zheng, Anqi; Shaw, George M.; Hahn, Beatrice H.; Kepler, Thomas B.; Korber, Bette T. M.; Kwong, Peter D.; Mascola, John R.; Haynes, Barton F.		NISC Comparative Sequencing Progra	Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus	NATURE			English	Article							B-CELL RESPONSES; HUMAN MONOCLONAL-ANTIBODIES; IN-SITU PROTEOLYSIS; CD4 BINDING-SITE; CONFORMATIONAL EPITOPE; POTENT NEUTRALIZATION; ENVELOPE GLYCOPROTEIN; SUBTYPE-B; CRYSTALLIZATION; EVOLUTION	Current human immunodeficiency virus-1 (HIV-1) vaccines elicit strain-specific neutralizing antibodies. However, cross-reactive neutralizing antibodies arise in approximately 20% of HIV-1-infected individuals, and details of their generation could provide a blueprint for effective vaccination. Here we report the isolation, evolution and structure of a broadly neutralizing antibody from an African donor followed from the time of infection. The mature antibody, CH103, neutralized approximately 55% of HIV-1 isolates, and its co-crystal structure with the HIV-1 envelope protein gp120 revealed a new loop-based mechanism of CD4-binding-site recognition. Virus and antibody gene sequencing revealed concomitant virus evolution and antibody maturation. Notably, the unmutated common ancestor of the CH103 lineage avidly bound the transmitted/founder HIV-1 envelope glycoprotein, and evolution of antibody neutralization breadth was preceded by extensive viral diversification in and near the CH103 epitope. These data determine the viral and antibody evolution leading to induction of a lineage of HIV-1 broadly neutralizing antibodies, and provide insights into strategies to elicit similar antibodies by vaccination.	[Liao, Hua-Xin; Gao, Feng; Alam, S. Munir; Wiehe, Kevin; Kelsoe, Garnett; Yang, Guang; Xia, Shi-Mao; Montefiori, David C.; Parks, Robert; Lloyd, Krissey E.; Scearce, Richard M.; Soderberg, Kelly A.; Chen, Yue; Cai, Fangping; Chen, Sheri; Haynes, Barton F.] Duke Univ, Sch Med, Dept Med, Human Vaccine Inst, Durham, NC 27710 USA; [Liao, Hua-Xin; Gao, Feng; Alam, S. Munir; Wiehe, Kevin; Kelsoe, Garnett; Yang, Guang; Xia, Shi-Mao; Montefiori, David C.; Parks, Robert; Lloyd, Krissey E.; Scearce, Richard M.; Soderberg, Kelly A.; Chen, Yue; Cai, Fangping; Chen, Sheri; Haynes, Barton F.] Duke Univ, Sch Med, Dept Immunol, Human Vaccine Inst, Durham, NC 27710 USA; [Liao, Hua-Xin; Gao, Feng; Alam, S. Munir; Wiehe, Kevin; Kelsoe, Garnett; Yang, Guang; Xia, Shi-Mao; Montefiori, David C.; Parks, Robert; Lloyd, Krissey E.; Scearce, Richard M.; Soderberg, Kelly A.; Chen, Yue; Cai, Fangping; Chen, Sheri; Haynes, Barton F.] Duke Ctr HIV AIDS Vaccine Immunol & Immunogen Dis, Durham, NC 27710 USA; [Lynch, Rebecca; Zhou, Tongqing; Zhu, Jiang; Shapiro, Lawrence; Louder, Mark K.; Tran, Lillian M.; Moquin, Stephanie; Du, Xiulian; Joyce, M. Gordon; Srivatsan, Sanjay; Zhang, Baoshan; Zheng, Anqi; Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Boyd, Scott D.; Fire, Andrew Z.; Roskin, Krishna M.] Stanford Univ, Dept Pathol, Palo Alto, CA 94305 USA; [Schramm, Chaim A.; Zhang, Zhenhai; Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Mullikin, James C.] NIH, NISC Comparat Sequencing Program, Bethesda, MD 20892 USA; [Mullikin, James C.] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Gnanakaran, S.; Hraber, Peter; Korber, Bette T. M.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87544 USA; [Cohen, Myron] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Cohen, Myron] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Cohen, Myron] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Kamanga, Gift] Univ North Carolina Project, Kamuzu Cent Hosp, Lilongwe, Malawi; [Shaw, George M.; Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Shaw, George M.; Hahn, Beatrice H.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Kepler, Thomas B.] Boston Univ, Dept Microbiol, Boston, MA 02215 USA	Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stanford University; Columbia University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); United States Department of Energy (DOE); Los Alamos National Laboratory; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Boston University	Liao, HX (corresponding author), Duke Univ, Sch Med, Dept Med, Human Vaccine Inst, Durham, NC 27710 USA.	hliao@duke.edu; barton.haynes@duke.edu	Zhou, Tongqing/A-6880-2010; Zhang, Zhenhai/GRX-5887-2022; Alam, S. Munir/AAC-6711-2019; Mascola, John/AAI-7193-2021; Shapiro, Lawrence/AAE-7172-2019	Zhou, Tongqing/0000-0002-3935-4637; Zhang, Zhenhai/0000-0002-4310-0525; Moquin, Stephanie/0000-0002-8696-4315; Kelsoe, Garnett/0000-0002-8770-040X; Hraber, Peter/0000-0002-2920-4897; Kepler, Thomas/0000-0002-1383-6865; Korber, Bette/0000-0002-2026-5757; Hahn, Beatrice/0000-0002-9400-9887; Fire, Andrew/0000-0001-6217-8312; Gnanakaran, S/0000-0002-9368-3044	National Institutes of Allergy and Infectious Diseases (NIAID); intramural National Institutes of Health (NIH); NIH, NIAID [AI067854, AI100645]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, UM1AI100645, U01AI067854, ZIAAI005022, U19AI067854, ZIAAI005089] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); intramural National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Allergy and Infectious Diseases (NIAID) and by intramural National Institutes of Health (NIH) support for the NIAID Vaccine Research Center, by grants from the NIH, NIAID, AI067854 (the Center for HIV/AIDS Vaccine Immunology) and AI100645 (the Center for Vaccine Immunology-Immunogen Discovery). The authors thank J. Pritchett, H. Chen, D. Pause, M. Cooper, E. Solomon, J. Blinn, K. Yarborough, E. Friberg, M. Smith, A. Hogan, C. Peckels, A. Foulger and T. Jeffries for technical assistance, and J. Kircherr and C. Andrews for project management. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38. The opinions herein are those of the authors and should not be construed as official or representing the views of the US Department of Health and Human Services, National Institute for Allergy and Infectious Diseases.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2011, J VIROL, V85, P11725, DOI 10.1128/JVI.05680-11; Andre S, 1998, J VIROL, V72, P1497; Bai Y, 2007, ACTA CRYSTALLOGR F, V63, P135, DOI 10.1107/S1744309107002904; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Chen W., 2008, AIDS RES HUMAN RETRO, V24; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes Barton F., 2005, Human Antibodies, V14, P59; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Kabat EA, 1991, SEQUENCES PROTEINS I; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; Lutteke T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-69; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Ma BJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002200; Malherbe DC, 2011, J VIROL, V85, P5262, DOI 10.1128/JVI.02419-10; Mandel CR, 2006, ACTA CRYSTALLOGR F, V62, P1041, DOI 10.1107/S1744309106038152; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moir S, 2008, J INFECT DIS, V197, P572, DOI 10.1086/526789; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Moore PL, 2009, CURR OPIN HIV AIDS, V4, P358, DOI 10.1097/COH.0b013e32832ea7e8; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sattentau Quentin J, 2010, F1000 Biol Rep, V2, P60, DOI 10.3410/B2-60; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109; Stamatatos L, 2012, CURR OPIN IMMUNOL, V24, P316, DOI 10.1016/j.coi.2012.04.006; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wolinsky SM, 1996, SCIENCE, V274, P1010, DOI 10.1126/science.274.5289.1010; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zar JH, 1974, BIOSTATISTICAL ANAL; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	71	719	767	5	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					469	+		10.1038/nature12053	http://dx.doi.org/10.1038/nature12053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23552890	Green Submitted, Green Accepted			2022-12-28	WOS:000317984400034
J	Tang, WHW; Wang, ZE; Levison, BS; Koeth, RA; Britt, EB; Fu, XM; Wu, YP; Hazen, SL				Tang, W. H. Wilson; Wang, Zeneng; Levison, Bruce S.; Koeth, Robert A.; Britt, Earl B.; Fu, Xiaoming; Wu, Yuping; Hazen, Stanley L.			Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GUT MICROBIOTA; TRIMETHYLAMINE; ATHEROSCLEROSIS; MODULATION; ENZYMES; BOWEL; MOUSE; OXIDE	Background Recent studies in animals have shown a mechanistic link between intestinal microbial metabolism of the choline moiety in dietary phosphatidylcholine (lecithin) and coronary artery disease through the production of a proatherosclerotic metabolite, trimethylamine-N-oxide (TMAO). We investigated the relationship among intestinal microbiota-dependent metabolism of dietary phosphatidylcholine, TMAO levels, and adverse cardiovascular events in humans. Methods We quantified plasma and urinary levels of TMAO and plasma choline and betaine levels by means of liquid chromatography and online tandem mass spectrometry after a phosphatidylcholine challenge (ingestion of two hard-boiled eggs and deuterium [d9]-labeled phosphatidylcholine) in healthy participants before and after the suppression of intestinal microbiota with oral broad-spectrum antibiotics. We further examined the relationship between fasting plasma levels of TMAO and incident major adverse cardiovascular events (death, myocardial infarction, or stroke) during 3 years of follow-up in 4007 patients undergoing elective coronary angiography. Results Time-dependent increases in levels of both TMAO and its d9 isotopologue, as well as other choline metabolites, were detected after the phosphatidylcholine challenge. Plasma levels of TMAO were markedly suppressed after the administration of antibiotics and then reappeared after withdrawal of antibiotics. Increased plasma levels of TMAO were associated with an increased risk of a major adverse cardiovascular event (hazard ratio for highest vs. lowest TMAO quartile, 2.54; 95% confidence interval, 1.96 to 3.28; P<0.001). An elevated TMAO level predicted an increased risk of major adverse cardiovascular events after adjustment for traditional risk factors (P<0.001), as well as in lower-risk subgroups. Conclusions The production of TMAO from dietary phosphatidylcholine is dependent on metabolism by the intestinal microbiota. Increased TMAO levels are associated with an increased risk of incident major adverse cardiovascular events. (Funded by the National Institutes of Health and others.)	[Tang, W. H. Wilson; Wang, Zeneng; Levison, Bruce S.; Koeth, Robert A.; Britt, Earl B.; Fu, Xiaoming; Wu, Yuping; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Hazen, SL (corresponding author), Cleveland Clin, 9500 Euclid Ave NC 10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021; Wang, Zeneng/AAK-6119-2021; Tang, Wai Hong Wilson/I-1238-2013	Tang, W. H. Wilson/0000-0002-8335-735X; Levison, Bruce/0000-0002-1816-368X	National Institutes of Health [R01HL103866, 1P20HL113452, P01HL098055, P01HL076491, R01HL103931, R01DK080732]; Cleveland Clinic/Case Western Reserve University Clinical and Translational Science Award [UL1TR000439]; Leonard Krieger Fund; Center of Innovation by AB SCIEX; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113452, R01HL103931, R01HL103866, P01HL076491, P01HL098055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Clinic/Case Western Reserve University Clinical and Translational Science Award; Leonard Krieger Fund; Center of Innovation by AB SCIEX; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the National Institutes of Health and its Office of Dietary Supplements (R01HL103866 and 1P20HL113452). The clinical study GeneBank was supported by grants from the National Institutes of Health (P01HL098055, P01HL076491, R01HL103931, and R01DK080732) and a Cleveland Clinic/Case Western Reserve University Clinical and Translational Science Award (UL1TR000439). Dr. Hazen was supported by a gift from the Leonard Krieger Fund. Mass spectrometry instrumentation used was housed within the Cleveland Clinic Mass Spectrometry Facility with partial support through a Center of Innovation by AB SCIEX.	ALWAIZ M, 1987, TOXICOLOGY, V43, P117, DOI 10.1016/0300-483X(87)90001-1; ALWAIZ M, 1992, METABOLISM, V41, P135, DOI 10.1016/0026-0495(92)90140-6; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bain MA, 2005, CURR DRUG METAB, V6, P227, DOI 10.2174/1389200054021807; Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011; Cannon CP, 2005, NEW ENGL J MED, V352, P1646, DOI 10.1056/NEJMoa043528; DELAHUERGA J, 1951, J CLIN INVEST, V30, P463, DOI 10.1172/JCI102463; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Erdmann CC, 1910, J BIOL CHEM, V8, P57; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grayston JT, 2005, NEW ENGL J MED, V352, P1637, DOI 10.1056/NEJMoa043526; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; IHLE BU, 1984, CLIN NEPHROL, V22, P82; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Lang DH, 1998, BIOCHEM PHARMACOL, V56, P1005, DOI 10.1016/S0006-2952(98)00218-4; Loscalzo J, 2011, CIRC RES, V109, P127, DOI 10.1161/RES.0b013e3182290620; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; MOLLER B, 1986, ARCH MICROBIOL, V145, P85, DOI 10.1007/BF00413032; Patterson KY, 2008, USDA DATABASE CHOLIN; Pimentel M, 2011, NEW ENGL J MED, V364, P22, DOI 10.1056/NEJMoa1004409; SIMENHOFF ML, 1976, LANCET, V2, P818; Stella C, 2006, J PROTEOME RES, V5, P2780, DOI 10.1021/pr060265y; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yancey PH, 2004, CELL MOL BIOL, V50, P371; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zhang AQ, 1999, FOOD CHEM TOXICOL, V37, P515, DOI 10.1016/S0278-6915(99)00028-9	27	1909	2026	18	375	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1575	1584		10.1056/NEJMoa1109400	http://dx.doi.org/10.1056/NEJMoa1109400			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130YK	23614584	Green Accepted			2022-12-28	WOS:000317956300006
J	London, MJ; Hur, K; Schwartz, GG; Henderson, WG				London, Martin J.; Hur, Kwan; Schwartz, Gregory G.; Henderson, William G.			Association of Perioperative beta-Blockade With Mortality and Cardiovascular Morbidity Following Major Noncardiac Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VASCULAR-SURGERY; AMERICAN-COLLEGE; OUTCOMES; RISK; QUALITY; CARE; GUIDELINES; THERAPY; PROGRAM; IMPACT	Importance The effectiveness of perioperative beta-blockade in patients undergoing noncardiac surgery remains controversial. Objective To determine the associations of early perioperative exposure to beta-blockers with 30-day postoperative outcome in patients undergoing noncardiac surgery. Design, Setting, and Patients A retrospective cohort analysis evaluating exposure to beta-blockers on the day of or following major noncardiac surgery among a population-based sample of 136 745 patients who were 1: 1 matched on propensity scores (37 805 matched pairs) treated at 104 VA medical centers from January 2005 through August 2010. Main Outcomes and Measures All cause 30-day mortality and cardiac morbidity (cardiac arrest or Q-wave myocardial infarction). Results Overall 55 138 patients (40.3%) were exposed to beta-blockers. Exposure was higher in the 66.7% of 13 863 patients undergoing vascular surgery (95% CI, 65.9%-67.5%) than in the 37.4% of 122 882 patients undergoing nonvascular surgery (95% CI, 37.1%-37.6%; P<.001). Exposure increased as Revised Cardiac Risk Index factors increased, with 25.3% (95% CI, 24.9%-25.6%) of those with no risk vs 71.3% (95% CI, 69.5%-73.2%) of those with 4 risk factors or more exposed to beta-blockers (P<.001). Death occurred among 1.1% (95% CI, 1.1%-1.2%) and cardiac morbidity occurred among 0.9% (95% CI, 0.8%-0.9%) of patients. In the propensity matched cohort, exposure was associated with lower mortality (relative risk [RR], 0.73; 95% CI, 0.65-0.83; P<.001; number need to treat [NNT], 241; 95% CI, 173-397). When stratified by cumulative numbers of Revised Cardiac Risk Index factors, beta-blocker exposure was associated with significantly lower mortality among patients with 2 factors (RR, 0.63 [95% CI, 0.50-0.80]; P<.001; NNT, 105 [95% CI, 69-212]), 3 factors (RR, 0.54 [95% CI, 0.39-0.73]; P<.001; NNT, 41 [95% CI, 28-80]), or 4 factors or more (RR, 0.40 [95% CI, 0.25-0.73]; P<.001; NNT, 18 [95% CI, 12-34]). This association was limited to patients undergoing nonvascular surgery. beta-Blocker exposure was also associated with a lower rate of nonfatal Q-wave infarction or cardiac arrest (RR, 0.67 [95% CI, 0.57-0.79]; P<.001; NNT, 339 [95% CI, 240-582]), again limited to patients undergoing nonvascular surgery. Conclusions and Relevance Among propensity-matched patients undergoing noncardiac, nonvascular surgery, perioperative beta-blocker exposure was associated with lower rates of 30-day all-cause mortality in patients with 2 or more Revised Cardiac Risk Index factors. Our findings support use of a cumulative number of Revised Cardiac Risk Index predictors in decision making regarding institution and continuation of perioperative beta-blockade. A multicenter randomized trial involving patients at a low to intermediate risk by these factors would be of interest to validate these observational findings. JAMA. 0;0(16):1704-1713 www.jama.com	[London, Martin J.] US Dept Vet Affairs Med Ctr, Dept Anesthesia & Perioperat Care, San Francisco, CA USA; [London, Martin J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hur, Kwan] US Dept Vet Affairs Med Ctr, Ctr Medicat Safety, Pharm Benefits Management Serv, Hines, IL USA; [Schwartz, Gregory G.] US Dept Vet Affairs Med Ctr, Cardiol Sect, Denver, CO USA; [Schwartz, Gregory G.] Univ Colorado, Denver, CO 80202 USA; [Henderson, William G.] Colorado Sch Publ Hlth, Hlth Outcomes Program, Aurora, CO USA; [Henderson, William G.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA	University of California System; University of California San Francisco; University of Colorado System; University of Colorado Denver; Colorado School of Public Health; Colorado School of Public Health	London, MJ (corresponding author), San Francisco VA Med Ctr, Dept Anesthesia & Perioperat Care, 4150 Clement St, San Francisco, CA 94121 USA.	londonm@anesthesia.ucsf.edu			Anesthesia Patient Safety Foundation	Anesthesia Patient Safety Foundation	This study was supported by a grant from the Anesthesia Patient Safety Foundation.	Agresti A, 2004, STAT MED, V23, P65, DOI 10.1002/sim.1589; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Badgett RG, 2010, ANESTHESIOLOGY, V113, P585, DOI 10.1097/ALN.0b013e3181e73eea; Bangalore S, 2012, JAMA-J AM MED ASSOC, V308, P1340, DOI 10.1001/jama.2012.12559; Bangalore S, 2008, LANCET, V372, P1962, DOI 10.1016/S0140-6736(08)61560-3; Bateman BT, 2009, ANESTHESIOLOGY, V110, P231, DOI 10.1097/ALN.0b013e318194b5ff; Bertges DJ, 2010, J VASC SURG, V52, P674, DOI 10.1016/j.jvs.2010.03.031; Davenport DL, 2007, J AM COLL SURGEONS, V204, P1199, DOI 10.1016/j.jamcollsurg.2007.02.065; Davis CL, 2007, J AM COLL SURGEONS, V204, P550, DOI 10.1016/j.jamcollsurg.2007.01.012; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2012, JAMA-J AM MED ASSOC, V307, P2295, DOI 10.1001/jama.2012.5502; Ellenberger C, 2011, ANESTHESIOLOGY, V114, P817, DOI 10.1097/ALN.0b013e31820fca0b; Fleisher LA, 2009, CIRCULATION, V120, pE169, DOI 10.1161/CIRCULATIONAHA.109.192690; Flu WJ, 2010, J AM COLL CARDIOL, V56, P1922, DOI 10.1016/j.jacc.2010.05.056; Hamel MB, 2005, J AM GERIATR SOC, V53, P424, DOI 10.1111/j.1532-5415.2005.53159.x; Hamilton BH, 2010, J AM COLL SURGEONS, V210, P125, DOI 10.1016/j.jamcollsurg.2009.10.021; Hammill BG, 2008, ANESTHESIOLOGY, V108, P559, DOI 10.1097/ALN.0b013e31816725ef; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Kwon S, 2012, ARCH SURG-CHICAGO, V147, P467, DOI 10.1001/archsurg.2011.1698; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Levy M, 2011, ANESTHESIOLOGY, V114, P796, DOI 10.1097/ALN.0b013e31820ad503; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Maynard C, 2004, DIABETES CARE, V27, pB22, DOI 10.2337/diacare.27.suppl_2.B22; Poldermans D, 2006, J AM COLL CARDIOL, V48, P964, DOI 10.1016/j.jacc.2006.03.059; Poldermans D, 2009, ANESTHESIOLOGY, V111, P940, DOI 10.1097/ALN.0b013e3181ba3bf4; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sales MM, 2005, AM J MANAG CARE, V11, P104; Smith MW, 2003, MED CARE RES REV, V60, p92S, DOI 10.1177/1077558703256726; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; van Klei WA, 2009, ANESTHESIOLOGY, V111, P717, DOI 10.1097/ALN.0b013e3181b6a761; Wallace AW, 2010, ANESTHESIOLOGY, V113, P794, DOI 10.1097/ALN.0b013e3181f1c061; Wijeysundera DN, 2012, CIRC-CARDIOVASC QUAL, V5, P558, DOI 10.1161/CIRCOUTCOMES.112.965632; Wu WC, 2007, JAMA-J AM MED ASSOC, V297, P2481, DOI 10.1001/jama.297.22.2481	37	153	154	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1704	1713		10.1001/jama.2013.4135	http://dx.doi.org/10.1001/jama.2013.4135			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130IG	23613075	Bronze			2022-12-28	WOS:000317906700027
J	Weiss, KB; Bagian, JP; Nasca, TJ				Weiss, Kevin B.; Bagian, James P.; Nasca, Thomas J.			The Clinical Learning Environment The Foundation of Graduate Medical Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Weiss, Kevin B.] Inst Accreditat, Chicago, IL USA; [Weiss, Kevin B.; Bagian, James P.] Clin Learning Environm Review Comm, Chicago, IL USA; [Nasca, Thomas J.] Accreditat Council Grad Med Educ, Chicago, IL USA; [Bagian, James P.] Univ Michigan, Ctr Healthcare Engn & Patient Safety, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Weiss, KB (corresponding author), Accreditat Council Grad Med Educ, Inst Accreditat, 20th Floor,515 N State St, Chicago, IL 60654 USA.	kweiss@acgme.org		Bagian, James/0000-0003-1792-6099				Combes JR, 2012, LIFELONG LEARNING PH; *I MED COMM QUAL H, 2000, ERR IS HUM BUILD SAF; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Nasca TJ, 2012, NEW ENGL J MED, V366, P1051, DOI 10.1056/NEJMsr1200117; Weiss Kevin B, 2012, J Grad Med Educ, V4, P396, DOI 10.4300/JGME-04-03-31	5	82	83	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1687	1688		10.1001/jama.2013.1931	http://dx.doi.org/10.1001/jama.2013.1931			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130IG	23613072				2022-12-28	WOS:000317906700021
J	Bhutta, ZA; Das, JK; Walker, N; Rizvi, A; Campbell, H; Rudan, I; Black, RE				Bhutta, Zulfiqar A.; Das, Jai K.; Walker, Neff; Rizvi, Arjumand; Campbell, Harry; Rudan, Igor; Black, Robert E.		Lancet Diarrhoea Pneumonia Interve	Childhood Pneumonia and Diarrhoea 2 Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost?	LANCET			English	Article							HEALTH RESEARCH INVESTMENTS; MIDDLE-INCOME COUNTRIES; SETTING PRIORITIES; ROTAVIRUS VACCINE; DOUBLE-BLIND; ECONOMIC-BENEFITS; ORAL REHYDRATION; CASE-MANAGEMENT; NALIDIXIC-ACID; MORTALITY	Global mortality in children younger than 5 years has fallen substantially in the past two decades from more than 12 million in 1990, to 6.9 million in 2011, but progress is inconsistent between countries. Pneumonia and diarrhoea are the two leading causes of death in this age group and have overlapping risk factors. Several interventions can effectively address these problems, but are not available to those in need. We systematically reviewed evidence showing the effectiveness of various potential preventive and therapeutic interventions against childhood diarrhoea and pneumonia, and relevant delivery strategies. We used the Lives Saved Tool model to assess the effect on mortality when these interventions are applied. We estimate that if implemented at present annual rates of increase in each of the 75 Countdown countries, these interventions and packages of care could save 54% of diarrhoea and 51% of pneumonia deaths by 2025 at a cost of US$3.8 billion. However, if coverage of these key evidence-based interventions were scaled up to at least 80%, and that for immunisations to at least 90%, 95% of diarrhoea and 67% of pneumonia deaths in children younger than 5 years could be eliminated by 2025 at a cost of $6.715 billion. New delivery platforms could promote equitable access and community platforms are important catalysts in this respect. Furthermore, several of these interventions could reduce morbidity and overall burden of disease, with possible benefits for developmental outcomes.	[Bhutta, Zulfiqar A.; Das, Jai K.; Rizvi, Arjumand] Aga Khan Univ, Div Woman & Child Hlth, Karachi 74800, Pakistan; [Bhutta, Zulfiqar A.; Walker, Neff; Black, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Campbell, Harry; Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	Aga Khan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Edinburgh	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Woman & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu	Rudan, Igor/I-1467-2012; Campbell, Harry/E-2959-2010	Rudan, Igor/0000-0001-6993-6884; Campbell, Harry/0000-0002-6169-6262; Das, Jai/0000-0002-2966-7162; Black, Robert/0000-0001-9926-7984	Bill & Melinda Gates Foundation; Bloomberg School of Public Health; Johns Hopkins University, Boston; University School of Public Health; Program for Global Pediatric Research, Hospital for Sick Children, Toronto	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Bloomberg School of Public Health; Johns Hopkins University, Boston; University School of Public Health; Program for Global Pediatric Research, Hospital for Sick Children, Toronto	Funding was provided by an unrestricted grant from the Bill & Melinda Gates Foundation to Aga Khan University and to collaborating universities and institutions (Bloomberg School of Public Health, Johns Hopkins University, Boston; University School of Public Health and Program for Global Pediatric Research, Hospital for Sick Children, Toronto). The funding source had no role or control over the content and process of development of these papers, or in drafting of the report. The views expressed in this report are solely those of the authors. We thank Yvonne Tam (Johns Hopkins University) for assisting with LiST modelling, Margaret Manley (Program for Global Pediatric Research, Toronto), and Asghar Ali (Aga Khan University, Karachi) for administrative support.	Addo-Yobo E, 2011, TROP MED INT HEALTH, V16, P995, DOI 10.1111/j.1365-3156.2011.02787.x; ALAM AN, 1994, SCAND J GASTROENTERO, V29, P313, DOI 10.3109/00365529409094842; Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Amadi B, 2002, LANCET, V360, P1375, DOI 10.1016/S0140-6736(02)11401-2; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P451; [Anonymous], 2001, Indian Pediatr, V38, P565; [Anonymous], LEV TRENDS CHILD MOR; [Anonymous], 2012, BUILDING FUTURE WOME; [Anonymous], 2009, DIARRH WHY CHILDR AR; Applegate JA, BMCPH IN PRESS; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; Bassani DG, BMCPH IN PRESS; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Bhutta Z.A., 2008, LANCET, V371, P417, DOI [10.1016/S0140-6736(07)61693-6, DOI 10.1016/S0140-6736(07)61693-6]; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2008, MATERN CHILD NUTR, V4, P1, DOI 10.1111/j.1740-8709.2007.00132.x; Bhutta ZA, 2008, BMJ-BRIT MED J, V336, P948, DOI 10.1136/bmj.39520.680718.94; Bhutta ZA, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010302; Bhutta ZA, 2009, PEDIATR INFECT DIS J, V28, pS22, DOI 10.1097/INF.0b013e31819588ac; Bruce N, BMCPH IN PRESS; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Chandani Y, 2012, AM J TROP MED HYG, V87, P120, DOI 10.4269/ajtmh.2012.11-0781; CHATTERJEE A, 1978, ARCH DIS CHILD, V53, P284, DOI 10.1136/adc.53.4.284; Chopra M, 2012, LANCET, V380, P1331, DOI 10.1016/S0140-6736(12)61423-8; Cunliffe NA, 2012, VACCINE, V30, pA36, DOI 10.1016/j.vaccine.2011.09.120; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Das JK, BMCPH IN PRESS; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Feng Xing Lin, 2012, J Glob Health, V2, P010405, DOI 10.7189/jogh.02.010405; Fischer Walker CL, 2012, BMC PUBLIC HEALTH, V12, P220, DOI DOI 10.1186/1471-2458-12-220; Fischer Walker CL, 2013, LANCET; Fontaine O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000041; Gaffey MF, BMCPH IN PRESS; Gu B, 2012, INT J ANTIMICROB AG, V40, P9, DOI 10.1016/j.ijantimicag.2012.02.005; Haider BA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005976.pub2; Haroon S, BMCPH IN PRESS; Imdad A, 2013, J PEDIATR-US, V162, pS107, DOI 10.1016/j.jpeds.2012.11.060; International Health Partnership, 2013, ONEHEALTH TOOL; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kabir I, 1996, J DIARRHOEAL DIS RES, V14, P243; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kosek M, 2009, J HEALTH POPUL NUTR, V27, P319; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; Lassi ZS, 2012, J DEV EFFECT, V4, P151, DOI 10.1080/19439342.2012.655911; Lenters LM, BMCPH IN PRESS; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Munos MK, 2010, INT J EPIDEMIOL, V39, P56, DOI 10.1093/ije/dyq022; Nair H, 2013, LANCET; Noriega FR, 1999, INFECT IMMUN, V67, P782, DOI 10.1128/IAI.67.2.782-788.1999; Ozawa S, 2012, VACCINE, V31, P96, DOI 10.1016/j.vaccine.2012.10.103; Ozawa S, 2011, HEALTH AFFAIR, V30, P1010, DOI 10.1377/hlthaff.2011.0381; Pun SB, 2011, EMERG INFECT DIS, V17, P2178, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Punpanich W, 2011, PEDIATR INFECT DIS J, V30, pE192, DOI 10.1097/INF.0b013e31822d989c; Rossignol JFA, 2001, J INFECT DIS, V184, P103, DOI 10.1086/321008; Roy SK, 1998, T ROY SOC TROP MED H, V92, P460, DOI 10.1016/S0035-9203(98)91094-X; Rudan I, 2008, CROAT MED J, V49, P307, DOI 10.3325/cmj.2008.3.307; Rudan I, 2007, CROAT MED J, V48, P595; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; Rudan I, 2008, CROAT MED J, V49, P720, DOI 10.3325/cmj.2008.49.720; Salam MA, 1998, LANCET, V352, P522, DOI 10.1016/S0140-6736(97)11457-X; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Sow SO, 2012, VACCINE, V30, pA71, DOI 10.1016/j.vaccine.2011.11.094; Stack ML, 2011, HEALTH AFFAIR, V30, P1021, DOI 10.1377/hlthaff.2011.0382; Sudfeld CR, 2010, INT J EPIDEMIOL, V39, P48, DOI 10.1093/ije/dyq021; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P155, DOI 10.1093/ije/dyq032; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; Thompson LM, 2011, ENVIRON HEALTH PERSP, V119, P1489, DOI 10.1289/ehp.1002928; Traa BS, 2010, INT J EPIDEMIOL, V39, P70, DOI 10.1093/ije/dyq024; United Nations Children's Fund (UNICEF), 2012, PNEUM DIARRH TACKL D; VandeVerg LL, 1996, VACCINE, V14, P1062, DOI 10.1016/0264-410X(96)00006-0; VARSANO I, 1991, J PEDIATR-US, V118, P627, DOI 10.1016/S0022-3476(05)83392-X; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Waddington H., 2009, WATER SANITATION HYG; Walker CLF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000428; Walker CLF, 2010, INT J EPIDEMIOL, V39, P63, DOI 10.1093/ije/dyq023; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; Wazny K, PLOS MED IN PRESS; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; WHO, GUID HIV INF FEED 20; WITTENBERG DF, 1989, J INFECT DIS, V159, P131, DOI 10.1093/infdis/159.1.131; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S23; Zaidi AKM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S13; ZIMBASA Dysentery Study Grp, 2002, PEDIATR INFECT DIS J, V21, P1136, DOI [10.1097/00006454-200212000-00010, 10.1097/01.inf.0000040824.83814.a9]	87	312	315	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1417	1429		10.1016/S0140-6736(13)60648-0	http://dx.doi.org/10.1016/S0140-6736(13)60648-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130EF	23582723				2022-12-28	WOS:000317894800039
J	Ali, H; Donovan, B; Wand, H; Read, TRH; Regan, DG; Grulich, AE; Fairley, CK; Guy, RJ				Ali, Hammad; Donovan, Basil; Wand, Handan; Read, Tim R. H.; Regan, David G.; Grulich, Andrew E.; Fairley, Christopher K.; Guy, Rebecca J.			Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HPV VACCINATION; COVERAGE; TRANSMISSION; ADOLESCENT; TYPE-16; WOMEN; BOYS	Objective To measure the effect on genital warts of the national human papillomavirus vaccination programme in Australia, which started in mid-2007. Design Trend analysis of national surveillance data. Setting Data collated from eight sexual health services from 2004 to 2011; the two largest clinics also collected self reported human papillomavirus vaccination status from 2009. Participants Between 2004 and 2011, 85 770 Australian born patients were seen for the first time; 7686 (9.0%) were found to have genital warts. Main outcome measure Rate ratios comparing trends in proportion of new patients diagnosed as having genital warts in the pre-vaccination period (2004 to mid-2007) and vaccination period (mid-2007 to the end of 2011). Results Large declines occurred in the proportions of under 21 year old (92.6%) and 21-30 year old (72.6%) women diagnosed as having genital warts in the vaccination period-from 11.5% in 2007 to 0.85% in 2011 (P<0.001) and from 11.3% in 2007 to 3.1% in 2011 (P<0.001), respectively. No significant decline in wart diagnoses was seen in women over 30 years of age. Significant declines occurred in proportions of under 21 year old (81.8%) and 21-30 year old (51.1%) heterosexual men diagnosed as having genital warts in the vaccination period-from 12.1% in 2007 to 2.2% in 2011 (P<0.001) and from 18.2% in 2007 to 8.9% in 2011 (P<0.001), respectively. No significant decline in genital wart diagnoses was seen in heterosexual men over 30 years of age. In 2011 no genital wart diagnoses were made among 235 women under 21 years of age who reported prior human papillomavirus vaccination. Conclusions The significant declines in the proportion of young women found to have genital warts and the absence of genital warts in vaccinated women in 2011 suggests that the human papillomavirus vaccine has a high efficacy outside of the trial setting. Large declines in diagnoses of genital warts in heterosexual men are probably due to herd immunity.	[Ali, Hammad; Donovan, Basil; Wand, Handan; Regan, David G.; Grulich, Andrew E.; Guy, Rebecca J.] Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia; [Donovan, Basil] Sydney Hosp, Sydney Sexual Hlth Ctr, Sydney, NSW 2000, Australia; [Read, Tim R. H.; Fairley, Christopher K.] Melbourne Sexual Hlth Ctr, Carlton, Vic 3053, Australia; [Read, Tim R. H.; Fairley, Christopher K.] Univ Melbourne, Sch Populat Hlth, Parkville, Vic 3010, Australia	University of New South Wales Sydney; Kirby Institute; University of Melbourne	Donovan, B (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia.	bdonovan@kirby.unsw.edu.au	Donovan, Basil J/K-1246-2012	Donovan, Basil J/0000-0001-8851-4126; Guy, Rebecca/0000-0002-2929-4634; Christopher, Fairley/0000-0001-9081-1664	CSL Biotherapies	CSL Biotherapies	CSL Biotherapies funded the surveillance network but had no role in study design; data collection, analysis, or interpretation; or writing the report. Only the Kirby Institute had access to the study data, and the authors had sole responsibility of decision for publication.	Australian Government Department of Health and Ageing, 2012, FACT SHEET NAT IMM P; Ball SLR, 2011, J MED VIROL, V83, P1345, DOI 10.1002/jmv.22111; Bauer HM, 2012, AM J PUBLIC HEALTH, V102, P833, DOI 10.2105/AJPH.2011.300465; Brill D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f924; Brotherton J, 2011, COMMUN DIS INTELL, V35, P197; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Brotherton JML, 2008, COMMUN DIS INTELL, V32, P457; Burchell AN, 2006, VACCINE, V24, P52, DOI 10.1016/j.vaccine.2006.05.031; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Dowdle WJ., 1999, MMWR MORB MORTAL S1, V48, P23; Forster AS, 2012, VACCINE, V30, P4505, DOI 10.1016/j.vaccine.2012.04.066; Garland SM, 2011, PREV MED, V53, pS29, DOI 10.1016/j.ypmed.2011.08.015; Garnett GP, 2005, J INFECT DIS, V191, pS97, DOI 10.1086/425271; Gertig DM, 2011, SEX HEALTH, V8, P171, DOI 10.1071/SH10001; Leval A, 2012, J INFECT DIS, V206, P860, DOI 10.1093/infdis/jis405; Oliphant J, 2011, NEW ZEAL MED J, V124, P51; Olsson SE, 2007, VACCINE, V25, P4931, DOI 10.1016/j.vaccine.2007.03.049; Pedrana A, 2012, SEX TRANSM DIS, V39, P651, DOI 10.1097/OLQ.0b013e318255df06; Regan DG, 2007, SEX HEALTH, V4, P147, DOI 10.1071/SH07042; Ryder N, 2011, INT J STD AIDS, V22, P335, DOI 10.1258/ijsa.2010.010458; The Hon Tanya Plibersek MP Minister for Health Australia, 2012, HPV VACCINE EXTENDED; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7	22	290	301	1	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2013	346								f2032	10.1136/bmj.f2032	http://dx.doi.org/10.1136/bmj.f2032			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131AZ	23599298	Green Submitted, hybrid			2022-12-28	WOS:000317964200001
J	Vieira-Pires, RS; Szollosi, A; Morais-Cabral, JH				Vieira-Pires, Ricardo S.; Szollosi, Andras; Morais-Cabral, Joao H.			The structure of the KtrAB potassium transporter	NATURE			English	Article							K+-UPTAKE SYSTEM; CRYSTAL-STRUCTURE; GLYCINE RESIDUES; GATING RING; CHANNEL; SELECTIVITY; MECHANISM; ADAPTATION; PCC-6803; COMPLEX	In bacteria, archaea, fungi and plants the Trk, Ktr and HKT ion transporters are key components of osmotic regulation, pH homeostasis and resistance to drought and high salinity. These ion transporters are functionally diverse: they can function as Na+ or K+ channels and possibly as cation/K+ symporters. They are closely related to potassium channels both at the level of the membrane protein and at the level of the cytosolic regulatory domains. Here we describe the crystal structure of a Ktr K+ transporter, the KtrAB complex from Bacillus subtilis. The structure shows the dimeric membrane protein KtrB assembled with a cytosolic octameric KtrA ring bound to ATP, an activating ligand. A comparison between the structure of KtrAB-ATP and the structures of the isolated full-length KtrA protein with ATP or ADP reveals a ligand-dependent conformational change in the octameric ring, raising new ideas about the mechanism of activation in these transporters.	[Vieira-Pires, Ricardo S.; Szollosi, Andras; Morais-Cabral, Joao H.] Univ Porto, IBMC, P-4150180 Oporto, Portugal	Universidade do Porto	Morais-Cabral, JH (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	jcabral@ibmc.up.pt	Morais-Cabral, Joao H/J-4914-2013; Vieira-Pires, Ricardo/J-5232-2013; Szollosi, Andras/J-5097-2013; Szollosi, Andras/P-4278-2019	Morais-Cabral, Joao H/0000-0002-4461-9716; Vieira-Pires, Ricardo/0000-0003-1830-3715; Szollosi, Andras/0000-0002-5570-4609	FEBS; EMBO; FEDER funds through the Operational Competitiveness Program-COMPETE; FCT-Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-022718 (PEst-C/SAU/LA0002/2011), FCOMP-01-0124-FEDER-009028 (PTDC/BIA-PRO/099861/2008) FCOMP-01-0124-FEDER-010781 (PTDC/QUI-BIQ/105342/2008)]; Fundação para a Ciência e a Tecnologia [PTDC/QUI-BIQ/105342/2008, PTDC/BIA-PRO/099861/2008] Funding Source: FCT	FEBS; EMBO(European Molecular Biology Organization (EMBO)); FEDER funds through the Operational Competitiveness Program-COMPETE; FCT-Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	We are grateful for access to ID14-1/ID14-4/ID-29 at ESRF (through the Portuguese BAG), PXII at SLS, XRD1 at ELETTRA and PROXIMA1 at SOLEIL and thank the respective support staff. A.S. was supported by FEBS (Long term fellowship). This work was funded by EMBO (Installation grant), by FEDER funds through the Operational Competitiveness Program-COMPETE and by National Funds through FCT-Fundacao para a Ciencia e a Tecnologia under the projects FCOMP-01-0124-FEDER-022718 (PEst-C/SAU/LA0002/2011), FCOMP-01-0124-FEDER-009028 (PTDC/BIA-PRO/099861/2008) and FCOMP-01-0124-FEDER-010781 (PTDC/QUI-BIQ/105342/2008). We also thank G. Gabant and M. Cadene at the 'Plateforme de Spectrometrie de Masse' at CBM, CNRS, Orleans for mass spectrometry analysis, and C. Harley for critical reading of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albright RA, 2007, J BIOL CHEM, V282, P35046, DOI 10.1074/jbc.M704260200; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; Berry S, 2003, FEBS LETT, V548, P53, DOI 10.1016/S0014-5793(03)00729-4; Cao Y, 2011, NATURE, V471, P336, DOI 10.1038/nature09731; Corratge-Faillie C, 2010, CELL MOL LIFE SCI, V67, P2511, DOI 10.1007/s00018-010-0317-7; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 1999, BIOPHYS J, V77, P775, DOI 10.1016/S0006-3495(99)76931-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hanelt I, 2011, EUR J CELL BIOL, V90, P696, DOI 10.1016/j.ejcb.2011.04.010; Hanelt I, 2010, J BIOL CHEM, V285, P10318, DOI 10.1074/jbc.M109.089870; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Hilf RJC, 2009, CURR OPIN STRUC BIOL, V19, P418, DOI 10.1016/j.sbi.2009.07.006; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Kroning N, 2007, J BIOL CHEM, V282, P14018, DOI 10.1074/jbc.M609084200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; Nimigean CM, 2006, NAT PROTOC, V1, P1207, DOI 10.1038/nprot.2006.166; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; Trudeau MC, 2012, J GEN PHYSIOL, V140, P457, DOI 10.1085/jgp.201210898; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414	42	82	83	2	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					323	+		10.1038/nature12055	http://dx.doi.org/10.1038/nature12055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23598340	Green Submitted			2022-12-28	WOS:000317599200029
J	Smith, R				Smith, Richard			Memories of Thatcher	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												richardswsmith@yahoo.co.uk						1989, BMJ, V298, P619	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2013	346								f2434	10.1136/bmj.f2434	http://dx.doi.org/10.1136/bmj.f2434			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AT	23596229				2022-12-28	WOS:000317963400013
J	Kiely, DG; Elliot, CA; Sabroe, I; Condliffe, R				Kiely, David G.; Elliot, Charlie A.; Sabroe, Ian; Condliffe, Robin			Pulmonary hypertension: diagnosis and management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CALCIUM-CHANNEL BLOCKERS; 6-MINUTE WALK TEST; ARTERIAL-HYPERTENSION; ECHOCARDIOGRAPHIC-ASSESSMENT; ORAL TREPROSTINIL; EJECTION FRACTION; HEART-FAILURE; DOUBLE-BLIND; THERAPY; SURVIVAL		[Kiely, David G.; Elliot, Charlie A.; Sabroe, Ian; Condliffe, Robin] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Pulm Vasc Dis Unit, Natl Pulm Hypertens Serv Sheffield, Sheffield S10 2JF, S Yorkshire, England; [Sabroe, Ian] Univ Sheffield, Sch Med, Fac Med Dent & Hlth, Acad Unit Resp Med,Dept Infect & Immun, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Kiely, DG (corresponding author), Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Pulm Vasc Dis Unit, Natl Pulm Hypertens Serv Sheffield, Sheffield S10 2JF, S Yorkshire, England.	david.kiely@sth.nhs.uk	Sabroe, Ian/I-5981-2013; Sabroe, Ian/AAE-5858-2019	Sabroe, Ian/0000-0001-9750-8975; Condliffe, Robin/0000-0002-3492-4143	Actelion; Bayer; Pfizer; United Therapeutics; Lily; GSK	Actelion; Bayer(Bayer AG); Pfizer(Pfizer); United Therapeutics; Lily; GSK(GlaxoSmithKline)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; DGK has received speaker fees, attended advisory boards, and received funding to attend meetings from Actelion, Bayer, Pfizer, United Therapeutics, Lily, and GSK; CAE has received speaker fees and attended advisory boards for Actelion, Bayer, and GSK; IS has received travel funding from Actelion and GSK; RC has received speaker fees from Actelion and GSK and has attended advisory boards for Actelion, Bayer, and GSK. The department has received funding for research and education through unrestricted grants from Actelion, Bayer, and Pfizer.	Arcasoy SM, 2003, AM J RESP CRIT CARE, V167, P735, DOI 10.1164/rccm.200210-1130OC; Armstrong I, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000806; Avouac J, 2010, J RHEUMATOL, V37, P2290, DOI 10.3899/jrheum.100245; Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Barst RJ, 2003, J AM COLL CARDIOL, V41, P2119, DOI 10.1016/S0735-1097(03)00463-7; Bedard E, 2009, EUR HEART J, V30, P256, DOI 10.1093/eurheartj/ehn597; Bonderman D, 2002, CIRCULATION, V105, P265, DOI 10.1161/hc0202.100239; Castro M, 1996, MAYO CLIN PROC, V71, P543, DOI 10.4065/71.6.543; Christie JD, 2012, J HEART LUNG TRANSPL; Colle IO, 2003, HEPATOLOGY, V37, P401, DOI 10.1053/jhep.2003.50060; Condliffe R, 2008, AM J RESP CRIT CARE, V177, P1122, DOI 10.1164/rccm.200712-1841OC; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Damy T, 2010, EUR HEART J, V31, P2280, DOI 10.1093/eurheartj/ehq245; Fessel Joshua P, 2011, Pulm Circ, V1, P305, DOI 10.4103/2045-8932.87293; Frank H, 1997, CHEST, V112, P714, DOI 10.1378/chest.112.3.714; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510; Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274; Gatzoulis MA, 2009, EUR RESPIR REV, V18, P154, DOI 10.1183/09059180.00003309; Ghofrani HA, 2012, CHEST, V142, P1027; Ghofrani HA, 2012, CHEST, V142, p1023A; Guazzi M, 2012, EUR RESPIR REV, V21, P338, DOI 10.1183/09059180.00004612; HADENGUE A, 1991, GASTROENTEROLOGY, V100, P520, DOI 10.1016/0016-5085(91)90225-A; Hatano S, 1975, WHO M OCT 15 17; Hiremath J, 2010, J HEART LUNG TRANSPL, V29, P137, DOI 10.1016/j.healun.2009.09.005; Hoeper MM, 2013, CIRCULATION, V127, P1128, DOI 10.1161/CIRCULATIONAHA.112.000765; Hoeper MM, 2005, EUR RESPIR J, V26, P858, DOI 10.1183/09031936.05.00075305; Howard LS, 2012, EUR RESPIR REV, V21, P239, DOI 10.1183/09059180.00003912; Humbert M, 2007, EUR RESPIR J, V30, P338, DOI 10.1183/09031936.00138706; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Hurdman J, 2012, EUR RESPIR J, V39, P945, DOI 10.1183/09031936.00078411; Jing ZC, 2013, CIRCULATION, V127, P624, DOI 10.1161/CIRCULATIONAHA.112.124388; Johnson SR, 2006, EUR RESPIR J, V28, P999, DOI 10.1183/09031936.06.00015206; Kalogeropoulos Andreas P, 2011, Congest Heart Fail, V17, P189, DOI 10.1111/j.1751-7133.2011.00234.x; Keogh AM, 2009, J AM COLL CARDIOL, V54, pS67, DOI 10.1016/j.jacc.2009.04.016; Kiely DG, 2010, BJOG-INT J OBSTET GY, V117, P565, DOI 10.1111/j.1471-0528.2009.02492.x; Klok FA, 2010, HAEMATOL-HEMATOL J, V95, P970, DOI 10.3324/haematol.2009.018960; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC; McLaughlin VV, 2010, J AM COLL CARDIOL, V55, P1915, DOI 10.1016/j.jacc.2010.01.027; Mereles D, 2006, CIRCULATION, V114, P1482, DOI 10.1161/CIRCULATIONAHA.106.618397; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Mizoguchi H, 2012, CIRC-CARDIOVASC INTE, V5, P748, DOI 10.1161/CIRCINTERVENTIONS.112.971077; Nagaya N, 2000, CIRCULATION, V102, P865; Nickel N, 2012, EUR RESPIR J, V39, P589, DOI 10.1183/09031936.00092311; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Paciocco G, 2001, EUR RESPIR J, V17, P647, DOI 10.1183/09031936.01.17406470; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Peacock AJ, 2007, EUR RESPIR J, V30, P104, DOI 10.1183/09031936.00092306; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Rajaram S, 2013, THORAX; Rajaram S, 2012, EUR RADIOL, V22, P310, DOI 10.1007/s00330-011-2252-x; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; RICH S, 1992, NEW ENGL J MED, V327, P76, DOI 10.1056/NEJM199207093270203; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Rubin LJ, 2012, CHEST, V142, p1026A; Sandoval J, EUR RESP J, V38, P1343; Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/ajrccm.165.6.2106079; Simonneau G, 2012, EUR RESPIR J, V40, P874, DOI 10.1183/09031936.00137511; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sitbon O, 2005, CIRCULATION, V111, P3105, DOI 10.1161/CIRCULATIONAHA.104.488486; Sitbon O, 2008, AM J RESP CRIT CARE, V177, P108, DOI 10.1164/rccm.200704-541OC; Stewart DJ, 2004, CIRCULATION, V109, pE172, DOI 10.1161/01.CIR.0000121684.52920.0E; Sun CG, 2003, J AM COLL CARDIOL, V41, P1028, DOI 10.1016/S0735-1097(02)02964-9; Swift AJ, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-40; Tapson V, 2013, CHEST IN PRESS; Tapson VE, 2012, CHEST, V142, P1383, DOI 10.1378/chest.11-2212; Thabut G, 2005, CHEST, V127, P1531, DOI 10.1378/chest.127.5.1531; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Tongers J, 2007, AM HEART J, V153, P127, DOI 10.1016/j.ahj.2006.09.008; Tunariu N, 2007, J NUCL MED, V48, P680, DOI 10.2967/jnumed.106.039438; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; Wensel R, 2002, CIRCULATION, V106, P319, DOI 10.1161/01.CIR.0000022687.18568.2A; WORSLEY DF, 1994, J NUCL MED, V35, P793	77	82	85	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2013	346								f2028	10.1136/bmj.f2028	http://dx.doi.org/10.1136/bmj.f2028			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131AO	23592451				2022-12-28	WOS:000317962900015
J	Nikolaou, S; Jenkins, DP				Nikolaou, Stella; Jenkins, David P.			CASE REPORT A treatable cause of shortness of breath	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							THROMBOEMBOLIC PULMONARY-HYPERTENSION; PERFUSION		[Nikolaou, Stella; Jenkins, David P.] Papworth Hosp, Cambridge CB23 3RE, England	Papworth Hospital	Nikolaou, S (corresponding author), Papworth Hosp, Cambridge CB23 3RE, England.	stella.nicolaou@gmail.com						Ali Jason M, 2012, Hosp Pract (1995), V40, P71, DOI 10.3810/hp.2012.08.991; Condliffe R, 2008, AM J RESP CRIT CARE, V177, P1122, DOI 10.1164/rccm.200712-1841OC; Fedullo P, 2011, AM J RESP CRIT CARE, V183, P1605, DOI 10.1164/rccm.201011-1854CI; Freed DH, 2008, EUR J CARDIO-THORAC, V34, P525, DOI 10.1016/j.ejcts.2008.04.018; Hoeper MM, 2006, CIRCULATION, V113, P2011, DOI 10.1161/CIRCULATIONAHA.105.602565; Hoey ETD, 2011, AM J ROENTGENOL, V196, P524, DOI 10.2214/AJR.10.4842; Jenkins D, 2012, EUR RESPIR REV, V21, P32, DOI 10.1183/09059180.00009211; Mayer E, 2011, J THORAC CARDIOV SUR, V141, P702, DOI 10.1016/j.jtcvs.2010.11.024; NHS, NAT AUD PULM HYP 201; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Tunariu N, 2007, J NUCL MED, V48, P680, DOI 10.2967/jnumed.106.039438; Vuylsteke A, 2011, LANCET, V378, P1379, DOI 10.1016/S0140-6736(11)61144-6	13	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2013	346								f1937	10.1136/bmj.f1937	http://dx.doi.org/10.1136/bmj.f1937			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131AI	23587563				2022-12-28	WOS:000317962200008
J	Pardey, PG; Beddow, JM; Kriticos, DJ; Hurley, TM; Park, RF; Duveiller, E; Sutherst, RW; Burdon, JJ; Hodson, D				Pardey, P. G.; Beddow, J. M.; Kriticos, D. J.; Hurley, T. M.; Park, R. F.; Duveiller, E.; Sutherst, R. W.; Burdon, J. J.; Hodson, D.			Right-Sizing Stem-Rust Research	SCIENCE			English	Editorial Material									[Pardey, P. G.; Beddow, J. M.; Kriticos, D. J.; Hurley, T. M.] Univ Minnesota, Int Sci & Technol Practice & Policy Ctr, Dept Appl Econ, St Paul, MN 55108 USA; [Pardey, P. G.; Beddow, J. M.; Hurley, T. M.] Univ Minnesota, Stakman Borlaug Cereal Rust Ctr, St Paul, MN 55108 USA; [Pardey, P. G.; Beddow, J. M.; Kriticos, D. J.; Hurley, T. M.; Burdon, J. J.] Commonwealth Sci & Ind Res Org, Canberra, ACT 3190, Australia; [Pardey, P. G.] Univ Pretoria, Dept Agr Econ Extens & Rural Dev, ZA-0028 Pretoria, South Africa; [Kriticos, D. J.] Charles Sturt Univ Wagga Wagga, EH Graham Ctr, Sydney, NSW 2678, Australia; [Park, R. F.] Univ Sydney, Australian Cereal Rust Control Program, Plant Breeding Inst, Eveleigh, NSW 2015, Australia; [Duveiller, E.; Hodson, D.] Int Maize & Wheat Improvement Ctr CIMMYT, El Batan, Mexico; [Sutherst, R. W.] Univ Queensland, Ctr Excellence Environm Decis, St Lucia, Qld 4072, Australia	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Pretoria; Charles Sturt University; University of Sydney; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of Queensland	Pardey, PG (corresponding author), Univ Minnesota, Int Sci & Technol Practice & Policy Ctr, Dept Appl Econ, St Paul, MN 55108 USA.	ppardey@umn.edu	Kriticos, Darren J/A-4170-2008; Burdon, Jeremy J/B-9913-2009	Kriticos, Darren J/0000-0003-2599-8105; Park, Robert/0000-0002-9145-5371; Hurley, Terrance/0000-0003-2135-7570				Agrios G. N., 2005, PLANT PATHOL; Beddow J.M., 2010, POTENTIAL GLOBAL CRO; Beddow J. M., 2012, MEASURING WORLDWIDE; Dubin H. J., 2009, 00910 INT FOOD POL R; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; National Association of Wheat Growers, 2012, W FARM PRESS    0320; Rao X., 2012, RECALIBRATING REPORT; Saari E. E., 1985, CEREAL RUSTS, V2; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; Sutherst R W, 2007, CLIMEX VERSION 3 USE; US Department of Agriculture, COMM COSTS RET	13	60	62	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					147	148		10.1126/science.122970	http://dx.doi.org/10.1126/science.122970			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580514				2022-12-28	WOS:000317341400038
J	Carlin, LM; Stamatiades, EG; Auffray, C; Hanna, RN; Glover, L; Vizcay-Barrena, G; Hedrick, CC; Cook, HT; Diebold, S; Geissmann, F				Carlin, Leo M.; Stamatiades, Efstathios G.; Auffray, Cedric; Hanna, Richard N.; Glover, Leanne; Vizcay-Barrena, Gema; Hedrick, Catherine C.; Cook, H. Terence; Diebold, Sandra; Geissmann, Frederic			Nr4a1-Dependent Ly6C(low) Monocytes Monitor Endothelial Cells and Orchestrate Their Disposal	CELL			English	Article							BONE-MARROW; FRACTALKINE EXPRESSION; LUPUS NEPHRITIS; RECRUITMENT; LIGAND; REVEALS; SUBSETS; LFA-1; ACCUMULATION; INITIATION	The functions of Nr4a1-dependent Ly6C(low) monocytes remain enigmatic. We show that they are enriched within capillaries and scavenge microparticles from their lumenal side in a steady state. In the kidney cortex, perturbation of homeostasis by a TLR7-dependent nucleic acid "danger" signal, which may signify viral infection or local cell death, triggers Gai-dependent intravascular retention of Ly6C(low) monocytes by the endothelium. Then, monocytes recruit neutrophils in a TLR7-dependent manner to mediate focal necrosis of endothelial cells, whereas the monocytes remove cellular debris. Prevention of Ly6C(low) monocyte development, crawling, or retention in Nr4a1(-/-), Itgal(-/-), and Tlr7(host-/-BM+/+) and Cx3cr1(-/-) mice, respectively, abolished neutrophil recruitment and endothelial killing. Prevention of neutrophil recruitment in Tlr7(host+/+BM-/-) mice or by neutrophil depletion also abolished endothelial cell necrosis. Therefore, Ly6C(low) monocytes are intravascular housekeepers that orchestrate the necrosis by neutrophils of endothelial cells that signal a local threat sensed via TLR7 followed by the in situ phagocytosis of cellular debris.	[Carlin, Leo M.; Stamatiades, Efstathios G.; Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England; [Carlin, Leo M.; Stamatiades, Efstathios G.; Diebold, Sandra; Geissmann, Frederic] Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 1UL, England; [Glover, Leanne; Vizcay-Barrena, Gema] Kings Coll London, Ctr Ultrastruct Imaging, London SE1 1UL, England; [Auffray, Cedric; Geissmann, Frederic] Paris Descartes Univ, Inst Necker, INSERM, U838, F-75015 Paris, France; [Hanna, Richard N.; Hedrick, Catherine C.] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA; [Cook, H. Terence] Univ London Imperial Coll Sci Technol & Med, Ctr Complement & Inflammat Res, London W12 0NN, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; La Jolla Institute for Immunology; Imperial College London	Geissmann, F (corresponding author), Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England.	frederic.geissmann@kcl.ac.uk	Auffray, Cedric/M-3225-2017; Carlin, Leo Marc/E-3434-2012	Carlin, Leo Marc/0000-0001-7172-5234; Allison, Leanne/0000-0003-2954-9892; Stamatiades, Efstathios/0000-0002-2785-9005; geissmann, frederic/0000-0001-5029-2468	Oliver Bird Rheumatism Programme, Nuffield Foundation, UK; Medical Research Council, UK [MRCG0900867]; European Research Council [ERC-2010-StG-261299 MPS2010]; European Science Foundation (ERC EURYI Award); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118765] Funding Source: NIH RePORTER; Medical Research Council [G0900867] Funding Source: researchfish; MRC [G0900867] Funding Source: UKRI	Oliver Bird Rheumatism Programme, Nuffield Foundation, UK; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); European Science Foundation (ERC EURYI Award); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	I. Charo, B. Engelhardt and J.V. Stein, and R. Alon kindly provided Ccr2<SUP>-/-</SUP>, Icam1<SUP>-/-</SUP> and Icam2<SUP>-/-</SUP>, and Igal<SUP>-/-</SUP> mice, respectively. The authors are also indebted to G. Burn and A. Fischer for helpful discussions, to C. Trouillet for the management of the Geissmann lab, and to A. McGuigan and her colleagues from the Biological Service Unit at King's College London, Guy's Campus, for support with mouse husbandry. E.G.S. is supported by a PhD fellowship from the Oliver Bird Rheumatism Programme, Nuffield Foundation, UK. Work was supported by grants to F. G. from the Medical Research Council, UK (MRCG0900867), the European Research Council (ERC-2010-StG-261299 MPS2010), and the European Science Foundation (ERC EURYI Award).	Amano H, 2005, ARTHRITIS RHEUM-US, V52, P2790, DOI 10.1002/art.21365; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Biburger M, 2011, IMMUNITY, V35, P932, DOI 10.1016/j.immuni.2011.11.009; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; DEFOUGEROLLES AR, 1993, J EXP MED, V177, P1187, DOI 10.1084/jem.177.4.1187; Devi S, 2013, NAT MED, V19, P107, DOI 10.1038/nm.3024; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Green DR, 2011, IMMUNITY, V35, P441, DOI 10.1016/j.immuni.2011.10.003; Gunzer M, 2005, BLOOD, V106, P2424, DOI 10.1182/blood-2005-01-0342; Hamers AAJ, 2012, CIRC RES, V110, P428, DOI 10.1161/CIRCRESAHA.111.260760; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hill GS, 2001, KIDNEY INT, V59, P304, DOI 10.1046/j.1523-1755.2001.00492.x; Hill GS, 2000, KIDNEY INT, V58, P1160, DOI 10.1046/j.1523-1755.2000.00272.x; Inoue A, 2005, ARTHRITIS RHEUM-US, V52, P1522, DOI 10.1002/art.21007; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Li WJ, 2012, J CLIN INVEST, V122, P2499, DOI 10.1172/JCI62970; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Metchnikoff E., 1893, LECT 9 LECT COMP PAT, P144; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nakatani K, 2010, AM J PHYSIOL-RENAL, V299, pF207, DOI 10.1152/ajprenal.00482.2009; Narni-Mancinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002457; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Santiago-Raber ML, 2009, ARTHRITIS RHEUM-US, V60, P2408, DOI 10.1002/art.24787; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; Sumagin R, 2010, J IMMUNOL, V185, P7057, DOI 10.4049/jimmunol.1001638; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; WESTLIN WF, 1993, AM J PATHOL, V142, P117; Yoshimoto S, 2007, AM J KIDNEY DIS, V50, P47, DOI 10.1053/j.ajkd.2007.04.012	48	490	504	2	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					362	375		10.1016/j.cell.2013.03.010	http://dx.doi.org/10.1016/j.cell.2013.03.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582326	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000317349700015
J	Connerney, J				Connerney, Jack			SOLAR SYSTEM Saturn's ring rain	NATURE			English	Editorial Material							MODEL; IONOSPHERE; EVOLUTION		NASA, Planetary Magnetospheres Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Connerney, J (corresponding author), NASA, Planetary Magnetospheres Lab, Goddard Space Flight Ctr, Code 695, Greenbelt, MD 20771 USA.	jack.connerney@nasa.gov	connerney, john/I-5127-2013	connerney, jack/0000-0001-7478-6462				Burton M. E., 2010, GEOPHYS RES LETT, V37, P24105; Canup RM, 2010, NATURE, V468, P943, DOI 10.1038/nature09661; CONNERNEY JEP, 1982, NATURE, V298, P44, DOI 10.1038/298044a0; CONNERNEY JEP, 1984, NATURE, V312, P136, DOI 10.1038/312136a0; CONNERNEY JEP, 1986, GEOPHYS RES LETT, V13, P773, DOI 10.1029/GL013i008p00773; Cuzzi JN, 2010, SCIENCE, V327, P1470, DOI 10.1126/science.1179118; Cuzzi JN, 1998, ICARUS, V132, P1, DOI 10.1006/icar.1997.5863; Fischer G, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016187; IP WH, 1983, J GEOPHYS RES-SPACE, V88, P819, DOI 10.1029/JA088iA02p00819; KAISER ML, 1984, J GEOPHYS RES-SPACE, V89, P2371, DOI 10.1029/JA089iA04p02371; Moore L, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027375; Moore L, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015692; NORTHROP TG, 1983, J GEOPHYS RES-SPACE, V88, P6102, DOI 10.1029/JA088iA08p06102; NORTHROP TG, 1987, ICARUS, V70, P124, DOI 10.1016/0019-1035(87)90079-0; O'Donoghue J, 2013, NATURE, V496, P193, DOI 10.1038/nature12049; Prange R, 2006, ICARUS, V180, P379, DOI 10.1016/j.icarus.2005.11.005; Salmon J, 2010, ICARUS, V209, P771, DOI 10.1016/j.icarus.2010.05.030; Tiscareno MS, 2006, NATURE, V440, P648, DOI 10.1038/nature04581	18	11	11	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					178	179		10.1038/496178a	http://dx.doi.org/10.1038/496178a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23579675				2022-12-28	WOS:000317346300032
J	Loggers, ET; Starks, H; Shannon-Dudley, M; Back, AL; Appelbaum, FR; Stewart, FM				Loggers, Elizabeth Trice; Starks, Helene; Shannon-Dudley, Moreen; Back, Anthony L.; Appelbaum, Frederick R.; Stewart, F. Marc			Implementing a Death with Dignity Program at a Comprehensive Cancer Center	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHYSICIAN-ASSISTED SUICIDE; OREGON DEATH; ATTITUDES; EXPERIENCES; CARE; AID	BACKGROUND The majority of Death with Dignity participants in Washington State and Oregon have received a diagnosis of terminal cancer. As more states consider legislation regarding physician-assisted death, the experience of a comprehensive cancer center may be informative. METHODS We describe the implementation of a Death with Dignity program at Seattle Cancer Care Alliance, the site of care for the Fred Hutchinson-University of Washington Cancer Consortium, a comprehensive cancer center in Seattle that serves the Pacific Northwest. Institution-level data were compared with publicly available state-wide data from Oregon and Washington. RESULTS A total of 114 patients inquired about our Death with Dignity program between March 5, 2009, and December 31, 2011. Of these, 44 (38.6%) did not pursue the program, and 30 (26.3%) initiated the process but either elected not to continue or died before completion. Of the 40 participants who, after counseling and upon request, received a prescription for a lethal dose of secobarbital (35.1% of the 114 patients who inquired about the program), all died, 24 after medication ingestion (60% of those obtaining prescriptions). The participants at our center accounted for 15.7% of all participants in the Death with Dignity program in Washington (255 persons) and were typically white, male, and well educated. The most common reasons for participation were loss of autonomy (97.2%), inability to engage in enjoyable activities (88.9%), and loss of dignity (75.0%). Eleven participants lived for more than 6 months after prescription receipt. Qualitatively, patients and families were grateful to receive the lethal prescription, whether it was used or not. CONCLUSIONS Overall, our Death with Dignity program has been well accepted by patients and clinicians.	[Loggers, Elizabeth Trice; Appelbaum, Frederick R.; Stewart, F. Marc] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Loggers, Elizabeth Trice] Univ Washington, Grp Hlth Res Inst, Seattle, WA 98195 USA; [Loggers, Elizabeth Trice; Shannon-Dudley, Moreen; Back, Anthony L.; Appelbaum, Frederick R.; Stewart, F. Marc] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle	Loggers, ET (corresponding author), 825 Eastlake Ave E, Seattle, WA 98109 USA.	eloggers@seattlecca.org		Loggers, Elizabeth/0000-0003-3432-0443	University of Washington Palliative Care Center of Excellence	University of Washington Palliative Care Center of Excellence	We thank Barbara Glidewell, M.B.S., C.E.C., former patient relations director, ombudsman, and assistant professor, Oregon Health and Science University (OHSU), and Linda Ganzini, M.D., M.P.H., professor of psychiatry and medicine, OHSU, for their consultation and expertise early in the formation of our Death with Dignity program; Danika Kubota for her administrative assistance; and the University of Washington Palliative Care Center of Excellence for its support.	Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Dobscha Steven K, 2004, J Palliat Med, V7, P451, DOI 10.1089/1096621041349374; Ganzini L, 2000, NEW ENGL J MED, V342, P1538; Ganzini L, 1996, AM J PSYCHIAT, V153, P1469; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; Ganzini L, 1997, NEW ENGL J MED, V336, P1824, DOI 10.1056/NEJM199706193362511; Ganzini L, 2001, JAMA-J AM MED ASSOC, V285, P2363, DOI 10.1001/jama.285.18.2363; Ganzini L, 2008, J GEN INTERN MED, V23, P154, DOI 10.1007/s11606-007-0476-x; Ganzini L, 2009, J PAIN SYMPTOM MANAG, V38, P807, DOI 10.1016/j.jpainsymman.2009.04.026; Ganzini L, 2009, ARCH INTERN MED, V169, P489, DOI 10.1001/archinternmed.2008.579; Ganzini L, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1682; Hafner K., 2012, NY TIMES, pA1; Hawaii State Legislature, REL DEATH DIGN; Smith KA, 2011, J PALLIAT MED, V14, P445, DOI 10.1089/jpm.2010.0425; Starks H, 2005, J PAIN SYMPTOM MANAG, V30, P215, DOI 10.1016/j.jpainsymman.2005.03.012; State and County QuickFacts, 2012, CODATA DER POP EST A; State of Vermont, 2011, ACT REL PAT CHOIC CO; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822	20	77	79	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1417	1424		10.1056/NEJMsa1213398	http://dx.doi.org/10.1056/NEJMsa1213398			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122QT	23574120				2022-12-28	WOS:000317333600009
J	Papenfort, K; Sun, Y; Miyakoshi, M; Vanderpool, CK; Vogel, J				Papenfort, Kai; Sun, Yan; Miyakoshi, Masatoshi; Vanderpool, Carin K.; Vogel, Joerg			Small RNA-Mediated Activation of Sugar Phosphatase mRNA Regulates Glucose Homeostasis	CELL			English	Article							BACTERIAL SMALL RNA; ESCHERICHIA-COLI; ALPHA-METHYLGLUCOSIDE; STREPTOCOCCUS-LACTIS; TARGET RECOGNITION; TRANSPORT; EXPRESSION; TRANSCRIPTION; EFFLUX; GROWTH	Glucose homeostasis is strictly controlled in all domains of life. Bacteria that are unable to balance intracellular sugar levels and deal with potentially toxic phosphosugars cease growth and risk being outcompeted. Here, we identify the conserved haloacid dehalogenase (HAD)-like enzyme YigL as the previously hypothesized phosphatase for detoxification of phosphosugars and reveal that its synthesis is activated by an Hfq-dependent small RNA in Salmonella typhimurium. We show that the glucose-6-P-responsive small RNA SgrS activates YigL synthesis in a translation-independent fashion by the selective stabilization of a decay intermediate of the dicistronic pldB-yigL messenger RNA (mRNA). Intriguingly, the major endoribonuclease RNase E, previously known to function together with small RNAs to degrade mRNA targets, is also essential for this process of mRNA activation. The exploitation of and targeted interference with regular RNA turnover described here may constitute a general route for small RNAs to rapidly activate both coding and noncoding genes.	[Papenfort, Kai; Miyakoshi, Masatoshi; Vogel, Joerg] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany; [Papenfort, Kai] Princeton Univ, Dept Mol Biol, Princeton, NJ 08540 USA; [Sun, Yan; Vanderpool, Carin K.] Univ Illinois, Dept Microbiol, Urbana, IL 61802 USA	University of Wurzburg; Princeton University; University of Illinois System; University of Illinois Urbana-Champaign	Vanderpool, CK (corresponding author), Univ Illinois, Dept Microbiol, Urbana, IL 61802 USA.	cvanderp@life.illinois.edu; joerg.vogel@uni-wuerzburg.de	Papenfort, Kai/L-3187-2017; Vogel, Jörg/D-5574-2011; Miyakoshi, Masatoshi/H-5256-2018	Papenfort, Kai/0000-0002-5560-9804; Vogel, Jörg/0000-0003-2220-1404; Miyakoshi, Masatoshi/0000-0002-4901-2809	American Cancer Society [ACS2008-01868]; DFG [SPP1258 (Vo875/2-2), SPP1316 (Vo875/6-1)]; BMBF NGFN program [01GS0806]; Bavarian BioSysNet program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092830] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); DFG(German Research Foundation (DFG)); BMBF NGFN program(Federal Ministry of Education & Research (BMBF)); Bavarian BioSysNet program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. L. Bassler and B. F. Luisi for comments on the manuscript, B. Plaschke for excellent technical assistance, D. Podkaminski for help with cloning and growth curves, B. F. Luisi for the gift of RNase E preparations, S. A. Gorski for help with the manuscript, and K. Forstner for help with phylogenetic analysis. K. P. is supported by a postdoctoral fellowship from the Human Frontiers in Science Program. The Vanderpool lab received support from the American Cancer Society (research scholar grant ACS2008-01868), and the Vogel lab received support from DFG Priority Programs SPP1258 (Vo875/2-2) and SPP1316 (Vo875/6-1), the BMBF NGFN program (grant 01GS0806), and the Bavarian BioSysNet program.	Adhya Sankar, 2003, Sci STKE, V2003, ppe22, DOI 10.1126/stke.2003.185.pe22; Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Bandyra KJ, 2012, MOL CELL, V47, P943, DOI 10.1016/j.molcel.2012.07.015; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; BUCALA R, 1985, P NATL ACAD SCI USA, V82, P8439, DOI 10.1073/pnas.82.24.8439; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Chou JY, 2010, NAT REV ENDOCRINOL, V6, P676, DOI 10.1038/nrendo.2010.189; Corcoran CP, 2012, MOL MICROBIOL, V84, P428, DOI 10.1111/j.1365-2958.2012.08031.x; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; HAGIHIRA H, 1963, BIOCHIM BIOPHYS ACTA, V78, P505, DOI 10.1016/0006-3002(63)90912-0; HAGUENAUER R, 1972, BIOCHIMIE, V54, P505, DOI 10.1016/S0300-9084(72)80235-9; HUBER RE, 1980, BIOCHEM BIOPH RES CO, V96, P656, DOI 10.1016/0006-291X(80)91405-9; IRANI MH, 1977, J BACTERIOL, V132, P398, DOI 10.1128/JB.132.2.398-410.1977; Jahreis K, 2008, FEMS MICROBIOL REV, V32, P891, DOI 10.1111/j.1574-6976.2008.00125.x; Jorgensen MG, 2012, MOL MICROBIOL, V84, P36, DOI 10.1111/j.1365-2958.2012.07976.x; KAASEN I, 1992, J BACTERIOL, V174, P889, DOI 10.1128/jb.174.3.889-898.1992; KADNER RJ, 1992, J GEN MICROBIOL, V138, P2007, DOI 10.1099/00221287-138-10-2007; Kawamoto H, 2006, MOL MICROBIOL, V61, P1013, DOI 10.1111/j.1365-2958.2006.05288.x; Kimata K, 2001, EMBO J, V20, P3587, DOI 10.1093/emboj/20.13.3587; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Lee SJ, 2009, P NATL ACAD SCI USA, V106, P19515, DOI 10.1073/pnas.0910586106; Liu JY, 1999, J BIOL CHEM, V274, P22977, DOI 10.1074/jbc.274.33.22977; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Moller T, 2002, GENE DEV, V16, P1696, DOI 10.1101/gad.231702; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Morita T, 2003, J BIOL CHEM, V278, P15608, DOI 10.1074/jbc.M300177200; Nilsson P, 1996, J BACTERIOL, V178, P683, DOI 10.1128/jb.178.3.683-690.1996; Opdyke JA, 2011, J MOL BIOL, V406, P29, DOI 10.1016/j.jmb.2010.12.009; Papenfort K, 2012, P NATL ACAD SCI USA, V109, pE757, DOI 10.1073/pnas.1119414109; Papenfort K, 2009, MOL MICROBIOL, V74, P139, DOI 10.1111/j.1365-2958.2009.06857.x; Pfeiffer V, 2009, NAT STRUCT MOL BIOL, V16, P840, DOI 10.1038/nsmb.1631; Pikis A, 2006, J BIOL CHEM, V281, P17900, DOI 10.1074/jbc.M601183200; Polakof S, 2011, COMP BIOCHEM PHYS B, V160, P123, DOI 10.1016/j.cbpb.2011.07.006; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reichenbach B, 2008, NUCLEIC ACIDS RES, V36, P2570, DOI 10.1093/nar/gkn091; REIZER J, 1983, J BACTERIOL, V156, P236, DOI 10.1128/JB.156.1.236-242.1983; Rice JB, 2011, NUCLEIC ACIDS RES, V39, P3806, DOI 10.1093/nar/gkq1219; Roberts A, 2005, PROTEINS, V58, P790, DOI 10.1002/prot.20267; ROGERS D, 1962, J BACTERIOL, V84, P877, DOI 10.1128/JB.84.5.877-881.1962; Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002; Sun Y, 2011, J BACTERIOL, V193, P143, DOI 10.1128/JB.01008-10; Svetlov V, 2012, CELL, V150, P243, DOI 10.1016/j.cell.2012.06.025; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Thomason MK, 2012, MOL MICROBIOL, V84, P17, DOI 10.1111/j.1365-2958.2012.07965.x; THOMPSON J, 1983, J BACTERIOL, V154, P819, DOI 10.1128/JB.154.2.819-830.1983; THOMPSON J, 1982, J BACTERIOL, V151, P1454, DOI 10.1128/JB.151.3.1454-1465.1982; Urban JH, 2008, PLOS BIOL, V6, P631, DOI 10.1371/journal.pbio.0060064; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Vanderpool CK, 2007, J BACTERIOL, V189, P2238, DOI 10.1128/JB.01689-06; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; WINKLER HH, 1971, J BACTERIOL, V106, P362, DOI 10.1128/JB.106.2.362-368.1971	61	149	154	0	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					426	437		10.1016/j.cell.2013.03.003	http://dx.doi.org/10.1016/j.cell.2013.03.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582330	Bronze, Green Accepted			2022-12-28	WOS:000317349700020
J	Moran, A; Bundy, B; Becker, DJ; DiMeglio, LA; Gitelman, SE; Goland, R; Greenbaum, CJ; Herold, KC; Marks, JB; Raskin, P; Sanda, S; Schatz, D; Wherrett, DK; Wilson, DM; Krischer, JP; Skyler, JS; Pickersgill, L; de Koning, E; Ziegler, AG; Boehm, B; Badenhoop, K; Schloot, N; Bak, JF; Pozzilli, P; Mauricio, D; Donath, MY; Castano, L; Wagner, A; Lervang, HH; Perrild, H; Mandrup-Poulsen, T				Moran, Antoinette; Bundy, Brian; Becker, Dorothy J.; DiMeglio, Linda A.; Gitelman, Stephen E.; Goland, Robin; Greenbaum, Carla J.; Herold, Kevan C.; Marks, Jennifer B.; Raskin, Philip; Sanda, Srinath; Schatz, Desmond; Wherrett, Diane K.; Wilson, Darrell M.; Krischer, Jeffrey P.; Skyler, Jay S.; Pickersgill, Linda; de Koning, Eelco; Ziegler, Anette-G; Boeehm, Bernhard; Badenhoop, Klaus; Schloot, Nanette; Bak, Jens Friis; Pozzilli, Paolo; Mauricio, Didac; Donath, Marc Y.; Castano, Luis; Waegner, Ana; Lervang, Hans Henrik; Perrild, Hans; Mandrup-Poulsen, Thomas		Type 1 Diabet TrialNet Canakinumab; AIDA Study Grp	Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials	LANCET			English	Article							BETA-CELL FUNCTION; INSULIN-SECRETION; PANCREATIC-ISLETS; THERAPY; CHILDREN; ANTI-CD3; MELLITUS; BIOSYNTHESIS; BLOCKADE	Background Innate immunity contributes to the pathogenesis of autoimmune diseases, such as type 1 diabetes, but until now no randomised, controlled trials of blockade of the key innate immune mediator interleukin-1 have been done. We aimed to assess whether canakinumab, a human monoclonal anti-interleukin-1 antibody, or anakinra, a human interleukin-1 receptor antagonist, improved beta-cell function in recent-onset type 1 diabetes. Methods We did two randomised, placebo-controlled trials in two groups of patients with recent-onset type 1 diabetes and mixed-meal-tolerance-test-stimulated C peptide of at least 0.2 nM. Patients in the canakinumab trial were aged 6-45 years and those in the anakinra trial were aged 18-35 years. Patients in the canakinumab trial were enrolled at 12 sites in the USA and Canada and those in the anakinra trial were enrolled at 14 sites across Europe. Participants were randomly assigned by computer-generated blocked randomisation to subcutaneous injection of either 2 mg/kg (maximum 300 mg) canakinumab or placebo monthly for 12 months or 100 mg anakinra or placebo daily for 9 months. Participants and carers were masked to treatment assignment. The primary endpoint was baseline-adjusted 2-h area under curve C-peptide response to the mixed meal tolerance test at 12 months (canakinumab trial) and 9 months (anakinra trial). Analyses were by intention to treat. These studies are registered with ClinicalTrials.gov, numbers NCT00947427 and NCT00711503, and EudraCT number 2007-007146-34. Findings Patients were enrolled in the canakinumab trial between Nov 12, 2010, and April 11, 2011, and in the anakinra trial between Jan 26, 2009, and May 25, 2011. 69 patients were randomly assigned to canakinumab (n=47) or placebo (n=22) monthly for 12 months and 69 were randomly assigned to anakinra (n=35) or placebo (n=34) daily for 9 months. No interim analyses were done. 45 canakinumab-treated and 21 placebo-treated patients in the canakinumab trial and 25 anakinra-treated and 26 placebo-treated patients in the anakinra trial were included in the primary analyses. The difference in C peptide area under curve between the canakinumab and placebo groups at 12 months was 0.01 nmol/L (95% CI -0.11 to 0.14; p=0.86), and between the anakinra and the placebo groups at 9 months was 0.02 nmol/L (-0.09 to 0.15; p=0.71). The number and severity of adverse events did not diff er between groups in the canakinumab trial. In the anakinra trial, patients in the anakinra group had significantly higher grades of adverse events than the placebo group (p=0.018), which was mainly because of a higher number of injection site reactions in the anakinra group. Interpretation Canakinumab and anakinra were safe but were not effective as single immunomodulatory drugs in recent-onset type 1 diabetes. Interleukin-1 blockade might be more effective in combination with treatments that target adaptive immunity in organ-specific autoimmune disorders.	[Moran, Antoinette] Univ Minnesota, Minneapolis, MN USA; [Bundy, Brian; Krischer, Jeffrey P.] Univ S Florida, Tampa, FL USA; [Becker, Dorothy J.] Univ Pittsburgh, Pittsburgh, PA USA; [DiMeglio, Linda A.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Gitelman, Stephen E.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Goland, Robin] Columbia Univ, New York, NY USA; [Greenbaum, Carla J.; Sanda, Srinath] Benaroya Res Inst, Seattle, WA USA; [Herold, Kevan C.] Yale Univ, New Haven, CT USA; [Marks, Jennifer B.] Univ Miami, Diabet Res Inst, Miami, FL 33136 USA; [Raskin, Philip] Univ Texas Southwestern Med Sch, Dallas, TX USA; [Schatz, Desmond] Univ Florida, Gainesville, FL USA; [Wherrett, Diane K.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Wilson, Darrell M.] Stanford Univ, Stanford, CA 94305 USA; [Skyler, Jay S.] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Pickersgill, Linda] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [de Koning, Eelco] Leiden Univ, Med Ctr, Leiden, Netherlands; [Ziegler, Anette-G] Tech Univ Munich, Klinikum Rechts Isar, Diabet Res Inst, Helmholtz Zentrum Munchen, D-80290 Munich, Germany; [Ziegler, Anette-G] Tech Univ Munich, Klinikum Rechts Isar, Forschergrp Diabet, D-80290 Munich, Germany; [Boeehm, Bernhard] Univ Ulm, D-89069 Ulm, Germany; [Badenhoop, Klaus] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Schloot, Nanette] German Diabet Ctr, Dusseldorf, Germany; [Bak, Jens Friis] Aarhus Univ Hosp, Hosp Enheden Vest, DK-8000 Aarhus, Denmark; [Pozzilli, Paolo] Univ Campus Biomed, Unit Diabet Prevent, Rome, Italy; [Mauricio, Didac] Hosp Arnau Vilanova, Lleida, Spain; [Donath, Marc Y.] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Castano, Luis] Hosp Univ Cruces, Bilbao, Spain; [Waegner, Ana] Complejo Hosp Univ Insular Maternoinfantil, Las Palmas Gran Canaria, Spain; [Lervang, Hans Henrik] Aalborg Hosp, Aalborg, Denmark; [Perrild, Hans] Bispebjerg Hosp, DK-2400 Copenhagen, Denmark; [Mandrup-Poulsen, Thomas] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark	University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University Bloomington; University of California System; University of California San Francisco; Columbia University; Benaroya Research Institute; Yale University; University of Miami; State University System of Florida; University of Florida; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Stanford University; University of Miami; Steno Diabetes Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Ulm University; Goethe University Frankfurt; Deutsches Diabetes-Zentrum (DDZ); Aarhus University; University Campus Bio-Medico - Rome Italy; University Hospital Arnau de Vilanova; University of Basel; Hospital Universitario Cruces; Aalborg University; Aalborg University Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Skyler, JS (corresponding author), Univ Miami, Miller Sch Med, Diabet Res Inst, 1450 NW 10th Ave,Suite 3054, Miami, FL 33136 USA.	jskyler@miami.edu; tmpo@sund.ku.dk	Vázquez, Federico/AAF-9825-2021; Skyler, Jay S/F-4211-2016; DiMeglio, Linda A./F-9277-2019; Vazquez, Federico/J-8833-2017; Wägner, Ana M/AAS-9601-2021; Ziegler, Anette-Gabriele/M-4614-2014; Mauricio, Didac/B-7951-2009; de Koning, Eelco JP/H-6030-2011; Boehm, Bernhard Otto/F-8750-2015	Vázquez, Federico/0000-0001-6493-2374; DiMeglio, Linda A./0000-0002-8033-6078; Vazquez, Federico/0000-0001-6493-2374; Wägner, Ana M/0000-0002-7663-9308; Ziegler, Anette-Gabriele/0000-0002-6290-5548; Mauricio, Didac/0000-0002-2868-0250; de Koning, Eelco JP/0000-0002-1232-7022; Castano, Luis/0000-0003-0437-9401; Knip, Mikael/0000-0003-0474-0033; GAZTAMBIDE, SONIA/0000-0003-3569-2265; Nowotny, Bettina/0000-0002-0671-9644; Pozzilli, Paolo/0000-0001-5090-636X; Mandrup-Poulsen, Thomas/0000-0002-3215-9273; Skyler, Jay/0000-0003-1136-8110; Andersen, Henrik Ullits/0000-0001-8048-9720	National Institutes of Health; Juvenile Diabetes Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005, UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982, UL1RR025761, M01RR000400, UL1RR029890, UL1RR024131, UL1RR025780, UL1RR024139, UL1RR024975, UL1RR024153, UL1RR031986, UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061010, P30DK063720, UC4DK097835, U01DK085509, U01DK061036, U01DK061040, UC4DK117009, U01DK061042, U01DK061055, U01DK061041, U01DK061034, U01DK085463, R01DK093954, U01DK085505, U01DK085461, U01DK061058, U01DK085499, U01DK085453, U01DK085466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health and Juvenile Diabetes Research Foundation.	Ablamunits V, 2012, DIABETES, V61, P145, DOI 10.2337/db11-1033; Alkanani AK, 2012, DIABETES, V61, P2525, DOI 10.2337/db12-0099; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Greenbaum CJ, 2008, DIABETES CARE, V31, P1966, DOI 10.2337/dc07-2451; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Herold KC, 2009, CLIN IMMUNOL, V132, P166, DOI 10.1016/j.clim.2009.04.007; Kaizer EC, 2007, J CLIN ENDOCR METAB, V92, P3705, DOI 10.1210/jc.2007-0979; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Ludvigsson J, 2012, NEW ENGL J MED, V366, P433, DOI 10.1056/NEJMoa1107096; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Mastrandrea L, 2009, DIABETES CARE, V32, P1244, DOI 10.2337/dc09-0054; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Sanda S, 2010, CLIN IMMUNOL, V136, P170, DOI 10.1016/j.clim.2010.04.009; SANDLER S, 1987, ENDOCRINOLOGY, V121, P1424, DOI 10.1210/endo-121-4-1424; SPINAS GA, 1987, DIABETOLOGIA, V30, P474, DOI 10.1007/BF00279615; Steele C, 2004, DIABETES, V53, P426, DOI 10.2337/diabetes.53.2.426; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Sumpter KM, 2011, PEDIATR DIABETES, V12, P656, DOI 10.1111/j.1399-5448.2011.00761.x; Wherrett DK, 2011, LANCET, V378, P319, DOI 10.1016/S0140-6736(11)60895-7; Yamada K, 1996, DIABETOLOGIA, V39, P1306, DOI 10.1007/s001250050574	25	229	233	0	51	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					1905	1915		10.1016/S0140-6736(13)60023-9	http://dx.doi.org/10.1016/S0140-6736(13)60023-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23562090	Green Accepted			2022-12-28	WOS:000320319500031
J	Hlatky, MA; Boothroyd, DB; Baker, L; Kazi, DS; Solomon, MD; Chang, TI; Shilane, D; Go, AS				Hlatky, Mark A.; Boothroyd, Derek B.; Baker, Laurence; Kazi, Dhruv S.; Solomon, Matthew D.; Chang, Tara I.; Shilane, David; Go, Alan S.			Comparative Effectiveness of Multivessel Coronary Bypass Surgery and Multivessel Percutaneous Coronary Intervention A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							FOLLOW-UP; RANDOMIZED-TRIAL; ARTERY-DISEASE; SMOKING-CESSATION; REVASCULARIZATION; ANGIOPLASTY; STRATEGIES; MORTALITY	Background: Randomized trials of coronary artery bypass graft (CABG) surgery and percutaneous coronary intervention (PCI) suggest that patient characteristics modify the effect of treatment on mortality. Objective: To assess whether clinical characteristics modify the comparative effectiveness of CABG versus PCI in an unselected, general patient population. Design: Observational treatment comparison using propensity score matching and Cox proportional hazards models. Setting: United States, 1992 to 2008. Patients: Medicare beneficiaries aged 66 years or older. Intervention: Multivessel CABG or multivessel PCI. Measurements: The CABG-PCI hazard ratio (HR) for all-cause mortality, with prespecified treatment-by-covariate interaction tests, and the absolute difference in life-years of survival in clinical subgroups after CABG or PCI, both over 5 years of follow-up. Results: Among 105 156 propensity score-matched patients, CABG was associated with lower mortality than PCI (HR, 0.92 [95% CI, 0.90 to 0.95]; P < 0.001). Association of CABG with lower mortality was significantly greater (interaction P <= 0.002 for each) among patients with diabetes (HR, 0.88), a history of tobacco use (HR, 0.82), heart failure (HR, 0.84), and peripheral arterial disease (HR, 0.85). The overall predicted difference in survival between CABG and PCI treatment over 5 years was 0.053 life-years (range, -0.017 to 0.579 life-years). Patients with diabetes, heart failure, peripheral arterial disease, or tobacco use had the largest predicted differences in survival after CABG, whereas those with none of these factors had slightly better survival after PCI. Limitation: Treatments were chosen by patients and physicians rather than being randomly assigned. Conclusion: Multivessel CABG is associated with lower long-term mortality than multivessel PCI in the community setting. This association is substantially modified by patient characteristics, with improvement in survival concentrated among patients with diabetes, tobacco use, heart failure, or peripheral arterial disease.	[Hlatky, Mark A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; Kaiser Permanente Northern Calif, Oakland, CA 94612 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Stanford University; Kaiser Permanente; University of California System; University of California San Francisco	Hlatky, MA (corresponding author), Stanford Univ, Sch Med, HRP Redwood Bldg,259 Campus Dr, Stanford, CA 94305 USA.	hlatky@stanford.edu	Go, Alan S./AAE-7745-2019	Baker, Laurence/0000-0001-5032-794X; Boothroyd, Derek Brian/0000-0001-5387-6995; Hlatky, Mark/0000-0003-4686-9441	National Heart, Lung, and Blood Institute [HL099872]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007357] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant Support: By grant HL099872 from the National Heart, Lung, and Blood Institute.	Booth J, 2008, CIRCULATION, V118, P381, DOI 10.1161/CIRCULATIONAHA.107.739144; Brooks MM, 2007, J AM COLL CARDIOL, V49, P1600, DOI 10.1016/j.jacc.2006.11.048; CROUSE JR, 1991, AM J EPIDEMIOL, V134, P699, DOI 10.1093/oxfordjournals.aje.a116146; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Hasdai D, 1997, NEW ENGL J MED, V336, P755, DOI 10.1056/NEJM199703133361103; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Hueb W, 2010, CIRCULATION, V122, P949, DOI 10.1161/CIRCULATIONAHA.109.911669; King SB, 2000, J AM COLL CARDIOL, V35, P1116, DOI 10.1016/S0735-1097(00)00546-5; Parsons LS, 2001, 26 ANN SAS US GROUP; Rodriguez AE, 2005, J AM COLL CARDIOL, V46, P582, DOI 10.1016/j.jacc.2004.12.081; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082; van Domburg RT, 2000, J AM COLL CARDIOL, V36, P878, DOI 10.1016/S0735-1097(00)00810-X; Weintraub WS, 2012, NEW ENGL J MED, V366, P1467, DOI 10.1056/NEJMoa1110717	14	56	59	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10					727	+		10.7326/0003-4819-158-10-201305210-00639	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-00639			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23609014	Green Accepted			2022-12-28	WOS:000319666200015
J	Giustina, M; Mech, A; Ramelow, S; Wittmann, B; Kofler, J; Beyer, J; Lita, A; Calkins, B; Gerrits, T; Nam, S; Ursin, R; Zeilinger, A				Giustina, Marissa; Mech, Alexandra; Ramelow, Sven; Wittmann, Bernhard; Kofler, Johannes; Beyer, Joern; Lita, Adriana; Calkins, Brice; Gerrits, Thomas; Nam, SaeWoo; Ursin, Rupert; Zeilinger, Anton			Bell violation using entangled photons without the fair-sampling assumption	NATURE			English	Article							INEQUALITY	The violation of a Bell inequality is an experimental observation that forces the abandonment of a local realistic viewpoint-namely, one in which physical properties are (probabilistically) defined before and independently of measurement, and in which no physical influence can propagate faster than the speed of light(1,2). All such experimental violations require additional assumptions depending on their specific construction, making them vulnerable to so-called loopholes. Here we use entangled photons to violate a Bell inequality while closing the fair-sampling loophole, that is, without assuming that the sample of measured photons accurately represents the entire ensemble(3). To do this, we use the Eberhard form of Bell's inequality, which is not vulnerable to the fair-sampling assumption and which allows a lower collection efficiency than other forms(4). Technical improvements of the photon source(5,6) and high-efficiency transition-edge sensors(7) were crucial for achieving a sufficiently high collection efficiency. Our experiment makes the photon the first physical system for which each of the main loopholes has been closed, albeit in different experiments.	[Giustina, Marissa; Mech, Alexandra; Ramelow, Sven; Wittmann, Bernhard; Kofler, Johannes; Ursin, Rupert; Zeilinger, Anton] Austrian Acad Sci, IQOQI, A-1090 Vienna, Austria; [Giustina, Marissa; Mech, Alexandra; Ramelow, Sven; Wittmann, Bernhard; Zeilinger, Anton] Univ Vienna, Fac Phys, A-1090 Vienna, Austria; [Kofler, Johannes] Max Planck Inst Quantum Opt MPQ, D-85748 Garching, Germany; [Beyer, Joern] Phys Tech Bundesanstalt, D-10587 Berlin, Germany; [Lita, Adriana; Calkins, Brice; Gerrits, Thomas; Nam, SaeWoo] NIST, Boulder, CO 80305 USA	Austrian Academy of Sciences; University of Vienna; Max Planck Society; Physikalisch-Technische Bundesanstalt (PTB); National Institute of Standards & Technology (NIST) - USA	Giustina, M (corresponding author), Austrian Acad Sci, IQOQI, Boltzmanngasse 3, A-1090 Vienna, Austria.	marissa.giustina@univie.ac.at; anton.zeilinger@univie.ac.at	Ursin, Rupert/E-9548-2012; Zeilinger, Anton/A-1170-2011; Ramelow, Sven/H-6798-2012	Ursin, Rupert/0000-0002-9403-269X; Ramelow, Sven/0000-0002-7801-4440	ERC [QIT4QAD 227844]; Austrian Science Fund (FWF) [SFB F4008, CoQuS]; Q-ESSENCE [248095]; QAP [15848]; Marie Curie Research Training Network EMALI [MRTN-CT-2006-035369]; John Templeton Foundation; NIST Quantum Information Science Initiative (QISI), an agency of the US Government	ERC(European Research Council (ERC)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Q-ESSENCE; QAP; Marie Curie Research Training Network EMALI(European Commission); John Templeton Foundation; NIST Quantum Information Science Initiative (QISI), an agency of the US Government	We acknowledge M. Schmidt of Physikalisch-Technische Bundesanstalt in Berlin, Germany, for assistance with setting up the TES-SQUID system. This work was supported by the ERC (Advanced Grant number QIT4QAD 227844), the Austrian Science Fund (FWF) under projects SFB F4008 and CoQuS, the grant Q-ESSENCE (number 248095), QAP (number 15848), the Marie Curie Research Training Network EMALI (number MRTN-CT-2006-035369) and the John Templeton Foundation. This work was also supported by the NIST Quantum Information Science Initiative (QISI), an agency of the US Government.	Alicki R., 2009, PREPRINT; Ansmann M, 2009, NATURE, V461, P504, DOI 10.1038/nature08363; ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bennet AJ, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031003; Brunner N, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.220403; CLAUSER JF, 1974, PHYS REV D, V10, P526, DOI 10.1103/PhysRevD.10.526; Drung D, 2007, IEEE T APPL SUPERCON, V17, P699, DOI 10.1109/TASC.2007.897403; EBERHARD PH, 1993, PHYS REV A, V47, pR747, DOI 10.1103/PhysRevA.47.R747; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Fedrizzi A, 2007, OPT EXPRESS, V15, P15377, DOI 10.1364/OE.15.015377; FREEDMAN SJ, 1972, PHYS REV LETT, V28, P938, DOI 10.1103/PhysRevLett.28.938; GARG A, 1987, PHYS REV D, V35, P3831, DOI 10.1103/PhysRevD.35.3831; Hofmann J, 2012, SCIENCE, V337, P72, DOI 10.1126/science.1221856; Kim T, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012316; KWIAT PG, 1994, PHYS REV A, V49, P3209, DOI 10.1103/PhysRevA.49.3209; Lita AE, 2008, OPT EXPRESS, V16, P3032, DOI 10.1364/OE.16.003032; Matsukevich DN, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.150404; Merali Z, 2011, SCIENCE, V331, P1380, DOI 10.1126/science.331.6023.1380; PEARLE PM, 1970, PHYS REV D, V2, P1418, DOI 10.1103/PhysRevD.2.1418; Ramelow S, 2013, OPT EXPRESS, V21, P6707, DOI 10.1364/OE.21.006707; Rosenfeld W, 2009, ADV SCI LETT, V2, P469, DOI 10.1166/asl.2009.1059; Rowe MA, 2001, NATURE, V409, P791, DOI 10.1038/35057215; Smith DH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1628; Vertesi T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.060401; Weihs G, 1998, PHYS REV LETT, V81, P5039, DOI 10.1103/PhysRevLett.81.5039; Wittmann B, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053030	29	297	300	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					227	230		10.1038/nature12012	http://dx.doi.org/10.1038/nature12012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23584590	Green Submitted			2022-12-28	WOS:000318558200033
J	Allen, V; Bates, KT; Li, ZH; Hutchinson, JR				Allen, Vivian; Bates, Karl T.; Li, Zhiheng; Hutchinson, John R.			Linking the evolution of body shape and locomotor biomechanics in bird-line archosaurs	NATURE			English	Article							ELECTROMYOGRAPHIC ANALYSIS; LIMB FUNCTION; PERFORMANCE; THEROPODS; MECHANICS; WALKING; FLIGHT	Locomotion in living birds (Neornithes) has two remarkable features: feather-assisted flight, and the use of unusually crouched hindlimbs for bipedal support and movement. When and how these defining functional traits evolved remains controversial(1-8). However, the advent of computer modelling approaches and the discoveries of exceptionally preserved key specimens now make it possible to use quantitative data on whole-body morphology to address the biomechanics underlying this issue. Here we use digital body reconstructions to quantify evolutionary trends in locomotor biomechanics (whole-body proportions and centre-of-mass position) across the clade Archosauria. We use three-dimensional digital reconstruction to estimate body shape from skeletal dimensions for 17 archosaurs along the ancestral bird line, including the exceptionally preserved, feathered taxa Microraptor, Archaeopteryx, Pengornis and Yixia-nornis, which represent key stages in the evolution of the avian body plan. Rather than a discrete transition from more-upright postures in the basal-most birds (Avialae) and their immediate outgroup deinonychosauria(5,6), our results support hypotheses of a gradual, stepwise acquisition of more-crouched limb postures across much of theropod evolution(1-4), although we find evidence of an accelerated change within the clade Maniraptora (birds and their closest relatives, such as deinonychosaurs). In addition, whereas reduction of the tail is widely accepted to be the primary morphological factor correlated with centre-of-mass position and, hence, evolution of hindlimb posture(1-8), we instead find that enlargement of the pectoral limb and several associated trends have a much stronger influence. Intriguingly, our support for the onset of accelerated morpho-functional trends within Maniraptora is closely correlated with the evolution of flight. Because we find that the evolution of enlarged forelimbs is strongly linked, via whole-body centre of mass, to hindlimb function during terrestrial locomotion, we suggest that the evolution of avian flight is linked to anatomical novelties in the pelvic limb as well as the pectoral.	[Allen, Vivian] Univ Jena, Inst Spezielle Zool & Evolut Biol, D-07743 Jena, Germany; [Allen, Vivian; Hutchinson, John R.] Univ London Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; [Bates, Karl T.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol 2, Liverpool L69 3GA, Merseyside, England; [Li, Zhiheng] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100034, Peoples R China; [Li, Zhiheng] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA	Friedrich Schiller University of Jena; University of London; University of London Royal Veterinary College; University of Liverpool; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Texas System; University of Texas Austin	Hutchinson, JR (corresponding author), Univ London Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England.	jrhutch@rvc.ac.uk	Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038	NERC [NE/G005877/1]; Royal Society International Joint Project; Sam and Doris Welles Fund (University of California); Natural Environment Research Council [NE/G005877/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society International Joint Project(Royal Society of London); Sam and Doris Welles Fund (University of California); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the following people and institutions for access to fossil specimens: S. Chapman, A. Milner, P. Holroyd, M. Goodwin, K. Padian, M. Ryan, G. Jackson, D. Chapman, H.-J. Siber, B. Pabst, Z. Zhou and M. Norell; and the NHM (UK), UCMP (USA), CMNH (USA), IVPP (Canada); Sauriermuseum Aathal (Switzerland) and AMNH (USA). We wish to thank the following people, institutions and companies for providing digitized specimens, reconstructed specimens or both: O. Grillo, H. Mallison, J. Hertel, J. Brougham, M. Davis, J. A. Bannister; and the Universidade Federal do Rio de Janeiro (Brazil), MNB (Germany), Crescendo Games (Canada), NOVA/WGBH (USA) and Mechanimal (USA). We thank J. Molnar and RVC for invaluable assistance in processing computed tomography and laser-scandata, and for video editing. This work was supported by the following grants and institutions: NERC grant no. NE/G005877/1 to J.R.H., a Royal Society International Joint Project to J. R. H. and Z. Zhou (not a co-author), and the Sam and Doris Welles Fund (University of California) as part of PhD funding to V.A.	Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Biewener AA, 2004, J APPL PHYSIOL, V97, P2266, DOI 10.1152/japplphysiol.00003.2004; Carrano MT, 1999, J MORPHOL, V240, P237, DOI 10.1002/(SICI)1097-4687(199906)240:3<237::AID-JMOR3>3.3.CO;2-E; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; Christiansen P, 2002, J ORNITHOL, V143, P356; CLARK J, 1975, J ZOOL, V176, P87; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; Gatesy SM, 1999, J MORPHOL, V240, P127, DOI 10.1002/(SICI)1097-4687(199905)240:2<127::AID-JMOR4>3.0.CO;2-Q; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; GATESY SM, 1991, J MORPHOL, V209, P83, DOI 10.1002/jmor.1052090107; Gatesy SM, 1996, EVOLUTION, V50, P331, DOI 10.1111/j.1558-5646.1996.tb04496.x; Gatesy SM, 1997, J VERTEBR PALEONTOL, V17, P308, DOI 10.1080/02724634.1997.10010977; Gatesy SM, 1997, J MORPHOL, V234, P197, DOI 10.1002/(SICI)1097-4687(199711)234:2<197::AID-JMOR6>3.0.CO;2-9; GATESY SM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P219; Hancock JA, 2007, IBIS, V149, P605, DOI 10.1111/j.1474-919X.2007.00688.x; Herr H, 2008, J EXP BIOL, V211, P467, DOI 10.1242/jeb.008573; Hutchinson J. R., 2001, COMP BIOCH PHYSL A, V131, P169; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Hutchinson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026037; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Hutchinson JR, 2004, J MORPHOL, V262, P421, DOI 10.1002/jmor.10241; Hutchinson JR, 2000, PALEOBIOLOGY, V26, P734, DOI 10.1666/0094-8373(2000)026<0734:AAATEO>2.0.CO;2; Jones TD, 2000, NATURE, V406, P716, DOI 10.1038/35021041; Marsh RL, 2006, J EXP BIOL, V209, P2050, DOI 10.1242/jeb.02226; Persons WS, 2011, ANAT REC, V294, P119, DOI 10.1002/ar.21290; Roberts TJ, 2002, J EXP BIOL, V205, P1485; Roberts TJ, 1998, J EXP BIOL, V201, P2753; TARSITANO S, 1983, Acta Palaeontologica Polonica, V28, P251; Turner AH, 2007, SCIENCE, V317, P1721, DOI 10.1126/science.1145076	30	87	87	2	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					104	107		10.1038/nature12059	http://dx.doi.org/10.1038/nature12059			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23615616	Green Published			2022-12-28	WOS:000318221500042
J	Boerma, T; Chopra, M; Creo, C; El-Halabi, S; Lindgren-Garcia, J; Moeti, T; Nordstrom, A; Phumaphi, J; Rasanathan, K				Boerma, Ties; Chopra, Mickey; Creo, Clare; El-Halabi, Shenaaz; Lindgren-Garcia, Johanna; Moeti, Themba; Nordstrom, Anders; Phumaphi, Joy; Rasanathan, Kumanan		Task Team Global Thematic Consulta	What do people want for health in the post-2015 agenda?	LANCET			English	Editorial Material									[Boerma, Ties; Creo, Clare] WHO, CH-1211 Geneva, Switzerland; [Chopra, Mickey; Rasanathan, Kumanan] UNICEF, New York, NY 10017 USA; [El-Halabi, Shenaaz; Moeti, Themba] Minist Hlth, Gaborone, Botswana; [Lindgren-Garcia, Johanna; Nordstrom, Anders] Minist Foreign Affairs, Stockholm, Sweden; [Phumaphi, Joy] Independent Expert Review Grp, Francistown, Botswana	World Health Organization; UNICEF	Rasanathan, K (corresponding author), UNICEF, New York, NY 10017 USA.	krasanathan@unicef.org						Berkley S, 2013, LANCET, V381, P1076, DOI 10.1016/S0140-6736(13)60722-9; Health in the Post-2015 Agenda, 2013, HLTH POST 2015 AG RE; Horton R, 2013, LANCET, V381, P890, DOI 10.1016/S0140-6736(13)60638-8; UN, 2013, HIGH LEVEL DIALOGUE	4	11	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 27	2013	381	9876					1441	1443		10.1016/S0140-6736(13)60765-5	http://dx.doi.org/10.1016/S0140-6736(13)60765-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139TK	23602316				2022-12-28	WOS:000318607300013
J	Schroll, JB; Bero, L; Gotzsche, PC				Schroll, Jeppe Bennekou; Bero, Lisa; Gotzsche, Peter C.			Searching for unpublished data for Cochrane reviews: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TRIALS; METAANALYSIS; PUBLICATION; BENEFITS	Objective To describe the experiences of authors of Cochrane reviews in searching for, getting access to, and using unpublished data. Design Cross sectional study. Setting Cochrane reviews. Participants 2184 corresponding authors of Cochrane reviews as of May 2012. Main outcome measure Frequencies of responses to open ended and closed questions in an online survey. Results Of 5915 authors contacted by email, 2184 replied (36.9% response rate). Of those, 1656 (75.8%) had searched for unpublished data. In 913 cases (55.1% of 1656), new data were obtained and we received details about these data for 794 data sources. The most common data source was "trialists/investigators," accounting for 73.9% (n=587) of the 794 data sources. Most of the data were used in the review (82.0%, 651/794) and in 53.4% (424/794) of cases data were provided in less than a month. Summary data were most common, provided by 50.8% (403/794) of the data sources, whereas 20.5% (163/794) provided individual patient data. In only 6.3% (50/794) of cases were data reported to have been obtained from the manufacturers, and this group waited longer and had to make more contacts to get the data. The data from manufacturers were less likely to be for individual patients and less likely to be used in the review. Data from regulatory agencies accounted for 3.0% (24/794) of the obtained data. Conclusions Most authors of Cochrane reviews who searched for unpublished data received useful information, primarily from trialists. Our response rate was low and the authors who did not respond were probably less likely to have searched for unpublished data. Manufacturers and regulatory agencies were uncommon sources of unpublished data.	[Schroll, Jeppe Bennekou; Gotzsche, Peter C.] Rigshosp, Nord Cochrane Ctr, Dept 7810, DK-2100 Copenhagen O, Denmark; [Bero, Lisa] Univ Calif San Francisco, San Francisco, CA 94143 USA	Rigshospitalet; University of California System; University of California San Francisco	Schroll, JB (corresponding author), Rigshosp, Nord Cochrane Ctr, Dept 7810, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	js@cochrane.dk		Bero, Lisa/0000-0003-1893-6651; Schroll, Jeppe Bennekou/0000-0002-1776-0562	Cochrane Collaboration Methods Innovation Fund	Cochrane Collaboration Methods Innovation Fund	This study was funded by the Cochrane Collaboration Methods Innovation Fund. The funder had no influence on the study design, interpretation of data, or the decision to publish the results.	Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Gibson CA, 2006, INT J TECHNOL ASSESS, V22, P267, DOI 10.1017/S0266462306051105; Gotzsche PC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2686; Hart B, 2011, BMJ-BRIT MED J, V344, pd7202; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Kaner EF, 1998, BRIT J GEN PRACT, V48, P1067; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Lefebvre C, 2011, COCHRANE COLLABORATI; MacLean CH, 2003, J CLIN EPIDEMIOL, V56, P44, DOI 10.1016/S0895-4356(02)00520-6; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Stafford N, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2521; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; van Driel ML, 2009, J CLIN EPIDEMIOL, V62, P838, DOI 10.1016/j.jclinepi.2008.09.010; Young T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000027.pub2	16	37	37	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2013	346								f2231	10.1136/bmj.f2231	http://dx.doi.org/10.1136/bmj.f2231			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134PL	23613540	Green Published, hybrid			2022-12-28	WOS:000318224800003
J	Butterworth, B; Kovas, Y				Butterworth, Brian; Kovas, Yulia			Understanding Neurocognitive Developmental Disorders Can Improve Education for All	SCIENCE			English	Review							DYSLEXIA; BRAIN; DYSCALCULIA; LANGUAGE; CHILDREN; ADHD; NEUROSCIENCE; IMPAIRMENTS; DEFICIT	Specific learning disabilities (SLDs) are estimated to affect up to 10% of the population, and they co-occur far more often than would be expected, given their prevalences. We need to understand the complex etiology of SLDs and their co-occurrences in order to underpin the training of teachers, school psychologists, and clinicians, so that they can reliably recognize SLDs and optimize the learning contexts for individual learners.	[Butterworth, Brian] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Butterworth, Brian] IRCCS Osped San Camillo, Venice, Italy; [Butterworth, Brian; Kovas, Yulia] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Kovas, Yulia] Tomsk State Univ, Dept Psychol, Tomsk 634050, Russia; [Kovas, Yulia] Univ London, Dept Psychol, London, England; Kings Coll London, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England	University of London; University College London; IRCCS Ospedale San Camillo; University of Melbourne; Tomsk State University; University of London; University of London; King's College London	Butterworth, B (corresponding author), UCL, Inst Cognit Neurosci, Alexandra House,17 Queen Sq, London WC1N 3AR, England.	b.butterworth@ucl.ac.uk	Kovas, Yulia/L-7116-2019	Kovas, Yulia/0000-0001-9633-6374				Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 1999, FED REG, V34; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bishop DVM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015112; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; Bruandet M, 2004, NEUROPSYCHOLOGIA, V42, P288, DOI 10.1016/j.neuropsychologia.2003.08.007; Butterworth B, 2011, SCIENCE, V332, P1049, DOI 10.1126/science.1201536; Butterworth B, 2010, ZDM-MATH EDUC, V42, P527, DOI 10.1007/s11858-010-0267-4; Dworzynski K, 2008, INFANT CHILD DEV, V17, P121, DOI 10.1002/icd.536; Frith U, 2012, Q J EXP PSYCHOL, V65, P2073, DOI 10.1080/17470218.2012.697178; Gabrieli JDE, 2009, SCIENCE, V325, P280, DOI 10.1126/science.1171999; Giraud AL, 2013, CURR OPIN NEUROBIOL, V23, P37, DOI 10.1016/j.conb.2012.09.003; Golan O, 2010, J AUTISM DEV DISORD, V40, P269, DOI 10.1007/s10803-009-0862-9; Gooch D, 2011, J CHILD PSYCHOL PSYC, V52, P195, DOI 10.1111/j.1469-7610.2010.02312.x; Goswami U, 2008, FORESIGHT MENTAL CAP; Isaacs EB, 2001, BRAIN, V124, P1701, DOI 10.1093/brain/124.9.1701; JERNIGAN TL, 1991, ARCH NEUROL-CHICAGO, V48, P539, DOI 10.1001/archneur.1991.00530170103028; Jones CRG, 2009, NEUROPSYCHOLOGY, V23, P718, DOI 10.1037/a0016360; Kovas Y, 2007, MONOGR SOC RES CHILD, V72, P1; Kovas Y, 2007, J LEARN DISABIL-US, V40, P554, DOI 10.1177/00222194070400060601; Krain AL, 2006, CLIN PSYCHOL REV, V26, P433, DOI 10.1016/j.cpr.2006.01.005; Landerl K, 2004, COGNITION, V93, P99, DOI 10.1016/j.cognition.2003.11.004; Landerl K, 2010, J CHILD PSYCHOL PSYC, V51, P287, DOI 10.1111/j.1469-7610.2009.02164.x; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P309, DOI 10.1016/j.jecp.2009.03.006; Mazzocco M.M.M., 2007, WHY IS MATH SO HARD, P151; McCandliss BD, 2010, P NATL ACAD SCI USA, V107, P8049, DOI 10.1073/pnas.1003431107; McLean JF, 1999, J EXP CHILD PSYCHOL, V74, P240, DOI 10.1006/jecp.1999.2516; Monuteaux MC, 2005, J LEARN DISABIL-US, V38, P86, DOI 10.1177/00222194050380010701; Morton J., 1995, MANUAL DEV PSYCHOPAT, V1, P357; Parsons S., 2005, DOES NUMERACY MATTER; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Plomin R, 2012, BEHAV GENETICS; Pourcain B. St., 2011, J AM ACAD CHILD ADOL, V50, pe5; Proal E, 2011, ARCH GEN PSYCHIAT, V68, P1122, DOI 10.1001/archgenpsychiatry.2011.117; Raven J., 1998, MANUAL RAVEN PROGR M; Scerri TS, 2010, EUR CHILD ADOLES PSY, V19, P179, DOI 10.1007/s00787-009-0081-0; Sexton CC, 2012, J LEARN DISABIL-US, V45, P538, DOI 10.1177/0022219411407772; Silani G, 2005, BRAIN, V128, P2453, DOI 10.1093/brain/awh579; St Pourcain B, 2011, J AM ACAD CHILD PSY, V50, P892, DOI 10.1016/j.jaac.2011.05.015; Swanson J, 1998, CURR OPIN NEUROBIOL, V8, P263, DOI 10.1016/S0959-4388(98)80150-5; Tanaka H, 2011, PSYCHOL SCI, V22, P1442, DOI 10.1177/0956797611419521; Wechsler D., 1992, WECHSLER INTELLIGENC; Wechsler D., 2012, WAIS 4 KASIKIRJA; World Health Organization, 1994, INT CLASS DIS 10	45	93	99	6	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					300	305		10.1126/science.1231022	http://dx.doi.org/10.1126/science.1231022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126XZ	23599478				2022-12-28	WOS:000317657500039
J	Fine, PEM; Goldacre, BM; Haines, A				Fine, P. E. M.; Goldacre, B. M.; Haines, A.			Epidemiology-a science for the people	LANCET			English	Editorial Material							EDUCATION; NEED		[Fine, P. E. M.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Goldacre, B. M.] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Haines, A.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Haines, A.] Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Fine, PEM (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	paul.fine@lshtm.ac.uk		Goldacre, Ben/0000-0002-5127-4728; Haines, Andy/0000-0002-8053-4605				[Anonymous], 1948, Br Med J, V2, P769; Banerjee AV, 2007, Q J ECON, V122, P1235, DOI 10.1162/qjec.122.3.1235; Bell CC, 2002, J NATL MED ASSOC, V94, P602; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Cooper BEJ, 2012, PUBLIC UNDERST SCI, V21, P664, DOI 10.1177/0963662511401782; Duflo, 2012, POOR EC BAREFOOT HED; Gotzsche PC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub3; Greenwood M., 1935, EPIDEMICS CROWD DIS; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Haynes L., 2012, TEST LEARN ADAPT DEV; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Karlan D., 2012, MORE GOOD INTENTIONS; LILIENFELD DE, 1978, AM J EPIDEMIOL, V107, P87, DOI 10.1093/oxfordjournals.aje.a112521; MacMahon B., 1960, EPIDEMIOLOGIC METHOD; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Oxman AD, 2010, LANCET, V375, P427, DOI 10.1016/S0140-6736(09)61251-4; Panum, 1940, OBSERVATIONS MADE EP; PETO R, 1987, STAT MED, V6, P233, DOI 10.1002/sim.4780060306; Ranson MK, 2007, BRIT MED J, V334, P1309, DOI 10.1136/bmj.39192.719583.AE; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Snow J., 1855, MODE COMMUNICATION C; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Timmermann V., 2011, Bulletin OEPP, V41, P14, DOI 10.1111/j.1365-2338.2010.02429.x; Torgerson C, 2011, SCIENCE, V333, P1220, DOI 10.1126/science.333.6047.1220-b; WILESMITH JW, 1988, VET REC, V123, P638; Wortley R, 2011, SECUR J, V24, P149, DOI 10.1057/sj.2009.22; [No title captured]; [No title captured]	29	19	21	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2013	381	9874					1249	1252		10.1016/S0140-6736(13)60766-7	http://dx.doi.org/10.1016/S0140-6736(13)60766-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122XD	23582383				2022-12-28	WOS:000317351000005
J	Lujambio, A; Akkari, L; Simon, J; Grace, D; Tschaharganeh, DF; Bolden, JE; Zhao, Z; Thapar, V; Joyce, JA; Krizhanovsky, V; Lowe, SW				Lujambio, Amaia; Akkari, Leila; Simon, Janelle; Grace, Danielle; Tschaharganeh, Darjus F.; Bolden, Jessica E.; Zhao, Zhen; Thapar, Vishal; Joyce, Johanna A.; Krizhanovsky, Valery; Lowe, Scott W.			Non-Cell-Autonomous Tumor Suppression by p53	CELL			English	Article							NF-KAPPA-B; OPPOSING ROLES; LIVER-CANCER; SENESCENCE; EXPRESSION; FIBROBLASTS; LIMITS; MICE; PHENOTYPE; APOPTOSIS	The p53 tumor suppressor can restrict malignant transformation by triggering cell-autonomous programs of cell-cycle arrest or apoptosis. p53 also promotes cellular senescence, a tumor-suppressive program that involves stable cell-cycle arrest and secretion of factors that modify the tissue microenvironment. In the presence of chronic liver damage, we show that ablation of a p53-dependent senescence program in hepatic stellate cells increases liver fibrosis and cirrhosis associated with reduced survival and enhances the transformation of adjacent epithelial cells into hepatocellular carcinoma. p53-expressing senescent stellate cells release factors that skew macrophage polarization toward a tumor-inhibiting M1-state capable of attacking senescent cells in culture, whereas proliferating p53-deficient stellate cells secrete factors that stimulate polarization of macrophages into a tumor-promoting M2-state and enhance the proliferation of premalignant cells. Hence, p53 can act non-cell autonomously to suppress tumorigenesis by promoting an antitumor microenvironment, in part, through secreted factors that modulate macrophage function.	[Lujambio, Amaia; Simon, Janelle; Grace, Danielle; Bolden, Jessica E.; Zhao, Zhen; Thapar, Vishal; Krizhanovsky, Valery; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Lujambio, Amaia; Akkari, Leila; Simon, Janelle; Grace, Danielle; Tschaharganeh, Darjus F.; Bolden, Jessica E.; Zhao, Zhen; Thapar, Vishal; Joyce, Johanna A.; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Krizhanovsky, Valery] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Simon, Janelle; Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center; Weizmann Institute of Science; Howard Hughes Medical Institute	Krizhanovsky, V (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	valery.krizhanovsky@weizmann.ac.il; lowes@mskcc.org	; Krizhanovsky, Valery/D-1336-2010	Lujambio, Amaia/0000-0002-2798-1481; Akkari, Leila/0000-0001-5479-641X; Zhao, Zhen/0000-0001-5271-4759; Krizhanovsky, Valery/0000-0002-3977-5482	NCI [U54 CA148967]; German Research Foundation (DFG); Israel Science Foundation; NIA [AG16379]; NATIONAL CANCER INSTITUTE [P01CA087497, U54CA148967, P30CA008748, P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG016379, R01AG016379] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Research Foundation (DFG)(German Research Foundation (DFG)); Israel Science Foundation(Israel Science Foundation); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully thank Jacqueline Cappellani and Sha Tian for excellent technical assistance; Prem Premsrirut for generating the TG-p53.1224 mouse strain; Orit Pappo for advice in pathological analyses; Vadim Pinskiy and Anna Chuprin for scanning the slides; Carolyn Zawislak for help with NK cell isolation; Anna Sabarovsky for assistance with ultrasound imaging; and Eusebio Manchado, Geulah Livshits, Shane Mayack, and Charles Sherr for constructive criticisms and careful editing of the manuscript. We also thank members of the Lowe laboratory for stimulating discussions. We thank CSHL and MSKCC animal facilities, CSHL histology facility, MSKCC Molecular Cytology Core, and MSKCC Genomics Core. A. L. is funded by EMBO-Long-Term Fellowship; J. A. J. and L. A. are funded by NCI U54 CA148967; D. F. T. is funded by the German Research Foundation (DFG); and V. K. is an incumbent of The Karl and Frances Korn Career Development Chair at Weizmann Institute of Science and is supported by Israel Science Foundation. S. W. L. is the Geoffrey Beene chair for Cancer Biology and is a Howard Hughes Medical Institute investigator. This work was supported by AG16379 grant from the NIA.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Crescenzi E, 2011, ONCOGENE, V30, P2707, DOI 10.1038/onc.2011.1; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Hesse M, 2000, AM J PATHOL, V157, P945, DOI 10.1016/S0002-9440(10)64607-X; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kiaris H, 2005, CANCER RES, V65, P1627, DOI 10.1158/0008-5472.CAN-04-3791; Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Marino S, 2000, GENE DEV, V14, P994; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Oakley F, 2005, AM J PATHOL, V166, P695, DOI 10.1016/S0002-9440(10)62291-2; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Tanikawa C, 2009, ONCOGENE, V28, P3081, DOI 10.1038/onc.2009.154; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670; Zimmermann HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021381	38	486	499	10	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					449	460		10.1016/j.cell.2013.03.020	http://dx.doi.org/10.1016/j.cell.2013.03.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23562644	Green Accepted, Bronze			2022-12-28	WOS:000317349700022
J	Subramanian, N; Natarajan, K; Clatworthy, MR; Wang, Z; Germain, RN				Subramanian, Naeha; Natarajan, Kannan; Clatworthy, Menna R.; Wang, Ze; Germain, Ronald N.			The Adaptor MAVS Promotes NLRP3 Mitochondrial Localization and Inflammasome Activation	CELL			English	Article							ANTIVIRAL SIGNALING PROTEIN; CASPASE-1 ACTIVATION; REPERFUSION INJURY; OXIDATIVE STRESS; IMMUNE-RESPONSE; CELLS; FORMS; ATP; ASC; EXPRESSION	NLRP3 is a key component of the macromolecular signaling complex called the inflammasome that promotes caspase 1-dependent production of IL-1 beta. The adaptor ASC is necessary for NLRP3-dependent inflammasome function, but it is not known whether ASC is a sufficient partner and whether inflammasome formation occurs in the cytosol or in association with mitochondria is controversial. Here, we show that the mitochondria-associated adaptor molecule, MAVS, is required for optimal NLRP3 inflammasome activity. MAVS mediates recruitment of NLRP3 to mitochondria, promoting production of IL-1b and the pathophysiologic activity of the NLRP3 inflammasome in vivo. Our data support a more complex model of NLRP3 inflammasome activation than previously appreciated, with at least two adapters required for maximal function. Because MAVS is a mitochondria-associated molecule previously considered to be uniquely involved in type 1 interferon production, these findings also reveal unexpected polygamous involvement of PYD/CARD-domain-containing adapters in innate immune signaling events.	[Subramanian, Naeha; Clatworthy, Menna R.; Wang, Ze; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Natarajan, Kannan] NIAID, Mol Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Clatworthy, Menna R.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 0XY, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Subramanian, N (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	subramaniann@niaid.nih.gov; rgermain@nih.gov	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Subramanian, Naeha/0000-0003-3754-0521	Intramural Research Program, NIAID, NIH; Wellcome Trust [WT081020]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000622, ZIAAI000974] Funding Source: NIH RePORTER	Intramural Research Program, NIAID, NIH; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program, NIAID, NIH, and a Wellcome Trust Intermediate Fellowship (WT081020) to M. R. C. We are grateful to Drs. Daniel Kastner, Michael Lenardo, and Iain Fraser for critical reading of the manuscript. We thank the Biological Imaging Section, NIAID, NIH for excellent imaging support; Dr. Vishva Dixit and Dr. Zhijian Chen for kindly providing mouse strains; Dr. Eicke Latz for generously providing HEK-293-ASC-YFP cells; Dr. Iain Fraser for providing lentiviral constructs; and Drs. Wolfgang Kastenmuller, Marlene Brandes, and Jae Jin Chae for helpful discussions. The authors declare that they have no competing financial interests.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Berry M, 2012, IMMUNOTHERAPY-UK, V4, P323, DOI [10.2217/IMT.11.175, 10.2217/imt.11.175]; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Cheng J, 2010, J CELL PHYSIOL, V222, P738, DOI 10.1002/jcp.22005; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Faubel S, 2004, KIDNEY INT, V66, P2202, DOI 10.1111/j.1523-1755.2004.66010.x; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Furuichi K, 2006, CRIT CARE MED, V34, P2447, DOI 10.1097/01.CCM.0000233878.36340.10; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Goldbach-Mansky R, 2009, J ALLERGY CLIN IMMUN, V124, P1141, DOI 10.1016/j.jaci.2009.11.016; Gu BJ, 2010, BLOOD, V115, P1621, DOI 10.1182/blood-2009-11-251744; Haq M, 1998, J AM SOC NEPHROL, V9, P614; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Li XD, 2011, P NATL ACAD SCI USA, V108, P17390, DOI 10.1073/pnas.1107114108; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rajan JV, 2010, FEBS LETT, V584, P4627, DOI 10.1016/j.febslet.2010.10.036; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Wagner RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004931; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	41	420	437	3	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					348	361		10.1016/j.cell.2013.02.054	http://dx.doi.org/10.1016/j.cell.2013.02.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582325	Green Accepted, Bronze			2022-12-28	WOS:000317349700014
J	Willenbring, H; Grompe, M				Willenbring, Holger; Grompe, Markus			A Therapy for Liver Failure Found in the JNK Yard	CELL			English	Editorial Material							CELL-CYCLE PROGRESSION	In the liver, the hepatocyte mass is kept stable through a tight balance between hepatocyte death and proliferation that is frequently lost upon acute or chronic liver injury. Wuestefeld et al. (2013) now identify a potentially druggable target that enhances hepatocyte proliferation and promotes liver regeneration, thereby preventing liver failure.	[Willenbring, Holger] Univ Calif San Francisco, Dept Surg, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Willenbring, Holger] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; [Grompe, Markus] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97239 USA; [Grompe, Markus] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97239 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Oregon Health & Science University; Oregon Health & Science University	Willenbring, H (corresponding author), Univ Calif San Francisco, Dept Surg, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	willenbringh@stemcell.ucsf.edu; grompem@ohsu.edu		Grompe, Markus/0000-0002-6616-4345	NCATS NIH HHS [UH3 TR000487, UH2 TR000487] Funding Source: Medline; NIDDK NIH HHS [P30 DK026743, R01 DK05192, R01 DK080852, P30 DK26743] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000487, UH3TR000487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Corazza N, 2006, J CLIN INVEST, V116, P2493, DOI 10.1172/JCI27726; Ido A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-55; Ng R, 2012, J CLIN INVEST, V122, P1097, DOI 10.1172/JCI46039; Nishina H, 1999, DEVELOPMENT, V126, P505; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wuestefeld T, 2013, CELL, V153, P389, DOI 10.1016/j.cell.2013.03.026; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	8	5	6	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					283	284		10.1016/j.cell.2013.03.033	http://dx.doi.org/10.1016/j.cell.2013.03.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582318	Green Accepted, Bronze			2022-12-28	WOS:000317349700007
J	Xing, MZ; Alzahrani, AS; Carson, KA; Viola, D; Elisei, R; Bendlova, B; Yip, L; Mian, C; Vianello, F; Tuttle, RM; Robenshtok, E; Fagin, JA; Puxeddu, E; Fugazzola, L; Czarniecka, A; Jarzab, B; O'Neill, CJ; Sywak, MS; Lam, AK; Riesco-Eizaguirre, G; Santisteban, P; Nakayama, H; Tufano, RP; Pai, SI; Zeiger, MA; Westra, WH; Clark, DP; Clifton-Bligh, R; Sidransky, D; Ladenson, PW; Sykorova, V				Xing, Mingzhao; Alzahrani, Ali S.; Carson, Kathryn A.; Viola, David; Elisei, Rossella; Bendlova, Bela; Yip, Linwah; Mian, Caterina; Vianello, Federica; Tuttle, R. Michael; Robenshtok, Eyal; Fagin, James A.; Puxeddu, Efisio; Fugazzola, Laura; Czarniecka, Agnieszka; Jarzab, Barbara; O'Neill, Christine J.; Sywak, Mark S.; Lam, Alfred K.; Riesco-Eizaguirre, Garcilaso; Santisteban, Pilar; Nakayama, Hirotaka; Tufano, Ralph P.; Pai, Sara I.; Zeiger, Martha A.; Westra, William H.; Clark, Douglas P.; Clifton-Bligh, Roderick; Sidransky, David; Ladenson, Paul W.; Sykorova, Vlasta			Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEEDLE-ASPIRATION BIOPSY; BRAF(V600E) MUTATION; GENE METHYLATION; HIGH PREVALENCE; CARCINOMA; RISK; PATHOGENESIS; RECURRENCE; GENOME; COHORT	Importance BRAF V600E is a prominent oncogene in papillary thyroid cancer (PTC), but its role in PTC-related patient mortality has not been established. Objective To investigate the relationship between BRAF V600E mutation and PTC-related mortality. Design, Setting, and Participants Retrospective study of 1849 patients (1411 women and 438 men) with a median age of 46 years (interquartile range, 34-58 years) and an overall median follow-up time of 33 months (interquartile range, 13-67 months) after initial treatment at 13 centers in 7 countries between 1978 and 2011. Main Outcomes and Measures Patient deaths specifically caused by PTC. Results Overall, mortality was 5.3% (45/845; 95% CI, 3.9%-7.1%) vs 1.1% (11/1004; 95% CI, 0.5%-2.0%) (P<.001) in BRAF V600E-positive vs mutation-negative patients. Deaths per 1000 person-years in the analysis of all PTC were 12.87 (95% CI, 9.61-17.24) vs 2.52 (95% CI, 1.40-4.55) in BRAF V600E-positive vs mutation-negative patients; the hazard ratio (HR) was 2.66 (95% CI, 1.30-5.43) after adjustment for age at diagnosis, sex, and medical center. Deaths per 1000 person-years in the analysis of the conventional variant of PTC were 11.80 (95% CI, 8.39-16.60) vs 2.25 (95% CI, 1.01-5.00) in BRAF V600E-positive vs mutation-negative patients; the adjusted HR was 3.53 (95% CI, 1.25-9.98). When lymph node metastasis, extrathyroidal invasion, and distant metastasis were also included in the model, the association of BRAF V600E with mortality for all PTC was no longer significant (HR, 1.21; 95% CI, 0.53-2.76). A higher BRAF V600E-associated patient mortality was also observed in several clinicopathological subcategories, but statistical significance was lost with adjustment for patient age, sex, and medical center. For example, in patients with lymph node metastasis, the deaths per 1000 person-years were 26.26 (95% CI, 19.1835.94) vs 5.93 (95% CI, 2.96-11.86) in BRAF V600E-positive vs mutation-negative patients (unadjusted HR, 4.43 [95% CI, 2.06-9.51]; adjusted HR, 1.46 [95% CI, 0.62-3.47]). In patients with distant tumor metastasis, deaths per 1000 person-years were 87.72 (95% CI, 62.68-122.77) vs 32.28 (95% CI, 16.14-64.55) in BRAF V600E-positive vs mutation-negative patients (unadjusted HR, 2.63 [95% CI, 1.21-5.72]; adjusted HR, 0.84 [95% CI, 0.27-2.62]). Conclusions and Relevance In this retrospective multicenter study, the presence of the BRAF V600E mutation was significantly associated with increased cancer-related mortality among patients with PTC. Because overall mortality in PTC is low and the association was not independent of tumor features, how to use BRAF V600E to manage mortality risk in patients with PTC is unclear. These findings support further investigation of the prognostic and therapeutic implications of BRAF V600E status in PTC. JAMA. 2013;309(14):1493-1501 www.jama.com	[Xing, Mingzhao; Alzahrani, Ali S.] Johns Hopkins Univ, Sch Med, Lab Cellular & Mol Thyroid Res, Baltimore, MD 21287 USA; [Ladenson, Paul W.] Johns Hopkins Univ, Div Endocrinol & Metab, Baltimore, MD 21287 USA; [Tufano, Ralph P.; Pai, Sara I.] Johns Hopkins Univ, Dept Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; [Zeiger, Martha A.] Johns Hopkins Univ, Endocrine Surg Sect, Dept Surg, Baltimore, MD 21287 USA; [Westra, William H.; Clark, Douglas P.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21287 USA; [Carson, Kathryn A.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch,Publ Hlth, Baltimore, MD 21287 USA; [Viola, David; Elisei, Rossella] Univ Pisa, Dept Clin & Expt Med, World Hlth Org, Collaborating Ctr Study & Treatment Thy roid Dis, Pisa, Italy; [Bendlova, Bela; Sykorova, Vlasta] Inst Endocrinol, Dept Mol Endocrinol, Prague, Czech Republic; [Yip, Linwah] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Mian, Caterina] Univ Padua, Operat Unit Endocrinol, Dept Internal Med DIMED, Padua, Italy; [Vianello, Federica] Inst Ricovero Cura Carattere Sci, Veneto Inst Oncol, Padua, Italy; [Tuttle, R. Michael; Robenshtok, Eyal; Fagin, James A.] Mem Sloan Kettering Canc Ctr, Dept Med Human Oncol & Pathogenesis, New York, NY 10021 USA; [Puxeddu, Efisio] Univ Perugia, Dept Internal Med, I-06100 Perugia, Italy; [Robenshtok, Eyal] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Czarniecka, Agnieszka] Maria Sklodowska Curie Mem Canc Ctr, Dept Oncol & Reconstruct Surg, Gliwice, Poland; [Jarzab, Barbara] Maria Sklodowska Curie Mem Canc Ctr, Dept & Endocrine Oncol, Gliwice, Poland; Inst Oncol, Gliwice, Poland; [O'Neill, Christine J.] Univ Sydney, Endocrine Surg Unit, St Leonards, NSW, Australia; [Clifton-Bligh, Roderick] Univ Sydney, Kolling Inst Med Res, St Leonards, NSW, Australia; [Lam, Alfred K.] Sch Med, Dept Canc Mol Pathol, Gold Coast, Qld, Australia; [Lam, Alfred K.] Griffith Hlth Inst, Gold Coast, Qld, Australia; [Riesco-Eizaguirre, Garcilaso] Hosp La Paz, Dept Endocrinol & Nutr, Hlth Res Inst, Madrid, Spain; [Riesco-Eizaguirre, Garcilaso; Santisteban, Pilar] Spanish Council Res, Biomed Res Inst Alberto Sols, Madrid, Spain; [Riesco-Eizaguirre, Garcilaso] Autonomous Univ Madrid, E-28049 Madrid, Spain; [Nakayama, Hirotaka] Kanagawa Canc Ctr, Dept Breast & Endocrine Surg, Yokohama, Kanagawa 2410815, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pisa; World Health Organization; Institute of Endocrinology - Prague; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); Memorial Sloan Kettering Cancer Center; University of Perugia; University of Milan; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of Sydney; University of Sydney; Kolling Institute of Medical Research; Menzies Health Institute Queensland; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Kanagawa Prefectural Cancer Center	Xing, MZ (corresponding author), Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, 1830 E Monument St,Ste 333, Baltimore, MD 21287 USA.	mxing1@jhmi.edu	Barbara, Jarzab/I-4654-2019; Lam, Alfred/C-1652-2008; Jarząb, Barbara/AAI-7942-2020; Riesco-Eizaguirre, Garcilaso/O-8750-2015; Viola, David/C-2864-2011; Czarniecka, Agnieszka/I-5137-2014; O'Neill, Christine/AAN-4385-2020; Fugazzola, laura/AAH-7803-2021; Santisteban, Pilar/E-7829-2016	Lam, Alfred/0000-0003-2771-564X; Jarząb, Barbara/0000-0001-9811-9584; Riesco-Eizaguirre, Garcilaso/0000-0002-2608-6397; Viola, David/0000-0001-7683-152X; Czarniecka, Agnieszka/0000-0003-1249-7205; O'Neill, Christine/0000-0002-3122-8660; Santisteban, Pilar/0000-0002-2758-796X; Pai, Sara/0000-0002-6341-9971; Clifton-Bligh, Roderick/0000-0002-1545-0368; MIAN, CATERINA/0000-0003-2615-8001; Vianello, Federica/0000-0001-7801-5825; ELISEI, ROSSELLA/0000-0002-5333-9257	Novartis; Sanofi; Ipsen; National Institutes of Health (NIH) [R01CA134225, R01CA113507]; National Center for Advancing Translational Sciences [UL1RR025005]; NIH Roadmap for Medical Research; Ministry of Science and Higher Education Research [N N403 194340, N N401 612440]; NIDCR/NCI SPORE [P50DE019032]; FIS, ISCIII [BFU2010-16025, RD06/0020/0060-RD12/0036/0030]; TIRONET [S2011/BMD-2328]; Byrne Foundation; Fondazione Cassa di Risparmio di Perugia; Associazione Italiana per la Ricerca sul Cancro (Italy) [IG 9338]; Beadle Family Foundation (San Antonio, Texas) [IGA MHCRNT 13901-4]; New South Wales Cancer Institute; Cancer Council of New South Wales;  [NIH-R01-CA50706]; NATIONAL CANCER INSTITUTE [R01CA050706, R01CA113507, P30CA008748, R01CA134225] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [P50DE019032] Funding Source: NIH RePORTER	Novartis(Novartis); Sanofi; Ipsen(Ipsen); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Higher Education Research; NIDCR/NCI SPORE; FIS, ISCIII(Instituto de Salud Carlos III); TIRONET; Byrne Foundation; Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia); Associazione Italiana per la Ricerca sul Cancro (Italy)(Fondazione AIRC per la ricerca sul cancro); Beadle Family Foundation (San Antonio, Texas); New South Wales Cancer Institute; Cancer Council of New South Wales(Cancer Council New South Wales); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Xing and Sidransky reported receiving royalties as co-holders of a licensed US patent related to BRAF V600E mutation in thyroid cancer. Dr Elisei reports board membership, consultancy, and/or payment for lectures/speakers bureaus for AstraZeneca, Bayer, Exelixis, Genzyme, and Roche. Dr Fagin reports that he is lead investigator in clinical trials with an AZ MEK inhibitor and receives grant support for preclinical studies with this and other compounds in BRAF mutant thyroid cancer models. Dr Puxeddu reports consultancy for Euro 7000. Dr Jarzab reports consultancy for AstraZeneca, employment by AstraZeneca, Novartis, Pfizer, Bayer, Roche, Eisai, OxiGene, and Exelixis for clinical trials, payment for lecturing and development of educational presentations by Novartis and Ipsen, payment for manuscript preparation by Molecular and Cellular Endocrinology, and payment for travel/meeting expenses by Novartis, Sanofi, and Ipsen. Dr Tufano reports consultancy for Ethicon Endosurgery and Medtronic. Dr Clifton-Bligh reports advisory board membership (money to his institution) for Amgen, Merck Sharp & Dohme, Ipsen, and Genzyme. No other disclosures were reported.r This project was supported by National Institutes of Health (NIH) grants R01CA134225 and R01CA113507 to Dr Xing. The statistical effort of Ms Carson for this project was supported by grant UL1RR025005 from the National Center for Advancing Translational Sciences and the NIH Roadmap for Medical Research. In addition, the studies at individual centers were supported as follows: the Ministry of Science and Higher Education Research grants N N403 194340 and N N401 612440 to Drs Czarniecka and Jarzab, respectively (Poland); grant NIDCR/NCI SPORE P50DE019032 to Dr Sindransky (United States); grants BFU2010-16025, RD06/0020/0060-RD12/0036/0030 FIS, ISCIII, and S2011/BMD-2328 TIRONET to Dr Santisteban (Spain); grant NIH-R01-CA50706 and Byrne Foundation funding to Dr Fagin (United States); grants from Fondazione Cassa di Risparmio di Perugia and Associazione Italiana per la Ricerca sul Cancro (IG 9338) (Italy) and the Beadle Family Foundation (San Antonio, Texas) to Dr Puxeddu; grant IGA MHCRNT 13901-4 to Drs Sykorova and Bendlova (Czech Republic); and grants from the New South Wales Cancer Institute to Dr O'Neill and from the Cancer Council of New South Wales to Dr Clifton-Bligh (Australia).	Brown RL, 2011, J CANCER, V2, P193, DOI 10.7150/jca.2.193; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Czarniecka A, 2010, ENDOKRYNOL POL, V61, P462; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P3943, DOI 10.1210/jc.2008-0607; Fugazzola L, 2004, CLIN ENDOCRINOL, V61, P239, DOI 10.1111/j.1365-2265.2004.02089.x; Fukushima T, 2003, ONCOGENE, V22, P6455, DOI 10.1038/sj.onc.1206739; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Hou P, 2012, CELL CYCLE, V11, P286, DOI 10.4161/cc.11.2.18707; Hou P, 2011, ENDOCR-RELAT CANCER, V18, P687, DOI 10.1530/ERC-11-0212; Howlader N, 2012, SEER CANC STAT REV 1; Kim TH, 2012, CANCER-AM CANCER SOC, V118, P1764, DOI 10.1002/cncr.26500; Kimura ET, 2003, CANCER RES, V63, P1454; Nakayama H, 2007, ANTICANCER RES, V27, P3645; Namba H, 2003, J CLIN ENDOCR METAB, V88, P4393, DOI 10.1210/jc.2003-030305; Nucera C, 2011, CANCER RES, V71, P2417, DOI 10.1158/0008-5472.CAN-10-3844; O'Neill CJ, 2010, SURGERY, V148, P1139, DOI 10.1016/j.surg.2010.09.005; Pelizzo MR, 2011, CLIN CHEM LAB MED, V49, P325, DOI 10.1515/CCLM.2011.031; Puxeddu E, 2004, J CLIN ENDOCR METAB, V89, P2414, DOI 10.1210/jc.2003-031425; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Riesco-Eizaguirre G, 2006, ENDOCR-RELAT CANCER, V13, P257, DOI 10.1677/erc.1.01119; Smith RA, 2011, HUM PATHOL, V42, P500, DOI 10.1016/j.humpath.2009.09.023; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Sykorova V, 2010, J ENDOCRINOL INVEST, V33, P318, DOI [10.1007/BF03346593, 10.3275/6722]; Tuttle RM, 2010, J NATL COMPR CANC NE, V8, P1228, DOI 10.6004/jnccn.2010.0093; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Xing MZ, 2010, MOL CELL ENDOCRINOL, V321, P86, DOI 10.1016/j.mce.2009.10.012; Xing MZ, 2009, J CLIN ONCOL, V27, P2977, DOI 10.1200/JCO.2008.20.1426; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Xu XL, 2003, CANCER RES, V63, P4561; Yip L, 2009, SURGERY, V146, P1215, DOI 10.1016/j.surg.2009.09.011	35	620	681	3	89	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1493	1501		10.1001/jama.2013.3190	http://dx.doi.org/10.1001/jama.2013.3190			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571588	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000317271700027
J	Poucet, B; Sargolini, F				Poucet, Bruno; Sargolini, Francesca			A Trace of Your Place	SCIENCE			English	Editorial Material							SPATIAL REPRESENTATION		[Poucet, Bruno; Sargolini, Francesca] Aix Marseille Univ, CNRS, Cognit Neurosci Lab, F-13331 Marseille 3, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Poucet, B (corresponding author), Aix Marseille Univ, CNRS, Cognit Neurosci Lab, F-13331 Marseille 3, France.	bruno.poucet@univ-amu.fr	Poucet, Bruno/B-4019-2010	Poucet, Bruno/0000-0003-2704-804X; Sargolini, Francesca/0000-0002-5038-3746				Barry C, 2012, P NATL ACAD SCI USA, V109, P17687, DOI 10.1073/pnas.1209918109; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Save E, 2000, HIPPOCAMPUS, V10, P64, DOI 10.1002/(SICI)1098-1063(2000)10:1<64::AID-HIPO7>3.3.CO;2-P; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	8	3	3	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2013	340	6128					35	36		10.1126/science.1237567	http://dx.doi.org/10.1126/science.1237567			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559237				2022-12-28	WOS:000317061100033
J	Bostrom, P; Frisen, J				Bostrom, Pontus; Frisen, Jonas			New Cells in Old Hearts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIAC REGENERATION; RENEWAL		[Bostrom, Pontus; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet	Bostrom, P (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.							Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Rosenzweig A, 2012, SCIENCE, V338, P1549, DOI 10.1126/science.1228951; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682	5	8	9	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1358	1360		10.1056/NEJMcibr1300157	http://dx.doi.org/10.1056/NEJMcibr1300157			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117YT	23550676				2022-12-28	WOS:000316989900017
J	Mentzer, A; Jacobs, M				Mentzer, Alex; Jacobs, Michael			A mass in the liver	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INVASIVE AMEBIASIS; HEPATIC AMEBIASIS; ABSCESS; INFECTION; COMPLICATIONS; HISTOLYTICA; EXPERIENCE; DIAGNOSIS		[Mentzer, Alex; Jacobs, Michael] Royal Free NHS Fdn Trust, Dept Infect Dis, London NW3 2QG, England		Mentzer, A (corresponding author), Royal Free NHS Fdn Trust, Dept Infect Dis, London NW3 2QG, England.	alexmentzer@doctors.net.uk		Mentzer, Alexander/0000-0002-4502-2209				ADAMS EB, 1977, MEDICINE, V56, P325, DOI 10.1097/00005792-197707000-00004; AIKAT BK, 1979, T ROY SOC TROP MED H, V73, P188, DOI 10.1016/0035-9203(79)90209-8; Alvarez JA, 2001, DIGEST SURG, V18, P283, DOI 10.1159/000050153; [Anonymous], BNF; ARELLANO J, 1992, ARCHIVES OF MEDICAL RESEARCH, VOL 23, NO 2, P269; Balasegaram M, 1981, Curr Probl Surg, V18, P282; BARNES PF, 1987, MEDICINE, V66, P472, DOI 10.1097/00005792-198711000-00005; Blessmann J, 2002, NEW ENGL J MED, V347, P1384, DOI 10.1056/NEJM200210243471722; Chavez-Tapia NC, 2009, COCHRANE DB SYST REV, V1; Cook GC., 2009, DISEASES-BASEL, DOI [10.1016/B978-1-4160-4470-3.50014-8, DOI 10.1016/B978-1-4160-4470-3.50014-8]; Cosme A, 2010, REV ESP ENFERM DIG, V102, P90, DOI 10.4321/s1130-01082010000200004; Garcia LS, 2000, J CLIN MICROBIOL, V38, P3337, DOI 10.1128/JCM.38.9.3337-3340.2000; GULATI PD, 1967, AM J MED, V42, P852, DOI 10.1016/0002-9343(67)90102-7; Haque R, 2006, ARCH MED RES, V37, P273, DOI 10.1016/j.arcmed.2005.09.001; Heneghan Helen M, 2011, BMC Res Notes, V4, P80, DOI 10.1186/1756-0500-4-80; Hoffner RJ, 1999, ANN EMERG MED, V34, P351, DOI 10.1016/S0196-0644(99)70130-7; Hope WW, 2008, AM SURGEON, V74, P178; Hung CC, 2005, ARCH INTERN MED, V165, P409, DOI 10.1001/archinte.165.4.409; IBARRAPEREZ C, 1981, CHEST, V79, P672, DOI 10.1378/chest.79.6.672; JACKSON TFHG, 1984, T ROY SOC TROP MED H, V78, P342, DOI 10.1016/0035-9203(84)90115-9; KATZENSTEIN D, 1982, MEDICINE, V61, P237, DOI 10.1097/00005792-198207000-00003; Khan R, 2008, WORLD J GASTROENTERO, V14, P2089, DOI 10.3748/wjg.14.2089; Khan Ujjawini, 2006, Indian J Gastroenterol, V25, P55; Lasserre R., 1979, PHIL J MICROBIOL INF, V8, P1; Lodhi S, 2004, TROP MED INT HEALTH, V9, P718, DOI 10.1111/j.1365-3156.2004.01246.x; Maldonado-Barrera CA, 2012, PARASITOL RES, V110, P1291, DOI 10.1007/s00436-011-2617-8; Mandell GL, 2010, MANDELL DOUGLAS BENN; MCAULEY JB, 1992, CLIN INFECT DIS, V14, P1161, DOI 10.1093/clinids/14.5.1161; MENG XY, 1994, SOUTHERN MED J, V87, P985, DOI 10.1097/00007611-199410000-00004; Mohsen AH, 2002, QJM-INT J MED, V95, P797, DOI 10.1093/qjmed/95.12.797; Park WB, 2007, EMERG INFECT DIS, V13, P516, DOI 10.3201/eid1303.060894; Petri A, 2002, LANGENBECK ARCH SURG, V387, P27, DOI 10.1007/s00423-002-0279-9; RAVDIN JI, 1995, CLIN INFECT DIS, V20, P1453, DOI 10.1093/clinids/20.6.1453; Salles JM, 2007, EXPERT REV ANTI-INFE, V5, P893, DOI 10.1586/14787210.5.5.893; Sarda Anil K, 2011, Korean J Hepatol, V17, P71, DOI 10.3350/kjhep.2011.17.1.71; Shandera WX, 1998, SOUTH MED J, V91, P829, DOI 10.1097/00007611-199809000-00005; STAMM WP, 1977, T ROY SOC TROP MED H, V71, P490, DOI 10.1016/0035-9203(77)90141-9; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Stanley SL, 2001, TRENDS PARASITOL, V17, P280, DOI 10.1016/S1471-4922(01)01903-1; Tengku SA, 2011, TROP BIOMED, V28, P194; THOMPSON JE, 1985, REV INFECT DIS, V7, P171; TOSSWILL JHC, 1980, J CLIN PATHOL, V33, P33, DOI 10.1136/jcp.33.1.33; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173	44	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2013	346								f2036	10.1136/bmj.f2036	http://dx.doi.org/10.1136/bmj.f2036			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122SG	23553973				2022-12-28	WOS:000317337800017
J	Kirshner, HS				Kirshner, Howard S.			Review: SSRIs somewhat improve dependence and disability after stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA	Vanderbilt University	Kirshner, HS (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA.				Stroke Research Network, UK; Scottish Stroke Research Network	Stroke Research Network, UK; Scottish Stroke Research Network	Stroke Research Network, UK, and Scottish Stroke Research Network.	Chen Y, 2006, ANN PHARMACOTHER, V40, P2115, DOI 10.1345/aph.1H389; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8	2	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6							JC12	10.7326/0003-4819-158-6-201303190-02012	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23553006				2022-12-28	WOS:000316565100011
J	Dekker, J; Wysocka, J; Mattaj, I; Aiden, EL; Pikaard, C				Dekker, Job; Wysocka, Joanna; Mattaj, Iain; Aiden, Erez Lieberman; Pikaard, Craig			Nuclear Biology: What's Been Most Surprising?	CELL			English	Editorial Material									[Dekker, Job] Univ Massachusetts, Sch Med, Amherst, MA 01003 USA; [Wysocka, Joanna] Stanford Univ, Stanford, CA 94305 USA; [Mattaj, Iain] European Mol Biol Lab, Heidelberg, Germany; [Aiden, Erez Lieberman] Harvard Univ, Cambridge, MA 02138 USA; [Pikaard, Craig] Indiana Univ, Bloomington, IN 47405 USA	University of Massachusetts System; University of Massachusetts Amherst; Stanford University; European Molecular Biology Laboratory (EMBL); Harvard University; Indiana University System; Indiana University Bloomington	Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Amherst, MA 01003 USA.		Aiden, Erez Lieberman/A-2908-2010; Pikaard, Craig S/K-8772-2012	Pikaard, Craig S/0000-0001-8204-7459; Mattaj, Iain/0000-0002-5537-8284	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008540] Funding Source: NIH RePORTER; NIH HHS [DP2 OD008540] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)			0	1	1	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1207	1208						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23616995				2022-12-28	WOS:000316192500001
J	Cunningham, D; Hawkes, EA; Jack, A; Qian, WD; Smith, P; Mouncey, P; Pocock, C; Ardeshna, KM; Radford, JA; McMillan, A; Davies, J; Turner, D; Kruger, A; Johnson, P; Gambell, J; Linch, D				Cunningham, David; Hawkes, Eliza A.; Jack, Andrew; Qian, Wendi; Smith, Paul; Mouncey, Paul; Pocock, Christopher; Ardeshna, Kirit M.; Radford, John A.; McMillan, Andrew; Davies, John; Turner, Deborah; Kruger, Anton; Johnson, Peter; Gambell, Joanna; Linch, David			Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; 3-WEEKLY CHOP CHEMOTHERAPY; POOR-PROGNOSIS; ELDERLY-PATIENTS; STANDARD CHOP; AGGRESSIVE LYMPHOMAS; YOUNG-PATIENTS; ACVBP; TRANSPLANTATION; MULTICENTER	Background Dose intensification with a combination of cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) every 2 weeks improves outcomes in patients older than 60 years with diffuse large B-cell lymphoma compared with CHOP every 3 weeks. We investigated whether this survival benefit from dose intensification persists in the presence of rituximab (R-CHOP) in all age groups. Methods Patients (aged >= 18 years) with previously untreated bulky stage IA to stage IV diffuse large B-cell lymphoma in 119 centres in the UK were randomly assigned centrally in a one-to-one ratio, using minimisation, to receive six cycles of R-CHOP every 14 days plus two cycles of rituximab (R-CHOP-14) or eight cycles of R-CHOP every 21 days (R-CHOP-21). R-CHOP-21 was intravenous cyclophosphamide 750 mg/m(2), doxorubicin 50 mg/m(2), vincristine 1.4 mg/m(2) (maximum dose 2 mg), and rituximab 375 mg/m(2) on day 1, and oral prednisolone 40 mg/m(2) on days 1-5, administered every 21 days for a total of eight cycles. R-CHOP-14 was intravenous cyclophosphamide 750 mg/m(2), doxorubicin 50 mg/m(2), vincristine 2 mg, rituximab 375 mg/m(2) on day 1, and oral prednisolone 100 mg on days 1-5, administered every 14 days for six cycles, followed by two further infusions of rituximab 375 mg/m(2) on day 1 every 14 days. The trial was not masked. The primary outcome was overall survival (OS). This study is registered, number ISCRTN 16017947. Findings 1080 patients were assigned to R-CHOP-21 (n=540) and R-CHOP-14 (n=540). With a median follow-up of 46 months (IQR 35-57), 2-year OS was 82.7% (79.5-85.9) in the R-CHOP-14 group and 80.8% (77.5-84.2) in the R-CHOP-21 (standard) group (hazard ratio 0.90, 95% CI 0.70-1.15; p=0.3763). No significant improvement was noted in 2-year progression-free survival (R-CHOP-14 75.4%, 71.8-79.1, and R-CHOP-21 74.8%, 71.0-78.4; 0.94, 0.76-1.17; p=0.5907). High international prognostic index, poor-prognosis molecular characteristics, and cell of origin were not predictive for benefit from either schedule. Grade 3 or 4 neutropenia was higher in the R-CHOP-21 group (318 [60%] of 534 vs 167 [31%] of 534), with no prophylactic use of recombinant human granulocyte-colony stimulating factor mandated in this group, whereas grade 3 or 4 thrombo cytopenia was higher with R-CHOP-14 (50 [9%] vs 28 [5%]); other frequent grade 3 or 4 adverse events were febrile neutropenia (58 [11%] vs 28 [5%]) and infection (125 [23%] vs 96 [18%]). Frequencies of non-haematological adverse events were similar in the R-CHOP-21 and R-CHOP-14 groups. Interpretation R-CHOP-14 is not superior to R-CHOP-21 chemotherapy for previously untreated diffuse large B-cell lymphoma; therefore, R-CHOP-21 remains the standard first-line treatment in patients with this haematological malignancy. No molecular or clinical subgroup benefited from dose intensification in this study.	[Cunningham, David; Hawkes, Eliza A.] Royal Marsden NHS Fdn Trust, London, England; [Cunningham, David; Hawkes, Eliza A.] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England; [Jack, Andrew] St James Inst Oncol, Leeds, W Yorkshire, England; [Qian, Wendi] Cambridge Canc Trials Ctr, Cambridge Clin Trials Unit Canc Theme, Cambridge, England; [Qian, Wendi] MRC, Biostat Unit Hub Trials Methodol, Cambridge, England; [Smith, Paul; Mouncey, Paul; Gambell, Joanna] Canc Res UK, London, England; [Smith, Paul; Mouncey, Paul; Gambell, Joanna] UCL Canc Inst, UCL Canc Trials Ctr, London, England; [Pocock, Christopher] East Kent Hosp, Canterbury, Kent, England; [Ardeshna, Kirit M.] Mt Vernon Canc Ctr, Northwood, Middx, England; [Radford, John A.] Univ Manchester, Manchester, Lancs, England; [Radford, John A.] Christie NHS Fdn Trust, Manchester, Lancs, England; [McMillan, Andrew] City Hosp Nottingham, Nottingham, England; [Davies, John] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Turner, Deborah] Torbay Hosp, Torquay, England; [Kruger, Anton] Royal Cornwall Hosp, Truro, England; [Johnson, Peter] Canc Res UK Ctr, Southampton, Hants, England; [Ardeshna, Kirit M.; Linch, David] UCL, London WC1E 6BT, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Saint James's University Hospital; MRC Biostatistics Unit; Cancer Research UK; University of London; University College London; Mount Vernon Cancer Centre; University of Manchester; Christie NHS Foundation Trust; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Edinburgh; Royal Cornwall Hospital; Cancer Research UK; University of London; University College London	Cunningham, D (corresponding author), Royal Marsden Hosp, Dept Med, Downs Rd, Sutton SM2 5PT, Surrey, England.	david.cunningham@rmh.nhs.uk	Hawkes, Eliza/G-2847-2019; Johnson, Peter/L-2403-2018; , andrew.mcmillan@nhs.net/N-1627-2019; Radford, John A/N-1331-2015; Johnson, Peter/O-3529-2019	Hawkes, Eliza/0000-0002-0376-2559; Johnson, Peter/0000-0003-2306-4974; Radford, John A/0000-0001-7898-2786; Johnson, Peter/0000-0003-2306-4974; Mouncey, Paul/0000-0002-8510-8517; Cunningham, David/0000-0001-5158-1069	Chugai Pharmaceutical; Cancer Research UK; National Institute for Health Research Biomedical Research Centres at both University College London; Royal Marsden NHS Foundation Trust; Institute of Cancer Research; Roche; Amgen; Sanofi-Aventis; Novartis; Astra-Zeneca; Merck KGA; Celgene; Genentech; Millennium; Chugai Pharma	Chugai Pharmaceutical; Cancer Research UK(Cancer Research UK); National Institute for Health Research Biomedical Research Centres at both University College London; Royal Marsden NHS Foundation Trust(Royal Society of New ZealandMarsden Fund (NZ)); Institute of Cancer Research; Roche(Roche Holding); Amgen(Amgen); Sanofi-Aventis(Sanofi-Aventis); Novartis(Novartis); Astra-Zeneca(AstraZeneca); Merck KGA; Celgene(Bristol-Myers SquibbCelgene Corporation); Genentech(Roche HoldingGenentech); Millennium(Takeda Pharmaceutical Company Ltd); Chugai Pharma	Chugai Pharmaceutical, Cancer Research UK, National Institute for Health Research Biomedical Research Centres scheme at both University College London and the Royal Marsden NHS Foundation Trust, and Institute of Cancer Research.; DC received research grants from Roche, Amgen, Sanofi-Aventis, Novartis, Astra-Zeneca, Merck KGA, and Celgene; participated on compensated advisory boards for Amgen, Roche, Merck, and Sanofi-Aventis, and uncompensated advisory boards for Roche (honoraria), Merck, and Sanofi-Aventis; and provided uncompensated expert testimony for Amgen. EAH has received travel expenses from Roche. AJ has received research grants from Roche and Genentech. CP has participated on compensated advisory boards for Roche and Pfizer, and received travel expenses from Roche. KMA has received research funding and honoraria from Roche. JAR has received research grants from Millennium, and provided expert testimony for Millennium Pharmaceuticals, Bayer-Schering, Roche, Napp Pharmaceuticals, Novartis, and GlaxoSmithKline. AM has received a research grant from Roche, and consultancy fees, honoraria, and travel expenses from Roche. JD has received consultancy fees and travel expenses from Roche. DT has received travel expenses from Roche. PJ has participated on a compensated advisory board for and received travel expenses from Roche. DL has received research grants from Roche and Chugai Pharma; participated on compensated advisory boards for Roche, Chugai, Amgen, and Hospira; and received honoraria from Roche, Chugai, and Celgene. The other authors declare that they have no conflicts of interest.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Coiffier B, 2010, BLOOD, V116, P2040, DOI 10.1182/blood-2010-03-276246; Delarue R, 2012, J CLIN ONCOL, V30; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Glass B, 2010, ANN ONCOL, V21, P2255, DOI 10.1093/annonc/mdq235; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Jaffe E.S., 2001, PATHOLOGY GENETICS T, VVolume 3; Johnson NA, 2009, BLOOD, V114, P2273, DOI 10.1182/blood-2009-03-212191; Le Gouill S, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.8003; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Li SY, 2012, MODERN PATHOL, V25, P145, DOI 10.1038/modpathol.2011.147; Linch DC, 2010, BRIT J HAEMATOL, V149, P237, DOI 10.1111/j.1365-2141.2010.08081.x; Ohmachi K, 2011, ANN ONCOL, V22, P1382, DOI 10.1093/annonc/mdq619; Pfreundschuh M, 2004, BLOOD, V104, P626, DOI 10.1182/blood-2003-06-2094; Pfreundschuh M, 2004, BLOOD, V104, P634, DOI 10.1182/blood-2003-06-2095; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Recher C, 2011, LANCET, V378, P1858, DOI 10.1016/S0140-6736(11)61040-4; Reyes F, 2005, NEW ENGL J MED, V352, P1197, DOI 10.1056/NEJMoa042040; Salles G, 2011, BLOOD, V117, P7070, DOI 10.1182/blood-2011-04-345256; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Stiff PJ, 2011, ASCO M S, V29, P8001; Tarella C, 2007, LEUKEMIA, V21, P1802, DOI 10.1038/sj.leu.2404781; Thieblemont C, 2011, J CLIN ONCOL, V29, P4079, DOI 10.1200/JCO.2011.35.4423; Tilly H, 2003, BLOOD, V102, P4284, DOI 10.1182/blood-2003-02-0542; Vitolo U, 2009, HAEMATOL-HEMATOL J, V94, P1250, DOI 10.3324/haematol.2009.007005; Vose JM, 2011, LANCET, V378, P1828, DOI 10.1016/S0140-6736(11)61269-5; Wilson WH, 2008, J CLIN ONCOL, V26, P2717, DOI 10.1200/JCO.2007.13.1391; Ziepert M, 2011, J CLIN ONCOL, V29, pE15, DOI 10.1200/JCO.2010.32.0127	35	346	361	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2013	381	9880					1817	1826		10.1016/S0140-6736(13)60313-X	http://dx.doi.org/10.1016/S0140-6736(13)60313-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151EO	23615461	Green Published			2022-12-28	WOS:000319443700027
J	Eads, JR; Meropol, NJ; Spivak, JL				Eads, Jennifer R.; Meropol, Neal J.; Spivak, Jerry L.			Update in Hematology and Oncology: Evidence Published in 2012	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Eads, Jennifer R.] Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Meropol, Neal J.; Spivak, Jerry L.] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Meropol, Neal J.; Spivak, Jerry L.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Johns Hopkins University	Eads, JR (corresponding author), Univ Hosp Case Med Ctr, 1100 Euclid Ave,Lakeside 1200, Cleveland, OH 44106 USA.	jennifer.eads@uhhospitals.org			NCI NIH HHS [K12 CA076917] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARBUI T, 2011, AM J HEMATOL, V29, P761; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Goldman JM, 2012, ONCOLOGY-NY, V26, P901; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Leboulleux S, 2012, LANCET ONCOL, V13, P897, DOI 10.1016/S1470-2045(12)70335-2; Lo GK, 2006, J THROMB HAEMOST, V4, P759, DOI 10.1111/j.1538-7836.2006.01787.x; Reilly JT, 2012, BRIT J HAEMATOL, V158, P453, DOI 10.1111/j.1365-2141.2012.09179.x; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Soverini S, 2011, BLOOD, V118, P1208, DOI 10.1182/blood-2010-12-326405; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Warkentin TE, 2012, AM J HEMATOL, V87, pS92, DOI 10.1002/ajh.23127	13	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10					755	760		10.7326/0003-4819-158-10-201305210-00105	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-00105			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23580059				2022-12-28	WOS:000319666200028
J	Magnus, D; Caplan, AL				Magnus, David; Caplan, Arthur L.			Risk, Consent, and SUPPORT	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Magnus, David] Stanford Univ, Ctr Biomed Eth, Stanford, CA 94305 USA; [Caplan, Arthur L.] NYU, Langone Med Ctr, Div Med Eth, New York, NY USA	Stanford University; New York University; NYU Langone Medical Center	Magnus, D (corresponding author), Stanford Univ, Ctr Biomed Eth, Stanford, CA 94305 USA.							Carlo WA, 2013, NEW ENGL J MED, V368, P1949, DOI 10.1056/NEJMc1304827; Drazen JM, 2013, NEW ENGL J MED, V368, P1929, DOI 10.1056/NEJMe1304996; Fiore LD, 2011, CLIN TRIALS, V8, P183, DOI [10.1177/1740774510395635, 10.1177/1740774511398368]; Greenspan JS, 2006, PEDIATRICS, V118, P1740, DOI 10.1542/peds.2006-1834; Silverman WA, 1980, RETROLENAL FIBROPLAS	5	46	46	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1864	1865		10.1056/NEJMp1305086	http://dx.doi.org/10.1056/NEJMp1305086			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143VK	23597408				2022-12-28	WOS:000318896200005
J	Mossadegh-Keller, N; Sarrazin, S; Kandalla, PK; Espinosa, L; Stanley, ER; Nutt, SL; Moore, J; Sieweke, MH				Mossadegh-Keller, Noushine; Sarrazin, Sandrine; Kandalla, Prashanth K.; Espinosa, Leon; Stanley, E. Richard; Nutt, Stephen L.; Moore, Jordan; Sieweke, Michael H.			M-CSF instructs myeloid lineage fate in single haematopoietic stem cells	NATURE			English	Article							PROGENITOR CELLS; IN-VIVO; COMMITMENT; MACROPHAGE; DIVERSIFICATION; INFECTION; HIERARCHY; CYTOKINES; CHOICE; MICE	Under stress conditions such as infection or inflammation the body rapidly needs to generate new blood cells that are adapted to the challenge. Haematopoietic cytokines are known to increase output of specific mature cells by affecting survival, expansion and differentiation of lineage-committed progenitors(1,2), but it has been debated whether long-term haematopoietic stem cells (HSCs) are susceptible to direct lineage-specifying effects of cytokines. Although genetic changes in transcription factor balance can sensitize HSCs to cytokine instruction(3), the initiation of HSC commitment is generally thought to be triggered by stochastic fluctuation in cell-intrinsic regulators such as lineage-specific transcription factors(4-7), leaving cytokines to ensure survival and proliferation of the progeny cells(8,9). Here we show that macrophage colony-stimulating factor (M-CSF, also called CSF1), a myeloid cytokine released during infection and inflammation, can directly induce the myeloid master regulator PU.1 and instruct myeloid cell-fate change in mouse HSCs, independently of selective survival or proliferation. Video imaging and single-cell gene expression analysis revealed that stimulation of highly purified HSCs with M-CSF in culture resulted in activation of the PU.1 promoter and an increased number of PU.1(+) cells with myeloid gene signature and differentiation potential. In vivo, high systemic levels of M-CSF directly stimulated M-CSF-receptor-dependent activation of endogenous PU.1 protein in single HSCs and induced a PU.1-dependent myeloid differentiation preference. Our data demonstrate that lineage-specific cytokines can act directly on HSCs in vitro and in vivo to instruct a change of cell identity. This fundamentally changes the current view of how HSCs respond to environmental challenge and implicates stress-induced cytokines as direct instructors of HSC fate.	[Mossadegh-Keller, Noushine; Sarrazin, Sandrine; Kandalla, Prashanth K.; Sieweke, Michael H.] Aix Marseille Univ, Ctr Immunol Marseille Luminy, UM2, F-13288 Marseille 09, France; [Mossadegh-Keller, Noushine; Sarrazin, Sandrine; Kandalla, Prashanth K.; Sieweke, Michael H.] INSERM, U1104, F-13288 Marseille 09, France; [Mossadegh-Keller, Noushine; Sarrazin, Sandrine; Kandalla, Prashanth K.; Sieweke, Michael H.] CNRS, UMR7280, F-13288 Marseille 09, France; [Espinosa, Leon] CNRS, Chim Bacterienne Lab, UMR 7283, F-13009 Marseille, France; [Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Moore, Jordan] Fluidigm Corp, San Francisco, CA 94080 USA; [Sieweke, Michael H.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Yeshiva University; Albert Einstein College of Medicine; Walter & Eliza Hall Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Sieweke, MH (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, UM2, Campus Luminy,Case 906, F-13288 Marseille 09, France.	sarrazin@ciml.univ-mrs.fr; sieweke@ciml.univ-mrs.fr	Espinosa, Leon/V-8410-2017; Nutt, Stephen L/C-9256-2013; Sieweke, Michael/AAR-7515-2020; Stanley, Evan R/J-9154-2013	Nutt, Stephen L/0000-0002-0020-6637; Sieweke, Michael/0000-0002-3228-9537; Stanley, Evan R/0000-0002-2910-2065; Mossadegh-Keller, Noushin/0000-0002-7088-3676	Association pour la recherche sur le Cancer [3422]; Agence nationale de la Recherche [BLAN07-1_205752]; NIH [CA 32551]; NATIONAL CANCER INSTITUTE [R01CA032551] Funding Source: NIH RePORTER	Association pour la recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence nationale de la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge grants from the 'Association pour la recherche sur le Cancer' (3422) and the 'Agence nationale de la Recherche' (BLAN07-1_205752). We thank P. Kastner and S. Chan for PU.1-GFP reporter mice; T. P. VuManh and J. Maurizio for bioinformatics; M. Barad, A. Zouine and M.-L. Thibult for flow cytometry support; L. Razafindramanana for animal handling; and J. Favret, P. Perrin and L. Chasson for tissue sectioning. E. R. S. is supported by NIH grant CA 32551. S.L.N. is an Australian Research Council Future Fellow and received Victorian State Government Operational and Australian Government NHMRC Independent Research Institute Infrastructure Support. M. H. S. is a 'Fondation pour la Recherche Medicale' (DEQ20071210559; DEQ20110421320) and INSERM-Helmholtz group leader.	Back J, 2005, EXP HEMATOL, V33, P395, DOI 10.1016/j.exphem.2004.12.010; Back J, 2004, BLOOD, V103, P3615, DOI 10.1182/blood-2003-11-4089; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; CHEERS C, 1988, INFECT IMMUN, V56, P2972, DOI 10.1128/IAI.56.11.2972-2978.1988; CHEERS C, 1988, INFECT IMMUN, V56, P247, DOI 10.1128/IAI.56.1.247-251.1988; Cross MA, 1997, CURR OPIN GENET DEV, V7, P609, DOI 10.1016/S0959-437X(97)80007-X; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hoebe RA, 2007, NAT BIOTECHNOL, V25, P249, DOI 10.1038/nbt1278; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Metcalf D, 2007, IMMUNITY, V26, P669, DOI 10.1016/j.immuni.2007.05.012; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Niu C, 2009, BLOOD, V114, P2087, DOI 10.1182/blood-2009-01-197921; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; R Development Core Team, 2012, R LANG ENV STAT COMP; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Roth P, 1997, J IMMUNOL, V158, P3874; Sarrazin S, 2009, CELL, V138, P300, DOI 10.1016/j.cell.2009.04.057; Schroeder T, 2011, NAT METHODS, V8, pS30, DOI [10.1038/NMETH.1577, 10.1038/nmeth.1577]; Socolovsky M, 1998, P NATL ACAD SCI USA, V95, P6573, DOI 10.1073/pnas.95.12.6573; Sudo T, 1995, ONCOGENE, V11, P2469; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29	37	238	242	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					239	+		10.1038/nature12026	http://dx.doi.org/10.1038/nature12026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23575636	Green Accepted			2022-12-28	WOS:000318558200036
J	Holmes, D				Holmes, David			Elizabeth Mason: "the face of child survival"	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 27	2013	381	9876					1451	1451		10.1016/S0140-6736(13)60774-6	http://dx.doi.org/10.1016/S0140-6736(13)60774-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139TK	23582726	Bronze			2022-12-28	WOS:000318607300017
J	Farroni, JS; Zwelling, L; Cortes, J; Kantarjian, H				Farroni, Jeffrey S.; Zwelling, Leonard; Cortes, Jorge; Kantarjian, Hagop			Saving Medicare through Patient-Centered Changes - The Case of Injectables	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Farroni, Jeffrey S.] Univ Texas MD Anderson Canc Ctr, Dept Crit Care, Houston, TX 77030 USA; [Zwelling, Leonard] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Cortes, Jorge; Kantarjian, Hagop] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Farroni, JS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Crit Care, Houston, TX 77030 USA.			Cortes, Jorge/0000-0002-8636-1071	NCI NIH HHS [P30 CA016672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bach P, 2012, NY TIMES; Centers for Medicare & Medicaid Services, CMS PUB, V10-02; Goldberg SL, 2010, J CLIN ONCOL, V28, P2847, DOI 10.1200/JCO.2009.25.2395; Himmelstein DU, 2012, ARCH INTERN MED, V172, P1764, DOI 10.1001/2013.jamainternmed.272	4	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1572	1573		10.1056/NEJMp1213485	http://dx.doi.org/10.1056/NEJMp1213485			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130YK	23614583				2022-12-28	WOS:000317956300005
J	Longmaid, HE				Longmaid, H. Esterbrook, III			One Last Teaching Moment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Beth Israel Deaconess Hosp Milton, Milton, MA USA	Harvard University; Beth Israel Deaconess Medical Center	Longmaid, HE (corresponding author), Beth Israel Deaconess Hosp Milton, Milton, MA USA.	helongmaid3@gmail.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1695	1695		10.1001/jama.2013.1803	http://dx.doi.org/10.1001/jama.2013.1803			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130IG	23613073				2022-12-28	WOS:000317906700025
J	Sauaia, A; Miller, JI; Moore, EE; Partrick, D				Sauaia, Angela; Miller, Joshua I.; Moore, Ernest E.; Partrick, David			Firearm Injuries of Children and Adolescents in 2 Colorado Trauma Centers: 2000-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sauaia, Angela; Miller, Joshua I.] Univ Colorado, Sch Publ Hlth, Denver, CO 80202 USA; [Moore, Ernest E.] Denver Hlth Med Ctr, Denver, CO USA; [Partrick, David] Childrens Hosp Colorado, Denver, CO USA	Colorado School of Public Health; University of Colorado System; University of Colorado Denver; Denver Health Medical Center; Children's Hospital Colorado	Sauaia, A (corresponding author), Univ Colorado, Sch Publ Hlth, Denver, CO 80202 USA.	angela.sauaia@ucdenver.edu						ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Eber GB, 2004, PEDIATRICS, V113, P1686, DOI 10.1542/peds.113.6.1686; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Kellermann AL, 2013, JAMA-J AM MED ASSOC, V309, P549, DOI 10.1001/jama.2012.208207; Senger C, 2011, J PEDIATR SURG, V46, P927, DOI 10.1016/j.jpedsurg.2011.02.032	6	10	10	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1683	1685		10.1001/jama.2013.3354	http://dx.doi.org/10.1001/jama.2013.3354			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130IG	23613070	Bronze			2022-12-28	WOS:000317906700019
J	Vale, CL; Tierney, JF; Burdett, S				Vale, Claire L.; Tierney, Jayne F.; Burdett, Sarah			Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIALS; METHODOLOGICAL QUALITY; CONSORT STATEMENT; METAANALYSIS; PUBLICATION; EXPLANATION; INFORMATION	Objective To evaluate the reliability of risk of bias assessments based on published trial reports, for determining trial inclusion in meta-analyses. Design Reliability evaluation of risk of bias assessments. Data sources 13 published individual participant data (IPD) meta-analyses in cancer were used to source 95 randomised controlled trials. Review methods Risk of bias was assessed using the Cochrane risk of bias tool (RevMan5.1) and accompanying guidance. Assessments were made for individual risk of bias domains and overall for each trial, using information from either trial reports alone or trial reports with additional information collected for IPD meta-analyses. Percentage agreements were calculated for individual domains and overall (<66%=low, >= 66%=fair, >= 90%=good). The two approaches were considered similarly reliable only when agreement was good. Results Percentage agreement between the two methods for sequence generation and incomplete outcome data was fair (69.5% (95% confidence interval 60.2% to 78.7%) and 80.0% (72.0% to 88.0%), respectively). However, percentage agreement was low for allocation concealment, selective outcome reporting, and overall risk of bias (48.4% (38.4% to 58.5%), 42.1% (32.2% to 52.0%), and 54.7% (44.7% to 64.7%), respectively). Supplementary information reduced the proportion of unclear assessments for all individual domains, consequently increasing the number of trials assessed as low risk of bias (and therefore available for inclusion in meta-analyses) from 23 (23%) based on publications alone to 66 (66%) based on publications with additional information. Conclusions Using cancer trial publications alone to assess risk of bias could be unreliable; thus, reviewers should be cautious about using them as a basis for trial inclusion, particularly for those trials assessed as unclear risk. Supplementary information from trialists should be sought to enable appropriate assessments and potentially reduce or overcome some risks of bias. Furthermore, guidance should ensure clarity on what constitutes risk of bias, particularly for the more subjective domains.	[Vale, Claire L.; Tierney, Jayne F.; Burdett, Sarah] MRC Clin Trials Unit, Metaanal Grp, London WC2B 6NH, England	Medical Research Council Clinical Trials Unit	Vale, CL (corresponding author), MRC Clin Trials Unit, Metaanal Grp, London WC2B 6NH, England.	cv@ctu.mrc.ac.uk		Vale, Claire/0000-0001-5157-0634; Tierney, Jayne/0000-0002-4734-3014	United Kingdom's Medical Research Council; Medical Research Council; MRC [MC_EX_G0800814] Funding Source: UKRI; Medical Research Council [MC_EX_G0800814] Funding Source: researchfish	United Kingdom's Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the United Kingdom's Medical Research Council.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the Medical Research Council for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Abol-Enein H, 2003, LANCET, V361, P1927; ALBERTI W, 1995, BRIT MED J, V311, P899; Altman DG, 1996, BRIT MED J, V313, P570; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Arnott SJ, 1998, INT J RADIAT ONCOL, V41, P579, DOI 10.1016/S0360-3016(97)00569-5; Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; Benedetti-Panici P, 2003, EUR J CANCER, V39, P2470, DOI 10.1016/S0959-8049(03)00425-8; Bono AV, 2005, EUR UROL, V48, P189, DOI 10.1016/j.eururo.2005.04.005; Burdett S, 1998, LANCET, V352, P257; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Dwan K, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-52; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Glioma Meta-analysis Trialists Group, 2002, COCHRANE DB SYST REV, V3; Hartling L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017242; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; McMinn AM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-81; Mhaskar R, 2012, J CLIN EPIDEMIOL, V65, P602, DOI 10.1016/j.jclinepi.2011.10.016; Non-small Cell Lung Cancer Collaborative Group, 2000, COCHRANE DB SYST REV, V2; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Spiegelhalter DJ, 2003, STAT MED, V22, P3687, DOI 10.1002/sim.1586; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Tierney JF, 1997, LANCET, V350, P1647; Vale C, 2008, J CLIN ONCOL, V26, P5802, DOI 10.1200/JCO.2008.16.4368; Viergever RF, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-210	34	38	39	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2013	346								f1798	10.1136/bmj.f1798	http://dx.doi.org/10.1136/bmj.f1798			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134PK	23610376	Green Published, hybrid			2022-12-28	WOS:000318224700001
J	Nix, P; Bastiani, M				Nix, Paola; Bastiani, Michael			Heterochronic Genes Turn Back the Clock in Old Neurons	SCIENCE			English	Editorial Material							LET-7; REGENERATION; MICRORNA; TARGETS; LIN-41; ACTS; RNA		[Nix, Paola; Bastiani, Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Nix, P (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	paolanix1@gmail.com; bastiani@biology.utah.edu						AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Blackmore M, 2006, J NEUROBIOL, V66, P348, DOI 10.1002/neu.20224; CHEN DF, 1995, P NATL ACAD SCI USA, V92, P7287, DOI 10.1073/pnas.92.16.7287; Chen JF, 2012, GENE DEV, V26, P803, DOI 10.1101/gad.187641.112; Chen LZ, 2011, NEURON, V71, P1043, DOI 10.1016/j.neuron.2011.07.009; Ecsedi M, 2013, GENE DEV, V27, P581, DOI 10.1101/gad.207266.112; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Harris DT, 2011, DEVELOPMENT, V138, P4051, DOI 10.1242/dev.065417; Lin YC, 2007, MOL BIOL EVOL, V24, P2525, DOI 10.1093/molbev/msm195; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schulman BRM, 2005, DEV DYNAM, V234, P1046, DOI 10.1002/dvdy.20599; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Zisoulis DG, 2012, NATURE, V486, P541, DOI 10.1038/nature11134; Zou Y, 2013, SCIENCE, V340, P372, DOI 10.1126/science.1231321; Zou Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002437	16	4	5	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					282	283		10.1126/science.1237921	http://dx.doi.org/10.1126/science.1237921			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599470				2022-12-28	WOS:000317657500031
J	Vaquerizas, JM; Cavalli, FMG; Conrad, T; Akhtar, A; Luscombe, NM				Vaquerizas, Juan M.; Cavalli, Florence M. G.; Conrad, Thomas; Akhtar, Asifa; Luscombe, Nicholas M.			Response to Comments on "Drosophila Dosage Compensation Involves Enhanced Pol II Recruitment to Male X-Linked Promoters"	SCIENCE			English	Editorial Material							CHROMOSOME; EXPRESSION		[Vaquerizas, Juan M.] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Cavalli, Florence M. G.] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1L7, Canada; [Conrad, Thomas] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Akhtar, Asifa] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Luscombe, Nicholas M.] UCL, UCL Genet Inst, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Luscombe, Nicholas M.] Canc Res UK, London Res Inst, London WC2A 3LY, England; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan	Max Planck Society; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Max Planck Society; Max Planck Society; University of London; University College London; Cancer Research UK; Okinawa Institute of Science & Technology Graduate University	Akhtar, A (corresponding author), Max Planck Inst Immunobiol & Epigenet, Stubeweg 51, D-79108 Freiburg, Germany.	akhtar@immunbio.mpg.de; nicholas.luscombe@ucl.ac.uk	Vaquerizas, Juan M/AAY-2339-2020; Vaquerizas, Juan M/F-2676-2011	Vaquerizas, Juan M/0000-0002-6583-6541; Vaquerizas, Juan M/0000-0002-6583-6541; Conrad, Thomas/0000-0001-5618-6295; Cavalli, Florence M. G./0000-0002-4409-9642	Cancer Research UK [16358] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Conrad T, 2012, SCIENCE, V337, P742, DOI 10.1126/science.1221428; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Johansson AM, 2012, MOL CELL BIOL, V32, P2121, DOI 10.1128/MCB.06622-11; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Straub T, 2013, SCIENCE, V340, DOI [10.1126/science.1231895, 10.1126/science.1231815]	7	13	13	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130								10.1126/science.1232874	http://dx.doi.org/10.1126/science.1232874			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599465				2022-12-28	WOS:000317657500025
J	Jasechko, S; Sharp, ZD; Gibson, JJ; Birks, SJ; Yi, Y; Fawcett, PJ				Jasechko, Scott; Sharp, Zachary D.; Gibson, John J.; Birks, S. Jean; Yi, Yi; Fawcett, Peter J.			Terrestrial water fluxes dominated by transpiration	NATURE			English	Article							EVAPOTRANSPIRATION; CARBON; ISOTOPE; CLIMATE; VAPOR; EVAPORATION; VEGETATION; BALANCE; SIZE	Renewable fresh water over continents has input from precipitation and losses to the atmosphere through evaporation and transpiration. Global-scale estimates of transpiration from climate models are poorly constrained owing to large uncertainties in stomatal conductance and the lack of catchment-scale measurements required for model calibration, resulting in a range of predictions spanning 20 to 65 per cent of total terrestrial evapotranspiration (14,000 to 41,000 km(3) per year) (refs 1-5). Here we use the distinct isotope effects of transpiration and evaporation to show that transpiration is by far the largest water flux from Earth's continents, representing 80 to 90 per cent of terrestrial evapotranspiration. On the basis of our analysis of a global data set of large lakes and rivers, we conclude that transpiration recycles 62,000 +/- 8,000 km(3) of water per year to the atmosphere, using half of all solar energy absorbed by land surfaces in the process. We also calculate CO2 uptake by terrestrial vegetation by connecting transpiration losses to carbon assimilation using water-use efficiency ratios of plants, and show the global gross primary productivity to be 129 +/- 32 gigatonnes of carbon per year, which agrees, within the uncertainty, with previous estimates(6). The dominance of transpiration water fluxes in continental evapotranspiration suggests that, from the point of view of water resource forecasting, climate model development should prioritize improvements in simulations of biological fluxes rather than physical (evaporation) fluxes.	[Jasechko, Scott; Sharp, Zachary D.; Fawcett, Peter J.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Gibson, John J.; Birks, S. Jean; Yi, Yi] Alberta Innovates Technol Futures, Victoria, BC V8Z 7X8, Canada; [Gibson, John J.; Yi, Yi] Univ Victoria, Dept Geog, Victoria, BC V8W 3R4, Canada; [Birks, S. Jean] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada	University of New Mexico; Alberta Innovates; University of Victoria; University of Waterloo	Jasechko, S (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA.	jasechko@unm.edu	yi, yi/HHY-7381-2022; Gibson, John/D-1897-2009	Gibson, John/0000-0001-5952-0228; Jasechko, Scott/0000-0001-6470-7708	Caswell Silver Foundation through the University of New Mexico	Caswell Silver Foundation through the University of New Mexico	We thank T. W. D. Edwards, T. Gleeson and M. C. Molles Jr for comments on the manuscript, and are grateful to O. Kwiecien, D. G. Miralles, B. K. Nyarko, K. Yoshimura and F. Yuan for providing access to isotope and gridded data sets. Support for this work was provided by a graduate fellowship awarded to S.J. by the Caswell Silver Foundation through the University of New Mexico.	Alton P, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003540; Beer C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029006; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; BUCK AL, 1981, J APPL METEOROL, V20, P1527, DOI 10.1175/1520-0450(1981)020<1527:NEFCVP>2.0.CO;2; Cao L, 2010, P NATL ACAD SCI USA, V107, P9513, DOI 10.1073/pnas.0913000107; Craig H., 1965, DEUTERIUM OXYGEN 18, P9, DOI DOI 10.1109/ISSRE.1993.624301; Dai A, 2002, J HYDROMETEOROL, V3, P660, DOI 10.1175/1525-7541(2002)003<0660:EOFDFC>2.0.CO;2; Dawson TE, 1996, TREE PHYSIOL, V16, P263; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Gerten D, 2005, PHYS CHEM EARTH, V30, P334, DOI 10.1016/J.PCE.2005.06.002; Gibson JJ, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002997; Global Energy and Water Cycle Experiment, 2012, INT SAT LAND SURF CL; Gonfiantini R., 1986, TERRESTRIAL ENV B, V2, P113, DOI [DOI 10.1016/B978-0-444-42225-5.50008-5, 10.1016/B978-0-444-42225-5.50008-5]; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HORITA J, 1994, GEOCHIM COSMOCHIM AC, V58, P3425, DOI 10.1016/0016-7037(94)90096-5; Ito A, 2012, J HYDROMETEOROL, V13, P681, DOI 10.1175/JHM-D-10-05034.1; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Lawrence DM, 2007, J HYDROMETEOROL, V8, P862, DOI 10.1175/JHM596.1; Miralles DG, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013530; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Reynolds JF, 2000, PLANT ECOL, V150, P145, DOI 10.1023/A:1026530522612; ROZANSKI K, 1993, CLIMATE CHANGE CONTI; Trenberth KE, 2009, B AM METEOROL SOC, V90, P311, DOI 10.1175/2008BAMS2634.1; Welp LR, 2008, PLANT CELL ENVIRON, V31, P1214, DOI 10.1111/j.1365-3040.2008.01826.x; Williams DG, 2004, AGR FOREST METEOROL, V125, P241, DOI 10.1016/j.agrformet.2004.04.008; Yakir D, 1996, NATURE, V380, P515, DOI 10.1038/380515a0; Yoshimura K, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010074	30	720	750	44	747	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					347	+		10.1038/nature11983	http://dx.doi.org/10.1038/nature11983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23552893				2022-12-28	WOS:000317599200034
J	Romanello, S; Spiri, D; Marcuzzi, E; Zanin, A; Boizeau, P; Riviere, S; Vizeneux, A; Moretti, R; Carbajal, R; Mercier, JC; Wood, C; Zuccotti, GV; Crichiutti, G; Alberti, C; Titomanlio, L				Romanello, Silvia; Spiri, Daniele; Marcuzzi, Elena; Zanin, Anna; Boizeau, Priscilla; Riviere, Simon; Vizeneux, Audrey; Moretti, Raffaella; Carbajal, Ricardo; Mercier, Jean-Christophe; Wood, Chantal; Zuccotti, Gian Vincenzo; Crichiutti, Giovanni; Alberti, Corinne; Titomanlio, Luigi			Association Between Childhood Migraine and History of Infantile Colic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEADACHE; PAIN; ADOLESCENCE; PREVALENCE; CHILDREN; TRIAL	Importance Infantile colic is a common cause of inconsolable crying during the first months of life and has been thought to be a pain syndrome. Migraine is a common cause of headache pain in childhood. Whether there is an association between these 2 types of pain in unknown. Objective To investigate a possible association between infantile colic and migraines in childhood. Design, Setting, and Participants A case-control study of 208 consecutive children aged 6 to 18 years presenting to the emergency department and diagnosed as having migraines in 3 European tertiary care hospitals between April 2012 and June 2012. The control group was composed of 471 children in the same age range who visited the emergency department of each participating center for minor trauma during the same period. A structured questionnaire identified personal history of infantile colic for case and control participants, confirmed by health booklets. A second study of 120 children diagnosed with tension-type headaches was done to test the specificity of the association. Main Outcomes and Measures Difference in the prevalence of infantile colic between children with and without a diagnosis of migraine. Results Children with migraine were more likely to have experienced infantile colic than those without migraine (72.6% vs 26.5%; odds ratio [OR], 6.61 [95% CI, 4.38-10.00]; P<.001), either migraine without aura (n=142; 73.9% vs 26.5%; OR, 7.01 [95% CI, 4.43-11.09]; P<.001), or migraine with aura (n=66; 69.7% vs 26.5%; OR, 5.73 [95% CI, 3.07-10.73]; P<.001). This association was not found for children with tension-type headache (35% vs 26.5%; OR, 1.46 [95% CI, 0.92-2.32]; P=.10). Conclusion and Relevance The presence of migraine in children and adolescents aged 6 to 18 years was associated with a history of infantile colic. Additional longitudinal studies are required. JAMA. 2013;309(15):1607-1612 www.jama.com	[Romanello, Silvia; Zanin, Anna; Riviere, Simon; Vizeneux, Audrey; Mercier, Jean-Christophe; Titomanlio, Luigi] Hosp Robert Debre, APHP, Dept Pediat Emergency Care, Paris, France; [Romanello, Silvia; Moretti, Raffaella; Wood, Chantal; Titomanlio, Luigi] Hosp Robert Debre, APHP, Pediat Migraine & Neurovasc Dis Unit, Paris, France; [Boizeau, Priscilla; Alberti, Corinne] Hosp Robert Debre, APHP, Clin Epidemiol Unit, Paris, France; [Romanello, Silvia; Zanin, Anna; Moretti, Raffaella; Titomanlio, Luigi] INSERM, UMR 676, Paris, France; [Spiri, Daniele; Zuccotti, Gian Vincenzo] Univ Milan, Dept Pediat, Luigi Sacco Hosp, Milan, Italy; [Marcuzzi, Elena; Crichiutti, Giovanni] Azienda Osped Univ Santa Maria Misericordia Udine, Dept Pediat, Udine, Italy; [Boizeau, Priscilla; Alberti, Corinne] INSERM, CIE 5, Paris, France; [Carbajal, Ricardo] Hosp Armand Trousseau, APHP, Dept Pediat Emergency Care, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Milan; Luigi Sacco Hospital; Hospital Santa Maria della Misericordia; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Titomanlio, L (corresponding author), Paris Diderot Univ, Robert Debre Hosp, APHP, Pediat Emergency Dept, 48 Bld Serurier, F-75019 Paris, France.	luigi.titomanlio@rdb.aphp.fr	Zanin, Anna/AAX-5706-2020; Zanin, Anna/AAA-7898-2022; Zuccotti, Gianvincenzo/H-8572-2017	Zanin, Anna/0000-0002-4210-8509; titomanlio, luigi/0000-0003-4909-803X; Zuccotti, Gianvincenzo/0000-0002-2795-9874				BARR RG, 1991, PEDIATRICS, V87, P623; Bendtsen L, 2010, CEPHALALGIA, V30, P1029, DOI 10.1177/0333102410365013; Bigal ME, 2010, HEADACHE, V50, P1130, DOI 10.1111/j.1526-4610.2010.01717.x; Bromberg J, 2012, HEADACHE, V52, P244, DOI 10.1111/j.1526-4610.2011.02031.x; Bruni O, 1997, CEPHALALGIA, V17, P492, DOI 10.1046/j.1468-2982.1997.1704492.x; Carson L, 2011, HEADACHE, V51, P707, DOI 10.1111/j.1526-4610.2011.01855.x; Critch JN, 2011, PAED CHILD HEALT-CAN, V16, P47, DOI 10.1093/pch/16.1.47; Engel MA, 2011, INFLAMM BOWEL DIS, V17, P1030, DOI 10.1002/ibd.21422; Fernandez-Mayoralas DM, 2010, PEDIATRICS, V126, pE187, DOI 10.1542/peds.2010-0012; Gelfand AA, 2012, NEUROLOGY, V79, P1392, DOI 10.1212/WNL.0b013e31826c1b7b; Gudmundsson G, 2010, MED HYPOTHESES, V75, P528, DOI 10.1016/j.mehy.2010.07.014; GUIDETTI V, 1984, CEPHALALGIA, V4, P237, DOI 10.1046/j.1468-2982.1984.0404237.x; Hall B, 2012, J PAEDIATR CHILD H, V48, P128, DOI 10.1111/j.1440-1754.2011.02061.x; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Jan MMS, 2001, CLIN PEDIATR, V40, P295, DOI 10.1177/000992280104000512; KATERJI MA, 1994, J CHILD NEUROL, V9, P336, DOI 10.1177/088307389400900325; Lee C, 2007, J DEV BEHAV PEDIATR, V28, P288, DOI 10.1097/DBP.0b013e3180327b55; Leung AKC, 2004, J R SOC PROMO HEALTH, V124, P162, DOI 10.1177/146642400412400407; Lewis KS, 2010, SEMIN PEDIATR NEUROL, V17, P224, DOI 10.1016/j.spen.2010.10.004; Lucassen PLBJ, 1998, BMJ-BRIT MED J, V316, P1563, DOI 10.1136/bmj.316.7144.1563; Magis D, 2011, CURR OPIN NEUROL, V24, P203, DOI 10.1097/WCO.0b013e3283462c3f; MCKENZIE S, 1991, ARCH DIS CHILD, V66, P1416, DOI 10.1136/adc.66.12.1416; Monteith TS, 2010, CURR PAIN HEADACHE R, V14, P424, DOI 10.1007/s11916-010-0149-z; Parisi P, 2011, ACTA PAEDIATR, V100, P491, DOI 10.1111/j.1651-2227.2010.02115.x; Perry R, 2011, PEDIATRICS, V127, P720, DOI 10.1542/peds.2010-2098; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stovner LJ, 2010, J HEADACHE PAIN, V11, P289, DOI 10.1007/s10194-010-0217-0; TAUBMAN B, 1984, PEDIATRICS, V74, P998; Varkey E, 2011, CEPHALALGIA, V31, P1428, DOI 10.1177/0333102411419681; WESSEL MA, 1954, PEDIATRICS, V14, P421	30	64	70	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1607	1612		10.1001/jama.2013.747	http://dx.doi.org/10.1001/jama.2013.747			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126FY	23592105	Bronze			2022-12-28	WOS:000317599500024
J	Stanbrook, MB				Stanbrook, Matthew B.			Review: Antibiotics reduce treatment failure in acute chronic obstructive pulmonary disease exacerbations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Health Network Toronto	Stanbrook, MB (corresponding author), Univ Toronto, Univ Hlth Network, Toronto, ON, Canada.							ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Global Strategy For The Diagnosis Management And Prevention Of Chronic Obstructive Pulmonary Disease, GLOB STRAT DIAGN MAN	2	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8							JC5	10.7326/0003-4819-158-8-201304160-02005	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588770				2022-12-28	WOS:000318062100008
J	Chong, YD				Chong, Yidong			OPTICAL DEVICES Photonic insulators with a twist	NATURE			English	Editorial Material							LOCALIZATION; PHASE; STATE		Nanyang Technol Univ, Sch Phys & Math Sci, Singapore 637371, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chong, YD (corresponding author), Nanyang Technol Univ, Sch Phys & Math Sci, Singapore 637371, Singapore.	yidong@ntu.edu.sg	Chong, Yidong/B-6995-2011; Chong, Yidong/E-1375-2012; Chong, Yidong/AAG-5144-2020	Chong, Yidong/0000-0002-8649-7884; Chong, Yidong/0000-0002-8649-7884; Chong, Yidong/0000-0002-8649-7884				Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Fang KJ, 2012, NAT PHOTONICS, V6, P782, DOI [10.1038/NPHOTON.2012.236, 10.1038/nphoton.2012.236]; Hafezi M., 2013, PREPRINT; Joannopoulos JD, 2008, PHOTONIC CRYSTALS: MOLDING THE FLOW OF LIGHT, 2ND EDITION, P1; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Lindner NH, 2011, NAT PHYS, V7, P490, DOI 10.1038/NPHYS1926; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Schwartz T, 2007, NATURE, V446, P52, DOI 10.1038/nature05623; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059	12	5	5	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					173	174		10.1038/496173a	http://dx.doi.org/10.1038/496173a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23579674				2022-12-28	WOS:000317346300028
J	Kleinman, A				Kleinman, Arthur			From Illness as Culture to Caregiving as Moral Experience	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICINE		[Kleinman, Arthur] Harvard Univ, Dept Anthropol, Cambridge, MA 02115 USA; [Kleinman, Arthur] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Kleinman, Arthur] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kleinman, A (corresponding author), Harvard Univ, Dept Anthropol, Cambridge, MA 02115 USA.							KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Kleinman A., 1988, ILLNESS NARRATIVES; KLEINMAN AM, 1973, INQUIRY, V16, P206, DOI 10.1080/00201747308601685; Kleinman A, 2012, LANCET, V380, P1550, DOI 10.1016/S0140-6736(12)61870-4; Kleinman Arthur, 2006, WHAT REALLY MATTERS	5	62	66	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1376	1377		10.1056/NEJMp1300678	http://dx.doi.org/10.1056/NEJMp1300678			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122QT	23574117	Green Submitted			2022-12-28	WOS:000317333600004
J	O'Donoghue, J; Stallard, TS; Melin, H; Jones, GH; Cowley, SWH; Miller, S; Baines, KH; Blake, JSD				O'Donoghue, J.; Stallard, T. S.; Melin, H.; Jones, G. H.; Cowley, S. W. H.; Miller, S.; Baines, K. H.; Blake, J. S. D.			The domination of Saturn's low-latitude ionosphere by ring 'rain'	NATURE			English	Article							MODEL	Saturn's ionosphere is produced when the otherwise neutral atmosphere is exposed to a flow of energetic charged particles or solar radiation(1). At low latitudes the solar radiation should result in a weak planet-wide glow in the infrared, corresponding to the planet's uniform illumination by the Sun(2). The observed electron density of the low-latitude ionosphere, however, is lower and its temperature higher than predicted by models(3-5). A planet-to-ring magnetic connection has been previously suggested, in which an influx of water from the rings could explain the lower-than-expected electron densities in Saturn's atmosphere(6-8). Here we report the detection of a pattern of features, extending across a broad latitude band from 25 to 60 degrees, that is superposed on the lower-latitude background glow, with peaks in emission that map along the planet's magnetic field lines to gaps in Saturn's rings. This pattern implies the transfer of charged species derived from water from the ring-plane to the ionosphere, an influx on a global scale, flooding between 30 to 43 per cent of the surface of Saturn's upper atmosphere. This ring 'rain' is important in modulating ionospheric emissions and suppressing electron densities.	[O'Donoghue, J.; Stallard, T. S.; Melin, H.; Cowley, S. W. H.; Blake, J. S. D.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Jones, G. H.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Jones, G. H.; Miller, S.] Univ London Birkbeck Coll, Ctr Planetary Sci, London WC1E 6BT, England; [Miller, S.] UCL, Dept Phys & Astron, Atmospher Phys Lab, London WC1E 6BT, England; [Baines, K. H.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Leicester; University of London; University College London; University of London; Birkbeck University London; University of London; University College London; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	O'Donoghue, J (corresponding author), Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England.	jod3@ion.le.ac.uk	Jones, Geraint H./C-1682-2008; O'Donoghue, James/Q-7187-2018; Stallard, Tom/W-8743-2019	Jones, Geraint H./0000-0002-5859-1136; O'Donoghue, James/0000-0002-4218-1191; Stallard, Tom/0000-0003-3990-670X; Miller, Steven/0000-0002-7159-6871; Cowley, Stanley/0000-0002-4041-0034	UK Science and Technology Facilities Council (STFC); Science and Technology Facilities Council [ST/G002223/1, ST/I505780/1, ST/K000977/1, ST/H002480/1, ST/K001000/1, PP/D005213/1] Funding Source: researchfish; STFC [PP/D005213/1, ST/H002480/1, ST/I505780/1, ST/G002223/1, ST/K001000/1, ST/K000977/1] Funding Source: UKRI	UK Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and NASA. The observations were made to support the Cassini auroral campaign. Ring profile data were provided by the Planetary Rings Node website<SUP>18</SUP>. Discussions within the international team led by T. S. S. on 'Comparative Jovian Aeronomy' have greatly benefited this work; this was hosted by the International Space Science Institute (ISSI). The UK Science and Technology Facilities Council (STFC) supported this work through the PhD Studentship of J.O'D. and grant support for T. S. S., H. M. and G.H.J.	Atreya S. K., 1984, SATURN, P239; Burton ME, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045148; Coates AJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022694; CONNERNEY JEP, 1984, NATURE, V312, P136, DOI 10.1038/312136a0; CONNERNEY JEP, 1986, GEOPHYS RES LETT, V13, P773, DOI 10.1029/GL013i008p00773; LILLIE CF, 1977, SPACE SCI REV, V21, P159, DOI 10.1007/BF00200849; Luhmann JG, 2006, ICARUS, V181, P465, DOI 10.1016/j.icarus.2005.11.022; McLean IS, 1998, P SOC PHOTO-OPT INS, V3354, P566, DOI 10.1117/12.317283; Mendillo M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021934; Miller SI, 2010, AM J ADDICTION, V19, P1, DOI 10.1111/j.1521-0391.2009.00012.x; Miller S, 2006, PHILOS T R SOC A, V364, P3121, DOI 10.1098/rsta.2006.1877; Moore PL, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001307; NORTHROP TG, 1983, J GEOPHYS RES-SPACE, V88, P6102, DOI 10.1029/JA088iA08p06102; NORTHROP TG, 1982, J GEOPHYS RES-SPACE, V87, P6045, DOI 10.1029/JA087iA08p06045; Smith CGA, 2007, NATURE, V445, P399, DOI 10.1038/nature05518; Stallard TS, 2012, PHILOS T R SOC A, V370, P5213, DOI 10.1098/rsta.2012.0028; WILSON GR, 1989, J GEOPHYS RES-SPACE, V94, P17287, DOI 10.1029/JA094iA12p17287; Yelle RV, 2004, CAMB PLANET, P185	18	59	59	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					193	195		10.1038/nature12049	http://dx.doi.org/10.1038/nature12049			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23579676	Green Submitted			2022-12-28	WOS:000317346300035
J	Vidal, EIO; Boas, PJFV; Valle, AP; Cerqueira, ATAR; Fukushima, FB				Vidal, Edison I. O.; Villas Boas, Paulo J. F.; Valle, Adriana P.; Cerqueira, Ana Teresa A. R.; Fukushima, Fernanda B.			Delirium in older adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HOME		[Vidal, Edison I. O.; Villas Boas, Paulo J. F.; Valle, Adriana P.] Univ Estadual Paulista UNESP, Dept Internal Med, BR-18618970 Botucatu, SP, Brazil; [Cerqueira, Ana Teresa A. R.] Univ Estadual Paulista UNESP, Neurol Psychiat & Psychol Dept, BR-18618970 Botucatu, SP, Brazil; [Fukushima, Fernanda B.] Univ Estadual Paulista UNESP, Dept Anesthesiol, BR-18618970 Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Vidal, EIO (corresponding author), Univ Estadual Paulista UNESP, Dept Internal Med, BR-18618970 Botucatu, SP, Brazil.	eiovidal@fmb.unesp.br	Fukushima, Fernanda Bono/AAR-2740-2021; Vidal, Edison Iglesias de Oliveira/G-1882-2012; Boas, Paulo J F Villas/I-4656-2014; Valle, Adriana P/F-9897-2014; Fukushima, Fernanda Bono/E-3196-2012; Valle, Adriana/ABI-5894-2020; RAMOS-CERQUEIRA, ANA TERESA DE ABREU/H-8564-2013	Vidal, Edison Iglesias de Oliveira/0000-0002-1573-4678; Boas, Paulo J F Villas/0000-0001-9876-3222; Valle, Adriana P/0000-0002-0090-8524; Fukushima, Fernanda Bono/0000-0001-8055-5425; RAMOS-CERQUEIRA, ANA TERESA DE ABREU/0000-0003-2374-8890				de Lange E, 2013, INT J GERIATR PSYCH, V28, P127, DOI 10.1002/gps.3814; Flaherty JH, 2011, J AM GERIATR SOC, V59, pS269, DOI 10.1111/j.1532-5415.2011.03675.x; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467; Kakuma R, 2003, J AM GERIATR SOC, V51, P443, DOI 10.1046/j.1532-5415.2003.51151.x; Leslie DL, 2011, J AM GERIATR SOC, V59, pS241, DOI 10.1111/j.1532-5415.2011.03671.x; Marcantonio ER, 2012, JAMA-J AM MED ASSOC, V308, P73, DOI 10.1001/jama.2012.6857; Morandi A, 2012, J AM GERIATR SOC, V60, P2005, DOI 10.1111/j.1532-5415.2012.04199.x; National Institute for Health and Clinical Excellence, 2010, DEL DIAGN PREV MAN C, V103; Siddiqi N, 2006, AGE AGEING, V35, P350, DOI 10.1093/ageing/afl005; Wong CL, 2010, JAMA-J AM MED ASSOC, V304, P779, DOI 10.1001/jama.2010.1182	11	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2013	346								f2031	10.1136/bmj.f2031	http://dx.doi.org/10.1136/bmj.f2031			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	125ZC	23571740				2022-12-28	WOS:000317579800004
J	Lapsley, P				Lapsley, Peter			Lessons from patients' journeys	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							A-PATIENTS-JOURNEY		BMA House, London WC1H 9JP, England		Lapsley, P (corresponding author), BMA House, London WC1H 9JP, England.	plapsley@bmj.com						Aaen AM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3669; Aliyu F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2881; [Anonymous], 2012, BMJ, V345, pe6938; Berghmans R, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5469; Dartington T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1712; Goodrich J, 2008, SEEING PERSON PATIEN; Jobling R, 2007, BMJ-BRIT MED J, V334, P953, DOI 10.1136/bmj.39184.615150.802; Kelly S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2947; Love C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3517; Reeve G, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2072; Sackett B, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1661; Saul K, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5203; Sonksen P, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5204; Sweeney K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2862; Tomlinson P, 2010, BRIT MED J, V340, pc150; Webb S, 2008, BMJ-BRIT MED J, V336, P444, DOI 10.1136/bmj.39485.698356.AD	16	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2013	346								f1988	10.1136/bmj.f1988	http://dx.doi.org/10.1136/bmj.f1988			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122SG	23553972	Bronze			2022-12-28	WOS:000317337800014
J	Dhalla, IA; Gomes, T; Yao, Z; Nagge, J; Persaud, N; Hellings, C; Mamdani, MM; Juurlink, DN				Dhalla, Irfan A.; Gomes, Tara; Yao, Zhan; Nagge, Jeff; Persaud, Navindra; Hellings, Chelsea; Mamdani, Muhammad M.; Juurlink, David N.			Chlorthalidone Versus Hydrochlorothiazide for the Treatment of Hypertension in Older Adults A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; BETA-BLOCKERS; RISK; METAANALYSIS; MORTALITY; MODELS	Background: Some evidence suggests that chlorthalidone may be superior to hydrochlorothiazide for the treatment of hypertension. Objective: To compare the effectiveness and safety of chlorthalidone and hydrochlorothiazide in older adults. Design: Propensity score-matched observational cohort study with up to 5 years of follow-up. Setting: Ontario, Canada. Patients: All individuals aged 66 years or older who were newly treated with chlorthalidone or hydrochlorothiazide and were not hospitalized for heart failure, stroke, or myocardial infarction in the prior year were eligible for inclusion. Each chlorthalidone recipient was matched to up to 2 hydrochlorothiazide recipients on the basis of age, sex, year of treatment initiation, and propensity score. Measurements: The primary outcome was a composite of death or hospitalization for heart failure, stroke, or myocardial infarction. Safety outcomes included hospitalization with hypokalemia or hyponatremia. Results: A total of 29 873 patients were studied. During follow-up, chlorthalidone recipients (n = 10 384) experienced the primary outcome at a rate of 3.2 events per 100 person-years of follow-up, and hydrochlorothiazide recipients experienced 3.4 events per 100 person-years of follow-up (adjusted hazard ratio, 0.93 [95% CI, 0.81 to 1.06]). Patients treated with chlorthalidone were more likely to be hospitalized with hypokalemia (adjusted hazard ratio, 3.06 [CI, 2.04 to 4.58]) or hyponatremia (adjusted hazard ratio, 1.68 [CI, 1.24 to 2.28]). In 9 post hoc analyses comparing patients initially prescribed 12.5, 25, or 50 mg of chlorthalidone per day with those prescribed 12.5, 25, or 50 mg of hydrochlorothiazide per day, the former were more likely to be hospitalized with hypokalemia for all 6 comparisons in which a statistically significant association was found. The results of other effectiveness and safety outcomes were also consistent with those of the main analysis. Limitation: Unmeasured differences in baseline characteristics or physician treatment approaches or an insufficiently large sample may have limited the ability to detect small differences in the comparative effectiveness of the drugs. Conclusion: As typically prescribed, chlorthalidone in older adults was not associated with fewer adverse cardiovascular events or deaths than hydrochlorothiazide. However, it was associated with a greater incidence of electrolyte abnormalities, particularly hypokalemia.	[Dhalla, Irfan A.; Gomes, Tara; Persaud, Navindra; Mamdani, Muhammad M.] St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Yao, Zhan; Hellings, Chelsea; Juurlink, David N.] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; [Nagge, Jeff] Univ Waterloo, Kitchener, ON N2G 1C5, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Waterloo	Dhalla, IA (corresponding author), St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.	dhallai@smh.ca	; Nagge, Jeff/B-8649-2018	Gomes, Tara/0000-0002-1468-1965; Nagge, Jeff/0000-0001-8954-1169	Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Canadian Institutes of Health Research	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Institute for Clinical Evaluative Sciences; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by a grant from the Ontario Ministry of Health and Long-Term Care to the Ontario Drug Policy Research Network, which is led by Drs. Mamdani and Juurlink. The project was supported by the Institute for Clinical Evaluative Sciences, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. Dr. Dhalla was supported by a New Investigator Award from the Canadian Institutes of Health Research.	Alderman MH, 2012, HYPERTENSION, V59, P926, DOI 10.1161/HYPERTENSIONAHA.111.180554; Carlberg B, 2004, LANCET, V364, P1684, DOI 10.1016/S0140-6736(04)17355-8; Carter BL, 2004, HYPERTENSION, V43, P4, DOI 10.1161/01.HYP.0000103632.19915.0E; Centers for Disease Control and Prevention, 2011, HYPERTENSION; Chobanian AV, 2008, NEW ENGL J MED, V359, P2485, DOI 10.1056/NEJMe0808690; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi KL, 2004, JAMA-J AM MED ASSOC, V292, P1816, DOI 10.1001/jama.292.15.1816-c; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dhalla IA, 2009, CAN MED ASSOC J, V181, P891, DOI 10.1503/cmaj.090784; Dorsch MP, 2011, HYPERTENSION, V57, P689, DOI 10.1161/HYPERTENSIONAHA.110.161505; Elliott WJ, 2008, J CLIN HYPERTENS, V10, P856, DOI 10.1111/j.1751-7176.2008.00029.x; Ernst ME, 2006, HYPERTENSION, V47, P352, DOI 10.1161/01.HYP.0000203309.07140.d3; Ernst ME, 2010, J CLIN HYPERTENS, V12, P927, DOI 10.1111/j.1751-7176.2010.00373.x; Ernst ME, 2010, AM J HYPERTENS, V23, P440, DOI 10.1038/ajh.2010.1; Flack JM, 2011, HYPERTENSION, V57, P665, DOI 10.1161/HYPERTENSIONAHA.110.164566; Gomes T, 2011, J UROLOGY, V186, P1340, DOI 10.1016/j.juro.2011.05.077; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Juurlink DN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2942; Kaplan NM, 2011, HYPERTENSION, V58, P994, DOI 10.1161/HYPERTENSIONAHA.111.183525; Kaplan NM, 2009, HYPERTENSION, V54, P951, DOI 10.1161/HYPERTENSIONAHA.109.135061; Khan N, 2006, CAN MED ASSOC J, V174, P1737, DOI 10.1503/cmaj.060110; Kurtz TW, 2010, HYPERTENSION, V56, P335, DOI 10.1161/HYPERTENSIONAHA.110.156166; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Leung AA, 2011, AM J MED, V124, P1064, DOI 10.1016/j.amjmed.2011.06.031; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Lund BC, 2012, J CLIN HYPERTENS, V14, P623, DOI 10.1111/j.1751-7176.2012.00679.x; Movig KLL, 2003, J CLIN EPIDEMIOL, V56, P530, DOI 10.1016/S0895-4356(03)00006-4; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Peterzan MA, 2012, HYPERTENSION, V59, P1104, DOI 10.1161/HYPERTENSIONAHA.111.190637; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P43, DOI 10.1001/jama.292.1.43-c; Ripatti S, 2000, BIOMETRICS, V56, P1016, DOI 10.1111/j.0006-341X.2000.01016.x; Roush GC, 2012, HYPERTENSION, V59, P1110, DOI 10.1161/HYPERTENSIONAHA.112.191106; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365	36	72	75	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6					447	+		10.7326/0003-4819-158-6-201303190-00004	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23552325				2022-12-28	WOS:000316565100014
J	Leder, K; Torresi, J; Libman, MD; Cramer, JP; Castelli, F; Schlagenhauf, P; Wilder-Smith, A; Wilson, ME; Keystone, JS; Schwartz, E; Barnett, ED; von Sonnenburg, F; Brownstein, JS; Cheng, AC; Sotir, MJ; Esposito, DH; Freedman, DO				Leder, Karin; Torresi, Joseph; Libman, Michael D.; Cramer, Jakob P.; Castelli, Francesco; Schlagenhauf, Patricia; Wilder-Smith, Annelies; Wilson, Mary E.; Keystone, Jay S.; Schwartz, Eli; Barnett, Elizabeth D.; von Sonnenburg, Frank; Brownstein, John S.; Cheng, Allen C.; Sotir, Mark J.; Esposito, Douglas H.; Freedman, David O.		GeoSentinel Surveillance Network	GeoSentinel Surveillance of Illness in Returned Travelers, 2007-2011	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; VISITING FRIENDS; INTERNATIONAL TRAVELERS; HEALTH-PROBLEMS; LARGE COHORT; MALARIA; DIARRHEA; FEVER; RISK; EPIDEMIOLOGY	Background: International travel continues to increase, particularly to Asia and Africa. Clinicians are increasingly likely to be consulted for advice before travel or by ill returned travelers. Objective: To describe typical diseases in returned travelers according to region, travel reason, and patient demographic characteristics; describe the pattern of low-frequency travel-associated diseases; and refine key messages for care before and after travel. Design: Descriptive, using GeoSentinel records. Setting: 53 tropical or travel disease units in 24 countries. Patients: 42 173 ill returned travelers seen between 2007 and 2011. Measurements: Frequencies of demographic characteristics, regions visited, and illnesses reported. Results: Asia (32.6%) and sub-Saharan Africa (26.7%) were the most common regions where illnesses were acquired. Three quarters of travel-related illness was due to gastrointestinal (34.0%), febrile (23.3%), and dermatologic (19.5%) diseases. Only 40.5% of all ill travelers reported pretravel medical visits. The relative frequency of many diseases varied with both travel destination and reason for travel, with travelers visiting friends and relatives in their country of origin having both a disproportionately high burden of serious febrile illness and very low rates of advice before travel (18.3%). Life-threatening diseases, such as Plasmodium falciparum malaria, melioidosis, and African trypanosomiasis, were reported. Limitations: Sentinel surveillance data collected by specialist clinics do not reflect healthy returning travelers or those with mild or self-limited illness. Data cannot be used to infer quantitative risk for illness. Conclusion: Many illnesses may have been preventable with appropriate advice, chemoprophylaxis, or vaccination. Clinicians can use these 5-year GeoSentinel data to help tailor more efficient pretravel preparation strategies and evaluate possible differential diagnoses of ill returned travelers according to destination and reason for travel.	Univ Melbourne, Monash Univ, Austin Hosp, Victorian Infect Dis Serv,Royal Melbourne Hosp, Melbourne, Vic, Australia; Alfred Hosp, Melbourne, Vic, Australia; McGill Univ, Ctr Trop Dis, Montreal, PQ, Canada; Toronto Gen Hosp, Trop Dis Unit, Toronto, ON, Canada; Univ Toronto, Toronto, ON, Canada; Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; Univ Munich, Munich, Germany; Univ Brescia, Brescia, Italy; Univ Zurich, World Hlth Org Collaborating Ctr Travelers Hlth, Ctr Travel Med, Zurich, Switzerland; Harvard Univ, Sch Publ Hlth, Boston Childrens Hosp, Maxwell Finland Lab Infect Dis,Boston Med Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Chaim Sheba Med Ctr, Ctr Geog Med, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, IL-69978 Tel Aviv, Israel; Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; Univ Alabama Birmingham, Gorgas Ctr Geog Med, Birmingham, AL USA	Florey Institute of Neuroscience & Mental Health; Monash University; Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Munich; University of Brescia; University of Zurich; World Health Organization; Boston Medical Center; Harvard University; Boston Children's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Chaim Sheba Medical Center; Tel Aviv University; Centers for Disease Control & Prevention - USA; University of Alabama System; University of Alabama Birmingham	Leder, K (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Alfred Ctr, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	karin.leder@monash.edu	Parola, Philippe/AAY-4346-2021; Gkrania-Klotsas, Effrossyni/AAT-8424-2021; Leder, Karin/AAD-2388-2019; Freedman, David O./AAV-2999-2020; Leder, Karin/H-4979-2014; Wilder-Smith, Annelies/F-8751-2015	Parola, Philippe/0000-0002-1061-1927; Gkrania-Klotsas, Effrossyni/0000-0002-0930-8330; Leder, Karin/0000-0003-1368-1039; Freedman, David O./0000-0002-5642-5257; Mendelson, Marc/0000-0001-6668-3893; Torresi, Joseph/0000-0002-8212-0887; Castelli, Francesco/0000-0001-9161-7804; Wilder-Smith, Annelies/0000-0003-0362-5375; Schlagenhauf, Patricia/0000-0002-1075-7010; Kain, Kevin/0000-0001-6068-1272; Cheng, Allen/0000-0003-3152-116X; Ursing, Johan/0000-0002-5508-9327; Perez-Molina, Jose Antonio/0000-0001-8735-4124; Okhuysen, Pablo/0000-0002-1596-3411; Barnett, Elizabeth/0000-0003-4822-5949; Aoun, Olivier/0000-0001-9554-8439	Centers for Disease Control and Prevention; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U50CI000359] Funding Source: NIH RePORTER; MRC [G0701652] Funding Source: UKRI	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Centers for Disease Control and Prevention.	Angell SY, 2005, ANN INTERN MED, V142, P67, DOI 10.7326/0003-4819-142-1-200501040-00013; [Anonymous], 2012, Wkly Epidemiol Rec, V87; Ansart S, 2007, AM J TROP MED HYG, V76, P184, DOI 10.4269/ajtmh.2007.76.184; Askling HH, 2005, EMERG INFECT DIS, V11, P436, DOI 10.3201/eid1103.040677; Bacaner N, 2004, JAMA-J AM MED ASSOC, V291, P2856, DOI 10.1001/jama.291.23.2856; Behrens RH, 2013, TRAVEL MED, P297; Boggild AK, 2012, J TRAVEL MED, V19, P4, DOI 10.1111/j.1708-8305.2011.00579.x; Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Castelli F, 2001, J TRAVEL MED, V8, pS26, DOI 10.1111/j.1708-8305.2001.tb00543.x; CAUMES E, 1995, CLIN INFECT DIS, V20, P542, DOI 10.1093/clinids/20.3.542; Centers for Disease Control and Prevention, 2012, CDC HLTH INF INT TRA; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1605; Connor BA, 2005, CLIN INFECT DIS, V41, pS577, DOI 10.1086/432956; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Dupont Andrew W, 2007, Curr Gastroenterol Rep, V9, P378, DOI 10.1007/s11894-007-0046-8; El Hajj L, 2004, INT J DERMATOL, V43, P120, DOI 10.1111/j.1365-4632.2004.01991.x; Field VK, 2010, HLTH INFORM OVERSEAS; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Fulford Martha, 2005, Curr Infect Dis Rep, V7, P48, DOI 10.1007/s11908-005-0023-z; Gautret P, 2007, VACCINE, V25, P2656, DOI 10.1016/j.vaccine.2006.12.034; Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2; Guse CE, 2007, J TRAVEL MED, V14, P279, DOI 10.1111/j.1708-8305.2007.00133.x; Hagmann S, 2010, J TRAVEL MED, V17, P193, DOI 10.1111/j.1708-8305.2010.00399.x; Hakanen A, 2003, EMERG INFECT DIS, V9, P267; HARGARTEN SW, 1991, ANN EMERG MED, V20, P622, DOI 10.1016/S0196-0644(05)82379-0; Herbinger KH, 2011, TROP MED INT HEALTH, V16, P1457, DOI 10.1111/j.1365-3156.2011.02840.x; Herbinger KH, 2012, J TRAVEL MED, V19, P150, DOI 10.1111/j.1708-8305.2011.00589.x; Heukelbach J, 2008, LANCET INFECT DIS, V8, P302, DOI 10.1016/S1473-3099(08)70098-7; Hill DR, 2000, AM J TROP MED HYG, V62, P585, DOI 10.4269/ajtmh.2000.62.585; Hill DR, 2000, J TRAVEL MED, V7, P259, DOI 10.2310/7060.2000.00075; Jensenius M, 2009, EMERG INFECT DIS, V15, P1791, DOI 10.3201/eid1511.090677; Joseph CA, 2010, EUROSURVEILLANCE, V15, P5; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Lalloo DG, 2008, BMJ-BRIT MED J, V336, P1362, DOI 10.1136/bmj.a153; LANGE WR, 1992, ARCH INTERN MED, V152, P2049, DOI 10.1001/archinte.152.10.2049; LaRocque RC, 2012, CLIN INFECT DIS, V54, P455, DOI 10.1093/cid/cir839; Leder K, 2004, CLIN INFECT DIS, V39, P1104, DOI 10.1086/424510; Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893; Lederman ER, 2008, INT J INFECT DIS, V12, P593, DOI 10.1016/j.ijid.2007.12.008; Lindgren E, 2012, SCIENCE, V336, P418, DOI 10.1126/science.1215735; Loutan L, 2003, INT J ANTIMICROB AG, V21, P158, DOI 10.1016/S0924-8579(02)00367-9; MacPherson DW, 2007, J TRAVEL MED, V14, P77, DOI 10.1111/j.1708-8305.2007.00107.x; Meltzer E, 2012, AM J TROP MED HYG, V87, P264, DOI 10.4269/ajtmh.2012.11-0512; Migchelsen SJ, 2011, INT J INFECT DIS, V15, pE517, DOI 10.1016/j.ijid.2011.03.018; Moore SJ, 2012, INFECT DIS CLIN N AM, V26, P655, DOI 10.1016/j.idc.2012.07.002; Morris-Jones R, 2012, INFECT DIS CLIN N AM, V26, P675, DOI 10.1016/j.idc.2012.05.010; O'Brien DP, 2006, J TRAVEL MED, V13, P145, DOI 10.1111/j.1708-8305.2006.00033.x; Odolini S, 2012, CLIN MICROBIOL INFEC, V18, P468, DOI 10.1111/j.1469-0691.2011.03596.x; PROCIV P, 1995, MED J AUSTRALIA, V163, P27, DOI 10.5694/j.1326-5377.1995.tb126084.x; Ryan ET, 2002, NEW ENGL J MED, V347, P505, DOI 10.1056/NEJMra020118; Siikamaki HM, 2011, J TRAVEL MED, V18, P239, DOI 10.1111/j.1708-8305.2011.00532.x; Solomon M, 2011, AM J TROP MED HYG, V85, P868, DOI 10.4269/ajtmh.2011.10-0471; Steffen R, 2004, J TRAVEL MED, V11, P231, DOI 10.2310/7060.2004.19007; Steffen R, 1999, JAMA-J AM MED ASSOC, V281, P811, DOI 10.1001/jama.281.9.811; STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84; Thabane M, 2007, ALIMENT PHARM THER, V26, P535, DOI 10.1111/j.1365-2036.2007.03399.x; Thabane M, 2009, WORLD J GASTROENTERO, V15, P3591, DOI 10.3748/wjg.15.3591; Tonellato DJ, 2009, J TRAVEL MED, V16, P304, DOI 10.1111/j.1708-8305.2009.00318.x; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; United Nations World Tourism Organization, 2011, UNWTO TOUR HIGHL 201; Vlieghe ER, 2008, J TRAVEL MED, V15, P419, DOI 10.1111/j.1708-8305.2008.00236.x; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; Wilson ME, 2007, CURR OPIN INFECT DIS, V20, P449; Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173; World Health Organization, 2012, INT TRAV HLTH 2012; Zaki SA, 2011, J INFECT DEV COUNTR, V5, P324, DOI 10.3855/jidc.1405	68	306	313	1	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6					456	+		10.7326/0003-4819-158-6-201303190-00005	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-00005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	292YJ	23552375	Green Accepted			2022-12-28	WOS:000329938300001
J	Hayes, D; Griffin, GB; Engel, GS				Hayes, Dugan; Griffin, Graham B.; Engel, Gregory S.			Engineering Coherence Among Excited States in Synthetic Heterodimer Systems	SCIENCE			English	Article							2-DIMENSIONAL ELECTRONIC SPECTROSCOPY; LIGHT-HARVESTING COMPLEXES; QUANTUM COHERENCE; ENERGY-TRANSFER; DYNAMICS; PHOTOSYNTHESIS; TEMPERATURE	The design principles that support persistent electronic coherence in biological light-harvesting systems are obscured by the complexity of such systems. Some electronic coherences in these systems survive for hundreds of femtoseconds at physiological temperatures, suggesting that coherent dynamics may play a role in photosynthetic energy transfer. Coherent effects may increase energy transfer efficiency relative to strictly incoherent transfer mechanisms. Simple, tractable, manipulable model systems are required in order to probe the fundamental physics underlying these persistent electronic coherences, but to date, these quantum effects have not been observed in small molecules. We have engineered a series of rigid synthetic heterodimers that can serve as such a model system and observed quantum beating signals in their two-dimensional electronic spectra consistent with the presence of persistent electronic coherences.	[Engel, Gregory S.] Univ Chicago, Dept Chem, Inst Biophys Dynam, Chicago, IL 60637 USA; Univ Chicago, James Franck Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Engel, GS (corresponding author), Univ Chicago, Dept Chem, Inst Biophys Dynam, 5735 S Ellis Ave, Chicago, IL 60637 USA.	gsengel@uchicago.edu	Engel, Gregory/C-1108-2012	Engel, Gregory/0000-0002-6740-5243; Hayes, Dugan/0000-0003-4171-5179	NSF Materials Research and Engineering Center [DMR 08-02054]; Air Force Office of Scientific Research [FA9550-09-1-0117]; Defense Threat Reduction Agency [HDTRA1-10-1-0091 P00002]; Defense Advanced Research Projects Agency QuBE program [N66001-10-1-4060]; Searle Foundation; NSF [CHE-1048528]; Direct For Mathematical & Physical Scien [1048528] Funding Source: National Science Foundation	NSF Materials Research and Engineering Center; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Defense Advanced Research Projects Agency QuBE program; Searle Foundation; NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Details of the synthesis, spectroscopy, and data analysis are included in the supplementary materials. The authors would like to thank the NSF Materials Research and Engineering Center (grant DMR 08-02054), Air Force Office of Scientific Research (grant FA9550-09-1-0117), Defense Threat Reduction Agency (HDTRA1-10-1-0091 P00002), the Defense Advanced Research Projects Agency QuBE program (grant N66001-10-1-4060), and the Searle Foundation for supporting this work. D.H. thanks the NSF Graduate Research Fellowship Program program for funding. The mass spectrometry facility used for this work is supported by NSF grant CHE-1048528. The authors gratefully acknowledge the experimental efforts of R. McGillicuddy, P. Dahlberg, K. A. Fransted, T. Jarvis, and C. J. Qin and thank S. Viswanathan and A. Fidler for useful discussions.	ARBELOA IL, 1981, J CHEM SOC FARAD T 2, V77, P1725, DOI 10.1039/f29817701725; Balevicius V, 2012, CHEM PHYS, V404, P94, DOI 10.1016/j.chemphys.2012.02.021; Bixner O, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4720492; Brixner T, 2004, J CHEM PHYS, V121, P4221, DOI 10.1063/1.1776112; Calhoun TR, 2009, J PHYS CHEM B, V113, P16291, DOI 10.1021/jp908300c; Caram JR, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4733710; Caycedo-Soler F, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3703504; Cheng YC, 2007, CHEM PHYS, V341, P285, DOI 10.1016/j.chemphys.2007.07.049; Cho S, 2011, J PHYS CHEM A, V115, P3990, DOI 10.1021/jp109174f; Christensson N, 2011, J PHYS CHEM B, V115, P5383, DOI 10.1021/jp109442b; Christensson N, 2012, J PHYS CHEM B, V116, P7449, DOI 10.1021/jp304649c; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; Cowan ML, 2004, CHEM PHYS LETT, V386, P184, DOI 10.1016/j.cplett.2004.01.027; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Engel GS, 2011, PROCEDIA CHEM, V3, DOI 10.1016/j.proche.2011.08.029; Harel E, 2012, P NATL ACAD SCI USA, V109, P706, DOI 10.1073/pnas.1110312109; Hayes D, 2011, FARADAY DISCUSS, V150, P459, DOI 10.1039/c0fd00030b; Hayes D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065042; Hybl JD, 2001, J CHEM PHYS, V115, P6606, DOI 10.1063/1.1398579; Ishizaki A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3155214; KNAPP EW, 1984, CHEM PHYS, V85, P73, DOI 10.1016/S0301-0104(84)85174-5; Lee H, 2007, SCIENCE, V316, P1462, DOI 10.1126/science.1142188; Milota F, 2009, ACCOUNTS CHEM RES, V42, P1364, DOI 10.1021/ar800282e; Panitchayangkoon G, 2011, P NATL ACAD SCI USA, V108, P20908, DOI 10.1073/pnas.1105234108; Panitchayangkoon G, 2010, P NATL ACAD SCI USA, V107, P12766, DOI 10.1073/pnas.1005484107; Prall BS, 2005, J PHYS CHEM A, V109, P10870, DOI 10.1021/jp054225d; Sun WC, 1997, J ORG CHEM, V62, P6469, DOI 10.1021/jo9706178; Tiwari V, 2013, P NATL ACAD SCI USA, V110, P1203, DOI 10.1073/pnas.1211157110; Walkup GK, 2000, J AM CHEM SOC, V122, P5644, DOI 10.1021/ja000868p; Wood RW, 1932, PHYS REV, V42, P0386, DOI 10.1103/PhysRev.42.386	30	110	111	2	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1431	1434		10.1126/science.1233828	http://dx.doi.org/10.1126/science.1233828			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23599263				2022-12-28	WOS:000320647000036
J	Maercker, A; Brewin, CR; Bryant, RA; Cloitre, M; Reed, GM; van Ommeren, M; Humayun, A; Jones, LM; Kagee, A; Llosa, AE; Rousseau, C; Somasundaram, DJ; Souza, R; Suzuki, Y; Weissbecker, I; Wessely, SC; First, MB; Saxena, S				Maercker, Andreas; Brewin, Chris R.; Bryant, Richard A.; Cloitre, Marylene; Reed, Geoffrey M.; van Ommeren, Mark; Humayun, Asma; Jones, Lynne M.; Kagee, Ashraf; Llosa, Augusto E.; Rousseau, Cecile; Somasundaram, Daya J.; Souza, Renato; Suzuki, Yuriko; Weissbecker, Inka; Wessely, Simon C.; First, Michael B.; Saxena, Shekhar			Proposals for mental disorders specifically associated with stress in the International Classification of Diseases-11	LANCET			English	Editorial Material							ADJUSTMENT DISORDERS; COMPLICATED GRIEF; HEALTH; PTSD		[Maercker, Andreas] Univ Zurich, Dept Psychol, Div Pyschopathol, CH-8050 Zurich, Switzerland; [Brewin, Chris R.] UCL, Dept Clin Educ & Hlth Psychol, London, England; [Bryant, Richard A.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Cloitre, Marylene] Natl Ctr PTSD, Div Disseminat & Training, Menlo Pk, CA USA; [Reed, Geoffrey M.; van Ommeren, Mark; Saxena, Shekhar] WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva, Switzerland; [Humayun, Asma] Benazir Bhutto Hosp, Inst Psychiat, Rawalpindi, Pakistan; [Jones, Lynne M.] Harvard Univ, Harvard Sch Publ Hlth, FXB Ctr Hlth & Human Rights, Cambridge, MA 02138 USA; [Kagee, Ashraf] Univ Stellenbosch, Dept Psychol, ZA-7600 Stellenbosch, South Africa; [Llosa, Augusto E.] Epictr, Paris, France; [Rousseau, Cecile] McGill Univ, Ctr Hlth, Dept Psychiat, Montreal, PQ, Canada; [Somasundaram, Daya J.] Univ Jaffna, Jaffna, Sri Lanka; [Somasundaram, Daya J.] Glenside Mental Hlth Serv, Glenside, SA, Australia; [Souza, Renato] Int Comm Red Cross, Geneva, Switzerland; [Suzuki, Yuriko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Tokyo, Japan; [Weissbecker, Inka] Int Med Corps, Washington, DC USA; [Wessely, Simon C.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [First, Michael B.] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY USA	University of Zurich; University of London; University College London; University of New South Wales Sydney; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; Stellenbosch University; McGill University; University Jaffna; National Center for Neurology & Psychiatry - Japan; University of London; King's College London; Columbia University	Maercker, A (corresponding author), Univ Zurich, Dept Psychol, Div Pyschopathol, Binzmuhlestr 14-17, CH-8050 Zurich, Switzerland.	maercker@psychologie.uzh.ch	Brewin, Chris R/C-4566-2008; Bryant, Richard/AAA-6479-2019; Kagee, Ashraf/H-4650-2019; Wessely, Simon C/A-8713-2008; Maercker, Andreas/D-2814-2017	Brewin, Chris R/0000-0002-7462-4460; Bryant, Richard/0000-0002-9607-819X; Maercker, Andreas/0000-0001-6925-3266; Weissbecker, Inka/0000-0001-9055-5234; Wessely, Simon Charles/0000-0002-6743-9929				Afana A., 2012, ARAB J PSYCHIAT, V23, P28; [Anonymous], 2008, WHO WORLD MENTAL HLT; Boscarino JA, 2004, ANN NY ACAD SCI, V1032, P141, DOI 10.1196/annals.1314.011; Brady KT, 1997, J CLIN PSYCHIAT, V58, P12; Brewin CR, 2009, J TRAUMA STRESS, V22, P366, DOI 10.1002/jts.20443; Cloitre M, 2011, J TRAUMA STRESS, V24, P615, DOI 10.1002/jts.20697; Cloitre M, 2009, J TRAUMA STRESS, V22, P399, DOI 10.1002/jts.20444; Evans SC, 2012, INT C PSYCH JUL 23 C; Forbes D, 2011, J AFFECT DISORDERS, V132, P165, DOI 10.1016/j.jad.2011.02.011; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; Maercker A, 2007, PSYCHOPATHOLOGY, V40, P135, DOI 10.1159/000099290; Miller G, 2005, SCIENCE, V309, P1030, DOI 10.1126/science.309.5737.1030; Morina N, 2008, INT J SOC PSYCHIATR, V54, P425, DOI 10.1177/0020764008090505; Nijrolder I, 2011, FAM PRACT, V28, P260, DOI 10.1093/fampra/cmq114; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Rosenblatt P, 2008, HDB BEREAVEMENT RES, P202; Semprini F, 2010, CNS SPECTRUMS, V15, P382, DOI 10.1017/S1092852900029254; Shear K, 2005, JAMA-J AM MED ASSOC, V293, P2601, DOI 10.1001/jama.293.21.2601; Shear MK, 2011, DEPRESS ANXIETY, V28, P103, DOI 10.1002/da.20780; Spitzer RL, 2007, J ANXIETY DISORD, V21, P233, DOI 10.1016/j.janxdis.2006.09.006; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Stein DJ, 2007, LANCET, V369, P139, DOI 10.1016/S0140-6736(07)60075-0; Strain JJ, 2008, COMPR PSYCHIAT, V49, P121, DOI 10.1016/j.comppsych.2007.10.002; Tol WA, 2011, LANCET, V378, P1581, DOI 10.1016/S0140-6736(11)61094-5; Weiss DS, 2012, J TRAUMA STRESS, V25, P239, DOI 10.1002/jts.21711; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; World Health Organisation (WHO), 2011, PSYCH 1 AID GUID FIE; World Health Organization, 2012, ICD 11 BET MENT BEH; World Health Organization, 2016, MHGAP INT GUID MENT	30	340	346	1	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2013	381	9878					1683	1685		10.1016/S0140-6736(12)62191-6	http://dx.doi.org/10.1016/S0140-6736(12)62191-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146SX	23583019				2022-12-28	WOS:000319112400036
J	Muller, D				Muller, David			Reforming Premedical Education - Out with the Old, In with the New	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							REQUIREMENTS		Icahn Sch Med Mt Sinai, Off Dean Med Educ, New York, NY USA	Icahn School of Medicine at Mount Sinai	Muller, D (corresponding author), Icahn Sch Med Mt Sinai, Off Dean Med Educ, New York, NY USA.							Barr DA, 2010, ADV HEALTH SCI EDUC, V15, P45, DOI 10.1007/s10459-009-9165-3; Dalen JE, 2009, AM J MED, V122, P104, DOI 10.1016/j.amjmed.2008.08.027; Dienstag JL, 2008, NEW ENGL J MED, V359, P221, DOI 10.1056/NEJMp0803098; Kanter SL, 2008, ACAD MED, V83, P623, DOI [10.1097/ACM.0b013e31817f7136, 10.1097/ACM.0b013e3181734623]; Muller D, 2010, ACAD MED, V85, P1378, DOI 10.1097/ACM.0b013e3181dbf22a	5	13	14	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1567	1569		10.1056/NEJMp1302259	http://dx.doi.org/10.1056/NEJMp1302259			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130YK	23574033				2022-12-28	WOS:000317956300003
J	Yartsev, MM; Ulanovsky, N				Yartsev, Michael M.; Ulanovsky, Nachum			Representation of Three-Dimensional Space in the Hippocampus of Flying Bats	SCIENCE			English	Article							SPATIAL REPRESENTATION; PLACE CELLS; GRID CELLS; COGNITIVE MAP; DYNAMICS; NEURONS; INCREASES; CODE	Many animals, on air, water, or land, navigate in three-dimensional (3D) environments, yet it remains unclear how brain circuits encode the animal's 3D position. We recorded single neurons in freely flying bats, using a wireless neural-telemetry system, and studied how hippocampal place cells encode 3D volumetric space during flight. Individual place cells were active in confined 3D volumes, and in >90% of the neurons, all three axes were encoded with similar resolution. The 3D place fields from different neurons spanned different locations and collectively represented uniformly the available space in the room. Theta rhythmicity was absent in the firing patterns of 3D place cells. These results suggest that the bat hippocampus represents 3D volumetric space by a uniform and nearly isotropic rate code.	[Yartsev, Michael M.; Ulanovsky, Nachum] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Ulanovsky, N (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	nachum.ulanovsky@weizmann.ac.il		Ulanovsky, Nachum/0000-0001-8598-4667; Yartsev, Michael/0000-0003-0952-2801	European Research Council (ERC-NEUROBAT); Human Frontiers Science Program [HFSP RGP0062/2009-C]; Israel Science Foundation [ISF 1017/08]; Minerva Foundation; Lev-Zion predoctoral excellence fellowship	European Research Council (ERC-NEUROBAT); Human Frontiers Science Program(Human Frontier Science Program); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Lev-Zion predoctoral excellence fellowship	We thank A. Treves, D. Derdikman, J.-M. Fellous, L. Las, Y. Yovel, M. Ahrens, and C. Brody for comments on the manuscript; R. Raz, K. Kamenitz, and M. Geva-Sagiv for the 3D trajectory reconstruction system; C. Stengel for the neural telemetry system; B. Pasmantirer and G. Ankaoua for mechanical designs; A. Rubin and A. Averkin for assistance with neural recordings and video calibrations; S. Kaufman, T. Dayan, and S. Dror for bat training; M. Weinberg and A. Tuval for veterinary oversight; C. Ra'anan and R. Eilam for histology; and M. P. Witter for advice on reconstruction of tetrode-track locations. This study was supported by research grants from the European Research Council (ERC-NEUROBAT), the Human Frontiers Science Program (HFSP RGP0062/2009-C), the Israel Science Foundation (ISF 1017/08), and the Minerva Foundation to N.U. and a Lev-Zion predoctoral excellence fellowship to M.M.Y.	Andersen P., 2007, HIPPOCAMPUS BOOK; Brown WM, 2006, NEURAL COMPUT, V18, P1511, DOI 10.1162/neco.2006.18.7.1511; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Fenton AA, 2008, J NEUROSCI, V28, P11250, DOI 10.1523/JNEUROSCI.2862-08.2008; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hayman R, 2011, NAT NEUROSCI, V14, P1182, DOI 10.1038/nn.2892; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Hori E, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00036; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Jeffery KJ, 2006, EXP BRAIN RES, V169, P218, DOI 10.1007/s00221-005-0138-3; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Knierim JJ, 2000, NAT NEUROSCI, V3, P209, DOI 10.1038/72910; Knierim JJ, 2001, J NEUROPHYSIOL, V85, P105, DOI 10.1152/jn.2001.85.1.105; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Ludvig N, 2004, BRAIN RES, V1014, P97, DOI 10.1016/j.brainres.2004.03.071; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; ONO T, 1993, J NEUROPHYSIOL, V70, P1516, DOI 10.1152/jn.1993.70.4.1516; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Taube JS, 2013, HIPPOCAMPUS, V23, P14, DOI 10.1002/hipo.22074; Tsoar A, 2011, P NATL ACAD SCI USA, V108, pE718, DOI 10.1073/pnas.1107365108; Ulanovsky N, 2008, P NATL ACAD SCI USA, V105, P8491, DOI 10.1073/pnas.0703550105; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Ulanovsky N, 2011, CURR BIOL, V21, pR886, DOI 10.1016/j.cub.2011.09.031; Ulanoysky N, 2011, HIPPOCAMPUS, V21, P150, DOI 10.1002/hipo.20731; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	28	188	190	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					367	372		10.1126/science.1235338	http://dx.doi.org/10.1126/science.1235338			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599496				2022-12-28	WOS:000317657500060
J	Weiner, SJ; Schwartz, A; Sharma, G; Binns-Calvey, A; Ashley, N; Kelly, B; Dayal, A; Patel, S; Weaver, FM; Harris, I				Weiner, Saul J.; Schwartz, Alan; Sharma, Gunjan; Binns-Calvey, Amy; Ashley, Naomi; Kelly, Brendan; Dayal, Amit; Patel, Sonal; Weaver, Frances M.; Harris, Ilene			Patient-Centered Decision Making and Health Care Outcomes An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							INTERACTION ANALYSIS SYSTEM; CONTEXTUAL ERRORS; COMMUNICATION	Background: Patient-centered decision making (PCDM) is the process of identifying clinically relevant, patient-specific circumstances and behaviors to formulate a contextually appropriate care plan. Objective: To ascertain whether encounters in which PCDM occurs are followed by improved health care outcomes compared with encounters where there is inattention to patient context. Design: Patients surreptitiously audio-recorded encounters with their physicians. Medical records of these encounters were then screened for "contextual red flags," such as deteriorating self-management of a chronic condition, that could reflect such underlying contextual factors as competing responsibilities or loss of social support. When a contextual factor was identified, either as a result of physician questioning or because a patient volunteered information, physicians were scored on the basis of whether they adapted the care plan to it. Setting: Internal medicine clinics at 2 Veterans Affairs facilities. Participants: 774 patients audio-recorded encounters with 139 resident physicians. Measurements: Individualized outcome measures were based on the contextual red flag, such as improved blood pressure control in a patient presenting with hypertension and loss of medication coverage. Outcome coders were blinded to physician performance. Results: Among 548 contextual red flags, 208 contextual factors were confirmed, either when physicians probed or patients volunteered information. Physician attention to contextual factors (both probing for them and addressing them in care plans) varied according to the presenting contextual red flags. Outcome data were available for 157 contextual factors, of which PCDM was found to address 96. Of these, health care outcomes improved in 68 (71%), compared with 28 (46%) of the 61 that were not addressed by PCDM (P = 0.002). Limitation: The extent to which the findings can be generalized to other clinical settings is unknown. Conclusion: Attention to patient needs and circumstances when planning care is associated with improved health care outcomes.	Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA; [Weiner, Saul J.] Univ Illinois, Chicago, IL 60607 USA; US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Hines, IL 60141 USA; Durham Vet Affairs Med Ctr, Durham, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Weiner, SJ (corresponding author), Univ Illinois, 2730 UH MC 103,601 South Morgan, Chicago, IL 60607 USA.	sweiner@uic.edu	Weaver, Frances/S-1540-2019	Schwartz, Alan/0000-0003-3809-6637	U.S. Department of Veterans Affairs, Health Services Research & Development Service	U.S. Department of Veterans Affairs, Health Services Research & Development Service	U.S. Department of Veterans Affairs, Health Services Research & Development Service.	McCormack LA, 2011, SOC SCI MED, V72, P1085, DOI 10.1016/j.socscimed.2011.01.020; Mead N, 2000, PATIENT EDUC COUNS, V39, P71, DOI 10.1016/S0738-3991(99)00092-0; Roter D, 2002, PATIENT EDUC COUNS, V46, P243, DOI 10.1016/S0738-3991(02)00012-5; Roter DL, 1997, JAMA-J AM MED ASSOC, V277, P350, DOI 10.1001/jama.277.4.350; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Schwartz A, 2012, BMJ QUAL SAF, V21, P918, DOI 10.1136/bmjqs-2012-000832; Schwartz A, 2010, JAMA-J AM MED ASSOC, V304, P1191, DOI 10.1001/jama.2010.1297; Smith RC, 2011, J GEN INTERN MED, V26, P185, DOI 10.1007/s11606-010-1496-5; Weiner SJ, 2007, MED DECIS MAKING, V27, P726, DOI 10.1177/0272989X07306113; Weiner Saul J, 2004, ACP J Club, V141, pA11; Weiner SJ, 2013, J GEN INTERN MED, V28, P254, DOI 10.1007/s11606-012-2221-3; Weiner SJ, 2010, ANN INTERN MED, V153, P69, DOI 10.7326/0003-4819-153-2-201007200-00002; Weiner SJ, 2004, J GEN INTERN MED, V19, P281, DOI 10.1111/j.1525-1497.2004.30261.x; Weiner SJ, 2009, ENCY MED DECISION MA, P198; Weiner SJ, 2013, CONTENT CODING CONTE	15	118	119	1	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8					573	+		10.7326/0003-4819-158-8-201304160-00001	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-00001			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	132IW	23588745				2022-12-28	WOS:000318062100013
J	Teijaro, JR; Ng, C; Lee, AM; Sullivan, BM; Sheehan, KCF; Welch, M; Schreiber, RD; de la Torre, JC; Oldstone, MBA				Teijaro, John R.; Cherie Ng; Lee, Andrew M.; Sullivan, Brian M.; Sheehan, Kathleen C. F.; Welch, Megan; Schreiber, Robert D.; de la Torre, Juan Carlos; Oldstone, Michael B. A.			Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling	SCIENCE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; VIRAL PERSISTENCE; DENDRITIC CELLS; IMMUNE ACTIVATION; GENOMIC ANALYSIS; T-CELLS; IMMUNOSUPPRESSION; MICE; VIVO; GLYCOPROTEIN	During persistent viral infections, chronic immune activation, negative immune regulator expression, an elevated interferon signature, and lymphoid tissue destruction correlate with disease progression. We demonstrated that blockade of type I interferon (IFN-I) signaling using an IFN-I receptor neutralizing antibody reduced immune system activation, decreased expression of negative immune regulatory molecules, and restored lymphoid architecture in mice persistently infected with lymphocytic choriomeningitis virus. IFN-I blockade before and after establishment of persistent virus infection resulted in enhanced virus clearance and was CD4 T cell-dependent. Hence, we demonstrate a direct causal link between IFN-I signaling, immune activation, negative immune regulator expression, lymphoid tissue disorganization, and virus persistence. Our results suggest that therapies targeting IFN-I may help control persistent virus infections.	[Teijaro, John R.; Cherie Ng; Lee, Andrew M.; Sullivan, Brian M.; Welch, Megan; de la Torre, Juan Carlos; Oldstone, Michael B. A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Sheehan, Kathleen C. F.; Schreiber, Robert D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Scripps Research Institute; Washington University (WUSTL)	Oldstone, MBA (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	mbaobo@scripps.edu	Schreiber, Robert/Q-7550-2019; Lee, Andrew/G-5470-2011	Sullivan, Brian/0000-0003-4277-6037; Schreiber, Robert/0000-0003-1590-2341	NIH [AI09484]; National Cancer Institute [NCI CA43059, U54AI057160]; American Heart fellowships [11POST7430106, HL007195, NS041219];  [AI077719];  [AI047140];  [AI007354]; NATIONAL CANCER INSTITUTE [R37CA043059, R01CA043059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160, R56AI047140, T32AI007354, R01AI009484, R37AI009484, R01AI047140, R01AI077719, R56AI077719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041219] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart fellowships; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank D. Fremgen, C. Cubitt, N. Ngo, and S. Rice for technical excellence. Data reported in the manuscript are tabulated in the main paper and in the supplementary materials. This research was supported by NIH grant AI09484 (M.B.A.O.); National Cancer Institute grants NCI CA43059 (R.D.S.) and U54AI057160 to the Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (MRCE) (R.D.S. and M.B.A.O.); grants AI077719 and AI047140 (J.C.d.l.T.), postdoctoral training grants AI007354; and American Heart fellowships 11POST7430106 (J.R.T.), HL007195 (C.N.), and NS041219 (B.M.S.).	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berger DP, 1999, VIROLOGY, V260, P136, DOI 10.1006/viro.1999.9811; Bergthaler A, 2010, P NATL ACAD SCI USA, V107, P21641, DOI 10.1073/pnas.1011998107; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Chang JJ, 2010, J INFECT DIS, V202, pS297, DOI 10.1086/655657; d'Ettorre G, 2011, AIDS RES HUM RETROV, V27, P355, DOI 10.1089/aid.2010.0342; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; EVANS CF, 1994, J VIROL, V68, P7367, DOI 10.1128/JVI.68.11.7367-7373.1994; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hahm B, 2005, IMMUNITY, V22, P247, DOI 10.1016/j.immuni.2005.01.005; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Macal M, 2012, CELL HOST MICROBE, V11, P617, DOI 10.1016/j.chom.2012.04.017; Manches O, 2009, J CLIN INVEST, V119, P3512, DOI 10.1172/JCI41509; Muller S, 2002, J VIROL, V76, P2375, DOI 10.1128/JVI.76.5.2375-2383.2002; Oldstone MBA, 2011, VIROLOGY, V411, P170, DOI 10.1016/j.virol.2010.11.023; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Saez-Cirion A, 2007, TRENDS IMMUNOL, V28, P532, DOI 10.1016/j.it.2007.09.002; SALVATO M, 1991, J VIROL, V65, P1863, DOI 10.1128/JVI.65.4.1863-1869.1991; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Sullivan BM, 2011, P NATL ACAD SCI USA, V108, P2969, DOI 10.1073/pnas.1019304108; Suresh M, 2002, J VIROL, V76, P3943, DOI 10.1128/JVI.76.8.3943-3951.2002; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157	36	523	535	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					207	211		10.1126/science.1235214	http://dx.doi.org/10.1126/science.1235214			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580529	Green Accepted			2022-12-28	WOS:000317341400058
J	Wuestefeld, T; Pesic, M; Rudalska, R; Dauch, D; Longerich, T; Kang, TW; Yevsa, T; Heinzmann, F; Hoenicke, L; Hohmeyer, A; Potapova, A; Rittelmeier, I; Jarek, M; Geffers, R; Scharfe, M; Klawonn, F; Schirmacher, P; Malek, NP; Ott, M; Nordheim, A; Vogel, A; Manns, MP; Zender, L				Wuestefeld, Torsten; Pesic, Marina; Rudalska, Ramona; Dauch, Daniel; Longerich, Thomas; Kang, Tae-Won; Yevsa, Tetyana; Heinzmann, Florian; Hoenicke, Lisa; Hohmeyer, Anja; Potapova, Anna; Rittelmeier, Ina; Jarek, Michael; Geffers, Robert; Scharfe, Maren; Klawonn, Frank; Schirmacher, Peter; Malek, Nisar P.; Ott, Michael; Nordheim, Alfred; Vogel, Arndt; Manns, Michael P.; Zender, Lars			A Direct In Vivo RNAi Screen Identifies MKK4 as a Key Regulator of Liver Regeneration	CELL			English	Article							TYROSINEMIA TYPE-I; PARTIAL-HEPATECTOMY; MICE; EXPRESSION; FIBROSIS; REVEALS; PROTEIN; MODEL; JNK	The liver harbors a distinct capacity for endogenous regeneration; however, liver regeneration is often impaired in disease and therefore insufficient to compensate for the loss of hepatocytes and organ function. Here we describe a functional genetic approach for the identification of gene targets that can be exploited to increase the regenerative capacity of hepatocytes. Pools of small hairpin RNAs (shRNAs) were directly and stably delivered into mouse livers to screen for genes modulating liver regeneration. Our studies identify the dual-specific kinase MKK4 as a master regulator of liver regeneration. MKK4 silencing robustly increased the regenerative capacity of hepatocytes in mouse models of liver regeneration and acute and chronic liver failure. Mechanistically, induction of MKK7 and a JNK1-dependent activation of the AP1 transcription factor ATF2 and the Ets factor ELK1 are crucial for increased regeneration of hepatocytes with MKK4 silencing.	[Wuestefeld, Torsten; Yevsa, Tetyana; Hohmeyer, Anja; Rittelmeier, Ina; Ott, Michael; Vogel, Arndt; Manns, Michael P.; Zender, Lars] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Wuestefeld, Torsten; Pesic, Marina; Rudalska, Ramona; Dauch, Daniel; Kang, Tae-Won; Heinzmann, Florian; Hoenicke, Lisa; Potapova, Anna; Jarek, Michael; Geffers, Robert; Scharfe, Maren; Klawonn, Frank; Zender, Lars] Helmholtz Ctr Infect Res HZI, D-38124 Braunschweig, Germany; [Wuestefeld, Torsten; Pesic, Marina; Rudalska, Ramona; Dauch, Daniel; Kang, Tae-Won; Heinzmann, Florian; Hoenicke, Lisa; Hohmeyer, Anja; Zender, Lars] Univ Tubingen, Div Translat Gastrointestinal Oncol, Dept Internal Med 1, D-72076 Tubingen, Germany; [Malek, Nisar P.] Univ Tubingen, Dept Internal Med 1, D-72076 Tubingen, Germany; [Longerich, Thomas; Schirmacher, Peter] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany; [Rittelmeier, Ina; Ott, Michael] Twincore Ctr Expt & Clin Infect Res, D-30625 Hannover, Germany; [Nordheim, Alfred] Univ Tubingen, Dept Mol Biol, Interfac Inst Cell Biol, D-72076 Tubingen, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center for Infection Research; Eberhard Karls University of Tubingen	Zender, L (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.	lars.zender@med.uni-tuebingen.de	Vogel, Arndt/A-8437-2012; Klawonn, Frank/HFH-5887-2022; Kang, Tae Won/S-4864-2019	Klawonn, Frank/0000-0001-9613-182X; Kang, Tae Won/0000-0003-1497-8926; /0000-0002-2430-4397; Hoenicke, Lisa/0000-0003-0613-8337; Nordheim, Alfred/0000-0003-4680-0778; Vogel, Arndt/0000-0003-0560-5538; Yevsa, Tetyana/0000-0003-0377-9198	German Research Foundation (DFG) [ZE 545/2-1, SFB/TRR77]; Helmholtz Association of German Research Centers [VH-NG-424]; European Commission; Wilhelm Sander Stiftung [2009.005.2]; Bear Necessities Pediatric Cancer Foundation; Federal German Ministry for Education and Research (BMBF)	German Research Foundation (DFG)(German Research Foundation (DFG)); Helmholtz Association of German Research Centers(Helmholtz Association); European Commission(European CommissionEuropean Commission Joint Research Centre); Wilhelm Sander Stiftung; Bear Necessities Pediatric Cancer Foundation; Federal German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank Drs. M. Kay and D. Largaespada for providing transposon vectors and transposase-encoding vectors; Dr. L. Grobe, A. Rinkel, N. Struever, Dr. H. Riedesel, and the team of the HZI animal facility for technical assistance; and Drs. J. Gil, K. Schulze-Osthoff, and J. Zuber for advice and discussions. This work was supported by grants of the German Research Foundation (DFG) to L. Z. (Emmy Noether Programme ZE 545/2-1, SFB/TRR77, project B4, "REBIRTH" cluster of Excellence, project "Liver regeneration"); the Helmholtz Association of German Research Centers (VH-NG-424 to L. Z.); the European Commission (project "HEPTROMIC" to L. Z.); the Wilhelm Sander Stiftung (2009.005.2 to L. Z.); the Bear Necessities Pediatric Cancer Foundation; and the Federal German Ministry for Education and Research (BMBF) (ARCHES AWARD to L. Z. and the project "virtual liver network" to A. N.). L. Z. holds an adjunct assistant professorship with the Cold Spring Harbor Laboratory, 11724 Cold Spring Harbor, USA. M. P., R. R., and D. D. contributed equally to this manuscript.	Ahn YH, 2011, MOL CELL BIOL, V31, P4270, DOI 10.1128/MCB.05562-11; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Cesari F, 2004, GENESIS, V38, P87, DOI 10.1002/gene.20003; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chistiakov DA, 2012, CELLS TISSUES ORGANS, V196, P291, DOI 10.1159/000335697; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Ganiatsas S, 1998, P NATL ACAD SCI USA, V95, P6881, DOI 10.1073/pnas.95.12.6881; GAUB J, 1984, HEPATOLOGY, V4, P902, DOI 10.1002/hep.1840040519; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; HICKMAN MA, 1994, HUM GENE THER, V5, P1477, DOI 10.1089/hum.1994.5.12-1477; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; McCusker C, 2011, GERONTOLOGY, V57, P565, DOI 10.1159/000323761; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Overturf K, 1997, HUM GENE THER, V8, P513, DOI 10.1089/hum.1997.8.5-513; Overturf K, 1997, AM J PATHOL, V151, P1273; PIERCE RA, 1987, J BIOL CHEM, V262, P1652; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Sakamoto T, 1999, HEPATOLOGY, V29, P403, DOI 10.1002/hep.510290244; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; STARZL TE, 1975, AM J SURG, V129, P587, DOI 10.1016/0002-9610(75)90323-2; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Teoh NC, 2009, J GASTROEN HEPATOL, V24, P1817, DOI 10.1111/j.1440-1746.2009.06121.x; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; World Health Organization, 2011, DEATHS EST 2008 CAUS; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yeasmin S, 2011, TUMOR BIOL, V32, P661, DOI 10.1007/s13277-011-0166-5; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	34	105	110	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					389	401		10.1016/j.cell.2013.03.026	http://dx.doi.org/10.1016/j.cell.2013.03.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582328	Bronze			2022-12-28	WOS:000317349700017
J	Reitschuler-Cross, EB; Arnold, B				Reitschuler-Cross, Eva B.; Arnold, Bob			Parenteral hydration did not improve dehydration or quality of life in advanced cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Reitschuler-Cross, Eva B.; Arnold, Bob] Univ Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reitschuler-Cross, EB (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.							Cohen MZ, 2012, J PAIN SYMPTOM MANAG, V43, P855, DOI 10.1016/j.jpainsymman.2011.06.016	1	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6							JC10	10.7326/0003-4819-158-6-201303190-02010	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23552960				2022-12-28	WOS:000316565100009
J	Kunins, HV; Farley, TA; Dowell, D				Kunins, Hillary V.; Farley, Thomas A.; Dowell, Deborah			Guidelines for Opioid Prescription: Why Emergency Physicians Need Support	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PAIN; MANAGEMENT		[Kunins, Hillary V.; Farley, Thomas A.; Dowell, Deborah] New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA	New York City Department of Health & Mental Hygiene	Kunins, HV (corresponding author), New York City Dept Hlth & Mental Hyg, 42-09 28th St,19th Floor, Queens, NY 11101 USA.							Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Boscarino JA, 2011, J ADDICT DIS, V30, P185, DOI 10.1080/10550887.2011.581961; Chu J, 2013, NEW YORK CITY EMERGE; Franklin GM, 2008, SPINE, V33, P199, DOI 10.1097/BRS.0b013e318160455c; Manchikanti L, 2011, PAIN PHYSICIAN, V14, P91; Mularski RA, 2006, J GEN INTERN MED, V21, P607, DOI 10.1111/j.1525-1497.2006.00415.x; Paone D, 2001, CITY HLTH INFORM, V30, P23; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; PORTER J, 1980, NEW ENGL J MED, V302, P123; Warner Margaret, 2011, NCHS Data Brief, P1; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	11	21	21	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					841	+		10.7326/0003-4819-158-11-201306040-00631	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00631			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164AA	23567824				2022-12-28	WOS:000320379800008
J	Jacobson, IM; Gordon, SC; Kowdley, KV; Yoshida, EM; Rodriguez-Torres, M; Sulkowski, MS; Shiffman, ML; Lawitz, E; Everson, G; Bennett, M; Schiff, E; Al-Assi, MT; Subramanian, GM; An, D; Lin, M; McNally, J; Brainard, D; Symonds, WT; McHutchison, JG; Patel, K; Feld, J; Pianko, S; Nelson, DR				Jacobson, Ira M.; Gordon, Stuart C.; Kowdley, Kris V.; Yoshida, Eric M.; Rodriguez-Torres, Maribel; Sulkowski, Mark S.; Shiffman, Mitchell L.; Lawitz, Eric; Everson, Gregory; Bennett, Michael; Schiff, Eugene; Al-Assi, M. Tarek; Subramanian, G. Mani; An, Di; Lin, Ming; McNally, John; Brainard, Diana; Symonds, William T.; McHutchison, John G.; Patel, Keyur; Feld, Jordan; Pianko, Stephen; Nelson, David R.			Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLUS RIBAVIRIN; MANAGEMENT	BACKGROUND Patients chronically infected with hepatitis C virus (HCV) genotype 2 or 3 for whom treatment with peginterferon is not an option, or who have not had a response to prior interferon treatment, currently have no approved treatment options. In phase 2 trials, regimens including the oral nucleotide polymerase inhibitor sofosbuvir have shown efficacy in patients with HCV genotype 2 or 3 infection. METHODS We conducted two randomized, phase 3 studies involving patients with chronic HCV genotype 2 or 3 infection. In one trial, patients for whom treatment with peginterferon was not an option received oral sofosbuvir and ribavirin (207 patients) or matching placebo (71) for 12 weeks. In a second trial, patients who had not had a response to prior interferon therapy received sofosbuvir and ribavirin for 12 weeks (103 patients) or 16 weeks (98). The primary end point was a sustained virologic response at 12 weeks after therapy. RESULTS Among patients for whom treatment with peginterferon was not an option, the rate of a sustained virologic response was 78% (95% confidence interval [CI], 72 to 83) with sofosbuvir and ribavirin, as compared with 0% with placebo (P<0.001). Among previously treated patients, the rate of response was 50% with 12 weeks of treatment, as compared with 73% with 16 weeks of treatment (difference, -23 percentage points; 95% CI, -35 to -11; P<0.001). In both studies, response rates were lower among patients with genotype 3 infection than among those with genotype 2 infection and, among patients with genotype 3 infection, lower among those with cirrhosis than among those without cirrhosis. The most common adverse events were headache, fatigue, nausea, and insomnia; the overall rate of discontinuation of sofosbuvir was low (1 to 2%). CONCLUSIONS In patients with HCV genotype 2 or 3 infection for whom treatment with peginterferon and ribavirin was not an option, 12 or 16 weeks of treatment with sofosbuvir and ribavirin was effective. Efficacy was increased among patients with HCV genotype 2 infection and those without cirrhosis. In previously treated patients with genotype 3 infection, 16 weeks of therapy was significantly more effective than 12 weeks. (Funded by Gilead Sciences; POSITRON and FUSION ClinicalTrials.gov numbers, NCT01542788 and NCT01604850, respectively.)	[Jacobson, Ira M.] Weill Cornell Med Coll, New York, NY 10021 USA; [Gordon, Stuart C.] Henry Ford Hlth Syst, Detroit, MI USA; [Kowdley, Kris V.] Virginia Mason Med Ctr, Inst Digest Dis, Seattle, WA 98101 USA; [Yoshida, Eric M.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Feld, Jordan] Univ Toronto, Toronto, ON, Canada; [Rodriguez-Torres, Maribel] Fdn Invest, San Juan, PR USA; [Sulkowski, Mark S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Shiffman, Mitchell L.] Bon Secours Hlth Syst, Liver Inst Virginia, Newport News, VA USA; [Lawitz, Eric] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78229 USA; [Al-Assi, M. Tarek] Texas Digest Dis Consultants, Arlington, TX USA; [Everson, Gregory] Univ Colorado Denver, Aurora, CO USA; [Bennett, Michael] Med Associates Res Grp, San Diego, CA USA; [Subramanian, G. Mani; An, Di; Lin, Ming; McNally, John; Brainard, Diana; Symonds, William T.; McHutchison, John G.] Gilead Sci Inc, Foster City, CA 94404 USA; [Schiff, Eugene] Univ Miami, Sch Med, Ctr Liver Dis, Miami, FL USA; [Nelson, David R.] Univ Florida, Gainesville, FL 32610 USA; [Patel, Keyur] Duke Univ, Durham, NC USA; [Pianko, Stephen] Monash Med Ctr, Melbourne, Vic, Australia; [Pianko, Stephen] Monash Univ, Melbourne, Vic 3004, Australia	Cornell University; Henry Ford Health System; Henry Ford Hospital; Virginia Mason Medical Center; University of British Columbia; University of Toronto; Johns Hopkins University; University of Texas System; University of Texas Health San Antonio; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Gilead Sciences; University of Miami; State University System of Florida; University of Florida; Duke University; Monash University; Monash University	Jacobson, IM (corresponding author), Weill Cornell Med Coll, 1305 York Ave, New York, NY 10021 USA.	imj2001@med.cornell.edu; david.nelson@medicine.ufl.edu	Feld, Jordan/AAH-5628-2020; Kowdley, Kris/AAF-5202-2019	Feld, Jordan/0000-0003-2640-2211; Afdhal, Nezam/0000-0002-7342-6593; Leggett, Barbara/0000-0003-2062-7380	Gilead Sciences; Abbott Laboratories; Achillion Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Enanta Pharmaceuticals; GlaxoSmithKline; Idenix Pharmaceuticals; Kadmon; Novartis; Presidio Pharmaceuticals; Roche; Merck; Tibotec Pharmaceuticals/Janssen Pharmaceuticals; Vertex Pharmaceuticals; Pfizer; CVS Caremark; Intercept Pharmaceuticals; Mochida Pharmaceutical; Ikaria; Janssen Pharmaceuticals; Beckman Coulter; Hoffmann-La Roche; Astellas Pharma; Akros Pharma; Genentech; Inhibitex; Janssen Research and Development Ireland; Pharmasset; Santaris Pharma; Anadys Pharmaceuticals; Human Genome Sciences; Idera Pharmaceuticals; Johnson Johnson; Scynexis; Siemens Healthcare Diagnostics; ZymoGenetics; AbbVie; Bayer; Conatus Pharmaceuticals; Gen-Probe; GlobeImmune; Roche/Genentech; Biolex Therapeutics; BioCryst Pharmaceuticals; Biotica; Tibotec Pharmaceuticals; Theravance; Medarex; Medtronic; Schering-Plough; ViroChem Pharma; Zymo-Genetics; Eisai Pharmaceuticals; Biotest; Roche Molecular Diagnostics; Salix Pharmaceuticals	Gilead Sciences(Gilead Sciences); Abbott Laboratories(Abbott Laboratories); Achillion Pharmaceuticals; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Enanta Pharmaceuticals; GlaxoSmithKline(GlaxoSmithKline); Idenix Pharmaceuticals; Kadmon; Novartis(Novartis); Presidio Pharmaceuticals; Roche(Roche Holding); Merck(Merck & Company); Tibotec Pharmaceuticals/Janssen Pharmaceuticals; Vertex Pharmaceuticals(Vertex Pharmaceuticals); Pfizer(Pfizer); CVS Caremark; Intercept Pharmaceuticals; Mochida Pharmaceutical; Ikaria; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Beckman Coulter; Hoffmann-La Roche(Hoffmann-La Roche); Astellas Pharma(Astellas Pharmaceuticals); Akros Pharma(Dexcel Pharma); Genentech(Roche HoldingGenentech); Inhibitex; Janssen Research and Development Ireland; Pharmasset; Santaris Pharma; Anadys Pharmaceuticals; Human Genome Sciences(GlaxoSmithKline); Idera Pharmaceuticals; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Scynexis; Siemens Healthcare Diagnostics; ZymoGenetics; AbbVie(AbbVie); Bayer(Bayer AG); Conatus Pharmaceuticals; Gen-Probe; GlobeImmune; Roche/Genentech(Roche HoldingGenentech); Biolex Therapeutics; BioCryst Pharmaceuticals; Biotica; Tibotec Pharmaceuticals; Theravance; Medarex; Medtronic(Medtronic); Schering-Plough(Merck & CompanySchering Plough Corporation); ViroChem Pharma(Dexcel Pharma); Zymo-Genetics; Eisai Pharmaceuticals(Eisai Co Ltd); Biotest; Roche Molecular Diagnostics; Salix Pharmaceuticals	Funded by Gilead Sciences; POSITRON and FUSION ClinicalTrials.gov numbers, NCT01542788 and NCT01604850, respectively.; Supported by Gilead Sciences.; Dr. Jacobson reports receiving consulting fees from Abbott Laboratories, Achillion Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Enanta Pharmaceuticals, Gilead Sciences, GlaxoSmithKline, Idenix Pharmaceuticals, Kadmon, Novartis, Presidio Pharmaceuticals, Roche, Merck, Tibotec Pharmaceuticals/Janssen Pharmaceuticals, and Vertex Pharmaceuticals; lecture fees from Bristol-Myers Squibb, Gilead Sciences, Roche, and Vertex Pharmaceuticals; and grant support from Abbott Laboratories, Achillion Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Novartis, Pfizer, Roche, Merck, Tibotec Pharmaceuticals/Janssen Pharmaceuticals, and Vertex Pharmaceuticals. Dr. Gordon reports receiving consulting fees from Bristol-Myers Squibb, CVS Caremark, Merck, Novartis, and Vertex Pharmaceuticals; and grant support from Abbott Laboratories, Bristol-Myers Squibb, GlaxoSmithKline, Merck, and Vertex Pharmaceuticals. Dr. Kowdley reports receiving consulting fees from Novartis; grant support from Bristol-Myers Squibb, Intercept Pharmaceuticals, Abbott Laboratories, Gilead Sciences, Merck, Mochida Pharmaceutical, Boehringer Ingelheim, Ikaria, Vertex Pharmaceuticals, Janssen Pharmaceuticals, and Beckman Coulter; royalties from UpToDate; and payment for the development of educational presentations from CME Outfitters and ViralEd; and serving on the advisory boards of Gilead Sciences, Abbott Laboratories, Vertex Pharmaceuticals, and Merck. Dr. Yoshida reports receiving grant support from Merck, Vertex Pharmaceuticals, Janssen Pharmaceuticals, Hoffmann-La Roche, Boehringer Ingelheim, Pfizer, Novartis, and Astellas Pharma; lecture fees from Vertex Pharmaceuticals, Merck, Gilead Sciences, and Hoffmann-La Roche; and payment for the development of educational presentations from Merck Canada. Dr. Rodriguez-Torres reports receiving consulting fees from Akros Pharma, Bristol-Myers Squibb, Genentech, Hoffmann-La Roche, Inhibitex, Janssen Research and Development Ireland, Pharmasset, Santaris Pharma, and Vertex Pharmaceuticals; and grant support from Abbott Laboratories, Akros Pharma, Anadys Pharmaceuticals, Beckman Coulter, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, GlaxoSmithKline, Hoffmann-La Roche, Human Genome Sciences, Idenix Pharmaceuticals, Idera Pharmaceuticals, Inhibitex, Johnson & Johnson, Merck, Mochida Pharmaceutical, Novartis, Pfizer, Santaris Pharma, Scynexis, Siemens Healthcare Diagnostics, Vertex Pharmaceuticals, ZymoGenetics, Gilead Sciences, and Pharmasset. Dr. Sulkowski reports receiving consulting fees and grant support from AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen Pharmaceuticals, Merck, Novartis, Roche, and Vertex Pharmaceuticals; and payment for the development of educational presentations and for travel from Merck and Janssen Pharmaceuticals. Dr. Shiffman reports receiving consulting fees from Bristol-Myers Squibb, Bayer, Boehringer Ingelheim, Conatus Pharmaceuticals, Gen-Probe, GlobeImmune, GlaxoSmithKline, Janssen Pharmaceuticals, Merck, Novartis, Roche, and Vertex Pharmaceuticals; grant support from Abbott Laboratories, Achillion Pharmaceuticals, Anadys Pharmaceuticals, Beckman Coulter, Bristol-Myers Squibb, Boehringer Ingelheim, GlobeImmune, Merck, Novartis, and Roche/Genentech; and payment for the development of educational presentations from Bayer, Gilead Sciences, Merck, and Vertex Pharmaceuticals. Dr.; Lawitz reports receiving consulting fees from Abbott Laboratories, Achillion Pharmaceuticals, Anadys Pharmaceuticals, Biolex Therapeutics, BioCryst Pharmaceuticals, Biotica, Enanta Pharmaceuticals, Gilead Sciences, GlobeImmune, Idenix Pharmaceuticals, Inhibitex, Janssen Pharmaceuticals, Merck, Novartis, Pharmasset, Santaris Pharma, Tibotec Pharmaceuticals, Theravance, and Vertex Pharmaceuticals; lecture fees from Merck, Vertex Pharmaceuticals, Gilead Sciences, and Kadmon; and grant support from Abbott Laboratories, Achillion Pharmaceuticals, Anadys Pharmaceuticals, Biolex Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, GlobeImmune, Idenix Pharmaceuticals, Idera Pharmaceuticals, Inhibitex, Intercept Pharmaceuticals, Janssen Pharmaceuticals, Medarex, Medtronic, Merck, Novartis, Pharmasset, Presidio Pharmaceuticals, Roche, Schering-Plough, Santaris Pharma, Scynexis, Vertex Pharmaceuticals, ViroChem Pharma, and Zymo-Genetics. Dr. Everson reports receiving consulting fees from Abbott Laboratories, Gilead Sciences, Novartis, Bristol-Myers Squibb, Eisai Pharmaceuticals, Biotest, Roche, Merck, and Janssen Pharmaceuticals; grant support from Abbott Laboratories, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, Novartis, Roche, Tibotec Pharmaceuticals, and Vertex Pharmaceuticals; and royalties related to filed patents and an exclusive licensing agreement with HepQuant; and serving on the Transplant Hepatology Board of the American Board of Internal Medicine, the Transplant Hepatology Board of the Accreditation Council for Graduate Medical Education, and the boards of Partners Seeking a Cure, HepC Connection, and the American Liver Foundation Rocky Mountain Division; and as serving as an expert witness for Murphy Decker Hensen and Cook-Olson; and holding 13 filings related to three patents in the United States, Europe, Canada, and Australia. Dr. Schiff reports receiving consulting fees from Gilead Sciences; grant support from Gilead Sciences, Bristol-Myers Squibb, and Roche Molecular Diagnostics; and royalties from Wiley; and serving on the boards of Gilead Sciences and Bristol-Myers Squibb. Dr. Al-Assi reports receiving grant support from Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Novartis, Merck, Pharmasset, Salix Pharmaceuticals, and Vertex Pharmaceuticals. Drs. Subramanian, An, Lin, McNally, Brainard, Symonds, and McHutchison report being employees of and receiving stock options from Gilead Sciences. Dr. Patel reports receiving consulting fees and payment for the development of educational presentations from Vertex Pharmaceuticals and Gilead Sciences; and grant support from Merck. Dr. Feld reports receiving lecture fees from Abbott Laboratories, Gilead Sciences, and Merck; and grant support from Gilead Sciences; and serving on the boards of Abbott Laboratories, Boehringer Ingelheim, Gilead Sciences, Janssen Pharmaceuticals, Merck, Roche, and Vertex Pharmaceuticals. Dr. Pianko reports receiving consulting fees from Gilead Sciences and Roche; grant support from Merck; and payment for the development of educational presentations from Gilead Sciences, Roche, Janssen Pharmaceuticals, and Merck. Dr. Nelson reports receiving grant support from Genentech, Kadmon, Merck, and Vertex Pharmaceuticals; and payment for the development of educational presentations from Clinical Care Options, Rush University Medical Center, Practice Point Communications, and Chronic Liver Disease Foundation.; No other potential conflict of interest relevant to this article was reported.	Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gane EJ, 2012, HEPATOLOGY, V56, p306A; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Lam AM, 2010, ANTIMICROB AGENTS CH, V54, P3187, DOI 10.1128/AAC.00399-10; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Marcellin P, 2012, HEPATOLOGY, V56, P2039, DOI 10.1002/hep.25892; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Negro F, 2010, BEST PRACT RES CL GA, V24, P183, DOI 10.1016/j.bpg.2009.10.012; Poynard T, 2009, GASTROENTEROLOGY, V136, P1618, DOI 10.1053/j.gastro.2009.01.039; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Sulkowski MS, 2011, NAT REV GASTRO HEPAT, V8, P212, DOI 10.1038/nrgastro.2011.21	14	845	877	1	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1867	1877		10.1056/NEJMoa1214854	http://dx.doi.org/10.1056/NEJMoa1214854			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143VK	23607593				2022-12-28	WOS:000318896200006
J	Paddon, CJ; Westfall, PJ; Pitera, DJ; Benjamin, K; Fisher, K; McPhee, D; Leavell, MD; Tai, A; Main, A; Eng, D; Polichuk, DR; Teoh, KH; Reed, DW; Treynor, T; Lenihan, J; Fleck, M; Bajad, S; Dang, G; Dengrove, D; Diola, D; Dorin, G; Ellens, KW; Fickes, S; Galazzo, J; Gaucher, SP; Geistlinger, T; Henry, R; Hepp, M; Horning, T; Iqbal, T; Jiang, H; Kizer, L; Lieu, B; Melis, D; Moss, N; Regentin, R; Secrest, S; Tsuruta, H; Vazquez, R; Westblade, LF; Xu, L; Yu, M; Zhang, Y; Zhao, L; Lievense, J; Covello, PS; Keasling, JD; Reiling, KK; Renninger, NS; Newman, JD				Paddon, C. J.; Westfall, P. J.; Pitera, D. J.; Benjamin, K.; Fisher, K.; McPhee, D.; Leavell, M. D.; Tai, A.; Main, A.; Eng, D.; Polichuk, D. R.; Teoh, K. H.; Reed, D. W.; Treynor, T.; Lenihan, J.; Fleck, M.; Bajad, S.; Dang, G.; Dengrove, D.; Diola, D.; Dorin, G.; Ellens, K. W.; Fickes, S.; Galazzo, J.; Gaucher, S. P.; Geistlinger, T.; Henry, R.; Hepp, M.; Horning, T.; Iqbal, T.; Jiang, H.; Kizer, L.; Lieu, B.; Melis, D.; Moss, N.; Regentin, R.; Secrest, S.; Tsuruta, H.; Vazquez, R.; Westblade, L. F.; Xu, L.; Yu, M.; Zhang, Y.; Zhao, L.; Lievense, J.; Covello, P. S.; Keasling, J. D.; Reiling, K. K.; Renninger, N. S.; Newman, J. D.			High-level semi-synthetic production of the potent antimalarial artemisinin	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DIHYDROARTEMISINIC ACID; MOLECULAR-CLONING; DRUG ARTEMISININ; GENE DISRUPTION; CYTOCHROME B(5); BIOSYNTHESIS; ANNUA; REDUCTASE; YEAST	In 2010 there were more than 200 million cases of malaria, and at least 655,000 deaths(1). The World Health Organization has recommended artemisinin-based combination therapies (ACTs) for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum. Artemisinin is a sesquiterpene endoperoxide with potent antimalarial properties, produced by the plant Artemisia annua. However, the supply of plant-derived artemisinin is unstable, resulting in shortages and price fluctuations, complicating production planning by ACT manufacturers(2). A stable source of affordable artemisinin is required. Here we use synthetic biology to develop strains of Saccharomyces cerevisiae (baker's yeast) for high-yielding biological production of artemisinic acid, a precursor of artemisinin. Previous attempts to produce commercially relevant concentrations of artemisinic acid were unsuccessful, allowing production of only 1.6 grams per litre of artemisinic acid(3). Here we demonstrate the complete biosynthetic pathway, including the discovery of a plant dehydrogenase and a second cytochrome that provide an efficient biosynthetic route to artemisinic acid, with fermentation titres of 25 grams per litre of artemisinic acid. Furthermore, we have developed a practical, efficient and scalable chemical process for the conversion of artemisinic acid to artemisinin using a chemical source of singlet oxygen, thus avoiding the need for specialized photochemical equipment. The strains and processes described here form the basis of a viable industrial process for the production of semi-synthetic artemisinin to stabilize the supply of artemisinin for derivatization into active pharmaceutical ingredients (for example, artesunate) for incorporation into ACTs. Because all intellectual property rights have been provided free of charge, this technology has the potential to increase provision of first-line antimalarial treatments to the developing world at a reduced average annual price.	[Paddon, C. J.; Westfall, P. J.; Pitera, D. J.; Benjamin, K.; Fisher, K.; McPhee, D.; Leavell, M. D.; Tai, A.; Main, A.; Eng, D.; Treynor, T.; Lenihan, J.; Fleck, M.; Bajad, S.; Dang, G.; Dengrove, D.; Diola, D.; Dorin, G.; Fickes, S.; Galazzo, J.; Gaucher, S. P.; Geistlinger, T.; Henry, R.; Horning, T.; Iqbal, T.; Jiang, H.; Kizer, L.; Lieu, B.; Melis, D.; Moss, N.; Regentin, R.; Secrest, S.; Tsuruta, H.; Vazquez, R.; Westblade, L. F.; Xu, L.; Yu, M.; Zhao, L.; Lievense, J.; Reiling, K. K.; Renninger, N. S.; Newman, J. D.] Amyris Inc, Emeryville, CA 94608 USA; [Polichuk, D. R.; Teoh, K. H.; Reed, D. W.; Ellens, K. W.; Hepp, M.; Zhang, Y.; Covello, P. S.] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada; [Keasling, J. D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Keasling, J. D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, J. D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Keasling, J. D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA	National Research Council Canada; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI	Paddon, CJ (corresponding author), Amyris Inc, 5885 Hollis St,Suite 100, Emeryville, CA 94608 USA.	paddon@amyris.com; newman@amyris.com	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Paddon, Christopher/0000-0003-4182-2855; Benjamin, Kirsten/0000-0003-4267-1972; Reed, Darwin/0000-0001-8038-8647	Institute for OneWorld Health	Institute for OneWorld Health	We thank D. Rathbone for advice on native A. annua ADH1 expression, and our friends and colleagues at Sanofi, especially D. Thibaut, C. Lehmann, C. Masson-Brocard, B. Dumas, P. Baduel and H. Farret. We also thank J. Rine, P. Ortiz de Montellano and H. van Dijken for many conversations. This research was conducted under the sponsorship of the Institute for OneWorld Health through generous support of the Bill & Melinda Gates Foundation for this non-profit project.	[Anonymous], MED CHEM BIOACTIVE N; Asadollahi MA, 2008, BIOTECHNOL BIOENG, V99, P666, DOI 10.1002/bit.21581; Bertea CM, 2005, PLANTA MED, V71, P40, DOI 10.1055/s-2005-837749; Boehme K., 1992, INORG CHEM, V31, P3468; Daugulis AJ, 1997, CURR OPIN BIOTECH, V8, P169, DOI 10.1016/S0958-1669(97)80097-3; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Hale V, 2007, AM J TROP MED HYG, V77, P198, DOI 10.4269/ajtmh.2007.77.198; Haynes RK, 2006, CURR TOP MED CHEM, V6, P509, DOI 10.2174/156802606776743129; HAYNES RK, 1990, J CHEM SOC CHEM COMM, P451, DOI 10.1039/c39900000451; Kim BJ, 2006, ORG PREP PROCED INT, V38, P1, DOI 10.1080/00304940609355981; Levesque F, 2012, ANGEW CHEM INT EDIT, V51, P1706, DOI 10.1002/anie.201107446; Nam JW, 2007, J EXP BOT, V58, P1421, DOI 10.1093/jxb/erm005; Paradise EM, 2008, BIOTECHNOL BIOENG, V100, P371, DOI 10.1002/bit.21766; PETERSON JA, 1976, J BIOL CHEM, V251, P4010; Polichuk DR, 2010, PHYTOCHEMISTRY, V71, P1264, DOI 10.1016/j.phytochem.2010.04.026; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Roth R. J., 1991, US Patent, Patent No. 4992561; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Sy LK, 2002, TETRAHEDRON, V58, P909, DOI 10.1016/S0040-4020(01)01192-9; Teoh KH, 2009, BOTANY, V87, P635, DOI 10.1139/B09-032; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; van Hoek P, 2000, BIOTECHNOL BIOENG, V68, P517; Vorachek-Warren MK, 2004, YEAST, V21, P163, DOI 10.1002/yea.1074; Westfall PJ, 2012, P NATL ACAD SCI USA, V109, P111, DOI 10.1073/pnas.1110740109; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang Y, 2008, J BIOL CHEM, V283, P21501, DOI 10.1074/jbc.M803090200	29	1198	1378	96	1407	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2013	496	7446					528	+		10.1038/nature12051	http://dx.doi.org/10.1038/nature12051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23575629	Bronze			2022-12-28	WOS:000317984400046
J	Blackhall, LJ				Blackhall, Leslie J.			Do patients need to know they are terminally ill? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; SURVIVAL; ILLNESS; HOSPICE		Univ Virginia, Sch Med, Charlottesville, VA 22908 USA	University of Virginia	Blackhall, LJ (corresponding author), Univ Virginia, Sch Med, Charlottesville, VA 22908 USA.	LB9X@hscmail.mcc.virginia.edu						Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Blackhall LJ, 2001, J URBAN HEALTH, V78, P59, DOI 10.1093/jurban/78.1.59; Christakis NA, 2000, WESTERN J MED, V172, P310, DOI 10.1136/ewjm.172.5.310; Connor SR, 2007, J PAIN SYMPTOM MANAG, V33, P238, DOI 10.1016/j.jpainsymman.2006.10.010; Curtis JR, 2003, J CRIT CARE, V18, P22, DOI 10.1053/jcrc.2003.YJCRC5; Fried TR, 2003, J AM GERIATR SOC, V51, P1398, DOI 10.1046/j.1532-5415.2003.51457.x; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; Hui D, 2012, J PAIN SYMPTOM MANAG, V43, P582, DOI 10.1016/j.jpainsymman.2011.04.016; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Saito AM, 2011, J PALLIAT MED, V14, P929, DOI 10.1089/jpm.2010.0522; Smith TJ, 2011, NEW ENGL J MED, V364, P2060, DOI 10.1056/NEJMsb1013826; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	12	6	6	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2013	346								f2560	10.1136/bmj.f2560	http://dx.doi.org/10.1136/bmj.f2560			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134PM	23615595				2022-12-28	WOS:000318224900017
J	Moore, W				Moore, Wendy			Flower power	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com						Oakeley H, 2012, DOCTORS IN THE MEDIC	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2013	346								f2525	10.1136/bmj.f2525	http://dx.doi.org/10.1136/bmj.f2525			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134PM	23615592				2022-12-28	WOS:000318224900013
J	Baroni, A; Piccolo, V				Baroni, Adone; Piccolo, Vincenzo			Red Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Baroni, Adone; Piccolo, Vincenzo] Univ Naples 2, Naples, Italy	Universita della Campania Vanvitelli	Baroni, A (corresponding author), Univ Naples 2, Naples, Italy.		Piccolo, Vincenzo/X-4163-2019	Piccolo, Vincenzo/0000-0001-7798-4368					0	11	11	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1536	1536		10.1056/NEJMicm1207155	http://dx.doi.org/10.1056/NEJMicm1207155			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126HC	23594006				2022-12-28	WOS:000317603300011
J	Lomas, A				Lomas, Alex			I'm a patient: show me the trial data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												alex@alexlomas.com						Adalimumab, BRIT NATL FORMULARY; Alrubaiy L, 2013, P422 BIOL REGISTER I, P422; Behm BW, 2008, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD006893; Goodyear M, 2006, BRIT MED J; Kmietowicz Z, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1636; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; NACC, 2010, GOOD DEC NICE ANTITN	7	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2013	346								f2336	10.1136/bmj.f2336	http://dx.doi.org/10.1136/bmj.f2336			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AO	23596128				2022-12-28	WOS:000317962900009
J	Adar, T; Paz, K				Adar, Tomer; Paz, Kalman			Pneumatosis Intestinalis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Adar, Tomer; Paz, Kalman] Shaare Zedek Med Ctr, Inst Digest Dis, Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center	Adar, T (corresponding author), Shaare Zedek Med Ctr, Inst Digest Dis, Jerusalem, Israel.	adartom@szmc.org.il							0	6	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					E19	E19		10.1056/NEJMicm1205591	http://dx.doi.org/10.1056/NEJMicm1205591			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122QT	23574141				2022-12-28	WOS:000317333600012
J	Baubec, T; Ivanek, R; Lienert, F; Schubeler, D				Baubec, Tuncay; Ivanek, Robert; Lienert, Florian; Schuebeler, Dirk			Methylation-Dependent and -Independent Genomic Targeting Principles of the MBD Protein Family	CELL			English	Article							EMBRYONIC STEM-CELLS; CPG-BINDING DOMAIN; DNA METHYLATION; TRANSCRIPTIONAL REPRESSOR; GENE-EXPRESSION; NEURONAL MECP2; RETT-SYNDROME; ACTIVE GENES; CHROMATIN; COMPLEX	To gain insight into the cellular readout of DNA methylation, we established a strategy for systematically profiling the genome-wide distribution of chromatin-interacting factors. This enabled us to create genomic maps for the methyl-CpG-binding domain (MBD) family of proteins, including disease-relevant mutants, deletions, and isoforms. In vivo binding of MBD proteins occurs predominantly as a linear function of local methylation density, requiring functional MBD domains and methyl-CPGs. This interaction directs specificity of MBD proteins to methylated, CpG-dense, and inactive regulatory regions. In contrast, binding to unmethylated sites varies between MBD proteins and is mediated via alternative domains or protein-protein interactions. Such targeting is exemplified by NuRD-complex-mediated tethering of MBD2 to a subset of unmethylated, active regulatory regions. Interestingly, MBD3 also occupies these sites, but like MBD2, binding is independent of the presence of hydroxymethylation. These functional binding maps reveal methylation-dependent and -independent binding modes and revise current models of DNA methylation readout through MBD proteins.	[Baubec, Tuncay; Ivanek, Robert; Lienert, Florian; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Schuebeler, Dirk] Univ Basel, Fac Sci, CH-4003 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	dirk@fmi.ch	Ivanek, Robert/A-8852-2008; Baubec, Tuncay/AAQ-8714-2021; Baubec, Tuncay/J-3719-2014	Baubec, Tuncay/0000-0001-8474-6587; Baubec, Tuncay/0000-0001-8474-6587; Ivanek, Robert/0000-0002-8403-056X	EMBO long-term postdoctoral fellowship; Novartis Research Foundation; European Union [FP7-HEALTH-2010-257082, FP7-282510]; European Research Council; SNF Sinergia program; Swiss initiative in Systems Biology	EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Novartis Research Foundation; European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); SNF Sinergia program; Swiss initiative in Systems Biology	We are grateful to Sophie Dessus-Babus, Tim Roloff (FMI), Ina Nissen, and Christian Beisel (ETH BSSE) for processing deep sequencing samples. We thank Christiane Wirbelauer and Leslie Hoerner for technical assistance and Michael Stadler, Dimos Gaidatzis, and Lukas Burger for bioinformatic advice and providing tools to process and analyze deep sequencing data. We thank Masaki Okano (RIKEN) for providing TKO cells; FMI facilities for technical support; and Nicolas Thoma (FMI), Matthew Lorincz (UBC Vancouver), Oliver Bell (HHMI/Stanford University), and members of the Schubeler lab for advice and critical comments on the manuscript. T. B. is supported by an EMBO long-term postdoctoral fellowship. Research in the laboratory of D. S. is supported by the Novartis Research Foundation, the European Union (NoE "EpiGeneSys" FP7-HEALTH-2010-257082 and the "Blueprint" consortium FP7-282510), the European Research Council (EpiGePlas), the SNF Sinergia program, and the Swiss initiative in Systems Biology (RTD Cell Plasticity).	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Boeke J, 2000, J BIOL CHEM, V275, P34963, DOI 10.1074/jbc.M005929200; Caballero IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004315; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016627; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	41	228	238	2	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					480	492		10.1016/j.cell.2013.03.011	http://dx.doi.org/10.1016/j.cell.2013.03.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582333	Bronze			2022-12-28	WOS:000317349700025
J	Marsh, JA; Hernandez, H; Hall, Z; Ahnert, SE; Perica, T; Robinson, CV; Teichmann, SA				Marsh, Joseph A.; Hernandez, Helena; Hall, Zoe; Ahnert, Sebastian E.; Perica, Tina; Robinson, Carol V.; Teichmann, Sarah A.			Protein Complexes Are under Evolutionary Selection to Assemble via Ordered Pathways	CELL			English	Article							GENE FUSION; GENERATION; NETWORKS; DATABASE	Is the order in which proteins assemble into complexes important for biological function? Here, we seek to address this by searching for evidence of evolutionary selection for ordered protein complex assembly. First, we experimentally characterize the assembly pathways of several heteromeric complexes and show that they can be simply predicted from their three-dimensional structures. Then, by mapping gene fusion events identified from fully sequenced genomes onto protein complex assembly pathways, we demonstrate evolutionary selection for conservation of assembly order. Furthermore, using structural and high-throughput interaction data, we show that fusion tends to optimize assembly by simplifying protein complex topologies. Finally, we observe protein structural constraints on the gene order of fusion that impact the potential for fusion to affect assembly. Together, these results reveal the intimate relationships among protein assembly, quaternary structure, and evolution and demonstrate on a genome-wide scale the biological importance of ordered assembly pathways.	[Marsh, Joseph A.; Teichmann, Sarah A.] EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; [Hernandez, Helena; Hall, Zoe; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Ahnert, Sebastian E.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Perica, Tina] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Teichmann, Sarah A.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	European Molecular Biology Laboratory (EMBL); University of Oxford; University of Cambridge; MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute	Robinson, CV (corresponding author), Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, S Parks Rd, Oxford OX1 3QZ, England.	carol.robinson@chem.ox.ac.uk; sarah.teichmann@ebi.ac.uk		Marsh, Joseph/0000-0003-4132-0628; Teichmann, Sarah/0000-0002-6294-6366; robinson, carol/0000-0001-7829-5505; Perica, Tina/0000-0003-3152-8425; Hall, Zoe/0000-0002-1434-8329	Medical Research Council (MRC) [U105161047]; Human Frontier Science Program Organization; MRC Programme Grant; Royal Society; ERC Advanced Grant; Royal Society Professorship; MRC [G1000819, MC_U105161047] Funding Source: UKRI; Medical Research Council [G1000819, MC_U105161047] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program Organization(Human Frontier Science Program); MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); ERC Advanced Grant(European Research Council (ERC)); Royal Society Professorship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank I. Schlichting (Max Planck Institute for Medical Research, Heidelberg), G. Waldrop (Louisiana State University), F. Raushel (Texas A&M University), and R. Hausinger (Michigan State University) for providing protein complex samples. We acknowledge E. Boeri-Erba and K. Wright for assistance with the MS experiments, and M. Babu and E. Natan for comments on the manuscript. J.A.M., T. P., and S. A. T. were supported by the Medical Research Council (MRC file reference number U105161047). J.A.M. was supported by a long-term fellowship from the Human Frontier Science Program Organization. H. H. was supported by an MRC Programme Grant. S. E. A. was supported by the Royal Society. C. V. R. was supported by an ERC Advanced Grant and a Royal Society Professorship.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bashton M, 2002, J MOL BIOL, V315, P927, DOI 10.1006/jmbi.2001.5288; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bjorklund AK, 2005, J MOL BIOL, V353, P911, DOI 10.1016/j.jmb.2005.08.067; Brooijmans N, 2002, PROTEINS, V48, P645, DOI 10.1002/prot.10139; Buljan M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r74; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Durand A, 2006, J BIOL CHEM, V281, P29558, DOI 10.1074/jbc.M602477200; Ellis RJ, 2007, ADV EXP MED BIOL, V594, P1; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Enright AJ, 2001, GENOME BIOL, V2; EVANS D R, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1351, DOI 10.1073/pnas.71.4.1351; Fong JH, 2007, J MOL BIOL, V366, P307, DOI 10.1016/j.jmb.2006.11.017; FRIEDMAN FK, 1979, ANNU REV BIOCHEM, V48, P217, DOI 10.1146/annurev.bi.48.070179.001245; Gallastegui N, 2010, TRENDS BIOCHEM SCI, V35, P634, DOI 10.1016/j.tibs.2010.05.005; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Jabri E, 1996, BIOCHEMISTRY-US, V35, P10616, DOI 10.1021/bi960424z; Kamburov A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-460; Kim WK, 2006, PLOS COMPUT BIOL, V2, P1151, DOI 10.1371/journal.pcbi.0020124; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Kummerfeld SK, 2005, TRENDS GENET, V21, P25, DOI 10.1016/j.tig.2004.11.007; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Leventhal C, 1969, MOSSBAUER SPECTROSCO, P22; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Marcotte Cynthia J Verjovsky, 2002, Appl Bioinformatics, V1, P93; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Marsh JA, 2012, CURR OPIN STRUC BIOL, V22, P643, DOI 10.1016/j.sbi.2012.08.008; Marsh JA, 2011, STRUCTURE, V19, P859, DOI 10.1016/j.str.2011.03.010; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Pasek S, 2006, BIOINFORMATICS, V22, P1418, DOI 10.1093/bioinformatics/btl135; Payne MS, 1997, BIOCHEMISTRY-US, V36, P5447, DOI 10.1021/bi962794t; Perica T, 2012, BIOCHEM SOC T, V40, P475, DOI 10.1042/BST20120056; POULSEN C, 1993, EUR J BIOCHEM, V212, P431, DOI 10.1111/j.1432-1033.1993.tb17679.x; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Reid AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010908; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Yanai I, 2001, P NATL ACAD SCI USA, V98, P7940, DOI 10.1073/pnas.141236298	47	156	158	1	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					461	470		10.1016/j.cell.2013.02.044	http://dx.doi.org/10.1016/j.cell.2013.02.044			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582331	Green Published, hybrid			2022-12-28	WOS:000317349700023
J	Gilmour, JP; Smith, LD; Heyward, AJ; Baird, AH; Pratchett, MS				Gilmour, James P.; Smith, Luke D.; Heyward, Andrew J.; Baird, Andrew H.; Pratchett, Morgan S.			Recovery of an Isolated Coral Reef System Following Severe Disturbance	SCIENCE			English	Article							COMMUNITIES; RESILIENCE; MANAGEMENT; DECLINE	Coral reef recovery from major disturbance is hypothesized to depend on the arrival of propagules from nearby undisturbed reefs. Therefore, reefs isolated by distance or current patterns are thought to be highly vulnerable to catastrophic disturbance. We found that on an isolated reef system in north Western Australia, coral cover increased from 9% to 44% within 12 years of a coral bleaching event, despite a 94% reduction in larval supply for 6 years after the bleaching. The initial increase in coral cover was the result of high rates of growth and survival of remnant colonies, followed by a rapid increase in juvenile recruitment as colonies matured. We show that isolated reefs can recover from major disturbance, and that the benefits of their isolation from chronic anthropogenic pressures can outweigh the costs of limited connectivity.	[Gilmour, James P.; Smith, Luke D.; Heyward, Andrew J.] Univ Western Australia, Oceans Inst, AIMS, Perth, WA 6009, Australia; [Baird, Andrew H.; Pratchett, Morgan S.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	Australian Institute of Marine Science; University of Western Australia; James Cook University	Gilmour, JP (corresponding author), Univ Western Australia, Oceans Inst, AIMS, Perth, WA 6009, Australia.	j.gilmour@aims.gov.au	Baird, Andrew Hamilton/C-8449-2009; Pratchett, Morgan S/A-9256-2010; Pratchett, Morgan/AAW-5179-2020	Baird, Andrew Hamilton/0000-0001-8504-4077; Pratchett, Morgan S/0000-0002-1862-8459; Pratchett, Morgan/0000-0002-1862-8459	Australian Federal Government through the Australian Institute of Marine Science; Browse LNG Development Joint Venture Participants, through the operator Woodside Energy Limited	Australian Federal Government through the Australian Institute of Marine Science; Browse LNG Development Joint Venture Participants, through the operator Woodside Energy Limited	The field work at Scott Reef was supported by crews of the AIMS Research Vessels Lady Basten, Cape Ferguson, and Solander. We thank K. Brooks, M. Case, J. Colquhoun, K. Cook, D. Ceccarelli, A. Cheal, J. Eagle, K. Fitzgerald, E. Gates, A. Halford, O. Hunt, D. Hoey, K. Markey, D. McKinney, S. Neale, R. Ninio, B. Radford, M. Rees, G. Suosaari, A. Thompson, M. Travers, and J. Underwood for help with data collection or analyses; J. Lough for help with sea surface temperature data; and K. Cook, A. McNeil, J. Oliver, and three anonymous reviewers for their comments. This research was jointly supported by the Australian Federal Government through the Australian Institute of Marine Science and the Browse LNG Development Joint Venture Participants, through the operator Woodside Energy Limited. J. P. G., L. D. S., and A. J. H. designed the experiments and collected and managed the data. J. P. G., L. D. S., A. H. B., and M. S. P. analyzed and interpreted the data, and all authors wrote the paper. Data used in this paper can be accessed at the AIMS Data Catalogue at http://data.aims.gov.au/metadataviewer/uuid/efc0b6f4-1eb1-48f0-8673-b161d68f0f2f.	Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; Done T, 2007, CORAL REEFS, V26, P789, DOI 10.1007/s00338-007-0265-3; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Gilmour JP, 2009, MAR BIOL, V156, P1297, DOI 10.1007/s00227-009-1171-8; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Lotze HK, 2011, TRENDS ECOL EVOL, V26, P595, DOI 10.1016/j.tree.2011.07.008; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; NOAA, 2013, COR REEF WATCH COR B; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Underwood JN, 2009, ECOL APPL, V19, P18, DOI 10.1890/07-1461.1; Van Woesik R, 2000, BIODIVERS CONSERV, V9, P1219, DOI 10.1023/A:1008913219660; Wilkinson C, 2000, STATUS CORAL REEFS W; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilkinson C., 2004, STATUS CORAL REEFS W; WITTENBERG M, 1992, MAR BIOL, V112, P131, DOI 10.1007/BF00349736	29	359	364	4	305	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2013	340	6128					69	71		10.1126/science.1232310	http://dx.doi.org/10.1126/science.1232310			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559247				2022-12-28	WOS:000317061100046
J	Jiang, H; Khan, S; Wang, Y; Charron, G; He, B; Sebastian, C; Du, JT; Kim, R; Ge, E; Mostoslavsky, R; Hang, HC; Hao, Q; Lin, HN				Jiang, Hong; Khan, Saba; Wang, Yi; Charron, Guillaume; He, Bin; Sebastian, Carlos; Du, Jintang; Kim, Ray; Ge, Eva; Mostoslavsky, Raul; Hang, Howard C.; Hao, Quan; Lin, Hening			SIRT6 regulates TNF-alpha secretion through hydrolysis of long-chain fatty acyl lysine	NATURE			English	Article							HISTONE DEACETYLASE; MAMMALIAN-CELLS; PROTEIN; PRECURSOR; ACYLATION; SIRTUINS; INSIGHTS; NAD(+); MICE	The Sir2 family of enzymes or sirtuins are known as nicotinamide adenine dinucleotide (NAD)-dependent deacetylases(1) and have been implicated in the regulation of transcription, genome stability, metabolism and lifespan(2,3). However, four of the seven mammalian sirtuins have very weak deacetylase activity in vitro. Here we show that human SIRT6 efficiently removes long-chain fatty acyl groups, such as myristoyl, from lysine residues. The crystal structure of SIRT6 reveals a large hydrophobic pocket that can accommodate long-chain fatty acyl groups. We demonstrate further that SIRT6 promotes the secretion of tumour necrosis factor-alpha (TNF-alpha) by removing the fatty acyl modification on K19 and K20 of TNF-alpha. Protein lysine fatty acylation has been known to occur in mammalian cells, but the function and regulatory mechanisms of this modification were unknown. Our data indicate that protein lysine fatty acylation is a novel mechanism that regulates protein secretion. The discovery of SIRT6 as an enzyme that controls protein lysine fatty acylation provides new opportunities to investigate the physiological function of a protein post-translational modification that has been little studied until now.	[Jiang, Hong; Khan, Saba; He, Bin; Du, Jintang; Kim, Ray; Ge, Eva; Lin, Hening] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Wang, Yi; Hao, Quan] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Charron, Guillaume; Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10065 USA; [Sebastian, Carlos; Mostoslavsky, Raul] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA	Cornell University; University of Hong Kong; Rockefeller University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lin, HN (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	qhao@hku.hk; hl379@cornell.edu	Sebastian, Carlos/CAG-6271-2022; Hao, Quan/C-4304-2009; Sebastian, Carlos/H-8014-2018	Sebastian, Carlos/0000-0001-6623-8028; Hao, Quan/0000-0002-9642-0514	NIH [R01GM086703, R01GM093072, R01GM087544];  [GRF766510]; NATIONAL CANCER INSTITUTE [R01CA175727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087544, R01GM093072, R01GM086703] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH R01GM086703 (H. L.), R01GM093072 (R. M.), Hong Kong GRF766510 (Q. H.) and NIH R01GM087544 (H. C. H.). We thank C. Zhang for help with the cloning of SIRT6 WT and H133Y to generate lentiviral particles and the staff at the Shanghai Synchrotron Radiation Facility for assistance during the data collection.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Sebastian C, 2008, J IMMUNOL, V180, P5898, DOI 10.4049/jimmunol.180.9.5898; Stephens Samuel B., 2008, V419, P197, DOI 10.1007/978-1-59745-033-1_14; STEVENSON FT, 1993, P NATL ACAD SCI USA, V90, P7245, DOI 10.1073/pnas.90.15.7245; STEVENSON FT, 1992, J EXP MED, V176, P1053, DOI 10.1084/jem.176.4.1053; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Wilson JP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001198; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhu AY, 2012, ACS CHEM BIOL, V7, P155, DOI 10.1021/cb200230x	29	470	486	5	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2013	496	7443					110	+		10.1038/nature12038	http://dx.doi.org/10.1038/nature12038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23552949	Green Accepted, Green Submitted			2022-12-28	WOS:000316993400035
J	McMichael, AJ				McMichael, Anthony J.			Globalization, Climate Change, and Human Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INFECTIOUS-DISEASES; POPULATION HEALTH; GLOBAL TRENDS; IMPACTS; EQUITY; POLICY; ENERGY; WORLD; RISK; FOOD		Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia	Australian National University	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, GPO Box 4, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au						[Anonymous], 2007, CONTRIBUTION WORKING; [Anonymous], 2011, WORLD POP PROSP 2010; Bambrick H., 2008, IMPACTS CLIMATE CHAN; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Beddington JR, 2012, SCIENCE, V335, P289, DOI 10.1126/science.1217941; Butler CD, 2010, J PUBLIC HEALTH-UK, V32, P157, DOI 10.1093/pubmed/fdq039; Butler CD, 2010, POSTGRAD MED J, V86, P230, DOI 10.1136/pgmj.2009.082727; Confalonieri U, 2007, CLIMATE CHANGE 2007, P391, DOI DOI 10.1016/J.JHYDR0L.2011.05.013; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; Dai A., 2010, DROUGHT GLOBAL WARMI; Drager N, 2007, B WORLD HEALTH ORGAN, V85, P162, DOI 10.2471/BLT.07.041079; Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079; Evengard B, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.11210; Grace K, 2012, APPL GEOGR, V35, P405, DOI 10.1016/j.apgeog.2012.06.017; Haines A, 2004, BMJ-BRIT MED J, V329, P394, DOI 10.1136/bmj.329.7462.394; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Hansen JE, 2008, PALEOCLIMATE IMPLICA; Hernandez MA, 2010, FIRES RUSSIA WHEAT P; Hibbard K. A., 2007, SUSTAINABILITY COLLA, P417; Hunt A, 2011, CLIMATIC CHANGE, V104, P13, DOI 10.1007/s10584-010-9975-6; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Knowlton K, 2007, AM J PUBLIC HEALTH, V97, P2028, DOI 10.2105/AJPH.2006.102947; Labonte R, 2011, ANNU REV PUBL HEALTH, V32, P263, DOI 10.1146/annurev-publhealth-031210-101225; Lee K, 2012, GLOBAL HLTH DIS PROG, P885; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; McMichael AJ, 2011, J INTERN MED, V270, P401, DOI 10.1111/j.1365-2796.2011.02415.x; McMichael AJ, 2011, ANNU REV PUBL HEALTH, V32, P179, DOI 10.1146/annurev-publhealth-031210-101203; McMichael A. J., 2011, CLIMATE CHANGE GLOBA, P114; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Moore S., 2009, CHINA SECURITY, V5, P25; Oceanic National, 2011, STAT CLIM 2011; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Pencheon D, 2009, J HEALTH SERV RES PO, V14, P2, DOI 10.1258/jhsrp.2008.008147; Perdue ML, 2005, AVIAN DIS, V49, P317, DOI 10.1637/7390-060305R.1; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Scheidel A, 2012, GLOBAL ENVIRON CHANG, V22, P588, DOI 10.1016/j.gloenvcha.2011.12.005; Shibuya K, 2003, BMJ-BRIT MED J, V327, P154, DOI 10.1136/bmj.327.7407.154; Smith K. R., 2009, Commonwealth Health Ministers' Update 2009, P59; Tripp JT., 1988, NEW YORK U J INT LAW, V20, P733; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Welton G., 2011, OXFAM RES REPORT IMP; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188	49	310	317	24	296	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1335	1343		10.1056/NEJMra1109341	http://dx.doi.org/10.1056/NEJMra1109341			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117YT	23550671				2022-12-28	WOS:000316989900010
J	de Leeuw, PW				de Leeuw, Peter W.			Aliskiren increased adverse events in patients with diabetes and kidney disease who were receiving ACE inhibitors or ARBs	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[de Leeuw, Peter W.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [de Leeuw, Peter W.] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands	Maastricht University; Maastricht University	de Leeuw, PW (corresponding author), Maastricht Univ, Med Ctr, Maastricht, Netherlands.		de Leeuw, Peter W./J-4552-2016	de Leeuw, Peter W./0000-0002-4949-5812; mcmurray, john/0000-0002-6317-3975				Harel Z, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e42; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pogue J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034785; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	4	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6							JC7	10.7326/0003-4819-158-6-201303190-02007	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23552833				2022-12-28	WOS:000316565100006
J	Bonifacio, E				Bonifacio, Ezio			Targeting innate immunity in type 1 diabetes: strike one	LANCET			English	Editorial Material							RHEUMATOID-ARTHRITIS; MELLITUS; INTERLEUKIN-1; ANTAGONIST; THERAPY; ONSET		[Bonifacio, Ezio] Tech Univ Dresden, Deutsch Forsch Gemeinschaft, Ctr Regenerat Therapies, D-01307 Dresden, Germany; [Bonifacio, Ezio] Tech Univ Dresden, Paul Langerhans Inst Dresden, German Ctr Diabet Res DZD, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Bonifacio, E (corresponding author), Tech Univ Dresden, Deutsch Forsch Gemeinschaft, Ctr Regenerat Therapies, D-01307 Dresden, Germany.	ezio.bonifacio@crt-dresden.de	Bonifacio, Ezio/E-7700-2010	Bonifacio, Ezio/0000-0002-8704-4713				Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; Eisenbarth GS, 1986, NEW ENGL J MED, V314, P1362; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Moran A, 2013, LANCET; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Ruperto N, 2012, NEW ENGL J MED, V367, P2396, DOI 10.1056/NEJMoa1205099; STILLER CR, 1984, SCIENCE, V223, P1362, DOI 10.1126/science.6367043; Sumpter KM, 2011, PEDIATR DIABETES, V12, P656, DOI 10.1111/j.1399-5448.2011.00761.x	12	0	0	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					1880	1881		10.1016/S0140-6736(13)60257-3	http://dx.doi.org/10.1016/S0140-6736(13)60257-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23562091				2022-12-28	WOS:000320319500006
J	Wang, TL; Fu, GB; Pan, XJ; Wu, JP; Gong, XQ; Wang, JW; Shi, YG				Wang, Tingliang; Fu, Guobin; Pan, Xiaojing; Wu, Jianping; Gong, Xinqi; Wang, Jiawei; Shi, Yigong			Structure of a bacterial energy-coupling factor transporter	NATURE			English	Article							MULTIDRUG ABC TRANSPORTER; MALTOSE TRANSPORTER; CRYSTAL-STRUCTURE; BINDING; PROKARYOTES; INTERMEDIATE; MECHANISM; SOFTWARE; DYNAMICS; AFFINITY	The energy-coupling factor (ECF) transporters constitute a novel family of conserved membrane transporters in prokaryotes that have a similar domain organization to the ATP-binding cassette transporters(1-3). Each ECF transporter comprises a pair of cytosolic ATPases (the A and A' components, or EcfA and EcfA'), a membrane-embedded substrate-binding protein (the S component, or EcfS) and a transmembrane energy-coupling component (the T component, or EcfT) that links the EcfA-EcfA' subcomplex to EcfS. The structure and transport mechanism of the quaternary ECF transporter remain largely unknown. Here we report the crystal structure of a nucleotide-free ECF transporter from Lactobacillus brevis at a resolution of 3.5 angstrom. The T component has a horseshoe-shaped open architecture, with five alpha-helices as transmembrane segments and two cytoplasmic alpha-helices as coupling modules connecting to the A and A' components. Strikingly, the S component, thought to be specific for hydroxymethyl pyrimidine, lies horizontally along the lipid membrane and is bound exclusively by the five transmembrane segments and the two cytoplasmic helices of the T component. These structural features suggest a plausible working model for the transport cycle of the ECF transporters.	[Wang, Tingliang; Fu, Guobin; Pan, Xiaojing; Wu, Jianping; Gong, Xinqi; Shi, Yigong] Tsinghua Univ, Minist Educ Key Lab Prot Sci, Beijing 100084, Peoples R China; [Wang, Tingliang; Fu, Guobin; Pan, Xiaojing; Wu, Jianping; Gong, Xinqi; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Wang, Tingliang; Fu, Guobin; Pan, Xiaojing; Wu, Jianping; Gong, Xinqi; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Minist Educ Key Lab Prot Sci, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology (973 Programs) [2009CB918801, 2013CB910602]; National Natural Science Foundation of China [31021002, 31130002]	Ministry of Science and Technology (973 Programs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank S. Huang and J. He at SSRF beamline BL17U for on-site assistance. This work was supported by funds from the Ministry of Science and Technology (973 Programs 2009CB918801 and 2013CB910602) and the National Natural Science Foundation of China (31021002 and 31130002).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berntsson RPA, 2012, P NATL ACAD SCI USA, V109, P13990, DOI 10.1073/pnas.1203219109; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; DeLano W.L, PYMOL MOL GRAPHICS S; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Eitinger T, 2011, FEMS MICROBIOL REV, V35, P3, DOI 10.1111/j.1574-6976.2010.00230.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erkens GB, 2012, BIOCHEMISTRY-US, V51, P4390, DOI 10.1021/bi300504v; Erkens GB, 2011, NAT STRUCT MOL BIOL, V18, P755, DOI 10.1038/nsmb.2073; Erkens GB, 2010, BIOCHEMISTRY-US, V49, P3203, DOI 10.1021/bi100154r; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Lezon TR, 2012, BIOPHYS J, V102, P1331, DOI 10.1016/j.bpj.2012.02.028; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Neubauer O, 2009, J BACTERIOL, V191, P6482, DOI 10.1128/JB.00965-09; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seyedarabi A, 2010, FEBS LETT, V584, P4163, DOI 10.1016/j.febslet.2010.09.006; Zhang P, 2010, NATURE, V468, P717, DOI 10.1038/nature09488	32	53	56	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					272	+		10.1038/nature12045	http://dx.doi.org/10.1038/nature12045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23584587				2022-12-28	WOS:000318558200043
J	Lorber, B				Lorber, Bennett			Update in Infectious Diseases: Evidence Published in 2012	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lorber, Bennett] Temple Univ Hosp & Med Sch, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Lorber, B (corresponding author), Temple Univ Hosp & Med Sch, Broad & Ontario, Philadelphia, PA 19140 USA.	bennett.lorber@temple.edu						Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1109; Pinto RZ, 2012, ANN INTERN MED, V157, P865, DOI 10.7326/0003-4819-157-12-201212180-00564	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2013	158	9					686	690		10.7326/0003-4819-158-9-201305070-00102	http://dx.doi.org/10.7326/0003-4819-158-9-201305070-00102			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146WV	23580004				2022-12-28	WOS:000319126900017
J	Samarasekera, U; Horton, R				Samarasekera, Udani; Horton, Richard			Continuing the child survival revival	LANCET			English	Editorial Material									[Samarasekera, Udani; Horton, Richard] The Lancet, London NW1 7BY, England		Samarasekera, U (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], LEV TRENDS CHILD MOR; Bhutta ZA, 2013, LANCET; Chopra M, 2013, LANCET; Fischer Walker CL, 2013, LANCET; Gill CJ, 2013, LANCET; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; The Institute for Health Metrics and Evaluation, 2012, FIN GLOB HLTH END GO; UN. Millennium Development Goals, MILL DEV GOALS GOAL; WHO, 2013, GLOB CONS GLOB ACT P; World Health Organization, 2011, AB DECL 10 YEARS	10	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1335	1336		10.1016/S0140-6736(13)60718-7	http://dx.doi.org/10.1016/S0140-6736(13)60718-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130EF	23582725				2022-12-28	WOS:000317894800005
J	Heys, JG; MacLeod, KM; Moss, CF; Hasselmo, ME				Heys, James G.; MacLeod, Katrina M.; Moss, Cynthia F.; Hasselmo, Michael E.			Bat and Rat Neurons Differ in Theta-Frequency Resonance Despite Similar Coding of Space	SCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; GRID CELLS; STELLATE CELLS; LAYER-II; SUBTHRESHOLD OSCILLATIONS; SPATIAL PERIODICITY; HCN1 CHANNELS; ORGANIZATION; MAP; MODELS	Both bats and rats exhibit grid cells in medial entorhinal cortex that fire as they visit a regular array of spatial locations. In rats, grid-cell firing field properties correlate with theta-frequency rhythmicity of spiking and membrane-potential resonance; however, bat grid cells do not exhibit theta rhythmic spiking, generating controversy over the role of theta rhythm. To test whether this discrepancy reflects differences in rhythmicity at a cellular level, we performed whole-cell patch recordings from entorhinal neurons in both species to record theta-frequency resonance. Bat neurons showed no theta-frequency resonance, suggesting grid-cell coding via different mechanisms in bats and rats or lack of theta rhythmic contributions to grid-cell firing in either species.	[Heys, James G.] Boston Univ, Ctr Memory & Brain, Grad Program Neurosci, Boston, MA 02215 USA; [MacLeod, Katrina M.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Moss, Cynthia F.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Hasselmo, Michael E.] Boston Univ, Ctr Memory & Brain, Dept Psychol, Boston, MA 02215 USA	Boston University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Boston University	Heys, JG (corresponding author), Boston Univ, Ctr Memory & Brain, Grad Program Neurosci, 2 Cummington St, Boston, MA 02215 USA.	jimheys@bu.edu; hasselmo@bu.edu	MacLeod, Katrina/F-4595-2015; Moss, Cynthia/J-5208-2017	MacLeod, Katrina/0000-0003-0632-1158; Hasselmo, Michael/0000-0002-9925-6377; Moss, Cynthia/0000-0001-6916-0000	Office of Naval Research [N00014-12-1-0339]; Multidisciplinary University Research Initiative [N00014-10-1-0936]	Office of Naval Research(Office of Naval Research); Multidisciplinary University Research Initiative(MURI)	We thank J. Ahn, J. Barcelo, C. Carr, W. Chapman, and M. Roesch for technical assistance and N. Spruston, J.-W. Lin, H. Eichenbaum, C. Stern, T. Gardner, and N. Ulanovsky for advice and comments. N. Ulanovsky and Y. Yovel helped us acquire Egyptian fruit bats for studies in supplementary materials. Research supported by Office of Naval Research grant N00014-12-1-0339 and Multidisciplinary University Research Initiative N00014-10-1-0936.	ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Barry C, 2012, NATURE, V488, pE1, DOI 10.1038/nature11276; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Boehlen A, 2010, J NEUROSCI, V30, P4585, DOI 10.1523/JNEUROSCI.4939-09.2010; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Buckmaster CA, 2004, J NEUROSCI, V24, P9811, DOI 10.1523/JNEUROSCI.1532-04.2004; Buhl E.H., 1991, Hippocampus, V1, P131, DOI 10.1002/hipo.450010203; Canto CB, 2012, HIPPOCAMPUS, V22, P1277, DOI 10.1002/hipo.20993; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; Dodson PD, 2011, J PHYSIOL-LONDON, V589, P2993, DOI 10.1113/jphysiol.2011.205021; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Dudman JT, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000290; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Garden DLF, 2008, NEURON, V60, P875, DOI 10.1016/j.neuron.2008.10.044; Gatome CW, 2010, BRAIN STRUCT FUNCT, V214, P375, DOI 10.1007/s00429-010-0239-z; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Giocomo LM, 2011, CELL, V147, P1159, DOI 10.1016/j.cell.2011.08.051; Giocomo LM, 2011, NEURON, V71, P589, DOI 10.1016/j.neuron.2011.07.023; Giocomo LM, 2009, J NEUROSCI, V29, P7625, DOI 10.1523/JNEUROSCI.0609-09.2009; Haas JS, 2007, J COMPUT NEUROSCI, V22, P161, DOI 10.1007/s10827-006-0005-7; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Heys JG, 2010, J NEUROPHYSIOL, V104, P258, DOI 10.1152/jn.00492.2009; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Kay LM, 2006, SEMIN CELL DEV BIOL, V17, P433, DOI 10.1016/j.semcdb.2006.04.012; Killian NJ, 2012, NATURE, V491, P761, DOI 10.1038/nature11587; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; Otmakhova NA, 2004, J NEUROPHYSIOL, V92, P2027, DOI 10.1152/jn.00427.2004; Schnupp JWH, 2009, NAT NEUROSCI, V12, P692, DOI 10.1038/nn.2325; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	39	41	41	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					363	367		10.1126/science.1233831	http://dx.doi.org/10.1126/science.1233831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599495				2022-12-28	WOS:000317657500059
J	Kouider, S; Stahlhut, C; Gelskov, SV; Barbosa, LS; Dutat, M; de Gardelle, V; Christophe, A; Dehaene, S; Dehaene-Lambertz, G				Kouider, Sid; Stahlhut, Carsten; Gelskov, Sofie V.; Barbosa, Leonardo S.; Dutat, Michel; de Gardelle, Vincent; Christophe, Anne; Dehaene, Stanislas; Dehaene-Lambertz, Ghislaine			A Neural Marker of Perceptual Consciousness in Infants	SCIENCE			English	Article							RECOGNITION MEMORY; BRAIN; FACE; MATURATION	Infants have a sophisticated behavioral and cognitive repertoire suggestive of a capacity for conscious reflection. Yet, demonstrating conscious access in infants remains challenging, mainly because they cannot report their thoughts. Here, to circumvent this problem, we studied whether an electrophysiological signature of consciousness found in adults, corresponding to a late nonlinear cortical response [similar to 300 milliseconds (ms)] to brief pictures, already exists in infants. We recorded event-related potentials while 5-, 12-, and 15-month-old infants (N = 80) viewed masked faces at various levels of visibility. In all age groups, we found a late slow wave showing a nonlinear profile at the expected perceptual thresholds. However, this late component shifted from a weak and delayed response in 5-month-olds (starting around 900 ms) to a more sustained and faster response in older infants (around 750 ms). These results reveal that the brain mechanisms underlying the threshold for conscious perception are already present in infancy but undergo a slow acceleration during development.	[Kouider, Sid; Gelskov, Sofie V.; Barbosa, Leonardo S.; Dutat, Michel; de Gardelle, Vincent; Christophe, Anne] EHESS CNRS ENS DEC, Lab Sci Cognit & Psycholinguist, F-75005 Paris, France; [Kouider, Sid; Stahlhut, Carsten] Tech Univ Denmark, Dept Informat & Math Modeling, Sect Cognit Syst, DK-2800 Lyngby, Denmark; [Gelskov, Sofie V.] Copenhagen Univ Hosp, Danish Res Ctr Magnet Res, DK-2650 Hvidovre, Denmark; [Dehaene, Stanislas] Coll France, F-75231 Paris, France; [Dehaene, Stanislas; Dehaene-Lambertz, Ghislaine] INSERM, U992, Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France; [Dehaene, Stanislas; Dehaene-Lambertz, Ghislaine] CEA, NeuroSpin Ctr, F-91191 Gif Sur Yvette, France; [Dehaene, Stanislas; Dehaene-Lambertz, Ghislaine] Univ Paris 11, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); Technical University of Denmark; University of Copenhagen; UDICE-French Research Universities; PSL Research University Paris; College de France; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Kouider, S (corresponding author), EHESS CNRS ENS DEC, Lab Sci Cognit & Psycholinguist, F-75005 Paris, France.	sid.kouider@ens.fr	Dehaene, Ghislaine/O-3633-2017; de Gardelle, Vincent/I-1226-2014; Christophe, Anne/B-9797-2008	Dehaene, Ghislaine/0000-0003-2221-9081; de Gardelle, Vincent/0000-0001-5977-5597; Christophe, Anne/0000-0001-7695-7528	Agence National de la Recherche; European Research Council; Lundbeck Foundation; McDonnell foundation	Agence National de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); McDonnell foundation	This research was supported by funding from the Agence National de la Recherche and from the European Research Council ("DynaMind" project) to S.K., from the Lundbeck Foundation (CIMBI project) to C.S. and from the McDonnell foundation to G.D.-L. We thank C. Summerfield for suggestions on the manuscript; A.-C. Fievet, and I. Vendelin for help with the data collection; and C. Billard (CHU Kremlin-Bicetre), D. Chabrol (Hopital Cochin), and L. K. Hansen (Danish Technical University) for their support to our research.	Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; COWEY A, 1995, NATURE, V373, P247, DOI 10.1038/373247a0; Csibra G., 2008, HDB DEV COGNITIVE NE, V2nd ed., P247; de Haan M, 1999, DEV PSYCHOL, V35, P1113, DOI 10.1037/0012-1649.35.4.1113; de Haan M, 2003, INT J PSYCHOPHYSIOL, V51, P45, DOI 10.1016/S0167-8760(03)00152-1; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; DIAMOND A, 1989, EXP BRAIN RES, V74, P24; Dubois J, 2006, NEUROIMAGE, V30, P1121, DOI 10.1016/j.neuroimage.2005.11.022; Friederici AD, 2002, NEUROREPORT, V13, P1251, DOI 10.1097/00001756-200207190-00006; Gelskov SV, 2010, COGNITION, V114, P285, DOI 10.1016/j.cognition.2009.09.012; KOENDERINK MJT, 1995, BRAIN RES, V678, P233, DOI 10.1016/0006-8993(95)00206-6; Kouider S., 2007, MENTAL PROCESSES HUM, P155; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Nelson CA, 1998, INT J PSYCHOPHYSIOL, V29, P145, DOI 10.1016/S0167-8760(98)00014-2; Quiroga RQ, 2008, P NATL ACAD SCI USA, V105, P3599, DOI 10.1073/pnas.0707043105; Reynolds GD, 2005, DEV PSYCHOL, V41, P598, DOI 10.1037/0012-1649.41.4.598; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Takahashi E, 2012, CEREB CORTEX, V22, P455, DOI 10.1093/cercor/bhr126; Teglas E, 2011, SCIENCE, V332, P1054, DOI 10.1126/science.1196404; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Weiskrantz L., 1997, CONSCIOUSNESS LOST F; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	28	97	97	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					376	380		10.1126/science.1232509	http://dx.doi.org/10.1126/science.1232509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126XZ	23599498	Green Published			2022-12-28	WOS:000317657500062
J	Rai, D; Lee, BK; Dalman, C; Golding, J; Lewis, G; Magnusson, C				Rai, Dheeraj; Lee, Brian K.; Dalman, Christina; Golding, Jean; Lewis, Glyn; Magnusson, Cecilia			Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; PSYCHIATRIC-DISORDERS; FETAL-GROWTH; EXPOSURE; BIRTH; MISCLASSIFICATION; REGISTER; OUTCOMES	Objective To study the association between parental depression and maternal antidepressant use during pregnancy with autism spectrum disorders in offspring. Design Population based nested case-control study. Setting Stockholm County, Sweden, 2001-07. Participants 4429 cases of autism spectrum disorder (1828 with and 2601 without intellectual disability) and 43 277 age and sex matched controls in the full sample (1679 cases of autism spectrum disorder and 16 845 controls with data on maternal antidepressant use nested within a cohort (n=589 114) of young people aged 0-17 years. Main outcome measure A diagnosis of autism spectrum disorder, with or without intellectual disability. Exposures Parental depression and other characteristics prospectively recorded in administrative registers before the birth of the child. Maternal antidepressant use, recorded at the first antenatal interview, was available for children born from 1995 onwards. Results A history of maternal (adjusted odds ratio 1.49, 95% confidence interval 1.08 to 2.08) but not paternal depression was associated with an increased risk of autism spectrum disorders in offspring. In the subsample with available data on drugs, this association was confined to women reporting antidepressant use during pregnancy (3.34, 1.50 to 7.47, P=0.003), irrespective of whether selective serotonin reuptake inhibitors (SSRIs) or non-selective monoamine reuptake inhibitors were reported. All associations were higher in cases of autism without intellectual disability, there being no evidence of an increased risk of autism with intellectual disability. Assuming an unconfounded, causal association, antidepressant use during pregnancy explained 0.6% of the cases of autism spectrum disorder. Conclusions In utero exposure to both SSRIs and non-selective monoamine reuptake inhibitors (tricyclic antidepressants) was associated with an increased risk of autism spectrum disorders, particularly without intellectual disability. Whether this association is causal or reflects the risk of autism with severe depression during pregnancy requires further research. However, assuming causality, antidepressant use during pregnancy is unlikely to have contributed significantly towards the dramatic increase in observed prevalence of autism spectrum disorders as it explained less than 1% of cases.	[Rai, Dheeraj; Lewis, Glyn] Univ Bristol, Sch Social & Community Med, Ctr Mental Hlth Addict & Suicide Res, Bristol BS8 2BN, Avon, England; [Rai, Dheeraj; Dalman, Christina; Magnusson, Cecilia] Karolinska Inst, Dept Publ Hlth Sci, Div Publ Hlth Epidemiol, Stockholm, Sweden; [Rai, Dheeraj] Avon & Wiltshire Partnership Mental Hlth NHS Trus, Bristol, Avon, England; [Lee, Brian K.] Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Golding, Jean] Univ Bristol, Sch Social & Community Med, Ctr Child & Adolescent Hlth, Bristol BS8 2BN, Avon, England	University of Bristol; Karolinska Institutet; Drexel University; University of Bristol	Rai, D (corresponding author), Univ Bristol, Sch Social & Community Med, Ctr Mental Hlth Addict & Suicide Res, Bristol BS8 2BN, Avon, England.	dheeraj.rai@bristol.ac.uk	Lewis, Glyn/E-9944-2012	Lewis, Glyn/0000-0001-5205-8245; Dalman, Christina/0000-0002-3579-2357; Golding, Jean/0000-0003-2826-3307; Rai, Dheeraj/0000-0002-7239-3523; Lee, Brian/0000-0002-3635-8034; Magnusson, Cecilia/0000-0002-8567-6725	Swedish Research Council [2012-3017, 523-2010-1052]; Stockholm County Council [2007008]; Swedish Council for Working Life and Social Research [2007-2064]; Swedish Regional agreement on medical training and clinical research (ALF); Medical Research Council [G0400085] Funding Source: researchfish; MRC [G0400085] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Regional agreement on medical training and clinical research (ALF); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Swedish Research Council (grant No 2012-3017). The data linkages and staff costs have also been supported by grants from the Stockholm County Council (2007008), Swedish Council for Working Life and Social Research (2007-2064), Swedish Research Council (523-2010-1052), and Swedish Regional agreement on medical training and clinical research (ALF). No funder had any role in the study design; data collection, analysis, or interpretation; in the writing of the report; or in the decision to submit the article for publication. The views expressed are those of the authors and not necessarily those of any of the funders or organisations they represent.	Abel KM, 2013, AM J PSYCHIAT, V170, P391, DOI 10.1176/appi.ajp.2012.12040543; [Anonymous], 2009, QUAL DAT REP PROC NA; Ax?n MBAHE., 2010, STOCKHOLM LANS LANDS; Axelsson O, 2003, ACTA OBSTET GYN SCAN, V82, P491, DOI 10.1034/j.1600-0412.2003.00172.x; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Chadman KK, 2011, PHARMACOL BIOCHEM BE, V97, P586, DOI 10.1016/j.pbb.2010.09.012; Croen LA, 2011, ARCH GEN PSYCHIAT, V68, P1104, DOI 10.1001/archgenpsychiatry.2011.73; Daniels JL, 2008, PEDIATRICS, V121, pE1357, DOI 10.1542/peds.2007-2296; Darling RD, 2011, J NEUROSCI, V31, P16709, DOI 10.1523/JNEUROSCI.3736-11.2011; DeLong GR, 1999, NEUROLOGY, V52, P911, DOI 10.1212/WNL.52.5.911; El Marroun H, 2012, ARCH GEN PSYCHIAT, V69, P706, DOI 10.1001/archgenpsychiatry.2011.2333; Gardener H, 2011, PEDIATRICS, V128, P344, DOI 10.1542/peds.2010-1036; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; GREENLAND S, 1980, AM J EPIDEMIOL, V112, P564, DOI 10.1093/oxfordjournals.aje.a113025; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Idring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041280; Jokiranta E, 2013, PSYCHIAT RES; Jorgensen L, 2010, ACTA PSYCHIAT SCAND, V121, P389, DOI 10.1111/j.1600-0447.2009.01500.x; Kallen B, 2011, EUR J CLIN PHARMACOL, V67, P839, DOI 10.1007/s00228-011-1021-8; Kinney DK, 2008, NEUROSCI BIOBEHAV R, V32, P1519, DOI 10.1016/j.neubiorev.2008.06.004; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Lee BK, 2012, J AUTISM DEV DISORD, V42, P2000, DOI 10.1007/s10803-011-1425-4; Levitt P, 2011, ARCH GEN PSYCHIAT, V68, P1093, DOI 10.1001/archgenpsychiatry.2011.98; Lund N, 2009, ARCH PEDIAT ADOL MED, V163, P949, DOI 10.1001/archpediatrics.2009.164; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P664, DOI 10.1016/j.pnpbp.2010.06.014; Magnusson C, 2012, BRIT J PSYCHIAT, V201, P109, DOI 10.1192/bjp.bp.111.095125; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Occhiogrosso M, 2012, AM J PSYCHIAT, V169, P134, DOI 10.1176/appi.ajp.2011.11040553; Ogburn EL, 2012, EPIDEMIOLOGY, V23, P433, DOI 10.1097/EDE.0b013e31824d1f63; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Rahimi R, 2006, REPROD TOXICOL, V22, P571, DOI 10.1016/j.reprotox.2006.03.019; Rai D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038893; Rai D, 2012, J AM ACAD CHILD PSY, V51, P467, DOI 10.1016/j.jaac.2012.02.012; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Rodriguez-Porcel F, 2011, ANAT REC, V294, P1726, DOI 10.1002/ar.21402; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Simpson KL, 2011, P NATL ACAD SCI USA, V108, P18465, DOI 10.1073/pnas.1109353108; Spinelli M, 2012, AM J PSYCHIAT, V169, P121, DOI 10.1176/appi.ajp.2011.11111622; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Stewart DE, 2011, NEW ENGL J MED, V365, P1605, DOI 10.1056/NEJMcp1102730; WHO, 2012, ICD 10 CLASS MENT BE; Yirmiya N, 2005, J CHILD PSYCHOL PSYC, V46, P69, DOI 10.1111/j.1469-7610.2004.00334.x; Zafeiriou DI, 2009, CURR NEUROPHARMACOL, V7, P150, DOI 10.2174/157015909788848848	46	178	179	2	61	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2013	346								f2059	10.1136/bmj.f2059	http://dx.doi.org/10.1136/bmj.f2059			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131BG	23604083	Green Published, hybrid			2022-12-28	WOS:000317965000001
J	Sleeman, KE; Collis, E				Sleeman, Katherine E.; Collis, Emily			Caring for a dying patient in hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE		[Sleeman, Katherine E.] Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London SE5 9PJ, England; [Collis, Emily] Cent London Community Healthcare Trust, St Charless Hosp, Pembridge Palliat Care Ctr, London W10 6DZ, England	University of London; King's College London	Sleeman, KE (corresponding author), Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London SE5 9PJ, England.	katherine.sleeman@kcl.ac.uk	Sleeman, Katherine/C-4941-2014	Sleeman, Katherine/0000-0002-9777-4373	National Institute for Health Research [CL-2010-17-009] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Association for Palliative Medicine, 2009, APM POS DOUBL EFF DE; Department of Health, 2012, 1 NAT VOICES SURV BE; Department of Health, 2008, END LIF CAR STRAT PR; General Medical Council, 2010, TREATM CAR END LIF G; Guy's and St Thomas' NHS Foundation Trust, AMBER CAR BUNDL; Jennings AL, 2002, THORAX, V57, P939, DOI 10.1136/thorax.57.11.939; Kamal AH, 2012, J PALLIAT MED, V15, P106, DOI 10.1089/jpm.2011.0110; Linklater GT, 2010, J ROY COLL PHYS EDIN, V40, P13, DOI 10.4997/JRCPE.2010.104; Liverpool Care Pathway for the Dying Patient (LCP), 2009, LIV CAR PATHW DYING; Mayor S, 2007, BRIT MED J, V334, P278, DOI 10.1136/bmj.39118.686100.DB; McCartney M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7316; National Care of the Dying Audit-Hospitals (NCDAH), 2012, NAT CAR DYING AUD HO; National Institute for Health and Clinical Excellence, 2011, QUAL STAND END LIF C; NHS Scotland, 2008, LIV DYING WELL NAT A; NHS UK. National end of life care programme, 2012, NAT END LIF CAR PROG; Royal College of Physicians and British Society of Gastroenterology, 2010, OR FEED DIFF DIL GUI; Simon ST, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007354.pub2; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007	18	15	16	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2013	346								f2174	10.1136/bmj.f2174	http://dx.doi.org/10.1136/bmj.f2174			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AT	23596214				2022-12-28	WOS:000317963400014
J	Tangri, N; Kitsios, GD; Inker, LA; Griffith, J; Naimark, DM; Walker, S; Rigatto, C; Uhlig, K; Kent, DM; Levey, AS				Tangri, Navdeep; Kitsios, Georgios D.; Inker, Lesley Ann; Griffith, John; Naimark, David M.; Walker, Simon; Rigatto, Claudio; Uhlig, Katrin; Kent, David M.; Levey, Andrew S.			Risk Prediction Models for Patients With Chronic Kidney Disease A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							TYPE-2 DIABETES-MELLITUS; COLLABORATIVE METAANALYSIS; CARDIOVASCULAR EVENTS; HIGHER ALBUMINURIA; DARBEPOETIN-ALPHA; IGA NEPHROPATHY; SCORING SYSTEM; ESTIMATED GFR; MORTALITY; PROGRESSION	Background: Patients with chronic kidney disease (CKD) are at increased risk for kidney failure, cardiovascular events, and all-cause mortality. Accurate models are needed to predict the individual risk for these outcomes. Purpose: To systematically review risk prediction models for kidney failure, cardiovascular events, and death in patients with CKD. Data Sources: MEDLINE search of English-language articles published from 1966 to November 2012. Study Selection: Cohort studies that examined adults with any stage of CKD who were not receiving dialysis and had not had a transplant; had at least 1 year of follow-up; and reported on a model that predicted the risk for kidney failure, cardiovascular events, or all-cause mortality. Data Extraction: Reviewers extracted data on study design, population characteristics, modeling methods, metrics of model performance, risk of bias, and clinical usefulness. Data Synthesis: Thirteen studies describing 23 models were found. Eight studies (11 models) involved kidney failure, 5 studies (6 models) involved all-cause mortality, and 3 studies (6 models) involved cardiovascular events. Measures of estimated glomerular filtration rate or serum creatinine level were included in 10 studies (17 models), and measures of proteinuria were included in 9 studies (15 models). Only 2 studies (4 models) met the criteria for clinical usefulness, of which 1 study (3 models) presented reclassification indices with clinically useful risk categories. Limitation: A validated risk-of-bias tool and comparisons of the performance of different models in the same validation population were lacking. Conclusion: Accurate, externally validated models for predicting risk for kidney failure in patients with CKD are available and ready for clinical testing. Further development of models for cardiovascular events and all-cause mortality is needed.	Univ Manitoba, Winnipeg, MB, Canada; Tufts Med Ctr, Boston, MA USA; Univ Toronto, Sunnybrook Hosp, Toronto, ON, Canada	University of Manitoba; Tufts Medical Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Tangri, N (corresponding author), Seven Oaks Gen Hosp, 2PD 13,2300 McPhillips St, Winnipeg, MB R2V 3M3, Canada.	ntangri@sogh.mb.ca		Kitsios, Georgios/0000-0002-1018-948X; Naimark, David Malcolm Joseph/0000-0002-0621-0637; Tangri, Navdeep/0000-0002-5075-6370	William B. Schwartz Research Fund, Division of Nephrology, Tufts Medical Center	William B. Schwartz Research Fund, Division of Nephrology, Tufts Medical Center	By the William B. Schwartz Research Fund, Division of Nephrology, Tufts Medical Center.	Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Bitton A, 2010, PROG CARDIOVASC DIS, V53, P68, DOI 10.1016/j.pcad.2010.04.001; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Counsell C, 2001, CEREBROVASC DIS, V12, P159, DOI 10.1159/000047699; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Desai AS, 2011, AM J KIDNEY DIS, V58, P717, DOI 10.1053/j.ajkd.2011.05.020; Dimitrov BD, 2003, NEPHRON CLIN PRACT, V95, pC47, DOI 10.1159/000073668; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P3068, DOI 10.1093/ndt/gfp273; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P1151, DOI 10.1001/jama.2010.303; Johnson ES, 2008, AM J KIDNEY DIS, V52, P653, DOI 10.1053/j.ajkd.2008.04.026; Johnson ES, 2007, AM J KIDNEY DIS, V50, P559, DOI 10.1053/j.ajkd.2007.07.006; Kagoma YK, 2011, AM J KIDNEY DIS, V57, P592, DOI 10.1053/j.ajkd.2010.08.029; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Kent DM, 2007, J AM SOC NEPHROL, V18, P1959, DOI 10.1681/ASN.2006101081; Kent DM, 2006, STROKE, V37, P2957, DOI 10.1161/01.STR.0000249054.96644.c6; Keogh C, 2011, THROMB HAEMOSTASIS, V106, P528, DOI 10.1160/TH11-02-0061; Landray MJ, 2010, AM J KIDNEY DIS, V56, P1082, DOI 10.1053/j.ajkd.2010.07.016; Levey AS, 2011, ANN INTERN MED, V154, P65, DOI 10.7326/0003-4819-154-1-201101040-00012; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lewis JB, 2010, J AM SOC NEPHROL, V21, P1086, DOI 10.1681/ASN.2010030236; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; McMurray JJV, 2011, AM HEART J, V162, P748, DOI 10.1016/j.ahj.2011.07.016; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; Oliver MJ, 2012, CLIN J AM SOC NEPHRO, V7, P466, DOI 10.2215/CJN.08920811; Palmer SC, 2007, ANN INTERN MED, V147, P840, DOI 10.7326/0003-4819-147-12-200712180-00004; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Peralta CA, 2011, J AM SOC NEPHROL, V22, P147, DOI 10.1681/ASN.2010050483; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Taal MW, 2008, KIDNEY INT, V73, P1216, DOI 10.1038/ki.2008.36; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Wakai K, 2006, NEPHROL DIAL TRANSPL, V21, P2800, DOI 10.1093/ndt/gfl342; Weiner DE, 2007, J AM COLL CARDIOL, V50, P217, DOI 10.1016/j.jacc.2007.03.037	42	133	135	1	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8					596	+		10.7326/0003-4819-158-8-201304160-00004	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588748				2022-12-28	WOS:000318062100016
J	Taatjes, CA; Welz, O; Eskola, AJ; Savee, JD; Scheer, AM; Shallcross, DE; Rotavera, B; Lee, EPF; Dyke, JM; Mok, DKW; Osborn, DL; Percival, CJ				Taatjes, Craig A.; Welz, Oliver; Eskola, Arkke J.; Savee, John D.; Scheer, Adam M.; Shallcross, Dudley E.; Rotavera, Brandon; Lee, Edmond P. F.; Dyke, John M.; Mok, Daniel K. W.; Osborn, David L.; Percival, Carl J.			Direct Measurements of Conformer-Dependent Reactivity of the Criegee Intermediate CH3CHOO	SCIENCE			English	Article							GAS-PHASE OZONOLYSIS; VOLATILE ORGANIC-COMPOUNDS; CARBONYL OXIDES.; ACETALDEHYDE; OXIDATION; CHEMISTRY; SPECTRUM; YIELD; VINYL; CH2I	Although carbonyl oxides, "Criegee intermediates," have long been implicated in tropospheric oxidation, there have been few direct measurements of their kinetics, and only for the simplest compound in the class, CH2OO. Here, we report production and reaction kinetics of the next larger Criegee intermediate, CH3CHOO. Moreover, we independently probed the two distinct CH3CHOO conformers, syn- and anti-, both of which react readily with SO2 and with NO2. We demonstrate that anti-CH3CHOO is substantially more reactive toward water and SO2 than is syn-CH3CHOO. Reaction with water may dominate tropospheric removal of Criegee intermediates and determine their atmospheric concentration. An upper limit is obtained for the reaction of syn-CH3CHOO with water, and the rate constant for reaction of anti-CH3CHOO with water is measured as 1.0 x 10(-14) +/- 0.4 x 10(-14) centimeter(3) second(-1).	[Taatjes, Craig A.; Welz, Oliver; Eskola, Arkke J.; Savee, John D.; Scheer, Adam M.; Rotavera, Brandon; Osborn, David L.] Sandia Natl Labs, Combust Res Facil, Livermore, CA 94551 USA; [Shallcross, Dudley E.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Lee, Edmond P. F.; Dyke, John M.] Univ Southampton, School Chem, Southampton SO17 1BJ, Hants, England; [Lee, Edmond P. F.; Mok, Daniel K. W.] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Percival, Carl J.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England	United States Department of Energy (DOE); Sandia National Laboratories; University of Bristol; University of Southampton; Hong Kong Polytechnic University; University of Manchester	Taatjes, CA (corresponding author), Sandia Natl Labs, Combust Res Facil, Mail Stop 9055, Livermore, CA 94551 USA.	cataatj@sandia.gov; Carl.Percival@manchester.ac.uk	Welz, Oliver/C-1165-2013; Mok, Daniel Kam-Wah/K-5826-2013; Dyke, John M./B-6458-2009; Osborn, David/A-2627-2009; Rotavera, Brandon/F-9529-2011	Welz, Oliver/0000-0003-1978-2412; Mok, Daniel Kam-Wah/0000-0002-6677-2949; Osborn, David/0000-0003-4304-8218; Percival, Carl/0000-0003-2525-160X; Taatjes, Craig/0000-0002-9271-0282	Division of Chemical Sciences, Geosciences, and Biosciences, the Office of Basic Energy Sciences, the U.S. Department of Energy; Natural Environment Research Council; Leverhulme Trust; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; National Nuclear Security Administration [DE-AC04-94-AL85000]; Research Grant Council of the Hong Kong Special Administrative Region [Polyu 5019/11P]; Engineering and Physical Sciences Research Council [EP/J003921/1] Funding Source: researchfish; Natural Environment Research Council [NE/G01972X/1, NE/K005316/1, NE/J009008/1, NE/K004905/1, NE/I01103X/1, NE/I014381/1] Funding Source: researchfish; EPSRC [EP/J003921/1] Funding Source: UKRI; NERC [NE/K005316/1, NE/I014381/1, NE/I01103X/1, NE/G01972X/1, NE/J009008/1, NE/K004905/1] Funding Source: UKRI	Division of Chemical Sciences, Geosciences, and Biosciences, the Office of Basic Energy Sciences, the U.S. Department of Energy(United States Department of Energy (DOE)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); National Nuclear Security Administration(National Nuclear Security Administration); Research Grant Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Additional pseudo-first-order rate constants, details of the experiments and calculations, and spectroscopic data underpinning this work are presented in the supplementary materials. The participation of O.W., A.J.E., J.D.S., D.L.O., and C.A.T. and the development of the experimental kinetics apparatus were funded by the Division of Chemical Sciences, Geosciences, and Biosciences, the Office of Basic Energy Sciences, the U.S. Department of Energy. D.E.S., J.M.D., and C.J.P. thank the Natural Environment Research Council for funding, and J.M.D. thanks the Leverhulme Trust for a senior fellowship. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231 at Lawrence Berkeley National Laboratory. Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the National Nuclear Security Administration under contract DE-AC04-94-AL85000. D.K.W.M., J.M.D., C.J.P., and E.P.F.L. acknowledge support from the Research Grant Council of the Hong Kong Special Administrative Region (grant no. Polyu 5019/11P) and the National Service for Computational Chemistry Software (UK) for computational resources. The experiments were conceived by C.A.T., C.J.P., and D.E.S.; designed by C.A.T., D.L.O., C.J.P., O.W., and A.J.E.; and carried out by O.W., J.D.S., A.J.E., A.M.S., B.R., C.J.P., C.A.T., and D.L.O. E.P.F.L., D.K.W.M., and J.M.D. were responsible for the quantum chemistry and Franck-Condon calculations. All authors participated in the data analysis and interpretation and contributed to the manuscript.	ALDERDICE DS, 1976, J CHEM SOC FARAD T 2, V72, P372, DOI 10.1039/f29767200372; Anglada JM, 2011, PHYS CHEM CHEM PHYS, V13, P13034, DOI 10.1039/c1cp20872a; Anglada JM, 1996, J AM CHEM SOC, V118, P4636, DOI 10.1021/ja953858a; Asatryan R, 2008, PHYS CHEM CHEM PHYS, V10, P1769, DOI 10.1039/b716179d; Beames JM, 2012, J AM CHEM SOC, V134, P20045, DOI 10.1021/ja310603j; Berndt T, 2012, J PHYS CHEM LETT, V3, P2892, DOI 10.1021/jz301158u; Carlsson PTM, 2012, PHYS CHEM CHEM PHYS, V14, P15637, DOI 10.1039/c2cp42992f; Donahue NM, 2011, PHYS CHEM CHEM PHYS, V13, P10848, DOI 10.1039/c0cp02564j; Fenske JD, 2000, J PHYS CHEM A, V104, P9921, DOI 10.1021/jp0016636; GAB S, 1985, NATURE, V316, P535, DOI 10.1038/316535a0; Harrison RM, 2006, SCI TOTAL ENVIRON, V360, P5, DOI 10.1016/j.scitotenv.2005.08.053; Huang HF, 2012, J PHYS CHEM LETT, V3, P3399, DOI 10.1021/jz301585c; Jenkin ME, 1997, ATMOS ENVIRON, V31, P81, DOI 10.1016/S1352-2310(96)00105-7; Jiang L, 2010, J PHYS CHEM A, V114, P12452, DOI 10.1021/jp107783z; Johnson D, 2008, CHEM SOC REV, V37, P699, DOI 10.1039/b704260b; Kurten T, 2012, J PHYS CHEM A, V116, P6823, DOI 10.1021/jp302511a; Kurten T, 2011, J PHYS CHEM A, V115, P8669, DOI 10.1021/jp203907d; Kuwata KT, 2010, J PHYS CHEM A, V114, P9192, DOI 10.1021/jp105358v; Mauldin RL, 2012, NATURE, V488, P193, DOI 10.1038/nature11278; Osborn DL, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3000004; Sebbar N, 2003, PHYS CHEM CHEM PHYS, V5, P300, DOI 10.1039/b207030h; SWEIGART DA, 1972, J AM CHEM SOC, V94, P5592, DOI 10.1021/ja00771a011; Taatjes CA, 2005, SCIENCE, V308, P1887, DOI 10.1126/science.1112532; Taatjes CA, 2008, J AM CHEM SOC, V130, P11883, DOI 10.1021/ja804165q; Taatjes CA, 2008, PHYS CHEM CHEM PHYS, V10, P20, DOI 10.1039/b713460f; Taatjes CA, 2012, PHYS CHEM CHEM PHYS, V14, P10391, DOI 10.1039/c2cp40294g; Vereecken L, 2012, PHYS CHEM CHEM PHYS, V14, P14682, DOI 10.1039/c2cp42300f; Vereecken L, 2012, CHEM SOC REV, V41, P6259, DOI 10.1039/c2cs35070j; Welz O, 2012, SCIENCE, V335, P204, DOI 10.1126/science.1213229	29	315	319	12	400	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					177	180		10.1126/science.1234689	http://dx.doi.org/10.1126/science.1234689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580524	Green Published			2022-12-28	WOS:000317341400050
J	Dunleavy, K; Pittaluga, S; Maeda, LS; Advani, R; Chen, CC; Hessler, J; Steinberg, SM; Grant, C; Wright, G; Varma, G; Staudt, LM; Jaffe, ES; Wilson, WH				Dunleavy, Kieron; Pittaluga, Stefania; Maeda, Lauren S.; Advani, Ranjana; Chen, Clara C.; Hessler, Julie; Steinberg, Seth M.; Grant, Cliona; Wright, George; Varma, Gaurav; Staudt, Louis M.; Jaffe, Elaine S.; Wilson, Wyndham H.			Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLASSICAL HODGKIN LYMPHOMA; GERMINAL-CENTER; CHEMOTHERAPY; DOXORUBICIN; AMPLIFICATION; RADIOTHERAPY; EXPRESSION; MANAGEMENT; SCLEROSIS; EFFICACY	BACKGROUND Primary mediastinal B-cell lymphoma is a distinct subtype of diffuse large-B-cell lymphoma that is closely related to nodular sclerosing Hodgkin's lymphoma. Patients are usually young and present with large mediastinal masses. There is no standard treatment, but the inadequacy of immunochemotherapy alone has resulted in routine consolidation with mediastinal radiotherapy, which has potentially serious late effects. We aimed to develop a strategy that improves the rate of cure and obviates the need for radiotherapy. METHODS We conducted a single-group, phase 2, prospective study of infusional dose-adjusted etoposide, doxorubicin, and cyclophosphamide with vincristine, prednisone, and rituximab (DA-EPOCH-R) and filgrastim without radiotherapy in 51 patients with untreated primary mediastinal B-cell lymphoma. We used results from a retrospective study of DA-EPOCH-R from another center to independently verify the outcomes. RESULTS The patients had a median age of 30 years (range, 19 to 52) and a median tumor diameter of 11 cm; 59% were women. During a median of 5 years of follow-up, the event-free survival rate was 93%, and the overall survival rate was 97%. Among the 16 patients who were involved in the retrospective analysis at another center, over a median of 3 years of follow-up, the event-free survival rate was 100%, and no patients received radiotherapy. No late morbidity or cardiac toxic effects were found in any patients. After follow-up ranging from 10 months to 14 years, all but 2 of the 51 patients (4%) who received DA-EPOCH-R alone were in complete remission. The 2 remaining patients received radiotherapy and were disease-free at follow-up. CONCLUSIONS Therapy with DA-EPOCH-R obviated the need for radiotherapy in patients with primary mediastinal B-cell lymphoma. (Funded by the National Cancer Institute; ClinicalTrials.gov number, NCT00001337.)	[Dunleavy, Kieron; Pittaluga, Stefania; Hessler, Julie; Steinberg, Seth M.; Grant, Cliona; Staudt, Louis M.; Jaffe, Elaine S.; Wilson, Wyndham H.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Chen, Clara C.] NCI, Ctr Clin, NIH, Bethesda, MD 20892 USA; [Wright, George] NCI, Biometr Res Branch, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA; [Maeda, Lauren S.; Advani, Ranjana; Varma, Gaurav] Stanford Univ, Sch Med, Div Oncol, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University	Wilson, WH (corresponding author), NCI, Metab Branch, Bldg 10,Rm 4N-115,9000 Rockville Pike, Bethesda, MD 20892 USA.	wilsonw@mail.nih.gov	Wright, George W/M-1660-2017; Carrasquillo, Jorge A/E-7120-2010; Staudt, Louis/AAC-5324-2019; Jaffe, Elaine/G-8981-2014	Maeda, Lauren/0000-0001-9215-2965; Varma, Gaurav/0000-0002-1903-9170; Advani, Ranjana/0000-0002-3219-2292; Jaffe, Elaine/0000-0003-4632-0301	National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIASC000550, ZIABC011070, ZIDSC007202] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007952] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Cancer Institute; Supported by the National Cancer Institute.	Bishop PC, 1999, J CLIN ONCOL, V17, P2479, DOI 10.1200/JCO.1999.17.8.2479; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Dunleavy K, 2005, BLOOD, V106, P623; Gerrard M, 2013, BLOOD, V121, P278, DOI 10.1182/blood-2012-04-422709; Gutierrez M, 2000, J CLIN ONCOL, V18, P3633, DOI 10.1200/JCO.2000.18.21.3633; Hodgson DC, 2011, HEMATOL-AM SOC HEMAT, P323, DOI 10.1182/asheducation-2011.1.323; Joos S, 2000, CANCER RES, V60, P549; Joos S, 1996, BLOOD, V87, P1571, DOI 10.1182/blood.V87.4.1571.bloodjournal8741571; Joos S, 2002, BLOOD, V99, P1381, DOI 10.1182/blood.V99.4.1381; Juweid ME, 2007, J CLIN ONCOL, V25, P571, DOI 10.1200/JCO.2006.08.2305; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kirwan M, 2009, HUM MUTAT, V30, P1567, DOI 10.1002/humu.21115; LEGHA SS, 1982, ANN INTERN MED, V96, P133, DOI 10.7326/0003-4819-96-2-133; LONGO DL, 1991, J CLIN ONCOL, V9, P1409, DOI 10.1200/JCO.1991.9.8.1409; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Pileri SA, 2003, LEUKEMIA LYMPHOMA, V44, pS21, DOI 10.1080/10428190310001623810; Pileri SA, 2003, AM J PATHOL, V162, P243, DOI 10.1016/S0002-9440(10)63815-1; Rieger M, 2011, ANN ONCOL, V22, P664, DOI 10.1093/annonc/mdq418; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Savage KJ, 2006, ANN ONCOL, V17, P123, DOI 10.1093/annonc/mdj030; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Swerdlow SH, 2008, WHO CLASSIFICATION T; van Besien K, 2001, J CLIN ONCOL, V19, P1855, DOI 10.1200/JCO.2001.19.6.1855; Vassilakopoulos TP, 2012, ONCOLOGIST, V17, P239, DOI 10.1634/theoncologist.2011-0275; WILSON WH, 1993, J CLIN ONCOL, V11, P1573, DOI 10.1200/JCO.1993.11.8.1573; Wilson WH, 2002, BLOOD, V99, P2685, DOI 10.1182/blood.V99.8.2685; Wilson WH, 2008, J CLIN ONCOL, V26, P2717, DOI 10.1200/JCO.2007.13.1391; Zinzani PL, 2001, HAEMATOLOGICA, V86, P187; Zinzani PL, 1999, BLOOD, V94, P3289, DOI 10.1182/blood.V94.10.3289.422k32_3289_3293	29	344	359	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1408	1416		10.1056/NEJMoa1214561	http://dx.doi.org/10.1056/NEJMoa1214561			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122QT	23574119	Green Accepted			2022-12-28	WOS:000317333600008
J	Hamilton, C				Hamilton, Clive			No, we should not just 'at least do the research'	NATURE			English	Editorial Material									Charles Sturt Univ, Canberra, ACT, Australia	Charles Sturt University	Hamilton, C (corresponding author), Charles Sturt Univ, Canberra, ACT, Australia.	e-mail@clivehamilton.com							0	19	20	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					139	139		10.1038/496139a	http://dx.doi.org/10.1038/496139a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	122VM	23579641	Bronze			2022-12-28	WOS:000317346300004
J	Wager, TD; Atlas, LY; Lindquist, MA; Roy, M; Woo, CW; Kross, E				Wager, Tor D.; Atlas, Lauren Y.; Lindquist, Martin A.; Roy, Mathieu; Woo, Choong-Wan; Kross, Ethan			An fMRI-Based Neurologic Signature of Physical Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN BRAIN; NOCICEPTIVE NEURONS; INSULAR CORTEX; ACTIVATION; RESPONSES; ANTICIPATION; ORGANIZATION; PERCEPTION; EXPERIENCE; TRIAL	BACKGROUND Persistent pain is measured by means of self-report, the sole reliance on which hampers diagnosis and treatment. Functional magnetic resonance imaging (fMRI) holds promise for identifying objective measures of pain, but brain measures that are sensitive and specific to physical pain have not yet been identified. METHODS In four studies involving a total of 114 participants, we developed an fMRI-based measure that predicts pain intensity at the level of the individual person. In study 1, we used machine-learning analyses to identify a pattern of fMRI activity across brain regions - a neurologic signature - that was associated with heat-induced pain. The pattern included the thalamus, the posterior and anterior insulae, the secondary somatosensory cortex, the anterior cingulate cortex, the periaqueductal gray matter, and other regions. In study 2, we tested the sensitivity and specificity of the signature to pain versus warmth in a new sample. In study 3, we assessed specificity relative to social pain, which activates many of the same brain regions as physical pain. In study 4, we assessed the responsiveness of the measure to the analgesic agent remifentanil. RESULTS In study 1, the neurologic signature showed sensitivity and specificity of 94% or more (95% confidence interval [CI], 89 to 98) in discriminating painful heat from nonpainful warmth, pain anticipation, and pain recall. In study 2, the signature discriminated between painful heat and nonpainful warmth with 93% sensitivity and specificity (95% CI, 84 to 100). In study 3, it discriminated between physical pain and social pain with 85% sensitivity (95% CI, 76 to 94) and 73% specificity (95% CI, 61 to 84) and with 95% sensitivity and specificity in a forced-choice test of which of two conditions was more painful. In study 4, the strength of the signature response was substantially reduced when remifentanil was administered. CONCLUSIONS It is possible to use fMRI to assess pain elicited by noxious heat in healthy persons. Future studies are needed to assess whether the signature predicts clinical pain. (Funded by the National Institute on Drug Abuse and others.)	[Wager, Tor D.; Roy, Mathieu; Woo, Choong-Wan] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80305 USA; [Atlas, Lauren Y.] NYU, Dept Psychol, New York, NY 10003 USA; [Lindquist, Martin A.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Kross, Ethan] Univ Michigan, Dept Psychol, Ann Arbor, MI USA	University of Colorado System; University of Colorado Boulder; New York University; Johns Hopkins University; University of Michigan System; University of Michigan	Wager, TD (corresponding author), Univ Colorado, Dept Psychol & Neurosci, 345 UCB, Boulder, CO 80305 USA.	tor.wager@colorado.edu	Roy, Mathieu/H-1963-2017; Atlas, Lauren/W-9619-2019; Woo, Choong-Wan/J-2030-2019; Atlas, Lauren Yvette/GXV-6811-2022	Woo, Choong-Wan/0000-0002-7423-5422; Atlas, Lauren/0000-0001-5693-4169; , Ethan/0000-0002-8664-2711	National Institute on Drug Abuse [1RC1DA028608, R01DA027794]; National Institute of Mental Health [R01MH076136]; National Science Foundation [0631637]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027794, R01DA035484, RC1DA028608] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded by the National Institute on Drug Abuse and others.; Supported by grants from the National Institute on Drug Abuse (1RC1DA028608 and R01DA027794), the National Institute of Mental Health (R01MH076136), and the National Science Foundation (0631637, to Dr. Wager).	Atlas LY, 2012, J NEUROSCI, V32, P8053, DOI 10.1523/JNEUROSCI.0383-12.2012; Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Bingel U, 2003, NEUROIMAGE, V18, P740, DOI 10.1016/S1053-8119(02)00033-2; Borsook D, 2006, NAT REV DRUG DISCOV, V5, P411, DOI 10.1038/nrd2027; Brodersen KH, 2012, NEUROIMAGE, V63, P1162, DOI 10.1016/j.neuroimage.2012.08.035; Brooks JCW, 2005, NEUROIMAGE, V27, P201, DOI 10.1016/j.neuroimage.2005.03.041; Brown JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024124; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; Cohen SP, 2012, ANN INTERN MED, V156, P551, DOI [10.7326/0003-4819-156-8-201204170-00397, 10.7326/0003-4819-156-8-201204170-00002]; Craig AD, 2001, J NEUROPHYSIOL, V86, P1459, DOI 10.1152/jn.2001.86.3.1459; DaSilva AFM, 2002, J NEUROSCI, V22, P8183; Derbyshire SWG, 2002, NEUROIMAGE, V16, P158, DOI 10.1006/nimg.2002.1066; DONG WK, 1989, BRAIN RES, V484, P314, DOI 10.1016/0006-8993(89)90375-2; Flor H., 2011, CHRONIC PAIN INTEGRA; Hastie T., 2009, UNSUPERVISED LEARNIN; Hua LH, 2005, AM J PHYSIOL-REG I, V289, pR319, DOI 10.1152/ajpregu.00123.2005; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kenshalo DR, 2000, J NEUROPHYSIOL, V84, P719, DOI 10.1152/jn.2000.84.2.719; Kross E, 2011, P NATL ACAD SCI USA, V108, P6270, DOI 10.1073/pnas.1102693108; Lindquist MA, 2009, NEUROIMAGE, V45, pS187, DOI 10.1016/j.neuroimage.2008.10.065; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Maihofner C, 2006, NEUROLOGY, V66, P711, DOI 10.1212/01.wnl.0000200961.49114.39; Marquand A, 2010, NEUROIMAGE, V49, P2178, DOI 10.1016/j.neuroimage.2009.10.072; Meier ML, 2012, J CLIN PERIODONTOL, V39, P441, DOI 10.1111/j.1600-051X.2012.01863.x; Minto CF, 1997, ANESTHESIOLOGY, V86, P10, DOI 10.1097/00000542-199701000-00004; Mitchell TM, 1997, AI MAG, V18, P11; Rish I, 2010, P INT C BRAIN INF TO; Schreckenberger M, 2005, NEUROLOGY, V64, P1175, DOI 10.1212/01.WNL.0000156353.17305.52; Schulz E, 2012, CEREB CORTEX, V22, P1118, DOI 10.1093/cercor/bhr186; SIKES RW, 1992, J NEUROPHYSIOL, V68, P1720, DOI 10.1152/jn.1992.68.5.1720; Strigo IA, 2003, J NEUROPHYSIOL, V89, P3294, DOI 10.1152/jn.01048.2002; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, WALL MELZACKS TXB PA; Wager TD, 2011, J NEUROSCI, V31, P439, DOI 10.1523/JNEUROSCI.3420-10.2011; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]	37	858	879	10	201	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1388	1397		10.1056/NEJMoa1204471	http://dx.doi.org/10.1056/NEJMoa1204471			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122QT	23574118	Green Accepted			2022-12-28	WOS:000317333600006
J	Pillay, N				Pillay, Navanethem			Maternal mortality and morbidity: a human rights imperative	LANCET			English	Editorial Material									Off United Nations High Commissioner Human Rights, CH-1211 Geneva, Switzerland		Pillay, N (corresponding author), Off United Nations High Commissioner Human Rights, CH-1211 Geneva, Switzerland.	lohanlon@ohchr.org						[Anonymous], 2012, AHRC2122 UN; Committee on Economic Social and Cultural Rights, 2000, EC1220004 COMM EC SO, P40; Every Woman Every Child, 2019, WHAT IS EV WOM EV CH; Report of the Special Rapporteur on the Right to Health Paul Hunt, 2006, A61338 UN; United Nations, 2010, AHRC1439 UN; United Nations Human Rights Office of the High Commissioner, 2012, HUM RIGHTS IND GUID; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Yamin AE, 2010, SUR, V7, P95	10	7	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2013	381	9873					1159	1160		10.1016/S0140-6736(13)60135-X	http://dx.doi.org/10.1016/S0140-6736(13)60135-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122WU	23561986				2022-12-28	WOS:000317350100004
J	Pincock, S				Pincock, Stephen			Hiroshi Nakajima Obituary	LANCET			English	Biographical-Item														Pincock, Stephen/0000-0003-1655-2902					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 6	2013	381	9873					1178	1178		10.1016/S0140-6736(13)60789-8	http://dx.doi.org/10.1016/S0140-6736(13)60789-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WU	23573527	Bronze			2022-12-28	WOS:000317350100015
J	D'Silva, J				D'Silva, Jeetha			Can India pull off its ambitious National Health Mission?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												j.dsilva@gmail.com						[Anonymous], 2013, COMMUNICATION; [Anonymous], 2013, DECCAN HERALD   0229; [Anonymous], 2010, NAT URB HLT IN PRESS; D'Silva J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1605; Health Division Planning Commission Government of India, 2012, REP STEER COMM HLTH; Ministry of Health and Family Welfare, 2010, NAT RUR HLTH MISS M; Mukherjee Pranab, 2012, COMMUNICATION; World Health Organization, 2012, WORLD HLTH STAT 2012	8	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2013	346								f2134	10.1136/bmj.f2134	http://dx.doi.org/10.1136/bmj.f2134			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122SM	23564924				2022-12-28	WOS:000317338400009
J	Struble, MD; Scerba, MT; Siegler, M; Lectka, T				Struble, Mark D.; Scerba, Michael T.; Siegler, Maxime; Lectka, Thomas			Evidence for a Symmetrical Fluoronium Ion in Solution	SCIENCE			English	Article							SOLVENT IONIZING POWER; Y-OTF SCALE; NONBONDED INTERACTIONS; HYDROGEN-FLUORINE; SOLVOLYSIS; DERIVATIVES; TOSYLATES; BROMONIUM; IODONIUM; OLEFINS	Halonium ions, in which formally positively charged halogens (chlorine, bromine, and iodine) are equivalently attached to two carbon atoms through three-center bonds, are well established in the synthetic chemistry of organochlorides, bromides, and iodides. Mechanistic studies of these ions have generated numerous insights into the origins of stereoselectivity in addition and displacement reactions. However, it has not been clear whether fluorine can form a halonium ion in the same manner. We present chemical and theoretical evidence for the transient generation of a true symmetrical fluoronium ion in solution from an appropriately configured precursor.	[Struble, Mark D.; Scerba, Michael T.; Siegler, Maxime; Lectka, Thomas] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	Johns Hopkins University	Lectka, T (corresponding author), Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA.	lectka@jhu.edu			John Simon Guggenheim Memorial Foundation; Johns Hopkins University	John Simon Guggenheim Memorial Foundation; Johns Hopkins University(Johns Hopkins University)	Supported by a John Simon Guggenheim Memorial Foundation fellowship (T. L.) and Johns Hopkins University Ernest M. Marks and Gary H. Posner fellowships (M. T. S.). We thank C. Moore for her input and assistance. Calculations and spectra reported in this paper are available in the supplementary materials. Metric parameters for the structure of 7 are available free of charge from the Cambridge Crystallographic Data Center under CCDC 915139.	ALLEN AD, 1985, J AM CHEM SOC, V107, P4513, DOI 10.1021/ja00301a023; [Anonymous], 2009, GAUSSIAN 09 REVISION; AUNER N, 1980, J ORGANOMET CHEM, V188, P25, DOI 10.1016/S0022-328X(00)83695-5; BENTLEY TW, 1982, J AM CHEM SOC, V104, P5741, DOI 10.1021/ja00385a031; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; BROWN RS, 1994, J AM CHEM SOC, V116, P2448, DOI 10.1021/ja00085a027; Chambers R. D., 2004, FLUORINE ORGANIC CHE, P128; CREARY X, 1985, J ORG CHEM, V50, P474, DOI 10.1021/jo00204a010; Grushin VV, 2000, CHEM SOC REV, V29, P315, DOI 10.1039/a909041j; HASSNER A, 1970, J AM CHEM SOC, V92, P4879, DOI 10.1021/ja00719a021; Jaime-Figueroa S, 2000, SPECTROCHIM ACTA A, V56, P1167, DOI 10.1016/S1386-1425(99)00215-2; KEVILL DN, 1985, J ORG CHEM, V50, P3330, DOI 10.1021/jo00218a017; MALLORY FB, 1975, J AM CHEM SOC, V97, P4770, DOI 10.1021/ja00849a057; MALLORY FB, 1985, J ORG CHEM, V50, P457, DOI 10.1021/jo00204a006; Murphy TJ, 2009, J CHEM EDUC, V86, P519, DOI 10.1021/ed086p519; Olah G. A., 1975, HALONIUM IONS; Roberts I, 1937, J AM CHEM SOC, V59, P947, DOI 10.1021/ja01284a507; Scerba MT, 2012, J ORG CHEM, V77, P1605, DOI 10.1021/jo2024152; SCHNEIDER HJ, 1981, J AM CHEM SOC, V103, P3501, DOI 10.1021/ja00402a040; SCHNEIDER HJ, 1986, CHEM BER-RECL, V119, P65, DOI 10.1002/cber.19861190107; Stoyanov ES, 2010, J AM CHEM SOC, V132, P4062, DOI 10.1021/ja100297b; Sunderhaus JD, 2003, ORG LETT, V5, P4571, DOI 10.1021/ol035695y; SUNKO DE, 1983, J AM CHEM SOC, V105, P5364, DOI 10.1021/ja00354a029; SVENSSON T, 1972, J AM CHEM SOC, V94, P2336, DOI 10.1021/ja00762a027; VIET N, 1992, J AM CHEM SOC, V114, P7127; von Schleyer P. R., 1995, PURE APPL CHEM, V67, P755; Wang HD, 2004, J AM CHEM SOC, V126, P8189, DOI 10.1021/ja048501y; *WAV INC, SPART 06 PROGR; Wehrli F. W., 1983, INTERPRETATION CARBO, P192; YIN TK, 1986, J ORG CHEM, V51, P2285, DOI 10.1021/jo00362a022	30	61	62	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					57	60		10.1126/science.1231247	http://dx.doi.org/10.1126/science.1231247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559245				2022-12-28	WOS:000317061100042
J	Li, Q; Zhou, L; Zhou, MH; Chen, ZP; Li, FR; Wu, HY; Xiang, NJ; Chen, EF; Tang, FY; Wang, DY; Meng, L; Hong, ZH; Tu, WX; Cao, Y; Li, LL; Ding, F; Liu, B; Wang, M; Xie, RH; Gao, RB; Li, XD; Bai, T; Zou, SM; He, J; Hu, JY; Xu, YT; Chai, CL; Wang, SW; Gao, YJ; Jin, LM; Zhang, YP; Luo, HM; Yu, HJ; He, JF; Li, Q; Wang, XJ; Gao, LD; Pang, XH; Liu, GH; Yan, YS; Yuan, H; Shu, YL; Yang, WZ; Wang, Y; Wu, F; Uyeki, TM; Feng, ZJ				Li, Qun; Zhou, Lei; Zhou, Minghao; Chen, Zhiping; Li, Furong; Wu, Huanyu; Xiang, Nijuan; Chen, Enfu; Tang, Fenyang; Wang, Dayan; Meng, Ling; Hong, Zhiheng; Tu, Wenxiao; Cao, Yang; Li, Leilei; Ding, Fan; Liu, Bo; Wang, Mei; Xie, Rongheng; Gao, Rongbao; Li, Xiaodan; Bai, Tian; Zou, Shumei; He, Jun; Hu, Jiayu; Xu, Yangting; Chai, Chengliang; Wang, Shiwen; Gao, Yongjun; Jin, Lianmei; Zhang, Yanping; Luo, Huiming; Yu, Hongjie; He, Jianfeng; Li, Qi; Wang, Xianjun; Gao, Lidong; Pang, Xinghuo; Liu, Guohua; Yan, Yansheng; Yuan, Hui; Shu, Yuelong; Yang, Weizhong; Wang, Yu; Wu, Fan; Uyeki, Timothy M.; Feng, Zijian			Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							A H7N9 VIRUS; TO-PERSON TRANSMISSION; RISK-FACTORS; H5N1 VIRUS; HUMAN ILLNESS; FERRETS; SURVEILLANCE; PROVINCE; DISEASE; MARKET	BackgroundThe first identified cases of avian influenza A(H7N9) virus infection in humans occurred in China during February and March 2013. We analyzed data obtained from field investigations to describe the epidemiologic characteristics of H7N9 cases in China identified as of December 1, 2013. MethodsField investigations were conducted for each confirmed case of H7N9 virus infection. A patient was considered to have a confirmed case if the presence of the H7N9 virus was verified by means of real-time reverse-transcriptase-polymerase-chain-reaction assay (RT-PCR), viral isolation, or serologic testing. Information on demographic characteristics, exposure history, and illness timelines was obtained from patients with confirmed cases. Close contacts were monitored for 7 days for symptoms of illness. Throat swabs were obtained from contacts in whom symptoms developed and were tested for the presence of the H7N9 virus by means of real-time RT-PCR. ResultsAmong 139 persons with confirmed H7N9 virus infection, the median age was 61 years (range, 2 to 91), 71% were male, and 73% were urban residents. Confirmed cases occurred in 12 areas of China. Nine persons were poultry workers, and of 131 persons with available data, 82% had a history of exposure to live animals, including chickens (82%). A total of 137 persons (99%) were hospitalized, 125 (90%) had pneumonia or respiratory failure, and 65 of 103 with available data (63%) were admitted to an intensive care unit. A total of 47 persons (34%) died in the hospital after a median duration of illness of 21 days, 88 were discharged from the hospital, and 2 remain hospitalized in critical condition; 2 patients were not admitted to a hospital. In four family clusters, human-to-human transmission of H7N9 virus could not be ruled out. Excluding secondary cases in clusters, 2675 close contacts of case patients completed the monitoring period; respiratory symptoms developed in 28 of them (1%); all tested negative for H7N9 virus. ConclusionsMost persons with confirmed H7N9 virus infection had severe lower respiratory tract illness, were epidemiologically unrelated, and had a history of recent exposure to poultry. However, limited, nonsustained human-to-human H7N9 virus transmission could not be ruled out in four families. The first cases of human infection with the avian influenza A(H7N9) virus were identified in China in early 2013. This report describes findings for 139 persons with confirmed H7N9 virus infection through December 1, 2013. The first identified cases of human infection with a novel influenza A(H7N9) virus occurred in eastern China during February and March 2013 and were characterized by rapidly progressive pneumonia, respiratory failure, the acute respiratory distress syndrome (ARDS), and fatal outcomes.(1) We analyzed available data from field investigations to characterize the descriptive epidemiology of laboratory-confirmed cases of avian influenza A(H7N9) virus infection in humans that were reported to the Chinese Center for Disease Control and Prevention (China CDC) as of December 1, 2013. In this report, we summarize the epidemiologic findings of case investigations and follow-up monitoring of close contacts of ...	[Li, Qun; Zhou, Lei; Xiang, Nijuan; Meng, Ling; Hong, Zhiheng; Tu, Wenxiao; Cao, Yang; Li, Leilei; Ding, Fan; Liu, Bo; Wang, Mei; Gao, Yongjun; Jin, Lianmei; Zhang, Yanping; Feng, Zijian] Publ Hlth Emergency Ctr, Beijing, Peoples R China; [Wang, Dayan; Gao, Rongbao; Li, Xiaodan; Bai, Tian; Zou, Shumei; Wang, Shiwen; Shu, Yuelong] Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Luo, Huiming; Yu, Hongjie; Yang, Weizhong; Wang, Yu] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China; [Xie, Rongheng] Chinese Field Epidemiol Training Program, Beijing, Peoples R China; [Pang, Xinghuo] Beijing Municipal Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhou, Minghao; Tang, Fenyang] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Xu, Yangting] Nanjing Prefecture Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Chen, Zhiping; Chen, Enfu; Chai, Chengliang] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Li, Furong; He, Jun] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Wu, Huanyu; Hu, Jiayu; Wu, Fan] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [He, Jianfeng] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Li, Qi] Hebei Prov Ctr Dis Control & Prevent, Shijiazhuang, Peoples R China; [Wang, Xianjun] Shandong Prov Ctr Dis Control & Prevent, Jinan, Peoples R China; [Gao, Lidong] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Liu, Guohua] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Yan, Yansheng] Fujian Prov Ctr Dis Control & Prevent, Fuzhou, Peoples R China; [Yuan, Hui] Jiangxi Prov Ctr Dis Control & Prevent, Nanchang, Peoples R China; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA	Feng, ZJ (corresponding author), Chinese Ctr Dis Control & Prevent, Publ Hlth Emergency Ctr, Beijing 102206, Peoples R China.	fwu@scdc.sh.cn; fengzj@chinacdc.cn	Yu, Hongjie/GZK-5351-2022; He, Jun/P-8974-2019; zhou, minghao/GZA-7244-2022	He, Jun/0000-0002-0463-7063; 	China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases; Research and Promotion of Key Technology on Health Emergency Preparation and Dispositions [201202006-01]; National Ministry of Science and Technology Emergency Research Project on human infection with avian influenza H7N9 virus [KJYJ-2013-01-02]; Jiangsu Province Health Development Project with Science and Education [ZX201109]; Science and Technology Development Plan of Shandong Province [2009GG10002054]	China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases; Research and Promotion of Key Technology on Health Emergency Preparation and Dispositions; National Ministry of Science and Technology Emergency Research Project on human infection with avian influenza H7N9 virus; Jiangsu Province Health Development Project with Science and Education; Science and Technology Development Plan of Shandong Province	Supported by the China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases, a grant (201202006-01) from Research and Promotion of Key Technology on Health Emergency Preparation and Dispositions, a grant (No. KJYJ-2013-01-02) from the National Ministry of Science and Technology Emergency Research Project on human infection with avian influenza H7N9 virus, a grant (No. ZX201109) from Jiangsu Province Health Development Project with Science and Education, and a grant (No. 2009GG10002054) from Science and Technology Development Plan of Shandong Province.	Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; Ai J, 2013, EUROSURVEILLANCE, V18, P4, DOI 10.2807/1560-7917.ES2013.18.26.20510; [Anonymous], WHO CAS DEF HUM INF; [Anonymous], 2010, MMWR RECOMM REP, V59, P1; [Anonymous], 2010, MMWR RECOMM REP, V59, P993; [Anonymous], 2007, EUROSURVEILLANCE, V12; Bai T, 2013, NEW ENGL J MED, V368, P2339, DOI 10.1056/NEJMc1305865; Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Chang SY, 2013, LANCET, V381, P1621, DOI 10.1016/S0140-6736(13)60943-5; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Huai Y, 2008, EMERG INFECT DIS, V14, P1819, DOI 10.3201/eid1411.080509; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Lv HK, 2013, EMERG INFECT DIS, V19, P1885, DOI 10.3201/eid1911.130717; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Muthuri SG, 2013, J INFECT DIS, V207, P553, DOI 10.1093/infdis/jis726; National Health and Family Planning Commission, GUID CAS CLIN INT DI; Ostrowsky B, 2012, EMERG INFECT DIS, V18, P1128, DOI 10.3201/eid1807.111913; Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010, MMWR RECOMM REP, V59, P1147; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; van Riel D, 2013, AM J PATHOL, V183, P1137, DOI 10.1016/j.ajpath.2013.06.011; Wang CM, 2014, J INFECT DIS, V209, P34, DOI 10.1093/infdis/jit478; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; WHO/GIP, 2003, CUM NUMB CONF HUM CA; Xiang NJ, 2013, EMERG INFECT DIS, V19, P1784, DOI 10.3201/eid1911.130865; Xu CL, 2013, EMERG INFECT DIS, V19, P1289, DOI 10.3201/eid1908.130662; Xu L, 2013, J INFECT DIS; Xu W, 2013, CLIN INFECT DIS, V57, P919, DOI 10.1093/cid/cit396; Yu H, 2013, LANCET; Yu HJ, 2006, LANCET, V367, P84, DOI 10.1016/S0140-6736(05)67894-4; Yu HJ, 2007, EMERG INFECT DIS, V13, P1061, DOI 10.3201/eid1307.061557; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Yu HJ, 2012, EMERG INFECT DIS, V18, P758, DOI 10.3201/eid1805.110356; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Zhang C, 2013, EURO SURVEILL, V18; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206	51	529	592	6	238	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6					520	532		10.1056/NEJMoa1304617	http://dx.doi.org/10.1056/NEJMoa1304617			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4NT	23614499	Green Accepted			2022-12-28	WOS:000331073500008
J	McNamara, M; Walsh, JME				McNamara, Megan; Walsh, Judith M. E.			Update in Women's Health: Evidence Published in 2012	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							POSTMENOPAUSAL HORMONE-THERAPY; DOSE ORAL-CONTRACEPTIVES; PUMP INHIBITOR THERAPY; RISK; MEDICATIONS; PREVENTION; FRACTURE; DISEASE		[McNamara, Megan] Case Western Reserve Univ, Cleveland, OH 44106 USA; Univ Calif San Francisco, Womens Hlth Clin Res Ctr, San Francisco, CA 94143 USA	Case Western Reserve University; University of California System; University of California San Francisco	McNamara, M (corresponding author), Case Western Reserve Univ, 10900 Euclid Ave, Cleveland, OH 44106 USA.	mxm700@case.edu						[Anonymous], 2012, MENOPAUSE, V19, P257, DOI 10.1097/gme.0b013e31824b970a; Baillargeon JP, 2005, J CLIN ENDOCR METAB, V90, P3863, DOI 10.1210/jc.2004-1958; Berg AO, 2004, ANN INTERN MED, V140, P382, DOI 10.7326/0003-4819-140-5-200403020-00021; Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032; Bolland MJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2040; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Chan WS, 2004, ARCH INTERN MED, V164, P741, DOI 10.1001/archinte.164.7.741; Corley DA, 2010, GASTROENTEROLOGY, V139, P93, DOI 10.1053/j.gastro.2010.03.055; Cronholm PF, 2011, AM FAM PHYSICIAN, V83, P1165; FDA Drug Safety Communication, 2011, POSS INCR RISK FRACT; Fleischer K, 2009, THROMB RES, V123, P429, DOI 10.1016/j.thromres.2008.04.022; Gray SL, 2010, ARCH INTERN MED, V170, P765, DOI 10.1001/archinternmed.2010.94; Guallar E, 2013, ANN INTERN MED, V158, P69, DOI 10.7326/0003-4819-158-1-201301010-00015; Lethaby A, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000547; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Moyer VA, 2013, ANN INTERN MED, V158, P47, DOI 10.7326/0003-4819-158-1-201301010-00553; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Pouwels S, 2011, OSTEOPOROSIS INT, V22, P903, DOI 10.1007/s00198-010-1337-8; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Targownik LE, 2008, CAN MED ASSOC J, V179, P319, DOI 10.1503/cmaj.071330; Targownik LE, 2007, AM J GASTROENTEROL, V102, P942, DOI 10.1111/j.1572-0241.2007.01106.x; U.S. Preventive Services Task Force, AHRQ PUBLICATION; Vestergaard P, 2006, CALCIFIED TISSUE INT, V79, P76, DOI 10.1007/s00223-006-0021-7; Yang YX, 2008, CURR DRUG SAF, V3, P204, DOI 10.2174/157488608785699414; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Yu EW, 2008, CALCIFIED TISSUE INT, V83, P251, DOI 10.1007/s00223-008-9170-1	27	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2013	159	3					203	+		10.7326/0003-4819-159-1-201307020-00104	http://dx.doi.org/10.7326/0003-4819-159-1-201307020-00104			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201RD	23579223				2022-12-28	WOS:000323159800006
J	Kim, SE; Huang, H; Zhao, M; Zhang, XJ; Zhang, AL; Semonov, MV; MacDonald, BT; Zhang, XW; Abreu, JG; Peng, LL; He, X				Kim, Sung-Eun; Huang, He; Zhao, Ming; Zhang, Xinjun; Zhang, Aili; Semonov, Mikhail V.; MacDonald, Bryan T.; Zhang, Xiaowu; Abreu, Jose Garcia; Peng, Leilei; He, Xi			Wnt Stabilization of beta-Catenin Reveals Principles for Morphogen Receptor-Scaffold Assemblies	SCIENCE			English	Article							DUAL-KINASE MECHANISM; NEGATIVE REGULATOR; SIGNALING PATHWAY; CORECEPTOR LRP6; AXIN; PHOSPHORYLATION; COMPLEX; INHIBITION; DEGRADATION; ACTIVATION	Wnt signaling stabilizes beta-catenin through the LRP6 receptor signaling complex, which antagonizes the beta-catenin destruction complex. The Axin scaffold and associated glycogen synthase kinase-3 (GSK3) have central roles in both assemblies, but the transduction mechanism from the receptor to the destruction complex is contentious. We report that Wnt signaling is governed by phosphorylation regulation of the Axin scaffolding function. Phosphorylation by GSK3 kept Axin activated ("open") for beta-catenin interaction and poised for engagement of LRP6. Formation of the Wnt-induced LRP6-Axin signaling complex promoted Axin dephosphorylation by protein phosphatase-1 and inactivated ("closed") Axin through an intramolecular interaction. Inactivation of Axin diminished its association with beta-catenin and LRP6, thereby inhibiting beta-catenin phosphorylation and enabling activated LRP6 to selectively recruit active Axin for inactivation reiteratively. Our findings reveal mechanisms for scaffold regulation and morphogen signaling.	[Kim, Sung-Eun; Huang, He; Zhang, Xinjun; Semonov, Mikhail V.; MacDonald, Bryan T.; Abreu, Jose Garcia; He, Xi] Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Ctr, Boston, MA 02115 USA; [Zhao, Ming; Zhang, Aili; Peng, Leilei] Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA; [Abreu, Jose Garcia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Zhang, Aili] Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Zhang, Xiaowu] Cell Signaling Technol, Danvers, MA 01923 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Arizona; Universidade Federal do Rio de Janeiro; Shanghai Jiao Tong University	He, X (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Ctr, Boston, MA 02115 USA.	xi.he@childrens.harvard.edu	Zhao, Ming/M-7930-2014; Abreu, Jose G/ABB-1199-2021; Kim, Sung-Eun/ABC-8837-2020; Abreu, Jose G/G-6159-2010	Zhao, Ming/0000-0001-9695-7322; Abreu, Jose G/0000-0002-1363-1755; Kim, Sung-Eun/0000-0001-8667-3887; Abreu, Jose G/0000-0002-9875-7786	National Research Foundation of Korea [KRF-2009-357-C00096]; Canadian Institute of Health Research; National Council for Scientific and Technological Development (CNPq, Brazil); NIH [R00EB008737, R01EB015481, RO1 GM074241]; Boston Children's Hospital Intellectual and Developmental Disabilities Research Center [P30 HD-18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB015481, R00EB008737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074241] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Children's Hospital Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Wu for the BCD2 construct; X. Yu for figs. S11 and S13; B. Doble and J. Woodgett for Gsk3-null mouse embryonic stem cells; A. Klein, M. Kirschner, T. Schwarz, J.-h. Wang, and X. H. laboratory members for comments; and M. Lin, B. Yu, M. Wan, X. Cao, and W. Wei for help. S.-E. K. and H. H. were supported partially by postdoctoral fellowships from National Research Foundation of Korea (KRF-2009-357-C00096) and Canadian Institute of Health Research, respectively. J. G. A. was funded partially by the National Council for Scientific and Technological Development (CNPq, Brazil) as a visiting scientist to the X. H. laboratory. L. P. acknowledges support by NIH (R00EB008737 and R01EB015481). X. H. acknowledges support by NIH (RO1 GM074241) and Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (P30 HD-18655).	Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Hernandez AR, 2012, SCIENCE, V338, P1337, DOI 10.1126/science.1228734; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jho EH, 1999, BIOCHEM BIOPH RES CO, V266, P28, DOI 10.1006/bbrc.1999.1760; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	30	164	167	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					867	870		10.1126/science.1232389	http://dx.doi.org/10.1126/science.1232389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23579495	Green Accepted			2022-12-28	WOS:000318997400045
J	Lawitz, E; Mangia, A; Wyles, D; Rodriguez-Torres, M; Hassanein, T; Gordon, SC; Schultz, M; Davis, MN; Kayali, Z; Reddy, KR; Jacobson, IM; Kowdley, KV; Nyberg, L; Subramanian, GM; Hyland, RH; Arterburn, S; Jiang, DY; McNally, J; Brainard, D; Symonds, WT; McHutchison, JG; Sheikh, AM; Younossi, Z; Gane, EJ				Lawitz, Eric; Mangia, Alessandra; Wyles, David; Rodriguez-Torres, Maribel; Hassanein, Tarek; Gordon, Stuart C.; Schultz, Michael; Davis, Mitchell N.; Kayali, Zeid; Reddy, K. Rajender; Jacobson, Ira M.; Kowdley, Kris V.; Nyberg, Lisa; Subramanian, G. Mani; Hyland, Robert H.; Arterburn, Sarah; Jiang, Deyuan; McNally, John; Brainard, Diana; Symonds, William T.; McHutchison, John G.; Sheikh, Aasim M.; Younossi, Zobair; Gane, Edward J.			Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS-INFECTION; PLUS RIBAVIRIN; PREVALENCE; POLYMERASE; ALPHA-2A; UPDATE	BACKGROUND In phase 2 trials, the nucleotide polymerase inhibitor sofosbuvir was effective in previously untreated patients with chronic hepatitis C virus (HCV) genotype 1, 2, or 3 infection. METHODS We conducted two phase 3 studies in previously untreated patients with HCV infection. In a single-group, open-label study, we administered a 12-week regimen of sofosbuvir plus peginterferon alfa-2a and ribavirin in 327 patients with HCV genotype 1, 4, 5, or 6 (of whom 98% had genotype 1 or 4). In a noninferiority trial, 499 patients with HCV genotype 2 or 3 infection were randomly assigned to receive sofosbuvir plus ribavirin for 12 weeks or peginterferon alfa-2a plus ribavirin for 24 weeks. In the two studies, the primary end point was a sustained virologic response at 12 weeks after the end of therapy. RESULTS In the single-group study, a sustained virologic response was reported in 90% of patients (95% confidence interval, 87 to 93). In the noninferiority trial, a sustained response was reported in 67% of patients in both the sofosbuvir-ribavirin group and the peginterferon-ribavirin group. Response rates in the sofosbuvir-ribavirin group were lower among patients with genotype 3 infection than among those with genotype 2 infection (56% vs. 97%). Adverse events (including fatigue, headache, nausea, and neutropenia) were less common with sofosbuvir than with peginterferon. CONCLUSIONS In a single-group study of sofosbuvir combined with peginterferon-ribavirin, patients with predominantly genotype 1 or 4 HCV infection had a rate of sustained virologic response of 90% at 12 weeks. In a noninferiority trial, patients with genotype 2 or 3 infection who received either sofosbuvir or peginterferon with ribavirin had nearly identical rates of response (67%). Adverse events were less frequent with sofosbuvir than with peginterferon. (Funded by Gilead Sciences; FISSION and NEUTRINO ClinicalTrials.gov numbers, NCT01497366 and NCT01641640, respectively.)	[Lawitz, Eric] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78215 USA; [Mangia, Alessandra] Casa Sollievo Sofferenza Hosp, San Giovanni Rotondo, Italy; [Wyles, David] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Hassanein, Tarek] Southern Calif Liver Ctr, Coronado, CA USA; [Kayali, Zeid] Arrowhead Reg Med Ctr, Colton, CA USA; [Nyberg, Lisa] Kaiser Permanente, San Diego, CA USA; [Subramanian, G. Mani; Hyland, Robert H.; Arterburn, Sarah; Jiang, Deyuan; McNally, John; Brainard, Diana; Symonds, William T.; McHutchison, John G.] Gilead Sci Inc, Foster City, CA 94404 USA; [Rodriguez-Torres, Maribel] Fdn Invest, San Juan, PR USA; [Gordon, Stuart C.] Henry Ford Hlth Syst, Detroit, MI USA; [Schultz, Michael] Dunedin Publ Hosp, Southern Dis trict Hlth Board, Gastroenterol Unit, Dunedin, New Zealand; [Gane, Edward J.] Auckland City Hosp, Auckland, New Zealand; [Davis, Mitchell N.] Digest CARE South Florida Ctr Gastroenterol, Wellington, New Zealand; [Reddy, K. Rajender] Univ Penn, Philadelphia, PA 19104 USA; [Jacobson, Ira M.] Weill Cornell Med Coll, New York, NY USA; [Kowdley, Kris V.] Virginia Mason Med Ctr, Inst Digest Dis, Seattle, WA 98101 USA; [Sheikh, Aasim M.] GI Specialists Georgia, Marietta, GA USA; [Younossi, Zobair] Inova Fairfax Hosp, Falls Church, VA USA	University of Texas System; University of Texas Health San Antonio; IRCCS Casa Sollievo Della Sofferenza; University of California System; University of California San Diego; Kaiser Permanente; Gilead Sciences; Henry Ford Health System; Henry Ford Hospital; Dunedin Public Hospital; Auckland City Hospital; University of Pennsylvania; Cornell University; Virginia Mason Medical Center; Inova Fairfax Hospital	Lawitz, E (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, 607 Camden St, San Antonio, TX 78215 USA.	lawitz@txliver.com; edgane@adhb.govt.nz	Mangia, A/AAL-5357-2020; Kowdley, Kris/AAF-5202-2019	Mangia, A/0000-0002-2600-3555; Davis, Mitchell/0000-0002-0526-5564	Gilead Sciences	Gilead Sciences(Gilead Sciences)	Funded by Gilead Sciences; FISSION and NEUTRINO ClinicalTrials.gov numbers, NCT01497366 and NCT01641640, respectively.; Supported by Gilead Sciences.	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Assis DN, 2012, CLIN PHARMACOL THER, V92, P294, DOI 10.1038/clpt.2012.103; Bourliere M, 2013, LIVER INT, V33, P46, DOI 10.1111/liv.12067; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kadmon Pharmaceuticals, 2011, RIB RIB TABL US PRES; Kowdley KV, 2013, LANCET; Lam AM, 2010, ANTIMICROB AGENTS CH, V54, P3187, DOI 10.1128/AAC.00399-10; Lawitz E, 2013, LANCET INFECT DIS; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Mohd Hanafiah K, HEPATOLOGY IN PRESS; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Wyles David L, 2012, Top Antivir Med, V20, P139	19	1324	1376	2	126	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1878	1887		10.1056/NEJMoa1214853	http://dx.doi.org/10.1056/NEJMoa1214853			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143VK	23607594				2022-12-28	WOS:000318896200007
J	Kramer, DB; Kesselheim, AS				Kramer, Daniel B.; Kesselheim, Aaron S.			The Medical Device Excise Tax - Over before It Begins?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kramer, Daniel B.; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kramer, Daniel B.] Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02215 USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Kramer, DB (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	NCATS NIH HHS [KL2 TR000168] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000168] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Center for Responsive Politics, MED SUPPL MAN SAL LO; Kaiser Family Foundation, SUMM NEW HLTH REF LA; Nexon D, 2010, HEALTH AFFAIR, V29, P1325, DOI 10.1377/hlthaff.2010.0436; Patil N., 2012, HEALTHCARE MED DEVIC; Van de Water Paul, 2013, EXCISE TAX MED DEVIC	5	3	3	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1767	1769		10.1056/NEJMp1304175	http://dx.doi.org/10.1056/NEJMp1304175			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138WA	23614473	Green Accepted			2022-12-28	WOS:000318540000004
J	Rohle, D; Popovici-Muller, J; Palaskas, N; Turcan, S; Grommes, C; Campos, C; Tsoi, J; Clark, O; Oldrini, B; Komisopoulou, E; Kunii, K; Pedraza, A; Schalm, S; Silverman, L; Miller, A; Wang, F; Yang, H; Chen, Y; Kernytsky, A; Rosenblum, MK; Liu, W; Biller, SA; Su, SM; Brennan, CW; Chan, TA; Graeber, TG; Yen, KE; Mellinghoff, IK				Rohle, Dan; Popovici-Muller, Janeta; Palaskas, Nicolaos; Turcan, Sevin; Grommes, Christian; Campos, Carl; Tsoi, Jennifer; Clark, Owen; Oldrini, Barbara; Komisopoulou, Evangelia; Kunii, Kaiko; Pedraza, Alicia; Schalm, Stefanie; Silverman, Lee; Miller, Alexandra; Wang, Fang; Yang, Hua; Chen, Yue; Kernytsky, Andrew; Rosenblum, Marc K.; Liu, Wei; Biller, Scott A.; Su, Shinsan M.; Brennan, Cameron W.; Chan, Timothy A.; Graeber, Thomas G.; Yen, Katharine E.; Mellinghoff, Ingo K.			An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells	SCIENCE			English	Article							INTEGRATED GENOMIC ANALYSIS; ACUTE MYELOID-LEUKEMIA; ONCOMETABOLITE 2-HYDROXYGLUTARATE; MUTATIONS; GLIOBLASTOMA; TRANSFORMATION; PHENOTYPE; BRAIN	The recent discovery of mutations in metabolic enzymes has rekindled interest in harnessing the altered metabolism of cancer cells for cancer therapy. One potential drug target is isocitrate dehydrogenase 1 (IDH1), which is mutated in multiple human cancers. Here, we examine the role of mutant IDH1 in fully transformed cells with endogenous IDH1 mutations. A selective R132H-IDH1 inhibitor (AGI-5198) identified through a high-throughput screen blocked, in a dose-dependent manner, the ability of the mutant enzyme (mIDH1) to produce R-2-hydroxyglutarate (R-2HG). Under conditions of near-complete R-2HG inhibition, the mIDH1 inhibitor induced demethylation of histone H3K9me3 and expression of genes associated with gliogenic differentiation. Blockade of mIDH1 impaired the growth of IDH1-mutant-but not IDH1-wild-type-glioma cells without appreciable changes in genome-wide DNA methylation. These data suggest that mIDH1 may promote glioma growth through mechanisms beyond its well-characterized epigenetic effects.	[Rohle, Dan; Palaskas, Nicolaos; Turcan, Sevin; Campos, Carl; Clark, Owen; Oldrini, Barbara; Brennan, Cameron W.; Chan, Timothy A.; Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Rohle, Dan; Mellinghoff, Ingo K.] Weill Cornell Grad Sch Biomed Sci, Dept Pharmacol, New York, NY 10021 USA; [Popovici-Muller, Janeta; Kunii, Kaiko; Schalm, Stefanie; Silverman, Lee; Wang, Fang; Yang, Hua; Chen, Yue; Kernytsky, Andrew; Liu, Wei; Biller, Scott A.; Su, Shinsan M.; Yen, Katharine E.] Agios Pharmaceut, Cambridge, MA 02139 USA; [Grommes, Christian; Miller, Alexandra; Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Rosenblum, Marc K.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pedraza, Alicia; Brennan, Cameron W.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Tsoi, Jennifer; Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Memorial Sloan Kettering Cancer Center; Agios Pharmaceuticals; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles	Yen, KE (corresponding author), Agios Pharmaceut, Cambridge, MA 02139 USA.	katharine.yen@agios.com; mellingi@mskcc.org	Chan, Timothy A/ABD-5850-2021; Turcan, Sevin/AAF-1095-2019; Brennan, Cameron/R-7082-2019	Turcan, Sevin/0000-0002-0885-5607; Brennan, Cameron/0000-0003-4064-8891; Campos, Carl/0000-0002-7616-8518; Graeber, Thomas/0000-0001-8574-9181; Miller, Alexandra/0000-0003-2048-579X; Mellinghoff, Ingo/0000-0002-4347-8149; PALASKAS, NICOLAOS/0000-0003-0783-0683	National Brain Tumor Society; National Institutes of Health [1R01NS080944-01, U54CA143798]; Leon Levy Foundation; James S. McDonnell Foundation; American Brain Tumor Association; Lymphoma Research Foundation; American Cancer Society; American Society of Clinical Oncology; NATIONAL CANCER INSTITUTE [T32CA160001, U54CA143798, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080944] Funding Source: NIH RePORTER	National Brain Tumor Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leon Levy Foundation; James S. McDonnell Foundation; American Brain Tumor Association; Lymphoma Research Foundation; American Cancer Society(American Cancer Society); American Society of Clinical Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. G. Kaelin Jr., for sharing unpublished results. This work was supported by the National Brain Tumor Society (T. G. G., K.E.Y., and I. K. M.), the National Institutes of Health (1R01NS080944-01 and U54CA143798), the Leon Levy Foundation (I. K. M), and the James S. McDonnell Foundation (I. K. M.). C. G. was supported through an American Brain Tumor Association Basic Research Fellowship Award and the Lymphoma Research Foundation. T. G. G. is the recipient of a Research Scholar Award from the American Cancer Society. I. K. M. is the recipient of an Advanced Clinical Research Award in Glioma from the American Society of Clinical Oncology. Agios Pharmaceuticals has filed a patent application on AGI-5198. Microarray data are deposited in the Gene Expression Omnibus (GEO accession no. GSE45200).	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Popovici-Muller J, 2012, ACS MED CHEM LETT, V3, P850, DOI 10.1021/ml300225h; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Sobieszczuk DF, 2010, GENE DEV, V24, P206, DOI 10.1101/gad.554510; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	27	820	896	5	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					626	630		10.1126/science.1236062	http://dx.doi.org/10.1126/science.1236062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23558169	Green Accepted			2022-12-28	WOS:000318268900052
J	Abdumalikov, AA; Fink, JM; Juliusson, K; Pechal, M; Berger, S; Wallraff, A; Filipp, S				Abdumalikov, A. A., Jr.; Fink, J. M.; Juliusson, K.; Pechal, M.; Berger, S.; Wallraff, A.; Filipp, S.			Experimental realization of non-Abelian non-adiabatic geometric gates	NATURE			English	Article							QUANTUM COMPUTATION; BERRYS PHASE	The geometric aspects of quantum mechanics are emphasized most prominently by the concept of geometric phases, which are acquired whenever a quantum system evolves along a path in Hilbert space, that is, the space of quantum states of the system. The geometric phase is determined only by the shape of this path(1-3) and is, in its simplest form, a real number. However, if the system has degenerate energy levels, then matrix-valued geometric state transformations, known as non-Abelian holonomies-the effect of which depends on the order of two consecutive paths-can be obtained(4). They are important, for example, for the creation of synthetic gauge fields in cold atomic gases(5) or the description of non-Abelian anyon statistics(6,7). Moreover, there are proposals(8,9) to exploit non-Abelian holonomic gates for the purposes of noise-resilient quantum computation. In contrast to Abelian geometric operations(10), non-Abelian ones have been observed only in nuclear quadrupole resonance experiments with a large number of spins, and without full characterization of the geometric process and its non-commutative nature(11,12). Here we realize non-Abelian non-adiabatic holonomic quantum operations(13,14) on a single, superconducting, artificial three-level atom(15) by applying a well-controlled, two-tone microwave drive. Using quantum process tomography, we determine fidelities of the resulting non-commuting gates that exceed 95 per cent. We show that two different quantum gates, originating from two distinct paths in Hilbert space, yield non-equivalent transformations when applied in different orders. This provides evidence for the non-Abelian character of the implemented holonomic quantum operations. In combination with a non-trivial two-quantum-bit gate, our method suggests a way to universal holonomic quantum computing.	[Abdumalikov, A. A., Jr.; Fink, J. M.; Juliusson, K.; Pechal, M.; Berger, S.; Wallraff, A.; Filipp, S.] Swiss Fed Inst Technol, Dept Phys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Abdumalikov, AA (corresponding author), Swiss Fed Inst Technol, Dept Phys, CH-8093 Zurich, Switzerland.	abdumalikov@phys.ethz.ch	Wallraff, Andreas J/C-2130-2009; Fink, Johannes M/C-1919-2008; Filipp, Stefan/F-4775-2013	Wallraff, Andreas J/0000-0002-3476-4485; Fink, Johannes M/0000-0001-8112-028X; Filipp, Stefan/0000-0002-1976-1817	EU; GEOMDISS; Swiss National Science Foundation; ETH Zurich	EU(European Commission); GEOMDISS; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	We are grateful to E. Sjoqvist and members of the EU-funded project GEOMDISS for discussions. We acknowledge feedback on the manuscript from P. Zanardi and I. Cirac. This work is supported financially by GEOMDISS, the Swiss National Science Foundation and ETH Zurich.	ANANDAN J, 1988, PHYS LETT A, V133, P171, DOI 10.1016/0375-9601(88)91010-9; Berry M, 2010, NAT PHYS, V6, P148, DOI 10.1038/nphys1608; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Bianchetti R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.223601; Bianchetti R, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.043840; Dalibard J, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1523; Duan LM, 2001, SCIENCE, V292, P1695, DOI 10.1126/science.1058835; Faoro L, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.028301; Filipp S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.030404; Jezek M, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.012305; Johansson M, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.062322; Kamleitner I, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.214518; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Leek PJ, 2007, SCIENCE, V318, P1889, DOI 10.1126/science.1149858; Mottonen M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.177201; Motzoi F, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.110501; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Pachos J. K., 2012, INTRO TOPOLOGICAL QU; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; PANCHARATNAM S, 1956, P INDIAN ACAD SCI A, V44, P247, DOI DOI 10.1007/BF03046050; Pechal M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.170401; Sjoqvist Erik, 2008, Physics, V1, DOI 10.1103/Physics.1.35; Sjoqvist E, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/103035; Solinas P, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.062315; TYCKO R, 1987, PHYS REV LETT, V58, P2281, DOI 10.1103/PhysRevLett.58.2281; WILCZEK F, 1984, PHYS REV LETT, V52, P2111, DOI 10.1103/PhysRevLett.52.2111; Wu H, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.032326; Zanardi P, 1999, PHYS LETT A, V264, P94, DOI 10.1016/S0375-9601(99)00803-8; Zhu SL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.097902; ZWANZIGER JW, 1990, PHYS REV A, V42, P3107, DOI 10.1103/PhysRevA.42.3107	31	247	247	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2013	496	7446					482	485		10.1038/nature12010	http://dx.doi.org/10.1038/nature12010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23594739	Green Submitted			2022-12-28	WOS:000317984400036
J	Chinthapalli, K				Chinthapalli, Krishna			NICE is dead; long live NICE	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK SHARING SCHEME; COST-EFFECTIVENESS; DECISIONS		BMJ, London WC1H 9JR, England		Chinthapalli, K (corresponding author), BMJ, London WC1H 9JR, England.	kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				[Anonymous], 2005, LANCET, V366, P1673; [Anonymous], 1999, BBC NEWS; [Anonymous], 1998, BBC NEWS; [Anonymous], 2013, GOVT RESPONSE HLTH S; Appleby J, 2007, BRIT MED J, V335, P358, DOI 10.1136/bmj.39308.560069.BE; Association of the British Pharmaceutical Industry, 2013, NEW INN SCOR SHOWS E; Association of the British Pharmaceutical Industry, 2012, GLOB PHARM IND MARK; Association of the British Pharmaceutical Industry, 2010, CANC DRUGS FUND CONS; Association of the British Pharmaceutical Industry, 2009, I KENN REV UNPUB; Barrett A, 2006, BRIT MED J, V333, P1118, DOI 10.1136/bmj.39008.624051.BE; Boggild M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4677; British Broadcasting Corporation (BBC), 2005, BBC NEWS; Burstrom K, 2006, HEALTH POLICY, V76, P359, DOI 10.1016/j.healthpol.2005.06.011; Claxton K, 2008, BMJ-BRIT MED J, V336, P251, DOI 10.1136/bmj.39434.500185.25; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Compston A, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2707; *DEP HLTH, 1998, 1 CLASS SERV QUAL NE; Department of Health, 2011, INN HLTH WEALTH ACC; Department of Health, 2012, CREAT CHANG IHW ON Y; Department of Health, 2012, CANC DRUGS FUND GUID; Department of Health, 2012, 11 DEP HLTH; Ford JA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000671; Gaebel W, 2005, BRIT J PSYCHIAT, V187, P248, DOI 10.1192/bjp.187.3.248; Health and Social Care Information Centre, 2013, NICE TECHN APPR NHS; Henry DA, 2005, JAMA-J AM MED ASSOC, V294, P2630, DOI 10.1001/jama.294.20.2630; Light DW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4348; McCabe C, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1786; National Institute for Health and Clinical Excellence, 2012, HLTH ACT MAK NICE ST; NICE, 2013, TECHN APPR TOP SEL; NICE, 2010, FACT SHEET CLIN GUID; NICE, 2013, TECHN APPR FULL TABL; Nicholson D, 2012, INNOVATION HLTH WEAL; Raftery J, 2006, BRIT MED J, V332, P1266, DOI 10.1136/bmj.332.7552.1266; Raftery J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1672; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Rawlins M, 2008, CLIN MED, V8, P579, DOI 10.7861/clinmedicine.8-6-579; Sikora K, 2009, DAILY MAIL; Sikora K., 2011, TELEGRAPH; World Health Organization, 2011, WORLD MED SIT 2011 M	39	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2013	346								f2546	10.1136/bmj.f2546	http://dx.doi.org/10.1136/bmj.f2546			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134PM	23615594				2022-12-28	WOS:000318224900015
J	Lin, J; Mueller, JPB; Wang, Q; Yuan, GH; Antoniou, N; Yuan, XC; Capasso, F				Lin, Jiao; Mueller, J. P. Balthasar; Wang, Qian; Yuan, Guanghui; Antoniou, Nicholas; Yuan, Xiao-Cong; Capasso, Federico			Polarization-Controlled Tunable Directional Coupling of Surface Plasmon Polaritons	SCIENCE			English	Article							EFFICIENT; LIGHT	Light can be coupled into propagating electromagnetic surface waves at a metal-dielectric interface known as surface plasmon polaritons (SPPs). This process has traditionally faced challenges in the polarization sensitivity of the coupling efficiency and in controlling the directionality of the SPPs. We designed and demonstrated plasmonic couplers that overcome these limits using polarization-sensitive apertures in a gold film. Our devices enable polarization-controlled tunable directional coupling with polarization-invariant total conversion efficiency and preserve the incident polarization information. Both bidirectional and unidirectional launching of SPPs are demonstrated. The design is further applied to circular structures that create radially convergent and divergent SPPs, illustrating that this concept can be extended to a broad range of applications.	[Lin, Jiao; Mueller, J. P. Balthasar; Capasso, Federico] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Lin, Jiao] Singapore Inst Mfg Technol, Singapore 638075, Singapore; [Wang, Qian; Yuan, Guanghui] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Antoniou, Nicholas] Harvard Univ, Ctr Nanoscale Syst, Cambridge, MA 02138 USA; [Yuan, Xiao-Cong] Nankai Univ, Minist Educ China, Key Lab Opt Informat Sci & Technol, Inst Modern Opt, Tianjin 300071, Peoples R China	Harvard University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute of Manufacturing Technology (SIMTech); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Harvard University; Ministry of Education, China; Nankai University	Capasso, F (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	capasso@seas.harvard.edu	Mueller, J. P. Balthasar/K-7812-2019; Lin, Jiao/B-6607-2009; Wang, Qian/GYD-8743-2022	Lin, Jiao/0000-0002-3943-5947; wang, qian/0000-0003-0750-7843	NSF [ECS-0335765]; Air Force Office of Scientific Research [FA9550-12-1-0289]; Agency for Science, Technology and Research (A*STAR), Singapore; National Natural Science Foundation of China [61036013, 61138003]; Ministry of Science and Technology of China [2009DFA52300]; National Research Foundation of Singapore [NRF-G-CRP 2007-01]	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Research Foundation of Singapore(National Research Foundation, Singapore)	Part of this work was performed at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by the NSF (under award ECS-0335765). CNS is part of Harvard University. This research is supported in part by the Air Force Office of Scientific Research under grant FA9550-12-1-0289. J.L. acknowledges the fellowship support from the Agency for Science, Technology and Research (A*STAR), Singapore. X.-C.Y. acknowledges the support given by the National Natural Science Foundation of China under grants 61036013 and 61138003, the Ministry of Science and Technology of China under grant 2009DFA52300 for China-Singapore collaborations, and the National Research Foundation of Singapore under grant NRF-G-CRP 2007-01. The authors express thanks to M. Kats (School of Engineering and Applied Sciences, Harvard University), K. A. C. Lee and Y. Zhou (Singapore Institute of Manufacturing Technology), and L. Du (Nanyang Technological University) for their assistance in the preparation of the manuscript. Data are available upon request.	Archambault A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195414; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Baron A, 2011, NANO LETT, V11, P4207, DOI 10.1021/nl202135w; Brongersma ML, 2010, SCIENCE, V328, P440, DOI 10.1126/science.1186905; Curto AG, 2010, SCIENCE, V329, P930, DOI 10.1126/science.1191922; Di Martino G, 2012, NANO LETT, V12, P2504, DOI 10.1021/nl300671w; Genevet P, 2011, APPL OPTICS, V50, pG56, DOI 10.1364/AO.50.000G56; Juan ML, 2011, NAT PHOTONICS, V5, P349, DOI [10.1038/nphoton.2011.56, 10.1038/NPHOTON.2011.56]; Kim S, 2008, NATURE, V453, P757, DOI 10.1038/nature07012; Kosako T, 2010, NAT PHOTONICS, V4, P312, DOI 10.1038/NPHOTON.2010.34; Lezec HJ, 2007, SCIENCE, V316, P430, DOI 10.1126/science.1139266; Liu YM, 2012, NANO LETT, V12, P4853, DOI 10.1021/nl302339z; Lopez-Tejeira F, 2007, NAT PHYS, V3, P324, DOI 10.1038/nphys584; Maier S. A., 2007, PLAMONICS FUNDAMENTA; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Tanemura T, 2011, NANO LETT, V11, P2693, DOI 10.1021/nl200938h; Yariv A., 2006, OXFORD SERIES ELECT; Yu NF, 2012, LASER PHOTONICS REV, V6, P24, DOI 10.1002/lpor.201100019; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713	20	917	951	47	958	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					331	334		10.1126/science.1233746	http://dx.doi.org/10.1126/science.1233746			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599488				2022-12-28	WOS:000317657500049
J	Grant, AM; Cotton, SC; Boachie, C; Ramsay, CR; Krukowski, ZH; Heading, RC; Campbell, MK				Grant, A. M.; Cotton, S. C.; Boachie, C.; Ramsay, C. R.; Krukowski, Z. H.; Heading, R. C.; Campbell, M. K.		REFLUX Trial Grp	Minimal access surgery compared with medical management for gastro-oesophageal reflux disease: five year follow-up of a randomised controlled trial (REFLUX)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LAPAROSCOPIC NISSEN FUNDOPLICATION; PROTON-PUMP INHIBITORS; UNDERSTANDING-CONTROLLED-TRIALS; ANTIREFLUX SURGERY; COST-EFFECTIVENESS; CLINICAL-TRIAL; LOTUS TRIAL; ESOMEPRAZOLE	Objectives To determine the long term clinical effectiveness of laparoscopic fundoplication as an alternative to drug treatment for chronic gastro-oesophageal reflux disease (GORD). Design Five year follow-up of multicentre, pragmatic randomised trial (with parallel non-randomised preference groups). Setting Initial recruitment in 21 UK hospitals. Participants Responders to annual questionnaires among 810 original participants. At entry, all had had GORD for >12 months. Intervention The surgeon chose the type of fundoplication. Medical therapy was reviewed and optimised by a specialist. Subsequent management was at the discretion of the clinician responsible for care, usually in primary care. Main outcome measures Primary outcome measure was self reported quality of life score on disease-specific REFLUX questionnaire. Other measures were health status (with SF-36 and EuroQol EQ-5D questionnaires), use of antireflux medication, and complications. Results By five years, 63% (112/178) of patients randomised to surgery and 13% (24/179) of those randomised to medical management had received a fundoplication (plus 85% (222/261) and 3% (6/192) of those who expressed a preference for surgery and for medical management). Among responders at 5 years, 44% (56/127) of those randomised to surgery were taking antireflux medication versus 82% (98/119) of those randomised to medical management. Differences in the REFLUX score significantly favoured the randomised surgery group (mean difference 8.5 (95% CI 3.9 to 13.1), P<0.001, at five years). SF-36 and EQ-5D scores also favoured surgery, but were not statistically significant at five years. After fundoplication, 3% (12/364) had surgical treatment for a complication and 4% (16) had subsequent reflux-related operations-most often revision of the wrap. Long term rates of dysphagia, flatulence, and inability to vomit were similar in the two randomised groups. Conclusions After five years, laparoscopic fundoplication continued to provide better relief of GORD symptoms than medical management. Adverse effects of surgery were uncommon and generally observed soon after surgery. A small proportion had re-operations. There was no evidence of long term adverse symptoms caused by surgery. Trial registration Current Controlled Trials ISRCTN15517081.	[Grant, A. M.; Cotton, S. C.; Boachie, C.; Ramsay, C. R.; Campbell, M. K.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; [Krukowski, Z. H.] Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland; [Heading, R. C.] Univ Durham, Wolfson Res Inst, Sch Med & Hlth, Stockton On Tees TS17 6BH, England	University of Aberdeen; University of Aberdeen; Durham University	Grant, AM (corresponding author), Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland.	a.grant@abdn.ac.uk	Ramsay, Craig/AAD-8249-2021; Toh, Simon Khay Chuan/X-7081-2019; Campbell, Marion/ABB-7063-2020	Ramsay, Craig/0000-0003-4043-7349; Toh, Simon Khay Chuan/0000-0001-5110-2371; Campbell, Marion/0000-0001-5386-4097; El-Omar, Emad/0000-0002-0011-3924	NIHR Health Technology Assessment Programme [97/10/03]; Chief Scientist Office of the Scottish Government Health Directorate; Chief Scientist Office [HSRU1] Funding Source: researchfish	NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Chief Scientist Office of the Scottish Government Health Directorate; Chief Scientist Office	This project was funded by the NIHR Health Technology Assessment Programme (Project No 97/10/03) and will be published in full in Health Technology Assessment. See the HTA Programme website for further information. The Health Services Research Unit is funded by the Chief Scientist Office of the Scottish Government Health Directorate.	Anvari M, 2006, SURG INNOV, V13, P238, DOI 10.1177/1553350606296389; Anvari M, 2011, SURG ENDOSC, V25, P2547, DOI 10.1007/s00464-011-1585-5; Attwood SEA, 2008, WORLD J SURG, V32, P995, DOI 10.1007/s00268-007-9409-4; Broeders JA, 2012, ANN SURG, V255, P637, DOI 10.1097/SLA.0b013e31824b31ad; BROOKS R, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9; Brown H., 1999, APPL MIXED MODELS ME; Dent J, 1999, GUT, V44, pS1, DOI 10.1136/gut.44.2008.S1; Epstein D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2576; Galmiche JP, 2011, JAMA-J AM MED ASSOC, V305, P1969, DOI 10.1001/jama.2011.626; Goeree R, 2011, VALUE HEALTH, V14, P263, DOI 10.1016/j.jval.2010.09.004; Grant A, 2008, HEALTH TECHNOL ASSES, V12, P1; Grant AM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2664; Grant AM, HLTH TECHNO IN PRESS; Jenkinson C, 1996, UK SF 36 ANAL INTERP; Lundell L, 2008, GUT, V57, P1207, DOI 10.1136/gut.2008.148833; Macran S, 2007, QUAL LIFE RES, V16, P331, DOI 10.1007/s11136-006-9005-3; Mahon D, 2005, BRIT J SURG, V92, P695, DOI 10.1002/bjs.4934; Nagelkerke N, 2000, STAT MED, V19, P1849, DOI 10.1002/1097-0258(20000730)19:14<1849::AID-SIM506>3.0.CO;2-1; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Torgerson DJ, 1998, BRIT MED J, V316, P360, DOI 10.1136/bmj.316.7128.360; Wileman SM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003243.pub2	21	48	50	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2013	346								f1908	10.1136/bmj.f1908	http://dx.doi.org/10.1136/bmj.f1908			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131AZ	23599318	Green Published, hybrid			2022-12-28	WOS:000317964200005
J	Klompas, M				Klompas, Michael			Complications of Mechanical Ventilation - The CDC's New Surveillance Paradigm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Klompas, Michael] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA; [Klompas, Michael] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Klompas, Michael] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Brigham & Women's Hospital	Klompas, M (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA.		Klompas, Michael/Z-2415-2019					Centers for Disease Control and Prevention (CDC), SURV VENT ASS EV; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P798, DOI 10.1016/j.ajic.2011.10.001; Hayashi Y, 2013, CLIN INFECT DIS, V56, P471, DOI 10.1093/cid/cis926; Klompas M, 2012, CRIT CARE MED, V40, P3154, DOI 10.1097/CCM.0b013e318260c6d9; Klompas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018062	5	119	129	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1472	1475		10.1056/NEJMp1300633	http://dx.doi.org/10.1056/NEJMp1300633			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126HC	23594002				2022-12-28	WOS:000317603300004
J	Assmus, B; Walter, DH; Seeger, FH; Leistner, DM; Steiner, J; Ziegler, I; Lutz, A; Khaled, W; Klotsche, J; Tonn, T; Dimmeler, S; Zeiher, AM				Assmus, Birgit; Walter, Dirk H.; Seeger, Florian H.; Leistner, David M.; Steiner, Julia; Ziegler, Ina; Lutz, Andreas; Khaled, Walaa; Klotsche, Jens; Tonn, Torsten; Dimmeler, Stefanie; Zeiher, Andreas M.			Effect of Shock Wave-Facilitated Intracoronary Cell Therapy on LVEF in Patients With Chronic Heart Failure The CELLWAVE Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; MOBILIZED PERIPHERAL-BLOOD; LEFT-VENTRICULAR FUNCTION; PROGENITOR CELLS; BONE-MARROW; STEM-CELLS; TRANSCORONARY TRANSPLANTATION; REGENERATION ENHANCEMENT; ISCHEMIC CARDIOMYOPATHY; EJECTION FRACTION	Importance The modest effects of clinical studies using intracoronary administration of autologous bone marrow-derived mononuclear cells (BMCs) in patients with chronic postinfarction heart failure may be attributed to impaired homing of BMCs to the target area. Extracorporeal shock wave treatment has been experimentally shown to increase homing factors in the target tissue, resulting in enhanced retention of applied BMCs. Objective To test the hypothesis that targeted cardiac shock wave pretreatment with subsequent application of BMCs improves recovery of left ventricular ejection fraction (LVEF) in patients with chronic heart failure. Design, Setting, and Participants The CELLWAVE double-blind, randomized, placebo-controlled trial conducted among patients with chronic heart failure treated at Goethe University Frankfurt, Germany, between 2006 and 2011. Interventions Single-blind low-dose (n=42), high-dose (n=40), or placebo (n=21) shock wave pretreatment targeted to the left ventricular anterior wall. Twenty-four hours later, patients receiving shock wave pretreatment were randomized to receive double-blind intracoronary infusion of BMCs or placebo, and patients receiving placebo shock wave received intracoronary infusion of BMCs. Main Outcomes and Measures Primary end point was change in LVEF from baseline to 4 months in the pooled groups shock wave + placebo infusion vs shock wave + BMCs; secondary end points included regional left ventricular function assessed by magnetic resonance imaging and clinical events. Results The primary end point was significantly improved in the shock wave + BMCs group (absolute change in LVEF, 3.2% [95% CI, 2.0% to 4.4%]), compared with the shock wave + placebo infusion group (1.0% [95% CI, -0.3% to 2.2%]) (P=.02). Regional wall thickening improved significantly in the shock wave + BMCs group (3.6% [95% CI, 2.0% to 5.2%]) but not in the shock wave + placebo infusion group (0.5% [95% CI, -1.2% to 2.1%]) (P=.01). Overall occurrence of major adverse cardiac events was significantly less frequent in the shock wave + BMCs group (n=32 events) compared with the placebo shock wave + BMCs (n=18) and shock wave + placebo infusion (n=61) groups (hazard ratio, 0.58 [95% CI, 0.40-0.85]; P=.02). Conclusions and Relevance Among patients with postinfarction chronic heart failure, shock wave-facilitated intracoronary administration of BMCs vs shock wave treatment alone resulted in a significant, albeit modest, improvement in LVEF at 4 months. Determining whether the increase in contractile function will translate into improved clinical outcomes requires confirmation in larger clinical end point trials.	[Assmus, Birgit; Walter, Dirk H.; Seeger, Florian H.; Leistner, David M.; Steiner, Julia; Ziegler, Ina; Zeiher, Andreas M.] Goethe Univ Frankfurt, Dept Med 3, Div Cardiol, D-60590 Frankfurt, Germany; [Seeger, Florian H.; Dimmeler, Stefanie] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany; [Lutz, Andreas; Khaled, Walaa] Domier Med Tech Syst GmbH, Wessling, Germany; [Klotsche, Jens] Leibnitz Inst, German Rheumatism Res Ctr, Berlin, Germany; [Tonn, Torsten] German Red Cross Blood Serv, Baden, Switzerland; [Tonn, Torsten] Goethe Univ Frankfurt, Inst Transfus Med & Immunohematol, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Deutsches Rheuma-Forschungszentrum (DRFZ); Goethe University Frankfurt	Zeiher, AM (corresponding author), Goethe Univ Frankfurt, Dept Med 3, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	zeiher@em.uni-frankfurt.de	Assmus, Birgit/AAX-3004-2021; Assmus, Birgit/L-3274-2017; Assmus, Birgit/ABF-6853-2021	Assmus, Birgit/0000-0003-2658-6444; Assmus, Birgit/0000-0003-2658-6444; Dimmeler, Stefanie/0000-0002-1045-2436; Leistner, David/0000-0002-4351-420X	German Research Foundation (DFG); European Union; German Ministry of Health and Education; t2cure GmbH	German Research Foundation (DFG)(German Research Foundation (DFG)); European Union(European Commission); German Ministry of Health and Education; t2cure GmbH	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Dimmeler and Dr Zeiher report that they are cofounders of t2cure, a forprofit company focused on regenerative therapies for cardiovascular disease, and for which they serve as scientific advisers and are shareholders. Dr Dimmeler reported serving on a scientific advisory board for Miragen; serving as a consultant to Merck; receiving grants or grants pending from the German Research Foundation (DFG) and the European Union; receiving payment for lectures from various entities; holding patents or patents pending (miR-29, miR-92); and receiving travel expenses from various entities. Dr Zeiher reported serving as a consultant to sanofiaventis, Capricor, and Baxter Healthcare; receiving a grant from the DFG; receiving grants or grants pending from the German Ministry of Health and Education; receiving payment for lectures from Bayer, Berlin Chemie, Orbus Neich, and AstraZeneca; and holding patents or patents pending from Siemens Healthcare. No other authors reported disclosures.; This study was supported by an unrestricted grant to the Goethe University Frankfort from t2cure GmbH.	Aicher A, 2006, CIRCULATION, V114, P2823, DOI 10.1161/CIRCULATIONAHA.106.628623; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Assmus B, 2007, CIRC RES, V100, P1234, DOI 10.1161/01.RES.0000264508.47717.6b; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Baek SJ, 2011, EXP MOL MED, V43, P596, DOI 10.3858/emm.2011.43.10.069; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cleland JGF, 2003, LANCET, V362, P14, DOI 10.1016/S0140-6736(03)13801-9; Ezekowitz JA, 2009, EUR HEART J, V30, P469, DOI 10.1093/eurheartj/ehn543; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Kang HJ, 2006, CIRCULATION, V114, pI145, DOI 10.1161/CIRCULATIONAHA.105.001107; Kissel CK, 2007, J AM COLL CARDIOL, V49, P2341, DOI 10.1016/j.jacc.2007.01.095; Kramer DG, 2010, J AM COLL CARDIOL, V56, P392, DOI 10.1016/j.jacc.2010.05.011; Leistner DM, 2011, CLIN RES CARDIOL, V100, P925, DOI 10.1007/s00392-011-0327-y; Li KH, 1988, J STATISTICAL COMPUT, V30, P57, DOI DOI 10.1080/00949658808811085; Liu JW, 2012, CIRC-CARDIOVASC IMAG, V5, P481, DOI 10.1161/CIRCIMAGING.111.969329; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Penn MS, 2009, CIRC RES, V104, P1133, DOI 10.1161/CIRCRESAHA.109.198929; Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schachinger V, 2008, CIRCULATION, V118, P1425, DOI 10.1161/CIRCULATIONAHA.108.777102; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Seeger FH, 2009, ARTERIOSCL THROM VAS, V29, P1802, DOI 10.1161/ATVBAHA.109.194688; Sovalat H, 2011, EXP HEMATOL, V39, P495, DOI 10.1016/j.exphem.2011.01.003; Steinhauser ML, 2011, EMBO MOL MED, V3, P701, DOI 10.1002/emmm.201100175; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Wong ML, 2004, J AM COLL CARDIOL, V43, P2022, DOI 10.1016/j.jacc.2003.12.053	30	126	131	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1622	1631		10.1001/jama.2013.3527	http://dx.doi.org/10.1001/jama.2013.3527			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126FY	23592107				2022-12-28	WOS:000317599500026
J	DeSilva, JM; Holt, KG; Churchill, SE; Carlson, KJ; Walker, CS; Zipfel, B; Berger, LR				DeSilva, Jeremy M.; Holt, Kenneth G.; Churchill, Steven E.; Carlson, Kristian J.; Walker, Christopher S.; Zipfel, Bernhard; Berger, Lee R.			The Lower Limb and Mechanics of Walking in Australopithecus sediba	SCIENCE			English	Article							PATELLOFEMORAL PAIN; FOOT MORPHOLOGY; HOMININ FOOT; GENUS HOMO; AFARENSIS; EVOLUTION; FEMUR; FEET; PROPORTIONS; LOCOMOTION	The discovery of a relatively complete Australopithecus sediba adult female skeleton permits a detailed locomotor analysis in which joint systems can be integrated to form a comprehensive picture of gait kinematics in this late australopith. Here we describe the lower limb anatomy of Au. sediba and hypothesize that this species walked with a fully extended leg and with an inverted foot during the swing phase of bipedal walking. Initial contact of the lateral foot with the ground resulted in a large pronatory torque around the joints of the foot that caused extreme medial weight transfer (hyperpronation) into the toe-off phase of the gait cycle (late pronation). These bipedal mechanics are different from those often reconstructed for other australopiths and suggest that there may have been several forms of bipedalism during the Plio-Pleistocene.	[DeSilva, Jeremy M.] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [DeSilva, Jeremy M.; Churchill, Steven E.; Carlson, Kristian J.; Zipfel, Bernhard; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Holt, Kenneth G.] Boston Univ, Dept Phys Therapy & Athlet Training, Sargent Coll, Boston, MA 02215 USA; [Churchill, Steven E.; Walker, Christopher S.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Zipfel, Bernhard] Univ Witwatersrand, Sch Geosci, Bernard Price Inst Palaeontol Res, ZA-2050 Johannesburg, South Africa	Boston University; University of Witwatersrand; Boston University; Duke University; Indiana University System; Indiana University Bloomington; University of Witwatersrand	DeSilva, JM (corresponding author), Boston Univ, Dept Anthropol, 232 Bay State Rd, Boston, MA 02215 USA.	jdesilva@bu.edu	Walker, Christopher/AAY-1966-2021; Churchill, Steven/AAA-9386-2022; Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629; Walker, Christopher/0000-0002-5173-2784; Zipfel, Bernhard/0000-0002-4251-884X	South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation; Evolutionary Studies Institute; University of the Witwatersrand; University of the Witwatersrand's Vice Chancellor's Discretionary Fund; National Geographic Society; Leakey Foundation; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; A. H. Schultz Foundation, Boston University; Duke University; Ray A. Rothrock '77 Fellowship; Texas AM University; Oppenheimer and Ackerman families	South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation(National Research Foundation - South Africa); Evolutionary Studies Institute; University of the Witwatersrand; University of the Witwatersrand's Vice Chancellor's Discretionary Fund; National Geographic Society(National Geographic Society); Leakey Foundation; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; A. H. Schultz Foundation, Boston University; Duke University; Ray A. Rothrock '77 Fellowship; Texas AM University; Oppenheimer and Ackerman families	We thank the South African Heritage Resource agency for the permits to work at the Malapa site; the Nash family for granting access to the Malapa site and continued support of research on their reserve; the South African Department of Science and Technology and the African Origins Platform (AOP), the South African National Research Foundation, the Evolutionary Studies Institute, the University of the Witwatersrand, the University of the Witwatersrand's Vice Chancellor's Discretionary Fund, the National Geographic Society, the Leakey Foundation, the Palaeontological Scientific Trust, the Andrew W. Mellon Foundation, the Ford Foundation, the U.S. Diplomatic Mission to South Africa, the French Embassy of South Africa, the A. H. Schultz Foundation, Boston University, Duke University, a Ray A. Rothrock '77 Fellowship and International Research Travel Assistance Grant of Texas A&M University, and the Oppenheimer and Ackerman families and Sir Richard Branson for funding; the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities; the Gauteng Government, Gauteng Department of Agriculture, Conservation and Environment and the Cradle of Humankind Management Authority; and our respective universities for ongoing support. We thank the VIP lab of the Palaeosciences Centre and the Microfocus X-ray CT facility of the Palaeosciences Centre at Wits; and for funding these facilities, we thank the University of the Witwatersrand Office of Research and the National Research Foundation Strategic Research Infrastructure Grant and AOP funding programs. For access to comparative specimens, we thank E. Mbua, P. Kiura, V. Iminjili, and the National Museums of Kenya; A. Kwekason, P. Msemwa, and the Tanzania Commission for Science and Technology; B. Billings, Fossil Primate Access Advisory and the School of Anatomical Sciences at the University of the Witwatersrand; S. Potze, L. C. Kgasi, and the Ditsong Museum; Y. Haile-Selassie, L. Jellema, and the Cleveland Museum of Natural History; J. Chupasko and the Harvard Museum of Comparative Zoology; D. Pilbeam, M. Morgan, O. Herschensohn, J. Rousseau, and the Harvard Museum of Archeology and Ethnology; E. Westwig and the American Museum of Natural History; M. Wolpoff and the Department of Anthropology at the University of Michigan; and O. Lovejoy (Kent State University). For technical and material support, we thank Duke University and the University of Zurich 2009 and 2010 Field Schools. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Other individuals who have given significant support to this project include B. de Klerk, W. Lawrence, C. Steininger, B. Kuhn, L. Pollarolo, J. Kretzen, D. Conforti, J. McCaffery, C. Dlamini, H. Visser, R. McCrae-Samuel, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, and M. Peltier. J. Smilg facilitated medical CT scanning of the specimens. The Au. sediba specimens are archived at the Evolutionary Studies Institute at the University of the Witwatersrand. All data used in this study are available upon request, including access to the original specimens, by bona fide scientists.	Aiello L, 1990, INTRO HUMAN EVOLUTIO; ASFAW B, 1985, AM J PHYS ANTHROPOL, V68, P535, DOI 10.1002/ajpa.1330680409; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; BENNETT MB, 1990, J ANAT, V171, P131; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; CLARK WEL, 1947, J ANAT, V81, P300; Crompton RH, 2012, J R SOC INTERFACE, V9, P707, DOI 10.1098/rsif.2011.0258; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; DeSilva JM, 2010, AM J PHYS ANTHROPOL, V141, P245, DOI 10.1002/ajpa.21140; Dugan J, 2009, J HUM EVOL, V57, P773, DOI 10.1016/j.jhevol.2009.07.006; Elftman H, 1935, AM J PHYS ANTHROPOL, V20, P69, DOI 10.1002/ajpa.1330200109; ENG JJ, 1993, PHYS THER, V73, P62, DOI 10.1093/ptj/73.2.62; GEBO DL, 1992, AM J PHYS ANTHROPOL, V89, P29, DOI 10.1002/ajpa.1330890105; Green DJ, 2007, J HUM EVOL, V52, P187, DOI 10.1016/j.jhevol.2006.09.001; Gross KD, 2007, ARTHRITIS RHEUM, V56, P2993, DOI 10.1002/art.22850; Haile-Selassie Y, 2012, NATURE, V483, P565, DOI 10.1038/nature10922; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; HEIPLE KG, 1971, AM J PHYS ANTHROPOL, V35, P75, DOI 10.1002/ajpa.1330350109; Holt K., 1995, REHABILITATION FOOT, P241; Irish JD, 2013, SCIENCE, V340, DOI 10.1126/science.1233062; Khamis S, 2007, GAIT POSTURE, V25, P127, DOI 10.1016/j.gaitpost.2006.02.005; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kirby KA, 2001, J AM PODIAT MED ASSN, V91, P465, DOI 10.7547/87507315-91-9-465; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; LATIMER B, 1990, AM J PHYS ANTHROPOL, V82, P125, DOI 10.1002/ajpa.1330820202; Lovejoy CO, 2007, GAIT POSTURE, V25, P325, DOI 10.1016/j.gaitpost.2006.05.001; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; McHenry HM, 1998, J HUM EVOL, V35, P1, DOI 10.1006/jhev.1997.0197; Michaud T. C., 2005, FUNCTIONAL SOFT TISS, P399; Organ JM, 2006, J HUM EVOL, V51, P113, DOI 10.1016/j.jhevol.2006.01.007; OUZOUNIAN TJ, 1989, FOOT ANKLE, V10, P140, DOI 10.1177/107110078901000305; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; POWERS CM, 1995, J ORTHOP SPORT PHYS, V22, P155, DOI 10.2519/jospt.1995.22.4.155; ROTHBART BA, 1988, J MANIP PHYSIOL THER, V11, P373; Schmid P, 2013, SCIENCE, V340, DOI 10.1126/science.1234598; Senut B., 1985, P193; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Tardieu C, 2006, AM J PHYS ANTHROPOL, V130, P491, DOI 10.1002/ajpa.20373; Tardieu C., 1981, PRIMATE EVOLUTIONARY, P68; Tardieu C, 2010, EVOL ANTHROPOL, V19, P174, DOI 10.1002/evan.20276; TIBERIO D, 1987, Journal of Orthopaedic and Sports Physical Therapy, V9, P160; Vereecke E, 2003, AM J PHYS ANTHROPOL, V120, P373, DOI 10.1002/ajpa.10163; WANNER JA, 1977, AM J PHYS ANTHROPOL, V47, P99, DOI 10.1002/ajpa.1330470117; Ward CV, 2011, SCIENCE, V331, P750, DOI 10.1126/science.1201463; Williams SA, 2013, SCIENCE, V340, DOI 10.1126/science.1232996; Wong L, 2008, J AM PODIAT MED ASSN, V98, P112, DOI 10.7547/0980112; Wunderlich R.E., 1999, THESIS STATE U NEW Y; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	51	96	98	1	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129							1232999	10.1126/science.1232999	http://dx.doi.org/10.1126/science.1232999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580534	Green Published			2022-12-28	WOS:000317341400003
J	Douglas, IJ; Langham, J; Bhaskaran, K; Brauer, R; Smeeth, L				Douglas, Ian J.; Langham, Julia; Bhaskaran, Krishnan; Brauer, Ruth; Smeeth, Liam			Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE	Objective To measure the association between orlistat and acute liver injury. Design Self controlled case series study. Setting Population based primary care setting, United Kingdom. Participants 94 695 patients receiving orlistat and registered in the UK Clinical Practice Research Datalink and linked with Hospital Episode Statistics data between 1999 and 2011. Main outcome measure Relative incidence of acute liver injury comparing periods when patients were receiving orlistat with periods of non-usage. Results Among 94 695 patients who received orlistat, 988 cases of acute liver injury were identified, with 335 confirmed as definite cases and 653 as probable cases. For all cases an increased incidence of liver injury was detected during the 90 day period before orlistat was first started, with an incidence rate ratio of 1.50 (95% confidence interval 1.10 to 2.06). The incidence remained raised during the first 30 days of treatment (2.21, 1.43 to 3.42), before returning to baseline levels with prolonged treatment. When the risk during the first 90 days of treatment was compared with the 90 days preceding first treatment, the incidence of liver injury was not increased (1.02, 0.67 to 1.56). An analysis restricted to definite cases showed no evidence of an increased risk of liver injury during treatment. Conclusion The incidence of acute liver injury was higher in the periods both immediately before and immediately after the start of orlistat treatment. This suggests that the observed increased risks of liver injury linked to the start of treatment may reflect changes in health status associated with the decision to begin treatment rather than any causal effect of the drug.	[Douglas, Ian J.; Langham, Julia; Bhaskaran, Krishnan; Brauer, Ruth; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Douglas, IJ (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	ian.douglas@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	Bhaskaran, Krishnan/0000-0001-5364-8757; Smeeth, Liam/0000-0002-9168-6022; Brauer, Ruth/0000-0001-8934-347X	Medical Research Council methodology fellowship; National Institute for Health Research postdoctoral fellowship; Wellcome Trust; MRC [G0802403] Funding Source: UKRI; Medical Research Council [MR/K006584/1, G0802403] Funding Source: researchfish; National Institute for Health Research [PDF-2011-04-007, NF-SI-0510-10090] Funding Source: researchfish	Medical Research Council methodology fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research postdoctoral fellowship(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available from the corresponding author) and declare: IJD is funded by a Medical Research Council methodology fellowship, KB is funded by a National Institute for Health Research postdoctoral fellowship, and LS is funded by a Wellcome Trust fellowship; IJD holds stock in GlaxoSmithKline and consults for GlaxoSmithKline, Takeda, and Gilead on topics not related to orlistat; LS consults for GlaxoSmithKline on topics not related to orlistat; and no other relationships or activities that could appear to have influenced the submitted work. The funders played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Diehl AM, 2010, GASTROENTEROL CLIN N, V39, P57, DOI 10.1016/j.gtc.2009.12.001; Food and Drug Administration, 2010, QUEST ANS ORL SEV LI; Food and Drug Administration, 2010, DRUG SAF COMM COMPL; Food and Drug Administration, 2009, ORL MARK ALL XEN EAR; Guerciolini R, 1997, INT J OBESITY, V21, pS12; Hospital Episode Statistics, 2012, HOSP EP STAT ONL; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; Morris M, 2012, OBESITY FACTS, V5, P485, DOI 10.1159/000341589; Office for National Statistics, 2000, SER MB6, V2, P149; Pratt NL, 2010, DRUG AGING, V27, P885, DOI 10.2165/11584490-000000000-00000; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342	13	39	42	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 12	2013	346								f1936	10.1136/bmj.f1936	http://dx.doi.org/10.1136/bmj.f1936			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126AB	23585064	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000317582400001
J	Feero, WG				Feero, W. Gregory			Genomics in Medicine Maturation, but Not Maturity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GENETIC ASSOCIATION; ALZHEIMER-DISEASE; ARTICLE; METAGENOMICS; MUTATIONS; OUTBREAK		[Feero, W. Gregory] Maine Dartmouth Family Med Residency, Augusta, ME USA		Feero, WG (corresponding author), Maine Dartmouth Family Med Residency, 4 Sheridan Dr,Ste 2, Fairfield, ME 04937 USA.	w.gregory.feero@mainegeneral.org						[Anonymous], 2013, JAMA-J AM MED ASSOC, V309, P1533, DOI [10.1001/jama.2013.2950, DOI 10.1001/JAMA.2013.2950]; [Anonymous], 2013, GEN HOM REF; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P74, DOI 10.1001/jama.2008.901; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P191, DOI 10.1001/jama.2008.946; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P304, DOI 10.1001/jama.2008.993; Cappola AR, 2013, JAMA-J AM MED ASSOC, V309, P1529, DOI 10.1001/jama.2013.3620; Chute CG, 2013, JAMA-J AM MED ASSOC, V309, P1467, DOI 10.1001/jama.2013.1414; Crotti L, 2013, JAMA-J AM MED ASSOC, V309, P1473, DOI 10.1001/jama.2013.3219; Feero WG, 2011, JAMA-J AM MED ASSOC, V306, P989, DOI 10.1001/jama.2011.1245; Ginsburg GS, 2013, JAMA-J AM MED ASSOC, V309, P1463, DOI 10.1001/jama.2013.1465; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Guttmacher AE, 2013, JAMA-J AM MED ASSOC, V309, P1525, DOI 10.1001/jama.2013.3373; Korf BR, 2013, JAMA-J AM MED ASSOC, V309, P1511, DOI 10.1001/jama.2013.3239; Loman NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/jama.2013.3231; McGuire AL, 2013, JAMA-J AM MED ASSOC, V309, P1465, DOI 10.1001/jama.2013.1438; National Human Genome Research Institute, 2013, TALK GLOSS GEN TERMS; National Human Genome Research Institute, SEQ COSTS DNA; National Human Genome Research Institute, 2003, INT CONS COMPL HUM G; Nussbaum RL, 2013, JAMA-J AM MED ASSOC, V309, P1527, DOI 10.1001/jama.2013.3507; Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973; Relman DA, 2013, JAMA-J AM MED ASSOC, V309, P1531, DOI 10.1001/jama.2013.3678; Shepardson NE, 2011, ARCH NEUROL-CHICAGO, V68, P1239, DOI 10.1001/archneurol.2011.203; Tuckson RV, 2013, JAMA-J AM MED ASSOC, V309, P1469, DOI 10.1001/jama.2013.1468; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190	24	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1522	1524		10.1001/jama.2013.3818	http://dx.doi.org/10.1001/jama.2013.3818			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571591				2022-12-28	WOS:000317271700030
J	Kamerow, D				Kamerow, Douglas			Science trumps politics on emergency contraception	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				[Anonymous], 2004, SCIENTIFIC INTEGRITY; Belluck Pam, 2013, NY TIMES        0917, pA1; Davidoff F, 2006, JAMA-J AM MED ASSOC, V296, P1775, DOI 10.1001/jama.296.14.1775; Editorial, 2013, NY TIMES, pA16; Kamerow D., 2011, VERY BAD PLAN SEBELI; Kamerow D., 2008, BMJ-BRIT MED J, V337, pa2093; Kliff S., 2013, WASHINGTON POST	7	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2013	346								f2217	10.1136/bmj.f2217	http://dx.doi.org/10.1136/bmj.f2217			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	125ZC	23571743				2022-12-28	WOS:000317579800008
J	Cornulier, T; Yoccoz, NG; Bretagnolle, V; Brommer, JE; Butet, A; Ecke, F; Elston, DA; Framstad, E; Henttonen, H; Hornfeldt, B; Huitu, O; Imholt, C; Ims, RA; Jacob, J; Jedrzejewska, B; Millon, A; Petty, SJ; Pietiainen, H; Tkadlec, E; Zub, K; Lambin, X				Cornulier, Thomas; Yoccoz, Nigel G.; Bretagnolle, Vincent; Brommer, Jon E.; Butet, Alain; Ecke, Frauke; Elston, David A.; Framstad, Erik; Henttonen, Heikki; Hornfeldt, Birger; Huitu, Otso; Imholt, Christian; Ims, Rolf A.; Jacob, Jens; Jedrzejewska, Bogumila; Millon, Alexandre; Petty, Steve J.; Pietiainen, Hannu; Tkadlec, Emil; Zub, Karol; Lambin, Xavier			Europe-Wide Dampening of Population Cycles in Keystone Herbivores	SCIENCE			English	Article							GREY-SIDED VOLE; DENSITY-DEPENDENCE; LEMMING CYCLES; MICROTUS-AGRESTIS; CLIMATE-CHANGE; DYNAMICS; COMPETITION; PREDATORS; OUTBREAKS; HOKKAIDO	Suggestions of collapse in small herbivore cycles since the 1980s have raised concerns about the loss of essential ecosystem functions. Whether such phenomena are general and result from extrinsic environmental changes or from intrinsic process stochasticity is currently unknown. Using a large compilation of time series of vole abundances, we demonstrate consistent cycle amplitude dampening associated with a reduction in winter population growth, although regulatory processes responsible for cyclicity have not been lost. The underlying syndrome of change throughout Europe and grass-eating vole species suggests a common climatic driver. Increasing intervals of low-amplitude small herbivore population fluctuations are expected in the future, and these may have cascading impacts on trophic webs across ecosystems.	[Cornulier, Thomas; Millon, Alexandre; Petty, Steve J.; Lambin, Xavier] Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 3TZ, Scotland; [Yoccoz, Nigel G.; Ims, Rolf A.] Univ Tromso, Dept Arctic & Marine Biol, N-9037 Tromso, Norway; [Bretagnolle, Vincent] CNRS, UPR 1934, Ctr Etud Biol Chize, F-79360 Beauvoir Sur Niort, France; [Brommer, Jon E.; Pietiainen, Hannu] Univ Helsinki, Dept Biosci, FI-00014 Helsinki, Finland; [Butet, Alain] Univ Rennes 1, UEB, UMR CNRS Ecobio 6553, Observ Sci Univ Rennes, F-35042 Rennes, France; [Ecke, Frauke; Hornfeldt, Birger] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Ecke, Frauke] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, S-75007 Uppsala, Sweden; [Elston, David A.] Biomath & Stat Scotland, Aberdeen AB15 8QH, Scotland; [Framstad, Erik] Norwegian Inst Nat Res, N-0349 Oslo, Norway; [Henttonen, Heikki] Finnish Forest Res Inst, Vantaa Unit, FI-01301 Vantaa, Finland; [Huitu, Otso] Finnish Forest Res Inst, Suonenjoki Unit, FI-77600 Suonenjoki, Finland; [Imholt, Christian; Jacob, Jens] Fed Res Ctr Cultivated Plants, Inst Plant Protect Hort & Forests, Julius Kuhn Inst, D-48161 Munster, Germany; [Jedrzejewska, Bogumila; Zub, Karol] Polish Acad Sci, Mammal Res Inst, PL-17230 Bialowieza, Poland; [Petty, Steve J.] Ctr Human & Ecol Sci, No Res Stn, Roslin EH25 9SY, Midlothian, Scotland; [Tkadlec, Emil] Palacky Univ Olomouc, Dept Ecol & Environm Sci, Olomouc 77146, Czech Republic; [Tkadlec, Emil] Acad Sci Czech Republic, Inst Vertebrate Biol, Prague 67502, Czech Republic	University of Aberdeen; UiT The Arctic University of Tromso; Centre National de la Recherche Scientifique (CNRS); University of Helsinki; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; James Hutton Institute; Norwegian Institute Nature Research; Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke); Julius Kuhn-Institut; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Palacky University Olomouc; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Lambin, X (corresponding author), Univ Aberdeen, Sch Biol Sci, Zool Bldg,Tillydrone Ave, Aberdeen AB24 3TZ, Scotland.	x.lambin@abdn.ac.uk	Millon, Alexandre/AAF-8624-2020; Zub, Karol/ABG-4802-2020; Cornulier, Thomas/AAC-9753-2022; Millon, Alexandre/R-6464-2017; Jacob, Jens/AAZ-7850-2020; Tkadlec, Emil/A-6230-2014; Jacob, Jens/C-2189-2013; Ecke, Frauke/AAW-6468-2021; Lambin, Xavier/E-8284-2011; Yoccoz, Nigel/C-8561-2014; Brommer, Jon E/C-3613-2008; Cornulier, Thomas/G-6841-2014; Elston, David A/H-8199-2013	Millon, Alexandre/0000-0002-9475-4123; Zub, Karol/0000-0001-7235-2206; Millon, Alexandre/0000-0002-9475-4123; Jacob, Jens/0000-0002-5136-6606; Ecke, Frauke/0000-0003-4208-345X; Lambin, Xavier/0000-0003-4643-2653; Yoccoz, Nigel/0000-0003-2192-1039; Brommer, Jon E/0000-0002-2435-2612; Cornulier, Thomas/0000-0003-2738-4801; Tkadlec, Emil/0000-0003-3782-8867	Natural Environment Research Council; Research Council of Norway; Agence Nationale de la Recherche; Scottish Government; Natural Environment Research Council [NE/G002045/1] Funding Source: researchfish; NERC [NE/G002045/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Research Council of Norway(Research Council of Norway); Agence Nationale de la Recherche(French National Research Agency (ANR)); Scottish Government; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by the national funders Natural Environment Research Council, Research Council of Norway, and Agence Nationale de la Recherche, part of the 2008 ERA-Net BiodivERsA call for research proposals. D. A. E. was funded by the Scottish Government. We thank R. B. O'Hara and F. Barraquand for useful methodological inputs and all the contributors to vole sampling over decades. General correspondence should be addressed to X. L. and specific requests to T. C. (cornulier@abdn.ac.uk). Raw data are available in supplementary text section IX). Authors declare no conflicts of interest. A. B., B. H., B.J., C. I., E. F., E. T., F. E., H. H., H. P., J.E.B., J.J., K.Z., O.H., S.J.P., V. B., and X. L. led the data collection; T. C., N.G.Y., R. A. I., A. M., and X. L. conceived the ideas for the paper and its structure; T. C., N.G.Y., D. A. E., and X. L. designed the analyses; T. C. and X. L. wrote the manuscript; and all authors discussed the results and commented on the manuscript.	Bell JR, 2012, ECOL LETT, V15, P310, DOI 10.1111/j.1461-0248.2011.01739.x; Bety J, 2002, J ANIM ECOL, V71, P88, DOI 10.1046/j.0021-8790.2001.00581.x; Bierman SM, 2006, AM NAT, V167, P583, DOI 10.1086/501076; Brommer JE, 2010, GLOBAL CHANGE BIOL, V16, P577, DOI 10.1111/j.1365-2486.2009.02012.x; Ecke F, 2006, LANDSCAPE ECOL, V21, P485, DOI 10.1007/s10980-005-2376-y; Fleming RA, 2002, ECOL MODEL, V149, P127, DOI 10.1016/S0304-3800(01)00519-1; Hansen TF, 1999, AM NAT, V154, P129, DOI 10.1086/303229; Hansen TF, 1999, P NATL ACAD SCI USA, V96, P986, DOI 10.1073/pnas.96.3.986; Hanski I, 1996, J ANIM ECOL, V65, P220, DOI 10.2307/5725; HANSSON L, 1983, OIKOS, V40, P258, DOI 10.2307/3544590; Hornfeldt B, 2004, OIKOS, V107, P376, DOI 10.1111/j.0030-1299.2004.13348.x; Hornfeldt B, 2005, P ROY SOC B-BIOL SCI, V272, P2045, DOI 10.1098/rspb.2005.3141; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Ims RA, 2011, P NATL ACAD SCI USA, V108, P1970, DOI 10.1073/pnas.1012714108; Johnson DM, 2010, P NATL ACAD SCI USA, V107, P20576, DOI 10.1073/pnas.1010270107; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Korslund L, 2006, J ANIM ECOL, V75, P156, DOI 10.1111/j.1365-2656.2005.01031.x; Olofsson J, 2012, NAT CLIM CHANGE, V2, P880, DOI 10.1038/NCLIMATE1537; Royama T., 1992, ANAL POPULATION DYNA, P55; Saitoh T, 2006, CLIM RES, V32, P109, DOI 10.3354/cr032109; Schmidt NM, 2012, P ROY SOC B-BIOL SCI, V279, P4417, DOI 10.1098/rspb.2012.1490; Smith MJ, 2006, AM NAT, V167, P695, DOI 10.1086/503119; Stenseth NC, 1999, OIKOS, V87, P427, DOI 10.2307/3546809; Stenseth NC, 2003, P NATL ACAD SCI USA, V100, P11478, DOI 10.1073/pnas.1935306100; Stenseth NC, 2003, FRONT ECOL ENVIRON, V1, P367, DOI 10.2307/3868189; Strann KB, 2002, ECOGRAPHY, V25, P81, DOI 10.1034/j.1600-0587.2002.250109.x; Summers RW, 1998, ECOGRAPHY, V21, P573, DOI 10.1111/j.1600-0587.1998.tb00549.x; Turchin P, 2000, NATURE, V405, P562, DOI 10.1038/35014595	29	185	193	3	329	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					63	66		10.1126/science.1228992	http://dx.doi.org/10.1126/science.1228992			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559246				2022-12-28	WOS:000317061100044
J	Mignot, E				Mignot, Emmanuel			The Perfect Hypnotic?	SCIENCE			English	Editorial Material							OREXIN RECEPTOR ANTAGONISM; CLINICAL-TRIAL; SLEEP; INSOMNIA; ALMOREXANT; NARCOLEPSY; PEPTIDES		Stanford Univ, Ctr Sleep Sci, Palo Alto, CA 94304 USA	Stanford University	Mignot, E (corresponding author), Stanford Univ, Ctr Sleep Sci, Palo Alto, CA 94304 USA.	mignot@stanford.edu						Black SW, 2013, SLEEP, V36, P325, DOI 10.5665/sleep.2442; Born J, 2012, NEURON, V75, P933, DOI 10.1016/j.neuron.2012.09.007; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Drake CL, 2003, DEPRESS ANXIETY, V18, P163, DOI 10.1002/da.10151; Herring WJ, 2012, NEUROLOGY, V79, P2265, DOI 10.1212/WNL.0b013e31827688ee; Hoever P, 2012, CLIN PHARMACOL THER, V91, P975, DOI 10.1038/clpt.2011.370; Hoever P, 2012, J PSYCHOPHARMACOL, V26, P1071, DOI 10.1177/0269881112448946; Nishino S., 2013, ESSENTIALS CLIN PHAR, P531; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Uslaner JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005213; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570	15	11	11	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					36	38		10.1126/science.1237998	http://dx.doi.org/10.1126/science.1237998			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559238				2022-12-28	WOS:000317061100034
J	Fawdry, R				Fawdry, Rupert			Paperless records are not in the best interest of every patient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hosp Coventry & Warwickshire NHS Trust, Univ Hosp, Coventry CV2 2DX, W Midlands, England	University of Warwick	Fawdry, R (corresponding author), Univ Hosp Coventry & Warwickshire NHS Trust, Univ Hosp, Clifford Bridge Rd, Coventry CV2 2DX, W Midlands, England.	rupertfawdry@gmail.com						Academy of Medical Royal Colleges, STAND DES HOSP IN PA; Alufa O., 2012, RBS SANTANDER DEAL C; Bewley S, 2011, BRIT MED J, V343, pd6484; Davies P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4905; Department of Health, 2012, POW INF PUTT ALL US; Fawdry R., 2013, BJHC            0129; Fawdry R, 2011, J ROY SOC MED, V104, P405, DOI 10.1258/jrsm.2011.110153; Limb M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6888; United States Copyright Office, 2012, 32 US COP OFF	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2013	346								f2064	10.1136/bmj.f2064	http://dx.doi.org/10.1136/bmj.f2064			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122SG	23553881				2022-12-28	WOS:000317337800016
J	Waksman, R; Barbash, IM				Waksman, Ron; Barbash, Israel M.			Radial access as a default for PCI: too early to call	LANCET			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; ANGIOGRAPHY; ARTERY		[Waksman, Ron; Barbash, Israel M.] MedStar Washington Hosp Ctr, Dept Internal Med, Div Cardiol, Washington, DC 20010 USA	MedStar Washington Hospital Center	Waksman, R (corresponding author), MedStar Washington Hosp Ctr, Dept Internal Med, Div Cardiol, Washington, DC 20010 USA.	ron.waksman@medstar.net						Bertrand OF, 2012, AM HEART J, V163, P632, DOI 10.1016/j.ahj.2012.01.015; Caputo RP, 2011, CATHETER CARDIO INTE, V78, P823, DOI 10.1002/ccd.23052; Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966; Hamon M, 2013, EUROINTERVENTION; Hildick-Smith DJR, 1998, INT J CARDIOL, V64, P231, DOI 10.1016/S0167-5273(98)00074-6; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Lo TS, 2009, HEART, V95, P410, DOI 10.1136/hrt.2008.150474; Romagnoli E, 2012, J AM COLL CARDIOL, V60, P2481, DOI 10.1016/j.jacc.2012.06.017; Verheugt FWA, 2011, JACC-CARDIOVASC INTE, V4, P191, DOI 10.1016/j.jcin.2010.10.011	9	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 7	2013	382	9895					841	842		10.1016/S0140-6736(13)60675-3	http://dx.doi.org/10.1016/S0140-6736(13)60675-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215WE	23594386				2022-12-28	WOS:000324240700009
J	Racoosin, JA; Roberson, DW; Pacanowski, MA; Nielsen, DR				Racoosin, Judith A.; Roberson, David W.; Pacanowski, Michael A.; Nielsen, David R.			New Evidence about an Old Drug - Risk with Codeine after Adenotonsillectomy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHILDREN; TONSILLECTOMY		[Racoosin, Judith A.; Pacanowski, Michael A.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Roberson, David W.; Nielsen, David R.] Amer Acad Otolaryngol Head & Neck Surg, Alexandria, VA USA; [Roberson, David W.] Boston Childrens Hosp, Dept Otolaryngol, Boston, MA USA; [Roberson, David W.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA	US Food & Drug Administration (FDA); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Racoosin, JA (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; Brown KA, 2006, ANESTHESIOLOGY, V105, P665, DOI 10.1097/00000542-200610000-00009; Crews KR, 2012, CLIN PHARMACOL THER, V91, P321, DOI 10.1038/clpt.2011.287; Davies L, LARYNGOSCOP IN PRESS; Kelly LE, 2012, PEDIATRICS, V129, pE1343, DOI 10.1542/peds.2011-2538	5	52	54	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2013	368	23					2155	2157		10.1056/NEJMp1302454	http://dx.doi.org/10.1056/NEJMp1302454			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DN	23614474				2022-12-28	WOS:000319948900003
J	Kellermann, AL; Peleg, K				Kellermann, Arthur L.; Peleg, Kobi			Lessons from Boston	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kellermann, Arthur L.] RAND Corp, Arlington, VA USA; [Peleg, Kobi] Tel Aviv Univ, Natl Ctr Trauma & Emergency Med Res, Disaster Med Dept, IL-69978 Tel Aviv, Israel	RAND Corporation; Tel Aviv University	Kellermann, AL (corresponding author), RAND Corp, Arlington, VA USA.							Gawande A., 2013, NEW YORKER; Golan R, 2013, INJURY; Peleg K, 2009, JAMA-J AM MED ASSOC, V302, P565, DOI 10.1001/jama.2009.1119; Smith JF, 2009, BOSTON GLOBE	4	46	50	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1956	1957		10.1056/NEJMp1305304	http://dx.doi.org/10.1056/NEJMp1305304			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194KD	23614472				2022-12-28	WOS:000322630700003
J	Gao, RB; Cao, B; Hu, YW; Feng, ZJ; Wang, DY; Hu, WF; Chen, J; Jie, ZJ; Qiu, HB; Xu, K; Xu, XW; Lu, HZ; Zhu, WF; Gao, ZC; Xiang, NJ; Shen, YZ; He, ZB; Gu, Y; Zhang, ZY; Yang, Y; Zhao, X; Zhou, L; Li, XD; Zou, SM; Zhang, Y; Li, XY; Yang, L; Guo, JF; Dong, J; Li, Q; Dong, LB; Zhu, Y; Bai, T; Wang, SW; Hao, P; Yang, WZ; Zhang, YP; Han, J; Yu, HJ; Li, DX; Gao, GF; Wu, GZ; Wang, Y; Yuan, ZH; Shu, YL				Gao, Rongbao; Cao, Bin; Hu, Yunwen; Feng, Zijian; Wang, Dayan; Hu, Wanfu; Chen, Jian; Jie, Zhijun; Qiu, Haibo; Xu, Ke; Xu, Xuewei; Lu, Hongzhou; Zhu, Wenfei; Gao, Zhancheng; Xiang, Nijuan; Shen, Yinzhong; He, Zebao; Gu, Yong; Zhang, Zhiyong; Yang, Yi; Zhao, Xiang; Zhou, Lei; Li, Xiaodan; Zou, Shumei; Zhang, Ye; Li, Xiyan; Yang, Lei; Guo, Junfeng; Dong, Jie; Li, Qun; Dong, Libo; Zhu, Yun; Bai, Tian; Wang, Shiwen; Hao, Pei; Yang, Weizhong; Zhang, Yanping; Han, Jun; Yu, Hongjie; Li, Dexin; Gao, George F.; Wu, Guizhen; Wang, Yu; Yuan, Zhenghong; Shu, Yuelong			Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRITISH-COLUMBIA; H5N1; TRANSMISSION; HEMAGGLUTININ; CHICKENS; OUTBREAK; FERRETS	BACKGROUND Infection of poultry with influenza A subtype H7 viruses occurs worldwide, but the introduction of this subtype to humans in Asia has not been observed previously. In March 2013, three urban residents of Shanghai or Anhui, China, presented with rapidly progressing lower respiratory tract infections and were found to be infected with a novel reassortant avian-origin influenza A (H7N9) virus. METHODS We obtained and analyzed clinical, epidemiologic, and virologic data from these patients. Respiratory specimens were tested for influenza and other respiratory viruses by means of real-time reverse-transcriptase-polymerase-chain-reaction assays, viral culturing, and sequence analyses. RESULTS A novel reassortant avian-origin influenza A (H7N9) virus was isolated from respiratory specimens obtained from all three patients and was identified as H7N9. Sequencing analyses revealed that all the genes from these three viruses were of avian origin, with six internal genes from avian influenza A (H9N2) viruses. Substitution Q226L (H3 numbering) at the 210-loop in the hemagglutinin (HA) gene was found in the A/Anhui/1/2013 and A/Shanghai/2/2013 virus but not in the A/Shanghai/1/2013 virus. A T160A mutation was identified at the 150-loop in the HA gene of all three viruses. A deletion of five amino acids in the neuraminidase (NA) stalk region was found in all three viruses. All three patients presented with fever, cough, and dyspnea. Two of the patients had a history of recent exposure to poultry. Chest radiography revealed diffuse opacities and consolidation. Complications included acute respiratory distress syndrome and multiorgan failure. All three patients died. CONCLUSIONS Novel reassortant H7N9 viruses were associated with severe and fatal respiratory disease in three patients. (Funded by the National Basic Research Program of China and others.)	[Gao, Rongbao; Wang, Dayan; Zhu, Wenfei; Zhao, Xiang; Li, Xiaodan; Zou, Shumei; Zhang, Ye; Li, Xiyan; Yang, Lei; Guo, Junfeng; Dong, Jie; Dong, Libo; Zhu, Yun; Bai, Tian; Wang, Shiwen; Han, Jun; Li, Dexin; Wu, Guizhen] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Cao, Bin] Capital Med Univ, Beijing Inst Resp Dis, Beijing Chao Yang Hosp, Beijing, Peoples R China; [Feng, Zijian; Xiang, Nijuan; Zhou, Lei; Li, Qun; Yang, Weizhong; Zhang, Yanping; Yu, Hongjie; Gao, George F.; Wang, Yu] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Gao, Zhancheng] Peking Univ Peoples Hosp, Beijing, Peoples R China; [Hu, Yunwen; Lu, Hongzhou; Zhang, Zhiyong; Yuan, Zhenghong] Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200032, Peoples R China; [Chen, Jian] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Jie, Zhijun; He, Zebao; Gu, Yong] Fudan Univ, Peoples Hosp Shanghai 5, Shanghai 200032, Peoples R China; [Hao, Pei] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Hu, Wanfu] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Qiu, Haibo; Yang, Yi] Southeast Univ, Zhongda Hosp, Nanjing, Jiangsu, Peoples R China; [Xu, Ke] Jiangsu Prov Ctr Dis Prevent & Control, Nanjing, Jiangsu, Peoples R China; [Xu, Xuewei] Chuzhou Ctr Dis Control & Prevent, Chuzhou, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University; Chinese Center for Disease Control & Prevention; Peking University; Fudan University; Shanghai Center for Disease Control & Prevention; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Southeast University - China	Shu, YL (corresponding author), Natl Hlth & Family Planning Commiss, Key Lab Med Virol, Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, 155 Changbai Rd, Beijing 102206, Peoples R China.	zhyuan@shmu.edu.cn; yshu@cnic.org.cn	Lang, Ming/HIK-0758-2022; Gao, George Fu/ABD-5229-2021; yang, yang/GVT-5210-2022; Qiu, Haibo/AAS-9047-2021; Yang, Lei/GSD-3834-2022; yang, yang/HGT-7999-2022; Yu, Hongjie/GZK-5351-2022	Qiu, Haibo/0000-0001-8589-4717; Hao, Pei/0000-0002-1498-7059	National Basic Research Program of China; National Basic Research Program (973) of China [2011CB504704]; National Natural Science Foundation of China [81070005/H0104, 81030032/H19]; China National Mega-projects for Infectious Diseases [2012ZX10004-211, 2013ZX10004-101]; Chinese National Influenza Center-Centers for Disease Control and Prevention (CDC) from the CDC China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases [5U51IP000334-03]; National Center for Immunization and Respiratory Diseases (NCIRD) [U51IP000334] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Mega-projects for Infectious Diseases; Chinese National Influenza Center-Centers for Disease Control and Prevention (CDC) from the CDC China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases; National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funded by the National Basic Research Program of China and others.; Supported by a grant (2011CB504704) from the National Basic Research Program (973) of China, grants (81070005/H0104 and 81030032/H19) from the National Natural Science Foundation of China, grants from the China National Mega-projects for Infectious Diseases (2012ZX10004-211 to Dr. Yuan and 2013ZX10004-101 to Dr. Dexin Li), and the Chinese National Influenza Center-Centers for Disease Control and Prevention (CDC) collaborative project 5U51IP000334-03 from the CDC China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases.	[Anonymous], 2007, EURO SURVEILL, V12; Arzey GG, 2012, EMERG INFECT DIS, V18, P814, DOI 10.3201/eid1805.111852; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; D'Silva D, 2009, PEDIATR INFECT DIS J, V28, P1138, DOI 10.1097/INF.0b013e3181c03cf2; Ekstrand JJ, 2012, SEMIN PEDIATR NEUROL, V19, P96, DOI 10.1016/j.spen.2012.02.004; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Ito T, 2000, VET MICROBIOL, V74, P71, DOI 10.1016/S0378-1135(00)00167-X; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Kwon TY, 2011, VET MICROBIOL, V153, P393, DOI 10.1016/j.vetmic.2011.06.011; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Li JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014722; Nguyen-Van-Tam JS, 2006, EUROSURVEILLANCE, V11; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sorrell EM, 2010, J VIROL, V84, P11831, DOI 10.1128/JVI.01460-10; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	25	1805	2122	22	1040	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1888	1897		10.1056/NEJMoa1304459	http://dx.doi.org/10.1056/NEJMoa1304459			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143VK	23577628	Green Published			2022-12-28	WOS:000318896200008
J	Chang, HM; Triboulet, R; Thornton, JE; Gregory, RI				Chang, Hao-Ming; Triboulet, Robinson; Thornton, James E.; Gregory, Richard I.			A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway	NATURE			English	Article							MICRORNA BIOGENESIS; RNA DEGRADATION; 3' URIDYLATION; MESSENGER-RNA; LET-7; EXOSOME; EXPRESSION; MATURATION; RECRUITS; ZCCHC11	The pluripotency factor Lin28 blocks the expression of let-7 microRNAs in undifferentiated cells during development, and functions as an oncogene in a subset of cancers(1). Lin28 binds to let-7 precursor (pre-let-7) RNAs and recruits 39 terminal uridylyl transferases to selectively inhibit let-7 biogenesis(2-4). Uridylated pre-let-7 is refractory to processing by Dicer, and is rapidly degraded by an unknown RNase(5). Here we identify Dis3l2 as the 3'-5' exonuclease responsible for the decay of uridylated pre-let-7 in mouse embryonic stem cells. Biochemical reconstitution assays show that 3' oligouridylation stimulates Dis3l2 activity in vitro, and knockdown of Dis3l2 in mouse embryonic stem cells leads to the stabilization of pre-let-7. Our study establishes 3' oligouridylation as an RNA decay signal for Dis3l2, and identifies the first physiological RNA substrate of this new exonuclease, which is mutated in the Perlman syndrome of fetal overgrowth and causes a predisposition to Wilms' tumour development(6).	[Chang, Hao-Ming; Triboulet, Robinson; Thornton, James E.; Gregory, Richard I.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Chang, Hao-Ming; Triboulet, Robinson; Thornton, James E.; Gregory, Richard I.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Chang, Hao-Ming; Triboulet, Robinson; Thornton, James E.; Gregory, Richard I.] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Gregory, RI (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.	rgregory@enders.tch.harvard.edu			US National Institute of General Medical Sciences (NIGMS) [R01GM086386]; American Cancer Society [121635-RSG-11-175-01-RMC]; National Science Foundation; Boston Children's Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086386] Funding Source: NIH RePORTER	US National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); Boston Children's Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. LaPierre for technical assistance and F.-L. Meng for Rrp44 and Exosc10 shRNA. Thanks to the Children's Hospital Boston/IDDRC Proteomics Core for mass spectrometry. R. I. G. was supported by grants from the US National Institute of General Medical Sciences (NIGMS) (R01GM086386) and The American Cancer Society (121635-RSG-11-175-01-RMC). J.E.T. was supported by a pre-doctoral fellowship from the National Science Foundation. R. T. was supported by the Wolbach fellowship from Boston Children's Hospital.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Astuti D, 2012, NAT GENET, V44, P277, DOI 10.1038/ng.1071; Chang HM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1909; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Malecki M, 2013, EMBO J, V32, P1842, DOI 10.1038/emboj.2013.63; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Norbury CJ, 2010, BIOCHEM SOC T, V38, P1150, DOI 10.1042/BST0381150; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Renard BY, 2009, PROTEOMICS, V9, P4978, DOI 10.1002/pmic.200900326; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Staals RHJ, 2010, EMBO J, V29, P2358, DOI 10.1038/emboj.2010.122; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	30	230	237	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					244	+		10.1038/nature12119	http://dx.doi.org/10.1038/nature12119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23594738	Green Submitted, Green Accepted			2022-12-28	WOS:000318558200037
J	Koh, H; Tavenner, M				Koh, Howard; Tavenner, Marilyn			Connecting to Health Insurance Coverage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AFFORDABLE CARE ACT		[Koh, Howard] US Dept HHS, Washington, DC 20201 USA; [Tavenner, Marilyn] US Dept HHS, Ctr Medicare Serv, Washington, DC 20201 USA; [Tavenner, Marilyn] US Dept HHS, Ctr Medicaid Serv, Washington, DC 20201 USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Koh, H (corresponding author), US Dept HHS, 200 Independence Ave SW,Ste 716-G, Washington, DC 20201 USA.	howard.koh@hhs.gov						Institute of Medicine, 2002, CAR COV TOO LITTL TO; Institute of Medicine Committee on Health Insurance Status and Its Consequences, 2009, AM UN CRIS CONS HLTH; Koh HK, 2010, NEW ENGL J MED, V363, P1296, DOI 10.1056/NEJMp1008560; Sommers BD, 2012, JAMA-J AM MED ASSOC, V307, P913, DOI 10.1001/jama.307.9.913; Weil A, 2012, NEW ENGL J MED, V366, P679, DOI 10.1056/NEJMp1200693	5	5	5	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2013	309	18					1893	1894		10.1001/jama.2013.3469	http://dx.doi.org/10.1001/jama.2013.3469			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138AZ	23588385				2022-12-28	WOS:000318481900020
J	Woolf, SH; Campos-Outcalt, D				Woolf, Steven H.; Campos-Outcalt, Doug			Severing the Link Between Coverage Policy and the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Woolf, Steven H.] Virginia Commonwealth Univ, Dept Family Med & Populat Hlth, Richmond, VA 23298 USA; [Campos-Outcalt, Doug] Univ Arizona, Coll Med, Dept Family Community & Prevent Med, Phoenix, AZ USA	Virginia Commonwealth University; University of Arizona	Woolf, SH (corresponding author), Virginia Commonwealth Univ, West Hosp, Dept Family Med & Populat Hlth, 1200 E Broad St,POB 980251, Richmond, VA 23298 USA.	swoolf@vcu.edu						[Anonymous], 2011, CLIN PREV SERV WOM C; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Hinman AR, 2005, AM J PREV MED, V29, P71, DOI 10.1016/j.amepre.2005.03.005; McKee M, 2003, EUR J PUBLIC HEALTH, V13, P289, DOI 10.1093/eurpub/13.4.289; Sackett D. L., 1997, EVIDENCE BASED MED P; Solanki G, 1999, AM J PREV MED, V17, P127, DOI 10.1016/S0749-3797(99)00057-4; Woolf SH, 1996, ANNU REV PUBL HEALTH, V17, P511, DOI 10.1146/annurev.pu.17.050196.002455	7	13	13	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2013	309	18					1899	1900		10.1001/jama.2013.3448	http://dx.doi.org/10.1001/jama.2013.3448			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138AZ	23598788				2022-12-28	WOS:000318481900023
J	Shukla, AK; Manglik, A; Kruse, AC; Xiao, KH; Reis, RI; Tseng, WC; Staus, DP; Hilger, D; Uysal, S; Huang, LY; Paduch, M; Tripathi-Shukla, P; Koide, A; Koide, S; Weis, WI; Kossiakoff, AA; Kobilka, BK; Lefkowitz, RJ				Shukla, Arun K.; Manglik, Aashish; Kruse, Andrew C.; Xiao, Kunhong; Reis, Rosana I.; Tseng, Wei-Chou; Staus, Dean P.; Hilger, Daniel; Uysal, Serdar; Huang, Li-Yin; Paduch, Marcin; Tripathi-Shukla, Prachi; Koide, Akiko; Koide, Shohei; Weis, William I.; Kossiakoff, Anthony A.; Kobilka, Brian K.; Lefkowitz, Robert J.			Structure of active beta-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide	NATURE			English	Article							CRYSTAL-STRUCTURE; BETA-ARRESTIN; TERNARY COMPLEX; LIGAND-BINDING; CONFORMATION; STATE; ENDOCYTOSIS; MECHANISM; DOMAIN	The functions of G-protein-coupled receptors (GPCRs) are primarily mediated and modulated by three families of proteins: the heterotrimeric G proteins, the G-protein-coupled receptor kinases (GRKs) and the arrestins(1). G proteins mediate activation of second-messenger-generating enzymes and other effectors, GRKs phosphorylate activated receptors(2), and arrestins subsequently bind phosphorylated receptors and cause receptor desensitization(3). Arrestins activated by interaction with phosphorylated receptors can also mediate G-protein-independent signalling by serving as adaptors to link receptors to numerous signalling pathways(4). Despite their central role in regulation and signalling of GPCRs, a structural understanding of beta-arrestin activation and interaction with GPCRs is still lacking. Here we report the crystal structure of beta-arrestin-1 (also called arrestin-2) in complex with a fully phosphorylated 29-amino-acid carboxy-terminal peptide derived from the human V2 vasopressin receptor (V2Rpp). This peptide has previously been shown to functionally and conformationally activate beta-arrestin-1 (ref. 5). To capture this active conformation, we used a conformationally selective synthetic antibody fragment (Fab30) that recognizes the phosphopeptide-activated state of beta-arrestin-1. The structure of the beta-arrestin-1-V2Rpp-Fab30 complex shows marked conformational differences in beta-arrestin-1 compared to its inactive conformation. These include rotation of the amino- and carboxy-terminal domains relative to each other, and a major reorientation of the 'lariat loop' implicated in maintaining the inactive state of beta-arrestin-1. These results reveal, at high resolution, a receptor-interacting interface on beta-arrestin, and they indicate a potentially general molecular mechanism for activation of these multifunctional signalling and regulatory proteins.	[Shukla, Arun K.; Xiao, Kunhong; Reis, Rosana I.; Tseng, Wei-Chou; Staus, Dean P.; Huang, Li-Yin; Tripathi-Shukla, Prachi; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Manglik, Aashish; Kruse, Andrew C.; Hilger, Daniel; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Uysal, Serdar; Paduch, Marcin; Koide, Akiko; Koide, Shohei; Kossiakoff, Anthony A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27706 USA	Duke University; Stanford University; University of Chicago; Stanford University; Duke University; Howard Hughes Medical Institute; Duke University	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	kobilka@stanford.edu; lefko001@receptor-biol.duke.edu	Weis, William I/G-1437-2011; Xiao, Kunhong/AAG-4275-2020; Lefkowitz, Robert/AAW-2649-2021; Hilger, Daniel/C-7297-2019; dos Reis, Rosana Maria/E-3346-2012	Weis, William I/0000-0002-5583-6150; Xiao, Kunhong/0000-0002-1069-1226; Hilger, Daniel/0000-0001-5179-1357; shukla, arun/0000-0003-2910-8288; Kobilka, Brian/0000-0001-5958-3990; Koide, Shohei/0000-0001-5473-4358; dos Reis, Rosana Maria/0000-0001-9631-4167; Reis, Rosana/0000-0002-0465-8331	Stanford Medical Scientist Training Program; American Heart Association; National Science Foundation; National Institutes of Health [NS028471, HL16037, HL70631, GM072688, GM087519, HL 075443]; Mathers Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, R37HL016037, R01HL016037, P01HL075443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072688, U54GM074946, U01GM094588, U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	Stanford Medical Scientist Training Program; American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Capel for technical assistance and V. Ronk, D. Addison and Q. Lennon for administrative and secretarial support. We thank S. Ahn and L. Wingler for critical reading of the manuscript. We acknowledge support from the Stanford Medical Scientist Training Program and the American Heart Association (A. M.), from the National Science Foundation (A. C. K.), from the National Institutes of Health Grants NS028471 (B. K. K.), HL16037 and HL70631 (R.J.L.), GM072688 and GM087519 (A. A. K. and S. K.), HL 075443 (K. X.) and from the Mathers Foundation (B. K. K. and W. I. W.). R. I. R is supported by a post-doctoral fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES. R.J.L. is an investigator with the Howard Hughes Medical Institute.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P15334; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rizk SS, 2011, NAT STRUCT MOL BIOL, V18, P437, DOI 10.1038/nsmb.2002; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Sommer ME, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2000; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	38	275	280	2	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					137	+		10.1038/nature12120	http://dx.doi.org/10.1038/nature12120			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23604254	Green Accepted, Green Submitted			2022-12-28	WOS:000318221500049
J	Schwarz, FW; Toth, J; van Aelst, K; Cui, GS; Clausing, S; Szczelkun, MD; Seidel, R				Schwarz, Friedrich W.; Toth, Julia; van Aelst, Kara; Cui, Guanshen; Clausing, Sylvia; Szczelkun, Mark D.; Seidel, Ralf			The Helicase-Like Domains of Type III Restriction Enzymes Trigger Long-Range Diffusion Along DNA	SCIENCE			English	Article							TRANSLOCATION; RECOGNITION; MECHANISM; DISSOCIATION; FILAMENTS; TRACKING; INSIGHTS; SITES; HEAD; MUTS	Helicases are ubiquitous adenosine triphosphatases (ATPases) with widespread roles in genome metabolism. Here, we report a previously undescribed functionality for ATPases with helicase-like domains; namely, that ATP hydrolysis can trigger ATP-independent long-range protein diffusion on DNA in one dimension (1D). Specifically, using single-molecule fluorescence microscopy we show that the Type III restriction enzyme EcoP15I uses its ATPase to switch into a distinct structural state that diffuses on DNA over long distances and long times. The switching occurs only upon binding to the target site and requires hydrolysis of similar to 30 ATPs. We define the mechanism for these enzymes and show how ATPase activity is involved in DNA target site verification and 1D signaling, roles that are common in DNA metabolism: for example, in nucleotide excision and mismatch repair.	[Schwarz, Friedrich W.; Clausing, Sylvia; Seidel, Ralf] Tech Univ Dresden, Ctr Biotechnol, DNA Motors Grp, D-01062 Dresden, Germany; [Toth, Julia; van Aelst, Kara; Cui, Guanshen; Szczelkun, Mark D.] Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Bristol BS8 1TD, Avon, England; [Seidel, Ralf] Univ Munster, Inst Mol & Cell Biol, D-48149 Munster, Germany	Technische Universitat Dresden; University of Bristol; University of Munster	Szczelkun, MD (corresponding author), Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	mark.szczelkun@bristol.ac.uk; ralf.seidel@uni-muenster.de	Seidel, Ralf/A-6531-2010	Seidel, Ralf/0000-0002-6642-053X; Szczelkun, Mark/0000-0002-2501-6602	Wellcome Trust [084086]; Deutsche Forschungsgemeinschaft (DFG) [SE 1646/1-1, SE 1646/7-1]; European Research Council [261224]; Dresden International Graduate School for Biomedicine and Bioengineering; DFG	Wellcome Trust(Wellcome Trust); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Dresden International Graduate School for Biomedicine and Bioengineering; DFG(German Research Foundation (DFG))	This work was supported by The Wellcome Trust (084086), the Deutsche Forschungsgemeinschaft (DFG, SE 1646/1-1, SE 1646/7-1), a starting grant of the European Research Council (261224), and the Dresden International Graduate School for Biomedicine and Bioengineering, funded by the DFG (to F.W.S.). We thank N. Savery and S. Halford for comments on the manuscript. The authors declare no conflict of interest.	Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Brutzer H, 2012, NANO LETT, V12, P473, DOI 10.1021/nl203876w; Cho WK, 2012, STRUCTURE, V20, P1264, DOI 10.1016/j.str.2012.04.017; Crampton N, 2007, EMBO J, V26, P3815, DOI 10.1038/sj.emboj.7601807; Dryden DTF, 2001, NUCLEIC ACIDS RES, V29, P3728, DOI 10.1093/nar/29.18.3728; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Gupta YK, 2012, J MOL BIOL, V420, P261, DOI 10.1016/j.jmb.2012.04.026; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; McClelland SE, 2005, J MOL BIOL, V348, P895, DOI 10.1016/j.jmb.2005.03.018; MEISEL A, 1995, EMBO J, V14, P2958, DOI 10.1002/j.1460-2075.1995.tb07296.x; MEISEL A, 1992, NATURE, V355, P467, DOI 10.1038/355467a0; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Qiu RY, 2012, EMBO J, V31, P2528, DOI 10.1038/emboj.2012.95; Raghavendra NK, 2012, FRONT BIOSCI-LANDMRK, V17, P1094, DOI 10.2741/3975; Ramanathan SP, 2009, P NATL ACAD SCI USA, V106, P1748, DOI 10.1073/pnas.0807193106; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Schwarz FW, 2011, NUCLEIC ACIDS RES, V39, P8042, DOI 10.1093/nar/gkr502; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Stanley LK, 2006, EMBO J, V25, P2230, DOI 10.1038/sj.emboj.7601104; Toth J, 2012, NUCLEIC ACIDS RES, V40, P6752, DOI 10.1093/nar/gks328; van Aelst K, 2010, P NATL ACAD SCI USA, V107, P9123, DOI 10.1073/pnas.1001637107; Webb MR, 2007, MOL BIOSYST, V3, P249, DOI 10.1039/b614154d; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025	25	53	55	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					353	356		10.1126/science.1231122	http://dx.doi.org/10.1126/science.1231122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599494	Green Accepted			2022-12-28	WOS:000317657500056
J	Amaral, M; Levy, C; Heyes, DJ; Lafite, P; Outeiro, TF; Giorgini, F; Leys, D; Scrutton, NS				Amaral, Marta; Levy, Colin; Heyes, Derren J.; Lafite, Pierre; Outeiro, Tiago F.; Giorgini, Flaviano; Leys, David; Scrutton, Nigel S.			Structural basis of kynurenine 3-monooxygenase inhibition	NATURE			English	Article							3-HYDROXYLASE INHIBITION; ENDOGENOUS METABOLITE; QUINOLINIC ACID; PATHWAY; MODEL; BRAIN; HYDROXYLASE; MICROGLIA; CATALYSIS; FLAVIN	Inhibition of kynurenine 3-monooxygenase (KMO), an enzyme in the eukaryotic tryptophan catabolic pathway (that is, kynurenine pathway), leads to amelioration of Huntington's-disease-relevant phenotypes in yeast, fruitfly and mouse models(1-5), as well as in a mouse model of Alzheimer's disease(3). KMO is a flavin adenine dinucleotide (FAD)-dependent monooxygenase and is located in the outer mitochondrial membrane where it converts L-kynurenine to 3-hydroxykynurenine. Perturbations in the levels of kynurenine pathway metabolites have been linked to the pathogenesis of a spectrum of brain disorders(6), as well as cancer(7,8) and several peripheral inflammatory conditions(9). Despite the importance of KMO as a target for neurodegenerative disease, the molecular basis of KMO inhibition by available lead compounds has remained unknown. Here we report the first crystal structure of Saccharomyces cerevisiae KMO, in the free form and in complex with the tight-binding inhibitor UPF 648. UPF 648 binds close to the FAD cofactor and perturbs the local active-site structure, preventing productive binding of the substrate L-kynurenine. Functional assays and targeted mutagenesis reveal that the active-site architecture and UPF 648 binding are essentially identical in human KMO, validating the yeast KMO-UPF 648 structure as a template for structure-based drug design. This will inform the search for new KMO inhibitors that are able to cross the blood-brain barrier in targeted therapies against neurodegenerative diseases such as Huntington's, Alzheimer's and Parkinson's diseases.	[Amaral, Marta; Levy, Colin; Heyes, Derren J.; Leys, David; Scrutton, Nigel S.] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [Amaral, Marta; Giorgini, Flaviano] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Amaral, Marta; Outeiro, Tiago F.] Inst Mol Med, Cell & Mol Neurosci Unit, P-1659028 Lisbon, Portugal; [Amaral, Marta; Outeiro, Tiago F.] Univ Lisbon, Fac Med, Inst Fisiol, P-1649028 Lisbon, Portugal; [Lafite, Pierre] Univ Orleans, Inst Chim Organ & Analyt, CNRS, UMR7311, F-45067 Orleans 2, France; [Outeiro, Tiago F.] Univ Med Ctr Gottingen, Ctr Nanoscale Microscopy & Mol Physiol Brain, Dept Neurodegenerat & Restorat Res, D-37073 Gottingen, Germany	University of Manchester; University of Leicester; Universidade de Lisboa; Universidade de Lisboa; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; University of Gottingen	Scrutton, NS (corresponding author), Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	nigel.scrutton@manchester.ac.uk	Outeiro, Tiago/M-8106-2019; Outeiro, Tiago/L-7351-2019; Lafite, Pierre/F-6806-2011; Outeiro, Tiago F/C-1067-2008	Outeiro, Tiago/0000-0003-1679-1727; Lafite, Pierre/0000-0003-1637-4966; Outeiro, Tiago F/0000-0003-1679-1727; Levy, Colin/0000-0002-9724-310X; amaral, marta/0000-0002-3503-9963; Heyes, Derren/0000-0002-7453-1571; Giorgini, Flaviano/0000-0001-7881-9508	EPSRC [EP/I037253/1, EP/J020192/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J020192/1, EP/I037253/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/D01963X/1] Funding Source: Medline	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Ceresoli-Borroni G, 2007, J NEUROSCI RES, V85, P845, DOI 10.1002/jnr.21183; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark CJ, 2005, INFECT IMMUN, V73, P5249, DOI 10.1128/IAI.73.8.5249-5251.2005; Copeland CS, 2013, NEUROPHARMACOLOGY, V66, P133, DOI 10.1016/j.neuropharm.2012.03.009; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cozzi A, 1999, J CEREBR BLOOD F MET, V19, P771, DOI 10.1097/00004647-199907000-00007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fazio F, 2012, MOL PHARMACOL, V81, P643, DOI 10.1124/mol.111.074765; Filippini P, 2012, CURR MED CHEM, V19, P5381, DOI 10.2174/092986712803833353; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Giorgini F, 2008, J BIOL CHEM, V283, P7390, DOI 10.1074/jbc.M708192200; Green EW, 2012, FLY, V6, P117, DOI 10.4161/fly.19999; Guillemin GJ, 2007, J NEUROSCI, V27, P12884, DOI 10.1523/JNEUROSCI.4101-07.2007; Guillemin GJ, 2003, ADV EXP MED BIOL, V527, P105; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Liu XD, 2009, STUD FUZZ SOFT COMP, V244, P3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; McCulloch KM, 2009, BIOCHEMISTRY-US, V48, P4139, DOI 10.1021/bi900149f; Moroni F, 2003, ADV EXP MED BIOL, V527, P127; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Ortiz-Maldonado M, 2001, BIOCHEMISTRY-US, V40, P1091, DOI 10.1021/bi002139s; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Platten M, 2012, ONCOIMMUNOLOGY, V1, P395, DOI 10.4161/onci.19071; Reinhart PH, 2011, CELL, V145, P813, DOI 10.1016/j.cell.2011.05.031; Richter A, 2003, EUR J PHARMACOL, V478, P47, DOI 10.1016/j.ejphar.2003.08.038; Samadi P, 2005, MOVEMENT DISORD, V20, P792, DOI 10.1002/mds.20596; Sapko MT, 2006, EXP NEUROL, V197, P31, DOI 10.1016/j.expneurol.2005.07.004; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Uemura T, 1998, J BIOCHEM, V123, P253; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	40	98	102	0	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					382	+		10.1038/nature12039	http://dx.doi.org/10.1038/nature12039			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23575632	Green Submitted, Green Accepted			2022-12-28	WOS:000317599200042
J	Black, ME				Black, Mary E.			The messianic cockroaches of sexual health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2013	346								f2362	10.1136/bmj.f2362	http://dx.doi.org/10.1136/bmj.f2362			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AO	23592473				2022-12-28	WOS:000317962900010
J	Boss, GR				Boss, Gerry R.			Allopurinol during acute gout attacks did not differ from delayed allopurinol for pain or recurrence	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MANAGEMENT; RHEUMATOLOGY		Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Boss, GR (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.			Boss, Gerry/0000-0002-9758-8714				Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269	3	0	0	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8							JC6	10.7326/0003-4819-158-8-201304160-02006	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588771				2022-12-28	WOS:000318062100009
J	Chatterjee, S; Chatterjee, S				Chatterjee, Saurav; Chatterjee, Sanjay			Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							METAANALYSIS		[Chatterjee, Saurav] Brown Univ, Providence, RI 02912 USA; [Chatterjee, Saurav] Providence VAMC, Providence, RI USA; [Chatterjee, Sanjay] Apollo Gleneagles Hosp, Kolkata, W Bengal, India	Brown University	Chatterjee, S (corresponding author), Brown Univ, Providence, RI 02912 USA.							Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Chatterjee S, 2012, ANN INTERN MED, V157, DOI 10.7326/0003-4819-157-2-201207170-02013; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933	3	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8							JC8	10.7326/0003-4819-158-8-201304160-02008	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588773				2022-12-28	WOS:000318062100011
J	Fenton, JJ; Xing, GB; Elmore, JG; Bang, H; Chen, SL; Lindfors, KK; Baldwin, LM				Fenton, Joshua J.; Xing, Guibo; Elmore, Joann G.; Bang, Heejung; Chen, Steven L.; Lindfors, Karen K.; Baldwin, Laura-Mae			Short-Term Outcomes of Screening Mammography Using Computer-Aided Detection A Population-Based Study of Medicare Enrollees	ANNALS OF INTERNAL MEDICINE			English	Article							BREAST-CANCER DETECTION; DIGITAL MAMMOGRAPHY; ASSISTED DETECTION; UNITED-STATES; PERFORMANCE; VALIDATION; IMPACT; CLAIMS; THERAPY; PROGRAM	Background: Computer-aided detection (CAD) has rapidly diffused into screening mammography practice despite limited and conflicting data on its clinical effect. Objective: To determine associations between CAD use during screening mammography and the incidence of ductal carcinoma in situ (DCIS) and invasive breast cancer, invasive cancer stage, and diagnostic testing. Design: Retrospective cohort study. Setting: Medicare program. Participants: Women aged 67 to 89 years having screening mammography between 2001 and 2006 in U. S. SEER (Surveillance, Epidemiology and End Results) regions (409 459 mammograms from 163 099 women). Measurements: Incident DCIS and invasive breast cancer within 1 year after mammography, invasive cancer stage, and diagnostic testing within 90 days after screening among women without breast cancer. Results: From 2001 to 2006, CAD prevalence increased from 3.6% to 60.5%. Use of CAD was associated with greater DCIS incidence (adjusted odds ratio [OR], 1.17 [95% CI, 1.11 to 1.23]) but no difference in invasive breast cancer incidence (adjusted OR, 1.00 [CI, 0.97 to 1.03]). Among women with invasive cancer, CAD was associated with greater likelihood of stage I to II versus III to IV cancer (adjusted OR, 1.27 [CI, 1.14 to 1.41]). In women without breast cancer, CAD was associated with increased odds of diagnostic mammography (adjusted OR, 1.28 [CI, 1.27 to 1.29]), breast ultrasonography (adjusted OR, 1.07 [CI, 1.06 to 1.09]), and breast biopsy (adjusted OR, 1.10 [CI, 1.08 to 1.12]). Limitation: Short follow-up for cancer stage, potential unmeasured confounding, and uncertain generalizability to younger women. Conclusion: Use of CAD during screening mammography among Medicare enrollees is associated with increased DCIS incidence, the diagnosis of invasive breast cancer at earlier stages, and increased diagnostic testing among women without breast cancer.	Univ Calif Davis, Ctr Healthcare Policy & Res, Sacramento, CA 95817 USA; Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA; City Hope Natl Med Ctr, Duarte, CA 91010 USA; Univ Washington, Seattle, WA 98195 USA	University of California System; University of California Davis; University of California System; University of California Davis; City of Hope; University of Washington; University of Washington Seattle	Fenton, JJ (corresponding author), Univ Calif Davis, Dept Family & Community Med, 4860 Y St,Suite 2300, Sacramento, CA 95817 USA.	joshua.fenton@ucdmc.ucdavis.edu	Fenton, Joshua/AAD-4114-2021	Fenton, Joshua/0000-0002-0581-835X	Center for Healthcare Policy and Research, University of California, Davis; Clinical and Translational Science Center; National Cancer Institute [K05 CA-104699]; NATIONAL CANCER INSTITUTE [K05CA104699, P30CA093373] Funding Source: NIH RePORTER	Center for Healthcare Policy and Research, University of California, Davis; Clinical and Translational Science Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Center for Healthcare Policy and Research, University of California, Davis.; By the Clinical and Translational Science Center and Center for Healthcare Policy and Research, University of California, Davis, and the National Cancer Institute (K05 CA-104699).	Autier P, 2009, J CLIN ONCOL, V27, P5919, DOI 10.1200/JCO.2009.22.7041; Baldwin LM, 2002, MED CARE, V40, P82; Bazzocchi M, 2007, RADIOL MED, V112, P329, DOI 10.1007/s11547-007-0145-5; Brancato B, 2008, BREAST CANCER RES TR, V111, P373, DOI 10.1007/s10549-007-9786-2; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Cupples TE, 2005, AM J ROENTGENOL, V185, P944, DOI 10.2214/AJR.04.1300; Duffy SW, 2003, EUR J CANCER, V39, P1755, DOI 10.1016/S0959-8049(03)00259-4; Edge SB, 2010, AJCC CANC STAGING MA; Fenton JJ, 2012, MED CARE; Fenton JJ, 2007, NEW ENGL J MED, V356, P1399, DOI 10.1056/NEJMoa066099; Fenton JJ, 2012, CANCER EPIDEM BIOMAR, V21, P1344, DOI 10.1158/1055-9965.EPI-12-0406; Fenton JJ, 2011, J NATL CANCER I, V103, P1152, DOI 10.1093/jnci/djr206; Fenton JJ, 2010, ARCH INTERN MED, V170, P987, DOI 10.1001/archinternmed.2010.104; Fenton JJ, 2009, CANCER EPIDEM BIOMAR, V18, P2186, DOI 10.1158/1055-9965.EPI-09-0338; Freer TW, 2001, RADIOLOGY, V220, P781, DOI 10.1148/radiol.2203001282; Gilbert FJ, 2008, NEW ENGL J MED, V359, P1675, DOI 10.1056/NEJMoa0803545; Gromet M, 2008, AM J ROENTGENOL, V190, P854, DOI 10.2214/AJR.07.2812; Gross CP, 2013, JAMA INTERN MED, V173, P220, DOI 10.1001/jamainternmed.2013.1397; Gur D, 2004, J NATL CANCER I, V96, P185, DOI 10.1093/jnci/djh067; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Jiang YL, 2007, RADIOLOGY, V243, P360, DOI 10.1148/radiol.2432060253; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Karssemeijer N, 2009, RADIOLOGY, V253, P353, DOI 10.1148/radiol.2532090225; Kerlikowske K, 1999, JAMA-J AM MED ASSOC, V282, P2156, DOI 10.1001/jama.282.22.2156; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Miglioretti DL, 2009, RADIOLOGY, V253, P632, DOI 10.1148/radiol.2533090070; Morton MJ, 2006, RADIOLOGY, V239, P375, DOI 10.1148/radiol.2392042121; Nelson HD, 2009, AHRQ PUBLICATION, V10-05142-EF-1; Neuhaus JM, 2001, ANNU REV PUBL HEALTH, V22, P115, DOI 10.1146/annurev.publhealth.22.1.115; Povyakalo AA, 2013, MED DECIS MAKING, V33, P98, DOI 10.1177/0272989X12465490; Rao VM, 2010, J AM COLL RADIOL, V7, P802, DOI 10.1016/j.jacr.2010.05.019; Romero C, 2011, AM J ROENTGENOL, V197, P1492, DOI 10.2214/AJR.09.3408; Taplin SH, 2006, AM J ROENTGENOL, V187, P1475, DOI 10.2214/AJR.05.0940; Taylor P, 2008, EUR J CANCER, V44, P798, DOI 10.1016/j.ejca.2008.02.016; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; van den Biggelaar FJHM, 2010, BREAST CANCER RES TR, V120, P499, DOI 10.1007/s10549-009-0409-y; Warren JL, 2002, MED CARE, V40, P3; Yankaskas BC, 2005, RADIOLOGY, V234, P363, DOI 10.1148/radiol.2342040048; Yasmeen S, 2011, CANCER-AM CANCER SOC, V117, P3252, DOI 10.1002/cncr.25857; Zheng B, 2001, RADIOLOGY, V221, P633, DOI 10.1148/radiol.2213010308	42	46	47	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8					580	+		10.7326/0003-4819-158-8-201304160-00002	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-00002			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588746	Green Accepted			2022-12-28	WOS:000318062100014
J	de Ruiter, DJ; DeWitt, TJ; Carlson, KB; Brophy, JK; Schroeder, L; Ackermann, RR; Churchill, SE; Berger, LR				de Ruiter, Darryl J.; DeWitt, Thomas J.; Carlson, Keely B.; Brophy, Juliet K.; Schroeder, Lauren; Ackermann, Rebecca R.; Churchill, Steven E.; Berger, Lee R.			Mandibular Remains Support Taxonomic Validity of Australopithecus sediba	SCIENCE			English	Article							HOMINID	Since the announcement of the species Australopithecus sediba, questions have been raised over whether the Malapa fossils represent a valid taxon or whether inadequate allowance was made for intraspecific variation, in particular with reference to the temporally and geographically proximate species Au. africanus. The morphology of mandibular remains of Au. sediba, including newly recovered material discussed here, shows that it is not merely a late-surviving morph of Au. africanus. Rather-as is seen elsewhere in the cranium, dentition, and postcranial skeleton-these mandibular remains share similarities with other australopiths but can be differentiated from the hypodigm of Au. africanus in both size and shape as well as in their ontogenetic growth trajectory.	[de Ruiter, Darryl J.; Carlson, Keely B.; Brophy, Juliet K.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [de Ruiter, Darryl J.; Brophy, Juliet K.; Churchill, Steven E.; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [DeWitt, Thomas J.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Brophy, Juliet K.] Loyola Univ, Dept Anthropol, Chicago, IL 60660 USA; [Schroeder, Lauren; Ackermann, Rebecca R.] Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa; [Churchill, Steven E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA	Texas A&M University System; Texas A&M University College Station; University of Witwatersrand; Texas A&M University System; Texas A&M University College Station; Loyola University Chicago; University of Cape Town; Duke University	de Ruiter, DJ (corresponding author), Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA.	deruiter@tamu.edu	Churchill, Steven/AAA-9386-2022; Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629; de Ruiter, Darryl/0000-0003-1183-0352; DeWitt, Thomas/0000-0001-7405-3904	South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation; Institute for Human Evolution (IHE); Palaeontological Scientific Trust (PAST); Andrew W. Mellon Foundation; L. S. B. Leakey Foundation Baldwin Fellowship; United States Diplomatic Mission to South Africa; French Embassy in South Africa; National Geographic Society; A. H. Schultz Foundation; Oppenheimer and Ackerman families; Program to Enhance Scholarly and Creative Activities; Texas A M University	South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation(National Research Foundation - South Africa); Institute for Human Evolution (IHE); Palaeontological Scientific Trust (PAST); Andrew W. Mellon Foundation; L. S. B. Leakey Foundation Baldwin Fellowship; United States Diplomatic Mission to South Africa; French Embassy in South Africa; National Geographic Society(National Geographic Society); A. H. Schultz Foundation; Oppenheimer and Ackerman families; Program to Enhance Scholarly and Creative Activities; Texas A M University	We thank the South African Heritage Resource agency for the permits to work on the Malapa site and the Nash family for granting access to the Malapa site and continued support of research on their reserve. The South African Department of Science and Technology, and the African Origins Platform (AOP), the South African National Research Foundation, the Institute for Human Evolution (IHE), the Palaeontological Scientific Trust (PAST), the Andrew W. Mellon Foundation, the L. S. B. Leakey Foundation Baldwin Fellowship, the United States Diplomatic Mission to South Africa, the French Embassy in South Africa, the National Geographic Society, the A. H. Schultz Foundation, the Oppenheimer and Ackerman families, Sir Richard Branson, and the Program to Enhance Scholarly and Creative Activities and the International Research Travel Award Grant of Texas A& M University all provided funding for this research. D. J. d. R. holds a Ray A. Rothrock ' 77 Fellowship at Texas A& M University, which provided additional funding. The University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology provided support and facilities. The authors declare that they have no real or apparent conflicts of interest. We thank E. Mbua, P. Kiura, V. Iminjili, and the National Museums of Kenya; P. Msemwa and the National Museum and House of Culture of Tanzania; S. Potze of the Ditsong Museum; B. Billings of the School of Anatomical Sciences of the University of the Witwatersrand; W. Seconna of the Iziko South African Museum; and L. M. Jellema of the Cleveland Museum of Natural History for access to comparative fossil and extant primate and human materials in their care. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, B. Eloff, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Other individuals who have given substantial support to this project include B. de Klerk, C. Steininger, B. Kuhn, L. Pollarolo, B. Zipfel, J. Kretzen, D. Conforti, J. McCaffery, C. Dlamini, H. Visser, R. McCrae-Samuel, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, M. Peltier, J. Cheverud, and D. Roach. The Au. sediba specimens are archived at the Evolutionary Studies Institute at the University of the Witwatersrand. All data used in this study are available upon request, including access to the original specimens, by bona fide scientists.	Ackermann Rebecca Rogers, 2002, Anatomical Record, V269, P142, DOI 10.1002/ar.10119; Balter M, 2010, SCIENCE, V328, P154, DOI 10.1126/science.328.5975.154; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Cherry M., 2010, NATURE, DOI [10.1038/news.2010.171, DOI 10.1038/NEWS.2010.171]; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; DeSilva JM, 2013, SCIENCE, V340, DOI 10.1126/science.1232999; GABUNIA L, 1995, NATURE, V373, P509, DOI 10.1038/373509a0; Irish JD, 2013, SCIENCE, V340, DOI 10.1126/science.1233062; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kimbel W.H., 2004, HUMAN EVOLUTION SERI; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Lague MR, 2008, J ANAT, V213, P670, DOI 10.1111/j.1469-7580.2008.00989.x; LELE S, 1995, AM J PHYS ANTHROPOL, V98, P73, DOI 10.1002/ajpa.1330980107; Moggi-Cecchi J, 1998, AM J PHYS ANTHROPOL, V106, P425, DOI 10.1002/(SICI)1096-8644(199808)106:4<425::AID-AJPA2>3.0.CO;2-I; Plavcan JM, 1997, J HUM EVOL, V32, P345, DOI 10.1006/jhev.1996.0096; Richtsmeier JT, 1998, J CRAN GENET DEV BIO, V18, P64; RICHTSMEIER JT, 1993, BIOL REV, V68, P381, DOI 10.1111/j.1469-185X.1993.tb00737.x; Schmid P, 2013, SCIENCE, V340, DOI 10.1126/science.1234598; Sokal RR, 1995, BIOMETRY; Williams SA, 2013, SCIENCE, V340, DOI 10.1126/science.1232996; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wood B, 2011, NATURE, V470, P347, DOI 10.1038/nature09709; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	24	30	30	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129							1232997	10.1126/science.1232997	http://dx.doi.org/10.1126/science.1232997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580533				2022-12-28	WOS:000317341400002
J	Williams, SA; Ostrofsky, KR; Frater, N; Churchill, SE; Schmid, P; Berger, LR				Williams, Scott A.; Ostrofsky, Kelly R.; Frater, Nakita; Churchill, Steven E.; Schmid, Peter; Berger, Lee R.			The Vertebral Column of Australopithecus sediba	SCIENCE			English	Article							LUMBAR LORDOSIS; STANDING POSITION; PARTIAL SKELETON; HOMO-ERECTUS; AFRICAN APES; SOUTH-AFRICA; EVOLUTION; HOMININS; PELVIS; SPINE	Two partial vertebral columns of Australopithecus sediba grant insight into aspects of early hominin spinal mobility, lumbar curvature, vertebral formula, and transitional vertebra position. Au. sediba likely possessed five non-rib-bearing lumbar vertebrae and five sacral elements, the same configuration that occurs modally in modern humans. This finding contrasts with other interpretations of early hominin regional vertebral numbers. Importantly, the transitional vertebra is distinct from and above the last rib-bearing vertebra in Au. sediba, resulting in a functionally longer lower back. This configuration, along with a strongly wedged last lumbar vertebra and other indicators of lordotic posture, would have contributed to a highly flexible spine that is derived compared with earlier members of the genus Australopithecus and similar to that of the Nariokotome Homo erectus skeleton.	[Williams, Scott A.] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Williams, Scott A.] New York Consortium Evolutionary Primatol, New York, NY 10024 USA; [Ostrofsky, Kelly R.; Churchill, Steven E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Frater, Nakita; Schmid, Peter] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [Churchill, Steven E.; Schmid, Peter; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa	New York University; Duke University; University of Zurich; University of Witwatersrand	Williams, SA (corresponding author), NYU, Dept Anthropol, Ctr Study Human Origins, 25 Waverly Pl, New York, NY 10003 USA.	sawilliams@nyu.edu	Churchill, Steven/AAA-9386-2022; Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629	University of the Witwatersrand; Ray A. Rothrock '77 Fellowship; South African Department of Science and Technology; Gauteng Provincial Government; South African National Research Foundation; African Origins Platform; Institute for Human Origins; National Geographic Society; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U. S. Diplomatic Mission to South Africa; French Embassy of South Africa; A. H. Schultz Foundation; Duke University; Texas AM University; Oppenheimer family; Ackerman family	University of the Witwatersrand; Ray A. Rothrock '77 Fellowship; South African Department of Science and Technology; Gauteng Provincial Government; South African National Research Foundation(National Research Foundation - South Africa); African Origins Platform; Institute for Human Origins; National Geographic Society(National Geographic Society); Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U. S. Diplomatic Mission to South Africa; French Embassy of South Africa; A. H. Schultz Foundation; Duke University; Texas AM University; Oppenheimer family; Ackerman family	We thank the South African Heritage Resource agency for the permits to work at the Malapa site; the Nash family for granting access to the Malapa site and continued support of research on their reserve; the South African Department of Science and Technology, the Gauteng Provincial Government, the South African National Research Foundation and the African Origins Platform, the Institute for Human Origins, University of the Witwatersrand, the University of the Witwatersrand's Vice Chancellor's Discretionary Fund, the National Geographic Society, the Palaeontological Scientific Trust, the Andrew W. Mellon Foundation, the Ford Foundation, the U. S. Diplomatic Mission to South Africa, the French Embassy of South Africa, the A. H. Schultz Foundation, Duke University, the Ray A. Rothrock '77 Fellowship and International Research Travel Assistance Grant of Texas A&M University, and the Oppenheimer and Ackerman families and R. Branson for funding; the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities; the Gauteng Government, and the Gauteng Department of Agriculture, Conservation and Environment and the Cradle of Humankind Management Authority; and our respective universities for ongoing support. We thank E. Mbua, P. Kiura, V. Iminjili, the National Museums of Kenya, B. Billings, B. Zipfel, the School of Anatomical Sciences at the University of the Witwatersrand, S. Potze, L. C. Kgasi, and the Ditsong Museum for access to comparative specimens; the Virtual Image Processing lab of the Palaeosciences Centre and the Microfocus X-ray CT facility of the Palaeosciences Centre at Wits for funding these facilities; the University of the Witwatersrand Office of Research and the National Research Fund Strategic Research Infrastructure Grant and African Origins Platform funding programs; and Duke University and the University of Zurich 2009 and 2010 Field Schools for technical and material support. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Other individuals who have given substantial support to this project include B. de Klerk, W. Lawrence, C. Steininger, B. Kuhn, L. Pollarolo, B. Zipfel, J. Kretzen, D. Conforti, J. McCaffery, C. Dlamini, H. Visser, R. McCrae-Samuel, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, and M. Peltier. J. Smilg facilitated computed tomography scanning of the specimens, A. Val provided information of CT slices, W. Sanders and K. Whitcome made data on fossil specimens and casts available, M. Grabowski provided helpful comments on the manuscript, and M. Shattuck provided valuable comments and assisted substantially with the revision of this manuscript. The Au. sediba specimens are archived at the Evolutionary Studies Institute at the University of the Witwatersrand. All data used in this study are available upon request, including access to the original specimens. Data reported in this study are available in the supplementary materials.	ABITBOL MM, 1995, J HUM EVOL, V28, P211, DOI 10.1006/jhev.1995.1017; ABITBOL MM, 1987, AM J PHYS ANTHROPOL, V72, P361; Been E, 2012, AM J PHYS ANTHROPOL, V147, P64, DOI 10.1002/ajpa.21633; Benade M. M., 1990, THESIS U WITWATERSAN; Berge C, 2010, J HUM EVOL, V58, P262, DOI 10.1016/j.jhevol.2009.11.006; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Betsch M, 2011, ARTHRIT CARE RES, V63, P1758, DOI 10.1002/acr.20601; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; DeSilva JM, 2013, SCIENCE, V340, DOI 10.1126/science.1232999; DICKSON RA, 1987, J BONE JOINT SURG BR, V69, P690, DOI 10.1302/0301-620X.69B5.3680325; Duval K, 2010, GAIT POSTURE, V32, P637, DOI 10.1016/j.gaitpost.2010.09.007; Grabowski MW, 2011, EVOLUTION, V65, P1336, DOI 10.1111/j.1558-5646.2011.01226.x; Haeusler M, 2002, J HUM EVOL, V43, P621, DOI 10.1006/jhev.2002.0595; Haeusler M, 2012, J HUM EVOL, V63, P557, DOI 10.1016/j.jhevol.2012.05.011; Haeusler M, 2011, J HUM EVOL, V61, P575, DOI 10.1016/j.jhevol.2011.07.004; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Khamis S, 2007, GAIT POSTURE, V25, P127, DOI 10.1016/j.gaitpost.2006.02.005; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Latimer Bruce, 1993, P266; Levine D, 1996, J ORTHOP SPORT PHYS, V24, P130, DOI 10.2519/jospt.1996.24.3.130; Lewton KL, 2012, EVOL BIOL, V39, P126, DOI 10.1007/s11692-011-9143-6; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lovejoy CO, 2010, PHILOS T R SOC B, V365, P3289, DOI 10.1098/rstb.2010.0112; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Mccollum MA, 2010, J EXP ZOOL PART B, V314B, P123, DOI 10.1002/jez.b.21316; Meyer M.R., 2005, THESIS U PENNSYLVANI; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Pilbeam D, 2004, J EXP ZOOL PART B, V302B, P241, DOI 10.1002/jez.b.22; Robinson J.T., 1972, EARLY HOMINID POSTUR; Rockwell H, 1938, J MORPHOL, V63, P87, DOI 10.1002/jmor.1050630105; Rosenman BA, 2008, THESIS KENT STATE U; Russo GA, 2010, AM J PHYS ANTHROPOL, V142, P600, DOI 10.1002/ajpa.21283; Sanders Rob, 2018, PRIDE STORY HARVEY M; Sanders WJ, 1998, J HUM EVOL, V34, P249, DOI 10.1006/jhev.1997.0193; SHAPIRO L, 1993, J HUM EVOL, V25, P433, DOI 10.1006/jhev.1993.1061; Shapiro Liza, 1993, P121; TOBIAS PV, 1992, T ROY SOC S AFR, V48, P1, DOI 10.1080/00359199209520253; Tobias PV, 1998, J ROY ANTHROPOL INST, V4, P283, DOI 10.2307/3034503; Toussaint M, 2003, S AFR J SCI, V99, P215; WALKER A, 1982, NATURE, V296, P248, DOI 10.1038/296248a0; Walker Alan, 1993, P95; Ward CV, 2005, SPINE, V30, P1808, DOI 10.1097/01.brs.0000174273.85164.67; Whitcome KK, 2007, NATURE, V450, P1075, DOI 10.1038/nature06342; Whitcome KK, 2012, J HUM EVOL, V62, P486, DOI 10.1016/j.jhevol.2012.01.008; Williams SA, 2011, THESIS U ILLINOIS UR; Williams SA, 2012, J HUM EVOL, V63, P552, DOI 10.1016/j.jhevol.2012.01.007; Williams SA, 2012, J EXP ZOOL PART B, V318B, P134, DOI 10.1002/jezb.21451; Williams SA, 2012, AM J PHYS ANTHROPOL, V148, P111, DOI 10.1002/ajpa.22049; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703; [No title captured]	51	57	57	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129								10.1126/science.1232996	http://dx.doi.org/10.1126/science.1232996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580532				2022-12-28	WOS:000317341400001
J	Heredia, JE; Mukundan, L; Chen, FM; Mueller, AA; Deo, RC; Locksley, RM; Rando, TA; Chawla, A				Heredia, Jose E.; Mukundan, Lata; Chen, Francis M.; Mueller, Alisa A.; Deo, Rahul C.; Locksley, Richard M.; Rando, Thomas A.; Chawla, Ajay			Type 2 Innate Signals Stimulate Fibro/Adipogenic Progenitors to Facilitate Muscle Regeneration	CELL			English	Article							IMMUNE-SYSTEM; MACROPHAGE; CELLS; INJURY; ACTIVATION; TISSUE; IL-4; HYPERTROPHY; EXPRESSION; REGULATOR	In vertebrates, activation of innate immunity is an early response to injury, implicating it in the regenerative process. However, the mechanisms by which innate signals might regulate stem cell functionality are unknown. Here, we demonstrate that type 2 innate immunity is required for regeneration of skeletal muscle after injury. Muscle damage results in rapid recruitment of eosinophils, which secrete IL-4 to activate the regenerative actions of muscle resident fibro/adipocyte progenitors (FAPs). In FAPs, IL-4/IL-13 signaling serves as a key switch to control their fate and functions. Activation of IL-4/IL-13 signaling promotes proliferation of FAPs to support myogenesis while inhibiting their differentiation into adipocytes. Surprisingly, type 2 cytokine signaling is also required in FAPs, but not in myeloid cells, for rapid clearance of necrotic debris, a process that is necessary for timely and complete regeneration of tissues.	[Heredia, Jose E.; Mukundan, Lata; Chen, Francis M.; Deo, Rahul C.; Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Deo, Rahul C.; Locksley, Richard M.; Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Mueller, Alisa A.; Rando, Thomas A.] Stanford Univ, Paul F Glenn Labs Biol Aging, Sch Med, Stanford, CA 94305 USA; [Mueller, Alisa A.; Rando, Thomas A.] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Deo, Rahul C.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Deo, Rahul C.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Rehabil Res & Dev Ctr Excellence, Palo Alto, CA 94304 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Chawla, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	ajay.chawla@ucsf.edu		Chen, Francis M./0000-0002-6615-4155; Rando, Thomas/0000-0001-5843-8564; Mueller, Alisa/0000-0002-1342-6962	NIH [DK081405, DP1AR064158, AG023806, AG036695, DP1 OD000392, 5T32HL007731]; California Institute for Regenerative Medicine Predoctoral Fellowship [TG2-01159]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007731, K08HL098361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062185, DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023806, P01AG036695, R01AG023806] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006415, DP1OD000392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine Predoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Chawla laboratory and B. Black for discussions and A. Loh for comments on the manuscript. This work was supported by NIH grant DK081405 and an NIH Director's Pioneer Award (DP1AR064158) to A. C.; by NIH grants R37 Merit Award (AG023806) and P01 (AG036695) and NIH Director's Pioneer Award (DP1 OD000392) to T. A. R.; by California Institute for Regenerative Medicine Predoctoral Fellowship (TG2-01159) to A. A. M.; by the NIH Training Grant (5T32HL007731) to J.E.M. All animal care and procedures were performed in accordance with Stanford University's A-PLAC and UCSF's IACUC guidelines.	Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Brunelli S, 2008, PHARMACOL RES, V58, P117, DOI 10.1016/j.phrs.2008.06.008; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Karp CL, 2012, J EXP MED, V209, P427, DOI 10.1084/jem.20120295; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; MCGARRY MP, 1991, J LEUKOCYTE BIOL, V50, P471, DOI 10.1002/jlb.50.5.471; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rosen ED, 2000, GENE DEV, V14, P1293; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; TIDBALL JG, 1995, MED SCI SPORT EXER, V27, P1022, DOI 10.1249/00005768-199507000-00011; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wynes MW, 2003, J IMMUNOL, V171, P3550, DOI 10.4049/jimmunol.171.7.3550; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656	45	481	490	2	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					376	388		10.1016/j.cell.2013.02.053	http://dx.doi.org/10.1016/j.cell.2013.02.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582327	Green Accepted, Bronze			2022-12-28	WOS:000317349700016
J	Pasterkamp, RJ; Kolodkin, AL				Pasterkamp, R. Jeroen; Kolodkin, Alex L.			SnapShot: Axon Guidance	CELL			English	Editorial Material							PROTOCADHERINS		[Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands; [Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, HHMI, Dept Neurosci, Baltimore, MD 21212 USA	Utrecht University; Utrecht University Medical Center; Howard Hughes Medical Institute; Johns Hopkins University	Pasterkamp, RJ (corresponding author), Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands.			Pasterkamp, Jeroen/0000-0003-1631-6440				Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Derijck AAHA, 2010, TRENDS CELL BIOL, V20, P568, DOI 10.1016/j.tcb.2010.06.007; Dickson BJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002055; Feldheim D.A., 2010, COLD SPRING HARB PER, V2; Kolodkin AL, 2011, COLD SPRING HARB PER, V3; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	10	15	15	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					494	+	494.e1	10.1016/j.cell.2013.03.031	http://dx.doi.org/10.1016/j.cell.2013.03.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582334	Bronze			2022-12-28	WOS:000317349700027
J	Neuman, MD; Bosk, CL				Neuman, Mark D.; Bosk, Charles L.			The art of medicine Medicine and the radiant city	LANCET			English	Editorial Material							PERFORMANCE		[Neuman, Mark D.; Bosk, Charles L.] Univ Penn, Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Neuman, Mark D.; Bosk, Charles L.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Bosk, Charles L.] Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Neuman, MD (corresponding author), Univ Penn, Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	neumanm@mail.med.upenn.edu						[Anonymous], 1998, SEEING STATE; Bowker GC., 2000, SORTING THINGS OUT C; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Feinstein A. R, 1967, CLIN JUDGMENT; FEINSTEIN AR, 1994, ANN INTERN MED, V120, P799, DOI 10.7326/0003-4819-120-9-199405010-00012; Hughes Robert, 1991, THE SHOCK OF THE NEW; Latour B., 1998, SCIENCE IN ACTION HO; Le Corbusier, 1967, THE RADIANT CITY ELE; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007	9	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 6	2013	381	9873					1176	1177		10.1016/S0140-6736(13)60788-6	http://dx.doi.org/10.1016/S0140-6736(13)60788-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WU	23573526				2022-12-28	WOS:000317350100014
J	Meijer, HA; Kong, YW; Lu, WT; Wilczynska, A; Spriggs, RV; Robinson, SW; Godfrey, JD; Willis, AE; Bushell, M				Meijer, H. A.; Kong, Y. W.; Lu, W. T.; Wilczynska, A.; Spriggs, R. V.; Robinson, S. W.; Godfrey, J. D.; Willis, A. E.; Bushell, M.			Translational Repression and eIF4A2 Activity Are Critical for MicroRNA-Mediated Gene Regulation	SCIENCE			English	Article							DEADENYLATION; INITIATION; INHIBITION; CCR4-NOT; GW182	MicroRNAs (miRNAs) control gene expression through both translational repression and degradation of target messenger RNAs (mRNAs). However, the interplay between these processes and the precise molecular mechanisms involved remain unclear. Here, we show that translational inhibition is the primary event required for mRNA degradation. Translational inhibition depends on miRNAs impairing the function of the eIF4F initiation complex. We define the RNA helicase eIF4A2 as the key factor of eIF4F through which miRNAs function. We uncover a correlation between the presence of miRNA target sites in the 3' untranslated region (3'UTR) of mRNAs and secondary structure in the 5'UTR and show that mRNAs with unstructured 5'UTRs are refractory to miRNA repression. These data support a linear model for miRNA-mediated gene regulation in which translational repression via eIF4A2 is required first, followed by mRNA destabilization.	[Meijer, H. A.; Kong, Y. W.; Lu, W. T.; Wilczynska, A.; Spriggs, R. V.; Robinson, S. W.; Godfrey, J. D.; Willis, A. E.; Bushell, M.] MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester	Bushell, M (corresponding author), MRC, Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	mb446@le.ac.uk	Lu, Wei-Ting/N-9398-2013	Lu, Wei-Ting/0000-0002-1405-4806; Kong, Yi Wen/0000-0002-4223-971X; Willis, Anne/0000-0002-1470-8531; Wilczynska, Ania/0000-0003-4548-9367	MRC, UK; BBSRC [BB/F02326X/2, BB/F011806/2, BB/F019017/2, BB/F019017/1, BB/F011806/1] Funding Source: UKRI; MRC [MC_UP_A600_1024, MC_UP_A600_1023, MC_EX_G0902052] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019017/2, BB/B500915/1, BB/F019017/1, BB/F02326X/2, BB/F011806/1, BB/F011806/2] Funding Source: researchfish; Medical Research Council [MC_UP_A600_1023, MC_EX_G0902052, MC_UP_A600_1024] Funding Source: researchfish	MRC, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank E. Smith, M. Stoneley, T. Poyry, E. Jan, C. Jopling, T. Achsel, M. Hentze, and J. Pelletier for helpful comments and reagents. This work was funded by the MRC, UK. M. B. is an MRC Senior Fellow, and A. E. W. is a Biotechnology and Biological Sciences Research Council Professorial Fellow.	Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Cooke A, 2010, J BIOL CHEM, V285, P28506, DOI 10.1074/jbc.M110.150763; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Galicia-Vazquez G, 2012, RNA, V18, P1373, DOI 10.1261/rna.033209.112; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mishima Y, 2012, P NATL ACAD SCI USA, V109, P1104, DOI 10.1073/pnas.1113350109; Moretti F, 2012, NAT STRUCT MOL BIOL, V19, P603, DOI 10.1038/nsmb.2309; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Petit AP, 2012, NUCLEIC ACIDS RES, V40, P11058, DOI 10.1093/nar/gks883; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zdanowicz A, 2009, MOL CELL, V35, P881, DOI 10.1016/j.molcel.2009.09.009	20	236	251	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2013	340	6128					82	85		10.1126/science.1231197	http://dx.doi.org/10.1126/science.1231197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559250				2022-12-28	WOS:000317061100050
J	DeLoughery, T				DeLoughery, Thomas			Aspirin did not reduce recurrence after a first-ever, unprovoked venous thromboembolism	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	DeLoughery, T (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.			Robledo, Kristy/0000-0003-0213-7652				Agnelli G., 2012, N ENGL J MED; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Rabinowitz I, 2012, ANN INTERN MED, V157, DOI 10.7326/0003-4819-157-8-201210160-02003; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6							JC2	10.7326/0003-4819-158-6-201303190-02002	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23552619				2022-12-28	WOS:000316565100001
J	Cohen, IG; Adashi, EY				Cohen, I. Glenn; Adashi, Eli Y.			Made-to-Order Embryos for Sale - A Brave New World?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cohen, I. Glenn] Harvard Univ, Sch Law, Cambridge, MA 02138 USA; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Harvard University; Brown University	Cohen, IG (corresponding author), Harvard Univ, Sch Law, Cambridge, MA 02138 USA.							Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P47, DOI 10.1016/j.fertnstert.2012.09.037; [Anonymous], 2003, HARVARD LAW REV, V117, P689; Cohen IG, 2012, AM J TRANSPLANT, V12, P1983, DOI 10.1111/j.1600-6143.2012.04092.x; Dostalik Polina M., 2010, N Y L SCH L REV, V55, P867; Reich JB, 2011, J HEALTH CARE L POLY, V14, P241; Zarembo A, 2012, LOS ANGELES TIMES	6	13	13	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 27	2013	368	26					2517	2519		10.1056/NEJMsb1215894	http://dx.doi.org/10.1056/NEJMsb1215894			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KQ	23574034				2022-12-28	WOS:000320926900016
J	Kirkwood, BR; Manu, A; ten Asbroek, AHA; Soremekun, S; Weobong, B; Gyan, T; Danso, S; Amenga-Etego, S; Tawiah-Agyemang, C; Owusu-Agyei, S; Hill, Z				Kirkwood, Betty R.; Manu, Alexander; ten Asbroek, Augustinus H. A.; Soremekun, Seyi; Weobong, Benedict; Gyan, Thomas; Danso, Samuel; Amenga-Etego, Seeba; Tawiah-Agyemang, Charlotte; Owusu-Agyei, Seth; Hill, Zelee			Effect of the Newhints home-visits intervention on neonatal mortality rate and care practices in Ghana: a cluster randomised controlled trial	LANCET			English	Article							RURAL GHANA; NEWBORN; MANAGEMENT; PACKAGE; BANGLADESH; COUNTRIES; PREVENT; DEATHS; INDIA	Background In 2009, on the basis of promising evidence from trials in south Asia, WHO and UNICEF issued a joint statement about home visits as a strategy to improve newborn survival. In the Newhints trial, we aimed to test this home-visits strategy in sub-Saharan Africa by assessing the effect on all-cause neonatal mortality rate (NMR) and essential newborn-care practices. Methods The Newhints cluster randomised trial was undertaken in 98 zones in seven districts in the Brong Ahafo Region, Ghana. 49 zones were randomly assigned to the Newhints intervention and 49 to the control intervention by use of restricted randomisation with stratification to ensure comparability between interventions. Community-based surveillance volunteers (CBSVs) in Newhints zones were trained to identify pregnant women in their community and to make two home visits during pregnancy and three in the first week of life to promote essential newborn-care practices, weigh and assess babies for danger signs, and refer as necessary. Primary outcomes were NMR and coverage of key essential newborn-care practices. Analyses were by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00623337. Findings 16 168 (99%) of 16 329 deliveries between November, 2008, and December, 2009, were livebirths; the status at 1 month was known for 15 619 (97%) livebirths. 482 neonatal deaths were recorded. Coverage data were available from 6029 women in Newhints zones; of these 4358 (72%) reported having CBSV visits during pregnancy and 3815 (63%) reported having postnatal visits. This coverage increased substantially from June, 2009, after the introduction of new implementation strategies and reached almost 90% for pregnancy visits by the end of the trial and 75% for postnatal visits. The Newhints intervention significantly increased coverage of key essential newborn-care behaviours, except for four or more antenatal-care visits (5975 [76%] of 7859 vs 5988 [74%] of 8121, respectively; relative risk 1.02, 95% CI 0.96-1.09; p = 0.52) and baby delivered in a facility (5373 [68%] vs 5539 [68%], respectively; 0.97, 0.81-1.14; p = 0.69). The largest increase was for care-seeking, with 102 (77%) of 132 sick babies in Newhints zones taken to a hospital or clinic compared with 77 (55%) of 139 in control zones (1.43, 1.17-1.76; p = 0.001). Increases were also noted in bednet use during pregnancy (5398 [69%] of 7859 vs 5135 [63%] of 8121, respectively; 1.12, 1.03-1.21; p = 0.005), money saved for delivery or emergency (5730 [86%] of 6681 vs 5525 [80%] of 6941, respectively; 1.09, 1.05-1.12; p < 0.0001), transport arranged in advance for facility (2496 [37%] vs 2061 [30%], respectively; 1.30, 1.12-1.49; p = 0.0004), birth assistant for home delivery washed hands with soap (1853 [93%] of 1992 vs 1817 [87%] of 2091, respectively; 1.05, 1.02-1.09; p = 0.001), initiation of breastfeeding in less than 1 h of birth (3743 [49%] of 7673 vs 3280 [41%] of 7921, respectively; 1.22, 1.07-1.40; p = 0.004), skin to skin contact (3355 [44%] vs 1931 [24%], respectively; 2.30, 1.85-2.87; p = 0.0002), first bath delayed for longer than 6 h (3131 [41%] vs 2269 [29%], respectively; 1.65, 1.27-2.13; p < 0.0001), exclusive breastfeeding for 26-32 days (1217 [86%] of 1414 vs 1091 [80%] of 1371; 1.10, 1.04-1.16; p = 0.001), and baby sleeping under bednet for 8-56 days (4548 [79%] of 5756 vs 4291 [73%] of 5846; 1.09, 1.03-1.15; p = 0.002). There were 230 neonatal deaths in the Newhints zones compared with 252 in the control zones. The overall NMRs per 1000 livebirths were 29.8 and 31.9, respectively (0.92, 0.75-1.12; p = 0.405). Interpretation The reduction in NMR with Newhints is consistent with the reductions achieved in three trials undertaken in programme settings in south Asia. Because there is no suggestion of any heterogeneity (p = 0.850) between these trials and Newhints, the meta-analysis summary estimate of a reduction of 12% (95% CI 5-18) provides the best evidence for the likely effect of the home-visits strategy delivered within programmes in sub-Saharan Africa and in south Asia. Improvements in the quality of delivery and neonatal care in health facilities and development of innovative, effective strategies to increase coverage of home visits on the day of birth could lead to the achievement of more substantial reductions.	[Kirkwood, Betty R.; ten Asbroek, Augustinus H. A.; Soremekun, Seyi; Owusu-Agyei, Seth] Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England; [Manu, Alexander; Weobong, Benedict; Gyan, Thomas; Danso, Samuel; Amenga-Etego, Seeba; Tawiah-Agyemang, Charlotte; Owusu-Agyei, Seth] Ghana Hlth Serv, Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo Reg, Ghana; [ten Asbroek, Augustinus H. A.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Hill, Zelee] UCL, Inst Global Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; Ghana Health Service; Kintampo Health Research Centre; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London	Kirkwood, BR (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Nutr & Publ Hlth Intervent Res, Keppel St, London WC1E 7HT, England.	betty.kirkwood@lshtm.ac.uk	Soremekun, Seyi/AAH-4018-2021; Gyan, thomas/J-6009-2013	Soremekun, Seyi/0000-0002-5531-0220; Owusu-Agyei, Seth/0000-0002-0807-1781; Kirkwood, Betty/0000-0001-5274-6072; Gyan, thomas/0000-0003-2972-964X	WHO; Bill & Melinda Gates Foundation; UK Department for International Development	WHO(World Health Organization); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK Department for International Development	WHO, Bill & Melinda Gates Foundation, and UK Department for International Development.	Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS92, DOI 10.1038/sj.jp.7211277; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bhandari N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1634; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Darmstadt GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009696; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Gogia S, 2010, B WORLD HEALTH ORGAN, V88, P658, DOI 10.2471/BLT.09.069369; Hill Z, 2008, J PERINATOL, V28, pS38, DOI 10.1038/jp.2008.172; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kirkwood BR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-58; Kirkwood BR, 2010, LANCET, V375, P1640, DOI 10.1016/S0140-6736(10)60311-X; Kirkwood BR, 2003, ESSENTIAL MED STAT; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lawn JE, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S2; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Manu AA, 2012, THESIS U LONDON; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Smits J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025239; WHO UNICEF, 2009, HOM VIS NEWB CHILD S	23	128	130	1	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 22	2013	381	9884					2184	2192		10.1016/S0140-6736(13)60095-1	http://dx.doi.org/10.1016/S0140-6736(13)60095-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KH	23578528				2022-12-28	WOS:000320925600035
J	Cheson, BD				Cheson, Bruce D.			Therapy for diffuse large B-cell lymphoma: getting personal	LANCET			English	Editorial Material							CHEMOTHERAPY PLUS RITUXIMAB; STANDARD REGIMEN CHOP; ELDERLY-PATIENTS; TRIAL		Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA	Georgetown University	Cheson, BD (corresponding author), Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	bdc4@georgetown.edu						Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Benito JM, 2012, BLOOD, V120; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Cunningham D, 2013, LANCET; Davids MS, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.304.304; Delarue R, 2013, LANCET ONCOL; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Flinn WI HM, 2012, BLOOD, V120, P3663; GORDON LI, 1992, NEW ENGL J MED, V327, P1342, DOI 10.1056/NEJM199211053271903; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Hernandez-Ilizaliturri FJ, 2011, CANCER-AM CANCER SOC, V117, P5058, DOI 10.1002/cncr.26135; JONES SE, 1979, CANCER, V43, P417, DOI 10.1002/1097-0142(197902)43:2<417::AID-CNCR2820430203>3.0.CO;2-I; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Pfreundschuh M, 2004, BLOOD, V104, P634, DOI 10.1182/blood-2003-06-2095; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Recher C, 2011, LANCET, V378, P1858, DOI 10.1016/S0140-6736(11)61040-4; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Ruan J, 2011, J CLIN ONCOL, V29, P690, DOI 10.1200/JCO.2010.31.1142; Sharman J, 2011, ASH ANN M, V118, P1787; Wilson WH, 2012, HAEMATOL-HEMATOL J, V97, P758, DOI 10.3324/haematol.2011.056531	20	6	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2013	381	9880					1793	1794		10.1016/S0140-6736(13)60849-1	http://dx.doi.org/10.1016/S0140-6736(13)60849-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151EO	23615460				2022-12-28	WOS:000319443700005
J	Thompson, LG; Mosley-Thompson, E; Davis, ME; Zagorodnov, VS; Howat, IM; Mikhatenko, VN; Lin, PN				Thompson, L. G.; Mosley-Thompson, E.; Davis, M. E.; Zagorodnov, V. S.; Howat, I. M.; Mikhatenko, V. N.; Lin, P. -N.			Annually Resolved Ice Core Records of Tropical Climate Variability over the Past similar to 1800 Years	SCIENCE			English	Article							INTERTROPICAL CONVERGENCE ZONE; MODELING DELTA-O-18; PRECIPITATION; PACIFIC; TEMPERATURES; ALTIPLANO; HUASCARAN; AMERICA; HISTORY; CAP	Ice cores from low Latitudes can provide a wealth of unique information about past climate in the tropics, but they are difficult to recover and few exist. Here, we report annually resolved ice core records from the Quelccaya ice cap (5670 meters above sea level) in Peru that extend back similar to 1800 years and provide a high-resolution record of climate variability there. Oxygen isotopic ratios (delta O-18) are linked to sea surface temperatures in the tropical eastern Pacific, whereas concentrations of ammonium and nitrate document the dominant role played by the migration of the Intertropical Convergence Zone in the region of the tropical Andes. Quetccaya continues to retreat and thin. Radiocarbon dates on wetland plants exposed along its retreating margins indicate that it has not been smaller for at least six millennia.	[Thompson, L. G.; Mosley-Thompson, E.; Davis, M. E.; Zagorodnov, V. S.; Howat, I. M.; Lin, P. -N.] Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA; [Thompson, L. G.; Howat, I. M.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Mosley-Thompson, E.] Ohio State Univ, Dept Geog, Columbus, OH 43210 USA; [Mikhatenko, V. N.] Russian Acad Sci, Inst Geog, Moscow V71, Russia	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Russian Academy of Sciences	Thompson, LG (corresponding author), Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA.	thompson.3@osu.edu	Mosley-Thompson, Ellen S/Z-2100-2018; Mikhalenko, Vladimir N/A-4253-2014; Howat, Ian M/A-3474-2008	Howat, Ian M/0000-0002-8072-6260	NSF [ATM-0318130]; Ohio State University's Climate, Water and Carbon Program; Div Atmospheric & Geospace Sciences [0823586] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Ohio State University's Climate, Water and Carbon Program; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by NSF Paleoclimate Program award ATM-0318130 and the Ohio State University's Climate, Water and Carbon Program. We thank all the field and laboratory team members, many from the Byrd Polar Research Center, who have worked so diligently over the years to acquire these ice cores and extract their preserved climate histories. We acknowledge the efforts of our Peruvian colleagues from the Servicio Nacional de Meteorologia e Hidrologia, C. Portocarrero, and our mountaineers, led by B. Vicencio, who cooperated with us to make the project possible. Accelerator mass spectrometry <SUP>14</SUP>C measurements were made at the National Ocean Sciences Accelerator Mass Spectrometry Facility (Woods Hole Oceanographic Institution). This is Byrd Polar Research Center Contribution Number 1430. The data are archived at the National Oceanic and Atmospheric Administration World Data Center-A for Paleoclimatology: ftp://ftp.ncdc.noaa.gov/pub/data/paleo/icecore/trop/quelccaya/quelccaya2013.txt.	Baker PA, 2001, SCIENCE, V291, P640, DOI 10.1126/science.291.5504.640; Bird BW, 2011, P NATL ACAD SCI USA, V108, P8583, DOI 10.1073/pnas.1003719108; Black DE, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001427; Boyle EA, 1997, GEOPHYS RES LETT, V24, P273, DOI 10.1029/97GL00081; Bradley RS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037712; Bradley RS, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016546; Buffen AM, 2009, QUATERNARY RES, V72, P157, DOI 10.1016/j.yqres.2009.02.007; Diaz HF, 2011, B AM METEOROL SOC, V92, P1487, DOI 10.1175/BAMS-D-10-05003.1; Dunbar R. B., 1996, CLIMATIC FLUCTUATION, P375; Francou B, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002959; Garreaud R, 2003, PALAEOGEOGR PALAEOCL, V194, P5, DOI 10.1016/S0031-0182(03)00269-4; Haase-Schramm A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000830; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Henderson KA, 1999, J GEOPHYS RES-ATMOS, V104, P31053, DOI 10.1029/1999JD900966; Jomelli V, 2009, PALAEOGEOGR PALAEOCL, V281, P269, DOI 10.1016/j.palaeo.2008.10.033; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kellerhals T, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012603; Klein A.G., 1995, B I FRANCAIS ETUDES, V24, P607; Koutavas A, 2004, ADV GLOB CHANGE RES, V21, P347, DOI 10.1007/978-1-4020-2944-8_12; Liu KB, 2005, QUATERNARY RES, V64, P272, DOI 10.1016/j.yqres.2005.06.001; Marengo JA, 2004, THEOR APPL CLIMATOL, V78, P79, DOI 10.1007/S00704-004-0045-8; Novello VF, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053936; Pepin NC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034026; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Rein B, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020161; Reuter J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041051; Robertson G. P., 1998, NATURE, V336, P757; Sachs JP, 2009, NAT GEOSCI, V2, P519, DOI 10.1038/ngeo554; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Solomon S., 2007, PHYS SCI BASIS WORKI; THOMPSON LG, 1986, SCIENCE, V234, P361, DOI 10.1126/science.234.4774.361; THOMPSON LG, 1985, SCIENCE, V229, P971, DOI 10.1126/science.229.4717.971; THOMPSON LG, 1988, NATURE, V336, P763, DOI 10.1038/336763a0; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; Thompson LG, 2006, P NATL ACAD SCI USA, V103, P10536, DOI 10.1073/pnas.0603900103; Thompson LG, 2011, ANN GLACIOL, V52, P23, DOI 10.3189/172756411799096231; Vuille M, 1999, INT J CLIMATOL, V19, P1579, DOI 10.1002/(SICI)1097-0088(19991130)19:14<1579::AID-JOC441>3.0.CO;2-N; Vuille M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD002039; Xue Y, 2003, J CLIMATE, V16, P1601, DOI 10.1175/1520-0442-16.10.1601	39	167	174	4	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					945	950		10.1126/science.1234210	http://dx.doi.org/10.1126/science.1234210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23558172				2022-12-28	WOS:000319344100038
J	Campbell, CS; Desai, A				Campbell, Christopher S.; Desai, Arshad			Tension sensing by Aurora B kinase is independent of survivin-based centromere localization	NATURE			English	Article							PROPER CHROMOSOME SEGREGATION; SACCHAROMYCES-CEREVISIAE; SPINDLE CHECKPOINT; BUDDING YEAST; PROTEIN-KINASE; COMPLEX; INCENP; PHOSPHORYLATION; ORIENTATION; BIORIENTATION	Accurate segregation of the replicated genome requires chromosome biorientation on the spindle. Biorientation is ensured by Aurora B kinase (Ipl1), a member of the four-subunit chromosomal passenger complex (CPC)(1,2). Localization of the CPC to the inner centromere is central to the current model for how tension ensures chromosome biorientation: kinetochore-spindle attachments that are not under tension remain close to the inner centromere and are destabilized by Aurora B phosphorylation, whereas kinetochores under tension are pulled away from the influence of Aurora B, stabilizing their microtubule attachments(3-5). Here we show that an engineered truncation of the Sli15 (known as INCENP in humans) subunit of budding yeast CPC that eliminates association with the inner centromere nevertheless supports proper chromosome segregation during both mitosis and meiosis. Truncated Sli15 suppresses the deletion phenotypes of the innercentromere-targeting proteins survivin (Bir1), borealin (Nbl1), Bub1 and Sgo1 (ref. 6). Unlike wild-type Sli15, truncated Sli15 localizes to pre-anaphase spindle microtubules. Premature targeting of full-length Sli15 to microtubules by preventing Cdk1 (also known as Cdc28) phosphorylation also suppresses the inviability of Bir1 deletion. These results suggest that activation of Aurora B kinase by clustering either on chromatin or on microtubules is sufficient for chromosome biorientation.	[Campbell, Christopher S.; Desai, Arshad] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92037 USA; [Campbell, Christopher S.; Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92037 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Desai, A (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92037 USA.	abdesai@ucsd.edu		Campbell, Christopher/0000-0002-3927-344X	National Institutes of Health (NIH) [GM074215]; Damon Runyon Cancer Research Foundation Fellowship [DRG 2007-09]; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation Fellowship; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank the Desai and Oegema laboratories for discussions; S. Sandall, H. Hu and E. Manrriquez for assistance; B. Ren's laboratory for help with ChIP experiments; S. Biggins, D. Dawson, G. Pereira, G. Barnes, P. Hieter and the Yeast Resource Center for strains and plasmids; and K. Oegema, R. Green and J. DeLuca for comments on the manuscript. This work was supported by a National Institutes of Health (NIH) grant (GM074215) to A. D. and a Damon Runyon Cancer Research Foundation Fellowship (DRG 2007-09) to C.S.C. A.D. receives salary and other support from the Ludwig Institute for Cancer Research.	Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Cho US, 2012, NAT STRUCT MOL BIOL, V19, P48, DOI 10.1038/nsmb.2178; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Makrantoni V, 2009, MOL CELL BIOL, V29, P4552, DOI 10.1128/MCB.01911-08; Nakajima Y, 2011, J CELL BIOL, V194, P137, DOI 10.1083/jcb.201009137; Ng TM, 2009, MOL BIOL CELL, V20, P3818, DOI 10.1091/mbc.E09-04-0330; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Rozelle DK, 2011, J CELL BIOL, V193, P285, DOI 10.1083/jcb.201011002; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sandall S, 2006, CELL, V127, P1179, DOI 10.1016/j.cell.2006.09.049; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Shimogawa MM, 2009, MOL BIOL CELL, V20, P915, DOI 10.1091/mbc.E08-07-0723; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tseng BS, 2010, DEV CELL, V18, P903, DOI 10.1016/j.devcel.2010.05.018; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208	30	95	95	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 2	2013	497	7447					118	+		10.1038/nature12057	http://dx.doi.org/10.1038/nature12057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23604256	Green Accepted			2022-12-28	WOS:000318221500045
J	Cross, M				Cross, Michael			Delivering a digital death	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												michaelcross@fastmail.fm						Department of Health, 2011, END LIF CAR PROJ STO; Intellect, 2013, NHS INF EV; National Audit Office, 2008, END LIFE CARE	3	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2013	346								f2528	10.1136/bmj.f2528	http://dx.doi.org/10.1136/bmj.f2528			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134PM	23615593				2022-12-28	WOS:000318224900014
J	Dechartres, A; Trinquart, L; Boutron, I; Ravaud, P				Dechartres, Agnes; Trinquart, Ludovic; Boutron, Isabelle; Ravaud, Philippe			Influence of trial sample size on treatment effect estimates: meta-epidemiological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; SYSTEMATIC REVIEWS; EMPIRICAL-EVIDENCE; QUALITY; METAANALYSES; BIAS; OUTCOMES; IMPACT; DISCREPANCIES; PUBLICATION	Objective To assess the influence of trial sample size on treatment effect estimates within meta-analyses. Design Meta-epidemiological study. Data sources 93 meta-analyses (735 randomised controlled trials) assessing therapeutic interventions with binary outcomes, published in the 10 leading journals of each medical subject category of the Journal Citation Reports or in the Cochrane Database of Systematic Reviews. Data extraction Sample size, outcome data, and risk of bias extracted from each trial. Data synthesis Trials within each meta-analysis were sorted by their sample size: using quarters within each meta-analysis (from quarter 1 with 25% of the smallest trials, to quarter 4 with 25% of the largest trials), and using size groups across meta-analyses (ranging from <50 to >= 1000 patients). Treatment effects were compared within each meta-analysis between quarters or between size groups by average ratios of odds ratios (where a ratio of odds ratios less than 1 indicates larger effects in smaller trials). Results Treatment effect estimates were significantly larger in smaller trials, regardless of sample size. Compared with quarter 4 (which included the largest trials), treatment effects were, on average, 32% larger in trials in quarter 1 (which included the smallest trials; ratio of odds ratios 0.68, 95% confidence interval 0.57 to 0.82), 17% larger in trials in quarter 2 (0.83, 0.75 to 0.91), and 12% larger in trials in quarter 3 (0.88, 0.82 to 0.95). Similar results were obtained when comparing treatment effect estimates between different size groups. Compared with trials of 1000 patients or more, treatment effects were, on average, 48% larger in trials with fewer than 50 patients (0.52, 0.41 to 0.66) and 10% larger in trials with 500-999 patients (0.90, 0.82 to 1.00). Conclusions Treatment effect estimates differed within meta-analyses solely based on trial sample size, with stronger effect estimates seen in small to moderately sized trials than in the largest trials.	[Dechartres, Agnes; Trinquart, Ludovic; Boutron, Isabelle; Ravaud, Philippe] INSERM, U738, Paris, France; [Dechartres, Agnes; Boutron, Isabelle; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75004 Paris, France; [Dechartres, Agnes; Boutron, Isabelle; Ravaud, Philippe] Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France; [Trinquart, Ludovic; Boutron, Isabelle; Ravaud, Philippe] French Cochrane Ctr, Paris, France; [Ravaud, Philippe] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Columbia University	Dechartres, A (corresponding author), INSERM, U738, Paris, France.	agnes.dechartres@htd.aphp.fr	ravaud, philippe/C-1694-2009; Trinquart, Ludovic/H-4961-2019	Trinquart, Ludovic/0000-0002-3028-4900; Boutron, Isabelle/0000-0002-5263-6241; Ravaud, Philippe/0000-0001-8264-9206	Programme Hospitalier de recherche Clinique Regional [AOR10017]; Fondation pour la Recherche Medicale [DEQ20101221475]	Programme Hospitalier de recherche Clinique Regional; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This study was funded by an academic grant from the Programme Hospitalier de recherche Clinique Regional (AOR10017). Our team is supported by an academic grant (DEQ20101221475) for the programme "Equipe espoir de la Recherche," from the Fondation pour la Recherche Medicale. The researchers declare that they are independent from the funders. The funders did not have any role in the study.	Bafeta A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e813; Brandler E, 2010, ACAD EMERG MED, V17, P1, DOI 10.1111/j.1553-2712.2009.00625.x; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Flather MD, 1997, CONTROL CLIN TRIALS, V18, P568, DOI 10.1016/S0197-2456(97)00024-X; Glasziou PP, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-23; Goodman S, 2011, ANN INTERN MED, V155, P61, DOI 10.7326/0003-4819-155-1-201107050-00010; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hopewell S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c723; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P1089, DOI 10.1001/jama.279.14.1089; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moja LP, 2005, BMJ-BRIT MED J, V330, P1053, DOI 10.1136/bmj.38414.515938.8F; Moreno SG, 2012, STAT MED, V31, P1407, DOI 10.1002/sim.4488; Moseley AM, 2009, J CLIN EPIDEMIOL, V62, P1021, DOI 10.1016/j.jclinepi.2008.09.018; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Rucker G, 2011, BIOMETRICAL J, V53, P351, DOI 10.1002/bimj.201000151; Rucker G, 2011, BIOSTATISTICS, V12, P122, DOI 10.1093/biostatistics/kxq046; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Shea B, 2002, EVAL HEALTH PROF, V25, P116, DOI 10.1177/0163278702025001008; Siersma V, 2007, STAT MED, V26, P2745, DOI 10.1002/SIM.2752; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; YUSUF S, 1990, STAT MED, V9, P73, DOI 10.1002/sim.4780090114; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421	34	268	268	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2013	346								f2304	10.1136/bmj.f2304	http://dx.doi.org/10.1136/bmj.f2304			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134PM	23616031	Green Published, hybrid			2022-12-28	WOS:000318224900003
J	Barry, C; Doeller, CF				Barry, Caswell; Doeller, Christian F.			3D Mapping in the Brain	SCIENCE			English	Editorial Material							GRID CELLS; 3-DIMENSIONAL SPACE; THETA OSCILLATIONS; FREQUENCY		[Barry, Caswell] UCL, Inst Cognit Neurosci, London WC1E 6BT, England; [Barry, Caswell] UCL, Inst Neurol, London WC1E 6BT, England; [Barry, Caswell] UCL, Inst Behav Neurosci, London WC1E 6BT, England; [Doeller, Christian F.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	University of London; University College London; University of London; University College London; University of London; University College London; Radboud University Nijmegen	Barry, C (corresponding author), UCL, Inst Cognit Neurosci, London WC1E 6BT, England.	caswell.barry@ucl.ac.uk; christian.doeller@donders.ru.nl			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barry C, 2012, NATURE, V488, pE1, DOI 10.1038/nature11276; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hayman R, 2011, NAT NEUROSCI, V14, P1182, DOI 10.1038/nn.2892; Heys JG, 2013, SCIENCE, V340, P363, DOI 10.1126/science.1233831; Kaplan R, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001267; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011; Yartsev MM, 2013, SCIENCE, V340, P367, DOI 10.1126/science.1235338; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	15	10	10	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					279	280		10.1126/science.1237569	http://dx.doi.org/10.1126/science.1237569			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599468	Green Published			2022-12-28	WOS:000317657500029
J	Houben, AJP; Bijl, PK; Pross, J; Bohaty, SM; Passchier, S; Stickley, CE; Rohl, U; Sugisaki, S; Tauxe, L; van de Flierdt, T; Olney, M; Sangiorgi, F; Sluijs, A; Escutia, C; Brinkhuis, H; Brinkhuis, H; Dotti, CE; Klaus, A; Fehr, A; Williams, T; Bendle, JA; Bijl, PK; Bohaty, SM; Carr, SA; Dunbar, RB; Flores, JA; Gonzalez, JJ; Hayden, TG; Iwai, M; Jimenez-Espejo, FJ; Katsuki, K; Kong, GS; Mckay, RM; Nakai, M; Olney, MP; Passchier, S; Pekar, SF; Pross, J; Riesselman, C; Rohl, U; Sakai, T; Salzmann, U; Shrivastava, PK; Stickley, CE; Sugisaki, S; Tauxe, L; Tuo, S; van de Flierdt, T; Welsh, K; Yamane, M				Houben, Alexander J. P.; Bijl, Peter K.; Pross, Joerg; Bohaty, Steven M.; Passchier, Sandra; Stickley, Catherine E.; Roehl, Ursula; Sugisaki, Saiko; Tauxe, Lisa; van de Flierdt, Tina; Olney, Matthew; Sangiorgi, Francesca; Sluijs, Appy; Escutia, Carlota; Brinkhuis, Henk; Brinkhuis, Henk; Dotti, Carlota Escutia; Klaus, Adam; Fehr, Annick; Williams, Trevor; Bendle, James A. P.; Bijl, Peter K.; Bohaty, Steven M.; Carr, Stephanie A.; Dunbar, Robert B.; Flores, Jose-Abel; Gonzalez, Jhon J.; Hayden, Travis G.; Iwai, Masao; Jimenez-Espejo, Francisco J.; Katsuki, Kota; Kong, Gee Soo; McKay, Robert M.; Nakai, Mutsumi; Olney, Matthew P.; Passchier, Sandra; Pekar, Stephen F.; Pross, Jorg; Riesselman, Christina; Rohl, Ursula; Sakai, Toyosaburo; Salzmann, Ulrich; Shrivastava, Prakash K.; Stickley, Catherine E.; Sugisaki, Saiko; Tauxe, Lisa; Tuo, Shouting; van de Flierdt, Tina; Welsh, Kevin; Yamane, Masako		Expedition 318 Scientists	Reorganization of Southern Ocean Plankton Ecosystem at the Onset of Antarctic Glaciation	SCIENCE			English	Article							ICE-SHEET EXPANSION; SEA-ICE; SEDIMENTOLOGICAL EVIDENCE; DINOFLAGELLATE CYSTS; INDICATORS; ICEHOUSE	The circum-Antarctic Southern Ocean is an important region for global marine food webs and carbon cycling because of sea-ice formation and its unique plankton ecosystem. However, the mechanisms underlying the installation of this distinct ecosystem and the geological timing of its development remain unknown. Here, we show, on the basis of fossil marine dinoflagellate cyst records, that a major restructuring of the Southern Ocean plankton ecosystem occurred abruptly and concomitant with the first major Antarctic glaciation in the earliest Oligocene (similar to 33.6 million years ago). This turnover marks a regime shift in zooplankton-phytoplankton interactions and community structure, which indicates the appearance of eutrophic and seasonally productive environments on the Antarctic margin. We conclude that earliest Oligocene cooling, ice-sheet expansion, and subsequent sea-ice formation were important drivers of biotic evolution in the Southern Ocean.	[Houben, Alexander J. P.; Bijl, Peter K.; Sangiorgi, Francesca; Sluijs, Appy; Brinkhuis, Henk] Univ Utrecht, Fac Geosci, Dept Earth Sci, LPP, NL-3584 CD Utrecht, Netherlands; [Pross, Joerg] Goethe Univ Frankfurt, Inst Geosci, Paleoenvironm Dynam Grp, D-60438 Frankfurt, Germany; [Pross, Joerg] Biodivers & Climate Res Ctr, D-60325 Frankfurt, Germany; [Bohaty, Steven M.] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Passchier, Sandra] Montclair State Univ, Dept Earth & Environm Studies, Montclair, NJ 07043 USA; [Stickley, Catherine E.] Univ Tromso, Dept Geol, N-9037 Tromso, Norway; [Roehl, Ursula] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Sugisaki, Saiko; Tauxe, Lisa] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [van de Flierdt, Tina] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Olney, Matthew] Univ S Florida, Dept Geol, Tampa, FL 33620 USA; [Escutia, Carlota] Inst Andaluz Ciencias Terra, Armilla 18100, Granada, Spain; [Brinkhuis, Henk; Bijl, Peter K.] Univ Utrecht, Lab Palaeobot & Palynol, Fac Geosci, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands; [Dotti, Carlota Escutia; Gonzalez, Jhon J.; Jimenez-Espejo, Francisco J.] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Granada 18002, Spain; [Klaus, Adam] Texas A&M Univ, Integrated Ocean Drilling Program, US Implementing Org, College Stn, TX 77845 USA; [Fehr, Annick] Univ Aachen, Inst Appl Geophys & Geothermal Energy, D-52074 Aachen, Germany; [Williams, Trevor] Columbia Univ, Lamont Doherty Earth Observ, Borehole Res Grp, Palisades, NY 10964 USA; [Bendle, James A. P.] Univ Glasgow, Geog & Earth Sci, Glasgow G12 8QQ, Lanark, Scotland; [Bohaty, Steven M.] Univ Southampton, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; [Carr, Stephanie A.] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA; [Dunbar, Robert B.; Riesselman, Christina] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Flores, Jose-Abel] Univ Salamanca, Fac Ciencias, Dept Geol, Geosci Grp, Salamanca 37008, Spain; [Hayden, Travis G.] Western Michigan Univ, Dept Geol, Kalamazoo, MI 49008 USA; [Iwai, Masao] Kochi Univ, Dept Nat Sci, Kochi 7808520, Japan; [Jimenez-Espejo, Francisco J.] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan; [Katsuki, Kota] Kochi Univ, Marine Ctr Adv Core Res, Kochi 7838502, Japan; [Kong, Gee Soo] Korea Inst Geosci & Mineral Resources, Petrol & Marine Res Div, Daejeon 305350, South Korea; [McKay, Robert M.] Victoria Univ Wellington, Antarct Res Ctr, Wellington 6140, New Zealand; [Nakai, Mutsumi] Daito Bunka Univ, Educ Dept, Tokyo 1758571, Japan; [Nakai, Mutsumi] Univ S Florida, Dept Geol, Tampa, FL 33620 USA; [Passchier, Sandra] Montclair State Univ, Earth & Environm Studies, Montclair, NJ 07043 USA; [Pekar, Stephen F.] CUNY Queens Coll, Sch Earth & Environm Sci, Flushing, NY 11367 USA; [Pross, Jorg] Goethe Univ Frankfurt, Inst Geosci, Paleoenvironm Dynam Grp, D-60438 Frankfurt, Germany; [Riesselman, Christina] US Geol Survey, Eastern Geol & Paleoclimate Sci Ctr, Reston, VA 20192 USA; [Rohl, Ursula] Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28359 Bremen, Germany; [Sakai, Toyosaburo] Utsunomiya Univ, Dept Geol, Utsunomiya, Tochigi 3218505, Japan; [Salzmann, Ulrich] Northumbria Univ, Sch Built & Nat Environm, Earth & Environm, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Shrivastava, Prakash K.] NIT, NH5P, Geol Survey India, Antarct Div, Faridabad 121001, Haryana, India; [Stickley, Catherine E.] Univ Tromso, Dept Geol, N-9037 Tromso, Norway; [Sugisaki, Saiko] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Sugisaki, Saiko; Tauxe, Lisa] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Tuo, Shouting] Tongji Univ, Sch Ocean & Earth Sci, Shanghai 200092, Peoples R China; [van de Flierdt, Tina] Imperial Coll London, Dept Earth Sci & Engn, London SW7 2AZ, England; [Welsh, Kevin] Univ Queensland, Sch Earth Sci, Brisbane, Qld 4072, Australia; [Yamane, Masako] Univ Tokyo, Earth & Planetary Sci, Tokyo 1130033, Japan	Utrecht University; Goethe University Frankfurt; NERC National Oceanography Centre; University of Southampton; Montclair State University; UiT The Arctic University of Tromso; University of Bremen; University of California System; University of California San Diego; Scripps Institution of Oceanography; Imperial College London; State University System of Florida; University of South Florida; Utrecht University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; Texas A&M University System; Texas A&M University College Station; RWTH Aachen University; Columbia University; University of Glasgow; NERC National Oceanography Centre; University of Southampton; Colorado School of Mines; Stanford University; University of Salamanca; Western Michigan University; Kochi University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kochi University; Korea Institute of Geoscience & Mineral Resources (KIGAM); Victoria University Wellington; State University System of Florida; University of South Florida; Montclair State University; City University of New York (CUNY) System; Queens College NY (CUNY); Goethe University Frankfurt; United States Department of the Interior; United States Geological Survey; University of Bremen; Utsunomiya University; Northumbria University; Geological Survey India; UiT The Arctic University of Tromso; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of California System; University of California San Diego; Scripps Institution of Oceanography; Tongji University; Imperial College London; University of Queensland; University of Tokyo	Houben, AJP (corresponding author), Netherlands Org Appl Sci Res TNO, Princetonlaan 6, NL-3584 CB Utrecht, Netherlands.	Alexander.Houben@TNO.nl	Passchier, Sandra/AAQ-2243-2021; Röhl, Ursula/G-5986-2011; Flores, José-Abel/D-4218-2009; Passchier, Sandra/GYU-2381-2022; McKay, Robert/N-2449-2015; Jimenez-Espejo, Francisco J/F-4486-2016; Escutia, Carlota/B-8614-2015; Passchier, Sandra/B-1993-2008; Sluijs, Appy/B-3726-2009; Salzmann, Ulrich/H-9929-2017; Jimenez-Espejo, Francisco J./AAR-2318-2020; Welsh, Kevin/A-9808-2012	Passchier, Sandra/0000-0001-7204-7025; Röhl, Ursula/0000-0001-9469-7053; Flores, José-Abel/0000-0003-1909-293X; McKay, Robert/0000-0002-5602-6985; Jimenez-Espejo, Francisco J/0000-0002-0335-8580; Escutia, Carlota/0000-0002-4932-8619; Passchier, Sandra/0000-0001-7204-7025; Sluijs, Appy/0000-0003-2382-0215; Salzmann, Ulrich/0000-0001-5598-5327; Bendle, James/0000-0002-6826-8658; Dunbar, Robert/0000-0002-9728-5609; Riesselman, Christina/0000-0002-2436-4306; Welsh, Kevin/0000-0002-4834-4190; Yamane, Masako/0000-0002-5063-0719; Houben, Alexander/0000-0002-9497-1048; Bijl, Peter/0000-0002-1710-4012; Brinkhuis, Henk/0000-0003-0253-6610	NSF [ANT-1245283, OCE 1058858, OCE 1054497]; Statoil; Netherlands Organisation for Scientific Research (NWO) [86610110]; LPP Foundation; German Research Foundation [PR 651/10, RO 1113/6]; Biodiversity and Climate Research Center within the Hessian Initiative for Scientific and Economic Excellence (LOEWE); Post-Expedition Activity award; Natural Environmental Research Council (UK) [NE/H025162/1, NE/H020098/1, NE/J019801/1]; European Commission [IRG 230828]; UK IODP [NE/I006257/1]; European Research Council [259627]; Spanish Ministry for Science and Innovation [CTM2011-2079]; Directorate For Geosciences [1245283] Funding Source: National Science Foundation; Division Of Ocean Sciences [1058858] Funding Source: National Science Foundation; Natural Environment Research Council [NE/H020098/1, NE/I00646X/2, NE/H014616/1, NE/I006257/1, NE/J019801/1, NE/I00646X/1, NE/H025162/1] Funding Source: researchfish; NERC [NE/I00646X/1, NE/I00646X/2, NE/H025162/1, NE/I006257/1, NE/H014616/1, NE/J019801/1, NE/H020098/1] Funding Source: UKRI	NSF(National Science Foundation (NSF)); Statoil; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); LPP Foundation; German Research Foundation(German Research Foundation (DFG)); Biodiversity and Climate Research Center within the Hessian Initiative for Scientific and Economic Excellence (LOEWE); Post-Expedition Activity award; Natural Environmental Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Commission(European CommissionEuropean Commission Joint Research Centre); UK IODP; European Research Council(European Research Council (ERC)European Commission); Spanish Ministry for Science and Innovation(Spanish Government); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research used samples from the ODP and the IODP. The ODP was sponsored by the NSF and participating countries under management of Joint Oceanographic Institutions (JOI) Incorporated. A.J.P.H. and H.B. thank Statoil for funding. P.K.B., F.S., and H.B. thank the Netherlands Organisation for Scientific Research (NWO) (grant 86610110) and the LPP Foundation for funding. J.P. and U.R. acknowledge support through the German Research Foundation (grants PR 651/10 and RO 1113/6). J.P. thanks the Biodiversity and Climate Research Center within the Hessian Initiative for Scientific and Economic Excellence (LOEWE) for support. S.P. acknowledges financial support from a Post-Expedition Activity award administered by the U.S. Science Support Program and research support from NSF award ANT-1245283. T.v.d.F. acknowledges the Natural Environmental Research Council (UK) for a cruise participation grant (NE/H025162/1) and the European Commission for a Marie Curie Reintegration grant (IRG 230828). S.M.B. and T.v.d.F. further acknowledge UK IODP funding (grant NE/I006257/1). S.M.B. acknowledges the Natural Environmental Research Council (UK) for a cruise participation grant (NE/H020098/1) and postcruise research support (NE/J019801/1). L.T. acknowledges support from NSF grants OCE 1058858 and OCE 1054497. A.S. thanks the European Research Council for ERC Starting Grant 259627. C.E. thanks the Spanish Ministry for Science and Innovation (grant CTM2011-2079). The reported data are available in the supplementary materials.	Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; Baker AJ, 2006, P ROY SOC B-BIOL SCI, V273, P11, DOI 10.1098/rspb.2005.3260; Balech E., 1968, ANTARCTIC MAP FOLIO; BARRON JA, 1989, LIFE SCI R, V44, P341; Bijl PK, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2009PA001905; Bohaty SM, 2012, EARTH PLANET SC LETT, V317, P251, DOI 10.1016/j.epsl.2011.11.037; Bouimetarhan I, 2009, MAR MICROPALEONTOL, V71, P113, DOI 10.1016/j.marmicro.2009.02.001; Brierley AS, 2002, SCIENCE, V295, P1890, DOI 10.1126/science.1068574; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto R, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001350; Dieckmann G. S., 2010, SEA ICE; EHRMANN WU, 1992, PALAEOGEOGR PALAEOCL, V93, P85, DOI 10.1016/0031-0182(92)90185-8; Escutia C., 2011, INTEGRATED OCEAN DRI, V318; Hannah M. J., 2001, TERRA ANTARTICA, V8, P383; Harland R, 1999, MAR MICROPALEONTOL, V37, P77, DOI 10.1016/S0377-8398(99)00016-X; Houben AJP, 2011, REV PALAEOBOT PALYNO, V165, P175, DOI 10.1016/j.revpalbo.2011.03.002; JACOBSON DM, 1986, J PHYCOL, V22, P249, DOI 10.1111/j.1529-8817.1986.tb00021.x; Kopczynska EE, 2007, POLAR BIOL, V31, P77, DOI 10.1007/s00300-007-0335-6; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Leventer A, 1998, ANTARCT RES SER, V73, P121; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Marret F, 1997, MAR MICROPALEONTOL, V29, P367, DOI 10.1016/S0377-8398(96)00049-7; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; Reichart GJ, 2003, MAR MICROPALEONTOL, V49, P303, DOI 10.1016/S0377-8398(03)00050-1; Scher HD, 2011, GEOLOGY, V39, P383, DOI 10.1130/G31726.1; Sluijs A, 2005, EARTH-SCI REV, V68, P281, DOI 10.1016/j.earscirev.2004.06.001; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Stickley C. E., 2004, PALEOCEONOGRAPHY, V19; Tauxe L, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002308; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; Wilson DS, 2012, PALAEOGEOGR PALAEOCL, V335, P24, DOI 10.1016/j.palaeo.2011.05.028; ZACHOS JC, 1992, GEOLOGY, V20, P569, DOI 10.1130/0091-7613(1992)020<0569:EOISEO>2.3.CO;2	34	81	83	8	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					341	344		10.1126/science.1223646	http://dx.doi.org/10.1126/science.1223646			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599491	Green Published			2022-12-28	WOS:000317657500052
J	McPherson, K				McPherson, Klim			Can we leave industry to lead efforts to improve population health? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England	University of Oxford	McPherson, K (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.	klim.mcpherson@obs-gyn.ox.ac.uk						Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Brussels Sunshine, 2010, HIGH TIM CIAA COM CL; Butland BJ, 2007, FORESIGHT TACKLING O; DUNN SP, 2010, EC JK GALBRAITH; Dunn S, 2011, J POST KEYNESIAN EC, V33, P491, DOI 10.2753/PKE0160-3477330305; Food Drink Europe, 2011, FOODDRINKEUROPE COMP; Gallo A, 1999, AGR INFORM B, V750; Mulley A. G., 2012, PATIENTS PREFERENCES; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	9	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2013	346								f2426	10.1136/bmj.f2426	http://dx.doi.org/10.1136/bmj.f2426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AT	23596227				2022-12-28	WOS:000317963400008
J	Ravichandran, B; Lustig, R				Ravichandran, Balaji; Lustig, Robert			Robert Lustig: The no candy man	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ravichandran, Balaji] Univ Oxford Queens Coll, Oxford OX1 4AW, England	University of Oxford	Ravichandran, B (corresponding author), Univ Oxford Queens Coll, Oxford OX1 4AW, England.	balaji.ravichandran@mod-langs.ox.ac.uk	Lustig, Robert/O-9380-2019	Lustig, Robert/0000-0001-6983-2639				Ravichandran B., 2013, SUGAR IS NEW TOBACCO	1	0	0	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2013	346								f2287	10.1136/bmj.f2287	http://dx.doi.org/10.1136/bmj.f2287			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AT	23596216				2022-12-28	WOS:000317963400005
J	Chertow, DS; O'Grady, NP				Chertow, Daniel S.; O'Grady, Naomi P.			In critically ill adults, supplemental parenteral nutrition reduced nosocomial infections	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chertow, Daniel S.; O'Grady, Naomi P.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Chertow, DS (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.							Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Critical Care Nutrition, CAN CLIN PRACT GUID	2	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8							JC3	10.7326/0003-4819-158-8-201304160-02003	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588768				2022-12-28	WOS:000318062100006
J	Hands, D				Hands, David			Francis inquiry has let the government off the hook	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hands, David] North Wales Hlth Author, Ffynnongroyw, Clwyd, Wales		Hands, D (corresponding author), Univ Glamorgan, Pontypridd CF37 1DL, M Glam, Wales.	davidmhands@hotmail.com						[Anonymous], 2011, TRANSCR EV WEDN 4 MA; [Anonymous], 2012, HLTH SERVICE J, P14; [Anonymous], 2011, PRIVATE EYE     0708; [Anonymous], 2010, 3751 HC; [Anonymous], 2013, 947 HC; Gooderham P, 21 WAYS SKIN WHISTLE; Jarman B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8239; KLEIN R, 2000, NEW POLITICS NHS; MAXWELL RJ, 1984, BRIT MED J, V288, P1470, DOI 10.1136/bmj.288.6428.1470; Paton C, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1979	10	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2013	346								f2320	10.1136/bmj.f2320	http://dx.doi.org/10.1136/bmj.f2320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AO	23596127				2022-12-28	WOS:000317962900008
J	Nelson, HD; Smith, B; Griffin, JC; Fu, RW				Nelson, Heidi D.; Smith, Beth; Griffin, Jessica C.; Fu, Rongwei			Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							SURGICAL ADJUVANT BREAST; BONE-MINERAL DENSITY; CONTINUING OUTCOMES RELEVANT; ITALIAN RANDOMIZED-TRIAL; VERTEBRAL FRACTURE RISK; QUALITY-OF-LIFE; POSTMENOPAUSAL WOMEN; MULTIPLE OUTCOMES; BOWEL PROJECT; CARDIOVASCULAR EVENTS	Background: Medications to reduce risk for primary breast cancer are recommended for women at increased risk; however, use is low. Purpose: To update evidence about the effectiveness and adverse effects of medications to reduce breast cancer risk, patient use of such medications, and methods for identifying women at increased risk for breast cancer. Data Sources: MEDLINE and Cochrane databases (through 5 December 2012), Scopus, Web of Science, clinical trial registries, and reference lists. Study Selection: English-language randomized trials of medication effectiveness and adverse effects, observational studies of adverse effects and patient use, and diagnostic accuracy studies of risk assessment. Data Extraction: Investigators independently extracted data on participants, study design, analysis, follow-up, and results, and a second investigator confirmed key data. Investigators independently dual-rated study quality and applicability using established criteria. Data Synthesis: Seven good-and fair-quality trials indicated that tamoxifen and raloxifene reduced incidence of invasive breast cancer by 7 to 9 cases in 1000 women over 5 years compared with placebo. New results from STAR (Study of Tamoxifen and Raloxifene) showed that tamoxifen reduced breast cancer incidence more than raloxifene by 5 cases in 1000 women. Neither reduced breast cancer-specific or all-cause mortality rates. Both reduced the incidence of fractures, but tamoxifen increased the incidence of thromboembolic events more than raloxifene by 4 cases in 1000 women. Tamoxifen increased the incidence of endometrial cancer and cataracts compared with placebo and raloxifene. Trials provided limited and heterogeneous data on medication adherence and persistence. Many women do not take tamoxifen because of associated harms. Thirteen risk-stratification models were modest predictors of breast cancer. Limitation: Data on mortality and adherence measures and for women who are nonwhite, are premenopausal, or have comorbid conditions were lacking. Conclusion: Medications reduced the incidence of invasive breast cancer and fractures and increased the incidence of thromboembolic events. Tamoxifen was more effective than raloxifene but also increased the incidence of endometrial cancer and cataracts. Use is limited by adverse effects and inaccurate methods to identify candidates.	[Nelson, Heidi D.] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Portland, OR 97239 USA; Providence Hlth & Serv, Providence Canc Ctr, Portland, OR USA	Oregon Health & Science University	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Mailcode BICC,3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA.	nelsonh@ohsu.edu			AHRQ [HHSA-290-2007-10057-1-EPC3]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By AHRQ (contract HHSA-290-2007-10057-1-EPC3).	Adams-Campbell LL, 2007, BREAST J, V13, P332, DOI 10.1111/j.1524-4741.2007.00439.x; Agency for Healthcare Research and Quality, 2012, METH GUID EFF COMP E; Amir E, 2003, J MED GENET, V40, P807, DOI 10.1136/jmg.40.11.807; Archer DF, 2009, MENOPAUSE, V16, P1109, DOI 10.1097/gme.0b013e3181a818db; Armstrong K, 2006, ARCH INTERN MED, V166, P2260, DOI 10.1001/archinte.166.20.2260; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; Barrett-Connor E, 2002, JAMA-J AM MED ASSOC, V287, P847, DOI 10.1001/jama.287.7.847; Barrett-Connor E, 2004, J BONE MINER RES, V19, P1270, DOI 10.1359/JBMR.040406; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Bastian LA, 2001, ARCH INTERN MED, V161, P1639, DOI 10.1001/archinte.161.13.1639; Blenkinsopp A, 1997, COMPLIANCE CONCORDAN; Bober SL, 2004, J CLIN ONCOL, V22, P4951, DOI 10.1200/JCO.2004.05.192; Boughey JC, 2010, J CLIN ONCOL, V28, P3591, DOI 10.1200/JCO.2010.28.0784; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Boyle P, 2004, EUR J CANCER PREV, V13, P183, DOI 10.1097/01.cej.0000130014.83901.53; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Chalas E, 2005, AM J OBSTET GYNECOL, V192, P1230, DOI 10.1016/j.ajog.2004.12.083; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; Chlebowski RT, 2007, JNCI-J NATL CANCER I, V99, P1695, DOI 10.1093/jnci/djm224; Christodoulakos GE, 2006, MATURITAS, V53, P413, DOI 10.1016/j.maturitas.2005.07.003; Cohen FJ, 2000, OBSTET GYNECOL, V95, P104, DOI 10.1016/S0029-7844(99)00554-2; Colditz GA, 2000, AM J EPIDEMIOL, V152, P950, DOI 10.1093/aje/152.10.950; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Coopey SB, 2012, BREAST CANCER RES TR, V136, P627, DOI 10.1007/s10549-012-2318-8; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cummings SR, 2008, NEW ENGL J MED, V359, P697, DOI 10.1056/NEJMoa0800743; Cuzick J, 2002, LANCET, V360, P817; Cuzick J, 2007, JNCI-J NATL CANCER I, V99, P272, DOI 10.1093/jnci/djk049; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Day R, 2001, ANN NY ACAD SCI, V949, P143; Day R, 2001, J NATL CANCER I, V93, P1615, DOI 10.1093/jnci/93.21.1615; Decarli A, 2006, J NATL CANCER I, V98, P1686, DOI 10.1093/jnci/djj463; Decensi A, 2005, CIRCULATION, V111, P650, DOI 10.1161/01.CIR.0000154545.84124.AC; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Duvernoy CS, 2005, MENOPAUSE, V12, P444, DOI 10.1097/01.GME.0000151653.02620.89; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fagerlin A, 2011, BREAST CANCER RES TR, V127, P681, DOI 10.1007/s10549-011-1450-1; Fagerlin A, 2010, BREAST CANCER RES TR, V119, P613, DOI 10.1007/s10549-009-0618-4; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Freedman AN, 2011, J CLIN ONCOL, V29, P2327, DOI 10.1200/JCO.2010.33.0258; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2007, J NATL CANCER I, V99, P1782, DOI 10.1093/jnci/djm223; Gail MH, 2007, JNCI-J NATL CANCER I, V99, P1657, DOI 10.1093/jnci/djm228; Goldstein SR, 2005, MENOPAUSE, V12, P160, DOI 10.1097/00042192-200512020-00010; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Grady D, 2004, OBSTET GYNECOL, V104, P837, DOI 10.1097/01.AOG.0000137349.79204.b8; Grady D, 2008, J NATL CANCER I, V100, P854, DOI 10.1093/jnci/djn153; Grady D, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.12.018; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Iqbal J, 2012, CANCER TREAT REV, V38, P318, DOI 10.1016/j.ctrv.2011.06.009; Johnell O, 2004, J FAM PRACTICE, V53, P789; Johnston CC, 2000, ARCH INTERN MED, V160, P3444, DOI 10.1001/archinte.160.22.3444; Jolly EE, 2003, MENOPAUSE, V10, P337, DOI 10.1097/01.GME.0000058772.59606.2A; Kaplan CP, 2012, BREAST CANCER RES TR, V133, P357, DOI 10.1007/s10549-012-1960-5; Keech CA, 2005, CURR MED RES OPIN, V21, P135, DOI 10.1185/030079904X18045; Kinney AY, 1998, CANCER EPIDEM BIOMAR, V7, P591; Kinsinger LS, 2002, ANN INTERN MED, V137, P59, DOI 10.7326/0003-4819-137-1-200207020-00017; LaCroix AZ, 2010, JNCI-J NATL CANCER I, V102, P1706, DOI 10.1093/jnci/djq415; Land SR, 2006, JAMA-J AM MED ASSOC, V295, P2742, DOI 10.1001/jama.295.23.joc60075; Land SR, 2011, CANCER PREV RES, V4, P1393, DOI 10.1158/1940-6207.CAPR-11-0172; Lee EO, 2004, CANCER NURS, V27, P400; Lippman ME, 2006, CLIN CANCER RES, V12, P5242, DOI 10.1158/1078-0432.CCR-06-0688; Lufkin EG, 1998, J BONE MINER RES, V13, P1747, DOI 10.1359/jbmr.1998.13.11.1747; Martino S, 2005, CURR MED RES OPIN, V21, P1441, DOI 10.1185/030079905X61839; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; Martino S, 2004, ONCOLOGIST, V9, P116, DOI 10.1634/theoncologist.9-2-116; McClung MR, 2006, MENOPAUSE, V13, P377, DOI 10.1097/01.gme.0000188736.69617.4f; McKay A, 2005, BREAST CANCER RES TR, V94, P153, DOI 10.1007/s10549-005-6932-6; Melnikow J, 2005, CANCER-AM CANCER SOC, V103, P1996, DOI 10.1002/cncr.20981; Meunier PJ, 1999, OSTEOPOROSIS INT, V10, P330, DOI 10.1007/s001980050236; Morii H, 2003, OSTEOPOROSIS INT, V14, P793, DOI 10.1007/s00198-003-1424-1; Nelson HD, 2009, COMP EFFECTIVENESS R; Nelson HD, 2009, ANN INTERN MED, V151, P703, DOI [10.7326/0000605-200911170-00147, 10.7326/0003-4819-151-10-200911170-00147]; Ozanne EM, 2010, BREAST J, V16, P38, DOI 10.1111/j.1524-4741.2009.00857.x; Palacios S, 2004, AM J OBSTET GYNECOL, V191, P121, DOI 10.1016/j.ajog.2003.10.701; Petracci E, 2011, JNCI-J NATL CANCER I, V103, P1037, DOI 10.1093/jnci/djr172; Port ER, 2001, ANN SURG ONCOL, V8, P580; Powles T, 1998, LANCET, V352, P98; Powles TJ, 2007, JNCI-J NATL CANCER I, V99, P283, DOI 10.1093/jnci/djk050; Rockhill B, 2003, J CLIN EPIDEMIOL, V56, P856, DOI 10.1016/S0895-4356(03)00124-0; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Runowicz CD, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.067; Schonfeld SJ, 2010, J CLIN ONCOL, V28, P2411, DOI 10.1200/JCO.2009.25.2767; Silverman SL, 2004, J AM GERIATR SOC, V52, P1543, DOI 10.1111/j.1532-5415.2004.52420.x; Siris ES, 2005, J BONE MINER RES, V20, P1514, DOI 10.1359/JBMR.050509; Tamimi RM, 2010, CANCER-AM CANCER SOC, V116, P4944, DOI 10.1002/cncr.25386; Taylor R, 2005, ANN FAM MED, V3, P242, DOI 10.1370/afm.284; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; U.S. Preventive Services Task Force, 2002, CHEM BREAST CANC REC; US. Food and Drug Administration, DRUGS; Vacek PM, 2011, BREAST CANCER RES TR, V130, P291, DOI 10.1007/s10549-011-1576-1; Veronesi A, 1998, TUMORI, V84, P372, DOI 10.1177/030089169808400312; Veronesi U, 1998, LANCET, V352, P93; Veronesi U, 2003, J NATL CANCER I, V95, P160, DOI 10.1093/jnci/95.2.160; Veronesi U, 2007, J NATL CANCER I, V99, P727, DOI 10.1093/jnci/djk154; Vogel Victor G., 2010, Journal of the National Cancer Institute Monographs, P181, DOI 10.1093/jncimonographs/lgq041; Vogel VG, 2010, CANCER PREV RES, V3, P696, DOI 10.1158/1940-6207.CAPR-10-0076; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Waters EA, 2012, BREAST CANCER RES TR, V134, P875, DOI 10.1007/s10549-012-2089-2	106	121	125	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8					604	+		10.7326/0003-4819-158-8-201304160-00005	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-00005			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588749				2022-12-28	WOS:000318062100017
J	Fine, P; Victora, CG; Rothman, KJ; Moore, PS; Chang, Y; Curtis, V; Heymann, DL; Slutkin, G; May, RM; Patel, V; Roberts, I; Wortley, R; Torgerson, C; Deaton, A				Fine, Paul; Victora, Cesar G.; Rothman, Kenneth J.; Moore, Patrick S.; Chang, Yuan; Curtis, Val; Heymann, David L.; Slutkin, Gary; May, Robert M.; Patel, Vikram; Roberts, Ian; Wortley, Richard; Torgerson, Carole; Deaton, Angus			John Snow's legacy: epidemiology without borders	LANCET			English	Review							COMMON MENTAL-DISORDERS; HEALTH; BURDEN; RISK; DISEASE; INTERVENTION; CHALLENGES; PROSPECTS; BEHAVIOR; VIOLENCE	This Review provides abstracts from a meeting held at the London School of Hygiene and Tropical Medicine, on April 11-12, 2013, to celebrate the legacy of John Snow. They describe conventional and unconventional applications of epidemiological methods to problems ranging from diarrhoeal disease, mental health, cancer, and accident care, to education, poverty, financial networks, crime, and violence. Common themes appear throughout, including recognition of the importance of Snow's example, the philosophical and practical implications of assessment of causality, and an emphasis on the evaluation of preventive, ameliorative, and curative interventions, in a wide variety of medical and societal examples. Almost all self-described epidemiologists nowadays work within the health arena, and this is the focus of most of the societies, journals, and courses that carry the name epidemiology. The range of applications evident in these contributions might encourage some of these institutions to consider broadening their remits. In so doing, they may contribute more directly to, and learn from, non-health-related areas that use the language and methods of epidemiology to address many important problems now facing the world.	[Fine, Paul; Curtis, Val; Patel, Vikram; Roberts, Ian] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Victora, Cesar G.] Univ Fed Pelotas, Pelotas, Brazil; [Rothman, Kenneth J.] RTI Hlth Solut, Res Triangle Inst, Res Triangle Pk, NC USA; [Rothman, Kenneth J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Moore, Patrick S.; Chang, Yuan] Univ Pittsburgh, Inst Canc, Canc Virol Program, Pittsburgh, PA 15213 USA; [Heymann, David L.] Chatham House Ctr Global Secur, London, England; [Slutkin, Gary] Univ Illinois, Sch Publ Hlth, Chicago, IL USA; [May, Robert M.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Wortley, Richard] UCL, UCL Jill Dando Inst Secur & Crime Sci, London, England; [Torgerson, Carole] Univ Durham, Sch Educ, Durham, England; [Deaton, Angus] Princeton Univ, Princeton, NJ 08544 USA	University of London; London School of Hygiene & Tropical Medicine; Universidade Federal de Pelotas; Research Triangle Institute; Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Oxford; University of London; University College London; Durham University; Princeton University	Fine, P (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	paul.fine@lshtm.ac.uk	Moore, Patrick/GVR-8294-2022; Victora, Cesar Gomes/Y-2455-2019; Chang, Yuan/F-4146-2011; Moore, Patrick S./F-3960-2011; Victora, Cesar G/D-4476-2013	Victora, Cesar Gomes/0000-0002-2465-2180; Chang, Yuan/0000-0003-1125-4041; Moore, Patrick S./0000-0002-8132-858X; Victora, Cesar G/0000-0002-2465-2180; Rothman, Kenneth/0000-0003-2398-1705; Patel, Vikram/0000-0003-1066-8584	NATIONAL CANCER INSTITUTE [R01CA170354, R01CA136806, R01CA136363] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA136363, R01 CA170354, R01 CA136806] Funding Source: Medline; Wellcome Trust [091834] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON R M, 1991; ANGRIST JD, 1990, AM ECON REV, V80, P313; [Anonymous], 2011, PSYCHOL CRIMINOLOGY; [Anonymous], 2011, UN FORC INTR CHOL HA; Arinaminpathy N, 2012, P NATL ACAD SCI USA, V109, P18338, DOI 10.1073/pnas.1213767109; Aunger R, BIOL THEORY IN PRESS; Aunger R, 2008, BIOL PHILOS, V23, P317, DOI 10.1007/s10539-007-9108-4; Banerjee A., 2011, POOR EC RADICAL RETH; Banerjee AV, 2009, ANNU REV ECON, V1, P151, DOI 10.1146/annurev.economics.050708.143235; Barker RG, 1968, ECOLOGICAL PSYCHOL C, Vvi; Barreto SM, 2012, INT J EPIDEMIOL, V41, P557, DOI 10.1093/ije/dys017; BBC News, 2013, BBC NEWS; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; Blakely T, 2011, INT J EPIDEMIOL, V40, P1109, DOI 10.1093/ije/dyr014; Buttorff C, 2012, B WORLD HEALTH ORGAN, V90, P813, DOI 10.2471/BLT.12.104133; CARD D, 1994, AM ECON REV, V84, P772; CDC, 2011, HAIT CHOL OUTBR; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Clarke RV., 2008, ENV CRIMINOLOGY CRIM, P178; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Curtis V., 2011, APPL EVOLUTIONARY PS, P259; Curtis V, 2011, LANCET INFECT DIS, V11, P312, DOI 10.1016/S1473-3099(10)70224-3; Dhillon PK, 2012, INT J EPIDEMIOL, V41, P847, DOI 10.1093/ije/dys046; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Ferrari AJ, 2013, PSYCHOL MED, V43, P471, DOI 10.1017/S0033291712001511; FREEDMAN DA, 1991, SOCIOL METHODOL, V21, P291, DOI 10.2307/270939; Garcea RL, 2013, NAT REV MICROBIOL, DOI [10.1038/ nrmicro2992, DOI 10.1038/NRMICRO2992]; Graham K., 2008, RAISING BAR PREVENTI; Guerriero C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018987; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Hethcote HW, 1984, LECT NOTES BIOMATHEM; Huesmann LR, 2007, CAMB HANDB PSYCHOL, P545; Institute for Justice and Democracy in Haiti, CHOL LIT; Judah G, 2009, AM J PUBLIC HEALTH, V99, pS405, DOI 10.2105/AJPH.2009.164160; Lash TL., 2009, APPL QUANTITATIVE BI; Laycock G., 2005, CRIME SCI NEW APPROA, P3; Lindquist E. F., 1940, STAT ANAL ED RES; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; May RM., 2012, FINANC TIMES; Nachega JB, 2012, INT J EPIDEMIOL, V41, P1829, DOI 10.1093/ije/dys189; Ouellette JA, 1998, PSYCHOL BULL, V124, P54, DOI 10.1037/0033-2909.124.1.54; Patel V, 2011, BRIT J PSYCHIAT, V199, P459, DOI 10.1192/bjp.bp.111.092155; Ransford CL, EPIDEMIOLOG IN PRESS, P232; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Russell B, 1912, PROBLEMS PHILOS HOME; Semmelweis I., 1983, ETIOLOGY CONCEPT PRO; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Skogan W, 2009, EVALUATION CEASEFIRE, P7; Slutkin Gary, 2013, CONTAGION VIOLENCE W, V94, P104; Smith GD, 2002, INT J EPIDEMIOL, V31, P920, DOI 10.1093/ije/31.5.920; Snow J., 1860, MODE COMMUNICATION C; Snow J., 1855, MODE COMMUNICATION C; Surkan PJ, 2011, B WORLD HEALTH ORGAN, V89, P607, DOI 10.2471/BLT.11.088187; Toporowski A, 2012, INT J EPIDEMIOL, V41, P540, DOI 10.1093/ije/dys018; Torgerson CJ, 2005, BRIT EDUC RES J, V31, P761, DOI 10.1080/01411920500314919; Torgerson DJ, 2008, DESIGNING RANDOMISED TRIALS IN HEALTH, EDUCATION AND THE SOCIAL SCIENCES: AN INTRODUCTION, P1, DOI 10.1057/9780230583993; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walters JE, 1931, J HIGH EDUC, V2, P446, DOI 10.2307/1974433; Webster DW, 2013, J URBAN HEALTH, V90, P27, DOI 10.1007/s11524-012-9731-5; Williams A, 1999, HEALTH ECON, V8, P1; World Health Organization, 2016, MHGAP INT GUID MENT	66	24	25	1	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2013	381	9874					1302	1311		10.1016/S0140-6736(13)60771-0	http://dx.doi.org/10.1016/S0140-6736(13)60771-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122XD	23582396	Green Accepted			2022-12-28	WOS:000317351000033
J	Austin, AT; Bustamante, MMC; Nardoto, GB; Mitre, SK; Perez, T; Ometto, JPHB; Ascarrunz, NL; Forti, MC; Longo, K; Gavito, ME; Enrich-Prast, A; Martinelli, LA				Austin, A. T.; Bustamante, M. M. C.; Nardoto, G. B.; Mitre, S. K.; Perez, T.; Ometto, J. P. H. B.; Ascarrunz, N. L.; Forti, M. C.; Longo, K.; Gavito, M. E.; Enrich-Prast, A.; Martinelli, L. A.			Latin America's Nitrogen Challenge	SCIENCE			English	Editorial Material							CYCLE; STREAMS; FOREST; TRENDS		[Austin, A. T.] Univ Buenos Aires, IFEVA CONICET, Buenos Aires, DF, Argentina; [Bustamante, M. M. C.; Nardoto, G. B.; Mitre, S. K.] Univ Brasilia, Brasilia, DF, Brazil; [Perez, T.] Inst Venezolano Invest Cient, Caracas, Venezuela; [Ometto, J. P. H. B.; Forti, M. C.; Longo, K.] Inst Nacl Pesquisas Espaciais, BR-12201 Sao Jose Dos Campos, Brazil; [Ascarrunz, N. L.] Inst Boliviano Invest Forestal, Santa Cruz, Bolivia; [Gavito, M. E.] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico; [Enrich-Prast, A.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Martinelli, L. A.] CENA Univ Sao Paulo, Piracicaba, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidade de Brasilia; Venezuelan Institute Science Research; Instituto Nacional de Pesquisas Espaciais (INPE); Universidad Nacional Autonoma de Mexico; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Martinelli, LA (corresponding author), CENA Univ Sao Paulo, Piracicaba, Brazil.	martinelli@cena.usp.br	Prast, Alex Enrich/AAL-4722-2021; Austin, Amy/E-7988-2011; MITRE, SIMONE/F-1789-2019; Ometto, Jean Pierre/B-3351-2013; Bustamante, Mercedes/AAQ-7231-2020; Bustamante, Mercedes/GQZ-8625-2022; Nardoto, Gabriela Bielefeld/J-7459-2012; Libardoni, Bruno G/P-3873-2014; Bustamante, Mercedes MC/H-7597-2015; Gavito, Mayra E/K-1639-2019; Martinelli, Luiz Antonio/F-7870-2011; Enrich-Prast, Alex/H-5391-2012	Prast, Alex Enrich/0000-0003-3561-0936; Austin, Amy/0000-0002-7468-5861; Ometto, Jean Pierre/0000-0002-4221-1039; Bustamante, Mercedes/0000-0003-1008-452X; Nardoto, Gabriela Bielefeld/0000-0001-8062-7417; Bustamante, Mercedes MC/0000-0003-1008-452X; Gavito, Mayra E/0000-0003-3556-7886; Martinelli, Luiz Antonio/0000-0002-7103-7551; 				Acemoglu D., 2012, WHY NATIONS FAIL; Acemoglu D, 2012, J ECON THEORY, V147, P570, DOI 10.1016/j.jet.2010.09.001; Alonso MF, 2010, ATMOS ENVIRON, V44, P5072, DOI 10.1016/j.atmosenv.2010.09.013; Austin AT, 2006, BIOGEOCHEMISTRY, V79, P45, DOI 10.1007/s10533-006-9002-1; Bleeker A, 2011, ENVIRON POLLUT, V159, P2280, DOI 10.1016/j.envpol.2010.10.036; Cerdeira AL, 2011, J AGR FOOD CHEM, V59, P5799, DOI 10.1021/jf102652y; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Chuvieco E, 2008, ECOL APPL, V18, P64, DOI 10.1890/06-2148.1; Daniel MHB, 2002, WATER AIR SOIL POLL, V136, P189, DOI 10.1023/A:1015287708170; Ferreira J, 2012, J APPL ECOL, V49, P535, DOI 10.1111/j.1365-2664.2012.02145.x; Filoso S, 2006, BIOGEOCHEMISTRY, V79, P61, DOI 10.1007/s10533-006-9003-0; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Herrero M, 2010, SCIENCE, V327, P822, DOI 10.1126/science.1183725; Hotez P. J., 2008, PLOS NEGLECT TROP D, V2, pe1757; Janssen R, 2011, ENERG POLICY, V39, P5717, DOI 10.1016/j.enpol.2011.01.047; Kay C, 2001, THIRD WORLD Q, V22, P741, DOI 10.1080/01436590120084584; Martinelli LA, 2006, BIOGEOCHEMISTRY, V79, P3, DOI 10.1007/s10533-006-9000-3; Martinelli LA, 2011, AGR SYST, V104, P419, DOI 10.1016/j.agsy.2011.01.006; Martinelli LA, 2011, NATURE, V474, P579, DOI 10.1038/474579a; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Ometo JPHB, 2000, FRESHWATER BIOL, V44, P327, DOI 10.1046/j.1365-2427.2000.00557.x; Salvagiotti F, 2008, FIELD CROP RES, V108, P1, DOI 10.1016/j.fcr.2008.03.001; Smaling EMA, 2008, AGR ECOSYST ENVIRON, V128, P185, DOI 10.1016/j.agee.2008.06.005; Trebs I, 2006, ATMOS CHEM PHYS, V6, P447, DOI 10.5194/acp-6-447-2006; van der Struijk LF, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003572	25	29	33	0	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					149	149		10.1126/science.1231679	http://dx.doi.org/10.1126/science.1231679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580515				2022-12-28	WOS:000317341400039
J	Betschinger, J; Nichols, J; Dietmann, S; Corrin, PD; Paddison, PJ; Smith, A				Betschinger, Joerg; Nichols, Jennifer; Dietmann, Sabine; Corrin, Philip D.; Paddison, Patrick J.; Smith, Austin			Exit from Pluripotency Is Gated by Intracellular Redistribution of the bHLH Transcription Factor Tfe3	CELL			English	Article							EMBRYONIC STEM-CELLS; GROUND-STATE PLURIPOTENCY; HOGG-DUBE-SYNDROME; SELF-RENEWAL; TUMOR-DEVELOPMENT; TSC2 MUTATION; GENE-PRODUCT; DIFFERENTIATION; FOLLICULIN; PROTEIN	Factors that sustain self-renewal of mouse embryonic stem cells (ESCs) are well described. In contrast, the machinery regulating exit from pluripotency is ill defined. In a large-scale small interfering RNA (siRNA) screen, we found that knockdown of the tumor suppressors Folliculin (Flcn) and Tsc2 prevent ESC commitment. Tsc2 lies upstream of mammalian target of rapamycin (mTOR), whereas Flcn acts downstream and in parallel. Flcn with its interaction partners Fnip1 and Fnip2 drives differentiation by restricting nuclear localization and activity of the bHLH transcription factor Tfe3. Conversely, enforced nuclear Tfe3 enables ESCs to withstand differentiation conditions. Genome-wide location and functional analyses showed that Tfe3 directly integrates into the pluripotency circuitry through transcriptional regulation of Esrrb. These findings identify a cell-intrinsic rheostat for destabilizing ground-state pluripotency to allow lineage commitment. Congruently, stage-specific subcellular relocalization of Tfe3 suggests that Flcn-Fnip1/2 contributes to developmental progression of the pluripotent epiblast in vivo.	[Betschinger, Joerg; Nichols, Jennifer; Dietmann, Sabine; Smith, Austin] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England; [Betschinger, Joerg; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Nichols, Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QR, England; [Corrin, Philip D.; Paddison, Patrick J.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA	University of Cambridge; University of Cambridge; University of Cambridge; Fred Hutchinson Cancer Center	Betschinger, J (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England.	jb579@cam.ac.uk; austin.smith@cscr.cam.ac.uk		Smith, Austin/0000-0002-3029-4682; Nichols, Jennifer/0000-0002-8650-1388; Dietmann, Sabine./0000-0001-6672-8457; Betschinger, Joerg/0000-0002-2627-8479	Medical Research Council; Wellcome Trust; European Commission [242129]; Human Frontier Science Program fellowship [LT00686/2007-L]; Medical Research Council [MC_PC_12009, G1100526] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); Human Frontier Science Program fellowship(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Tuzer Kalkan and Graziano Martello for help, advice, and reagents; Raja Kittappa, Martin Leeb, and Harry Leitch for comments; Ravi Nookala for discussion; Ge Guo for providing OEC-2 EpiSCs; and Sandra Gomez-Lopez and Jose Silva for sharing CreERT2, pDONR221-Klf4, and -Nanog plasmids. We are grateful to Laura Schmidt for generously providing Flcn antibodies and mice; Kathryn Lilley, Mike Deery, and Svenja Hesters of the Cambridge Centre for Proteomics for performing and analyzing mass spectrometry; Rachael Walker for flow cytometry; William Mansfield and Charles-Etienne Dumeau for blastocyst injections; Samuel Jameson and team for husbandry; Peter Humphreys for image quantification; Maike Paramor for ChIP-Seq library generation; and Rosalind Drummond and Melanie Rittirsch for technical assistance. This study was funded by the Medical Research Council, Wellcome Trust, and the European Commission FP7 project SyBOSS (242129). J.B. is recipient of a Human Frontier Science Program fellowship (LT00686/2007-L), P.J.P. is a Pew Scholar in Biomedical Sciences, and A. S. is a Medical Research Council Professor. J.B. performed and interpreted experiments, J.N. performed embryo immunohistochemistry and ESC derivations, S. D. performed bioinformatical analysis, and P. D. C. and P. J. P. provided and assisted with the siRNA-screening platform. A. S. supervised the study and wrote the paper with J.B.	Armah HB, 2010, ARCH PATHOL LAB MED, V134, P124, DOI 10.1043/2008-0391-RSR.1; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Baba M, 2012, BLOOD, V120, P1254, DOI 10.1182/blood-2012-02-410407; Brannon M, 1999, DEVELOPMENT, V126, P3159; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chanut-Delalande H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010245; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hong SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015793; Huan CM, 2006, NAT IMMUNOL, V7, P1082, DOI 10.1038/ni1378; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kobayashi T, 1999, CANCER RES, V59, P1206; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Miller AJ, 2004, CANCER RES, V64, P509, DOI 10.1158/0008-5472.CAN-03-2440; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Park H, 2012, IMMUNITY, V36, P769, DOI 10.1016/j.immuni.2012.02.019; Percharde M, 2012, GENE DEV, V26, P2286, DOI 10.1101/gad.195545.112; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Piao XH, 2009, BIOCHEM BIOPH RES CO, V389, P16, DOI 10.1016/j.bbrc.2009.08.070; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Steingrimsson E, 2002, P NATL ACAD SCI USA, V99, P4477, DOI 10.1073/pnas.072071099; Takagi Y, 2008, ONCOGENE, V27, P5339, DOI 10.1038/onc.2008.261; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tarleton HP, 2010, MECH DEVELOP, V127, P107, DOI 10.1016/j.mod.2009.10.002; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Westerman BA, 2011, J EXP MED, V208, P2675, DOI 10.1084/jem.20102037; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Yang SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003112; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	50	228	233	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					335	347		10.1016/j.cell.2013.03.012	http://dx.doi.org/10.1016/j.cell.2013.03.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582324	Green Published, hybrid			2022-12-28	WOS:000317349700013
J	Grigoropoulos, NF; Petter, R; Van 't Veer, MB; Scott, MA; Follows, GA				Grigoropoulos, Nicholas F.; Petter, Roger; Van 't Veer, Mars B.; Scott, Mike A.; Follows, George A.			Leukaemia update. Part 2: managing patients with leukaemia in the community	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; QUALITY-OF-LIFE; B-CELL RECEPTOR; SUPPORTIVE CARE; ADULT SURVIVORS; CHEMOTHERAPY; GUIDELINES; MANAGEMENT; CANCER		[Grigoropoulos, Nicholas F.] Univ Cambridge, Cambridge Univ Hosp NHS Fdn Trust, Div Mol Histopathol, Dept Pathol, Cambridge, England; [Petter, Roger] Linton Hlth Ctr, Cambridge, England; [Van 't Veer, Mars B.; Scott, Mike A.; Follows, George A.] Cambridge Univ Hosp NHS Fdn Trust, Dept Haematol, Cambridge CB2 0QQ, England	University of Cambridge; University of Cambridge	Follows, GA (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Dept Haematol, Cambridge CB2 0QQ, England.	george.follows@addenbrookes.nhs.uk						[Anonymous], 2008, CLASSIFICATION OF TU; Baden LR, 2012, J NATL COMPR CANC NE, V10, P1412, DOI 10.6004/jnccn.2012.0146; Billio A, 2010, COCHRANE DB SYST REV, V1; Bishop L, 2007, INT J LAB HEMATOL, V29, P261, DOI 10.1111/j.1751-553X.2007.00931.x; Candy B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003448.pub3; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; Chabner BA, 2012, MANAGEMENT OF ADVERS; CLARK OA, 2003, COCHRANE DB SYST REV, V3; Culhane B., 1983, GUIDELINES FOR CANCE, P487; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; Department of Health, 2013, CHEMOTHERAPY IN THE; Deschler B, 2013, HAEMATOLOGICA, V98, P208, DOI 10.3324/haematol.2012.067892; Dignan FL, 2012, BRIT J HAEMATOL, V158, P62, DOI 10.1111/j.1365-2141.2012.09131.x; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; dos Santos LV, 2012, JNCI-J NATL CANCER I, V104, P1280, DOI 10.1093/jnci/djs335; Else M, 2012, LEUKEMIA LYMPHOMA, V53, P1289, DOI 10.3109/10428194.2011.649479; Ettinger David S, 2007, J Natl Compr Canc Netw, V5, P12; Falanga A, 2009, J CLIN ONCOL, V27, P4848, DOI 10.1200/JCO.2009.22.8197; Hoellenriegel J, 2011, BLOOD, V118, P3603, DOI 10.1182/blood-2011-05-352492; JACKSON DV, 1988, AM J MED, V84, P1016, DOI 10.1016/0002-9343(88)90306-3; Jansen AJG, 2004, TRANSFUSION MED, V14, P33, DOI 10.1111/j.0958-7578.2004.00477.x; Kelsey P, 2003, BRIT J HAEMATOL, V122, P10; Kris MG, 2006, J CLIN ONCOL, V24, P2932, DOI 10.1200/JCO.2006.06.9591; Ljungman P, 2005, BRIT J HAEMATOL, V130, P96, DOI 10.1111/j.1365-2141.2005.05582.x; Milligan DW, 2006, BLOOD, V107, P4614, DOI 10.1182/blood-2005-10-4202; Morton LM, 2013, BLOOD; Mulrooney DA, 2008, SLEEP, V31, P271, DOI 10.1093/sleep/31.2.271; Murphy MF, 2001, BRIT J HAEMATOL, V113, P24; Oscier D, 2012, BRIT J HAEMATOL, V159, P541, DOI 10.1111/bjh.12067; Pashankar FD, 2011, J PEDIAT HEMATOL ONC, V33, pE300, DOI 10.1097/MPH.0b013e31821a0795; Phillips R, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5368; Snowden JA, 2011, BRIT J HAEMATOL, V154, P76, DOI 10.1111/j.1365-2141.2011.08574.x; Steffens M, 2008, CLIN ENDOCRINOL, V69, P819, DOI 10.1111/j.1365-2265.2008.03283.x; Stensheim H, 2011, INT J CANCER, V129, P1225, DOI 10.1002/ijc.26045	34	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2013	346								f1932	10.1136/bmj.f1932	http://dx.doi.org/10.1136/bmj.f1932			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125ZC	23571739				2022-12-28	WOS:000317579800003
J	Gokmen, MR; Cosyns, JP; Arlt, VM; Stiborova, M; Phillips, DH; Schmeiser, HH; Simmonds, MSJ; Cook, HT; Vanherweghem, JL; Nortier, JL; Lord, GM				Goekmen, M. Refik; Cosyns, Jean-Pierre; Arlt, Volker M.; Stiborova, Marie; Phillips, David H.; Schmeiser, Heinz H.; Simmonds, Monique S. J.; Cook, H. Terence; Vanherweghem, Jean-Louis; Nortier, Joelle L.; Lord, Graham M.			The Epidemiology, Diagnosis, and Management of Aristolochic Acid Nephropathy A Narrative Review	ANNALS OF INTERNAL MEDICINE			English	Review							BALKAN ENDEMIC NEPHROPATHY; CHINESE HERBS NEPHROPATHY; INTERSTITIAL RENAL FIBROSIS; TRACT UROTHELIAL CARCINOMA; DNA-ADDUCTS; KIDNEY-TRANSPLANTATION; FANCONI-SYNDROME; RISK-FACTOR; EXPOSURE; ETIOLOGY	It has been 20 years since the first description of a rapidly progressive renal disease that is associated with the consumption of Chinese herbs containing aristolochic acid (AA) and is now termed aristolochic acid nephropathy (AAN). Recent data have shown that AA is also the primary causative agent in Balkan endemic nephropathy and associated urothelial cancer. Aristolochic acid nephropathy is associated with a high long-term risk for renal failure and urothelial cancer, and the potential worldwide population exposure is enormous. This evidence-based review of the diagnostic approach to and management of AAN draws on the authors' experience with the largest and longest-studied combined cohort of patients with this condition. It is hoped that a better understanding of the importance of this underrecognized and severe condition will improve epidemiologic, preventive, and therapeutic strategies to reduce the global burden of this disease. Ann Intern Med. 2013; 158: 469-477.	Kings Coll London, London SE1 9RT, England; Univ London Imperial Coll Sci Technol & Med, London, England; Catholic Univ Louvain, Clin Univ St Luc, B-200 Brussels, Belgium; Univ Libre Bruxelles, Erasme Hosp, Brussels, Belgium; Charles Univ Prague, Prague 12840 2, Czech Republic; German Canc Res Ctr, Heidelberg, Germany; Royal Bot Gardens, Surrey, England	University of London; King's College London; Imperial College London; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Charles University Prague; Helmholtz Association; German Cancer Research Center (DKFZ); Royal Botanic Gardens, Kew	Lord, GM (corresponding author), Kings Coll London, Dept Expt Immunobiol, Div Transplantat Immunol & Mucosal Biol, Guys Hosp, 5th Floor,Tower Wing, London SE1 9RT, England.	graham.lord@kcl.ac.uk	Stiborova, Marie/A-5982-2015; Abraham, Sabu/E-1144-2019	Stiborova, Marie/0000-0001-5430-4403; Abraham, Sabu/0000-0002-0916-5827; Gokmen, Refik/0000-0001-7388-217X; Nortier, Joelle/0000-0003-3609-8217; Lord, Graham/0000-0003-2069-4743; Arlt, Volker Manfred/0000-0003-4314-9318; Phillips, David/0000-0001-8509-3485	Association for International Cancer Research; NIHR Clinical Lectureship; Kidney Research UK; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre at King's College London; Cancer Research UK; Cancer Research UK [14329] Funding Source: researchfish; Medical Research Council [MR/J006742/1, G0801056B] Funding Source: researchfish; National Institute for Health Research [CL-2010-17-010] Funding Source: researchfish	Association for International Cancer Research; NIHR Clinical Lectureship; Kidney Research UK(Kidney Research UK (KRUK)); NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre at King's College London; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The preparation of this review was supported in part by a project grant from the Association for International Cancer Research. Dr. Gokmen is supported by an NIHR Clinical Lectureship and was previously supported by Kidney Research UK. Drs. Gokmen and Lord are supported by the NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. Drs. Arlt and Phillips are supported by Cancer Research UK.	Arlt VM, 2004, INT J CANCER, V111, P977, DOI 10.1002/ijc.20316; Arlt VM, 2002, INT J CANCER, V101, P500, DOI 10.1002/ijc.10602; Arlt VM, 2007, CARCINOGENESIS, V28, P2253, DOI 10.1093/carcin/bgm082; Bieler CA, 1997, CARCINOGENESIS, V18, P1063, DOI 10.1093/carcin/18.5.1063; Chau WN, 2011, MED J AUSTRALIA, V194, P367, DOI 10.5694/j.1326-5377.2011.tb03011.x; Chen CY, 2007, J FORMOS MED ASSOC, V106, P992, DOI 10.1016/S0929-6646(08)60074-1; Chen CH, 2012, P NATL ACAD SCI USA, V109, P8241, DOI 10.1073/pnas.1119920109; Chen DM, 2012, CLIN NEPHROL, V78, P54, DOI 10.5414/CN107414; COSYNS JP, 1994, LANCET, V344, P188, DOI 10.1016/S0140-6736(94)92786-3; Cosyns JP, 2003, DRUG SAFETY, V26, P33, DOI 10.2165/00002018-200326010-00004; COSYNS JP, 1994, KIDNEY INT, V45, P1680, DOI 10.1038/ki.1994.220; Cosyns JP, 1999, AM J KIDNEY DIS, V33, P1011, DOI 10.1016/S0272-6386(99)70136-8; Cukuranovic R, 2005, RENAL FAILURE, V27, P701, DOI 10.1080/08860220500242769; Debelle FD, 2004, KIDNEY INT, V66, P1815, DOI 10.1111/j.1523-1755.2004.00905.x; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; DEPIERREUX M, 1994, AM J KIDNEY DIS, V24, P172, DOI 10.1016/S0272-6386(12)80178-8; Djukanovic L, 2002, INT J ARTIF ORGANS, V25, P852, DOI 10.1177/039139880202500907; Gokmen MR, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4000; Gold LS, 2003, NEW ENGL J MED, V349, P1576, DOI 10.1056/NEJM200310163491619; Grollman AP, 2007, P NATL ACAD SCI USA, V104, P12129, DOI 10.1073/pnas.0701248104; Heinrich M, 2009, J ETHNOPHARMACOL, V125, P108, DOI 10.1016/j.jep.2009.05.028; Hranjec T, 2005, CROAT MED J, V46, P116; Hsieh Shu-Ching, 2008, Chin Med, V3, P13, DOI 10.1186/1749-8546-3-13; Hsieh Y F, 1979, Taiwan Yi Xue Hui Za Zhi, V78, P749; International Agency for Research on Cancer (IARC), 2012, IARC MONOGR EVAL C A, V100A, P347; Ivic M, 1969, Lijec Vjesn, V91, P1273; Jelakovic B, 2012, KIDNEY INT, V81, P559, DOI 10.1038/ki.2011.371; Krumme B, 2001, NEPHROL DIAL TRANSPL, V16, P400, DOI 10.1093/ndt/16.2.400; Kucab JE, 2010, FEBS J, V277, P2567, DOI [10.1111/j.1742-4658.2010.07676.x, 10.1111/j.1742-464X.2010.07676.x]; Lai MN, 2010, JNCI-J NATL CANCER I, V102, P179, DOI 10.1093/jnci/djp467; Lai MN, 2009, NEPHROLOGY, V14, P227, DOI 10.1111/j.1440-1797.2008.01061.x; Laing C, 2006, LANCET, V368, P338, DOI 10.1016/S0140-6736(06)69079-X; Lee S, 2004, NEPHROLOGY, V9, P126, DOI 10.1111/j.1440-1797.2003.00232.x; Lemy A, 2008, AM J KIDNEY DIS, V51, P471, DOI 10.1053/j.ajkd.2007.11.015; Li Wei-hua, 2005, Zhonghua Yi Xue Za Zhi, V85, P2487; Lord GM, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2003.11.024; Lord GM, 1999, LANCET, V354, P481, DOI 10.1016/S0140-6736(99)03380-2; Lord GM, 2001, LANCET, V358, P1515, DOI 10.1016/S0140-6736(01)06576-X; Martinez MCM, 2002, NEPHROL DIAL TRANSPL, V17, P408, DOI 10.1093/ndt/17.3.408; Meyer M M, 2000, Proc (Bayl Univ Med Cent), V13, P334; Minzhi S., 2000, ADV COURSE BASKETBAL, Vfirst; National Toxicology Program, 2008, REP CARC BACKGR DOC; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; Nortier JL, 2003, NEPHROL DIAL TRANSPL, V18, P426, DOI 10.1093/ndt/18.2.426; Pena JM, 1996, NEPHROL DIAL TRANSPL, V11, P1359, DOI 10.1093/ndt/11.7.1359; Pesic I, 2011, J PROTEOMICS, V74, P1994, DOI 10.1016/j.jprot.2011.05.020; Polenakovic M, 1998, OXFORD TXB CLIN NEPH, P1203; Poon WingTat, 2007, Hong Kong Journal of Nephrology, V9, P7, DOI 10.1016/S1561-5413(07)60003-9; POURRAT J, 1994, PRESSE MED, V23, P1669; Pozdzik AA, 2010, HISTOPATHOLOGY, V56, P449, DOI 10.1111/j.1365-2559.2010.03509.x; Rai BP, 2012, BJU INT, V110, P1426, DOI 10.1111/j.1464-410X.2012.11341.x; Reginster F, 1997, NEPHROL DIAL TRANSPL, V12, P81, DOI 10.1093/ndt/12.1.81; Rojas J.-P., 2010, INDEPENDENT; Roupret M, 2011, EUR UROL, V59, P584, DOI 10.1016/j.eururo.2010.12.042; Schmeiser HH, 2012, ENVIRON MOL MUTAGEN, V53, P636, DOI 10.1002/em.21732; Schmeiser HH, 1996, CANCER RES, V56, P2025; Stefanovic V, 2006, AM J NEPHROL, V26, P1, DOI 10.1159/000090705; Stefanovic V, 2007, RENAL FAILURE, V29, P867, DOI 10.1080/08860220701600732; Stefanovic V, 2011, RENAL FAILURE, V33, P176, DOI 10.3109/0886022X.2011.552152; Stengel B, 1998, NEPHROLOGIE, V19, P15; Tanaka A, 2000, CLIN NEPHROL, V53, P301; TANCHEV I, 1956, Suvr Med (Sofiia), V7, P14; Tatu CA, 1998, ENVIRON HEALTH PERSP, V106, P689, DOI 10.2307/3434257; U.S. Food and Drug Administration, 2001, BOT PROD DET FDA CON; U.S. Food and Drug Administration, 2001, DIET SUPPL ARS AC; VANHAELEN M, 1994, LANCET, V343, P174, DOI 10.1016/S0140-6736(94)90964-4; VANHERWEGHEM JL, 1995, NEPHROL DIAL TRANSPL, V10, P270; Vanherweghem JL, 1997, LANCET, V349, P1399, DOI 10.1016/S0140-6736(05)63243-6; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Vanherweghem JL, 1996, AM J KIDNEY DIS, V27, P209, DOI 10.1016/S0272-6386(96)90542-9; Wu KM, 2007, PHYTOMEDICINE, V14, P273, DOI 10.1016/j.phymed.2006.05.009; Yang CS, 2000, AM J KIDNEY DIS, V35, P313, DOI 10.1016/S0272-6386(00)70343-X; Yang L, 2012, NEPHROL DIAL TRANSPL, V27, P292, DOI 10.1093/ndt/gfr291; Yang MH, 2002, UROLOGY, V59, P681, DOI 10.1016/S0090-4295(02)01529-7; Yuan M, 2009, UROL INT, V83, P200, DOI 10.1159/000230024; Zhu SH, 2010, FORENSIC SCI INT, V199, pE5, DOI 10.1016/j.forsciint.2010.02.003; Zlotta AR, 2011, EUR UROL, V59, P1026, DOI 10.1016/j.eururo.2011.03.027	77	108	112	1	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6					469	477		10.7326/0003-4819-158-6-201303190-00006	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23552405				2022-12-28	WOS:000316565100015
J	Hill, NS				Hill, Nicholas S.			Review: Lower rather than higher tidal volume benefits ventilated patients without ARDS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Tufts Med Ctr, Boston, MA USA	Tufts Medical Center	Hill, NS (corresponding author), Tufts Med Ctr, Boston, MA USA.		Serpa Neto, Ary/D-1927-2012	Serpa Neto, Ary/0000-0003-1520-9387				Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Ferguson ND, 2012, JAMA-J AM MED ASSOC, V308, P1689, DOI 10.1001/jama.2012.14509	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6							JC4	10.7326/0003-4819-158-6-201303190-02004	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23552719				2022-12-28	WOS:000316565100003
J	Baarlink, C; Wang, HC; Grosse, R				Baarlink, Christian; Wang, Haicui; Grosse, Robert			Nuclear Actin Network Assembly by Formins Regulates the SRF Coactivator MAL	SCIENCE			English	Article							SERUM RESPONSE FACTOR; AUTOREGULATORY DOMAIN; GENE-TRANSCRIPTION; DYNAMICS; MDIA1	Formins are potent activators of actin filament assembly in the cytoplasm. In turn, cytoplasmic actin polymerization can promote release of actin from megakaryocytic acute leukemia (MAL) protein for serum response factor (SRF) transcriptional activity. We found that formins polymerized actin inside the mammalian nucleus to drive serum-dependent MAL-SRF activity. Serum stimulated rapid assembly of actin filaments within the nucleus in a formin-dependent manner. The endogenous formin mDia was regulated with an optogenetic tool, which allowed for photoreactive release of nuclear formin autoinhibition. Activated mDia promoted rapid and reversible nuclear actin network assembly, subsequent MAL nuclear accumulation, and SRF activity. Thus, a dynamic polymeric actin structure within the nucleus is part of the serum response.	[Baarlink, Christian; Wang, Haicui; Grosse, Robert] Univ Marburg, Inst Pharmacol, BPC, D-35032 Marburg, Germany	Philipps University Marburg	Grosse, R (corresponding author), Univ Marburg, Inst Pharmacol, BPC, D-35032 Marburg, Germany.	robert.grosse@staff.uni-marburg.de		Grosse, Robert/0000-0002-3380-5273	Deutsche Forschungsgemeinschaft [GR 2111/2-1, SFB 593]; Deutsche Krebshilfe e.V. [108293]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe e.V.(Deutsche Krebshilfe)	We thank J. V. Small for advice on rapid actin fixation, L. O. Essen and C. Taxis for advice on using the LOV-domain, M. Innocenti for mDia2 antibodies, B. Di Ventura for critical reading of the manuscript, and laboratory members for discussions. This work was funded by grants from the Deutsche Forschungsgemeinschaft (GR 2111/2-1 and SFB 593) and the Deutsche Krebshilfe e.V. (108293) to R. G. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Baarlink C, 2010, CELL, V142, DOI 10.1016/j.cell.2010.06.030; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Copeland SJ, 2007, J BIOL CHEM, V282, P30120, DOI 10.1074/jbc.M703834200; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Gauvin TJ, 2009, BIOCHEMISTRY-US, V48, P9327, DOI 10.1021/bi901354z; Gieni RS, 2009, BIOCHEM CELL BIOL, V87, P283, DOI 10.1139/O08-133; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Jockusch BM, 2006, TRENDS CELL BIOL, V16, P391, DOI 10.1016/j.tcb.2006.06.006; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Miki T, 2009, J BIOL CHEM, V284, P5753, DOI 10.1074/jbc.M806191200; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Vartiainen MK, 2008, FEBS LETT, V582, P2033, DOI 10.1016/j.febslet.2008.04.010; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019	20	239	243	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					864	867		10.1126/science.1235038	http://dx.doi.org/10.1126/science.1235038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23558171				2022-12-28	WOS:000318997400044
J	Caron, SJC; Ruta, V; Abbott, LF; Axel, R				Caron, Sophie J. C.; Ruta, Vanessa; Abbott, L. F.; Axel, Richard			Random convergence of olfactory inputs in the Drosophila mushroom body	NATURE			English	Article							IMAGING REVEALS; NEURONS; MAP; REPRESENTATION; ABLATION	The mushroom body in the fruitfly Drosophila melanogaster is an associative brain centre that translates odour representations into learned behavioural responses(1). Kenyon cells, the intrinsic neurons of the mushroom body, integrate input from olfactory glomeruli to encode odours as sparse distributed patterns of neural activity(2,3). We have developed anatomic tracing techniques to identify the glomerular origin of the inputs that converge onto 200 individual Kenyon cells. Here we show that each Kenyon cell integrates input from a different and apparently random combination of glomeruli. The glomerular inputs to individual Kenyon cells show no discernible organization with respect to their odour tuning, anatomic features or developmental origins. Moreover, different classes of Kenyon cells do not seem to preferentially integrate inputs from specific combinations of glomeruli. This organization of glomerular connections to the mushroom body could allow the fly to contextualize novel sensory experiences, a feature consistent with the role of this brain centre in mediating learned olfactory associations and behaviours.	[Caron, Sophie J. C.; Abbott, L. F.; Axel, Richard] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Ruta, Vanessa] Rockefeller Univ, Lab Neurophysiol & Behav, New York, NY 10065 USA; [Abbott, L. F.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Axel, Richard] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Axel, Richard] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Rockefeller University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.	ra27@columbia.edu		CARON, SOPHIE/0000-0002-9230-2983; Axel, Richard/0000-0002-3141-4076; Ruta, Vanessa/0000-0002-4963-2768	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; Howard Hughes Medical Institute; Swartz Foundation; Gatsby Foundation; Pew Charitable Trusts; McKnight Foundation; New York Stem Cell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Swartz Foundation; Gatsby Foundation; Pew Charitable Trusts; McKnight Foundation; New York Stem Cell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Bargmann, T. Jessell, F. Maderspacher, L. Paninski and members of the Axel laboratory for comments on the manuscript; C. Franqui for assistance with fly work; and P. Kisloff, M. Gutierrez and A. Nemes for assistance with general laboratory concerns and the preparation of this manuscript. This work was funded in part by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (R. A.). Further financial support was provided by the Howard Hughes Medical Institute (R. A.), by the Swartz and Gatsby Foundations (L. F. A.) and by the Pew Charitable Trusts, McKnight Foundation, and New York Stem Cell Foundation (V.R.).	Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Butcher NJ, 2012, J COMP NEUROL, V520, P2185, DOI 10.1002/cne.23037; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Honegger KS, 2011, J NEUROSCI, V31, P11772, DOI 10.1523/JNEUROSCI.1099-11.2011; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Keleman K, 2012, NATURE, V489, P145, DOI 10.1038/nature11345; Leiss F, 2009, J COMP NEUROL, V517, P808, DOI 10.1002/cne.22184; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu HH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000461; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155	28	221	223	0	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					113	+		10.1038/nature12063	http://dx.doi.org/10.1038/nature12063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23615618	Green Published, Green Accepted			2022-12-28	WOS:000318221500044
J	Edmiston, R; Mitchell, C				Edmiston, Rachel; Mitchell, Caroline			Hearing loss in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Edmiston, Rachel] Tameside Gen Hosp, ENT Dept, Ashton Under Lyne OL6 9RW, England; [Mitchell, Caroline] Univ Sheffield, Community Sci Ctr, No Gen Hosp, Inst Gen Practice & Primary Care, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital; University of Sheffield	Edmiston, R (corresponding author), Tameside Gen Hosp, ENT Dept, Ashton Under Lyne OL6 9RW, England.	rachel.edmiston@nhs.net		Mitchell, Caroline/0000-0002-4790-0095				Boatman DF, 2007, NEUROLOGY, V68, P1311, DOI 10.1212/01.wnl.0000259524.08148.16; Faulconbridge RL, 2011, HEARING AIDS GET ONE; Pirozzo S, 2003, BRIT MED J, V327, P967, DOI 10.1136/bmj.327.7421.967; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449	4	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2013	346								f2496	10.1136/bmj.f2496	http://dx.doi.org/10.1136/bmj.f2496			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134PN	23618723	Green Accepted			2022-12-28	WOS:000318225000004
J	Eurich, DT; Simpson, S; Senthilselvan, A; Asche, CV; Sandhu-Minhas, JK; McAlister, FA				Eurich, D. T.; Simpson, S.; Senthilselvan, A.; Asche, C. V.; Sandhu-Minhas, J. K.; McAlister, F. A.			Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITORS; INCRETIN-BASED THERAPIES; CARDIOVASCULAR OUTCOMES; ACUTE-PANCREATITIS; GLYCEMIC CONTROL; MORTALITY; METFORMIN; RISK; SULFONYLUREA; EXENATIDE	Objective To determine if the use of sitagliptin in newly treated patients with type 2 diabetes is associated with any changes in clinical outcomes. Design Retrospective population based cohort study. Setting Large national commercially insured US claims and integrated laboratory database. Participants Inception cohort of new users of oral antidiabetic drugs between 2004 and 2009 followed until death, termination of medical insurance, or December 31 2010. Main outcome measure Composite endpoint of all cause hospital admission and all cause mortality, assessed with time varying Cox proportional hazards regression after adjustment for demographics, clinical and laboratory data, pharmacy claims data, healthcare use, and time varying propensity scores. Results The cohort included 72 738 new users of oral antidiabetic drugs (8032 (11%) used sitagliptin; 7293 (91%) were taking it in combination with other agents) followed for a total of 182 409 patient years. The mean age was 52 (SD 9) years, 54% (39 573) were men, 11% (8111) had ischemic heart disease, and 9% (6378) had diabetes related complications at the time their first antidiabetic drug was prescribed. 14 215 (20%) patients met the combined endpoint. Sitagliptin users showed similar rates of all cause hospital admission or mortality to patients not using sitagliptin (adjusted hazard ratio 0.98, 95% confidence interval 0.91 to 1.06), including patients with a history of ischemic heart disease (adjusted hazard ratio 1.10, 0.94 to 1.28) and those with estimated glomerular filtration rate below 60 mL/min (1.11, 0.88 to 1.41). Conclusions Sitagliptin use was not associated with an excess risk of all cause hospital admission or death compared with other glucose lowering agents among newly treated patients with type 2 diabetes. Most patients prescribed sitagliptin in this cohort were concordant with clinical practice guidelines, in that it was used as add-on treatment.	[Eurich, D. T.; Senthilselvan, A.] Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB T6G 2G3, Canada; [Eurich, D. T.; Simpson, S.; Sandhu-Minhas, J. K.] Univ Alberta, Alliance Canadian Hlth Outcomes Res Diabet, Edmonton, AB T6G 2E1, Canada; [Simpson, S.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2B7, Canada; [Asche, C. V.] Univ Illinois, Coll Med Peoria, Ctr Hlth Outcomes, Peoria, IL 61656 USA; [Asche, C. V.] Univ Illinois, Coll Pharm, Dept Pharm Adm, Chicago, IL 60612 USA; [McAlister, F. A.] Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB T6G 2B7, Canada; [McAlister, F. A.] Univ Alberta, Edmonton, AB T6G 2B7, Canada	University of Alberta; University of Alberta; University of Alberta; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Alberta; University of Alberta	Eurich, DT (corresponding author), Univ Alberta, Li Ka Shing Ctr Hlth Res Innovat 2 040, Edmonton, AB T6G 2E1, Canada.	deurich@ualberta.ca	; McAlister, Finlay/C-4151-2013	Simpson, Scot/0000-0002-9880-2129; McAlister, Finlay/0000-0001-7435-3341	Canadian Diabetes Association [OG-2-09-2691-DE]; Canadian Institutes of Health Research (CIHR) [MOP-126093]; Alberta Innovates Health Solution (AIHS); CIHR	Canadian Diabetes Association; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solution (AIHS); CIHR(Canadian Institutes of Health Research (CIHR))	This work was funded by operating grants from the Canadian Diabetes Association (OG-2-09-2691-DE) and the Canadian Institutes of Health Research (CIHR) (MOP-126093). DTE receives salary support from Alberta Innovates Health Solution (AIHS) and the CIHR. FAM is a senior health scholar with AIHS. The study sponsors played no role in study design or conduct; collection, analysis, or interpretation of data; writing of the report; or the decision to submit the paper for publication.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; Austin PC, 2011, MED CARE, V49, P940, DOI 10.1097/MLR.0b013e318229360e; Borah BJ, 2009, CLIN THER, V31, P623, DOI 10.1016/j.clinthera.2009.03.005; Bowker SL, 2010, DIABETOLOGIA, V53, P1631, DOI 10.1007/s00125-010-1750-8; Burgmaier M, 2013, DIABETIC MED, V30, P289, DOI 10.1111/j.1464-5491.2012.03746.x; Canadian Diabetes Association Expert Panel Committee, 2008, CAN J DIABETES, V32, pS168; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Dore DD, 2009, CURR MED RES OPIN, V25, P1019, DOI [10.1185/03007990902820519, 10.1185/03007990902820519 ]; Drucker DJ, 2010, DIABETES CARE, V33, P428, DOI 10.2337/dc09-1499; Duh MS, 2009, AM J MANAG CARE, V15, P681; Eurich DT, 2005, DIABETES CARE, V28, P2345, DOI 10.2337/diacare.28.10.2345; Evans JMM, 2006, DIABETOLOGIA, V49, P930, DOI 10.1007/s00125-006-0176-9; Frederich R, 2010, POSTGRAD MED, V122, P16, DOI 10.3810/pgm.2010.05.2138; Garg R, 2010, DIABETES CARE, V33, P2349, DOI 10.2337/dc10-0482; Huberman M, 1999, AM J EPIDEMIOL, V150, P1340; Inzucchi SE, 2008, CIRCULATION, V117, P574, DOI 10.1161/CIRCULATIONAHA.107.735795; Johns Hopkins University, 2012, J HOPK ACG SYST; Johnson JA, 2005, DIABETIC MED, V22, P497, DOI 10.1111/j.1464-5491.2005.01448.x; Johnson JA, 2002, DIABETES CARE, V25, P2244, DOI 10.2337/diacare.25.12.2244; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; McAlister FA, 2008, EUR J HEART FAIL, V10, P703, DOI 10.1016/j.ejheart.2008.05.013; Monami M, 2011, CURR MED RES OPIN, V27, P57, DOI 10.1185/03007995.2011.602964; National Institute for Health and Clinical Excellence, 2011, QUAL STAT 4 GLYC CON; Okerson T, 2012, CARDIOVASC THER, V30, pe146, DOI 10.1111/j.1755-5922.2010.00256.x; Patil HR, 2012, AM J CARDIOL, V110, P826, DOI 10.1016/j.amjcard.2012.04.061; Pendergrass M, 2012, DIABETES OBES METAB, V14, P596, DOI 10.1111/j.1463-1326.2012.01567.x; Penson DF, 2001, J CLIN EPIDEMIOL, V54, P350, DOI 10.1016/S0895-4356(00)00312-7; Peters A, 2010, AM J MED, V123, pS28, DOI 10.1016/j.amjmed.2009.12.007; Ranganath LR, 2008, J CLIN PATHOL, V61, P401, DOI 10.1136/jcp.2006.043232; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Riedel AA, 2007, PHARMACOTHERAPY, V27, P1102, DOI 10.1592/phco.27.8.1102; Segal JB, 2007, CLIN THER, V29, P1784, DOI 10.1016/j.clinthera.2007.08.021; Simpson SH, 2006, CAN MED ASSOC J, V174, P169, DOI 10.1503/cmaj.050748; Willemen MJ, 2011, DIABETES CARE, V34, P369, DOI 10.2337/dc10-1771; Winkelmayer WC, 2008, ARCH INTERN MED, V168, P2368, DOI 10.1001/archinte.168.21.2368	36	59	62	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2013	346								f2267	10.1136/bmj.f2267	http://dx.doi.org/10.1136/bmj.f2267			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134PN	23618722	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000318225000001
J	Flegal, KM; Kit, BK; Graubard, BI				Flegal, Katherine M.; Kit, Brian K.; Graubard, Barry I.			Overweight, Obesity, and All-Cause Mortality Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ILLNESS		[Flegal, Katherine M.; Kit, Brian K.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; [Graubard, Barry I.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Flegal, KM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA.	kmf2@cdc.gov	Flegal, Katherine M/A-4608-2013	Flegal, Katherine/0000-0002-0838-469X	NATIONAL CANCER INSTITUTE [ZIACP010181] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Flegal KM, 2007, AM J EPIDEMIOL, V166, P975, DOI 10.1093/aje/kwm152; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Heymsfield SB, 2013, JAMA-J AM MED ASSOC, V309, P87, DOI 10.1001/jama.2012.185445	4	17	18	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1681	1682		10.1001/jama.2013.3101	http://dx.doi.org/10.1001/jama.2013.3101			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130IG	23613067				2022-12-28	WOS:000317906700016
J	Dai, L; Korolev, KS; Gore, J				Dai, Lei; Korolev, Kirill S.; Gore, Jeff			Slower recovery in space before collapse of connected populations	NATURE			English	Article							EARLY-WARNING SIGNALS; REGIME SHIFTS; CATASTROPHIC SHIFTS; TIPPING POINT; ECOSYSTEMS; INDICATOR; DYNAMICS; FOREST	Slower recovery from perturbations near a tipping point and its indirect signatures in fluctuation patterns have been suggested to foreshadow catastrophes in a wide variety of systems(1,2). Recent studies of populations in the field and in the laboratory have used time-series data to confirm some of the theoretically predicted early warning indicators, such as an increase in recovery time or in the size and timescale of fluctuations(3-6). However, the predictive power of temporal warning signals is limited by the demand for long-term observations. Large-scale spatial data are more accessible, but the performance of warning signals in spatially extended systems(7-10) needs to be examined empirically(3,11-13). Here we use spatially extended yeast populations, an experimental system with a fold bifurcation (tipping point)(6), to evaluate early warning signals based on spatio-temporal fluctuations and to identify a novel spatial warning indicator. We found that two leading indicators based on fluctuations increased before collapse of connected populations; however, the magnitudes of the increases were smaller than those observed in isolated populations, possibly because local variation is reduced by dispersal. Furthermore, we propose a generic indicator based on deterministic spatial patterns, which we call 'recovery length'. As the spatial counterpart of recovery time(14), recovery length is the distance necessary for connected populations to recover from spatial perturbations. In our experiments, recovery length increased substantially before population collapse, suggesting that the spatial scale of recovery can provide a superior warning signal before tipping points in spatially extended systems.	[Dai, Lei; Korolev, Kirill S.; Gore, Jeff] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Dai, L (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	dailei@mit.edu; gore@mit.edu			Whitaker Health Sciences Fund Fellowship; Pappalardo Fellowship; NIH [NIH R00 GM085279-02, NIH DP2]; NSF CAREER Award; Sloan Research Fellowship; Pew Scholars Program; Allen Investigator Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM085279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [DP2AG044279] Funding Source: NIH RePORTER	Whitaker Health Sciences Fund Fellowship; Pappalardo Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Sloan Research Fellowship(Alfred P. Sloan Foundation); Pew Scholars Program; Allen Investigator Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank D. Vorselen, T. Krieger, D. Seekell, M. Pace and members of the Gore laboratory (A. Sanchez, M. Datta, E. Yurtsev, T. Artemova, K. Axelrod and A. Chen) for comments on the manuscript. T. Krieger performed initial simulations for the connected populations. Y. Zhang and O. Ornek collected preliminary data for the experiment to measure recovery length. This work was supported by a Whitaker Health Sciences Fund Fellowship (to L.D.), a Pappalardo Fellowship (to K.S.K.), an NIH R00 Pathways to Independence Award (NIH R00 GM085279-02), an NIH New Innovator Award (NIH DP2), an NSF CAREER Award, a Sloan Research Fellowship, the Pew Scholars Program and the Allen Investigator Program.	Boettiger C, 2012, P ROY SOC B-BIOL SCI, V279, P4734, DOI 10.1098/rspb.2012.2085; Brock WA, 2010, ECOL MONOGR, V80, P353, DOI 10.1890/09-1824.1; Carpenter SR, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00016.1; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; DECARLO LT, 1993, BEHAV RES THER, V31, P781, DOI 10.1016/0005-7967(93)90009-J; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Fernandez A, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/P09014; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Isbell F., 2013, ECOL LETT; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kleinen T., 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Lindegren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038410; Litzow MA, 2008, ECOL APPL, V18, P1331, DOI 10.1890/07-0998.1; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; OUYANG Q, 1991, NATURE, V352, P610, DOI 10.1038/352610a0; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Sole R. V., 1995, Complexity, V1, P13; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723	33	128	137	3	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					355	+		10.1038/nature12071	http://dx.doi.org/10.1038/nature12071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23575630	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000317599200036
J	Clarfield, AM				Clarfield, A. Mark			Mind the Gap	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Clarfield, A. Mark] Ben Gurion Univ Negev, Soroka Hosp, IL-84105 Beer Sheva, Israel; [Clarfield, A. Mark] Ben Gurion Univ Negev, Fac Hlth Sci, Med Sch Int Hlth, IL-84105 Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University	Clarfield, AM (corresponding author), Ben Gurion Univ Negev, Soroka Hosp, IL-84105 Beer Sheva, Israel.	markclar@bgu.ac.il							0	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1597	1598		10.1001/jama.2013.742	http://dx.doi.org/10.1001/jama.2013.742			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126FY	23592103				2022-12-28	WOS:000317599500022
J	Eappen, S; Lane, BH; Rosenberg, B; Lipsitz, SA; Sadoff, D; Matheson, D; Berry, WR; Lester, M; Gawande, AA				Eappen, Sunil; Lane, Bennett H.; Rosenberg, Barry; Lipsitz, Stuart A.; Sadoff, David; Matheson, Dave; Berry, William R.; Lester, Mark; Gawande, Atul A.			Relationship Between Occurrence of Surgical Complications and Hospital Finances	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LENGTH-OF-STAY; POSTOPERATIVE COMPLICATIONS; SAFETY CHECKLIST; ADVERSE EVENTS; RISK-FACTORS; QUALITY; SURGERY; COSTS; PROGRAM; PERFORMANCE	Importance The effect of surgical complications on hospital finances is unclear. Objective To determine the relationship between major surgical complications and per-encounter hospital costs and revenues by payer type. Design, Setting, and Participants Retrospective analysis of administrative data for all inpatient surgical discharges during 2010 from a nonprofit 12-hospital system in the southern United States. Discharges were categorized by principal procedure and occurrence of 1 or more postsurgical complications, using International Classification of Diseases, Ninth Revision, diagnosis and procedure codes. Nine common surgical procedures and 10 major complications across 4 payer types were analyzed. Hospital costs and revenue at discharge were obtained from hospital accounting systems and classified by payer type. Main Outcomes and Measures Hospital costs, revenues, and contribution margin (defined as revenue minus variable expenses) were compared for patients with and without surgical complications according to payer type. Results Of 34 256 surgical discharges, 1820 patients (5.3%; 95% CI, 4.4%-6.4%) experienced 1 or more postsurgical complications. Compared with absence of complications, complications were associated with a $39 017 (95% CI, $20 069-$50 394; P<.001) higher contribution margin per patient with private insurance ($55 953 vs $16 936) and a $1749 (95% CI, $976-$3287; P<.001) higher contribution margin per patient with Medicare ($3629 vs $1880). For this hospital system in which private insurers covered 40% of patients (13 544), Medicare covered 45% (15 406), Medicaid covered 4% (1336), and self-payment covered 6% (2202), occurrence of complications was associated with an $8084 (95% CI, $4903-$9740; P<.001) higher contribution margin per patient ($15 726 vs $7642) and with a $7435 lower per-patient total margin (95% CI, $5103-$10 507; P<.001) ($1013 vs -$6422). Conclusions and Relevance In this hospital system, the occurrence of postsurgical complications was associated with a higher per-encounter hospital contribution margin for patients covered by Medicare and private insurance but a lower one for patients covered by Medicaid and who self-paid. Depending on payer mix, many hospitals have the potential for adverse near-term financial consequences for decreasing postsurgical complications. JAMA. 2013;309(15):1599-1606 www.jama.com	[Eappen, Sunil] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02115 USA; [Lane, Bennett H.; Rosenberg, Barry; Sadoff, David; Matheson, Dave] Boston Consulting Grp Inc, Boston, MA USA; [Lipsitz, Stuart A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Berry, William R.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Lester, Mark] Texas Hlth Resources, Arlington, TX USA; [Gawande, Atul A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Gawande, Atul A.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Boston Consulting Group (BCG); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Gawande, AA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Kresge Bldg,Room 400, Boston, MA 02115 USA.	agawande@hsph.harvard.edu		Lane, Bennett/0000-0001-9860-2285; Gawande, Atul/0000-0002-1824-9176	Boston Consulting Group; Texas Health Resources	Boston Consulting Group; Texas Health Resources	This research was supported by funding from the Boston Consulting Group and Texas Health Resources.	Agency for Healthcare Research and Quality, 2008, HEALTHC COST UT PROJ; Andrews RM., 2011, NATL HOSP BILL MOST; Bazzoli GJ, 2003, HEALTH AFFAIR, V22, P40, DOI 10.1377/hlthaff.22.6.40; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Center for Medicare and Medicaid Services, 2010, NAT HLTH CAR EXP DAT; Centers for Medicare & Medicaid Services (CMS), HHS MED PROGR CHANG, P33; Centers for Medicare & Medicaid Services (CMS), 2008, HHS MED PROGR CHANG; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Conley DM, 2011, J AM COLL SURGEONS, V212, P873, DOI 10.1016/j.jamcollsurg.2011.01.052; Davenport DL, 2005, ANN SURG, V242, P463, DOI 10.1097/01.sla.0000183348.15117.ab; de Lissovoy G, 2009, AM J INFECT CONTROL, V37, P387, DOI 10.1016/j.ajic.2008.12.010; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Delia D, 2008, HEALTH AFFAIR, V27, P1688, DOI 10.1377/hlthaff.27.6.1688; DiCiccio TJ, 1996, STAT SCI, V11, P189; Dimick JB, 2006, J AM COLL SURGEONS, V202, P933, DOI 10.1016/j.jamcollsurg.2006.02.015; Dimick JB, 2004, J AM COLL SURGEONS, V199, P531, DOI 10.1016/j.jamcollsurg.2004.05.276; Dimick JB, 2003, J AM COLL SURGEONS, V196, P671, DOI 10.1016/S1072-7515(03)00122-4; Englesbe MJ, 2007, ANN SURG, V246, P456, DOI 10.1097/SLA.0b013e31814855f2; Farley DO, 2002, MED CARE RES REV, V59, P319, DOI 10.1177/1077558702059003005; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; Goodman DC, 2009, HYP IM SIGN PROC EV, P1; Gordon HS, 2005, MED CARE, V43, P159, DOI 10.1097/00005650-200502000-00009; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Horton NJ, 1999, STAT MED, V18, P213, DOI 10.1002/(SICI)1097-0258(19990130)18:2<213::AID-SIM999>3.0.CO;2-E; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kable AK, 2002, INT J QUAL HEALTH C, V14, P269, DOI 10.1093/intqhc/14.4.269; Khan NA, 2006, J GEN INTERN MED, V21, P177, DOI 10.1111/j.1525-1497.2006.00319.x; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Korn EL., 1999, ANAL HLTH SURVEYS; Krupka DC, 2012, HEALTH AFFAIR, V31, P2571, DOI 10.1377/hlthaff.2011.0605; Librero J, 2004, INT J QUAL HEALTH C, V16, P51, DOI 10.1093/intqhc/mzh008; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; Medicare program, 2007, FED REGISTER, V72, P47379; Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506; Penel N, 2008, INT J ORAL MAX SURG, V37, P135, DOI 10.1016/j.ijom.2007.08.002; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rajakaruna C, 2005, J THORAC CARDIOV SUR, V130, P1270, DOI 10.1016/j.jtcvs.2005.06.050; Rosenberg BL, 2005, SURGERY, V137, P285, DOI 10.1016/j.surg.2004.09.007; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Schauffler HH, 2001, ANNU REV PUBL HEALTH, V22, P69, DOI 10.1146/annurev.publhealth.22.1.69; Sisko AM, 2010, HEALTH AFFAIR, V29, P1933, DOI 10.1377/hlthaff.2010.0788; The DRG Handbook, 2006, DRG HDB; Thompson DA, 2006, ANN SURG, V243, P547, DOI 10.1097/01.sla.0000207097.38963.3b; Wachter RM, 2009, NEW ENGL J MED, V361, P1401, DOI 10.1056/NEJMsb0903885; Wright SB, 2003, INFECT CONT HOSP EP, V24, P946, DOI 10.1086/502164	46	144	145	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1599	1606		10.1001/jama.2013.2773	http://dx.doi.org/10.1001/jama.2013.2773			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126FY	23592104	Green Published			2022-12-28	WOS:000317599500023
J	Perrat, PN; DasGupta, S; Wang, J; Theurkauf, W; Weng, ZP; Rosbash, M; Waddell, S				Perrat, Paola N.; DasGupta, Shamik; Wang, Jie; Theurkauf, William; Weng, Zhiping; Rosbash, Michael; Waddell, Scott			Transposition-Driven Genomic Heterogeneity in the Drosophila Brain	SCIENCE			English	Article							L1 RETROTRANSPOSITION; TRANSPOSABLE ELEMENTS; MELANOGASTER; CELLS; MEMORY; RNAS; PATHWAY; EVOLUTION; GERMLINE; NEURONS	Recent studies in mammals have documented the neural expression and mobility of retrotransposons and have suggested that neural genomes are diverse mosaics. We found that transposition occurs among memory-relevant neurons in the Drosophila brain. Cell type-specific gene expression profiling revealed that transposon expression is more abundant in mushroom body (MB) alpha beta neurons than in neighboring MB neurons. The Piwi-interacting RNA (piRNA) proteins Aubergine and Argonaute 3, known to suppress transposons in the fly germline, are expressed in the brain and appear less abundant in alpha beta MB neurons. Loss of piRNA proteins correlates with elevated transposon expression in the brain. Paired-end deep sequencing identified more than 200 de novo transposon insertions in alpha beta neurons, including insertions into memory-relevant loci. Our observations indicate that genomic heterogeneity is a conserved feature of the brain.	[Perrat, Paola N.; DasGupta, Shamik; Waddell, Scott] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [DasGupta, Shamik; Waddell, Scott] Univ Oxford, Ctr Neural Circuits & Behav, Oxford OX1 3TA, England; [Wang, Jie; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Theurkauf, William] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Rosbash, Michael] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; [Rosbash, Michael] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02454 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Oxford; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Brandeis University; Howard Hughes Medical Institute; Brandeis University	Waddell, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	scott.waddell@cncb.ox.ac.uk		Waddell, Scott/0000-0003-4503-6229; DasGupta, Shamik/0000-0001-5803-8982; DasGupta, Shamik/0000-0001-5566-7548; Theurkauf, William/0000-0001-7342-1912	Wellcome Trust; Gatsby Charitable Foundation; Oxford Martin School; NlH [MH069883, MH081982]; NIH [NS044232, NS045713, R01HD049116]; Ellison Medical Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069883, R01MH081982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232, P30NS045713] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; Oxford Martin School; NlH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Data are available through ArrayExpress (www.ebi.ac.uk/arrayexpress) and NCBI Short Read (www.ncbi.nlm.nih.gov/sites/sra) archives as E-MEXP-3798 and SRP017718, respectively. We thank A. Vodala, J. Menet, K. Abruzzi, and N. Francis for advice with techniques. Supported by a Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences, the Gatsby Charitable Foundation, Oxford Martin School and grants MH069883 and MH081982 from NlH (S. W.), NIH grants NS044232 and NS045713 and the Ellison Medical Foundation (M. R.), and NIH grant R01HD049116 (Z.W. and W.T.).	Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Blum AL, 2009, CURR BIOL, V19, P1341, DOI 10.1016/j.cub.2009.07.016; BOZZETTI MP, 1995, P NATL ACAD SCI USA, V92, P6067, DOI 10.1073/pnas.92.13.6067; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Gage FH, 2012, SCI AM, V306, P26, DOI 10.1038/scientificamerican0312-26; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hovhanyan A, 2009, J NEUROGENET, V23, P42, DOI 10.1080/01677060802471700; JAKUBCZAK JL, 1991, P NATL ACAD SCI USA, V88, P3295, DOI 10.1073/pnas.88.8.3295; KAMINKER JS, 2002, GENOME BIOL, V0003; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Khurana JS, 2011, CELL, V147, P1551, DOI 10.1016/j.cell.2011.11.042; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; Moreau-Fauvarque C, 1998, MECH DEVELOP, V78, P47, DOI 10.1016/S0925-4773(98)00147-6; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011; SCHUPBACH T, 1991, GENETICS, V129, P1119; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Tan Y, 2010, NEURON, V67, P810, DOI 10.1016/j.neuron.2010.08.020; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; Trannoy S, 2011, CURR BIOL, V21, P1647, DOI 10.1016/j.cub.2011.08.032; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155	44	161	168	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2013	340	6128					91	95		10.1126/science.1231965	http://dx.doi.org/10.1126/science.1231965			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559253	Green Accepted			2022-12-28	WOS:000317061100053
J	McCormack, RP; Williams, AR; Goldfrank, LR; Caplan, AL; Ross, S; Rotrosen, J				McCormack, Ryan P.; Williams, Arthur R.; Goldfrank, Lewis R.; Caplan, Arthur L.; Ross, Stephen; Rotrosen, John			Commitment to assessment and treatment: comprehensive care for patients gravely disabled by alcohol use disorders	LANCET			English	Editorial Material							ADDICTION; DEPENDENCE; COERCION; ABUSE		[McCormack, Ryan P.; Goldfrank, Lewis R.] NYU, Sch Med, Dept Emergency Med, New York, NY USA; [Williams, Arthur R.; Caplan, Arthur L.] NYU, Sch Med, Dept Populat Hlth, Div Med Eth, New York, NY USA; [Ross, Stephen; Rotrosen, John] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Ross, Stephen] NYU, Coll Dent, New York, NY USA; [Rotrosen, John] VA New York Harbor Healthcare Syst, New York, NY USA	New York University; New York University; New York University; New York University	McCormack, RP (corresponding author), Bellevue Hosp, 462 1st Ave,OBV 345A, New York, NY 10016 USA.	ryan.mccormack@nyumc.org	McCormack, Ryan/AAF-4325-2022; McCormack, Ryan/AFI-8740-2022; Williams, Arthur Robin/H-8511-2019	McCormack, Ryan/0000-0002-7210-4736; McCormack, Ryan/0000-0002-7210-4736; Williams, Arthur Robin/0000-0002-7380-6203				Caplan A, 2008, ADDICTION, V103, P1919, DOI 10.1111/j.1360-0443.2008.02369.x; Chandler RK, 2009, JAMA-J AM MED ASSOC, V301, P183, DOI 10.1001/jama.2008.976; GAYLIN W, 2003, PERVERSION AUTONOMY; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Israelsson M, 2012, EUR ADDICT RES, V18, P302, DOI 10.1159/000341716; Janssens MJPA, 2004, J MED ETHICS, V30, P453, DOI 10.1136/jme.2002.002212; Macavoy M G, 1990, Drug Alcohol Rev, V9, P267, DOI 10.1080/09595239000185351; Murphy L, 2012, NATL VITAL STAT REPO, V69; Pritchard E, 2007, 14 ANCD; Rosenman S, 1998, AUST NZ J PSYCHIAT, V32, P785, DOI 10.3109/00048679809073867; Schaub M, 2010, EUR ADDICT RES, V16, P53, DOI 10.1159/000265938; Schomerus G, 2011, ALCOHOL ALCOHOLISM, V46, P105, DOI 10.1093/alcalc/agq089; Stone AA., 1984, LAW PSYCHIAT MORALIT, P133; Sullivan MA, 2008, AM J ADDICTION, V17, P36, DOI 10.1080/10550490701756369; Treffert Darold A, 1974, Prism, V2, P49; Wild TC, 2002, EUR ADDICT RES, V8, P84, DOI 10.1159/000052059; Williamson Laura, 2012, Am J Public Health, V102, pe5, DOI 10.2105/AJPH.2011.300629; World Health Organization, 2001, M MOSC RUSS 22 23 AP	18	19	21	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2013	382	9896					995	997		10.1016/S0140-6736(12)62206-5	http://dx.doi.org/10.1016/S0140-6736(12)62206-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215VD	23602314				2022-12-28	WOS:000324238000032
J	George, NT; Irving, TC; Williams, CD; Daniel, TL				George, N. T.; Irving, T. C.; Williams, C. D.; Daniel, T. L.			The Cross-Bridge Spring: Can Cool Muscles Store Elastic Energy?	SCIENCE			English	Article							TEMPERATURE-GRADIENTS; FLIGHT-MUSCLE; DYNAMICS; FORCE	Muscles not only generate force. They may act as springs, providing energy storage to drive locomotion. Although extensible myofilaments are implicated as sites of energy storage, we show that intramuscular temperature gradients may enable molecular motors (cross-bridges) to store elastic strain energy. By using time-resolved small-angle x-ray diffraction paired with in situ measurements of mechanical energy exchange in flight muscles of Manduca sexta, we produced high-speed movies of x-ray equatorial reflections, indicating cross-bridge association with myofilaments. A temperature gradient within the flight muscle leads to lower cross-bridge cycling in the cooler regions. Those cross-bridges could elastically return energy at the extrema of muscle lengthening and shortening, helping drive cyclic wing motions. These results suggest that cross-bridges can perform functions other than contraction, acting as molecular links for elastic energy storage.	[George, N. T.; Williams, C. D.; Daniel, T. L.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Irving, T. C.] IIT, Ctr Synchrotron Radiat Res & Instrument, Chicago, IL 60616 USA; [Irving, T. C.] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA; [Williams, C. D.] Harvard Univ, Dept Organism & Evolutionary Biol, Concord Field Stn, Cambridge, MA 01451 USA	University of Washington; University of Washington Seattle; Illinois Institute of Technology; Illinois Institute of Technology; Harvard University	Daniel, TL (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	danielt@uw.edu			NSF [DGE-0718124, IOS-1022471, EEC 1028725]; University of Washington Komen Endowed Chair; U.S. Department of Energy [DE-AC02-06CH11357]; NIH [2P41RR008630-17, 9 P41 GM103622-17]; Direct For Biological Sciences [1022058] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); University of Washington Komen Endowed Chair; U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H.-M. Hsu, E. Carrington, and R. Huey for their contributions. This research was supported by NSF Graduate Research Fellowship no. DGE-0718124 to N.T.G., NSF grant IOS-1022471 to T. L. D and T. C. I., NSF grant EEC 1028725 to T. L. D., and the University of Washington Komen Endowed Chair to T. L. D. Use of the Advanced Photon Source was supported by the U.S. Department of Energy under contract no. DE-AC02-06CH11357. Use of BioCAT was supported by grants from the NIH (2P41RR008630-17 and 9 P41 GM103622-17). The data reported in this paper are deposited in the Dryad Repository (http://dx.doi.org/10.5061/dryad.cg873). For inquiries about materials, please contact N.T.G. (ntgeorge@uw.edu).	ALEXANDER RM, 1984, AM ZOOL, V24, P85; ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; BENNETT AF, 1985, J EXP BIOL, V115, P333; CAREY FG, 1966, P NATL ACAD SCI USA, V56, P1464, DOI 10.1073/pnas.56.5.1464; Dickinson M, 2005, NATURE, V433, P330, DOI 10.1038/nature03230; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; ELLINGTON CP, 1985, J EXP BIOL, V115, P293; George NT, 2012, J EXP BIOL, V215, P471, DOI 10.1242/jeb.062901; George NT, 2011, J EXP BIOL, V214, P894, DOI 10.1242/jeb.047969; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; Irving TC, 2006, MOL B INT U, P197; JENSEN M, 1962, PHILOS T ROY SOC B, V245, P137, DOI 10.1098/rstb.1962.0008; JOSEPHSON RK, 1984, J EXP BIOL, V108, P77; MILLER A, 1970, NATURE, V226, P1060, DOI 10.1038/2261060a0; Nishikawa KC, 2012, P ROY SOC B-BIOL SCI, V279, P981, DOI 10.1098/rspb.2011.1304; TIDBALL JG, 1986, AM J PHYSIOL, V250, pR56, DOI 10.1152/ajpregu.1986.250.1.R56; Tu MS, 2004, J EXP BIOL, V207, P2455, DOI 10.1242/jeb.01039; Wang G, 2001, J PHYSIOL-LONDON, V531, P219, DOI 10.1111/j.1469-7793.2001.0219j.x; Williams CD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002770	20	25	25	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1217	1220		10.1126/science.1229573	http://dx.doi.org/10.1126/science.1229573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23618763	Green Accepted			2022-12-28	WOS:000319972800046
J	Wu, WZ; Wen, XN; Wang, ZL				Wu, Wenzhuo; Wen, Xiaonan; Wang, Zhong Lin			Taxel-Addressable Matrix of Vertical-Nanowire Piezotronic Transistors for Active and Adaptive Tactile Imaging	SCIENCE			English	Article							ARTIFICIAL SKIN; ELECTRONICS; PRESSURE; SENSORS; CIRCUITS; SWITCHES; GROWTH; ARRAYS	Designing, fabricating, and integrating arrays of nanodevices into a functional system are the key to transferring nanoscate science into applicable nanotechnotogy. We report large-array three-dimensional (3D) circuitry integration of piezotronic transistors based on vertical zinc oxide nanowires as an active taxel-addressable pressure/force sensor matrix for tactile imaging. Using the piezoelectric polarization charges created at a metal-semiconductor interface under strain to gate/modulate the transport process of local charge carriers, we designed independently addressable two-terminal transistor arrays, which convert mechanical stimuli applied to the devices into local electronic controlling signals. The device matrix can achieve shape-adaptive high-resolution tactile imaging and self-powered, multidimensional active sensing. The 3D piezotronic transistor array may have applications in human-electronics interfacing, smart skin, and micro- and nanoelectromechanical systems.	[Wu, Wenzhuo; Wen, Xiaonan; Wang, Zhong Lin] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; [Wang, Zhong Lin] Chinese Acad Sci, Beijing Inst Nanoenergy & Nanosyst, Beijing 100083, Peoples R China	University System of Georgia; Georgia Institute of Technology; Chinese Academy of Sciences; Beijing Institute of Nanoenergy & Nanosystems, CAS	Wang, ZL (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.	zhong.wang@mse.gatech.edu	Wang, Zhong Lin/E-2176-2011; Wen, Xiaonan/I-7850-2013; wang, jie/GRS-0942-2022; Wu, Wenzhuo/G-1334-2010	Wang, Zhong Lin/0000-0002-5530-0380; Wen, Xiaonan/0000-0002-8263-9718; Wu, Wenzhuo/0000-0003-0362-6650	U.S. Department of Energy, Office of Basic Energy Sciences [DE-FG02-07ER46394]; NSF; Chinese Academy of Sciences [KJCX2-YW-M13]; Defense Advanced Research Projects Agency, U.S. Air Force	U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Chinese Academy of Sciences(Chinese Academy of Sciences); Defense Advanced Research Projects Agency, U.S. Air Force	We thank Y. Zhang for helpful discussions and P. Shao for guidance in using the optical noncontact profilometer. Supported by the Defense Advanced Research Projects Agency, U.S. Air Force, U.S. Department of Energy, Office of Basic Energy Sciences (award DE-FG02-07ER46394), NSF, and the Knowledge Innovation Program of the Chinese Academy of Sciences (grant KJCX2-YW-M13).	Ahn JH, 2006, SCIENCE, V314, P1754, DOI 10.1126/science.1132394; Bryllert T, 2006, IEEE ELECTR DEVICE L, V27, P323, DOI 10.1109/LED.2006.873371; Javey A, 2007, NANO LETT, V7, P773, DOI 10.1021/nl063056l; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Lipomi DJ, 2011, NAT NANOTECHNOL, V6, P788, DOI [10.1038/nnano.2011.184, 10.1038/NNANO.2011.184]; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/NMAT2834, 10.1038/nmat2834]; Mascaro SA, 2001, IEEE T ROBOTIC AUTOM, V17, P698, DOI 10.1109/70.964669; Nam S, 2009, P NATL ACAD SCI USA, V106, P21035, DOI 10.1073/pnas.0911713106; Nemeth B, 2012, ADV MATER, V24, P1238, DOI 10.1002/adma.201104345; Sekitani T, 2009, SCIENCE, V326, P1516, DOI 10.1126/science.1179963; Shi J, 2012, ADV MATER, V24, P4683, DOI 10.1002/adma.201104386; Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101; Takei K, 2010, NAT MATER, V9, P821, DOI [10.1038/nmat2835, 10.1038/NMAT2835]; Wang Z. L., 2013, PIEZOTRONICS PIEZOPH; Wang ZL, 2007, ADV MATER, V19, P889, DOI 10.1002/adma.200602918; Wang ZL, 2012, ANGEW CHEM INT EDIT, V51, P11700, DOI 10.1002/anie.201201656; Wang ZL, 2012, ADV MATER, V24, P4632, DOI 10.1002/adma.201104365; Wang ZL, 2010, NANO TODAY, V5, P540, DOI 10.1016/j.nantod.2010.10.008; Wei YG, 2010, NANO LETT, V10, P3414, DOI 10.1021/nl1014298; Wu WZ, 2011, NANO LETT, V11, P2779, DOI 10.1021/nl201074a; Wu WZ, 2010, ADV MATER, V22, P4711, DOI 10.1002/adma.201001925; Zhang Y, 2011, ADV MATER, V23, P3004, DOI 10.1002/adma.201100906; Zhou J, 2008, NANO LETT, V8, P3973, DOI 10.1021/nl802497e	25	695	717	33	824	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					952	957		10.1126/science.1234855	http://dx.doi.org/10.1126/science.1234855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23618761				2022-12-28	WOS:000319344100040
J	Ali, MK; Bullard, KM; Saaddine, JB; Cowie, CC; Imperatore, G; Gregg, EW				Ali, Mohammed K.; Bullard, Kai McKeever; Saaddine, Jinan B.; Cowie, Catherine C.; Imperatore, Giuseppina; Gregg, Edward W.			Achievement of Goals in U.S. Diabetes Care, 1999-2010	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERFORMANCE-MEASURES; GLYCEMIC TARGETS; US ADULTS; FOLLOW-UP; HEALTH; MORTALITY; QUALITY; DISEASE; INTERVENTION; MANAGEMENT	Background Tracking national progress in diabetes care may aid in the evaluation of past efforts and identify residual gaps in care. Methods We analyzed data for adults with self-reported diabetes from the National Health and Nutrition Examination Survey and the Behavioral Risk Factor Surveillance System to examine risk-factor control, preventive practices, and risk scores for coronary heart disease over the 1999-2010 period. Results From 1999 through 2010, the weighted proportion of survey participants who met recommended goals for diabetes care increased, by 7.9 percentage points (95% confidence interval [CI], 0.8 to 15.0) for glycemic control (glycated hemoglobin level <7.0%), 9.4 percentage points (95% CI, 3.0 to 15.8) for individualized glycemic targets, 11.7 percentage points (95% CI, 5.7 to 17.7) for blood pressure (target, <130/80 mm Hg), and 20.8 percentage points (95% CI, 11.6 to 30.0) for lipid levels (target level of low-density lipoprotein [LDL] cholesterol, <100 mg per deciliter [2.6 mmol per liter]). Tobacco use did not change significantly, but the 10-year probability of coronary heart disease decreased by 2.8 to 3.7 percentage points. However, 33.4 to 48.7% of persons with diabetes still did not meet the targets for glycemic control, blood pressure, or LDL cholesterol level. Only 14.3% met the targets for all three of these measures and for tobacco use. Adherence to the recommendations for annual eye and dental examinations was unchanged, but annual lipid-level measurement and foot examination increased by 5.5 percentage points (95% CI, 1.6 to 9.4) and 6.8 percentage points (95% CI, 4.8 to 8.8), respectively. Annual vaccination for influenza and receipt of pneumococcal vaccination for participants 65 years of age or older rose by 4.5 percentage points (95% CI, 0.8 to 8.2) and 6.9 percentage points (95% CI, 3.4 to 10.4), respectively, and daily glucose monitoring increased by 12.7 percentage points (95% CI, 10.3 to 15.1). Conclusions Although there were improvements in risk-factor control and adherence to preventive practices from 1999 to 2010, tobacco use remained high, and almost half of U.S. adults with diabetes did not meet the recommended goals for diabetes care.	[Ali, Mohammed K.; Bullard, Kai McKeever; Saaddine, Jinan B.; Imperatore, Giuseppina; Gregg, Edward W.] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; [Ali, Mohammed K.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Cowie, Catherine C.] NIDDK, NIH, Bethesda, MD USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ali, MK (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Mailstop K10,4770 Buford Hwy NE, Atlanta, GA 30341 USA.	ise1@cdc.gov	Ali, Mohammed K/N-9833-2013	Gregg, Edward/0000-0003-2381-6822; Ali, Mohammed/0000-0001-7266-2503				Ahmann AJ, 2007, AM J MANAG CARE, V13, pS41; Alexander GC, 2008, ARCH INTERN MED, V168, P2088, DOI 10.1001/archinte.168.19.2088; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; [Anonymous], 2013, PERF MEAS END DIAB; [Anonymous], 2012, DIAB DAT TRENDS HOSP; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gary TL, 2003, ETHNIC DIS, V13, P47; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gregg EW, 2012, DIABETES CARE, V35, P1252, DOI 10.2337/dc11-1162; Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kralewski JE, 2012, HEALTH AFFAIR, V31, P1830, DOI 10.1377/hlthaff.2011.0887; Laiteerapong N, 2013, DIABETES CARE, V36, P84, DOI 10.2337/dc11-2344; McWilliams JM, 2007, JAMA-J AM MED ASSOC, V298, P2886, DOI 10.1001/jama.298.24.2886; Mohiuddin SM, 2007, CHEST, V131, P446, DOI 10.1378/chest.06-1587; Moritz T, 2009, NEW ENGL J MED, V361, P1024, DOI 10.1056/NEJMc096250; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; National Committee for Quality Assurance, 2012, STAT HLTH CAR QUAL; O'Connor PJ, 2011, DIABETES CARE, V34, P1651, DOI 10.2337/dc11-0735; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pogach L, 2011, JAMA-J AM MED ASSOC, V305, P709, DOI 10.1001/jama.2011.153; Ratner RE, 2011, DIABETES CARE, V34, P1054, DOI 10.2337/dc10-1987; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Rossi MCE, 2011, DIABETES CARE, V34, P347, DOI 10.2337/dc10-1709; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stevens RJ, 2002, CLIN SCI, V102, P679, DOI 10.1042/cs1020679; TRIAD Study Grp, 2010, DIABETES CARE, V33, P940, DOI 10.2337/dc09-1802; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	40	665	683	0	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1613	1624		10.1056/NEJMsa1213829	http://dx.doi.org/10.1056/NEJMsa1213829			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130YK	23614587				2022-12-28	WOS:000317956300010
J	de Roode, JC; Lefevre, T; Hunter, MD				de Roode, Jacobus C.; Lefevre, Thierry; Hunter, Mark D.			Self-Medication in Animals	SCIENCE			English	Editorial Material							TOXINS; RESIN		[de Roode, Jacobus C.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Lefevre, Thierry] Inst Rech Dev, Malad Infect & Vecteurs Ecol Genet Evolut Control, F-34394 Montpellier, France; [Hunter, Mark D.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Emory University; Institut de Recherche pour le Developpement (IRD); University of Michigan System; University of Michigan	de Roode, JC (corresponding author), Emory Univ, Dept Biol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	jderood@emory.edu	Lefèvre, Thierry/E-2157-2011	Lefèvre, Thierry/0000-0002-9736-6142; Hunter, Mark/0000-0003-3761-8237				Castella G, 2008, ANIM BEHAV, V75, P1591, DOI 10.1016/j.anbehav.2007.10.014; de Roode JC, 2011, J EVOLUTION BIOL, V24, P712, DOI 10.1111/j.1420-9101.2010.02213.x; FOSTER MA, 1992, J ANIM ECOL, V61, P509, DOI 10.2307/5606; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; Huffman MA, 2003, P NUTR SOC, V62, P371, DOI 10.1079/PNS2003257; Janzen D.H., 1978, P73; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; Lefevre T, 2010, ECOL LETT, V13, P1485, DOI 10.1111/j.1461-0248.2010.01537.x; Lozano GA, 1998, ADV STUD BEHAV, V27, P291; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Raubenheimer D, 2009, INTEGR COMP BIOL, V49, P329, DOI 10.1093/icb/icp050; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Suarez-Rodriguez M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0931	15	151	153	5	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					150	151		10.1126/science.1235824	http://dx.doi.org/10.1126/science.1235824			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580516				2022-12-28	WOS:000317341400040
J	Su, YT; Huang, YH; Witek, HA; Lee, YP				Su, Yu-Te; Huang, Yu-Hsuan; Witek, Henryk A.; Lee, Yuan-Pern			Infrared Absorption Spectrum of the Simplest Criegee Intermediate CH2OO	SCIENCE			English	Article							GAS-PHASE OZONOLYSIS; CARBONYL OXIDES; MECHANISMS; CHEMISTRY; RADICALS; HEATS	The Criegee intermediates are carbonyl oxides postulated to play key roles in the reactions of ozone with unsaturated hydrocarbons; these reactions constitute an important mechanism for the removal of unsaturated hydrocarbons and for the production of OH in the atmosphere. Here, we report the transient infrared (IR) absorption spectrum of the simplest Criegee intermediate CH2OO, produced from CH2I + O-2 in a flow reactor, using a step-scan Fourier-transform spectrometer. The five observed bands provide definitive identification of this intermediate. The observed vibrational frequencies are more consistent with a zwitterion rather than a diradical structure of CH2OO. The direct IR detection of CH2OO should prove useful for kinetic and mechanistic investigations of the Criegee mechanism.	[Su, Yu-Te; Huang, Yu-Hsuan; Witek, Henryk A.; Lee, Yuan-Pern] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu 30010, Taiwan; [Su, Yu-Te; Huang, Yu-Hsuan; Witek, Henryk A.; Lee, Yuan-Pern] Natl Chiao Tung Univ, Inst Mol Sci, Hsinchu 30010, Taiwan; [Lee, Yuan-Pern] Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Witek, HA (corresponding author), Natl Chiao Tung Univ, Dept Appl Chem, 1001 Ta Hsueh Rd, Hsinchu 30010, Taiwan.	hwitek@mail.nctu.edu.tw; yplee@mail.nctu.edu.tw	Lee, Yuan-Pern/F-7938-2012; Witek, Henryk A/A-3427-2012	Lee, Yuan-Pern/0000-0001-6418-7378; Witek, Henryk A/0000-0002-9013-1287	National Science Council of Taiwan [NSC102-2745-M009-001-ASP, NSC99-2113-M-009-011-MY3]; Ministry of Education, Taiwan ("Aim for the Top University Plan" of National Chiao Tung University)	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan ("Aim for the Top University Plan" of National Chiao Tung University)	Calculation details and a compilation of anharmonic vibrational levels and IR intensities for possible intermediate structures with additional simulation plots are presented in the supplementary materials. National Science Council of Taiwan (grants NSC102-2745-M009-001-ASP and NSC99-2113-M-009-011-MY3) and the Ministry of Education, Taiwan ("Aim for the Top University Plan" of National Chiao Tung University) supported this work. The National Center for High-Performance Computing provided computer time. We thank G. Rauhut for his assistance in the calculations of anharmonic vibrational frequencies.	Angeli C, 2001, J CHEM PHYS, V114, P10252, DOI 10.1063/1.1361246; Anglada JM, 2011, PHYS CHEM CHEM PHYS, V13, P13034, DOI 10.1039/c1cp20872a; BAUGHCUM SL, 1980, J CHEM PHYS, V72, P6531, DOI 10.1063/1.439111; Beames JM, 2012, J AM CHEM SOC, V134, P20045, DOI 10.1021/ja310603j; BUNNELLE WH, 1991, CHEM REV, V91, P335, DOI 10.1021/cr00003a003; Calvert J. G., 2000, MECH ATMOSPHERIC OXI, P172; Chen JD, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3556817; Chen SH, 2001, CHEM PHYS LETT, V333, P365, DOI 10.1016/S0009-2614(00)01372-5; Chen SY, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3352315; Chu LK, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2211610; Cool TA, 2005, INT J MASS SPECTROM, V247, P18, DOI 10.1016/j.ijms.2005.08.018; CREMER D, 1993, CHEM PHYS LETT, V209, P547, DOI 10.1016/0009-2614(93)80131-8; Criegee R., 1949, CHEM BER, V9, P564; Fang DC, 2002, J PHYS CHEM A, V106, P2988, DOI 10.1021/jp014129m; Golec B, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3664304; Gravestock TJ, 2010, CHEMPHYSCHEM, V11, P3928, DOI 10.1002/cphc.201000575; HARDING LB, 1978, J AM CHEM SOC, V100, P7180, DOI 10.1021/ja00491a010; Harrison RM, 2006, SCI TOTAL ENVIRON, V360, P5, DOI 10.1016/j.scitotenv.2005.08.053; HATAKEYAMA S, 1994, RES CHEM INTERMEDIAT, V20, P503, DOI 10.1163/156856794X00432; Horie O, 1998, ACCOUNTS CHEM RES, V31, P387, DOI 10.1021/ar9702740; Huang DR, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2807241; Huang HF, 2012, J PHYS CHEM LETT, V3, P3399, DOI 10.1021/jz301585c; Johnson D, 2008, CHEM SOC REV, V37, P699, DOI 10.1039/b704260b; Marston G, 2012, SCIENCE, V335, P178, DOI 10.1126/science.1217165; McFiggans G, 2004, ATMOS CHEM PHYS, V4, P701, DOI 10.5194/acp-4-701-2004; Nandi S, 2002, J PHYS CHEM A, V106, P7547, DOI 10.1021/jp0126816; Neff M, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3243862; Nguyen MT, 2007, CHEM PHYS LETT, V448, P183, DOI 10.1016/j.cplett.2007.10.033; SANDER W, 1990, ANGEW CHEM INT EDIT, V29, P344, DOI 10.1002/anie.199003441; Taatjes CA, 2008, J AM CHEM SOC, V130, P11883, DOI 10.1021/ja804165q; Vereecken L, 2012, CHEM SOC REV, V41, P6259, DOI 10.1039/c2cs35070j; Welz O, 2012, SCIENCE, V335, P204, DOI 10.1126/science.1213229; Werner HJ, 2012, WIRES COMPUT MOL SCI, V2, P242, DOI 10.1002/wcms.82	33	207	209	6	293	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					174	176		10.1126/science.1234369	http://dx.doi.org/10.1126/science.1234369			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580523				2022-12-28	WOS:000317341400049
J	Brunton, BW; Botvinick, MM; Brody, CD				Brunton, Bingni W.; Botvinick, Matthew M.; Brody, Carlos D.			Rats and Humans Can Optimally Accumulate Evidence for Decision-Making	SCIENCE			English	Article							DRIFT-DIFFUSION MODEL; VISUAL FIXATIONS; AUDITORY-CORTEX; CHOICE; ACCURACY; TIME; DISCRIMINATION; SPEED; INTEGRATION; REFLECTS	The gradual and noisy accumulation of evidence is a fundamental component of decision-making, with noise playing a key role as the source of variability and errors. However, the origins of this noise have never been determined. We developed decision-making tasks in which sensory evidence is delivered in randomly timed pulses, and analyzed the resulting data with models that use the richly detailed information of each trial's pulse timing to distinguish between different decision-making mechanisms. This analysis allowed measurement of the magnitude of noise in the accumulator's memory, separately from noise associated with incoming sensory evidence. In our tasks, the accumulator's memory was noiseless, for both rats and humans. In contrast, the addition of new sensory evidence was the primary source of variability. We suggest our task and modeling approach as a powerful method for revealing internal properties of decision-making processes.	[Brunton, Bingni W.; Botvinick, Matthew M.; Brody, Carlos D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Brunton, Bingni W.; Brody, Carlos D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Botvinick, Matthew M.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Brody, Carlos D.] Howard Hughes Med Inst, Chevy Chase, MD USA	Princeton University; Princeton University; Princeton University; Howard Hughes Medical Institute	Brody, CD (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	brody@princeton.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Brunton B. W., 2009, ANN M SOC NEUR CHIC; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Krajbich I, 2011, P NATL ACAD SCI USA, V108, P13852, DOI 10.1073/pnas.1101328108; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Link SW, 1992, WAVE THEORY DIFFEREN; MacKay D. J. C., 2003, INFORM THEORY INFERE; Milosavljevic M, 2010, JUDGM DECIS MAK, V5, P437; Neri P, 1999, NATURE, V401, P695, DOI 10.1038/44409; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Paninski L, 2004, NEURAL COMPUT, V16, P2533, DOI 10.1162/0899766042321797; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Sanders JI, 2012, J NEUROPHYSIOL, V108, P3416, DOI 10.1152/jn.00669.2012; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Zariwala H., 2007, THESIS STONY BROOK U	28	312	313	4	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					95	98		10.1126/science.1233912	http://dx.doi.org/10.1126/science.1233912			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559254				2022-12-28	WOS:000317061100054
J	Ko, H; Cossell, L; Baragli, C; Antolik, J; Clopath, C; Hofer, SB; Mrsic-Flogel, TD				Ko, Ho; Cossell, Lee; Baragli, Chiara; Antolik, Jan; Clopath, Claudia; Hofer, Sonja B.; Mrsic-Flogel, Thomas D.			The emergence of functional microcircuits in visual cortex	NATURE			English	Article							BIDIRECTIONAL SYNAPTIC PLASTICITY; RECEPTIVE-FIELDS; CORTICAL-NEURONS; ORIENTATION SELECTIVITY; HORIZONTAL CONNECTIONS; PYRAMIDAL NEURONS; STRIATE CORTEX; IN-VIVO; NETWORKS; MODEL	Sensory processing occurs in neocortical microcircuits in which synaptic connectivity is highly structured(1-4) and excitatory neurons form subnetworks that process related sensory information(5,6). However, the developmental mechanisms underlying the formation of functionally organized connectivity in cortical microcircuits remain unknown. Here we directly relate patterns of excitatory synaptic connectivity to visual response properties of neighbouring layer 2/3 pyramidal neurons in mouse visual cortex at different postnatal ages, using two-photon calcium imaging in vivo and multiple whole-cell recordings in vitro. Although neural responses were already highly selective for visual stimuli at eye opening, neurons responding to similar visual features were not yet preferentially connected, indicating that the emergence of feature selectivity does not depend on the precise arrangement of local synaptic connections. After eye opening, local connectivity reorganized extensively: more connections formed selectively between neurons with similar visual responses and connections were eliminated between visually unresponsive neurons, but the overall connectivity rate did not change. We propose a sequential model of cortical microcircuit development based on activity-dependent mechanisms of plasticity whereby neurons first acquire feature preference by selecting feedforward inputs before the onset of sensory experience-a process that may be facilitated by early electrical coupling between neuronal subsets(7-9)-and then patterned input drives the formation of functional subnetworks through a redistribution of recurrent synaptic connections.	[Ko, Ho; Cossell, Lee; Baragli, Chiara; Antolik, Jan; Hofer, Sonja B.; Mrsic-Flogel, Thomas D.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6DE, England; [Clopath, Claudia] Columbia Univ, Ctr Theoret Neurosci, New York, NY 10032 USA	University of London; University College London; Columbia University	Hofer, SB (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, 21 Univ St, London WC1E 6DE, England.	s.hofer@ucl.ac.uk; t.mrsic-flogel@ucl.ac.uk	Ko, Ho/AAH-2755-2020; Ko, Ho/I-7513-2016; Antolík, Ján/ABA-4973-2021	Ko, Ho/0000-0002-0254-3274; Ko, Ho/0000-0002-0254-3274; Antolík, Ján/0000-0002-7223-4426; Hofer, Sonja/0000-0003-4921-8521; Mrsic-Flogel, Tom/0000-0002-8947-408X	Wellcome Trust; Medical Research Council; European Research Council; 7th Framework of European Commission 'EuroV1sion' grant; Swiss National Science Foundation [PA00P3_139703]	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); 7th Framework of European Commission 'EuroV1sion' grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank C. Akerman, D. Attwell, R. Froemke, M. Hausser, C. Levelt, C. Lohmann, T. Margrie, J. Sjostrom and members of the Mrsic-Flogel laboratory for advice and comments on the manuscript. We thank D. Farquarson, D. Halpin, A. Hogben of the University College London machine shop for custom parts. The work was supported by the Wellcome Trust (T.D.M.-F., S. B. H., C. B.), the Medical Research Council (L. C.), the European Research Council and the 7th Framework of European Commission 'EuroV1sion' grant (T.D.M.-F.), and the Swiss National Science Foundation (C. C., grant no. PA00P3_139703).	Agresti A., 2002, CATEGORICAL DATA ANA, P181; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Badel L, 2008, J NEUROPHYSIOL, V99, P656, DOI 10.1152/jn.01107.2007; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; CALLAWAY EM, 1990, J NEUROSCI, V10, P1134; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Frick A, 2007, J PHYSIOL-LONDON, V585, P103, DOI 10.1113/jphysiol.2007.141788; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Innocenti GM, 2005, NAT REV NEUROSCI, V6, P955, DOI 10.1038/nrn1790; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Krug K, 2001, J NEUROPHYSIOL, V85, P1436, DOI 10.1152/jn.2001.85.4.1436; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; O'Connor DH, 2005, J NEUROPHYSIOL, V94, P1565, DOI 10.1152/jn.00047.2005; Ohtsuki G, 2012, NEURON, V75, P65, DOI 10.1016/j.neuron.2012.05.023; Ostojic S, 2009, J COMPUT NEUROSCI, V26, P369, DOI 10.1007/s10827-008-0117-3; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Purves D, 1996, TRENDS NEUROSCI, V19, P460, DOI 10.1016/S0166-2236(96)20038-4; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 2004, J PHYSIOL-LONDON, V558, P717, DOI 10.1113/jphysiol.2004.065771; Rochefort NL, 2011, NEURON, V71, P425, DOI 10.1016/j.neuron.2011.06.013; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; Smyth D, 2003, J NEUROSCI, V23, P4746; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379	47	249	250	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					96	+		10.1038/nature12015	http://dx.doi.org/10.1038/nature12015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23552948	Green Accepted			2022-12-28	WOS:000316993400032
J	Cotter, C; Sturrock, HJW; Hsiang, MS; Liu, J; Phillips, AA; Hwang, J; Gueye, CS; Fullman, N; Gosling, RD; Feachem, RGA				Cotter, Chris; Sturrock, Hugh J. W.; Hsiang, Michelle S.; Liu, Jenny; Phillips, Allison A.; Hwang, Jimee; Gueye, Cara Smith; Fullman, Nancy; Gosling, Roly D.; Feachem, Richard G. A.			The changing epidemiology of malaria elimination: new strategies for new challenges	LANCET			English	Review							PLASMODIUM-FALCIPARUM INFECTIONS; SOUTH-AFRICA; KNOWLESI MALARIA; VIVAX MALARIA; PERSONAL PROTECTION; INTEGRATED CONTROL; COUNTRY EMBARKING; HIGH-PREVALENCE; RISK-FACTORS; PROVINCE	Malaria-eliminating countries achieved remarkable success in reducing their malaria burdens between 2000 and 2010. As a result, the epidemiology of malaria in these settings has become more complex. Malaria is increasingly imported, caused by Plasmodium vivax in settings outside sub-Saharan Africa, and clustered in small geographical areas or clustered demographically into subpopulations, which are often predominantly adult men, with shared social, behavioural, and geographical risk characteristics. The shift in the populations most at risk of malaria raises important questions for malaria-eliminating countries, since traditional control interventions are likely to be less effective. Approaches to elimination need to be aligned with these changes through the development and adoption of novel strategies and methods. Knowledge of the changing epidemiological trends of malaria in the eliminating countries will ensure improved targeting of interventions to continue to shrink the malaria map.	[Cotter, Chris; Sturrock, Hugh J. W.; Hsiang, Michelle S.; Liu, Jenny; Phillips, Allison A.; Hwang, Jimee; Gueye, Cara Smith; Fullman, Nancy; Gosling, Roly D.; Feachem, Richard G. A.] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94105 USA; [Hsiang, Michelle S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94105 USA; [Hwang, Jimee] Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA	Cotter, C (corresponding author), Univ Calif San Francisco, Global Hlth Grp, 50 Beale St,Suite 1200, San Francisco, CA 94105 USA.	cotterc@globalhealth.ucsf.edu		Sturrock, Hugh/0000-0002-0029-3101	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The work of the Global Health Group on malaria elimination is supported by a grant from the Bill & Melinda Gates Foundation. We thank the reviewers of this paper, including Patrick Kachur and John MacArthur of the CDC malaria branch, for their helpful comments; and Saehee Lee, Kelly Sanders, Kerstin Svendsen, and Hyun-Ju Woo for their assistance in data collection and preparation of the report.	Abeyasinghe RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043162; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Al-Zahrani Mohammed Hassan, 2012, 7 MAL EL GROUP M 201; Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; Amarasinghe SW, 1999, SOCIOECONOMIC STUDY; Andriopoulos P, 2013, INT J INFECT DIS, V17, pE125, DOI 10.1016/j.ijid.2012.09.009; [Anonymous], 2012, EL 8 E8 REG IN PAV W; [Anonymous], DEF MAL AS PAC AM MI; [Anonymous], 1995, B LATIN AM RES; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Atta Hoda, 2008, Eastern Mediterranean Health Journal, V14, pS82; Baird JK, 2013, CLIN MICROBIOL REV, V26, P36, DOI 10.1128/CMR.00074-12; Baird JK, 2010, LANCET, V376, P1883, DOI 10.1016/S0140-6736(10)61494-8; Baird JK, 2009, TRAVEL MED INFECT DI, V7, P269, DOI 10.1016/j.tmaid.2009.06.004; Baltzell KA, 2013, AM J TROP MED HYG, V88, P289, DOI 10.4269/ajtmh.2012.12-0095; Barber BE, 2013, CLIN INFECT DIS, V56, P383, DOI 10.1093/cid/cis902; Barclay VC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-304; Bhumiratana A, 2013, TRAVEL MED INFECT DI, V11, P37, DOI 10.1016/j.tmaid.2012.11.002; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bruce-Chwatt LJ, 1960, B WORLD HEALTH ORGAN, V21, P737; Bureau of Vector- Borne Disease, 2010, NAT STRAT PLAN MAL C; Cai WD, 2010, SEX TRANSM INFECT, V86, P15, DOI 10.1136/sti.2009.037440; Chai Jong-Yil, 1999, Korean Journal of Parasitology, V37, P129, DOI 10.3347/kjp.1999.37.3.129; Chinese Center for Disease Control and Prevention, 2006, ROUND 6 PROP MAL CON; Chiyaka C, 2013, SCIENCE, V339, P909, DOI 10.1126/science.1229509; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Collins WE, 2004, AM J TROP MED HYG, V70, P642, DOI 10.4269/ajtmh.2004.70.642; Congpuong K, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-288; Cordray MS, 2012, AM J TROP MED HYG, V87, P223, DOI 10.4269/ajtmh.2012.11-0685; Cousens SN, 1995, CASE CONTROL STUDIES; Cox-Singh J, 2008, TRENDS PARASITOL, V24, P406, DOI 10.1016/j.pt.2008.06.001; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Craig MH, 2004, TROP MED INT HEALTH, V9, P1258, DOI 10.1111/j.1365-3156.2004.01341.x; CURTIS CF, 1994, T R SOC TROP MED HYG, V88, P371; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Das P, 2010, LANCET, V376, P1515, DOI 10.1016/S0140-6736(10)61551-6; Davaalkham J, 2011, AIDS RES HUM RETROV, V27, P1073, DOI [10.1089/aid.2010.0196, 10.1089/AID.2010.0196]; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Feachem RGA, 2009, SHRINKING MALARIA MA; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gandhi K, 2012, AM J TROP MED HYG, V86, P775, DOI 10.4269/ajtmh.2012.11-0478; Gerritsen AAM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-162; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Gosling RD, 2011, CLIN MICROBIOL INFEC, V17, P1617, DOI 10.1111/j.1469-0691.2011.03660.x; Gosling RD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-346; Gueye CS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-344; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Heimer R, 2002, ADDICTION, V97, P1277, DOI 10.1046/j.1360-0443.2002.t01-1-00211.x; Hill N, 2007, BRIT MED J, V335, P1023, DOI 10.1136/bmj.39356.574641.55; Hiwat H, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-10; Hotez PJ, 2009, CLIN PHARMACOL THER, V85, P659, DOI 10.1038/clpt.2009.16; Hsiang MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029550; Humphreys M., 2001, MALARIA POVERTY RACE; Incardona S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-37; John GK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-280; Johnston LG, 2006, J URBAN HEALTH, V83, pI16, DOI 10.1007/s11524-006-9099-5; Kanapathy V, 2007, REG S MAN LAB MIGR E; Kaneko A, 2010, ACTA TROP, V114, P177, DOI 10.1016/j.actatropica.2010.01.012; Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005; Kazembe LN, 2007, ACTA TROP, V102, P126, DOI 10.1016/j.actatropica.2007.04.012; Kelly GC, 2012, TRENDS PARASITOL, V28, P297, DOI 10.1016/j.pt.2012.04.002; Khamsiriwatchara A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-120; Kimani EW, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-63; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P986, DOI 10.1046/j.1365-3156.2001.00817.x; Koepfli C, 2009, J INFECT DIS, V199, P1074, DOI 10.1086/597303; Korenromp EL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-18; Lansang MAD, 1997, ACTA TROP, V63, P257, DOI 10.1016/S0001-706X(96)00625-0; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6; Macauley C, 2005, SOC SCI MED, V60, P563, DOI 10.1016/j.socscimed.2004.05.025; Mae Sot IRIN UN Office for the Coordination of Humanitarian Affairs, 2012, MYANM THAIL STRUGGL; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Mantecon A, 2008, ADICCIONES, V20, P161, DOI 10.20882/adicciones.280; MARCELO L, 1994, AM J TROP MED HYG, V51, P16, DOI 10.4269/ajtmh.1994.51.16; Marsh K, 2010, LANCET, V376, P1626, DOI 10.1016/S0140-6736(10)61499-7; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; Ministry of Health Sri Lanka and World Health Organization and the University of California-San Francisco, 2012, EL MAL CAS STUD 3 PR; Specos MMM, 2010, T ROY SOC TROP MED H, V104, P653, DOI 10.1016/j.trstmh.2010.06.004; Moonasar D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-294; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; National Program for Control of Tropical Diseases (CENCET), 2008, ROUND 8 PROP STRENGT; Ngo DT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007369; Ngomane L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-19; Nunuhe M, 2011, NAMIBIA ANGOLA SIGN; O'Sullivan M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-235; Ogoma SB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000773; Oguike MC, 2011, INT J PARASITOL, V41, P677, DOI 10.1016/j.ijpara.2011.01.004; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P421, DOI 10.1046/j.1365-3156.2002.00881.x; PACKARD RM, 1986, SOC SCI MED, V22, P861, DOI 10.1016/0277-9536(86)90240-6; Pan American Health Organization, 2010, REP SIT MAL AM; PIGOTT DM, 2006, MALARIA J, V11, P246, DOI DOI 10.1186/1475-2875-11-246); Pilipinas Shell Foundation, 2002, ROUND 2 PROP ADV MAL; Pinto J, 2000, ACTA TROP, V76, P185, DOI 10.1016/S0001-706X(00)00100-5; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Qi G, 2012, 7 MAL EL GROUP M AL; Rajahram GS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-284; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Rowland M, 1999, T ROY SOC TROP MED H, V93, P465, DOI 10.1016/S0035-9203(99)90341-3; Rowland M, 2004, TROP MED INT HEALTH, V9, P335, DOI 10.1111/j.1365-3156.2004.01198.x; RUEBUSH TK, 1992, AM J TROP MED HYG, V46, P248, DOI 10.4269/ajtmh.1992.46.248; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; Sanders K, 2012, MALARIA CHEMOTHERAPY, V1, P1; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; SEVILLACASAS E, 1993, SOC SCI MED, V37, P1155, DOI 10.1016/0277-9536(93)90255-3; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Steenkeste N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-108; Sturrock H.J.W., 2012, MALAR J S1, V11, pO6; Sun SJ, 2002, EMERG INFECT DIS, V8, P1216; Sutcliffe CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031396; Tatarsky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023832; Tatem AJ, 2010, LANCET, V376, P1579, DOI 10.1016/S0140-6736(10)61301-3; Tobgay T, 2011, ACTA TROP, V117, P225, DOI 10.1016/j.actatropica.2010.11.008; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Vannice KS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-372; Vector Borne Disease Control Program: Sabah State Malaysia, 2012, VECT BORN DIS CONTR; Vector Borne Disease Control Program: Solomon Islands, VECT BORN DIS CONTR; Vector Borne Disease Control Program (VBDCP) Ministry of Health Solomon Islands, NAT MAL STRAT VIS 20; Vinetz JM, 2002, AM J TROP MED HYG, V66, P639, DOI 10.4269/ajtmh.2002.66.639; VITTAL M, 1984, Indian Journal of Medical Sciences, V38, P201; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; Wangdi K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-89; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2012, WHO HAILS POL LEAD S; WHO, 2012, DIS SURV MAL EL OP M; WHO, 2008, GLOB MAL CONTR EL RE; WHO, 2006, INF CONS MAL CLIM SE; World Bank, 2022, WORLD DEV IND; Yangzom T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-9; Zacarias OP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-79; Zhou Hua-Yun, 2011, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V23, P402	142	396	406	3	135	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2013	382	9895					900	911		10.1016/S0140-6736(13)60310-4	http://dx.doi.org/10.1016/S0140-6736(13)60310-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215WE	23594387				2022-12-28	WOS:000324240700032
J	Pellegrino, JW				Pellegrino, James W.			Proficiency in Science: Assessment Challenges and Opportunities	SCIENCE			English	Review								Proficiency in science is being defined through performance expectations that intertwine science practices, cross-cutting concepts, and core content knowledge. These descriptions of what it means to know and do science pose challenges for assessment design and use, whether at the classroom instructional level or the system level for monitoring the progress of science education. There are systematic ways to approach assessment development that can address design challenges, as well as examples of the application of such principles in science assessment. This Review considers challenges and opportunities that exist for design and use of assessments that can support science teaching and learning consistent with a contemporary view of what it means to be proficient in science.	Univ Illinois, Learning Sci Res Inst, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Pellegrino, JW (corresponding author), Univ Illinois, Learning Sci Res Inst, Chicago, IL 60607 USA.	pellegjw@uic.edu						Alonzo A. C., 2012, LEARNING PROGR SCI; American Association of Medical Colleges, 2012, MR5 5TH COMPREHENSIV; [Anonymous], ACHIEVE; College Board, 2010, FROM RESEARCH TO PRA; College Board, 2011, THE AP BIOLOGY CURRI; College Board, 2012, AP BIOLOGY COURSE AN; College Board, 2009, SCIENCE COLLEGE BOAR; College Board, 2011, THE AP CHEMISTRY CUR; Committee on Conceptual Framework for the New K-12 Science Education Standards, 2012, FRAM K 12 SCI ED PRA; Fu AC, 2009, SCIENCE, V326, P1637, DOI 10.1126/science.1177780; Gobert J., 2012, J ED DATA MINING, V4, P153; Huff K, 2010, APPL MEAS EDUC, V23, P310, DOI 10.1080/08957347.2010.510956; Mislevy R.J., 2006, ED MEASUREMENT ISSUE, V25, P6, DOI [10.1111/j.1745-3992.2006.00075.x, DOI 10.1111/J.1745-3992.2006.00075.X]; Mislevy RJ, 2006, HANDBOOK OF TEST DEVELOPMENT, P61; National Assessment Governing Board, 2008, SCIENCE FRAMEWORK FO; National Center for Educational Statistics, 2012, NCES 2012 465; National Center for Educational Statistics (NCES), 2012, THE NATIONS REPORT C; National Research Council, 2001, KNOWING WHAT STUDENT; Natl Res Council, 2009, LEARNING SCIENCE IN INFORMAL ENVIRONMENTS: PEOPLE, PLACES, AND PURSUITS, P1; Organization for Economic Cooperation and Development (OECD), 2009, PISA 2009 ASSESSMENT; Pelczar M. P., 2010, NCES 2001 004; Pellegrino JW, 2010, J RES TECHNOL EDUC, V43, P119, DOI 10.1080/15391523.2010.10782565; Pellegrino JW, 2012, J RES SCI TEACH, V49, P831, DOI 10.1002/tea.21032; Pratt H., 2012, THE NSTA READERS GUI; Quellmalz ES, 2012, J RES SCI TEACH, V49, P363, DOI 10.1002/tea.21005; Schweingruber H. A., 2007, TAKING SCIENCE TO SC; Singer S. R., 2012, DISCIPLINE BASED EDU; Songer NB, 2012, J RES SCI TEACH, V49, P683, DOI 10.1002/tea.21033; SONGER NB, 2012, J RES SCI TEACH, V49, P141, DOI DOI 10.1002/tea.20454; Wiggins G., 2005, UNDERSTANDING DESIGN; Wood WB, 2009, SCIENCE, V325, P1627, DOI 10.1126/science.1180821	31	43	48	4	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					320	323		10.1126/science.1232065	http://dx.doi.org/10.1126/science.1232065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126XZ	23599485	Green Submitted			2022-12-28	WOS:000317657500046
J	Ding, YG; Fang, H				Ding, Ying-Guo; Fang, Hong			Edematous Erythema, Subcutaneous Plaques, and Severe Pain in the Lower Extremities in an Immunocompromised Patient	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ORGAN TRANSPLANT RECIPIENTS; CUTANEOUS CRYPTOCOCCOSIS; CELLULITIS		[Ding, Ying-Guo; Fang, Hong] Zhejiang Univ, Dept Dermatol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Fang, H (corresponding author), Zhejiang Univ, Dept Dermatol, Affiliated Hosp 1, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	fanghongzy@sina.com		Fang, Hong/0000-0002-5917-2283				Abuav R, 2010, CUTIS, V85, P303; Adachi M, 2009, CLIN EXP DERMATOL, V34, pE751, DOI 10.1111/j.1365-2230.2009.03472.x; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Fallah H, 2011, AUSTRALAS J DERMATOL, V52, P288, DOI 10.1111/j.1440-0960.2011.00820.x; Leao CA, 2011, MED MYCOL, V49, P352, DOI 10.3109/13693786.2010.530697; Moe K, 2005, ARCH DERMATOL, V141, P913, DOI 10.1001/archderm.141.7.913; Muller CSL, 2010, EUR J DERMATOL, V20, P657, DOI 10.1684/ejd.2010.1043; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Probst C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-239; Sun HY, 2010, MED MYCOL, V48, P785, DOI 10.3109/13693780903496617	10	6	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1632	1633		10.1001/jama.2013.3740	http://dx.doi.org/10.1001/jama.2013.3740			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126FY	23592108				2022-12-28	WOS:000317599500027
J	Emanuel, EJ				Emanuel, Ezekiel J.			The Future of Biomedical Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CELL LUNG-CANCER; BEVACIZUMAB		[Emanuel, Ezekiel J.] Univ Penn, Off Vice Provost, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Emanuel, EJ (corresponding author), Univ Penn, Dept Med Eth & Hlth Policy, 122 Coll Hall, Philadelphia, PA 19104 USA.	vp-global@upenn.edu						[Anonymous], C JOING COMM SEQ FIS; [Anonymous], MED CHIP; *C BUDG OFF, TECHN CHANG GROWTH H; Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225; Goulart B, 2011, VALUE HEALTH, V14, P836, DOI 10.1016/j.jval.2011.04.004; NEWPORT F, US 46 HOLD CREATIONI; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Tappenden P, 2007, HEALTH TECHNOL ASSES, V11, P1	8	23	23	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1589	1590		10.1001/jama.2013.2096	http://dx.doi.org/10.1001/jama.2013.2096			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126FY	23559019				2022-12-28	WOS:000317599500018
J	Farnan, JM; Sulmasy, LS; Worster, BK; Chaudhry, HJ; Rhyne, JA; Arora, VM				Farnan, Jeanne M.; Sulmasy, Lois Snyder; Worster, Brooke K.; Chaudhry, Humayun J.; Rhyne, Janelle A.; Arora, Vineet M.		Amer Coll Phys Ethics; Amer Coll Phys Council Associates; Federation State Med Boards	Online Medical Professionalism: Patient and Public Relationships: Policy Statement From the American College of Physicians and the Federation of State Medical Boards	ANNALS OF INTERNAL MEDICINE			English	Article							SOCIAL NETWORKING; COMMUNICATION; ETHICS; AGE	User-created content and communications on Web-based applications, such as networking sites, media sharing sites, or blog platforms, have dramatically increased in popularity over the past several years, but there has been little policy or guidance on the best practices to inform standards for the professional conduct of physicians in the digital environment. Areas of specific concern include the use of such media for nonclinical purposes, implications for confidentiality, the use of social media in patient education, and how all of this affects the public's trust in physicians as patient-physician interactions extend into the digital environment. Opportunities afforded by online applications represent a new frontier in medicine as physicians and patients become more connected. This position paper from the American College of Physicians and the Federation of State Medical Boards examines and provides recommendations about the influence of social media on the patient-physician relationship, the role of these media in public perception of physician behaviors, and strategies for physician-physician communication that preserve confidentiality while best using these technologies. Ann Intern Med. 2013;158:620-627. www.annals.org For author affiliations, see end of text. This article was published at www.annals.org on 11 April 2013.	Univ Chicago, Chicago, IL 60637 USA; [Sulmasy, Lois Snyder] Amer Coll Physicians, Philadelphia, PA 19106 USA; Federat State Med Boards, Euless, TX USA; South East Area Hlth Educ Ctr, Wilmington, NC USA	University of Chicago; American College of Physicians	Sulmasy, LS (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	lsnyder@acponline.org		Arora, Vineet/0000-0002-4745-7599				American Medical Association, 2013, 3I02 CEJA AM MED ASS; [Anonymous], 2010, CNN             0129; [Anonymous], 2004, J R SOC MED, V97, P455; Associated Press, ASS PRESS; Bailey RA, 2011, HLTH LAWYER, V23, P13; Cain J, 2010, AM J HEALTH-SYST PH, V67, P1635, DOI 10.2146/ajhp090658; Carroll J, 2010, HLTH LEADERS ME 0713; Chaudhry HJ, 2008, CURR ATHEROSCLER REP, V10, P19, DOI 10.1007/s11883-008-0004-4; Chretien KC, 2011, ACAD MED, V86, P1545, DOI 10.1097/ACM.0b013e3182356128; Chretien KC, 2009, JAMA-J AM MED ASSOC, V302, P1309, DOI 10.1001/jama.2009.1387; Clinton BK, 2010, HARVARD REV PSYCHIAT, V18, P103, DOI 10.3109/10673221003683861; Cruess RL, 1997, ACAD MED, V72, P941, DOI 10.1097/00001888-199711000-00009; Cruess SR, 2004, AMA VIRTUAL MENT APR; Dolan P, 2011, AMA MEDNEWS     0418; Dolan P, 2011, AMA MEDNEWS     0801; Farnan JM, 2009, ACAD MED, V84, P1479, DOI 10.1097/ACM.0b013e3181bb17af; Farnan JM, 2010, AJOB PRIM RES, V1, P3, DOI [DOI 10.1080/21507711003697527, 10.1080/21507711003697527]; Federation of State Medical Boards, 2012, APPR US TEL TECHN PR; Federation of State Medical Boards of the United States Inc, 2002, MOD GUID APPR US INT; Greysen SR, 2012, JAMA-J AM MED ASSOC, V307, P1141, DOI 10.1001/jama.2012.330; Hayter CRR, 2006, J MED HUMANIT, V27, P215, DOI 10.1007/s10912-006-9019-4; Imprivata, 2012, 2012 TEXT MESS HEALT; Jain SH, 2009, NEW ENGL J MED, V361, P649, DOI 10.1056/NEJMp0901277; Joseph-Williams N, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1307; Kind T, 2012, MED ED ONLINE; Lawrence L, 2011, ACP INTERNIST    SEP; Leong SL, 2005, J AM BOARD FAM PRACT, V18, P180, DOI 10.3122/jabfm.18.3.180; Liederman EM, 2003, J AM MED INFORM ASSN, V10, P260, DOI 10.1197/jamia.M1259; Lu E., MED CHANGE BLOG; Mathews A.W., 2009, WALL STREET J; Mostaghimi A, 2011, ANN INTERN MED, V154, P560, DOI 10.7326/0003-4819-154-8-201104190-00008; Moubarak G, 2011, J MED ETHICS, V37, P101, DOI 10.1136/jme.2010.036293; O'Reilly KB, 2011, AMA MED NEWS    0711; Parikh SM, 2010, ACAD MED, V85, P930, DOI 10.1097/ACM.0b013e3181dbe54b; Pew Internet The, HLTH INF IS POP PURS; Robert Wood Johnson Foundation, 2011, PROJ ECHO FORC MULT; Sacopulos MJ, 2012, MED JUSTICE BLOG; Shore R, 2011, J CLIN ETHIC, V22, P165; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Sorrel A, 2010, AM MED NEWS     1004; Spielberg AR, 1998, JAMA-J AM MED ASSOC, V280, P1353, DOI 10.1001/jama.280.15.1353; Thompson LA, 2008, J GEN INTERN MED, V23, P954, DOI 10.1007/s11606-008-0538-8; Tode C, 2011, MOBILE COMMERCE 1007; Tweet MS, 2011, MAYO CLIN PROC, V86, P845, DOI 10.4065/mcp.2011.0312; United Kingdom General Medicine Council, LIST ETH GUID; Vartabedian B, 2011, SOCIAL MEDIA BL 0523; Wagstaff Keith, 2011, TIME; Weiss G, 2010, MEDSCAPE BUSINE 0104	48	232	235	2	58	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8					620	+		10.7326/0003-4819-158-8-201304160-00100	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-00100			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	132IW	23579867				2022-12-28	WOS:000318062100018
J	Irish, JD; Guatelli-Steinberg, D; Legge, SS; de Ruiter, DJ; Berger, LR				Irish, Joel D.; Guatelli-Steinberg, Debbie; Legge, Scott S.; de Ruiter, Darryl J.; Berger, Lee R.			Dental Morphology and the Phylogenetic "Place" of Australopithecus sediba	SCIENCE			English	Article							ORIGINS; PLIOPLEISTOCENE; TEETH	To characterize further the Australopithecus sediba hypodigm, we describe 22 dental traits in specimens MH1 and MH2. Like other skeletal elements, the teeth present a mosaic of primitive and derived features. The new nonmetric data are then qualitatively and phenetically compared with those in eight other African hominin samples, before cladistic analyses using a gorilla outgroup. There is some distinction, largely driven by contrasting molar traits, from East African australopiths. However, Au. sediba links with Au. africanus to form a South African australopith clade. These species present five apomorphies, including shared expressions of Carabelli's upper first molar (UM1) and protostylid lower first molar (LM1). Five synapomorphies are also evident between them and monophyletic Homo habilis/rudolfensis + H. erectus. Finally, a South African australopith + Homo clade is supported by four shared derived states, including identical LM1 cusp 7 expression.	[Irish, Joel D.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 3AF, Merseyside, England; [Guatelli-Steinberg, Debbie] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Guatelli-Steinberg, Debbie] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Legge, Scott S.] Macalester Coll, Dept Anthropol, St Paul, MN 55105 USA; [de Ruiter, Darryl J.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [de Ruiter, Darryl J.; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa	Liverpool John Moores University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Macalester College; Texas A&M University System; Texas A&M University College Station; University of Witwatersrand	Irish, JD (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 3AF, Merseyside, England.	j.d.irish@ljmu.ac.uk	Legge, Scott S/I-4162-2019; Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629; de Ruiter, Darryl/0000-0003-1183-0352; Irish, Joel D./0000-0001-7857-8847	National Science Foundation [BCS-0840674, BNS-0104731, BNS-9013942]; National Geographic Society; Wenner-Gren Foundation; Institute for Bioarchaeology; University of Alaska; Combined Prehistoric and Hierakonpolis Expeditions; Leakey Foundation; Ohio State University; Wallace Travel Fund; Macalester College; Paul Anderson Interdisciplinary Summer Research Fund; Texas AM University	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Wenner-Gren Foundation; Institute for Bioarchaeology; University of Alaska; Combined Prehistoric and Hierakonpolis Expeditions; Leakey Foundation; Ohio State University(Ohio State University); Wallace Travel Fund; Macalester College; Paul Anderson Interdisciplinary Summer Research Fund; Texas AM University	Collection of the recent African comparative data was funded by monies to J. D. I. from the National Science Foundation (BCS-0840674, BNS-0104731, BNS-9013942), National Geographic Society, Wenner-Gren Foundation, Institute for Bioarchaeology, University of Alaska, and the Combined Prehistoric and Hierakonpolis Expeditions. The innumerable individuals at >25 institutions from which the data were collected cannot be listed in this restricted space, but their help is greatly appreciated. These and the Au. sediba ASUDAS raw data are in the possession of J. D. I. Collection of the early hominin comparative data was funded by grants to D. G.-S. from the Leakey Foundation and Ohio State University. The authors thank D. Johanson and W. Kimbel for allowing D. G.-S. to study the Hadar fossils, M. Yilma of the National Museum of Ethiopia, C. Kiarie of the National Museums of Kenya, P. Msemwa and E. Maro of the National Museum of Tanzania, the Ethiopian government, and the governments of Kenya and Tanzania. H. Fourie and F. Thackery provided access to fossils at the Transvaal Museum in Pretoria; P. Tobias, B. Kramer, and K. Kuykendall provided access to the fossils at the University of the Witwatersrand. I. Tattersall, J. Schwartz, J. Lukacs, H. McHenry, I. Pike, J. McKee, and T. Harrison advised D. G.-S. regarding the logistics of her research in east and South Africa. The ASUDAS hominin data are in the possession of D. G.-S. The assistance of A. Gill and M. Harman at the Powell-Cotton Museum, Birchington, UK, from which the gorilla crown data (in the possession of S. S. L.) were recorded, is greatly appreciated. Funding for S. S. L. was provided by the Wallace Travel Fund, Macalester College, and the Paul Anderson Interdisciplinary Summer Research Fund; funding for D. J. D. was provided by the Ray A. Rothrock Fellowship, Texas A&M University.	Abbott S.A., 1984, THESIS U LONDON; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; DeSilva JM, 2013, SCIENCE, V340, DOI 10.1126/science.1232999; Falk D., 1988, P85; Grine Frederick E., 2009, P49, DOI 10.1007/978-1-4020-9980-9_6; Guatelli-Steinberg D, 2005, AM J PHYS ANTHROPOL, V128, P477, DOI 10.1002/ajpa.20194; Hunter JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011844; Irish JD, 2005, AM J PHYS ANTHROPOL, V128, P520, DOI 10.1002/ajpa.20109; Irish JD, 2003, J HUM EVOL, V45, P113, DOI 10.1016/S0047-2484(03)00090-3; Irish JD, 1998, J HUM EVOL, V34, P81, DOI 10.1006/jhev.1997.0191; IRISH JD, 1993, THESIS ARIZONA STATE; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Kupczik K., 2003, THESIS U LONDON; Olson T.R., 1985, P102; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Schmid P, 2013, SCIENCE, V340, DOI 10.1126/science.1234598; Scott G.R., 1997, ANTHR MODERN HUMAN T, DOI 10.1017/CBO9781316529843; Smith HF, 2008, J HUM EVOL, V54, P684, DOI 10.1016/j.jhevol.2007.10.012; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Strait DS, 1997, J HUM EVOL, V32, P17, DOI 10.1006/jhev.1996.0097; Swofford D.L., 2002, PHYLOGENETIC ANAL US; TURNER CG, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P13; Ungar PS, 2011, YEARB PHYS ANTHROPOL, V54, P47; Williams SA, 2013, SCIENCE, V340, DOI 10.1126/science.1232996; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	30	55	55	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129							1233062	10.1126/science.1233062	http://dx.doi.org/10.1126/science.1233062			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580535				2022-12-28	WOS:000317341400004
J	Franco, M; Bilal, U; Ordunez, P; Benet, M; Morejon, A; Caballero, B; Kennelly, JF; Cooper, RS				Franco, Manuel; Bilal, Usama; Ordunez, Pedro; Benet, Mikhail; Morejon, Alain; Caballero, Benjamin; Kennelly, Joan F.; Cooper, Richard S.			Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological comparison of secular trends	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; RISK-FACTORS; OBESITY; DISEASE; ADULTS; HEALTH; PREVENTION; PREVALENCE; OVERWEIGHT; SMOKING	Objective To evaluate the associations between population-wide loss and gain in weight with diabetes prevalence, incidence, and mortality, as well as cardiovascular and cancer mortality trends, in Cuba over a 30 year interval. Design Repeated cross sectional surveys and ecological comparison of secular trends. Setting Cuba and the province of Cienfuegos, from 1980 to 2010. Participants Measurements in Cienfuegos included a representative sample of 1657, 1351, 1667, and 1492 adults in 1991, 1995, 2001, and 2010, respectively. National surveys included a representative sample of 14 304, 22 851, and 8031 participants in 1995, 2001, and 2010, respectively. Main outcome measures Changes in smoking, daily energy intake, physical activity, and body weight were tracked from 1980 to 2010 using national and regional surveys. Data for diabetes prevalence and incidence were obtained from national population based registries. Mortality trends were modelled using national vital statistics. Results Rapid declines in diabetes and heart disease accompanied an average population-wide loss of 5.5 kg in weight, driven by an economic crisis in the mid-1990s. A rebound in population weight followed in 1995 (33.5% prevalence of overweight and obesity) and exceeded pre-crisis levels by 2010 (52.9% prevalence). The population-wide increase in weight was immediately followed by a 116% increase in diabetes prevalence and 140% increase in diabetes incidence. Six years into the weight rebound phase, diabetes mortality increased by 49% (from 9.3 deaths per 10 000 people in 2002 to 13.9 deaths per 10 000 people in 2010). A deceleration in the rate of decline in mortality from coronary heart disease was also observed. Conclusions In relation to the Cuban experience in 1980-2010, there is an association at the population level between weight reduction and death from diabetes and cardiovascular disease; the opposite effect on the diabetes and cardiovascular burden was seen on population-wide weight gain.	[Franco, Manuel; Bilal, Usama] Univ Alcala de Henares, Sch Med, Social & Cardiovasc Epidemiol Res Grp, Madrid, Spain; [Franco, Manuel] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ordunez, Pedro] Pan Amer Hlth Org, Project Chron Dis Prevent & Control, Washington, DC USA; [Ordunez, Pedro; Benet, Mikhail; Morejon, Alain] Univ Ciencias Med, Ctr Estudios Enfermedades Cron, Cienfuegos, Cuba; [Caballero, Benjamin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Human Nutr, Baltimore, MD USA; [Kennelly, Joan F.] Univ Illinois, Sch Publ Hlth, Div Community Hlth Sci, Chicago, IL USA; [Cooper, Richard S.] Loyola Univ, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL 60153 USA	Universidad de Alcala; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pan American Health Organization; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Loyola University Chicago	Franco, M (corresponding author), Ctr Nacl Invest Cardiovasc Madrid, Dept Epidemiol Atherothrombosis & Cardiovasc Imag, Madrid, Spain.	mfranco@uah.es	Benet, Marta/H-4168-2017; Benet, Mikhail/AAS-2086-2020; Morejon, Alain/AAS-4280-2020; FRANCO, MANUEL/T-5409-2018	Morejon, Alain/0000-0002-4652-1771; Bilal, Usama/0000-0002-9868-7773; FRANCO, MANUEL/0000-0003-1366-9398				Arnold AM, 2010, J GERONTOL A-BIOL, V65, P63, DOI 10.1093/gerona/glp050; Arnold Y, 2012, REV PERU EPIDEMIOL, V16, P6; Barcelo A, 1993, REV CUB ENDOCRINOL, V4, P59; Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; Benet Rodríguez Mikhail, 2010, Medisur, V8, P56; BERN C, 1995, NEW ENGL J MED, V333, P1176; Borowy I, 2013, J CLEAN PROD, V38, P17, DOI 10.1016/j.jclepro.2011.11.057; Borowy I, 2011, SOC SCI MED, V72, P1489, DOI 10.1016/j.socscimed.2011.03.008; Campion EW, 2013, NEW ENGL J MED, V368, P297, DOI 10.1056/NEJMp1215226; Capewell S, 2011, LANCET, V378, P752, DOI 10.1016/S0140-6736(10)62302-1; Colditz GA, 2012, ANNU REV PUBL HEALTH, V33, P137, DOI 10.1146/annurev-publhealth-031811-124627; Cooper RS, 2008, INT J OBESITY, V32, pS47, DOI 10.1038/ijo.2008.85; Cooper RS, 2006, AM J PUBLIC HEALTH, V96, P94, DOI 10.2105/AJPH.2004.051417; Durazo-Arvizu RA, 1998, AM J EPIDEMIOL, V147, P739, DOI 10.1093/oxfordjournals.aje.a009518; Espinosa-Brito A, 2004, BRIT MED J, V328, P166, DOI 10.1136/bmj.328.7432.166-a; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Field AE, 2004, OBES RES, V12, P267, DOI 10.1038/oby.2004.34; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356; Franco M, 2008, CAN MED ASSOC J, V178, P1032, DOI 10.1503/cmaj.071677; Franco M, 2007, AM J EPIDEMIOL, V166, P1374, DOI 10.1093/aje/kwm226; Houston TK, 2006, BMJ-BRIT MED J, V332, P1064, DOI 10.1136/bmj.38779.584028.55; Keck C William, 2012, Am J Public Health, V102, pe13, DOI 10.2105/AJPH.2012.300822; Lazo M, 2006, LANCET, V367, P985, DOI 10.1016/S0140-6736(06)68422-5; National Cancer Institute, 2012, JOINPOINT REGRESSION; National Institutes of Health, 2012, WEIGHT LOSS DOES NOT; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; OrdunezGarcia PO, 1996, AM J PUBLIC HEALTH, V86, P738, DOI 10.2105/AJPH.86.5.738; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Rios Massabot NE, 2005, REV CUB SALUD PUBLIC, V31, P345; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Rzehak P, 2007, EUR J EPIDEMIOL, V22, P665, DOI 10.1007/s10654-007-9167-5; Simmons RK, 2012, LANCET, V380, P1741, DOI 10.1016/S0140-6736(12)61422-6; Stevens VL, 2012, AM J EPIDEMIOL, V175, P785, DOI 10.1093/aje/kwr378; Stuckler D, 2012, J EPIDEMIOL COMMUN H, V66, P410, DOI 10.1136/jech.2010.121376; Taing KY, 2012, OBESITY, V20, P407, DOI 10.1038/oby.2011.207; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Wannamethee SG, 2002, ARCH INTERN MED, V162, P2575, DOI 10.1001/archinte.162.22.2575; Waring ME, 2010, AM J EPIDEMIOL, V171, P550, DOI 10.1093/aje/kwp433; West KM, 1978, EPIDEMIOLOGY OF DIAB; World Bank, 2012, WORLD BANK DATA CUBA; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005	43	102	106	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2013	346								f1515	10.1136/bmj.f1515	http://dx.doi.org/10.1136/bmj.f1515			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	125ZC	23571838	Green Published, hybrid			2022-12-28	WOS:000317579800001
J	Moutanabbir, O; Isheim, D; Blumtritt, H; Senz, S; Pippel, E; Seidman, DN				Moutanabbir, Oussama; Isheim, Dieter; Blumtritt, Horst; Senz, Stephan; Pippel, Eckhard; Seidman, David N.			Colossal injection of catalyst atoms into silicon nanowires	NATURE			English	Article							GROUP-III; GROWTH; GERMANIUM; NUCLEATION; ELEMENTS	The incorporation of impurities during the growth of nanowires from the vapour phase alters their basic properties substantially, and this process is critical in an extended range of emerging nanometre-scale technologies(1-4). In particular, achieving precise control of the behaviour of group III and group V dopants has been a crucial step in the development of silicon (Si) nanowire-based devices(5-7). Recently(8-11) it has been demonstrated that the use of aluminium (Al) as a growth catalyst, instead of the usual gold, also yields an effective p-type doping, thereby enabling a novel and efficient route to functionalizing Si nanowires. Besides the technological implications, this self-doping implies the detachment of Al from the catalyst and its injection into the growing nanowire, involving atomic-scale processes that are crucial for the fundamental understanding of the catalytic assembly of nanowires. Here we present an atomic-level, quantitative study of this phenomenon of catalyst dissolution by three-dimensional atom-by-atom mapping of individual Al-catalysed Si nanowires using highly focused ultraviolet-laser-assisted atom-probe tomography. Although the observed incorporation of the catalyst atoms into nanowires exceeds by orders of magnitude the equilibrium solid solubility(12) and solid-solution concentrations in known non-equilibrium processes(13,14), the Al impurities are found to be homogeneously distributed in the nanowire and do not form precipitates or clusters. As well as the anticipated effect on the electrical properties, this kinetics-driven colossal injection also has direct implications for nanowire morphology. We discuss the observed strong deviation from equilibrium using a model of solute trapping at step edges, and identify the key growth parameters behind this phenomenon on the basis of a kinetic model of step-flow growth of nanowires. The control of this phenomenon provides opportunities to create a new class of nanoscale devices by precisely tailoring the shape and composition of metal-catalysed nanowires.	[Moutanabbir, Oussama] Ecole Polytech, Dept Engn Phys, Montreal, PQ H3C 3A7, Canada; [Isheim, Dieter; Seidman, David N.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Isheim, Dieter; Seidman, David N.] Northwestern Univ, NUCAPT, Evanston, IL 60208 USA; [Blumtritt, Horst; Senz, Stephan; Pippel, Eckhard] Max Planck Inst Microstruct Phys, D-06120 Halle, Saale, Germany	Universite de Montreal; Polytechnique Montreal; Northwestern University; Northwestern University; Max Planck Society	Moutanabbir, O (corresponding author), Ecole Polytech, Dept Engn Phys, CP 6079,Succursale Ctr Ville, Montreal, PQ H3C 3A7, Canada.	oussama.moutanabbir@polymtl.ca	Seidman, David/B-6697-2009; Moutanabbir, Oussama/A-4001-2009		NSERC; Canada Research Chair; Ecole Polytechnique de Montreal (PIED); US-Israel Binational Science Foundation; Max Planck Institute of Microstructure Physics	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ecole Polytechnique de Montreal (PIED); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Max Planck Institute of Microstructure Physics	O.M. acknowledges support from NSERC, the Canada Research Chair, and Ecole Polytechnique de Montreal (PIED). S. S. is grateful to Y. Wang for help in the growth of nanowires. The atom-probe tomography research was performed in the Northwestern University Center for Atom-Probe Tomography (NUCAPT), with partial support from the US-Israel Binational Science Foundation and the Max Planck Institute of Microstructure Physics.	AZIZ MJ, 1982, J APPL PHYS, V53, P1158, DOI 10.1063/1.329867; BAKER JC, 1969, ACTA METALL MATER, V17, P575, DOI 10.1016/0001-6160(69)90116-3; Choi SY, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3544933; Civale Y, 2008, ELECTROCHEM SOLID ST, V11, pH74, DOI 10.1149/1.2836739; GIVARGIZOV EI, 1971, J CRYST GROWTH, V9, P326, DOI 10.1016/0022-0248(71)90250-8; Goldman L. M., 1987, Journal of Materials Research, V2, P524, DOI 10.1557/JMR.1987.0524; Hannon JB, 2006, NATURE, V440, P69, DOI 10.1038/nature04574; Heitsch AT, 2008, J AM CHEM SOC, V130, P5436, DOI 10.1021/ja8011353; Ho JC, 2008, NAT MATER, V7, P62, DOI 10.1038/nmat2058; Hochbaum AI, 2010, CHEM REV, V110, P527, DOI 10.1021/cr900075v; Hoffmann S, 2009, NANO LETT, V9, P1341, DOI 10.1021/nl802977m; Ke Y, 2009, NANO LETT, V9, P4494, DOI 10.1021/nl902808r; Kelzenberg MD, 2010, NAT MATER, V9, P239, DOI [10.1038/NMAT2635, 10.1038/nmat2635]; Kim BJ, 2008, SCIENCE, V322, P1070, DOI 10.1126/science.1163494; Kodambaka S, 2007, SCIENCE, V316, P729, DOI 10.1126/science.1139105; Kumar RR, 2012, MATER LETT, V82, P163, DOI 10.1016/j.matlet.2012.05.090; Moutanabbir O, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3531816; Moutanabbir O, 2011, ACS NANO, V5, P1313, DOI 10.1021/nn1030274; Murray J. L., 1984, B ALLOY PHASE DIAGR, V5, P74, DOI DOI 10.1007/BF02868729; Nast O, 2000, J APPL PHYS, V88, P124, DOI 10.1063/1.373632; Perea DE, 2009, NAT NANOTECHNOL, V4, P315, DOI [10.1038/nnano.2009.51, 10.1038/NNANO.2009.51]; REITANO R, 1994, J APPL PHYS, V76, P1518, DOI 10.1063/1.357728; Schwalbach EJ, 2008, NANO LETT, V8, P3739, DOI 10.1021/nl801987j; Seidman DN, 2009, MRS BULL, V34, P717, DOI 10.1557/mrs2009.194; TRUMBORE FA, 1960, AT&T TECH J, V39, P205, DOI 10.1002/j.1538-7305.1960.tb03928.x; Wacaser BA, 2009, NANO LETT, V9, P3296, DOI 10.1021/nl9015792; Wang YW, 2006, NAT NANOTECHNOL, V1, P186, DOI 10.1038/nnano.2006.133; Wen CY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.195502; Wen CY, 2009, SCIENCE, V326, P1247, DOI 10.1126/science.1178606; WHITE CW, 1980, J APPL PHYS, V51, P738, DOI 10.1063/1.327334; Xie P, 2012, NAT NANOTECHNOL, V7, P119, DOI [10.1038/nnano.2011.217, 10.1038/NNANO.2011.217]; Yan H, 2011, NATURE, V470, P240, DOI 10.1038/nature09749	32	122	122	1	288	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2013	496	7443					78	82		10.1038/nature11999	http://dx.doi.org/10.1038/nature11999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117ZZ	23552946				2022-12-28	WOS:000316993400028
J	Rodgers, M				Rodgers, Michael			Primary Raynaud's Phenomenon	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands	University of Groningen	Rodgers, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands.	m.g.g.rodgers@umcg.nl							0	3	3	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1344	1344		10.1056/NEJMicm1209600	http://dx.doi.org/10.1056/NEJMicm1209600			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117YT	23550672				2022-12-28	WOS:000316989900011
J	Attia, MW				Attia, Magdy W.			Review: Adding corticosteroids to antibiotics improves pain relief in patients with sore throat	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Attia, Magdy W.] Alfred I DuPont Hosp Children, Wilmington, DE USA; [Attia, Magdy W.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA	Nemours Alfred I. duPont Hospital for Children; Jefferson University	Attia, MW (corresponding author), Alfred I DuPont Hosp Children, Wilmington, DE USA.				British Society of Antimicrobial Chemotherapy	British Society of Antimicrobial Chemotherapy	British Society of Antimicrobial Chemotherapy.		0	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6							JC11	10.7326/0003-4819-158-6-201303190-02011	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23552984				2022-12-28	WOS:000316565100010
J	Ko, M; An, J; Bandukwala, HS; Chavez, L; Aijo, T; Pastor, WA; Segal, MF; Li, HM; Koh, KP; Lahdesmaki, H; Hogan, PG; Aravind, L; Rao, A				Ko, Myunggon; An, Jungeun; Bandukwala, Hozefa S.; Chavez, Lukas; Aijo, Tarmo; Pastor, William A.; Segal, Matthew F.; Li, Huiming; Koh, Kian Peng; Lahdesmaki, Harri; Hogan, Patrick G.; Aravind, L.; Rao, Anjana			Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX	NATURE			English	Article							CPG ISLANDS; 5-HYDROXYMETHYLCYTOSINE CONTENT; DNA; BINDING; DIFFERENTIATION; COMPLEX; DATABASE; PATHWAY; RINF	TET (ten-eleven-translocation) proteins are Fe(II)- and alpha-ketogluta-rate-dependent dioxygenases(1-3) that modify the methylation status of DNA by successively oxidizing 5-methylcytosine to 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxycytosine(1,3-5), potential intermediates in the active erasure of DNA-methylation marks(5,6). Here we show that IDAX (also known as CXXC4), a reported inhibitor of Wnt signalling(7) that has been implicated in malignant renal cell carcinoma(8) and colonic villous adenoma(9), regulates TET2 protein expression. IDAX was originally encoded within an ancestral TET2 gene that underwent a chromosomal gene inversion during evolution, thus separating the TET2 CXXC domain from the catalytic domain. The IDAX CXXC domain binds DNA sequences containing unmethylated CpG dinucleotides, localizes to promoters and CpG islands in genomic DNA and interacts directly with the catalytic domain of TET2. Unexpectedly, IDAX expression results in caspase activation and TET2 protein downregulation, in a manner that depends on DNA binding through the IDAX CXXC domain, suggesting that IDAX recruits TET2 to DNA before degradation. IDAX depletion prevents TET2 downregulation in differentiating mouse embryonic stem cells, and short hairpin RNA against IDAX increases TET2 protein expression in the human monocytic cell line U937. Notably, we find that the expression and activity of TET3 is also regulated through its CXXC domain. Taken together, these results establish the separate and linked CXXC domains of TET2 and TET3, respectively, as previously unknown regulators of caspase activation and TET enzymatic activity.	[Ko, Myunggon; An, Jungeun; Bandukwala, Hozefa S.; Chavez, Lukas; Aijo, Tarmo; Pastor, William A.; Segal, Matthew F.; Hogan, Patrick G.; Rao, Anjana] La Jolla Inst Allergy & Immunol, Div Signaling & Gene Express, La Jolla, CA 92037 USA; [Aijo, Tarmo; Lahdesmaki, Harri] Aalto Univ, Sch Sci, Dept Informat & Comp Sci, FI-00076 Aalto, Finland; [Li, Huiming; Koh, Kian Peng; Rao, Anjana] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Li, Huiming; Koh, Kian Peng; Rao, Anjana] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Rao, Anjana] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; Aalto University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Rao, A (corresponding author), La Jolla Inst Allergy & Immunol, Div Signaling & Gene Express, La Jolla, CA 92037 USA.	arao@liai.org	Koh, Kian Peng/S-6279-2016	Koh, Kian Peng/0000-0003-2523-5175; Aijo, Tarmo/0000-0002-3008-4634; Aravind, L/0000-0003-0771-253X; Ko, Myunggon/0000-0002-6007-2570; Chavez, Lukas/0000-0002-8718-8848	National Institutes of Health (NIH) [HD065812, CA151535]; California Institute of Regenerative Medicine and Translational Research [RM-01729]; Leukemia and Lymphoma Society [TRP 6187-12]; NIH [AI40127]; Leukemia and Lymphoma Society; Lady Tata Memorial Trust; GlaxoSmithKline-Immune Disease Institute Alliance; National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065812] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA151535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040127, R01AI044432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine and Translational Research; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Lady Tata Memorial Trust; GlaxoSmithKline-Immune Disease Institute Alliance; National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Seumois, M. Ku and J. Day for help with library preparation, B. Ren for use of his Illumina Hi-Seq 2000, J. A. Zepeda-Martinez for the recombinant Flag-TET2<SUP>CD</SUP>, and members of the Rao laboratory for discussions. This work was supported by National Institutes of Health (NIH) R01 grants HD065812 and CA151535, grant RM-01729 from the California Institute of Regenerative Medicine and Translational Research, grant TRP 6187-12 from the Leukemia and Lymphoma Society (to A. R.) and NIH R01 grant AI40127 (to P. G. H. and A. R). We also gratefully acknowledge a Special Fellow Award from the Leukemia and Lymphoma Society (to M. K.), postdoctoral fellowships from the Lady Tata Memorial Trust and from the GlaxoSmithKline-Immune Disease Institute Alliance (to H. S. B.) and a predoctoral graduate research fellowship from the National Science Foundation (to W.A.P.).	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Haffner MC, 2011, ONCOTARGET, V2, P627; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Huang C. C., 1996, PAC S BIOCOMPUT, P724, DOI DOI 10.1142/9789814531399; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iyer LM, 2011, PROG MOL BIOL TRANSL, V101, P25, DOI 10.1016/B978-0-12-387685-0.00002-0; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Kim MS, 2010, J BIOL CHEM, V285, P14585, DOI 10.1074/jbc.M109.094334; Knappskog S, 2011, ANN ONCOL, V22, P2208, DOI 10.1093/annonc/mdq737; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kojima T, 2009, ONCOGENE, V28, P297, DOI 10.1038/onc.2008.391; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Maiti A, 2011, DNA REPAIR, V10, P545, DOI 10.1016/j.dnarep.2011.03.004; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Nguyen AV, 2010, INT J MOL MED, V26, P121, DOI 10.3892/ijmm_00000443; Pendino F, 2009, BLOOD, V113, P3172, DOI 10.1182/blood-2008-07-170035; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	40	257	266	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					122	+		10.1038/nature12052	http://dx.doi.org/10.1038/nature12052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23563267	Green Accepted			2022-12-28	WOS:000318221500046
J	Lynch, J; Maslin, M; Balzter, H; Sweeting, M				Lynch, Jim; Maslin, Mark; Balzter, Heiko; Sweeting, Martin			Choose satellites to monitor deforestation	NATURE			English	Editorial Material							FORESTS		[Lynch, Jim] Univ Surrey, Ctr Environm Strategy, Guildford GU2 5XH, Surrey, England; [Maslin, Mark] UCL, Dept Geog, London WC1E 6BT, England; [Balzter, Heiko] Univ Leicester, Ctr Landscape & Climate Res, Leicester LE1 7RH, Leics, England; [Sweeting, Martin] Univ Surrey, Surrey Space Ctr, Guildford GU2 5XH, Surrey, England	University of Surrey; University of London; University College London; University of Leicester; University of Surrey	Lynch, J (corresponding author), Univ Surrey, Ctr Environm Strategy, Guildford GU2 5XH, Surrey, England.	j.lynch@surrey.ac.uk	Balzter, Heiko/B-5976-2008	Balzter, Heiko/0000-0002-9053-4684; Maslin, Mark/0000-0001-9957-3463				[Anonymous], 2012, GREEN CARBON BLACK T; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Global Observation of Forest and Land Cover Dynamics, 2012, RED GREENH GAS EM DE; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Herold Martin, 2011, Carbon Balance Manag, V6, P13, DOI 10.1186/1750-0680-6-13; Maslin M, 2011, NATURE, V475, P445, DOI 10.1038/475445a	7	54	54	3	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 18	2013	496	7445					293	294		10.1038/496293a	http://dx.doi.org/10.1038/496293a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126FV	23598323				2022-12-28	WOS:000317599200012
J	Vickers, AJ; Ulmert, D; Sjoberg, DD; Bennette, CJ; Bjork, T; Gerdtsson, A; Manjer, J; Nilsson, PM; Dahlin, A; Bjartell, A; Scardino, PT; Lilja, H				Vickers, Andrew J.; Ulmert, David; Sjoberg, Daniel D.; Bennette, Caroline J.; Bjork, Thomas; Gerdtsson, Axel; Manjer, Jonas; Nilsson, Peter M.; Dahlin, Anders; Bjartell, Anders; Scardino, Peter T.; Lilja, Hans			Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REFERENCE RANGES; MEN; SERUM; DIAGNOSIS; MORTALITY; REPRODUCIBILITY; PREDICTION; MUTATIONS; REGISTER; PLASMA	Objective To determine the association between concentration of prostate specific antigen (PSA) at age 40-55 and subsequent risk of prostate cancer metastasis and mortality in an unscreened population to evaluate when to start screening for prostate cancer and whether rescreening could be risk stratified. Design Case-control study with 1: 3 matching nested within a highly representative population based cohort study. Setting Malmo Preventive Project, Sweden. Participants 21 277 Swedish men aged 27-52 (74% of the eligible population) who provided blood at baseline in 1974-84, and 4922 men invited to provide a second sample six years later. Rates of PSA testing remained extremely low during median follow-up of 27 years. Main outcome measures Metastasis or death from prostate cancer ascertained by review of case notes. Results Risk of death from prostate cancer was associated with baseline PSA: 44% (95% confidence interval 34% to 53%) of deaths occurred in men with a PSA concentration in the highest 10th of the distribution of concentrations at age 45-49 (>= 1.6 mu g/L), with a similar proportion for the highest 10th at age 51-55 (>= 2.4 mu g/L: 44%, 32% to 56%). Although a 25-30 year risk of prostate cancer metastasis could not be ruled out by concentrations below the median at age 45-49 (0.68 mu g/L) or 51-55 (0.85 mu g/L), the 15 year risk remained low at 0.09% (0.03% to 0.23%) at age 45-49 and 0.28% (0.11% to 0.66%) at age 51-55, suggesting that longer intervals between screening would be appropriate in this group. Conclusion Measurement of PSA concentration in early midlife can identify a small group of men at increased risk of prostate cancer metastasis several decades later. Careful surveillance is warranted in these men. Given existing data on the risk of death by PSA concentration at age 60, these results suggest that three lifetime PSA tests (mid to late 40s, early 50s, and 60) are probably sufficient for at least half of men.	[Vickers, Andrew J.; Sjoberg, Daniel D.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Ulmert, David; Scardino, Peter T.; Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Urol Surg, New York, NY 10065 USA; [Ulmert, David; Bjork, Thomas; Gerdtsson, Axel; Bjartell, Anders] Lund Univ, Dept Urol, Skane Univ Hosp, Malmo, Sweden; [Bennette, Caroline J.] Univ Washington, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Manjer, Jonas] Lund Univ, Dept Surg, Skane Univ Hosp, Malmo, Sweden; [Nilsson, Peter M.] Lund Univ, Dept Med, Skane Univ Hosp, Malmo, Sweden; [Dahlin, Anders] Lund Univ, Dept Clin Microbiol, Skane Univ Hosp, Malmo, Sweden; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Lab Med, New York, NY 10065 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Med GU Oncol, New York, NY 10065 USA; [Lilja, Hans] Lund Univ, Dept Lab Med & Clin Sci Malmo, Skane Univ Hosp, Malmo, Sweden; [Lilja, Hans] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Lund University; Skane University Hospital; University of Washington; University of Washington Seattle; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Lund University; Skane University Hospital; University of Oxford	Lilja, H (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave,Box 213, New York, NY 10065 USA.	liljah@mskcc.org	Lilja, Hans/S-9703-2019	Lilja, Hans/0000-0001-5871-7846; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Vickers, Andrew/0000-0003-1525-6503; Sjoberg, Daniel/0000-0003-0862-2018; Gerdtsson, Axel/0000-0003-4033-5078	National Cancer Institute [R33 CA 127768-03, P50-CA92629]; Swedish Cancer Society [11-0624]; Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust; University of Oxford, Fundacion Federico SA; MSKCC PCPR (Prevention Control and Population Research Program) Goldstein Grant; NATIONAL CANCER INSTITUTE [P50CA092629, P30CA008748, R33CA127768] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Cancer Society(Swedish Cancer Society); Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust; University of Oxford, Fundacion Federico SA; MSKCC PCPR (Prevention Control and Population Research Program) Goldstein Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Cancer Institute (grant No R33 CA 127768-03, P50-CA92629); Swedish Cancer Society (11-0624); the Sidney Kimmel Center for Prostate and Urologic Cancers; David H Koch through the Prostate Cancer Foundation, the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford, Fundacion Federico SA, and MSKCC PCPR (Prevention Control and Population Research Program) Goldstein Grant. DU was supported by the David H Koch Young Investigator Award from the Prostate Cancer Foundation.	ANDERSON JR, 1995, UROLOGY, V46, P54, DOI 10.1016/S0090-4295(99)80158-7; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bul M, 2011, EUR UROL, V59, P498, DOI 10.1016/j.eururo.2011.01.001; CARTER HB, 1992, JAMA-J AM MED ASSOC, V267, P2215, DOI 10.1001/jama.267.16.2215; Connolly D, 2008, CANCER EPIDEM BIOMAR, V17, P271, DOI 10.1158/1055-9965.EPI-07-0515; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Jonsson H, 2011, INT J CANCER, V129, P1881, DOI 10.1002/ijc.25846; Kalish LA, 1999, UROLOGY, V54, P1022, DOI 10.1016/S0090-4295(99)00349-0; Kuller LH, 2004, CANCER EPIDEM BIOMAR, V13, P373; Lilja H, 2007, J CLIN ONCOL, V25, P431, DOI 10.1200/JCO.2006.06.9351; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Mitra AV, 2011, BJU INT, V107, P28, DOI 10.1111/j.1464-410X.2010.09648.x; Moskowitz CS, 2008, STAT MED, V27, P3191, DOI 10.1002/sim.3151; Orsted DD, 2012, EUR UROL, V61, P865, DOI 10.1016/j.eururo.2011.11.007; Roobol MJ, 2005, UROLOGY, V65, P343, DOI 10.1016/j.urology.2004.09.046; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Sandblom G, 2003, SCAND J UROL NEPHROL, V37, P112, DOI 10.1080/00365590310008839; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; STENMAN UH, 1994, LANCET, V344, P1594, DOI 10.1016/S0140-6736(94)90405-7; Ulmert D, 2006, CLIN CHEM, V52, P235, DOI 10.1373/clinchem.2005.050641; Ulmert D, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-6; van Leeuwen PJ, 2012, EUR UROL, V61, P171, DOI 10.1016/j.eururo.2011.08.002; van Leeuwen PJ, 2010, CANCER-AM CANCER SOC, V116, P4857, DOI 10.1002/cncr.25474; Vickers AJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4521; WHITTEMORE AS, 1995, J NATL CANCER I, V87, P354, DOI 10.1093/jnci/87.5.354	27	130	130	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2013	346								f2023	10.1136/bmj.f2023	http://dx.doi.org/10.1136/bmj.f2023			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131AO	23596126	Green Published, hybrid			2022-12-28	WOS:000317962900002
J	Gilmour, S; Hamakawa, T; Shibuya, K				Gilmour, Stuart; Hamakawa, Tomohiro; Shibuya, Kenji			Cash-transfer programmes in developing countries	LANCET			English	Editorial Material							MIDDLE-INCOME COUNTRIES; HEALTH; INTERVENTIONS; IMPACT		[Gilmour, Stuart; Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Bunkyo Ku, Tokyo 1130003, Japan; [Hamakawa, Tomohiro] Univ Tokyo, Global Hlth Leadership Program, Bunkyo Ku, Tokyo 1130003, Japan	University of Tokyo; University of Tokyo	Shibuya, K (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Bunkyo Ku, Tokyo 1130003, Japan.	shibuyak@m.u-tokyo.ac.jp		Shibuya, Kenji/0000-0003-2528-7530				Adato M, 2009, AIDS CARE, V21, P60, DOI 10.1080/09540120903112351; Bassett L, 2008, CAN CONDITIONAL CASH; Bassett L, 2011, CONTROL AND ACCOUNTA; Doetinchem O, 2008, CONDITIONAL CASH TRA; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Ranganathan M, 2012, PREV MED, V55, pS95, DOI 10.1016/j.ypmed.2011.11.015; Rawlings L, 2003, POLICY RESEARCH WORK; Robertson L, 2013, LANCET, V381, P1283, DOI 10.1016/S0140-6736(12)62168-0; Shibuya K, 2008, LANCET, V371, P789, DOI 10.1016/S0140-6736(08)60356-6	11	5	5	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 13	2013	381	9874					1254	1255		10.1016/S0140-6736(13)60358-X	http://dx.doi.org/10.1016/S0140-6736(13)60358-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122XD	23582384				2022-12-28	WOS:000317351000007
J	Goyal, A; Singh, N; Bal, A; Behera, D				Goyal, Abhishek; Singh, Navneet; Bal, Amanjit; Behera, Digambar			Gynaecomastia, galactorrhoea, and lung cancer in a man	LANCET			English	Editorial Material									[Goyal, Abhishek; Singh, Navneet; Behera, Digambar] Postgrad Inst Med Educ & Res PGIMER, Dept Pulm Med, Chandigarh 160012, India; [Bal, Amanjit] Postgrad Inst Med Educ & Res PGIMER, Dept Histopathol, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Singh, N (corresponding author), Postgrad Inst Med Educ & Res PGIMER, Dept Pulm Med, Sect 12, Chandigarh 160012, India.	navneetchd@yahoo.com	Singh, Navneet/B-5408-2011	Singh, Navneet/0000-0002-8389-0701				Behera D, 1984, Indian J Chest Dis Allied Sci, V26, P238; BEHERA D, 1987, Indian Journal of Chest Diseases and Allied Sciences, V29, P112; Huang WY, 2012, AM FAM PHYSICIAN, V85, P1073; Liu G, 1999, J CLIN ONCOL, V17, P1956, DOI 10.1200/JCO.1999.17.6.1956; YOSHIMURA M, 1994, CANCER, V73, P2745, DOI 10.1002/1097-0142(19940601)73:11<2745::AID-CNCR2820731116>3.0.CO;2-V	5	5	6	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 13	2013	381	9874					1332	1332		10.1016/S0140-6736(13)60181-6	http://dx.doi.org/10.1016/S0140-6736(13)60181-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122XD	23582397				2022-12-28	WOS:000317351000036
J	Famm, K; Litt, B; Tracey, KJ; Boyden, ES; Slaoui, M				Famm, Kristoffer; Litt, Brian; Tracey, Kevin J.; Boyden, Edward S.; Slaoui, Moncef			A jump-start for electroceuticals	NATURE			English	Editorial Material									[Famm, Kristoffer] GlaxoSmithKline, Bioelect Res & Dev, Brentford TW8 9GS, England	GlaxoSmithKline	Famm, K (corresponding author), GlaxoSmithKline, Bioelect Res & Dev, Brentford TW8 9GS, England.	kristoffer.h.famm@gsk.com		Tracey, Kevin J/0000-0003-1884-6314	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS063930, R01NS048598] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057226] Funding Source: Medline; NINDS NIH HHS [R01 NS048598, U24 NS063930] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alivisatos AP, 2013, ACS NANO, V7, P1850, DOI 10.1021/nn4012847; Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Chow BY, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003101; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Kandel E.R., 2012, PRINCIPLES NEURAL SC; Kodandaramaiah SB, 2012, NAT METHODS, V9, P585, DOI [10.1038/NMETH.1993, 10.1038/nmeth.1993]; KOOPMAN FA, 2012, ARTHRITIS RHEUM S, V64; Rapoport BI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042492; Wang ZL, 2012, ANGEW CHEM INT EDIT, V51, P11700, DOI 10.1002/anie.201201656	10	339	350	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					159	161		10.1038/496159a	http://dx.doi.org/10.1038/496159a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	122VM	23579662	Green Submitted, Green Accepted			2022-12-28	WOS:000317346300017
J	Ginn, S				Ginn, Stephen			HEALTHCARE IN PRISONS Promoting health in prison	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Ginn, S (corresponding author), BMJ, London WC1H 9JR, England.	mail@stephenginn.com						[Anonymous], 2010, ANN REP 2010 11; [Anonymous], 2012, GEN LIF SURV OV; [Anonymous], 2012, INFECT INSIDE, V8; [Anonymous], STAT RAC CRIM JUST S; [Anonymous], 2300 HM PRIS SERV; [Anonymous], 2010, ASH FACTSHEET SMOKEF; Armstrong S, 2010, USER VIEWS PUNISHMEN; Burgess-Allen J, 2006, INT J PRISON HEALTH, V2, P291, DOI 10.1080/17449200601070369; Cabinet Office Social Exclusion Task Force, 2006, REACH OUT ACT PLAN S; Care Quality Commission, 2010, COMM HLTH CAR PRIS 2; Cleary V, HLTH PROT AG LECT 20; de Viggiani N, 2007, SOCIOL HEALTH ILL, V29, P115, DOI 10.1111/j.1467-9566.2007.00474.x; Department of Health, 2003, ACQ BEST PRACT GUID; Department of Health, 2010, SMOK FUT; Department of Health, 2012, HLTH PROT PRIS REP 2; Department of Health, 2010, INCL HLTH IMPR PRIM; Department of Health, 2002, HLTH PROM PRIS SHAR; Department of Health, 2011, HLTH PROT PRIS REP 2; Dooris M, 2009, PERSPECT PUBLIC HEAL, V129, P29, DOI 10.1177/1757913908098881; Douglas N, 2009, J EPIDEMIOL COMMUNIT, V63, P9; Drug Policy Commission Reducing drug use, 2008, DRUG POL COMM RED DR; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Garside R, 2013, UK JUSTICE POLICY RE, V2; Gilbert R L, 2004, Commun Dis Public Health, V7, P306; Ginn S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8318; Ginn Stephen, 2012, BMJ, V345, pe7280, DOI 10.1136/bmj.e7280; Ginn S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6263; Ginn S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5921; Hartwig C, 2008, REPORT TOBACCO SMOKI; Home Affairs Committee, 2012, DRUGS BREAK CYCL; Jewkes Yvonne, 2005, CRIMINAL JUSTICE MAT, V59, P26; Kauffman RM, 2008, TOB CONTROL, V17, P357, DOI 10.1136/tc.2007.024448; Lacey Nicola, 2012, CURRENT LEGAL PROBLE, V65, P1; MacAskill A, 2007, STOP SMOKING SUPPORT; Matrix Knowledge Group, EC CASE PRIS 2007; Medlicott Diana, 2001, SURVIVING PRISON PLA; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Ministry of Justice, ANN REP ACC 2011 201; Niven S, 2005, RESETTLEMENT OUTCOME; Office for National Statistics, 2011, CRIM ENGL WAL Q 1 RE; Prison Reform Trust, 2012, BROML BRIEF NOV 2012; Pritchard C, 1997, J ROY SOC HEALTH, V117, P180, DOI 10.1177/146642409711700310; Revolving Doors Agency, 2011, TURN TID VIS PAP MUL; Scott David, 2010, CONTROVERSIAL ISSUES; Singleton N, 1999, SUBSTANCE MISUSE PRI; Smith C., 2000, HOWARD J, V39, P339, DOI [10.1111/1468-2311.00174, https://doi.org/10.1111/1468-2311.00174, DOI 10.1111/1468-2311.00174]; Story A, 2007, THORAX, V62, P667, DOI 10.1136/thx.2006.065409; UK Focal Point, 2011, UK DRUG SIT 2011; Weild A R, 2000, Commun Dis Public Health, V3, P121; Williamson M, IMPROVING HLTH SOCIA; Yates S., TB PRISONS	51	7	7	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2013	346								f2216	10.1136/bmj.f2216	http://dx.doi.org/10.1136/bmj.f2216			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	125ZP	23578474				2022-12-28	WOS:000317581200003
J	McGuire, AL; McCullough, LB; Evans, JP				McGuire, Amy L.; McCullough, Laurence B.; Evans, James P.			The Indispensable Role of Professional Judgment in Genomic Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McGuire, Amy L.; McCullough, Laurence B.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Evans, James P.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA	Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	McGuire, AL (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, 1 Baylor Plaza,MS420, Houston, TX 77030 USA.	amcguire@bcm.edu			NHGRI NIH HHS [U01 HG006485, U01 HG006487, U01-HG006485, U01 HG006500, U01-HG006500, U01-HG006487] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006500, U01HG006485, U01HG006487] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Beauchamp T., 1986, HIST THEORY INFORM C; Brierley KL, 2012, CANCER J, V18, P303, DOI 10.1097/PPO.0b013e3182609490; Knoppers BM, 2006, EUR J HUM GENET, V14, P1170, DOI 10.1038/sj.ejhg.5201690; Langreth R, 2012, BLOOMBERG NEWS; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880	5	26	26	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1465	1466		10.1001/jama.2013.1438	http://dx.doi.org/10.1001/jama.2013.1438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571582	Green Accepted			2022-12-28	WOS:000317271700021
J	Saidha, S; Calabresi, PA				Saidha, Shiv; Calabresi, Peter A.			Anti-interleukin-2 receptor alpha for multiple sclerosis?	LANCET			English	Editorial Material							DACLIZUMAB; INTERLEUKIN-2; ACTIVATION		[Saidha, Shiv] Beaumont Univ Hosp, Dept Neurol, Dublin, Ireland; [Calabresi, Peter A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA	Johns Hopkins University	Calabresi, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA.	calabresi@jhmi.edu	Saidha, Shiv/S-1771-2019; Calabresi, Peter A./AAF-2288-2019	Saidha, Shiv/0000-0001-6387-0714; Calabresi, Peter/0000-0002-7776-6472				Alcina A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004137; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; GOLD R, 2013, LANCET; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Martin JF, 2010, J IMMUNOL, V185, P1311, DOI 10.4049/jimmunol.0902238; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Rose JW, 2004, ANN NEUROL, V56, P864, DOI 10.1002/ana.20287; Saidha S, 2012, ANN NY ACAD SCI, V1247, P117, DOI 10.1111/j.1749-6632.2011.06272.x; Sheridan JP, 2011, MULT SCLER J, V17, P1441, DOI 10.1177/1352458511414755; Smith FO, 2008, CLIN CANCER RES, V14, P5610, DOI 10.1158/1078-0432.CCR-08-0116; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Waldmann TA, 2007, J CLIN IMMUNOL, V27, P1, DOI 10.1007/s10875-006-9060-0; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Wynn D, 2010, LANCET NEUROL, V9, P381, DOI 10.1016/S1474-4422(10)70033-8	14	1	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 22	2013	381	9884					2141	2143		10.1016/S0140-6736(13)60065-3	http://dx.doi.org/10.1016/S0140-6736(13)60065-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KH	23562008				2022-12-28	WOS:000320925600008
J	Balabanova, D; Mills, A; Conteh, L; Akkazieva, B; Banteyerga, H; Dash, U; Gilson, L; Harmer, A; Ibraimova, A; Islam, Z; Kidanu, A; Koehlmoos, TP; Limwattananon, S; Muraleedharan, VR; Murzalieva, G; Palafox, B; Panichkriangkrai, W; Patcharanarumol, W; Penn-Kekana, L; Powell-Jackson, T; Tangcharoensathien, V; McKee, M				Balabanova, Dina; Mills, Anne; Conteh, Lesong; Akkazieva, Baktygul; Banteyerga, Hailom; Dash, Umakant; Gilson, Lucy; Harmer, Andrew; Ibraimova, Ainura; Islam, Ziaul; Kidanu, Aklilu; Koehlmoos, Tracey P.; Limwattananon, Supon; Muraleedharan, V. R.; Murzalieva, Gulgun; Palafox, Benjamin; Panichkriangkrai, Warisa; Patcharanarumol, Walaiporn; Penn-Kekana, Loveday; Powell-Jackson, Timothy; Tangcharoensathien, Viroj; McKee, Martin			Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening	LANCET			English	Article							MATERNAL MORTALITY; TAMIL-NADU; CARE; WORKERS; BANGLADESH; MANAGEMENT; COUNTRIES; FRAMEWORK; ETHIOPIA; MATLAB	In 1985, the Rockefeller Foundation published Good health at low cost to discuss why some countries or regions achieve better health and social outcomes than do others at a similar level of income and to show the role of political will and socially progressive policies. 25 years on, the Good Health at Low Cost project revisited these places but looked anew at Bangladesh, Ethiopia, Kyrgyzstan, Thailand, and the Indian state of Tamil Nadu, which have all either achieved substantial improvements in health or access to services or implemented innovative health policies relative to their neighbours. A series of comparative case studies (2009-11) looked at how and why each region accomplished these changes. Attributes of success included good governance and political commitment, effective bureaucracies that preserve institutional memory and can learn from experience, and the ability to innovate and adapt to resource limitations. Furthermore, the capacity to respond to population needs and build resilience into health systems in the face of political unrest, economic crises, and natural disasters was important. Transport infrastructure, female empowerment, and education also played a part. Health systems are complex and no simple recipe exists for success. Yet in the countries and regions studied, progress has been assisted by institutional stability, with continuity of reforms despite political and economic turmoil, learning lessons from experience, seizing windows of opportunity, and ensuring sensitivity to context. These experiences show that improvements in health can still be achieved in countries with relatively few resources, though strategic investment is necessary to address new challenges such as complex chronic diseases and growing population expectations.	[Balabanova, Dina; Mills, Anne; Gilson, Lucy; Palafox, Benjamin; Penn-Kekana, Loveday; Powell-Jackson, Timothy; McKee, Martin] Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London WC1H 9SH, England; [Conteh, Lesong] Univ London Imperial Coll Sci Technol & Med, Ctr Hlth Policy, London, England; [Conteh, Lesong] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Akkazieva, Baktygul; Ibraimova, Ainura] USAID Qual Hlth Care Project, Bishkek, Kyrgyzstan; [Banteyerga, Hailom] Univ Addis Ababa, Coll Humanities Language Studies Commun & Journal, Addis Ababa, Ethiopia; [Dash, Umakant; Muraleedharan, V. R.] Indian Inst Technol, Dept Humanities & Social Sci, Madras 600036, Tamil Nadu, India; [Gilson, Lucy] Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Econ Unit, ZA-7925 Cape Town, South Africa; [Harmer, Andrew] Univ Edinburgh, Sch Social & Polit Sci, Global Publ Hlth Unit, Edinburgh, Midlothian, Scotland; [Islam, Ziaul; Koehlmoos, Tracey P.] Icddrb, Ctr Equ & Hlth Syst, Dhaka, Bangladesh; [Banteyerga, Hailom; Kidanu, Aklilu] Miz Hasab Res Ctr, Addis Ababa, Ethiopia; [Limwattananon, Supon] Khon Kaen Univ, Khon Kaen, Thailand; [Murzalieva, Gulgun] Hlth Policy Anal Ctr, Bishkek, Kyrgyzstan	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Imperial College London; Addis Ababa University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; University of Cape Town; University of Edinburgh; International Centre for Diarrhoeal Disease Research (ICDDR); Khon Kaen University	Balabanova, D (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London WC1H 9SH, England.	dina.balabanova@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Conteh, Lesong/ABE-9550-2020; Gilson, Lucy/R-8846-2019; Mckee, Martin/E-6673-2018; Dash, Umakant/K-9963-2017	McKee, Marc D/0000-0001-8349-965X; Conteh, Lesong/0000-0002-0719-3672; Gilson, Lucy/0000-0002-2775-7703; Mckee, Martin/0000-0002-0121-9683; Mills, Anne/0000-0001-9863-9950; Dash, Umakant/0000-0001-5348-9530	Rockefeller Foundation; Medical Research Council [MR/K010174/1B] Funding Source: researchfish	Rockefeller Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the Rockefeller Foundation for continued support, as part of the Good Health at Low Cost 2011 project, particularly Ariel Pablos-Mendes, Stefan Nachuk, Lily Dorment, and Mushtaque Chowdhury; the steering committee, particularly Gill Walt, Carine Ronsmans, Simon Cousens, and Ulla Griffiths, for valuable guidance on framing the research questions, study design, and interpretation of findings; and the experts who participated in the Bellagio project meeting in 2010, who advised on the comparative chapters. This study was funded by the Rockefeller Foundation. The opinions expressed in this report do not necessarily reflect the policies of the London School of Hygiene and Tropical Medicine or the Rockefeller Foundation. The study was approved by the ethics committee of the London School of Hygiene and Tropical Medicine (GHLC 5560 04.08.09). All study countries obtained approval from their national ethics committees.	Abdraimova A, 2009, REPORT RAPID ASSESSM; Admassie A, 2009, IMPACT EVALUATION ET; Ahmed R., 1990, DEVELOPMENTAL IMPACT; [Anonymous], 2008, PRIM HLTH CAR NOW MO; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Assefa Y, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000056; Atun R, 2010, HEALTH POLICY PLANN, V25, P104, DOI 10.1093/heapol/czp055; Balabanova D, 2011, GOOD HLTH LOW COST 2; Banteyerga H, 2010, SYSTEM WIDE EFFECTS; Bennett S, 2000, ECON POLIT WEEKLY, V35, P59; BHUIYA A, 1992, J DIARRHOEAL DIS RES, V10, P10; Bhutta Z, 2009, MATERNAL NEWBORN HLT; Blood Archer K., 2002, CRUEL BIRTH BANGLADE; Bossert TJ, 2008, HLTH GOVERNANCE CONC; Bureau of Policy and Strategy, 2008, THAIL HLTH PROF 2001; Castleden M, 2011, J PUBLIC HEALTH-UK, V33, P369, DOI 10.1093/pubmed/fdr027; Census, 2011, CENS IND 2011; Central Statistics Agency ICF Macro Calverton Addis Ababa, 2011, ETH DEM HLTH SURV 20; Central statistics agency ORC, 2006, ETH DEM HLTH SURV 20; Cercone J., 2008, GOOD PRACTICES HLTH, P183; Chowdhury AMR, 2004, J INT DEV, V16, P369, DOI DOI 10.1002/JID.1083; Chowdhury ME, 2009, J HEALTH POPUL NUTR, V27, P108; CHOWDHURY Z, 1996, POLITICS ESSENTIAL D; Clark Mary A, 2004, CRUCIAL NEEDS WEAK I, P189; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; DANIDA, 1999, COUNTR REP IND EV DA; Das Gupta M, 2009, IMPROVE PUBLIC HLTH; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Dercon S., 2008, IMPACT AGR EXTENSION; DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1; DEV S, 2002, CAUSES FERTILITY DEC; DFID, 2010, POLITICS POVERTY ELI; Directorate General of Drug Administration, 2010, LIST LOC ALL PHARM M; Dolea C, 2010, B WORLD HEALTH ORGAN, V88, P379, DOI 10.2471/BLT.09.070607; Ethiopian Federal Ministry of Health, 2008, HLTH HLTH REL IND; Expanded Programme on Immunization (Bangladesh), 2009, BANGL EPI COV EV SUR; Falkingham J, 2010, HEALTH POLICY PLANN, V25, P427, DOI 10.1093/heapol/czq011; Federal HIV/AIDS Prevention and Control Office Federal Ministry of Health, 2010, REP PROGR IMPL UN DE, P33; FINKELSTEIN L. S., 1995, GLOBAL GOV, V1, P367, DOI DOI 10.1163/19426720-001-03-90000007; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gaudin S, 2006, SOC SCI MED, V62, P694, DOI 10.1016/j.socscimed.2005.06.042; Gertler P, 2002, AM ECON REV, V92, P51, DOI 10.1257/000282802760015603; Gilson L, 2012, HLTH POLICY SYSTEMS; *GOV IND MIN HLTH, 2008, HIV SENT SURV HIV ES; Government of India, 2009, NAT HLTH ACC IND 200; Government of India, 2010, EC SURV IND 2010 11; Government of Tamil Nadu, 2011, GOV TAM NAD STAT HDB; Government of Tamil Nadu, 1990, ANN POL NOT 1990 200, P1990; Guilmoto CZ, 2005, FERTILITY TRANSITION; Halstead S, 1985, GOOD HLTH LOW COST; Hamid S. A., 2010, CAN MICROHEALTH INSU; HARBISON SF, 1985, POPUL RES POLICY REV, V4, P149, DOI 10.1007/BF00127549; Human Rights Watch, 2009, NO TALL ANG ACC MAT; Ibraimova A., 2011, Health Systems in Transition (European Observatory on Health Systems and Policies), V13; [India Registrar General of India], 2011, SPEC B MAT MORT IND; Institute for Health Metrics and Evaluation, 2010, INF CHILD MORT EST C; *INT I POP SCI MAC, NAT FAM HLTH SURV NF, V1; International Institute for Population Sciences and Macro International, 2008, NAT FAM HLTH SURV NF; Islam S., 1992, HIST BANGLADESH 1704, V1; Jakab M, 2009, 57 HLTH POL AN UN; Jindawatana A, 1988, 1 THAI NATL HLTH ASS; Koehlmoos T, 2009, UNDERSTANDING ROLE E; Koehlmoos TP, 2010, COCHRANE DB SYST REV, V2011; Kutzin J, 2001, HEALTH POLICY, V56, P171, DOI 10.1016/S0168-8510(00)00149-4; Kutzin J., 2003, HLTH EXPENDITURES RE; Kutzin J, 2010, HEALTH ECON POLICY L, V5, P135, DOI 10.1017/S1744133110000010; Lalitha N., 2008, ECON POLIT WEEKLY, V43, P66; Mahmood SS, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-18; MCPAKE B, 2006, HSDWP1006; Meredith M., 2006, STATE AFRICA HIST 50; Mills A, 2012, HEALTH POLICY PLANN, V27, P1, DOI 10.1093/heapol/czr006; Ministry of Finance and Economic Development, 2006, ETH BUILD PROGR PLAN; Ministry of Health, 2011, EV NAT HLTH PROGR MA; Mirzoev T, 2010, INT J HEALTH PLAN M, V25, P270, DOI 10.1002/hpm.971; Narayana D., 2008, J HUM DEV, V9, P265, DOI [10.1080/14649880802078801, DOI 10.1080/14649880802078801]; National Institute of Population Research and Training (NIPORT) MEASURE Evaluation UNC-CH USA International Centre for Diarrhoeal Disease Research Bangladesh (ICDDR B), 2011, BANGL MAT MORT HLTH; National Institute of Population Research and Training (NIPORT) Mitra and Associates Macro International, 2009, BANGL DEM HLTH SURV; National Statistical Committee of the Kyrgyz Republic UNICEF, 2006, KYRG MON SIT CHILDR; Negusse Haile, 2007, Hum Resour Health, V5, P21, DOI 10.1186/1478-4491-5-21; Office of the Registrar General and Census Commissioner India, 2006, POP PROJ IND STAT 20; Ooms G, 2010, LANCET, V375, P1403, DOI 10.1016/S0140-6736(10)60207-3; Padmanaban P, 2009, J HEALTH POPUL NUTR, V27, P202; Pitayarangsarit S, 2007, SOUND CHOICES ENHANC, P147; Pitayarangsarit S, 2009, B WORLD HEALTH ORGAN, V87, P724; Pitt MM, 2006, ECON DEV CULT CHANGE, V54, P791, DOI 10.1086/503580; Planning Commission Government of India, 2011, HIGH LEV EXP GROUP R; Prachuabmoh V, 2003, J POPULATION RES, V20, P35, DOI DOI 10.1007/BF03031794; Rao KD, 2008, 1 HRH; Ravindran TKS, 1999, ECON POLIT WEEKLY, V34, pWS34; Rechel B, 2012, HEALTH POLICY PLANN, V27, P281, DOI 10.1093/heapol/czr040; Redwood-Campbell L, 2011, PREHOSP DISASTER MED, V26, P184, DOI 10.1017/S1049023X11006388; Registrar General of India, 2009, SAMPL REG SYST SPEC; Registrar General of India, 2011, MAT CHILD MORT TOT F; Registrar General of India, 2011, SRS B, V46; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; RUSSELL S, 1999, J INT DEV, V11, P767, DOI DOI 10.1002/(SICI)1099-1328(199907/08)11:5<LESS; San Sebastian M, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-16; Sen G, 2007, UNEQUAL UNFAIR INEFF; Siddiqi S, 2009, HEALTH POLICY, V90, P13, DOI 10.1016/j.healthpol.2008.08.005; Sindall C, 1997, HEALTH PROMOT INT, V12, P5, DOI 10.1093/heapro/12.1.5; Social Security Department International Labour Organization, 2007, 19 SOC SEC DEP INT L; Starfield B, 1998, PRIMARY CARE BALANCI; Sundewall Jesper, 2006, Health Res Policy Syst, V4, P5, DOI 10.1186/1478-4505-4-5; Tangcharoensathien V, 2009, TARGETING U LESSONS, P301; *THAIL NAT STAT OF, 2006, MON SIT CHILDR WOM T; Thailand National Statistical Office, 2007, EXP LIF BIRTH SURV P; The 2009-2010 NHA working group, 2012, NAT HLTH ACC THAIL 2; Tissot Laurent, 2002, TECHNOLOGICAL TRAJEC; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; UNICEF, 2010, RUR ETH HLTH EXT WOR; United Nations, 2011, MDG PLUS CAS STUD TH; United Nations Department of Economic and Social Affairs, 2012, WORLD POP PROSP 2010; United Nations Development Program, 2010, HUM DEV REP 2010 REA; Wagstaff A, 2007, J HEALTH ECON, V26, P82, DOI 10.1016/j.jhealeco.2006.07.001; Wakabi W, 2008, LANCET, V372, P880, DOI 10.1016/S0140-6736(08)61381-1; WHO, 2011, NAT HLTH ACC COUNTR; WHO, 2010, THAIL COUNTR CAS STU; WHO, 2007, EV BUS STRENGTH HLTH; WHO Country Office for Bangladesh, 2007, WHO COUNTR COOP STRA; WHO Regional Office for Europe, 2012, EUR HLTH ALL DAT HFA; WHO Regional Office for South-East Asia, 2007, 11 HLTH QUEST 11 SEE; WHO Regional Office for South-East Asia, 2009, SAF PREG TAM NAD VIS; WIBULPOLPRASERT S, 2003, 25 YEARS RURAL DOCTO; World Bank, 2022, WORLD DEV IND; World Health Organization, 2011, WORLD HLTH STAT 2011; World Health Organization, 2000, WORLD HLTH REP 2000; Yin R.K, 2011, CASE STUDY RES DESIG	128	169	172	0	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 15	2013	381	9883					2118	2133		10.1016/S0140-6736(12)62000-5	http://dx.doi.org/10.1016/S0140-6736(12)62000-5			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KA	23574803				2022-12-28	WOS:000320924800035
J	Xu, K; Zhang, MH; Zhao, Q; Yu, F; Guo, H; Wang, CY; He, FY; Ding, JP; Zhang, P				Xu, Ke; Zhang, Minhua; Zhao, Qin; Yu, Fang; Guo, Hui; Wang, Chengyuan; He, Fangyuan; Ding, Jianping; Zhang, Peng			Crystal structure of a folate energy-coupling factor transporter from Lactobacillus brevis	NATURE			English	Article							ABC TRANSPORTER; MALTOSE TRANSPORTER; BINDING-PROTEIN; PROKARYOTES; MECHANISM; INTERMEDIATE; COMPLEX	ATP-binding cassette (ABC) transporters, composed of importers and exporters, form one of the biggest protein superfamilies that transport a variety of substrates across the membrane, powered by ATP hydrolysis. Most ABC transporters are composed of two transmembrane domains and two cytoplasmic nucleotide-binding domains. Also, importers from prokaryotes usually have extra solute-binding proteins in the periplasm that are responsible for the binding of substrates(1,2). Structures of importers have been reported that suggested a two-state model for the transport mechanism(3-11). Energy-coupling factor (ECF) transporters belong to a new class of ATP-binding cassette importers. Each ECF transporter comprises an energy-coupling module consisting of a transmembrane T protein (EcfT), two nucleotide-binding proteins (EcfA and EcfA'), and another transmembrane substrate-specific binding S protein(12-14) (EcfS). Despite the similarities with ABC transporters, ECF transporters have different organizational and functional properties. The lack of solute-binding proteins in ECF transporters differentiates them clearly from the canonical ABC importers(15). Previously reported structures of the EcfS proteins RibU and ThiT clearly demonstrated the binding site of substrate riboflavin and thiamine, respectively(16,17). However, the organization of the four different components and the transport mechanism of ECF transporters remain unknown. Here we present the structure of an intact folate ECF transporter from Lactobacillus brevis at a resolution of 3 angstrom. This structure was captured in an inward-facing, nucleotide-free conformation with no bound substrate. The folate-binding protein FolT is nearly parallel to the membrane and is bound almost entirely by EcfT, which adopts an L shape and connects to EcfA and EcfA' through two coupling helices. Two conserved XRX motifs from the coupling helices of EcfT have a vital role in energy coupling by docking into EcfA-EcfA'. We propose a transport model that involves a substantial conformational change of FolT.	[Xu, Ke; Zhang, Minhua; Zhao, Qin; Guo, Hui; Wang, Chengyuan; He, Fangyuan; Zhang, Peng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai 200032, Peoples R China; [Yu, Fang; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Zhang, Peng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, CAS Key Lab Synthet Biol, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, P (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	pengzhang01@sibs.ac.cn		ding, jian ping/0000-0001-7029-7346; zhang, peng/0000-0003-0408-2923	Ministry of Science and Technology of China [2013CB127000]; Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2012OHTP, 2009CSP001, 2011KIP101, KSCX2-EW-J-12]; Shanghai 'Pujiang Talent' programme [11PJ1411300]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai 'Pujiang Talent' programme	We thank X. Chen and G. Zhao for reading the manuscript and the staff members of Shanghai Synchrotron Radiation Facility for technical assistance in data collection. This work was supported by grants from the Ministry of Science and Technology of China (2013CB127000), the Shanghai Institutes for Biological Sciences, the Chinese Academy of Sciences (2012OHTP, 2009CSP001, 2011KIP101, KSCX2-EW-J-12) and the Shanghai 'Pujiang Talent' programme (11PJ1411300).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Berntsson RPA, 2012, P NATL ACAD SCI USA, V109, P13990, DOI 10.1073/pnas.1203219109; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Eitinger T, 2011, FEMS MICROBIOL REV, V35, P3, DOI 10.1111/j.1574-6976.2010.00230.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erkens GB, 2012, BIOCHEMISTRY-US, V51, P4390, DOI 10.1021/bi300504v; Erkens GB, 2011, NAT STRUCT MOL BIOL, V18, P755, DOI 10.1038/nsmb.2073; Eudes A, 2008, J BACTERIOL, V190, P7591, DOI 10.1128/JB.01070-08; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Neubauer O, 2009, J BACTERIOL, V191, P6482, DOI 10.1128/JB.00965-09; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; ter Beek J, 2011, J BIOL CHEM, V286, P5471, DOI 10.1074/jbc.M110.199224; Zhang P, 2010, NATURE, V468, P717, DOI 10.1038/nature09488	27	72	75	4	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					268	+		10.1038/nature12046	http://dx.doi.org/10.1038/nature12046			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23584589				2022-12-28	WOS:000318558200042
J	Borucki, WJ; Agol, E; Fressin, F; Kaltenegger, L; Rowe, J; Isaacson, H; Fischer, D; Batalha, N; Lissauer, JJ; Marcy, GW; Fabrycky, D; Desert, JM; Bryson, ST; Barclay, T; Bastien, F; Boss, A; Brugamyer, E; Buchhave, LA; Burke, C; Caldwell, DA; Carter, J; Charbonneau, D; Crepp, JR; Christensen-Dalsgaard, J; Christiansen, JL; Ciardi, D; Cochran, WD; DeVore, E; Doyle, L; Dupree, AK; Endl, M; Everett, ME; Ford, EB; Fortney, J; Gautier, TN; Geary, JC; Gould, A; Haas, M; Henze, C; Howard, AW; Howell, SB; Huber, D; Jenkins, JM; Kjeldsen, H; Kolbl, R; Kolodziejczak, J; Latham, DW; Lee, BL; Lopez, E; Mullally, F; Orosz, JA; Prsa, A; Quintana, EV; Sanchis-Ojeda, R; Sasselov, D; Seader, S; Shporer, A; Steffen, JH; Still, M; Tenenbaum, P; Thompson, SE; Torres, G; Twicken, JD; Welsh, WF; Winn, JN				Borucki, William J.; Agol, Eric; Fressin, Francois; Kaltenegger, Lisa; Rowe, Jason; Isaacson, Howard; Fischer, Debra; Batalha, Natalie; Lissauer, Jack J.; Marcy, Geoffrey W.; Fabrycky, Daniel; Desert, Jean-Michel; Bryson, Stephen T.; Barclay, Thomas; Bastien, Fabienne; Boss, Alan; Brugamyer, Erik; Buchhave, Lars A.; Burke, Chris; Caldwell, Douglas A.; Carter, Josh; Charbonneau, David; Crepp, Justin R.; Christensen-Dalsgaard, Jorgen; Christiansen, Jessie L.; Ciardi, David; Cochran, William D.; DeVore, Edna; Doyle, Laurance; Dupree, Andrea K.; Endl, Michael; Everett, Mark E.; Ford, Eric B.; Fortney, Jonathan; Gautier, Thomas N., III; Geary, John C.; Gould, Alan; Haas, Michael; Henze, Christopher; Howard, Andrew W.; Howell, Steve B.; Huber, Daniel; Jenkins, Jon M.; Kjeldsen, Hans; Kolbl, Rea; Kolodziejczak, Jeffery; Latham, David W.; Lee, Brian L.; Lopez, Eric; Mullally, Fergal; Orosz, Jerome A.; Prsa, Andrej; Quintana, Elisa V.; Sanchis-Ojeda, Roberto; Sasselov, Dimitar; Seader, Shawn; Shporer, Avi; Steffen, Jason H.; Still, Martin; Tenenbaum, Peter; Thompson, Susan E.; Torres, Guillermo; Twicken, Joseph D.; Welsh, William F.; Winn, Joshua N.			Kepler-62: A Five-Planet System with Planets of 1.4 and 1.6 Earth Radii in the Habitable Zone	SCIENCE			English	Article							SUN-LIKE STAR; TRANSITING PLANET; CANDIDATES; SCIENCE; MASS; II.	We present the detection of five planets-Kepler-62b, c, d, e, and f-of size 1.31, 0.54, 1.95, 1.61 and 1.41 Earth radii (R-circle plus), orbiting a K2V star at periods of 5.7, 12.4, 18.2, 122.4, and 267.3 days, respectively. The outermost planets, Kepler-62e and -62f, are super-Earth-size (1.25 R-circle plus < planet radius <= 2.0 R-circle plus) planets in the habitable zone of their host star, respectively receiving 1.2 +/- 0.2 times and 0.41 +/- 0.05 times the solar flux at Earth's orbit. Theoretical models of Kepler-62e and -62f for a stellar age of similar to 7 billion years suggest that both planets could be solid, either with a rocky composition or composed of mostly solid water in their bulk.	[Borucki, William J.; Batalha, Natalie; Lissauer, Jack J.; Bryson, Stephen T.; Haas, Michael; Henze, Christopher; Howell, Steve B.; Huber, Daniel] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Agol, Eric; Lee, Brian L.] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [Fressin, Francois; Kaltenegger, Lisa; Desert, Jean-Michel; Carter, Josh; Charbonneau, David; Dupree, Andrea K.; Geary, John C.; Latham, David W.; Sasselov, Dimitar; Torres, Guillermo] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Kaltenegger, Lisa] Max Planck Inst Astron, D-69115 Heidelberg, Germany; [Rowe, Jason; Burke, Chris; Caldwell, Douglas A.; Christiansen, Jessie L.; DeVore, Edna; Doyle, Laurance; Jenkins, Jon M.; Mullally, Fergal; Quintana, Elisa V.; Seader, Shawn; Tenenbaum, Peter; Thompson, Susan E.; Twicken, Joseph D.] SETI Inst, Mountain View, CA 94043 USA; [Isaacson, Howard; Marcy, Geoffrey W.; Kolbl, Rea] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Fischer, Debra] Yale Univ, New Haven, CT 06520 USA; [Fabrycky, Daniel; Fortney, Jonathan; Lopez, Eric; Shporer, Avi] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Fabrycky, Daniel] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Barclay, Thomas; Still, Martin] Bay Area Environm Res Inst, Moffett Field, CA 94035 USA; [Bastien, Fabienne] Vanderbilt Univ, Nashville, TN 37235 USA; [Boss, Alan] Carnegie Inst Sci, Washington, DC 20015 USA; [Brugamyer, Erik; Cochran, William D.; Endl, Michael] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Buchhave, Lars A.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Crepp, Justin R.] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Crepp, Justin R.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Christensen-Dalsgaard, Jorgen; Kjeldsen, Hans] Aarhus Univ, Dept Phys & Astron, Aarhus, Denmark; [Ciardi, David] CALTECH, Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Everett, Mark E.] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Ford, Eric B.] Univ Florida, Gainesville, FL 32611 USA; [Gautier, Thomas N., III] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Gould, Alan] Lawrence Hall Sci, Berkeley, CA 94720 USA; [Howard, Andrew W.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Kolodziejczak, Jeffery] George C Marshall Space Flight Ctr, Huntsville, AL 35805 USA; [Orosz, Jerome A.; Welsh, William F.] San Diego State Univ, San Diego, CA 92182 USA; [Prsa, Andrej] Villanova Univ, Villanova, PA 19085 USA; [Shporer, Avi] Las Cumbres Observ Global Telescope, Goleta, CA 93117 USA; [Steffen, Jason H.] Northwestern Univ, Evanston, IL 60208 USA; [Sanchis-Ojeda, Roberto; Winn, Joshua N.] MIT, Cambridge, MA 02139 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Washington; University of Washington Seattle; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Max Planck Society; University of California System; University of California Berkeley; Yale University; University of California System; University of California Santa Cruz; University of Chicago; Vanderbilt University; Carnegie Institution for Science; University of Texas System; University of Texas Austin; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; California Institute of Technology; University of Notre Dame; Aarhus University; California Institute of Technology; National Optical Astronomy Observatory; State University System of Florida; University of Florida; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Hawaii System; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; California State University System; San Diego State University; Villanova University; Northwestern University; Massachusetts Institute of Technology (MIT)	Borucki, WJ (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	william.j.borucki@nasa.gov	Caldwell, Douglas A/L-7911-2014; Ford, Eric B./AAB-5479-2019; Steffen, Jason H./A-4320-2013; Welsh, William/AAS-3445-2021; Howard, Andrew/D-4148-2015; Buchhave, Lars A./ABF-2000-2020; Kaltenegger, Lisa/F-1176-2018; Shporer, Avi/Y-2777-2019; Cochran, William D/M-4421-2014; Huber, Daniel/AAE-9440-2019; Fischer, Debra A/C-1639-2014; Fortney, Jonathan/F-8813-2014	Caldwell, Douglas A/0000-0003-1963-9616; Ford, Eric B./0000-0001-6545-639X; Howard, Andrew/0000-0001-8638-0320; Buchhave, Lars A./0000-0003-1605-5666; Kaltenegger, Lisa/0000-0002-0436-1802; Shporer, Avi/0000-0002-1836-3120; Cochran, William D/0000-0001-9662-3496; Huber, Daniel/0000-0001-8832-4488; Fischer, Debra A/0000-0003-2221-0861; Rowe, Jason/0000-0002-5904-1865; Dupree, Andrea/0000-0002-8985-8489; Ciardi, David/0000-0002-5741-3047; Burke, Christopher/0000-0002-7754-9486; Steffen, Jason/0000-0003-2202-3847; Fabrycky, Daniel/0000-0003-3750-0183; Fortney, Jonathan/0000-0002-9843-4354; Christensen-Dalsgaard, Jorgen/0000-0001-5137-0966; Barclay, Thomas/0000-0001-7139-2724; Latham, David/0000-0001-9911-7388; Agol, Eric/0000-0002-0802-9145; Batalha, Natalie/0000-0002-7030-9519; Christiansen, Jessie/0000-0002-8035-4778	NASA's Science Mission Directorate; W. M. Keck Foundation; Deutsche Forschungsgemeinschaft [ENP Ka 3142/1-1]; NASA Astrobiology Institute; Danish National Research Foundation; ASTERISK project; European Research Council [267864]; NASA through the Kepler Participating Scientist Program (PSP); NSF [AST-1109928, AST-0645416]; NASA [ADAP12-0172]; NASA PSP [NNX08AR04G, NNX12AF73G]; NASA; Division Of Astronomical Sciences [1109928] Funding Source: National Science Foundation	NASA's Science Mission Directorate; W. M. Keck Foundation(W.M. Keck Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NASA Astrobiology Institute; Danish National Research Foundation(Danmarks Grundforskningsfond); ASTERISK project; European Research Council(European Research Council (ERC)European Commission); NASA through the Kepler Participating Scientist Program (PSP); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NASA PSP; NASA(National Aeronautics & Space Administration (NASA)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Kepler was competitively selected as the 10th Discovery mission. Funding for this mission is provided by NASA's Science Mission Directorate. Some of the data presented herein were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership of the California Institute of Technology, the University of California, and NASA. The Keck Observatory was made possible by the generous financial support of the W. M. Keck Foundation. L.K. acknowledges support from Deutsche Forschungsgemeinschaft grants ENP Ka 3142/1-1 and NASA Astrobiology Institute. Funding for the Stellar Astrophysics Centre is provided by the Danish National Research Foundation. The research is supported by the ASTERISK project (Asteroseismic Investigations with SONG and Kepler) funded by European Research Council grant 267864. W. F. W. and J.A.O. acknowledge support from NASA through the Kepler Participating Scientist Program (PSP) and from NSF grant AST-1109928. D.F. acknowledges support from NASA ADAP12-0172. O.R.S.-O. and J.N.W. are supported by the Kepler PSP through grant NNX12AC76G. E.F. is partially supported by NASA PSP grants NNX08AR04G and NNX12AF73G. E.A. acknowledges NSF career grant AST-0645416. We also thank the Spitzer staff at IPAC and in particular N. Silbermann for checking and scheduling the Spitzer observations. The Spitzer Space Telescope is operated by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. We thank the many people who gave so generously of their time to make this mission a success. All data products are available to the public at the Mikulski Archive for Space Telescopes, http://stdatu.stsci.edu/kepler.	Agol E, 2005, MON NOT R ASTRON SOC, V359, P567, DOI 10.1111/j.1365-2966.2005.08922.x; Argabright VS, 2008, P SOC PHOTO-OPT INS, V7010, pL102, DOI 10.1117/12.789913; Ballard S, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/200; Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Batalha NM, 2010, ASTROPHYS J LETT, V713, pL109, DOI 10.1088/2041-8205/713/2/L109; Borucki W., 2009, P IAU, V4, pS253; Borucki WJ, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/120; Borucki WJ, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/19; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Desert JM, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/200913093; Fressin F, 2012, NATURE, V482, P195, DOI 10.1038/nature10780; Fressin F, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/5; Gautier TN, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/15; Hatzes AP, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/75; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Howell SB, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/123; Jenkins JM, 2010, ASTROPHYS J LETT, V713, pL87, DOI 10.1088/2041-8205/713/2/L87; Kaltenegger L, 2011, ASTROPHYS J LETT, V736, DOI 10.1088/2041-8205/736/2/L25; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Rogers LA, 2010, ASTROPHYS J, V716, P1208, DOI 10.1088/0004-637X/716/2/1208; Selsis F, 2007, ASTRON ASTROPHYS, V476, P1373, DOI 10.1051/0004-6361:20078091; Torres G, 2004, ASTROPHYS J, V614, P979, DOI 10.1086/423734; Torres G., 2011, ASTROPHYS J, V700, P1589; Williams D. M., 2002, INT J ASTROBIOL, V1, P61, DOI [10.1017/S1473550402001064, DOI 10.1017/S1473550402001064]	26	153	154	0	572	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					587	590		10.1126/science.1234702	http://dx.doi.org/10.1126/science.1234702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23599262	Green Submitted, Green Accepted			2022-12-28	WOS:000318268900042
J	Fletcher, JM; Harniman, RL; Barnes, FRH; Boyle, AL; Collins, A; Mantell, J; Sharp, TH; Antognozzi, M; Booth, PJ; Linden, N; Miles, MJ; Sessions, RB; Verkade, P; Woolfson, DN				Fletcher, Jordan M.; Harniman, Robert L.; Barnes, Frederick R. H.; Boyle, Aimee L.; Collins, Andrew; Mantell, Judith; Sharp, Thomas H.; Antognozzi, Massimo; Booth, Paula J.; Linden, Noah; Miles, Mervyn J.; Sessions, Richard B.; Verkade, Paul; Woolfson, Derek N.			Self-Assembling Cages from Coiled-Coil Peptide Modules	SCIENCE			English	Article							SYNTHETIC BIOLOGY; PROTEIN; DESIGN; OLIGOMERS; SYSTEMS; CORE	An ability to mimic the boundaries of biological compartments would improve our understanding of self-assembly and provide routes to new materials for the delivery of drugs and biologicals and the development of protocells. We show that short designed peptides can be combined to form unilamellar spheres approximately 100 nanometers in diameter. The design comprises two, noncovalent, heterodimeric and homotrimeric coiled-coil bundles. These are joined back to back to render two complementary hubs, which when mixed form hexagonal networks that close to form cages. This design strategy offers control over chemistry, self-assembly, reversibility, and size of such particles.	[Fletcher, Jordan M.; Harniman, Robert L.; Barnes, Frederick R. H.; Boyle, Aimee L.; Collins, Andrew; Sharp, Thomas H.; Woolfson, Derek N.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Harniman, Robert L.; Antognozzi, Massimo; Miles, Mervyn J.] Univ Bristol, HH Wills Phys Lab, Sch Phys, Bristol BS8 1TL, Avon, England; [Harniman, Robert L.; Antognozzi, Massimo; Miles, Mervyn J.] Univ Bristol, Ctr Nanosci & Quantum Informat NSQI, Bristol BS8 1FD, Avon, England; [Collins, Andrew] Univ Bristol, NSQI, Bristol Ctr Funct Nanomat, Bristol BS8 1FD, Avon, England; [Mantell, Judith; Sharp, Thomas H.; Booth, Paula J.; Sessions, Richard B.; Verkade, Paul; Woolfson, Derek N.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Linden, Noah] Univ Bristol, Sch Math, Bristol BS8 1TW, Avon, England; [Verkade, Paul] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Bristol	Woolfson, DN (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	d.n.woolfson@bristol.ac.uk	Harniman, Robert/A-6355-2012; Verkade, Paul/N-7240-2014; Woolfson, Dek Neil/ABC-4338-2021	Harniman, Robert/0000-0002-3452-1213; Verkade, Paul/0000-0002-2497-1026; Boyle, Aimee/0000-0003-4176-6080; Sharp, Thomas/0000-0002-1990-2333; Collins, Andrew/0000-0003-3088-1710; Booth, Paula Jane/0000-0003-3893-360X; Antognozzi, Massimo/0000-0001-5396-0564; Woolfson, Derek/0000-0002-0394-3202; Sessions, Richard/0000-0003-0320-0895; Fletcher, Jordan/0000-0003-3203-4355	BBSRC [BB/G008833/1]; EPSRC; Wellcome University Award; EPSRC [EP/K03927X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G008833/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K03927X/1, EP/J501426/1, GR/T03727/01] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome University Award; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the Woolfson group for valuable discussions; the BBSRC for funding to D.N.W. and P.J.B. (BB/G008833/1) and for a studentship to A. L. B.; and the EPSRC for studentships to R. L. H. and T. H. S. J.M. is supported by a Wellcome University Award. We are grateful to the University of Bristol Advanced Computing Research Centre and the eInfraStructureSouth Consortium for high-performance computing; and Jonathan Jones and the EM Unit (EMU) School of Chemistry University of Bristol for EM access. The peptides described have been added to the Pcomp database for synthetic biology (http://coiledcoils.chm.bris.ac.uk/pcomp/index.php).	Agapakis CM, 2012, NAT CHEM BIOL, V8, P527, DOI [10.1038/NCHEMBIO.975, 10.1038/nchembio.975]; Antognozzi M, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384002; Boato F, 2007, ANGEW CHEM INT EDIT, V46, P9015, DOI 10.1002/anie.200702805; Brodin JD, 2012, NAT CHEM, V4, P375, DOI [10.1038/NCHEM.1290, 10.1038/nchem.1290]; Bromley EHC, 2008, ACS CHEM BIOL, V3, P38, DOI 10.1021/cb700249v; Bromley EHC, 2009, J AM CHEM SOC, V131, P928, DOI 10.1021/ja804231a; Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586; Fletcher JM, 2012, ACS SYNTH BIOL, V1, P240, DOI 10.1021/sb300028q; Hammer DA, 2012, FEBS LETT, V586, P2882, DOI 10.1016/j.febslet.2012.07.044; Harniman RL, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/8/085703; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Lodish H., 2008, MOL CELL BIOL, V6th ed.; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; OFFER G, 1995, J MOL BIOL, V249, P967, DOI 10.1006/jmbi.1995.0352; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; Pires MM, 2012, LANGMUIR, V28, P1993, DOI 10.1021/la203848r; Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Uchida M, 2007, ADV MATER, V19, P1025, DOI 10.1002/adma.200601168; Worsdorfer B, 2011, SCIENCE, V331, P589, DOI 10.1126/science.1199081; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2	24	375	389	11	641	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					595	599		10.1126/science.1233936	http://dx.doi.org/10.1126/science.1233936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23579496	Green Accepted			2022-12-28	WOS:000318268900044
J	Horikawa, T; Tamaki, M; Miyawaki, Y; Kamitani, Y				Horikawa, T.; Tamaki, M.; Miyawaki, Y.; Kamitani, Y.			Neural Decoding of Visual Imagery During Sleep	SCIENCE			English	Article							EYE-MOVEMENTS; BRAIN; REM; REPRESENTATION; ACTIVATION; OBJECT; CORTEX	Visual imagery during sleep has long been a topic of persistent speculation, but its private nature has hampered objective analysis. Here we present a neural decoding approach in which machine-learning models predict the contents of visual imagery during the sleep-onset period, given measured brain activity, by discovering links between human functional magnetic resonance imaging patterns and verbal reports with the assistance of lexical and image databases. Decoding models trained on stimulus-induced brain activity in visual cortical areas showed accurate classification, detection, and identification of contents. Our findings demonstrate that specific visual experience during sleep is represented by brain activity patterns shared by stimulus perception, providing a means to uncover subjective contents of dreaming using objective neural measurement.	[Horikawa, T.; Tamaki, M.; Miyawaki, Y.; Kamitani, Y.] ATR Computat Neurosci Labs, Kyoto 6190288, Japan; [Horikawa, T.; Kamitani, Y.] Nara Inst Sci & Technol, Nara 6300192, Japan; [Miyawaki, Y.] Natl Inst Informat & Commun Technol, Kyoto 6190288, Japan	Nara Institute of Science & Technology; National Institute of Information & Communications Technology (NICT) - Japan	Kamitani, Y (corresponding author), ATR Computat Neurosci Labs, Kyoto 6190288, Japan.	kmtn@atr.jp		Horikawa, Tomoyasu/0000-0002-6524-9398; Miyawaki, Yoichi/0000-0001-9581-926X; Tamaki, Masako/0000-0001-7621-8039	Strategic Research Program for Brain Science (MEXT); Strategic Information and Communications R&D Promotion Programme (SOUMU); National Institute of Information and Communications Technology; Nissan Science Foundation; Ministry of Internal Affairs and Communications	Strategic Research Program for Brain Science (MEXT); Strategic Information and Communications R&D Promotion Programme (SOUMU); National Institute of Information and Communications Technology; Nissan Science Foundation; Ministry of Internal Affairs and Communications	We thank Y. Onuki, T. Beck, Y. Fujiwara, G. Pandey, and T. Kubo for assistance with early experiments and M. Takemiya and P. Sukhanov for comments on the manuscript. This work was supported by grants from the Strategic Research Program for Brain Science (MEXT), the Strategic Information and Communications R&D Promotion Programme (SOUMU), the National Institute of Information and Communications Technology, the Nissan Science Foundation, and the Ministry of Internal Affairs and Communications (Novel and innovative R&D making use of brain structures).	[Anonymous], 1994, SLEEP ONSET NORMAL A, DOI DOI 10.1037/10166-014; Braun AR, 1998, SCIENCE, V279, P91, DOI 10.1126/science.279.5347.91; DEMENT W, 1957, J EXP PSYCHOL, V53, P339, DOI 10.1037/h0048189; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Dresler M, 2011, CURR BIOL, V21, P1833, DOI 10.1016/j.cub.2011.09.029; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fellbaum Christiane, 1998, WORDNET ELECT DATABA; Finke RA., 1989, PRINCIPLES MENTAL IM; FOULKES DAVID, 1965, J ABNORM PSYCHOL, V70, P231, DOI 10.1037/h0022217; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hobson JA, 2009, NAT REV NEUROSCI, V10, P803, DOI 10.1038/nrn2716; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Maquet P, 2000, J SLEEP RES, V9, P207; Marzano C, 2011, J NEUROSCI, V31, P6674, DOI 10.1523/JNEUROSCI.0412-11.2011; Miyauchi S, 2009, EXP BRAIN RES, V192, P657, DOI 10.1007/s00221-008-1579-2; Miyawaki Y, 2008, NEURON, V60, P915, DOI 10.1016/j.neuron.2008.11.004; Nir Y, 2010, TRENDS COGN SCI, V14, P88, DOI 10.1016/j.tics.2009.12.001; Oudiette D, 2012, CONSCIOUS COGN, V21, P1129, DOI 10.1016/j.concog.2012.04.010; Stickgold R, 2000, SCIENCE, V290, P350, DOI 10.1126/science.290.5490.350; Stokes M, 2009, J NEUROSCI, V29, P1565, DOI 10.1523/JNEUROSCI.4657-08.2009; Vapnik V., 1998, STAT LEARNING THEORY; VOGEL GW, 1972, ARCH GEN PSYCHIAT, V26, P449; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yotsumoto Y, 2009, CURR BIOL, V19, P1278, DOI 10.1016/j.cub.2009.06.011	29	272	281	3	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					639	642		10.1126/science.1234330	http://dx.doi.org/10.1126/science.1234330			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23558170				2022-12-28	WOS:000318268900055
J	Pelechano, V; Wei, W; Steinmetz, LM				Pelechano, Vicent; Wei, Wu; Steinmetz, Lars M.			Extensive transcriptional heterogeneity revealed by isoform profiling	NATURE			English	Article							GENOME-WIDE ANALYSIS; SACCHAROMYCES-CEREVISIAE; YEAST; POLYADENYLATION; ORGANIZATION; TRANSLATION; SWITCH	Transcript function is determined by sequence elements arranged on an individual RNA molecule. Variation in transcripts can affect messenger RNA stability, localization and translation(1), or produce truncated proteins that differ in localization(2) or function(3). Given the existence of overlapping, variable transcript isoforms, determining the functional impact of the transcriptome requires identification of full-length transcripts, rather than just the genomic regions that are transcribed(4,5). Here, by jointly determining both transcript ends for millions of RNA molecules, we reveal an extensive layer of isoform diversity previously hidden among overlapping RNA molecules. Variation in transcript boundaries seems to be the rule rather than the exception, even within a single population of yeast cells. Over 26 major transcript isoforms per protein-coding gene were expressed in yeast. Hundreds of short coding RNAs and truncated versions of proteins are concomitantly encoded by alternative transcript isoforms, increasing protein diversity. In addition, approximately 70% of genes express alternative isoforms that vary in post-transcriptional regulatory elements, and tandem genes frequently produce overlapping or even bicistronic transcripts. This extensive transcript diversity is generated by a relatively simple eukaryotic genome with limited splicing, and within a genetically homogeneous population of cells. Our findings have implications for genome compaction, evolution and phenotypic diversity between single cells. These data also indicate that isoform diversity as well as RNA abundance should be considered when assessing the functional repertoire of genomes.	[Pelechano, Vicent; Wei, Wu; Steinmetz, Lars M.] European Mol Biol Lab EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Wei, Wu; Steinmetz, Lars M.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	European Molecular Biology Laboratory (EMBL); Stanford University	Steinmetz, LM (corresponding author), European Mol Biol Lab EMBL, Genome Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	larsms@embl.de	Pelechano, Vicent/ABF-2597-2020; Pelechano, Vicent/A-8431-2011; Wei, Wu/AAC-8285-2020	Pelechano, Vicent/0000-0002-9415-788X; Pelechano, Vicent/0000-0002-9415-788X; Wei, Wu/0000-0001-5643-8739; Steinmetz, Lars/0000-0002-3962-2865	National Institutes of Health; EMBO fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO fellowship(European Molecular Biology Organization (EMBO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Aiyar for help in editing and refining the manuscript. We thank W. Huber, C. Zhu, A. I. Jarvelin, S. Clauder-Munster, J. Zaugg, S. Adjalley, G. Lin and the members of the Steinmetz laboratory for helpful discussions and critical comments on the manuscript. We thank V. N. Gladyshev and C. Pineau for sharing published data. This study was technically supported by the EMBL Genomics Core Facility. This study was financially supported by the National Institutes of Health (to L.M.S.). V. P. was supported by an EMBO fellowship.	CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; CHATTON B, 1988, J BIOL CHEM, V263, P52; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Fournier CT, 2012, J PROTEOME RES, V11, P5712, DOI 10.1021/pr300538f; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Majumdar S, 2004, EUR J BIOCHEM, V271, P753, DOI 10.1111/j.1432-1033.2003.03974.x; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; Miura F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-574; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Riordan DP, 2011, NUCLEIC ACIDS RES, V39, P1501, DOI 10.1093/nar/gkq920; Ruan XA, 2012, METHODS MOL BIOL, V809, P535, DOI 10.1007/978-1-61779-376-9_35; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Ungewitter E, 2010, GENE DEV, V24, P2408, DOI 10.1101/gad.1987810; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Wilkening S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1249; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	27	264	267	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					127	+		10.1038/nature12121	http://dx.doi.org/10.1038/nature12121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23615609	Green Accepted			2022-12-28	WOS:000318221500047
J	Yosipovitch, G; Bernhard, JD				Yosipovitch, Gil; Bernhard, Jeffrey D.			Chronic Pruritus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UREMIC PRURITUS; DOUBLE-BLIND; HEMODIALYSIS-PATIENTS; ATOPIC-DERMATITIS; TOPICAL CORTICOSTEROIDS; CONTROLLED-TRIAL; NOCTURNAL ITCH; MIRTAZAPINE; GABAPENTIN; CROSSOVER	An otherwise healthy 55-year-old man reports that he has been itchy all over for 6 months. The itch interferes with falling asleep and wakes him repeatedly during the night. Initially, there was no rash, but during the past 4 months, itchy nodules and plaques have developed on his back, arms, and legs. Treatment with sedating and nonsedating oral antihistamines and topical glucocorticoids has had no effect. How would you evaluate and manage this case?	[Yosipovitch, Gil] Wake Forest Univ, Baptist Med Ctr, Dept Dermatol, Winston Salem, NC 27157 USA; [Yosipovitch, Gil] Wake Forest Univ, Baptist Med Ctr, Dept Neurobiol, Winston Salem, NC 27157 USA; [Yosipovitch, Gil] Wake Forest Univ, Baptist Med Ctr, Dept Anat, Winston Salem, NC 27157 USA; [Bernhard, Jeffrey D.] Univ Massachusetts, Sch Med, Worcester, MA USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of Massachusetts System; University of Massachusetts Worcester	Yosipovitch, G (corresponding author), Wake Forest Univ, Baptist Med Ctr, Dept Dermatol, Winston Salem, NC 27157 USA.	gyosipov@wakehealth.edu	Yosipovitch, Gil/K-3517-2019		Medicis; Biogen Idec; GlaxoSmithKline; Johnson Johnson; Mitsubishi; Regeneron; Leo Pharma; Sanofi-Aventis; Cosmoderm; Dr. Reddy's Laboratories; Brickell Biotech; Procter Gamble; Unilever; Creabilis; Dignity Sciences; LEO Foundation; Elorac; Trevi Therapeutics	Medicis; Biogen Idec(Biogen); GlaxoSmithKline(GlaxoSmithKline); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Mitsubishi; Regeneron(Regeneron); Leo Pharma(LEO Pharma); Sanofi-Aventis(Sanofi-Aventis); Cosmoderm; Dr. Reddy's Laboratories; Brickell Biotech; Procter Gamble(Procter & Gamble); Unilever(Unilever); Creabilis; Dignity Sciences; LEO Foundation(LEO Pharma); Elorac; Trevi Therapeutics	Dr. Yosipovitch reports receiving consulting fees from Medicis, Biogen Idec, GlaxoSmithKline, Johnson & Johnson, Mitsubishi, Regeneron, Leo Pharma, Sanofi-Aventis, Cosmoderm, Dr. Reddy's Laboratories, Brickell Biotech, Procter & Gamble, Unilever, Creabilis, and Dignity Sciences and grant support from GlaxoSmithKline, LEO Foundation, and Cosmoderm; and Dr. Bernhard, consulting fees from Elorac and Trevi Therapeutics. No other potential conflict of interest relevant to this article was reported.	Ali SM, 2013, ACTA DERM VENEREOL; Bathe A, 2009, ACTA DERM-VENEREOL, V89, P498, DOI 10.2340/00015555-0684; Bingham LG, 2009, J AM ACAD DERMATOL, V60, P792, DOI 10.1016/j.jaad.2008.12.043; Dabade TS, 2012, J AM ACAD DERMATOL, V67, P100, DOI 10.1016/j.jaad.2011.06.025; Dalgard F, 2012, ACTA DERM-VENEREOL, V92, P547, DOI 10.2340/00015555-1309; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Davis MP, 2003, J PAIN SYMPTOM MANAG, V25, P288, DOI 10.1016/S0885-3924(02)00645-0; Dawn A, 2009, BRIT J DERMATOL, V160, P642, DOI 10.1111/j.1365-2133.2008.08941.x; Dawn AG, 2006, J AM ACAD DERMATOL, V54, P527, DOI 10.1016/j.jaad.2005.12.010; Demierre MF, 2006, J AM ACAD DERMATOL, V55, P543, DOI 10.1016/j.jaad.2006.04.025; DRAKE LA, 1994, J AM ACAD DERMATOL, V31, P613, DOI 10.1016/S0190-9622(94)70225-X; Ebrchen J, 2008, J AM ACAD DERMATOL, V58, pS36, DOI 10.1016/j.jaad.2007.07.017; GILCHREST BA, 1979, ANN INTERN MED, V91, P17, DOI 10.7326/0003-4819-91-1-17; Goodkin R, 2003, J AM ACAD DERMATOL, V48, P521, DOI 10.1067/mjd.2003.203; Gunal AI, 2004, NEPHROL DIAL TRANSPL, V19, P3137, DOI 10.1093/ndt/gfh496; Hoare C, 2000, Health Technol Assess, V4, P1; Hundley JL, 2004, J AM ACAD DERMATOL, V50, P889, DOI 10.1016/j.jaad.2004.01.045; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Kini SP, 2011, ARCH DERMATOL, V147, P1153, DOI 10.1001/archdermatol.2011.178; Ko MJ, 2011, BRIT J DERMATOL, V165, P633, DOI 10.1111/j.1365-2133.2011.10448.x; Kumagai H, 2010, NEPHROL DIAL TRANSPL, V25, P1251, DOI 10.1093/ndt/gfp588; Ley HL, 2013, CLIN DERMATOL, V31, P31, DOI 10.1016/j.clindermatol.2011.11.004; Manenti L, 2005, J NEPHROL, V18, P86; Matterne U, 2011, ACTA DERM-VENEREOL, V91, P674, DOI 10.2340/00015555-1159; Mayo MJ, 2007, HEPATOLOGY, V45, P666, DOI 10.1002/hep.21553; O'Donoghue Michael, 2005, Dermatol Ther, V18, P333; Papoiu ADP, 2012, NEUROIMAGE, V59, P3611, DOI 10.1016/j.neuroimage.2011.10.099; Papoiu ADP, 2010, EXPERT OPIN PHARMACO, V11, P1359, DOI 10.1517/14656566.2010.481670; Patel T, 2007, J AM ACAD DERMATOL, V57, P873, DOI 10.1016/j.jaad.2007.04.008; Patel T, 2007, ACTA DERM-VENEREOL, V87, P295, DOI 10.2340/00015555-0280; Pauli-Magnus C, 2000, J AM SOC NEPHROL, V11, P514, DOI 10.1681/ASN.V113514; Peer G, 1996, LANCET, V348, P1552, DOI 10.1016/S0140-6736(96)04176-1; Phan NQ, 2010, J AM ACAD DERMATOL, V63, P680, DOI 10.1016/j.jaad.2009.08.052; Rivard Jennifer, 2005, Dermatol Ther, V18, P344, DOI 10.1111/j.1529-8019.2005.00032.x; Stander S, 2010, DERMATOLOGY, V221, P229, DOI 10.1159/000319862; Stander S, 2007, ACTA DERM-VENEREOL, V87, P291, DOI 10.2340/00015555-0305; Stander S, 2009, ACTA DERM-VENEREOL, V89, P45, DOI 10.2340/00015555-0553; Stander S, 2013, BR J DERMATOL; Stander Sonja, 2006, Ther Clin Risk Manag, V2, P213; Suys E, 2012, J AM ACAD DERMATOL, V66, P327, DOI 10.1016/j.jaad.2011.05.024; van Os-Medendorp H, 2007, BRIT J DERMATOL, V156, P1235, DOI 10.1111/j.1365-2133.2007.07919.x; WALLENGREN J, 1995, J AM ACAD DERMATOL, V32, P287, DOI 10.1016/0190-9622(95)90152-3; Weisshaar E, 2012, ACTA DERM-VENEREOL, V92, P563, DOI 10.2340/00015555-1400; Weisshaar E, 2009, ACTA DERM-VENEREOL, V89, P339, DOI 10.2340/00015555-0662; Wikstrom B, 2005, J AM SOC NEPHROL, V16, P3742, DOI 10.1681/ASN.2005020152; Yamamoto Y, 2009, ARCH DERMATOL, V145, P1384, DOI 10.1001/archdermatol.2009.290; Yosipovitch G, 2000, BRIT J DERMATOL, V143, P969, DOI 10.1046/j.1365-2133.2000.03829.x; Yosipovitch G, 2003, LANCET, V361, P690, DOI 10.1016/S0140-6736(03)12570-6; Yosipovitch G, 2012, FITZPATRICKS DERMATO, P1146; Yosipovitch G, 2008, DERMATOL THER, V21, P32, DOI 10.1111/j.1529-8019.2008.00167.x; Yosipovitch G, 2010, DERMATOL THER, V23, P590, DOI 10.1111/j.1529-8019.2010.01366.x; Young TA, 2009, J DERMATOL TREAT, V20, P76, DOI 10.1080/09546630802441218; Zylicz Z, 2003, J PAIN SYMPTOM MANAG, V26, P1105, DOI 10.1016/j.jpainsymman.2003.05.004	53	243	259	2	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1625	1634		10.1056/NEJMcp1208814	http://dx.doi.org/10.1056/NEJMcp1208814			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130YK	23614588				2022-12-28	WOS:000317956300011
J	Christensen, J; Gronborg, TK; Sorensen, MJ; Schendel, D; Parner, ET; Pedersen, LH; Vestergaard, M				Christensen, Jakob; Gronborg, Therese Koops; Sorensen, Merete Juul; Schendel, Diana; Parner, Erik Thorlund; Pedersen, Lars Henning; Vestergaard, Mogens			Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BEHAVIORAL ALTERATIONS; ANIMAL-MODEL; ACID; CHILDREN; PREGNANCY; REGISTRATION; WOMEN; BIRTH; AGE	Importance Valproate is used for the treatment of epilepsy and other neuropsychological disorders and may be the only treatment option for women of childbearing potential. However, prenatal exposure to valproate may increase the risk of autism. Objective To determine whether prenatal exposure to valproate is associated with an increased risk of autism in offspring. Design, Setting, and Participants Population-based study of all children born alive in Denmark from 1996 to 2006. National registers were used to identify children exposed to valproate during pregnancy and diagnosed with autism spectrum disorders (childhood autism [autistic disorder], Asperger syndrome, atypical autism, and other or unspecified pervasive developmental disorders). We analyzed the risks associated with all autism spectrum disorders as well as childhood autism. Data were analyzed by Cox regression adjusting for potential confounders (maternal age at conception, paternal age at conception, parental psychiatric history, gestational age, birth weight, sex, congenital malformations, and parity). Children were followed up from birth until the day of autism spectrum disorder diagnosis, death, emigration, or December 31, 2010, whichever came first. Main Outcomes and Measures Absolute risk (cumulative incidence) and the hazard ratio (HR) of autism spectrum disorder and childhood autism in children after exposure to valproate in pregnancy. Results Of 655 615 children born from 1996 through 2006, 5437 were identified with autism spectrum disorder, including 2067 with childhood autism. The mean age of the children at end of follow-up was 8.84 years (range, 4-14; median, 8.85). The estimated absolute risk after 14 years of follow-up was 1.53% (95% CI, 1.47%-1.58%) for autism spectrum disorder and 0.48% (95% CI, 0.46%-0.51%) for childhood autism. Overall, the 508 children exposed to valproate had an absolute risk of 4.42% (95% CI, 2.59%-7.46%) for autism spectrum disorder (adjusted HR, 2.9 [95% CI, 1.7-4.9]) and an absolute risk of 2.50% (95% CI, 1.30%-4.81%) for childhood autism (adjusted HR, 5.2 [95% CI, 2.7-10.0]). When restricting the cohort to the 6584 children born to women with epilepsy, the absolute risk of autism spectrum disorder among 432 children exposed to valproate was 4.15% (95% CI, 2.20%-7.81%) (adjusted HR, 1.7 [95% CI, 0.9-3.2]), and the absolute risk of childhood autism was 2.95% (95% CI, 1.42%-6.11%) (adjusted HR, 2.9 [95% CI, 1.4-6.0]) vs 2.44% (95% CI, 1.88%-3.16%) for autism spectrum disorder and 1.02% (95% CI, 0.70%-1.49%) for childhood autism among 6152 children not exposed to valproate. Conclusions and Relevance Maternal use of valproate during pregnancy was associated with a significantly increased risk of autism spectrum disorder and childhood autism in the offspring, even after adjusting for maternal epilepsy. For women of childbearing potential who use antiepileptic medications, these findings must be balanced against the treatment benefits for women who require valproate for epilepsy control. JAMA. 2013;309(16):1696-1703 www.jama.com	[Christensen, Jakob] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Clin Pharmacol, DK-8000 Aarhus C, Denmark; [Gronborg, Therese Koops; Parner, Erik Thorlund] Aarhus Univ, Inst Publ Hlth, Dept Biostat, Aarhus, Denmark; [Pedersen, Lars Henning] Aarhus Univ, Inst Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Pedersen, Lars Henning] Aarhus Univ, Inst Clin Med, Dept Obstet & Gynaecol, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Inst Publ Hlth, Res Unit, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Inst Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Sorensen, Merete Juul] Aarhus Univ Hosp, Reg Ctr Child & Adolescent Psychiat, Risskov, Denmark; [Schendel, Diana] Ctr Dis Control & Prevent, Atlanta, GA USA	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Centers for Disease Control & Prevention - USA	Christensen, J (corresponding author), Aarhus Univ Hosp, Dept Neurol, Norrebrogade 44, DK-8000 Aarhus C, Denmark.	jakob@farm.au.dk	Parner, Erik Thorlund/F-5532-2010; Vestergaard, Mogens/M-9333-2014	Parner, Erik Thorlund/0000-0003-3661-1922; Vestergaard, Mogens/0000-0001-8830-2174; Schendel, Diana/0000-0002-8588-1227; Christensen, Jakob/0000-0002-9385-6435	UCB Nordic; Danish Epilepsy Association; Danish Council for Independent Research; European Research Council (European Union) [260242]; Danish Medical Research Council [09-072986]	UCB Nordic(UCB Pharma SA); Danish Epilepsy Association; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); European Research Council (European Union)(European Research Council (ERC)European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Christensen reported receiving honoraria for serving on the scientific advisory boards of UCB Nordic and Eisai AB; receiving lecture honoraria from UCB Nordic and Eisai AB; and receiving travel funding from UCB Nordic. Dr Parner reported receiving grants from Autism Speaks and the National Institutes of Health. No other authors reported disclosures.; Dr Christensen receives research support from the Danish Epilepsy Association. Dr Pedersen is supported by a Sapere Aude-Postdoctoral grant from the Danish Council for Independent Research. This study was supported by grants from the European Research Council (the European Union Seventh Framework Programme, ERC-2010-StG No. 260242) and the Danish Medical Research Council (09-072986).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Bromley RL, 2008, NEUROLOGY, V71, P1923, DOI 10.1212/01.wnl.0000339399.64213.1a; Bromley RL, 2013, J NEUROL NEUROSUR PS, V84, P637, DOI 10.1136/jnnp-2012-304270; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; Gardener H, 2011, PEDIATRICS, V128, P344, DOI 10.1542/peds.2010-1036; Holmes GL, 2007, EPILEPSY BEHAV, V11, P270, DOI 10.1016/j.yebeh.2007.08.022; Jentink J, 2010, NEW ENGL J MED, V362, P2185, DOI 10.1056/NEJMoa0907328; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Lauritsen MB, 2010, J AUTISM DEV DISORD, V40, P139, DOI 10.1007/s10803-009-0818-0; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Markram K, 2008, NEUROPSYCHOPHARMACOL, V33, P901, DOI 10.1038/sj.npp.1301453; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Meador KJ, 2007, EPILEPSY BEHAV, V11, P292, DOI 10.1016/j.yebeh.2007.08.009; Miles JH, 2011, GENET MED, V13, P278, DOI 10.1097/GIM.0b013e3181ff67ba; Moore SJ, 2000, J MED GENET, V37, P489, DOI 10.1136/jmg.37.7.489; Olesen AW, 2004, ACTA OBSTET GYN SCAN, V83, P1039, DOI 10.1111/j.0001-6349.2004.00193.x; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rasalam AD, 2005, DEV MED CHILD NEUROL, V47, P551, DOI 10.1017/S0012162205001076; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; Schmidt RJ, 2012, AM J CLIN NUTR, V96, P80, DOI 10.3945/ajcn.110.004416; Schneider T, 2006, NEUROPSYCHOPHARMACOL, V31, P36, DOI 10.1038/sj.npp.1300767; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Sui L, 2012, BRAIN RES BULL, V87, P556, DOI 10.1016/j.brainresbull.2012.01.011; Suren P, 2013, JAMA-J AM MED ASSOC, V309, P570, DOI 10.1001/jama.2012.155925; Symons MJ, 2002, J CLIN EPIDEMIOL, V55, P893, DOI 10.1016/S0895-4356(02)00443-2; Tamura T, 2005, PEDIATRICS, V116, P703, DOI 10.1542/peds.2004-2189; Vajda FJE, 2006, EUR J NEUROL, V13, P645, DOI 10.1111/j.1468-1331.2006.01359.x; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; WHO Collaborating Centre for Drug Statistics Methodology (WHOCC), DEF DAIL DOS DEF GEN	36	672	700	4	116	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1696	1703		10.1001/jama.2013.2270	http://dx.doi.org/10.1001/jama.2013.2270			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130IG	23613074	Green Accepted			2022-12-28	WOS:000317906700026
J	Engheta, N				Engheta, Nader			Pursuing Near-Zero Response	SCIENCE			English	Editorial Material							INDEX		Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA	University of Pennsylvania	Engheta, N (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.	engheta@ee.upenn.edu						Alu A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.143902; Alu A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.043902; Alu A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.045102; Argyropoulos C, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045129; Boltasseva A, 2011, SCIENCE, V331, P290, DOI 10.1126/science.1198258; Davoyan AR, 2013, OPT EXPRESS, V21, P3279, DOI 10.1364/OE.21.003279; Edwards B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.033903; Fleury R, 2012, APPL PHYS A-MATER, V109, P781, DOI 10.1007/s00339-012-7345-0; Huang XQ, 2011, NAT MATER, V10, P582, DOI [10.1038/NMAT3030, 10.1038/nmat3030]; Litchinitser NM, 2008, OPT LETT, V33, P2350, DOI 10.1364/OL.33.002350; Silveirinha M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.157403; Smolyaninov II, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.213901; Vesseur EJR, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.013902; Ziolkowski RW, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046608	14	250	255	5	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					286	287		10.1126/science.1235589	http://dx.doi.org/10.1126/science.1235589			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599473				2022-12-28	WOS:000317657500034
J	Stage, EK; Asturias, H; Cheuk, T; Daro, PA; Hampton, SB				Stage, E. K.; Asturias, H.; Cheuk, T.; Daro, P. A.; Hampton, S. B.			Opportunities and Challenges in Next Generation Standards	SCIENCE			English	Editorial Material									[Stage, E. K.; Asturias, H.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Cheuk, T.] Stanford Univ, Grad Sch Educ, Stanford, CA 94305 USA; [Daro, P. A.; Hampton, S. B.] Natl Ctr Educ & Econ, Washington, DC 20006 USA	University of California System; University of California Berkeley; Stanford University	Stage, EK (corresponding author), Univ Calif Berkeley, Lawrence Hall Sci, Berkeley, CA 94720 USA.	stage@berkeley.edu						American Association for the Advancement of Science, 1993, PROJ 2061 BENCHM SCI; Banilower E. R., 2013, REP 2012 NAT SURV SC; Board on Science Education National Research Council (NRC), 2011, FRAM K 12 SCI ED PRA; Cheuk T, 2012, COMP 3 CONTENT STAND; Coffey J, 2013, SCIENCE, V339, P489, DOI 10.1126/science.1225590; Commission on Mathematics and Science Education (US), 2009, OPP EQ TRANSF MATH S; Gewertz C., 2012, ED WEEK, V32, pS2; National Academy of Engineering and Committee on Standards for K-12 Engineering Education NRC, 2010, K 12 STAND ENG; National Governors' Association (NGA) Center for Best Practices & Council of Chief State School, 2010, COMM COR STAT STAND; *NRC NAT COMM SCI, 1996, NAT SCI ED STAND; Pearson PD, 2010, SCIENCE, V328, P459, DOI 10.1126/science.1182595; President's Council of Advisors on Science and Technology, 2010, PREP INSP K 12 ED SC; Robelen E. W., 2013, ED WEEK, V32, P13; Schmidt W., 1997, SPLINTERED VISION IN; Tai RH, 2006, SCIENCE, V312, P1143, DOI 10.1126/science.1128690; Weiman C., 2012, ISSUES SCI TECHNOL, V2012	16	37	37	5	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					276	277		10.1126/science.1234011	http://dx.doi.org/10.1126/science.1234011			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126XZ	23599466				2022-12-28	WOS:000317657500027
J	Vereecken, L				Vereecken, Luc			Lifting the Veil on an Old Mystery	SCIENCE			English	Editorial Material							CRIEGEE INTERMEDIATE CH2OO; SO2		Max Planck Inst Chem, D-55128 Mainz, Germany	Max Planck Society	Vereecken, L (corresponding author), Max Planck Inst Chem, D-55128 Mainz, Germany.	luc.vereecken@mpic.de	Vereecken, Luc/D-5025-2016	Vereecken, Luc/0000-0001-7845-684X				Beames JM, 2012, J AM CHEM SOC, V134, P20045, DOI 10.1021/ja310603j; Berndt T, 2012, J PHYS CHEM LETT, V3, P2892, DOI 10.1021/jz301158u; Criegee R., 1949, LIEBIGS ANN CHEM, V564, P9; Lee EPF, 2012, CHEM-EUR J, V18, P12411, DOI 10.1002/chem.201200848; Mauldin RL, 2012, NATURE, V488, P193, DOI 10.1038/nature11278; Novelli A., 2012, ATM CHEM MECH C DAV; Su YT, 2013, SCIENCE, V340, P174, DOI 10.1126/science.1234369; Taatjes CA, 2008, J AM CHEM SOC, V130, P11883, DOI 10.1021/ja804165q; Taatjes CA, 2013, SCIENCE, V340, P177, DOI 10.1126/science.1234689; Taatjes CA, 2012, PHYS CHEM CHEM PHYS, V14, P10391, DOI 10.1039/c2cp40294g; Vereecken L, 2012, PHYS CHEM CHEM PHYS, V14, P14682, DOI 10.1039/c2cp42300f; Vereecken L, 2012, CHEM SOC REV, V41, P6259, DOI 10.1039/c2cs35070j; Welz O, 2012, SCIENCE, V335, P204, DOI 10.1126/science.1213229	13	19	19	0	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129					154	155		10.1126/science.1236475	http://dx.doi.org/10.1126/science.1236475			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580519				2022-12-28	WOS:000317341400043
J	Weekes, MP; Tan, SYL; Poole, E; Talbot, S; Antrobus, R; Smith, DL; Montag, C; Gygi, SP; Sinclair, JH; Lehner, PJ				Weekes, Michael P.; Tan, Shireen Y. L.; Poole, Emma; Talbot, Suzanne; Antrobus, Robin; Smith, Duncan L.; Montag, Christina; Gygi, Steven P.; Sinclair, John H.; Lehner, Paul J.			Latency-Associated Degradation of the MRP1 Drug Transporter During Latent Human Cytomegalovirus Infection	SCIENCE			English	Article							MULTIDRUG-RESISTANCE; DENDRITIC CELLS; GENE-EXPRESSION; REACTIVATION; RECEPTOR; FAMILY; MODEL	The reactivation of latent human cytomegalovirus (HCMV) infection after transplantation is associated with high morbidity and mortality. In vivo, myeloid cells and their progenitors are an important site of HCMV latency, whose establishment and/or maintenance require expression of the viral transcript UL138. Using stable isotope labeling by amino acids in cell culture-based mass spectrometry, we found a dramatic UL138-mediated loss of cell surface multidrug resistance-associated protein-1 (MRP1) and the reduction of substrate export by this transporter. Latency-associated loss of MRP1 and accumulation of the cytotoxic drug vincristine, an MRP1 substrate, depleted virus from naturally latent CD14(+) and CD34(+) progenitors, all of which are in vivo sites of latency. The UL138-mediated loss of MRP1 provides a marker for detecting latent HCMV infection and a therapeutic target for eliminating latently infected cells before transplantation.	[Weekes, Michael P.; Tan, Shireen Y. L.; Talbot, Suzanne; Antrobus, Robin; Lehner, Paul J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Poole, Emma; Sinclair, John H.] Univ Cambridge, Sch Clin, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Smith, Duncan L.] Univ Manchester, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England; [Montag, Christina] Charite, Childrens Hosp, Lab Mol Biol, D-10117 Berlin, Germany; [Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Paterson Institute for Cancer Research; University of Manchester; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Harvard Medical School	Lehner, PJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	pjl30@cam.ac.uk		Poole, Emma/0000-0003-3904-6121; Lehner, Paul Joseph/0000-0001-9383-1054; Weekes, Michael/0000-0003-3196-5545	Cambridge Institute for Medical Research; Wellcome Trust [093966/Z/10/Z, 084957/Z/08/Z]; Agency for Science, Technology and Research, Singapore; MRC [G0701279]; NIHR Cambridge Biomedical Research Centre; Medical Research Council [MR/K021087/1, G0701279] Funding Source: researchfish; MRC [MR/K021087/1] Funding Source: UKRI	Cambridge Institute for Medical Research; Wellcome Trust(Wellcome Trust); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to M. Reeves for discussions and cells. All data are tabulated in the main paper and the supplementary materials. This work was supported by a Next Generation Fellowship from the Cambridge Institute for Medical Research and a Wellcome Trust Fellowship (093966/Z/10/Z) to M.P.W.; a grant from the Agency for Science, Technology and Research, Singapore to S.Y.L.T.; an MRC Programme grant (G0701279) to J.H.S.; and a Wellcome Trust Senior Fellowship (084957/Z/08/Z) to P.J.L. This work was also supported by the NIHR Cambridge Biomedical Research Centre, and the Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award. P.J.L., J.H.S., M.P.W., and R.A. are authors on patent application PCT/GB2012/051094 filed by Cambridge Enterprise, entitled "Detection and depletion of HCMV infected cells."	ALMQUIST KC, 1995, CANCER RES, V55, P102; Avdic S, 2011, J VIROL, V85, P7465, DOI 10.1128/JVI.00088-11; Goodrum FD, 2002, P NATL ACAD SCI USA, V99, P16255, DOI 10.1073/pnas.252630899; Goodrum F, 2007, BLOOD, V110, P937, DOI 10.1182/blood-2007-01-070078; Grainger L, 2010, J VIROL, V84, P9472, DOI 10.1128/JVI.00855-10; Hahn G, 1998, P NATL ACAD SCI USA, V95, P3937, DOI 10.1073/pnas.95.7.3937; Hargett D, 2010, P NATL ACAD SCI USA, V107, P20039, DOI 10.1073/pnas.1014509107; Huang MM, 2012, J VIROL, V86, P8507, DOI 10.1128/JVI.00598-12; Jin J, 2009, INT J CANCER, V124, P233, DOI 10.1002/ijc.23892; KONDO K, 1994, P NATL ACAD SCI USA, V91, P11879, DOI 10.1073/pnas.91.25.11879; MARQUARDT D, 1990, CANCER RES, V50, P1426; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Montag C, 2011, J VIROL, V85, P11409, DOI 10.1128/JVI.05028-11; Nichols WG, 2002, J INFECT DIS, V185, P273, DOI 10.1086/338624; Petrucelli A, 2009, J VIROL, V83, P5615, DOI 10.1128/JVI.01989-08; Rajagopal A, 2002, CANCER RES, V62, P391; Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0; Reeves MB, 2005, P NATL ACAD SCI USA, V102, P4140, DOI 10.1073/pnas.0408994102; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Sinclair J, 2008, J CLIN VIROL, V41, P180, DOI 10.1016/j.jcv.2007.11.014; Sinclair J, 2010, BBA-GENE REGUL MECH, V1799, P286, DOI 10.1016/j.bbagrm.2009.08.001; Slobedman B, 2010, FUTURE MICROBIOL, V5, P883, DOI 10.2217/FMB.10.58; TAYLORWIEDEMAN J, 1991, J GEN VIROL, V72, P2059, DOI 10.1099/0022-1317-72-9-2059; van de Ven R, 2006, J IMMUNOL, V176, P5191, DOI 10.4049/jimmunol.176.9.5191; Weekes MP, 2012, J PROTEOME RES, V11, P1475, DOI 10.1021/pr201135e	27	103	110	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					199	202		10.1126/science.1235047	http://dx.doi.org/10.1126/science.1235047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580527	Green Accepted			2022-12-28	WOS:000317341400056
J	Ferrier, KL; Huppert, KL; Perron, JT				Ferrier, Ken L.; Huppert, Kimberly L.; Perron, J. Taylor			Climatic control of bedrock river incision	NATURE			English	Article							EROSION RATES; LANDSCAPE RESPONSE; SIERRA-NEVADA; MODEL; KAUAI; PRECIPITATION; VARIABILITY; TECTONICS; EVOLUTION; VOLCANISM	Bedrock river incision drives the development of much of Earth's surface topography(1-3), and thereby shapes the structure of mountain belts(4) and modulates Earth's habitability through its effects on soil erosion(5), nutrient fluxes(6) and global climate(7). Although it has long been expected that river incision rates should depend strongly on precipitation rates, quantifying the effects of precipitation rates on bedrock river incision rates has proved difficult, partly because river incision rates are difficult to measure and partly because non-climatic factors can obscure climatic effects at sites where river incision rates have been measured(8,9). Here we present measurements of river incision rates across one of Earth's steepest rainfall gradients, which show that precipitation rates do indeed influence long-term bedrock river incision rates. We apply a widely used empirical law for bedrock river incision(3,9-11) to a series of rivers on the Hawaiian island of Kaua'i, where mean annual precipitation ranges from 0.5 metres to 9.5 metres (ref. 12)-over 70 per cent of the global range(13)-and river incision rates averaged over millions of years can be inferred from the depth of river canyons and the age of the volcanic bedrock. Both a time-averaged analysis and numerical modelling of transient river incision reveal that the long-term efficiency of bedrock river incision across Kaua'i is positively correlated with upstream-averaged mean annual precipitation rates. We provide theoretical context for this result by demonstrating that our measurements are consistent with a linear dependence of river incision rates on stream power, the rate of energy expenditure by the flow on the riverbed. These observations provide rare empirical evidence for the long-proposed coupling between climate and river incision, suggesting that previously proposed feed-backs among topography, climate and tectonics may occur.	[Ferrier, Ken L.; Huppert, Kimberly L.; Perron, J. Taylor] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Ferrier, KL (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	ferrier@fas.harvard.edu	Perron, J. Taylor/D-8983-2012	Perron, J. Taylor/0000-0002-0404-8701; Huppert, Kimberly/0000-0002-2130-8499; Ferrier, Ken/0000-0003-4098-166X	Massachusetts Institute of Technology	Massachusetts Institute of Technology	This study was supported by the Massachusetts Institute of Technology. We thank M. Slosberg for assistance with topographic analyses, S. Willett for comments that improved the manuscript and M. Rosener, S. Mukhopadhyay, M. Lamb, B. Mackey, J. Scheingross, J. Stock and C. Blay for field assistance and discussions. We thank the State of Hawaii Agribusiness Development Corporation, Landis Ignacio of the Kekaha Agriculture Association, the State of Hawaii Department of Land and Natural Resources, Divisions of State Parks and of Forestry and Wildlife, the US Fish and Wildlife Service and the Alapai and Napolis families for field access.	Bookhagen B, 2012, EARTH PLANET SC LETT, V327, P97, DOI 10.1016/j.epsl.2012.02.005; Brocklehurst SH, 2002, GEOMORPHOLOGY, V42, P1, DOI 10.1016/S0169-555X(01)00069-1; Burbank DW, 2003, NATURE, V426, P652, DOI 10.1038/nature02187; Chadwick OA, 2003, CHEM GEOL, V202, P195, DOI 10.1016/j.chemgeo.2002.09.001; CLAGUE DA, 1988, CONTRIB MINERAL PETR, V99, P202, DOI 10.1007/BF00371461; Dadson SJ, 2003, NATURE, V426, P648, DOI 10.1038/nature02150; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Dunne T., 1978, WATER ENV PLANNING; Fernandes NF, 1997, WATER RESOUR RES, V33, P1307, DOI 10.1029/97WR00534; Ferrier K. L., GEOL SOC AM IN PRESS; Garcia MO, 2010, J PETROL, V51, P1507, DOI 10.1093/petrology/egq027; Gayer E, 2008, EARTH PLANET SC LETT, V266, P303, DOI 10.1016/j.epsl.2007.11.019; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; HOWARD AD, 1983, GEOL SOC AM BULL, V94, P739, DOI 10.1130/0016-7606(1983)94<739:CCIB>2.0.CO;2; HOWARD AD, 1994, WATER RESOUR RES, V30, P2261, DOI 10.1029/94WR00757; Leopold L.B., 1953, US GEOLOGICAL SURVEY; MCDOUGALL I, 1979, EARTH PLANET SC LETT, V46, P31, DOI 10.1016/0012-821X(79)90063-3; Montgomery DR, 2001, WATER RESOUR RES, V37, P1841, DOI 10.1029/2000WR900393; Moon S, 2011, NAT GEOSCI, V4, P469, DOI [10.1038/NGEO1159, 10.1038/ngeo1159]; OCALLAGHAN JF, 1984, COMPUT VISION GRAPH, V28, P323, DOI [10.1016/S0734-189X(84)80011-0, 10.1016/0734-189X(89)90053-4]; Poveda G, 2000, GEOPHYS RES LETT, V27, P1675, DOI 10.1029/1999GL006091; PRESS WH, 1992, NUMERICAL RECIPES; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Reiners PW, 2003, NATURE, V426, P645, DOI 10.1038/nature02111; Riebe CS, 2004, EARTH PLANET SC LETT, V224, P547, DOI 10.1016/j.epsl.2004.05.019; Riebe CS, 2001, GEOLOGY, V29, P447, DOI 10.1130/0091-7613(2001)029<0447:MCCOER>2.0.CO;2; Roe GH, 2008, AM J SCI, V308, P815, DOI 10.2475/07.2008.01; Seidl M.A., 1992, CATENA S, V23, P101, DOI DOI 10.1029/2007WR006219; SEIDL MA, 1994, J GEOL, V102, P457, DOI 10.1086/629686; Sherrod DR, 2007, 20071089 US GEOL SUR; Snyder NP, 2000, GEOL SOC AM BULL, V112, P1250, DOI 10.1130/0016-7606(2000)112<1250:LRTTFD>2.3.CO;2; Stock JD, 1999, J GEOPHYS RES-SOL EA, V104, P4983, DOI 10.1029/98JB02139; von Blanckenburg F, 2005, EARTH PLANET SC LETT, V237, P462, DOI 10.1016/j.epsl.2005.06.030; Walling DE, 1983, BACKGROUND PALAEOHYD, V158, P69; Whipple KX, 1999, J GEOPHYS RES-SOL EA, V104, P17661, DOI 10.1029/1999JB900120; Whipple KX, 2004, ANNU REV EARTH PL SC, V32, P151, DOI 10.1146/annurev.earth.32.101802.120356; Willett SD, 1999, J GEOPHYS RES-SOL EA, V104, P28957, DOI 10.1029/1999JB900248; Wobus C, 2006, GEOL SOC AM SPEC PAP, V398, P55, DOI 10.1130/2006.2398(04); Wohl E, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2008JF000989	39	142	146	4	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					206	+		10.1038/nature11982	http://dx.doi.org/10.1038/nature11982			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23579679				2022-12-28	WOS:000317346300038
J	Hoen, B; Duval, X				Hoen, Bruno; Duval, Xavier			Infective Endocarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CULTURE-NEGATIVE ENDOCARDITIS; STAPHYLOCOCCUS-AUREUS; ANTIPLATELET THERAPY; EMBOLIC EVENTS; CEREBROVASCULAR COMPLICATIONS; ANTIBIOTIC-TREATMENT; VALVE SURGERY; MORTALITY; DIAGNOSIS; GUIDELINES	A 55-year-old man with a history of mitral regurgitation seeks care after an episode of transient weakness in his right arm and speech difficulties. He underwent dental scaling 1 month earlier. He notes recent intermittent fevers and weight loss. On cardiac examination, his regurgitation murmur appears to be unchanged. A transthoracic echocardiogram shows a mobile, 12-mm mitral-valve vegetation and grade 2 (mild) regurgitation. Magnetic resonance imaging of the brain reveals recent ischemic lesions. How should the patient be further evaluated and treated?	[Hoen, Bruno] Univ Franche Comte, Ctr Hosp Reg Univ, Serv Malad Infect & Trop, F-25030 Besancon, France; [Hoen, Bruno] Univ Franche Comte, CNRS, Unite Mixte Rech Chronoenvironm 6249, F-25030 Besancon, France; [Hoen, Bruno; Duval, Xavier] Assoc Pour Etude & Prevent Endocardite Infectieus, Paris, France; [Duval, Xavier] INSERM, Ctr Invest Clin 007, AP HP, Hop Univ Bichat, Bichat, France; [Duval, Xavier] Univ Paris 07, Unite Format & Rech Med Bichat, INSERM, U738, Bichat, France	Universite de Franche-Comte; CHU Besancon; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Hoen, B (corresponding author), CHRU Besancon, Serv Malad Infect & Trop, F-25030 Besancon, France.	bruno.hoen@univ-fcomte.fr			Pfizer	Pfizer(Pfizer)	Dr. Duval reports receiving grant support through his institution from Pfizer and travel expenses from Roche. No other potential conflict of interest relevant to this article was reported.	Anavekar NS, 2007, CLIN INFECT DIS, V44, P1398; Anavekar NS, 2007, CLIN INFECT DIS, V44, P1180, DOI 10.1086/513197; Baddour LM, 2008, CIRCULATION, V118, pE497, DOI 10.1161/CIRCULATIONAHA.108.190868; Bannay A, 2011, EUR HEART J, V32, P2003, DOI 10.1093/eurheartj/ehp008; Benito N, 2009, ANN INTERN MED, V150, P586, DOI 10.7326/0003-4819-150-9-200905050-00004; Botelho-Nevers E, 2009, ARCH INTERN MED, V169, P1290, DOI 10.1001/archinternmed.2009.192; Brouqui P, 2001, CLIN MICROBIOL REV, V14, P177, DOI 10.1128/CMR.14.1.177-207.2001; Chan KL, 2003, J AM COLL CARDIOL, V42, P775, DOI 10.1016/S0735-1097(03)00829-5; Chan KL, 2008, CLIN INFECT DIS, V46, P37, DOI 10.1086/524021; CORR P, 1995, AM J NEURORADIOL, V16, P745; Cosgrove SE, 2009, CLIN INFECT DIS, V48, P713, DOI 10.1086/597031; Crawford Michael H., 2003, Cardiology Clinics, V21, P159, DOI 10.1016/S0733-8651(03)00023-7; Das I, 2011, EUR J CLIN MICROBIOL, V30, P807, DOI 10.1007/s10096-011-1160-y; de Sa DDC, 2010, MAYO CLIN PROC, V85, P422, DOI 10.4065/mcp.2009.0585; DeSimone DC, 2012, CIRCULATION, V126, P60, DOI 10.1161/CIRCULATIONAHA.112.095281; Di Salvo G, 2001, J AM COLL CARDIOL, V37, P1069, DOI 10.1016/S0735-1097(00)01206-7; Dickerman SA, 2007, AM HEART J, V154, P1086, DOI 10.1016/j.ahj.2007.07.023; Durante-Mangoni E, 2012, CLIN INFECT DIS, V54, P347, DOI 10.1093/cid/cir805; Duval X, 2012, J AM COLL CARDIOL, V59, P1968, DOI 10.1016/j.jacc.2012.02.029; Duval X, 2010, ANN INTERN MED, V152, P497, DOI 10.7326/0003-4819-152-8-201004200-00006; Fedeli U, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-48; Federspiel JJ, 2012, ARCH INTERN MED, V172, P363, DOI 10.1001/archinternmed.2011.1027; Fernandez-Hidalgo N, 2013, CLIN INFECT DIS, V56, P1261, DOI 10.1093/cid/cit052; Fournier PE, 2010, CLIN INFECT DIS, V51, P131, DOI 10.1086/653675; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Francioli P, 1995, CLIN INFECT DIS, V21, P1406, DOI 10.1093/clinids/21.6.1406; Gavalda Joan, 2007, Ann Intern Med, V146, P574; Gould FK, 2012, J ANTIMICROB CHEMOTH, V67, P269, DOI 10.1093/jac/dkr450; Greub G, 2005, AM J MED, V118, P230, DOI 10.1016/j.amjmed.2004.12.014; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Heldman AW, 1996, AM J MED, V101, P68, DOI 10.1016/S0002-9343(96)00070-8; Houpikian P, 2005, MEDICINE, V84, P162, DOI 10.1097/01.md.0000165658.82869.17; Kang DH, 2012, NEW ENGL J MED, V366, P2466, DOI 10.1056/NEJMoa1112843; Lepidi H, 2006, J INFECT DIS, V193, P1711, DOI 10.1086/504438; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Morris AJ, 2005, CLIN INFECT DIS, V41, P187, DOI 10.1086/430908; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Olaison L, 2002, CLIN INFECT DIS, V34, P159, DOI 10.1086/338233; Pepin J, 2009, CLIN MICROBIOL INFEC, V15, P193, DOI 10.1111/j.1469-0691.2008.02665.x; Peters PJ, 2006, LANCET INFECT DIS, V6, P742, DOI 10.1016/S1473-3099(06)70631-4; Richet H, 2008, J ANTIMICROB CHEMOTH, V62, P1434, DOI 10.1093/jac/dkn423; Richey R, 2008, BMJ-BRIT MED J, V336, P770, DOI 10.1136/bmj.39510.423148.AD; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Sexton DJ, 1998, CLIN INFECT DIS, V27, P1470, DOI 10.1086/515038; Snygg-Martin U, 2011, SCAND J INFECT DIS, V43, P899, DOI 10.3109/00365548.2011.603742; Sonneville R, 2011, CRIT CARE MED, V39, P1474, DOI 10.1097/CCM.0b013e3182120b41; Stehbens WE, 2000, CARDIOVASC PATHOL, V9, P161, DOI 10.1016/S1054-8807(00)00037-5; Sy RW, 2010, EUR HEART J, V31, P1890, DOI 10.1093/eurheartj/ehq110; Thornhill Martin H, 2011, BMJ, V342, pd2392, DOI 10.1136/bmj.d2392; Thuny F, 2005, CIRCULATION, V112, P69, DOI 10.1161/CIRCULATIONAHA.104.493155; Thuny F, 2007, EUR HEART J, V28, P1155, DOI 10.1093/eurheartj/ehm005; Thuny F, 2011, EUR HEART J, V32, P2027, DOI 10.1093/eurheartj/ehp089; Tleyjeh IM, 2007, CHEST, V132, P1025, DOI 10.1378/chest.06-2048; Tornos P, 1999, ARCH INTERN MED, V159, P473, DOI 10.1001/archinte.159.5.473; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095	56	314	342	3	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1425	1433		10.1056/NEJMcp1206782	http://dx.doi.org/10.1056/NEJMcp1206782			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122QT	23574121				2022-12-28	WOS:000317333600010
J	Reitz, C; Jun, G; Naj, A; Rajbhandary, R; Vardarajan, BN; Wang, LS; Valladares, O; Lin, CF; Larson, EB; Graff-Radford, NR; Evans, D; De Jager, PL; Crane, PK; Buxbaum, JD; Murrell, JR; Raj, T; Ertekin-Taner, N; Logue, M; Baldwin, CT; Green, RC; Barnes, LL; Cantwell, LB; Fallin, MD; Go, RCP; Griffith, P; Obisesan, TO; Manly, JJ; Lunetta, KL; Kamboh, MI; Lopez, OL; Bennett, DA; Hendrie, H; Hall, KS; Goate, AM; Byrd, GS; Kukull, WA; Foroud, TM; Haines, JL; Farrer, LA; Pericak-Vance, MA; Schellenberg, GD; Mayeux, R				Reitz, Christiane; Jun, Gyungah; Naj, Adam; Rajbhandary, Ruchita; Vardarajan, Badri Narayan; Wang, Li-San; Valladares, Otto; Lin, Chiao-Feng; Larson, Eric B.; Graff-Radford, Neill R.; Evans, Denis; De Jager, Philip L.; Crane, Paul K.; Buxbaum, Joseph D.; Murrell, Jill R.; Raj, Towfique; Ertekin-Taner, Nilufer; Logue, Mark; Baldwin, Clinton T.; Green, Robert C.; Barnes, Lisa L.; Cantwell, Laura B.; Fallin, M. Daniele; Go, Rodney C. P.; Griffith, Patrick; Obisesan, Thomas O.; Manly, Jennifer J.; Lunetta, Kathryn L.; Kamboh, M. Ilyas; Lopez, Oscar L.; Bennett, David A.; Hendrie, Hugh; Hall, Kathleen S.; Goate, Alison M.; Byrd, Goldie S.; Kukull, Walter A.; Foroud, Tatiana M.; Haines, Jonathan L.; Farrer, Lindsay A.; Pericak-Vance, Margaret A.; Schellenberg, Gerard D.; Mayeux, Richard		Alzheimer Dis Genetics Consortium	Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E epsilon 4, and the Risk of Late-Onset Alzheimer Disease in African Americans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; MILD COGNITIVE IMPAIRMENT; IDENTIFIES VARIANTS; COMMON VARIANTS; AGING PROJECT; DEMENTIA; CLU; METAANALYSIS; IMPUTATION; GENOTYPE	Importance Genetic variants associated with susceptibility to late-onset Alzheimer disease are known for individuals of European ancestry, but whether the same or different variants account for the genetic risk of Alzheimer disease in African American individuals is unknown. Identification of disease-associated variants helps identify targets for genetic testing, prevention, and treatment. Objective To identify genetic loci associated with late-onset Alzheimer disease in African Americans. Design, Setting, and Participants The Alzheimer Disease Genetics Consortium (ADGC) assembled multiple data sets representing a total of 5896 African Americans (1968 case participants, 3928 control participants) 60 years or older that were collected between 1989 and 2011 at multiple sites. The association of Alzheimer disease with genotyped and imputed single-nucleotide polymorphisms (SNPs) was assessed in case-control and in family-based data sets. Results from individual data sets were combined to perform an inverse variance-weighted meta-analysis, first with genome-wide analyses and subsequently with gene-based tests for previously reported loci. Main Outcomes and Measures Presence of Alzheimer disease according to standardized criteria. Results Genome-wide significance in fully adjusted models (sex, age, APOE genotype, population stratification) was observed for a SNP in ABCA7 (rs115550680, allele=G; frequency, 0.09 cases and 0.06 controls; odds ratio [OR], 1.79 [95% CI, 1.47-2.12]; P=2.2 x 10(-9)), which is in linkage disequilibrium with SNPs previously associated with Alzheimer disease in Europeans (0.8<D'<0.9). The effect size for the SNP in ABCA7 was comparable with that of the APOE epsilon 4-determining SNP rs429358 (allele=C; frequency, 0.30 cases and 0.18 controls; OR, 2.31 [95% CI, 2.19-2.42]; P=5.5 x 10(-47)). Several loci previously associated with Alzheimer disease but not reaching significance in genome-wide analyses were replicated in gene-based analyses accounting for linkage disequilibrium between markers and correcting for number of tests performed per gene (CR1, BIN1, EPHA1, CD33; 0.0005<empirical P<.001). Conclusions and Relevance In this meta-analysis of data from African American participants, Alzheimer disease was significantly associated with variants in ABCA7 and with other genes that have been associated with Alzheimer disease in individuals of European ancestry. Replication and functional validation of this finding is needed before this information is used in clinical settings. JAMA. 2013;309(14):1483-1492 www.jama.com	[Reitz, Christiane; Mayeux, Richard] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Coll Phys & Surg, New York, NY 10032 USA; [Reitz, Christiane; Mayeux, Richard] Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY 10032 USA; [Reitz, Christiane; Mayeux, Richard] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10032 USA; [Mayeux, Richard] Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY 10032 USA; [Mayeux, Richard] Columbia Univ, Dept Epidemiol, Coll Phys & Surg, New York, NY 10032 USA; [Jun, Gyungah; Vardarajan, Badri Narayan; Logue, Mark; Baldwin, Clinton T.; Farrer, Lindsay A.] Boston Univ, Dept Med, Genet Program, Boston, MA 02215 USA; [Jun, Gyungah; Vardarajan, Badri Narayan; Lunetta, Kathryn L.; Farrer, Lindsay A.] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Dept Ophthalmol, Boston, MA 02215 USA; [Farrer, Lindsay A.] Boston Univ, Dept Epidemiol, Boston, MA 02215 USA; [Farrer, Lindsay A.] Boston Univ, Dept Neurol, Boston, MA 02215 USA; [Naj, Adam; Rajbhandary, Ruchita; Pericak-Vance, Margaret A.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL USA; [Wang, Li-San; Valladares, Otto; Lin, Chiao-Feng; Cantwell, Laura B.; Manly, Jennifer J.; Schellenberg, Gerard D.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Crane, Paul K.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Kukull, Walter A.] Univ Washington, Natl Alzheimers Coordinating Ctr, Seattle, WA 98195 USA; [Kukull, Walter A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Larson, Eric B.] Grp Hlth, Grp Hlth Res Inst, Seattle, WA USA; [Graff-Radford, Neill R.; Ertekin-Taner, Nilufer] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Graff-Radford, Neill R.; Ertekin-Taner, Nilufer] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Evans, Denis] Rush Univ, Rush Inst Hlth Aging, Dept Internal Med, Med Ctr, Chicago, IL 60612 USA; [Barnes, Lisa L.] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA; [Barnes, Lisa L.] Rush Univ, Dept Behav Sci, Med Ctr, Chicago, IL 60612 USA; [Bennett, David A.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Program Translat Neuropsychiat Genom, Dept Neurol, Boston, MA 02115 USA; [De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA USA; [De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Murrell, Jill R.; Foroud, Tatiana M.] Indiana Univ, Dept Med & Mol Genet, Bloomington, IN 47405 USA; [Hendrie, Hugh] Indiana Univ, Ctr Aging Res, Bloomington, IN 47405 USA; [Hendrie, Hugh; Hall, Kathleen S.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN USA; [Green, Robert C.] Brigham & Womens Hosp, Partners Ctr Personalized Genet Med, Boston, MA 02115 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [Fallin, M. Daniele] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Go, Rodney C. P.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL USA; [Griffith, Patrick] Meharry Med Coll, Dept Neurol, Nashville, TN 37208 USA; [Obisesan, Thomas O.] Howard Univ Hosp, Div Geriatr, Washington, DC USA; [Kamboh, M. Ilyas] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Kamboh, M. Ilyas; Lopez, Oscar L.] Univ Pittsburgh, Alzheimers Dis Res Ctr, Pittsburgh, PA USA; [Haines, Jonathan L.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Haines, Jonathan L.] Vanderbilt Univ, Vanderbilt Ctr Human Genet Res, Nashville, TN USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Boston University; Boston University; Boston University; Boston University; Boston University; University of Miami; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mayo Clinic; Mayo Clinic; Rush University; Rush University; Rush University; Rush University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Harvard University; Brigham & Women's Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Meharry Medical College; Howard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Vanderbilt University	Mayeux, R (corresponding author), Columbia Univ, Gertrude H Sergievsky Ctr, 630 W 168th St, New York, NY 10032 USA.	rpm2@columbia.edu	Tsuang, Debby/L-7234-2016; Reitz, Christiane/GNP-0257-2022; Haines, Jonathan/C-3374-2012; Mayeux, Richard/E-9788-2013; Farrer, Lindsay/AAS-1035-2020; Raj, Towfique/ABD-7620-2021; Buxbaum, Joseph D/G-6001-2010	Tsuang, Debby/0000-0002-4716-1894; Haines, Jonathan/0000-0002-4351-4728; Mayeux, Richard/0000-0001-6519-9696; Obisesan, Thomas Olabode/0000-0002-0291-512X; Farrer, Lindsay/0000-0001-5533-4225; Reisberg, Barry/0000-0002-9104-7423; Valladares, Otto/0000-0001-8055-2187; Jun, Gyungah/0000-0002-3230-8697; Lunetta, Kathryn/0000-0002-9268-810X; Baldwin, Clinton/0000-0002-3275-9463; Leverenz, James/0000-0002-0896-0749; Kukull, Walter/0000-0001-8761-9014; DeKosky, Steven/0000-0003-3743-2758; Buxbaum, Joseph/0000-0001-8898-8313; Lin, Chiao-Feng/0000-0002-6177-8807; Logue, Mark/0000-0001-9347-7892; Kamboh, M. Ilyas/0000-0002-3453-1438; Goate, Alison/0000-0002-0576-2472; Ferris, Steven/0000-0001-8641-6223; Crane, Paul/0000-0003-4278-7465	Eisai; Pfizer; Alzheimer's Association; National Institute on Aging (NIA); Mertz; Lundbeck; Genentech; Amgen; Athena Diagnostics; Alzheimer's Association [IIRG-0889720, IIRG-05-14147]; National Institute of Neurological Disorders and Stroke [NS39764]; National Institute of Mental Health [MH60451]; GlaxoSmithKline; Office of Research and Development, Biomedical Laboratory Research Program, US Department of Veterans Affairs Administration; NIA [U01-AG032984, RC2-AG036528, U01-AG016976, U24 AG026395, U24 AG026390, R01AG037212, R37 AG015473, K23AG034550, U24-AG021886, R01AG009956, RC2 AG036650, UO1 AG06781, UO1 HG004610, R01 AG009029, 5R01AG20688, P50 AG005133, AG05128, AG025688, P30AG10133, P50AG005146, P50AG005134]; National Institute on Aging [P01AG002219, P30AG08051, MO1RR00096, UL1RR029893, AG030653, R01 AG019085, R01 AG1101, R01 AG030146, R01AG30146, R01AG17917, R01AG15819, R01AG028786, R01AG22018, P30AG10161, P50AG16574, R01 AG032990, KL2 RR024151, R01MH080295, R01AG017173, R01AG025259, R01AG33193, P50AG008702]; National Institute on Aging (NIA) [P30AG028377, R01 AG027944, R01 AG028786, P20 MD000546, R01 AG28786-01A1, AG005138, P50 AG05681, P01 AG03991, P01 AG026276, P30AG019610, P30AG13846, U01-AG10483, R01CA129769, P30AG013854, P30AG008017, R01AG026916, R01AG019085, P50AG016582, UL1RR02777, R01AG031581, P30AG010129]; NIA. [P50AG016573, P50AG016575, P50AG016576, P50AG016577, P50AG016570, P50AG005131, P50AG023501, P50AG019724, P30AG028383, P50AG008671, P30AG010124, P50AG005142, P30AG012300, AG010491, AG027944, AG021547, AG019757, P50AG005136]; NATIONAL CANCER INSTITUTE [R01CA129769] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893, KL2RR024151, M01RR000096] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006375, U01HG004610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451, R01MH080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036768, P50NS039764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030653, R01AG028786, P50AG005142, P01AG019724, R01AG017173, R01AG030146, R01AG033193, R01AG015819, U01AG016976, P50AG005681, P30AG010129, R01AG036040, P50AG005146, P01AG026276, K23AG034550, U24AG021886, R01AG026390, R01AG009029, P50AG005136, P30AG010124, P30AG008051, P30AG013846, R01AG041797, U01AG032984, P50AG005131, P50AG016582, P30AG013854, P50AG005128, P01AG002219, R01AG020688, R01AG031581, P30AG028383, R01AG022018, R01AG017917, R01AG009956, R01AG037212, RC2AG036528, U24AG026395, P50AG016574, R37AG015473, P50AG005133, P30AG010133, P30AG008017, R01AG025259, R01AG021547, P50AG025688, P50AG008671, P01AG003991, P50AG005138, P50AG023501, P30AG012300, P01AG007232, R01AG027944, R01AG040770, P50AG005134, P01AG010491, R01AG026916, R01AG019757, P30AG019610, P50AG016570, R01AG011101, P30AG010161, U01AG006781, U01AG010483, P50AG008702, U19AG010483, R01AG032990, RC2AG036650, R01AG015473, P50AG016573, R01AG019085, P30AG028377] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD000546] Funding Source: NIH RePORTER	Eisai(Eisai Co Ltd); Pfizer(Pfizer); Alzheimer's Association(Alzheimer's Association); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Mertz; Lundbeck(Lundbeck Corporation); Genentech(Roche HoldingGenentech); Amgen(Amgen); Athena Diagnostics; Alzheimer's Association(Alzheimer's Association); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); GlaxoSmithKline(GlaxoSmithKline); Office of Research and Development, Biomedical Laboratory Research Program, US Department of Veterans Affairs Administration; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Baldwin reported serving as a consultant for the Center for Human Genetics Inc. Dr Go reported receiving travel support from the National Institutes of Health (NIH). Dr Griffith reported receiving payment for lectures from Eisai and Pfizer. Dr Manly reported serving as a board member for the International Neuropsychological Society; receiving grants or grants pending from the Alzheimer's Association and the National Institute on Aging (NIA); and receiving travel expenses from the Alzheimer's Association. Dr Kamboh reported receiving travel support from the NIH. Dr Lopez reported receiving consulting fees or honoraria from Mertz and Lundbeck. Dr Bennett reported receiving travel support from the NIH. Dr Goate reported serving as a consultant for Finnegan; providing expert testimony in cases involving the genetics of Alzheimer disease; receiving grants or grants pending from Genentech and Pfizer; receiving payment for lectures from Pfizer, Genentech, and Amgen; and receiving patent royalties from Taconic for a tau mutation. Dr Pericak-Vance reported receiving revenues from Athena Diagnostics. No other authors reported disclosures.; The NIA supported this work through grants U01-AG032984, RC2-AG036528, U01-AG016976 (Dr Kukull); U24 AG026395, U24 AG026390, R01AG037212, R37 AG015473 (Dr Mayeux); K23AG034550 (Dr Reitz); U24-AG021886 (Dr Foroud); R01AG009956, RC2 AG036650 (Dr Hall); UO1 AG06781, UO1 HG004610 (Dr Larson); R01 AG009029 (Dr Farrer); 5R01AG20688 (Dr Fallin); P50 AG005133, AG030653 (Dr Kamboh); R01 AG019085 (Dr Haines); R01 AG1101, R01 AG030146, RC2 AG036650 (Dr Evans); P30AG10161, R01AG15819, R01AG30146, R01AG17917, R01AG15819 (Dr Bennett); R01AG028786 (Dr Manly); R01AG22018, P30AG10161 (Dr Barnes); P50AG16574 (Dr Ertekin-Taner, Dr Graff-Radford), R01 AG032990 (Dr Ertekin-Taner), KL2 RR024151 (Dr Ertekin-Taner); R01 AG027944, R01 AG028786 (Dr Pericak-Vance); P20 MD000546, R01 AG28786-01A1 (Dr Byrd); AG005138 (Dr Buxbaum); P50 AG05681, P01 AG03991, P01 AG026276 (Dr Goate); and P30AG019610, P30AG13846, U01-AG10483, R01CA129769, R01MH080295, R01AG017173, R01AG025259, R01AG33193, P50AG008702, P30AG028377, AG05128, AG025688, P30AG10133, P50AG005146, P50AG005134, P01AG002219, P30AG08051, MO1RR00096, UL1RR029893, P30AG013854, P30AG008017, R01AG026916, R01AG019085, P50AG016582, UL1RR02777, R01AG031581, P30AG010129, P50AG016573, P50AG016575, P50AG016576, P50AG016577, P50AG016570, P50AG005131, P50AG023501, P50AG019724, P30AG028383, P50AG008671, P30AG010124, P50AG005142, P30AG012300, AG010491, AG027944, AG021547, AG019757, P50AG005136 (Alzheimer Disease GeneticsConsortium [ADGC]). We thank Creighton Phelps, Stephen Synder, and Marilyn Miller from the NIA, who are exofficio members of the ADGC. Support was also provided by the Alzheimer's Association (IIRG-0889720 [Dr Farrer] and IIRG-05-14147 [Dr Pericak-Vance]), National Institute of Neurological Disorders and Stroke grant NS39764, National Institute of Mental Health grant MH60451, GlaxoSmithKline, and the Office of Research and Development, Biomedical Laboratory Research Program, US Department of Veterans Affairs Administration. For the ADGC, biological samples and associated phenotypic data used in primary data analyses were stored at principal investigators' institutions and at the National Cell Repository for Alzheimer's Disease (NCRAD) at Indiana University, funded by the NIA. Associated phenotypic data used in secondary data analyses were stored at the National Alzheimer's Coordinating Center and at the NIA Alzheimer's Disease Data Storage Site at the University of Pennsylvania, funded by the NIA. Contributors to the genetic analysis data included principal investigators on projects ndividually funded by the NIA, other NIH institutes, or private entities.	Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; Barnes LL, 2012, CURR ALZHEIMER RES, V9, P734, DOI 10.2174/156720512801322627; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bennett DA, 2005, NEUROEPIDEMIOLOGY, V25, P163, DOI 10.1159/000087446; Bennett DA, 2005, NEUROLOGY, V64, P834, DOI 10.1212/01.WNL.0000152982.47274.9E; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; Bienias JL, 2003, J ALZHEIMERS DIS, V5, P349, DOI 10.3233/JAD-2003-5501; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Chan SL, 2008, J NEUROCHEM, V106, P793, DOI 10.1111/j.1471-4159.2008.05433.x; Chanda P, 2012, J HUM GENET, V57, P411, DOI 10.1038/jhg.2012.43; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Fratiglioni L, 1999, DRUG AGING, V15, P365, DOI 10.2165/00002512-199915050-00004; Gatz M, 1997, J GERONTOL A-BIOL, V52, pM117, DOI 10.1093/gerona/52A.2.M117; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Hancock DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050610; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HIXSON JE, 1990, J LIPID RES, V31, P545; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Kamboh MI, 2012, NEUROBIOL AGING, V33, P518, DOI 10.1016/j.neurobiolaging.2010.04.015; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee JH, 2008, ARCH NEUROL-CHICAGO, V65, P1518, DOI 10.1001/archneur.65.11.1518; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Logue MW, 2011, ARCH NEUROL-CHICAGO, V68, P1569, DOI 10.1001/archneurol.2011.646; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meier IB, 2012, J INT NEUROPSYCH SOC, V18, P414, DOI 10.1017/S1355617712000227; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Murrell JR, 2006, ARCH NEUROL-CHICAGO, V63, P431, DOI 10.1001/archneur.63.3.431; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reitz C, 2011, ARCH NEUROL-CHICAGO, V68, P99, DOI 10.1001/archneurol.2010.346; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shepardson NE, 2011, ARCH NEUROL-CHICAGO, V68, P1239, DOI 10.1001/archneurol.2011.203; Slooter AJC, 1998, ARCH NEUROL-CHICAGO, V55, P964, DOI 10.1001/archneur.55.7.964; Storandt M, 2006, NEUROLOGY, V67, P467, DOI 10.1212/01.wnl.0000228231.26111.6e; Tanaka N, 2011, J ATHEROSCLER THROMB, V18, P274, DOI 10.5551/jat.6726; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; US Census Bureau, 1991, 1990 CENS POP HOUS S; Wittwer CT, 1997, BIOTECHNIQUES, V22, P176, DOI 10.2144/97221pf02	53	269	272	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1483	1492		10.1001/jama.2013.2973	http://dx.doi.org/10.1001/jama.2013.2973			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571587	Green Accepted, Bronze			2022-12-28	WOS:000317271700026
J	Nerenberg, R				Nerenberg, Robert			Breathing Perchlorate	SCIENCE			English	Editorial Material							REDUCTION; METABOLISM		Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Nerenberg, R (corresponding author), Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA.	nerenberg.1@nd.edu	Nerenberg, Robert/L-7560-2016	Nerenberg, Robert/0000-0003-2203-5004				ATTAWAY H, 1993, J IND MICROBIOL, V12, P408, DOI 10.1007/BF01569673; Balk M, 2008, APPL ENVIRON MICROB, V74, P403, DOI 10.1128/AEM.01743-07; Bardiya N, 2011, MICROBIOL RES, V166, P237, DOI 10.1016/j.micres.2010.11.005; Coates JD, 2004, NAT REV MICROBIOL, V2, P569, DOI 10.1038/nrmicro926; Dasgupta PK, 2005, ENVIRON SCI TECHNOL, V39, P1569, DOI 10.1021/es048612x; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Hershman JM, 2005, THYROID, V15, P427, DOI 10.1089/thy.2005.15.427; Liebensteiner MG, 2013, SCIENCE, V340, P85, DOI 10.1126/science.1233957; Maixner F, 2008, ENVIRON MICROBIOL, V10, P3043, DOI 10.1111/j.1462-2920.2008.01646.x; Nerenberg R, 2008, WATER RES, V42, P1151, DOI 10.1016/j.watres.2007.08.033; Nilsson T, 2013, BBA-BIOENERGETICS, V1827, P189, DOI 10.1016/j.bbabio.2012.06.010; Quastel J. H., 1929, BIOCHEM, V19, P304; Rao B, 2010, ENVIRON SCI TECHNOL, V44, P8429, DOI 10.1021/es1024228	13	10	10	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					38	39		10.1126/science.1236336	http://dx.doi.org/10.1126/science.1236336			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559239				2022-12-28	WOS:000317061100035
J	Polidoro, B; Carpenter, K				Polidoro, Beth; Carpenter, Kent			Dynamics of Coral Reef Recovery	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; OCEAN ACIDIFICATION; CONNECTIVITY; POPULATIONS; RESILIENCE; IMPACTS		[Polidoro, Beth; Carpenter, Kent] IUCN Species Survival Commiss, Gland, Switzerland; [Polidoro, Beth; Carpenter, Kent] IUCN Species Survival Commiss, Cambridge, England; [Polidoro, Beth] Arizona State Univ, New Coll Interdisciplinary Arts & Sci, Phoenix, AZ 85069 USA; [Carpenter, Kent] Old Dominion Univ, Dept Biol Sci, IUCN Marine Biodivers Unit, Norfolk, VA 23529 USA	Arizona State University; Arizona State University-Downtown Phoenix; Old Dominion University	Polidoro, B (corresponding author), IUCN Species Survival Commiss, Gland, Switzerland.	beth.polidoro@asu.edu						Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; Wilkinson C, 2008, STATUS CORAL REEFS W	15	14	16	9	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					34	35		10.1126/science.1236833	http://dx.doi.org/10.1126/science.1236833			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559236				2022-12-28	WOS:000317061100032
J	Aburto, NJ; Ziolkovska, A; Hooper, L; Elliott, P; Cappuccio, FP; Meerpohl, JJ				Aburto, Nancy J.; Ziolkovska, Anna; Hooper, Lee; Elliott, Paul; Cappuccio, Francesco P.; Meerpohl, Joerg J.			Effect of lower sodium intake on health: systematic review and meta-analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MODEST SALT REDUCTION; BLOOD-PRESSURE RESPONSE; URINARY ALBUMIN EXCRETION; PLASMA-RENIN ACTIVITY; PULSE-WAVE VELOCITY; DIETARY-SODIUM; CARDIOVASCULAR-DISEASE; DOUBLE-BLIND; POTASSIUM INTAKE; MILD HYPERTENSION	Objective To assess the effect of decreased sodium intake on blood pressure, related cardiovascular diseases, and potential adverse effects such as changes in blood lipids, catecholamine levels, and renal function. Design Systematic review and meta-analysis. Data sources Cochrane Central Register of Controlled Trials, Medline, Embase, WHO International Clinical Trials Registry Platform, the Latin American and Caribbean health science literature database, and the reference lists of previous reviews. Study selection Randomised controlled trials and prospective cohort studies in non-acutely ill adults and children assessing the relations between sodium intake and blood pressure, renal function, blood lipids, and catecholamine levels, and in non-acutely ill adults all cause mortality, cardiovascular disease, stroke, and coronary heart disease. Study appraisal and synthesis Potential studies were screened independently and in duplicate and study characteristics and outcomes extracted. When possible we conducted a meta-analysis to estimate the effect of lower sodium intake using the inverse variance method and a random effects model. We present results as mean differences or risk ratios, with 95% confidence intervals. Results We included 14 cohort studies and five randomised controlled trials reporting all cause mortality, cardiovascular disease, stroke, or coronary heart disease; and 37 randomised controlled trials measuring blood pressure, renal function, blood lipids, and catecholamine levels in adults. Nine controlled trials and one cohort study in children reporting on blood pressure were also included. In adults a reduction in sodium intake significantly reduced resting systolic blood pressure by 3.39 mm Hg (95% confidence interval 2.46 to 4.31) and resting diastolic blood pressure by 1.54 mm Hg (0.98 to 2.11). When sodium intake was <2 g/day versus >= 2 g/day, systolic blood pressure was reduced by 3.47 mm Hg (0.76 to 6.18) and diastolic blood pressure by 1.81 mm Hg (0.54 to 3.08). Decreased sodium intake had no significant adverse effect on blood lipids, catecholamine levels, or renal function in adults (P>0.05). There were insufficient randomised controlled trials to assess the effects of reduced sodium intake on mortality and morbidity. The associations in cohort studies between sodium intake and all cause mortality, incident fatal and non-fatal cardiovascular disease, and coronary heart disease were non-significant (P>0.05). Increased sodium intake was associated with an increased risk of stroke (risk ratio 1.24, 95% confidence interval 1.08 to 1.43), stroke mortality (1.63, 1.27 to 2.10), and coronary heart disease mortality (1.32, 1.13 to 1.53). In children, a reduction in sodium intake significantly reduced systolic blood pressure by 0.84 mm Hg (0.25 to 1.43) and diastolic blood pressure by 0.87 mm Hg (0.14 to 1.60). Conclusions High quality evidence in non-acutely ill adults shows that reduced sodium intake reduces blood pressure and has no adverse effect on blood lipids, catecholamine levels, or renal function, and moderate quality evidence in children shows that a reduction in sodium intake reduces blood pressure. Lower sodium intake is also associated with a reduced risk of stroke and fatal coronary heart disease in adults. The totality of evidence suggests that most people will likely benefit from reducing sodium intake.	[Aburto, Nancy J.; Ziolkovska, Anna] World Hlth Org, Nutr Policy & Sci Advice Unit, Dept Nutr Hlth & Dev, CH-1211 Geneva 27, Switzerland; [Hooper, Lee] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Elliott, Paul] Imperial Coll London, Dept Epidemiol & Biostat, London, England; [Elliott, Paul] Imperial Coll London, MRC HPA Ctr Environm & Hlth, London, England; [Cappuccio, Francesco P.] Univ Warwick, World Hlth Org Collaborating Ctr Nutr, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England; [Meerpohl, Joerg J.] Univ Med Ctr Freiburg, German Cochrane Ctr, Inst Med Biometry & Med Informat, Freiburg, Germany	World Health Organization; University of East Anglia; Imperial College London; Imperial College London; University of Warwick; World Health Organization; University of Freiburg	Aburto, NJ (corresponding author), World Hlth Org, Nutr Policy & Sci Advice Unit, Dept Nutr Hlth & Dev, CH-1211 Geneva 27, Switzerland.	nancy.aburto@wfp.org	Meerpohl, Joerg J/J-4224-2013; Hooper, Lee/D-2795-2009; Cappuccio, Francesco Paolo/ABF-1094-2020	Meerpohl, Joerg J/0000-0002-1333-5403; Hooper, Lee/0000-0002-7904-3331; Cappuccio, Francesco Paolo/0000-0002-7842-5493; Elliott, Paul/0000-0002-7511-5684	WHO funds; Kidney Evaluation Association Japan; government of Japan; government of Republic of Korea; National Institute for Health Research Biomedical Research Centre based at Imperial College Healthcare NHS Trust; Imperial College London; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007734] Funding Source: NIH RePORTER; Medical Research Council [G0700931, G0801056B, G0801056] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10136] Funding Source: researchfish; Breast Cancer Campaign [2012MayPR070] Funding Source: researchfish; MRC [G0700931, G0801056] Funding Source: UKRI	WHO funds; Kidney Evaluation Association Japan; government of Japan; government of Republic of Korea(Korean Government); National Institute for Health Research Biomedical Research Centre based at Imperial College Healthcare NHS Trust; Imperial College London(General Electric); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Breast Cancer Campaign; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This review was supported by WHO funds, the Kidney Evaluation Association Japan, and the governments of Japan and Republic of Korea.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: LH, FPC, PE, and JJM received funding from WHO to attend NUGAG Subgroup of Diet and Health meetings, PE receives support from the National Institute for Health Research Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London, FPC is an unpaid member of Consensus Action on Salt and Health (CASH), World Action on Salt and Health (WASH), unpaid advisor to the WHO and the PAHO, a member of the National Heart Forum and former member of the executive committee and trustee of the British Hypertension Society, PE is an unpaid member of CASH, WASH, and an unpaid advisor to WHO; no further financial support from any organisation for the submitted work that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. NJA was a staff member of WHO at the time this work was conducted. The author alone is responsible for the views expressed in this publication and they do not necessarily represent the views, decisions, or policies of WHO.	ALDERMAN MH, 1995, HYPERTENSION, V25, P1144, DOI 10.1161/01.HYP.25.6.1144; ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605; Alderman MH, 2012, CURR HYPERTENS REP, V14, P193, DOI 10.1007/s11906-012-0275-6; Alderman MH, 2010, JAMA-J AM MED ASSOC, V303, P448, DOI 10.1001/jama.2010.69; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; ANDERSSON OK, 1984, HYPERTENSION, V6, P814, DOI 10.1161/01.HYP.6.6.814; [Anonymous], 1990, Arch Intern Med, V150, P153, DOI 10.1001/archinte.150.1.153; [Anonymous], 1989, CLIN EXP HYPERTENS A, V11, P1011; [Anonymous], 2011, BRENNER RECTORS KIDN; BENETOS A, 1992, J HYPERTENS, V10, P355, DOI 10.1097/00004872-199204000-00006; Borghi L, 2012, LINKS WATER SALT INT; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Calabrese E J, 1985, Toxicol Ind Health, V1, P19; Campbell N, 2011, NUTR METAB CARDIOVAS, V21, P617, DOI 10.1016/j.numecd.2011.08.001; Campbell NRC, 2011, CAN J CARDIOL, V27, P404, DOI 10.1016/j.cjca.2011.05.003; Cappuccio FP, 1997, LANCET, V350, P850, DOI 10.1016/S0140-6736(97)02264-2; CHALMERS J, 1986, J HYPERTENS, V4, pS629; CHALMERS JP, 1989, LANCET, V1, P399; Chang HY, 2006, AM J CLIN NUTR, V83, P1289, DOI 10.1093/ajcn/83.6.1289; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; COBIAC L, 1992, J HYPERTENS, V10, P87, DOI 10.1097/00004872-199201000-00014; Cohen HW, 2008, J GEN INTERN MED, V23, P1297, DOI 10.1007/s11606-008-0645-6; Cook NR, 2009, ARCH INTERN MED, V169, P32, DOI 10.1001/archinternmed.2008.523; Cook NR, 2005, J HUM HYPERTENS, V19, P47, DOI 10.1038/sj.jhh.1001775; COOK NR, 1995, ARCH INTERN MED, V155, P701, DOI 10.1001/archinte.155.7.701; Cook NR, 2007, BMJ-BRIT MED J, V55, P1; Cutler JA, 1997, AM J CLIN NUTR, V65, P643, DOI 10.1093/ajcn/65.2.643S; Deeks J J, 2003, Health Technol Assess, V7, piii; Denny SD, 2006, AM J MED, V119, P327, DOI [10.1016/j.amjmed.2005.08.027, 10.1016/j.amjmed.2005.10.042]; Desai M, 2006, AAPS J, V8, pE146, DOI 10.1208/aapsj080117; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Dietary Guidelines Advisory Committee, 2010, AD SOD WHAT IS REL S; Dietary Guidelines Advisory Committee's NEL evidence-based systematic reviews, 2011, WHAT IS EFF RED SOD; DODSON PM, 1989, BMJ-BRIT MED J, V298, P227, DOI 10.1136/bmj.298.6668.227; Ekinci EI, 2011, DIABETES CARE, V34, P703, DOI 10.2337/dc10-1723; ELLIOTT P, 1988, BRIT MED J, V297, P319; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; ELLISON RC, 1989, J CLIN EPIDEMIOL, V42, P201, DOI 10.1016/0895-4356(89)90056-5; ERWTEMAN TM, 1984, BMJ-BRIT MED J, V289, P406, DOI 10.1136/bmj.289.6442.406; FAGERBERG B, 1985, HYPERTENSION, V7, P586, DOI 10.1161/01.HYP.7.4.586; FAGERBERG B, 1984, BRIT MED J, V288, P11, DOI 10.1136/bmj.288.6410.11; Fotherby MD, 1997, J HUM HYPERTENS, V11, P361, DOI 10.1038/sj.jhh.1000436; FOTHERBY MD, 1993, J HYPERTENS, V11, P657, DOI 10.1097/00004872-199306000-00010; Gates PE, 2004, HYPERTENSION, V44, P35, DOI 10.1161/01.HYP.0000132767.74476.64; GELEIJNSE JM, 1990, BMJ-BRIT MED J, V300, P899, DOI 10.1136/bmj.300.6729.899; Geleijnse JM, 1995, J HUM HYPERTENS, V9, P975; Geleijnse JM, 2007, EUR J EPIDEMIOL, V22, P763, DOI 10.1007/s10654-007-9186-2; GILLUM RF, 1981, HYPERTENSION, V3, P698, DOI 10.1161/01.HYP.3.6.698; Gonzalez MC, 2011, AM J HYPERTENS, V24, P1181, DOI 10.1038/ajh.2011.172; Graudal NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub3; GROBBEE DE, 1987, J HYPERTENS, V5, P115, DOI 10.1097/00004872-198702000-00016; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Harsha DW, 2004, HYPERTENSION, V43, P393, DOI 10.1161/01.HYP.0000113046.83819.a2; He FJ, 2008, J HUM HYPERTENS, V22, P729; He FJ, 2009, J HYPERTENS, V27, pS31; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2006, HYPERTENSION, V48, P861, DOI 10.1161/01.HYP.0000245672.27270.4a; He FJ, 2011, KIDNEY INT, V80, P696, DOI 10.1038/ki.2011.246; He FJ, 2009, HYPERTENSION, V54, P482, DOI 10.1161/HYPERTENSIONAHA.109.133223; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; He JA, 1999, JAMA-J AM MED ASSOC, V282, P2027, DOI 10.1001/jama.282.21.2027; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; Hooper L, 2004, Cochrane Database Syst Rev, pCD003656; Howe P. R. C., 1985, Proceedings of the Nutrition Society of Australia, V10, P121; HOWE PRC, 1994, J HUM HYPERTENS, V8, P43; HOWE PRC, 1991, J HYPERTENS, V9, P181, DOI 10.1097/00004872-199102000-00014; HU HH, 1992, STROKE, V23, P1237, DOI 10.1161/01.STR.23.9.1237; KAGAN A, 1985, STROKE, V16, P390, DOI 10.1161/01.STR.16.3.390; Klemmer P, 2012, LOWERING SALT INTAKE; Kumanyika SK, 2005, J HUM HYPERTENS, V19, P33, DOI 10.1038/sj.jhh.1001774; Larsson SC, 2008, ARCH INTERN MED, V168, P459, DOI 10.1001/archinte.168.5.459; Lasser Vera I., 1995, Annals of Epidemiology, V5, P156, DOI 10.1016/1047-2797(94)00060-7; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MACGREGOR GA, 1982, LANCET, V1, P351, DOI 10.1016/S0140-6736(82)91389-7; MACGREGOR GA, 1989, LANCET, V2, P1244, DOI 10.1016/S0140-6736(89)91852-7; McCarron DA, 1997, AM J HYPERTENS, V10, P68, DOI 10.1016/S0895-7061(96)00295-6; McPherson K, 2002, CORONARY HEART DIS E; Meade T, 2010, J RENIN-ANGIO-ALDO S, V11, P91, DOI 10.1177/1470320310365015; MEADE TW, 1993, NEW ENGL J MED, V329, P616, DOI 10.1056/NEJM199308263290905; Meland E, 1997, SCAND J CLIN LAB INV, V57, P501, DOI 10.3109/00365519709084600; Meland E, 2009, SCAND J PRIM HEALTH, V27, P97, DOI 10.1080/02813430802661795; Melander O, 2007, J HYPERTENS, V25, P619, DOI 10.1097/HJH.0b013e328013cd50; Mensah GA., 2004, ATLAS HEART DIS STRO; Miller Judith A., 1993, Journal of the American Society of Nephrology, V4, P583; MILLER JZ, 1988, AM J CLIN NUTR, V47, P113, DOI 10.1093/ajcn/47.1.113; MORGAN T, 1978, LANCET, V1, P227; MORGAN TO, 1981, MED J AUSTRALIA, V2, P396, DOI 10.5694/j.1326-5377.1981.tb101026.x; Muhlhauser I, 1996, DIABETOLOGIA, V39, P212, DOI 10.1007/BF00403965; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Nagata C, 2004, STROKE, V35, P1543, DOI 10.1161/01.STR.0000130425.50441.b0; NESTEL PJ, 1993, J HYPERTENS, V11, P1387, DOI 10.1097/00004872-199312000-00011; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Palacios C, 2004, J CLIN ENDOCR METAB, V89, P1858, DOI 10.1210/jc.2003-031446; PARIJS J, 1973, AM HEART J, V85, P22, DOI 10.1016/0002-8703(73)90522-X; Paterna S, 2008, CLIN SCI, V114, P221, DOI 10.1042/CS20070193; Pirrelli A, 1980, Boll Soc Ital Cardiol, V25, P173; PUSKA P, 1983, LANCET, V1, P1; RICHARDS AM, 1984, LANCET, V1, P757, DOI 10.1016/S0140-6736(84)91276-5; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; RUPPERT M, 1993, J HYPERTENS, V11, P743, DOI 10.1097/00004872-199307000-00010; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Satterfield S, 1991, Ann Epidemiol, V1, P455; SCIARRONE SEG, 1992, J HYPERTENS, V10, P287, DOI 10.1097/00004872-199203000-00013; SILMAN AJ, 1983, LANCET, V1, P1179; SINAIKO AR, 1993, HYPERTENSION, V21, P989, DOI 10.1161/01.HYP.21.6.989; Stamler J, 2003, J HUM HYPERTENS, V17, P655, DOI 10.1038/sj.jhh.1001608; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Strasswer T, 1987, MILD HYPERTENSION DR; Strazzullo Pasquale, 2009, BMJ, V339, pb4567, DOI 10.1136/bmj.b4567; Suckling R, 2010, J HYPERTENS, V28, pE219, DOI 10.1097/01.hjh.0000378867.74072.1c; Swift PA, 2005, HYPERTENSION, V46, P308, DOI 10.1161/01.HYP.0000172662.12480.7f; Swift PA, 2006, J AM SOC NEPHROL, V17, p657A; Adler Alma J, 2014, Cochrane Database Syst Rev, pCD009217, DOI [10.1002/14651858.CD009217, 10.1002/14651858.CD009217.pub3]; TREVISAN M, 1981, CLIN SCI, V61, pS29, DOI 10.1042/cs061029s; TunstallPedoe H, 1997, BRIT MED J, V315, P722, DOI 10.1136/bmj.315.7110.722; Tuomilehto J, 2001, LANCET, V2001, P357; Umesawa M, 2008, AM J CLIN NUTR, V88, P195, DOI 10.1093/ajcn/88.1.195; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Vogt L, 2008, J AM SOC NEPHROL, V19, P999, DOI 10.1681/ASN.2007060693; Volpe M, 2010, CLIN CARDIOL, V33, P700, DOI 10.1002/clc.20813; WATT GCM, 1983, BMJ-BRIT MED J, V286, P432, DOI 10.1136/bmj.286.6363.432; Weir MR, 2010, J CARDIOVASC PHARM T, V15, P356, DOI 10.1177/1074248410377173; WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; WHO, 2003, WHO TECH REP SER, V916, P1; WHO, 2010, WHO HDB GUID DEV; World Health Organization, 2009, GLOB HLTH RISKS MORT, P62; World Health Organization, 2007, PREV CARD DIS GUID A; World Health Organization, 2010, GLOB STAT REP NONC D, P164; World Health Organization, 2012, WORLD HLTH STAT 2012, P176	141	782	801	15	71	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2013	346								f1326	10.1136/bmj.f1326	http://dx.doi.org/10.1136/bmj.f1326			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122SI	23558163	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000317338000002
J	Hawkes, N				Hawkes, Nigel			Take me to your leader	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE					nigel.hawkes1@btinternet.com						Dyer C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2030; Gerada C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1239; Hawkes N, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1484	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2013	346								f2092	10.1136/bmj.f2092	http://dx.doi.org/10.1136/bmj.f2092			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	122SG	23553974				2022-12-28	WOS:000317337800012
J	Benner, EJ; Luciano, D; Jo, R; Abdi, K; Paez-Gonzalez, P; Sheng, HX; Warner, DS; Liu, CL; Eroglu, C; Kuo, CT				Benner, Eric J.; Luciano, Dominic; Jo, Rebecca; Abdi, Khadar; Paez-Gonzalez, Patricia; Sheng, Huaxin; Warner, David S.; Liu, Chunlei; Eroglu, Cagla; Kuo, Chay T.			Protective astrogenesis from the SVZ niche after injury is controlled by Notch modulator Thbs4	NATURE			English	Article							ADULT SUBVENTRICULAR ZONE; CEREBRAL-ISCHEMIA; STEM-CELL; ASTROCYTES; THROMBOSPONDIN-4; GLIOGENESIS; NEUROBLASTS; RECOVERY; REVEALS; REPAIR	Postnatal/adult neural stem cells (NSCs) within the rodent subventricular zone (SVZ; also called subependymal zone) generate doublecortin (Dcx)(+) neuroblasts that migrate and integrate into olfactory bulb circuitry(1,2). Continuous production of neuroblasts is controlled by the SVZ microenvironmental niche(3,4). It is generally thought that enhancing the neurogenic activities of endogenous NSCs may provide needed therapeutic options for disease states and after brain injury. However, SVZ NSCs can also differentiate into astrocytes. It remains unclear whether there are conditions that favour astrogenesis over neurogenesis in the SVZ niche, and whether astrocytes produced there have different properties compared with astrocytes produced elsewhere in the brain(5). Here we show in mice that SVZ-generated astrocytes express high levels of thrombospondin 4 (Thbs4)(6,7), a secreted homopentameric glycoprotein, in contrast to cortical astrocytes, which express low levels of Thbs4. We found that localized photothrombotic/ischaemic cortical injury initiates a marked increase in Thbs4(hi) astrocyte production from the postnatal SVZ niche. Tamoxifen-inducible nestin-creER(tm)4 lineage tracing demonstrated that it is these SVZ-generated Thbs4(hi) astrocytes, and not Dcx(+) neuroblasts, that home-in on the injured cortex. This robust post-injury astrogenic response required SVZ Notch activation modulated by Thbs4 via direct Notch1 receptor binding and endocytosis to activate downstream signals, including increased Nfia transcription factor expression important for glia production(8). Consequently, Thbs4 homozygous knockout mice (Thbs4(KO/KO)) showed severe defects in cortical-injury-induced SVZ astrogenesis, instead producing cells expressing Dcx migrating from SVZ to the injury sites. These alterations in cellular responses resulted in abnormal glial scar formation after injury, and significantly increased microvascular haemorrhage into the brain parenchyma of Thbs4(KO/KO) mice. Taken together, these findings have important implications for post-injury applications of endogenous and transplanted NSCs in the therapeutic setting, as well as disease states where Thbs family members have important roles(9,10).	[Benner, Eric J.; Jo, Rebecca; Kuo, Chay T.] Duke Univ, Sch Med, Dept Pediat, George & Jean Brumley Neonatal Perinatal Res Inst, Durham, NC 27710 USA; [Luciano, Dominic; Jo, Rebecca; Abdi, Khadar; Paez-Gonzalez, Patricia; Eroglu, Cagla; Kuo, Chay T.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Luciano, Dominic; Eroglu, Cagla; Kuo, Chay T.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; [Sheng, Huaxin; Warner, David S.] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27710 USA; [Liu, Chunlei] Duke Univ, Sch Med, Dept Radiol, Brain Imaging & Anal Ctr, Durham, NC 27710 USA; [Liu, Chunlei] Duke Univ, Sch Med, Dept Radiol, Durham, NC 27710 USA; [Eroglu, Cagla; Kuo, Chay T.] Duke Univ, Sch Med, Duke Inst Brain Sci, Durham, NC 27710 USA; [Kuo, Chay T.] Duke Univ, Sch Med, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Kuo, CT (corresponding author), Duke Univ, Sch Med, Dept Pediat, George & Jean Brumley Neonatal Perinatal Res Inst, Durham, NC 27710 USA.	chay.kuo@duke.edu	Eroglu, Cagla/P-5315-2014; Paez-Gonzalez, Patricia/E-5069-2018	Eroglu, Cagla/0000-0002-7204-0218; Paez-Gonzalez, Patricia/0000-0002-6786-3869; Liu, Chunlei/0000-0001-8816-4832	National Biomedical Technology Resource Center [P41 RR005959, P41 EB015897]; George and Jean Brumley Endowment; Sontag Foundation; David and Lucile Packard Foundation; March of Dimes; NIH [1 DP2 OD004453-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043494] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031833] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004453] Funding Source: NIH RePORTER	National Biomedical Technology Resource Center; George and Jean Brumley Endowment; Sontag Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); March of Dimes(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Melton (Harvard) for R26R-NICD mice; T. Honjo (Kyoto) for RBPjk-flox mice; F. Wang for R26R-tdTomato mice; E. Rawlins (Cambridge) for Foxj1-creER<SUP>t2</SUP> mice; B. Deneen (B. C. M.) and S. Singh for discussions; G. Lyons, R. Andersen, P. Heine, D. Fromme and S. Collins for project assistance; Duke Flow Cytometry Facility for help with FACS; W. Li and Duke Center for In vivo microscopy/brain imaging for MRI analyses; and T. Lechler, A. West and B. Hogan for comments on manuscript. This work was supported by National Biomedical Technology Resource Center Grant P41 RR005959 (C. L.) of P41 EB015897 to Duke Center for In Vivo Microscopy; George and Jean Brumley Endowment, Sontag Foundation, David and Lucile Packard Foundation, March of Dimes, and NIH Director's New Innovator Award 1 DP2 OD004453-01 (C.T.K.).	Aboody K, 2011, NEURON, V70, P597, DOI 10.1016/j.neuron.2011.05.007; Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Eroglu C, 2009, J CELL COMMUN SIGNAL, V3, P167, DOI 10.1007/s12079-009-0078-y; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Frolova EG, 2010, CIRC RES, V107, P1313, DOI 10.1161/CIRCRESAHA.110.232371; Givogri MI, 2006, DEV NEUROSCI-BASEL, V28, P81, DOI 10.1159/000090755; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Johnson GA, 2002, RADIOLOGY, V222, P789, DOI 10.1148/radiol.2223010531; Kelsch W, 2010, ANNU REV NEUROSCI, V33, P131, DOI 10.1146/annurev-neuro-060909-153252; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; LAWLER J, 1993, J CELL BIOL, V120, P1059, DOI 10.1083/jcb.120.4.1059; Lee JK, 2007, SURG NEUROL, V67, P620, DOI 10.1016/j.surneu.2006.08.077; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maxwell KA, 2005, DEV NEUROSCI-BASEL, V27, P121, DOI 10.1159/000085983; McDowell KA, 2010, J NEUROSCI, V30, P7453, DOI 10.1523/JNEUROSCI.3997-09.2010; Meng H, 2009, J BIOL CHEM, V284, P7866, DOI 10.1074/jbc.M803650200; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; MOSELEY ME, 1993, STROKE, V24, pI60; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Paez-Gonzalez P, 2011, NEURON, V71, P61, DOI 10.1016/j.neuron.2011.05.029; Patel MR, 1996, STROKE, V27, P2321, DOI 10.1161/01.STR.27.12.2321; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Yamamoto S, 2010, CURR TOP DEV BIOL, V92, P165, DOI 10.1016/S0070-2153(10)92005-X	39	189	198	4	59	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					369	+		10.1038/nature12069	http://dx.doi.org/10.1038/nature12069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23615612	Green Accepted, Green Submitted			2022-12-28	WOS:000318952000038
J	Murtaza, M; Dawson, SJ; Tsui, DWY; Gale, D; Forshew, T; Piskorz, AM; Parkinson, C; Chin, SF; Kingsbury, Z; Wong, ASC; Marass, F; Humphray, S; Hadfield, J; Bentley, D; Chin, TM; Brenton, JD; Caldas, C; Rosenfeld, N				Murtaza, Muhammed; Dawson, Sarah-Jane; Tsui, Dana W. Y.; Gale, Davina; Forshew, Tim; Piskorz, Anna M.; Parkinson, Christine; Chin, Suet-Feung; Kingsbury, Zoya; Wong, Alvin S. C.; Marass, Francesco; Humphray, Sean; Hadfield, James; Bentley, David; Chin, Tan Min; Brenton, James D.; Caldas, Carlos; Rosenfeld, Nitzan			Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA	NATURE			English	Article							TUMOR-CELLS; EVOLUTION; MUTATIONS; HETEROGENEITY; ACTIVATION	Cancers acquire resistance to systemic treatment as a result of clonal evolution and selection(1,2). Repeat biopsies to study genomic evolution as a result of therapy are difficult, invasive and may be confounded by intra-tumour heterogeneity(3,4). Recent studies have shown that genomic alterations in solid cancers can be characterized by massively parallel sequencing of circulating cell-free tumour DNA released from cancer cells into plasma, representing a noninvasive liquid biopsy(5-7). Here we report sequencing of cancer exomes in serial plasma samples to track genomic evolution of metastatic cancers in response to therapy. Six patients with advanced breast, ovarian and lung cancers were followed over 1-2 years. For each case, exome sequencing was performed on 2-5 plasma samples (19 in total) spanning multiple courses of treatment, at selected time points when the allele fraction of tumour mutations in plasma was high, allowing improved sensitivity. For two cases, synchronous biopsies were also analysed, confirming genome-wide representation of the tumour genome in plasma. Quantification of allele fractions in plasma identified increased representation of mutant alleles in association with emergence of therapy resistance. These included an activating mutation in PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) following treatment with paclitaxel(8); a truncating mutation in RB1 (retinoblastoma 1) following treatment with cisplatin(9); a truncating mutation in MED1 (mediator complex subunit 1) following treatment with tamoxifen and trastuzumab(10,11), and following subsequent treatment with lapatinib(12,13), a splicing mutation in GAS6 (growth arrest-specific 6) in the same patient; and a resistance-conferring mutation in EGFR (epidermal growth factor receptor; T790M) following treatment with gefitinib(14). These results establish proof of principle that exome-wide analysis of circulating tumour DNA could complement current invasive biopsy approaches to identify mutations associated with acquired drug resistance in advanced cancers. Serial analysis of cancer genomes in plasma constitutes a new paradigm for the study of clonal evolution in human cancers.	[Murtaza, Muhammed; Dawson, Sarah-Jane; Tsui, Dana W. Y.; Gale, Davina; Forshew, Tim; Piskorz, Anna M.; Parkinson, Christine; Chin, Suet-Feung; Marass, Francesco; Hadfield, James; Brenton, James D.; Caldas, Carlos; Rosenfeld, Nitzan] Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Murtaza, Muhammed; Dawson, Sarah-Jane; Tsui, Dana W. Y.; Gale, Davina; Forshew, Tim; Piskorz, Anna M.; Parkinson, Christine; Chin, Suet-Feung; Marass, Francesco; Hadfield, James; Brenton, James D.; Caldas, Carlos; Rosenfeld, Nitzan] Univ Cambridge, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Dawson, Sarah-Jane; Parkinson, Christine; Brenton, James D.; Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Dawson, Sarah-Jane; Parkinson, Christine; Brenton, James D.; Caldas, Carlos] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 2QQ, England; [Kingsbury, Zoya] Illumina Inc, Saffron Walden CB10 1XL, England; [Wong, Alvin S. C.; Chin, Tan Min] Natl Univ Hlth Syst, Natl Univ Canc Inst, Dept Haematol Oncol, Singapore 119074, Singapore; [Chin, Tan Min] Natl Univ Singapore, Ctr Translat Med, Canc Sci Inst, Singapore 117599, Singapore; [Brenton, James D.; Caldas, Carlos] Cambridge Expt Canc Med Ctr, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; CRUK Cambridge Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Illumina; National University of Singapore; National University of Singapore	Brenton, JD (corresponding author), Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.	james.brenton@cruk.cam.ac.uk; carlos.caldas@cruk.cam.ac.uk; nitzan.rosenfeld@cruk.cam.ac.uk	ravegnini, gloria/K-1330-2016; Marass, Francesco/U-5220-2019; Brenton, James D/B-3174-2008; Caldas, Carlos/U-7250-2019; Hadfield, James/A-1874-2013	ravegnini, gloria/0000-0002-7774-402X; Marass, Francesco/0000-0002-8993-7320; Brenton, James D/0000-0002-5738-6683; Caldas, Carlos/0000-0003-3547-1489; Murtaza, Muhammed/0000-0001-7557-2861; Dawson, Sarah-Jane/0000-0002-8276-0374; Forshew, Tim/0000-0003-2093-7020; Hadfield, James/0000-0001-9868-4989; chin, suet-feung/0000-0001-5697-1082	NIHR Cambridge Biomedical Research Centre; Cancer Science Institute; National University of Singapore; Hematology-Oncology Research Group, National University Health System, Singapore; Cancer Research UK; University of Cambridge; National Institute for Health Research Cambridge Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Hutchison Whampoa Limited; National Medical Research Council, Singapore; Australian NHMRC/RG Menzies Early Career Fellowship; Cancer Research UK [16942, 11906, 15601, 22310] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Science Institute; National University of Singapore(National University of Singapore); Hematology-Oncology Research Group, National University Health System, Singapore; Cancer Research UK(Cancer Research UK); University of Cambridge(University of Cambridge); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Hutchison Whampoa Limited; National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian NHMRC/RG Menzies Early Career Fellowship; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank J. Langmore and K. Solomon (Rubicon Genomics) for early access to library preparation products. We thank L. Jones, S. Richardson, C. Hodgkin and H. Biggs for recruiting patients into the DETECT and CTCR-OVO4 studies, all medical and ancillary staff in the breast and gynaecological cancer clinic and patients for consenting to participate. We thank the Human Research Tissue Bank at Addenbrooke's Hospital which is supported by the NIHR Cambridge Biomedical Research Centre. We thank the Cancer Science Institute, National University of Singapore, and the Hematology-Oncology Research Group, National University Health System, Singapore for their support. We acknowledge the support of Cancer Research UK, the University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge Experimental Cancer Medicine Centre, Hutchison Whampoa Limited, and the National Medical Research Council, Singapore. S.-J.D. is supported by an Australian NHMRC/RG Menzies Early Career Fellowship that is administered through the Peter MacCallum Cancer Centre, Victoria, Australia.	Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Chang H, 2011, BREAST CANCER RES TR, V125, P55, DOI 10.1007/s10549-010-0825-z; Cui JJ, 2012, CANCER RES, V72, P5625, DOI 10.1158/0008-5472.CAN-12-1305; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; Nagalingam A, 2012, CARCINOGENESIS, V33, P918, DOI 10.1093/carcin/bgs105; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Punnoose EA, 2012, CLIN CANCER RES, V18, P2391, DOI 10.1158/1078-0432.CCR-11-3148; Sato K, 2012, EMBO J, V31, P3524, DOI 10.1038/emboj.2012.197; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; VanderWeele DJ, 2004, MOL CANCER THER, V3, P1605; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu CC, 2011, BIOCHEM BIOPH RES CO, V405, P168, DOI 10.1016/j.bbrc.2011.01.001; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	29	1206	1311	5	384	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					108	112		10.1038/nature12065	http://dx.doi.org/10.1038/nature12065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23563269				2022-12-28	WOS:000318221500043
J	Halfon, N; Conway, PH				Halfon, Neal; Conway, Patrick H.			The Opportunities and Challenges of a Lifelong Health System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Halfon, Neal] Univ Calif Los Angeles, Ctr Healthier Children Families & Communities, Los Angeles, CA 90024 USA; [Halfon, Neal] UCLA David Geffen Sch Med, Dept Pediat, Los Angeles, CA USA; [Halfon, Neal] UCLA Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA; [Halfon, Neal] UCLA Luskin Sch Publ Affairs, Dept Publ Policy, Los Angeles, CA USA; [Conway, Patrick H.] Ctr Medicare Serv, Baltimore, MD USA; [Conway, Patrick H.] Ctr Medicaid Serv, Baltimore, MD USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Cincinnati Children's Hospital Medical Center	Halfon, N (corresponding author), Univ Calif Los Angeles, Ctr Healthier Children Families & Communities, Los Angeles, CA 90024 USA.							Braveman P, 2008, OVERCOMING OBSTACLES; Halfon N, 2002, MILBANK Q, V80, P433, DOI 10.1111/1468-0009.00019; Lambrew JM, 2007, WELLNESS TRUST PRIOR; Sawhill IV, 2012, ARE WE HEADED PERMAN	4	17	17	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1569	1571		10.1056/NEJMp1215897	http://dx.doi.org/10.1056/NEJMp1215897			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130YK	23614582				2022-12-28	WOS:000317956300004
J	Roca, FJ; Ramakrishnan, L				Roca, Francisco J.; Ramakrishnan, Lalita			TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen Species	CELL			English	Article							TUMOR-NECROSIS-FACTOR; CELL-DEATH; PERMEABILITY TRANSITION; INFLAMMATORY RESPONSE; PROGRAMMED NECROSIS; TUBERCULOSIS; ZEBRAFISH; APOPTOSIS; KINASE; LOCUS	Tumor necrosis factor (TNF) constitutes a critical host defense against tuberculosis, but its excess is also implicated in tuberculosis pathogenesis in zebrafish and humans. Using the zebrafish, we elucidate the pathways by which TNF mediates tuberculosis pathogenesis. TNF excess induces mitochondrial reactive oxygen species (ROS) in infected macrophages through RIP1-RIP3-dependent pathways. While initially increasing macrophage microbicidal activity, ROS rapidly induce programmed necrosis (necroptosis) and release mycobacteria into the growth-permissive extracellular milieu. TNF-induced necroptosis occurs through two pathways: modulation of mitochondrial cyclophilin D, implicated in mitochondrial permeability transition pore formation, and acid sphingomyelinase-mediated ceramide production. Combined genetic blockade of cyclophilin D and acid sphingomyelinase renders the high TNF state hyperresistant by preventing macrophage necrosis while preserving increased microbicidal activity. Similarly, the cyclophilin D-inhibiting drug alisporivir and the acid sphingomyelinase-inactivating drug, desipramine, synergize to reverse susceptibility, suggesting the therapeutic potential of these orally active drugs against tuberculosis and possibly other TNF-mediated diseases.	[Roca, Francisco J.; Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	lalitar@uw.edu		Ramakrishnan, Lalita/0000-0003-0692-5533	NIH; NWRCE for Biodefense and Emerging Infectious Diseases Research; educational ministry of Spain; NIH Director's Pioneer Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054503, R01AI036396] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006782] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWRCE for Biodefense and Emerging Infectious Diseases Research; educational ministry of Spain; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank X. Lei and Novartis for the gifts of necrosulfonamide and alisporivir, respectively, C.-T. Yang for the Tg(mpeg1: YFP) zebrafish line; A. Oberst and D. Tobin for advice and discussion; C. Cosma for advice on statistical analysis; A. Pagan, J. Szumowski, C. Cosma, A. Oberst, D. Tobin, and K. Takaki for manuscript review; and J. Cameron for fish facility management. Funded by grants from the NIH and the NWRCE for Biodefense and Emerging Infectious Diseases Research (L.R.), and a postdoctoral fellowship from the educational ministry of Spain (F.J.R). L.R. is a recipient of the NIH Director's Pioneer Award.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Berg RD, 2012, TRENDS MOL MED, V18, P689, DOI 10.1016/j.molmed.2012.10.002; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Cadieux N, 2011, MICROBIOL-SGM, V157, P793, DOI 10.1099/mic.0.041996-0; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cirillo SLG, 2009, INFECT IMMUN, V77, P2557, DOI 10.1128/IAI.01481-08; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; CROMPTON M, 1988, BIOCHEM J, V255, P357; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; Dumitru CA, 2006, ONCOGENE, V25, P5612, DOI 10.1038/sj.onc.1209568; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Elojeimy S, 2006, FEBS LETT, V580, P4751, DOI 10.1016/j.febslet.2006.07.071; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Galluzzi L, 2011, INT REV CEL MOL BIO, V289, P1, DOI 10.1016/B978-0-12-386039-2.00001-8; He SN, 2012, J PATHOL, V227, P431, DOI 10.1002/path.4013; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Keystone EC, 2010, J RHEUMATOL, V37, P27, DOI 10.3899/jrheum.091463; Kim HJ, 2010, ARCH PHARM RES, V33, P1813, DOI 10.1007/s12272-010-1114-4; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kweon SM, 2001, BIOSCIENCE REP, V21, P341, DOI 10.1023/A:1013290316939; LASTER SM, 1988, J IMMUNOL, V141, P2629; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lee J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018367; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Quarato G, 2012, HEPATOLOGY, V55, P1333, DOI 10.1002/hep.25514; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Schoeman JF, 1997, PEDIATRICS, V99, P226, DOI 10.1542/peds.99.2.226; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Sohn H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002435; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Su FY, 2007, ZEBRAFISH, V4, P187, DOI 10.1089/zeb.2007.0505; Subbian S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-4; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takaki K, 2012, CELL REP, V2, P175, DOI 10.1016/j.celrep.2012.06.008; Thon L, 2005, FASEB J, V19, P1945, DOI 10.1096/fj.05-3726com; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wallis RS, 2005, CLIN INFECT DIS, V41, P201, DOI 10.1086/430914; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	60	374	390	3	95	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					521	534		10.1016/j.cell.2013.03.022	http://dx.doi.org/10.1016/j.cell.2013.03.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23582643	Bronze, Green Accepted			2022-12-28	WOS:000318063500007
J	Shen, L; Wu, H; Diep, D; Yamaguchi, S; D'Alessio, AC; Fung, HL; Zhang, K; Zhang, Y				Shen, Li; Wu, Hao; Diep, Dinh; Yamaguchi, Shinpei; D'Alessio, Ana C.; Fung, Ho-Lim; Zhang, Kun; Zhang, Yi			Genome-wide Analysis Reveals TET- and TDG-Dependent 5-Methylcytosine Oxidation Dynamics	CELL			English	Article							EMBRYONIC STEM-CELLS; THYMINE DNA GLYCOSYLASE; GENE-EXPRESSION; POSTNATAL-DEVELOPMENT; METHYLATION PATTERNS; BASE-RESOLUTION; MAMMALIAN DNA; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION; CHROMATIN	TET dioxygenases successively oxidize 5-methylcytosine (5mC) in mammalian genomes to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC). 5fC/5caC can be excised and repaired to regenerate unmodified cytosines by thymine-DNA glycosylase (TDG) and base excision repair (BER) pathway, but it is unclear to what extent and at which part of the genome this active demethylation process takes place. Here, we have generated genome-wide distribution maps of 5hmC/5fC/5caC using modification-specific antibodies in wild-type and Tdg-deficient mouse embryonic stem cells (ESCs). In wild-type mouse ESCs, 5fC/5caC accumulates to detectable levels at major satellite repeats but not at nonrepetitive loci. In contrast, Tdg depletion in mouse ESCs causes marked accumulation of 5fC and 5caC at a large number of proximal and distal gene regulatory elements. Thus, these results reveal the genome-wide view of iterative 5mC oxidation dynamics and indicate that TET/TDG-dependent active DNA demethylation process occurs extensively in the mammalian genome.	[Shen, Li; Wu, Hao; Yamaguchi, Shinpei; D'Alessio, Ana C.; Zhang, Yi] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Shen, Li; Wu, Hao; Yamaguchi, Shinpei; D'Alessio, Ana C.; Zhang, Yi] Harvard Univ, Sch Med, Program Cellular & Mol Med, Boston, MA 02115 USA; [Shen, Li; Wu, Hao; Yamaguchi, Shinpei; D'Alessio, Ana C.; Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Wu, Hao] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Diep, Dinh; Fung, Ho-Lim; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; University of California System; University of California San Diego	Wu, H (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, WAB-149G,200 Longwood Ave, Boston, MA 02115 USA.	haowu7@gmail.com; yzhang@genetics.med.harvard.edu	Wu, Hao/G-4145-2013; Zhang, Kun/ABE-6349-2020; Yamaguchi, Shinpei/HCH-5553-2022; Wu, Hao/H-3899-2017	Wu, Hao/0000-0002-1256-6891; Zhang, Kun/0000-0002-7596-5224; Wu, Hao/0000-0003-1269-7354; Yamaguchi, Shinpei/0000-0002-9377-4835; Wu, Hao/0000-0003-4395-6929; Zhang, Yi/0000-0002-2789-0811	NIH [U01DK089565, R01GM097253]; Jane Coffin Childs Funds for Medical Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097253] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Funds for Medical Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Jin He and Falong Lu for their helpful discussions. This project is supported by NIH grant U01DK089565 (to Y.Z.) and R01GM097253 (to K.Z.). H.W. is supported by a postdoctoral fellowship (Merck Fellow) from Jane Coffin Childs Funds for Medical Research. D.D. is a CIRM predoctoral fellow. Y.Z. is an investigator of the Howard Hughes Medical Institute.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khare T, 2012, NAT STRUCT MOL BIOL, V19, P1037, DOI 10.1038/nsmb.2372; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Nakamura J, 1998, CANCER RES, V58, P222; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Raiber EA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r69; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Song CX, 2012, NAT BIOTECHNOL, V30, P1107, DOI 10.1038/nbt.2398; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu H, 2011, CELL CYCLE, V10, P2428, DOI 10.4161/cc.10.15.16930; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamaguchi S, 2013, CELL RES, V23, P329, DOI 10.1038/cr.2013.22; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	73	362	374	4	108	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 25	2013	153	3					692	706		10.1016/j.cell.2013.04.002	http://dx.doi.org/10.1016/j.cell.2013.04.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23602152	Bronze, Green Accepted			2022-12-28	WOS:000318063500020
J	Wu, JJ; Caperton, C				Wu, Jashin J.; Caperton, Caroline			Psoriasis Flare from Koebner's Phenomenon after Acupuncture	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wu, Jashin J.] Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA; [Caperton, Caroline] Jackson Mem Hosp, Miami, FL 33136 USA	Kaiser Permanente	Wu, JJ (corresponding author), Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA.			Wu, Jashin/0000-0002-1722-1892					0	4	4	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1635	1635		10.1056/NEJMicm1205716	http://dx.doi.org/10.1056/NEJMicm1205716			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130YK	23614589				2022-12-28	WOS:000317956300012
J	Collis, E; Sleeman, KE				Collis, Emily; Sleeman, Katherine E.			Do patients need to know they are terminally ill? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER		[Collis, Emily] Cent London Community Healthcare Trust, St Charles Hosp, Pembridge Palliat Care Ctr, London W10 6DZ, England; [Sleeman, Katherine E.] Kings Coll London, Cicely Saunders Inst, London WC2R 2LS, England	Imperial College London; University of London; King's College London	Collis, E (corresponding author), Cent London Community Healthcare Trust, St Charles Hosp, Pembridge Palliat Care Ctr, London W10 6DZ, England.	emily.collis@clch.nhs.uk	Sleeman, Katherine/C-4941-2014	Sleeman, Katherine/0000-0002-9777-4373	National Institute for Health Research [CL-2010-17-009] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bennett M, 1996, POSTGRAD MED J, V72, P25, DOI 10.1136/pgmj.72.843.25; CALMAN KC, 1984, J MED ETHICS, V10, P124, DOI 10.1136/jme.10.3.124; DAVIES E, 1973, P ROY SOC MED, V66, P533; Department for Work and Pensions, BEN INC DIS MAT BER; General Medical Council, 2010, TREATM CAR END LIF G; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; GOSTIN LO, 1995, JAMA-J AM MED ASSOC, V274, P844; Rousseau P, 2000, WESTERN J MED, V173, P117, DOI 10.1136/ewjm.173.2.117; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410	9	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2013	346								f2589	10.1136/bmj.f2589	http://dx.doi.org/10.1136/bmj.f2589			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134PM	23615596				2022-12-28	WOS:000318224900018
J	van Duren, BH; Moghul, M; Appleton, SG; van Boxel, GI				van Duren, B. H.; Moghul, M.; Appleton, S. G.; van Boxel, G. I.			The acute abdomen	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIVERTICULAR-DISEASE; CHEST RADIOGRAPHY; SEVERE SEPSIS; PNEUMOPERITONEUM; PERFORATION; TRIAL; ULTRASONOGRAPHY; MANAGEMENT; ULCER; AIR		[van Duren, B. H.; Moghul, M.] Horton Gen Hosp, Dept Gen Surg, Banbury OX16 9AL, England; [Appleton, S. G.; van Boxel, G. I.] Wycombe Gen Hosp, Dept Gen Surg, High Wycombe HP11 2TT, Bucks, England		van Boxel, GI (corresponding author), Wycombe Gen Hosp, Dept Gen Surg, High Wycombe HP11 2TT, Bucks, England.	gijs.vanboxel@gmail.com		van Duren, Bernard/0000-0003-1877-8227				Alazzawi S, 2010, ANN ROY COLL SURG, V92, P697, DOI 10.1308/003588410X12699663904998; Bansal J, 2012, EMERG RADIOL, V19, P115, DOI 10.1007/s10140-011-1007-y; Bertleff MJOE, 2009, WORLD J SURG, V33, P1368, DOI 10.1007/s00268-009-0054-y; Chen CH, 2001, HEPATO-GASTROENTEROL, V48, P1082; Chiu YH, 2009, AM J EMERG MED, V27, P320, DOI 10.1016/j.ajem.2008.03.004; CROFTS TJ, 1989, NEW ENGL J MED, V320, P970, DOI 10.1056/NEJM198904133201504; Daniels R, 2011, EMERG MED J, V28, P507, DOI 10.1136/emj.2010.095067; De Jong J J, 1999, Ned Tijdschr Geneeskd, V143, P2033; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Guillem P, 2002, J CHIR-PARIS, V139, P5; Hinchey E J, 1978, Adv Surg, V12, P85; Hoffmann B, 2012, EUR J EMERG MED, V19, P284, DOI 10.1097/MEJ.0b013e3283543cd3; KEANE TE, 1988, BRIT J SURG, V75, P583, DOI 10.1002/bjs.1800750629; Kumar A, 2012, J TRAUMA ACUTE CARE, V73, P542, DOI 10.1097/TA.0b013e31825c157f; Lo BM, 2010, J EMERG MED, V38, P36, DOI 10.1016/j.jemermed.2008.01.011; MARSHALL BJ, 1988, LANCET, V2, P1437; Miller R E, 1973, CRC Crit Rev Clin Radiol Nucl Med, V4, P61; MILLER RE, 1971, AMER J ROENTGENOL RA, V112, P574, DOI 10.2214/ajr.112.3.574; MILLER RE, 1980, AM J ROENTGENOL, V135, P487, DOI 10.2214/ajr.135.3.487; PARKS TG, 1975, CLIN GASTROENTEROL, V4, P53; Sahoo SP, 2011, INDIAN J SURG, V73, P370, DOI 10.1007/s12262-011-0265-y; Shapey IM, 2012, ANN R COLL SURG ENGL, V94, P246; STAPAKIS JC, 1992, J COMPUT ASSIST TOMO, V16, P713, DOI 10.1097/00004728-199209000-00008; Sturgeon JP, 2012, BMJ CASE REP, V2012; TAYLOR H, 1957, GASTROENTEROLOGY, V33, P353; Toorenvliet BR, 2010, COLORECTAL DIS, V12, P862, DOI 10.1111/j.1463-1318.2009.02052.x; Varin DSE, 2009, EUR J EMERG MED, V16, P305, DOI 10.1097/MEJ.0b013e32832c3ab9; Vermeulen J, 2010, WORLD J SURG, V34, P587, DOI 10.1007/s00268-009-0372-0; Weizman AV, 2011, CAN J GASTROENTEROL, V25, P385, DOI 10.1155/2011/795241; Williams N, 1997, ANN ROY COLL SURG, V79, P8; WINEK TG, 1988, ARCH SURG-CHICAGO, V123, P709; WOODRING JH, 1995, AM J ROENTGENOL, V165, P45, DOI 10.2214/ajr.165.1.7785629	32	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2013	346								f2549	10.1136/bmj.f2549	http://dx.doi.org/10.1136/bmj.f2549			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134PM	23616034				2022-12-28	WOS:000318224900016
J	Suteewong, T; Sai, H; Hovden, R; Muller, D; Bradbury, MS; Gruner, SM; Wiesner, U				Suteewong, Teeraporn; Sai, Hiroaki; Hovden, Robert; Muller, David; Bradbury, Michelle S.; Gruner, Sol M.; Wiesner, Ulrich			Multicompartment Mesoporous Silica Nanoparticles with Branched Shapes: An Epitaxial Growth Mechanism	SCIENCE			English	Article							INDUCED PHASE-TRANSFORMATION; CAGE-TYPE; CRYSTALS; P6MM; PM(3)OVER-BARN; PACKING	Mesoporous nanomaterials have attracted widespread interest because of their structural versatility for applications including catalysis, separation, and nanomedicine. We report a one-pot synthesis method for a class of mesoporous silica nanoparticles (MSNs) containing both cubic and hexagonally structured compartments within one particle. These multicompartment MSNs (mc-MSNs) consist of a core with cage-like cubic mesoporous morphology and up to four branches with hexagonally packed cylindrical mesopores epitaxially growing out of the cubic core vertices. The extent of cylindrical mesostructure growth can be controlled via a single additive in the synthesis. Results suggest a path toward high levels of architectural complexity in locally amorphous, mesostructured nanoparticles, which could enable tuning of different pore environments of the same particle for specific chemistries in catalysis or drug delivery.	[Suteewong, Teeraporn; Sai, Hiroaki; Wiesner, Ulrich] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Suteewong, Teeraporn; Bradbury, Michelle S.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA; [Hovden, Robert; Muller, David] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Muller, David; Gruner, Sol M.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA; [Gruner, Sol M.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Gruner, Sol M.] Cornell Univ, CHESS, Ithaca, NY 14853 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	Wiesner, U (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	ubw1@cornell.edu	Gruner, Sol/G-2924-2010; Muller, David/A-7745-2010; Sai, Hiroaki/C-9970-2014	Gruner, Sol/0000-0002-1171-4426; Muller, David/0000-0003-4129-0473; Sai, Hiroaki/0000-0002-4268-2148	NSF [DMR-1104773]; Partnership for Research and Education in Materials (PREM) program at Norfolk State University through NSF [DMR-1205457]; Cornell Center for Materials Research; NSF Materials Research Science and Engineering Centers program [DMR-1120296]; National Institute of General Medical Sciences under NSF [DMR-0936384]; Thai Government Scholarship under the Ministry of Science and Technology; NATIONAL CANCER INSTITUTE [R01CA161280] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1104773] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Partnership for Research and Education in Materials (PREM) program at Norfolk State University through NSF; Cornell Center for Materials Research; NSF Materials Research Science and Engineering Centers program; National Institute of General Medical Sciences under NSF(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Thai Government Scholarship under the Ministry of Science and Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Supported by NSF single-investigator grant DMR-1104773 and by a Partnership for Research and Education in Materials (PREM) program at Norfolk State University through NSF grant DMR-1205457. We thank L. Estroff, R. Dieckmann, and K. Hur (Cornell University) for discussions on multiple branch growth and K. W. Tan (Cornell University) for assistance with EM. This work made use of the TEM and STEM supported by the Cornell Center for Materials Research with support from the NSF Materials Research Science and Engineering Centers program (DMR-1120296), and CHESS, which is supported by the NSF and the National Institute of General Medical Sciences under NSF award DMR-0936384. T.S. is grateful for a Thai Government Scholarship under the Ministry of Science and Technology.	Atluri R, 2010, MICROPOR MESOPOR MAT, V133, P27, DOI 10.1016/j.micromeso.2010.04.007; Atluri R, 2009, LANGMUIR, V25, P3189, DOI 10.1021/la803727u; Chandrawati R, 2011, J PHYS CHEM LETT, V2, P2639, DOI 10.1021/jz200994n; Che SN, 2001, J AM CHEM SOC, V123, P12089, DOI 10.1021/ja0118237; Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768; DITTERT LW, 1963, J PHARM SCI, V52, P852, DOI 10.1002/jps.2600520908; Han L, 2011, J AM CHEM SOC, V133, P11524, DOI 10.1021/ja200683t; Han L, 2009, CHEM-EUR J, V15, P2818, DOI 10.1002/chem.200801688; Hoffmann F, 2006, ANGEW CHEM INT EDIT, V45, P3216, DOI 10.1002/anie.200503075; Kamiya S, 2003, SOLID STATE SCI, V5, P197, DOI 10.1016/S1293-2558(02)00094-8; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350; Manna L, 2003, NAT MATER, V2, P382, DOI 10.1038/nmat902; Ogura M, 2004, J AM CHEM SOC, V126, P10937, DOI 10.1021/ja047785j; Schulz-Ekloff G, 1999, INT J INORG MATER, V1, P97, DOI 10.1016/S1463-0176(99)00015-0; Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012; Srinivasu P, 2006, CATAL TODAY, V111, P379, DOI 10.1016/j.cattod.2005.10.049; Suteewong T, 2012, CHEM MATER, V24, P3895, DOI 10.1021/cm301857e; Suteewong T, 2011, J AM CHEM SOC, V133, P172, DOI 10.1021/ja1061664; Suteewong T, 2010, J MATER CHEM, V20, P7807, DOI 10.1039/c0jm01002b; Talapin DV, 2007, NANO LETT, V7, P2951, DOI 10.1021/nl072003g; Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Xiao CH, 2012, NATURE, V487, P349, DOI 10.1038/nature11230; YANAGISAWA T, 1990, B CHEM SOC JPN, V63, P988, DOI 10.1246/bcsj.63.988; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165	26	131	133	11	433	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					337	341		10.1126/science.1231391	http://dx.doi.org/10.1126/science.1231391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599490	Green Accepted			2022-12-28	WOS:000317657500051
J	Bell, KJ; Fulcher, ML; Rowlands, DS; Kerse, N				Bell, Kevin J.; Fulcher, Mark L.; Rowlands, David S.; Kerse, Ngaire			Impact of autologous blood injections in treatment of mid-portion Achilles tendinopathy: double blind randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLATELET-RICH PLASMA; ELBOW TENDINOPATHY; CLINICAL-TRIAL; COL5A1 GENE; VISA-A; EPICONDYLITIS; MANAGEMENT; THERAPY; QUESTIONNAIRE; CELLS	Objective To assess the effectiveness of two peritendinous autologous blood injections in addition to a standardised eccentric calf strengthening programme in improving pain and function in patients with mid-portion Achilles tendinopathy. Design Single centre, participant and single assessor blinded, parallel group, randomised, controlled trial. Setting Single sports medicine clinic in New Zealand. Participants 53 adults (mean age 49, 53% men) with symptoms of unilateral mid-portion Achilles tendinopathy for at least three months. Participants were excluded if they had a history of previous Achilles tendon rupture or surgery or had undergone previous adjuvant treatments such as injectable therapies, glyceryl trinitrate patches, or extracorporeal shockwave therapy. Interventions All participants underwent two unguided peritendinous injections one month apart with a standardised protocol. The treatment group had 3 mL of their own whole blood injected while the control group had no substance injected (needling only). Participants in both groups carried out a standardised and monitored 12 week eccentric calf training programme. Follow-up was at one, two, three and six months. Main outcome measures The primary outcome measure was the change in symptoms and function from baseline to six months with the Victorian Institute of Sport Assessment-Achilles (VISA-A) score. Secondary outcomes were the participant's perceived rehabilitation and their ability to return to sport. Results 26 participants were randomly assigned to the treatment group and 27 to the control group. In total, 50 (94%) completed the six month study, with 25 in each group. Clear and clinically worthwhile improvements in the VISA-A score were evident at six months in both the treatment (change in score 18.7, 95% confidence interval 12.3 to 25.1) and control (19.9, 13.6 to 26.2) groups. The overall effect of treatment was not significant (P=0.689) and the 95% confidence intervals at all points precluded clinically meaningful benefit or harm. There was no significant difference between groups in secondary outcomes or in the levels of compliance with the eccentric calf strengthening programme. No adverse events were reported. Conclusion The administration of two unguided peritendinous autologous blood injections one month apart, in addition to a standardised eccentric training programme, provides no additional benefit in the treatment of mid-portion Achilles tendinopathy.	[Bell, Kevin J.] Sydney Sports Med Ctr, Sydney, NSW 2127, Australia; [Fulcher, Mark L.; Kerse, Ngaire] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand; [Rowlands, David S.] Massey Univ, Sch Sport & Exercise, Wellington, New Zealand	University of Auckland; Massey University	Bell, KJ (corresponding author), Sydney Sports Med Ctr, POB 3275, Rhodes, NSW 2138, Australia.	kevtherev77@hotmail.com	Kerse, Ngaire/AFF-8119-2022					Abbassian A, 2009, BRIT J HOSP MED, V70, P519, DOI 10.12968/hmed.2009.70.9.43869; Alfredson H, 2003, CLIN SPORT MED, V22, P727, DOI 10.1016/S0278-5919(03)00010-3; Alfredson H, 1998, AM J SPORT MED, V26, P360, DOI 10.1177/03635465980260030301; Alfredson Hakan, 2005, Foot Ankle Clin, V10, P321, DOI 10.1016/j.fcl.2005.01.002; ASTROM M, 1995, CLIN ORTHOP RELAT R, P151; Bisset L, 2006, BMJ-BRIT MED J, V333, P939, DOI 10.1136/bmj.38961.584653.AE; Brown R, 2006, BRIT J SPORT MED, V40, P275, DOI 10.1136/bjsm.2005.021931; Connell DA, 2006, SKELETAL RADIOL, V35, P371, DOI 10.1007/s00256-006-0081-9; Creaney L, 2011, BRIT J SPORT MED, V45, P966, DOI 10.1136/bjsm.2010.082503; de Jonge S, 2011, AM J SPORT MED, V39, P1623, DOI 10.1177/0363546511404877; de Vos RJ, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.032532; de Vos RJ, 2010, JAMA-J AM MED ASSOC, V303, P144, DOI 10.1001/jama.2009.1986; Edwards SG, 2003, J HAND SURG-AM, V28A, P272, DOI 10.1053/jhsu.2003.50041; Fredberg U, 2004, SCAND J RHEUMATOL, V33, P94, DOI 10.1080/03009740310004126; Gaweda K, 2010, INT J SPORTS MED, V31, P577, DOI 10.1055/s-0030-1255028; Iversen JV, 2012, INT J SPORTS PHYS TH, V7, P76; IWASAKI M, 1995, J BONE JOINT SURG AM, V77A, P543, DOI 10.2106/00004623-199504000-00007; James SLJ, 2007, BRIT J SPORT MED, V41, P518, DOI 10.1136/bjsm.2006.034686; Kajikawa Y, 2008, J CELL PHYSIOL, V215, P837, DOI 10.1002/jcp.21368; Kazemi M, 2010, AM J PHYS MED REHAB, V89, P660, DOI 10.1097/PHM.0b013e3181ddcb31; Kingma JJ, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.030916; Lake JE, 2009, FOOT ANKLE CLIN, V14, P663, DOI 10.1016/j.fcl.2009.07.003; LEADBETTER WB, 1995, CLIN SPORT MED, V14, P353; Longo UG, 2009, SPORTS MED ARTHROSC, V17, P112, DOI 10.1097/JSA.0b013e3181a3d625; Magnussen RA, 2009, CLIN J SPORT MED, V19, P54, DOI 10.1097/JSM.0b013e31818ef090; Mishra A, 2006, AM J SPORT MED, V34, P1774, DOI 10.1177/0363546506288850; Mokone GG, 2006, SCAND J MED SCI SPOR, V16, P19, DOI 10.1111/j.1600-0838.2005.00439.x; Ohta T, 2008, J BIOL CHEM, V283, P9377, DOI 10.1074/jbc.M709377200; Orchard J, 2008, CLIN ORTHOP RELAT R, V466, P1625, DOI 10.1007/s11999-008-0254-z; Ozturan Kutay E, 2010, Orthopedics, V33, P84, DOI 10.3928/01477447-20100104-09; Pearson J, 2012, J SPORT REHABIL, V21, P218, DOI 10.1123/jsr.21.3.218; Raleigh SM, 2009, BRIT J SPORT MED, V43, P514, DOI 10.1136/bjsm.2008.053892; Rasmussen S, 2008, ACTA ORTHOP, V79, P249, DOI 10.1080/17453670710015058; Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335; Rolf C, 1997, FOOT ANKLE INT, V18, P565, DOI 10.1177/107110079701800906; Rompe JD, 2007, AM J SPORT MED, V35, P374, DOI 10.1177/0363546506295940; Rompe JD, 2008, DISABIL REHABIL, V30, P1666, DOI 10.1080/09638280701785825; September AV, 2009, BRIT J SPORT MED, V43, P357, DOI 10.1136/bjsm.2008.048793; Snedecor G.W., 1989, AMES IOWA STATE U PR; Suresh SPS, 2006, BRIT J SPORT MED, V40, P935, DOI 10.1136/bjsm.2006.029983; Thanasas C, 2011, AM J SPORT MED, V39, P2130, DOI 10.1177/0363546511417113; Wolf JM, 2011, J HAND SURG-AM, V36A, P1269, DOI 10.1016/j.jhsa.2011.05.014; Yelland MJ, 2011, BRIT J SPORT MED, V45, P421, DOI 10.1136/bjsm.2009.057968; Zafar MS, 2009, SPORTS MED ARTHROSC, V17, P190, DOI 10.1097/JSA.0b013e3181b37eb7; Zeisig E, 2008, BRIT J SPORT MED, V42, P267, DOI 10.1136/bjsm.2007.042762	45	43	44	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2013	346								f2310	10.1136/bmj.f2310	http://dx.doi.org/10.1136/bmj.f2310			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131AZ	23599320	Green Published, hybrid			2022-12-28	WOS:000317964200006
J	Malinowski, JT; Sharpe, RJ; Johnson, JS				Malinowski, Justin T.; Sharpe, Robert J.; Johnson, Jeffrey S.			Enantioselective Synthesis of Pactamycin, a Complex Antitumor Antibiotic	SCIENCE			English	Article							ASYMMETRIC MANNICH REACTIONS; NATURAL-PRODUCTS; ACYL IMINES; CORE	Medicinal application of many complex natural products is precluded by the impracticality of their chemical synthesis. Pactamycin, the most structurally intricate aminocyclopentitol antibiotic, displays potent antiproliferative properties across multiple phylogenetic domains, but it is highly cytotoxic. A limited number of analogs produced by genetic engineering technologies show reduced cytotoxicity against mammalian cells, renewing promise for therapeutic applications. For decades, an efficient synthesis of pactamycin amenable to analog derivatizations has eluded researchers. Here, we present a short asymmetric total synthesis of pactamycin. An enantioselective Mannich reaction and symmetry-breaking reduction sequence was designed to enable assembly of the entire carbon core skeleton in under five steps and control critical three-dimensional (stereochemical) functional group relationships. This modular route totals 15 steps and is immediately amenable for structural analog synthesis.	[Malinowski, Justin T.; Sharpe, Robert J.; Johnson, Jeffrey S.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Johnson, JS (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	jsj@unc.edu			National Institute of General Medical Sciences [R01 GM084927]; American Chemical Society Division of Organic Chemistry; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084927] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Chemical Society Division of Organic Chemistry(American Chemical Society); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was supported by award no. R01 GM084927 from the National Institute of General Medical Sciences. J.T.M. acknowledges an American Chemical Society Division of Organic Chemistry graduate fellowship. R.J.S acknowledges an NSF graduate research fellowship. X-ray crystallography was performed by P. White (University of North Carolina). The Cambridge Crystallographic Data Centre (CCDC) contains the supplementary crystallographic data for this paper, under deposition no. 914582. These data can be obtained free of charge from via www.ccdc.cam.ac.uk/data_request/cif. A patent application on the route and compounds presented in this paper has been filed through the University of North Carolina.	Argoudelis A. D., 1962, ANTIMICROB AGENTS CH, V1962, P191; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Dinos G, 2004, MOL CELL, V13, P113, DOI 10.1016/S1097-2765(04)00002-4; DOBASHI K, 1986, J ANTIBIOT, V39, P1779, DOI 10.7164/antibiotics.39.1779; Drahl C, 2005, ANGEW CHEM INT EDIT, V44, P5788, DOI 10.1002/anie.200500900; Duchamp D. J., 1972, AM CRYST ASS WINT M; Hanessian S, 2011, ANGEW CHEM INT EDIT, V50, P3497, DOI 10.1002/anie.201008079; Hanessian S, 2012, J ORG CHEM, V77, P9458, DOI 10.1021/jo301638z; Haussener TJ, 2012, ORG LETT, V14, P3632, DOI 10.1021/ol301461e; Iwatsuki M, 2012, J ANTIBIOT, V65, P169, DOI 10.1038/ja.2011.136; Keasling JD, 2012, NATURE, V492, P188, DOI 10.1038/492188a; Knapp S, 2007, ORG LETT, V9, P1359, DOI 10.1021/ol0702472; Li Y, 2007, J ORG CHEM, V72, P2344, DOI 10.1021/jo061456n; Lou S, 2005, J AM CHEM SOC, V127, P11256, DOI 10.1021/ja0537373; Lu WL, 2011, CHEM BIOL, V18, P425, DOI 10.1016/j.chembiol.2011.01.016; Malinowski JT, 2012, ORG LETT, V14, P2878, DOI 10.1021/ol301140c; Matsumoto N, 2012, RSC ADV, V2, P9448, DOI 10.1039/c2ra21060f; Nakanishi K., 1999, COMPREHENSIVE NATURA, V1, P23; Otoguro K, 2010, J ANTIBIOT, V63, P381, DOI 10.1038/ja.2010.50; PEARLMAN WM, 1967, TETRAHEDRON LETT, P1663; Serrano P, 2002, J ORG CHEM, V67, P7165, DOI 10.1021/jo0261146; Shi L, 2010, ANGEW CHEM INT EDIT, V49, P9250, DOI 10.1002/anie.201005156; Ting A, 2006, ORG LETT, V8, P2003, DOI 10.1021/ol060304b; Trost BM, 1999, J AM CHEM SOC, V121, P6183, DOI 10.1021/ja9901821; Tsujimoto T, 2005, SYNLETT, P433, DOI 10.1055/s-2004-837223; VERLAAK JMJ, 1982, TETRAHEDRON LETT, V23, P5463; von Nussbaum F, 2006, ANGEW CHEM INT EDIT, V45, P5072, DOI 10.1002/anie.200600350; WELLER DD, 1978, J ANTIBIOT, V31, P997, DOI 10.7164/antibiotics.31.997; WILEY PF, 1970, J ORG CHEM, V35, P1420, DOI 10.1021/jo00830a035	30	78	78	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129					180	182		10.1126/science.1234756	http://dx.doi.org/10.1126/science.1234756			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580525	Green Accepted, Green Submitted			2022-12-28	WOS:000317341400051
J	Salimpoor, VN; van den Bosch, I; Kovacevic, N; McIntosh, AR; Dagher, A; Zatorre, RJ				Salimpoor, Valorie N.; van den Bosch, Iris; Kovacevic, Natasa; McIntosh, Anthony Randal; Dagher, Alain; Zatorre, Robert J.			Interactions Between the Nucleus Accumbens and Auditory Cortices Predict Music Reward Value	SCIENCE			English	Article							DOPAMINE; ERRORS; BRAIN; STRIATUM; CORTEX	We used functional magnetic resonance imaging to investigate neural processes when music gains reward value the first time it is heard. The degree of activity in the mesolimbic striatal regions, especially the nucleus accumbens, during music listening was the best predictor of the amount listeners were willing to spend on previously unheard music in an auction paradigm. Importantly, the auditory cortices, amygdala, and ventromedial prefrontal regions showed increased activity during listening conditions requiring valuation, but did not predict reward value, which was instead predicted by increasing functional connectivity of these regions with the nucleus accumbens as the reward value increased. Thus, aesthetic rewards arise from the interaction between mesolimbic reward circuitry and cortical networks involved in perceptual analysis and valuation.	[Salimpoor, Valorie N.; Dagher, Alain; Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Salimpoor, Valorie N.; Kovacevic, Natasa; McIntosh, Anthony Randal] Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [Salimpoor, Valorie N.; Zatorre, Robert J.] BRAMS Int Lab Brain Mus & Sound Res, Montreal, PQ, Canada; [van den Bosch, Iris] Univ Utrecht, NL-3508 TC Utrecht, Netherlands	McGill University; University of Toronto; University Toronto Affiliates; Baycrest; Universite de Montreal; Utrecht University	Salimpoor, VN (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	vsalimpoor@research.baycrest.org		McIntosh, Anthony/0000-0002-1784-5662	Canadian Institutes for Health Research; Canada Fund for Innovation; Natural Science and Engineering Research Council (CREATE); Montreal Neurological Institute (MNI); Centre for Interdisciplinary Research in Music Media and Technology	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Fund for Innovation(Canada Foundation for Innovation); Natural Science and Engineering Research Council (CREATE); Montreal Neurological Institute (MNI); Centre for Interdisciplinary Research in Music Media and Technology	Funding for this work was provided via grants from the Canadian Institutes for Health Research and the Canada Fund for Innovation (to R.J.Z.) and awards from the Natural Science and Engineering Research Council (CREATE), Montreal Neurological Institute (MNI), and the Centre for Interdisciplinary Research in Music Media and Technology (to V.N.S.). We thank the staff of the MNI McConnell Brain Imaging Centre. The authors have no conflicts of interest to report.	BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Bharucha J. J., 1994, MUSICAL PERCEPTIONS, P213; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Conard NJ, 2009, NATURE, V460, P737, DOI 10.1038/nature08169; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Huron D.B., 2006, SWEET ANTICIPATION M; Koelsch S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00110; Koelsch S, 2010, TRENDS COGN SCI, V14, P131, DOI 10.1016/j.tics.2010.01.002; Kuss K, 2013, SOC COGN AFFECT NEUR, V8, P216, DOI 10.1093/scan/nsr088; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; MELIS MR, 1995, NEUROSCI BIOBEHAV R, V19, P19, DOI 10.1016/0149-7634(94)00020-2; Meyer L., 1956, EMOTION MEANING MUSI; Niv Y, 2012, J NEUROSCI, V32, P551, DOI 10.1523/JNEUROSCI.5498-10.2012; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Wong DF, 2006, NEUROPSYCHOPHARMACOL, V31, P2716, DOI 10.1038/sj.npp.1301194; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zatorre RJ, 2012, SPRINGER HANDB AUDIT, V43, P261, DOI 10.1007/978-1-4614-2314-0_10	26	323	333	8	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					216	219		10.1126/science.1231059	http://dx.doi.org/10.1126/science.1231059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580531				2022-12-28	WOS:000317341400060
J	Spence, D				Spence, Des			The doctor won't see you now	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], 2012, GUARDIAN; Black L-A, 2012, CONSULTANT LED OUTPA; Imison Candace, 2010, REFERRAL MANAGEMENT; Kings Fund, GEN EL 2010 FREQ ASK	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 12	2013	346								f2323	10.1136/bmj.f2323	http://dx.doi.org/10.1136/bmj.f2323			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126AB	23585069				2022-12-28	WOS:000317582400006
J	Drife, JO				Drife, James Owen			A grandad writes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												J.O.Drife@leeds.ac.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2013	346								f2214	10.1136/bmj.f2214	http://dx.doi.org/10.1136/bmj.f2214			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	125ZC	23571742				2022-12-28	WOS:000317579800007
J	Ribas, A; Hodi, FS; Callahan, M; Konto, C; Wolchok, J				Ribas, Antoni; Hodi, F. Stephen; Callahan, Margaret; Konto, Cyril; Wolchok, Jedd			Hepatotoxicity with Combination of Vemurafenib and Ipilimumab	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							ANTITUMOR-ACTIVITY; IMMUNOTHERAPY; MELANOMA		[Ribas, Antoni] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Hodi, F. Stephen] Dana Farber Canc Inst, Boston, MA 02115 USA; [Callahan, Margaret; Wolchok, Jedd] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Konto, Cyril] Bristol Myers Squibb Co, Wallingford, CT 06492 USA	University of California System; University of California Los Angeles; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Bristol-Myers Squibb	Ribas, A (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90024 USA.	wolchokj@mskcc.org			NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; Comin-Anduix B, 2010, CLIN CANCER RES, V16, P6040, DOI 10.1158/1078-0432.CCR-10-1911; Koya RC, 2012, CANCER RES, V72, P3928, DOI 10.1158/0008-5472.CAN-11-2837; Liu CW, 2013, CLIN CANCER RES, V19, P393, DOI 10.1158/1078-0432.CCR-12-1626; McArthur GA, 2013, J CLIN ONCOL, V31, P499, DOI 10.1200/JCO.2012.45.5568	5	565	580	2	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1365	1366		10.1056/NEJMc1302338	http://dx.doi.org/10.1056/NEJMc1302338			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117YT	23550685				2022-12-28	WOS:000316989900026
J	Dantzer, B; Newman, AEM; Boonstra, R; Palme, R; Boutin, S; Humphries, MM; McAdam, AG				Dantzer, Ben; Newman, Amy E. M.; Boonstra, Rudy; Palme, Rupert; Boutin, Stan; Humphries, Murray M.; McAdam, Andrew G.			Density Triggers Maternal Hormones That Increase Adaptive Offspring Growth in a Wild Mammal	SCIENCE			English	Article							FEMALE RED SQUIRRELS; CORTICOSTEROID RECEPTORS; STRESS-RESPONSE; PRENATAL STRESS; NATURAL-POPULATION; BEHAVIOR; SELECTION; SURVIVAL; REPRODUCTION; LACTATION	In fluctuating environments, mothers may enhance the fitness of their offspring by adjusting offspring phenotypes to match the environment they will experience at independence. In free-ranging red squirrels, natural selection on offspring postnatal growth rates varies according to population density, with selection favoring faster-growing offspring under high-density conditions. We show that exposing mothers to high-density cues, accomplished via playbacks of territorial vocalizations, led to increased offspring growth rates in the absence of additional food resources. Experimental elevation of actual and perceived density induced higher maternal glucocorticoid levels, and females with naturally or experimentally increased glucocorticoids produced offspring that grew faster than controls. Therefore, social cues reflecting population density were sufficient to elicit increased offspring growth through an adaptive hormone-mediated maternal effect.	[Dantzer, Ben; McAdam, Andrew G.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Newman, Amy E. M.; McAdam, Andrew G.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Boonstra, Rudy] Univ Toronto Scarborough, Ctr Neurobiol Stress, Toronto, ON M1C 1A4, Canada; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci Biochem, A-1210 Vienna, Austria; [Boutin, Stan] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Humphries, Murray M.] McGill Univ, Ste Anne De Bellevue, PQ H9X 3V9, Canada	Michigan State University; University of Guelph; University of Toronto; University Toronto Scarborough; University of Veterinary Medicine Vienna; University of Alberta; McGill University	Dantzer, B (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	bendantzer@gmail.com	McAdam, Andrew G/G-1802-2010; Boutin, Stan A/A-2619-2014; Palme, Rupert/A-3499-2008; Dantzer, Ben/E-9779-2011	McAdam, Andrew G/0000-0001-7323-2572; Boutin, Stan A/0000-0001-6317-038X; Palme, Rupert/0000-0001-9466-3662; Dantzer, Ben/0000-0002-3058-265X; Newman, Amy E. M./0000-0003-1005-8380	Natural Sciences and Engineering Research Council of Canada; NSF [DEB-0515849, IOS-1110436]; Ontario Ministry of Research Innovation; Kluane Red Squirrel Project [69]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSF(National Science Foundation (NSF)); Ontario Ministry of Research Innovation(Ministry of Research and Innovation, Ontario); Kluane Red Squirrel Project	We thank Agnes Moose and family for access to their traditional trapping area; F. E. Stewart, S. E. Evans, S. E. McFarlane, Q. E. Fletcher, S. Hossain, R. W. Taylor, and all squirrelers for assistance; A. Sykes and E. Anderson for data management; and A. Charmantier, T. Getty, K. E. Holekamp, J. S. Lonstein, C. T. Williams, T. D. Williams, and three anonymous reviewers for incisive comments. Funded by Natural Sciences and Engineering Research Council of Canada, NSF (DEB-0515849 and IOS-1110436), and Ontario Ministry of Research Innovation. Data have been deposited in the Dryad Repository (http://dx.doi.org/10.5061/dryad.b3h4q). This is publication no. 69 of the Kluane Red Squirrel Project.	Bates D., 2008, LME4 LINEAR MIXED EF; BECKER CD, 1993, CAN J ZOOL, V71, P1326, DOI 10.1139/z93-183; Berteaux D, 2000, ECOLOGY, V81, P1311, DOI 10.1890/0012-9658(2000)081[1311:BDIFNA]2.0.CO;2; Boonstra R, 2013, FUNCT ECOL, V27, P11, DOI 10.1111/1365-2435.12008; BOUTIN S, 1993, J ANIM ECOL, V62, P364, DOI 10.2307/5367; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Boutin S, 2006, SCIENCE, V314, P1928, DOI 10.1126/science.1135520; Casolini P, 1997, NEUROSCIENCE, V79, P1005, DOI 10.1016/S0306-4522(96)00668-9; Catalani A, 2000, NEUROSCIENCE, V100, P319, DOI 10.1016/S0306-4522(00)00277-3; Catalani A, 2002, PHARMACOL BIOCHEM BE, V73, P105, DOI 10.1016/S0091-3057(02)00755-4; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Dantzer B, 2012, BEHAV ECOL SOCIOBIOL, V66, P865, DOI 10.1007/s00265-012-1335-2; Dantzer B, 2011, GEN COMP ENDOCR, V174, P124, DOI 10.1016/j.ygcen.2011.08.010; Dantzer B, 2011, ANIM BEHAV, V81, P469, DOI 10.1016/j.anbehav.2010.11.021; Dantzer B, 2010, GEN COMP ENDOCR, V167, P279, DOI 10.1016/j.ygcen.2010.03.024; Descamps S, 2008, J ANIM ECOL, V77, P305, DOI 10.1111/j.1365-2656.2007.01340.x; Descamps S, 2009, P ROY SOC B-BIOL SCI, V276, P1129, DOI 10.1098/rspb.2008.1401; Digweed SM, 2012, CURR ZOOL, V58, P758, DOI 10.1093/czoolo/58.5.758; Drake AJ, 2005, AM J PHYSIOL-REG I, V288, pR34, DOI 10.1152/ajpregu.00106.2004; Elton CS, 1924, BR J EXP BIOL, V2, P119; Fletcher QE, 2010, ECOLOGY, V91, P2673, DOI 10.1890/09-1816.1; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Humphries MM, 1996, J ANIM ECOL, V65, P332, DOI 10.2307/5879; Humphries MM, 2000, ECOLOGY, V81, P2867, DOI 10.2307/177347; KUHN CM, 1990, DEV PSYCHOBIOL, V23, P395, DOI 10.1002/dev.420230503; Lamontagne JM, 2007, J ECOL, V95, P991, DOI 10.1111/j.1365-2745.2007.01266.x; LARSEN KW, 1994, ECOLOGY, V75, P214, DOI 10.2307/1939395; LEVINS R, 1968, EVOLUT CHANGING ENV; Love OP, 2008, AM NAT, V172, pE135, DOI 10.1086/590959; MacColl ADC, 2011, TRENDS ECOL EVOL, V26, P514, DOI 10.1016/j.tree.2011.06.009; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Mateo JM, 2008, NEUROBIOL LEARN MEM, V89, P582, DOI 10.1016/j.nlm.2007.11.002; McAdam AG, 2004, P ROY SOC B-BIOL SCI, V271, P75, DOI 10.1098/rspb.2003.2572; McAdam AG, 2003, EVOLUTION, V57, P1689; McAdam AG, 2002, EVOLUTION, V56, P846; Mcadam AG, 2007, ECOSCIENCE, V14, P362, DOI 10.2980/1195-6860(2007)14[362:LHOFRS]2.0.CO;2; MOORE CL, 1986, DEV PSYCHOBIOL, V19, P235, DOI 10.1002/dev.420190309; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Mueller BR, 2006, PHYSIOL BEHAV, V88, P605, DOI 10.1016/j.physbeh.2006.05.019; Pinheiro JC, 2009, MIXED EFFECTS MODELS; *R DEV COR TEAM, 2008, R LANGUAGE ENVIRON; Reale D, 2003, EVOLUTION, V57, P2416; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Shonfield J., 2010, THESIS; SMITH CC, 1968, ECOL MONOGR, V38, P31, DOI 10.2307/1948536; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; WADE MJ, 1990, EVOLUTION, V44, P1947, DOI [10.2307/2409605, 10.1111/j.1558-5646.1990.tb04301.x]; WASSER SK, 1993, J REPROD FERTIL, V97, P569, DOI 10.1530/jrf.0.0970569; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x	53	264	265	3	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1215	1217		10.1126/science.1235765	http://dx.doi.org/10.1126/science.1235765			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23599265				2022-12-28	WOS:000319972800045
J	Wang, F; Travins, J; DeLaBarre, B; Penard-Lacronique, V; Schalm, S; Hansen, E; Straley, K; Kernytsky, A; Liu, W; Gliser, C; Yang, H; Gross, S; Artin, E; Saada, V; Mylonas, E; Quivoron, C; Popovici-Muller, J; Saunders, JO; Salituro, FG; Yan, SQ; Murray, S; Wei, WT; Gao, Y; Dang, L; Dorsch, M; Agresta, S; Schenkein, DP; Biller, SA; Su, SM; de Botton, S; Yen, KE				Wang, Fang; Travins, Jeremy; DeLaBarre, Byron; Penard-Lacronique, Virginie; Schalm, Stefanie; Hansen, Erica; Straley, Kimberly; Kernytsky, Andrew; Liu, Wei; Gliser, Camelia; Yang, Hua; Gross, Stefan; Artin, Erin; Saada, Veronique; Mylonas, Elena; Quivoron, Cyril; Popovici-Muller, Janeta; Saunders, Jeffrey O.; Salituro, Francesco G.; Yan, Shunqi; Murray, Stuart; Wei, Wentao; Gao, Yi; Dang, Lenny; Dorsch, Marion; Agresta, Sam; Schenkein, David P.; Biller, Scott A.; Su, Shinsan M.; de Botton, Stephane; Yen, Katharine E.			Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation	SCIENCE			English	Article							ONCOMETABOLITE 2-HYDROXYGLUTARATE; HEMATOPOIETIC PROGENITORS; ISOCITRATE DEHYDROGENASE; MUTATION; SUFFICIENT	A number of human cancers harbor somatic point mutations in the genes encoding isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2). These mutations alter residues in the enzyme active sites and confer a gain-of-function in cancer cells, resulting in the accumulation and secretion of the oncometabolite (R)-2-hydroxyglutarate (2HG). We developed a small molecule, AGI-6780, that potently and selectively inhibits the tumor-associated mutant IDH2/R140Q. A crystal structure of AGI-6780 complexed with IDH2/R140Q revealed that the inhibitor binds in an allosteric manner at the dimer interface. The results of steady-state enzymology analysis were consistent with allostery and slow-tight binding by AGI-6780. Treatment with AGI-6780 induced differentiation of TF-1 erythroleukemia and primary human acute myelogenous leukemia cells in vitro. These data provide proof-of-concept that inhibitors targeting mutant IDH2/R140Q could have potential applications as a differentiation therapy for cancer.	[Wang, Fang; Travins, Jeremy; DeLaBarre, Byron; Schalm, Stefanie; Hansen, Erica; Straley, Kimberly; Kernytsky, Andrew; Liu, Wei; Gliser, Camelia; Yang, Hua; Gross, Stefan; Artin, Erin; Popovici-Muller, Janeta; Saunders, Jeffrey O.; Salituro, Francesco G.; Murray, Stuart; Dang, Lenny; Dorsch, Marion; Agresta, Sam; Schenkein, David P.; Biller, Scott A.; Su, Shinsan M.; Yen, Katharine E.] Agios Pharmaceut, Cambridge, MA 02139 USA; [Penard-Lacronique, Virginie; Mylonas, Elena; Quivoron, Cyril; de Botton, Stephane] INSERM, U985, F-94805 Villejuif, France; [Penard-Lacronique, Virginie; Saada, Veronique; Mylonas, Elena; Quivoron, Cyril; de Botton, Stephane] Inst Gustave Roussy, F-94805 Villejuif, France; [Penard-Lacronique, Virginie; Mylonas, Elena; Quivoron, Cyril; de Botton, Stephane] Univ Paris 11, F-91405 Orsay, France; [Yan, Shunqi] Schrodinger Inc, New York, NY 10036 USA; [Wei, Wentao] Viva Biotech, Shanghai 201201, Peoples R China; [Gao, Yi] Shanghai ChemPartner Co, Pudong New Area, Shanghai 201203, Peoples R China	Agios Pharmaceuticals; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Yen, KE (corresponding author), Agios Pharmaceut, Cambridge, MA 02139 USA.	katharine.yen@agios.com	Penard-Lacronique, Virginie/R-1938-2019; Penard-Lacronique, Virginie/E-5729-2016	Penard-Lacronique, Virginie/0000-0001-9435-7331; Penard-Lacronique, Virginie/0000-0001-9435-7331; Dang, Lenny/0000-0002-2073-6109; Quivoron, Cyril/0000-0002-9871-0187; Mylonas, Elena/0000-0001-6831-969X; Veronique, SAADA/0000-0001-8021-9050; DE BOTTON, stephane/0000-0002-8126-4942				Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Fathi AT, 2012, BLOOD, V120, P4649, DOI 10.1182/blood-2012-06-438267; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Huss R, 2000, STEM CELLS, V18, P252, DOI 10.1634/stemcells.18-4-252; Jin GL, 2013, CANCER RES, V73, P496, DOI 10.1158/0008-5472.CAN-12-2852; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Peng YJ, 2008, PROTEIN SCI, V17, P1542, DOI 10.1110/ps.035675.108; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Pronier E, 2011, BLOOD, V118, P2551, DOI 10.1182/blood-2010-12-324707; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang B, 2010, CELL RES, V20, P1188, DOI 10.1038/cr.2010.145; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444	22	583	634	3	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					622	626		10.1126/science.1234769	http://dx.doi.org/10.1126/science.1234769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23558173				2022-12-28	WOS:000318268900051
J	Chopra, M; Mason, E; Borrazzo, J; Campbell, H; Rudan, I; Liu, L; Black, RE; Bhutta, ZA				Chopra, Mickey; Mason, Elizabeth; Borrazzo, John; Campbell, Harry; Rudan, Igor; Liu, Li; Black, Robert E.; Bhutta, Zulfiqar A.			Ending of preventable deaths from pneumonia and diarrhoea: an achievable goal	LANCET			English	Article							CHILD-MORTALITY; INTEGRATED MANAGEMENT; BANGLADESH; COUNTDOWN; ILLNESS; TRENDS; IMPACT; CARE	Global under-5 mortality has fallen rapidly from 12 million deaths in 1990, to 6.9 million in 2011; however, this number still falls short of the target of a two-thirds reduction or a maximum of 4 million deaths by 2015. Acceleration of reductions in deaths due to pneumonia and diarrhoea, which together account for about 2 million child deaths every year, is essential if the target is to be met. Scaling up of existing interventions against the two diseases to 80% and immunisation to 90% would eliminate more than two-thirds of deaths from these two diseases at a cost of US$6.715 billion by 2025. Modelling in this report shows that if all countries could attain the rates of decline of the regional leaders, then cause-specific death rates of fewer than three deaths per 1000 livebirths from pneumonia and less than one death per 1000 livebirths from diarrhoea could be achieved by 2025. These rates are those at which preventable deaths have been avoided. Increasing of awareness of the size of the problem; strengthening of leadership, intersectoral collaboration, and resource mobilisation; and increasing of efficiency through the selection of the optimum mix of a growing set of cost-effective interventions depending on local contexts are the priority actions needed to achieve the goal of ending preventable deaths from pneumonia and diarrhoea by 2025.	[Chopra, Mickey] UNICEF, New York, NY 10017 USA; [Mason, Elizabeth] WHO, CH-1211 Geneva, Switzerland; [Borrazzo, John] US Agcy Int Dev, Washington, DC 20523 USA; [Campbell, Harry; Rudan, Igor] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Liu, Li; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Bhutta, Zulfiqar A.] Aga Khan Univ, Karachi, Pakistan	UNICEF; World Health Organization; United States Agency for International Development (USAID); University of Edinburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Aga Khan University	Chopra, M (corresponding author), UNICEF, 3 United Nations Plaza, New York, NY 10017 USA.	mchopra@unicef.org	Campbell, Harry/E-2959-2010; liu, li/HGC-0900-2022; Rudan, Igor/I-1467-2012	Campbell, Harry/0000-0002-6169-6262; Rudan, Igor/0000-0001-6993-6884; Black, Robert/0000-0001-9926-7984	Bill & Melinda Gates Foundation; Bloomberg School of Public Health Johns Hopkins University; Boston University School of Public Health; Program for Global Pediatric Research, Hospital for Sick Children, Toronto	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Bloomberg School of Public Health Johns Hopkins University; Boston University School of Public Health; Program for Global Pediatric Research, Hospital for Sick Children, Toronto	The work summarised in this Series was supported by an unrestricted grant from the Bill & Melinda Gates Foundation to the Aga Khan University and through it to collaborating universities and institutions (Bloomberg School of Public Health Johns Hopkins University; Boston University School of Public Health; and Program for Global Pediatric Research, Hospital for Sick Children, Toronto). The funding agency had no influence or control over the content and process for the development of this Series. The contents of this article are the responsibility of the authors and do not necessarily reflect the views of the United States Agency for International Development or the United States Government.	Amaral J, 2005, HEALTH POLICY PLANN, V20, pI42, DOI 10.1093/heapol/czi058; Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Bhutta ZA, 2013, LANCET; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES H; Feng Xing Lin, 2012, J Glob Health, V2, P010405, DOI 10.7189/jogh.02.010405; Fischer Walker CL, 2013, LANCET; Fontaine O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000041; Gill CJ, 2013, LANCET; Institute of Development Studies, 2011, COMM LED TOT SAN; Isanaka S, 2012, B WORLD HEALTH ORGAN, V90, P635, DOI 10.2471/BLT.12.109504; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Matlin SA, 2009, MONITORING FINANCIAL; Nannine N, 2010, UNDER 5 MORTALITY ST; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; Rudan I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000308; Sayem AM, 2011, J HEALTH POPUL NUTR, V29, P92; Schellenberg JA, 2004, HEALTH POLICY PLANN, V19, P1, DOI 10.1093/heapol/czh001; UNICEF, 2011, LEV TRENDS CHILD MOR; UNICEF and WHO, 2012, PROGR DRINKING WATER; UNICEF Press Centre, 2015, NIG LAUNCH IN SAV ON; USAID, PUBL PRIV PARTN INTR; USAID, 2010, INTR IMPR TREATM CHI; Waters Donald, 2012, J Glob Health, V2, P020402, DOI 10.7189/jogh.02.020402; Wegman ME, 2001, J NUTR, V131, p401S, DOI 10.1093/jn/131.2.401S; You DZ, 2010, LANCET, V376, P931, DOI 10.1016/S0140-6736(10)61429-8	28	77	78	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 27	2013	381	9876					1499	1506		10.1016/S0140-6736(13)60319-0	http://dx.doi.org/10.1016/S0140-6736(13)60319-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139TK	23582721				2022-12-28	WOS:000318607300039
J	Chew, E; Juneja, S				Chew, Edward; Juneja, Surender			Botryoid White-Cell Nuclei	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chew, Edward; Juneja, Surender] Royal Melbourne Hosp, Melbourne, Vic, Australia	Royal Melbourne Hospital	Chew, E (corresponding author), Royal Melbourne Hosp, Melbourne, Vic, Australia.		Juneja, Surender K/H-9017-2019						0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					E22	E22		10.1056/NEJMicm1214467	http://dx.doi.org/10.1056/NEJMicm1214467			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130YK	23614606				2022-12-28	WOS:000317956300001
J	Gostin, LO; Buckley, GJ; Kelley, PW				Gostin, Lawrence O.; Buckley, Gillian J.; Kelley, Patrick W.			Stemming the Global Trade in Falsified and Substandard Medicines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DRUGS		[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, Washington, DC 20001 USA; [Buckley, Gillian J.; Kelley, Patrick W.] Natl Acad Sci, Inst Med, Board Global Hlth, Washington, DC 20418 USA	Georgetown University; National Academies of Sciences, Engineering & Medicine	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Arie S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e951; Bate R, 2013, INT J TUBERC LUNG D, V17, P308, DOI 10.5588/ijtld.12.0355; Centers for Disease Control and Prevention, MULTISTATE FUNGAL ME; Institute of Medicine of the National Academies, 2013, COUNTERING THE PROBL; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; United Nations Office on Drugs and Crime, 2009, TRANSNATIONAL TRAFFI; World Health Organization, 2012, BUILDING GLOBAL CAPA	7	23	23	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1693	1694		10.1001/jama.2013.3048	http://dx.doi.org/10.1001/jama.2013.3048			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130IG	23579391	Green Published			2022-12-28	WOS:000317906700024
J	Riechers, DA; Bradford, CM; Clements, DL; Dowell, CD; Perez-Fournon, I; Ivison, RJ; Bridge, C; Conley, A; Fu, H; Vieira, JD; Wardlow, J; Calanog, J; Cooray, A; Hurley, P; Neri, R; Kamenetzky, J; Aguirre, JE; Altieri, B; Arumugam, V; Benford, DJ; Bethermin, M; Bock, J; Burgarella, D; Cabrera-Lavers, A; Chapman, SC; Cox, P; Dunlop, JS; Earle, L; Farrah, D; Ferrero, P; Franceschini, A; Gavazzi, R; Glenn, J; Solares, EAG; Gurwell, MA; Halpern, M; Hatziminaoglou, E; Hyde, A; Ibar, E; Kovacs, A; Krips, M; Lupu, RE; Maloney, PR; Martinez-Navajas, P; Matsuhara, H; Murphy, EJ; Naylor, BJ; Nguyen, HT; Oliver, SJ; Omont, A; Page, MJ; Petitpas, G; Rangwala, N; Roseboom, IG; Scott, D; Smith, AJ; Staguhn, JG; Streblyanska, A; Thomson, AP; Valtchanov, I; Viero, M; Wang, L; Zemcov, M; Zmuidzinas, J				Riechers, Dominik A.; Bradford, C. M.; Clements, D. L.; Dowell, C. D.; Perez-Fournon, I.; Ivison, R. J.; Bridge, C.; Conley, A.; Fu, Hai; Vieira, J. D.; Wardlow, J.; Calanog, J.; Cooray, A.; Hurley, P.; Neri, R.; Kamenetzky, J.; Aguirre, J. E.; Altieri, B.; Arumugam, V.; Benford, D. J.; Bethermin, M.; Bock, J.; Burgarella, D.; Cabrera-Lavers, A.; Chapman, S. C.; Cox, P.; Dunlop, J. S.; Earle, L.; Farrah, D.; Ferrero, P.; Franceschini, A.; Gavazzi, R.; Glenn, J.; Solares, E. A. Gonzalez; Gurwell, M. A.; Halpern, M.; Hatziminaoglou, E.; Hyde, A.; Ibar, E.; Kovacs, A.; Krips, M.; Lupu, R. E.; Maloney, P. R.; Martinez-Navajas, P.; Matsuhara, H.; Murphy, E. J.; Naylor, B. J.; Nguyen, H. T.; Oliver, S. J.; Omont, A.; Page, M. J.; Petitpas, G.; Rangwala, N.; Roseboom, I. G.; Scott, D.; Smith, A. J.; Staguhn, J. G.; Streblyanska, A.; Thomson, A. P.; Valtchanov, I.; Viero, M.; Wang, L.; Zemcov, M.; Zmuidzinas, J.			A dust-obscured massive maximum-starburst galaxy at a redshift of 6.34	NATURE			English	Article							STAR-FORMING GALAXIES; MOLECULAR GAS; SUBMILLIMETER GALAXIES; HOST GALAXY; QUASARS; DISKS	Massive present-day early-type (elliptical and lenticular) galaxies probably gained the bulk of their stellar mass and heavy elements through intense, dust-enshrouded starbursts-that is, increased rates of star formation-in the most massive dark-matter haloes at early epochs. However, it remains unknown how soon after the Big Bang massive starburst progenitors exist. The measured redshift (z) distribution of dusty, massive starbursts has long been suspected to be biased low in z owing to selection effects(1), as confirmed by recent findings of systems with redshifts as high as similar to 5 (refs 2-4). Here we report the identification of a massive starburst galaxy at z = 6.34 through a submillimetre colour-selection technique. We unambiguously determined the redshift from a suite of molecular and atomic fine-structure cooling lines. These measurements reveal a hundred billion solar masses of highly excited, chemically evolved interstellar medium in this galaxy, which constitutes at least 40 per cent of the baryonic mass. A 'maximum starburst' converts the gas into stars at a rate more than 2,000 times that of the Milky Way, a rate among the highest observed at any epoch. Despite the overall downturn in cosmic star formation towards the highest redshifts(5), it seems that environments mature enough to form the most massive, intense starbursts existed at least as early as 880 million years after the Big Bang.	[Riechers, Dominik A.; Bradford, C. M.; Dowell, C. D.; Bridge, C.; Vieira, J. D.; Cooray, A.; Bock, J.; Kovacs, A.; Murphy, E. J.; Nguyen, H. T.; Viero, M.; Zemcov, M.; Zmuidzinas, J.] CALTECH, 1200 East Calif Blvd,MC 249-17, Pasadena, CA 91125 USA; [Riechers, Dominik A.] Cornell Univ, Ithaca, NY 14853 USA; [Bradford, C. M.; Dowell, C. D.; Bock, J.; Naylor, B. J.; Nguyen, H. T.; Zemcov, M.; Zmuidzinas, J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Clements, D. L.; Hyde, A.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Astrophys Grp, London SW7 2AZ, England; [Perez-Fournon, I.; Cabrera-Lavers, A.; Ferrero, P.; Martinez-Navajas, P.; Streblyanska, A.] Inst Astrofis Canarias, E-38200 Tenerife, Spain; [Perez-Fournon, I.; Cabrera-Lavers, A.; Ferrero, P.; Martinez-Navajas, P.; Streblyanska, A.] Univ La Laguna, Dept Astrofis, E-38205 Tenerife, Spain; [Ivison, R. J.; Ibar, E.] Royal Observ, UK Astron Technol Ctr, Edinburgh EH9 3HJ, Midlothian, Scotland; [Ivison, R. J.; Arumugam, V.; Dunlop, J. S.; Roseboom, I. G.; Thomson, A. P.] Univ Edinburgh, Royal Observ, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland; [Conley, A.; Earle, L.; Glenn, J.; Maloney, P. R.] Univ Colorado, Ctr Astrophys & Space Astron UCB 389, Boulder, CO 80309 USA; [Fu, Hai; Wardlow, J.; Calanog, J.; Cooray, A.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Hurley, P.; Oliver, S. J.; Roseboom, I. G.; Smith, A. J.; Wang, L.] Univ Sussex, Dept Phys & Astron, Ctr Astron, Brighton BN1 9QH, E Sussex, England; [Neri, R.; Cox, P.; Krips, M.] Inst Radio Astron Millimetr, F-38406 St Martin Dheres, France; [Kamenetzky, J.; Glenn, J.; Rangwala, N.] Univ Colorado, Dept Astrophys & Planetary Sci, CASA UCB 389, Boulder, CO 80309 USA; [Aguirre, J. E.; Lupu, R. E.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Altieri, B.; Valtchanov, I.] European Space Astron Ctr, Herschel Sci Ctr, Madrid 28691, Spain; [Benford, D. J.; Staguhn, J. G.] NASA, Observat Cosmol Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Bethermin, M.] Univ Paris Diderot, CEA Saclay, Lab AIM Paris Saclay, CEA,DSM,Irfu,CNRS, F-91191 Gif Sur Yvette, France; [Bethermin, M.] Univ Paris Sud, Univ Pris 11, Inst Astrophys Spatiale IAS, F-91405 Orsay, France; [Bethermin, M.] CNRS, UMR 8617, F-91405 Orsay, France; [Burgarella, D.] Aix Marseille Univ, CNRS, Lab Astrophys Marseille, UMR7326, F-13388 Marseille, France; [Cabrera-Lavers, A.] Grantecan SA, Ctr Astrofis La Palma, E-38712 Brena Baja, La Palma, Spain; [Chapman, S. C.; Solares, E. A. Gonzalez] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Farrah, D.] Virginia Tech, Dept Phys, Blacksburg, VA 24061 USA; [Franceschini, A.] Univ Padua, Dipartimento Fis & Astron, I-35122 Padua, Italy; [Gavazzi, R.; Omont, A.] Univ Paris 06, CNRS, Inst Astrophys Paris, UMR 7095, F-75014 Paris, France; [Gurwell, M. A.; Petitpas, G.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Halpern, M.; Scott, D.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Hatziminaoglou, E.] ESO, D-85748 Garching, Germany; [Kovacs, A.] Univ Minnesota, Inst Astrophys, Minneapolis, MN 55455 USA; [Matsuhara, H.] Japan Aerosp & Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Murphy, E. J.] CALTECH, Infrared Proc & Anal Ctr, Pasadena, CA 91125 USA; [Page, M. J.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Staguhn, J. G.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA	California Institute of Technology; Cornell University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Imperial College London; Instituto de Astrofisica de Canarias; Universidad de la Laguna; University of Edinburgh; University of Edinburgh; University of Colorado System; University of Colorado Boulder; University of California System; University of California Irvine; University of Sussex; University of Colorado System; University of Colorado Boulder; University of Pennsylvania; European Space Agency; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; University of Cambridge; Virginia Polytechnic Institute & State University; University of Padua; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of British Columbia; University of Minnesota System; University of Minnesota Twin Cities; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); California Institute of Technology; University of London; University College London; Johns Hopkins University	Riechers, DA (corresponding author), CALTECH, 1200 East Calif Blvd,MC 249-17, Pasadena, CA 91125 USA.	dr@astro.cornell.edu	Kovacs, Attila/C-1171-2010; Perez-Fournon, Ismael/AAG-9049-2019; Ibar, Edo/AAI-5516-2020; Wardlow, Julie L/C-9903-2015; Benford, Dominic/D-4760-2012; Ivison, R. J./G-4450-2011; Lupu, Roxana/P-9060-2014; Murphy, Eric/AAE-8450-2021	Kovacs, Attila/0000-0001-8991-9088; Perez-Fournon, Ismael/0000-0002-2807-6459; Wardlow, Julie L/0000-0003-2376-8971; Benford, Dominic/0000-0002-9884-4206; Ivison, R. J./0000-0001-5118-1313; Lupu, Roxana/0000-0003-3444-5908; Gurwell, Mark/0000-0003-0685-3621; Streblyanska, Alina/0000-0001-8876-9102; Bethermin, Matthieu/0000-0002-3915-2015; Farrah, Duncan/0000-0003-1748-2010; Hurley, Peter/0000-0001-8393-8544; Earle, Lieko/0000-0002-6631-0808; Scott, Douglas/0000-0002-6878-9840; Fu, Hai/0000-0001-9608-6395; Thomson, Alasdair/0000-0003-2002-6913; Altieri, Bruno/0000-0003-3936-0284	STFC [ST/F007027/1, ST/J001422/1, ST/I000976/1, ST/K000977/1, ST/L001314/1, ST/F006977/1, ST/J000647/1, ST/I005765/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F006977/1, ST/F007027/1, ST/I000976/1, ST/K000977/1, ST/H00243X/1, ST/L001314/1, ST/J001422/1, ST/I005765/1, ST/J000647/1] Funding Source: researchfish; UK Space Agency [ST/J004812/1, ST/G003874/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [1106284] Funding Source: National Science Foundation	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Bethermin M, 2012, ASTROPHYS J LETT, V757, DOI 10.1088/2041-8205/757/2/L23; Bouwens RJ, 2006, ASTROPHYS J, V653, P53, DOI 10.1086/498733; Bouwens RJ, 2011, NATURE, V469, P504, DOI 10.1038/nature09717; Capak PL, 2011, NATURE, V470, P233, DOI 10.1038/nature09681; Chapman SC, 2003, NATURE, V422, P695, DOI 10.1038/nature01540; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; Elmegreen BG, 1999, ASTROPHYS J, V517, P103, DOI 10.1086/307200; Gonzalez-Alfonso E, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118029; Jiang LH, 2009, ASTRON J, V138, P305, DOI 10.1088/0004-6256/138/1/305; Karim A., 2012, MON NOT R A IN PRESS; Krumholz MR, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/69; Lagos CD, 2011, MON NOT R ASTRON SOC, V416, P1566, DOI 10.1111/j.1365-2966.2011.19160.x; McMillan PJ, 2011, MON NOT R ASTRON SOC, V414, P2446, DOI 10.1111/j.1365-2966.2011.18564.x; Michalowski MJ, 2010, ASTROPHYS J, V712, P942, DOI 10.1088/0004-637X/712/2/942; Murray N, 2010, ASTROPHYS J, V709, P424, DOI 10.1088/0004-637X/709/1/424; Oliver SJ, 2012, MON NOT R ASTRON SOC, V424, P1614, DOI 10.1111/j.1365-2966.2012.20912.x; Overzier RA, 2009, MON NOT R ASTRON SOC, V394, P577, DOI 10.1111/j.1365-2966.2008.14264.x; Rangwala N, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/94; Riechers DA, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/1/L31; Robertson BE, 2010, NATURE, V468, P49, DOI 10.1038/nature09527; SODROSKI TJ, 1994, ASTROPHYS J, V428, P638, DOI 10.1086/174274; Stacey GJ, 2010, ASTROPHYS J, V724, P957, DOI 10.1088/0004-637X/724/2/957; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168; Tacconi LJ, 2010, NATURE, V463, P781, DOI 10.1038/nature08773; Thompson TA, 2005, ASTROPHYS J, V630, P167, DOI 10.1086/431923; van der Werf PP, 2011, ASTROPHYS J LETT, V741, DOI 10.1088/2041-8205/741/2/L38; Vieira JD, 2013, NATURE, V495, P344, DOI 10.1038/nature12001; Walter F, 2003, NATURE, V424, P406, DOI 10.1038/nature01821; Walter F, 2012, NATURE, V486, P233, DOI 10.1038/nature11073; Walter F, 2009, NATURE, V457, P699, DOI 10.1038/nature07681	30	401	401	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					329	333		10.1038/nature12050	http://dx.doi.org/10.1038/nature12050			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23598341	Green Submitted, Green Accepted			2022-12-28	WOS:000317599200030
J	Polis, MA				Polis, Michael A.			A clinical decision-support system with interactive alerts improved CD4 cell count in HIV	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									NIAID, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Polis, MA (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.			Lester, William/0000-0003-4086-9280; Robbins, Gregory/0000-0001-7545-5817				Kellermann AL, 2013, HEALTH AFFAIR, V32, P63, DOI 10.1377/hlthaff.2012.0693; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8							JC11	10.7326/0003-4819-158-8-201304160-02011	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588764				2022-12-28	WOS:000318062100002
J	Rusk, M; Cato, RK				Rusk, Matthew; Cato, Robert K.			Update in General Internal Medicine: Evidence Published in 2012	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Rusk, Matthew; Cato, Robert K.] Univ Penn, Penn Presbyterian Med Ctr, Penn Ctr Primary Care, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Presbyterian Medical Center	Rusk, M (corresponding author), Univ Penn, Penn Presbyterian Med Ctr, Penn Ctr Primary Care, Med ARts Bldg,3900 Filbert St,Suite 102, Philadelphia, PA 19104 USA.							Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Eichinger S, 2003, JAMA-J AM MED ASSOC, V290, P1071, DOI 10.1001/jama.290.8.1071; Eikelboom JW, 2012, NEW ENGL J MED, V366, P1936, DOI 10.1056/NEJMe1202504; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; McNaughton-Collins MF, 2011, NEW ENGL J MED, V365, P1951, DOI 10.1056/NEJMp1111894; Nguyen NT, 2011, J AM COLL SURGEONS, V213, P261, DOI 10.1016/j.jamcollsurg.2011.04.030; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; WOTORS T, 2010, INT J CANCER, V126, P2387	14	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8					615	619		10.7326/0003-4819-158-8-201304160-00101	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-00101			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23579948				2022-12-28	WOS:000318062100030
J	Toren, P; Margel, D; Kulkarni, G; Finelli, A; Zlotta, A; Fleshner, N				Toren, Paul; Margel, David; Kulkarni, Girish; Finelli, Antonio; Zlotta, Alexandre; Fleshner, Neil			Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE URINARY RETENTION; COMBINATION THERAPY; 5-ALPHA-REDUCTASE INHIBITORS; RISK; FINASTERIDE; CANCER; IMPACT; SYMPTOMS; OUTCOMES; COST	Objective To assess the role of dutasteride in preventing clinical progression of benign prostatic hyperplasia in asymptomatic men with larger prostates. Design Post hoc analysis of four year, double blind Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study Participants 1617 men randomised to dutasteride or placebo with a prostate size >40 mL and baseline International Prostate Symptom Score (IPSS) <8. Subjects who took medications for benign prostatic hyperplasia were excluded at study entry. Interventions Placebo or dutasteride 0.5 mg daily. Main outcome measures Comparison of risk of clinical progression of benign prostatic hyperplasia at four years (defined as a >= 4 point worsening on IPSS, acute urinary retention, urinary tract infection, or surgery related to benign prostatic hyperplasia). Results 825 participants took placebo, 792 took dutasteride. A total of 464 (29%) experienced clinical progression benign prostatic hyperplasia, 297(36%) taking placebo, 167 (21%) taking dutasteride (P<0.001). The relative risk reduction was 41% and the absolute risk reduction 15%, with a number needed to treat (NNT) of 7. Among men who had acute urinary retention and surgery related to benign prostatic hyperplasia, the absolute risk reduction for dutasteride was 6.0% and 3.8%, respectively. On multivariable regression analysis adjusting for covariates, dutasteride significantly reduced clinical progression of benign prostatic hyperplasia with an odds ratio of 0.47 (95% CI 0.37 to 0.59, P<0.001). Analysis of time to first event yielded a hazard ratio of 0.673 (P<0.001) for those taking dutasteride. Sexual adverse events were most common and similar to prior reports. Limitations Further prospective studies may be warranted to demonstrate generalisability of these results. Conclusions This study is the first to explore the benefit of treating asymptomatic or mildly symptomatic men with an enlarged prostate. Dutasteride significantly decreased the incidence of benign prostatic hyperplasia clinical progression.	[Toren, Paul; Margel, David; Kulkarni, Girish; Finelli, Antonio; Zlotta, Alexandre; Fleshner, Neil] Univ Toronto, Univ Hlth Network, Dept Surg, Div Urol, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Fleshner, N (corresponding author), Univ Toronto, Univ Hlth Network, Dept Surg, Div Urol, 610 Univ Ave,3-130, Toronto, ON M5G 2M9, Canada.	neil.fleshner@uhn.ca	Zlotta, Alexandre/K-8285-2015; Margel, David/AAP-4294-2020	Toren, Paul/0000-0002-5762-5787	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; AF, NF, and AZ have received research grants and honorariums from GlaxoSmithKline; NF and AF do consultancy for GlaxoSmithKline and Merck; no other relationships or activities that could appear to have influenced the submitted work.	Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Barry MJ, 2013, J UROLOGY, V189, P987, DOI 10.1016/j.juro.2012.08.257; BARRY MJ, 1995, J UROLOGY, V154, P1770, DOI 10.1016/S0022-5347(01)66780-6; Bartsch G, 2004, BJU INT, V93, P27, DOI 10.1111/j.1464-410X.2004.04646.x; Boyle P, 1996, UROLOGY, V48, P398, DOI 10.1016/S0090-4295(96)00353-6; Briyanti A, 2007, EUR J CANCER, V43, P2669, DOI 10.1016/j.ejca.2007.09.022; Freedland SJ, 2005, J CLIN ONCOL, V23, P7546, DOI 10.1200/JCO.2005.05.525; Hamilton RJ, 2012, EUR UROL, V62, P242, DOI 10.1016/j.eururo.2012.04.016; Jacobsen SJ, 1997, J UROLOGY, V158, P481, DOI 10.1016/S0022-5347(01)64508-7; Jacobsen SJ, 1999, J UROLOGY, V162, P1301, DOI 10.1016/S0022-5347(05)68271-7; Johansen TEB, 2012, BJU INT, V109, P731, DOI 10.1111/j.1464-410X.2011.10511.x; Kaplan S, 2000, UROLOGY, V56, P610, DOI 10.1016/S0090-4295(00)00724-X; Kirby RS, 2010, BJU INT, V105, P901, DOI 10.1111/j.1464-410X.2010.09274.x; McConnell JD, 1998, NEW ENGL J MED, V338, P557, DOI 10.1056/NEJM199802263380901; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Oelke M, 2012, GUIDELINES MANAGEMEN; Parsons JK, 2012, EUR UROL, V62, P234, DOI 10.1016/j.eururo.2012.03.007; Roehrborn CG, 2011, UROLOGY, V78, P641, DOI 10.1016/j.urology.2011.03.063; Roehrborn CG, 2010, EUR UROL, V57, P123, DOI 10.1016/j.eururo.2009.09.035; Siami P, 2007, CONTEMP CLIN TRIALS, V28, P770, DOI 10.1016/j.cct.2007.07.008; Tacklind J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006015.pub3; Theoret MR, 2011, NEW ENGL J MED, V365, P97, DOI 10.1056/NEJMp1106783; Thomas K, 2005, BJU INT, V95, P72, DOI 10.1111/j.1464-410X.2004.05254.x; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Watson V, 2004, J UROLOGY, V172, P2321, DOI 10.1097/01.ju.0000140957.31325.7f; Wei JT, 2008, J UROLOGY, V179, pS75, DOI 10.1016/j.juro.2008.03.141	26	23	27	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2013	346								f2109	10.1136/bmj.f2109	http://dx.doi.org/10.1136/bmj.f2109			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131AI	23587564	Green Published, hybrid			2022-12-28	WOS:000317962200001
J	Churchill, SE; Holliday, TW; Carlson, KJ; Jashashvili, T; Macias, ME; Mathews, S; Sparling, TL; Schmid, P; de Ruiter, DJ; Berger, LR				Churchill, Steven E.; Holliday, Trenton W.; Carlson, Kristian J.; Jashashvili, Tea; Macias, Marisa E.; Mathews, Sandra; Sparling, Tawnee L.; Schmid, Peter; de Ruiter, Darryl J.; Berger, Lee R.			The Upper Limb of Australopithecus sediba	SCIENCE			English	Article							LOCOMOTOR ANATOMY; BODY PROPORTIONS; PARTIAL SKELETON; HADAR FORMATION; HOMO-HABILIS; AFARENSIS; HOMINID; BIOMECHANICS; MORPHOLOGY; ONTOGENY	The evolution of the human upper limb involved a change in function from its use for both locomotion and prehension (as in apes) to a predominantly prehensile and manipulative role. Well-preserved forelimb remains of 1.98-million-year-old Australopithecus sediba from Malapa, South Africa, contribute to our understanding of this evolutionary transition. Whereas other aspects of their postcranial anatomy evince mosaic combinations of primitive (australopith-like) and derived (Homo-like) features, the upper limbs (excluding the hand and wrist) of the Malapa hominins are predominantly primitive and suggest the retention of substantial climbing and suspensory ability. The use of the forelimb primarily for prehension and manipulation appears to arise later, likely with the emergence of Homo erectus.	[Churchill, Steven E.; Macias, Marisa E.; Sparling, Tawnee L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Churchill, Steven E.; Holliday, Trenton W.; Carlson, Kristian J.; Jashashvili, Tea; Schmid, Peter; de Ruiter, Darryl J.; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Holliday, Trenton W.] Tulane Univ, Dept Anthropol, New Orleans, LA 70118 USA; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Jashashvili, Tea] Georgian Natl Museum, GE-0105 Tbilisi, Georgia; [Mathews, Sandra; Schmid, Peter] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [de Ruiter, Darryl J.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA	Duke University; University of Witwatersrand; Tulane University; Indiana University System; Indiana University Bloomington; University of Zurich; Texas A&M University System; Texas A&M University College Station	Churchill, SE (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Box 90383, Durham, NC 27708 USA.	churchy@duke.edu	Berger, Lee Rogers/AAC-3484-2020; Churchill, Steven/AAA-9386-2022	Berger, Lee Rogers/0000-0002-0367-7629; Sparling, Tawnee/0000-0001-5237-0984; de Ruiter, Darryl/0000-0003-1183-0352	Gauteng Provincial Government; South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation (NRF); Evolutionary Studies Institute (University of the Witwatersrand); University of the Witwatersrand's Vice Chancellor's Discretionary Fund; National Geographic Society; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; Claude Leon Foundation; Strategic Planning and Resource Allocation Committee of the University of the Witwatersrand; A. H. Schultz Foundation; Duke University; Ray A. Rothrock '77 Fellowship; Texas AM University; Oppenheimer and Ackerman families; University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences; Bernard Price Institute for Palaeontology	Gauteng Provincial Government; South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation (NRF)(National Research Foundation - South Africa); Evolutionary Studies Institute (University of the Witwatersrand); University of the Witwatersrand's Vice Chancellor's Discretionary Fund; National Geographic Society(National Geographic Society); Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; Claude Leon Foundation; Strategic Planning and Resource Allocation Committee of the University of the Witwatersrand; A. H. Schultz Foundation; Duke University; Ray A. Rothrock '77 Fellowship; Texas AM University; Oppenheimer and Ackerman families; University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences; Bernard Price Institute for Palaeontology	We thank the South African Heritage Resource agency for the permits to work at the Malapa site; the Nash family for granting access to the Malapa site and continued support of research on their reserve; the Gauteng Provincial Government, the South African Department of Science and Technology, the African Origins Platform (AOP), the South African National Research Foundation (NRF), the Evolutionary Studies Institute (University of the Witwatersrand), the University of the Witwatersrand's Vice Chancellor's Discretionary Fund, the National Geographic Society, the Palaeontological Scientific Trust, the Andrew W. Mellon Foundation, the Ford Foundation, the U.S. Diplomatic Mission to South Africa, the French Embassy of South Africa, the Claude Leon Foundation, the Strategic Planning and Resource Allocation Committee of the University of the Witwatersrand, the A. H. Schultz Foundation, Duke University, the Ray A. Rothrock '77 Fellowship and International Research Travel Assistance Grant of Texas A&M University, and the Oppenheimer and Ackerman families and Sir Richard Branson for funding; the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities; Gauteng Department of Agriculture, Conservation and Environment and the Cradle of Humankind Management Authority; and our respective universities for ongoing support. We thank the Virtual Image Processing Laboratory and the Microfocus X-ray Computed Tomography Facility of the Palaeosciences Centre at the University of the Witwatersrand; for funding these facilities, we thank the University of the Witwatersrand Office of Research and the NRF SRIG (Strategic Research Infrastructure Grant) and AOP funding programs. For access to comparative specimens, we thank E. Mbua, P. Kiura, V. Iminjili, and the National Museums of Kenya; B. Billings, B. Zipfel, and the School of Anatomical Sciences at the University of the Witwatersrand; S. Potze and L. C. Kgasi at the Ditsong Museum; E. Westwig at the American Museum of Natural History; L. Gordon at the National Museum of Natural History; and M. Ponce de Le~n and C. Zollikofer at the Anthropological Institute and Museum. For technical and material support we thank, Duke University, the University of Zurich 2009 and 2010 Field Schools, A. B. Taylor, C. E. Terhune, and C. E. Wall. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Other individuals who have given major support to this project include B. de Klerk, W. Lawrence, C. Steininger, B. Kuhn, L. Pollarolo, B. Zipfel, J. Kretzen, D. Conforti, J. McCaffery, C. Dlamini, H. Visser, R. McCrae-Samuel, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, and M. Peltier. J. Smilg facilitated computed tomography scanning of the specimens. The Au. sediba specimens are archived at the Evolutionary Studies Institute at the University of the Witwatersrand. All data used in this study are available upon request, including access to the original specimens, by bona fide scientists.	Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; ASHTON E. H., 1964, PROC ZOOL SOC LONDON, V142, P49; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Carretero JM, 1999, J HUM EVOL, V37, P459, DOI 10.1006/jhev.1999.0342; Clarke RJ, 1998, S AFR J SCI, V94, P460; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; Drapeau MSM, 2008, J HUM EVOL, V55, P86, DOI 10.1016/j.jhevol.2008.01.005; Drapeau MSM, 2005, J HUM EVOL, V48, P593, DOI 10.1016/j.jhevol.2005.02.005; Graves WW, 1921, AM J PHYS ANTHROPOL, V4, P111, DOI 10.1002/ajpa.1330040202; Green DJ, 2007, J HUM EVOL, V52, P187, DOI 10.1016/j.jhevol.2006.09.001; Green DJ, 2012, SCIENCE, V338, P514, DOI 10.1126/science.1227123; Haeusler M, 2004, J HUM EVOL, V46, P433, DOI 10.1016/j.jhevol.2004.01.004; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; HUNT KD, 1991, AM J PHYS ANTHROPOL, V86, P521, DOI 10.1002/ajpa.1330860408; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P403, DOI 10.1002/ajpa.1330570403; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Kimbel WH, 2009, YEARB PHYS ANTHROPOL, V52, P2, DOI 10.1002/ajpa.21183; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Larson SG, 1996, J HUM EVOL, V31, P239, DOI 10.1006/jhev.1996.0059; Larson SG, 2007, EVOL ANTHROPOL, V16, P172, DOI 10.1002/evan.20149; Leakey R.E., 1989, P167; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; LOVEJOY CO, 1982, AM J PHYS ANTHROPOL, V57, P637, DOI 10.1002/ajpa.1330570409; McHenry HM, 1998, J HUM EVOL, V35, P1, DOI 10.1006/jhev.1997.0197; Melillo S. M., 2011, THESIS STANFORD U; OHMAN JC, 1986, AM J PHYS ANTHROPOL, V70, P209, DOI 10.1002/ajpa.1330700208; Partridge TC, 2003, SCIENCE, V300, P607, DOI 10.1126/science.1081651; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Pontzer H, 2010, J HUM EVOL, V58, P492, DOI 10.1016/j.jhevol.2010.03.006; Reno PL, 2005, CURR ANTHROPOL, V46, P575, DOI 10.1086/431528; Richmond B., 2009, PAL SOC M PALEOANTHR, V2009; Richmond BG, 2002, J HUM EVOL, V43, P529, DOI 10.1006/jhev.2002.0594; Richmond BG, 2007, J HUM EVOL, V53, P678, DOI 10.1016/j.jhevol.2007.05.011; Ruff Christopher B., 1993, P234; Schmid P, 2013, SCIENCE, V340, DOI 10.1126/science.1234598; Sobush DC, 1996, J ORTHOP SPORT PHYS, V23, P39, DOI 10.2519/jospt.1996.23.1.39; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; Toussaint M, 2003, S AFR J SCI, V99, P215; Voisin JL, 2010, ANTHROPOLOGIE, V114, P354, DOI 10.1016/j.anthro.2010.05.005; Walker Alan, 1993, P95; Wood B, 2011, NATURE, V470, P347, DOI 10.1038/nature09709; Young NM, 2008, AM J PHYS ANTHROPOL, V136, P247, DOI 10.1002/ajpa.20799; Young NM, 2010, P NATL ACAD SCI USA, V107, P3400, DOI 10.1073/pnas.0911856107	48	75	76	2	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129							1233477	10.1126/science.1233477	http://dx.doi.org/10.1126/science.1233477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580536				2022-12-28	WOS:000317341400005
J	Codelli, JA; Reisman, SE				Codelli, Julian A.; Reisman, Sarah E.			Pactamycin Made Easy	SCIENCE			English	Editorial Material									[Codelli, Julian A.; Reisman, Sarah E.] CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Codelli, JA (corresponding author), CALTECH, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	jcodelli@caltech.edu; reisman@caltech.edu						Argoudelis A. D., 1962, ANTIMICROB AGENTS CH, V1962, P191; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Dinos G, 2004, MOL CELL, V13, P113, DOI 10.1016/S1097-2765(04)00002-4; Hanessian S, 2011, ANGEW CHEM INT EDIT, V50, P3497, DOI 10.1002/anie.201008079; Hanessian S, 2012, J ORG CHEM, V77, P9458, DOI 10.1021/jo301638z; Iwatsuki M, 2012, J ANTIBIOT, V65, P169, DOI 10.1038/ja.2011.136; Lu WL, 2011, CHEM BIOL, V18, P425, DOI 10.1016/j.chembiol.2011.01.016; Malinowski JT, 2013, SCIENCE, V340, P180, DOI 10.1126/science.1234756; Otoguro K, 2010, J ANTIBIOT, V63, P381, DOI 10.1038/ja.2010.50	9	3	3	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129					152	153		10.1126/science.1236882	http://dx.doi.org/10.1126/science.1236882			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580517				2022-12-28	WOS:000317341400041
J	Apps, R; Qi, Y; Carlson, JM; Chen, HY; Gao, XJ; Thomas, R; Yuki, Y; Del Prete, GQ; Goulder, P; Brumme, ZL; Brumme, CJ; John, M; Mallal, S; Nelson, G; Bosch, R; Heckerman, D; Stein, JL; Soderberg, KA; Moody, MA; Denny, TN; Zeng, X; Fang, JY; Moffett, A; Lifson, JD; Goedert, JJ; Buchbinder, S; Kirk, GD; Fellay, J; McLaren, P; Deeks, SG; Pereyra, F; Walker, B; Michael, NL; Weintrob, A; Wolinsky, S; Liao, W; Carrington, M				Apps, Richard; Qi, Ying; Carlson, Jonathan M.; Chen, Haoyan; Gao, Xiaojiang; Thomas, Rasmi; Yuki, Yuko; Del Prete, Greg Q.; Goulder, Philip; Brumme, Zabrina L.; Brumme, Chanson J.; John, Mina; Mallal, Simon; Nelson, George; Bosch, Ronald; Heckerman, David; Stein, Judy L.; Soderberg, Kelly A.; Moody, M. Anthony; Denny, Thomas N.; Zeng, Xue; Fang, Jingyuan; Moffett, Ashley; Lifson, Jeffrey D.; Goedert, James J.; Buchbinder, Susan; Kirk, Gregory D.; Fellay, Jacques; McLaren, Paul; Deeks, Steven G.; Pereyra, Florencia; Walker, Bruce; Michael, Nelson L.; Weintrob, Amy; Wolinsky, Steven; Liao, Wilson; Carrington, Mary			Influence of HLA-C Expression Level on HIV Control	SCIENCE			English	Article							INFLAMMATORY-BOWEL-DISEASE; T-CELL RESPONSES; DETERMINANTS; ASSOCIATIONS; METAANALYSIS; ALLELES; SYNAPSE; ESCAPE; NUMBER	A variant upstream of human leukocyte antigen C (HLA-C) shows the most significant genome-wide effect on HIV control in European Americans and is also associated with the level of HLA-C expression. We characterized the differential cell surface expression levels of all common HLA-C allotypes and tested directly for effects of HLA-C expression on outcomes of HIV infection in 5243 individuals. Increasing HLA-C expression was associated with protection against multiple outcomes independently of individual HLA allelic effects in both African and European Americans, regardless of their distinct HLA-C frequencies and linkage relationships with HLA-B and HLA-A. Higher HLA-C expression was correlated with increased likelihood of cytotoxic T lymphocyte responses and frequency of viral escape mutation. In contrast, high HLA-C expression had a deleterious effect in Crohn's disease, suggesting a broader influence of HLA expression levels in human disease.	[Apps, Richard; Qi, Ying; Gao, Xiaojiang; Thomas, Rasmi; Yuki, Yuko; Carrington, Mary] SAIC Frederick Inc, Frederick Natl Lab Canc Res, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21702 USA; [Apps, Richard; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Goulder, Philip; Pereyra, Florencia; Walker, Bruce; Carrington, Mary] Massachusetts Gen Hosp, MIT, Ragon Inst, Boston, MA 02114 USA; [Apps, Richard; Qi, Ying; Gao, Xiaojiang; Yuki, Yuko; Goulder, Philip; Pereyra, Florencia; Walker, Bruce; Carrington, Mary] Harvard Univ, Boston, MA 02114 USA; [Carlson, Jonathan M.; Heckerman, David; Zeng, Xue] Microsoft Res, ESci Grp, Los Angeles, CA 90024 USA; [Chen, Haoyan; Fang, Jingyuan; Liao, Wilson] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94115 USA; [Chen, Haoyan; Lifson, Jeffrey D.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Dept Gastroenterol,Ren Ji Hosp, Shanghai 200001, Peoples R China; [Del Prete, Greg Q.] SAIC Frederick Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD 21702 USA; [Goulder, Philip] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Goulder, Philip] Univ Oxford, Dept Paediat, Oxford OX1 3SY, England; [Brumme, Zabrina L.; Brumme, Chanson J.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Brumme, Zabrina L.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [John, Mina; Mallal, Simon] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia; [Nelson, George] SAIC Frederick Inc, Frederick Natl Lab Canc Res, Ctr Canc Res Genet Core, Basic Res Program, Frederick, MD 21702 USA; [Bosch, Ronald] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Stein, Judy L.; Soderberg, Kelly A.; Moody, M. Anthony; Denny, Thomas N.] Duke Univ, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Zeng, Xue] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Dermatol, Beijing 100053, Peoples R China; [Moffett, Ashley] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Goedert, James J.] NCI, Div Canc Epidemiol & Genet, Infect & Immunoepidemiol Branch, Bethesda, MD 20892 USA; [Buchbinder, Susan] San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; [Kirk, Gregory D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Fellay, Jacques; McLaren, Paul] Univ Lausanne Hosp, Inst Microbiol, CH-1015 Lausanne, Switzerland; [Fellay, Jacques; McLaren, Paul] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94105 USA; [Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Weintrob, Amy] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20817 USA; [Wolinsky, Steven] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Microsoft; University of California System; University of California San Francisco; Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Kwazulu Natal; University of Oxford; B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Murdoch University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Harvard T.H. Chan School of Public Health; Duke University; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); San Francisco Department of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of California System; University of California San Francisco; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Uniformed Services University of the Health Sciences - USA; Northwestern University; Feinberg School of Medicine	Carrington, M (corresponding author), SAIC Frederick Inc, Frederick Natl Lab Canc Res, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21702 USA.	carringm@mail.nih.gov	Fellay, Jacques/A-6681-2009; Moffett, Ashley/J-9754-2013; Del Prete, Gregory/C-2030-2012; Mallal, Simon Alexander/HDM-9561-2022; Wolinsky, Steven/B-2893-2012; Moody, M/AAB-6947-2020; ZENG, XUE/AAE-2915-2021; Thomas, Rasmi/AAI-4921-2020	Fellay, Jacques/0000-0002-8240-939X; Mallal, Simon Alexander/0000-0002-7036-1309; Moody, M/0000-0002-3890-5855; McLaren, Paul/0000-0001-6019-7018; fang, jingyuan/0000-0003-2282-0248; Brumme, Chanson/0000-0003-2722-5288; Denny, Thomas/0000-0002-7364-8276; Liao, Wilson/0000-0001-7883-6439; Wolinsky, Steven/0000-0002-9625-6697; Brumme, Zabrina/0000-0002-8157-1037	National Institutes of Health (NIH) [HHSN261200800001E, N02-CP-55504, RO1-AI046995, R01-DA04334, R01-DA12568, R01-AI060460]; Bill & Melinda Gates Foundation [38599]; Mark and Lisa Schwartz Foundation; Wellcome Trust; NIH National Institute of Allergy and Infectious Diseases (NIAID) Center for HIV/AIDS Vaccine Immunology [U01-AI-067854]; Australian National Health and Medical Research Council [384702]; National Institutes of Health [K08AR057763, R01-DA-04334, R01-DA-12568]; Creative and Novel Ideas in HIV Research Program [P30 AI027767-24]; Swiss National Science Foundation [33CSC0-108787]; NIAID; National Cancer Institute; National Heart, Lung, and Blood Institute [UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041];  [RO1 AI087145];  [K24AI069994];  [P30 AI027763];  [UL1 RR024131];  [P30 MH62246];  [R24 AI067039]; NATIONAL CANCER INSTITUTE [ZIABC010791, ZIACP010214, ZICBC011237] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131, M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, R01AI046995, U01AI035040, U01AI035043, U01AI035041, R24AI067039, U01AI035042, R01AI087145, U01AI037613, R01AI060460, U01AI035039, U01AI037984, P30AI027767, K24AI069994, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065174, K08AR057763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004334, R01DA012568, U01DA036297] Funding Source: NIH RePORTER; British Heart Foundation [PG/09/077/27964] Funding Source: researchfish	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Mark and Lisa Schwartz Foundation; Wellcome Trust(Wellcome Trust); NIH National Institute of Allergy and Infectious Diseases (NIAID) Center for HIV/AIDS Vaccine Immunology; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creative and Novel Ideas in HIV Research Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); British Heart Foundation(British Heart Foundation)	This study makes use of data generated by the Wellcome Trust Case Control Consortium (WTCCC); a full list of investigators who contributed to the generation of this data is available at www.wtccc.org.uk. The data reported in this paper are tabulated in the main paper and supplementary materials. Data and materials will be shared subject to institutional review board (IRB) provisions regarding patient privacy. Please contact the corresponding author. Those interested in obtaining Center for HIV/AIDS Vaccine Immunology (CHAVI) samples used in this study should contact M. C. and M. A. M. A Simple Letter Agreement for the Transfer of Materials will be executed between the institutions involved, and an IRB approval/exemption should be obtained by the recipient institution when appropriate. Clinical specimens from the Multicenter AIDS Cohort Study (MACS) are subject to the terms and conditions of the MACS Master Material Transfer Agreement for Non-Profit Institutions. The project has been funded in part with federal funds from the National Institutes of Health (NIH) under contracts HHSN261200800001E, N02-CP-55504, RO1-AI046995, R01-DA04334, R01-DA12568, and R01-AI060460. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services or the Department of Defense, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government. This research was supported in part by grants from the Bill & Melinda Gates Foundation as part of the Collaboration for AIDS Vaccine Discovery and grant ID38599, the Mark and Lisa Schwartz Foundation, the Wellcome Trust, the NIH National Institute of Allergy and Infectious Diseases (NIAID) Center for HIV/AIDS Vaccine Immunology (U01-AI-067854), and the Australian National Health and Medical Research Council (Program Grant 384702). Further funding was from the National Institutes of Health grant K08AR057763 and the Creative and Novel Ideas in HIV Research Program through a supplement to the University of Alabama at the Birmingham Center For AIDS Research funding (P30 AI027767-24), made possible by collaborative efforts of the Office of AIDS Research, NIAID, and the International AIDS Society. We thank M. Trubey and A. Lara for cytometry assistance and all the patients and investigators contributing to samples studied in the WTCCC, CHAVI, Multicenter Hemophilia Cohort Study, San Francisco City Clinic Cohort, Massachusetts General Hospital Controller Cohort, United States Military HIV Natural History Study, DC Gay Cohort Study, British Columbia HOMER cohort, Western Australian HIV Cohort Study, US AIDS Clinical Trials Group, Durban, AIDS Linked to Intravenous Experience (supported by National Institutes of Health grants R01-DA-04334 and R01-DA-12568), Swiss HIV Cohort Study (supported by the Swiss National Science Foundation grant number 33CSC0-108787), Study on the Consequences of Protease Inhibitor Era (supported by grants RO1 AI087145, K24AI069994, P30 AI027763, UL1 RR024131, P30 MH62246, and R24 AI067039), and MACS cohorts (funded by NIAID, with supplemental funding from the National Cancer Institute and the National Heart, Lung, and Blood Institute [grants UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, and UO1-AI-35041].	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bashirova AA, 2011, ANNU REV IMMUNOL, V29, P295, DOI 10.1146/annurev-immunol-031210-101332; Blais ME, 2012, J IMMUNOL, V188, P4663, DOI 10.4049/jimmunol.1103472; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Corrah TW, 2011, J VIROL, V85, P3367, DOI 10.1128/JVI.02276-10; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Heckerman D, 2007, J COMPUT BIOL, V14, P736, DOI 10.1089/cmb.2007.R013; KAGEYAMA S, 1995, J IMMUNOL, V154, P567; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOEFFLER HP, 1984, P NATL ACAD SCI-BIOL, V81, P4080, DOI 10.1073/pnas.81.13.4080; Newman B, 2004, AM J GASTROENTEROL, V99, P306, DOI 10.1111/j.1572-0241.2004.04038.x; O'hUigin C, 2011, AM J HUM GENET, V89, P424, DOI 10.1016/j.ajhg.2011.07.024; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Stokkers PCF, 1999, GUT, V45, P395, DOI 10.1136/gut.45.3.395; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Wright JK, 2010, J VIROL, V84, P10820, DOI 10.1128/JVI.01084-10	25	283	286	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					87	91		10.1126/science.1232685	http://dx.doi.org/10.1126/science.1232685			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559252	Green Submitted, Green Accepted			2022-12-28	WOS:000317061100052
J	Villar, G; Graham, AD; Bayley, H				Villar, Gabriel; Graham, Alexander D.; Bayley, Hagan			A Tissue-Like Printed Material	SCIENCE			English	Article							MICROFLUIDIC DEVICE; DROPLET NETWORKS; LIPID-BILAYERS; WATER DROPLETS; PERMEABILITY	Living cells communicate and cooperate to produce the emergent properties of tissues. Synthetic mimics of cells, such as liposomes, are typically incapable of cooperation and therefore cannot readily display sophisticated collective behavior. We printed tens of thousands of picoliter aqueous droplets that become joined by single lipid bilayers to form a cohesive material with cooperating compartments. Three-dimensional structures can be built with heterologous droplets in software-defined arrangements. The droplet networks can be functionalized with membrane proteins; for example, to allow rapid electrical communication along a specific path. The networks can also be programmed by osmolarity gradients to fold into otherwise unattainable designed structures. Printed droplet networks might be interfaced with tissues, used as tissue engineering substrates, or developed as mimics of living tissue.	[Villar, Gabriel; Graham, Alexander D.; Bayley, Hagan] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	University of Oxford	Bayley, H (corresponding author), Univ Oxford, Dept Chem, Oxford OX1 3TA, England.	hagan.bayley@chem.ox.ac.uk	Taylor, Graham/A-4027-2012	Bayley, Hagan/0000-0003-2499-6116	National Institutes of Health; European Commission's Seventh Framework Programme Revolutionary Approaches and Devices for Nucleic Acid Analysis Consortium; Engineering and Physical Sciences Research Council Life Sciences Interface Doctoral Training Centre studentship; Biotechnology and Biological Sciences Research Council Doctoral Training Programme in Molecular Biochemistry and Chemical Biology studentship; Biotechnology and Biological Sciences Research Council [1112403] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission's Seventh Framework Programme Revolutionary Approaches and Devices for Nucleic Acid Analysis Consortium; Engineering and Physical Sciences Research Council Life Sciences Interface Doctoral Training Centre studentship; Biotechnology and Biological Sciences Research Council Doctoral Training Programme in Molecular Biochemistry and Chemical Biology studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank Q. Li for the alpha HL protein and A. Wainman for assistance with confocal microscopy. This work was supported by grants from the National Institutes of Health and the European Commission's Seventh Framework Programme Revolutionary Approaches and Devices for Nucleic Acid Analysis Consortium. G. V. was supported by an Engineering and Physical Sciences Research Council Life Sciences Interface Doctoral Training Centre studentship. A. D. G. was supported by a Biotechnology and Biological Sciences Research Council Doctoral Training Programme in Molecular Biochemistry and Chemical Biology studentship. The authors have submitted a patent application related to this work. The authors declare no competing financial interests. G. V., A. D. G., and H. B. planned the research. G. V. and A. D. G. designed the experimental system and performed the experiments. G. V. wrote the software, performed the modeling, and analyzed the data. G. V. and H. B. wrote the paper.	Bai YP, 2010, LAB CHIP, V10, P1281, DOI 10.1039/b925133b; BOROSKE E, 1981, BIOPHYS J, V34, P95, DOI 10.1016/S0006-3495(81)84839-4; Dixit SS, 2012, LANGMUIR, V28, P7442, DOI 10.1021/la3005739; Dixit SS, 2010, LANGMUIR, V26, P6193, DOI 10.1021/la1010067; Eisenstein M, 2012, NAT METHODS, V9, P13, DOI 10.1038/nmeth.1842; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Funakoshi K, 2006, ANAL CHEM, V78, P8169, DOI 10.1021/ac0613479; Holden MA, 2007, J AM CHEM SOC, V129, P8650, DOI 10.1021/ja072292a; HU ZB, 1995, SCIENCE, V269, P525, DOI 10.1126/science.269.5223.525; Kim J, 2012, SCIENCE, V335, P1201, DOI 10.1126/science.1215309; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Liang HY, 2011, P NATL ACAD SCI USA, V108, P5516, DOI 10.1073/pnas.1007808108; Maglia G, 2009, NAT NANOTECHNOL, V4, P437, DOI [10.1038/NNANO.2009.121, 10.1038/nnano.2009.121]; Malmstadt N, 2006, NANO LETT, V6, P1961, DOI 10.1021/nl0611034; Nakagawa S, 2010, CURR OPIN STRUC BIOL, V20, P423, DOI 10.1016/j.sbi.2010.05.003; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Needham D, 2011, NAT NANOTECHNOL, V6, P761, DOI 10.1038/nnano.2011.218; Poulin P, 1998, LANGMUIR, V14, P6341, DOI 10.1021/la9801413; Poulos JL, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3167283; Sarles SA, 2010, ANAL CHEM, V82, P959, DOI 10.1021/ac902555z; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; Stanley CE, 2010, CHEM COMMUN, V46, P1620, DOI 10.1039/b924897h; Thiam AR, 2012, LANGMUIR, V28, P6291, DOI 10.1021/la3003349; Thutupalli S, 2011, SOFT MATTER, V7, P1312, DOI 10.1039/c0sm00312c; Villar G, 2011, NAT NANOTECHNOL, V6, P803, DOI [10.1038/NNANO.2011.183, 10.1038/nnano.2011.183]; Xu J, 2010, ADV MATER, V22, P120, DOI 10.1002/adma.200901945; Zagnoni M, 2010, LAB CHIP, V10, P3069, DOI [10.1039/c01c00219d, 10.1039/c0lc00219d]	27	403	413	11	544	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2013	340	6128					48	52		10.1126/science.1229495	http://dx.doi.org/10.1126/science.1229495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118XS	23559243	Green Accepted			2022-12-28	WOS:000317061100040
J	Hurd, MD; Martorell, P; Delavande, A; Mullen, KJ; Langa, KM				Hurd, Michael D.; Martorell, Paco; Delavande, Adeline; Mullen, Kathleen J.; Langa, Kenneth M.			Monetary Costs of Dementia in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALZHEIMERS-DISEASE; PREVALENCE; HEALTH; DEMOGRAPHICS; CARE	Background Dementia affects a large and growing number of older adults in the United States. The monetary costs attributable to dementia are likely to be similarly large and to continue to increase. Methods In a subsample (856 persons) of the population in the Health and Retirement Study (HRS), a nationally representative longitudinal study of older adults, the diagnosis of dementia was determined with the use of a detailed in-home cognitive assessment that was 3 to 4 hours in duration and a review by an expert panel. We then imputed cognitive status to the full HRS sample (10,903 persons, 31,936 person-years) on the basis of measures of cognitive and functional status available for all HRS respondents, thereby identifying persons in the larger sample with a high probability of dementia. The market costs associated with care for persons with dementia were determined on the basis of self-reported out-of-pocket spending and the utilization of nursing home care; Medicare claims data were used to identify costs paid by Medicare. Hours of informal (unpaid) care were valued either as the cost of equivalent formal (paid) care or as the estimated wages forgone by informal caregivers. Results The estimated prevalence of dementia among persons older than 70 years of age in the United States in 2010 was 14.7%. The yearly monetary cost per person that was attributable to dementia was either $56,290 (95% confidence interval [CI], $42,746 to $69,834) or $41,689 (95% CI, $31,017 to $52,362), depending on the method used to value informal care. These individual costs suggest that the total monetary cost of dementia in 2010 was between $157 billion and $215 billion. Medicare paid approximately $11 billion of this cost. Conclusions Dementia represents a substantial financial burden on society, one that is similar to the financial burden of heart disease and cancer. (Funded by the National Institute on Aging.)	[Hurd, Michael D.; Martorell, Paco; Delavande, Adeline; Mullen, Kathleen J.] RAND, Santa Monica, CA 90401 USA; [Hurd, Michael D.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Hurd, Michael D.] Network Studies Pens Aging & Retirement, Tillburg, Netherlands; [Delavande, Adeline] Univ Essex, Colchester CO4 3SQ, Essex, England; [Langa, Kenneth M.] Univ Michigan, Div Gen Med, Vet Affairs Ann Arbor Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Healthcare Policy, Ann Arbor, MI 48109 USA	RAND Corporation; National Bureau of Economic Research; University of Essex; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hurd, MD (corresponding author), RAND, Ctr Aging, 1776 Main St, Santa Monica, CA 90401 USA.	mhurd@rand.org		Delavande, Adeline/0000-0001-8691-6359; Langa, Kenneth/0000-0002-2798-1836	National Institute on Aging [R01AG030155, U01 AG09740]; Social Security Administration; NATIONAL INSTITUTE ON AGING [R01AG030155, U01AG009740] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Social Security Administration; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a grant from the National Institute on Aging (R01AG030155). The Health and Retirement Study is conducted by the Institute for Social Research at the University of Michigan, with grants from the National Institute on Aging (U01 AG09740) and the Social Security Administration.	Abraham KG, 2005, MARKET DESIGNING NON, P55; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2012, NAT PLAN AD IN PRESS; [Anonymous], 2012, TOT EXP PERC DISTR S; [Anonymous], 2010, MARK SURV LONG TERM; [Anonymous], 2004, STAT LONG TERM HLTH; [Anonymous], 2005, STAT LONG TERM HLTH; Association A.s., 2010, ALZHEIMERS DEMENT, P158, DOI [10.1016/j.jalz.2010.01.009, DOI 10.1016/J.JALZ.2010.01.009]; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; BDO Siedman Eljay American Health Care Association, 2007, REP SHORTF MED FUND; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Delavande A, 2013, ALZHEIMERS DEMENT, V9, P19, DOI 10.1016/j.jalz.2011.11.003; Eljay American Health Care Association, 2009, REP SHORTF MED FUND; Eljay American Health Care Association, 2008, REP SHORTF MED FUND; Eljay American Health Care Association, 2010, REP SHORTF MED FUND; Grabowski DC, 2004, HLTH AFFAIRS MILLW S; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Johnston J, 1997, NEUROPSY NEUROPSY BE, P11; JORM AF, 1995, PSYCHOL MED, V25, P437; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Langa KM, 2005, NEUROEPIDEMIOLOGY, V25, P181, DOI 10.1159/000087448; Langa KM, 2001, J GEN INTERN MED, V16, P770, DOI 10.1111/j.1525-1497.2001.10123.x; Norgard TM, 1997, J GERONTOL B-PSYCHOL, V52, P93, DOI 10.1093/geronb/52B.Special_Issue.93; Ofstedal MB., 2005, HRS DOCUMENTATION RE, DOI DOI 10.1371/journal.pone.0144722; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; PLASSMAN BL, 1994, NEUROPSY NEUROPSY BE, V7, P235; Plassman Brenda L, 2006, Alzheimers Dement, V2, P2, DOI 10.1016/j.jalz.2005.11.001; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103; Wilson RS, 2011, ALZHEIMERS DEMENT, V7, P74, DOI 10.1016/j.jalz.2010.11.006	30	864	875	2	96	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2013	368	14					1326	1334		10.1056/NEJMsa1204629	http://dx.doi.org/10.1056/NEJMsa1204629			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117YT	23550670	Green Accepted			2022-12-28	WOS:000316989900009
J	Lauzier, F				Lauzier, Francois			Hydroxyethyl starch 130/0.4 and saline did not differ for mortality at 90 days in ICU patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SEVERE SEPSIS; RESUSCITATION		Univ Laval, Quebec City, PQ, Canada	Laval University	Lauzier, F (corresponding author), Univ Laval, Quebec City, PQ, Canada.		Lauzier, Francois/B-9237-2015	Lauzier, Francois/0000-0002-6530-5513; Myburgh, John/0000-0003-4088-7016; Bellomo, Rinaldo/0000-0002-1650-8939				Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6							JC5	10.7326/0003-4819-158-6-201303190-02005	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23552762				2022-12-28	WOS:000316565100004
J	Dyer, MS; Collins, C; Hodgeman, D; Chater, PA; Demont, A; Romani, S; Sayers, R; Thomas, MF; Claridge, JB; Darling, GR; Rosseinsky, MJ				Dyer, Matthew S.; Collins, Christopher; Hodgeman, Darren; Chater, Philip A.; Demont, Antoine; Romani, Simon; Sayers, Ruth; Thomas, Michael F.; Claridge, John B.; Darling, George R.; Rosseinsky, Matthew J.			Computationally Assisted Identification of Functional Inorganic Materials	SCIENCE			English	Article							CRYSTAL-STRUCTURE PREDICTION; FERRITES	The design of complex inorganic materials is a challenge because of the diversity of their potential structures. We present a method for the computational identification of materials containing multiple atom types in multiple geometries by ranking candidate structures assembled from extended modules containing chemically realistic atomic environments. Many existing functional materials can be described in this way, and their properties are often determined by the chemistry and electronic structure of their constituent modules. To demonstrate the approach, we isolated the oxide Y2.24Ba2.28Ca3.48Fe7.44Cu0.56O21, with a largest unit cell dimension of over 60 angstroms and 148 atoms in the unit cell, by using a combination of this method and experimental work and show that it has the properties necessary to function as a solid oxide fuel-cell cathode.	[Dyer, Matthew S.; Collins, Christopher; Hodgeman, Darren; Chater, Philip A.; Demont, Antoine; Sayers, Ruth; Claridge, John B.; Darling, George R.; Rosseinsky, Matthew J.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England; [Romani, Simon] Univ Liverpool, Sch Engn, Ctr Mat & Struct, Liverpool L69 3GH, Merseyside, England; [Thomas, Michael F.] Univ Liverpool, Dept Phys, Liverpool L69 7ZE, Merseyside, England	University of Liverpool; University of Liverpool; University of Liverpool	Rosseinsky, MJ (corresponding author), Univ Liverpool, Dept Chem, Crown St, Liverpool L69 7ZD, Merseyside, England.	m.j.rosseinsky@liverpool.ac.uk	Chater, Philip/AAF-8956-2019; Dyer, Matthew S/E-8633-2017; Dyer, Matthew S/Q-2762-2019; Claridge, John B/I-7395-2012	Chater, Philip/0000-0002-5513-9400; Dyer, Matthew S/0000-0002-4923-3003; Dyer, Matthew S/0000-0002-4923-3003; Claridge, John B/0000-0003-4849-6714; Darling, George/0000-0001-9329-9993; Collins, Christopher/0000-0002-0101-4426	European Research Council (ERC) [227987 RLUCIM]; Engineering and Physical Sciences Research Council [EP/F067496/1, EP/H000925/1] Funding Source: researchfish; EPSRC [EP/F067496/1, EP/H000925/1] Funding Source: UKRI	European Research Council (ERC)(European Research Council (ERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is funded by the European Research Council (ERC Grant agreement 227987 RLUCIM). It was carried out with the support of the Diamond Light Source (DLS) and ISIS. We thank C. Tang, J. Parker, and S. Thompson for assistance in using beamline I11 (DLS) and A. Daoud-Aladine for assistance in using the High Resolution Powder Diffractometer (HRPD, ISIS). CCDC 887926 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif, by e-mailing data_request@ccdc.cam.ac.uk, or by contacting the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033. We also thank M. S. Islam (Department of Chemistry, University of Bath) for helpful discussion with regards to	BATTLE PD, 1990, J SOLID STATE CHEM, V84, P237, DOI 10.1016/0022-4596(90)90322-O; CATLOW CRA, 1984, ACTA CRYSTALLOGR B, V40, P195, DOI 10.1107/S010876818400197X; DARRIET J, 1995, J MATER CHEM, V5, P543, DOI 10.1039/jm9950500543; Demont A, 2010, CHEM MATER, V22, P6598, DOI 10.1021/cm102475n; Draznieks CM, 2000, ANGEW CHEM INT EDIT, V39, P2270; Dusastre V, 1999, SOLID STATE IONICS, V126, P163, DOI 10.1016/S0167-2738(99)00108-3; Ferraris G, 2004, CRYSTALLOGRAPHY MODU; Fischer CC, 2006, NAT MATER, V5, P641, DOI 10.1038/nmat1691; Friedrichs OD, 1999, NATURE, V400, P644, DOI 10.1038/23210; Gladishevskii E. I., 1972, VISN VIV U K, V14, P9; JEFREY GA, 1966, ACTA CRYSTALLOGR, V20, P538; Le Bail A, 2005, J APPL CRYSTALLOGR, V38, P389, DOI 10.1107/S0021889805002384; Lehmann CW, 2011, ANGEW CHEM INT EDIT, V50, P5616, DOI 10.1002/anie.201101530; Levy O, 2010, J AM CHEM SOC, V132, P4830, DOI 10.1021/ja9105623; LIMADEFARIA J, 1990, ACTA CRYSTALLOGR A, V46, P1; Martonak R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.075503; Mitchell RH, 2002, PEROVSKITES ANCIENT; Neumann MA, 2008, ANGEW CHEM INT EDIT, V47, P2427, DOI 10.1002/anie.200704247; Ozgur U, 2009, J MATER SCI-MATER EL, V20, P789, DOI 10.1007/s10854-009-9923-2; Oganov AR, 2010, REV MINERAL GEOCHEM, V71, P271, DOI 10.2138/rmg.2010.71.13; Orlov I, 2007, ACTA CRYSTALLOGR B, V63, P703, DOI 10.1107/S0108768107038104; Piquini P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.186403; Smit J., 1959, FERRITES; Svarcova S, 2008, SOLID STATE IONICS, V178, P1787, DOI 10.1016/j.ssi.2007.11.031; THOMPSON JB, 1978, AM MINERAL, V63, P239; Wang K, 2008, J POWER SOURCES, V179, P60, DOI 10.1016/j.jpowsour.2007.12.051; Wevers MAC, 1998, J SOLID STATE CHEM, V136, P233, DOI 10.1006/jssc.1997.7688; Woodley SM, 1999, PHYS CHEM CHEM PHYS, V1, P2535, DOI 10.1039/a901227c; Zacate MO, 2000, PHILOS MAG A, V80, P797, DOI 10.1080/01418610008212083; Zhang X, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.014109; Zvyagin BB, 2003, Z KRISTALLOGR, V218, P210, DOI 10.1524/zkri.218.3.210.20747	31	47	49	1	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2013	340	6134					847	852		10.1126/science.1226558	http://dx.doi.org/10.1126/science.1226558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23579498				2022-12-28	WOS:000318997400040
J	Hochreiter-Hufford, AE; Lee, CS; Kinchen, JM; Sokolowski, JD; Arandjelovic, S; Call, JA; Klibanov, AL; Yan, Z; Mandell, JW; Ravichandran, KS				Hochreiter-Hufford, Amelia E.; Lee, Chang Sup; Kinchen, Jason M.; Sokolowski, Jennifer D.; Arandjelovic, Sanja; Call, Jarrod A.; Klibanov, Alexander L.; Yan, Zhen; Mandell, James W.; Ravichandran, Kodi S.			Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion	NATURE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; ENGULFMENT RECEPTOR; IN-VIVO; FIND-ME; EXPRESSION; DROSOPHILA; MOUSE; PROTEIN; GENE	Skeletal muscle arises from the fusion of precursor myoblasts into multinucleated myofibres(1,2). Although conserved transcription factors and signalling proteins involved in myogenesis have been identified, upstream regulators are less well understood. Here we report an unexpected discovery that the membrane protein BAI1, previously linked to recognition of apoptotic cells by phagocytes(3), promotes myoblast fusion. Endogenous BAI1 expression increased during myoblast fusion, and BAI1 overexpression enhanced myoblast fusion by means of signalling through ELMO/Dock180/Rac1 proteins(4). During myoblast fusion, a fraction of myoblasts within the population underwent apoptosis and exposed phosphatidylserine, an established ligand for BAI1 (ref. 3). Blocking apoptosis potently impaired myoblast fusion, and adding back apoptotic myoblasts restored fusion. Furthermore, primary human myoblasts could be induced to form myotubes by adding apoptotic myoblasts, even under normal growth conditions. Mechanistically, apoptotic cells did not directly fuse with the healthy myoblasts, rather the apoptotic cells induced a contact-dependent signalling with neighbours to promote fusion among the healthy myoblasts. In vivo, myofibres from Bai1(-/-) mice are smaller than those from wild-type littermates. Muscle regeneration after injury was also impaired in Bai1(-/-) mice, highlighting a role for BAI1 in mammalian myogenesis. Collectively, these data identify apoptotic cells as a new type of cue that induces signalling via the phosphatidylserine receptor BAI1 to promote fusion of healthy myoblasts, with important implications for muscle development and repair.	[Hochreiter-Hufford, Amelia E.; Lee, Chang Sup; Kinchen, Jason M.; Arandjelovic, Sanja; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Hochreiter-Hufford, Amelia E.; Lee, Chang Sup; Kinchen, Jason M.; Arandjelovic, Sanja; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Immunol Ctr, Charlottesville, VA 22908 USA; [Hochreiter-Hufford, Amelia E.; Lee, Chang Sup; Kinchen, Jason M.; Sokolowski, Jennifer D.; Arandjelovic, Sanja; Mandell, James W.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Sokolowski, Jennifer D.; Mandell, James W.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; [Call, Jarrod A.; Klibanov, Alexander L.; Yan, Zhen] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Call, Jarrod A.; Klibanov, Alexander L.; Yan, Zhen] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA.	Ravi@virginia.edu	Kinchen, Jason/ABC-5663-2021	Call, Jarrod/0000-0002-1094-4940; Ravichandran, Kodi/0000-0001-9049-1410; Yan, Zhen/0000-0002-4826-9813; Kinchen, Jason/0000-0001-8430-2265	National Institute of General Medical Sciences/National Institutes of Health; Center for Cell Clearance at the University of Virginia; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267, R01GM064709] Funding Source: NIH RePORTER	National Institute of General Medical Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Center for Cell Clearance at the University of Virginia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Ravichandran laboratory for their valuable suggestions at many stages of this work. We also thank L. Haney, A. Bruce and A. Dutta for technical suggestions and assistance and M. Hufford and A. Fond for help with statistical analysis. We thank members of the University of Virginia Flow Cytometry Core, Research Histology Core, and Gene Targeting and Transgenic Facility for cell sorting, histological services and transgenic mouse generation. This work was supported by a grant from the National Institute of General Medical Sciences/National Institutes of Health and the Center for Cell Clearance at the University of Virginia.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bialek P, 2011, PHYSIOL GENOMICS, V43, P1075, DOI 10.1152/physiolgenomics.00247.2010; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Cornelison DDW, 2008, J CELL BIOCHEM, V105, P663, DOI 10.1002/jcb.21892; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Geisbrecht ER, 2008, DEV BIOL, V314, P137, DOI 10.1016/j.ydbio.2007.11.022; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Jeong J, 2011, BIOCHEM BIOPH RES CO, V414, P9, DOI 10.1016/j.bbrc.2011.08.128; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Moore CA, 2007, DEVELOPMENT, V134, P3145, DOI 10.1242/dev.001214; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Phaneuf S, 2001, MED SCI SPORT EXER, V33, P393, DOI 10.1097/00005768-200103000-00010; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Sokolowski JD, 2011, BRAIN BEHAV IMMUN, V25, P915, DOI 10.1016/j.bbi.2010.09.021; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Vasyutina E, 2009, P NATL ACAD SCI USA, V106, P8935, DOI 10.1073/pnas.0902501106; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200	31	200	206	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					263	+		10.1038/nature12135	http://dx.doi.org/10.1038/nature12135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23615608	Green Accepted			2022-12-28	WOS:000318558200041
J	Reinhard, CT; Planavsky, NJ; Lyons, TW				Reinhard, Christopher T.; Planavsky, Noah J.; Lyons, Timothy W.			Long-term sedimentary recycling of rare sulphur isotope anomalies	NATURE			English	Article							MASS-INDEPENDENT SULFUR; MODELING ATMOSPHERIC O-2; OXYGEN; CO2; EVOLUTION; EARTH; FLUCTUATIONS; PROPORTIONS; OXIDATION; CYCLES	The accumulation of substantial quantities of O-2 in the atmosphere has come to control the chemistry and ecological structure of Earth's surface. Non-mass-dependent (NMD) sulphur isotope anomalies in the rock record(1) are the central tool used to reconstruct the redox history of the early atmosphere. The generation and initial delivery of these anomalies to marine sediments requires low partial pressures of atmospheric O-2 (p(O2); refs 2, 3), and the disappearance of NMD anomalies from the rock record 2.32 billion years ago(1,4) is thought to have signalled a departure from persistently low atmospheric oxygen levels (less than about 10(-5) times the present atmospheric level) during approximately the first two billion years of Earth's history. Here we present a model study designed to describe the long-term surface recycling of crustal NMD anomalies, and show that the record of this geochemical signal is likely to display a 'crustalmemory effect' following increases in atmospheric p(O2) above this threshold. Once NMD anomalies have been buried in the upper crust they are extremely resistant to removal, and can be erased only through successive cycles of weathering, dilution and burial on an oxygenated Earth surface. This recycling results in the residual incorporation ofNMDanomalies into the sedimentary record long after synchronous atmospheric generation of the isotopic signal has ceased, with dynamic and measurable signals probably surviving for as long as 10-100 million years subsequent to an increase in atmospheric p(O2) to more than 10(-5) times the present atmospheric level. Our results can reconcile geochemical evidence for oxygen production and transient accumulation with the maintenance of NMD anomalies on the early Earth(5-8), and suggest that future work should investigate the notion that temporally continuous generation of new NMD sulphur isotope anomalies in the atmosphere was likely to have ceased long before their ultimate disappearance from the rock record.	[Reinhard, Christopher T.; Planavsky, Noah J.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91126 USA; [Reinhard, Christopher T.; Planavsky, Noah J.; Lyons, Timothy W.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA	California Institute of Technology; University of California System; University of California Riverside	Reinhard, CT (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91126 USA.	reinhard@caltech.edu			NSF-EAR; NASA Exobiology Program; O. K. Earl Postdoctoral Fellowship in Geological and Planetary Sciences at the California Institute of Technology; NSF-EAR-PDF; Directorate For Geosciences [1144317] Funding Source: National Science Foundation	NSF-EAR(National Science Foundation (NSF)); NASA Exobiology Program(National Aeronautics & Space Administration (NASA)); O. K. Earl Postdoctoral Fellowship in Geological and Planetary Sciences at the California Institute of Technology; NSF-EAR-PDF; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding from NSF-EAR and the NASA Exobiology Program supported this research. C. T. R. acknowledges support from an O. K. Earl Postdoctoral Fellowship in Geological and Planetary Sciences at the California Institute of Technology. N.J.P. acknowledges support from NSF-EAR-PDF. Comments and criticism from L. Kump, B. Wing, A. Bekker and K. Konhauser greatly improved the manuscript.	Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Andres RJ, 1998, J GEOPHYS RES-ATMOS, V103, P25251, DOI 10.1029/98JD02091; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Bekker A, 2009, SCIENCE, V326, P1086, DOI 10.1126/science.1177742; BERNER RA, 1991, AM J SCI, V291, P339, DOI 10.2475/ajs.291.4.339; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; BERNER RA, 1989, GLOBAL PLANET CHANGE, V75, P97; Berner RA, 2001, GEOCHIM COSMOCHIM AC, V65, P685, DOI 10.1016/S0016-7037(00)00572-X; BERNER RA, 1987, AM J SCI, V287, P177, DOI 10.2475/ajs.287.3.177; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; BERRESHEIM H, 1983, J GEOPHYS RES-OCEANS, V88, P3732, DOI 10.1029/JC088iC06p03732; BLATT H, 1975, GEOL SOC AM BULL, V86, P1085, DOI 10.1130/0016-7606(1975)86<1085:POEIMA>2.0.CO;2; BLUTH GJS, 1991, AM J SCI, V291, P284, DOI 10.2475/ajs.291.3.284; Canfield DE, 2004, AM J SCI, V304, P839, DOI 10.2475/ajs.304.10.839; Canfield DE, 2006, PHILOS T R SOC B, V361, P1819, DOI 10.1098/rstb.2006.1906; Canfield DE, 2009, P NATL ACAD SCI USA, V106, P8123, DOI 10.1073/pnas.0902037106; CHRISTENSEN UR, 1985, J GEOPHYS RES-SOLID, V90, P2995, DOI 10.1029/JB090iB04p02995; Evans DA, 1997, NATURE, V386, P262, DOI 10.1038/386262a0; Farquhar J, 2005, GEOL SOC SPEC PUBL, V248, P167, DOI 10.1144/GSL.SP.2005.248.01.09; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J, 2002, SCIENCE, V298, P2369, DOI 10.1126/science.1078617; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Frei R, 2009, NATURE, V461, P250, DOI 10.1038/nature08266; Garrels R.M., 1972, MAR CHEM, V1, P27, DOI [10.1016/0304-4203(72)90004-7, DOI 10.1016/0304-4203(72)90004-7]; GARRELS RM, 1976, AM SCI, V64, P306; GARRELS RM, 1984, AM J SCI, V284, P989, DOI 10.2475/ajs.284.9.989; GARRELS RM, 1969, SCIENCE, V163, P570, DOI 10.1126/science.163.3867.570; Garvin J, 2009, SCIENCE, V323, P1045, DOI 10.1126/science.1165675; Goldblatt C, 2006, NATURE, V443, P683, DOI 10.1038/nature05169; Gregor C. B., 1985, GEOL SOC LOND MEM, V10, P284; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Halevy I, 2010, SCIENCE, V329, P204, DOI 10.1126/science.1190298; Halmer MM, 2002, J VOLCANOL GEOTH RES, V115, P511, DOI 10.1016/S0377-0273(01)00318-3; Kaufman AJ, 2007, SCIENCE, V317, P1900, DOI 10.1126/science.1138700; Konhauser KO, 2011, NATURE, V478, P369, DOI 10.1038/nature10511; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; KUMP LR, 1986, AM J SCI, V286, P337, DOI 10.2475/ajs.286.5.337; Lenardic A, 2006, GEOPH MONOG SERIES, V164, P33, DOI 10.1029/164GM04; LI Y, 1972, AM J SCI, V272, P119, DOI 10.2475/ajs.272.2.119; Maynard JB, 2010, ECON GEOL, V105, P535, DOI 10.2113/gsecongeo.105.3.535; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Padhi CM, 2012, EARTH PLANET SC LETT, V341, P1, DOI 10.1016/j.epsl.2012.06.013; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Reinhard CT, 2009, SCIENCE, V326, P713, DOI 10.1126/science.1176711; Royer DL, 2007, NATURE, V446, P530, DOI 10.1038/nature05699; Royer DL, 2001, EARTH-SCI REV, V54, P349, DOI 10.1016/S0012-8252(00)00042-8; SCHUBERT G, 1980, J GEOPHYS RES, V85, P2531, DOI 10.1029/JB085iB05p02531; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; Ueno Y, 2008, GEOCHIM COSMOCHIM AC, V72, P5675, DOI 10.1016/j.gca.2008.08.026; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2	52	67	68	1	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					100	+		10.1038/nature12021	http://dx.doi.org/10.1038/nature12021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23615613				2022-12-28	WOS:000318221500041
J	Kelly, MJ; Sagar, P; Klepeis, VE				Kelly, Michael J.; Sagar, Pallavi; Klepeis, Veronica E.			Case 13-2013: A 6-Year-Old Girl with Bone and Joint Pain and Abdominal Distention	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CLINICAL-FEATURES; CHILDHOOD; LYMPHOMA; CHILDREN; NEUROBLASTOMA; DISEASE; TUMOR		[Kelly, Michael J.] Tufts Univ, Sch Med, Div Pediat Hematol Oncol, Dept Pediat,Floating Hosp Children,Tufts Med Ctr, Boston, MA 02111 USA; [Kelly, Michael J.] Tufts Univ, Sch Med, Dept Pediat, Boston, MA 02111 USA; [Sagar, Pallavi] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Klepeis, Veronica E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sagar, Pallavi] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Klepeis, Veronica E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Floating Hospital For Children; Tufts Medical Center; Tufts University; Tufts University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kelly, MJ (corresponding author), Tufts Univ, Sch Med, Div Pediat Hematol Oncol, Dept Pediat,Floating Hosp Children,Tufts Med Ctr, Boston, MA 02111 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012889] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Borowitz M. J., 2008, WHO CLASSIFICATION T, P168; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Borowitz MJ, 2008, WHO CLASSIFICATION T, P171; Cabral DA, 1999, J PEDIATR-US, V134, P53, DOI 10.1016/S0022-3476(99)70372-0; FILIATRAULT D, 1987, PEDIATR RADIOL, V17, P137, DOI 10.1007/BF02388091; Gerald WL, 1998, J CLIN ONCOL, V16, P3028, DOI 10.1200/JCO.1998.16.9.3028; Gross TG, 2011, PRINCIPLES PRACTICE; Gross Thomas G, 2008, Curr Hematol Malig Rep, V3, P167, DOI 10.1007/s11899-008-0024-8; McClain KL, 2011, PRINCIPLES PRACTICE; Neth O, 2000, MED PEDIATR ONCOL, V35, P20, DOI 10.1002/1096-911X(200007)35:1<20::AID-MPO4>3.0.CO;2-L; Nordkamp LO, 2009, J PEDIAT HEMATOL ONC, V31, P930, DOI 10.1097/MPH.0b013e3181bc9c85; Patte C, 2001, BLOOD, V97, P3370, DOI 10.1182/blood.V97.11.3370; Pizzo PA, 2011, PRINCIPLES PRACTICE; Pui CH, 2001, J CLIN ONCOL, V19, P697, DOI 10.1200/JCO.2001.19.3.697; Reiter A, 1999, BLOOD, V94, P3294; SANDLUND JT, 1994, J CLIN ONCOL, V12, P895, DOI 10.1200/JCO.1994.12.5.895; Schultz KR, 2007, BLOOD, V109, P926, DOI 10.1182/blood-2006-01-024729; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Timmerman R, 2003, NEW ENGL J MED, V349, pE4, DOI 10.1056/ENEJMicm020675	19	0	0	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1636	1645		10.1056/NEJMcpc1208151	http://dx.doi.org/10.1056/NEJMcpc1208151			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130YK	23614590				2022-12-28	WOS:000317956300013
J	Shaw, D; Elger, B				Shaw, David; Elger, Bernice			Evidence-Based Persuasion An Ethical Imperative	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Shaw, David; Elger, Bernice] Univ Basel, Inst Biomed Eth, CH-4056 Basel, Switzerland	University of Basel	Shaw, D (corresponding author), Univ Basel, Inst Biomed Eth, Bernouillistr 28, CH-4056 Basel, Switzerland.	david.shaw@unibas.ch	Elger, Bernice Simone/V-7265-2017	Elger, Bernice Simone/0000-0002-4249-7399				Barilan YM, 2001, J MED PHILOS, V26, P13; Beauchamp TL, 2001, PRINCIPLES BIOMEDICA, P94; Health Protection Agency (UK), MMR VACC GEN INF; Manai D., 2010, INFORM GESTION RISQU; Singer P, 1993, PRACTICAL ETHICS, P195; Swindell JS, 2010, ANN FAM MED, V8, P260, DOI 10.1370/afm.1118; The Independent UK Panel on Breast Cancer Screening, BEN HARMS BREAST CAN	7	43	44	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1689	1690		10.1001/jama.2013.2179	http://dx.doi.org/10.1001/jama.2013.2179			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130IG	23568671				2022-12-28	WOS:000317906700022
J	Wager, E				Wager, Elizabeth			PUBLICATION ETHICS The UK should lead the way on research integrity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MISCONDUCT					liz@sideview.demon.co.uk		Wager, Elizabeth/0000-0002-4202-7813				Elton Terry S, 2012, CAS SUMM TS ELT; Godecharle S, 2013, LANCET, V381, P1097, DOI 10.1016/S0140-6736(13)60759-X; Higher Education Funding Council for England, 2013, CONC SUPP RES INT; Kleiert S, 2012, COOPERATION RES I J; National Institute for Health Research, 2012, NEWS LAUNCH RES INT; Research Councils UK, 2010, REP UK RES INT FUT W; Retraction Watch, 2011, RETRACTION WATC 0714; Retraction Watch, 2011, RETRACTION WATC 0208; Sutherly B., 2013, COLUMBUS DISPAT 0106; Third World Conference on Research Integrity, MONTR STAT RES INT C; Universities UK, CONC SUPP RES INT; Wager E, 2012, ANAESTHESIA, V67, P462, DOI 10.1111/j.1365-2044.2012.07132.x; Wager E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6586; Wager L., 2012, L WAGER LAUNCH CONCO; Wellcome Trust, 2012, CONC AIMS STRENGTH U	15	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2013	346								f2348	10.1136/bmj.f2348	http://dx.doi.org/10.1136/bmj.f2348			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134PK	23610377				2022-12-28	WOS:000318224700002
J	Wilson, SM				Wilson, Suzanne M.			Professional Development for Science Teachers	SCIENCE			English	Review							IMPACT; ACHIEVEMENT; INSTRUCTION; INQUIRY	The Next Generation Science Standards will require large-scale professional development (PD) for all science teachers. Existing research on effective teacher PD suggests factors that are associated with substantial changes in teacher knowledge and practice, as well as students' science achievement. But the complexity of the U. S. educational system continues to thwart the search for a straightforward answer to the question of how to support teachers. Interventions that take a systemic approach to reform hold promise for improving PD effectiveness.	Michigan State Univ, Dept Teacher Educ, E Lansing, MI 48824 USA	Michigan State University	Wilson, SM (corresponding author), Michigan State Univ, Dept Teacher Educ, E Lansing, MI 48824 USA.	swilson@msu.edu	Wilson, Suzanne M./H-5993-2019					Aud S, 2010, CONDITION ED 2010; Banilower ER, 2007, J RES SCI TEACH, V44, P375, DOI 10.1002/tea.20145; Bryk A.S., 2010, ORG SCH IMPROVEMENT; Cuevas P, 2005, J RES SCI TEACH, V42, P337, DOI 10.1002/tea.20053; Davis EA., 2005, ED RES, V34, P3, DOI [10.3102/0013189X034003003, DOI 10.3102/0013189X034003003]; Dede C, 2009, J TEACH EDUC, V60, P8, DOI 10.1177/0022487108327554; Desimone LM, 2009, EDUC RESEARCHER, V38, P181, DOI 10.3102/0013189X08331140; Desimone LM, 2002, EDUC EVAL POLICY AN, V24, P81, DOI 10.3102/01623737024002081; Elmore R. F., 2012, INTERNAL COHERENCE A; Freeman J. G., 2004, J SCI TEACHER ED, V15, P111; Garet M.S., 2011, MIDDLE SCH MATH PROF; Garet MS, 2001, AM EDUC RES J, V38, P915, DOI 10.3102/00028312038004915; Garet MS., 2008, IMPACT 2 PROFESSIONA; Grigg J, 2013, EDUC EVAL POLICY AN, V35, P38, DOI 10.3102/0162373712461851; Heller JI, 2012, J RES SCI TEACH, V49, P333, DOI 10.1002/tea.21004; Lakshmanan A, 2011, J RES SCI TEACH, V48, P534, DOI 10.1002/tea.20404; Lara-Alecio R, 2012, J RES SCI TEACH, V49, P987, DOI 10.1002/tea.21031; Lee O, 2008, J RES SCI TEACH, V45, P726, DOI 10.1002/tea.20231; Marx RW, 1998, TEACH TEACH EDUC, V14, P33, DOI 10.1016/S0742-051X(98)00059-6; National Research Council (NRC), 2007, TAK SCI SCH; NRC, 2012, FRAM K 12 SCI ED PRA; Ortega I., 2009, NATL SCI TEACHER ASS; Osborne J, 2013, J RES SCI TEACH, V50, P315, DOI 10.1002/tea.21073; Penuel WR, 2007, AM EDUC RES J, V44, P921, DOI 10.3102/0002831207308221; Penuel WR, 2011, AM EDUC RES J, V48, P996, DOI 10.3102/0002831211410864; Roth KJ, 2011, J RES SCI TEACH, V48, P117, DOI 10.1002/tea.20408; Schneider R.M., 2002, J SCI TEACHER ED, V13, P221, DOI [https://doi.org/10.1023/A:1016569117024, DOI 10.1023/A:1016569117024]; Supovitz JA, 2000, J RES SCI TEACH, V37, P963, DOI 10.1002/1098-2736(200011)37:9<963::AID-TEA6>3.0.CO;2-0	28	156	160	8	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					310	313		10.1126/science.1230725	http://dx.doi.org/10.1126/science.1230725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126XZ	23599481				2022-12-28	WOS:000317657500042
J	Amemiya, CT; Alfoldi, J; Lee, AP; Fan, SH; Philippe, H; MacCallum, I; Braasch, I; Manousaki, T; Schneider, I; Rohner, N; Organ, C; Chalopin, D; Smith, JJ; Robinson, M; Dorrington, RA; Gerdol, M; Aken, B; Biscotti, MA; Barucca, M; Baurain, D; Berlin, AM; Blatch, GL; Buonocore, F; Burmester, T; Campbell, MS; Canapa, A; Cannon, JP; Christoffels, A; De Moro, G; Edkins, AL; Fan, L; Fausto, AM; Feiner, N; Forconi, M; Gamieldien, J; Gnerre, S; Gnirke, A; Goldstone, JV; Haerty, W; Hahn, ME; Hesse, U; Hoffmann, S; Johnson, J; Karchner, SI; Kuraku, S; Lara, M; Levin, JZ; Litman, GW; Mauceli, E; Miyake, T; Mueller, MG; Nelson, DR; Nitsche, A; Olmo, E; Ota, T; Pallavicini, A; Panji, S; Picone, B; Ponting, CP; Prohaska, SJ; Przybylski, D; Saha, NR; Ravi, V; Ribeiro, FJ; Sauka-Spengler, T; Scapigliati, G; Searle, SMJ; Sharpe, T; Simakov, O; Stadler, PF; Stegeman, JJ; Sumiyama, K; Tabbaa, D; Tafer, H; Turner-Maier, J; van Heusden, P; White, S; Williams, L; Yandell, M; Brinkmann, H; Volff, JN; Tabin, CJ; Shubin, N; Schartl, M; Jaffe, DB; Postlethwait, JH; Venkatesh, B; Di Palma, F; Lander, ES; Meyer, A; Lindblad-Toh, K				Amemiya, Chris T.; Alfoeldi, Jessica; Lee, Alison P.; Fan, Shaohua; Philippe, Herve; MacCallum, Iain; Braasch, Ingo; Manousaki, Tereza; Schneider, Igor; Rohner, Nicolas; Organ, Chris; Chalopin, Domitille; Smith, Jeramiah J.; Robinson, Mark; Dorrington, Rosemary A.; Gerdol, Marco; Aken, Bronwen; Biscotti, Maria Assunta; Barucca, Marco; Baurain, Denis; Berlin, Aaron M.; Blatch, Gregory L.; Buonocore, Francesco; Burmester, Thorsten; Campbell, Michael S.; Canapa, Adriana; Cannon, John P.; Christoffels, Alan; De Moro, Gianluca; Edkins, Adrienne L.; Fan, Lin; Fausto, Anna Maria; Feiner, Nathalie; Forconi, Mariko; Gamieldien, Junaid; Gnerre, Sante; Gnirke, Andreas; Goldstone, Jared V.; Haerty, Wilfried; Hahn, Mark E.; Hesse, Uljana; Hoffmann, Steve; Johnson, Jeremy; Karchner, Sibel I.; Kuraku, Shigehiro; Lara, Marcia; Levin, Joshua Z.; Litman, Gary W.; Mauceli, Evan; Miyake, Tsutomu; Mueller, M. Gail; Nelson, David R.; Nitsche, Anne; Olmo, Ettore; Ota, Tatsuya; Pallavicini, Alberto; Panji, Sumir; Picone, Barbara; Ponting, Chris P.; Prohaska, Sonja J.; Przybylski, Dariusz; Saha, Nil Ratan; Ravi, Vydianathan; Ribeiro, Filipe J.; Sauka-Spengler, Tatjana; Scapigliati, Giuseppe; Searle, Stephen M. J.; Sharpe, Ted; Simakov, Oleg; Stadler, Peter F.; Stegeman, John J.; Sumiyama, Kenta; Tabbaa, Diana; Tafer, Hakim; Turner-Maier, Jason; van Heusden, Peter; White, Simon; Williams, Louise; Yandell, Mark; Brinkmann, Henner; Volff, Jean-Nicolas; Tabin, Clifford J.; Shubin, Neil; Schartl, Manfred; Jaffe, David B.; Postlethwait, John H.; Venkatesh, Byrappa; Di Palma, Federica; Lander, Eric S.; Meyer, Axel; Lindblad-Toh, Kerstin			The African coelacanth genome provides insights into tetrapod evolution	NATURE			English	Article							MITOCHONDRIAL GENOME; LIVING FOSSIL; SEQUENCE; MODEL; GENES; TRANSCRIPTION; CHROMOSOMES; RETENTION; REVEALS; ORIGIN	The discovery of a living coelacanth specimen in 1938 was remarkable, as this lineage of lobe-finned fish was thought to have become extinct 70 million years ago. The modern coelacanth looks remarkably similar to many of its ancient relatives, and its evolutionary proximity to our own fish ancestors provides a glimpse of the fish that first walked on land. Here we report the genome sequence of the African coelacanth, Latimeria chalumnae. Through a phylogenomic analysis, we conclude that the lungfish, and not the coelacanth, is the closest living relative of tetrapods. Coelacanth protein-coding genes are significantly more slowly evolving than those of tetrapods, unlike other genomic features. Analyses of changes in genes and regulatory elements during the vertebrate adaptation to land highlight genes involved in immunity, nitrogen excretion and the development of fins, tail, ear, eye, brain and olfaction. Functional assays of enhancers involved in the fin-to-limb transition and in the emergence of extra-embryonic tissues show the importance of the coelacanth genome as a blueprint for understanding tetrapod evolution.	[Amemiya, Chris T.; Robinson, Mark; Saha, Nil Ratan] Benaroya Res Inst, Mol Genet Program, Seattle, WA 98101 USA; [Amemiya, Chris T.] Univ Washington, Dept Biol, Seattle, WA 98105 USA; [Alfoeldi, Jessica; MacCallum, Iain; Berlin, Aaron M.; Fan, Lin; Gnerre, Sante; Gnirke, Andreas; Johnson, Jeremy; Lara, Marcia; Levin, Joshua Z.; Mauceli, Evan; Przybylski, Dariusz; Ribeiro, Filipe J.; Sharpe, Ted; Tabbaa, Diana; Turner-Maier, Jason; Williams, Louise; Jaffe, David B.; Di Palma, Federica; Lander, Eric S.; Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Lee, Alison P.; Ravi, Vydianathan; Venkatesh, Byrappa] ASTAR, Inst Mol & Cell Biol, Comparat Genom Lab, Singapore 138673, Singapore; [Fan, Shaohua; Manousaki, Tereza; Feiner, Nathalie; Kuraku, Shigehiro; Simakov, Oleg; Meyer, Axel] Univ Konstanz, Dept Biol, D-78464 Constance, Germany; [Philippe, Herve; Brinkmann, Henner] Univ Montreal, Ctr Robert Cedergren, Dept Biochim, Montreal, PQ H3T 1J4, Canada; [Braasch, Ingo; Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Manousaki, Tereza; Meyer, Axel] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78464 Constance, Germany; [Schneider, Igor] Fed Univ Para, Inst Ciencias Biol, BR-66075110 Belem, Para, Brazil; [Rohner, Nicolas; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Organ, Chris] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; [Chalopin, Domitille; Volff, Jean-Nicolas] Ecole Normale Super Lyon, Inst Genom Fonct Lyon, F-69007 Lyon, France; [Smith, Jeramiah J.] Univ Kentucky, Dept Biol, Lexington, KY 40506 USA; [Dorrington, Rosemary A.; Blatch, Gregory L.; Edkins, Adrienne L.] Rhodes Univ, Dept Biochem Microbiol & Biotechnol, Biomed Biotechnol Res Unit BioBRU, ZA-6139 Grahamstown, South Africa; [Gerdol, Marco; De Moro, Gianluca; Pallavicini, Alberto] Univ Trieste, Dept Life Sci, I-34128 Trieste, Italy; [Aken, Bronwen; Searle, Stephen M. J.; White, Simon] Wellcome Trust Sanger Inst, Dept Informat, Hinxton CB10 1SA, S Cambs, England; [Biscotti, Maria Assunta; Barucca, Marco; Canapa, Adriana; Forconi, Mariko; Olmo, Ettore] Polytech Univ Marche, Dept Life & Environm Sci, I-60131 Ancona, Italy; [Baurain, Denis] Univ Liege, Dept Life Sci, B-4000 Liege, Belgium; [Blatch, Gregory L.] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia; [Buonocore, Francesco; Fausto, Anna Maria; Scapigliati, Giuseppe] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst, I-01100 Viterbo, Italy; [Burmester, Thorsten] Univ Hamburg, Dept Biol, D-20146 Hamburg, Germany; [Campbell, Michael S.; Yandell, Mark] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; [Cannon, John P.; Litman, Gary W.] Univ S Florida, Morsani Coll Med, Childrens Res Inst, Dept Pediat, St Petersburg, FL 33701 USA; [Christoffels, Alan; Gamieldien, Junaid; Hesse, Uljana; Panji, Sumir; Picone, Barbara; van Heusden, Peter] Univ Western Cape, South African Natl Bioinformat Inst, ZA-7535 Bellville, South Africa; [Feiner, Nathalie; Meyer, Axel] Univ Konstanz, Int Max Planck Res Sch Organismal Biol, D-78464 Constance, Germany; [Goldstone, Jared V.; Hahn, Mark E.; Karchner, Sibel I.; Stegeman, John J.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Haerty, Wilfried; Ponting, Chris P.] Univ Oxford, MRC Funct Genom Unit, Oxford OX1 3PT, England; [Hoffmann, Steve] Univ Leipzig, LIFE Res Ctr Civilizat Dis, Transcriptome Bioinformat Grp, D-04109 Leipzig, Germany; [Miyake, Tsutomu] Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 2238522, Japan; [Mueller, M. Gail] Univ S Florida, All Childrens Hosp, Dept Mol Genet, St Petersburg, FL 33701 USA; [Nelson, David R.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Nitsche, Anne; Stadler, Peter F.; Tafer, Hakim] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Ota, Tatsuya] Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama 2400193, Japan; [Prohaska, Sonja J.] Univ Leipzig, Dept Comp Sci, Computat EvoDevo Grp, D-04109 Leipzig, Germany; [Sauka-Spengler, Tatjana] Univ Oxford, Weatherall Inst Mol Med, Oxford OX1 2JD, England; [Simakov, Oleg] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Sumiyama, Kenta] Natl Inst Genet, Divis Populat Genet, Mishima, Shizuoka 4118540, Japan; [Shubin, Neil] Univ Chicago, Chicago, IL 60637 USA; [Schartl, Manfred] Univ Wurzburg, Dept Physiol Chem, D-97070 Wurzburg, Germany; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, S-75123 Uppsala, Sweden	Benaroya Research Institute; University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Konstanz; Universite de Montreal; University of Oregon; University of Konstanz; Universidade Federal do Para; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Kentucky; Rhodes University; University of Trieste; Wellcome Trust Sanger Institute; Marche Polytechnic University; University of Liege; Victoria University; Tuscia University; University of Hamburg; Utah System of Higher Education; University of Utah; State University System of Florida; University of South Florida; University of the Western Cape; Max Planck Society; University of Konstanz; Woods Hole Oceanographic Institution; University of Oxford; Leipzig University; Keio University; State University System of Florida; University of South Florida; University of Tennessee System; University of Tennessee Health Science Center; Leipzig University; Graduate University for Advanced Studies - Japan; Leipzig University; University of Oxford; European Molecular Biology Laboratory (EMBL); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Chicago; University of Wurzburg; Uppsala University	Amemiya, CT (corresponding author), Benaroya Res Inst, Mol Genet Program, Seattle, WA 98101 USA.	camemiya@benaroyaresearch.org; jalfoldi@broadinstitute.org; axel.meyer@uni-konstanz.de; kersli@broadinstitute.org	Fausto, Anna Maria/AAB-6778-2020; Berlin, Aaron M/AFY-6549-2022; Simakov, Oleg/AAV-2494-2020; Pallavicini, Alberto/J-4158-2012; Burmester, Thorsten/I-7225-2013; Pallavicini, Alberto/H-9281-2019; Ravi, Vydianathan/B-2759-2009; Ponting, Chris/AAV-2621-2021; Gerdol, Marco/D-2115-2013; Edkins, Adrienne L/C-8704-2012; Stadler, Peter F. F/L-7857-2015; Christoffels, Alan/C-3269-2014; Meyer, Axel/C-9826-2009; Simakov, Oleg/G-4572-2015; Schneider, Igor/K-6164-2012; Baurain, Denis/S-4048-2019; Hoffmann, Steve/E-1438-2013; Buonocore, Francesco/AAA-5236-2020; Picone, barbara/C-9349-2018; Sumiyama, Kenta/ABD-5577-2020; Hahn, Mark/AAV-7516-2020; Lee, Alison/HCH-1286-2022; Feiner, Nathalie/C-8538-2014; Kuraku, Shigehiro/B-2801-2009; Blatch, Gregory Lloyd/Q-5900-2019; Braasch, Ingo/A-6948-2010; Sumiyama, Kenta/L-5902-2013	Berlin, Aaron M/0000-0002-0714-2808; Simakov, Oleg/0000-0002-3585-4511; Pallavicini, Alberto/0000-0001-7174-4603; Burmester, Thorsten/0000-0002-5772-7863; Pallavicini, Alberto/0000-0001-7174-4603; Ravi, Vydianathan/0000-0003-0807-7697; Gerdol, Marco/0000-0001-6411-0813; Edkins, Adrienne L/0000-0002-3615-6651; Stadler, Peter F. F/0000-0002-5016-5191; Christoffels, Alan/0000-0002-0420-2916; Meyer, Axel/0000-0002-0888-8193; Simakov, Oleg/0000-0002-3585-4511; Schneider, Igor/0000-0002-9046-7338; Baurain, Denis/0000-0003-2388-6185; Picone, barbara/0000-0002-6987-7121; Sumiyama, Kenta/0000-0001-8785-5439; Hahn, Mark/0000-0003-4358-2082; Lee, Alison/0000-0002-3773-1021; Kuraku, Shigehiro/0000-0003-1464-8388; Blatch, Gregory Lloyd/0000-0003-0778-8577; Braasch, Ingo/0000-0003-4766-611X; Sumiyama, Kenta/0000-0001-8785-5439; De Moro, Gianluca/0000-0002-5542-0278; Di-Palma, Federica/0000-0002-4394-0102; FAUSTO, Anna Maria/0000-0001-5800-7473; Nelson, David/0000-0003-0583-5421; Buonocore, Francesco/0000-0001-8045-5651; Hesse, Uljana/0000-0001-8746-4702; Tafer, Hakim/0000-0002-6252-9802; Ponting, Chris/0000-0003-0202-7816; Goldstone, Jared/0000-0002-9618-4961; Levin, Joshua/0000-0002-0170-3598; Smith, Jeramiah/0000-0001-5333-5531; Venkatesh, Byrappa/0000-0003-3620-0277; van Heusden, Peter/0000-0001-6553-5274; Rohner, Nicolas/0000-0003-3248-2772; Sauka-Spengler, Tatjana/0000-0001-9289-0263; Aken, Bronwen/0000-0002-3032-4095; Ota, Tatsuya/0000-0002-1115-5169; White, Simon/0000-0001-6375-2363; Schartl, Manfred/0000-0001-9882-5948; scapigliati, giuseppe/0000-0001-9730-9394; Haerty, Wilfried/0000-0003-0111-191X; Ribeiro, Filipe/0000-0003-3843-7702	South African National Department of Science and Technology; National Human Genome Research Institute (NHGRI); European Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR032670] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003474, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007381, R01ES006272] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011199, R01OD011116] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish; Medical Research Council [MC_U137761446] Funding Source: researchfish; BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI; MRC [MC_U137761446] Funding Source: UKRI	South African National Department of Science and Technology; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); European Science Foundation(European Science Foundation (ESF)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Acquisition and storage of Latimeria chalumnae samples was supported by grants from the African Coelacanth Ecosystem Programme of the South African National Department of Science and Technology. Generation of the Latimeria chalumnae and Protopterus annectens sequences by the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University was supported by grants from the National Human Genome Research Institute (NHGRI). K.L.T. is the recipient of a EURYI award from the European Science Foundation. We would also like to thank the Genomics Sequencing Platform of the Broad Institute for sequencing the L. chalumnae genome and L. chalumnae and P. annectens transcriptomes, S. Ahamada, R. Stobbs and the Association pour le Protection de Gombesa (APG) for their help in obtaining coelacanth samples, Y. Zhao for the use of data from Rana chensinensis, and L. Gaffney, C. Hamilton and J. Westlund for assistance with figure preparation.	Amemiya CT, 2010, P NATL ACAD SCI USA, V107, P3622, DOI 10.1073/pnas.0914312107; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bengten E, 2000, CURR TOP MICROBIOL, V248, P189; BOGART JP, 1994, J HERED, V85, P322, DOI 10.1093/oxfordjournals.jhered.a111470; Braasch I, 2011, P NATL ACAD SCI USA, V108, pE47, DOI 10.1073/pnas.1101594108; Brinkmann H, 2004, P NATL ACAD SCI USA, V101, P4900, DOI 10.1073/pnas.0400609101; Canapa A, 2012, J EXP ZOOL PART B, V318B, P404, DOI 10.1002/jez.b.22455; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Carroll RL, 1988, VERTEBRATE PALEONTOL; Erdmann MV, 1998, NATURE, V395, P335, DOI 10.1038/26376; Gekas C, 2010, INT J DEV BIOL, V54, P1089, DOI 10.1387/ijdb.103070cg; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gregory T. Ryan, 2005, P3; Haberle J, 2011, HUM MUTAT, V32, P579, DOI 10.1002/humu.21406; Holder MT, 1999, P NATL ACAD SCI USA, V96, P12616, DOI 10.1073/pnas.96.22.12616; Inoue JG, 2005, GENE, V349, P227, DOI 10.1016/j.gene.2005.01.008; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Jovelin R, 2010, J EXP ZOOL PART B, V314B, P33, DOI 10.1002/jez.b.21307; Larsson TA, 2007, GEN COMP ENDOCR, V150, P337, DOI 10.1016/j.ygcen.2006.09.002; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; MEYER A, 1992, J MOL EVOL, V35, P102; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; Noonan JP, 2004, GENOME RES, V14, P2397, DOI 10.1101/gr.2972804; Nulens R., 2010, LATIMERIA SPP SMITHI, V3; Ota T, 2003, P NATL ACAD SCI USA, V100, P2501, DOI 10.1073/pnas.0538029100; Pallavicini A., BMC GENOMIC IN PRESS; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Scotti M, 2012, DEVELOPMENT, V139, P731, DOI 10.1242/dev.075408; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Smith JJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-219; Smith JJ, 2012, MOL BIOL EVOL, V29, P985, DOI 10.1093/molbev/msr267; Smith JLB, 1939, NATURE, V143, P455, DOI 10.1038/143455a0; Smith JLB, 1956, OLD FOURLEGS STORY C; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; TAJIMA F, 1993, GENETICS, V135, P599; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Voss SR, 2011, GENOME RES, V21, P1306, DOI 10.1101/gr.116491.110; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; WRIGHT PA, 1995, J EXP BIOL, V198, P273; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Zardoya R, 1997, GENETICS, V146, P995; Zhang J, 2010, NATURE, V466, P234, DOI 10.1038/nature09137; Zhu M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1764; Zimmer, 1999, WATERS EDGE FISH FIN; [No title captured]	49	462	477	14	426	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					311	316		10.1038/nature12027	http://dx.doi.org/10.1038/nature12027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23598338	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000317599200027
J	Davies, E				Davies, Edward			Media on trial for coverage of Philadelphia abortionist	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												edavies@bmj.com							0	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2013	346								f2520	10.1136/bmj.f2520	http://dx.doi.org/10.1136/bmj.f2520			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AZ	23599367				2022-12-28	WOS:000317964200013
J	Heyland, D; Muscedere, J; Wischmeyer, PE; Cook, D; Jones, G; Albert, M; Elke, G; Berger, MM; Day, AG				Heyland, Daren; Muscedere, John; Wischmeyer, Paul E.; Cook, Deborah; Jones, Gwynne; Albert, Martin; Elke, Gunnar; Berger, Mette M.; Day, Andrew G.		Canadian Critical Care Trials Grp	A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OXIDATIVE STRESS; SELENIUM; SUPPLEMENTATION	BACKGROUND Critically ill patients have considerable oxidative stress. Glutamine and antioxidant supplementation may offer therapeutic benefit, although current data are conflicting. METHODS In this blinded 2-by-2 factorial trial, we randomly assigned 1223 critically ill adults in 40 intensive care units (ICUs) in Canada, the United States, and Europe who had multiorgan failure and were receiving mechanical ventilation to receive supplements of glutamine, antioxidants, both, or placebo. Supplements were started within 24 hours after admission to the ICU and were provided both intravenously and enterally. The primary outcome was 28-day mortality. Because of the interim-analysis plan, a P value of less than 0.044 at the final analysis was considered to indicate statistical significance. RESULTS There was a trend toward increased mortality at 28 days among patients who received glutamine as compared with those who did not receive glutamine (32.4% vs. 27.2%; adjusted odds ratio, 1.28; 95% confidence interval [CI], 1.00 to 1.64; P = 0.05). In-hospital mortality and mortality at 6 months were significantly higher among those who received glutamine than among those who did not. Glutamine had no effect on rates of organ failure or infectious complications. Antioxidants had no effect on 28-day mortality (30.8%, vs. 28.8% with no antioxidants; adjusted odds ratio, 1.09; 95% CI, 0.86 to 1.40; P = 0.48) or any other secondary end point. There were no differences among the groups with respect to serious adverse events (P = 0.83). CONCLUSIONS Early provision of glutamine or antioxidants did not improve clinical outcomes, and glutamine was associated with an increase in mortality among critically ill patients with multiorgan failure. (Funded by the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00133978.)	[Heyland, Daren; Muscedere, John; Day, Andrew G.] Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada; [Cook, Deborah] St Josephs Healthcare, Hamilton, ON, Canada; [Jones, Gwynne] Ottawa Hosp, Ottawa, ON, Canada; [Albert, Martin] Hop Sacre Coeur, Montreal, PQ H4J 1C5, Canada; [Wischmeyer, Paul E.] Univ Colorado, Sch Med, Aurora, CO USA; [Elke, Gunnar] Univ Med Ctr Schleswig Holstein, Kiel, Germany; [Berger, Mette M.] CHU Vaudois, Lausanne, Switzerland	Queens University - Canada; University of Ottawa; Ottawa Hospital Research Institute; Universite de Montreal; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Kiel; Schleswig Holstein University Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Heyland, D (corresponding author), Kingston Gen Hosp, Angada 4, Kingston, ON K7L 2V7, Canada.	dkh2@queensu.ca	BERGER, Mette/AAF-1284-2020; Elke, Gunnar/S-8579-2016; Muscedere, John/AAH-9291-2021	BERGER, Mette/0000-0001-5427-1648; Elke, Gunnar/0000-0002-4948-1605; 	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by the Canadian Institutes of Health Research.	Andrews PJD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1542; Angstwurm MWA, 2007, CRIT CARE MED, V35, P118, DOI 10.1097/01.CCM.0000251124.83436.0E; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; ClinicalTrials.gov, TRIAL GLUT ANT SUPPL; de Vega JMA, 2002, CRIT CARE MED, V30, P1782, DOI 10.1097/00003246-200208000-00018; GOODE HF, 1995, CRIT CARE MED, V23, P646, DOI 10.1097/00003246-199504000-00011; Goodyear-Bruch C, 2002, AM J CRIT CARE, V11, P543, DOI 10.4037/ajcc2002.11.6.543; Hardy G, 2012, NUTR CLIN PRACT, V27, P21, DOI 10.1177/0884533611434116; Heyland DK, 2007, JPEN-PARENTER ENTER, V31, P109, DOI 10.1177/0148607107031002109; Heyland DK, 2006, P NUTR SOC, V65, P250, DOI 10.1079/PNS2006505; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Johnson CC, 2010, P NUTR SOC, V69, P119, DOI 10.1017/S0029665109991807; Manzanares W, 2012, CRIT CARE, V16, DOI 10.1186/cc11316; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; Motoyama T, 2003, CRIT CARE MED, V31, P1048, DOI 10.1097/01.CCM.0000055371.27268.36; Novak F, 2002, CRIT CARE MED, V30, P2022, DOI 10.1097/00003246-200209000-00011; Oudemans-van Straaten HM, 2001, INTENS CARE MED, V27, P84, DOI 10.1007/s001340000703; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Wang Z, 2009, SHOCK, V32, P140, DOI 10.1097/SHK.0b013e318193c35d; Wernerman J, 2011, ACTA ANAESTH SCAND, V55, P812, DOI 10.1111/j.1399-6576.2011.02453.x	20	523	569	1	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1489	1497		10.1056/NEJMoa1212722	http://dx.doi.org/10.1056/NEJMoa1212722			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126HC	23594003	Green Published, Bronze			2022-12-28	WOS:000317603300006
J	Hill, MD				Hill, Michael D.			Review: A dichotomized ABCD2 score has limited ability to predict stroke risk <= 90 days after TIA	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRANSIENT ISCHEMIC ATTACK		Univ Calgary, Calgary, AB, Canada	University of Calgary	Hill, MD (corresponding author), Univ Calgary, Calgary, AB, Canada.		Hill, Michael D/C-9073-2012	Hill, Michael D/0000-0002-6269-1543; Srikanth, Velandai/0000-0002-8442-8981				Coutts SB, 2011, CAN J NEUROL SCI, V38, P78; Coutts SB, 2012, STROKE, V43, P1013, DOI 10.1161/STROKEAHA.111.637421; Perry JJ, 2011, CAN MED ASSOC J, V183, P1137, DOI 10.1503/cmaj.101668; Wu CM, 2007, ARCH INTERN MED, V167, P2417, DOI 10.1001/archinte.167.22.2417	4	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8							JC12	10.7326/0003-4819-158-8-201304160-02012	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588765				2022-12-28	WOS:000318062100003
J	Berry, A				Berry, Andrew			Evolution's red-hot radical	NATURE			English	Editorial Material									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Berry, A (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	berry@oeb.harvard.edu						Berry A, 2008, NATURE, V453, P1188, DOI 10.1038/4531188a; Fichman Martin, 2004, ELUSIVE VICTORIAN EV, DOI [10.7208/chicago/9780226246154.001.0001, DOI 10.7208/CHICAGO/9780226246154.001.0001]; Johnson N. A., 2008, NATURAL SELECTION IN, P114; Mayr E, 1942, SYSTEMATICS ORIGIN S; Wallace A.R., 1865, T LINN SOC LOND, V1, P1, DOI [10.1111/j.1096-3642.1865.tb00178.x, DOI 10.1111/J.1096-3642.1865.TB00178.X]; Wallace AR, 1855, ANN MAGAZINE NATURAL, V16, P184, DOI DOI 10.1080/037454809495509; Wallace AR, 1857, ANN MAGAZINE NATUR S, V20, P473; [No title captured]	8	7	7	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					162	164		10.1038/496162a	http://dx.doi.org/10.1038/496162a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	122VM	23579663	Bronze			2022-12-28	WOS:000317346300018
J	Jiang, JS; Miracco, EJ; Hong, K; Eckert, B; Chan, H; Cash, DD; Min, BS; Zhou, ZH; Collins, K; Feigon, J				Jiang, Jiansen; Miracco, Edward J.; Hong, Kyungah; Eckert, Barbara; Chan, Henry; Cash, Darian D.; Min, Bosun; Zhou, Z. Hong; Collins, Kathleen; Feigon, Juli			The architecture of Tetrahymena telomerase holoenzyme	NATURE			English	Article							RNA-BINDING DOMAIN; STEM-LOOP IV; MOLECULAR-STRUCTURE DETERMINATION; CATALYTIC SUBUNIT TERT; N-TERMINAL DOMAIN; REVERSE-TRANSCRIPTASE; ELECTRON-MICROSCOPY; STRUCTURAL BASIS; PROTEIN P65; XPLOR-NIH	Telomerase adds telomeric repeats to chromosome ends using an internal RNA template and a specialized telomerase reverse transcriptase (TERT), thereby maintaining genome integrity. Little is known about the physical relationships among protein and RNA subunits within a biologically functional holoenzyme. Here we describe the architecture of Tetrahymena thermophila telomerase holoenzyme determined by electron microscopy. Six of the seven proteins and the TERT-binding regions of telomerase RNA (TER) have been localized by affinity labelling. Fitting with high-resolution structures reveals the organization of TERT, TER and p65 in the ribonucleoprotein (RNP) catalytic core. p50 has an unanticipated role as a hub between the RNP catalytic core, p75-p19-p45 subcomplex, and the DNA-binding Teb1. A complete in vitro holoenzyme reconstitution assigns function to these interactions in processive telomeric repeat synthesis. These studies provide the first view of the extensive network of subunit associations necessary for telomerase holoenzyme assembly and physiological function.	[Jiang, Jiansen; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Jiang, Jiansen; Miracco, Edward J.; Chan, Henry; Cash, Darian D.; Feigon, Juli] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Jiang, Jiansen; Zhou, Z. Hong; Feigon, Juli] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA; [Hong, Kyungah; Eckert, Barbara; Min, Bosun; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Berkeley	Feigon, J (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	hong.zhou@ucla.edu; kcollins@berkeley.edu; feigon@mbi.ucla.edu	Zhou, Z Hong/HDN-0747-2022; Jiang, Jiansen/J-2057-2015	Jiang, Jiansen/0000-0002-1692-7906	NSF [MCB1022379]; NIH [GM48123, GM54198, GM071940, AI069015, 1S10RR23057]; Ruth L. Kirschstein NRSA postdoctoral fellowship [GM101874]; Ruth L. Kirschstein NRSA pre-doctoral training grant fellowship [GM007185]; CNSI; UCLA; Div Of Molecular and Cellular Bioscience [1022379] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054198, F32GM101874, R01GM071940, T32GM007185, R01GM048123] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NRSA pre-doctoral training grant fellowship; CNSI; UCLA(University of California System); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from NSF MCB1022379 and NIH GM48123 to J.F., NIH GM54198 to K. C., GM071940 and AI069015 to Z.H.Z., Ruth L. Kirschstein NRSA postdoctoral fellowship GM101874 to E.J.M., and Ruth L. Kirschstein NRSA pre-doctoral training grant GM007185 fellowship for H. C. and D. D. C. We acknowledge the use of instruments at the Electron Imaging Center for NanoMachines supported by NIH (1S10RR23057 to ZHZ) and CNSI at UCLA.	Akiyama BM, 2012, RNA, V18, P653, DOI 10.1261/rna.031377.111; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blackburn EH, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003558; Bley CJ, 2011, P NATL ACAD SCI USA, V108, P20333, DOI 10.1073/pnas.1100270108; Bryan TM, 2000, MOL CELL, V6, P493, DOI 10.1016/S1097-2765(00)00048-4; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen Y, 2006, EMBO J, V25, P3156, DOI 10.1038/sj.emboj.7601195; Cole DI, 2012, J AM CHEM SOC, V134, P20070, DOI 10.1021/ja305636u; Collins K, 2011, CURR OPIN CHEM BIOL, V15, P643, DOI 10.1016/j.cbpa.2011.07.011; Couvillion MT, 2012, METHOD CELL BIOL, V109, P347, DOI 10.1016/B978-0-12-385967-9.00012-8; Cunningham DD, 2005, MOL CELL BIOL, V25, P4442, DOI 10.1128/MCB.25.11.4442-4454.2005; Eckert B, 2012, J BIOL CHEM, V287, P12805, DOI 10.1074/jbc.M112.339853; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Friedman KL, 1999, GENE DEV, V13, P2863, DOI 10.1101/gad.13.21.2863; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Jacks A, 2003, STRUCTURE, V11, P833, DOI 10.1016/S0969-2126(03)00121-7; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Lai CK, 2003, MOL CELL, V11, P1673, DOI 10.1016/S1097-2765(03)00232-6; Lai CK, 2002, GENE DEV, V16, P415, DOI 10.1101/gad.962602; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; Lee J, 2010, NUCLEIC ACIDS RES, V38, P2279, DOI 10.1093/nar/gkp1173; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mason DX, 2003, MOL CELL BIOL, V23, P5606, DOI 10.1128/MCB.23.16.5606-5613.2003; Min BS, 2010, J BIOL CHEM, V285, P16434, DOI 10.1074/jbc.M110.119172; Min BS, 2009, MOL CELL, V36, P609, DOI 10.1016/j.molcel.2009.09.041; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mitchell M, 2010, NAT STRUCT MOL BIOL, V17, P513, DOI 10.1038/nsmb.1777; O'Connor CM, 2006, MOL CELL BIOL, V26, P2029, DOI 10.1128/MCB.26.6.2029-2036.2006; O'Connor CM, 2005, J BIOL CHEM, V280, P17533, DOI 10.1074/jbc.M501211200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Richards RJ, 2006, RNA, V12, P1475, DOI 10.1261/rna.112306; Richards RJ, 2006, NUCLEIC ACIDS RES, V34, P816, DOI 10.1093/nar/gkj481; Robart AR, 2011, MOL CELL, V42, P308, DOI 10.1016/j.molcel.2011.03.012; Romi E, 2007, P NATL ACAD SCI USA, V104, P8791, DOI 10.1073/pnas.0703157104; Rosenfeld KK, 2011, J MOL BIOL, V410, P77, DOI 10.1016/j.jmb.2011.04.040; Rouda S, 2007, STRUCTURE, V15, P1403, DOI 10.1016/j.str.2007.09.007; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sexton AN, 2012, J BIOL CHEM, V287, P34455, DOI 10.1074/jbc.M112.394767; Singh M, 2012, MOL CELL, V47, P16, DOI 10.1016/j.molcel.2012.05.018; Steczkiewicz K, 2011, P NATL ACAD SCI USA, V108, P9443, DOI 10.1073/pnas.1015399108; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; Talley JM, 2011, J BIOL CHEM, V286, P26431, DOI 10.1074/jbc.M111.228635; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; Ulyanov NB, 2007, NUCLEIC ACIDS RES, V35, P6150, DOI 10.1093/nar/gkm660; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Witkin KL, 2004, GENE DEV, V18, P1107, DOI 10.1101/gad.1201704; Wu JY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1033; Yen WF, 2011, P NATL ACAD SCI USA, V108, P20370, DOI 10.1073/pnas.1017855108; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zeng ZX, 2011, P NATL ACAD SCI USA, V108, P20357, DOI 10.1073/pnas.1113624108	65	84	90	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					187	+		10.1038/nature12062	http://dx.doi.org/10.1038/nature12062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23552895	Green Accepted, Green Submitted			2022-12-28	WOS:000317346300034
J	Liberman, LM; Benfey, PN				Liberman, Louisa M.; Benfey, Philip N.			Polarized Radicals	CELL			English	Editorial Material							CASPARIAN STRIP; BARRIER	Establishing polarized surfaces enables cells to carry out specialized tasks. In this issue, Lee et al. present a mechanism for cell polarization in which localized peroxidases are used to position the Casparian strip, a diffusion barrier deposited between endodermal cells in plant roots.	[Liberman, Louisa M.; Benfey, Philip N.] Duke Univ, Dept Biol, Duke Ctr Syst Biol, Durham, NC 27708 USA; [Benfey, Philip N.] Duke Univ, Howard Hughes Med Inst, Durham, NC 27708 USA	Duke University; Duke University; Howard Hughes Medical Institute	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Duke Ctr Syst Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu						Alassimone J, 2012, PROTOPLASMA, V249, P433, DOI 10.1007/s00709-011-0302-5; BONNETT HT, 1968, J CELL BIOL, V37, P199, DOI 10.1083/jcb.37.1.199; Cederholm HM, 2012, WIRES DEV BIOL, V1, P675, DOI 10.1002/wdev.49; Lee Y, 2013, CELL, V153, P402, DOI 10.1016/j.cell.2013.02.045; NAGAHASHI G, 1974, SCIENCE, V183, P670, DOI 10.1126/science.183.4125.670; Naseer S, 2012, P NATL ACAD SCI USA, V109, P10101, DOI 10.1073/pnas.1205726109; PEIRSON DR, 1969, CAN J BOTANY, V47, P1869, DOI 10.1139/b69-274; Roppolo D, 2011, NATURE, V473, P380, DOI 10.1038/nature10070; VANFLEET DS, 1961, BOT REV, V27, P165, DOI 10.1007/BF02860082	9	1	1	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					285	286		10.1016/j.cell.2013.03.042	http://dx.doi.org/10.1016/j.cell.2013.03.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582319	Bronze			2022-12-28	WOS:000317349700008
J	White, RH				White, Richard H.			Scores poorly predict major bleeding (c-statistics <= 0.61) during oral anticoagulant therapy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Davis, Sacramento, CA 95817 USA	University of California System; University of California Davis	White, RH (corresponding author), Univ Calif Davis, Sacramento, CA 95817 USA.			Rodondi, Nicolas/0000-0001-9083-6896; Waeber, Gerard/0000-0003-4193-788X					0	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2013	158	6							JC13	10.7326/0003-4819-158-6-201303190-02013	http://dx.doi.org/10.7326/0003-4819-158-6-201303190-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	112AY	23553040				2022-12-28	WOS:000316565100012
J	Marx, V				Marx, Vivien			A BETTER BREW	NATURE			English	Editorial Material							CELL CULTURE											Buganim Y, 2012, CELL CYCLE, V11, P4485, DOI 10.4161/cc.22665; Daquinag A. C., 2013, TISSUE ENG PART C-ME, P336; Goral VN, 2013, LAB CHIP, V13, P1039, DOI 10.1039/c2lc41102d; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Villa-Diaz LG, 2013, STEM CELLS, V31, P1, DOI 10.1002/stem.1260	7	365	380	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 11	2013	496	7444					253	258		10.1038/496253a	http://dx.doi.org/10.1038/496253a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23765498	Bronze			2022-12-28	WOS:000317346300050
J	Schiffman, M; Castle, PE; Jeronimo, J; Rodriguez, AC; Wacholder, S				Schiffman, Mark; Castle, Philip E.; Jeronimo, Jose; Rodriguez, Ana C.; Wacholder, Sholom			Human papillomavirus and cervical cancer	LANCET			English	Review							ATYPICAL SQUAMOUS-CELLS; LIQUID-BASED CYTOLOGY; INTRAEPITHELIAL NEOPLASIA GRADE-2; CARCINOMA IN-SITU; INTERNATIONAL INCIDENCE RATES; ASCUS-LSIL TRIAGE; HYBRID CAPTURE 2; RISK-FACTORS; FOLLOW-UP; COST-EFFECTIVENESS	Cervical cancer is the second most common cancer in women, worldwide, and knowledge regarding its cause and pathogenesis is expanding rapidly. Persistent infection with one of about 15 genotypes of carcinogenic human papillomavirus (HPV) causes almost all cases. There are four major steps in cervical cancer development: infection of metaplastic epithelium at the cervical transformation zone, viral persistence, progression of persistently infected epithelium to cervical precancer, and invasion through the basement membrane of the epithelium. Infection is extremely common in young women in their first decade of sexual. activity. Persistent infections and precancer are established, typically within 5-10 years, from less than 10% of new infections. Invasive cancer arises over many years, even decades, in a minority of women with precancer, with a peak or plateau in risk at about 35-55 years of age. Each genotype of HPV acts as an independent infection, with differing carcinogenic risks linked to evolutionary species. Our understanding has led to improved prevention and clinical management strategies, including improved screening tests and vaccines. The new HPV-oriented model of cervical carcinogenesis should gradually replace older morphological models based only on cytology and histology. If applied wisely, HPV-related technology can minimise the incidence of cervical cancer, and the morbidity and mortality it causes, even in low-resource settings.	NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schiffman, M (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA.	schiffmm@mail.nih.gov	Schiffman, Mark/B-9766-2015; Castle, Philip/AAP-6395-2020; franceschi, silvia/M-2452-2014	Castle, Philip/0000-0003-1082-6554; franceschi, silvia/0000-0003-4181-8071; Crosbie, Emma/0000-0003-0284-8630	Department of Health [NIHR-CS-012-009] Funding Source: Medline	Department of Health		Altekruse SF, 2003, AM J OBSTET GYNECOL, V188, P657, DOI 10.1067/mob.2003.132; Arbyn M, 2005, GYNECOL ONCOL, V99, pS7, DOI 10.1016/j.ygyno.2005.07.033; Arbyn M, 2004, JNCI-J NATL CANCER I, V96, P280, DOI 10.1093/jnci/djh037; Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Bais AG, 2007, INT J CANCER, V120, P1505, DOI 10.1002/ijc.22484; Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; BRINTON LA, IN PRESS PRINCIPLES; Bulk S, 2006, BRIT J CANCER, V94, P171, DOI 10.1038/sj.bjc.6602915; Bulkmans NWJ, 2007, BRIT J CANCER, V96, P1419, DOI 10.1038/sj.bjc.6603653; Burchell AN, 2006, VACCINE, V24, P52, DOI 10.1016/j.vaccine.2006.05.031; Carozzi FM, 2005, AM J CLIN PATHOL, V124, P716, DOI 10.1309/84E5WHJQHK83BGQD; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Castle PE, 2002, CANCER-AM CANCER SOC, V95, P2145, DOI 10.1002/cncr.10927; Castle PE, 2006, CANCER RES, V66, P1218, DOI 10.1158/0008-5472.CAN-05-3066; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Castle PE, 2005, JNCI-J NATL CANCER I, V97, P1066, DOI 10.1093/jnci/dji186; Castle PE, 2004, J INFECT DIS, V190, P458, DOI 10.1086/421916; CASTLE PE, IN PRESS AM J OBSTET; Castle PE, 2007, AM J CLIN PATHOL, V127, P805, DOI 10.1309/PT3PNC1QL2F4D2VL; Chang A R, 1990, Cytopathology, V1, P321, DOI 10.1111/j.1365-2303.1990.tb00369.x; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Cox JT, 1999, LANCET, V353, P857, DOI 10.1016/S0140-6736(98)00392-4; Cox JT, 2003, AM J OBSTET GYNECOL, V188, P1406, DOI 10.1067/mob.2003.461; Cuzick J, 2003, LANCET, V362, P1871, DOI 10.1016/S0140-6736(03)14955-0; Cuzick J, 2006, VACCINE, V24, P90, DOI 10.1016/j.vaccine.2006.05.122; Davey DD, 2004, ARCH PATHOL LAB MED, V128, P1224; Davey E, 2006, LANCET, V367, P122, DOI 10.1016/S0140-6736(06)67961-0; Davey E, 2007, BRIT MED J, V335, P31, DOI 10.1136/bmj.39219.645475.55; de Gonzalez AB, 2004, BRIT J CANCER, V90, P1787, DOI 10.1038/sj.bjc.6601764; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Dobbs SP, 2000, BRIT J OBSTET GYNAEC, V107, P1298, DOI 10.1111/j.1471-0528.2000.tb11623.x; Doeberitz MV, 2002, EUR J CANCER, V38, P2229, DOI 10.1016/S0959-8049(02)00462-8; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Dunn ST, 2007, J VIROL METHODS, V143, P45, DOI 10.1016/j.jviromet.2007.02.006; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Ferris DG, 2006, AM J OBSTET GYNECOL, V194, P704, DOI 10.1016/j.ajog.2005.10.204; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Fox R, 2006, CYTOPATHOLOGY, V17, P175, DOI 10.1111/j.1365-2303.2006.00302.x; Franco EL, 2006, VACCINE, V24, P171, DOI 10.1016/j.vaccine.2006.05.061; French DP, 2004, BRIT J CANCER, V91, P1887, DOI 10.1038/sj.bjc.6602224; Gage JC, 2006, OBSTET GYNECOL, V108, P264, DOI 10.1097/01.AOG.0000220505.18525.85; Gambhira R, 2006, CANCER RES, V66, P11120, DOI 10.1158/0008-5472.CAN-06-2560; Garcia F, 2003, OBSTET GYNECOL, V102, P266, DOI 10.1016/S0029-7844(03)00517-9; Garcia-Closas R, 2005, INT J CANCER, V117, P629, DOI 10.1002/ijc.21193; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garnett GP, 2006, VACCINE, V24, P178, DOI 10.1016/j.vaccine.2006.05.116; Gillison Maura L, 2003, J Natl Cancer Inst Monogr, P57; Goldhaber-Fiebert Jeremy D, 2006, Cost Eff Resour Alloc, V4, P13, DOI 10.1186/1478-7547-4-13; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Goldie SJ, 2006, VACCINE, V24, P164, DOI 10.1016/j.vaccine.2006.05.114; Green J, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002225.PUB2; Guido R, 2003, AM J OBSTET GYNECOL, V188, P1401, DOI 10.1067/mob.2003.456; Gustafsson L, 1997, CANCER CAUSE CONTROL, V8, P755, DOI 10.1023/A:1018435522475; Gustafsson L, 1997, INT J CANCER, V71, P159, DOI 10.1002/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#; Harris TG, 2005, JAMA-J AM MED ASSOC, V293, P1471, DOI 10.1001/jama.293.12.1471; Harro CD, 2001, JNCI-J NATL CANCER I, V93, P284, DOI 10.1093/jnci/93.4.284; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Hildesheim A, 1999, AM J OBSTET GYNECOL, V180, P571, DOI 10.1016/S0002-9378(99)70256-5; HILDESHEIM A, IN PRESS JAMA; Hogewoning CJA, 2003, INT J CANCER, V107, P811, DOI 10.1002/ijc.11474; *IN COLL EP STUD C, 2006, INT J CANCER, V119, P1108; *IN COLL EP STUD C, 2006, INT J CANCER, V118, P1481; Inglis S, 2006, VACCINE, V24, P99, DOI 10.1016/j.vaccine.2006.05.119; Jacobson DL, 1999, INT J GYNECOL OBSTET, V66, P7, DOI 10.1016/S0020-7292(99)00037-5; JERONIMO J, 2007, AM J OBSTET GYNECOL, V197; Josefsson AM, 2000, LANCET, V355, P2189, DOI 10.1016/S0140-6736(00)02401-6; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Kahn JA, 2007, HEALTH PSYCHOL, V26, P192, DOI 10.1037/0278-6133.26.2.192; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Khan MJ, 2005, CANCER-AM CANCER SOC, V104, P61, DOI 10.1002/cncr.21129; KINLEN LJ, 1978, LANCET, V2, P463; Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5; Kitchener HC, 2006, VACCINE, V24, P63, DOI 10.1016/j.vaccine.2006.05.113; Kiviat N B, 1992, IARC Sci Publ, P59; Kjaer S, 2006, CANCER RES, V66, P10630, DOI 10.1158/0008-5472.CAN-06-1057; Kovacic MB, 2006, CANCER RES, V66, P10112, DOI 10.1158/0008-5472.CAN-06-1812; Kreimer AR, 2006, CANCER EPIDEM BIOMAR, V15, P908, DOI 10.1158/1055-9965.EPI-05-0845; Kulasingam SL, 2006, JNCI-J NATL CANCER I, V98, P92, DOI 10.1093/jnci/djj009; KURMAN RJ, 1988, AM J OBSTET GYNECOL, V159, P293, DOI 10.1016/S0002-9378(88)80070-X; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lorincz AT, 2002, LANCET, V360, P228, DOI 10.1016/S0140-6736(02)09463-1; Malpica A, 2005, GYNECOL ONCOL, V99, pS38, DOI 10.1016/j.ygyno.2005.07.040; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; Mao C, 2006, OBSTET GYNECOL, V107, P18, DOI 10.1097/01.AOG.0000192397.41191.fb; Mendez F, 2005, J INFECT DIS, V192, P1158, DOI 10.1086/444391; Molden T, 2005, CANCER EPIDEM BIOMAR, V14, P367, DOI 10.1158/1055-9965.EPI-04-0410; Moscicki AB, 2001, JAMA-J AM MED ASSOC, V285, P2995, DOI 10.1001/jama.285.23.2995; Moscicki AB, 2004, LANCET, V364, P1678, DOI 10.1016/S0140-6736(04)17354-6; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Nardelli-Haefliger D, 2003, JNCI-J NATL CANCER I, V95, P1128, DOI 10.1093/jnci/djg018; Newall AT, 2007, LANCET INFECT DIS, V7, P289, DOI 10.1016/S1473-3099(07)70083-X; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Pagliusi SR, 2006, VACCINE, V24, P193, DOI 10.1016/j.vaccine.2006.06.016; Palefsky JM, 2006, VACCINE, V24, P140, DOI 10.1016/j.vaccine.2006.05.120; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Pirami L, 1997, J CLIN PATHOL, V50, P600, DOI 10.1136/jcp.50.7.600; Plante M, 2005, GYNECOL ONCOL, V98, P3, DOI 10.1016/j.ygyno.2005.04.014; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Pretorius Robert G, 2006, J Low Genit Tract Dis, V10, P5, DOI 10.1097/01.lgt.0000192694.85549.3d; Prokopczyk B, 1997, J NATL CANCER I, V89, P868, DOI 10.1093/jnci/89.12.868; Richardson H, 2003, CANCER EPIDEM BIOMAR, V12, P485; Richardson H, 2005, CANCER EPIDEM BIOMAR, V14, P1149, DOI 10.1158/1055-9965.EPI-04-0230; RICHART RM, 1969, AM J OBSTET GYNECOL, V105, P386, DOI 10.1016/0002-9378(69)90268-3; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Rodriguez AC, 2007, SEX TRANSM DIS, V34, P494, DOI 10.1097/01.olq.0000251241.03088.a0; Ronco G, 2007, BRIT MED J, V335, P28, DOI 10.1136/bmj.39196.740995.BE; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Ronco G, 2006, LANCET ONCOL, V7, P547, DOI 10.1016/S1470-2045(06)70731-8; ROSE RC, 1993, J VIROL, V67, P1936, DOI 10.1128/JVI.67.4.1936-1944.1993; Sangiva-Lugoma G, 2006, INT J CANCER, V119, P1389, DOI 10.1002/ijc.21972; Sankaranarayanan R, 2005, INT J CANCER, V116, P617, DOI 10.1002/ijc.21050; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Santos CL, 2004, INT J GYNECOL OBSTET, V87, P44, DOI 10.1016/j.ijgo.2004.06.014; Sarian LO, 2005, J MED SCREEN, V12, P142, DOI 10.1258/0969141054855328; Saslow D, 2007, CA-CANCER J CLIN, V57, P7, DOI 10.3322/canjclin.57.1.7; Sawaya GF, 2003, NEW ENGL J MED, V349, P1501, DOI 10.1056/NEJMoa035419; Schiffman M, 2005, NEW ENGL J MED, V353, P2101, DOI 10.1056/NEJMp058171; Schiffman M, 2005, J NATL CANCER I, V97, P147, DOI 10.1093/jnci/dji014; Schiffman M, 2000, ACTA CYTOL, V44, P726, DOI 10.1159/000328554; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schiffman M, 2005, AM J CLIN PATHOL, V124, P722, DOI 10.1309/E067X0L1U3CY37NW; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Schiller JT, 2006, VACCINE, V24, P147, DOI 10.1016/j.vaccine.2006.05.123; Seamans Yancy, 2006, BMC Womens Health, V6, P2, DOI 10.1186/1472-6874-6-2; Shepherd R., 2011, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD001035, DOI 10.1002/14651858.CD001035]; Sherman Mark E, 2003, J Natl Cancer Inst Monogr, P72; Sherman ME, 2005, CANCER-AM CANCER SOC, V103, P1258, DOI 10.1002/cncr.20877; Sherman ME, 2003, CANCER EPIDEM BIOMAR, V12, P1038; Sherman ME, 2003, CANCER EPIDEM BIOMAR, V12, P372; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Smith JS, 2003, LANCET, V361, P1159, DOI 10.1016/S0140-6736(03)12949-2; Smith JS, 2004, INT J CANCER, V111, P431, DOI 10.1002/ijc.20257; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Solomon D, 2007, CA-CANCER J CLIN, V57, P105, DOI 10.3322/canjclin.57.2.105; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Stoler MH, 2007, AM J CLIN PATHOL, V127, P1; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Szarewski A, 1996, LANCET, V347, P941, DOI 10.1016/S0140-6736(96)91417-8; Tavassoli FA, 2003, PATHOLOGY GENETICS T, P259; van Doorn LJ, 2002, J CLIN MICROBIOL, V40, P979, DOI 10.1128/JCM.40.3.979-983.2002; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Viscidi RP, 2004, CANCER EPIDEM BIOMAR, V13, P324, DOI 10.1158/1055-9965.EPI-03-0166; Walker JL, 2006, AM J OBSTET GYNECOL, V195, P341, DOI 10.1016/j.ajog.2006.02.047; Wang SS, 2003, BRIT J CANCER, V89, P1248, DOI 10.1038/sj.bjc.6601272; WANG SS, 2003, J NATL CANC I MONOGR, V31, P35, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003480; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; Wentzensen N, 2006, CANCER-AM CANCER SOC, V107, P2307, DOI 10.1002/cncr.22247; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Woodman CBJ, 2003, LANCET, V361, P40, DOI 10.1016/S0140-6736(03)12120-4; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8; Wright TC, 2003, NEW ENGL J MED, V348, P489, DOI 10.1056/NEJMp020178; Wright TC, 2001, AM J OBSTET GYNECOL, V184, P279, DOI 10.1067/mob.2001.108999; Ylitalo N, 2000, LANCET, V355, P2194, DOI 10.1016/S0140-6736(00)02402-8; 2005, CERVIX CANC SCREENIN	171	1843	1945	23	467	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2007	370	9590					890	907		10.1016/S0140-6736(07)61416-0	http://dx.doi.org/10.1016/S0140-6736(07)61416-0			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214JH	23618600				2022-12-28	WOS:000249733300033
